text,label,seq_length,text_4mer,text_5mer,text_6mer,text_7mer,annotation,orig_index
CTGTCG TGTCGG GTCGGC TCGGCG CGGCGG GGCGGT GCGGTC CGGTCG GGTCGA GTCGAA TCGAAA CGAAAC GAAACA AAACAC AACACT ACACTG CACTGG ACTGGG CTGGGA TGGGAT GGGATC GGATCG GATCGA ATCGAC TCGACC CGACCA GACCAC ACCACG CCACGG CACGGT ACGGTG CGGTGA GGTGAT GTGATC TGATCT GATCTG ATCTGC TCTGCT CTGCTC TGCTCC GCTCCG CTCCGA TCCGAC CCGACA CGACAA GACAAG ACAAGA CAAGAC AAGACC AGACCG GACCGG ACCGGC CCGGCA CGGCAC GGCACC GCACCT CACCTT ACCTTG CCTTGA CTTGAC TTGACC TGACCA GACCAT ACCATG CCATGA CATGAA ATGAAC TGAACC GAACCA AACCAG ACCAGA CCAGAT CAGATG AGATGA GATGAC ATGACC TGACCG GACCGC ACCGCC CCGCCC CGCCCG GCCCGG CCCGGG CCGGGC CGGGCT GGGCTG GGCTGG GCTGGC CTGGCT TGGCTG GGCTGG GCTGGT CTGGTT TGGTTT GGTTTG GTTTGC TTTGCC TTGCCG TGCCGG GCCGGG CCGGGC CGGGCA GGGCAG GGCAGG GCAGGG CAGGGT AGGGTT GGGTTT GGTTTT GTTTTT TTTTTC TTTTCG TTTCGG TTCGGT TCGGTC CGGTCA GGTCAG GTCAGC TCAGCG CAGCGG AGCGGC GCGGCG CGGCGA GGCGAG GCGAGG CGAGGG GAGGGC AGGGCT GGGCTA GGCTAT GCTATT CTATTC TATTCG ATTCGG TTCGGC TCGGCG CGGCGG GGCGGA GCGGAT CGGATG GGATGG GATGGG,2,142,CTGTGTGT GCT TGTGTGTCTC C G GTGTCTCGCG  TCTCGCGGGG G CCGGGGCGC C G GGGGCGCGCG G G GCGCGCGGGG GG TTTCGGGGTTGAT G GGGGTGTCTC C G GTGTCTCGCG G T TCC TCGAGA A C CGGAAAA A G GAGAAG CAA A A AAG AAACAC GG  AAAACCA C G ACACACACAC C CCACAT CT T A ACACTCTGCT G CCTGTGGGG G TTGGGGGGG G G GGGGGGGAGA A G GGGGAGATACTT G GAGATTC C A ATATCCACCG G T TCTCGCGAGA A C CGGA GACAC C G GAGACACCCC GG  ACACCCCACA A CCCACACCAGCACACG GGC TACGCGGGG G CACCCGGGGTGT T G GGTG G G GTAC TGAGA A TTGAAT T G GAGATATCGG C ACCCATCTCTT T TCTCTCTGTG G CG CCTGTGCGC TCG TGTGCGCTGAGT GA TGCTTT TC  CTCTCTCCCC C TGACCCGG C TTCCGCGAGA A CC AGACAC C G GAGACACACA AAG CTACACAAA C AGCAAAG G A AAA AAGAGA AGAGACCGAC G GACCAACCCC C A ACCCGCG G C CCCCGCGGG C CGCGGGGCGC  GGGGCCTTCA A G GCGCATCGGTGC C CACAC ATCC C ATTTA GTG T C CCCCTGCATT T C CTCTTTTGTG G TTTCTTGA GGGGA T TGTGAGACAC A A GAC GACCCC C AG CAG A C CCCCACATAT T C CACATATGTG G A ATATG CCGA  GCCA GAAAA CCT GAGAAAACC AAACACCCC C A ACACC TC TGTCGCCACAGA CAAA CAAC AGA GGCTCGATAT T G CTGATATGTG  TCAAGATGTGAA T TGTGAAC C G GAGACC A ACACCCCGCG  CCCCGGC GTT CGGCCCC C G GCGCCCT CC C C CCCCCCCGCG TGC CCCCGCGG CGCGGGGG GGGGGGGCGC C G GGGCT CGT G GCCTGTG G C CTCTGTGGG CG TTGGC GGC C G GGGGCGCTCT T G GCGCTCTGTG  GACTGTGGC AG TTGGGGTGT T G GGGGTC C GTGTTACC AGT T TTTTTTTGTG G T TTG CGC C T TGTGCGCCCC GAC GCGCCCCGCG G C CCCCGCGGGG G C CGCGGGA GG G GAC GGGGC GGC GGGGCGCACA A G GCGCACAGAG G C CACAGAGGGG G A AGAGGGGGGG CGGGGGGGTGT T G GGGGT CGTT T GC G TCTT T T TTCA T T TTTTT CGTT T T CATTTTTCTC C T TTTTCTCGG TTCGCGGGG  CGCGGGGTGT T G GGGGTGTCTC C G GTGTCTCACA A TTCACAG AC CCCAGAGCGC  CG CAGCGG GGCGCGGTTTG C CGGGCGC C G GGGGCGCGCG G G GCCGGCGAGA A C CGCGAGAGTC G G GACT AGGC CG A AGAGGGGGGG G G GGGGGGGC GC GT GGGGCCT T GGC GCTCTAGG  CTCTATATGCTT T TAATTTT T A ATATTTTC TT TTCG TTTAG GG G C CGCGGGGCGC C GCG GGCGCGCG G G GCGCGGG TA G CGTTGCGGGAGA TGA GGGGAT G GAGATAC TG AAA ATATGGG G T TGTGGGGG,G CGTCTC C TCTG GA TCCG G G GTGTCTCGCGAGG G T TCTCGGGCGC C CCGGGGCGCGCG G G GGGGCGCGCGGGG G GG CGCGCGGGT GG  CGTG GGTGTC ATC G GGGGTGTCTCGGG G G GTGTCTCGCGAGA TGTGAAAA A C CGCGAACCAAAAA A GC CTGGAACC A AAAACACACA A ATT AACACAGG AC  CG ACCAGCACACT GACTG CACACACTTG  ACACTCTGTGGGG G C CTCGATGGGGGGG G T TGTGGGGGGGAGA  GGGGAGATAT T G GGGGAGATATCTC C G GAATCG GGCC ATATCTCGCGAGA A T TCCGAAC CAT CGCTGGACACCTTT GAGACACCCCACA A AAC ACCCCACACAC  CCCCA CCACGCG G C CACACACGCGGGG G A ACCGGGGTGT T C CGCCGGGTGTGTG G G GG TCGTGTGAA G GTGTGTGA GCTC T T TGTGAGATATCTC C G GAGATATCTCTCT T AA GATC TGT GG T TCTCTCTGTGCGC GATTGCGCTT T TGTGCGCTCTCTC A A GCGCTCTCTCCCC C C CTCTCTCCCCGCG G TTCGTCCCGGGA CACCCGCGGGACAC C CC ACGAGACACACA A GCAGGACACACAAAA A A ACACACAAAAGAG G C CACAAAAGAGAGA C G AAAAGAGAGAC ACC A AGAGAGAGACCCC C GGACACCCCGCG CC CG ACCCCGCGGGG G C CCCCGGGCGC C C CGCGGGGCGCACA A G GGGGCGCAAC C G GCGCACACGAATTTC C CACACACCCGGGG C CACCGGTTATTT T C CGCTTTTGTG G C CTCTTTTG GGTT A T TTTTGTGACTGC T ATTGAACC TGC GTCGGACCCAGACA A ACACCCCACT AT T C CCGG CATATGG C CACATATGTGATTTA A TGGG GGG TGTGAGAAAACAC C G GAAACACCGGTC A AA GTACCCCACA A A ACACCCCACAGAG G C CCCCACAGAGAGA A C CAAGAGATAT T AAGAGATTG C C GAGATATGTGAGA  ATATGTGAAC C T TGTGAGACACCCT C G GACA ACCCCGCG G A ACACCCCGCGCGC C C CCCCGCGCG ACC  AC CGCGCGCCCCCG AC GGCCCCCCCG ACCAG CCCCGAAACG  CCCCGCGGGGGGG TGT CGCGGGGGGGCGC C G GGGGGGCTCT T G GGGGCGCT GCTG G G GCGCTCTGTGGTGGGGCGC C TCC TGGGGCGCTCT T G GGGGCGCTCTGTG TCGG TGCTCTGGAAGG G C CTCTGTGGGGTGT T T TG AGGGTGTTTT T G GGGGTGTTTTTGA GTTAACGTTTTTTTGTG G T TTGTT AATGCGC C TGAGTTGGCCCC GA  TGTGCGCCCCGCG G GAC GCCCCGCGGGG G C CCCCGCGGGG G C CGCGGGGGGGCGC ATT GGGGGGGCCA A G GGGGCG A GAAG GG  GCGCACAGAGGG GG C CAACAAGGGGGGG G ACC AGGGGTGT T G GGGGGGGTT GT G GGCC TTT CGTTGT G GTGTTTTTTTTTT T T TTTTTTTTCC TT T T TTGA CC TTCTC C TTTTTTCTCGCG GGG TTTCGCGGGACG TCGGGGTGAGT CTTTCGGGGTTC GATCCTGTCTCACA TC  GTGTCTCAG CAG  GC TCTCACAGAGCC C CAAGCGCGCG GCA AGAGCGCGCGGT C GCGCGCGGGGCGC G G GCGCGCG  GGGGCGCGCGAC TA G GCCGAGT AG G C CGCGAGC GGGTGAG G GACCAAGGGG G ATGGAGGGGGGGCGC C G GGGGGGGCGCTCT T G GGGGCGCTCTATA GGCGCTCTATATAT T C CTCTACTTC GTT T T TATATATTTTCAT C A ATATTTTCTCGG T TTTCGCGGGG G T TCTCGGC  CGCGGGGCGCGG GGGCGCGCGGCACG G GCGCGGGAG CA C CGCGGGATAT TG TGAGGAGATATGCT G G GAGATATGTGGGG G A ATATGTGGG T,ACATGTGTCTCGCG G TCTGCACGTCTCGCGGGG AC  GTGTCTCGCG GGCC T TCTCGCGGGCG GCG CGGTCGGGGCGCGCGGGG ACA GGGGCGCGCGGGGTGT T GGCGGGTGTCTC C C CGCGGGGTGTCTCGCG G G GGGGTGTCTCGCGAGA A G GTGTCTCGCGAGAAAA A TCTGTCGC AGAAAAAAA  CGCGAGAAAAAAACAC C G GAGAAAAAAAC TGCA  AAAAAAACACACACAC C A AAAACACACACACTGGC CC ACACACACG GTG G CTTTTGTACTCTGT TGG G A ACACTCTGTGGGGGGG G C CTTGATGGGGGGGAGGTA T TGGGGGGAGATAT T G GGGGAGATATCTC  GGGGAGATATCTCGCTCG G GAGATTCG ACGA A A ATATCTCGCGAGACGT C TTCGCGAGACACCCC C C CGCGAGACACCCCACA A GGACCCAAC C A ACAA GTTCACACGCG G C CCCCACACACGCGGGG TA CACACGCGGGGTGT T A ACACGCGGGGTGTGTG G CG CCGGTGAGA GG  GGGGTGTGTGAGATCGGT G GTGTGTGAAACAG TC C T TGTGAGATATCTCTCT T G GAGATATCTCTA CTG G A ATATCTCTCTGTGCGC C TTCTTGATGCGCTCT T C CTTTGTGCCTCC T TGACCCG TCCCC C GGG GCTCTCTCCCCGCG  CTT GTCCCCGCGAGA  TCTCCTTGT TCTGC C CCGGT ATGACACAG GGGC CGCGAGACACACAAAA A G GAGACACACAAAAGAG G AACCG GCAACCGCG GA A CCAAAAGAGAGACAC CGAAC AAGAGACC ACCCC C A AGAGAGACACCCCGCG G G GAACCCCGCGGG TG AA GCCGCGGGGCC CGCGCCGGCACA CCTCGGGGCGCAC GAC CAC GGGGCGAGCACACCCC C G GCGCACACACCCCTGG T C CAAT ACCA CCTTTT T A ACCCTCTTTTGTG G CT ACCTCTTCTGTGA CCA CCTTTTGTGATGGATTC T TTTTGTGAGACACCCC GCG TGCTGGACACCCCACA A G GAGACACC ACCATCACT ATGGCATATGTG G CGA CCA TTATGTTC CACATATGTGAGAAA ACGAATGTGAGAAAACAC C T TGGAAGATACCCC  GCGAAAACCCACA GC  AAAACACCCCACAG GTG A ACACCAT GCTAGAGA A G CCCCACAGAGAGATCCAG C CACAGAG GATATGTG G A AGAGAGATATGTGAGA GAT ACGACAC  ATATGTGAGACACCCC C T TGTGAGACACCCCGCG G G GAGACACCCCGCGCGC C AACCGAGCGCGACC C CCCGCGCCCCCCC C C CGCGCGCCGGCCG CA CG GCCCCCCCGCGG GAG CTCGCCCCCGCGGGG G CAGGCCGCGGGTTCCCA AC C CGC AGGGGGCGCTCT CTC GGGGCGCTCTGTG G GCGGGGCGCTCTGTGGGG G G GCGCTCTGCGAGGCGC C C CTCTGGACGGCGCTCT TGG TGGGCGCTTG G G GGCT GCTCTGTGGGG  GAGCTGCATGGGGTT C CTCTGTGGGGTGTTTT GAC TGTGGGGTCCATTTTT CCGGGTTTTTTGGC G G GTGTTTTTTTGTGCGC C T TT CATGCCC C T TTAAGTGCCCGG T TGTGCGCCCCGCGGGG G G GCGCCT GCGGGGGGG G C CCCCGCGGGGGGGCTG C TCGGGGGGGCCA A G GGGGGGGCGCACAGAGA GGATTGCACAG CCGG G G GCGCAGGCC CGGGATGG C CAACCAGGGGGGCTAC T A AGAGGGGGCCGGGGTT T G GGGGGC CTTTTT T G GGGGTGTTTTTTT T GATCTTTTTTTTTTT GCTTTTTTTTTTTTCTC  TTTTTTTTTTCTCGCG G T TTTTTTTCTCGT T GCG T TTTTCTCGCGGGGTGT  TCTCG GG CGGTCTC AGG CGCGGGGTGTCTCACA A G GGGGTGTCTCACAGAG G G GTGTCTCAAGCGC C T TCTCACAGAGC CCCG G CGGACAGAGCGCGCGGCT G A AGAGCC TCGGGGCGC C G GCGCGCGGGGCGGCCGGG C CGCGGGCGGCGCGAGA A G GGGGCGCGCGACTGAG G G GCGCGCGAAGGT C CGCGAGAGAGGGGGGG G G GAGAGAGGGGGGGCGC CGG AGAGGGGGCAGGCTCT T G GGGGGGGCCAT CAGC  GG TCGCTCTATATAT T G GCGCTCTATATT C CTCTATATATTTTCGGT TATATGGCTGATCGAGAG AGA TTCTCGCGGGG GG  TTTTCTCGCGGGC C T CCCGGGGCGCGGGA CA CGCGGGGCGCGAT GG G GGGCGCGCGGGGA AA GCGCGCGGGATAT T C CGCGGGGAGATATGTG G G GGG CGATATGTGGGG G GGATGGG,CTGC GTCGCGGTCTG TGATTGTGCTTCGCGGGGCGC C G GTGTCTCGCGGGCG GCG TAGAG GCGGGGCGCGCGGGG G C CGCGGGGCGCGCGGGGTGT T G GGCCAGCGT GGGTGTCTC C G GCGCGCGGGGTGTCTCGCG G CAA CGGGGTGTCTCGGA A GG GGTCTCGCGAGAAAA A GCC GTCTCGCCGAAAAA A T TCTCGCGAGAAAAAAACAC C C CGCGAGAAAAAAACACACA A GAACGAAAAAAACACAC TAC C A AAAAAAACACACACACTCT T A AAAACACACACACTCTGTG  CATGGCACACTCTGTGGGG G CGCACACACTCTGTGGGGGGG G GCTGTGGGGAGA GGA CTCGGTGGGGGGGAGATAT T T TGTGGGGGGGAGGCATCTC C G GGGGGGGACT C GTCGCG G G GGGATATCGG A G GAGATCAGGACCGAGACTGC ATAT GTTGACACCC TGGACGAGACACCCCAGAAA C CGCGAGACACCCCACACAC TCGACCCCACACACGCG G A ACACCCCACACACG CCGG G C CCCACACGGGTGT GG CACACGCGGGGTGTGTG G AC ACAGCGGGGTGTGTGAGA A CGGTGTGTGAGATAT CTT GGGGTGTGTGAGATATTTC C G GTGTGTGAGATATCCT T T TGACCC TATCTCTGGTTG G G GAGATATCGG CTGTGCGC C A ATACCTCTCTGCGGGCTGATT T TCTCTTGCGCTCTCTC C CAGG ACGCTCTCTCCCC  TGTGCGCTCTCTCCCCGGCTG G GGGTCCTCTCCCCGCG GA A C CTCTCAGACCGCGAGACAC C T TCTCCTGACGAGACACACA A C CCCCGCGAGACACACAA CG CG TCGACACACAAAAGAG G G GAGACACACAAAAG TCGA A A ACACACAAAAGAGAGACAC C C CACAAAAGAGAGACACCCC C A AAAAGAGAGACACC GGCG  AGTCCGACACCC GGCTGG G G GAGACACCCCGGGCGC C A ACCCGCTGGGCGCACA A CCGGCCGCGGGGCGCACACAC C C CGCGGGGCCACCA C GCCGGGCGA CACACCCCTGGTT GGG TT ACCCCTCTTTT T C CACACACCCCTGATTTGG A ACCCTTTGTGAGA A C CCCCTTTGTGAGACC C CTGACTTGCCGACCCC C T TTTTGTGAT GACCCCACA A TACCG TGACACCCCACATAT T G GAGACCCACATATGTG G A ACATCCATATGTGAGA A C TTCCACATATGTGAGAAAA A C CAATGTGAAACAC C A ATATGG TGCTAACACCCC GAT TGTGAGAAAACTGAGGCCA A G GAGATACCCCACAGAG G AACCCCACAGAGAGA A AA AACCCCACAGAGAAT T C CCGC CAGAGAGATGGGTG G C ACCAGAGAGATGTTCGACGG AC AGGATATGTGAGACAC GATC TTGAGACACCCTGC A ATATGGTTC TCCG TGTGAACCCCGCGCGC C G GAGACACCCCGCGCGCCCC C AACCCCGCGCGCCCGGCC C C CCCCGCGCGCCCCCCG G C CGG TGCCCCCCCGCGGGG GTT GCGCCTC CCGCGGGGGGG G C CCCCCCCGCGGGGGGGCCCAC C CCCCGCGGGGGGGCGCTT C GAGGGGGCGCTCTGTG G G GGGGGCAGGCTCTGT CG G GGGGC GCTGGGGCGGGGTC GCCG CTGTGGGGCGCTCT T CTGGGGCGCTTTTTG G T TGGC GGCCGGCTGTGGGG G G GGGCTCTGACAGGTGT CGGCGAGCTCTGGGTT CGGCGATGGTTCGTTTTT TCGTGGCT GTTTTTTTGTG G G GGGGTGTTTTTTTGTGCTGGCCG GTGTTTTTTTGTGCC T GTGCC CCTTTTTGTGCGCCGAACG TGA TTTTGTGCGCCCCGCGGCGAG TTGCGCCCCGCGGGGGGG G G GCGCCCCGCGGGGCGC C C CCCCGCGGGGGGGCGCACA  CGCGG GTGGCGCAGGCAG  GG GGGGCGCACAGGG G G GGGGCTTTCAGGCAGGGGG CTG CTGCACAGTTCGGTGGTGT T CCAGAGGCACGGTATGT A AGAGGGGGGGTGTT CATT T G GGGGGG GGTTTTTTTTTT T G GCTTTTGATTTTTTTT T GTCGTTTCC TTTTTCGGCC T TTTTTTTTTTCT TCG TGA TTTTTTTTTTCTCGGA GG G T TTTTTTTCTCGCGGGT T T TTTTCTCGCGGGC GTCTC ATGTGCTCGCGGGGTGTCTCACA A C CGCGGGGTGTCTCAACGAG  GGGGTGTCTCACAGGC C G GTGTCATCAGCGCGCG CGC TCTCACAGGCGCGGG C CACAGAGCGCGGGCGC GCGGGCGCGCG G GCTGGCGCGGGGCGCGTGAGA A C CGCGGGGCCGAAG  ACACTGGCGCGAGGGG  GCGCGCGAGAGAGGGGGGG G C CGCGAGAGAGGGGGGGCGC  GAGAGAGGGGGCGAGCTCT T A AGCTGGGGGGCGCTCTATA A G GGGGGGGCCTATATATCT G GGTC GCTCTATATATTTT  GCGCTCTATATATTCCCC C CTCTAATTTTCTCGG T TATATATCTTCCGGGG G A ATATTTTCTCGCGGCGGGC ATG TTAGGTCGCGGGGCGCGCG G T TCTCGCGGGGCGCGCGG CGCGGGGCGCGCGG TCGGGA GGGCCGG TGAT T G GCGCGCGGGGATGGTG G C CGCGGGGAGATATGTGGGG  GGGGAGATATGTGGGGG,"ID   ATA1_SYNY3              Reviewed;         905 AA.
AC   P37367; P73840;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   05-FEB-2025, entry version 171.
DE   RecName: Full=Cation-transporting ATPase pma1;
DE            EC=7.2.2.-;
GN   Name=pma1; OrderedLocusNames=sll1614;
OS   Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa).
OC   Bacteria; Bacillati; Cyanobacteriota; Cyanophyceae; Synechococcales;
OC   Merismopediaceae; Synechocystis.
OX   NCBI_TaxID=1111708;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8263933; DOI=10.1006/jmbi.1993.1684;
RA   Geisler M., Richter J., Schumann J.;
RT   ""Molecular cloning of a P-type ATPase gene from the cyanobacterium
RT   Synechocystis sp. PCC 6803. Homology to eukaryotic Ca(2+)-ATPases."";
RL   J. Mol. Biol. 234:1284-1289(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 27184 / PCC 6803 / Kazusa;
RX   PubMed=8905231; DOI=10.1093/dnares/3.3.109;
RA   Kaneko T., Sato S., Kotani H., Tanaka A., Asamizu E., Nakamura Y.,
RA   Miyajima N., Hirosawa M., Sugiura M., Sasamoto S., Kimura T., Hosouchi T.,
RA   Matsuno A., Muraki A., Nakazaki N., Naruo K., Okumura S., Shimpo S.,
RA   Takeuchi C., Wada T., Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   ""Sequence analysis of the genome of the unicellular cyanobacterium
RT   Synechocystis sp. strain PCC6803. II. Sequence determination of the entire
RT   genome and assignment of potential protein-coding regions."";
RL   DNA Res. 3:109-136(1996).
CC   -!- FUNCTION: Could mediate calcium influx.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIA subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X71022; CAA50340.1; -; Genomic_DNA.
DR   EMBL; BA000022; BAA17897.1; -; Genomic_DNA.
DR   PIR; S75035; S75035.
DR   AlphaFoldDB; P37367; -.
DR   SMR; P37367; -.
DR   IntAct; P37367; 51.
DR   STRING; 1148.gene:10498766; -.
DR   TCDB; 3.A.3.2.4; the p-type atpase (p-atpase) superfamily.
DR   PaxDb; 1148-1652980; -.
DR   EnsemblBacteria; BAA17897; BAA17897; BAA17897.
DR   KEGG; syn:sll1614; -.
DR   eggNOG; COG0474; Bacteria.
DR   InParanoid; P37367; -.
DR   PhylomeDB; P37367; -.
DR   Proteomes; UP000001425; Chromosome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0005388; F:P-type calcium transporter activity; IBA:GO_Central.
DR   CDD; cd02080; P-type_ATPase_cation; 1.
DR   FunFam; 3.40.50.1000:FF:000028; Calcium-transporting P-type ATPase, putative; 1.
DR   FunFam; 3.40.1110.10:FF:000094; Cation-transporting P-type ATPase; 1.
DR   FunFam; 3.40.50.1000:FF:000001; Phospholipid-transporting ATPase IC; 1.
DR   FunFam; 2.70.150.10:FF:000160; Sarcoplasmic/endoplasmic reticulum calcium ATPase 1; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR050510; Cation_transp_ATPase_P-type.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01494; ATPase_P-type; 3.
DR   PANTHER; PTHR43294:SF20; P-TYPE ATPASE; 1.
DR   PANTHER; PTHR43294; SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00120; HATPASE.
DR   SFLD; SFLDS00003; Haloacid_Dehalogenase; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell membrane; Magnesium; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Translocase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..905
FT                   /note=""Cation-transporting ATPase pma1""
FT                   /id=""PRO_0000046178""
FT   TRANSMEM        60..80
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        81..101
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        248..268
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        283..303
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        716..736
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        774..794
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        809..829
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        848..868
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        880..900
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   ACT_SITE        333
FT                   /note=""4-aspartylphosphate intermediate""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        1..34
FT                   /note=""MDFPTLSSYLHHHRPGEDILADLHTDPGLGLTAE -> MGAFPLPPNQYGFP
FT                   HLKFLPPSPSTRGRHSCRFAHRSRFRSDSG (in Ref. 1; CAA50340)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        288
FT                   /note=""A -> G (in Ref. 1; CAA50340)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        897
FT                   /note=""A -> R (in Ref. 1; CAA50340)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   905 AA;  97590 MW;  0E438F17DE581D61 CRC64;
     MDFPTLSSYL HHHRPGEDIL ADLHTDPGLG LTAEAVAQRY EQYGRNELKF KPGKPAWLRF
     LLQFHQPLLY ILLIAGTVKA FLGSWTNAWV IWGVTLVNAI IGYIQEAKAE GAIASLAKAV
     TTEATVLRDG QNLRIPSQDL VIGDIVSLAS GDKVPADLRL LKVRNLQVDE SALTGEAVPV
     EKAVELLPEE TPLAERLNMA YAGSFVTFGQ GTGVVVATAN ATEMGQISQS MEKQVSLMTP
     LTRKFAKFSH TLLYVIVTLA AFTFAVGWGR GGSPLEMFEA AVALAVSAIP EGLPAVVTVT
     LAIGVNRMAK RNAIIRKLPA VEALGSATVV CSDKTGTLTE NQMTVQAVYA GGKHYEVSGG
     GYSPKGEFWQ VMGEEVDNVL LDGLPPVLEE CLLTGMLCND SQLEHRGDDW AVVGDPTEGA
     LLASAAKAGF SQAGLASQKP RLDSIPFESD YQYMATLHDG DGRTIYVKGS VESLLQRCES
     MLLDDGQMVS IDRGEIEENV EDMAQQGLRV LAFAKKTVEP HHHAIDHGDI ETGLIFLGLQ
     GMIDPPRPEA IAAVHACHDA GIEVKMITGD HISTAQAIAK RMGIAAEGDG IAFEGRQLAT
     MGPAELAQAA EDSCVFARVA PAQKLQLVEA LQEKGHIVAM TGDGVNDAPA LKRADIGIAM
     GKGGTEVARE SSDMLLTDDN FASIEAAVEE GRTVYQNLRK AIAFLLPVNG GESMTILISV
     LLALNLPILS LQVLWLNMIN SITMTVPLAF EAKSPGIMQQ APRNPNEPLI TKKLLHRILL
     VSLFNWILIF GMFEWVNRTY DDLALARTMA IQALVAARVI YLLSISQLGR SFLGYVTGKR
     QTITKASILL LGIAVAIALQ IGFSQLPFMN VLFKTAPMDW QQWAICLLPM IPMVPVAILA
     NRLDP
//
",3884
GGCTTC GCTTCG CTTCGC TTCGCC TCGCCG CGCCGG GCCGGC CCGGCG CGGCGG GGCGGC GCGGCA CGGCAC GGCACG GCACGT CACGTC ACGTCG CGTCGA GTCGAA TCGAAT CGAATC GAATCG AATCGC ATCGCG TCGCGG CGCGGG GCGGGG CGGGGC GGGGCC GGGCCA GGCCAT GCCATG CCATGT CATGTT ATGTTC TGTTCA GTTCAT TTCATC TCATCA CATCAG ATCAGC TCAGCC CAGCCT AGCCTG GCCTGA CCTGAA CTGAAG TGAAGC GAAGCC AAGCCG AGCCGC GCCGCC CCGCCG CGCCGG GCCGGA CCGGAG CGGAGG GGAGGA GAGGAG AGGAGC GGAGCG GAGCGC AGCGCG GCGCGG CGCGGT GCGGTG CGGTGG GGTGGC GTGGCG TGGCGT GGCGTG GCGTGT CGTGTC GTGTCG TGTCGA GTCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGG GGCGGA GCGGAC CGGACG GGACGT GACGTG ACGTGA CGTGAT GTGATC TGATCG GATCGA ATCGAC TCGACC CGACCG GACCGG ACCGGT CCGGTT CGGTTG GGTTGC GTTGCG TTGCGC TGCGCC GCGCCG CGCCGG GCCGGG CCGGGC CGGGCG GGGCGC GGCGCT GCGCTT CGCTTT GCTTTA CTTTAT TTTATC TTATCC TATCCG ATCCGG TCCGGT CCGGTG CGGTGC GGTGCC GTGCCG TGCCGG GCCGGG CCGGGC CGGGCA GGGCAT GGCATC GCATCC CATCCG ATCCGT TCCGTC CCGTCT CGTCTT GTCTTT TCTTTT CTTTTC TTTTCA TTTCAT TTCATG TCATGT CATGTT ATGTTT TGTTTG GTTTGC TTTGCG,2,145,GGCT GCTT CTTC TTCG TCGC CGCC GCCG CCGG CGGC GGCG GCGG CGGC GGCA GCAC CACG ACGT CGTC GTCG TCGA CGAA GAAT AATC ATCG TCGC CGCG GCGG CGGG GGGG GGGC GGCC GCCA CCAT CATG ATGT TGTT GTTC TTCA TCAT CATC ATCA TCAG CAGC AGCC GCCT CCTG CTGA TGAA GAAG AAGC AGCC GCCG CCGC CGCC GCCG CCGG CGGA GGAG GAGG AGGA GGAG GAGC AGCG GCGC CGCG GCGG CGGT GGTG GTGG TGGC GGCG GCGT CGTG GTGT TGTC GTCG TCGA CGAC GACG ACGG CGGC GGCG GCGG CGGA GGAC GACG ACGT CGTG GTGA TGAT GATC ATCG TCGA CGAC GACC ACCG CCGG CGGT GGTT GTTG TTGC TGCG GCGC CGCC GCCG CCGG CGGG GGGC GGCG GCGC CGCT GCTT CTTT TTTA TTAT TATC ATCC TCCG CCGG CGGT GGTG GTGC TGCC GCCG CCGG CGGG GGGC GGCA GCAT CATC ATCC TCCG CCGT CGTC GTCT TCTT CTTT TTTT TTTC TTCA TCAT CATG ATGT TGTT GTTT TTTG TTGC TGCG,GGCTT GCTTC CTTCG TTCGC TCGCC CGCCG GCCGG CCGGC CGGCG GGCGG GCGGC CGGCA GGCAC GCACG CACGT ACGTC CGTCG GTCGA TCGAA CGAAT GAATC AATCG ATCGC TCGCG CGCGG GCGGG CGGGG GGGGC GGGCC GGCCA GCCAT CCATG CATGT ATGTT TGTTC GTTCA TTCAT TCATC CATCA ATCAG TCAGC CAGCC AGCCT GCCTG CCTGA CTGAA TGAAG GAAGC AAGCC AGCCG GCCGC CCGCC CGCCG GCCGG CCGGA CGGAG GGAGG GAGGA AGGAG GGAGC GAGCG AGCGC GCGCG CGCGG GCGGT CGGTG GGTGG GTGGC TGGCG GGCGT GCGTG CGTGT GTGTC TGTCG GTCGA TCGAC CGACG GACGG ACGGC CGGCG GGCGG GCGGA CGGAC GGACG GACGT ACGTG CGTGA GTGAT TGATC GATCG ATCGA TCGAC CGACC GACCG ACCGG CCGGT CGGTT GGTTG GTTGC TTGCG TGCGC GCGCC CGCCG GCCGG CCGGG CGGGC GGGCG GGCGC GCGCT CGCTT GCTTT CTTTA TTTAT TTATC TATCC ATCCG TCCGG CCGGT CGGTG GGTGC GTGCC TGCCG GCCGG CCGGG CGGGC GGGCA GGCAT GCATC CATCC ATCCG TCCGT CCGTC CGTCT GTCTT TCTTT CTTTT TTTTC TTTCA TTCAT TCATG CATGT ATGTT TGTTT GTTTG TTTGC TTGCG,GGCTTC GCTTCG CTTCGC TTCGCC TCGCCG CGCCGG GCCGGC CCGGCG CGGCGG GGCGGC GCGGCA CGGCAC GGCACG GCACGT CACGTC ACGTCG CGTCGA GTCGAA TCGAAT CGAATC GAATCG AATCGC ATCGCG TCGCGG CGCGGG GCGGGG CGGGGC GGGGCC GGGCCA GGCCAT GCCATG CCATGT CATGTT ATGTTC TGTTCA GTTCAT TTCATC TCATCA CATCAG ATCAGC TCAGCC CAGCCT AGCCTG GCCTGA CCTGAA CTGAAG TGAAGC GAAGCC AAGCCG AGCCGC GCCGCC CCGCCG CGCCGG GCCGGA CCGGAG CGGAGG GGAGGA GAGGAG AGGAGC GGAGCG GAGCGC AGCGCG GCGCGG CGCGGT GCGGTG CGGTGG GGTGGC GTGGCG TGGCGT GGCGTG GCGTGT CGTGTC GTGTCG TGTCGA GTCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGG GGCGGA GCGGAC CGGACG GGACGT GACGTG ACGTGA CGTGAT GTGATC TGATCG GATCGA ATCGAC TCGACC CGACCG GACCGG ACCGGT CCGGTT CGGTTG GGTTGC GTTGCG TTGCGC TGCGCC GCGCCG CGCCGG GCCGGG CCGGGC CGGGCG GGGCGC GGCGCT GCGCTT CGCTTT GCTTTA CTTTAT TTTATC TTATCC TATCCG ATCCGG TCCGGT CCGGTG CGGTGC GGTGCC GTGCCG TGCCGG GCCGGG CCGGGC CGGGCA GGGCAT GGCATC GCATCC CATCCG ATCCGT TCCGTC CCGTCT CGTCTT GTCTTT TCTTTT CTTTTC TTTTCA TTTCAT TTCATG TCATGT CATGTT ATGTTT TGTTTG GTTTGC TTTGCG,GGCTTCG GCTTCGC CTTCGCC TTCGCCG TCGCCGG CGCCGGC GCCGGCG CCGGCGG CGGCGGC GGCGGCA GCGGCAC CGGCACG GGCACGT GCACGTC CACGTCG ACGTCGA CGTCGAA GTCGAAT TCGAATC CGAATCG GAATCGC AATCGCG ATCGCGG TCGCGGG CGCGGGG GCGGGGC CGGGGCC GGGGCCA GGGCCAT GGCCATG GCCATGT CCATGTT CATGTTC ATGTTCA TGTTCAT GTTCATC TTCATCA TCATCAG CATCAGC ATCAGCC TCAGCCT CAGCCTG AGCCTGA GCCTGAA CCTGAAG CTGAAGC TGAAGCC GAAGCCG AAGCCGC AGCCGCC GCCGCCG CCGCCGG CGCCGGA GCCGGAG CCGGAGG CGGAGGA GGAGGAG GAGGAGC AGGAGCG GGAGCGC GAGCGCG AGCGCGG GCGCGGT CGCGGTG GCGGTGG CGGTGGC GGTGGCG GTGGCGT TGGCGTG GGCGTGT GCGTGTC CGTGTCG GTGTCGA TGTCGAC GTCGACG TCGACGG CGACGGC GACGGCG ACGGCGG CGGCGGA GGCGGAC GCGGACG CGGACGT GGACGTG GACGTGA ACGTGAT CGTGATC GTGATCG TGATCGA GATCGAC ATCGACC TCGACCG CGACCGG GACCGGT ACCGGTT CCGGTTG CGGTTGC GGTTGCG GTTGCGC TTGCGCC TGCGCCG GCGCCGG CGCCGGG GCCGGGC CCGGGCG CGGGCGC GGGCGCT GGCGCTT GCGCTTT CGCTTTA GCTTTAT CTTTATC TTTATCC TTATCCG TATCCGG ATCCGGT TCCGGTG CCGGTGC CGGTGCC GGTGCCG GTGCCGG TGCCGGG GCCGGGC CCGGGCA CGGGCAT GGGCATC GGCATCC GCATCCG CATCCGT ATCCGTC TCCGTCT CCGTCTT CGTCTTT GTCTTTT TCTTTTC CTTTTCA TTTTCAT TTTCATG TTCATGT TCATGTT CATGTTT ATGTTTG TGTTTGC GTTTGCG,"ID   MDTC_EDWI9              Reviewed;        1026 AA.
AC   C5BHN3;
DT   16-NOV-2011, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 1.
DT   05-FEB-2025, entry version 82.
DE   RecName: Full=Multidrug resistance protein MdtC {ECO:0000255|HAMAP-Rule:MF_01424};
DE   AltName: Full=Multidrug transporter MdtC {ECO:0000255|HAMAP-Rule:MF_01424};
GN   Name=mdtC {ECO:0000255|HAMAP-Rule:MF_01424};
GN   OrderedLocusNames=NT01EI_1169;
OS   Edwardsiella ictaluri (strain 93-146).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Hafniaceae; Edwardsiella.
OX   NCBI_TaxID=634503;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=93-146;
RA   Williams M.L., Gillaspy A.F., Dyer D.W., Thune R.L., Waldbieser G.C.,
RA   Schuster S.C., Gipson J., Zaitshik J., Landry C., Lawrence M.L.;
RT   ""Complete genome sequence of Edwardsiella ictaluri 93-146."";
RL   Submitted (MAR-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBUNIT: Part of a tripartite efflux system composed of MdtA, MdtB and
CC       MdtC. MdtC forms a heteromultimer with MdtB. {ECO:0000255|HAMAP-
CC       Rule:MF_01424}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01424}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01424}.
CC   -!- SIMILARITY: Belongs to the resistance-nodulation-cell division (RND)
CC       (TC 2.A.6) family. MdtC subfamily. {ECO:0000255|HAMAP-Rule:MF_01424}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001600; ACR68377.1; -; Genomic_DNA.
DR   RefSeq; WP_015870552.1; NC_012779.2.
DR   AlphaFoldDB; C5BHN3; -.
DR   SMR; C5BHN3; -.
DR   STRING; 67780.B6E78_16165; -.
DR   GeneID; 69538196; -.
DR   KEGG; eic:NT01EI_1169; -.
DR   PATRIC; fig|634503.3.peg.1059; -.
DR   HOGENOM; CLU_002755_1_2_6; -.
DR   OrthoDB; 9757904at2; -.
DR   Proteomes; UP000001485; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:TreeGrafter.
DR   FunFam; 1.20.1640.10:FF:000001; Efflux pump membrane transporter; 1.
DR   FunFam; 3.30.70.1430:FF:000001; Efflux pump membrane transporter; 1.
DR   Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR   Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR   Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR   Gene3D; 3.30.2090.10; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR   HAMAP; MF_01424; MdtC; 1.
DR   InterPro; IPR027463; AcrB_DN_DC_subdom.
DR   InterPro; IPR001036; Acrflvin-R.
DR   InterPro; IPR023931; Multidrug-R_MdtC.
DR   PANTHER; PTHR32063; -; 1.
DR   PANTHER; PTHR32063:SF34; MULTIDRUG RESISTANCE PROTEIN MDTC; 1.
DR   Pfam; PF00873; ACR_tran; 1.
DR   PRINTS; PR00702; ACRIFLAVINRP.
DR   SUPFAM; SSF82693; Multidrug efflux transporter AcrB pore domain, PN1, PN2, PC1 and PC2 subdomains; 4.
DR   SUPFAM; SSF82714; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Membrane; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1026
FT                   /note=""Multidrug resistance protein MdtC""
FT                   /id=""PRO_0000414033""
FT   TRANSMEM        16..36
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        333..353
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        360..380
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        387..407
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        435..455
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        459..479
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        528..548
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        853..873
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        897..917
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        953..973
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
FT   TRANSMEM        984..1004
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01424""
SQ   SEQUENCE   1026 AA;  110510 MW;  DA954A51D0FB5932 CRC64;
     MSGFALFINR PVATSLLALA ITLVGLLGLR LLPVAPLPQV DFPVIMVSAS LPGASAETMA
     ASVAMPLERA LGRIAGVNEM TSSSSLGTTR IILQFNLDRN IDGAARDVQA ALNAAQSLLP
     SGMPSRPSYR KANPSDAPIA ILTLTSAQYS QGDLYDLAST RLAQKIAQIN GVGDVSVSGS
     SLPAVRIDLN PDALFNQGTS LDTVRQAIAS ANVRRPLGAV ADDGRRWQVQ SNDALMTAQE
     YRPLIIRYRD GAPLRLQDVA RISDGVEDVR NAGMSNGQPA ILIMIRRSAD ANIIETVDRL
     RSDLPALQAL LPGGVSLDIA QDRTPTIRAS LREVEQSLAI AIALVILVVF LFLRSARATL
     IPAVTVPVSL IGTCAAIYLC GFSLNNLSLM ALTIASGFVV DDAIVVLENI ARHIEDGLSP
     HRAALAGVRE VGFTVFSISL SLAAVFIPLL FMGGIPGRLF HEFAITLSAS IAISLLIALT
     LTPMMCARLL RPRHTDGGMR PTALRRLSAL LQRGYALSLN WTLDHARWVL LTLLAVIGLN
     IWLYISIPKT FFPQQDTGRL MGFIQADQSI SFQAMRGKLQ DFMHIVRADP DVDNVTGFTG
     GTRVNSGMMF IALKPLGERK QDAQQVIARL RTRLSHEPGA NLFLMAVQDI RAGGRQGNAS
     YQYTLLSDDL AVLRHWEPQV RKALAALPQL TDVSTDQQDK GTEMLLTYDR PAMARLGIKV
     SEVNTLLSNA FGQRQISTLY QPLNQYHVVM EVDPRYAQDE RALDKMFIIN QAGQPIPLSG
     FASWLPANAP LSVNHQGLSA AATISFNLPP GGSLSDASDA IAHAMTALGT PPSLRGTFAG
     TALLFQQAQS SQLLLILAAI ATVYIVLGIL YESYIHPLTI LSTLPSAGVG ALLALMLFNA
     PFSLIALIGI MLLIGLVKKN AILLVDFALT AEREQHLSAR DAIYQACLLR FRPILMTTLA
     ALFGALPLAF SYGDGAELRQ PLGITIVGGL LVSQILTLYT TPVVYLYMEK LRARFSRQKA
     LPPLAY
//
",23548
TATGAA ATGAAC TGAACT GAACTT AACTTA ACTTAA CTTAAG TTAAGC TAAGCA AAGCAT AGCATG GCATGG CATGGT ATGGTA TGGTAC GGTACA GTACAT TACATT ACATTT CATTTA ATTTAC TTTACT TTACTT TACTTG ACTTGT CTTGTG TTGTGC TGTGCT GTGCTA TGCTAG GCTAGT CTAGTG TAGTGA AGTGAG GTGAGT TGAGTA GAGTAC AGTACA GTACAC TACACT ACACTG CACTGG ACTGGT CTGGTA TGGTAA GGTAAT GTAATT TAATTA AATTAC ATTACC TTACCA TACCAG ACCAGT CCAGTG CAGTGT AGTGTG GTGTGG TGTGGT GTGGTC TGGTCA GGTCAC GTCACT TCACTA CACTAT ACTATA CTATAA TATAAA,0,67,TATG ATGA TGAA GAAC AACT ACTT CTTA TTAA TAAG AAGC AGCA GCAT CATG ATGG TGGT GGTA GTAC TACA ACAT CATT ATTT TTTA TTAC TACT ACTT CTTG TTGT TGTG GTGC TGCT GCTA CTAG TAGT AGTG GTGA TGAG GAGT AGTA GTAC TACA ACAC CACT ACTG CTGG TGGT GGTA GTAA TAAT AATT ATTA TTAC TACC ACCA CCAG CAGT AGTG GTGT TGTG GTGG TGGT GGTC GTCA TCAC CACT ACTA CTAT TATA ATAA TAAA,TATGA ATGAA TGAAC GAACT AACTT ACTTA CTTAA TTAAG TAAGC AAGCA AGCAT GCATG CATGG ATGGT TGGTA GGTAC GTACA TACAT ACATT CATTT ATTTA TTTAC TTACT TACTT ACTTG CTTGT TTGTG TGTGC GTGCT TGCTA GCTAG CTAGT TAGTG AGTGA GTGAG TGAGT GAGTA AGTAC GTACA TACAC ACACT CACTG ACTGG CTGGT TGGTA GGTAA GTAAT TAATT AATTA ATTAC TTACC TACCA ACCAG CCAGT CAGTG AGTGT GTGTG TGTGG GTGGT TGGTC GGTCA GTCAC TCACT CACTA ACTAT CTATA TATAA ATAAA,TATGAA ATGAAC TGAACT GAACTT AACTTA ACTTAA CTTAAG TTAAGC TAAGCA AAGCAT AGCATG GCATGG CATGGT ATGGTA TGGTAC GGTACA GTACAT TACATT ACATTT CATTTA ATTTAC TTTACT TTACTT TACTTG ACTTGT CTTGTG TTGTGC TGTGCT GTGCTA TGCTAG GCTAGT CTAGTG TAGTGA AGTGAG GTGAGT TGAGTA GAGTAC AGTACA GTACAC TACACT ACACTG CACTGG ACTGGT CTGGTA TGGTAA GGTAAT GTAATT TAATTA AATTAC ATTACC TTACCA TACCAG ACCAGT CCAGTG CAGTGT AGTGTG GTGTGG TGTGGT GTGGTC TGGTCA GGTCAC GTCACT TCACTA CACTAT ACTATA CTATAA TATAAA,TATGAAC ATGAACT TGAACTT GAACTTA AACTTAA ACTTAAG CTTAAGC TTAAGCA TAAGCAT AAGCATG AGCATGG GCATGGT CATGGTA ATGGTAC TGGTACA GGTACAT GTACATT TACATTT ACATTTA CATTTAC ATTTACT TTTACTT TTACTTG TACTTGT ACTTGTG CTTGTGC TTGTGCT TGTGCTA GTGCTAG TGCTAGT GCTAGTG CTAGTGA TAGTGAG AGTGAGT GTGAGTA TGAGTAC GAGTACA AGTACAC GTACACT TACACTG ACACTGG CACTGGT ACTGGTA CTGGTAA TGGTAAT GGTAATT GTAATTA TAATTAC AATTACC ATTACCA TTACCAG TACCAGT ACCAGTG CCAGTGT CAGTGTG AGTGTGG GTGTGGT TGTGGTC GTGGTCA TGGTCAC GGTCACT GTCACTA TCACTAT CACTATA ACTATAA CTATAAA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",34592
AGTTTA GTTTAA TTTAAC TTAACA TAACAA AACAAG ACAAGA CAAGAA AAGAAG AGAAGA GAAGAT AAGATT AGATTT GATTTT ATTTTT TTTTTT TTTTTG TTTTGA TTTGAA TTGAAG TGAAGA GAAGAT AAGATA AGATAA GATAAA ATAAAG TAAAGG AAAGGC AAGGCT AGGCTT GGCTTC GCTTCT CTTCTT TTCTTA TCTTAG CTTAGA TTAGAA TAGAAG AGAAGT GAAGTT AAGTTG AGTTGA GTTGAA TTGAAA TGAAAC GAAACT AAACTC AACTCC ACTCCA CTCCAA TCCAAT CCAATG CAATGA AATGAT ATGATG TGATGC GATGCA ATGCAT TGCATC GCATCC CATCCA ATCCAA TCCAAT CCAATT CAATTG AATTGC ATTGCA TTGCAG TGCAGG GCAGGT CAGGTG AGGTGG GGTGGG GTGGGG TGGGGC GGGGCA GGGCAA GGCAAA GCAAAT CAAATG AAATGC AATGCA ATGCAA TGCAAA GCAAAA CAAAAC AAAACC AAACCA AACCAT ACCATT CCATTT CATTTG ATTTGT TTTGTT TTGTTA TGTTAC GTTACA TTACAC TACACA ACACAT CACATC ACATCA CATCAT,3,103,AGTT GTTT TTTA TTAA TAAC AACA ACAA CAAG AAGA AGAA GAAG AAGA AGAT GATT ATTT TTTT TTTT TTTT TTTG TTGA TGAA GAAG AAGA AGAT GATA ATAA TAAA AAAG AAGG AGGC GGCT GCTT CTTC TTCT TCTT CTTA TTAG TAGA AGAA GAAG AAGT AGTT GTTG TTGA TGAA GAAA AAAC AACT ACTC CTCC TCCA CCAA CAAT AATG ATGA TGAT GATG ATGC TGCA GCAT CATC ATCC TCCA CCAA CAAT AATT ATTG TTGC TGCA GCAG CAGG AGGT GGTG GTGG TGGG GGGG GGGC GGCA GCAA CAAA AAAT AATG ATGC TGCA GCAA CAAA AAAA AAAC AACC ACCA CCAT CATT ATTT TTTG TTGT TGTT GTTA TTAC TACA ACAC CACA ACAT CATC ATCA TCAT,AGTTT GTTTA TTTAA TTAAC TAACA AACAA ACAAG CAAGA AAGAA AGAAG GAAGA AAGAT AGATT GATTT ATTTT TTTTT TTTTT TTTTG TTTGA TTGAA TGAAG GAAGA AAGAT AGATA GATAA ATAAA TAAAG AAAGG AAGGC AGGCT GGCTT GCTTC CTTCT TTCTT TCTTA CTTAG TTAGA TAGAA AGAAG GAAGT AAGTT AGTTG GTTGA TTGAA TGAAA GAAAC AAACT AACTC ACTCC CTCCA TCCAA CCAAT CAATG AATGA ATGAT TGATG GATGC ATGCA TGCAT GCATC CATCC ATCCA TCCAA CCAAT CAATT AATTG ATTGC TTGCA TGCAG GCAGG CAGGT AGGTG GGTGG GTGGG TGGGG GGGGC GGGCA GGCAA GCAAA CAAAT AAATG AATGC ATGCA TGCAA GCAAA CAAAA AAAAC AAACC AACCA ACCAT CCATT CATTT ATTTG TTTGT TTGTT TGTTA GTTAC TTACA TACAC ACACA CACAT ACATC CATCA ATCAT,AGTTTA GTTTAA TTTAAC TTAACA TAACAA AACAAG ACAAGA CAAGAA AAGAAG AGAAGA GAAGAT AAGATT AGATTT GATTTT ATTTTT TTTTTT TTTTTG TTTTGA TTTGAA TTGAAG TGAAGA GAAGAT AAGATA AGATAA GATAAA ATAAAG TAAAGG AAAGGC AAGGCT AGGCTT GGCTTC GCTTCT CTTCTT TTCTTA TCTTAG CTTAGA TTAGAA TAGAAG AGAAGT GAAGTT AAGTTG AGTTGA GTTGAA TTGAAA TGAAAC GAAACT AAACTC AACTCC ACTCCA CTCCAA TCCAAT CCAATG CAATGA AATGAT ATGATG TGATGC GATGCA ATGCAT TGCATC GCATCC CATCCA ATCCAA TCCAAT CCAATT CAATTG AATTGC ATTGCA TTGCAG TGCAGG GCAGGT CAGGTG AGGTGG GGTGGG GTGGGG TGGGGC GGGGCA GGGCAA GGCAAA GCAAAT CAAATG AAATGC AATGCA ATGCAA TGCAAA GCAAAA CAAAAC AAAACC AAACCA AACCAT ACCATT CCATTT CATTTG ATTTGT TTTGTT TTGTTA TGTTAC GTTACA TTACAC TACACA ACACAT CACATC ACATCA CATCAT,AGTTTAA GTTTAAC TTTAACA TTAACAA TAACAAG AACAAGA ACAAGAA CAAGAAG AAGAAGA AGAAGAT GAAGATT AAGATTT AGATTTT GATTTTT ATTTTTT TTTTTTG TTTTTGA TTTTGAA TTTGAAG TTGAAGA TGAAGAT GAAGATA AAGATAA AGATAAA GATAAAG ATAAAGG TAAAGGC AAAGGCT AAGGCTT AGGCTTC GGCTTCT GCTTCTT CTTCTTA TTCTTAG TCTTAGA CTTAGAA TTAGAAG TAGAAGT AGAAGTT GAAGTTG AAGTTGA AGTTGAA GTTGAAA TTGAAAC TGAAACT GAAACTC AAACTCC AACTCCA ACTCCAA CTCCAAT TCCAATG CCAATGA CAATGAT AATGATG ATGATGC TGATGCA GATGCAT ATGCATC TGCATCC GCATCCA CATCCAA ATCCAAT TCCAATT CCAATTG CAATTGC AATTGCA ATTGCAG TTGCAGG TGCAGGT GCAGGTG CAGGTGG AGGTGGG GGTGGGG GTGGGGC TGGGGCA GGGGCAA GGGCAAA GGCAAAT GCAAATG CAAATGC AAATGCA AATGCAA ATGCAAA TGCAAAA GCAAAAC CAAAACC AAAACCA AAACCAT AACCATT ACCATTT CCATTTG CATTTGT ATTTGTT TTTGTTA TTGTTAC TGTTACA GTTACAC TTACACA TACACAT ACACATC CACATCA ACATCAT,"ID   SYK_ALIB4               Reviewed;         504 AA.
AC   A8ESJ5;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   05-FEB-2025, entry version 98.
DE   RecName: Full=Lysine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_00252};
DE            EC=6.1.1.6 {ECO:0000255|HAMAP-Rule:MF_00252};
DE   AltName: Full=Lysyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_00252};
DE            Short=LysRS {ECO:0000255|HAMAP-Rule:MF_00252};
GN   Name=lysS {ECO:0000255|HAMAP-Rule:MF_00252};
GN   OrderedLocusNames=Abu_0654;
OS   Aliarcobacter butzleri (strain RM4018) (Arcobacter butzleri).
OC   Bacteria; Campylobacterota; Epsilonproteobacteria; Campylobacterales;
OC   Arcobacteraceae; Aliarcobacter.
OX   NCBI_TaxID=367737;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=RM4018;
RX   PubMed=18159241; DOI=10.1371/journal.pone.0001358;
RA   Miller W.G., Parker C.T., Rubenfield M., Mendz G.L., Woesten M.M.S.M.,
RA   Ussery D.W., Stolz J.F., Binnewies T.T., Hallin P.F., Wang G., Malek J.A.,
RA   Rogosin A., Stanker L.H., Mandrell R.E.;
RT   ""The complete genome sequence and analysis of the Epsilonproteobacterium
RT   Arcobacter butzleri."";
RL   PLoS ONE 2:E1358-E1358(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tRNA(Lys) + L-lysine + ATP = L-lysyl-tRNA(Lys) + AMP +
CC         diphosphate; Xref=Rhea:RHEA:20792, Rhea:RHEA-COMP:9696, Rhea:RHEA-
CC         COMP:9697, ChEBI:CHEBI:30616, ChEBI:CHEBI:32551, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78529, ChEBI:CHEBI:456215; EC=6.1.1.6;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00252};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00252};
CC       Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_00252};
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_00252}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00252}.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00252}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000361; ABV66919.1; -; Genomic_DNA.
DR   RefSeq; WP_012012425.1; NC_009850.1.
DR   AlphaFoldDB; A8ESJ5; -.
DR   SMR; A8ESJ5; -.
DR   STRING; 367737.Abu_0654; -.
DR   GeneID; 24304222; -.
DR   KEGG; abu:Abu_0654; -.
DR   eggNOG; COG1190; Bacteria.
DR   HOGENOM; CLU_008255_6_0_7; -.
DR   Proteomes; UP000001136; Chromosome.
DR   GO; GO:0005829; C:cytosol; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004824; F:lysine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000049; F:tRNA binding; IEA:TreeGrafter.
DR   GO; GO:0006430; P:lysyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR   CDD; cd00775; LysRS_core; 1.
DR   CDD; cd04322; LysRS_N; 1.
DR   FunFam; 2.40.50.140:FF:000024; Lysine--tRNA ligase; 1.
DR   Gene3D; 3.30.930.10; Bira Bifunctional Protein, Domain 2; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   HAMAP; MF_00252; Lys_tRNA_synth_class2; 1.
DR   InterPro; IPR004364; Aa-tRNA-synt_II.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR002313; Lys-tRNA-ligase_II.
DR   InterPro; IPR044136; Lys-tRNA-ligase_II_N.
DR   InterPro; IPR018149; Lys-tRNA-synth_II_C.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR004365; NA-bd_OB_tRNA.
DR   NCBIfam; TIGR00499; lysS_bact; 1.
DR   PANTHER; PTHR42918:SF15; LYSINE--TRNA LIGASE, CHLOROPLASTIC_MITOCHONDRIAL; 1.
DR   PANTHER; PTHR42918; LYSYL-TRNA SYNTHETASE; 1.
DR   Pfam; PF00152; tRNA-synt_2; 1.
DR   Pfam; PF01336; tRNA_anti-codon; 1.
DR   PRINTS; PR00982; TRNASYNTHLYS.
DR   SUPFAM; SSF55681; Class II aaRS and biotin synthetases; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..504
FT                   /note=""Lysine--tRNA ligase""
FT                   /id=""PRO_1000059039""
FT   BINDING         404
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""1""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00252""
FT   BINDING         411
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""1""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00252""
FT   BINDING         411
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""2""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00252""
SQ   SEQUENCE   504 AA;  58209 MW;  6C4FDE4D58BA9749 CRC64;
     MFENIYIQQR IEKANKLRED GINPYSNESS RNCTISKYLN VNSDIFQLEE KRDENRNYTV
     AGRIKFFRLM GKASFLKIED ESGMLQIYVA RDNLPENFYN EVFKKNIEVG DIIEISGYPF
     VTGHGELSLH ADSLKILTKA ISPLPEKFHG IQDKELRYRQ RYLDLIMNSE VRKTFHIRSK
     VISLTRRFFE NKGFLEVETP MMHPIAGGAN AKPFVTHFNA LGVDRFLRIA PELYLKRLIV
     GGFEAVFEIN RNFRNEGMDA THNPEFTSIE FYWAYKTYKD LIVLTKEYFE YLFENLNLPT
     ILPYGEFKID FNKFSEIPLI QSLYEIGGVP QDIVEDKDKI LAFLKANNLE ANANLNLGQL
     QGELFDEFVE AKLINPTFIT EYPVEISPLA RRSDEKPHLT DRFELFIAGK EIANAFSELN
     DPIDQLQRFE GQIAAKEAGD DEAHEMDEDF VNALSYGMAP TAGQGIGIDR LVMMLTNEHS
     IRDVLLFPAM KPIKQEIDLY SEEK
//
",2389
GCTACT CTACTG TACTGT ACTGTA CTGTAG TGTAGT GTAGTA TAGTAA AGTAAT GTAATT TAATTG AATTGG ATTGGA TTGGAA TGGAAC GGAACA GAACAA AACAAG ACAAGC CAAGCA AAGCAA AGCAAA GCAAAT CAAATT AAATTC AATTCT ATTCTA TTCTAT TCTATG CTATGG TATGGT ATGGTG TGGTGG GGTGGT GTGGTT TGGTTG GGTTGG GTTGGC TTGGCA TGGCAC GGCACA GCACAA CACAAC ACAACA CAACAT AACATG ACATGT CATGTT ATGTTA TGTTAA GTTAAA TTAAAA TAAAAA AAAAAC AAAACT AAACTG AACTGT ACTGTT CTGTTT TGTTTA GTTTAT TTTATA TTATAG TATAGT ATAGTG TAGTGA AGTGAT GTGATG TGATGT GATGTA ATGTAG TGTAGA GTAGAA TAGAAA AGAAAA GAAAAC AAAACC AAACCC AACCCT ACCCTC CCCTCA CCTCAC CTCACC TCACCT CACCTT ACCTTA CCTTAT CTTATG TTATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGG GTTGGG TTGGGA TGGGAT GGGATT GGATTA GATTAT,0,100,GCTA CTAC TACT ACTG CTGT TGTA GTAG TAGT AGTA GTAA TAAT AATT ATTG TTGG TGGA GGAA GAAC AACA ACAA CAAG AAGC AGCA GCAA CAAA AAAT AATT ATTC TTCT TCTA CTAT TATG ATGG TGGT GGTG GTGG TGGT GGTT GTTG TTGG TGGC GGCA GCAC CACA ACAA CAAC AACA ACAT CATG ATGT TGTT GTTA TTAA TAAA AAAA AAAA AAAC AACT ACTG CTGT TGTT GTTT TTTA TTAT TATA ATAG TAGT AGTG GTGA TGAT GATG ATGT TGTA GTAG TAGA AGAA GAAA AAAA AAAC AACC ACCC CCCT CCTC CTCA TCAC CACC ACCT CCTT CTTA TTAT TATG ATGG TGGG GGGT GGTT GTTG TTGG TGGG GGGA GGAT GATT ATTA TTAT,GCTAC CTACT TACTG ACTGT CTGTA TGTAG GTAGT TAGTA AGTAA GTAAT TAATT AATTG ATTGG TTGGA TGGAA GGAAC GAACA AACAA ACAAG CAAGC AAGCA AGCAA GCAAA CAAAT AAATT AATTC ATTCT TTCTA TCTAT CTATG TATGG ATGGT TGGTG GGTGG GTGGT TGGTT GGTTG GTTGG TTGGC TGGCA GGCAC GCACA CACAA ACAAC CAACA AACAT ACATG CATGT ATGTT TGTTA GTTAA TTAAA TAAAA AAAAA AAAAC AAACT AACTG ACTGT CTGTT TGTTT GTTTA TTTAT TTATA TATAG ATAGT TAGTG AGTGA GTGAT TGATG GATGT ATGTA TGTAG GTAGA TAGAA AGAAA GAAAA AAAAC AAACC AACCC ACCCT CCCTC CCTCA CTCAC TCACC CACCT ACCTT CCTTA CTTAT TTATG TATGG ATGGG TGGGT GGGTT GGTTG GTTGG TTGGG TGGGA GGGAT GGATT GATTA ATTAT,GCTACT CTACTG TACTGT ACTGTA CTGTAG TGTAGT GTAGTA TAGTAA AGTAAT GTAATT TAATTG AATTGG ATTGGA TTGGAA TGGAAC GGAACA GAACAA AACAAG ACAAGC CAAGCA AAGCAA AGCAAA GCAAAT CAAATT AAATTC AATTCT ATTCTA TTCTAT TCTATG CTATGG TATGGT ATGGTG TGGTGG GGTGGT GTGGTT TGGTTG GGTTGG GTTGGC TTGGCA TGGCAC GGCACA GCACAA CACAAC ACAACA CAACAT AACATG ACATGT CATGTT ATGTTA TGTTAA GTTAAA TTAAAA TAAAAA AAAAAC AAAACT AAACTG AACTGT ACTGTT CTGTTT TGTTTA GTTTAT TTTATA TTATAG TATAGT ATAGTG TAGTGA AGTGAT GTGATG TGATGT GATGTA ATGTAG TGTAGA GTAGAA TAGAAA AGAAAA GAAAAC AAAACC AAACCC AACCCT ACCCTC CCCTCA CCTCAC CTCACC TCACCT CACCTT ACCTTA CCTTAT CTTATG TTATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGG GTTGGG TTGGGA TGGGAT GGGATT GGATTA GATTAT,GCTACTG CTACTGT TACTGTA ACTGTAG CTGTAGT TGTAGTA GTAGTAA TAGTAAT AGTAATT GTAATTG TAATTGG AATTGGA ATTGGAA TTGGAAC TGGAACA GGAACAA GAACAAG AACAAGC ACAAGCA CAAGCAA AAGCAAA AGCAAAT GCAAATT CAAATTC AAATTCT AATTCTA ATTCTAT TTCTATG TCTATGG CTATGGT TATGGTG ATGGTGG TGGTGGT GGTGGTT GTGGTTG TGGTTGG GGTTGGC GTTGGCA TTGGCAC TGGCACA GGCACAA GCACAAC CACAACA ACAACAT CAACATG AACATGT ACATGTT CATGTTA ATGTTAA TGTTAAA GTTAAAA TTAAAAA TAAAAAC AAAAACT AAAACTG AAACTGT AACTGTT ACTGTTT CTGTTTA TGTTTAT GTTTATA TTTATAG TTATAGT TATAGTG ATAGTGA TAGTGAT AGTGATG GTGATGT TGATGTA GATGTAG ATGTAGA TGTAGAA GTAGAAA TAGAAAA AGAAAAC GAAAACC AAAACCC AAACCCT AACCCTC ACCCTCA CCCTCAC CCTCACC CTCACCT TCACCTT CACCTTA ACCTTAT CCTTATG CTTATGG TTATGGG TATGGGT ATGGGTT TGGGTTG GGGTTGG GGTTGGG GTTGGGA TTGGGAT TGGGATT GGGATTA GGATTAT,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",6357
AATCTT ATCTTA TCTTAG CTTAGA TTAGAC TAGACG AGACGG GACGGT ACGGTC CGGTCT GGTCTC GTCTCG TCTCGT CTCGTT TCGTTG CGTTGG GTTGGG TTGGGT TGGGTC GGGTCG GGTCGG GTCGGA TCGGAG CGGAGA GGAGAT GAGATG AGATGT GATGTG ATGTGG TGTGGA GTGGAT TGGATA GGATAA GATAAA ATAAAG TAAAGG AAAGGG AAGGGC AGGGCC GGGCCG GGCCGC GCCGCT CCGCTC CGCTCT GCTCTC CTCTCA TCTCAA CTCAAT TCAATT CAATTA AATTAA ATTAAC TTAACA TAACAT AACATG ACATGG CATGGC ATGGCA TGGCAA GGCAAG GCAAGG CAAGGA AAGGAA AGGAAG GGAAGG GAAGGA AAGGAC AGGACT GGACTT GACTTA ACTTAA CTTAAA TTAAAA TAAAAT AAAATC AAATCC AATCCC ATCCCT TCCCTC CCCTCG CCTCGA CTCGAG TCGAGG CGAGGA GAGGAC AGGACA GGACAA GACAAG ACAAGG CAAGGC AAGGCG AGGCGT GGCGTT GCGTTC CGTTCC GTTCCA TTCCAA TCCAAT CCAATT CAATTA AATTAA ATTAAC TTAACC TAACCC AACCCC ACCCCA CCCCAA CCCAAA CCAAAA CAAAAG AAAAGC AAAGCA AAGCAA AGCAAT GCAATC CAATCC AATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGA GATGAC ATGACC TGACCA GACCAA ACCAAA CCAAAT CAAATT AAATTG AATTGG ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG,1,145,AATC ATCT TCTT CTTA TTAG TAGA AGAC GACG ACGG CGGT GGTC GTCT TCTC CTCG TCGT CGTT GTTG TTGG TGGG GGGT GGTC GTCG TCGG CGGA GGAG GAGA AGAT GATG ATGT TGTG GTGG TGGA GGAT GATA ATAA TAAA AAAG AAGG AGGG GGGC GGCC GCCG CCGC CGCT GCTC CTCT TCTC CTCA TCAA CAAT AATT ATTA TTAA TAAC AACA ACAT CATG ATGG TGGC GGCA GCAA CAAG AAGG AGGA GGAA GAAG AAGG AGGA GGAC GACT ACTT CTTA TTAA TAAA AAAA AAAT AATC ATCC TCCC CCCT CCTC CTCG TCGA CGAG GAGG AGGA GGAC GACA ACAA CAAG AAGG AGGC GGCG GCGT CGTT GTTC TTCC TCCA CCAA CAAT AATT ATTA TTAA TAAC AACC ACCC CCCC CCCA CCAA CAAA AAAA AAAG AAGC AGCA GCAA CAAT AATC ATCC TCCA CCAG CAGA AGAT GATG ATGA TGAC GACC ACCA CCAA CAAA AAAT AATT ATTG TTGG TGGC GGCT GCTA CTAC TACT ACTA CTAC TACC ACCG CCGA CGAA GAAG AAGA AGAG,AATCT ATCTT TCTTA CTTAG TTAGA TAGAC AGACG GACGG ACGGT CGGTC GGTCT GTCTC TCTCG CTCGT TCGTT CGTTG GTTGG TTGGG TGGGT GGGTC GGTCG GTCGG TCGGA CGGAG GGAGA GAGAT AGATG GATGT ATGTG TGTGG GTGGA TGGAT GGATA GATAA ATAAA TAAAG AAAGG AAGGG AGGGC GGGCC GGCCG GCCGC CCGCT CGCTC GCTCT CTCTC TCTCA CTCAA TCAAT CAATT AATTA ATTAA TTAAC TAACA AACAT ACATG CATGG ATGGC TGGCA GGCAA GCAAG CAAGG AAGGA AGGAA GGAAG GAAGG AAGGA AGGAC GGACT GACTT ACTTA CTTAA TTAAA TAAAA AAAAT AAATC AATCC ATCCC TCCCT CCCTC CCTCG CTCGA TCGAG CGAGG GAGGA AGGAC GGACA GACAA ACAAG CAAGG AAGGC AGGCG GGCGT GCGTT CGTTC GTTCC TTCCA TCCAA CCAAT CAATT AATTA ATTAA TTAAC TAACC AACCC ACCCC CCCCA CCCAA CCAAA CAAAA AAAAG AAAGC AAGCA AGCAA GCAAT CAATC AATCC ATCCA TCCAG CCAGA CAGAT AGATG GATGA ATGAC TGACC GACCA ACCAA CCAAA CAAAT AAATT AATTG ATTGG TTGGC TGGCT GGCTA GCTAC CTACT TACTA ACTAC CTACC TACCG ACCGA CCGAA CGAAG GAAGA AAGAG,AATCTT ATCTTA TCTTAG CTTAGA TTAGAC TAGACG AGACGG GACGGT ACGGTC CGGTCT GGTCTC GTCTCG TCTCGT CTCGTT TCGTTG CGTTGG GTTGGG TTGGGT TGGGTC GGGTCG GGTCGG GTCGGA TCGGAG CGGAGA GGAGAT GAGATG AGATGT GATGTG ATGTGG TGTGGA GTGGAT TGGATA GGATAA GATAAA ATAAAG TAAAGG AAAGGG AAGGGC AGGGCC GGGCCG GGCCGC GCCGCT CCGCTC CGCTCT GCTCTC CTCTCA TCTCAA CTCAAT TCAATT CAATTA AATTAA ATTAAC TTAACA TAACAT AACATG ACATGG CATGGC ATGGCA TGGCAA GGCAAG GCAAGG CAAGGA AAGGAA AGGAAG GGAAGG GAAGGA AAGGAC AGGACT GGACTT GACTTA ACTTAA CTTAAA TTAAAA TAAAAT AAAATC AAATCC AATCCC ATCCCT TCCCTC CCCTCG CCTCGA CTCGAG TCGAGG CGAGGA GAGGAC AGGACA GGACAA GACAAG ACAAGG CAAGGC AAGGCG AGGCGT GGCGTT GCGTTC CGTTCC GTTCCA TTCCAA TCCAAT CCAATT CAATTA AATTAA ATTAAC TTAACC TAACCC AACCCC ACCCCA CCCCAA CCCAAA CCAAAA CAAAAG AAAAGC AAAGCA AAGCAA AGCAAT GCAATC CAATCC AATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGA GATGAC ATGACC TGACCA GACCAA ACCAAA CCAAAT CAAATT AAATTG AATTGG ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG,AATCTTA ATCTTAG TCTTAGA CTTAGAC TTAGACG TAGACGG AGACGGT GACGGTC ACGGTCT CGGTCTC GGTCTCG GTCTCGT TCTCGTT CTCGTTG TCGTTGG CGTTGGG GTTGGGT TTGGGTC TGGGTCG GGGTCGG GGTCGGA GTCGGAG TCGGAGA CGGAGAT GGAGATG GAGATGT AGATGTG GATGTGG ATGTGGA TGTGGAT GTGGATA TGGATAA GGATAAA GATAAAG ATAAAGG TAAAGGG AAAGGGC AAGGGCC AGGGCCG GGGCCGC GGCCGCT GCCGCTC CCGCTCT CGCTCTC GCTCTCA CTCTCAA TCTCAAT CTCAATT TCAATTA CAATTAA AATTAAC ATTAACA TTAACAT TAACATG AACATGG ACATGGC CATGGCA ATGGCAA TGGCAAG GGCAAGG GCAAGGA CAAGGAA AAGGAAG AGGAAGG GGAAGGA GAAGGAC AAGGACT AGGACTT GGACTTA GACTTAA ACTTAAA CTTAAAA TTAAAAT TAAAATC AAAATCC AAATCCC AATCCCT ATCCCTC TCCCTCG CCCTCGA CCTCGAG CTCGAGG TCGAGGA CGAGGAC GAGGACA AGGACAA GGACAAG GACAAGG ACAAGGC CAAGGCG AAGGCGT AGGCGTT GGCGTTC GCGTTCC CGTTCCA GTTCCAA TTCCAAT TCCAATT CCAATTA CAATTAA AATTAAC ATTAACC TTAACCC TAACCCC AACCCCA ACCCCAA CCCCAAA CCCAAAA CCAAAAG CAAAAGC AAAAGCA AAAGCAA AAGCAAT AGCAATC GCAATCC CAATCCA AATCCAG ATCCAGA TCCAGAT CCAGATG CAGATGA AGATGAC GATGACC ATGACCA TGACCAA GACCAAA ACCAAAT CCAAATT CAAATTG AAATTGG AATTGGC ATTGGCT TTGGCTA TGGCTAC GGCTACT GCTACTA CTACTAC TACTACC ACTACCG CTACCGA TACCGAA ACCGAAG CCGAAGA CGAAGAG,"ID   ORF9B_SARS2             Reviewed;          97 AA.
AC   P0DTD2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   27-NOV-2024, entry version 24.
DE   RecName: Full=ORF9b protein;
DE            Short=ORF9b;
DE   AltName: Full=Accessory protein 9b;
DE   AltName: Full=ORF-9b;
DE   AltName: Full=Protein 9b;
GN   ORFNames=9b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.05 ANGSTROMS), INTERACTION WITH HUMAN
RP   TOMM70, AND SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH HOST TOMM70.
RX   PubMed=32728199; DOI=10.1038/s41423-020-0514-8;
RA   Jiang H.W., Zhang H.N., Meng Q.F., Xie J., Li Y., Chen H., Zheng Y.X.,
RA   Wang X.N., Qi H., Zhang J., Wang P.H., Han Z.G., Tao S.C.;
RT   ""SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting
RT   TOM70."";
RL   Cell. Mol. Immunol. 17:998-1000(2020).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF SER-53, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   HOST TOMM70.
RX   PubMed=34502139; DOI=10.3390/ijms22179233;
RA   Brandherm L., Kobas A.M., Kloehn M., Brueggemann Y., Pfaender S.,
RA   Rassow J., Kreimendahl S.;
RT   ""Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding
RT   Sites in TOM70 and Recruitment of Hsp90."";
RL   Int. J. Mol. Sci. 22:0-0(2021).
RN   [5] {ECO:0007744|PDB:6Z4U}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS), AND HOMODIMERIZATION.
RA   Weeks S.D., De Graef S., Munawar A.;
RT   ""X-ray Crystallographic Structure of Orf9b from SARS-CoV-2."";
RL   Submitted (MAY-2020) to the PDB data bank.
RN   [6]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.20 ANGSTROMS) OF 1-97, AND INTERACTION
RP   WITH HOST TOMM70.
RX   PubMed=33990585; DOI=10.1038/s41467-021-23118-8;
RA   Gao X., Zhu K., Qin B., Olieric V., Wang M., Cui S.;
RT   ""Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests
RT   unusual virus-host interactions."";
RL   Nat. Commun. 12:2843-2843(2021).
CC   -!- FUNCTION: Plays a role in inhibiting the host innate immune response by
CC       targeting the mitochondrial-associated innate immune response. Acts by
CC       binding to host TOMM70, inhibiting its binding to HSP90AB1 thereby
CC       disrupting the interferon activation pathway.
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:34502139}.
CC   -!- SUBUNIT: Homodimer (Ref.5). Interacts with host TOMM70
CC       (PubMed:33060197, PubMed:32728199, PubMed:34502139, PubMed:33990585);
CC       the interaction occurs only with monomer (PubMed:33990585).
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:33060197,
CC       ECO:0000269|PubMed:33990585, ECO:0000269|PubMed:34502139,
CC       ECO:0000269|Ref.5}.
CC   -!- INTERACTION:
CC       P0DTD2; P0DTD2: 9b; NbExp=5; IntAct=EBI-25475909, EBI-25475909;
CC       P0DTD2; Q9Y6K9: IKBKG; Xeno; NbExp=3; IntAct=EBI-25475909, EBI-81279;
CC       P0DTD2; O94826: TOMM70; Xeno; NbExp=28; IntAct=EBI-25475909, EBI-2800236;
CC   -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34502139}. Host
CC       mitochondrion {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- MISCELLANEOUS: The open reading frame (ORF) encoding for this protein
CC       overlaps with the N ORF. {ECO:0000269|PubMed:32015508}.
CC   -!- SIMILARITY: Belongs to the coronavirus group 2 protein 9b family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   PDB; 6Z4U; X-ray; 1.95 A; A/B=1-97.
DR   PDB; 7DHG; X-ray; 2.20 A; B=1-97.
DR   PDB; 7KDT; EM; 3.05 A; B=1-97.
DR   PDB; 7YE7; X-ray; 2.95 A; A/B/C/D=1-97.
DR   PDB; 7YE8; X-ray; 3.01 A; A/B/C/D=1-97.
DR   PDBsum; 6Z4U; -.
DR   PDBsum; 7DHG; -.
DR   PDBsum; 7KDT; -.
DR   PDBsum; 7YE7; -.
DR   PDBsum; 7YE8; -.
DR   EMDB; EMD-22829; -.
DR   SMR; P0DTD2; -.
DR   BioGRID; 4383874; 613.
DR   ComplexPortal; CPX-6100; SARS-CoV-2 9b complex.
DR   IntAct; P0DTD2; 94.
DR   MINT; P0DTD2; -.
DR   iPTMnet; P0DTD2; -.
DR   AGR; RefSeq:P0DTD2; -.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9727281; Translation of Accessory Proteins.
DR   PRO; PR:P0DTD2; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0033650; C:host cell mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProt.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:ComplexPortal.
DR   GO; GO:0098799; C:outer mitochondrial membrane protein complex; ISO:ComplexPortal.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; IDA:ComplexPortal.
DR   GO; GO:0090258; P:negative regulation of mitochondrial fission; ISO:ComplexPortal.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; ISO:ComplexPortal.
DR   GO; GO:0039545; P:symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity; IDA:UniProt.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21955; SARS-CoV_ORF9b; 1.
DR   InterPro; IPR018542; Protein_9b_Betacoronavirus.
DR   InterPro; IPR037223; Protein_9b_SARS.
DR   Pfam; PF09399; bCoV_lipid_BD; 1.
DR   SUPFAM; SSF141666; SARS ORF9b-like; 1.
DR   PROSITE; PS51920; SARS_9B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Host cytoplasm; Host mitochondrion; Host-virus interaction;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host MAVS by virus; Inhibition of host RLR pathway by virus;
KW   Reference proteome; Viral immunoevasion.
FT   CHAIN           1..97
FT                   /note=""ORF9b protein""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT                   /id=""PRO_0000449657""
FT   DOMAIN          8..97
FT                   /note=""9b""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01268""
FT   MOTIF           45..53
FT                   /note=""Nuclear export signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT   VARIANT         10
FT                   /note=""P -> S (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         27..29
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         60
FT                   /note=""T -> A (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         77
FT                   /note=""Q -> E (in strain: Gamma/P.1)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         53
FT                   /note=""S->E: Complete loss of binding to host TOMM70.""
FT                   /evidence=""ECO:0000269|PubMed:34502139""
FT   HELIX           5..7
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          12..15
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          19..23
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          40..42
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          44..50
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          52..61
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          64..66
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          68..74
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          78..80
FT                   /evidence=""ECO:0007829|PDB:7YE7""
FT   HELIX           84..86
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          89..96
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
SQ   SEQUENCE   97 AA;  10797 MW;  62CFB65C1804545E CRC64;
     MDPKISEMHP ALRLVDPQIQ LAVTRMENAV GRDQNNVGPK VYPIILRLGS PLSLNMARKT
     LNSLEDKAFQ LTPIAVQMTK LATTEELPDE FVVVTVK
//
",34946
GCAGGT CAGGTT AGGTTT GGTTTA GTTTAT TTTATT TTATTC TATTCG ATTCGC TTCGCT TCGCTA CGCTAT GCTATT CTATTT TATTTA ATTTAT TTTATC TTATCA TATCAG ATCAGA TCAGAC CAGACT AGACTC GACTCA ACTCAG CTCAGA TCAGAC CAGACT AGACTA GACTAA ACTAAC CTAACT TAACTC AACTCT ACTCTC CTCTCG TCTCGT CTCGTC TCGTCG CGTCGG GTCGGG TCGGGG CGGGGC GGGGCG GGGCGC GGCGCC GCGCCC CGCCCG GCCCGC CCCGCT CCGCTG CGCTGT GCTGTG CTGTGT TGTGTC GTGTCT TGTCTC GTCTCT TCTCTA CTCTAG TCTAGT CTAGTC TAGTCA AGTCAA GTCAAT TCAATC CAATCC AATCCA ATCCAT TCCATC CCATCA CATCAT ATCATT TCATTT CATTTC ATTTCC TTTCCT TTCCTC TCCTCC CCTCCA CTCCAC TCCACT CCACTT CACTTT ACTTTT CTTTTT TTTTTC TTTTCC TTTCCC TTCCCT TCCCTT CCCTTG CCTTGC CTTGCT TTGCTG TGCTGC GCTGCA CTGCAG TGCAGA GCAGAA CAGAAA AGAAAA GAAAAT AAAATT AAATTC AATTCC ATTCCG TTCCGT TCCGTT CCGTTT CGTTTC GTTTCT TTTCTT TTCTTA TCTTAC CTTACT TTACTC TACTCT ACTCTA CTCTAA TCTAAT CTAATA TAATAA AATAAC ATAACT TAACTC AACTCT ACTCTA CTCTAT TCTATT CTATTG TATTGC ATTGCC TTGCCA TGCCAT GCCATT CCATTC CATTCC ATTCCC TTCCCA TCCCAC CCCACA,1,142,GCAG CAGG AGGT GGTT GTTT TTTA TTAT TATT ATTC TTCG TCGC CGCT GCTA CTAT TATT ATTT TTTA TTAT TATC ATCA TCAG CAGA AGAC GACT ACTC CTCA TCAG CAGA AGAC GACT ACTA CTAA TAAC AACT ACTC CTCT TCTC CTCG TCGT CGTC GTCG TCGG CGGG GGGG GGGC GGCG GCGC CGCC GCCC CCCG CCGC CGCT GCTG CTGT TGTG GTGT TGTC GTCT TCTC CTCT TCTA CTAG TAGT AGTC GTCA TCAA CAAT AATC ATCC TCCA CCAT CATC ATCA TCAT CATT ATTT TTTC TTCC TCCT CCTC CTCC TCCA CCAC CACT ACTT CTTT TTTT TTTT TTTC TTCC TCCC CCCT CCTT CTTG TTGC TGCT GCTG CTGC TGCA GCAG CAGA AGAA GAAA AAAA AAAT AATT ATTC TTCC TCCG CCGT CGTT GTTT TTTC TTCT TCTT CTTA TTAC TACT ACTC CTCT TCTA CTAA TAAT AATA ATAA TAAC AACT ACTC CTCT TCTA CTAT TATT ATTG TTGC TGCC GCCA CCAT CATT ATTC TTCC TCCC CCCA CCAC CACA,GCAGG CAGGT AGGTT GGTTT GTTTA TTTAT TTATT TATTC ATTCG TTCGC TCGCT CGCTA GCTAT CTATT TATTT ATTTA TTTAT TTATC TATCA ATCAG TCAGA CAGAC AGACT GACTC ACTCA CTCAG TCAGA CAGAC AGACT GACTA ACTAA CTAAC TAACT AACTC ACTCT CTCTC TCTCG CTCGT TCGTC CGTCG GTCGG TCGGG CGGGG GGGGC GGGCG GGCGC GCGCC CGCCC GCCCG CCCGC CCGCT CGCTG GCTGT CTGTG TGTGT GTGTC TGTCT GTCTC TCTCT CTCTA TCTAG CTAGT TAGTC AGTCA GTCAA TCAAT CAATC AATCC ATCCA TCCAT CCATC CATCA ATCAT TCATT CATTT ATTTC TTTCC TTCCT TCCTC CCTCC CTCCA TCCAC CCACT CACTT ACTTT CTTTT TTTTT TTTTC TTTCC TTCCC TCCCT CCCTT CCTTG CTTGC TTGCT TGCTG GCTGC CTGCA TGCAG GCAGA CAGAA AGAAA GAAAA AAAAT AAATT AATTC ATTCC TTCCG TCCGT CCGTT CGTTT GTTTC TTTCT TTCTT TCTTA CTTAC TTACT TACTC ACTCT CTCTA TCTAA CTAAT TAATA AATAA ATAAC TAACT AACTC ACTCT CTCTA TCTAT CTATT TATTG ATTGC TTGCC TGCCA GCCAT CCATT CATTC ATTCC TTCCC TCCCA CCCAC CCACA,GCAGGT CAGGTT AGGTTT GGTTTA GTTTAT TTTATT TTATTC TATTCG ATTCGC TTCGCT TCGCTA CGCTAT GCTATT CTATTT TATTTA ATTTAT TTTATC TTATCA TATCAG ATCAGA TCAGAC CAGACT AGACTC GACTCA ACTCAG CTCAGA TCAGAC CAGACT AGACTA GACTAA ACTAAC CTAACT TAACTC AACTCT ACTCTC CTCTCG TCTCGT CTCGTC TCGTCG CGTCGG GTCGGG TCGGGG CGGGGC GGGGCG GGGCGC GGCGCC GCGCCC CGCCCG GCCCGC CCCGCT CCGCTG CGCTGT GCTGTG CTGTGT TGTGTC GTGTCT TGTCTC GTCTCT TCTCTA CTCTAG TCTAGT CTAGTC TAGTCA AGTCAA GTCAAT TCAATC CAATCC AATCCA ATCCAT TCCATC CCATCA CATCAT ATCATT TCATTT CATTTC ATTTCC TTTCCT TTCCTC TCCTCC CCTCCA CTCCAC TCCACT CCACTT CACTTT ACTTTT CTTTTT TTTTTC TTTTCC TTTCCC TTCCCT TCCCTT CCCTTG CCTTGC CTTGCT TTGCTG TGCTGC GCTGCA CTGCAG TGCAGA GCAGAA CAGAAA AGAAAA GAAAAT AAAATT AAATTC AATTCC ATTCCG TTCCGT TCCGTT CCGTTT CGTTTC GTTTCT TTTCTT TTCTTA TCTTAC CTTACT TTACTC TACTCT ACTCTA CTCTAA TCTAAT CTAATA TAATAA AATAAC ATAACT TAACTC AACTCT ACTCTA CTCTAT TCTATT CTATTG TATTGC ATTGCC TTGCCA TGCCAT GCCATT CCATTC CATTCC ATTCCC TTCCCA TCCCAC CCCACA,GCAGGTT CAGGTTT AGGTTTA GGTTTAT GTTTATT TTTATTC TTATTCG TATTCGC ATTCGCT TTCGCTA TCGCTAT CGCTATT GCTATTT CTATTTA TATTTAT ATTTATC TTTATCA TTATCAG TATCAGA ATCAGAC TCAGACT CAGACTC AGACTCA GACTCAG ACTCAGA CTCAGAC TCAGACT CAGACTA AGACTAA GACTAAC ACTAACT CTAACTC TAACTCT AACTCTC ACTCTCG CTCTCGT TCTCGTC CTCGTCG TCGTCGG CGTCGGG GTCGGGG TCGGGGC CGGGGCG GGGGCGC GGGCGCC GGCGCCC GCGCCCG CGCCCGC GCCCGCT CCCGCTG CCGCTGT CGCTGTG GCTGTGT CTGTGTC TGTGTCT GTGTCTC TGTCTCT GTCTCTA TCTCTAG CTCTAGT TCTAGTC CTAGTCA TAGTCAA AGTCAAT GTCAATC TCAATCC CAATCCA AATCCAT ATCCATC TCCATCA CCATCAT CATCATT ATCATTT TCATTTC CATTTCC ATTTCCT TTTCCTC TTCCTCC TCCTCCA CCTCCAC CTCCACT TCCACTT CCACTTT CACTTTT ACTTTTT CTTTTTC TTTTTCC TTTTCCC TTTCCCT TTCCCTT TCCCTTG CCCTTGC CCTTGCT CTTGCTG TTGCTGC TGCTGCA GCTGCAG CTGCAGA TGCAGAA GCAGAAA CAGAAAA AGAAAAT GAAAATT AAAATTC AAATTCC AATTCCG ATTCCGT TTCCGTT TCCGTTT CCGTTTC CGTTTCT GTTTCTT TTTCTTA TTCTTAC TCTTACT CTTACTC TTACTCT TACTCTA ACTCTAA CTCTAAT TCTAATA CTAATAA TAATAAC AATAACT ATAACTC TAACTCT AACTCTA ACTCTAT CTCTATT TCTATTG CTATTGC TATTGCC ATTGCCA TTGCCAT TGCCATT GCCATTC CCATTCC CATTCCC ATTCCCA TTCCCAC TCCCACA,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",50404
GTTACA TTACAG TACAGC ACAGCG CAGCGT AGCGTA GCGTAT CGTATA GTATAA TATAAT ATAATG TAATGG AATGGT ATGGTT TGGTTA GGTTAT GTTATC TTATCT TATCTT ATCTTA TCTTAC CTTACT TTACTT TACTTC ACTTCT CTTCTT TTCTTC TCTTCT CTTCTT TTCTTC TCTTCT CTTCTA TTCTAA TCTAAA CTAAAA TAAAAC AAAACA AAACAC AACACC ACACCT CACCTG ACCTGA CCTGAA CTGAAG TGAAGA GAAGAA AAGAAC AGAACA GAACAT AACATT ACATTT CATTTT ATTTTA TTTTAT TTTATT TTATTG TATTGA ATTGAA TTGAAA TGAAAC GAAACC AAACCA AACCAT ACCATC CCATCT CATCTC ATCTCA TCTCAC CTCACT TCACTT CACTTG ACTTGC CTTGCT TTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCC GTTCCT TTCCTA TCCTAT CCTATA CTATAA TATAAA ATAAAG TAAAGA AAAGAT AAGATT AGATTG GATTGG ATTGGT TTGGTC TGGTCC GGTCCT GTCCTA TCCTAT CCTATT CTATTC TATTCT ATTCTG TTCTGG TCTGGA CTGGAC TGGACA GGACAA GACAAT ACAATC CAATCT AATCTA ATCTAC TCTACA CTACAC TACACA ACACAA CACAAC ACAACT CAACTA AACTAG ACTAGG CTAGGT TAGGTA AGGTAT GGTATA GTATAG TATAGA ATAGAA TAGAAT AGAATT GAATTT AATTTC ATTTCT TTTCTT TTCTTA TCTTAA CTTAAG,0,136,GTTA TTAC TACA ACAG CAGC AGCG GCGT CGTA GTAT TATA ATAA TAAT AATG ATGG TGGT GGTT GTTA TTAT TATC ATCT TCTT CTTA TTAC TACT ACTT CTTC TTCT TCTT CTTC TTCT TCTT CTTC TTCT TCTA CTAA TAAA AAAA AAAC AACA ACAC CACC ACCT CCTG CTGA TGAA GAAG AAGA AGAA GAAC AACA ACAT CATT ATTT TTTT TTTA TTAT TATT ATTG TTGA TGAA GAAA AAAC AACC ACCA CCAT CATC ATCT TCTC CTCA TCAC CACT ACTT CTTG TTGC TGCT GCTG CTGG TGGT GGTT GTTC TTCC TCCT CCTA CTAT TATA ATAA TAAA AAAG AAGA AGAT GATT ATTG TTGG TGGT GGTC GTCC TCCT CCTA CTAT TATT ATTC TTCT TCTG CTGG TGGA GGAC GACA ACAA CAAT AATC ATCT TCTA CTAC TACA ACAC CACA ACAA CAAC AACT ACTA CTAG TAGG AGGT GGTA GTAT TATA ATAG TAGA AGAA GAAT AATT ATTT TTTC TTCT TCTT CTTA TTAA TAAG,GTTAC TTACA TACAG ACAGC CAGCG AGCGT GCGTA CGTAT GTATA TATAA ATAAT TAATG AATGG ATGGT TGGTT GGTTA GTTAT TTATC TATCT ATCTT TCTTA CTTAC TTACT TACTT ACTTC CTTCT TTCTT TCTTC CTTCT TTCTT TCTTC CTTCT TTCTA TCTAA CTAAA TAAAA AAAAC AAACA AACAC ACACC CACCT ACCTG CCTGA CTGAA TGAAG GAAGA AAGAA AGAAC GAACA AACAT ACATT CATTT ATTTT TTTTA TTTAT TTATT TATTG ATTGA TTGAA TGAAA GAAAC AAACC AACCA ACCAT CCATC CATCT ATCTC TCTCA CTCAC TCACT CACTT ACTTG CTTGC TTGCT TGCTG GCTGG CTGGT TGGTT GGTTC GTTCC TTCCT TCCTA CCTAT CTATA TATAA ATAAA TAAAG AAAGA AAGAT AGATT GATTG ATTGG TTGGT TGGTC GGTCC GTCCT TCCTA CCTAT CTATT TATTC ATTCT TTCTG TCTGG CTGGA TGGAC GGACA GACAA ACAAT CAATC AATCT ATCTA TCTAC CTACA TACAC ACACA CACAA ACAAC CAACT AACTA ACTAG CTAGG TAGGT AGGTA GGTAT GTATA TATAG ATAGA TAGAA AGAAT GAATT AATTT ATTTC TTTCT TTCTT TCTTA CTTAA TTAAG,GTTACA TTACAG TACAGC ACAGCG CAGCGT AGCGTA GCGTAT CGTATA GTATAA TATAAT ATAATG TAATGG AATGGT ATGGTT TGGTTA GGTTAT GTTATC TTATCT TATCTT ATCTTA TCTTAC CTTACT TTACTT TACTTC ACTTCT CTTCTT TTCTTC TCTTCT CTTCTT TTCTTC TCTTCT CTTCTA TTCTAA TCTAAA CTAAAA TAAAAC AAAACA AAACAC AACACC ACACCT CACCTG ACCTGA CCTGAA CTGAAG TGAAGA GAAGAA AAGAAC AGAACA GAACAT AACATT ACATTT CATTTT ATTTTA TTTTAT TTTATT TTATTG TATTGA ATTGAA TTGAAA TGAAAC GAAACC AAACCA AACCAT ACCATC CCATCT CATCTC ATCTCA TCTCAC CTCACT TCACTT CACTTG ACTTGC CTTGCT TTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCC GTTCCT TTCCTA TCCTAT CCTATA CTATAA TATAAA ATAAAG TAAAGA AAAGAT AAGATT AGATTG GATTGG ATTGGT TTGGTC TGGTCC GGTCCT GTCCTA TCCTAT CCTATT CTATTC TATTCT ATTCTG TTCTGG TCTGGA CTGGAC TGGACA GGACAA GACAAT ACAATC CAATCT AATCTA ATCTAC TCTACA CTACAC TACACA ACACAA CACAAC ACAACT CAACTA AACTAG ACTAGG CTAGGT TAGGTA AGGTAT GGTATA GTATAG TATAGA ATAGAA TAGAAT AGAATT GAATTT AATTTC ATTTCT TTTCTT TTCTTA TCTTAA CTTAAG,GTTACAG TTACAGC TACAGCG ACAGCGT CAGCGTA AGCGTAT GCGTATA CGTATAA GTATAAT TATAATG ATAATGG TAATGGT AATGGTT ATGGTTA TGGTTAT GGTTATC GTTATCT TTATCTT TATCTTA ATCTTAC TCTTACT CTTACTT TTACTTC TACTTCT ACTTCTT CTTCTTC TTCTTCT TCTTCTT CTTCTTC TTCTTCT TCTTCTA CTTCTAA TTCTAAA TCTAAAA CTAAAAC TAAAACA AAAACAC AAACACC AACACCT ACACCTG CACCTGA ACCTGAA CCTGAAG CTGAAGA TGAAGAA GAAGAAC AAGAACA AGAACAT GAACATT AACATTT ACATTTT CATTTTA ATTTTAT TTTTATT TTTATTG TTATTGA TATTGAA ATTGAAA TTGAAAC TGAAACC GAAACCA AAACCAT AACCATC ACCATCT CCATCTC CATCTCA ATCTCAC TCTCACT CTCACTT TCACTTG CACTTGC ACTTGCT CTTGCTG TTGCTGG TGCTGGT GCTGGTT CTGGTTC TGGTTCC GGTTCCT GTTCCTA TTCCTAT TCCTATA CCTATAA CTATAAA TATAAAG ATAAAGA TAAAGAT AAAGATT AAGATTG AGATTGG GATTGGT ATTGGTC TTGGTCC TGGTCCT GGTCCTA GTCCTAT TCCTATT CCTATTC CTATTCT TATTCTG ATTCTGG TTCTGGA TCTGGAC CTGGACA TGGACAA GGACAAT GACAATC ACAATCT CAATCTA AATCTAC ATCTACA TCTACAC CTACACA TACACAA ACACAAC CACAACT ACAACTA CAACTAG AACTAGG ACTAGGT CTAGGTA TAGGTAT AGGTATA GGTATAG GTATAGA TATAGAA ATAGAAT TAGAATT AGAATTT GAATTTC AATTTCT ATTTCTT TTTCTTA TTCTTAA TCTTAAG,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",1843
GGTCTG GTCTGG TCTGGA CTGGAA TGGAAG GGAAGT GAAGTG AAGTGG AGTGGA GTGGAT TGGATG GGATGC GATGCC ATGCCA TGCCAT GCCATC CCATCG CATCGT ATCGTT TCGTTC CGTTCC GTTCCG TTCCGG TCCGGT CCGGTC CGGTCG GGTCGC GTCGCA TCGCAC CGCACC GCACCG CACCGG ACCGGC CCGGCT CGGCTT GGCTTT GCTTTC CTTTCA TTTCAA TTCAAT TCAATG CAATGG AATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGT GTTGTG TTGTGG TGTGGT GTGGTG TGGTGG GGTGGG GTGGGT TGGGTG GGGTGA GGTGAG GTGAGG TGAGGT GAGGTT AGGTTC GGTTCT GTTCTC TTCTCG TCTCGA CTCGAA TCGAAG CGAAGT GAAGTA AAGTAG AGTAGT GTAGTG TAGTGC AGTGCC GTGCCG TGCCGC GCCGCA CCGCAT CGCATC GCATCC CATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGC GATGCC ATGCCG TGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTG AGTTGC GTTGCG TTGCGC TGCGCG GCGCGT CGCGTT GCGTTA CGTTAC GTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGT AAAGTC AAGTCA AGTCAG GTCAGC TCAGCA CAGCAC AGCACA GCACAG CACAGG ACAGGC CAGGCT AGGCTC GGCTCT GCTCTG CTCTGA TCTGAG CTGAGA TGAGAT GAGATT AGATTT GATTTT ATTTTG TTTTGC TTTGCA TTGCAG TGCAGA GCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGT,3,145,GGTC GTCT TCTG CTGG TGGA GGAA GAAG AAGT AGTG GTGG TGGA GGAT GATG ATGC TGCC GCCA CCAT CATC ATCG TCGT CGTT GTTC TTCC TCCG CCGG CGGT GGTC GTCG TCGC CGCA GCAC CACC ACCG CCGG CGGC GGCT GCTT CTTT TTTC TTCA TCAA CAAT AATG ATGG TGGT GGTG GTGT TGTT GTTG TTGT TGTG GTGG TGGT GGTG GTGG TGGG GGGT GGTG GTGA TGAG GAGG AGGT GGTT GTTC TTCT TCTC CTCG TCGA CGAA GAAG AAGT AGTA GTAG TAGT AGTG GTGC TGCC GCCG CCGC CGCA GCAT CATC ATCC TCCA CCAG CAGA AGAT GATG ATGC TGCC GCCG CCGA CGAC GACA ACAA CAAG AAGT AGTT GTTG TTGC TGCG GCGC CGCG GCGT CGTT GTTA TTAC TACT ACTA CTAA TAAA AAAG AAGT AGTC GTCA TCAG CAGC AGCA GCAC CACA ACAG CAGG AGGC GGCT GCTC CTCT TCTG CTGA TGAG GAGA AGAT GATT ATTT TTTT TTTG TTGC TGCA GCAG CAGA AGAT GATT ATTG TTGT TGTG GTGT TGTG GTGT,GGTCT GTCTG TCTGG CTGGA TGGAA GGAAG GAAGT AAGTG AGTGG GTGGA TGGAT GGATG GATGC ATGCC TGCCA GCCAT CCATC CATCG ATCGT TCGTT CGTTC GTTCC TTCCG TCCGG CCGGT CGGTC GGTCG GTCGC TCGCA CGCAC GCACC CACCG ACCGG CCGGC CGGCT GGCTT GCTTT CTTTC TTTCA TTCAA TCAAT CAATG AATGG ATGGT TGGTG GGTGT GTGTT TGTTG GTTGT TTGTG TGTGG GTGGT TGGTG GGTGG GTGGG TGGGT GGGTG GGTGA GTGAG TGAGG GAGGT AGGTT GGTTC GTTCT TTCTC TCTCG CTCGA TCGAA CGAAG GAAGT AAGTA AGTAG GTAGT TAGTG AGTGC GTGCC TGCCG GCCGC CCGCA CGCAT GCATC CATCC ATCCA TCCAG CCAGA CAGAT AGATG GATGC ATGCC TGCCG GCCGA CCGAC CGACA GACAA ACAAG CAAGT AAGTT AGTTG GTTGC TTGCG TGCGC GCGCG CGCGT GCGTT CGTTA GTTAC TTACT TACTA ACTAA CTAAA TAAAG AAAGT AAGTC AGTCA GTCAG TCAGC CAGCA AGCAC GCACA CACAG ACAGG CAGGC AGGCT GGCTC GCTCT CTCTG TCTGA CTGAG TGAGA GAGAT AGATT GATTT ATTTT TTTTG TTTGC TTGCA TGCAG GCAGA CAGAT AGATT GATTG ATTGT TTGTG TGTGT GTGTG TGTGT,GGTCTG GTCTGG TCTGGA CTGGAA TGGAAG GGAAGT GAAGTG AAGTGG AGTGGA GTGGAT TGGATG GGATGC GATGCC ATGCCA TGCCAT GCCATC CCATCG CATCGT ATCGTT TCGTTC CGTTCC GTTCCG TTCCGG TCCGGT CCGGTC CGGTCG GGTCGC GTCGCA TCGCAC CGCACC GCACCG CACCGG ACCGGC CCGGCT CGGCTT GGCTTT GCTTTC CTTTCA TTTCAA TTCAAT TCAATG CAATGG AATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGT GTTGTG TTGTGG TGTGGT GTGGTG TGGTGG GGTGGG GTGGGT TGGGTG GGGTGA GGTGAG GTGAGG TGAGGT GAGGTT AGGTTC GGTTCT GTTCTC TTCTCG TCTCGA CTCGAA TCGAAG CGAAGT GAAGTA AAGTAG AGTAGT GTAGTG TAGTGC AGTGCC GTGCCG TGCCGC GCCGCA CCGCAT CGCATC GCATCC CATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGC GATGCC ATGCCG TGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTG AGTTGC GTTGCG TTGCGC TGCGCG GCGCGT CGCGTT GCGTTA CGTTAC GTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGT AAAGTC AAGTCA AGTCAG GTCAGC TCAGCA CAGCAC AGCACA GCACAG CACAGG ACAGGC CAGGCT AGGCTC GGCTCT GCTCTG CTCTGA TCTGAG CTGAGA TGAGAT GAGATT AGATTT GATTTT ATTTTG TTTTGC TTTGCA TTGCAG TGCAGA GCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGT,GGTCTGG GTCTGGA TCTGGAA CTGGAAG TGGAAGT GGAAGTG GAAGTGG AAGTGGA AGTGGAT GTGGATG TGGATGC GGATGCC GATGCCA ATGCCAT TGCCATC GCCATCG CCATCGT CATCGTT ATCGTTC TCGTTCC CGTTCCG GTTCCGG TTCCGGT TCCGGTC CCGGTCG CGGTCGC GGTCGCA GTCGCAC TCGCACC CGCACCG GCACCGG CACCGGC ACCGGCT CCGGCTT CGGCTTT GGCTTTC GCTTTCA CTTTCAA TTTCAAT TTCAATG TCAATGG CAATGGT AATGGTG ATGGTGT TGGTGTT GGTGTTG GTGTTGT TGTTGTG GTTGTGG TTGTGGT TGTGGTG GTGGTGG TGGTGGG GGTGGGT GTGGGTG TGGGTGA GGGTGAG GGTGAGG GTGAGGT TGAGGTT GAGGTTC AGGTTCT GGTTCTC GTTCTCG TTCTCGA TCTCGAA CTCGAAG TCGAAGT CGAAGTA GAAGTAG AAGTAGT AGTAGTG GTAGTGC TAGTGCC AGTGCCG GTGCCGC TGCCGCA GCCGCAT CCGCATC CGCATCC GCATCCA CATCCAG ATCCAGA TCCAGAT CCAGATG CAGATGC AGATGCC GATGCCG ATGCCGA TGCCGAC GCCGACA CCGACAA CGACAAG GACAAGT ACAAGTT CAAGTTG AAGTTGC AGTTGCG GTTGCGC TTGCGCG TGCGCGT GCGCGTT CGCGTTA GCGTTAC CGTTACT GTTACTA TTACTAA TACTAAA ACTAAAG CTAAAGT TAAAGTC AAAGTCA AAGTCAG AGTCAGC GTCAGCA TCAGCAC CAGCACA AGCACAG GCACAGG CACAGGC ACAGGCT CAGGCTC AGGCTCT GGCTCTG GCTCTGA CTCTGAG TCTGAGA CTGAGAT TGAGATT GAGATTT AGATTTT GATTTTG ATTTTGC TTTTGCA TTTGCAG TTGCAGA TGCAGAT GCAGATT CAGATTG AGATTGT GATTGTG ATTGTGT TTGTGTG TGTGTGT,"ID   SYFB_PSEAE              Reviewed;         792 AA.
AC   Q9I0A4;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   05-FEB-2025, entry version 132.
DE   RecName: Full=Phenylalanine--tRNA ligase beta subunit {ECO:0000255|HAMAP-Rule:MF_00283};
DE            EC=6.1.1.20 {ECO:0000255|HAMAP-Rule:MF_00283};
DE   AltName: Full=Phenylalanyl-tRNA synthetase beta subunit {ECO:0000255|HAMAP-Rule:MF_00283};
DE            Short=PheRS {ECO:0000255|HAMAP-Rule:MF_00283};
GN   Name=pheT {ECO:0000255|HAMAP-Rule:MF_00283}; OrderedLocusNames=PA2739;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   ""Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen."";
RL   Nature 406:959-964(2000).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tRNA(Phe) + L-phenylalanine + ATP = L-phenylalanyl-tRNA(Phe) +
CC         AMP + diphosphate + H(+); Xref=Rhea:RHEA:19413, Rhea:RHEA-COMP:9668,
CC         Rhea:RHEA-COMP:9699, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:58095, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78531, ChEBI:CHEBI:456215; EC=6.1.1.20;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00283};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00283};
CC       Note=Binds 2 magnesium ions per tetramer. {ECO:0000255|HAMAP-
CC       Rule:MF_00283};
CC   -!- SUBUNIT: Tetramer of two alpha and two beta subunits.
CC       {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   -!- SIMILARITY: Belongs to the phenylalanyl-tRNA synthetase beta subunit
CC       family. Type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG06127.1; -; Genomic_DNA.
DR   PIR; A83303; A83303.
DR   RefSeq; NP_251429.1; NC_002516.2.
DR   RefSeq; WP_003114408.1; NZ_QZGE01000011.1.
DR   PDB; 4P71; X-ray; 2.79 A; A/B=1-792.
DR   PDB; 4P72; X-ray; 2.62 A; A/B=1-792.
DR   PDB; 4P73; X-ray; 3.03 A; A/B=1-792.
DR   PDB; 4P74; X-ray; 2.70 A; A/B=1-792.
DR   PDB; 4P75; X-ray; 2.96 A; A/B=1-792.
DR   PDBsum; 4P71; -.
DR   PDBsum; 4P72; -.
DR   PDBsum; 4P73; -.
DR   PDBsum; 4P74; -.
DR   PDBsum; 4P75; -.
DR   AlphaFoldDB; Q9I0A4; -.
DR   SMR; Q9I0A4; -.
DR   STRING; 208964.PA2739; -.
DR   BindingDB; Q9I0A4; -.
DR   PaxDb; 208964-PA2739; -.
DR   GeneID; 882969; -.
DR   KEGG; pae:PA2739; -.
DR   PATRIC; fig|208964.12.peg.2864; -.
DR   PseudoCAP; PA2739; -.
DR   HOGENOM; CLU_016891_0_0_6; -.
DR   InParanoid; Q9I0A4; -.
DR   OrthoDB; 9805455at2; -.
DR   PhylomeDB; Q9I0A4; -.
DR   BioCyc; PAER208964:G1FZ6-2778-MONOMER; -.
DR   EvolutionaryTrace; Q9I0A4; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0009328; C:phenylalanine-tRNA ligase complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004826; F:phenylalanine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006432; P:phenylalanyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd00769; PheRS_beta_core; 1.
DR   CDD; cd02796; tRNA_bind_bactPheRS; 1.
DR   FunFam; 2.40.50.140:FF:000045; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.56.10:FF:000002; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.70.380:FF:000001; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.930.10:FF:000022; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.50.40.10:FF:000001; Phenylalanine--tRNA ligase beta subunit; 1.
DR   Gene3D; 3.30.56.10; -; 2.
DR   Gene3D; 3.30.930.10; Bira Bifunctional Protein, Domain 2; 1.
DR   Gene3D; 3.30.70.380; Ferrodoxin-fold anticodon-binding domain; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.50.40.10; Phenylalanyl-trna Synthetase, Chain B, domain 3; 1.
DR   HAMAP; MF_00283; Phe_tRNA_synth_beta1; 1.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR005146; B3/B4_tRNA-bd.
DR   InterPro; IPR009061; DNA-bd_dom_put_sf.
DR   InterPro; IPR005121; Fdx_antiC-bd.
DR   InterPro; IPR036690; Fdx_antiC-bd_sf.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR045060; Phe-tRNA-ligase_IIc_bsu.
DR   InterPro; IPR004532; Phe-tRNA-ligase_IIc_bsu_bact.
DR   InterPro; IPR020825; Phe-tRNA_synthase-like_B3/B4.
DR   InterPro; IPR041616; PheRS_beta_core.
DR   InterPro; IPR002547; tRNA-bd_dom.
DR   InterPro; IPR033714; tRNA_bind_bactPheRS.
DR   InterPro; IPR005147; tRNA_synthase_B5-dom.
DR   NCBIfam; TIGR00472; pheT_bact; 1.
DR   NCBIfam; NF045760; YtpR; 1.
DR   PANTHER; PTHR10947:SF0; PHENYLALANINE--TRNA LIGASE BETA SUBUNIT; 1.
DR   PANTHER; PTHR10947; PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN AND LEUCINE-RICH REPEAT-CONTAINING PROTEIN 47; 1.
DR   Pfam; PF03483; B3_4; 1.
DR   Pfam; PF03484; B5; 1.
DR   Pfam; PF03147; FDX-ACB; 1.
DR   Pfam; PF01588; tRNA_bind; 1.
DR   Pfam; PF17759; tRNA_synthFbeta; 1.
DR   SMART; SM00873; B3_4; 1.
DR   SMART; SM00874; B5; 1.
DR   SMART; SM00896; FDX-ACB; 1.
DR   SUPFAM; SSF54991; Anticodon-binding domain of PheRS; 1.
DR   SUPFAM; SSF55681; Class II aaRS and biotin synthetases; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   SUPFAM; SSF56037; PheT/TilS domain; 1.
DR   SUPFAM; SSF46955; Putative DNA-binding domain; 1.
DR   PROSITE; PS51483; B5; 1.
DR   PROSITE; PS51447; FDX_ACB; 1.
DR   PROSITE; PS50886; TRBD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Protein biosynthesis;
KW   Reference proteome; RNA-binding; tRNA-binding.
FT   CHAIN           1..792
FT                   /note=""Phenylalanine--tRNA ligase beta subunit""
FT                   /id=""PRO_0000126932""
FT   DOMAIN          39..147
FT                   /note=""tRNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   DOMAIN          400..476
FT                   /note=""B5""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   DOMAIN          698..791
FT                   /note=""FDX-ACB""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         454
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         460
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         463
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         464
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   STRAND          2..4
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           5..11
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           18..27
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          31..39
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          43..55
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          63..68
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          73..78
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          88..98
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            99..101
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          107..109
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          112..114
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          116..118
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           122..124
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           146..149
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          155..160
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           166..168
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           171..182
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          204..208
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            209..211
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          213..222
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           231..238
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            239..241
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           247..259
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          264..267
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           268..270
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          273..279
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          285..288
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          293..295
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          300..304
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          306..312
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            313..315
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          316..318
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            319..321
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          330..336
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           339..342
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            343..346
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           347..349
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           354..361
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            365..367
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           368..383
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          386..394
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           396..398
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          405..408
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           409..416
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           422..431
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          435..438
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          443..447
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           458..469
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           471..473
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          480..482
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          490..492
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           495..504
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          514..516
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           518..524
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           539..541
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           549..560
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            561..563
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          567..578
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            580..582
FT                   /evidence=""ECO:0007829|PDB:4P74""
FT   STRAND          584..598
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           611..622
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   TURN            623..625
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           628..630
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          631..635
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          641..651
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          654..662
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           664..669
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          676..682
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           683..685
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          703..712
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           717..727
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          732..741
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          743..746
FT                   /evidence=""ECO:0007829|PDB:4P73""
FT   STRAND          750..759
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   STRAND          762..764
FT                   /evidence=""ECO:0007829|PDB:4P72""
FT   HELIX           768..786
FT                   /evidence=""ECO:0007829|PDB:4P72""
SQ   SEQUENCE   792 AA;  86800 MW;  118328D5656EAE76 CRC64;
     MKFSEKWLRS WANPQVSHDE LVARLSMVGL EVDADLPVAG AFSGVVVGEV LSTEQHPDAD
     KLRVCQVSNG SETFQVVCGA PNVRAGLKIP FAMIGAELPD DFKIKKAKLR GVESFGMLCS
     AKELQISEEN AGLLELPADA PVGQDVRTYL ELADYTIEVG LTPNRGDCLS LAGLAREVSA
     IYDVPLAPVA VDAVAAQHDE TRPVELAAPA ACPRYLGRVI RNVDLSRPTP LWMVERLRRS
     DIRSIDPVVD VTNYVMIELG QPMHAFDLAE INGGVRVRMA EDGEKLVLLD GQEITLRADT
     LVIADHQRAL AIAGVMGGEH SGVSDSTRDL FLEAAFFDTI ALAGKARSYG LHTDSSHRFE
     RGVDSQLARK AMERATRLIL DIVGGEPGPI VEQVSEAHLP KVAPITLRAE RVTQMLGMPL
     DAAEIVRLLQ ALELTVVADG EGQWSVGVPS HRFDISLEVD LIEELARLYG YNRLPVRYPQ
     ARLAPNNKPE ARAALPLLRR LLVARGYQEA ITFSFIDPAL FELFDPGTQP LTLANPISAD
     MAAMRSSLWP GLVKALQHNL NRQQSRVRLF ESGLRFVGQL EGLKQEAMLA GAICGKRLPE
     GWANGRDGVD FFDAKADVEA VLASAGALGD FSFVPGEHPA LHPGQTARIE REGRLVGYLG
     ALHPELAKKL DLEQPVFLFE LLLAEVVDGH LPKFRELSRF PEVRRDLALL VDQDVPAQDI
     LTQIRAAAGE WLTDLRLFDV YHGKGIDPHR KSLAVGLTWQ HPSRTLNDDE VNSTTQNIVT
     SLEERFNATL RK
//
",22682
ACACTG CACTGT ACTGTA CTGTAT TGTATG GTATGT TATGTA ATGTAA TGTAAC GTAACC TAACCC AACCCT ACCCTG CCCTGG CCTGGA CTGGAA TGGAAC GGAACC GAACCC AACCCT ACCCTG CCCTGT CCTGTC CTGTCT TGTCTC GTCTCA TCTCAT CTCATG TCATGT CATGTG ATGTGC TGTGCT GTGCTG TGCTGC GCTGCG CTGCGG TGCGGT GCGGTG CGGTGC GGTGCA GTGCAC TGCACT GCACTC CACTCT ACTCTA CTCTAC TCTACT CTACTG TACTGG ACTGGA CTGGAG TGGAGC GGAGCA GAGCAA AGCAAG GCAAGA CAAGAT AAGATC AGATCG GATCGG ATCGGC TCGGCC CGGCCG GGCCGT GCCGTA CCGTAT CGTATC GTATCG TATCGT ATCGTT TCGTTT CGTTTA GTTTAT TTTATG TTATGG TATGGA ATGGAG TGGAGC GGAGCA GAGCAT AGCATC GCATCG,3,82,ACAC CACT ACTG CTGT TGTA GTAT TATG ATGT TGTA GTAA TAAC AACC ACCC CCCT CCTG CTGG TGGA GGAA GAAC AACC ACCC CCCT CCTG CTGT TGTC GTCT TCTC CTCA TCAT CATG ATGT TGTG GTGC TGCT GCTG CTGC TGCG GCGG CGGT GGTG GTGC TGCA GCAC CACT ACTC CTCT TCTA CTAC TACT ACTG CTGG TGGA GGAG GAGC AGCA GCAA CAAG AAGA AGAT GATC ATCG TCGG CGGC GGCC GCCG CCGT CGTA GTAT TATC ATCG TCGT CGTT GTTT TTTA TTAT TATG ATGG TGGA GGAG GAGC AGCA GCAT CATC ATCG,ACACT CACTG ACTGT CTGTA TGTAT GTATG TATGT ATGTA TGTAA GTAAC TAACC AACCC ACCCT CCCTG CCTGG CTGGA TGGAA GGAAC GAACC AACCC ACCCT CCCTG CCTGT CTGTC TGTCT GTCTC TCTCA CTCAT TCATG CATGT ATGTG TGTGC GTGCT TGCTG GCTGC CTGCG TGCGG GCGGT CGGTG GGTGC GTGCA TGCAC GCACT CACTC ACTCT CTCTA TCTAC CTACT TACTG ACTGG CTGGA TGGAG GGAGC GAGCA AGCAA GCAAG CAAGA AAGAT AGATC GATCG ATCGG TCGGC CGGCC GGCCG GCCGT CCGTA CGTAT GTATC TATCG ATCGT TCGTT CGTTT GTTTA TTTAT TTATG TATGG ATGGA TGGAG GGAGC GAGCA AGCAT GCATC CATCG,ACACTG CACTGT ACTGTA CTGTAT TGTATG GTATGT TATGTA ATGTAA TGTAAC GTAACC TAACCC AACCCT ACCCTG CCCTGG CCTGGA CTGGAA TGGAAC GGAACC GAACCC AACCCT ACCCTG CCCTGT CCTGTC CTGTCT TGTCTC GTCTCA TCTCAT CTCATG TCATGT CATGTG ATGTGC TGTGCT GTGCTG TGCTGC GCTGCG CTGCGG TGCGGT GCGGTG CGGTGC GGTGCA GTGCAC TGCACT GCACTC CACTCT ACTCTA CTCTAC TCTACT CTACTG TACTGG ACTGGA CTGGAG TGGAGC GGAGCA GAGCAA AGCAAG GCAAGA CAAGAT AAGATC AGATCG GATCGG ATCGGC TCGGCC CGGCCG GGCCGT GCCGTA CCGTAT CGTATC GTATCG TATCGT ATCGTT TCGTTT CGTTTA GTTTAT TTTATG TTATGG TATGGA ATGGAG TGGAGC GGAGCA GAGCAT AGCATC GCATCG,ACACTGT CACTGTA ACTGTAT CTGTATG TGTATGT GTATGTA TATGTAA ATGTAAC TGTAACC GTAACCC TAACCCT AACCCTG ACCCTGG CCCTGGA CCTGGAA CTGGAAC TGGAACC GGAACCC GAACCCT AACCCTG ACCCTGT CCCTGTC CCTGTCT CTGTCTC TGTCTCA GTCTCAT TCTCATG CTCATGT TCATGTG CATGTGC ATGTGCT TGTGCTG GTGCTGC TGCTGCG GCTGCGG CTGCGGT TGCGGTG GCGGTGC CGGTGCA GGTGCAC GTGCACT TGCACTC GCACTCT CACTCTA ACTCTAC CTCTACT TCTACTG CTACTGG TACTGGA ACTGGAG CTGGAGC TGGAGCA GGAGCAA GAGCAAG AGCAAGA GCAAGAT CAAGATC AAGATCG AGATCGG GATCGGC ATCGGCC TCGGCCG CGGCCGT GGCCGTA GCCGTAT CCGTATC CGTATCG GTATCGT TATCGTT ATCGTTT TCGTTTA CGTTTAT GTTTATG TTTATGG TTATGGA TATGGAG ATGGAGC TGGAGCA GGAGCAT GAGCATC AGCATCG,"ID   TADA_BUCAP              Reviewed;         151 AA.
AC   Q8K9R4;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   05-FEB-2025, entry version 113.
DE   RecName: Full=tRNA-specific adenosine deaminase {ECO:0000255|HAMAP-Rule:MF_00972};
DE            EC=3.5.4.33 {ECO:0000255|HAMAP-Rule:MF_00972};
GN   Name=tadA {ECO:0000255|HAMAP-Rule:MF_00972};
GN   OrderedLocusNames=BUsg_246;
OS   Buchnera aphidicola subsp. Schizaphis graminum (strain Sg).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Erwiniaceae; Buchnera.
OX   NCBI_TaxID=198804;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Sg;
RX   PubMed=12089438; DOI=10.1126/science.1071278;
RA   Tamas I., Klasson L., Canbaeck B., Naeslund A.K., Eriksson A.-S.,
RA   Wernegreen J.J., Sandstroem J.P., Moran N.A., Andersson S.G.E.;
RT   ""50 million years of genomic stasis in endosymbiotic bacteria."";
RL   Science 296:2376-2379(2002).
CC   -!- FUNCTION: Catalyzes the deamination of adenosine to inosine at the
CC       wobble position 34 of tRNA(Arg2). {ECO:0000255|HAMAP-Rule:MF_00972}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine(34) in tRNA + H2O + H(+) = inosine(34) in tRNA +
CC         NH4(+); Xref=Rhea:RHEA:43168, Rhea:RHEA-COMP:10373, Rhea:RHEA-
CC         COMP:10374, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:74411, ChEBI:CHEBI:82852; EC=3.5.4.33;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00972};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00972};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_00972};
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_00972}.
CC   -!- SIMILARITY: Belongs to the cytidine and deoxycytidylate deaminase
CC       family. {ECO:0000255|HAMAP-Rule:MF_00972}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE013218; AAM67805.1; -; Genomic_DNA.
DR   RefSeq; WP_011053772.1; NC_004061.1.
DR   AlphaFoldDB; Q8K9R4; -.
DR   SMR; Q8K9R4; -.
DR   STRING; 198804.BUsg_246; -.
DR   GeneID; 93003716; -.
DR   KEGG; bas:BUsg_246; -.
DR   eggNOG; COG0590; Bacteria.
DR   HOGENOM; CLU_025810_3_0_6; -.
DR   Proteomes; UP000000416; Chromosome.
DR   GO; GO:0052717; F:tRNA-specific adenosine-34 deaminase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0002100; P:tRNA wobble adenosine to inosine editing; IEA:UniProtKB-UniRule.
DR   CDD; cd01285; nucleoside_deaminase; 1.
DR   Gene3D; 3.40.140.10; Cytidine Deaminase, domain 2; 1.
DR   HAMAP; MF_00972; tRNA_aden_deaminase; 1.
DR   InterPro; IPR016192; APOBEC/CMP_deaminase_Zn-bd.
DR   InterPro; IPR002125; CMP_dCMP_dom.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR028883; tRNA_aden_deaminase.
DR   PANTHER; PTHR11079; CYTOSINE DEAMINASE FAMILY MEMBER; 1.
DR   PANTHER; PTHR11079:SF202; TRNA-SPECIFIC ADENOSINE DEAMINASE; 1.
DR   Pfam; PF14437; MafB19-deam; 1.
DR   SUPFAM; SSF53927; Cytidine deaminase-like; 1.
DR   PROSITE; PS00903; CYT_DCMP_DEAMINASES_1; 1.
DR   PROSITE; PS51747; CYT_DCMP_DEAMINASES_2; 1.
PE   3: Inferred from homology;
KW   Hydrolase; Metal-binding; tRNA processing; Zinc.
FT   CHAIN           1..151
FT                   /note=""tRNA-specific adenosine deaminase""
FT                   /id=""PRO_0000171730""
FT   DOMAIN          4..122
FT                   /note=""CMP/dCMP-type deaminase""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01083""
FT   ACT_SITE        57
FT                   /note=""Proton donor""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00972""
FT   BINDING         55
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /ligand_note=""catalytic""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00972""
FT   BINDING         85
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /ligand_note=""catalytic""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00972""
FT   BINDING         88
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /ligand_note=""catalytic""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00972""
SQ   SEQUENCE   151 AA;  17502 MW;  8B3F699B11203951 CRC64;
     MKSNRDSYWM KIALKYAYYA EENGEVPIGA ILVFQEKIIG TGWNSVISQN DSTAHAEIIA
     LREAGRNIKN YRLVNTTLYV TLQPCMMCCG AIINSRIKRL VFGASYKDLK KNPFLKKIFI
     NLEKNKLKIK KHIMRNECAK ILSNFFKNKR F
//
",46537
AAGAGA AGAGAG GAGAGG AGAGGT GAGGTG AGGTGA GGTGAT GTGATA TGATAA GATAAA ATAAAA TAAAAG AAAAGT AAAGTG AAGTGT AGTGTA GTGTAT TGTATA GTATAT TATATT ATATTA TATTAC ATTACA TTACAC TACACT ACACTA CACTAG ACTAGT CTAGTA TAGTAA AGTAAT GTAATC TAATCC AATCCT ATCCTA TCCTAC CCTACC CTACCA TACCAC ACCACA CCACAT CACATT ACATTC CATTCC ATTCCA TTCCAC TCCACC CCACCT CACCTA ACCTAG CCTAGA CTAGAT TAGATG AGATGG GATGGT ATGGTG TGGTGA GGTGAA GTGAAG TGAAGT GAAGTT AAGTTA AGTTAT GTTATC TTATCA TATCAC ATCACC TCACCT CACCTT ACCTTT CCTTTG CTTTGA TTTGAC TTGACA TGACAA GACAAT ACAATC CAATCT AATCTT ATCTTA TCTTAA CTTAAG TTAAGA TAAGAC AAGACA AGACAC GACACC ACACCT CACCTG ACCTGT CCTGTT CTGTTG TGTTGC GTTGCT TTGCTT TGCTTA GCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATC ACATCT CATCTC ATCTCC TCTCCG CTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA TCGTAT CGTATG GTATGC TATGCC ATGCCG TGCCGT GCCGTC CCGTCT CGTCTT,0,145,AAGA AGAG GAGA AGAG GAGG AGGT GGTG GTGA TGAT GATA ATAA TAAA AAAA AAAG AAGT AGTG GTGT TGTA GTAT TATA ATAT TATT ATTA TTAC TACA ACAC CACT ACTA CTAG TAGT AGTA GTAA TAAT AATC ATCC TCCT CCTA CTAC TACC ACCA CCAC CACA ACAT CATT ATTC TTCC TCCA CCAC CACC ACCT CCTA CTAG TAGA AGAT GATG ATGG TGGT GGTG GTGA TGAA GAAG AAGT AGTT GTTA TTAT TATC ATCA TCAC CACC ACCT CCTT CTTT TTTG TTGA TGAC GACA ACAA CAAT AATC ATCT TCTT CTTA TTAA TAAG AAGA AGAC GACA ACAC CACC ACCT CCTG CTGT TGTT GTTG TTGC TGCT GCTT CTTA TTAT TATA ATAC TACA ACAC CACA ACAT CATC ATCT TCTC CTCC TCCG CCGA CGAG GAGC AGCC GCCC CCCA CCAC CACG ACGA CGAG GAGA AGAC GACT ACTC CTCC TCCT CCTG CTGA TGAG GAGC AGCA GCAT CATC ATCT TCTC CTCG TCGT CGTA GTAT TATG ATGC TGCC GCCG CCGT CGTC GTCT TCTT,AAGAG AGAGA GAGAG AGAGG GAGGT AGGTG GGTGA GTGAT TGATA GATAA ATAAA TAAAA AAAAG AAAGT AAGTG AGTGT GTGTA TGTAT GTATA TATAT ATATT TATTA ATTAC TTACA TACAC ACACT CACTA ACTAG CTAGT TAGTA AGTAA GTAAT TAATC AATCC ATCCT TCCTA CCTAC CTACC TACCA ACCAC CCACA CACAT ACATT CATTC ATTCC TTCCA TCCAC CCACC CACCT ACCTA CCTAG CTAGA TAGAT AGATG GATGG ATGGT TGGTG GGTGA GTGAA TGAAG GAAGT AAGTT AGTTA GTTAT TTATC TATCA ATCAC TCACC CACCT ACCTT CCTTT CTTTG TTTGA TTGAC TGACA GACAA ACAAT CAATC AATCT ATCTT TCTTA CTTAA TTAAG TAAGA AAGAC AGACA GACAC ACACC CACCT ACCTG CCTGT CTGTT TGTTG GTTGC TTGCT TGCTT GCTTA CTTAT TTATA TATAC ATACA TACAC ACACA CACAT ACATC CATCT ATCTC TCTCC CTCCG TCCGA CCGAG CGAGC GAGCC AGCCC GCCCA CCCAC CCACG CACGA ACGAG CGAGA GAGAC AGACT GACTC ACTCC CTCCT TCCTG CCTGA CTGAG TGAGC GAGCA AGCAT GCATC CATCT ATCTC TCTCG CTCGT TCGTA CGTAT GTATG TATGC ATGCC TGCCG GCCGT CCGTC CGTCT GTCTT,AAGAGA AGAGAG GAGAGG AGAGGT GAGGTG AGGTGA GGTGAT GTGATA TGATAA GATAAA ATAAAA TAAAAG AAAAGT AAAGTG AAGTGT AGTGTA GTGTAT TGTATA GTATAT TATATT ATATTA TATTAC ATTACA TTACAC TACACT ACACTA CACTAG ACTAGT CTAGTA TAGTAA AGTAAT GTAATC TAATCC AATCCT ATCCTA TCCTAC CCTACC CTACCA TACCAC ACCACA CCACAT CACATT ACATTC CATTCC ATTCCA TTCCAC TCCACC CCACCT CACCTA ACCTAG CCTAGA CTAGAT TAGATG AGATGG GATGGT ATGGTG TGGTGA GGTGAA GTGAAG TGAAGT GAAGTT AAGTTA AGTTAT GTTATC TTATCA TATCAC ATCACC TCACCT CACCTT ACCTTT CCTTTG CTTTGA TTTGAC TTGACA TGACAA GACAAT ACAATC CAATCT AATCTT ATCTTA TCTTAA CTTAAG TTAAGA TAAGAC AAGACA AGACAC GACACC ACACCT CACCTG ACCTGT CCTGTT CTGTTG TGTTGC GTTGCT TTGCTT TGCTTA GCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATC ACATCT CATCTC ATCTCC TCTCCG CTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA TCGTAT CGTATG GTATGC TATGCC ATGCCG TGCCGT GCCGTC CCGTCT CGTCTT,AAGAGAG AGAGAGG GAGAGGT AGAGGTG GAGGTGA AGGTGAT GGTGATA GTGATAA TGATAAA GATAAAA ATAAAAG TAAAAGT AAAAGTG AAAGTGT AAGTGTA AGTGTAT GTGTATA TGTATAT GTATATT TATATTA ATATTAC TATTACA ATTACAC TTACACT TACACTA ACACTAG CACTAGT ACTAGTA CTAGTAA TAGTAAT AGTAATC GTAATCC TAATCCT AATCCTA ATCCTAC TCCTACC CCTACCA CTACCAC TACCACA ACCACAT CCACATT CACATTC ACATTCC CATTCCA ATTCCAC TTCCACC TCCACCT CCACCTA CACCTAG ACCTAGA CCTAGAT CTAGATG TAGATGG AGATGGT GATGGTG ATGGTGA TGGTGAA GGTGAAG GTGAAGT TGAAGTT GAAGTTA AAGTTAT AGTTATC GTTATCA TTATCAC TATCACC ATCACCT TCACCTT CACCTTT ACCTTTG CCTTTGA CTTTGAC TTTGACA TTGACAA TGACAAT GACAATC ACAATCT CAATCTT AATCTTA ATCTTAA TCTTAAG CTTAAGA TTAAGAC TAAGACA AAGACAC AGACACC GACACCT ACACCTG CACCTGT ACCTGTT CCTGTTG CTGTTGC TGTTGCT GTTGCTT TTGCTTA TGCTTAT GCTTATA CTTATAC TTATACA TATACAC ATACACA TACACAT ACACATC CACATCT ACATCTC CATCTCC ATCTCCG TCTCCGA CTCCGAG TCCGAGC CCGAGCC CGAGCCC GAGCCCA AGCCCAC GCCCACG CCCACGA CCACGAG CACGAGA ACGAGAC CGAGACT GAGACTC AGACTCC GACTCCT ACTCCTG CTCCTGA TCCTGAG CCTGAGC CTGAGCA TGAGCAT GAGCATC AGCATCT GCATCTC CATCTCG ATCTCGT TCTCGTA CTCGTAT TCGTATG CGTATGC GTATGCC TATGCCG ATGCCGT TGCCGTC GCCGTCT CCGTCTT,"ID   R1A_SARS2               Reviewed;        4405 AA.
AC   P0DTC1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1a;
DE            Short=pp1a;
DE   AltName: Full=ORF1a polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69;
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=RNA-capping enzyme subunit nsp9;
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=Non-structural protein 11;
DE              Short=nsp11;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [5]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [6]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [7]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (NON-STRUCTURAL PROTEIN 10),
RP   MUTAGENESIS OF ASN-4141 AND ASN-4142, AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [8]
RP   REVIEW, SUBUNIT (NON-STRUCTURAL PROTEIN 7), AND SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [9]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [10]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [11]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN
RP   COMPLEX WITH ALPHA-KETOAMIDE INHIBITORS, SUBUNIT (3C-LIKE PROTEINASE NSP5),
RP   ACTIVE SITE, AND ACTIVITY REGULATION.
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE APOENZYME AND
RP   IN COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5), AND CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7 AND NON-STRUCTURAL PROTEIN 8, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 7), AND
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [16]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7 AND NON-STRUCTURAL PROTEIN 8, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 7), AND
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [18]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7 AND NON-STRUCTURAL PROTEIN 8, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 7), AND
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION OF NON-STRUCTURAL PROTEIN 3.
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7 AND NON-STRUCTURAL PROTEIN 8 IN COMPLEX WITH ZINC ION, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), AND FUNCTION (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), CATALYTIC ACTIVITY (NON-STRUCTURAL
RP   PROTEIN 3), ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 3), AND MUTAGENESIS
RP   OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [23]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [24]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   AND INTERACTION WITH HOST TBK1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [25]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), AND SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [26]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [27]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [28]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9 AND NON-STRUCTURAL
RP   PROTEIN 10, AND SUBUNIT (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [29]
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
CC   -!- FUNCTION: [Replicase polyprotein 1a]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by nsp3 and nsp4, while nsp6 zippers
CC       ER membranes and connects to lipid droplets (PubMed:35551511).
CC       {ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [3C-like proteinase nsp5]: Cleaves the C-terminus of
CC       replicase polyprotein at 11 sites (PubMed:32321856). Recognizes
CC       substrates containing the core sequence [ILMVF]-Q-|-[SGACN]
CC       (PubMed:32198291, PubMed:32272481). May cleave human NLRP1 in lung
CC       epithelial cells, thereby activating the NLRP1 inflammasome pathway
CC       (PubMed:35594856). May cleave human GSDMD, triggering alternative
CC       GSDME-mediated epithelial cell death upon activation of the NLRP1
CC       inflammasome, which may enhance the release interleukins 1B, 6, 16 and
CC       18 (PubMed:35594856). Also able to bind an ADP-ribose-1''-phosphate
CC       (ADRP) (PubMed:32198291, PubMed:32272481).
CC       {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481,
CC       ECO:0000269|PubMed:32321856, ECO:0000269|PubMed:32680882,
CC       ECO:0000269|PubMed:35594856}.
CC   -!- FUNCTION: [Non-structural protein 6]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by nsp3 and nsp4, while nsp6 zippers
CC       ER membranes and connects to lipid droplets (LDs) (PubMed:35551511).
CC       LDs are consumed during DMV formation (PubMed:35551511). Binds to host
CC       TBK1 without affecting TBK1 phosphorylation; the interaction with TBK1
CC       decreases IRF3 phosphorylation, which leads to reduced IFN-beta
CC       production (PubMed:32979938). {ECO:0000269|PubMed:32979938,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 7]: Plays a role in viral RNA
CC       synthesis (PubMed:32277040, PubMed:32358203, PubMed:32438371,
CC       PubMed:32526208). Forms a hexadecamer with nsp8 (8 subunits of each)
CC       that may participate in viral replication by acting as a primase.
CC       Alternatively, may synthesize substantially longer products than
CC       oligonucleotide primers (By similarity). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32277040, ECO:0000269|PubMed:32358203,
CC       ECO:0000269|PubMed:32438371, ECO:0000269|PubMed:32526208}.
CC   -!- FUNCTION: [Non-structural protein 8]: Plays a role in viral RNA
CC       synthesis (PubMed:32277040, PubMed:32358203, PubMed:32438371,
CC       PubMed:32526208). Forms a hexadecamer with nsp7 (8 subunits of each)
CC       that may participate in viral replication by acting as a primase.
CC       Alternatively, may synthesize substantially longer products than
CC       oligonucleotide primers (By similarity). Interacts with ribosome signal
CC       recognition particle RNA (SRP) (PubMed:33080218). Together with NSP9,
CC       suppress protein integration into the cell membrane, thereby disrupting
CC       host immune defenses (PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32277040, ECO:0000269|PubMed:32358203,
CC       ECO:0000269|PubMed:32438371, ECO:0000269|PubMed:32526208,
CC       ECO:0000269|PubMed:33080218}.
CC   -!- FUNCTION: [RNA-capping enzyme subunit nsp9]: Catalytic subunit of viral
CC       RNA capping enzyme which catalyzes the RNA guanylyltransferase reaction
CC       for genomic and sub-genomic RNAs (PubMed:35944563). The kinase-like
CC       NiRAN domain of NSP12 transfers RNA to the amino terminus of NSP9,
CC       forming a covalent RNA-protein intermediate (PubMed:35944563).
CC       Subsequently, the NiRAN domain transfers RNA to GDP, forming the core
CC       cap structure GpppA-RNA (PubMed:35944563). The NSP14 and NSP16
CC       methyltransferases then add methyl groups to form functional cap
CC       structures (PubMed:35944563). Interacts with ribosome signal
CC       recognition particle RNA (SRP) (PubMed:33080218). Together with NSP8,
CC       suppress protein integration into the cell membrane, thereby disrupting
CC       host immune defenses (PubMed:33080218). {ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:35944563}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease (By
CC       similarity) and nsp16 2'-O-methyltransferase activities
CC       (PubMed:35944563). Therefore plays an essential role in viral mRNAs cap
CC       methylation. {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:35944563}.
CC   -!- CATALYTIC ACTIVITY: [Papain-like protease nsp3]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:32726803};
CC   -!- CATALYTIC ACTIVITY: [3C-like proteinase nsp5]:
CC       Reaction=TSAVLQ-|-SGFRK-NH2 and SGVTFQ-|-GKFKK the two peptides
CC         corresponding to the two self-cleavage sites of the SARS 3C-like
CC         proteinase are the two most reactive peptide substrates. The enzyme
CC         exhibits a strong preference for substrates containing Gln at P1
CC         position and Leu at P2 position.; EC=3.4.22.69;
CC         Evidence={ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481,
CC         ECO:0000269|PubMed:32321856};
CC   -!- CATALYTIC ACTIVITY: [RNA-capping enzyme subunit nsp9]:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000269|PubMed:35944563};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:67014;
CC         Evidence={ECO:0000269|PubMed:35944563};
CC   -!- ACTIVITY REGULATION: [Non-structural protein 6]: Inhibited ex vivo by
CC       K22. It may shift NSP6 zippering activity towards the nuclear envelope,
CC       thereby impairing formation of the NSP6-compartment necessary for viral
CC       transcription/replication. {ECO:0000269|PubMed:35551511}.
CC   -!- ACTIVITY REGULATION: [Papain-like protease nsp3]: Inhibited in vitro by
CC       GRL-0617. {ECO:0000269|PubMed:32726803}.
CC   -!- ACTIVITY REGULATION: [3C-like proteinase nsp5]: Inhibited by pyridone-
CC       containing alpha-ketoamides compounds 13a and 13b. In turn, alpha-
CC       ketoamide 13b (tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-
CC       ((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-
CC       2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate) inhibits SARS-CoV-2
CC       replication in human lung cells (PubMed:32198291). Inhibited ex vivo by
CC       michael acceptor inhibitor N3 (PubMed:32272481). Inhibited ex vivo by
CC       compound 11a and 11b (PubMed:32321856). {ECO:0000269|PubM",52888
ATGGAG TGGAGA GGAGAG GAGAGC AGAGCC GAGCCT AGCCTT GCCTTG CCTTGT CTTGTC TTGTCC TGTCCC GTCCCT TCCCTG CCCTGG CCTGGT CTGGTT TGGTTT GGTTTC GTTTCA TTTCAA TTCAAC TCAACG CAACGA AACGAG ACGAGA CGAGAA GAGAAA AGAAAA GAAAAC AAAACA AAACAC AACACA ACACAC CACACG ACACGT CACGTC ACGTCC CGTCCA GTCCAA TCCAAC CCAACT CAACTC AACTCA ACTCAG CTCAGT TCAGTT CAGTTT AGTTTG GTTTGC TTTGCC TTGCCT TGCCTG GCCTGT CCTGTT CTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGG ACAGGT CAGGTT AGGTTC GGTTCG GTTCGC TTCGCG TCGCGA CGCGAC GCGACG CGACGT GACGTG ACGTGC CGTGCT GTGCTC TGCTCG GCTCGT CTCGTA,0,79,ATGG TGGA GGAG GAGA AGAG GAGC AGCC GCCT CCTT CTTG TTGT TGTC GTCC TCCC CCCT CCTG CTGG TGGT GGTT GTTT TTTC TTCA TCAA CAAC AACG ACGA CGAG GAGA AGAA GAAA AAAA AAAC AACA ACAC CACA ACAC CACG ACGT CGTC GTCC TCCA CCAA CAAC AACT ACTC CTCA TCAG CAGT AGTT GTTT TTTG TTGC TGCC GCCT CCTG CTGT TGTT GTTT TTTT TTTA TTAC TACA ACAG CAGG AGGT GGTT GTTC TTCG TCGC CGCG GCGA CGAC GACG ACGT CGTG GTGC TGCT GCTC CTCG TCGT CGTA,ATGGA TGGAG GGAGA GAGAG AGAGC GAGCC AGCCT GCCTT CCTTG CTTGT TTGTC TGTCC GTCCC TCCCT CCCTG CCTGG CTGGT TGGTT GGTTT GTTTC TTTCA TTCAA TCAAC CAACG AACGA ACGAG CGAGA GAGAA AGAAA GAAAA AAAAC AAACA AACAC ACACA CACAC ACACG CACGT ACGTC CGTCC GTCCA TCCAA CCAAC CAACT AACTC ACTCA CTCAG TCAGT CAGTT AGTTT GTTTG TTTGC TTGCC TGCCT GCCTG CCTGT CTGTT TGTTT GTTTT TTTTA TTTAC TTACA TACAG ACAGG CAGGT AGGTT GGTTC GTTCG TTCGC TCGCG CGCGA GCGAC CGACG GACGT ACGTG CGTGC GTGCT TGCTC GCTCG CTCGT TCGTA,ATGGAG TGGAGA GGAGAG GAGAGC AGAGCC GAGCCT AGCCTT GCCTTG CCTTGT CTTGTC TTGTCC TGTCCC GTCCCT TCCCTG CCCTGG CCTGGT CTGGTT TGGTTT GGTTTC GTTTCA TTTCAA TTCAAC TCAACG CAACGA AACGAG ACGAGA CGAGAA GAGAAA AGAAAA GAAAAC AAAACA AAACAC AACACA ACACAC CACACG ACACGT CACGTC ACGTCC CGTCCA GTCCAA TCCAAC CCAACT CAACTC AACTCA ACTCAG CTCAGT TCAGTT CAGTTT AGTTTG GTTTGC TTTGCC TTGCCT TGCCTG GCCTGT CCTGTT CTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGG ACAGGT CAGGTT AGGTTC GGTTCG GTTCGC TTCGCG TCGCGA CGCGAC GCGACG CGACGT GACGTG ACGTGC CGTGCT GTGCTC TGCTCG GCTCGT CTCGTA,ATGGAGA TGGAGAG GGAGAGC GAGAGCC AGAGCCT GAGCCTT AGCCTTG GCCTTGT CCTTGTC CTTGTCC TTGTCCC TGTCCCT GTCCCTG TCCCTGG CCCTGGT CCTGGTT CTGGTTT TGGTTTC GGTTTCA GTTTCAA TTTCAAC TTCAACG TCAACGA CAACGAG AACGAGA ACGAGAA CGAGAAA GAGAAAA AGAAAAC GAAAACA AAAACAC AAACACA AACACAC ACACACG CACACGT ACACGTC CACGTCC ACGTCCA CGTCCAA GTCCAAC TCCAACT CCAACTC CAACTCA AACTCAG ACTCAGT CTCAGTT TCAGTTT CAGTTTG AGTTTGC GTTTGCC TTTGCCT TTGCCTG TGCCTGT GCCTGTT CCTGTTT CTGTTTT TGTTTTA GTTTTAC TTTTACA TTTACAG TTACAGG TACAGGT ACAGGTT CAGGTTC AGGTTCG GGTTCGC GTTCGCG TTCGCGA TCGCGAC CGCGACG GCGACGT CGACGTG GACGTGC ACGTGCT CGTGCTC GTGCTCG TGCTCGT GCTCGTA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",52808
CTGTAT TGTATG GTATGT TATGTG ATGTGC TGTGCC GTGCCG TGCCGG GCCGGA CCGGAG CGGAGA GGAGAA GAGAAA AGAAAA GAAAAA AAAAAT AAAATC AAATCA AATCAG ATCAGG TCAGGA CAGGAT AGGATG GGATGA GATGAC ATGACA TGACAT GACATC ACATCC CATCCC ATCCCG TCCCGA CCCGAT CCGATT CGATTT GATTTT ATTTTC TTTTCG TTTCGA TTCGAC TCGACA CGACAC GACACC ACACCA CACCAG ACCAGC CCAGCG CAGCGA AGCGAA GCGAAA CGAAAG GAAAGC AAAGCA AAGCAC AGCACT GCACTT CACTTT ACTTTC CTTTCA TTTCAG TTCAGC TCAGCT CAGCTA AGCTAC,2,64,CTGT TGTA GTAT TATG ATGT TGTG GTGC TGCC GCCG CCGG CGGA GGAG GAGA AGAA GAAA AAAA AAAA AAAT AATC ATCA TCAG CAGG AGGA GGAT GATG ATGA TGAC GACA ACAT CATC ATCC TCCC CCCG CCGA CGAT GATT ATTT TTTT TTTC TTCG TCGA CGAC GACA ACAC CACC ACCA CCAG CAGC AGCG GCGA CGAA GAAA AAAG AAGC AGCA GCAC CACT ACTT CTTT TTTC TTCA TCAG CAGC AGCT GCTA CTAC,CTGTA TGTAT GTATG TATGT ATGTG TGTGC GTGCC TGCCG GCCGG CCGGA CGGAG GGAGA GAGAA AGAAA GAAAA AAAAA AAAAT AAATC AATCA ATCAG TCAGG CAGGA AGGAT GGATG GATGA ATGAC TGACA GACAT ACATC CATCC ATCCC TCCCG CCCGA CCGAT CGATT GATTT ATTTT TTTTC TTTCG TTCGA TCGAC CGACA GACAC ACACC CACCA ACCAG CCAGC CAGCG AGCGA GCGAA CGAAA GAAAG AAAGC AAGCA AGCAC GCACT CACTT ACTTT CTTTC TTTCA TTCAG TCAGC CAGCT AGCTA GCTAC,CTGTAT TGTATG GTATGT TATGTG ATGTGC TGTGCC GTGCCG TGCCGG GCCGGA CCGGAG CGGAGA GGAGAA GAGAAA AGAAAA GAAAAA AAAAAT AAAATC AAATCA AATCAG ATCAGG TCAGGA CAGGAT AGGATG GGATGA GATGAC ATGACA TGACAT GACATC ACATCC CATCCC ATCCCG TCCCGA CCCGAT CCGATT CGATTT GATTTT ATTTTC TTTTCG TTTCGA TTCGAC TCGACA CGACAC GACACC ACACCA CACCAG ACCAGC CCAGCG CAGCGA AGCGAA GCGAAA CGAAAG GAAAGC AAAGCA AAGCAC AGCACT GCACTT CACTTT ACTTTC CTTTCA TTTCAG TTCAGC TCAGCT CAGCTA AGCTAC,CTGTATG TGTATGT GTATGTG TATGTGC ATGTGCC TGTGCCG GTGCCGG TGCCGGA GCCGGAG CCGGAGA CGGAGAA GGAGAAA GAGAAAA AGAAAAA GAAAAAT AAAAATC AAAATCA AAATCAG AATCAGG ATCAGGA TCAGGAT CAGGATG AGGATGA GGATGAC GATGACA ATGACAT TGACATC GACATCC ACATCCC CATCCCG ATCCCGA TCCCGAT CCCGATT CCGATTT CGATTTT GATTTTC ATTTTCG TTTTCGA TTTCGAC TTCGACA TCGACAC CGACACC GACACCA ACACCAG CACCAGC ACCAGCG CCAGCGA CAGCGAA AGCGAAA GCGAAAG CGAAAGC GAAAGCA AAAGCAC AAGCACT AGCACTT GCACTTT CACTTTC ACTTTCA CTTTCAG TTTCAGC TTCAGCT TCAGCTA CAGCTAC,"ID   LPTD_PSE14              Reviewed;         926 AA.
AC   Q48NT4;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   05-FEB-2025, entry version 84.
DE   RecName: Full=LPS-assembly protein LptD {ECO:0000255|HAMAP-Rule:MF_01411};
DE   Flags: Precursor;
GN   Name=lptD {ECO:0000255|HAMAP-Rule:MF_01411}; Synonyms=imp, ostA;
GN   OrderedLocusNames=PSPPH_0636;
OS   Pseudomonas savastanoi pv. phaseolicola (strain 1448A / Race 6)
OS   (Pseudomonas syringae pv. phaseolicola (strain 1448A / Race 6)).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=264730;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1448A / Race 6;
RX   PubMed=16159782; DOI=10.1128/jb.187.18.6488-6498.2005;
RA   Joardar V., Lindeberg M., Jackson R.W., Selengut J., Dodson R.,
RA   Brinkac L.M., Daugherty S.C., DeBoy R.T., Durkin A.S., Gwinn Giglio M.,
RA   Madupu R., Nelson W.C., Rosovitz M.J., Sullivan S.A., Crabtree J.,
RA   Creasy T., Davidsen T.M., Haft D.H., Zafar N., Zhou L., Halpin R.,
RA   Holley T., Khouri H.M., Feldblyum T.V., White O., Fraser C.M.,
RA   Chatterjee A.K., Cartinhour S., Schneider D., Mansfield J.W., Collmer A.,
RA   Buell R.;
RT   ""Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola
RT   1448A reveals divergence among pathovars in genes involved in virulence and
RT   transposition."";
RL   J. Bacteriol. 187:6488-6498(2005).
CC   -!- FUNCTION: Together with LptE, is involved in the assembly of
CC       lipopolysaccharide (LPS) at the surface of the outer membrane.
CC       {ECO:0000255|HAMAP-Rule:MF_01411}.
CC   -!- SUBUNIT: Component of the lipopolysaccharide transport and assembly
CC       complex. Interacts with LptE and LptA. {ECO:0000255|HAMAP-
CC       Rule:MF_01411}.
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01411}.
CC   -!- SIMILARITY: Belongs to the LptD family. {ECO:0000255|HAMAP-
CC       Rule:MF_01411}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAZ34876.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000058; AAZ34876.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; WP_019741166.1; NC_005773.3.
DR   AlphaFoldDB; Q48NT4; -.
DR   SMR; Q48NT4; -.
DR   KEGG; psp:PSPPH_0636; -.
DR   eggNOG; COG1452; Bacteria.
DR   HOGENOM; CLU_009039_1_0_6; -.
DR   Proteomes; UP000000551; Chromosome.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1990351; C:transporter complex; IEA:TreeGrafter.
DR   GO; GO:0043165; P:Gram-negative-bacterium-type cell outer membrane assembly; IEA:UniProtKB-UniRule.
DR   GO; GO:0015920; P:lipopolysaccharide transport; IEA:InterPro.
DR   Gene3D; 2.60.450.10; Lipopolysaccharide (LPS) transport protein A like domain; 1.
DR   HAMAP; MF_01411; LPS_assembly_LptD; 1.
DR   InterPro; IPR020889; LipoPS_assembly_LptD.
DR   InterPro; IPR050218; LptD.
DR   InterPro; IPR007543; LptD_C.
DR   InterPro; IPR005653; OstA-like_N.
DR   PANTHER; PTHR30189; LPS-ASSEMBLY PROTEIN; 1.
DR   PANTHER; PTHR30189:SF1; LPS-ASSEMBLY PROTEIN LPTD; 1.
DR   Pfam; PF04453; LptD; 1.
DR   Pfam; PF03968; LptD_N; 1.
PE   3: Inferred from homology;
KW   Cell outer membrane; Membrane; Signal.
FT   SIGNAL          1..22
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01411""
FT   CHAIN           23..926
FT                   /note=""LPS-assembly protein LptD""
FT                   /id=""PRO_0000281627""
FT   REGION          58..99
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
SQ   SEQUENCE   926 AA;  104603 MW;  848590894FE84194 CRC64;
     MALKSPAFRK KFPLLVTGSL LAMQPLATQF VVAAEQYDCS VSASGAWNCA PKSNAAAVDL
     PPRPVHDTTS VSSNGTVTSQ STSSGEQVAG TQLVTEAKGK GLRSRSADYS HLDWVPREKL
     TAAQLAETGP YCSGAYVEPI RPGMDDKTPM KDAPMFVGAK ASRYEQEAQV ATLAGDVVLR
     QGSMQVQAQE AALHQAENRG ELNGDVRLRD NGALIVGDKA ELQLDTGEAR VDNAEYVLHK
     SNIRGNALYA KRAENAIIRL KDGTYTTCEP NSNAWTLKGN NITLNPATGF GTATNVTLRV
     KDIPVLYTPY IYFPIDDRRQ SGFLPPTIAA GGDNGFTLVT PYYFNLAPNY DATLYPRYMA
     DRGLLMEGEF RYLTKGSEGQ FGGAYLNDEN DDRKLQSDYD KTRWMINWQH KGGLDTRWLT
     QVDYTDISDP YYFQDLETDQ IGVKRTDFLN QQGSLTYRGD SYAATLNAQA YKLATVANIT
     PYNRLPQLTL NGTLPYNPGG LKFDYQTEAV RFERDLRSGA FIDEDGNSET RLDNNISGLA
     RANGDRLNLA PSVSLPMNWT YGFLTPKLKY VYTQYALDLD SQGKSSLLAG EEYSSSQSRS
     VPIFSVDSGL YFDRNTNWFG KDYRQTLEPR LFYLYVPEKD QTDIPVFDTS ESTFNYASLF
     RDNRFTGSDR IGDENKLSLG ITNRWIEDNG FERQRFSIGQ ALYFEDRKVQ LPGVVFADRD
     DARANVSPYA LEYEYRFNRD WRFNSDFNWD PDSKSTRSGS AMFHYQPEDN PNKIVNLGYR
     YRNDQIRYDE STGRWIVGGG DYGRPGDANY VKDYYKIQQH DFSVIWPIVP QWSLISRWQY
     DYNRERTIEA FGGFEYDNCC WKMRLVNRYW VDYDEFSQAA PQNEKGDRGI FLQIVLKGLG
     GVTGAKVDSF LDKGIQGYRE REDQAF
//
",26690
CAATAT AATATG ATATGA TATGAG ATGAGT TGAGTA GAGTAT AGTATG GTATGG TATGGT ATGGTA TGGTAC GGTACT GTACTG TACTGA ACTGAA CTGAAG TGAAGA GAAGAT AAGATG AGATGA GATGAT ATGATT TGATTA GATTAC ATTACC TTACCA TACCAA ACCAAG CCAAGG CAAGGT AAGGTA AGGTAA GGTAAA GTAAAC TAAACC AAACCT AACCTT ACCTTT CCTTTG CTTTGG TTTGGA TTGGAA TGGAAT GGAATT GAATTT AATTTG ATTTGG TTTGGT TTGGTG TGGTGC GGTGCC GTGCCA TGCCAC GCCACT CCACTT CACTTC ACTTCT CTTCTG TTCTGC TCTGCT CTGCTG TGCTGC GCTGCT CTGCTC TGCTCT GCTCTT CTCTTC TCTTCA CTTCAA TTCAAC TCAACC CAACCT AACCTG ACCTGA CCTGAA CTGAAG TGAAGA GAAGAA AAGAAG AGAAGA GAAGAG AAGAGC AGAGCA GAGCAA AGCAAG GCAAGA CAAGAA AAGAAG AGAAGA GAAGAA AAGAAG AGAAGA GAAGAT AAGATT AGATTG GATTGG ATTGGT TTGGTT TGGTTA GGTTAG GTTAGA TTAGAT TAGATG AGATGA GATGAT ATGATG TGATGA GATGAT ATGATA TGATAG GATAGT ATAGTC TAGTCC AGTCCT GTCCTG TCCTGT CCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA,0,145,CAAT AATA ATAT TATG ATGA TGAG GAGT AGTA GTAT TATG ATGG TGGT GGTA GTAC TACT ACTG CTGA TGAA GAAG AAGA AGAT GATG ATGA TGAT GATT ATTA TTAC TACC ACCA CCAA CAAG AAGG AGGT GGTA GTAA TAAA AAAC AACC ACCT CCTT CTTT TTTG TTGG TGGA GGAA GAAT AATT ATTT TTTG TTGG TGGT GGTG GTGC TGCC GCCA CCAC CACT ACTT CTTC TTCT TCTG CTGC TGCT GCTG CTGC TGCT GCTC CTCT TCTT CTTC TTCA TCAA CAAC AACC ACCT CCTG CTGA TGAA GAAG AAGA AGAA GAAG AAGA AGAG GAGC AGCA GCAA CAAG AAGA AGAA GAAG AAGA AGAA GAAG AAGA AGAT GATT ATTG TTGG TGGT GGTT GTTA TTAG TAGA AGAT GATG ATGA TGAT GATG ATGA TGAT GATA ATAG TAGT AGTC GTCC TCCT CCTG CTGT TGTC GTCT TCTC CTCT TCTT CTTA TTAT TATA ATAC TACA ACAC CACA ACAT CATT ATTC TTCC TCCG CCGA CGAG GAGC AGCC GCCC CCCA CCAC CACG ACGA CGAG GAGA,CAATA AATAT ATATG TATGA ATGAG TGAGT GAGTA AGTAT GTATG TATGG ATGGT TGGTA GGTAC GTACT TACTG ACTGA CTGAA TGAAG GAAGA AAGAT AGATG GATGA ATGAT TGATT GATTA ATTAC TTACC TACCA ACCAA CCAAG CAAGG AAGGT AGGTA GGTAA GTAAA TAAAC AAACC AACCT ACCTT CCTTT CTTTG TTTGG TTGGA TGGAA GGAAT GAATT AATTT ATTTG TTTGG TTGGT TGGTG GGTGC GTGCC TGCCA GCCAC CCACT CACTT ACTTC CTTCT TTCTG TCTGC CTGCT TGCTG GCTGC CTGCT TGCTC GCTCT CTCTT TCTTC CTTCA TTCAA TCAAC CAACC AACCT ACCTG CCTGA CTGAA TGAAG GAAGA AAGAA AGAAG GAAGA AAGAG AGAGC GAGCA AGCAA GCAAG CAAGA AAGAA AGAAG GAAGA AAGAA AGAAG GAAGA AAGAT AGATT GATTG ATTGG TTGGT TGGTT GGTTA GTTAG TTAGA TAGAT AGATG GATGA ATGAT TGATG GATGA ATGAT TGATA GATAG ATAGT TAGTC AGTCC GTCCT TCCTG CCTGT CTGTC TGTCT GTCTC TCTCT CTCTT TCTTA CTTAT TTATA TATAC ATACA TACAC ACACA CACAT ACATT CATTC ATTCC TTCCG TCCGA CCGAG CGAGC GAGCC AGCCC GCCCA CCCAC CCACG CACGA ACGAG CGAGA,CAATAT AATATG ATATGA TATGAG ATGAGT TGAGTA GAGTAT AGTATG GTATGG TATGGT ATGGTA TGGTAC GGTACT GTACTG TACTGA ACTGAA CTGAAG TGAAGA GAAGAT AAGATG AGATGA GATGAT ATGATT TGATTA GATTAC ATTACC TTACCA TACCAA ACCAAG CCAAGG CAAGGT AAGGTA AGGTAA GGTAAA GTAAAC TAAACC AAACCT AACCTT ACCTTT CCTTTG CTTTGG TTTGGA TTGGAA TGGAAT GGAATT GAATTT AATTTG ATTTGG TTTGGT TTGGTG TGGTGC GGTGCC GTGCCA TGCCAC GCCACT CCACTT CACTTC ACTTCT CTTCTG TTCTGC TCTGCT CTGCTG TGCTGC GCTGCT CTGCTC TGCTCT GCTCTT CTCTTC TCTTCA CTTCAA TTCAAC TCAACC CAACCT AACCTG ACCTGA CCTGAA CTGAAG TGAAGA GAAGAA AAGAAG AGAAGA GAAGAG AAGAGC AGAGCA GAGCAA AGCAAG GCAAGA CAAGAA AAGAAG AGAAGA GAAGAA AAGAAG AGAAGA GAAGAT AAGATT AGATTG GATTGG ATTGGT TTGGTT TGGTTA GGTTAG GTTAGA TTAGAT TAGATG AGATGA GATGAT ATGATG TGATGA GATGAT ATGATA TGATAG GATAGT ATAGTC TAGTCC AGTCCT GTCCTG TCCTGT CCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA,CAATATG AATATGA ATATGAG TATGAGT ATGAGTA TGAGTAT GAGTATG AGTATGG GTATGGT TATGGTA ATGGTAC TGGTACT GGTACTG GTACTGA TACTGAA ACTGAAG CTGAAGA TGAAGAT GAAGATG AAGATGA AGATGAT GATGATT ATGATTA TGATTAC GATTACC ATTACCA TTACCAA TACCAAG ACCAAGG CCAAGGT CAAGGTA AAGGTAA AGGTAAA GGTAAAC GTAAACC TAAACCT AAACCTT AACCTTT ACCTTTG CCTTTGG CTTTGGA TTTGGAA TTGGAAT TGGAATT GGAATTT GAATTTG AATTTGG ATTTGGT TTTGGTG TTGGTGC TGGTGCC GGTGCCA GTGCCAC TGCCACT GCCACTT CCACTTC CACTTCT ACTTCTG CTTCTGC TTCTGCT TCTGCTG CTGCTGC TGCTGCT GCTGCTC CTGCTCT TGCTCTT GCTCTTC CTCTTCA TCTTCAA CTTCAAC TTCAACC TCAACCT CAACCTG AACCTGA ACCTGAA CCTGAAG CTGAAGA TGAAGAA GAAGAAG AAGAAGA AGAAGAG GAAGAGC AAGAGCA AGAGCAA GAGCAAG AGCAAGA GCAAGAA CAAGAAG AAGAAGA AGAAGAA GAAGAAG AAGAAGA AGAAGAT GAAGATT AAGATTG AGATTGG GATTGGT ATTGGTT TTGGTTA TGGTTAG GGTTAGA GTTAGAT TTAGATG TAGATGA AGATGAT GATGATG ATGATGA TGATGAT GATGATA ATGATAG TGATAGT GATAGTC ATAGTCC TAGTCCT AGTCCTG GTCCTGT TCCTGTC CCTGTCT CTGTCTC TGTCTCT GTCTCTT TCTCTTA CTCTTAT TCTTATA CTTATAC TTATACA TATACAC ATACACA TACACAT ACACATT CACATTC ACATTCC CATTCCG ATTCCGA TTCCGAG TCCGAGC CCGAGCC CGAGCCC GAGCCCA AGCCCAC GCCCACG CCCACGA CCACGAG CACGAGA,"ID   R1A_SARS                Reviewed;        4382 AA.
AC   P0C6U8; P59641;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   05-FEB-2025, entry version 124.
DE   RecName: Full=Replicase polyprotein 1a;
DE            Short=pp1a;
DE   AltName: Full=ORF1a polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3;
DE              Short=PL-PRO;
DE              EC=3.4.19.12 {ECO:0000269|PubMed:17692280};
DE              EC=3.4.22.- {ECO:0000269|PubMed:12917450, ECO:0000269|PubMed:16306590, ECO:0000269|PubMed:17692280};
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:12917450};
DE     AltName: Full=Main protease;
DE              Short=Mpro;
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=RNA-capping enzyme subunit nsp9;
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE              EC=2.7.7.50;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=Non-structural protein 11;
DE              Short=nsp11;
GN   ORFNames=1a;
OS   Severe acute respiratory syndrome coronavirus (SARS-CoV).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus.
OX   NCBI_TaxID=694009;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
OH   NCBI_TaxID=9675; Paguma larvata (Masked palm civet).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Urbani;
RX   PubMed=12730500; DOI=10.1126/science.1085952;
RA   Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R.,
RA   Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.-H., Tong S.,
RA   Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D.,
RA   Peret T.C.T., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S.,
RA   Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R.,
RA   Guenther S., Osterhaus A.D.M.E., Drosten C., Pallansch M.A., Anderson L.J.,
RA   Bellini W.J.;
RT   ""Characterization of a novel coronavirus associated with severe acute
RT   respiratory syndrome."";
RL   Science 300:1394-1399(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Tor2;
RX   PubMed=12730501; DOI=10.1126/science.1085953;
RA   Marra M.A., Jones S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A.,
RA   Butterfield Y.S.N., Khattra J., Asano J.K., Barber S.A., Chan S.Y.,
RA   Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R.,
RA   Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S.,
RA   Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M.,
RA   Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K.,
RA   Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R.,
RA   Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A.,
RA   Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S.,
RA   Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M.,
RA   Skowronski D.M., Upton C., Roper R.L.;
RT   ""The genome sequence of the SARS-associated coronavirus."";
RL   Science 300:1399-1404(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate CUHK-Su10, and Isolate CUHK-W1;
RX   PubMed=12853594; DOI=10.1056/nejm200307103490216;
RA   Tsui S.K.W., Chim S.S.C., Lo Y.M.D.;
RT   ""Coronavirus genomic-sequence variations and the epidemiology of the severe
RT   acute respiratory syndrome."";
RL   N. Engl. J. Med. 349:187-188(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate GZ50, Isolate SZ16, and Isolate SZ3;
RX   PubMed=12958366; DOI=10.1126/science.1087139;
RA   Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W.,
RA   Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W.,
RA   Shortridge K.F., Yuen K.Y., Peiris J.S.M., Poon L.L.M.;
RT   ""Isolation and characterization of viruses related to the SARS coronavirus
RT   from animals in southern China."";
RL   Science 302:276-278(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate HKU-39849;
RX   PubMed=12876307; DOI=10.1177/15353702-0322807-13;
RA   Zeng F.Y., Chan C.W., Chan M.N., Chen J.D., Chow K.Y.C., Hon C.C.C.,
RA   Hui R.K.H., Li J., Li V.Y.Y., Wang C.Y., Wang P.Y., Guan Y., Zheng B.,
RA   Poon L.L.M., Chan K.H., Yuen K.Y., Peiris J.S.M., Leung F.C.;
RT   ""The complete genome sequence of severe acute respiratory syndrome
RT   coronavirus strain HKU-39849 (HK-39)."";
RL   Exp. Biol. Med. 228:866-873(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Sin2500, Isolate Sin2677, Isolate Sin2679, Isolate
RC   Sin2748, and Isolate sin2774;
RX   PubMed=12781537; DOI=10.1016/s0140-6736(03)13414-9;
RA   Ruan Y., Wei C.L., Ling A.E., Vega V.B., Thoreau H., Se Thoe S.Y.,
RA   Chia J.-M., Ng P., Chiu K.P., Lim L., Zhang T., Chan K.P., Oon L.E.L.,
RA   Ng M.L., Leo S.Y., Ng L.F.P., Ren E.C., Stanton L.W., Long P.M., Liu E.T.;
RT   ""Comparative full-length genome sequence analysis of 14 SARS coronavirus
RT   isolates and common mutations associated with putative origins of
RT   infection."";
RL   Lancet 361:1779-1785(2003).
RN   [7]
RP   ERRATUM OF PUBMED:12781537.
RA   Ruan Y., Wei C.L., Ling A.E., Vega V.B., Thoreau H., Se Thoe S.Y.,
RA   Chia J.-M., Ng P., Chiu K.P., Lim L., Zhang T., Chan K.P., Oon L.E.L.,
RA   Ng M.L., Leo S.Y., Ng L.F.P., Ren E.C., Stanton L.W., Long P.M., Liu E.T.;
RL   Lancet 361:1832-1832(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate ZJ01;
RX   PubMed=14527350;
RA   Li L., Wang Z., Lu Y., Bao Q., Chen S., Wu N., Cheng S., Weng J., Zhang Y.,
RA   Yan J., Mei L., Wang X., Zhu H., Yu Y., Zhang M., Li M., Yao J., Lu Q.,
RA   Yao P., Bo X., Wo J., Wang S., Hu S.;
RT   ""Severe acute respiratory syndrome-associated coronavirus genotype and its
RT   characterization."";
RL   Chin. Med. J. 116:1288-1292(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate BJ01, Isolate BJ02, Isolate BJ03, Isolate BJ04, and
RC   Isolate GD01;
RA   Qin E., Zhu Q., Yu M., Fan B., Chang G., Si B., Yang B., Peng W., Jiang T.,
RA   Liu B., Deng Y., Liu H., Zhang Y., Wang C., Li Y., Gan Y., Li X., Lu F.,
RA   Tan G., Yang R., Cao W.S., Wang J., Chen W., Cong L., Deng Y., Dong W.,
RA   Han Y., Hu W., Lei M., Li C., Li G., Li G., Li H., Li S., Li S., Li W.,
RA   Li W., Lin W., Liu J., Liu Z., Lu H., Ni P., Qi Q., Sun Y., Tang L.,
RA   Tong Z., Wang J., Wang X., Wu Q., Xi Y., Xu Z., Yang L., Ye C., Ye J.,
RA   Zhang B., Zhang F., Zhang J., Zhang X., Zhou J., Yang H.;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate TW1;
RA   Yeh S.-H., Kao C.-L., Tsai C.-Y., Liu C.-J., Chen D.-S., Chen P.-J.;
RT   ""The complete genome of SARS coronavirus clone TW1."";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate FRA;
RX   PubMed=14645828; DOI=10.1126/science.302.5650.1504b;
RA   Eickmann M., Becker S., Klenk H.-D., Doerr H.W., Stadler K., Censini S.,
RA   Guidotti S., Masignani V., Scarselli M., Mora M., Donati C., Han J.H.,
RA   Song H.C., Abrignani S., Covacci A., Rappuoli R.;
RT   ""Phylogeny of the SARS coronavirus."";
RL   Science 302:1504-1505(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Frankfurt-1;
RA   Thiel V., Hertzig T., Putics A., Ivanov K.A., Schelle B., Bayer S.,
RA   Scheiner B., Weinand H., Weissbrich B., Ziebuhr J.;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate TWC;
RA   Yang J.-Y., Lin J.-H., Chiu S.-C., Wang S.-F., Lee S.C., Lin Y.-C.,
RA   Hsu C.-K., Chen H.-Y., Chang J.G., Chen P.-J., Su I.-J.;
RT   ""Genomic sequence of SARS isolate from the first fatal case in Taiwan."";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Shanghai QXC1;
RA   Yuan Z., Zhang X., Hu Y., Lan S., Wang H., Zhou Z., Wen Y.;
RT   ""Analysis of SARS coronavirus genome in Shanghai isolates."";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate HSR 1;
RA   Canducci F., Clementi M., Poli G., Vicenzi E.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate Taiwan TC1, Isolate Taiwan TC2, and Isolate Taiwan TC3;
RA   Chang J.-G.C., Lin T.-H., Chen C.-M., Lin C.-S., Chan W.-L., Shih M.-C.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate TWH, Isolate TWJ, Isolate TWK, Isolate TWS, and Isolate
RC   TWY;
RA   Shu H.Y., Wu K.M., Tsai S.F.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate AS;
RA   Balotta C., Corvasce S., Violin M., Galli M., Moroni M., Vigevani G.M.,
RA   Ruan Y.J., Salemi M.;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate ZJ01;
RA   Wang Z., Cheng S., Zhang Y.;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1-507 AND 1655-4382.
RC   STRAIN=Isolate Shanghai LY;
RA   Yuan Z., Zhang X., Hu Y., Lan S., Wang H., Zhou Z., Wen Y.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [21]
RP   PROTEOLYTIC CLEAVAGE (ISOFORM REPLICASE POLYPROTEIN 1A), CATALYTIC ACTIVITY
RP   (3C-LIKE PROTEINASE NSP5), AND CATALYTIC ACTIVITY (PAPAIN-LIKE PROTEASE
RP   NSP3).
RX   PubMed=12917450; DOI=10.1099/vir.0.19424-0;
RA   Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S.,
RA   Weissbrich B., Snijder E.J., Rabenau H., Doerr H.W., Gorbalenya A.E.,
RA   Ziebuhr J.;
RT   ""Mechanisms and enzymes involved in SARS coronavirus genome expression."";
RL   J. Gen. Virol. 84:2305-2315(2003).
RN   [22]
RP   PROTEOLYTIC CLEAVAGE (ISOFORM REPLICASE POLYPROTEIN 1A).
RX   PubMed=15331731; DOI=10.1128/jvi.78.18.9977-9986.2004;
RA   Prentice E., McAuliffe J., Lu X., Subbarao K., Denison M.R.;
RT   ""Identification and characterization of severe acute respiratory syndrome
RT   coronavirus replicase proteins."";
RL   J. Virol. 78:9977-9986(2004).
RN   [23]
RP   PROTEOLYTIC CLEAVAGE (ISOFORM REPLICASE POLYPROTEIN 1A).
RC   STRAIN=Isolate Urbani;
RX   PubMed=15564471; DOI=10.1128/jvi.78.24.13600-13612.2004;
RA   Harcourt B.H., Jukneliene D., Kanjanahaluethai A., Bechill J.,
RA   Severson K.M., Smith C.M., Rota P.A., Baker S.C.;
RT   ""Identification of severe acute respiratory syndrome coronavirus replicase
RT   products and characterization of papain-like protease activity."";
RL   J. Virol. 78:13600-13612(2004).
RN   [24]
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), AND BIOPHYSICOCHEMICAL PROPERTIES (3C-LIKE PROTEINASE NSP5).
RX   PubMed=14561748; DOI=10.1074/jbc.m310875200;
RA   Fan K., Wei P., Feng Q., Chen S., Huang C., Ma L., Lai B., Pei J., Liu Y.,
RA   Chen J., Lai L.;
RT   ""Biosynthesis, purification, and substrate specificity of severe acute
RT   respiratory syndrome coronavirus 3C-like proteinase."";
RL   J. Biol. Chem. 279:1637-1642(2004).
RN   [25]
RP   CATALYTIC ACTIVITY (PAPAIN-LIKE PROTEASE NSP3), FUNCTION (PAPAIN-LIKE
RP   PROTEASE NSP3), PROTEOLYTIC CLEAVAGE (ISOFORM REPLICASE POLYPROTEIN 1A),
RP   COFACTOR (PAPAIN-LIKE PROTEASE NSP3), MUTAGENESIS OF CYS-1651; CYS-1688;
RP   CYS-1729; CYS-1732; CYS-1764; CYS-1766 AND ASP-1826, AND ACTIVE SITE
RP   (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=16306590; DOI=10.1128/jvi.79.24.15189-15198.2005;
RA   Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., Baker S.C.;
RT   ""The papain-like protease of severe acute respiratory syndrome coronavirus
RT   has deubiquitinating activity."";
RL   J. Virol. 79:15189-15198(2005).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=16226257; DOI=10.1016/j.febslet.2005.09.075;
RA   Lin C.W., Tsai F.J., Wan L., Lai C.C., Lin K.H., Hsieh T.H., Shiu S.Y.,
RA   Li J.Y.;
RT   ""Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+
RT   ATPase G1 subunit."";
RL   FEBS Lett. 579:6089-6094(2005).
RN   [27]
RP   SUBUNIT (3C-LIKE PROTEINASE NSP5).
RX   PubMed=15507456; DOI=10.1074/jbc.m408211200;
RA   Chen S., Chen L., Tan J., Chen J., Du L., Sun T., Shen J., Chen K.,
RA   Jiang H., Shen X.;
RT   ""Severe acute respiratory syndrome coronavirus 3C-like proteinase N
RT   terminus is indispensable for proteolytic activity but not for enzyme
RT   dimerization. Biochemical and thermodynamic investigation in conjunction
RT   with molecular dynamics simulations."";
RL   J. Biol. Chem. 280:164-173(2005).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=17024178; DOI=10.1038/sj.emboj.7601368;
RA   Imbert I., Guillemot J.-C., Bourhis J.-M., Bussetta C., Coutard B.,
RA   Egloff M.-P., Ferron F., Gorbalenya A.E., Canard B.;
RT   ""A second, non-canonical RNA-dependent RNA polymerase in SARS
RT   coronavirus."";
RL   EMBO J. 25:4933-4942(2006).
RN   [29]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3).
RX   PubMed=17692280; DOI=10.1016/j.abb.2007.07.006;
RA   Lindner H.A., Lytvyn V., Qi H., Lachance P., Ziomek E., Menard R.;
RT   ""Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus
RT   papain-like protease."";
RL   Arch. Biochem. Biophys. 466:8-14(2007).
RN   [30]
RP   INTERACTION WITH ORF6 PROTEIN (NON-STRUCTURAL PROTEIN 8).
RX   PubMed=17532020; DOI=10.1016/j.virol.2007.04.029;
RA   Kumar P., Gunalan V., Liu B., Chow V.T., Druce J., Birch C., Catton M.,
RA   Fielding B.C., Tan Y.J., Lal S.K.;
RT   ""The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with
RT   its ORF6 accessory protein."";
RL   Virology 366:293-303(2007).
RN   [31]
RP   TOPOLOGY (PAPAIN-LIKE PROTEASE NSP3), TOPOLOGY (NON-STRUCTURAL PROTEIN 4),
RP   AND TOPOLOGY (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=18842706; DOI=10.1128/jvi.01219-08;
RA   Oostra M., Hagemeijer M.C., van Gent M., Bekker C.P., te Lintelo E.G.,
RA   Rottier P.J., de Haan C.A.;
RT   ""Topology and membrane anchoring of the coronavirus replication complex:
RT   not all hydrophobic domains of nsp3 and nsp6 are membrane spanning."";
RL   J. Virol. 82:12392-12405(2008).
RN   [32]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=19369340; DOI=10.1128/jvi.02220-08;
RA   Frieman M., Ratia K., Johnston R.E., Mesecar A.D., Baric R.S.;
RT   ""Severe acute respiratory syndrome coronavirus papain-like protease
RT   ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and
RT   NF-kappaB signaling."";
RL   J. Virol. 83:6689-6705(2009).
RN   [33]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), AND INTERACTION WITH HOST PHB AND PHB2
RP   (NON-STRUCTURAL PROTEIN 2).
RX   PubMed=19640993; DOI=10.1128/jvi.00842-09;
RA   Cornillez-Ty C.T., Liao L., Yates J.R., Kuhn P., Buchmeier M.J.;
RT   ""Severe acute respiratory syndrome coronavirus nonstructural protein 2
RT   interacts with a host protein complex involved in mitochondrial biogenesis
RT   and intracellular signaling."";
RL   J. Virol. 83:10314-10318(2009).
RN   [34]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=19153232; DOI=10.1128/jvi.01505-08;
RA   Miknis Z.J., Donaldson E.F., Umland T.C., Rimmer R.A., Baric R.S.,
RA   Schultz L.W.;
RT   ""Severe acute respiratory syndrome coronavirus nsp9 dimerization is
RT   essential for efficient viral growth."";
RL   J. Virol. 83:3007-3018(2009).
RN   [35]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=22174690; DOI=10.1371/journal.ppat.1002433;
RA   Huang C., Lokugamage K.G., Rozovics J.M., Narayanan K., Semler B.L.,
RA   Makino S.;
RT   ""SARS coronavirus nsp1 protein induces template-dependent endonucleolytic
RT   cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA
RT   cleavage."";
RL   PLoS Pathog. 7:E1002433-E1002433(2011).
RN   [36]
RP   INTERACTION WITH PAPAIN-LIKE PROTEASE NSP3 (NON-STRUCTURAL PROTEIN 4),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 4), AND INTERACTION WITH
RP   NON-STRUCTURAL PROTEIN 6 (NON-STRUCTURAL PROTEIN 4).
RX   PubMed=21345958; DOI=10.1128/jvi.00042-11;
RA   Hagemeijer M.C., Ulasli M., Vonk A.M., Reggiori F., Rottier P.J.,
RA   de Haan C.A.;
RT   ""Mobility and interactions of coronavirus nonstructural protein 4."";
RL   J. Virol. 85:4572-4577(2011).
RN   [37]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=23035226; DOI=10.1128/jvi.01958-12;
RA   Lokugamage K.G., Narayanan K., Huang C., Makino S.;
RT   ""Severe acute respiratory syndrome coronavirus protein nsp1 is a novel
RT   eukaryotic translation inhibitor that represses multiple steps of
RT   translation initiation."";
RL   J. Virol. 86:13598-13608(2012).
RN   [38]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 7), AND FUNCTION (NON-STRUCTURAL PROTEIN
RP   8).
RX   PubMed=22039154; DOI=10.1093/nar/gkr893;
RA   te Velthuis A.J., van den Worm S.H., Snijder E.J.;
RT   ""The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA
RT   polymerase capable of both de novo initiation and primer extension."";
RL   Nucleic Acids Res. 40:1737-1747(2012).
RN   [39]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 10), AND INTERACTION WITH PROOFREADING
RP   EXORIBONUCLEASE NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=22635272; DOI=10.1073/pnas.1201130109;
RA   Bouvet M., Imbert I., Subissi L., Gluais L., Canard B., Decroly E.;
RT   ""RNA 3'-end mismatch excision by the severe acute respiratory syndrome
RT   coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex."";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:9372-9377(2012).
RN   [40]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 4), FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND FUNCTION
RP   (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=23943763; DOI=10.1128/mbio.00524-13;
RA   Angelini M.M., Akhlaghpour M., Neuman B.W., Buchmeier M.J.;
RT   ""Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4,
RT   and 6 induce double-membrane vesicles."";
RL   MBio 4:0-0(2013).
RN   [41]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=24991833; DOI=10.4161/auto.29309;
RA   Cottam E.M., Whelband M.C., Wileman T.;
RT   ""Coronavirus NSP6 restricts autophagosome expansion."";
RL   Autophagy 10:1426-1441(2014).
RN   [42]
RP   REVIEW.
RX   PubMed=24410069; DOI=10.1089/dna.2013.2304;
RA   Angelini M.M., Neuman B.W., Buchmeier M.J.;
RT   ""Untangling membrane rearrangement in the nidovirales."";
RL   DNA Cell Biol. 33:122-127(2014).
RN   [43]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=24622840; DOI=10.1007/s13238-014-0026-3;
RA   Chen X., Yang X., Zheng Y., Yang Y., Xing Y., Chen Z.;
RT   ""SARS coronavirus papain-like protease inhibits the type I interferon
RT   signaling pathway through interaction with the STING-TRAF3-TBK1 complex."";
RL   Protein Cell 5:369-381(2014).
RN   [44]
RP   INTERACTION WITH NUP93 (HOST TRANSLATION INHIBITOR NSP1), AND FUNCTION
RP   (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=30943371; DOI=10.1139/bcb-2018-0394;
RA   Gomez G.N., Abrar F., Dodhia M.P., Gonzalez F.G., Nag A.;
RT   ""SARS coronavirus protein nsp1 disrupts localization of Nup93 from the
RT   nuclear pore complex."";
RL   Biochem. Cell Biol. 97:758-766(2019).
RN   [45]
RP   PROTEOLYTIC CLEAVAGE (ISOFORM REPLICASE POLYPROTEIN 1A), MASS SPECTROMETRY
RP   (NON-STRUCTURAL PROTEIN 8), MASS SPECTROMETRY (NON-STRUCTURAL PROTEIN 9),
RP   AND MASS SPECTROMETRY (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=32083638; DOI=10.1042/bcj20200029;
RA   Krichel B., Falke S., Hilgenfeld R., Redecke L., Uetrecht C.;
RT   ""Processing of the SARS-CoV pp1a/ab nsp7-10 region."";
RL   Biochem. J. 477:1009-1019(2020).
RN   [46]
RP   3D-STRUCTURE MODELING OF 3241-3540, AND CHARACTERIZATION (3C-LIKE
RP   PROTEINASE NSP5).
RX   PubMed=12746549; DOI=10.1126/science.1085658;
RA   Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R.;
RT   ""Coronavirus main proteinase (3CLpro) structure: basis for design of anti-
RT   SARS drugs."";
RL   Science 300:1763-1767(2003).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 4118-4230 (NON-STRUCTURAL PROTEIN
RP   9).
RC   STRAIN=Isolate Frankfurt-1;
RX   PubMed=12925794; DOI=10.1107/s0907444903016779;
RA   Campanacci V., Egloff M.-P., Longhi S., Ferron F., Rancurel C.,
RA   Salomoni A., Durousseau C., Tocque F., Bremond N., Dobbe J.C.,
RA   Snijder E.J., Canard B., Cambillau C.;
RT   ""Structural genomics of the SARS coronavirus: cloning, expression,
RT   crystallization and preliminary crystallographic study of the Nsp9
RT   protein."";
RL   Acta Crystallogr. D 59:1628-1631(2003).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 4118-4230.
RX   PubMed=15007178; DOI=10.1073/pnas.0307877101;
RA   Egloff M.-P., Ferron F., Campanacci V., Longhi S., Rancurel C.,
RA   Dutartre H., Snijder E.J., Gorbalenya A.E., Cambillau C., Canard B.;
RT   ""The severe acute respiratory syndrome-coronavirus replicative protein nsp9
RT   is a single-stranded RNA-binding subunit unique in the RNA virus world."";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3792-3796(2004).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 4107-4230.
RX   PubMed=14962394; DOI=10.1016/j.str.2004.01.016;
RA   Sutton G., Fry E., Carter L., Sainsbury S., Walter T., Nettleship J.,
RA   Berrow N., Owens R., Gilbert R., Davidson A., Siddell S., Poon L.L.M.,
RA   Diprose J., Alderton D., Walsh M., Grimes J.M., Stuart D.I.;
RT   ""The nsp9 replicase protein of SARS-coronavirus, structure and functional
RT   insights."";
RL   Structure 12:341-353(2004).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 3837-4117 AND 3920-4117,
RP   INTERACTION WITH NON-STRUCTURAL PROTEIN 7 (NON-STRUCTURAL PROTEIN 8), AND
RP   INTERACTION WITH NON-STRUCTURAL PROTEIN 8 (NON-STRUCTURAL PROTEIN 7).
RX   PubMed=16228002; DOI=10.1038/nsmb999;
RA   Zhai Y., Sun F., Li X., Pang H., Xu X., Bartlam M., Rao Z.;
RT   ""Insights into SARS-CoV transcription and replication from the structure of
RT   the nsp7-nsp8 hexadecamer."";
RL   Nat. Struct. Mol. Biol. 12:980-986(2005).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1002-1176.
RX   PubMed=16271890; DOI=10.1016/j.str.2005.07.022;
RA   Saikatendu K.S., Joseph J.S., Subramanian V., Clayton T., Griffith M.,
RA   Moy K., Velasquez J., Neuman B.W., Buchmeier M.J., Stevens R.C., Kuhn P.;
RT   ""Structural basis of severe acute respiratory syndrome coronavirus ADP-
RT   ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3."";
RL   Structure 13:1665-1675(2005).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1541-1854.
RX   PubMed=16581910; DOI=10.1073/pnas.0510851103;
RA   Ratia K., Saikatendu K.S., Santarsiero B.D., Barretto N., Baker S.C.,
RA   Stevens R.C., Mesecar A.D.;
RT   ""Severe acute respiratory syndrome coronavirus papain-like protease:
RT   structure of a viral deubiquitinating enzyme."";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5717-5722(2006).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 4240-4362.
RC   STRAIN=Isolate Tor2;
RX   PubMed=16873246; DOI=10.1128/jvi.00467-06;
RA   Joseph J.S., Saikatendu K.S., Subramanian V., Neuman B.W., Brooun A.,
RA   Griffith M., Moy K., Yadav M.K., Velasquez J., Buchmeier M.J.,
RA   Stevens R.C., Kuhn P.;
RT   ""Crystal structure of nonstructural protein 10 from the severe acute
RT   respiratory syndrome coronavirus reveals a novel fold with two zinc-binding
RT   motifs."";
RL   J. Virol. 80:7894-7901(2006).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 4231-4378.
RX   PubMed=16873247; DOI=10.1128/jvi.00483-06;
RA   Su D., Lou Z., Sun F., Zhai Y., Yang H., Zhang R., Joachimiak A.,
RA   Zhang X.C., Bartlam M., Rao Z.;
RT   ""Dodecamer structure of severe acute respiratory syndrome coronavirus
RT   nonstructural protein nsp10."";
RL   J. Virol. 80:7902-7908(2006).
RN   [55]
RP   STRUCTURE BY NMR OF 13-127.
RX   PubMed=17202208; DOI=10.1128/jvi.01939-06;
RA   Almeida M.S., Johnson M.A., Herrmann T., Geralt M., Wuthrich K.;
RT   ""Novel beta-barrel fold in the nuclear magnetic resonance structure of the
RT   replicase nonstructural protein 1 from the severe acute respiratory
RT   syndrome coronavirus."";
RL   J. Virol. 81:3151-3161(2007).
RN   [56]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3241-3546.
RG   RIKEN structural genomics initiative (RSGI);
RT   ""Crystal structure of Sars coronavirus main proteinase(3CLPRO)."";
RL   Submitted (JUL-2007) to the PDB data bank.
CC   -!- FUNCTION: [Isoform Replicase polyprotein 1a]: Multifunctional protein
CC       involved in the transcription and replication of viral RNAs. Contains
CC       the proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000305}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome
CC       complex further induces an endonucleolytic cleavage near the 5'UTR of
CC       host mRNAs, targeting them for degradation. Viral mRNAs are not
CC       susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the
CC       presence of a 5'-end leader sequence and are therefore protected from
CC       degradation. By suppressing host gene expression, nsp1 facilitates
CC       efficient viral gene expression in infected cells and evasion from host
CC       immune response (PubMed:23035226). May disrupt nuclear pore function by
CC       binding and displacing host NUP93 (PubMed:30943371).
CC       {ECO:0000269|PubMed:23035226, ECO:0000269|PubMed:30943371}.
CC   -!- FUNCTION: [Non-structural protein 2]: May play a role in the modulation
CC       of host cell survival signaling pathway by interacting with host PHB
CC       and PHB2 (PubMed:19640993). Indeed, these two proteins play a role in
CC       maintaining the functional integrity of the mitochondria and protecting
CC       cells from various stresses (PubMed:19640993).
CC       {ECO:0000269|PubMed:19640993}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. In addition,
CC       PL-PRO possesses a deubiquitinating/deISGylating activity and processes
CC       both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:17692280). Plays a role in host membrane
CC       rearrangement that leads to creation of cytoplasmic double-membrane
CC       vesicles (DMV) necessary for viral replication (PubMed:23943763). Nsp3,
CC       nsp4 and nsp6 together are sufficient to form DMV (PubMed:23943763,
CC       PubMed:24410069). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:19369340, PubMed:24622840).
CC       Prevents also host NF-kappa-B signaling (PubMed:19369340,
CC       PubMed:24622840). {ECO:0000269|PubMed:16271890,
CC       ECO:0000269|PubMed:17692280, ECO:0000269|PubMed:19369340,
CC       ECO:0000269|PubMed:23943763, ECO:0000269|PubMed:24622840,
CC       ECO:0000303|PubMed:24410069}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in host membrane
CC       rearrangement that leads to creation of cytoplasmic double-membrane
CC       vesicles (DMV) necessary for viral replication (PubMed:23943763,
CC       PubMed:24410069). Alone appears incapable to induce membrane curvature,
CC       but together with nsp3 is able to induce paired membranes
CC       (PubMed:23943763). Nsp3, nsp4 and nsp6 together are sufficient to form
CC       DMV (PubMed:23943763, PubMed:24410069). {ECO:0000269|PubMed:23943763,
CC       ECO:0000303|PubMed:24410069}.
CC   -!- FUNCTION: [3C-like proteinase nsp5]: Cleaves the C-terminus of
CC       replicase polyprotein at 11 sites. Recognizes substrates containing the
CC       core sequence [ILMVF]-Q-|-[SGACN]. Also able to bind an ADP-ribose-1''-
CC       phosphate (ADRP). May cleave host ATP6V1G1 thereby modifying host
CC       vacuoles intracellular pH. {ECO:0000255|PROSITE-ProRule:PRU00772,
CC       ECO:0000269|PubMed:16226257}.
CC   -!- FUNCTION: [Non-structural protein 6]: Plays a role in host membrane
CC       rearrangement that leads to creation of cytoplasmic double-membrane
CC       vesicles (DMV) necessary for viral replication (PubMed:23943763). Nsp3,
CC       nsp4 and nsp6 together are sufficient to form DMV (PubMed:23943763,
CC       PubMed:24410069). Plays a role in the initial induction of
CC       autophagosomes from host endoplasmic reticulum. Later, limits the
CC       expansion of these phagosomes that are no longer able to deliver viral
CC       components to lysosomes (PubMed:24991833).
CC       {ECO:0000269|PubMed:23943763, ECO:0000269|PubMed:24991833,
CC       ECO:0000303|PubMed:24410069}.
CC   -!- FUNCTION: [Non-structural protein 7]: Forms a hexadecamer with nsp8 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000269|PubMed:22039154}.
CC   -!- FUNCTION: [Non-structural protein 8]: Forms a hexadecamer with nsp7 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000269|PubMed:22039154}.
CC   -!- FUNCTION: [RNA-capping enzyme subunit nsp9]: Catalytic subunit of viral
CC       RNA capping enzyme which catalyzes the RNA guanylyltransferase reaction
CC       for genomic and sub-genomic RNAs. The kinase-like NiRAN domain of NSP12
CC       transfers RNA to the amino terminus of NSP9, forming a covalent RNA-
CC       protein intermediate. Subsequently, the NiRAN domain transfers RNA to
CC       GDP, forming the core cap structure GpppA-RNA. The NSP14 and NSP16
CC       methyltransferases then add methyl groups to form functional cap
CC       structures. {ECO:0000250|UniProtKB:P0DTC1,
CC       ECO:0000269|PubMed:19153232}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16
CC       2'-O-methyltransferase activities. Therefore plays an essential role in
CC       viral mRNAs cap methylation. {ECO:0000269|PubMed:22635272}.
CC   -!- CATALYTIC ACTIVITY: [3C-like proteinase nsp5]:
CC       Reaction=TSAVLQ-|-SGFRK-NH2 and SGVTFQ-|-GKFKK the two peptides
CC         corresponding to the two self-cleavage sites of the SARS 3C-like
CC         proteinase are the two most reactive peptide substrates. The enzyme
CC         exhibits a strong preference for substrates containing Gln at P1
CC         position and Leu at P2 position.; EC=3.4.22.69;
CC         Evidence={ECO:0000269|PubMed:12917450, ECO:0000269|PubMed:14561748};
CC   -!- CATALYTIC ACTIVITY: [Papain-like protease nsp3]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:12917450,
CC         ECO:0000269|PubMed:17692280};
CC   -!- CATALYTIC ACTIVITY: [RNA-capping enzyme subunit nsp9]:
CC       Reaction=a 5'-end diphospho-ribonuc",52854
CGGCGT GGCGTG GCGTGT CGTGTA GTGTAG TGTAGG GTAGGC TAGGCG AGGCGA GGCGAG GCGAGC CGAGCG GAGCGA AGCGAC GCGACA CGACAG GACAGA ACAGAT CAGATC AGATCG GATCGT ATCGTG TCGTGC CGTGCT GTGCTG TGCTGA GCTGAT CTGATT TGATTG GATTGA ATTGAG TTGAGC TGAGCA GAGCAG AGCAGG GCAGGC CAGGCC AGGCCT GGCCTT GCCTTT CCTTTG CTTTGG TTTGGT TTGGTC TGGTCG GGTCGG GTCGGC TCGGCG CGGCGT GGCGTT GCGTTA CGTTAC GTTACC TTACCG TACCGA ACCGAA CCGAAA CGAAAT GAAATC AAATCT AATCTT ATCTTG TCTTGC CTTGCC TTGCCC TGCCCG GCCCGG CCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGG GTGGGC TGGGCA GGGCAG GGCAGA GCAGAC CAGACG AGACGG GACGGT ACGGTG CGGTGG GGTGGT GTGGTA TGGTAA GGTAAT GTAATC TAATCG AATCGA ATCGAT TCGATC CGATCG GATCGC ATCGCG TCGCGC CGCGCT GCGCTT CGCTTT GCTTTT CTTTTT TTTTTC TTTTCG TTTCGC TTCGCA TCGCAG CGCAGT GCAGTT CAGTTG AGTTGA GTTGAT TTGATC TGATCG GATCGT ATCGTC TCGTCC CGTCCA GTCCAT TCCATG CCATGG CATGGG ATGGGA TGGGAA GGGAAC GGAACA GAACAC AACACT ACACTG CACTGG ACTGGG CTGGGG TGGGGT GGGGTA GGGTAT GGTATT GTATTG TATTGG ATTGGG TTGGGA TGGGAG GGGAGG GGAGGG,0,142,CGGC GGCG GCGT CGTG GTGT TGTA GTAG TAGG AGGC GGCG GCGA CGAG GAGC AGCG GCGA CGAC GACA ACAG CAGA AGAT GATC ATCG TCGT CGTG GTGC TGCT GCTG CTGA TGAT GATT ATTG TTGA TGAG GAGC AGCA GCAG CAGG AGGC GGCC GCCT CCTT CTTT TTTG TTGG TGGT GGTC GTCG TCGG CGGC GGCG GCGT CGTT GTTA TTAC TACC ACCG CCGA CGAA GAAA AAAT AATC ATCT TCTT CTTG TTGC TGCC GCCC CCCG CCGG CGGC GGCG GCGT CGTG GTGG TGGG GGGC GGCA GCAG CAGA AGAC GACG ACGG CGGT GGTG GTGG TGGT GGTA GTAA TAAT AATC ATCG TCGA CGAT GATC ATCG TCGC CGCG GCGC CGCT GCTT CTTT TTTT TTTT TTTC TTCG TCGC CGCA GCAG CAGT AGTT GTTG TTGA TGAT GATC ATCG TCGT CGTC GTCC TCCA CCAT CATG ATGG TGGG GGGA GGAA GAAC AACA ACAC CACT ACTG CTGG TGGG GGGG GGGT GGTA GTAT TATT ATTG TTGG TGGG GGGA GGAG GAGG AGGG,CGGCG GGCGT GCGTG CGTGT GTGTA TGTAG GTAGG TAGGC AGGCG GGCGA GCGAG CGAGC GAGCG AGCGA GCGAC CGACA GACAG ACAGA CAGAT AGATC GATCG ATCGT TCGTG CGTGC GTGCT TGCTG GCTGA CTGAT TGATT GATTG ATTGA TTGAG TGAGC GAGCA AGCAG GCAGG CAGGC AGGCC GGCCT GCCTT CCTTT CTTTG TTTGG TTGGT TGGTC GGTCG GTCGG TCGGC CGGCG GGCGT GCGTT CGTTA GTTAC TTACC TACCG ACCGA CCGAA CGAAA GAAAT AAATC AATCT ATCTT TCTTG CTTGC TTGCC TGCCC GCCCG CCCGG CCGGC CGGCG GGCGT GCGTG CGTGG GTGGG TGGGC GGGCA GGCAG GCAGA CAGAC AGACG GACGG ACGGT CGGTG GGTGG GTGGT TGGTA GGTAA GTAAT TAATC AATCG ATCGA TCGAT CGATC GATCG ATCGC TCGCG CGCGC GCGCT CGCTT GCTTT CTTTT TTTTT TTTTC TTTCG TTCGC TCGCA CGCAG GCAGT CAGTT AGTTG GTTGA TTGAT TGATC GATCG ATCGT TCGTC CGTCC GTCCA TCCAT CCATG CATGG ATGGG TGGGA GGGAA GGAAC GAACA AACAC ACACT CACTG ACTGG CTGGG TGGGG GGGGT GGGTA GGTAT GTATT TATTG ATTGG TTGGG TGGGA GGGAG GGAGG GAGGG,CGGCGT GGCGTG GCGTGT CGTGTA GTGTAG TGTAGG GTAGGC TAGGCG AGGCGA GGCGAG GCGAGC CGAGCG GAGCGA AGCGAC GCGACA CGACAG GACAGA ACAGAT CAGATC AGATCG GATCGT ATCGTG TCGTGC CGTGCT GTGCTG TGCTGA GCTGAT CTGATT TGATTG GATTGA ATTGAG TTGAGC TGAGCA GAGCAG AGCAGG GCAGGC CAGGCC AGGCCT GGCCTT GCCTTT CCTTTG CTTTGG TTTGGT TTGGTC TGGTCG GGTCGG GTCGGC TCGGCG CGGCGT GGCGTT GCGTTA CGTTAC GTTACC TTACCG TACCGA ACCGAA CCGAAA CGAAAT GAAATC AAATCT AATCTT ATCTTG TCTTGC CTTGCC TTGCCC TGCCCG GCCCGG CCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGG GTGGGC TGGGCA GGGCAG GGCAGA GCAGAC CAGACG AGACGG GACGGT ACGGTG CGGTGG GGTGGT GTGGTA TGGTAA GGTAAT GTAATC TAATCG AATCGA ATCGAT TCGATC CGATCG GATCGC ATCGCG TCGCGC CGCGCT GCGCTT CGCTTT GCTTTT CTTTTT TTTTTC TTTTCG TTTCGC TTCGCA TCGCAG CGCAGT GCAGTT CAGTTG AGTTGA GTTGAT TTGATC TGATCG GATCGT ATCGTC TCGTCC CGTCCA GTCCAT TCCATG CCATGG CATGGG ATGGGA TGGGAA GGGAAC GGAACA GAACAC AACACT ACACTG CACTGG ACTGGG CTGGGG TGGGGT GGGGTA GGGTAT GGTATT GTATTG TATTGG ATTGGG TTGGGA TGGGAG GGGAGG GGAGGG,CGGCGTG GGCGTGT GCGTGTA CGTGTAG GTGTAGG TGTAGGC GTAGGCG TAGGCGA AGGCGAG GGCGAGC GCGAGCG CGAGCGA GAGCGAC AGCGACA GCGACAG CGACAGA GACAGAT ACAGATC CAGATCG AGATCGT GATCGTG ATCGTGC TCGTGCT CGTGCTG GTGCTGA TGCTGAT GCTGATT CTGATTG TGATTGA GATTGAG ATTGAGC TTGAGCA TGAGCAG GAGCAGG AGCAGGC GCAGGCC CAGGCCT AGGCCTT GGCCTTT GCCTTTG CCTTTGG CTTTGGT TTTGGTC TTGGTCG TGGTCGG GGTCGGC GTCGGCG TCGGCGT CGGCGTT GGCGTTA GCGTTAC CGTTACC GTTACCG TTACCGA TACCGAA ACCGAAA CCGAAAT CGAAATC GAAATCT AAATCTT AATCTTG ATCTTGC TCTTGCC CTTGCCC TTGCCCG TGCCCGG GCCCGGC CCCGGCG CCGGCGT CGGCGTG GGCGTGG GCGTGGG CGTGGGC GTGGGCA TGGGCAG GGGCAGA GGCAGAC GCAGACG CAGACGG AGACGGT GACGGTG ACGGTGG CGGTGGT GGTGGTA GTGGTAA TGGTAAT GGTAATC GTAATCG TAATCGA AATCGAT ATCGATC TCGATCG CGATCGC GATCGCG ATCGCGC TCGCGCT CGCGCTT GCGCTTT CGCTTTT GCTTTTT CTTTTTC TTTTTCG TTTTCGC TTTCGCA TTCGCAG TCGCAGT CGCAGTT GCAGTTG CAGTTGA AGTTGAT GTTGATC TTGATCG TGATCGT GATCGTC ATCGTCC TCGTCCA CGTCCAT GTCCATG TCCATGG CCATGGG CATGGGA ATGGGAA TGGGAAC GGGAACA GGAACAC GAACACT AACACTG ACACTGG CACTGGG ACTGGGG CTGGGGT TGGGGTA GGGGTAT GGGTATT GGTATTG GTATTGG TATTGGG ATTGGGA TTGGGAG TGGGAGG GGGAGGG,"ID   MAO2_HAEIN              Reviewed;         756 AA.
AC   P43837;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   27-NOV-2024, entry version 141.
DE   RecName: Full=NADP-dependent malic enzyme;
DE            Short=NADP-ME;
DE            EC=1.1.1.40;
GN   Name=maeB; OrderedLocusNames=HI_1245;
OS   Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pasteurellales;
OC   Pasteurellaceae; Haemophilus.
OX   NCBI_TaxID=71421;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 51907 / DSM 11121 / KW20 / Rd;
RX   PubMed=7542800; DOI=10.1126/science.7542800;
RA   Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F.,
RA   Kerlavage A.R., Bult C.J., Tomb J.-F., Dougherty B.A., Merrick J.M.,
RA   McKenney K., Sutton G.G., FitzHugh W., Fields C.A., Gocayne J.D.,
RA   Scott J.D., Shirley R., Liu L.-I., Glodek A., Kelley J.M., Weidman J.F.,
RA   Phillips C.A., Spriggs T., Hedblom E., Cotton M.D., Utterback T.R.,
RA   Hanna M.C., Nguyen D.T., Saudek D.M., Brandon R.C., Fine L.D.,
RA   Fritchman J.L., Fuhrmann J.L., Geoghagen N.S.M., Gnehm C.L., McDonald L.A.,
RA   Small K.V., Fraser C.M., Smith H.O., Venter J.C.;
RT   ""Whole-genome random sequencing and assembly of Haemophilus influenzae
RT   Rd."";
RL   Science 269:496-512(1995).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-malate + NADP(+) = pyruvate + CO2 + NADPH;
CC         Xref=Rhea:RHEA:18253, ChEBI:CHEBI:15361, ChEBI:CHEBI:15589,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.40;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=oxaloacetate + H(+) = pyruvate + CO2; Xref=Rhea:RHEA:15641,
CC         ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, ChEBI:CHEBI:16452,
CC         ChEBI:CHEBI:16526; EC=1.1.1.40;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Divalent metal cations. Prefers magnesium or manganese.
CC       {ECO:0000250};
CC   -!- SIMILARITY: In the N-terminal section; belongs to the malic enzymes
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the phosphate
CC       acetyltransferase and butyryltransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42023; AAC22896.1; -; Genomic_DNA.
DR   PIR; F64112; F64112.
DR   RefSeq; NP_439401.1; NC_000907.1.
DR   AlphaFoldDB; P43837; -.
DR   SMR; P43837; -.
DR   STRING; 71421.HI_1245; -.
DR   EnsemblBacteria; AAC22896; AAC22896; HI_1245.
DR   KEGG; hin:HI_1245; -.
DR   PATRIC; fig|71421.8.peg.1297; -.
DR   eggNOG; COG0280; Bacteria.
DR   eggNOG; COG0281; Bacteria.
DR   HOGENOM; CLU_012366_0_0_6; -.
DR   OrthoDB; 9805787at2; -.
DR   PhylomeDB; P43837; -.
DR   BioCyc; HINF71421:G1GJ1-1275-MONOMER; -.
DR   Proteomes; UP000000579; Chromosome.
DR   GO; GO:0016746; F:acyltransferase activity; IEA:InterPro.
DR   GO; GO:0004473; F:malate dehydrogenase (decarboxylating) (NADP+) activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006108; P:malate metabolic process; IEA:InterPro.
DR   CDD; cd05311; NAD_bind_2_malic_enz; 1.
DR   FunFam; 3.40.50.10380:FF:000003; NADP-dependent malic enzyme; 1.
DR   FunFam; 3.40.50.720:FF:000095; NADP-dependent malic enzyme; 1.
DR   Gene3D; 3.40.50.10950; -; 1.
DR   Gene3D; 3.40.50.10750; Isocitrate/Isopropylmalate dehydrogenase-like; 1.
DR   Gene3D; 3.40.50.10380; Malic enzyme, N-terminal domain; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR046346; Aminoacid_DH-like_N_sf.
DR   InterPro; IPR051674; Malate_Decarboxylase.
DR   InterPro; IPR015884; Malic_enzyme_CS.
DR   InterPro; IPR012301; Malic_N_dom.
DR   InterPro; IPR037062; Malic_N_dom_sf.
DR   InterPro; IPR012302; Malic_NAD-bd.
DR   InterPro; IPR045213; Malic_NAD-bd_bact_type.
DR   InterPro; IPR012188; ME_PTA.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR042113; P_AcTrfase_dom1.
DR   InterPro; IPR042112; P_AcTrfase_dom2.
DR   InterPro; IPR002505; PTA_PTB.
DR   PANTHER; PTHR43237; NADP-DEPENDENT MALIC ENZYME; 1.
DR   PANTHER; PTHR43237:SF4; NADP-DEPENDENT MALIC ENZYME; 1.
DR   Pfam; PF00390; malic; 1.
DR   Pfam; PF03949; Malic_M; 1.
DR   Pfam; PF01515; PTA_PTB; 1.
DR   PIRSF; PIRSF036684; ME_PTA; 1.
DR   SMART; SM01274; malic; 1.
DR   SMART; SM00919; Malic_M; 1.
DR   SUPFAM; SSF53223; Aminoacid dehydrogenase-like, N-terminal domain; 1.
DR   SUPFAM; SSF53659; Isocitrate/Isopropylmalate dehydrogenase-like; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00331; MALIC_ENZYMES; 1.
PE   3: Inferred from homology;
KW   Metal-binding; Multifunctional enzyme; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..756
FT                   /note=""NADP-dependent malic enzyme""
FT                   /id=""PRO_0000160243""
FT   REGION          1..428
FT                   /note=""Malic enzyme""
FT   REGION          429..756
FT                   /note=""Phosphate acetyltransferase""
FT   ACT_SITE        39
FT                   /note=""Proton donor""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   ACT_SITE        94
FT                   /note=""Proton acceptor""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         136
FT                   /ligand=""a divalent metal cation""
FT                   /ligand_id=""ChEBI:CHEBI:60240""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         137
FT                   /ligand=""a divalent metal cation""
FT                   /ligand_id=""ChEBI:CHEBI:60240""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         162
FT                   /ligand=""a divalent metal cation""
FT                   /ligand_id=""ChEBI:CHEBI:60240""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         195..198
FT                   /ligand=""NADP(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58349""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         288
FT                   /ligand=""NADP(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58349""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
FT   BINDING         320
FT                   /ligand=""NADP(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58349""
FT                   /evidence=""ECO:0000250|UniProtKB:P40927""
SQ   SEQUENCE   756 AA;  81880 MW;  8D303736F08B8E3B CRC64;
     MTEQLRQAAL DFHEFPIPGK IEVTPTKSLA TQRDLALAYS PGVAEPCLEI EKDPAASYKY
     TARGNLVAVI SNGTAVLGLG NIGALAGKPV MEGKGVLFKK FAGINVFDIE VNEHDPDKLV
     DIIASLEPTF GGVNLEDIKA PECFYIEQKL RERMNIPVFH DDQHGTAIIS AAAIINSLRI
     VGKKIEDVRL VASGAGAASI ACLNLLLSLG MKRENITVCD SKGVVYKGRD DKMDQTKKEY
     AIEDNGWRKL ADAIPNADIF LGCSAAGALT QDMVKSMAAH PIILALANPN PEITPPEAKA
     VRPDAIVCTG RSDYPNQVNN VLCFPFIFRG ALDVGATTIN EEMKRAAVYA IADLALEEQN
     EVVTSAYGGE GATFGADYVI PRPFDPRLIV RIAPAVAKAA MESGVATRPI QNWDAYVEKL
     TQFVYKTSLF MRPIFSQAKS AKQRIILAEG EENKALHATQ EVISMGLANP ILIGRRSVIE
     EKIKKLGLRL TAGVDFEIVD NEDNPRYEEC WKHYYELTKR KGITPAIAKR VVRSNTTVLA
     STLLSLGYAD ALVCGLFGSY GKHLASIRDI IGLKDGVKTA AALNSLVLPT GNVFLTDTHV
     NSNPTAEELA EITLMAAEEI HRFGIEPAVA LLSHSNFGSS DSLGAPKMRE VLQIVKERNP
     HLMIDGEMRG DLAMNEAHRK ELMPDSPLKG SANLLVFPDL SASRISYSLL RGTTTAITVG
     PILMGMNKSA HILNPGASVR RIINMIAYAA VKAQQE
//
",26839
ACTTAT CTTATG TTATGT TATGTC ATGTCC TGTCCC GTCCCT TCCCTG CCCTGC CCTGCA CTGCAC TGCACA GCACAA CACAAG ACAAGA CAAGAA AAGAAA AGAAAA GAAAAG AAAAGA AAAGAA AAGAAC AGAACT GAACTT AACTTC ACTTCA CTTCAC TTCACA TCACAA CACAAC ACAACT CAACTG AACTGC ACTGCT CTGCTC TGCTCC GCTCCT CTCCTG TCCTGC CCTGCC CTGCCA TGCCAT GCCATT CCATTT CATTTG ATTTGT TTTGTC TTGTCA TGTCAT GTCATG TCATGA CATGAT ATGATG TGATGG GATGGA ATGGAA TGGAAA GGAAAA GAAAAG AAAAGC AAAGCA AAGCAC AGCACA GCACAC CACACT ACACTT CACTTT ACTTTC CTTTCC TTTCCT TTCCTC TCCTCG CCTCGT CTCGTG TCGTGA CGTGAA GTGAAG TGAAGG GAAGGT AAGGTG AGGTGT GGTGTC GTGTCT TGTCTT GTCTTT TCTTTG CTTTGT TTTGTT TTGTTT TGTTTC GTTTCA TTTCAA TTCAAA TCAAAT CAAATG AAATGG AATGGC ATGGCA TGGCAC GGCACA GCACAC CACACA ACACAC CACACT ACACTG CACTGG ACTGGT CTGGTT TGGTTT GGTTTG GTTTGT TTTGTA,1,112,ACTCTTTT T C CTCTTTTAGG GGT TTTTC AAAT T TTG TATA ATG G ACA ATGGT TCT TGGAAA ATC C GAA GTCC TCC C TTCCTT CC C C CCCCCCCTCT T C CCCCTCTGTG G C CTCTGTGCC TT ATGCCA A G GCGCACACC C CACACACACA A AACAC CAA A C CACAAAAGG A AAAAGAGAA ACTTAGAGAAAA A GAAGGAAAAACT  AAAAAGC AA ATG AAAAAAAGG A AAAAGAGAGA A A AGAGAGAAAA A GGAAAACAC C AAACACTCT T A ACCACTG  CTT C CTCTTCACA A TTTTCTCA AAA T TCTCACACAC C C CACACACACA A A ACACAAA A C CACAAAC C ATTCCT  TG ACACTCTGTG G C CTCTGTGC AT TGGCTCT T G GCGCTCTCTC C C CTCTCC TC T TCTC  TT CCCCTCTGG C CTCTGTGCAAATCC TG TGCC C GATG CCCATAT T CTA CATATTTT C G ATATTTTTTT T T TTTTGTG G T TTTTGTGTGT T T TGTGTCTGTC T A GTGTCACTCA TT  TCTCACATAT T C CACATGCCTG G AGC ATGTGAGA A T TGTGAGATAT T G GAGATATGA GG A ATATGTGGGG G T TGTGGTTTGA A G GGGGAGAAAA  CC GAGTCAAAAA A A AAAAAAA GAAAAAGCAAG G A AAAAGAGCGC C A AGAGCGCACA A G GCGCATTCAC C C CACACCAC GCGCCACACACAC C C CACACTCACT T A ACACTCTTA TT C CT AGTTT TTGGATG TC C T TTAACTCCCC C T TCTCCCCTTTGT CCCTCTCCA TT CTCTCGCG G TTCGGT T C CGCGTGTGTTCG G GTGTGTGAGA A TTGATGTA G GAGAAAAGAG TC  GAAGG CAG A AGAGGGGTCA T G GGGGTGTGG G GTGTGTGTGT T T TGTGTGTCTC C G GTGTCTCTCT T T TCT TCTTCCCT CT TCTTTTTTT T T TTTTTTTGCTTG TGTTTTGTGTGT T T TGTGTGTTTT T G GTGTTTTT CT TTTTTTTCTC C T TTTTATCACA A T TCTCACAAAA A C CACAAAAA GTA AG TAATAT T A AAAATATG TAG A ATTGGGG G TT ATGGGGCGC C G GGGGCAAGCA TG CA GCAACTAC C C CACACACA ATA A ACCACAC C C CAACAACACCT ACACAAC C C CACACACTCT A A ACACTGTCTG G C CTCTGTGGGG G T TGTGGA TGT T G GGGGTTT T G GTGTTTTTTT T T TTGTACT TG AAA TTTTGTGTGT T T TGTTT,C TTCCTTAA CTG CA TTATATAT ACT TTACATATATGTG G TACATATATGCACGT T A GGATGTGTGTCTC ACT TGTGTGTCTCCCC C G GTGTCTCCCCCC T TCTCC CCCCTCT  CCCCCCCTCTGGTGG CCCCCCTTGCGC C C CTCTGGA GCACA A T TGTGCGG CAC GGC G GCGCAAC ACACA A C CACACACACAAAA A AACACAAAAGAG G C CACAAAAGAGACT A A AAATT ACGAAAA  AGAGAGAAAAAAA A GGAAAAAAAAAG A A AACACAAAAAGAA G AA TAAA TGTGCGA A A AAAAGAGAGAAAA A A AGGAAAACAC C G GAGAAAACACTCT  AAACTG AT A ACT TCTTTTCTC C C CTT ATTCTCACA  AA TTTCACACAC C T TCCACACACA  CACACACACAAAA A A ACACACAAAACTTAC C CACAAAACCT T A AAAACACTCTGTG TTC ACACTCTGTGCGC C C CTCTGTGCGCTCT T T TGAGAGCTCTCCACC G GCGCTCTCCC  ATCTCTCCCCT TGT TCTTCCTCTGTG G C CCCCTCTGTGCGC C C CTCTGTTGGCCCC C T TGTGCCCATGA GCGCCCCACATAT T CCCACATATTTT T CCATAAGAGATT T A CATTTTG  TTTTTTTGC CT T TTTGCTGTTC TCC TGTGTGTCCTTA G GTGTCTCAG TAT T T TCCATTG  CACATATGTGAA AGGCTTGTGAGATAT T TTGAGATATGG TGCA GA ATATGTGGGG G A CTATGTGGGGATGC TGGGAA GGAAAAAA G GAGAAAAAAAAAA A AAAAAAGAG G A AATGTAGCGC C A AATTTGCACA A A AGAGCGCACACAC C G GCGCACACCA A CG GCACACACACAC C A ACACACACACTGA  CACACCTTTCC ACTCACTTTTTTT T C CTCA TTTTTCAAATTTTTCTCCCC C T TTTTCC TCT T T TCTT CCTCTCTC C C CCCCTCTCTCGCG G C CTCTCTCGCGTGT T T TCTCGCGTTG TG G C CGCGTGTGTGAGA A GAC GTGCA GAAAA A TCT TGAGAAAAGAG CTG GATTTAAGAGG TC AAAAGAGGGGTGT CTT AGAGGGGTGTGG GGGTGTGAAGGT T G GTTGTGTCTC C TACTGTCTCTCT T G GTTT TCTCTTTT  TCTGTAA TT T C CTCTTGAATTGTG CAT TTTTTATGTGTGT T T TTTTGTGTGTCT T TGTGTGTTTTTTT T G GTGTTTTTG ATC C T TTTTCTCAAAG TTTTCTCACAAAA A TAAATCACAAAAACTTA CCAAG AAATAT T A AATC AATTG G A AAA CATGTGG ATTT ATGTGGGGCGC CA  TGTGGGGCGCACA A GGATGG GCACACAC C G GCCACCA  CAAAA ATCACAC  ACACATGGACAC TAATACACACACACACAC  AC TAACTTTCT C CATCTTGTCTGG AAGAACTCTGTGGGG G C CTCTGCACGGTGT T T TGGGTGTTTT T G GTGGTAAGT G GTGTTTTT CTG TTTTTTGTGTGT AAA TTTTGTGTGTA,CACCTTTTATATAT T CAC TCCTATTCTG T TT CTTATATGTGTGT T T TATATATGTGTGTCTC C A ATTTGTGTGTCTCCCC C T TGTGTCCCCC C G GTGTCGCCCCCCCTCT T TC CGGCCCTCTGTG G CCCCCCTCTGTGC CCCCTCTGGTAGCATGAA C CTTGCGCACACAC  TT TGTGCGCACACACAAACAGA GCGCAACAAA A C CAGCCACAAAGAG GT ACAAG AAGA GCT A C CAACAAAGAGAGAAAA A A AAAATAGAGAAAAAAA A ATG AGAGAAAAAAAAAAG GAGAAAAAAAAAAGAG G ACA AAAAGAGA A A AAAAAAAGGAAAA A A AAAT AGAGAAAACAGCC A AGAGAGAAACTGGTT G GACATAACACTCTTTT T A AAACTCTTTTCTC  ACACTTTCTCACA CCCCTT CACACAC C T TTTTCTCACACACATTGA TC GTCACACCAAAA A C CACACACAAACAC C A ACACACC AACACTCT T CCAAAACACTCTGTG G A AAAACC TTGCGC C A ACACTG ACACGCTCT  TGCTGGCTC T TGTGCGCTCTCTCCC T TC GCGCTCTCTCCCCTCT T C CTCTCCTTCCTCTGTG A C TCCTGTGC TC CCCCTTGCGCCCAAC C CTCTGTGCCACTTGCA A T TGTCCCCACATT GGCCCCAGAAATTT CTC CCACATATTTT T CCATATTG ATG G A ATATTTTTTTGTGTT T TTCTGCA TGTGTCC T TTTTGTGTGTCCA A T CTTGTGTCTCACTCAT T G GTGTCTCACATATGTG G TC CTCACATATGTGAGA A CTTCCATTGAGATAT T A ATATGTGAGATATGTG G T TGTTGGATATGTGGGG  GAATGTGG AA GAA A ATATGTGGGGA AGAA A T TGTGGGGAGAAAAAAA A G GGGGAGAAAAAAAAAA AAAGA GAATTTAAAAAGCAAGC AAAAAAAAG CTGC T G AAAAA TCAGCGCACA CTC AAAAGAGCGCACACC AGAAAGCGCAGCAACACA A GGCACACACACAC TG CACACACACACACTCT T A ACACACACGTTCTTTT T C CAACTACTCTTTTTTT T ATGTACTCTTTTTTTC CCC C CTCTTTTTTTCTCCC T TTTTCTCCCCTCT ACA TTTTCTCCCCTCTCAA AAGTCCTCGCG G C CCCCTA ATCGCGTGT T CCATTCGGGTGTG TG TCTCGCGTGTGTGA ACA C CGCGTGTGCA GAAAA A G GTGTGTGAGAAAAGAG G T TGTGAGAAAAGAGGGG G G GAGAAAAGAGGGGTGT T A AAAAGAGGGGTGTGTG G A AGGG GGTGTGTGTGT T G GGGGTGTGTGTTC C G GTGTGTTGTCTGA T T TGTGTGTCATGCTT TTC A GTGTCTCTCTTTTTTT GTT TCTCTCTTTTTATGTG G C CTCTTTTTTTGTGTGT T T TTTTTTGATGTGTTT T TTTTGTGTGTTTTTTT T T TGTGTGTTTTCTC  GTGTTTTTTTCTCACA A TCC CTGTCACAAAA  TTTTCTCA CAA TTCACAAAAAAATAT T C CACAAAAAAA ATGTG TTG AAAAAAATATGTGGAGGG A AAAATCACGGC ATTGGGGCGCACA AC G TTGGTCCGCACACAC C G GGGGCACTACAGGAGCACACACACACAC C CACTCACACACACT TCA A A ACACACACCAACACAC C C CACACACATTTACTCT T A ACACACACACTTTTG C CACACACTCTGTGGGG G A ACACTCTGTGGGGTGT T C CTCTGTGGCGTGTTTT T TC CT TA GTT T G GGGGTTGCTTTGTCTG G G GTGTTTTTTTG ACG ATT TTTCCATGC,ACTCTTTTACATG TTG G C CTAC TATATGTGTGT T T TTTTACTGATGTGTTC C T TAGCCTGTGTCTCCCC C A ATTGTGTCTCCCCCCC C TC ATGTGTCTCCCCCCCTCT T GTGTGTCTGCTCACCTCTGACAATG TCTCCCCCCCTCTGTGCGC C C CCCCC CATC TGCGCACA  CCCCTTGCGCACACAC  GCA ATGCAAGCACACACA A T TGTGCGCACACCTGGCTAA A G GCGCAATGCACCAAAAGAG G CCACCAAAAGAGACA A A ACACACAAAGAGAAAA A CCGTCATTCAAGAGAAAAAAA A A AAAAGAGAGAAAAAAAAA A AGAGAAAAAAAAAGG G GAGAAAAAAAAAAGAGAGA A A AAAAAAAGAGAGAAAA A A AAAAAAAGTCGGAAAACCTTC AA TAAGAGAGAATTCACTCGT AGAGAGAAAACACTCTTAACT G GAGAAAACACTCTTTTCTC GAT AAAACACTCTTTTCTCACA AAA ACCTTTTCCACAC C C CTCTTAACTCAACACA A T TT GGTCACACACAAA A T TGC AACACAAAC C CCTG TGC ACAAACTCT T A ACACAAACTG TG  CACAAAACACTCTGTGCGC C A AATT CTGTCTGCTCT T A ACACTCTGTGCGCTCTCCCTC C CTCTGTCCGCTCTCTCCCC C TCACTGC GTTCCCCTCT T GACTCTCCACCTGTG G C CTTCCCCTCTGTGCGC C T TCTCCCCTCTGTGCGCCCC  CCCCTCTGG TCCAA C CTCTGTGCGCCCCACATAT T T TGTGCGCCCCACATATTTT T G GCTATCCATATATTTTTTT G T CCCCACATATTTTTTG G C CACATATTTTTTCATGTGT TGT ATATTTTTTGTGTCGTTTTGTGTGTCTCACA T A TTTTGACAGTCTCACATCAC TGTGTGTCTCACATATGTG G G GTGTCTCACATATGACTA T TCTCACAATGACACAT T C CACATATGTGAC AATGTG G ATTTTGAGATATGTGGG T TGTGATCAATGTGGGGAGA A G GAGATTGGGGAAA A A ATATGTGGGGATATTG AA  AA TGTGGGGAGAAAAAAAAAA A G GGGGAAAAAAA TTAG G GAAAAAAAC AGCACA AAAAAAAAAAGAGCT CA A AAAAAAAGAGCGCACACAC C A AAAAGAGCCG  CTCA  CT AGAGCGCAACACACAC  GCGCAGC ACACACACTCT ATG CAACACACACTCTTTT T AACACACACTCTTTTTTT T C CACACACTTTTTTCC C ACACTCTTTTTTCCCC C C CTCTTTTTTTCTCCACACT T T TTCA TCCCCTCTCTT C T TTTTCATGCCTCTCTCGGCATGC TCATGCCTAGAAAGGT  CCCCTCTCTCGCGTGTGTG G C CTCTCTCGCAAGTGTGAGA A T TCTCGTCAGTGTGAGAAAA A C CGCGTGTGTGAGAAAAGAG G GGTGTGAGAAAAGAGGGG T C TGTGAGAACGTAGGGGT GAGAAAAGAGGGGTGTGTG G A AAGCAAGGGGTC GGT T A ACACAGTGTGTGTCTC C G GGGGTGTGTGTGTCCT T G GTGTGTGTGTCTCTCTTT TGTCTCTCTTTTTTT T GCAAGTCCTTTTTTTGTG G TCA TCTCTTTTGTGTGT CACTTTTTGTGTT T TTTTTTTGGGTC TTTTTT T TGCTTTGTGTGTTTTCTC C T TGTGTGTTTTTTTCGATCA A G GTGTTTTTTTCTTGAA A T TTTTTTTCCCCCAAAA A T TTTTCCAAAAAAATAT T TTTGTCAACAAAAATGTG G C CACAAAAAAATATGTGGGG G A AAAAAAATCACTGGGGCGC  AAAATGTGTGGGGCGCAACTA A ATT CTGGGGCGCACACC T TGTGGGGCGCACACTGT TCA GGGCGCACACTCCAAGC G GCGCAAT ACACACCA A C CACCTCACACACACAC CAC ACACACACGGTCACCT T C CACACACACACACTCTGTG G A ACACAACTCTGTGGGG G C CACACGA CTGTGGGGTGT T A ACACTCTGTGGGGTGTTTC GCA CTGAATGGGGTTTTTT T T TGAGGCTTGTTTTTTTGA AG G GGGGTGTTTTT TCTTCGT T G GTGTTTTTTGTGTA,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",36674
AAGATC AGATCA GATCAC ATCACG TCACGG CACGGG ACGGGA CGGGAG GGGAGC GGAGCC GAGCCG AGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTT AGTTTC GTTTCT TTTCTC TTCTCT TCTCTC CTCTCG TCTCGC CTCGCG TCGCGC CGCGCC GCGCCT CGCCTC GCCTCC CCTCCC CTCCCC TCCCCG CCCCGC CCCGCC CCGCCG CGCCGA GCCGAC CCGACA CGACAC GACACG ACACGA CACGAC ACGACG CGACGC GACGCT ACGCTC CGCTCA GCTCAT CTCATC TCATCA CATCAA ATCAAG TCAAGA CAAGAC AAGACG AGACGG GACGGT ACGGTG CGGTGG GGTGGT GTGGTC TGGTCG GGTCGG GTCGGT TCGGTT CGGTTC GGTTCT GTTCTT TTCTTC TCTTCC CTTCCG TTCCGC TCCGCC CCGCCT CGCCTC GCCTCC CCTCCA CTCCAT TCCATC CCATCG CATCGC ATCGCG TCGCGC CGCGCT GCGCTG CGCTGC GCTGCG CTGCGA TGCGAA GCGAAG CGAAGC GAAGCC AAGCCT AGCCTG GCCTGT CCTGTT CTGTTT TGTTTC GTTTCT TTTCTG TTCTGT TCTGTT CTGTTC TGTTCT GTTCTT TTCTTC TCTTCG CTTCGG TTCGGC TCGGCG CGGCGC GGCGCC GCGCCG CGCCGT GCCGTG CCGTGA CGTGAC GTGACG TGACGA GACGAT ACGATG CGATGA GATGAT ATGATG TGATGG GATGGT ATGGTG TGGTGG GGTGGC GTGGCG TGGCGA GGCGAC GCGACG CGACGA GACGAG ACGAGC CGAGCC GAGCCC AGCCCC GCCCCT CCCCTA CCCTAT,2,145,AAGA AGAT GATC ATCA TCAC CACG ACGG CGGG GGGA GGAG GAGC AGCC GCCG CCGA CGAC GACA ACAA CAAG AAGT AGTT GTTT TTTC TTCT TCTC CTCT TCTC CTCG TCGC CGCG GCGC CGCC GCCT CCTC CTCC TCCC CCCC CCCG CCGC CGCC GCCG CCGA CGAC GACA ACAC CACG ACGA CGAC GACG ACGC CGCT GCTC CTCA TCAT CATC ATCA TCAA CAAG AAGA AGAC GACG ACGG CGGT GGTG GTGG TGGT GGTC GTCG TCGG CGGT GGTT GTTC TTCT TCTT CTTC TTCC TCCG CCGC CGCC GCCT CCTC CTCC TCCA CCAT CATC ATCG TCGC CGCG GCGC CGCT GCTG CTGC TGCG GCGA CGAA GAAG AAGC AGCC GCCT CCTG CTGT TGTT GTTT TTTC TTCT TCTG CTGT TGTT GTTC TTCT TCTT CTTC TTCG TCGG CGGC GGCG GCGC CGCC GCCG CCGT CGTG GTGA TGAC GACG ACGA CGAT GATG ATGA TGAT GATG ATGG TGGT GGTG GTGG TGGC GGCG GCGA CGAC GACG ACGA CGAG GAGC AGCC GCCC CCCC CCCT CCTA CTAT,AAGAT AGATC GATCA ATCAC TCACG CACGG ACGGG CGGGA GGGAG GGAGC GAGCC AGCCG GCCGA CCGAC CGACA GACAA ACAAG CAAGT AAGTT AGTTT GTTTC TTTCT TTCTC TCTCT CTCTC TCTCG CTCGC TCGCG CGCGC GCGCC CGCCT GCCTC CCTCC CTCCC TCCCC CCCCG CCCGC CCGCC CGCCG GCCGA CCGAC CGACA GACAC ACACG CACGA ACGAC CGACG GACGC ACGCT CGCTC GCTCA CTCAT TCATC CATCA ATCAA TCAAG CAAGA AAGAC AGACG GACGG ACGGT CGGTG GGTGG GTGGT TGGTC GGTCG GTCGG TCGGT CGGTT GGTTC GTTCT TTCTT TCTTC CTTCC TTCCG TCCGC CCGCC CGCCT GCCTC CCTCC CTCCA TCCAT CCATC CATCG ATCGC TCGCG CGCGC GCGCT CGCTG GCTGC CTGCG TGCGA GCGAA CGAAG GAAGC AAGCC AGCCT GCCTG CCTGT CTGTT TGTTT GTTTC TTTCT TTCTG TCTGT CTGTT TGTTC GTTCT TTCTT TCTTC CTTCG TTCGG TCGGC CGGCG GGCGC GCGCC CGCCG GCCGT CCGTG CGTGA GTGAC TGACG GACGA ACGAT CGATG GATGA ATGAT TGATG GATGG ATGGT TGGTG GGTGG GTGGC TGGCG GGCGA GCGAC CGACG GACGA ACGAG CGAGC GAGCC AGCCC GCCCC CCCCT CCCTA CCTAT,AAGATC AGATCA GATCAC ATCACG TCACGG CACGGG ACGGGA CGGGAG GGGAGC GGAGCC GAGCCG AGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTT AGTTTC GTTTCT TTTCTC TTCTCT TCTCTC CTCTCG TCTCGC CTCGCG TCGCGC CGCGCC GCGCCT CGCCTC GCCTCC CCTCCC CTCCCC TCCCCG CCCCGC CCCGCC CCGCCG CGCCGA GCCGAC CCGACA CGACAC GACACG ACACGA CACGAC ACGACG CGACGC GACGCT ACGCTC CGCTCA GCTCAT CTCATC TCATCA CATCAA ATCAAG TCAAGA CAAGAC AAGACG AGACGG GACGGT ACGGTG CGGTGG GGTGGT GTGGTC TGGTCG GGTCGG GTCGGT TCGGTT CGGTTC GGTTCT GTTCTT TTCTTC TCTTCC CTTCCG TTCCGC TCCGCC CCGCCT CGCCTC GCCTCC CCTCCA CTCCAT TCCATC CCATCG CATCGC ATCGCG TCGCGC CGCGCT GCGCTG CGCTGC GCTGCG CTGCGA TGCGAA GCGAAG CGAAGC GAAGCC AAGCCT AGCCTG GCCTGT CCTGTT CTGTTT TGTTTC GTTTCT TTTCTG TTCTGT TCTGTT CTGTTC TGTTCT GTTCTT TTCTTC TCTTCG CTTCGG TTCGGC TCGGCG CGGCGC GGCGCC GCGCCG CGCCGT GCCGTG CCGTGA CGTGAC GTGACG TGACGA GACGAT ACGATG CGATGA GATGAT ATGATG TGATGG GATGGT ATGGTG TGGTGG GGTGGC GTGGCG TGGCGA GGCGAC GCGACG CGACGA GACGAG ACGAGC CGAGCC GAGCCC AGCCCC GCCCCT CCCCTA CCCTAT,AAGATCA AGATCAC GATCACG ATCACGG TCACGGG CACGGGA ACGGGAG CGGGAGC GGGAGCC GGAGCCG GAGCCGA AGCCGAC GCCGACA CCGACAA CGACAAG GACAAGT ACAAGTT CAAGTTT AAGTTTC AGTTTCT GTTTCTC TTTCTCT TTCTCTC TCTCTCG CTCTCGC TCTCGCG CTCGCGC TCGCGCC CGCGCCT GCGCCTC CGCCTCC GCCTCCC CCTCCCC CTCCCCG TCCCCGC CCCCGCC CCCGCCG CCGCCGA CGCCGAC GCCGACA CCGACAC CGACACG GACACGA ACACGAC CACGACG ACGACGC CGACGCT GACGCTC ACGCTCA CGCTCAT GCTCATC CTCATCA TCATCAA CATCAAG ATCAAGA TCAAGAC CAAGACG AAGACGG AGACGGT GACGGTG ACGGTGG CGGTGGT GGTGGTC GTGGTCG TGGTCGG GGTCGGT GTCGGTT TCGGTTC CGGTTCT GGTTCTT GTTCTTC TTCTTCC TCTTCCG CTTCCGC TTCCGCC TCCGCCT CCGCCTC CGCCTCC GCCTCCA CCTCCAT CTCCATC TCCATCG CCATCGC CATCGCG ATCGCGC TCGCGCT CGCGCTG GCGCTGC CGCTGCG GCTGCGA CTGCGAA TGCGAAG GCGAAGC CGAAGCC GAAGCCT AAGCCTG AGCCTGT GCCTGTT CCTGTTT CTGTTTC TGTTTCT GTTTCTG TTTCTGT TTCTGTT TCTGTTC CTGTTCT TGTTCTT GTTCTTC TTCTTCG TCTTCGG CTTCGGC TTCGGCG TCGGCGC CGGCGCC GGCGCCG GCGCCGT CGCCGTG GCCGTGA CCGTGAC CGTGACG GTGACGA TGACGAT GACGATG ACGATGA CGATGAT GATGATG ATGATGG TGATGGT GATGGTG ATGGTGG TGGTGGC GGTGGCG GTGGCGA TGGCGAC GGCGACG GCGACGA CGACGAG GACGAGC ACGAGCC CGAGCCC GAGCCCC AGCCCCT GCCCCTA CCCCTAT,"ID   AB25B_ORYSJ             Reviewed;         641 AA.
AC   Q9FNU2; I0IVW0;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   05-FEB-2025, entry version 155.
DE   RecName: Full=ABC transporter B family member 25 {ECO:0000303|PubMed:18299247};
DE            Short=ABC transporter ABCB.25 {ECO:0000303|PubMed:18299247};
DE            Short=OsABCB25 {ECO:0000303|PubMed:18299247};
DE   AltName: Full=Protein ALS1 homolog {ECO:0000305};
DE   AltName: Full=Protein ALUMINUM SENSITIVE 1 {ECO:0000303|PubMed:22035218};
DE            Short=OsALS1 {ECO:0000303|PubMed:22035218};
GN   Name=ABCB25 {ECO:0000303|PubMed:18299247};
GN   Synonyms=ALS1 {ECO:0000303|PubMed:22035218};
GN   OrderedLocusNames=Os03g0755100 {ECO:0000312|EMBL:BAF13225.1},
GN   LOC_Os03g54790 {ECO:0000312|EMBL:ABF98942.1};
GN   ORFNames=OSJNBb0081K01.19 {ECO:0000312|EMBL:AAR01687.1};
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=11244114; DOI=10.1104/pp.125.3.1342;
RA   Dubcovsky J., Ramakrishna W., SanMiguel P.J., Busso C.S., Yan L.,
RA   Shiloff B.A., Bennetzen J.L.;
RT   ""Comparative sequence analysis of colinear barley and rice bacterial
RT   artificial chromosomes."";
RL   Plant Physiol. 125:1342-1353(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INDUCTION BY ALUMINUM, AND DISRUPTION PHENOTYPE.
RX   PubMed=22035218; DOI=10.1111/j.1365-313x.2011.04837.x;
RA   Huang C.F., Yamaji N., Chen Z., Ma J.F.;
RT   ""A tonoplast-localized half-size ABC transporter is required for internal
RT   detoxification of aluminum in rice."";
RL   Plant J. 69:857-867(2012).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16109971; DOI=10.1101/gr.3869505;
RG   The rice chromosome 3 sequencing consortium;
RA   Buell C.R., Yuan Q., Ouyang S., Liu J., Zhu W., Wang A., Maiti R., Haas B.,
RA   Wortman J., Pertea M., Jones K.M., Kim M., Overton L., Tsitrin T.,
RA   Fadrosh D., Bera J., Weaver B., Jin S., Johri S., Reardon M., Webb K.,
RA   Hill J., Moffat K., Tallon L., Van Aken S., Lewis M., Utterback T.,
RA   Feldblyum T., Zismann V., Iobst S., Hsiao J., de Vazeille A.R.,
RA   Salzberg S.L., White O., Fraser C.M., Yu Y., Kim H., Rambo T., Currie J.,
RA   Collura K., Kernodle-Thompson S., Wei F., Kudrna K., Ammiraju J.S.S.,
RA   Luo M., Goicoechea J.L., Wing R.A., Henry D., Oates R., Palmer M.,
RA   Pries G., Saski C., Simmons J., Soderlund C., Nelson W., de la Bastide M.,
RA   Spiegel L., Nascimento L., Huang E., Preston R., Zutavern T., Palmer L.,
RA   O'Shaughnessy A., Dike S., McCombie W.R., Minx P., Cordum H., Wilson R.,
RA   Jin W., Lee H.R., Jiang J., Jackson S.;
RT   ""Sequence, annotation, and analysis of synteny between rice chromosome 3
RT   and diverged grass species."";
RL   Genome Res. 15:1284-1291(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   ""The map-based sequence of the rice genome."";
RL   Nature 436:793-800(2005).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   ""The rice annotation project database (RAP-DB): 2008 update."";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [6]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H., McCombie W.R.,
RA   Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S., Childs K.L.,
RA   Davidson R.M., Lin H., Quesada-Ocampo L., Vaillancourt B., Sakai H.,
RA   Lee S.S., Kim J., Numa H., Itoh T., Buell C.R., Matsumoto T.;
RT   ""Improvement of the Oryza sativa Nipponbare reference genome using next
RT   generation sequence and optical map data."";
RL   Rice 6:4-4(2013).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12869764; DOI=10.1126/science.1081288;
RG   The rice full-length cDNA consortium;
RT   ""Collection, mapping, and annotation of over 28,000 cDNA clones from
RT   japonica rice."";
RL   Science 301:376-379(2003).
RN   [8]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=18299247; DOI=10.1016/j.tplants.2008.02.001;
RA   Verrier P.J., Bird D., Burla B., Dassa E., Forestier C., Geisler M.,
RA   Klein M., Kolukisaoglu H.U., Lee Y., Martinoia E., Murphy A., Rea P.A.,
RA   Samuels L., Schulz B., Spalding E.J., Yazaki K., Theodoulou F.L.;
RT   ""Plant ABC proteins - a unified nomenclature and updated inventory."";
RL   Trends Plant Sci. 13:151-159(2008).
CC   -!- FUNCTION: Metal transporter involved in the sequestration of aluminum
CC       into vacuoles, which is required for cellular detoxification of
CC       aluminum. {ECO:0000269|PubMed:22035218}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane {ECO:0000269|PubMed:22035218};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in primary roots ans lateral roots.
CC       {ECO:0000269|PubMed:22035218}.
CC   -!- INDUCTION: Induced by aluminum in roots. {ECO:0000269|PubMed:22035218}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype under normal growth
CC       conditions, but mutant plants are hypersensitive to aluminum.
CC       {ECO:0000269|PubMed:22035218}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB family.
CC       Multidrug resistance exporter (TC 3.A.1.201) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY013245; AAG45492.1; -; Genomic_DNA.
DR   EMBL; AB625451; BAM09409.1; -; mRNA.
DR   EMBL; AC120509; AAR01687.1; -; Genomic_DNA.
DR   EMBL; DP000009; ABF98942.1; -; Genomic_DNA.
DR   EMBL; AP008209; BAF13225.1; -; Genomic_DNA.
DR   EMBL; AP014959; BAS86444.1; -; Genomic_DNA.
DR   EMBL; AK066049; BAG89793.1; -; mRNA.
DR   AlphaFoldDB; Q9FNU2; -.
DR   SMR; Q9FNU2; -.
DR   STRING; 39947.Q9FNU2; -.
DR   PaxDb; 39947-Q9FNU2; -.
DR   EnsemblPlants; Os03t0755100-01; Os03t0755100-01; Os03g0755100.
DR   Gramene; Os03t0755100-01; Os03t0755100-01; Os03g0755100.
DR   eggNOG; KOG0058; Eukaryota.
DR   HOGENOM; CLU_000604_84_3_1; -.
DR   InParanoid; Q9FNU2; -.
DR   OMA; YYYELYT; -.
DR   PlantReactome; R-OSA-9639136; Response to Aluminum stress.
DR   Proteomes; UP000000763; Chromosome 3.
DR   Proteomes; UP000059680; Chromosome 3.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:UniProtKB.
DR   GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR   GO; GO:0015083; F:aluminum ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:1902602; P:aluminum ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0140982; P:detoxification of aluminum ion; IMP:UniProtKB.
DR   GO; GO:0010044; P:response to aluminum ion; IMP:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   CDD; cd18780; ABC_6TM_AtABCB27_like; 1.
DR   CDD; cd03249; ABC_MTABC3_MDL1_MDL2; 1.
DR   FunFam; 1.20.1560.10:FF:000058; ABC transporter B family member 25; 1.
DR   FunFam; 3.40.50.300:FF:000836; ABC transporter B family member 25; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039421; Type_1_exporter.
DR   PANTHER; PTHR43394:SF1; ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43394; ATP-DEPENDENT PERMEASE MDL1, MITOCHONDRIAL; 1.
DR   Pfam; PF00664; ABC_membrane; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   PIRSF; PIRSF002773; ABC_prm/ATPase_B; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Membrane; Nucleotide-binding; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Vacuole.
FT   CHAIN           1..641
FT                   /note=""ABC transporter B family member 25""
FT                   /id=""PRO_0000405575""
FT   TRANSMEM        52..72
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        100..120
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        191..211
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        284..304
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        320..340
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   DOMAIN          55..346
FT                   /note=""ABC transmembrane type-1""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00441""
FT   DOMAIN          380..617
FT                   /note=""ABC transporter""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""
FT   BINDING         415..422
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""
SQ   SEQUENCE   641 AA;  69200 MW;  F82D17EABADE0134 CRC64;
     MGKNLRIKTG NRAPLLAQGE TSRALSDLEE GSNVQPENVG FCRVIKLARH DAGKLVIATM
     ALLVASLSNI LVPKYGGKII DIVSRDVRRP EDKAQALDDV TGTILYIVII VVTGSVCTAL
     RAWLFNSASE RVVARLRKDL FSHLVNQEIA FFDVTRTGEL LSRLSEDTQI IKNAATTNLS
     EALRNITTTS IGLGFMFATS WKLTLLALVI VPVISIAVRK FGRFLRELSH QTQAAAAVAS
     SIAEESFGAI RTVRSFAQES HEVLRYGEKV DETLKLGLKQ AKVVGMFSGG LNAASTLSVV
     IVVIYGANLT INGYMTTGSL TSFILYSLTV GSSVSALSGL YTTVMKASGA SRRVFQLLDR
     VSSMANSGDR CPTNENDGEV ELDDVWFAYP SRPSHMILKG ITLKLTPGSK VALVGPSGGG
     KTTIANLIER FYDPLKGRIL LNGVPLPEIS HQFLHRKVSI VSQEPVLFNC SIEENIAYGL
     EGKASSADVE NAAKMANAHN FICSFPDQYK TVVGERGIRL SGGQKQRVAI ARALLMNPRV
     LLLDEATSAL DAESEYLVQD AMDSLMKGRT VLVIAHRLST VKSADTVAVI SDGQIVESGT
     HDELLSRDGI YTALVKRQLQ GPRFEGTSNA TAEIEPISNG Q
//
",44568
GCTACT CTACTC TACTCC ACTCCT CTCCTT TCCTTC CCTTCA CTTCAG TTCAGA TCAGAT CAGATT AGATTT GATTTT ATTTTG TTTTGT TTTGTT TTGTTC TGTTCT GTTCTC TTCTCG TCTCGC CTCGCT TCGCTA CGCTAC GCTACT CTACTG TACTGC ACTGCA CTGCAA TGCAAC GCAACG CAACGA AACGAC ACGACA CGACAC GACACC ACACCG CACCGA ACCGAA CCGAAA CGAAAC GAAACA AAACAA AACAAG ACAAGC CAAGCC AAGCCT AGCCTC GCCTCA CCTCAC CTCACT TCACTC CACTCC ACTCCT CTCCTT TCCTTT CCTTTT CTTTTC TTTTCG TTTCGG TTCGGA TCGGAT CGGATG GGATGG GATGGC ATGGCT TGGCTT GGCTTA GCTTAT CTTATT TTATTG TATTGT ATTGTT TTGTTG TGTTGG GTTGGC TTGGCG TGGCGT GGCGTT GCGTTG CGTTGC GTTGCA TTGCAC TGCACT GCACTT CACTTC ACTTCT CTTCTT TTCTTG TCTTGC CTTGCT TTGCTG TGCTGT GCTGTT CTGTTT TGTTTT GTTTTT TTTTTC TTTTCA TTTCAG TTCAGC TCAGCG CAGCGC AGCGCG GCGCGC CGCGCC GCGCCT CGCCTC GCCTCC CCTCCA CTCCAA TCCAAA CCAAAA CAAAAT AAAATC AAATCA AATCAT ATCATA TCATAA CATAAC ATAACT TAACTC AACTCC ACTCCC CTCCCA TCCCAA CCCAAA CCAAAA CAAAAA AAAAAG AAAAGA AAAGAG AAGAGA AGAGAT GAGATG AGATGG GATGGC ATGGCA TGGCAA GGCAAC GCAACT CAACTA AACTAG ACTAGC CTAGCA,1,145,GCTA CTAC TACT ACTC CTCC TCCT CCTT CTTC TTCA TCAG CAGA AGAT GATT ATTT TTTT TTTG TTGT TGTT GTTC TTCT TCTC CTCG TCGC CGCT GCTA CTAC TACT ACTG CTGC TGCA GCAA CAAC AACG ACGA CGAC GACA ACAC CACC ACCG CCGA CGAA GAAA AAAC AACA ACAA CAAG AAGC AGCC GCCT CCTC CTCA TCAC CACT ACTC CTCC TCCT CCTT CTTT TTTT TTTC TTCG TCGG CGGA GGAT GATG ATGG TGGC GGCT GCTT CTTA TTAT TATT ATTG TTGT TGTT GTTG TTGG TGGC GGCG GCGT CGTT GTTG TTGC TGCA GCAC CACT ACTT CTTC TTCT TCTT CTTG TTGC TGCT GCTG CTGT TGTT GTTT TTTT TTTT TTTC TTCA TCAG CAGC AGCG GCGC CGCG GCGC CGCC GCCT CCTC CTCC TCCA CCAA CAAA AAAA AAAT AATC ATCA TCAT CATA ATAA TAAC AACT ACTC CTCC TCCC CCCA CCAA CAAA AAAA AAAA AAAG AAGA AGAG GAGA AGAT GATG ATGG TGGC GGCA GCAA CAAC AACT ACTA CTAG TAGC AGCA,GCTAC CTACT TACTC ACTCC CTCCT TCCTT CCTTC CTTCA TTCAG TCAGA CAGAT AGATT GATTT ATTTT TTTTG TTTGT TTGTT TGTTC GTTCT TTCTC TCTCG CTCGC TCGCT CGCTA GCTAC CTACT TACTG ACTGC CTGCA TGCAA GCAAC CAACG AACGA ACGAC CGACA GACAC ACACC CACCG ACCGA CCGAA CGAAA GAAAC AAACA AACAA ACAAG CAAGC AAGCC AGCCT GCCTC CCTCA CTCAC TCACT CACTC ACTCC CTCCT TCCTT CCTTT CTTTT TTTTC TTTCG TTCGG TCGGA CGGAT GGATG GATGG ATGGC TGGCT GGCTT GCTTA CTTAT TTATT TATTG ATTGT TTGTT TGTTG GTTGG TTGGC TGGCG GGCGT GCGTT CGTTG GTTGC TTGCA TGCAC GCACT CACTT ACTTC CTTCT TTCTT TCTTG CTTGC TTGCT TGCTG GCTGT CTGTT TGTTT GTTTT TTTTT TTTTC TTTCA TTCAG TCAGC CAGCG AGCGC GCGCG CGCGC GCGCC CGCCT GCCTC CCTCC CTCCA TCCAA CCAAA CAAAA AAAAT AAATC AATCA ATCAT TCATA CATAA ATAAC TAACT AACTC ACTCC CTCCC TCCCA CCCAA CCAAA CAAAA AAAAA AAAAG AAAGA AAGAG AGAGA GAGAT AGATG GATGG ATGGC TGGCA GGCAA GCAAC CAACT AACTA ACTAG CTAGC TAGCA,GCTACT CTACTC TACTCC ACTCCT CTCCTT TCCTTC CCTTCA CTTCAG TTCAGA TCAGAT CAGATT AGATTT GATTTT ATTTTG TTTTGT TTTGTT TTGTTC TGTTCT GTTCTC TTCTCG TCTCGC CTCGCT TCGCTA CGCTAC GCTACT CTACTG TACTGC ACTGCA CTGCAA TGCAAC GCAACG CAACGA AACGAC ACGACA CGACAC GACACC ACACCG CACCGA ACCGAA CCGAAA CGAAAC GAAACA AAACAA AACAAG ACAAGC CAAGCC AAGCCT AGCCTC GCCTCA CCTCAC CTCACT TCACTC CACTCC ACTCCT CTCCTT TCCTTT CCTTTT CTTTTC TTTTCG TTTCGG TTCGGA TCGGAT CGGATG GGATGG GATGGC ATGGCT TGGCTT GGCTTA GCTTAT CTTATT TTATTG TATTGT ATTGTT TTGTTG TGTTGG GTTGGC TTGGCG TGGCGT GGCGTT GCGTTG CGTTGC GTTGCA TTGCAC TGCACT GCACTT CACTTC ACTTCT CTTCTT TTCTTG TCTTGC CTTGCT TTGCTG TGCTGT GCTGTT CTGTTT TGTTTT GTTTTT TTTTTC TTTTCA TTTCAG TTCAGC TCAGCG CAGCGC AGCGCG GCGCGC CGCGCC GCGCCT CGCCTC GCCTCC CCTCCA CTCCAA TCCAAA CCAAAA CAAAAT AAAATC AAATCA AATCAT ATCATA TCATAA CATAAC ATAACT TAACTC AACTCC ACTCCC CTCCCA TCCCAA CCCAAA CCAAAA CAAAAA AAAAAG AAAAGA AAAGAG AAGAGA AGAGAT GAGATG AGATGG GATGGC ATGGCA TGGCAA GGCAAC GCAACT CAACTA AACTAG ACTAGC CTAGCA,GCTACTC CTACTCC TACTCCT ACTCCTT CTCCTTC TCCTTCA CCTTCAG CTTCAGA TTCAGAT TCAGATT CAGATTT AGATTTT GATTTTG ATTTTGT TTTTGTT TTTGTTC TTGTTCT TGTTCTC GTTCTCG TTCTCGC TCTCGCT CTCGCTA TCGCTAC CGCTACT GCTACTG CTACTGC TACTGCA ACTGCAA CTGCAAC TGCAACG GCAACGA CAACGAC AACGACA ACGACAC CGACACC GACACCG ACACCGA CACCGAA ACCGAAA CCGAAAC CGAAACA GAAACAA AAACAAG AACAAGC ACAAGCC CAAGCCT AAGCCTC AGCCTCA GCCTCAC CCTCACT CTCACTC TCACTCC CACTCCT ACTCCTT CTCCTTT TCCTTTT CCTTTTC CTTTTCG TTTTCGG TTTCGGA TTCGGAT TCGGATG CGGATGG GGATGGC GATGGCT ATGGCTT TGGCTTA GGCTTAT GCTTATT CTTATTG TTATTGT TATTGTT ATTGTTG TTGTTGG TGTTGGC GTTGGCG TTGGCGT TGGCGTT GGCGTTG GCGTTGC CGTTGCA GTTGCAC TTGCACT TGCACTT GCACTTC CACTTCT ACTTCTT CTTCTTG TTCTTGC TCTTGCT CTTGCTG TTGCTGT TGCTGTT GCTGTTT CTGTTTT TGTTTTT GTTTTTC TTTTTCA TTTTCAG TTTCAGC TTCAGCG TCAGCGC CAGCGCG AGCGCGC GCGCGCC CGCGCCT GCGCCTC CGCCTCC GCCTCCA CCTCCAA CTCCAAA TCCAAAA CCAAAAT CAAAATC AAAATCA AAATCAT AATCATA ATCATAA TCATAAC CATAACT ATAACTC TAACTCC AACTCCC ACTCCCA CTCCCAA TCCCAAA CCCAAAA CCAAAAA CAAAAAG AAAAAGA AAAAGAG AAAGAGA AAGAGAT AGAGATG GAGATGG AGATGGC GATGGCA ATGGCAA TGGCAAC GGCAACT GCAACTA CAACTAG AACTAGC ACTAGCA,"ID   AP3A_SARS2              Reviewed;         275 AA.
AC   P0DTC3;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 25.
DE   RecName: Full=ORF3a protein;
DE            Short=ORF3a;
DE   AltName: Full=Accessory protein 3a;
DE   AltName: Full=Protein 3a;
DE   AltName: Full=Protein U274;
DE   AltName: Full=Protein X1;
GN   ORFNames=3a;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3]
RP   FUNCTION.
RX   PubMed=33157038; DOI=10.1016/j.cell.2020.10.039;
RA   Ghosh S., Dellibovi-Ragheb T.A., Kerviel A., Pak E., Qiu Q., Fisher M.,
RA   Takvorian P.M., Bleck C., Hsu V.W., Fehr A.R., Perlman S., Achar S.R.,
RA   Straus M.R., Whittaker G.R., de Haan C.A.M., Kehrl J., Altan-Bonnet G.,
RA   Altan-Bonnet N.;
RT   ""beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic
RT   Secretory Pathway."";
RL   Cell 183:1520-1535(2020).
RN   [4]
RP   FUNCTION, INTERACTION WITH HOST VPS39, AND SUBCELLULAR LOCATION.
RX   PubMed=33422265; DOI=10.1016/j.devcel.2020.12.010;
RA   Miao G., Zhao H., Li Y., Ji M., Chen Y., Shi Y., Bi Y., Wang P., Zhang H.;
RT   ""ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated
RT   assembly of the SNARE complex required for autolysosome formation."";
RL   Dev. Cell 56:427-442(2020).
RN   [5]
RP   FUNCTION, INTERACTION WITH HOST HMGB1 AND HOST HMOX1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=35239449; DOI=10.1080/15548627.2022.2039992;
RA   Zhang X., Yang Z., Pan T., Long X., Sun Q., Wang P.H., Li X., Kuang E.;
RT   ""SARS-CoV-2 ORF3a induces RETREG1/FAM134B-dependent reticulophagy and
RT   triggers sequential ER stress and inflammatory responses during SARS-CoV-2
RT   infection."";
RL   Autophagy 0:0-0(2022).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.1 ANGSTROMS), FUNCTION, SUBUNIT,
RP   MUTAGENESIS OF 1-MET--LEU-41; 57-GLN-SER-58; GLN-57 AND GLN-116, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=34158638; DOI=10.1038/s41594-021-00619-0;
RA   Kern D.M., Sorum B., Mali S.S., Hoel C.M., Sridharan S., Remis J.P.,
RA   Toso D.B., Kotecha A., Bautista D.M., Brohawn S.G.;
RT   ""Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs."";
RL   Nat. Struct. Mol. Biol. 28:573-582(2021).
CC   -!- FUNCTION: Plays a role in viral egress via lysosomal trafficking
CC       (PubMed:33157038, PubMed:33422265). Forms homotetrameric ion channels
CC       (viroporins) localized at endosomes and lysosomes, that may induce
CC       deacidification of lysosomes, allowing safe egress of virions via
CC       lysosomal trafficking (PubMed:33157038, PubMed:33422265,
CC       PubMed:34158638). Also blocks autolysosome formation by binding and
CC       sequestering the host component VPS39 for homotypic fusion and protein
CC       sorting (HOPS) on late endosomes (PubMed:33422265). This prevents
CC       fusion of autophagosomes with lysosomes, disrupting autophagy and
CC       facilitating virus egress (PubMed:33422265). Induces host
CC       RETREG1/FAM134B-dependent reticulophagy by interacting with host HMGB1
CC       and enhancing the association between HMGB1 and host BECN1
CC       (PubMed:35239449). This induces endoplasmic reticulum stress and
CC       inflammatory responses and facilitates viral infection
CC       (PubMed:35239449). {ECO:0000269|PubMed:33157038,
CC       ECO:0000269|PubMed:33422265, ECO:0000269|PubMed:34158638,
CC       ECO:0000269|PubMed:35239449}.
CC   -!- SUBUNIT: Homodimer (PubMed:34158638), a subset forms homotetramer of
CC       two homodimers linked non covalently (PubMed:34158638). Interacts with
CC       M, S and E proteins. Also interacts with the accessory protein 7a (By
CC       similarity). Interacts with host VPS39, sequestering it on late
CC       endosomes (PubMed:33422265). Interacts with host HMGB1; the interaction
CC       enhances the association between HMGB1 and host BECN1, promoting
CC       reticulophagy (PubMed:35239449). Interacts with HMOX1; the interaction
CC       promotes ORF3A-induced autophagy but is unlikely to be involved in
CC       ORF3A-mediated induction of reticulophagy (PubMed:35239449).
CC       {ECO:0000250|UniProtKB:P59632, ECO:0000269|PubMed:33422265,
CC       ECO:0000269|PubMed:34158638, ECO:0000269|PubMed:35239449}.
CC   -!- INTERACTION:
CC       P0DTC3; P0DTC3: 3a; NbExp=4; IntAct=EBI-25475894, EBI-25475894;
CC       P0DTC3; P0DTD8: 7b; NbExp=3; IntAct=EBI-25475894, EBI-25475914;
CC       P0DTC3; Q9Y673: ALG5; Xeno; NbExp=4; IntAct=EBI-25475894, EBI-11725055;
CC       P0DTC3; Q01518: CAP1; Xeno; NbExp=3; IntAct=EBI-25475894, EBI-2808398;
CC       P0DTC3; P09601: HMOX1; Xeno; NbExp=4; IntAct=EBI-25475894, EBI-2806151;
CC       P0DTC3; Q12846: STX4; Xeno; NbExp=4; IntAct=EBI-25475894, EBI-744942;
CC       P0DTC3; Q8NBJ7: SUMF2; Xeno; NbExp=3; IntAct=EBI-25475894, EBI-723091;
CC       P0DTC3; Q9UH99: SUN2; Xeno; NbExp=3; IntAct=EBI-25475894, EBI-1044964;
CC       P0DTC3; Q9P2Y5: UVRAG; Xeno; NbExp=6; IntAct=EBI-25475894, EBI-2952704;
CC       P0DTC3; P51809: VAMP7; Xeno; NbExp=4; IntAct=EBI-25475894, EBI-1052205;
CC       P0DTC3; Q96JC1: VPS39; Xeno; NbExp=19; IntAct=EBI-25475894, EBI-1050197;
CC       P0DTC3; P49754: VPS41; Xeno; NbExp=4; IntAct=EBI-25475894, EBI-2130459;
CC       P0DTC3; Q8NAF0: ZNF579; Xeno; NbExp=2; IntAct=EBI-25475894, EBI-6164383;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000250|UniProtKB:P59632}. Host cell
CC       membrane {ECO:0000250|UniProtKB:P59632, ECO:0000269|PubMed:33060197,
CC       ECO:0000269|PubMed:34158638}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P59632, ECO:0000269|PubMed:34158638}. Host
CC       endoplasmic reticulum membrane {ECO:0000269|PubMed:35239449}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:34158638}. Secreted
CC       {ECO:0000250|UniProtKB:P59632}. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P59632, ECO:0000269|PubMed:33060197}. Host
CC       endosome {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:33422265}.
CC       Host lysosome {ECO:0000269|PubMed:33422265}. Note=The cell surface
CC       expressed protein can undergo endocytosis. The protein is secreted in
CC       association with membranous structures. {ECO:0000250|UniProtKB:P59632}.
CC   -!- DOMAIN: The second or the third transmembrane region are responsible
CC       for Golgi localization. {ECO:0000250|UniProtKB:P59632}.
CC   -!- PTM: Exists in both O-glycosylated and non-glycosylated forms. The
CC       glycosylated form is associated with the virion.
CC       {ECO:0000250|UniProtKB:P59632}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43417.1; -; Genomic_RNA.
DR   PDB; 6XDC; EM; 2.90 A; A/B=1-275.
DR   PDB; 7KJR; EM; 2.08 A; A/B=1-275.
DR   PDB; 8EQJ; EM; 3.00 A; A/B=1-275.
DR   PDB; 8EQT; EM; 3.40 A; A/B=1-275.
DR   PDB; 8EQU; EM; 2.80 A; A/B=1-275.
DR   PDB; 8T5P; X-ray; 2.50 A; G/H/I=36-40.
DR   PDB; 8T5Q; X-ray; 1.90 A; G/H/I=36-40.
DR   PDBsum; 6XDC; -.
DR   PDBsum; 7KJR; -.
DR   PDBsum; 8EQJ; -.
DR   PDBsum; 8EQT; -.
DR   PDBsum; 8EQU; -.
DR   PDBsum; 8T5P; -.
DR   PDBsum; 8T5Q; -.
DR   EMDB; EMD-22136; -.
DR   EMDB; EMD-22898; -.
DR   EMDB; EMD-28538; -.
DR   EMDB; EMD-28545; -.
DR   EMDB; EMD-28546; -.
DR   SMR; P0DTC3; -.
DR   BioGRID; 4383868; 1267.
DR   ComplexPortal; CPX-6098; SARS-CoV-2 3a complex.
DR   IntAct; P0DTC3; 468.
DR   MINT; P0DTC3; -.
DR   TCDB; 1.A.57.1.5; the human sars coronavirus viroporin (sars-vp) family.
DR   GlyGen; P0DTC3; 2 sites.
DR   iPTMnet; P0DTC3; -.
DR   DNASU; 43740569; -.
DR   KEGG; vg:43740569; -.
DR   AGR; RefSeq:YP_009724391; -.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694719; Maturation of protein 3a.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9754560; SARS-CoV-2 modulates autophagy.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   PRO; PR:P0DTC3; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:DisProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044165; C:host cell endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0044167; C:host cell endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044174; C:host cell endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0044187; C:host cell lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:ComplexPortal.
DR   GO; GO:0055036; C:virion membrane; TAS:Reactome.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IPI:ComplexPortal.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IPI:ComplexPortal.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140677; F:molecular function activator activity; IMP:DisProt.
DR   GO; GO:0005216; F:monoatomic ion channel activity; IEA:InterPro.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0140883; P:induction by virus of host reticulophagy; IDA:UniProtKB.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:ComplexPortal.
DR   CDD; cd21648; SARS-CoV-like_ORF3a; 1.
DR   DisProt; DP03003; -.
DR   InterPro; IPR046446; a/bCoV_VIROPORIN_3A-like_CD.
DR   InterPro; IPR046445; a/bCoV_VIROPORIN_3A-like_TM.
DR   InterPro; IPR024407; Protein_3a_bCoV.
DR   Pfam; PF11289; bCoV_viroporin; 1.
DR   PROSITE; PS51967; COV_VIROPORIN_3A_CD; 1.
DR   PROSITE; PS51966; COV_VIROPORIN_3A_TM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activation of host autophagy by virus; Glycoprotein;
KW   Host cell membrane; Host cytoplasm; Host endoplasmic reticulum;
KW   Host endosome; Host lysosome; Host membrane; Host-virus interaction;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Secreted;
KW   Transmembrane; Transmembrane helix; Transport; Viral ion channel; Virion.
FT   CHAIN           1..275
FT                   /note=""ORF3a protein""
FT                   /id=""PRO_0000449650""
FT   TOPO_DOM        1..42
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TRANSMEM        43..61
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TOPO_DOM        62..67
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TRANSMEM        68..93
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TOPO_DOM        94..101
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TRANSMEM        102..126
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   TOPO_DOM        127..275
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   DOMAIN          33..141
FT                   /note=""CoV 3a-like viroporin TM""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01311""
FT   DOMAIN          145..237
FT                   /note=""CoV 3a-like viroporin CD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01312""
FT   REGION          1..39
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000305|PubMed:35108439""
FT   REGION          239..275
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000305|PubMed:35108439""
FT   SITE            133
FT                   /note=""Involved in polymerization""
FT                   /evidence=""ECO:0000250|UniProtKB:P59632""
FT   CARBOHYD        32
FT                   /note=""O-linked (GalNAc...) threonine; by host""
FT                   /evidence=""ECO:0000250|UniProtKB:P59632""
FT   CARBOHYD        34
FT                   /note=""O-linked (GalNAc...) threonine; by host""
FT                   /evidence=""ECO:0000255""
FT   VARIANT         26
FT                   /note=""S -> L (in strain: Delta/B.1.617.2 and
FT                   Kappa/B.1.617.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         42
FT                   /note=""P -> L (in strain: Iota/B.1.526)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         57
FT                   /note=""Q -> H (in strain: Beta/B.1.351, Epsilon/B.1.429,
FT                   Iota/B.1.526 and Mu/B.1.621)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         171
FT                   /note=""S -> L (in strain: Beta/B.1.351)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         223
FT                   /note=""T -> I (in strain: Omicron/BA.2, Omicron/BA.2.12.1,
FT                   Omicron/BA.2.75, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/BQ.1.1, Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         253
FT                   /note=""S -> P (in strain: Gamma/P.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         257
FT                   /note=""Missing (in strain: Mu/B.1.621)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         1..41
FT                   /note=""Missing: Partial loss of Ca(2+) and NMDG(+)
FT                   permeability. Increased localization at host plasma
FT                   membrane.""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   MUTAGEN         57..58
FT                   /note=""QS->EL: Partial loss of Ca(2+) and NMDG(+)
FT                   permeability.""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   MUTAGEN         57
FT                   /note=""Q->H: No effect on ion permeability.""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   MUTAGEN         116
FT                   /note=""Q->L: Partial loss of Ca(2+) and NMDG(+)
FT                   permeability.""
FT                   /evidence=""ECO:0000269|PubMed:34158638""
FT   HELIX           44..60
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   HELIX           68..99
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   HELIX           103..105
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   HELIX           106..133
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   HELIX           137..140
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          144..150
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          155..160
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          165..172
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          183..186
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          189..192
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          199..204
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          209..218
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   HELIX           220..223
FT                   /evidence=""ECO:0007829|PDB:7KJR""
FT   STRAND          228..235
FT                   /evidence=""ECO:0007829|PDB:7KJR""
SQ   SEQUENCE   275 AA;  31123 MW;  4688E6D477E031C4 CRC64;
     MDLFMRIFTI GTVTLKQGEI KDATPSDFVR ATATIPIQAS LPFGWLIVGV ALLAVFQSAS
     KIITLKKRWQ LALSKGVHFV CNLLLLFVTV YSHLLLVAAG LEAPFLYLYA LVYFLQSINF
     VRIIMRLWLC WKCRSKNPLL YDANYFLCWH TNCYDYCIPY NSVTSSIVIT SGDGTTSPIS
     EHDYQIGGYT EKWESGVKDC VVLHSYFTSD YYQLYSTQLS TDTGVEHVTF FIYNKIVDEP
     EEHVQIHTID GSSGVVNPVM EPIYDEPTTT TSVPL
//
",50639
TACACC ACACCC CACCCG ACCCGC CCCGCT CCGCTT CGCTTC GCTTCC CTTCCT TTCCTG TCCTGA CCTGAT CTGATC TGATCC GATCCC ATCCCG TCCCGG CCCGGG CCGGGC CGGGCC GGGCCT GGCCTC GCCTCG CCTCGT CTCGTG TCGTGA CGTGAT GTGATG TGATGA GATGAT ATGATG TGATGA GATGAG ATGAGC TGAGCG GAGCGT AGCGTG GCGTGC CGTGCT GTGCTG TGCTGC GCTGCA CTGCAG TGCAGA GCAGAA CAGAAC AGAACG GAACGC AACGCG ACGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCC TCGCCA CGCCAA GCCAAC CCAACA CAACAG AACAGC ACAGCT CAGCTC AGCTCG GCTCGT CTCGTC TCGTCC CGTCCA GTCCAG TCCAGC CCAGCC CAGCCT AGCCTG GCCTGA CCTGAT CTGATC TGATCC GATCCA ATCCAG TCCAGA CCAGAG CAGAGC AGAGCA GAGCAA AGCAAG GCAAGA CAAGAT AAGATC AGATCA GATCAC ATCACC TCACCG CACCGG ACCGGC CCGGCA CGGCAA GGCAAC GCAACC CAACCT AACCTG ACCTGG CCTGGT CTGGTC TGGTCT GGTCTT GTCTTC TCTTCC CTTCCT TTCCTG TCCTGC CCTGCT CTGCTG TGCTGC GCTGCT CTGCTG TGCTGA GCTGAC CTGACG TGACGC GACGCC ACGCCG CGCCGC GCCGCT CCGCTG CGCTGT GCTGTC CTGTCG TGTCGC GTCGCC TCGCCC CGCCCC GCCCCT CCCCTG CCCTGG CCTGGC CTGGCC TGGCCT GGCCTG GCCTGG CCTGGT CTGGTT TGGTTC,2,142,TACA ACAC CACC ACCC CCCG CCGC CGCT GCTT CTTC TTCC TCCT CCTG CTGA TGAT GATC ATCC TCCC CCCG CCGG CGGG GGGC GGCC GCCT CCTC CTCG TCGT CGTG GTGA TGAT GATG ATGA TGAT GATG ATGA TGAG GAGC AGCG GCGT CGTG GTGC TGCT GCTG CTGC TGCA GCAG CAGA AGAA GAAC AACG ACGC CGCG GCGT CGTT GTTC TTCG TCGC CGCC GCCA CCAA CAAC AACA ACAG CAGC AGCT GCTC CTCG TCGT CGTC GTCC TCCA CCAG CAGC AGCC GCCT CCTG CTGA TGAT GATC ATCC TCCA CCAG CAGA AGAG GAGC AGCA GCAA CAAG AAGA AGAT GATC ATCA TCAC CACC ACCG CCGG CGGC GGCA GCAA CAAC AACC ACCT CCTG CTGG TGGT GGTC GTCT TCTT CTTC TTCC TCCT CCTG CTGC TGCT GCTG CTGC TGCT GCTG CTGA TGAC GACG ACGC CGCC GCCG CCGC CGCT GCTG CTGT TGTC GTCG TCGC CGCC GCCC CCCC CCCT CCTG CTGG TGGC GGCC GCCT CCTG CTGG TGGT GGTT GTTC,TACAC ACACC CACCC ACCCG CCCGC CCGCT CGCTT GCTTC CTTCC TTCCT TCCTG CCTGA CTGAT TGATC GATCC ATCCC TCCCG CCCGG CCGGG CGGGC GGGCC GGCCT GCCTC CCTCG CTCGT TCGTG CGTGA GTGAT TGATG GATGA ATGAT TGATG GATGA ATGAG TGAGC GAGCG AGCGT GCGTG CGTGC GTGCT TGCTG GCTGC CTGCA TGCAG GCAGA CAGAA AGAAC GAACG AACGC ACGCG CGCGT GCGTT CGTTC GTTCG TTCGC TCGCC CGCCA GCCAA CCAAC CAACA AACAG ACAGC CAGCT AGCTC GCTCG CTCGT TCGTC CGTCC GTCCA TCCAG CCAGC CAGCC AGCCT GCCTG CCTGA CTGAT TGATC GATCC ATCCA TCCAG CCAGA CAGAG AGAGC GAGCA AGCAA GCAAG CAAGA AAGAT AGATC GATCA ATCAC TCACC CACCG ACCGG CCGGC CGGCA GGCAA GCAAC CAACC AACCT ACCTG CCTGG CTGGT TGGTC GGTCT GTCTT TCTTC CTTCC TTCCT TCCTG CCTGC CTGCT TGCTG GCTGC CTGCT TGCTG GCTGA CTGAC TGACG GACGC ACGCC CGCCG GCCGC CCGCT CGCTG GCTGT CTGTC TGTCG GTCGC TCGCC CGCCC GCCCC CCCCT CCCTG CCTGG CTGGC TGGCC GGCCT GCCTG CCTGG CTGGT TGGTT GGTTC,TACACC ACACCC CACCCG ACCCGC CCCGCT CCGCTT CGCTTC GCTTCC CTTCCT TTCCTG TCCTGA CCTGAT CTGATC TGATCC GATCCC ATCCCG TCCCGG CCCGGG CCGGGC CGGGCC GGGCCT GGCCTC GCCTCG CCTCGT CTCGTG TCGTGA CGTGAT GTGATG TGATGA GATGAT ATGATG TGATGA GATGAG ATGAGC TGAGCG GAGCGT AGCGTG GCGTGC CGTGCT GTGCTG TGCTGC GCTGCA CTGCAG TGCAGA GCAGAA CAGAAC AGAACG GAACGC AACGCG ACGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCC TCGCCA CGCCAA GCCAAC CCAACA CAACAG AACAGC ACAGCT CAGCTC AGCTCG GCTCGT CTCGTC TCGTCC CGTCCA GTCCAG TCCAGC CCAGCC CAGCCT AGCCTG GCCTGA CCTGAT CTGATC TGATCC GATCCA ATCCAG TCCAGA CCAGAG CAGAGC AGAGCA GAGCAA AGCAAG GCAAGA CAAGAT AAGATC AGATCA GATCAC ATCACC TCACCG CACCGG ACCGGC CCGGCA CGGCAA GGCAAC GCAACC CAACCT AACCTG ACCTGG CCTGGT CTGGTC TGGTCT GGTCTT GTCTTC TCTTCC CTTCCT TTCCTG TCCTGC CCTGCT CTGCTG TGCTGC GCTGCT CTGCTG TGCTGA GCTGAC CTGACG TGACGC GACGCC ACGCCG CGCCGC GCCGCT CCGCTG CGCTGT GCTGTC CTGTCG TGTCGC GTCGCC TCGCCC CGCCCC GCCCCT CCCCTG CCCTGG CCTGGC CTGGCC TGGCCT GGCCTG GCCTGG CCTGGT CTGGTT TGGTTC,TACACCC ACACCCG CACCCGC ACCCGCT CCCGCTT CCGCTTC CGCTTCC GCTTCCT CTTCCTG TTCCTGA TCCTGAT CCTGATC CTGATCC TGATCCC GATCCCG ATCCCGG TCCCGGG CCCGGGC CCGGGCC CGGGCCT GGGCCTC GGCCTCG GCCTCGT CCTCGTG CTCGTGA TCGTGAT CGTGATG GTGATGA TGATGAT GATGATG ATGATGA TGATGAG GATGAGC ATGAGCG TGAGCGT GAGCGTG AGCGTGC GCGTGCT CGTGCTG GTGCTGC TGCTGCA GCTGCAG CTGCAGA TGCAGAA GCAGAAC CAGAACG AGAACGC GAACGCG AACGCGT ACGCGTT CGCGTTC GCGTTCG CGTTCGC GTTCGCC TTCGCCA TCGCCAA CGCCAAC GCCAACA CCAACAG CAACAGC AACAGCT ACAGCTC CAGCTCG AGCTCGT GCTCGTC CTCGTCC TCGTCCA CGTCCAG GTCCAGC TCCAGCC CCAGCCT CAGCCTG AGCCTGA GCCTGAT CCTGATC CTGATCC TGATCCA GATCCAG ATCCAGA TCCAGAG CCAGAGC CAGAGCA AGAGCAA GAGCAAG AGCAAGA GCAAGAT CAAGATC AAGATCA AGATCAC GATCACC ATCACCG TCACCGG CACCGGC ACCGGCA CCGGCAA CGGCAAC GGCAACC GCAACCT CAACCTG AACCTGG ACCTGGT CCTGGTC CTGGTCT TGGTCTT GGTCTTC GTCTTCC TCTTCCT CTTCCTG TTCCTGC TCCTGCT CCTGCTG CTGCTGC TGCTGCT GCTGCTG CTGCTGA TGCTGAC GCTGACG CTGACGC TGACGCC GACGCCG ACGCCGC CGCCGCT GCCGCTG CCGCTGT CGCTGTC GCTGTCG CTGTCGC TGTCGCC GTCGCCC TCGCCCC CGCCCCT GCCCCTG CCCCTGG CCCTGGC CCTGGCC CTGGCCT TGGCCTG GGCCTGG GCCTGGT CCTGGTT CTGGTTC,"ID   YADH_ECO57              Reviewed;         256 AA.
AC   P0AFN8; P36880; P75657; Q8KMY9;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   05-FEB-2025, entry version 105.
DE   RecName: Full=Inner membrane transport permease YadH;
GN   Name=yadH; OrderedLocusNames=Z0139, ECs0132;
OS   Escherichia coli O157:H7.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / EDL933 / ATCC 700927 / EHEC;
RX   PubMed=11206551; DOI=10.1038/35054089;
RA   Perna N.T., Plunkett G. III, Burland V., Mau B., Glasner J.D., Rose D.J.,
RA   Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A., Posfai G.,
RA   Hackett J., Klink S., Boutin A., Shao Y., Miller L., Grotbeck E.J.,
RA   Davis N.W., Lim A., Dimalanta E.T., Potamousis K., Apodaca J.,
RA   Anantharaman T.S., Lin J., Yen G., Schwartz D.C., Welch R.A.,
RA   Blattner F.R.;
RT   ""Genome sequence of enterohaemorrhagic Escherichia coli O157:H7."";
RL   Nature 409:529-533(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=11258796; DOI=10.1093/dnares/8.1.11;
RA   Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K.,
RA   Han C.-G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T., Iida T.,
RA   Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T., Kuhara S.,
RA   Shiba T., Hattori M., Shinagawa H.;
RT   ""Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and
RT   genomic comparison with a laboratory strain K-12."";
RL   DNA Res. 8:11-22(2001).
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ABC-2 integral membrane protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE005174; AAG54432.1; -; Genomic_DNA.
DR   EMBL; BA000007; BAB33555.1; -; Genomic_DNA.
DR   PIR; D85496; D85496.
DR   PIR; D90645; D90645.
DR   RefSeq; NP_308159.1; NC_002695.1.
DR   RefSeq; WP_000972203.1; NZ_VOAI01000002.1.
DR   AlphaFoldDB; P0AFN8; -.
DR   SMR; P0AFN8; -.
DR   STRING; 155864.Z0139; -.
DR   GeneID; 913717; -.
DR   GeneID; 93777308; -.
DR   KEGG; ece:Z0139; -.
DR   KEGG; ecs:ECs_0132; -.
DR   PATRIC; fig|386585.9.peg.231; -.
DR   eggNOG; COG0842; Bacteria.
DR   HOGENOM; CLU_039483_3_0_6; -.
DR   OMA; VAWIFKT; -.
DR   Proteomes; UP000000558; Chromosome.
DR   Proteomes; UP000002519; Chromosome.
DR   GO; GO:0043190; C:ATP-binding cassette (ABC) transporter complex; IEA:InterPro.
DR   GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro.
DR   InterPro; IPR052522; ABC-2_transport_permease.
DR   InterPro; IPR013525; ABC2_TM.
DR   InterPro; IPR047817; ABC2_TM_bact-type.
DR   InterPro; IPR000412; ABC_2_transport.
DR   PANTHER; PTHR43332:SF2; INNER MEMBRANE TRANSPORT PERMEASE YADH; 1.
DR   PANTHER; PTHR43332; INNER MEMBRANE TRANSPORT PERMEASE YADH-RELATED; 1.
DR   Pfam; PF01061; ABC2_membrane; 1.
DR   PIRSF; PIRSF006648; DrrB; 1.
DR   PRINTS; PR00164; ABC2TRNSPORT.
DR   PROSITE; PS51012; ABC_TM2; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..256
FT                   /note=""Inner membrane transport permease YadH""
FT                   /id=""PRO_0000182999""
FT   TOPO_DOM        1..22
FT                   /note=""Periplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        23..43
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        44..52
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        53..73
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        74..94
FT                   /note=""Periplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        95..115
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        116
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        117..137
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        138
FT                   /note=""Periplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        139..159
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        160..169
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        170..190
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        191..223
FT                   /note=""Periplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        224..244
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        245..256
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   DOMAIN          22..251
FT                   /note=""ABC transmembrane type-2""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00442""
SQ   SEQUENCE   256 AA;  28516 MW;  2AE10E6CB143F708 CRC64;
     MMHLYWVALK SIWAKEIHRF MRIWVQTLVP PVITMTLYFI IFGNLIGSRI GDMHGFSYMQ
     FIVPGLIMMS VITNAYANVA SSFFGAKFQR NIEELLVAPV PTHVIIAGYV GGGVARGLFV
     GILVTAISLF FVPFQVHSWV FVALTLVLTA VLFSLAGLLN GVFAKTFDDI SLVPTFVLTP
     LTYLGGVFYS LTLLPPFWQG LSHLNPIVYM ISGFRYGFLG INDVPLVTTF GVLVVFIVAF
     YLICWSLIQR GRGLRS
//
",251
GTGTAT TGTATT GTATTA TATTAC ATTACC TTACCG TACCGC ACCGCC CCGCCT CGCCTG GCCTGC CCTGCG CTGCGC TGCGCA GCGCAA CGCAAG GCAAGC CAAGCG AAGCGC AGCGCC GCGCCG CGCCGC GCCGCA CCGCAG CGCAGC GCAGCG CAGCGA AGCGAC GCGACC CGACCG GACCGC ACCGCA CCGCAA CGCAAG GCAAGG CAAGGC AAGGCC AGGCCG GGCCGG GCCGGC CCGGCA CGGCAA GGCAAC GCAACG CAACGT AACGTG ACGTGG CGTGGC GTGGCC TGGCCG GGCCGA GCCGAT CCGATT CGATTT GATTTT ATTTTT TTTTTG TTTTGC TTTGCC TTGCCG TGCCGC GCCGCC CCGCCG CGCCGC GCCGCT CCGCTG CGCTGG GCTGGG CTGGGG TGGGGC GGGGCA GGGCAA GGCAAG GCAAGG CAAGGA AAGGAC AGGACT GGACTA GACTAC ACTACC CTACCG TACCGC ACCGCT CCGCTA CGCTAC GCTACA CTACAT TACATG ACATGG CATGGT ATGGTG TGGTGG GGTGGT GTGGTA TGGTAC GGTACT GTACTG TACTGG ACTGGA CTGGAC TGGACG GGACGC GACGCC ACGCCG CGCCGA GCCGAC CCGACA CGACAG GACAGC ACAGCG CAGCGT AGCGTG GCGTGA CGTGAT GTGATG,3,115,TGTGT T TGCGGTATA A G GTGTATATACTCTGTATTT  TA ATATTTTATA A T TTTTATACAC C T TATACG ACC C A ACACCCCGGGTG CA CCGCGC C CTTTCGCCC C G GCGCCCCTCT T C CCCGACTGTG G C CTC T TG TGTGCGCGG CG G GCGCGCGCGC C C CGCGCGCACA A G GCGCAAA A C CACAAAAGAG GC  AAAAGAGCGC C A AGAGCGCGCG G G GCGCGCGCGC  CGCGCGCCCC C G TAGCCCCGCG G C CCCCGCGCGC C CCGCGCACA A G GCGCACAGAG G CGGCCAGG AC A AGAGCGCGCG GCGGA CCG CGGA GACAC C GCT GACACCCC C ACGCCCGCG G C CCCCGCGCGC C C CGCGCCA A G GCGCACAAAA A CCAAAAGAG  AAAAGAGGG AAGGGC C G GGGGCGCCC G GCGCCCCGCG  CCT ACGGTGGT G CGCGGGC C GGGCGCACA A GG GGCACAAAA A C CACAAAACAC CCG AAAT ACGCG ACC ACCGTGT T C CGCGTTA TG  GTGTGTGGGG G T TGTGG ACGC C G GGGCCCC C G GCCCGCG G C CCG TCGAGA A C CGCCTGATAT T G CTATTTT T AC TATTTAC TTTTTTT T T TTTTTGCTTT  TTTTTTTG CTG T TTTTGTGCCC C T TGTGCGCCCC C G GCGCCCCGCG  CCCCGCGCGC C C CGC G GCGCCCG  CCCCGCGCGC C C CG CAGCTCT T G GCGCT GCTG  CC GACTGTGGGG G T TGTTTGGGGG  GC GGGGGGGGG G GGGGGGC C G GGGGCGCACA A GGCACAAAA A CCAAAAGAG  AAAAGAGGGG G A AGAGGGGAGGCA G GGGGAGACC G GAGACCT T A CGACCGCGA C CTCTATACAC CGA TATACACCC A ACCTACCGCG G C CCCCGGGCGC GG  CGTG GCTCT T G ACTA A C CTCTAGC T TTACACACA A A ACACACATAT T C CACATACACGCG A ATATGTGGTGTG T TGGG GGTGT T G GGGGTGACTG G G GAGTGTGGGG CCG TGTGGA GGT T G GGCG GTACGTA GGTATACAC C TC ATGGACT GAT A ACCGCCTGCGCCG TG CTGG T TGTGGAACGGTGGAGACAC  GT GAGACACGCG  ACACGACTGC C C CGCGCGCCCC C G GCGCCCCGCG G CG CCCG ATGA A C CGCGAGTGAC C G GAGACATGA A ACACACAGG C CACAGAGCGC C AAGCTA CG G G GCGG GT T C CGGTGTG C CGCCGTGTGACGAG G TGATTGATAT G CC GGATATG,GACAAGTA G GTGTGTATATAT T G GTGTATATATTTT T T TAATTTGCTA A A ATTTATACGACC T TTTTATACACCC T TATGG GCG A ACCGCCCGCGCGC  CCCCGGACGCCCC C C CGCGCGCCCCTCT T GGCC CTCTGTG G C CCCCTTGCGC  CTAC  TGGCGCG G T TGTGCGCGAGCGC T G GCGCGCGCGCACA  CGCGCGCACAAAA A G GCGCACAA GGAG G CCAAAAGAGCC A AAAAGAGCCG G A AGAGCGCGCGCGC C G GCGCGGCCAAGC CCGCGCCCCGG G GCGCCCCGCGCGC ACT CCCCGCGCGCACA TACCGCGCACAGG GGCGAA TGGAGCC C CACAGAGCGCGCG G A AGCGCGCGCGAGA A G GCGCGCGAGACAC C C CGAC ACCCC C GGACACCCCGACATATC GCCGACCGC C C CCCCGCGCGCAA C CGGG GCACAAGCAA GAGGGCCAAGAG G CGCCCAACA CCTGG C CTGTGT GGCGC C A AGAGGGGCGCCCC C G GGGGCGGTCCGG G GCCAACCGCGGGG G C CCCCGCGGGGCGC C C CGGGCCA CGA GG CGGCACAAAA ACC GCCAGCAAAACAC C C CACAAGATCG G AAACACG AAGCAC G ACACGTG G CGGCCGTGTGACCGG GAC GTGTGGGCGC TGCTGGGGCTTTCC C G GGGCCCCGA G GCGCCCCG ACA C CCCCGCGAACGAT T C CGCGAGATATTTT C G GAGATATTTTTTGAT A ATATTGTGT T TTTTTTTTTTTTT T T TTTTTTTTTTGTG G T TTTTGGTAGC C T TTTTGGCCCC GCG TGTGC CACCGCG G G GCGCCCCGCGCGC C C CCCCGCGCCC C C CGCGCGCCCCGCG G G GCGCCCGCGC C CCCGGCTCT T C CGCGCGCTCTGTG CAA GCGCTCTGTGGGG G C CTCTGTGGC ACGCG T TGTGGGGGGGGGG G GCCGGGGGGGGGCGC C G GGGGGGGCGCACC A G GGGGCGCACAAAA  GGGCACAAAAGAG G C CA TGAAGAGGGG G ACT AAGAGGGGAGA A A AGAGGTGCGACCTGC G GGGGAGACACTG GT G GAGACACTCTATA A A ACC CCTAG CAC C CAGGCTATACACCGTG TATACA GCCGCG G AACCCCGTTTGC  CCCCGCGCCT T C CGGCTCTAA G GCGCTCTACAG CTCTAACACA A T CGTACCATAT T A ACACACATATGTG G C CACATATGTGGGG G A ATATGTGGGGTGT T T TGTGGGGTG GG G GGGGTGTGCAGGG  GTC TTGGGGTGT T T TGTGGGGTGTATA A GAAGGCCGTATACAC ACCGTATACACTCT T T TAACTCTGTG G A ACACTCTGTGGGG  CTCTGTGGGGAGA A T TGTGGGGAGACAC T A GGGGAGACACGCG G G GAGACACGCGCGC GGG ACACGCGCGCCCC  CGCGCGCCCG G G GCGCCCCGGA CTGCCGCGAG G CGCGATTTACAA G GACGCACATACAG  ACGC CG GCAAGCGC CAGCGTGCGCG G A AGAGCGCGTG GT T G GCC TCGTTTAG CAGCGTGTT GA A G GTTGAGATAT T TTGAGATATG,GTGTGTGGACC AT T T TGTGTTATGT TT G CTATATTTTATA A T CGTATTTATACAC AC  ATATTTACACCCC  TTTTATACACCCCGCG G T TATACCCGCGCGCC AG ACACCCCGCGCGCCCC C C CCCGCGCCAGGCT T C CGCCGCCT TTTG G G GCCCTCTGTGCGC C C CCCCTCTGTGCCG  CTACTTGCGCGCGCGC C A TGTGCGCGCGCGCACA CG  GCCCGC GCAAGCAA C CGCGCGCACAAAAGAG G G GCGCACAAGC  CA CAGGCACCAGCCG G A AAAAGAGCGCGGC C A AGAGCGCGCCGGCCAA CC GCGGCCTGGA GG C CGCGCGCCCCGCGCGC C GG CGCCCCGGCCGCACA A CCGCGCACAGAG  CGCGCGCACAGAGCGC C GCAAGCACAGAGCG CCG G C CACAGC GGCGCGTA A AGAGCGCGCGA GCAC C G GCGCGCGA CAC CCC C CCGAGACACCCG ATG GCACCCCGCGCGC CGCTG CAACCGCGCGCACA A C CCCCGCGCGCACAAAA  CGGCACAAAG  CC GCGCACAAAAGAGGGG TGA CACAAAAGAGGGGCGC C A AAAAGCCGGTAGGCCC C TGACAGGGGCGCCCCGCG CGC GGGGCGCCCCGCGGGG G G GCGCCCCGGGCGC C CCCG GACGGGGCGCACA ACG CGCGGGGCGCAAA A GGGCGCACAAC G GCCC CAAACTACGCG G C CACAAAACACGCGTGGCT A AAAACCGTGTGTG G ACGTGTGTGGGG G C GTCGTTGGGCCGC C G GTGTGGGCGCCCC C TCATTGGGGCGCCCCGCG G G GG GCGCCCCGCGAGA A G GCCGCCCGCGAGATAT T C CCCCGCGAGATATTTT T C CGCGAGATGGGGCATT T GG CGATATTTTTTTTTT CTG ATATTTTTTTTTTTT T TTTTTTTTCTGTTGTG CTGTTTTTGGGCC T TTTTTTTGTGC CGGCAC TTTGTGCG G TGCG CGC TGTGCGCCCGCGC TGC GCGCCCCGCGCGCCTATC CCCGCGCCGCGCCCCGCG  CGCGCGCCC AG TGC C G GCGCCCCGC AGCTCT T C CCCGCGCTTTTTG G CCGCGA CTGTGGGG G GGACGCTCTGTGGGGGGG ACG CTT ATGGGGGCA GG G T TGTGGATTGGGGGCGC C G GGGGGGGGGGCGCAGGGA G GGGGGGC GCACAAAA A G GGGGCGCAACCAAGAG G G GCTTTCAAAAGGG  GTC CCAAAAGAGGGGAGA A A AAAAGCCTGGAGACAC C AAGGGTAGACACTCT T G GGGGAGACAACCTATA A GGACACTCTAAC C A ACACTCTATACACCCC C C CTCTATACACCAGGCG G T GGTACCCGCGCGC C A ACAAGCCGCGCGCTCT T CGG CCGCGCGCTCTATA A CCGCGCTCTATACC AAGC GCGCTCTAACACA A C CTCTATACACA TGAT T T TATACACACATATGTG G A ACACACATATGTGGGG G CGACCATATGTGGGT T A ATG GTGGGGTGTG ACG TCCGTGGGGTGTGTGGGG G G GGGTGTGGGGTGT T G CGGTGTGGGCGTA A T TGTGGGGTGTATACAC C G GGC AATTTACCTGCT CGT GTTACACTTG G T TATACCTGTGG CCG A ACACTCTGGGAGA A C CTCTGGGAGACAC C T TGTGGGGAGACACGCG G G GGAACACGCGCGC  GA AGACGG GGCC GCC A ACACGCGCA CCCGG CGCCCGCGC CCGGA CGAA G GCGCC CCCGAGACAC ACC CCCCGCGA GAACACA  TACGAGACACAAG GACGACACACAGAGCGC GGT ACACACAGAGCGTACG G C CACAGAGCGCGT GGT T ACCGAGCGCGCGTGTGTG GCC GAGCGGA GTGTGAGCTGCC CGCGT GCGATAT T G GTGTGTGAGATATG,GTGTGTGTATATCTGTT ACG TGTGTGTATATATTTTA GGA G GTGTATATATT GATACTGGCGC TATATATT CTTACACCCC C A ATATTTTATACACCCCGCG G TACGTTTTACACCCCGCGCGC  TATACACCCCGCGCGCC TGC A ACACCCCGCGCGCCCCTCT T C CCCCGCGCGCCCCTCTGTG G C CGGCCCCTCCG GCGC C GTGCT G TTCTGTGCCG GGCGGACCTCTGTGCGCGGC C C CTCGCTGCTTTCA A TGCGTGCGCGGCACAAA G GCGCGCGCGCCT C GCG C CGCGCGCACAACGCACCGC  GCGCAAAGAGCCGCG C CACAAAGCCGCGC C A AAAAGACTGCGCGTGCCC A AGAGCGCGCGCGCCCCGCG G G GCGCGCGCGCCCCGCGCC C CGCGCGCCCCGCGCGCACA  GCGCCCCGGGACAGAG G C CCCCGCGCCGACAGAGCGC C C CGCGCGCACAGAGCCG G GGC CAGAGCGCGCGAGA A C CAAACAGCGCGGACAC C A AGAGCGCACGAGACACCCC C G GCGCGCGAGACACCCCGCG G C CGCGAGACACCAC CGCGC C GC TACCCTGCGCGCACA A AACCCCGGCTGCAACTAA CAA CCCCG GCCAAGG AG G C CGCGCGCACAAGG GGG GCGCACAAAAGAGGGGCC C CACAAAAGGGCGCCCC C A AAAAGGCTGGCGCCCCGCG G A AGAGGGGCCCGCGGGG G G GGGGCGCCCCGCGGGGCATGTGAGCAGCCCCGCGGGGCGCACA A C CCCGAGGCCAAA GA C CGCGGGGCGCACAAG TAC C G GGGGCGCACAAAACACG GCGCACAAGT CGTAAG CACAACT ACGCGTGTGTG CAGACGCGTGTGCC GG G A ACACGCGCGTGTGGGGCGC C C CGCGTTGCTGG TTGCCC G GTGTGTGGGGCGCCAAC TGTGGG CGCCGA A GCTGGGCCAACCGCGAGATAT T G GCGCCCCGCGAGATATTGAC CCCCGCGA CCATTGCGTT T C CGGCAGATATTTTTTG T G GAGATATTTTTTTTTTTTT T A ATATTTTTTTTTTTTTGAA G T TTCGCTTTTTTTTGT CGC C TGTGTTTTTATTGTGCGCCCC C T TTTTTC TTGCGCCCCGCG TTGGCCC T TGTGCGCCCCGCGCGCCTGGC GACAGCCCCGCTGGCCCCGCG G C CCACCCG GCCCCGCGCGC C C CGCGCGCCCGCAGGCT  GCGCCG TCGCCGCCTGTG CCGCGCCTGTGGGG G C CGCGCTGGG GGG G GGCTATTAC GGGGGGGGAG C CTCTGTGG CAGGCGC C T TGTGGGGGGGCGCACA A G GGGGG GCGGCGCGCAATT A GTA GGGGGCGCAA GAG G G GGGGCGCACAAAAGAGGGG G G GCGCACAAAAGAGGGGAGA A CGGGAGCGCAAGGGGAGACAC C AGCAAAGAGGGGAGACCAAAACT A AGAGG CCGACACTCTATA AAG GGGGAGACAGCCTATACAC GG GACACTCTATACACCCC C A ACACTCTATACCCGATGG CTTACTATACACCCCGTTGCGCC T TATACAGCCCGCGCGCTCT T A ACACCGCACTATA  CCCGCGGTCGCCCGC CGT CGCGCTCTATACACACAGAA CTATACACACATAT T C CTCTATACACAATGTG G T TATACACACATGC TGGC GG A ACACACATATGTGGGGT CGT CCG CGTGGTGTGTG GCG ATATGTGGTGGGTGTGGGG CCG TGGGTGTGTGGGCTT G GGGGTGTGTGGGGTC GTA A G GTGTGTGGGGTGTATACTTA TGTGGGGTGTAACTCT T G GGGGTGTATACACT GGTG G G GTGTATACCTGGACGG G T TATACACTCTGAC GGAGA A A ACAAGCTGTGGGGAGACAC C C CTCTGGGTAAGACGCG T C TGTGGCTAGACACACGCGC C G GGGGAGACACGGCCCC  GAGACT TCGCGCCCCGT CG A AC TTCGCGCCCCGCCGGA TGGCGCGCCCCGCGAGACTGGC G GCGCCCCGCGAGACCA A CCCGCGAACACA G C CGCGAACACAGAGCGC C G GAG CACACAGAGCG ACG G A ACACGCAGAGCGCGCGTGT G T CACAGCAAGCGTGGGTGG A AGAGCGCGCGTGTGGTAGA A GGCGCGTGTGTGAGATAT TGC CGCGTCCTTGAGATATG,"ID   OPGH_PSEA8              Reviewed;         861 AA.
AC   B7V3H0;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 1.
DT   05-FEB-2025, entry version 71.
DE   RecName: Full=Glucans biosynthesis glucosyltransferase H {ECO:0000255|HAMAP-Rule:MF_01072};
DE            EC=2.4.1.- {ECO:0000255|HAMAP-Rule:MF_01072};
GN   Name=opgH {ECO:0000255|HAMAP-Rule:MF_01072};
GN   OrderedLocusNames=PLES_54671;
OS   Pseudomonas aeruginosa (strain LESB58).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=557722;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LESB58;
RX   PubMed=19047519; DOI=10.1101/gr.086082.108;
RA   Winstanley C., Langille M.G.I., Fothergill J.L., Kukavica-Ibrulj I.,
RA   Paradis-Bleau C., Sanschagrin F., Thomson N.R., Winsor G.L., Quail M.A.,
RA   Lennard N., Bignell A., Clarke L., Seeger K., Saunders D., Harris D.,
RA   Parkhill J., Hancock R.E.W., Brinkman F.S.L., Levesque R.C.;
RT   ""Newly introduced genomic prophage islands are critical determinants of in
RT   vivo competitiveness in the Liverpool epidemic strain of Pseudomonas
RT   aeruginosa."";
RL   Genome Res. 19:12-23(2009).
CC   -!- FUNCTION: Involved in the biosynthesis of osmoregulated periplasmic
CC       glucans (OPGs). {ECO:0000255|HAMAP-Rule:MF_01072}.
CC   -!- PATHWAY: Glycan metabolism; osmoregulated periplasmic glucan (OPG)
CC       biosynthesis. {ECO:0000255|HAMAP-Rule:MF_01072}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01072}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01072}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. OpgH
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01072}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FM209186; CAW30221.1; -; Genomic_DNA.
DR   RefSeq; WP_003103448.1; NC_011770.1.
DR   AlphaFoldDB; B7V3H0; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   KEGG; pag:PLES_54671; -.
DR   HOGENOM; CLU_015730_0_0_6; -.
DR   UniPathway; UPA00637; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016758; F:hexosyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0009250; P:glucan biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd04191; Glucan_BSP_MdoH; 1.
DR   FunFam; 3.90.550.10:FF:000047; Glucans biosynthesis glucosyltransferase H; 1.
DR   Gene3D; 3.90.550.10; Spore Coat Polysaccharide Biosynthesis Protein SpsA, Chain A; 1.
DR   HAMAP; MF_01072; MdoH_OpgH; 1.
DR   InterPro; IPR023725; Glucans_biosynth_gluTrFase_H.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR050321; Glycosyltr_2/OpgH_subfam.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR43867; CELLULOSE SYNTHASE CATALYTIC SUBUNIT A [UDP-FORMING]; 1.
DR   PANTHER; PTHR43867:SF5; GLUCANS BIOSYNTHESIS GLUCOSYLTRANSFERASE H; 1.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Glycosyltransferase; Membrane;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..861
FT                   /note=""Glucans biosynthesis glucosyltransferase H""
FT                   /id=""PRO_1000136657""
FT   TRANSMEM        142..162
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
FT   TRANSMEM        188..208
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
FT   TRANSMEM        516..536
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
FT   TRANSMEM        573..593
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
FT   TRANSMEM        600..620
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
FT   TRANSMEM        683..703
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01072""
SQ   SEQUENCE   861 AA;  96995 MW;  63557B5A83107E7E CRC64;
     MNNPSTTKAP LADYLAHLPL AEEERERLGE SASFSELHAR LAGAEGAAAD AGGDPALASV
     RARLQLGTPE LDDAEMFGVD AQGRTFLKIS PPIRRTKVIP EPWRTNILVR GWRRLTGRSN
     PPKPKRALPR ARWQRVGSLR RFILLLLMLA QTSVATYYMK GILPYQGWAF VDLEELAQQS
     LLDTVQQVLP YVIQFGILAL FAILFCWVSA GFWTALMGFW ELLTGRDRYR ISGSSAGSEP
     IAADARTAIV MPICNEDVPR VFAGLRATVE SMAATGEMER FDFFVLSDTN DPDIAVAEQQ
     AWLELCRETK GFGKIFYRRR RRRVKRKSGN IDDFCRRWGG DYRYMVVMDA DSVMSGDCLA
     KLVRLMEANP EAGIIQTAPK ASGMDTLYAR MQQFATRVYG PLFTAGLHFW QLGESHYWGH
     NAIIRMQPFI DHCALAPLPG KGSFAGAILS HDFVEAALMR RAGWGVWIAY DLDGSYEELP
     PNLLDELKRD RRWCHGNLMN FRLFLVKGMH PVHRAVFLTG VMSYLSAPLW FFFLVLSTAL
     LAVHQLMEPQ YFLEPRQLFP IWPQWHPEKA IALFSTTLTL LFLPKLLSVM LIWAKGAKGF
     GGVIRVTLSM LLEMFFSVLL APVRMLFHTR FVLAAFLGWS VQWNSPQRDD DATPWSEAIR
     RHGMQTLLGI AWTLLVAWLN PRFLWWLSPI VGSLILSIPV SVISSRVKLG LRARDEKLFL
     IPEEYDTPRE LRATDEYTYE NRWHALKDGF LKAAVDPLLN ALACAMGTAR HNRAQAIETV
     RGERIGKAID KGPEQLDGAT RLALLSDPVA LSRLHTRVWE EDRDDWLGRW RKAEADDPHA
     ASVPLAQVVP GDAGLLPAAQ S
//
",25721
CTTTAT TTTATG TTATGC TATGCA ATGCAT TGCATT GCATTT CATTTG ATTTGC TTTGCA TTGCAT TGCATC GCATCA CATCAG ATCAGA TCAGAG CAGAGG AGAGGC GAGGCT AGGCTG GGCTGC GCTGCT CTGCTC TGCTCG GCTCGT CTCGTG TCGTGT CGTGTT GTGTTG TGTTGT GTTGTA TTGTAC TGTACG GTACGA TACGAT ACGATC CGATCA GATCAA ATCAAT TCAATT CAATTT AATTTT ATTTTC TTTTCT TTTCTC TTCTCC TCTCCC CTCCCG TCCCGC CCCGCA CCGCAC CGCACT GCACTC CACTCT ACTCTT CTCTTG TCTTGA CTTGAA TTGAAA TGAAAC GAAACT AAACTG AACTGC ACTGCT CTGCTC TGCTCA GCTCAA CTCAAA TCAAAA CAAAAT AAAATT AAATTC AATTCT ATTCTG TTCTGT TCTGTG CTGTGC TGTGCG GTGCGT TGCGTG GCGTGT CGTGTT GTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGA ACAGAA CAGAAG AGAAGG GAAGGC AAGGCC,0,94,CTTT TTTA TTAT TATG ATGC TGCA GCAT CATT ATTT TTTG TTGC TGCA GCAT CATC ATCA TCAG CAGA AGAG GAGG AGGC GGCT GCTG CTGC TGCT GCTC CTCG TCGT CGTG GTGT TGTT GTTG TTGT TGTA GTAC TACG ACGA CGAT GATC ATCA TCAA CAAT AATT ATTT TTTT TTTC TTCT TCTC CTCC TCCC CCCG CCGC CGCA GCAC CACT ACTC CTCT TCTT CTTG TTGA TGAA GAAA AAAC AACT ACTG CTGC TGCT GCTC CTCA TCAA CAAA AAAA AAAT AATT ATTC TTCT TCTG CTGT TGTG GTGC TGCG GCGT CGTG GTGT TGTT GTTT TTTT TTTA TTAC TACA ACAG CAGA AGAA GAAG AAGG AGGC GGCC,CTTTA TTTAT TTATG TATGC ATGCA TGCAT GCATT CATTT ATTTG TTTGC TTGCA TGCAT GCATC CATCA ATCAG TCAGA CAGAG AGAGG GAGGC AGGCT GGCTG GCTGC CTGCT TGCTC GCTCG CTCGT TCGTG CGTGT GTGTT TGTTG GTTGT TTGTA TGTAC GTACG TACGA ACGAT CGATC GATCA ATCAA TCAAT CAATT AATTT ATTTT TTTTC TTTCT TTCTC TCTCC CTCCC TCCCG CCCGC CCGCA CGCAC GCACT CACTC ACTCT CTCTT TCTTG CTTGA TTGAA TGAAA GAAAC AAACT AACTG ACTGC CTGCT TGCTC GCTCA CTCAA TCAAA CAAAA AAAAT AAATT AATTC ATTCT TTCTG TCTGT CTGTG TGTGC GTGCG TGCGT GCGTG CGTGT GTGTT TGTTT GTTTT TTTTA TTTAC TTACA TACAG ACAGA CAGAA AGAAG GAAGG AAGGC AGGCC,CTTTAT TTTATG TTATGC TATGCA ATGCAT TGCATT GCATTT CATTTG ATTTGC TTTGCA TTGCAT TGCATC GCATCA CATCAG ATCAGA TCAGAG CAGAGG AGAGGC GAGGCT AGGCTG GGCTGC GCTGCT CTGCTC TGCTCG GCTCGT CTCGTG TCGTGT CGTGTT GTGTTG TGTTGT GTTGTA TTGTAC TGTACG GTACGA TACGAT ACGATC CGATCA GATCAA ATCAAT TCAATT CAATTT AATTTT ATTTTC TTTTCT TTTCTC TTCTCC TCTCCC CTCCCG TCCCGC CCCGCA CCGCAC CGCACT GCACTC CACTCT ACTCTT CTCTTG TCTTGA CTTGAA TTGAAA TGAAAC GAAACT AAACTG AACTGC ACTGCT CTGCTC TGCTCA GCTCAA CTCAAA TCAAAA CAAAAT AAAATT AAATTC AATTCT ATTCTG TTCTGT TCTGTG CTGTGC TGTGCG GTGCGT TGCGTG GCGTGT CGTGTT GTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGA ACAGAA CAGAAG AGAAGG GAAGGC AAGGCC,CTTTATG TTTATGC TTATGCA TATGCAT ATGCATT TGCATTT GCATTTG CATTTGC ATTTGCA TTTGCAT TTGCATC TGCATCA GCATCAG CATCAGA ATCAGAG TCAGAGG CAGAGGC AGAGGCT GAGGCTG AGGCTGC GGCTGCT GCTGCTC CTGCTCG TGCTCGT GCTCGTG CTCGTGT TCGTGTT CGTGTTG GTGTTGT TGTTGTA GTTGTAC TTGTACG TGTACGA GTACGAT TACGATC ACGATCA CGATCAA GATCAAT ATCAATT TCAATTT CAATTTT AATTTTC ATTTTCT TTTTCTC TTTCTCC TTCTCCC TCTCCCG CTCCCGC TCCCGCA CCCGCAC CCGCACT CGCACTC GCACTCT CACTCTT ACTCTTG CTCTTGA TCTTGAA CTTGAAA TTGAAAC TGAAACT GAAACTG AAACTGC AACTGCT ACTGCTC CTGCTCA TGCTCAA GCTCAAA CTCAAAA TCAAAAT CAAAATT AAAATTC AAATTCT AATTCTG ATTCTGT TTCTGTG TCTGTGC CTGTGCG TGTGCGT GTGCGTG TGCGTGT GCGTGTT CGTGTTT GTGTTTT TGTTTTA GTTTTAC TTTTACA TTTACAG TTACAGA TACAGAA ACAGAAG CAGAAGG AGAAGGC GAAGGCC,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",3465
GCCAAT CCAATG CAATGC AATGCT ATGCTC TGCTCA GCTCAT CTCATG TCATGC CATGCA ATGCAC TGCACT GCACTT CACTTT ACTTTT CTTTTA TTTTAT TTTATC TTATCT TATCTA ATCTAC TCTACT CTACTG TACTGA ACTGAT CTGATG TGATGG GATGGA ATGGAA TGGAAA GGAAAC GAAACA AAACAA AACAAA ACAAAA CAAAAT AAAATT AAATTG AATTGC ATTGCC TTGCCG TGCCGA GCCGAT CCGATC CGATCA GATCAG ATCAGC TCAGCA CAGCAT AGCATG GCATGC CATGCC ATGCCC TGCCCG GCCCGC CCCGCA CCGCAA CGCAAT GCAATT CAATTT AATTTA ATTTAC TTTACA TTACAA TACAAC ACAACA CAACAC AACACA ACACAG CACAGA ACAGAC CAGACT AGACTT GACTTT ACTTTA CTTTAT TTTATG TTATGA TATGAG,0,79,GCCA CCAA CAAT AATG ATGC TGCT GCTC CTCA TCAT CATG ATGC TGCA GCAC CACT ACTT CTTT TTTT TTTA TTAT TATC ATCT TCTA CTAC TACT ACTG CTGA TGAT GATG ATGG TGGA GGAA GAAA AAAC AACA ACAA CAAA AAAA AAAT AATT ATTG TTGC TGCC GCCG CCGA CGAT GATC ATCA TCAG CAGC AGCA GCAT CATG ATGC TGCC GCCC CCCG CCGC CGCA GCAA CAAT AATT ATTT TTTA TTAC TACA ACAA CAAC AACA ACAC CACA ACAG CAGA AGAC GACT ACTT CTTT TTTA TTAT TATG ATGA TGAG,GCCAA CCAAT CAATG AATGC ATGCT TGCTC GCTCA CTCAT TCATG CATGC ATGCA TGCAC GCACT CACTT ACTTT CTTTT TTTTA TTTAT TTATC TATCT ATCTA TCTAC CTACT TACTG ACTGA CTGAT TGATG GATGG ATGGA TGGAA GGAAA GAAAC AAACA AACAA ACAAA CAAAA AAAAT AAATT AATTG ATTGC TTGCC TGCCG GCCGA CCGAT CGATC GATCA ATCAG TCAGC CAGCA AGCAT GCATG CATGC ATGCC TGCCC GCCCG CCCGC CCGCA CGCAA GCAAT CAATT AATTT ATTTA TTTAC TTACA TACAA ACAAC CAACA AACAC ACACA CACAG ACAGA CAGAC AGACT GACTT ACTTT CTTTA TTTAT TTATG TATGA ATGAG,GCCAAT CCAATG CAATGC AATGCT ATGCTC TGCTCA GCTCAT CTCATG TCATGC CATGCA ATGCAC TGCACT GCACTT CACTTT ACTTTT CTTTTA TTTTAT TTTATC TTATCT TATCTA ATCTAC TCTACT CTACTG TACTGA ACTGAT CTGATG TGATGG GATGGA ATGGAA TGGAAA GGAAAC GAAACA AAACAA AACAAA ACAAAA CAAAAT AAAATT AAATTG AATTGC ATTGCC TTGCCG TGCCGA GCCGAT CCGATC CGATCA GATCAG ATCAGC TCAGCA CAGCAT AGCATG GCATGC CATGCC ATGCCC TGCCCG GCCCGC CCCGCA CCGCAA CGCAAT GCAATT CAATTT AATTTA ATTTAC TTTACA TTACAA TACAAC ACAACA CAACAC AACACA ACACAG CACAGA ACAGAC CAGACT AGACTT GACTTT ACTTTA CTTTAT TTTATG TTATGA TATGAG,GCCAATG CCAATGC CAATGCT AATGCTC ATGCTCA TGCTCAT GCTCATG CTCATGC TCATGCA CATGCAC ATGCACT TGCACTT GCACTTT CACTTTT ACTTTTA CTTTTAT TTTTATC TTTATCT TTATCTA TATCTAC ATCTACT TCTACTG CTACTGA TACTGAT ACTGATG CTGATGG TGATGGA GATGGAA ATGGAAA TGGAAAC GGAAACA GAAACAA AAACAAA AACAAAA ACAAAAT CAAAATT AAAATTG AAATTGC AATTGCC ATTGCCG TTGCCGA TGCCGAT GCCGATC CCGATCA CGATCAG GATCAGC ATCAGCA TCAGCAT CAGCATG AGCATGC GCATGCC CATGCCC ATGCCCG TGCCCGC GCCCGCA CCCGCAA CCGCAAT CGCAATT GCAATTT CAATTTA AATTTAC ATTTACA TTTACAA TTACAAC TACAACA ACAACAC CAACACA AACACAG ACACAGA CACAGAC ACAGACT CAGACTT AGACTTT GACTTTA ACTTTAT CTTTATG TTTATGA TTATGAG,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",4508
TCCATG CCATGA CATGAA ATGAAA TGAAAT GAAATG AAATGC AATGCC ATGCCG TGCCGC GCCGCG CCGCGC CGCGCC GCGCCG CGCCGA GCCGAA CCGAAG CGAAGA GAAGAC AAGACA AGACAA GACAAG ACAAGG CAAGGG AAGGGC AGGGCG GGGCGA GGCGAC GCGACT CGACTA GACTAC ACTACT CTACTA TACTAC ACTACC CTACCT TACCTG ACCTGG CCTGGT CTGGTG TGGTGA GGTGAA GTGAAC TGAACG GAACGG AACGGC ACGGCA CGGCAA GGCAAC GCAACA CAACAA AACAAA ACAAAA CAAAAT AAAATG AAATGT AATGTG ATGTGG TGTGGA GTGGAT TGGATC GGATCA GATCAC ATCACG TCACGA CACGAA ACGAAC CGAACG GAACGG AACGGC ACGGCA CGGCAC GGCACG GCACGG CACGGT ACGGTT CGGTTT GGTTTG GTTTGC TTTGCA TTGCAA TGCAAC GCAACC CAACCA AACCAC ACCACG CCACGG CACGGC ACGGCC CGGCCT GGCCTG GCCTGT CCTGTT CTGTTG TGTTGT GTTGTA TTGTAT TGTATG GTATGT TATGTC ATGTCA TGTCAA GTCAAA TCAAAA CAAAAC AAAACG AAACGG AACGGA ACGGAC CGGACA GGACAA GACAAG ACAAGG CAAGGA AAGGAC AGGACG GGACGC GACGCG ACGCGG CGCGGG GCGGGC CGGGCG GGGCGC GGCGCG GCGCGA CGCGAA GCGAAC CGAACG GAACGG AACGGC ACGGCG CGGCGT GGCGTG GCGTGA CGTGAG GTGAGC TGAGCT GAGCTG AGCTGC GCTGCT CTGCTT TGCTTC GCTTCA CTTCAT TTCATC,3,145,TCCA CCAT CATG ATGA TGAA GAAA AAAT AATG ATGC TGCC GCCG CCGC CGCG GCGC CGCC GCCG CCGA CGAA GAAG AAGA AGAC GACA ACAA CAAG AAGG AGGG GGGC GGCG GCGA CGAC GACT ACTA CTAC TACT ACTA CTAC TACC ACCT CCTG CTGG TGGT GGTG GTGA TGAA GAAC AACG ACGG CGGC GGCA GCAA CAAC AACA ACAA CAAA AAAA AAAT AATG ATGT TGTG GTGG TGGA GGAT GATC ATCA TCAC CACG ACGA CGAA GAAC AACG ACGG CGGC GGCA GCAC CACG ACGG CGGT GGTT GTTT TTTG TTGC TGCA GCAA CAAC AACC ACCA CCAC CACG ACGG CGGC GGCC GCCT CCTG CTGT TGTT GTTG TTGT TGTA GTAT TATG ATGT TGTC GTCA TCAA CAAA AAAA AAAC AACG ACGG CGGA GGAC GACA ACAA CAAG AAGG AGGA GGAC GACG ACGC CGCG GCGG CGGG GGGC GGCG GCGC CGCG GCGA CGAA GAAC AACG ACGG CGGC GGCG GCGT CGTG GTGA TGAG GAGC AGCT GCTG CTGC TGCT GCTT CTTC TTCA TCAT CATC,TCCAT CCATG CATGA ATGAA TGAAA GAAAT AAATG AATGC ATGCC TGCCG GCCGC CCGCG CGCGC GCGCC CGCCG GCCGA CCGAA CGAAG GAAGA AAGAC AGACA GACAA ACAAG CAAGG AAGGG AGGGC GGGCG GGCGA GCGAC CGACT GACTA ACTAC CTACT TACTA ACTAC CTACC TACCT ACCTG CCTGG CTGGT TGGTG GGTGA GTGAA TGAAC GAACG AACGG ACGGC CGGCA GGCAA GCAAC CAACA AACAA ACAAA CAAAA AAAAT AAATG AATGT ATGTG TGTGG GTGGA TGGAT GGATC GATCA ATCAC TCACG CACGA ACGAA CGAAC GAACG AACGG ACGGC CGGCA GGCAC GCACG CACGG ACGGT CGGTT GGTTT GTTTG TTTGC TTGCA TGCAA GCAAC CAACC AACCA ACCAC CCACG CACGG ACGGC CGGCC GGCCT GCCTG CCTGT CTGTT TGTTG GTTGT TTGTA TGTAT GTATG TATGT ATGTC TGTCA GTCAA TCAAA CAAAA AAAAC AAACG AACGG ACGGA CGGAC GGACA GACAA ACAAG CAAGG AAGGA AGGAC GGACG GACGC ACGCG CGCGG GCGGG CGGGC GGGCG GGCGC GCGCG CGCGA GCGAA CGAAC GAACG AACGG ACGGC CGGCG GGCGT GCGTG CGTGA GTGAG TGAGC GAGCT AGCTG GCTGC CTGCT TGCTT GCTTC CTTCA TTCAT TCATC,TCCATG CCATGA CATGAA ATGAAA TGAAAT GAAATG AAATGC AATGCC ATGCCG TGCCGC GCCGCG CCGCGC CGCGCC GCGCCG CGCCGA GCCGAA CCGAAG CGAAGA GAAGAC AAGACA AGACAA GACAAG ACAAGG CAAGGG AAGGGC AGGGCG GGGCGA GGCGAC GCGACT CGACTA GACTAC ACTACT CTACTA TACTAC ACTACC CTACCT TACCTG ACCTGG CCTGGT CTGGTG TGGTGA GGTGAA GTGAAC TGAACG GAACGG AACGGC ACGGCA CGGCAA GGCAAC GCAACA CAACAA AACAAA ACAAAA CAAAAT AAAATG AAATGT AATGTG ATGTGG TGTGGA GTGGAT TGGATC GGATCA GATCAC ATCACG TCACGA CACGAA ACGAAC CGAACG GAACGG AACGGC ACGGCA CGGCAC GGCACG GCACGG CACGGT ACGGTT CGGTTT GGTTTG GTTTGC TTTGCA TTGCAA TGCAAC GCAACC CAACCA AACCAC ACCACG CCACGG CACGGC ACGGCC CGGCCT GGCCTG GCCTGT CCTGTT CTGTTG TGTTGT GTTGTA TTGTAT TGTATG GTATGT TATGTC ATGTCA TGTCAA GTCAAA TCAAAA CAAAAC AAAACG AAACGG AACGGA ACGGAC CGGACA GGACAA GACAAG ACAAGG CAAGGA AAGGAC AGGACG GGACGC GACGCG ACGCGG CGCGGG GCGGGC CGGGCG GGGCGC GGCGCG GCGCGA CGCGAA GCGAAC CGAACG GAACGG AACGGC ACGGCG CGGCGT GGCGTG GCGTGA CGTGAG GTGAGC TGAGCT GAGCTG AGCTGC GCTGCT CTGCTT TGCTTC GCTTCA CTTCAT TTCATC,TCCATGA CCATGAA CATGAAA ATGAAAT TGAAATG GAAATGC AAATGCC AATGCCG ATGCCGC TGCCGCG GCCGCGC CCGCGCC CGCGCCG GCGCCGA CGCCGAA GCCGAAG CCGAAGA CGAAGAC GAAGACA AAGACAA AGACAAG GACAAGG ACAAGGG CAAGGGC AAGGGCG AGGGCGA GGGCGAC GGCGACT GCGACTA CGACTAC GACTACT ACTACTA CTACTAC TACTACC ACTACCT CTACCTG TACCTGG ACCTGGT CCTGGTG CTGGTGA TGGTGAA GGTGAAC GTGAACG TGAACGG GAACGGC AACGGCA ACGGCAA CGGCAAC GGCAACA GCAACAA CAACAAA AACAAAA ACAAAAT CAAAATG AAAATGT AAATGTG AATGTGG ATGTGGA TGTGGAT GTGGATC TGGATCA GGATCAC GATCACG ATCACGA TCACGAA CACGAAC ACGAACG CGAACGG GAACGGC AACGGCA ACGGCAC CGGCACG GGCACGG GCACGGT CACGGTT ACGGTTT CGGTTTG GGTTTGC GTTTGCA TTTGCAA TTGCAAC TGCAACC GCAACCA CAACCAC AACCACG ACCACGG CCACGGC CACGGCC ACGGCCT CGGCCTG GGCCTGT GCCTGTT CCTGTTG CTGTTGT TGTTGTA GTTGTAT TTGTATG TGTATGT GTATGTC TATGTCA ATGTCAA TGTCAAA GTCAAAA TCAAAAC CAAAACG AAAACGG AAACGGA AACGGAC ACGGACA CGGACAA GGACAAG GACAAGG ACAAGGA CAAGGAC AAGGACG AGGACGC GGACGCG GACGCGG ACGCGGG CGCGGGC GCGGGCG CGGGCGC GGGCGCG GGCGCGA GCGCGAA CGCGAAC GCGAACG CGAACGG GAACGGC AACGGCG ACGGCGT CGGCGTG GGCGTGA GCGTGAG CGTGAGC GTGAGCT TGAGCTG GAGCTGC AGCTGCT GCTGCTT CTGCTTC TGCTTCA GCTTCAT CTTCATC,"ID   MBCD_SOLTU              Reviewed;         412 AA.
AC   Q9FS88; M1CK01;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2013, sequence version 2.
DT   05-FEB-2025, entry version 129.
DE   RecName: Full=2-methylacyl-CoA dehydrogenase, mitochondrial;
DE            EC=1.3.8.5 {ECO:0000269|PubMed:15574432};
DE   AltName: Full=2-methylbutanoyl-CoA dehydrogenase;
DE   AltName: Full=2-methylbutyryl-CoA dehydrogenase;
DE            Short=2MBCD;
DE   AltName: Full=Isovaleryl-CoA dehydrogenase 1;
DE            Short=St-IVD1;
DE   Flags: Precursor;
GN   Name=2MBCD; Synonyms=IVD1; ORFNames=PGSC0003DMG400026901;
OS   Solanum tuberosum (Potato).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Solanales; Solanaceae; Solanoideae; Solaneae; Solanum.
OX   NCBI_TaxID=4113 {ECO:0000312|EMBL:CAC08233.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Bintje; TISSUE=Tuber;
RX   PubMed=11231285; DOI=10.1046/j.1432-1327.2001.01999.x;
RA   Faivre-Nitschke S.E., Couee I., Vermel M., Grienenberger J.-M.,
RA   Gualberto J.M.;
RT   ""Purification, characterization and cloning of isovaleryl-CoA dehydrogenase
RT   from higher plant mitochondria."";
RL   Eur. J. Biochem. 268:1332-1339(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. DM1-3 516 R44;
RX   PubMed=21743474; DOI=10.1038/nature10158;
RG   The Potato Genome Sequencing Consortium;
RT   ""Genome sequence and analysis of the tuber crop potato."";
RL   Nature 475:189-195(2011).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   SUBSTRATE SPECIFICITY, AND 3D-STRUCTURE MODELING.
RX   PubMed=15574432; DOI=10.1074/jbc.m412640200;
RA   Goetzman E.S., Mohsen A.W., Prasad K., Vockley J.;
RT   ""Convergent evolution of a 2-methylbutyryl-CoA dehydrogenase from
RT   isovaleryl-CoA dehydrogenase in Solanum tuberosum."";
RL   J. Biol. Chem. 280:4873-4879(2005).
CC   -!- FUNCTION: Short/branched-chain acyl-CoA dehydrogenase (SBCAD). Uses 2-
CC       methylbutanoyl-CoA as substrate. Minor activity with the straight-chain
CC       substrates, butanoyl-CoA, valeryl-CoA, hexanoyl-CoA, and octanoyl-CoA
CC       but no activity with isovaleryl-CoA. {ECO:0000269|PubMed:15574432}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylbutanoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] + H(+) = (2E)-2-methylbut-2-enoyl-CoA + reduced
CC         [electron-transfer flavoprotein]; Xref=Rhea:RHEA:43780, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57336, ChEBI:CHEBI:57337, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307; EC=1.3.8.5;
CC         Evidence={ECO:0000269|PubMed:15574432};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P26440};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1 uM for 2-methylbutanoyl-CoA {ECO:0000269|PubMed:15574432};
CC         Note=kcat is 1.77 sec(-1) per tetramer for 2-methylbutanoyl-CoA.;
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15574432}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11231285}.
CC   -!- TISSUE SPECIFICITY: Expressed in flowers.
CC       {ECO:0000269|PubMed:11231285}.
CC   -!- MISCELLANEOUS: Due to a high homology with IVD, this protein was
CC       initially thought to be a second copy of the isovaleryl-CoA
CC       dehydrogenase (PubMed:11231285), but based on 3D-structure modeling and
CC       mutagenesis of the human isovaleryl-CoA dehydrogenase, Val-116, Val-
CC       120, Val-124, Met-389 and Ala-393 were shown to provide the substrate
CC       specificity for 2-methylbutanoyl-CoA (PubMed:15574432).
CC       {ECO:0000305|PubMed:11231285, ECO:0000305|PubMed:15574432}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ278987; CAC08233.1; -; mRNA.
DR   RefSeq; NP_001275043.1; NM_001288114.1.
DR   AlphaFoldDB; Q9FS88; -.
DR   SMR; Q9FS88; -.
DR   STRING; 4113.Q9FS88; -.
DR   PaxDb; 4113-PGSC0003DMT400069152; -.
DR   EnsemblPlants; PGSC0003DMT400069152; PGSC0003DMT400069152; PGSC0003DMG400026901.
DR   GeneID; 102589539; -.
DR   Gramene; PGSC0003DMT400069152; PGSC0003DMT400069152; PGSC0003DMG400026901.
DR   KEGG; sot:102589539; -.
DR   eggNOG; KOG0141; Eukaryota.
DR   HOGENOM; CLU_018204_0_1_1; -.
DR   InParanoid; Q9FS88; -.
DR   OMA; YNVERMM; -.
DR   OrthoDB; 9988775at2759; -.
DR   SABIO-RK; Q9FS88; -.
DR   Proteomes; UP000011115; Unassembled WGS sequence.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0008470; F:3-methylbutanoyl-CoA dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0003853; F:short-chain 2-methyl fatty acyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:1902192; P:2-methylbut-2-enoyl-CoA(4-) metabolic process; IDA:UniProtKB.
DR   GO; GO:1902190; P:2-methylbutanoyl-CoA(4-) catabolic process; IDA:UniProtKB.
DR   GO; GO:0006552; P:L-leucine catabolic process; IBA:GO_Central.
DR   CDD; cd01156; IVD; 1.
DR   FunFam; 1.10.540.10:FF:000007; Isovaleryl-CoA dehydrogenase, mitochondrial; 1.
DR   FunFam; 2.40.110.10:FF:000004; Isovaleryl-CoA dehydrogenase, mitochondrial; 1.
DR   FunFam; 1.20.140.10:FF:000003; isovaleryl-CoA dehydrogenase, mitochondrial; 1.
DR   Gene3D; 1.10.540.10; Acyl-CoA dehydrogenase/oxidase, N-terminal domain; 1.
DR   Gene3D; 2.40.110.10; Butyryl-CoA Dehydrogenase, subunit A, domain 2; 1.
DR   Gene3D; 1.20.140.10; Butyryl-CoA Dehydrogenase, subunit A, domain 3; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_mid-dom.
DR   InterPro; IPR046373; Acyl-CoA_Oxase/DH_mid-dom_sf.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom_sf.
DR   InterPro; IPR034183; IVD.
DR   PANTHER; PTHR43884:SF27; 2-METHYLACYL-COA DEHYDROGENASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43884; ACYL-COA DEHYDROGENASE; 1.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   PIRSF; PIRSF016578; HsaA; 1.
DR   SUPFAM; SSF47203; Acyl-CoA dehydrogenase C-terminal domain-like; 1.
DR   SUPFAM; SSF56645; Acyl-CoA dehydrogenase NM domain-like; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   FAD; Flavoprotein; Mitochondrion; Oxidoreductase; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..25
FT                   /note=""Mitochondrion""
FT                   /evidence=""ECO:0000305""
FT   CHAIN           26..412
FT                   /note=""2-methylacyl-CoA dehydrogenase, mitochondrial""
FT                   /id=""PRO_0000000536""
FT   ACT_SITE        273
FT                   /note=""Proton acceptor""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         154..163
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         163
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         187..189
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         209..210
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         264
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         271..274
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         299
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         310
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         367..371
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         394..395
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   BINDING         396..398
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250|UniProtKB:P26440""
FT   CONFLICT        15..17
FT                   /note=""VKS -> AKN (in Ref. 1; CAC08233)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        252
FT                   /note=""N -> K (in Ref. 1; CAC08233)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   412 AA;  45086 MW;  B6F7617173C9ABF8 CRC64;
     MHKLFAVRSL SSAIVKSFKS LQNQQAAFST SLLLDDTQKQ FKESVAKFAQ ENIAPYAEKI
     DRTNSFPKEI NLWKLMGDFN LHGITAPEEY GGLNLGYLYH CIALEEISRA SGAVAVSYGV
     QSNVCINQLV RNGTPDQKQK YLPKLISGDH IGALAMSEPN AGSDVVSMKC RADRVDGGYV
     LNGNKMWCTN GPVANTLIVY AKTDTTAGSK GITAFIIEKE MPGFSTAQKL DKLGMRGSDT
     CELVFENCFV PNENVLGQEG KGVYVLMSGL DLERLVLAAG PVGIMQACMD IVIPYVRQRE
     QFGRPIGEFQ LIQGKLADMY TALQSSRSYV YAVAKDCDNG KIDPKDCSGT ILLAAERATQ
     VALQAIQCLG GNGYINEYPT GRLLRDAKMY EIAAGTSEIR RLVIGRELFK HQ
//
",23672
CTAGTT TAGTTG AGTTGT GTTGTA TTGTAA TGTAAT GTAATG TAATGG AATGGC ATGGCC TGGCCT GGCCTA GCCTAC CCTACA CTACAT TACATT ACATTA CATTAC ATTACA TTACAG TACAGG ACAGGT CAGGTG AGGTGG GGTGGT GTGGTG TGGTGT GGTGTT GTGTTG TGTTGT GTTGTT TTGTTC TGTTCA GTTCAG TTCAGT TCAGTT CAGTTG AGTTGA GTTGAC TTGACT TGACTT GACTTC ACTTCG CTTCGC TTCGCA TCGCAG CGCAGT GCAGTG CAGTGG AGTGGC GTGGCT TGGCTA GGCTAA GCTAAC CTAACT TAACTA AACTAA ACTAAC CTAACA TAACAT AACATC ACATCT CATCTT ATCTTT TCTTTG CTTTGG TTTGGC TTGGCA TGGCAC GGCACT GCACTG CACTGT ACTGTT CTGTTT TGTTTA GTTTAT TTTATG TTATGA TATGAA ATGAAA TGAAAA GAAAAA AAAAAC AAAACT AAACTC AACTCA ACTCAA CTCAAA TCAAAC CAAACC AAACCC AACCCG ACCCGT CCCGTC CCGTCC CGTCCT GTCCTT TCCTTG CCTTGA CTTGAT TTGATT TGATTG GATTGG ATTGGC TTGGCT TGGCTT GGCTTG GCTTGA CTTGAA TTGAAG TGAAGA GAAGAG AAGAGA AGAGAA GAGAAG AGAAGT GAAGTT AAGTTT AGTTTA GTTTAA TTTAAG TTAAGG TAAGGA AAGGAA AGGAAG GGAAGG GAAGGT AAGGTG AGGTGT GGTGTA GTGTAG TGTAGA GTAGAG TAGAGT AGAGTT GAGTTT AGTTTC GTTTCT TTTCTT TTCTTA TCTTAG CTTAGA,0,142,CTAG TAGT AGTT GTTG TTGT TGTA GTAA TAAT AATG ATGG TGGC GGCC GCCT CCTA CTAC TACA ACAT CATT ATTA TTAC TACA ACAG CAGG AGGT GGTG GTGG TGGT GGTG GTGT TGTT GTTG TTGT TGTT GTTC TTCA TCAG CAGT AGTT GTTG TTGA TGAC GACT ACTT CTTC TTCG TCGC CGCA GCAG CAGT AGTG GTGG TGGC GGCT GCTA CTAA TAAC AACT ACTA CTAA TAAC AACA ACAT CATC ATCT TCTT CTTT TTTG TTGG TGGC GGCA GCAC CACT ACTG CTGT TGTT GTTT TTTA TTAT TATG ATGA TGAA GAAA AAAA AAAA AAAC AACT ACTC CTCA TCAA CAAA AAAC AACC ACCC CCCG CCGT CGTC GTCC TCCT CCTT CTTG TTGA TGAT GATT ATTG TTGG TGGC GGCT GCTT CTTG TTGA TGAA GAAG AAGA AGAG GAGA AGAA GAAG AAGT AGTT GTTT TTTA TTAA TAAG AAGG AGGA GGAA GAAG AAGG AGGT GGTG GTGT TGTA GTAG TAGA AGAG GAGT AGTT GTTT TTTC TTCT TCTT CTTA TTAG TAGA,CTAGT TAGTT AGTTG GTTGT TTGTA TGTAA GTAAT TAATG AATGG ATGGC TGGCC GGCCT GCCTA CCTAC CTACA TACAT ACATT CATTA ATTAC TTACA TACAG ACAGG CAGGT AGGTG GGTGG GTGGT TGGTG GGTGT GTGTT TGTTG GTTGT TTGTT TGTTC GTTCA TTCAG TCAGT CAGTT AGTTG GTTGA TTGAC TGACT GACTT ACTTC CTTCG TTCGC TCGCA CGCAG GCAGT CAGTG AGTGG GTGGC TGGCT GGCTA GCTAA CTAAC TAACT AACTA ACTAA CTAAC TAACA AACAT ACATC CATCT ATCTT TCTTT CTTTG TTTGG TTGGC TGGCA GGCAC GCACT CACTG ACTGT CTGTT TGTTT GTTTA TTTAT TTATG TATGA ATGAA TGAAA GAAAA AAAAA AAAAC AAACT AACTC ACTCA CTCAA TCAAA CAAAC AAACC AACCC ACCCG CCCGT CCGTC CGTCC GTCCT TCCTT CCTTG CTTGA TTGAT TGATT GATTG ATTGG TTGGC TGGCT GGCTT GCTTG CTTGA TTGAA TGAAG GAAGA AAGAG AGAGA GAGAA AGAAG GAAGT AAGTT AGTTT GTTTA TTTAA TTAAG TAAGG AAGGA AGGAA GGAAG GAAGG AAGGT AGGTG GGTGT GTGTA TGTAG GTAGA TAGAG AGAGT GAGTT AGTTT GTTTC TTTCT TTCTT TCTTA CTTAG TTAGA,CTAGTT TAGTTG AGTTGT GTTGTA TTGTAA TGTAAT GTAATG TAATGG AATGGC ATGGCC TGGCCT GGCCTA GCCTAC CCTACA CTACAT TACATT ACATTA CATTAC ATTACA TTACAG TACAGG ACAGGT CAGGTG AGGTGG GGTGGT GTGGTG TGGTGT GGTGTT GTGTTG TGTTGT GTTGTT TTGTTC TGTTCA GTTCAG TTCAGT TCAGTT CAGTTG AGTTGA GTTGAC TTGACT TGACTT GACTTC ACTTCG CTTCGC TTCGCA TCGCAG CGCAGT GCAGTG CAGTGG AGTGGC GTGGCT TGGCTA GGCTAA GCTAAC CTAACT TAACTA AACTAA ACTAAC CTAACA TAACAT AACATC ACATCT CATCTT ATCTTT TCTTTG CTTTGG TTTGGC TTGGCA TGGCAC GGCACT GCACTG CACTGT ACTGTT CTGTTT TGTTTA GTTTAT TTTATG TTATGA TATGAA ATGAAA TGAAAA GAAAAA AAAAAC AAAACT AAACTC AACTCA ACTCAA CTCAAA TCAAAC CAAACC AAACCC AACCCG ACCCGT CCCGTC CCGTCC CGTCCT GTCCTT TCCTTG CCTTGA CTTGAT TTGATT TGATTG GATTGG ATTGGC TTGGCT TGGCTT GGCTTG GCTTGA CTTGAA TTGAAG TGAAGA GAAGAG AAGAGA AGAGAA GAGAAG AGAAGT GAAGTT AAGTTT AGTTTA GTTTAA TTTAAG TTAAGG TAAGGA AAGGAA AGGAAG GGAAGG GAAGGT AAGGTG AGGTGT GGTGTA GTGTAG TGTAGA GTAGAG TAGAGT AGAGTT GAGTTT AGTTTC GTTTCT TTTCTT TTCTTA TCTTAG CTTAGA,CTAGTTG TAGTTGT AGTTGTA GTTGTAA TTGTAAT TGTAATG GTAATGG TAATGGC AATGGCC ATGGCCT TGGCCTA GGCCTAC GCCTACA CCTACAT CTACATT TACATTA ACATTAC CATTACA ATTACAG TTACAGG TACAGGT ACAGGTG CAGGTGG AGGTGGT GGTGGTG GTGGTGT TGGTGTT GGTGTTG GTGTTGT TGTTGTT GTTGTTC TTGTTCA TGTTCAG GTTCAGT TTCAGTT TCAGTTG CAGTTGA AGTTGAC GTTGACT TTGACTT TGACTTC GACTTCG ACTTCGC CTTCGCA TTCGCAG TCGCAGT CGCAGTG GCAGTGG CAGTGGC AGTGGCT GTGGCTA TGGCTAA GGCTAAC GCTAACT CTAACTA TAACTAA AACTAAC ACTAACA CTAACAT TAACATC AACATCT ACATCTT CATCTTT ATCTTTG TCTTTGG CTTTGGC TTTGGCA TTGGCAC TGGCACT GGCACTG GCACTGT CACTGTT ACTGTTT CTGTTTA TGTTTAT GTTTATG TTTATGA TTATGAA TATGAAA ATGAAAA TGAAAAA GAAAAAC AAAAACT AAAACTC AAACTCA AACTCAA ACTCAAA CTCAAAC TCAAACC CAAACCC AAACCCG AACCCGT ACCCGTC CCCGTCC CCGTCCT CGTCCTT GTCCTTG TCCTTGA CCTTGAT CTTGATT TTGATTG TGATTGG GATTGGC ATTGGCT TTGGCTT TGGCTTG GGCTTGA GCTTGAA CTTGAAG TTGAAGA TGAAGAG GAAGAGA AAGAGAA AGAGAAG GAGAAGT AGAAGTT GAAGTTT AAGTTTA AGTTTAA GTTTAAG TTTAAGG TTAAGGA TAAGGAA AAGGAAG AGGAAGG GGAAGGT GAAGGTG AAGGTGT AGGTGTA GGTGTAG GTGTAGA TGTAGAG GTAGAGT TAGAGTT AGAGTTT GAGTTTC AGTTTCT GTTTCTT TTTCTTA TTCTTAG TCTTAGA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",1675
CACGGC ACGGCG CGGCGA GGCGAC GCGACC CGACCC GACCCC ACCCCC CCCCCG CCCCGA CCCGAG CCGAGA CGAGAT GAGATC AGATCT GATCTC ATCTCC TCTCCA CTCCAC TCCACT CCACTA CACTAT ACTATC CTATCC TATCCT ATCCTC TCCTCT CCTCTT CTCTTC TCTTCG CTTCGT TTCGTC TCGTCG CGTCGG GTCGGC TCGGCA CGGCAG GGCAGC GCAGCG CAGCGT AGCGTC GCGTCA CGTCAG GTCAGA TCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTA GTGTAT TGTATA GTATAA TATAAG ATAAGA TAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGG ACAGGA CAGGAC AGGACC GGACCG GACCGC ACCGCC CCGCCT CGCCTC GCCTCA CCTCAA CTCAAT TCAATG CAATGA AATGAG ATGAGG TGAGGT GAGGTT AGGTTG GGTTGC GTTGCC TTGCCA TGCCAA GCCAAG CCAAGA CAAGAA AAGAAT AGAATT GAATTT AATTTA ATTTAA TTTAAA TTAAAT TAAATG AAATGA AATGAA ATGAAT TGAATC GAATCT AATCTC ATCTCT TCTCTC CTCTCA TCTCAT CTCATC TCATCG CATCGA ATCGAT TCGATC CGATCT GATCTC ATCTCC TCTCCA CTCCAA TCCAAG CCAAGA CAAGAA AAGAAC AGAACT GAACTT AACTTG ACTTGG CTTGGA TTGGAA TGGAAA GGAAAG GAAAGT AAAGTA AAGTAT AGTATG GTATGA TATGAG ATGAGC TGAGCA GAGCAG AGCAGT GCAGTA CAGTAT AGTATA GTATAT TATATA,1,142,CACG ACGG CGGC GGCG GCGA CGAC GACC ACCC CCCC CCCC CCCG CCGA CGAG GAGA AGAT GATC ATCT TCTC CTCC TCCA CCAC CACT ACTA CTAT TATC ATCC TCCT CCTC CTCT TCTT CTTC TTCG TCGT CGTC GTCG TCGG CGGC GGCA GCAG CAGC AGCG GCGT CGTC GTCA TCAG CAGA AGAT GATT ATTG TTGT TGTG GTGT TGTA GTAT TATA ATAA TAAG AAGA AGAG GAGA AGAC GACA ACAG CAGG AGGA GGAC GACC ACCG CCGC CGCC GCCT CCTC CTCA TCAA CAAT AATG ATGA TGAG GAGG AGGT GGTT GTTG TTGC TGCC GCCA CCAA CAAG AAGA AGAA GAAT AATT ATTT TTTA TTAA TAAA AAAT AATG ATGA TGAA GAAT AATC ATCT TCTC CTCT TCTC CTCA TCAT CATC ATCG TCGA CGAT GATC ATCT TCTC CTCC TCCA CCAA CAAG AAGA AGAA GAAC AACT ACTT CTTG TTGG TGGA GGAA GAAA AAAG AAGT AGTA GTAT TATG ATGA TGAG GAGC AGCA GCAG CAGT AGTA GTAT TATA ATAT TATA,CACGG ACGGC CGGCG GGCGA GCGAC CGACC GACCC ACCCC CCCCC CCCCG CCCGA CCGAG CGAGA GAGAT AGATC GATCT ATCTC TCTCC CTCCA TCCAC CCACT CACTA ACTAT CTATC TATCC ATCCT TCCTC CCTCT CTCTT TCTTC CTTCG TTCGT TCGTC CGTCG GTCGG TCGGC CGGCA GGCAG GCAGC CAGCG AGCGT GCGTC CGTCA GTCAG TCAGA CAGAT AGATT GATTG ATTGT TTGTG TGTGT GTGTA TGTAT GTATA TATAA ATAAG TAAGA AAGAG AGAGA GAGAC AGACA GACAG ACAGG CAGGA AGGAC GGACC GACCG ACCGC CCGCC CGCCT GCCTC CCTCA CTCAA TCAAT CAATG AATGA ATGAG TGAGG GAGGT AGGTT GGTTG GTTGC TTGCC TGCCA GCCAA CCAAG CAAGA AAGAA AGAAT GAATT AATTT ATTTA TTTAA TTAAA TAAAT AAATG AATGA ATGAA TGAAT GAATC AATCT ATCTC TCTCT CTCTC TCTCA CTCAT TCATC CATCG ATCGA TCGAT CGATC GATCT ATCTC TCTCC CTCCA TCCAA CCAAG CAAGA AAGAA AGAAC GAACT AACTT ACTTG CTTGG TTGGA TGGAA GGAAA GAAAG AAAGT AAGTA AGTAT GTATG TATGA ATGAG TGAGC GAGCA AGCAG GCAGT CAGTA AGTAT GTATA TATAT ATATA,CACGGC ACGGCG CGGCGA GGCGAC GCGACC CGACCC GACCCC ACCCCC CCCCCG CCCCGA CCCGAG CCGAGA CGAGAT GAGATC AGATCT GATCTC ATCTCC TCTCCA CTCCAC TCCACT CCACTA CACTAT ACTATC CTATCC TATCCT ATCCTC TCCTCT CCTCTT CTCTTC TCTTCG CTTCGT TTCGTC TCGTCG CGTCGG GTCGGC TCGGCA CGGCAG GGCAGC GCAGCG CAGCGT AGCGTC GCGTCA CGTCAG GTCAGA TCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTA GTGTAT TGTATA GTATAA TATAAG ATAAGA TAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGG ACAGGA CAGGAC AGGACC GGACCG GACCGC ACCGCC CCGCCT CGCCTC GCCTCA CCTCAA CTCAAT TCAATG CAATGA AATGAG ATGAGG TGAGGT GAGGTT AGGTTG GGTTGC GTTGCC TTGCCA TGCCAA GCCAAG CCAAGA CAAGAA AAGAAT AGAATT GAATTT AATTTA ATTTAA TTTAAA TTAAAT TAAATG AAATGA AATGAA ATGAAT TGAATC GAATCT AATCTC ATCTCT TCTCTC CTCTCA TCTCAT CTCATC TCATCG CATCGA ATCGAT TCGATC CGATCT GATCTC ATCTCC TCTCCA CTCCAA TCCAAG CCAAGA CAAGAA AAGAAC AGAACT GAACTT AACTTG ACTTGG CTTGGA TTGGAA TGGAAA GGAAAG GAAAGT AAAGTA AAGTAT AGTATG GTATGA TATGAG ATGAGC TGAGCA GAGCAG AGCAGT GCAGTA CAGTAT AGTATA GTATAT TATATA,CACGGCG ACGGCGA CGGCGAC GGCGACC GCGACCC CGACCCC GACCCCC ACCCCCG CCCCCGA CCCCGAG CCCGAGA CCGAGAT CGAGATC GAGATCT AGATCTC GATCTCC ATCTCCA TCTCCAC CTCCACT TCCACTA CCACTAT CACTATC ACTATCC CTATCCT TATCCTC ATCCTCT TCCTCTT CCTCTTC CTCTTCG TCTTCGT CTTCGTC TTCGTCG TCGTCGG CGTCGGC GTCGGCA TCGGCAG CGGCAGC GGCAGCG GCAGCGT CAGCGTC AGCGTCA GCGTCAG CGTCAGA GTCAGAT TCAGATT CAGATTG AGATTGT GATTGTG ATTGTGT TTGTGTA TGTGTAT GTGTATA TGTATAA GTATAAG TATAAGA ATAAGAG TAAGAGA AAGAGAC AGAGACA GAGACAG AGACAGG GACAGGA ACAGGAC CAGGACC AGGACCG GGACCGC GACCGCC ACCGCCT CCGCCTC CGCCTCA GCCTCAA CCTCAAT CTCAATG TCAATGA CAATGAG AATGAGG ATGAGGT TGAGGTT GAGGTTG AGGTTGC GGTTGCC GTTGCCA TTGCCAA TGCCAAG GCCAAGA CCAAGAA CAAGAAT AAGAATT AGAATTT GAATTTA AATTTAA ATTTAAA TTTAAAT TTAAATG TAAATGA AAATGAA AATGAAT ATGAATC TGAATCT GAATCTC AATCTCT ATCTCTC TCTCTCA CTCTCAT TCTCATC CTCATCG TCATCGA CATCGAT ATCGATC TCGATCT CGATCTC GATCTCC ATCTCCA TCTCCAA CTCCAAG TCCAAGA CCAAGAA CAAGAAC AAGAACT AGAACTT GAACTTG AACTTGG ACTTGGA CTTGGAA TTGGAAA TGGAAAG GGAAAGT GAAAGTA AAAGTAT AAGTATG AGTATGA GTATGAG TATGAGC ATGAGCA TGAGCAG GAGCAGT AGCAGTA GCAGTAT CAGTATA AGTATAT GTATATA,"ID   SPIKE_BC279             Reviewed;        1241 AA.
AC   Q0Q475;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 1.
DT   27-NOV-2024, entry version 84.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Bat coronavirus 279/2005 (BtCoV) (BtCoV/279/2005).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=389167;
OH   NCBI_TaxID=196889; Rhinolophus macrotis (Big-eared horseshoe bat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=16840328; DOI=10.1128/jvi.00697-06;
RA   Tang X.C., Zhang J.X., Zhang S.Y., Wang P., Fan X.H., Li L.F., Li G.,
RA   Dong B.Q., Liu W., Cheung C.L., Xu K.M., Song W.J., Vijaykrishna D.,
RA   Poon L.L.M., Peiris J.S.M., Smith G.J., Chen H., Guan Y.;
RT   ""Prevalence and genetic diversity of coronaviruses in bats from China."";
RL   J. Virol. 80:7481-7490(2006).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- FUNCTION: [Spike protein S2]: Mediates fusion of the virion and
CC       cellular membranes by acting as a class I viral fusion protein. Under
CC       the current model, the protein has at least three conformational
CC       states: pre-fusion native state, pre-hairpin intermediate state, and
CC       post-fusion hairpin state. During viral and target cell membrane
CC       fusion, the coiled coil regions (heptad repeats) assume a trimer-of-
CC       hairpins structure, positioning the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. The formation of this
CC       structure appears to drive apposition and subsequent fusion of viral
CC       and target cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- FUNCTION: [Spike protein S2']: Acts as a viral fusion peptide which is
CC       unmasked following S2 cleavage occurring upon virus endocytosis.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- SUBUNIT: Homotrimer; each monomer consists of a S1 and a S2 subunit.
CC       The resulting peplomers protrude from the virus surface as spikes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- SUBCELLULAR LOCATION: Virion membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04099}; Single-pass type I membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_04099}. Host endoplasmic reticulum-Golgi intermediate
CC       compartment membrane {ECO:0000255|HAMAP-Rule:MF_04099}; Single-pass
CC       type I membrane protein {ECO:0000255|HAMAP-Rule:MF_04099}. Host cell
CC       membrane {ECO:0000255|HAMAP-Rule:MF_04099}; Single-pass type I membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04099}. Note=Accumulates in the
CC       endoplasmic reticulum-Golgi intermediate compartment, where it
CC       participates in virus particle assembly. Some S oligomers are
CC       transported to the host plasma membrane, where they may mediate cell-
CC       cell fusion. {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- DOMAIN: Fusion peptide 1 (FP1) and fusion peptide 2 (FP2) function
CC       cooperatively and have a membrane-ordering effect on lipid headgroups
CC       and shallow hydrophobic regions of target bilayers. They are considered
CC       as two domains of an extended, bipartite FP. The membrane-ordering
CC       activity is calcium-dependent and also dependent on correct folding,
CC       which is maintained by an internal disulfide bond in FP2.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield mature proteins. The
CC       precursor is processed into S1 and S2 by host cell furin or another
CC       cellular protease to yield the mature S1 and S2 proteins. Additionally,
CC       a second cleavage leads to the release of a fusion peptide after viral
CC       attachment to host cell receptor. {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- PTM: The cytoplasmic Cys-rich domain is palmitoylated. Spike
CC       glycoprotein is digested within host endosomes. {ECO:0000255|HAMAP-
CC       Rule:MF_04099}.
CC   -!- MISCELLANEOUS: Bat coronavirus 279/2005 is highly similar to SARS-CoV
CC       (SARS-like).
CC   -!- SIMILARITY: Belongs to the betacoronaviruses spike protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ648857; ABG47069.1; -; Genomic_RNA.
DR   BMRB; Q0Q475; -.
DR   SMR; Q0Q475; -.
DR   GlyCosmos; Q0Q475; 23 sites, No reported glycans.
DR   Proteomes; UP000006573; Genome.
DR   GO; GO:0044173; C:host cell endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-UniRule.
DR   GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0075509; P:endocytosis involved in viral entry into host cell; IEA:UniProtKB-UniRule.
DR   GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0019064; P:fusion of virus membrane with host plasma membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0046813; P:receptor-mediated virion attachment to host cell; IEA:UniProtKB-UniRule.
DR   CDD; cd21624; SARS-CoV-like_Spike_S1_NTD; 1.
DR   CDD; cd21477; SARS-CoV-like_Spike_S1_RBD; 1.
DR   CDD; cd22378; SARS-CoV-like_Spike_SD1-2_S1-S2_S2; 1.
DR   FunFam; 1.20.5.300:FF:000003; Spike glycoprotein; 1.
DR   Gene3D; 1.20.5.300; -; 1.
DR   Gene3D; 3.30.70.1840; -; 2.
DR   Gene3D; 1.20.5.790; Single helix bin; 1.
DR   Gene3D; 2.60.120.960; Spike glycoprotein, N-terminal domain; 1.
DR   HAMAP; MF_04099; BETA_CORONA_SPIKE; 1.
DR   InterPro; IPR032500; bCoV_S1_N.
DR   InterPro; IPR042578; BETA_CORONA_SPIKE.
DR   InterPro; IPR043473; S2_sf_CoV.
DR   InterPro; IPR043002; Spike_N_sf.
DR   InterPro; IPR044341; Spike_S1_N_SARS-CoV-like.
DR   InterPro; IPR018548; Spike_S1_RBD_bCoV.
DR   InterPro; IPR036326; Spike_S1_RBD_sf_bCoV.
DR   InterPro; IPR002552; Spike_S2_CoV.
DR   InterPro; IPR044873; Spike_S2_CoV_HR1.
DR   InterPro; IPR044874; Spike_S2_CoV_HR2.
DR   Pfam; PF16451; bCoV_S1_N; 1.
DR   Pfam; PF09408; bCoV_S1_RBD; 1.
DR   Pfam; PF01601; CoV_S2; 1.
DR   SUPFAM; SSF111474; Coronavirus S2 glycoprotein; 2.
DR   SUPFAM; SSF143587; SARS receptor-binding domain-like; 1.
DR   PROSITE; PS51921; BCOV_S1_CTD; 1.
DR   PROSITE; PS51922; BCOV_S1_NTD; 1.
DR   PROSITE; PS51923; COV_S2_HR1; 1.
DR   PROSITE; PS51924; COV_S2_HR2; 1.
PE   3: Inferred from homology;
KW   Coiled coil; Disulfide bond;
KW   Fusion of virus membrane with host endosomal membrane;
KW   Fusion of virus membrane with host membrane; Glycoprotein;
KW   Host cell membrane; Host membrane; Host-virus interaction; Lipoprotein;
KW   Membrane; Palmitate; Signal; Transmembrane; Transmembrane helix;
KW   Viral attachment to host cell; Viral envelope protein;
KW   Viral penetration into host cytoplasm; Virion; Virulence;
KW   Virus entry into host cell.
FT   SIGNAL          1..13
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CHAIN           14..1241
FT                   /note=""Spike glycoprotein""
FT                   /id=""PRO_0000289926""
FT   CHAIN           14..653
FT                   /note=""Spike protein S1""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT                   /id=""PRO_0000444056""
FT   CHAIN           654..1241
FT                   /note=""Spike protein S2""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT                   /id=""PRO_0000289928""
FT   CHAIN           784..1241
FT                   /note=""Spike protein S2'""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT                   /id=""PRO_0000444057""
FT   TOPO_DOM        14..1181
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   TRANSMEM        1182..1202
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   TOPO_DOM        1203..1241
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   DOMAIN          14..294
FT                   /note=""BetaCoV S1-NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01270""
FT   DOMAIN          325..499
FT                   /note=""BetaCoV S1-CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01269""
FT   REGION          784..805
FT                   /note=""Fusion peptide 1""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   REGION          803..823
FT                   /note=""Fusion peptide 2""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   REGION          888..938
FT                   /note=""Heptad repeat 1""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   REGION          1131..1170
FT                   /note=""Heptad repeat 2""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   COILED          917..961
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   COILED          1143..1171
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   MOTIF           1237..1241
FT                   /note=""KxHxx""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   SITE            653..654
FT                   /note=""Cleavage""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   SITE            783..784
FT                   /note=""Cleavage""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        65
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        115
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        124
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        125
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        162
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        231
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        273
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        298
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        322
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        334
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        361
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        575
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        588
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        629
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        677
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        685
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        769
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1042
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1066
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1102
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1126
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1141
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   CARBOHYD        1162
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
FT   DISULFID        19..139
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01270""
FT   DISULFID        134..163
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01270""
FT   DISULFID        282..292
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01270""
FT   DISULFID        327..352
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01269""
FT   DISULFID        370..423
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01269""
FT   DISULFID        382..497
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01269""
FT   DISULFID        808..819
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04099""
SQ   SEQUENCE   1241 AA;  137942 MW;  441A3F3EBBEF9A2F CRC64;
     MKVLIFALLF SLAKAQEGCG IISRKPQPKM EKVSSSRRGV YYNDDIFRSD VLHLTQDYFL
     PFDSNLTQYF SLNIDSNKYT YFDNPILDFG DGVYFAATEK SNVIRGWIFG SSFDNTTQSA
     IIVNNSTHII IRVCNFNLCK EPMYTVSKGT QQSSWVYQSA FNCTYDRVEK SFQLDTAPKT
     GNFKDLREYV FKNRDGFLSV YQTYTAVNLP RGFPAGFSVL RPILKLPFGI NITSYRVVMT
     MFSQFNSNFL PESAAYYVGN LKYTTFMLSF NENGTITDAV DCSQNPLAEL KCTIKNFNVS
     KGIYQTSNFR VTPTQEVVRF PNITNRCPFD KVFNASRFPN VYAWERTKIS DCVADYTVLY
     NSTSFSTFKC YGVSPSKLID LCFTSVYADT FLIRSSEVRQ VAPGETGVIA DYNYKLPDDF
     TGCVIAWNTA QQDQGQYYYR SYRKEKLKPF ERDLSSDENG VYTLSTYDFY PSIPVEYQAT
     RVVVLSFELL NAPATVCGPK LSTQLVKNQC VNFNFNGLRG TGVLTTSSKR FQSFQQFGRD
     TSDFTDSVRD PQTLEILDIS PCSFGGVSVI TPGTNASSEV AVLYQDVNCT DVPTSIHADQ
     LTPAWRVYST GVNVFQTQAG CLIGAEHVNA SYECDIPIGA GICASYHTAS VLRSTGQKSI
     VAYTMSLGAE NSIAYANNSI AIPTNFSISV TTEVMPVSIA KTSVDCTMYI CGDSLECSNL
     LLQYGSFCTQ LNRALTGIAI EQDKNTQEVF AQVKQMYKTP AIKDFGGFNF SQILPDPSKP
     TKRSFIEDLL FNKVTLADAG FMKQYGECLG DISARDLICA QKFNGLTVLP PLLTDEMIAA
     YTAALVSGTA TAGWTFGAGS ALQIPFAMQM AYRFNGIGVT QNVLYENQKQ IANQFNKAIS
     QIQESLTTTS TALGKLQDVV NDNAQALNTL VKQLSSNFGA ISSVLNDILS RLDKVEAEVQ
     IDRLITGRLQ SLQTYVTQQL IRAAEIRASA NLAATKMSEC VLGQSKRVDF CGKGYHLMSF
     PQAAPHGVVF LHVTYVPSQE RNFTTAPAIC HEGKAYFPRE GVFVSNGTSW FITQRNFYSP
     QIITTDNTFV AGNCDVVIGI INNTVYDPLQ PELDSFKEEL DKYFKNHTSP DVDLGDISGI
     NASVVNIQKE IDRLNEVAKN LNESLIDLQE LGKYEQYIKW PWYVWLGFIA GLIAIVMVTI
     LLCCMTSCCS CLKGACSCGS CCKFDEDDSE PVLKGVKLHY T
//
",58376
CCGTTT CGTTTG GTTTGC TTTGCA TTGCAT TGCATA GCATAC CATACG ATACGC TACGCC ACGCCT CGCCTC GCCTCT CCTCTT CTCTTT TCTTTG CTTTGC TTTGCA TTGCAA TGCAAG GCAAGG CAAGGC AAGGCC AGGCCA GGCCAC GCCACT CCACTA CACTAT ACTATC CTATCC TATCCA ATCCAG TCCAGC CCAGCC CAGCCG AGCCGA GCCGAA CCGAAC CGAACT GAACTG AACTGC ACTGCT CTGCTG TGCTGA GCTGAA CTGAAA TGAAAG GAAAGA AAAGAA AAGAAG AGAAGC GAAGCC AAGCCA AGCCAC GCCACT CCACTG CACTGA ACTGAA CTGAAG TGAAGA GAAGAG AAGAGG AGAGGA GAGGAC AGGACT GGACTT GACTTC ACTTCG CTTCGG TTCGGT TCGGTA CGGTAC GGTACA GTACAG TACAGA ACAGAA CAGAAT AGAATT GAATTT AATTTC ATTTCT TTTCTG TTCTGG TCTGGA CTGGAC TGGACT GGACTA GACTAT ACTATA CTATAA TATAAG ATAAGA TAAGAT AAGATG AGATGG GATGGC ATGGCC TGGCCG GGCCGT GCCGTG CCGTGA CGTGAA GTGAAA TGAAAA GAAAAT AAAATA AAATAG AATAGT ATAGTC TAGTCG AGTCGA GTCGAA TCGAAG CGAAGG GAAGGC AAGGCA AGGCAT GGCATA GCATAG CATAGA ATAGAC TAGACA AGACAG GACAGC ACAGCG CAGCGC AGCGCC GCGCCA CGCCAT GCCATA CCATAG CATAGC ATAGCG TAGCGC AGCGCA GCGCAT CGCATA GCATAT CATATA ATATAC TATACA ATACAA TACAAC ACAACA CAACAG,3,145,CCGT CGTT GTTT TTTG TTGC TGCA GCAT CATA ATAC TACG ACGC CGCC GCCT CCTC CTCT TCTT CTTT TTTG TTGC TGCA GCAA CAAG AAGG AGGC GGCC GCCA CCAC CACT ACTA CTAT TATC ATCC TCCA CCAG CAGC AGCC GCCG CCGA CGAA GAAC AACT ACTG CTGC TGCT GCTG CTGA TGAA GAAA AAAG AAGA AGAA GAAG AAGC AGCC GCCA CCAC CACT ACTG CTGA TGAA GAAG AAGA AGAG GAGG AGGA GGAC GACT ACTT CTTC TTCG TCGG CGGT GGTA GTAC TACA ACAG CAGA AGAA GAAT AATT ATTT TTTC TTCT TCTG CTGG TGGA GGAC GACT ACTA CTAT TATA ATAA TAAG AAGA AGAT GATG ATGG TGGC GGCC GCCG CCGT CGTG GTGA TGAA GAAA AAAA AAAT AATA ATAG TAGT AGTC GTCG TCGA CGAA GAAG AAGG AGGC GGCA GCAT CATA ATAG TAGA AGAC GACA ACAG CAGC AGCG GCGC CGCC GCCA CCAT CATA ATAG TAGC AGCG GCGC CGCA GCAT CATA ATAT TATA ATAC TACA ACAA CAAC AACA ACAG,CCGTT CGTTT GTTTG TTTGC TTGCA TGCAT GCATA CATAC ATACG TACGC ACGCC CGCCT GCCTC CCTCT CTCTT TCTTT CTTTG TTTGC TTGCA TGCAA GCAAG CAAGG AAGGC AGGCC GGCCA GCCAC CCACT CACTA ACTAT CTATC TATCC ATCCA TCCAG CCAGC CAGCC AGCCG GCCGA CCGAA CGAAC GAACT AACTG ACTGC CTGCT TGCTG GCTGA CTGAA TGAAA GAAAG AAAGA AAGAA AGAAG GAAGC AAGCC AGCCA GCCAC CCACT CACTG ACTGA CTGAA TGAAG GAAGA AAGAG AGAGG GAGGA AGGAC GGACT GACTT ACTTC CTTCG TTCGG TCGGT CGGTA GGTAC GTACA TACAG ACAGA CAGAA AGAAT GAATT AATTT ATTTC TTTCT TTCTG TCTGG CTGGA TGGAC GGACT GACTA ACTAT CTATA TATAA ATAAG TAAGA AAGAT AGATG GATGG ATGGC TGGCC GGCCG GCCGT CCGTG CGTGA GTGAA TGAAA GAAAA AAAAT AAATA AATAG ATAGT TAGTC AGTCG GTCGA TCGAA CGAAG GAAGG AAGGC AGGCA GGCAT GCATA CATAG ATAGA TAGAC AGACA GACAG ACAGC CAGCG AGCGC GCGCC CGCCA GCCAT CCATA CATAG ATAGC TAGCG AGCGC GCGCA CGCAT GCATA CATAT ATATA TATAC ATACA TACAA ACAAC CAACA AACAG,CCGTTT CGTTTG GTTTGC TTTGCA TTGCAT TGCATA GCATAC CATACG ATACGC TACGCC ACGCCT CGCCTC GCCTCT CCTCTT CTCTTT TCTTTG CTTTGC TTTGCA TTGCAA TGCAAG GCAAGG CAAGGC AAGGCC AGGCCA GGCCAC GCCACT CCACTA CACTAT ACTATC CTATCC TATCCA ATCCAG TCCAGC CCAGCC CAGCCG AGCCGA GCCGAA CCGAAC CGAACT GAACTG AACTGC ACTGCT CTGCTG TGCTGA GCTGAA CTGAAA TGAAAG GAAAGA AAAGAA AAGAAG AGAAGC GAAGCC AAGCCA AGCCAC GCCACT CCACTG CACTGA ACTGAA CTGAAG TGAAGA GAAGAG AAGAGG AGAGGA GAGGAC AGGACT GGACTT GACTTC ACTTCG CTTCGG TTCGGT TCGGTA CGGTAC GGTACA GTACAG TACAGA ACAGAA CAGAAT AGAATT GAATTT AATTTC ATTTCT TTTCTG TTCTGG TCTGGA CTGGAC TGGACT GGACTA GACTAT ACTATA CTATAA TATAAG ATAAGA TAAGAT AAGATG AGATGG GATGGC ATGGCC TGGCCG GGCCGT GCCGTG CCGTGA CGTGAA GTGAAA TGAAAA GAAAAT AAAATA AAATAG AATAGT ATAGTC TAGTCG AGTCGA GTCGAA TCGAAG CGAAGG GAAGGC AAGGCA AGGCAT GGCATA GCATAG CATAGA ATAGAC TAGACA AGACAG GACAGC ACAGCG CAGCGC AGCGCC GCGCCA CGCCAT GCCATA CCATAG CATAGC ATAGCG TAGCGC AGCGCA GCGCAT CGCATA GCATAT CATATA ATATAC TATACA ATACAA TACAAC ACAACA CAACAG,CCGTTTG CGTTTGC GTTTGCA TTTGCAT TTGCATA TGCATAC GCATACG CATACGC ATACGCC TACGCCT ACGCCTC CGCCTCT GCCTCTT CCTCTTT CTCTTTG TCTTTGC CTTTGCA TTTGCAA TTGCAAG TGCAAGG GCAAGGC CAAGGCC AAGGCCA AGGCCAC GGCCACT GCCACTA CCACTAT CACTATC ACTATCC CTATCCA TATCCAG ATCCAGC TCCAGCC CCAGCCG CAGCCGA AGCCGAA GCCGAAC CCGAACT CGAACTG GAACTGC AACTGCT ACTGCTG CTGCTGA TGCTGAA GCTGAAA CTGAAAG TGAAAGA GAAAGAA AAAGAAG AAGAAGC AGAAGCC GAAGCCA AAGCCAC AGCCACT GCCACTG CCACTGA CACTGAA ACTGAAG CTGAAGA TGAAGAG GAAGAGG AAGAGGA AGAGGAC GAGGACT AGGACTT GGACTTC GACTTCG ACTTCGG CTTCGGT TTCGGTA TCGGTAC CGGTACA GGTACAG GTACAGA TACAGAA ACAGAAT CAGAATT AGAATTT GAATTTC AATTTCT ATTTCTG TTTCTGG TTCTGGA TCTGGAC CTGGACT TGGACTA GGACTAT GACTATA ACTATAA CTATAAG TATAAGA ATAAGAT TAAGATG AAGATGG AGATGGC GATGGCC ATGGCCG TGGCCGT GGCCGTG GCCGTGA CCGTGAA CGTGAAA GTGAAAA TGAAAAT GAAAATA AAAATAG AAATAGT AATAGTC ATAGTCG TAGTCGA AGTCGAA GTCGAAG TCGAAGG CGAAGGC GAAGGCA AAGGCAT AGGCATA GGCATAG GCATAGA CATAGAC ATAGACA TAGACAG AGACAGC GACAGCG ACAGCGC CAGCGCC AGCGCCA GCGCCAT CGCCATA GCCATAG CCATAGC CATAGCG ATAGCGC TAGCGCA AGCGCAT GCGCATA CGCATAT GCATATA CATATAC ATATACA TATACAA ATACAAC TACAACA ACAACAG,"ID   PROA_BACFN              Reviewed;         415 AA.
AC   Q5LI24;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 1.
DT   05-FEB-2025, entry version 115.
DE   RecName: Full=Gamma-glutamyl phosphate reductase {ECO:0000255|HAMAP-Rule:MF_00412};
DE            Short=GPR {ECO:0000255|HAMAP-Rule:MF_00412};
DE            EC=1.2.1.41 {ECO:0000255|HAMAP-Rule:MF_00412};
DE   AltName: Full=Glutamate-5-semialdehyde dehydrogenase {ECO:0000255|HAMAP-Rule:MF_00412};
DE   AltName: Full=Glutamyl-gamma-semialdehyde dehydrogenase {ECO:0000255|HAMAP-Rule:MF_00412};
DE            Short=GSA dehydrogenase {ECO:0000255|HAMAP-Rule:MF_00412};
GN   Name=proA {ECO:0000255|HAMAP-Rule:MF_00412}; OrderedLocusNames=BF0443;
OS   Bacteroides fragilis (strain ATCC 25285 / DSM 2151 / CCUG 4856 / JCM 11019
OS   / LMG 10263 / NCTC 9343 / Onslow / VPI 2553 / EN-2).
OC   Bacteria; Bacteroidota; Bacteroidia; Bacteroidales; Bacteroidaceae;
OC   Bacteroides.
OX   NCBI_TaxID=272559;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25285 / DSM 2151 / CCUG 4856 / JCM 11019 / LMG 10263 /
RC   NCTC 9343 / Onslow / VPI 2553 / EN-2;
RX   PubMed=15746427; DOI=10.1126/science.1107008;
RA   Cerdeno-Tarraga A.-M., Patrick S., Crossman L.C., Blakely G., Abratt V.,
RA   Lennard N., Poxton I., Duerden B., Harris B., Quail M.A., Barron A.,
RA   Clark L., Corton C., Doggett J., Holden M.T.G., Larke N., Line A., Lord A.,
RA   Norbertczak H., Ormond D., Price C., Rabbinowitsch E., Woodward J.,
RA   Barrell B.G., Parkhill J.;
RT   ""Extensive DNA inversions in the B. fragilis genome control variable gene
RT   expression."";
RL   Science 307:1463-1465(2005).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of L-glutamate 5-
CC       phosphate into L-glutamate 5-semialdehyde and phosphate. The product
CC       spontaneously undergoes cyclization to form 1-pyrroline-5-carboxylate.
CC       {ECO:0000255|HAMAP-Rule:MF_00412}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamate 5-semialdehyde + phosphate + NADP(+) = L-glutamyl
CC         5-phosphate + NADPH + H(+); Xref=Rhea:RHEA:19541, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57783, ChEBI:CHEBI:58066,
CC         ChEBI:CHEBI:58274, ChEBI:CHEBI:58349; EC=1.2.1.41;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00412};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-glutamate
CC       5-semialdehyde from L-glutamate: step 2/2. {ECO:0000255|HAMAP-
CC       Rule:MF_00412}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00412}.
CC   -!- SIMILARITY: Belongs to the gamma-glutamyl phosphate reductase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00412}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR626927; CAH06204.1; -; Genomic_DNA.
DR   RefSeq; WP_010992045.1; NZ_UFTH01000001.1.
DR   AlphaFoldDB; Q5LI24; -.
DR   SMR; Q5LI24; -.
DR   PaxDb; 272559-BF9343_0425; -.
DR   GeneID; 60367455; -.
DR   KEGG; bfs:BF9343_0425; -.
DR   eggNOG; COG0014; Bacteria.
DR   HOGENOM; CLU_030231_0_0_10; -.
DR   UniPathway; UPA00098; UER00360.
DR   Proteomes; UP000006731; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004350; F:glutamate-5-semialdehyde dehydrogenase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd07079; ALDH_F18-19_ProA-GPR; 1.
DR   Gene3D; 3.40.605.10; Aldehyde Dehydrogenase, Chain A, domain 1; 1.
DR   Gene3D; 3.40.309.10; Aldehyde Dehydrogenase, Chain A, domain 2; 1.
DR   HAMAP; MF_00412; ProA; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR020593; G-glutamylP_reductase_CS.
DR   InterPro; IPR012134; Glu-5-SA_DH.
DR   InterPro; IPR000965; GPR_dom.
DR   NCBIfam; TIGR00407; proA; 1.
DR   PANTHER; PTHR11063:SF8; DELTA-1-PYRROLINE-5-CARBOXYLATE SYNTHASE; 1.
DR   PANTHER; PTHR11063; GLUTAMATE SEMIALDEHYDE DEHYDROGENASE; 1.
DR   PIRSF; PIRSF000151; GPR; 1.
DR   SUPFAM; SSF53720; ALDH-like; 1.
DR   PROSITE; PS01223; PROA; 1.
PE   3: Inferred from homology;
KW   Amino-acid biosynthesis; Cytoplasm; NADP; Oxidoreductase;
KW   Proline biosynthesis.
FT   CHAIN           1..415
FT                   /note=""Gamma-glutamyl phosphate reductase""
FT                   /id=""PRO_0000189689""
SQ   SEQUENCE   415 AA;  45705 MW;  B3D5059FB4C84A70 CRC64;
     MNLNDTFAAV QAAGRHLALL PDDRINQILN AVAEAALEQT SYILSENRKD LERMSPDNPK
     YDRLRLTEER LRGIASDIRN VATLPSPLGR ILKESIRPNG MRLTKISVPF GVIGIIYEAR
     PNVSFDVFSL CLKSGNACIL KGGSDADYSN RAIVEVIHQV LRQFNIDTHM VELLPADREA
     TRELLHATGY VDLIIPRGSS ALINFVRQNA TIPVIETGAG ICHTYFDEYG DTAKGAAIIH
     NAKTRRVSVC NALDCVIVHE SRLSDLPLLC EKLKADKVII YADPSAYQAL EGHYPAGLLK
     PATPESFGTE FLDYKMAIKT VNSFENALGH IQEYSSRHSE SIVTENPERA ALFTRMVDAA
     CVYTNVSTAF TDGAQFGLGA EIGISTQKLH ARGPMGLEEI TSYKWIIEGD GQTRQ
//
",26129
CCTTCA CTTCAG TTCAGG TCAGGG CAGGGA AGGGAA GGGAAT GGAATT GAATTT AATTTG ATTTGG TTTGGA TTGGAC TGGACA GGACAC GACACT ACACTA CACTAC ACTACA CTACAT TACATC ACATCA CATCAG ATCAGC TCAGCA CAGCAG AGCAGA GCAGAA CAGAAA AGAAAA GAAAAT AAAATT AAATTT AATTTG ATTTGC TTTGCA TTGCAT TGCATC GCATCA CATCAA ATCAAC TCAACT CAACTC AACTCT ACTCTT CTCTTC TCTTCT CTTCTT TTCTTT TCTTTA CTTTAA TTTAAG TTAAGC TAAGCT AAGCTT AGCTTA GCTTAG CTTAGA TTAGAG TAGAGA AGAGAC GAGACG AGACGA GACGAG ACGAGT CGAGTT GAGTTG AGTTGG GTTGGG TTGGGA TGGGAC GGGACA GGACAA GACAAA ACAAAC CAAACC AAACCT AACCTT ACCTTT CCTTTG CTTTGT TTTGTT TTGTTA TGTTAT GTTATT TTATTG TATTGT ATTGTT TTGTTA TGTTAC GTTACA TTACAC TACACA ACACAC CACACA ACACAA CACAAT ACAATG CAATGA AATGAG,2,100,CCTT CTTC TTCA TCAG CAGG AGGG GGGA GGAA GAAT AATT ATTT TTTG TTGG TGGA GGAC GACA ACAC CACT ACTA CTAC TACA ACAT CATC ATCA TCAG CAGC AGCA GCAG CAGA AGAA GAAA AAAA AAAT AATT ATTT TTTG TTGC TGCA GCAT CATC ATCA TCAA CAAC AACT ACTC CTCT TCTT CTTC TTCT TCTT CTTT TTTA TTAA TAAG AAGC AGCT GCTT CTTA TTAG TAGA AGAG GAGA AGAC GACG ACGA CGAG GAGT AGTT GTTG TTGG TGGG GGGA GGAC GACA ACAA CAAA AAAC AACC ACCT CCTT CTTT TTTG TTGT TGTT GTTA TTAT TATT ATTG TTGT TGTT GTTA TTAC TACA ACAC CACA ACAC CACA ACAA CAAT AATG ATGA TGAG,CCTTC CTTCA TTCAG TCAGG CAGGG AGGGA GGGAA GGAAT GAATT AATTT ATTTG TTTGG TTGGA TGGAC GGACA GACAC ACACT CACTA ACTAC CTACA TACAT ACATC CATCA ATCAG TCAGC CAGCA AGCAG GCAGA CAGAA AGAAA GAAAA AAAAT AAATT AATTT ATTTG TTTGC TTGCA TGCAT GCATC CATCA ATCAA TCAAC CAACT AACTC ACTCT CTCTT TCTTC CTTCT TTCTT TCTTT CTTTA TTTAA TTAAG TAAGC AAGCT AGCTT GCTTA CTTAG TTAGA TAGAG AGAGA GAGAC AGACG GACGA ACGAG CGAGT GAGTT AGTTG GTTGG TTGGG TGGGA GGGAC GGACA GACAA ACAAA CAAAC AAACC AACCT ACCTT CCTTT CTTTG TTTGT TTGTT TGTTA GTTAT TTATT TATTG ATTGT TTGTT TGTTA GTTAC TTACA TACAC ACACA CACAC ACACA CACAA ACAAT CAATG AATGA ATGAG,CCTTCA CTTCAG TTCAGG TCAGGG CAGGGA AGGGAA GGGAAT GGAATT GAATTT AATTTG ATTTGG TTTGGA TTGGAC TGGACA GGACAC GACACT ACACTA CACTAC ACTACA CTACAT TACATC ACATCA CATCAG ATCAGC TCAGCA CAGCAG AGCAGA GCAGAA CAGAAA AGAAAA GAAAAT AAAATT AAATTT AATTTG ATTTGC TTTGCA TTGCAT TGCATC GCATCA CATCAA ATCAAC TCAACT CAACTC AACTCT ACTCTT CTCTTC TCTTCT CTTCTT TTCTTT TCTTTA CTTTAA TTTAAG TTAAGC TAAGCT AAGCTT AGCTTA GCTTAG CTTAGA TTAGAG TAGAGA AGAGAC GAGACG AGACGA GACGAG ACGAGT CGAGTT GAGTTG AGTTGG GTTGGG TTGGGA TGGGAC GGGACA GGACAA GACAAA ACAAAC CAAACC AAACCT AACCTT ACCTTT CCTTTG CTTTGT TTTGTT TTGTTA TGTTAT GTTATT TTATTG TATTGT ATTGTT TTGTTA TGTTAC GTTACA TTACAC TACACA ACACAC CACACA ACACAA CACAAT ACAATG CAATGA AATGAG,CCTTCAG CTTCAGG TTCAGGG TCAGGGA CAGGGAA AGGGAAT GGGAATT GGAATTT GAATTTG AATTTGG ATTTGGA TTTGGAC TTGGACA TGGACAC GGACACT GACACTA ACACTAC CACTACA ACTACAT CTACATC TACATCA ACATCAG CATCAGC ATCAGCA TCAGCAG CAGCAGA AGCAGAA GCAGAAA CAGAAAA AGAAAAT GAAAATT AAAATTT AAATTTG AATTTGC ATTTGCA TTTGCAT TTGCATC TGCATCA GCATCAA CATCAAC ATCAACT TCAACTC CAACTCT AACTCTT ACTCTTC CTCTTCT TCTTCTT CTTCTTT TTCTTTA TCTTTAA CTTTAAG TTTAAGC TTAAGCT TAAGCTT AAGCTTA AGCTTAG GCTTAGA CTTAGAG TTAGAGA TAGAGAC AGAGACG GAGACGA AGACGAG GACGAGT ACGAGTT CGAGTTG GAGTTGG AGTTGGG GTTGGGA TTGGGAC TGGGACA GGGACAA GGACAAA GACAAAC ACAAACC CAAACCT AAACCTT AACCTTT ACCTTTG CCTTTGT CTTTGTT TTTGTTA TTGTTAT TGTTATT GTTATTG TTATTGT TATTGTT ATTGTTA TTGTTAC TGTTACA GTTACAC TTACACA TACACAC ACACACA CACACAA ACACAAT CACAATG ACAATGA CAATGAG,"ID   LOLD_BACTN              Reviewed;         218 AA.
AC   Q8A1M1;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   05-FEB-2025, entry version 117.
DE   RecName: Full=Lipoprotein-releasing system ATP-binding protein LolD {ECO:0000255|HAMAP-Rule:MF_01708};
DE            EC=7.6.2.- {ECO:0000255|HAMAP-Rule:MF_01708};
GN   Name=lolD {ECO:0000255|HAMAP-Rule:MF_01708};
GN   OrderedLocusNames=BT_3640;
OS   Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 /
OS   CCUG 10774 / NCTC 10582 / VPI-5482 / E50).
OC   Bacteria; Bacteroidota; Bacteroidia; Bacteroidales; Bacteroidaceae;
OC   Bacteroides.
OX   NCBI_TaxID=226186;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 /
RC   VPI-5482 / E50;
RX   PubMed=12663928; DOI=10.1126/science.1080029;
RA   Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C.,
RA   Hooper L.V., Gordon J.I.;
RT   ""A genomic view of the human-Bacteroides thetaiotaomicron symbiosis."";
RL   Science 299:2074-2076(2003).
CC   -!- FUNCTION: Part of the ABC transporter complex LolCDE involved in the
CC       translocation of mature outer membrane-directed lipoproteins, from the
CC       inner membrane to the periplasmic chaperone, LolA. Responsible for the
CC       formation of the LolA-lipoprotein complex in an ATP-dependent manner.
CC       {ECO:0000255|HAMAP-Rule:MF_01708}.
CC   -!- SUBUNIT: The complex is composed of two ATP-binding proteins (LolD) and
CC       two transmembrane proteins (LolC and LolE). {ECO:0000255|HAMAP-
CC       Rule:MF_01708}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01708}; Peripheral membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01708}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. Lipoprotein
CC       translocase (TC 3.A.1.125) family. {ECO:0000255|HAMAP-Rule:MF_01708}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE015928; AAO78745.1; -; Genomic_DNA.
DR   RefSeq; NP_812551.1; NC_004663.1.
DR   RefSeq; WP_008762585.1; NC_004663.1.
DR   AlphaFoldDB; Q8A1M1; -.
DR   SMR; Q8A1M1; -.
DR   STRING; 226186.BT_3640; -.
DR   PaxDb; 226186-BT_3640; -.
DR   EnsemblBacteria; AAO78745; AAO78745; BT_3640.
DR   GeneID; 60924811; -.
DR   KEGG; bth:BT_3640; -.
DR   PATRIC; fig|226186.12.peg.3700; -.
DR   eggNOG; COG1136; Bacteria.
DR   HOGENOM; CLU_000604_1_22_10; -.
DR   InParanoid; Q8A1M1; -.
DR   OrthoDB; 9782239at2; -.
DR   Proteomes; UP000001414; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0022857; F:transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   CDD; cd03255; ABC_MJ0796_LolCDE_FtsE; 1.
DR   FunFam; 3.40.50.300:FF:000230; Lipoprotein-releasing system ATP-binding protein LolD; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR017911; MacB-like_ATP-bd.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR42798:SF2; ABC TRANSPORTER ATP-BINDING PROTEIN MG467-RELATED; 1.
DR   PANTHER; PTHR42798; LIPOPROTEIN-RELEASING SYSTEM ATP-BINDING PROTEIN LOLD; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
DR   PROSITE; PS51244; LOLD; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell inner membrane; Cell membrane; Membrane;
KW   Nucleotide-binding; Reference proteome; Translocase; Transport.
FT   CHAIN           1..218
FT                   /note=""Lipoprotein-releasing system ATP-binding protein
FT                   LolD""
FT                   /id=""PRO_0000092418""
FT   DOMAIN          2..218
FT                   /note=""ABC transporter""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01708""
FT   BINDING         34..41
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01708""
SQ   SEQUENCE   218 AA;  23762 MW;  BC25F106751614A6 CRC64;
     MIKLEGITKS FGSLQVLKGI DLEINKGEIV SIVGPSGAGK TTLLQIMGTL DEPDAGTVAI
     DGTVVSRMKE KELSAFRNKN IGFVFQFHQL LPEFTALENV MIPAFIAGVS SKEANERAME
     ILAFMGLTDR ASHKPNELSG GEKQRVAVAR ALINHPAVIL ADEPSGSLDT HNKEDLHQLF
     FDLRDRLGQT FVIVTHDEGL AKITDRTVHM VDGTIKKD
//
",12888
AGATTC GATTCT ATTCTT TTCTTT TCTTTA CTTTAC TTTACA TTACAG TACAGT ACAGTT CAGTTG AGTTGG GTTGGT TTGGTA TGGTAA GGTAAT GTAATG TAATGC AATGCT ATGCTA TGCTAA GCTAAG CTAAGG TAAGGA AAGGAA AGGAAG GGAAGC GAAGCA AAGCAA AGCAAG GCAAGA CAAGAA AAGAAA AGAAAA GAAAAT AAAATC AAATCT AATCTG ATCTGT TCTGTT CTGTTG TGTTGT GTTGTT TTGTTT TGTTTA GTTTAT TTTATG TTATGC TATGCA ATGCAA TGCAAC GCAACT CAACTG AACTGG ACTGGA CTGGAT TGGATT GGATTT GATTTA ATTTAT TTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTA GGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTA TTCTAC TCTACT CTACTT TACTTA ACTTAA CTTAAT TTAATT TAATTA AATTAT ATTATT TTATTG TATTGC ATTGCT TTGCTG TGCTGT GCTGTT CTGTTA TGTTAT GTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTT GGTTTA GTTTAG TTTAGG TTAGGA TAGGAG AGGAGC GGAGCT GAGCTA AGCTAT GCTATT CTATTG TATTGT ATTGTA TTGTAT TGTATT GTATTC TATTCT ATTCTT TTCTTA TCTTAA CTTAAA TTAAAC TAAACT AAACTC AACTCA ACTCAC CTCACC TCACCA CACCAG ACCAGA CCAGAG CAGAGG AGAGGG GAGGGT AGGGTG GGGTGC GGTGCT GTGCTC TGCTCA GCTCAA CTCAAT TCAATA CAATAT AATATT ATATTA TATTAT,2,142,AGAT GATT ATTC TTCT TCTT CTTT TTTA TTAC TACA ACAG CAGT AGTT GTTG TTGG TGGT GGTA GTAA TAAT AATG ATGC TGCT GCTA CTAA TAAG AAGG AGGA GGAA GAAG AAGC AGCA GCAA CAAG AAGA AGAA GAAA AAAA AAAT AATC ATCT TCTG CTGT TGTT GTTG TTGT TGTT GTTT TTTA TTAT TATG ATGC TGCA GCAA CAAC AACT ACTG CTGG TGGA GGAT GATT ATTT TTTA TTAT TATT ATTG TTGG TGGT GGTT GTTA TTAC TACT ACTT CTTC TTCT TCTA CTAC TACT ACTT CTTA TTAA TAAT AATT ATTA TTAT TATT ATTG TTGC TGCT GCTG CTGT TGTT GTTA TTAT TATT ATTG TTGG TGGT GGTT GTTT TTTA TTAG TAGG AGGA GGAG GAGC AGCT GCTA CTAT TATT ATTG TTGT TGTA GTAT TATT ATTC TTCT TCTT CTTA TTAA TAAA AAAC AACT ACTC CTCA TCAC CACC ACCA CCAG CAGA AGAG GAGG AGGG GGGT GGTG GTGC TGCT GCTC CTCA TCAA CAAT AATA ATAT TATT ATTA TTAT,AGATT GATTC ATTCT TTCTT TCTTT CTTTA TTTAC TTACA TACAG ACAGT CAGTT AGTTG GTTGG TTGGT TGGTA GGTAA GTAAT TAATG AATGC ATGCT TGCTA GCTAA CTAAG TAAGG AAGGA AGGAA GGAAG GAAGC AAGCA AGCAA GCAAG CAAGA AAGAA AGAAA GAAAA AAAAT AAATC AATCT ATCTG TCTGT CTGTT TGTTG GTTGT TTGTT TGTTT GTTTA TTTAT TTATG TATGC ATGCA TGCAA GCAAC CAACT AACTG ACTGG CTGGA TGGAT GGATT GATTT ATTTA TTTAT TTATT TATTG ATTGG TTGGT TGGTT GGTTA GTTAC TTACT TACTT ACTTC CTTCT TTCTA TCTAC CTACT TACTT ACTTA CTTAA TTAAT TAATT AATTA ATTAT TTATT TATTG ATTGC TTGCT TGCTG GCTGT CTGTT TGTTA GTTAT TTATT TATTG ATTGG TTGGT TGGTT GGTTT GTTTA TTTAG TTAGG TAGGA AGGAG GGAGC GAGCT AGCTA GCTAT CTATT TATTG ATTGT TTGTA TGTAT GTATT TATTC ATTCT TTCTT TCTTA CTTAA TTAAA TAAAC AAACT AACTC ACTCA CTCAC TCACC CACCA ACCAG CCAGA CAGAG AGAGG GAGGG AGGGT GGGTG GGTGC GTGCT TGCTC GCTCA CTCAA TCAAT CAATA AATAT ATATT TATTA ATTAT,AGATTC GATTCT ATTCTT TTCTTT TCTTTA CTTTAC TTTACA TTACAG TACAGT ACAGTT CAGTTG AGTTGG GTTGGT TTGGTA TGGTAA GGTAAT GTAATG TAATGC AATGCT ATGCTA TGCTAA GCTAAG CTAAGG TAAGGA AAGGAA AGGAAG GGAAGC GAAGCA AAGCAA AGCAAG GCAAGA CAAGAA AAGAAA AGAAAA GAAAAT AAAATC AAATCT AATCTG ATCTGT TCTGTT CTGTTG TGTTGT GTTGTT TTGTTT TGTTTA GTTTAT TTTATG TTATGC TATGCA ATGCAA TGCAAC GCAACT CAACTG AACTGG ACTGGA CTGGAT TGGATT GGATTT GATTTA ATTTAT TTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTA GGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTA TTCTAC TCTACT CTACTT TACTTA ACTTAA CTTAAT TTAATT TAATTA AATTAT ATTATT TTATTG TATTGC ATTGCT TTGCTG TGCTGT GCTGTT CTGTTA TGTTAT GTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTT GGTTTA GTTTAG TTTAGG TTAGGA TAGGAG AGGAGC GGAGCT GAGCTA AGCTAT GCTATT CTATTG TATTGT ATTGTA TTGTAT TGTATT GTATTC TATTCT ATTCTT TTCTTA TCTTAA CTTAAA TTAAAC TAAACT AAACTC AACTCA ACTCAC CTCACC TCACCA CACCAG ACCAGA CCAGAG CAGAGG AGAGGG GAGGGT AGGGTG GGGTGC GGTGCT GTGCTC TGCTCA GCTCAA CTCAAT TCAATA CAATAT AATATT ATATTA TATTAT,AGATTCT GATTCTT ATTCTTT TTCTTTA TCTTTAC CTTTACA TTTACAG TTACAGT TACAGTT ACAGTTG CAGTTGG AGTTGGT GTTGGTA TTGGTAA TGGTAAT GGTAATG GTAATGC TAATGCT AATGCTA ATGCTAA TGCTAAG GCTAAGG CTAAGGA TAAGGAA AAGGAAG AGGAAGC GGAAGCA GAAGCAA AAGCAAG AGCAAGA GCAAGAA CAAGAAA AAGAAAA AGAAAAT GAAAATC AAAATCT AAATCTG AATCTGT ATCTGTT TCTGTTG CTGTTGT TGTTGTT GTTGTTT TTGTTTA TGTTTAT GTTTATG TTTATGC TTATGCA TATGCAA ATGCAAC TGCAACT GCAACTG CAACTGG AACTGGA ACTGGAT CTGGATT TGGATTT GGATTTA GATTTAT ATTTATT TTTATTG TTATTGG TATTGGT ATTGGTT TTGGTTA TGGTTAC GGTTACT GTTACTT TTACTTC TACTTCT ACTTCTA CTTCTAC TTCTACT TCTACTT CTACTTA TACTTAA ACTTAAT CTTAATT TTAATTA TAATTAT AATTATT ATTATTG TTATTGC TATTGCT ATTGCTG TTGCTGT TGCTGTT GCTGTTA CTGTTAT TGTTATT GTTATTG TTATTGG TATTGGT ATTGGTT TTGGTTT TGGTTTA GGTTTAG GTTTAGG TTTAGGA TTAGGAG TAGGAGC AGGAGCT GGAGCTA GAGCTAT AGCTATT GCTATTG CTATTGT TATTGTA ATTGTAT TTGTATT TGTATTC GTATTCT TATTCTT ATTCTTA TTCTTAA TCTTAAA CTTAAAC TTAAACT TAAACTC AAACTCA AACTCAC ACTCACC CTCACCA TCACCAG CACCAGA ACCAGAG CCAGAGG CAGAGGG AGAGGGT GAGGGTG AGGGTGC GGGTGCT GGTGCTC GTGCTCA TGCTCAA GCTCAAT CTCAATA TCAATAT CAATATT AATATTA ATATTAT,"ID   ACTP_YERE8              Reviewed;         551 AA.
AC   A1JIK1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   05-FEB-2025, entry version 95.
DE   RecName: Full=Cation/acetate symporter ActP {ECO:0000255|HAMAP-Rule:MF_01426};
DE   AltName: Full=Acetate permease {ECO:0000255|HAMAP-Rule:MF_01426};
DE   AltName: Full=Acetate transporter ActP {ECO:0000255|HAMAP-Rule:MF_01426};
GN   Name=actP {ECO:0000255|HAMAP-Rule:MF_01426}; OrderedLocusNames=YE0307;
OS   Yersinia enterocolitica serotype O:8 / biotype 1B (strain NCTC 13174 /
OS   8081).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Yersiniaceae; Yersinia.
OX   NCBI_TaxID=393305;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 13174 / 8081;
RX   PubMed=17173484; DOI=10.1371/journal.pgen.0020206;
RA   Thomson N.R., Howard S., Wren B.W., Holden M.T.G., Crossman L.,
RA   Challis G.L., Churcher C., Mungall K., Brooks K., Chillingworth T.,
RA   Feltwell T., Abdellah Z., Hauser H., Jagels K., Maddison M., Moule S.,
RA   Sanders M., Whitehead S., Quail M.A., Dougan G., Parkhill J.,
RA   Prentice M.B.;
RT   ""The complete genome sequence and comparative genome analysis of the high
RT   pathogenicity Yersinia enterocolitica strain 8081."";
RL   PLoS Genet. 2:2039-2051(2006).
CC   -!- FUNCTION: Transports acetate. {ECO:0000255|HAMAP-Rule:MF_01426}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01426}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01426}.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF) (TC 2.A.21)
CC       family. {ECO:0000255|HAMAP-Rule:MF_01426}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM286415; CAL10439.1; -; Genomic_DNA.
DR   RefSeq; WP_005175651.1; NC_008800.1.
DR   RefSeq; YP_001004688.1; NC_008800.1.
DR   AlphaFoldDB; A1JIK1; -.
DR   SMR; A1JIK1; -.
DR   GeneID; 31411460; -.
DR   KEGG; yen:YE0307; -.
DR   PATRIC; fig|393305.7.peg.400; -.
DR   eggNOG; COG4147; Bacteria.
DR   HOGENOM; CLU_018808_8_3_6; -.
DR   OrthoDB; 9764416at2; -.
DR   Proteomes; UP000000642; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015123; F:acetate transmembrane transporter activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0043879; F:glycolate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0006847; P:plasma membrane acetate transport; IEA:TreeGrafter.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   CDD; cd11480; SLC5sbd_u4; 1.
DR   FunFam; 1.20.1730.10:FF:000001; Cation/acetate symporter ActP; 1.
DR   Gene3D; 1.20.1730.10; Sodium/glucose cotransporter; 1.
DR   HAMAP; MF_01426; Acet_symport_ActP; 1.
DR   InterPro; IPR014083; Cation/Ac_symporter_ActP.
DR   InterPro; IPR038377; Na/Glc_symporter_sf.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   InterPro; IPR018212; Na/solute_symporter_CS.
DR   InterPro; IPR050277; Sodium:Solute_Symporter.
DR   NCBIfam; TIGR00813; sss; 1.
DR   NCBIfam; TIGR02711; symport_actP; 1.
DR   PANTHER; PTHR48086:SF6; CATION_ACETATE SYMPORTER ACTP; 1.
DR   PANTHER; PTHR48086; SODIUM/PROLINE SYMPORTER-RELATED; 1.
DR   Pfam; PF00474; SSF; 1.
DR   PROSITE; PS00456; NA_SOLUT_SYMP_1; 1.
DR   PROSITE; PS00457; NA_SOLUT_SYMP_2; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Ion transport; Membrane; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..551
FT                   /note=""Cation/acetate symporter ActP""
FT                   /id=""PRO_1000024343""
FT   TRANSMEM        34..54
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        77..97
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        104..124
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        150..170
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        184..204
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        207..227
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        263..283
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        304..324
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        356..376
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        406..426
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        430..450
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        469..489
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        498..518
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
SQ   SEQUENCE   551 AA;  59314 MW;  18C4D0FA7148EF17 CRC64;
     MKTRHWSVLS LLALPALSQA EAITGEVHRQ PLNIEAIVMF VLFVGATLYI TYWASKRTRS
     RGDYYTAGGR ITGFQNGLAI AGDFMSAASF LGISALVYTS GYDGLIYSIG FLIGWPIILF
     LIAERLRNLG RYTFADVASY RLKQRPIRTL SACGSLVVVA LYLIAQMVGA GKLIELLFGL
     NYHVAVVLVG ILMVMYVLFG GMLATTWVQI IKAVLLLAGA SFMALMVMKS VNFNFNTLFS
     EAVKVHPKGL SIMSPGGLVS DPISALSLGL ALMFGTAGLP HILMRFFTVS DAKEARKSVF
     YATGFIGYFY ILTFIIGFGA ILLVGPNPAF KDAAGALLGG NNMAAVHLAD AVGGSFFLGF
     ISAVAFATIL AVVAGLTLAG ASAVSHDLYA SVIKKGKANE RDELKVSKIT VVVLGFVAIG
     LGILFEKQNI AFMVGLAFSI AASCNFPIIF ISMYWEKLTT RGAMIGGWLG LLTAVILMIL
     GPTIWVTILG HAKPIYPYEY PALFSMIVAF VGIWFFSITD NSEEGQQERL RFKAQFVRSQ
     TGLGASQSSS H
//
",41091
CATGAG ATGAGG TGAGGA GAGGAT AGGATG GGATGG GATGGC ATGGCG TGGCGA GGCGAA GCGAAG CGAAGA GAAGAT AAGATT AGATTA GATTAT ATTATG TTATGT TATGTT ATGTTC TGTTCC GTTCCC TTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCC CCTCCA CTCCAA TCCAAA CCAAAT CAAATT AAATTT AATTTA ATTTAC TTTACC TTACCG TACCGT ACCGTA CCGTAT CGTATT GTATTC TATTCT ATTCTC TTCTCA TCTCAC CTCACA TCACAT CACATC ACATCA CATCAG ATCAGT TCAGTT CAGTTT AGTTTT GTTTTC TTTTCT TTTCTT TTCTTC TCTTCC CTTCCA TTCCAT TCCATC CCATCG CATCGC ATCGCA TCGCAG CGCAGG GCAGGT CAGGTG AGGTGC GGTGCA GTGCAG TGCAGG GCAGGT CAGGTC AGGTCC GGTCCT GTCCTG TCCTGT CCTGTC CTGTCA TGTCAC GTCACA TCACAG CACAGG ACAGGT CAGGTC AGGTCC GGTCCG GTCCGA TCCGAT CCGATC CGATCC GATCCT ATCCTT TCCTTG CCTTGC CTTGCA TTGCAT TGCATC GCATCT CATCTG ATCTGT TCTGTT CTGTTT TGTTTT GTTTTT TTTTTG TTTTGG TTTGGA TTGGAT TGGATG GGATGG GATGGG ATGGGT TGGGTT GGGTTC GGTTCC GTTCCG TTCCGG TCCGGT CCGGTA CGGTAT GGTATT GTATTG TATTGC ATTGCT TTGCTC TGCTCT GCTCTG CTCTGG TCTGGC CTGGCT TGGCTC GGCTCA GCTCAT CTCATC TCATCA CATCAT ATCATC TCATCG CATCGG ATCGGC,2,145,CATG ATGA TGAG GAGG AGGA GGAT GATG ATGG TGGC GGCG GCGA CGAA GAAG AAGA AGAT GATT ATTA TTAT TATG ATGT TGTT GTTC TTCC TCCC CCCT CCTC CTCC TCCT CCTC CTCC TCCA CCAA CAAA AAAT AATT ATTT TTTA TTAC TACC ACCG CCGT CGTA GTAT TATT ATTC TTCT TCTC CTCA TCAC CACA ACAT CATC ATCA TCAG CAGT AGTT GTTT TTTT TTTC TTCT TCTT CTTC TTCC TCCA CCAT CATC ATCG TCGC CGCA GCAG CAGG AGGT GGTG GTGC TGCA GCAG CAGG AGGT GGTC GTCC TCCT CCTG CTGT TGTC GTCA TCAC CACA ACAG CAGG AGGT GGTC GTCC TCCG CCGA CGAT GATC ATCC TCCT CCTT CTTG TTGC TGCA GCAT CATC ATCT TCTG CTGT TGTT GTTT TTTT TTTT TTTG TTGG TGGA GGAT GATG ATGG TGGG GGGT GGTT GTTC TTCC TCCG CCGG CGGT GGTA GTAT TATT ATTG TTGC TGCT GCTC CTCT TCTG CTGG TGGC GGCT GCTC CTCA TCAT CATC ATCA TCAT CATC ATCG TCGG CGGC,CATGA ATGAG TGAGG GAGGA AGGAT GGATG GATGG ATGGC TGGCG GGCGA GCGAA CGAAG GAAGA AAGAT AGATT GATTA ATTAT TTATG TATGT ATGTT TGTTC GTTCC TTCCC TCCCT CCCTC CCTCC CTCCT TCCTC CCTCC CTCCA TCCAA CCAAA CAAAT AAATT AATTT ATTTA TTTAC TTACC TACCG ACCGT CCGTA CGTAT GTATT TATTC ATTCT TTCTC TCTCA CTCAC TCACA CACAT ACATC CATCA ATCAG TCAGT CAGTT AGTTT GTTTT TTTTC TTTCT TTCTT TCTTC CTTCC TTCCA TCCAT CCATC CATCG ATCGC TCGCA CGCAG GCAGG CAGGT AGGTG GGTGC GTGCA TGCAG GCAGG CAGGT AGGTC GGTCC GTCCT TCCTG CCTGT CTGTC TGTCA GTCAC TCACA CACAG ACAGG CAGGT AGGTC GGTCC GTCCG TCCGA CCGAT CGATC GATCC ATCCT TCCTT CCTTG CTTGC TTGCA TGCAT GCATC CATCT ATCTG TCTGT CTGTT TGTTT GTTTT TTTTT TTTTG TTTGG TTGGA TGGAT GGATG GATGG ATGGG TGGGT GGGTT GGTTC GTTCC TTCCG TCCGG CCGGT CGGTA GGTAT GTATT TATTG ATTGC TTGCT TGCTC GCTCT CTCTG TCTGG CTGGC TGGCT GGCTC GCTCA CTCAT TCATC CATCA ATCAT TCATC CATCG ATCGG TCGGC,CATGAG ATGAGG TGAGGA GAGGAT AGGATG GGATGG GATGGC ATGGCG TGGCGA GGCGAA GCGAAG CGAAGA GAAGAT AAGATT AGATTA GATTAT ATTATG TTATGT TATGTT ATGTTC TGTTCC GTTCCC TTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCC CCTCCA CTCCAA TCCAAA CCAAAT CAAATT AAATTT AATTTA ATTTAC TTTACC TTACCG TACCGT ACCGTA CCGTAT CGTATT GTATTC TATTCT ATTCTC TTCTCA TCTCAC CTCACA TCACAT CACATC ACATCA CATCAG ATCAGT TCAGTT CAGTTT AGTTTT GTTTTC TTTTCT TTTCTT TTCTTC TCTTCC CTTCCA TTCCAT TCCATC CCATCG CATCGC ATCGCA TCGCAG CGCAGG GCAGGT CAGGTG AGGTGC GGTGCA GTGCAG TGCAGG GCAGGT CAGGTC AGGTCC GGTCCT GTCCTG TCCTGT CCTGTC CTGTCA TGTCAC GTCACA TCACAG CACAGG ACAGGT CAGGTC AGGTCC GGTCCG GTCCGA TCCGAT CCGATC CGATCC GATCCT ATCCTT TCCTTG CCTTGC CTTGCA TTGCAT TGCATC GCATCT CATCTG ATCTGT TCTGTT CTGTTT TGTTTT GTTTTT TTTTTG TTTTGG TTTGGA TTGGAT TGGATG GGATGG GATGGG ATGGGT TGGGTT GGGTTC GGTTCC GTTCCG TTCCGG TCCGGT CCGGTA CGGTAT GGTATT GTATTG TATTGC ATTGCT TTGCTC TGCTCT GCTCTG CTCTGG TCTGGC CTGGCT TGGCTC GGCTCA GCTCAT CTCATC TCATCA CATCAT ATCATC TCATCG CATCGG ATCGGC,CATGAGG ATGAGGA TGAGGAT GAGGATG AGGATGG GGATGGC GATGGCG ATGGCGA TGGCGAA GGCGAAG GCGAAGA CGAAGAT GAAGATT AAGATTA AGATTAT GATTATG ATTATGT TTATGTT TATGTTC ATGTTCC TGTTCCC GTTCCCT TTCCCTC TCCCTCC CCCTCCT CCTCCTC CTCCTCC TCCTCCA CCTCCAA CTCCAAA TCCAAAT CCAAATT CAAATTT AAATTTA AATTTAC ATTTACC TTTACCG TTACCGT TACCGTA ACCGTAT CCGTATT CGTATTC GTATTCT TATTCTC ATTCTCA TTCTCAC TCTCACA CTCACAT TCACATC CACATCA ACATCAG CATCAGT ATCAGTT TCAGTTT CAGTTTT AGTTTTC GTTTTCT TTTTCTT TTTCTTC TTCTTCC TCTTCCA CTTCCAT TTCCATC TCCATCG CCATCGC CATCGCA ATCGCAG TCGCAGG CGCAGGT GCAGGTG CAGGTGC AGGTGCA GGTGCAG GTGCAGG TGCAGGT GCAGGTC CAGGTCC AGGTCCT GGTCCTG GTCCTGT TCCTGTC CCTGTCA CTGTCAC TGTCACA GTCACAG TCACAGG CACAGGT ACAGGTC CAGGTCC AGGTCCG GGTCCGA GTCCGAT TCCGATC CCGATCC CGATCCT GATCCTT ATCCTTG TCCTTGC CCTTGCA CTTGCAT TTGCATC TGCATCT GCATCTG CATCTGT ATCTGTT TCTGTTT CTGTTTT TGTTTTT GTTTTTG TTTTTGG TTTTGGA TTTGGAT TTGGATG TGGATGG GGATGGG GATGGGT ATGGGTT TGGGTTC GGGTTCC GGTTCCG GTTCCGG TTCCGGT TCCGGTA CCGGTAT CGGTATT GGTATTG GTATTGC TATTGCT ATTGCTC TTGCTCT TGCTCTG GCTCTGG CTCTGGC TCTGGCT CTGGCTC TGGCTCA GGCTCAT GCTCATC CTCATCA TCATCAT CATCATC ATCATCG TCATCGG CATCGGC,"ID   CSTA_BACSU              Reviewed;         598 AA.
AC   P94532;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 2.
DT   05-FEB-2025, entry version 122.
DE   RecName: Full=Peptide transporter CstA {ECO:0000305};
DE   AltName: Full=Carbon starvation protein A homolog {ECO:0000305};
GN   Name=cstA; OrderedLocusNames=BSU28710;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=8969504; DOI=10.1099/13500872-142-11-3067;
RA   Wipat A., Carter N., Brignell C.S., Guy J.B., Piper K., Sanders J.,
RA   Emmerson P.T., Harwood C.R.;
RT   ""The dnaB-pheA (256 degrees-240 degrees) region of the Bacillus subtilis
RT   chromosome containing genes responsible for stress responses, the
RT   utilization of plant cell walls and primary metabolism."";
RL   Microbiology 142:3067-3078(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   ""The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis."";
RL   Nature 390:249-256(1997).
RN   [3]
RP   SEQUENCE REVISION TO 497.
RX   PubMed=19383706; DOI=10.1099/mic.0.027839-0;
RA   Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A.,
RA   Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.;
RT   ""From a consortium sequence to a unified sequence: the Bacillus subtilis
RT   168 reference genome a decade later."";
RL   Microbiology 155:1758-1775(2009).
CC   -!- FUNCTION: Involved in peptide utilization.
CC       {ECO:0000250|UniProtKB:P15078}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- SIMILARITY: Belongs to the peptide transporter carbon starvation (CstA)
CC       (TC 2.A.114) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z75208; CAA99596.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB14831.2; -; Genomic_DNA.
DR   PIR; A69609; A69609.
DR   RefSeq; NP_390749.2; NC_000964.3.
DR   RefSeq; WP_003229512.1; NZ_OZ025638.1.
DR   AlphaFoldDB; P94532; -.
DR   IntAct; P94532; 1.
DR   STRING; 224308.BSU28710; -.
DR   PaxDb; 224308-BSU28710; -.
DR   EnsemblBacteria; CAB14831; CAB14831; BSU_28710.
DR   GeneID; 937970; -.
DR   KEGG; bsu:BSU28710; -.
DR   PATRIC; fig|224308.179.peg.3119; -.
DR   eggNOG; COG1966; Bacteria.
DR   InParanoid; P94532; -.
DR   OrthoDB; 9761224at2; -.
DR   PhylomeDB; P94532; -.
DR   BioCyc; BSUB:BSU28710-MONOMER; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031669; P:cellular response to nutrient levels; IBA:GO_Central.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:InterPro.
DR   GO; GO:0015833; P:peptide transport; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR051605; CstA.
DR   InterPro; IPR003706; CstA_N.
DR   PANTHER; PTHR30252; INNER MEMBRANE PEPTIDE TRANSPORTER; 1.
DR   PANTHER; PTHR30252:SF3; PYRUVATE_PROTON SYMPORTER BTST; 1.
DR   Pfam; PF02554; CstA; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Membrane; Peptide transport; Protein transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..598
FT                   /note=""Peptide transporter CstA""
FT                   /id=""PRO_0000190045""
FT   TRANSMEM        6..26
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        62..82
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        86..106
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        132..152
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        159..179
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        191..211
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        222..242
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        254..274
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        291..311
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        328..348
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        391..411
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        414..434
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        461..481
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        488..508
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        521..541
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        557..577
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   CONFLICT        497
FT                   /note=""Q -> R (in Ref. 1; CAA99596)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   598 AA;  64333 MW;  A81C1180802433F4 CRC64;
     MNAVTIVIAS MCILAIAYRL YGTFMMVKVL KVNDDKPTPA HALEDGKDYV PTNKWVSFGH
     HFAAIAAAGP LVGPILAAQF GYLPGLLWLL IGAVIGGAVH DIVVLFASMR KNGKSLSEVA
     KDELGPVAGF CTGLSMLFII TITMAGLSMV VLHALERNPW GTFAVGITIP IAMGVGLFYK
     KTGNLKLAST VGFLFLMAGV FIGPWVQTTA LGDFLTLDTK TLAIALPVYA FFAAALPVWL
     LLAPRDYLSS FMKIGVFIAL IVGVFVVNPS IPFPAFTEFV KGGGPVLAGP VWPFISITIA
     CGAISGFHAF VGSGTTPKML NKWSDMKPVA FGAMLVECLV GIMALIAATA LQPADYFAIN
     STPEVFRTLG MNVVHLPELS GEIGLDLEGR TGGAVTLAVG MTYIFTGMPF FSHLASYFFQ
     FVIMFEAVFI LTAIDAGTRV ARYLIQDFFG EVYKPLKKTD WIPGSVFASA LACLMWGYLL
     YSGDIGSIWA LFGVSNQLMA SVGLIIGATI VLKIADKRRY ILTCLIPLAY LYVTVNYAGY
     WMVRNVYLNP EAAGYSVLNG VLSIIMLVLG FIIIVAAVKK WAQMWKDPSL RMEASIPG
//
",39328
GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGA GGGGAC GGGACT GGACTA GACTAT ACTATG CTATGG TATGGT ATGGTG TGGTGA GGTGAT GTGATG TGATGC GATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGT GTTGTT TTGTTT TGTTTA GTTTAC TTTACC TTACCG TACCGA ACCGAG CCGAGG CGAGGT GAGGTA AGGTAC GGTACA GTACAA TACAAC ACAACA CAACAA AACAAC ACAACT CAACTT AACTTA ACTTAC CTTACA TTACAA TACAAA ACAAAT CAAATT AAATTA AATTAA ATTAAA TTAAAT TAAATG AAATGT AATGTT ATGTTG TGTTGG GTTGGT TTGGTG TGGTGA GGTGAT GTGATT TGATTA GATTAT ATTATT TTATTT TATTTT ATTTTG TTTTGT TTTGTG TTGTGC TGTGCT GTGCTG TGCTGA GCTGAC CTGACA TGACAT GACATC ACATCA CATCAC ATCACA TCACAT,0,145,GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGG GGGA GGAC GACT ACTA CTAT TATG ATGG TGGT GGTG GTGA TGAT GATG ATGC TGCT GCTG CTGT TGTT GTTG TTGT TGTT GTTT TTTA TTAC TACC ACCG CCGA CGAG GAGG AGGT GGTA GTAC TACA ACAA CAAC AACA ACAA CAAC AACT ACTT CTTA TTAC TACA ACAA CAAA AAAT AATT ATTA TTAA TAAA AAAT AATG ATGT TGTT GTTG TTGG TGGT GGTG GTGA TGAT GATT ATTA TTAT TATT ATTT TTTT TTTG TTGT TGTG GTGC TGCT GCTG CTGA TGAC GACA ACAT CATC ATCA TCAC CACA ACAT,GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGG GGGGA GGGAC GGACT GACTA ACTAT CTATG TATGG ATGGT TGGTG GGTGA GTGAT TGATG GATGC ATGCT TGCTG GCTGT CTGTT TGTTG GTTGT TTGTT TGTTT GTTTA TTTAC TTACC TACCG ACCGA CCGAG CGAGG GAGGT AGGTA GGTAC GTACA TACAA ACAAC CAACA AACAA ACAAC CAACT AACTT ACTTA CTTAC TTACA TACAA ACAAA CAAAT AAATT AATTA ATTAA TTAAA TAAAT AAATG AATGT ATGTT TGTTG GTTGG TTGGT TGGTG GGTGA GTGAT TGATT GATTA ATTAT TTATT TATTT ATTTT TTTTG TTTGT TTGTG TGTGC GTGCT TGCTG GCTGA CTGAC TGACA GACAT ACATC CATCA ATCAC TCACA CACAT,GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGG GGGGGA GGGGAC GGGACT GGACTA GACTAT ACTATG CTATGG TATGGT ATGGTG TGGTGA GGTGAT GTGATG TGATGC GATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGT GTTGTT TTGTTT TGTTTA GTTTAC TTTACC TTACCG TACCGA ACCGAG CCGAGG CGAGGT GAGGTA AGGTAC GGTACA GTACAA TACAAC ACAACA CAACAA AACAAC ACAACT CAACTT AACTTA ACTTAC CTTACA TTACAA TACAAA ACAAAT CAAATT AAATTA AATTAA ATTAAA TTAAAT TAAATG AAATGT AATGTT ATGTTG TGTTGG GTTGGT TTGGTG TGGTGA GGTGAT GTGATT TGATTA GATTAT ATTATT TTATTT TATTTT ATTTTG TTTTGT TTTGTG TTGTGC TGTGCT GTGCTG TGCTGA GCTGAC CTGACA TGACAT GACATC ACATCA CATCAC ATCACA TCACAT,GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGG GGGGGGA GGGGGAC GGGGACT GGGACTA GGACTAT GACTATG ACTATGG CTATGGT TATGGTG ATGGTGA TGGTGAT GGTGATG GTGATGC TGATGCT GATGCTG ATGCTGT TGCTGTT GCTGTTG CTGTTGT TGTTGTT GTTGTTT TTGTTTA TGTTTAC GTTTACC TTTACCG TTACCGA TACCGAG ACCGAGG CCGAGGT CGAGGTA GAGGTAC AGGTACA GGTACAA GTACAAC TACAACA ACAACAA CAACAAC AACAACT ACAACTT CAACTTA AACTTAC ACTTACA CTTACAA TTACAAA TACAAAT ACAAATT CAAATTA AAATTAA AATTAAA ATTAAAT TTAAATG TAAATGT AAATGTT AATGTTG ATGTTGG TGTTGGT GTTGGTG TTGGTGA TGGTGAT GGTGATT GTGATTA TGATTAT GATTATT ATTATTT TTATTTT TATTTTG ATTTTGT TTTTGTG TTTGTGC TTGTGCT TGTGCTG GTGCTGA TGCTGAC GCTGACA CTGACAT TGACATC GACATCA ACATCAC CATCACA ATCACAT,"ID   R1AB_BCHK3              Reviewed;        7067 AA.
AC   P0C6W2; Q3LZX2;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   05-FEB-2025, entry version 109.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE              Short=nsp1;
DE     AltName: Full=Leader protein;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like proteinase nsp3;
DE              Short=PL-PRO;
DE              EC=3.4.19.12;
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.-;
DE     AltName: Full=nsp5;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9;
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE     AltName: Full=p12;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50;
DE     AltName: Full=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              Short=ExoN;
DE              EC=2.1.1.56;
DE              EC=3.1.13.-;
DE     AltName: Full=nsp14;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.-;
DE     AltName: Full=NendoU;
DE     AltName: Full=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Bat coronavirus HKU3 (BtCoV) (SARS-like coronavirus HKU3).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=442736;
OH   NCBI_TaxID=89399; Rhinolophus sinicus (Chinese rufous horseshoe bat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate HKU3-1;
RX   PubMed=16169905; DOI=10.1073/pnas.0506735102;
RA   Lau S.K.P., Woo P.C.Y., Li K.S.M., Huang Y., Tsoi H.-W., Wong B.H.L.,
RA   Wong S.S.Y., Leung S.-Y., Chan K.-H., Yuen K.-Y.;
RT   ""Severe acute respiratory syndrome coronavirus-like virus in Chinese
RT   horseshoe bats."";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14040-14045(2005).
CC   -!- FUNCTION: The replicase polyprotein of coronaviruses is a
CC       multifunctional protein: it contains the activities necessary for the
CC       transcription of negative stranded RNA, leader RNA, subgenomic mRNAs
CC       and progeny virion RNA as well as proteinases responsible for the
CC       cleavage of the polyprotein into functional products.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome
CC       complex further induces an endonucleolytic cleavage near the 5'UTR of
CC       host mRNAs, targeting them for degradation. Viral mRNAs are not
CC       susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the
CC       presence of a 5'-end leader sequence and are therefore protected from
CC       degradation. By suppressing host gene expression, nsp1 facilitates
CC       efficient viral gene expression in infected cells and evasion from host
CC       immune response. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 2]: May play a role in the modulation
CC       of host cell survival signaling pathway by interacting with host PHB
CC       and PHB2. Indeed, these two proteins play a role in maintaining the
CC       functional integrity of the mitochondria and protecting cells from
CC       various stresses. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Papain-like proteinase nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. In addition,
CC       PL-PRO possesses a deubiquitinating/deISGylating activity and processes
CC       both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates. Participates together with nsp4 in the assembly of virally-
CC       induced cytoplasmic double-membrane vesicles necessary for viral
CC       replication. Antagonizes innate immune induction of type I interferon
CC       by blocking the phosphorylation, dimerization and subsequent nuclear
CC       translocation of host IRF3. Prevents also host NF-kappa-B signaling.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 4]: Participates in the assembly of
CC       virally-induced cytoplasmic double-membrane vesicles necessary for
CC       viral replication. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [3C-like proteinase nsp5]: Cleaves the C-terminus of
CC       replicase polyprotein at 11 sites. Recognizes substrates containing the
CC       core sequence [ILMVF]-Q-|-[SGACN]. Also able to bind an ADP-ribose-1''-
CC       phosphate (ADRP). {ECO:0000250|UniProtKB:P0C6X7, ECO:0000255|PROSITE-
CC       ProRule:PRU00772}.
CC   -!- FUNCTION: [Non-structural protein 6]: Plays a role in the initial
CC       induction of autophagosomes from host endoplasmic reticulum. Later,
CC       limits the expansion of these phagosomes that are no longer able to
CC       deliver viral components to lysosomes. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 7]: Forms a hexadecamer with nsp8 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 8]: Forms a hexadecamer with nsp7 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Viral protein genome-linked nsp9]: Forms a primer, NSP9-pU,
CC       which is utilized by the polymerase for the initiation of RNA chains.
CC       Interacts with ribosome signal recognition particle RNA (SRP). Together
CC       with NSP8, suppress protein integration into the cell membrane, thereby
CC       disrupting host immune defenses. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16
CC       2'-O-methyltransferase activities. Therefore plays an essential role in
CC       viral mRNAs cap methylation. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [RNA-directed RNA polymerase nsp12]: RNA-directed RNA
CC       polymerase that catalyzes the transcription of viral genomic and
CC       subgenomic RNAs. Acts in complex with nsp7 and nsp8 to transcribe both
CC       the minus and positive strands of genomic RNA. The kinase-like NiRAN
CC       domain of NSP12 attaches one or more nucleotides to the amino terminus
CC       of NSP9, forming a covalent RNA-protein intermediate that serves as
CC       transcription/replication primer. Subgenomic RNAs (sgRNAs) are formed
CC       by discontinuous transcription: The polymerase has the ability to pause
CC       at transcription-regulating sequences (TRS) and jump to the leader TRS,
CC       resulting in a major deletion. This creates a series of subgenomic RNAs
CC       that are replicated, transcribed and translated. In addition, Nsp12 is
CC       a subunit of the viral RNA capping enzyme that catalyzes the RNA
CC       guanylyltransferase reaction for genomic and sub-genomic RNAs.
CC       Subsequently, the NiRAN domain transfers RNA to GDP, and forms the core
CC       cap structure GpppA-RNA. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Helicase nsp13]: Multi-functional protein with a zinc-
CC       binding domain in N-terminus displaying RNA and DNA duplex-unwinding
CC       activities with 5' to 3' polarity. Activity of helicase is dependent on
CC       magnesium. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Guanine-N7 methyltransferase nsp14]: Plays a role in viral
CC       RNA synthesis through two distinct activities. The N7-guanine
CC       methyltransferase activity plays a role in the formation of the cap
CC       structure GpppA-RNA. The proofreading exoribonuclease reduces the
CC       sensitivity of the virus to RNA mutagens during replication. This
CC       activity acts on both ssRNA and dsRNA in a 3'-5' direction.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Uridylate-specific endoribonuclease nsp15]: Plays a role in
CC       viral transcription/replication and prevents the simultaneous
CC       activation of host cell dsRNA sensors, such as MDA5/IFIH1, OAS, and PKR
CC       (By similarity). Acts by degrading the 5'-polyuridines generated during
CC       replication of the poly(A) region of viral genomic and subgenomic RNAs.
CC       Catalyzes a two-step reaction in which a 2'3'-cyclic phosphate (2'3'-
CC       cP) is first generated by 2'-O transesterification, which is then
CC       hydrolyzed to a 3'-phosphate (3'-P) (By similarity). If not degraded,
CC       poly(U) RNA would hybridize with poly(A) RNA tails and activate host
CC       dsRNA sensors (By similarity). {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [2'-O-methyltransferase nsp16]: Methyltransferase that
CC       mediates mRNA cap 2'-O-ribose methylation to the 5'-cap structure of
CC       viral mRNAs. N7-methyl guanosine cap is a prerequisite for binding of
CC       nsp16. Therefore plays an essential role in viral mRNAs cap methylation
CC       which is essential to evade immune system.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) +
CC         diphosphate; Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC         COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- CATALYTIC ACTIVITY: [Papain-like proteinase nsp3]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12;
CC   -!- CATALYTIC ACTIVITY: [2'-O-methyltransferase nsp16]:
CC       Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside
CC         in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA + S-
CC         adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:67020, Rhea:RHEA-
CC         COMP:17167, Rhea:RHEA-COMP:17168, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167609; EC=2.1.1.57;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [Uridylate-specific endoribonuclease nsp15]:
CC       Reaction=uridylyl-uridylyl-ribonucleotide-RNA = a 3'-end uridylyl-
CC         2',3'-cyclophospho-uridine-RNA + a 5'-end dephospho-ribonucleoside-
CC         RNA; Xref=Rhea:RHEA:67732, Rhea:RHEA-COMP:13936, Rhea:RHEA-
CC         COMP:17334, Rhea:RHEA-COMP:17335, ChEBI:CHEBI:138284,
CC         ChEBI:CHEBI:173079, ChEBI:CHEBI:173080;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67013;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- CATALYTIC ACTIVITY: [Guanine-N7 methyltransferase nsp14]:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + S-
CC         adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67009;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [Uridylate-specific endoribonuclease nsp15]:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       Note=Likely affects Nsp15 binding to RNA.
CC       {ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [RNA-directed RNA polymerase nsp12]:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- SUBUNIT: [Non-structural protein 2]: Interacts with host PHB and PHB2.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 4]: Interacts with papain-like
CC       protease nsp3 and non-structural protein 6.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [3C-like proteinase nsp5]: Monomer. Homodimer. Only the
CC       homodimer shows catalytic activity. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 7]: Interacts with nsp8 and nsp12 to
CC       form the replication-transcription complex (RTC): nsp12, nsp7, two
CC       subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 8]: Interacts with nsp7, nsp13 and
CC       nsp12 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Viral protein genome-linked nsp9]: Interacts with nsp12.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 10]: Interacts with proofreading
CC       exoribonuclease nsp14 and 2'-O-methyltransferase nsp16; these
CC       interactions enhance nsp14 and nsp16 enzymatic activities.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [RNA-directed RNA polymerase nsp12]: Interacts with nsp7 and
CC       nsp8 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13. Interacts with
CC       nsp9. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Helicase nsp13]: Interacts with nsp8 to form the replication-
CC       transcription complex (RTC): nsp12, nsp7, two subunits of nsp8, and up
CC       to two subunits of nsp13. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBCELLULAR LOCATION: [Papain-like proteinase nsp3]: Host membrane;
CC       Multi-pass membrane protein. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 4]: Host membrane; Multi-
CC       pass membrane protein. Host cytoplasm. Note=Localizes in virally-
CC       induced cytoplasmic double-membrane vesicles.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 6]: Host membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 7]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 8]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Viral protein genome-linked nsp9]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9
CC       and nsp10 are localized in cytoplasmic foci, largely perinuclear. Late
CC       in infection, they merge into confluent complexes (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 10]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Helicase nsp13]: Host endoplasmic reticulum-
CC       Golgi intermediate compartment {ECO:0000305}. Note=The helicase
CC       interacts with the N protein in membranous complexes and colocalizes
CC       with sites of synthesis of new viral RNA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Uridylate-specific endoribonuclease nsp15]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC       Name=Replicase polyprotein 1ab; Synonyms=pp1ab;
CC         IsoId=P0C6W2-1; Sequence=Displayed;
CC       Name=Replicase polyprotein 1a; Synonyms=pp1a, ORF1a polyprotein;
CC         IsoId=P0C6F8-1; Sequence=External;
CC   -!- DOMAIN: The hydrophobic domains (HD) could mediate the membrane
CC       association of the replication complex and thereby alter the
CC       architecture of the host cell membrane. {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages in vivo by its own proteases yield
CC       mature proteins. 3CL-PRO and PL-PRO proteinases are autocatalytically
CC       processed (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Bat coronavirus HKU3 is highly similar to SARS-CoV
CC       (SARS-like).
CC   -!- MISCELLANEOUS: [Isoform Replicase polyprotein 1ab]: Produced by -1
CC       ribosomal frameshifting at the 1a-1b genes boundary.
CC   -!- SIMILARITY: Belongs to the coronaviruses polyprotein 1ab family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ022305; AAY88865.2; -; Genomic_RNA.
DR   BMRB; P0C6W2; -.
DR   SMR; P0C6W2; -.
DR   MEROPS; C16.009; -.
DR   MEROPS; C30.005; -.
DR   Proteomes; UP000007450; Segment.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000175; F:3'-5'-RNA exonuclease activity; IEA:InterPro.
DR   GO; GO:0043139; F:5'-3' DNA helicase activity; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0036121; F:double-stranded DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0061749; F:forked DNA-dependent helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009378; F:four-way junction helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0002151; F:G-quadruplex RNA binding; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0004482; F:mRNA 5'-cap (guanine-N7-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0008242; F:omega peptidase activity; IEA:InterPro.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:1990518; F:single-stranded 3'-5' DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0039595; P:symbiont-mediated degradation of host mRNA; IEA:UniProtKB-KW.
DR   GO; GO:0039648; P:symbiont-mediated perturbation of host ubiquitin-like protein modification; IEA:UniProtKB-KW.
DR   GO; GO:0039657; P:symbiont-mediated suppression of host gene expression; IEA:UniProtKB-KW.
DR   GO; GO:0039579; P:symbiont-mediated suppression of host ISG15-protein conjugation; IEA:UniProtKB-KW.
DR   GO; GO:0085034; P:symbiont-mediated suppression of host NF-kappaB cascade; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0019082; P:viral protein processing; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   GO; GO:0075523; P:viral translational frameshifting; IEA:UniProtKB-KW.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21409; 1B_cv_Nsp13-like; 1.
DR   CDD; cd21560; betaCoV-Nsp6; 1.
DR   CDD; cd21722; betaCoV_Nsp13-helicase; 1.
DR   CDD; cd21659; betaCoV_Nsp14; 1.
DR   CDD; cd21516; betaCoV_Nsp2_SARS-like; 1.
DR   CDD; cd21666; betaCoV_Nsp5_Mpro; 1.
DR   CDD; cd21827; betaCoV_Nsp7; 1.
DR   CDD; cd21831; betaCoV_Nsp8; 1.
DR   CDD; cd21898; betaCoV_Nsp9; 1.
DR   CDD; cd21732; betaCoV_PLPro; 1.
DR   CDD; cd20762; capping_2-OMTase_Nidovirales; 1.
DR   CDD; cd21872; CoV_Nsp10; 1.
DR   CDD; cd21473; cv_Nsp4_TM; 1.
DR   CDD; cd21167; M_alpha_beta_cv_Nsp15-like; 1.
DR   CDD; cd21563; Macro_cv_SUD-M_Nsp3-like; 1.
DR   CDD; cd21562; Macro_cv_SUD-N_Nsp3-like; 1.
DR   CDD; cd21557; Macro_X_Nsp3-like; 1.
DR   CDD; cd21161; NendoU_cv_Nsp15-like; 1.
DR   CDD; cd21171; NTD_alpha_betaCoV_Nsp15-like; 1.
DR   CDD; cd22662; SARS-CoV-like_Nsp1_C; 1.
DR   CDD; cd21796; SARS-CoV-like_Nsp1_N; 1.
DR   CDD; cd21814; SARS-CoV-like_Nsp3_betaSM; 1.
DR   CDD; cd21822; SARS-CoV-like_Nsp3_NAB; 1.
DR   CDD; cd21591; SARS-CoV-like_RdRp; 1.
DR   CDD; cd21689; stalk_CoV_Nsp13-like; 1.
DR   CDD; cd21525; SUD_C_SARS-CoV_Nsp3; 1.
DR   CDD; cd21717; TM_Y_SARS-CoV-like_Nsp3_C; 1.
DR   CDD; cd21467; Ubl1_cv_Nsp3_N-like; 1.
DR   CDD; cd21401; ZBD_cv_Nsp13-like; 1.
DR   FunFam; 1.10.8.370:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 2.40.10.250:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.40.220.30:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.30.160.820:FF:000001; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.150:FF:000162; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001105; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001139; Orf1ab polyprotein; 1.
DR   FunFam; 1.10.150.420:FF:000001; Replicase polyprotein; 1.
DR   FunFam; 1.10.1840.10:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 1.10.8.1190:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 2.40.10.10:FF:000033; Replicase polyprotein 1a; 1.
DR   FunFam; 3.40.50.11580:FF:000001; Replicase polyprotein 1ab; 1.
DR   Gene3D; 1.10.8.1190; -; 1.
DR   Gene3D; 2.60.120.1680; -; 1.
DR   Gene3D; 3.10.20.350; -; 1.
DR   Gene3D; 3.10.20.540; -; 1.
DR   Gene3D; 3.40.50.11580; -; 1.
DR   Gene3D; 6.10.140.2090; -; 1.
DR   Gene3D; 1.10.150.420; Coronavirus nonstructural protein 4 C-terminus; 1.
DR   Gene3D; 3.40.30.150; Coronavirus polyprotein cleavage domain; 1.
DR   Gene3D; 3.40.220.10; Leucine Aminopeptidase, subunit E, domain 1; 1.
DR   Gene3D; 1.10.1840.10; main proteinase (3clpro) structure, domain 3; 1.
DR   Gene3D; 3.30.160.820; Nsp15 N-terminal domain-like; 1.
DR   Gene3D; 3.40.220.20; Nsp3, SUD-M subdomain; 1.
DR   Gene3D; 3.40.220.30; Nsp3, SUD-N subdomain; 1.
DR   Gene3D; 1.10.8.370; nsp7 replicase; 1.
DR   Gene3D; 3.30.70.3540; Nsp8 replicase, head domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   Gene3D; 2.40.10.250; Replicase NSP9; 1.
DR   Gene3D; 3.40.50.11020; Replicase polyprotein, nucleic acid-binding domain; 1.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR027351; (+)RNA_virus_helicase_core_dom.
DR   InterPro; IPR046443; a/bCoV_NSP1_glob.
DR   InterPro; IPR046440; AV_NSP11N_COV_NSP15M.
DR   InterPro; IPR046442; bCoV_NSP1_C.
DR   InterPro; IPR050534; Coronavir_polyprotein_1ab.
DR   InterPro; IPR043608; CoV_NSP15_M.
DR   InterPro; IPR043606; CoV_NSP15_N.
DR   InterPro; IPR043613; CoV_NSP2_C.
DR   InterPro; IPR047573; CoV_NSP2_M.
DR   InterPro; IPR049894; COV_NSP3_3ECTO.
DR   InterPro; IPR043611; CoV_NSP3_C.
DR   InterPro; IPR047566; CoV_NSP3_Y.
DR   InterPro; IPR032505; CoV_NSP4_C.
DR   InterPro; IPR043612; CoV_NSP4_N.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR041679; DNA2/NAM7-like_C.
DR   InterPro; IPR022733; DPUP_SUD_C_bCoV.
DR   InterPro; IPR037227; EndoU-like.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR044371; Macro_X_NSP3-like.
DR   InterPro; IPR046435; N7_MTase_CoV.
DR   InterPro; IPR043609; NendoU_nidovirus.
DR   InterPro; IPR044863; NIRAN.
DR   InterPro; IPR046438; NIV_2_O_MTASE.
DR   InterPro; IPR046436; NIV_EXON.
DR   InterPro; IPR036333; NSP10_sf_CoV.
DR   InterPro; IPR047570; NSP12_IF_CoV.
DR   InterPro; IPR044343; NSP13_1B_dom_CoV.
DR   InterPro; IPR048673; NSP13_stalk_CoV.
DR   InterPro; IPR048672; NSP13_ZBD_CoV.
DR   InterPro; IPR027352; NSP13_ZBD_CoV-like.
DR   InterPro; IPR044315; NSP14_betaCoV.
DR   InterPro; IPR009466; NSP14_CoV.
DR   InterPro; IPR044330; NSP15_alpha_betaCoV_N.
DR   InterPro; IPR044322; NSP15_M_alpha_beta_CoV.
DR   InterPro; IPR043174; NSP15_middle_sf.
DR   InterPro; IPR042515; NSP15_N_CoV.
DR   InterPro; IPR044401; NSP15_NendoU_CoV.
DR   InterPro; IPR009461; NSP16_CoV-like.
DR   InterPro; IPR021590; NSP1_glob_bCoV.
DR   InterPro; IPR038030; NSP1_glob_sf_bCoV.
DR   InterPro; IPR043615; NSP2_N_CoV.
DR   InterPro; IPR044389; NSP2_SARS-CoV-like.
DR   InterPro; IPR024375; NSP3_bCoV.
DR   InterPro; IPR047567; NSP3_G2M_bCoV.
DR   InterPro; IPR024358; NSP3_N_bCoV.
DR   InterPro; IPR032592; NSP3_NAB_bCoV.
DR   InterPro; IPR042570; NSP3_NAB_bCoV_sf.
DR   InterPro; IPR038166; NSP3_PL2pro_sf_bCoV.
DR   InterPro; IPR038400; NSP3_SUD-M_sf_bCoV.
DR   InterPro; IPR044864; NSP3_SUD-N_bCoV.
DR   InterPro; IPR044374; NSP3_SUD-N_SARS-CoV.
DR   InterPro; IPR043478; NSP3_SUD-N_sf_bCoV.
DR   InterPro; IPR044357; NSP3_Ubl1_dom_CoV.
DR   InterPro; IPR044353; Nsp3_Ubl2_dom_CoV.
DR   InterPro; IPR038083; NSP3A-like.
DR   InterPro; IPR038123; NSP4_C_sf_CoV.
DR   InterPro; IPR044367; NSP6_betaCoV.
DR   InterPro; IPR043610; NSP6_CoV.
DR   InterPro; IPR014828; NSP7_CoV.
DR   InterPro; IPR037204; NSP7_sf_CoV.
DR   InterPro; IPR014829; NSP8_CoV.
DR   InterPro; IPR037230; NSP8_sf_CoV.
DR   InterPro; IPR014822; NSP9_CoV.
DR   InterPro; IPR036499; NSP9_sf_CoV.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR013016; Peptidase_C16_CoV.
DR   InterPro; IPR008740; Peptidase_C30_CoV.
DR   InterPro; IPR043477; Peptidase_C30_dom3_CoV.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR043177; PLpro_N_sf_CoV.
DR   InterPro; IPR043503; PLpro_palm_finger_dom_CoV.
DR   InterPro; IPR043178; PLpro_thumb_sf_CoV.
DR   InterPro; IPR046441; RdRp_CoV.
DR   InterPro; IPR009469; RdRp_N_CoV.
DR   InterPro; IPR044351; RdRp_SARS-CoV-like.
DR   InterPro; IPR001205; RNA-dir_pol_C.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR018995; RNA_synth_NSP10_CoV.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR43788; DNA2/NAM7 HELICASE FAMILY MEMBER; 1.
DR   PANTHER; PTHR43788:SF16; HELICASE WITH ZINC FINGER 2; 1.
DR   Pfam; PF13087; AAA_12; 1.
DR   Pfam; PF16251; bCoV_NAB; 1.
DR   Pfam; PF11501; bCoV_NSP1; 1.
DR   Pfam; PF12379; bCoV_NSP3_N; 1.
DR   Pfam; PF12124; bCoV_SUD_C; 1.
DR   Pfam; PF11633; bCoV_SUD_M; 1.
DR   Pfam; PF06471; CoV_ExoN; 1.
DR   Pfam; PF06460; CoV_Methyltr_2; 1.
DR   Pfam; PF09401; CoV_NSP10; 1.
DR   Pfam; PF20631; CoV_NSP13_1B; 1.
DR   Pfam; PF20633; CoV_NSP13_stalk; 1.
DR   Pfam; PF20632; CoV_NSP13_ZBD; 1.
DR   Pfam; PF19215; CoV_NSP15_C; 1.
DR   Pfam; PF19216; CoV_NSP15_M; 1.
DR   Pfam; PF19219; CoV_NSP15_N; 1.
DR   Pfam; PF19212; CoV_NSP2_C; 1.
DR   Pfam; PF19211; CoV_NSP2_N; 1.
DR   Pfam; PF19218; CoV_NSP3_C; 1.
DR   Pfam; PF16348; CoV_NSP4_C; 1.
DR   Pfam; PF19217; CoV_NSP4_N; 1.
DR   Pfam; PF19213; CoV_NSP6; 1.
DR   Pfam; PF08716; CoV_NSP7; 1.
DR   Pfam; PF08717; CoV_NSP8; 1.
DR   Pfam; PF08710; CoV_NSP9; 1.
DR   Pfam; PF08715; CoV_peptidase; 1.
DR   Pfam; PF06478; CoV_RPol_N; 1.
DR   Pfam; PF01661; Macro; 1.
DR   Pfam; PF05409; Peptidase_C30; 1.
DR   Pfam; PF00680; RdRP_1; 1.
DR   SMART; SM00506; A1pp; 1.
DR   SUPFAM; SSF144246; Coronavirus NSP10-like; 1.
DR   SUPFAM; SSF140367; Coronavirus NSP7-like; 1.
DR   SUPFAM; SSF143076; Coronavirus NSP8-like; 1.
DR   SUPFAM; SSF56672; DNA/RNA polymerases; 1.
DR   SUPFAM; SSF142877; EndoU-like; 1.
DR   SUPFAM; SSF52949; Macro domain-like; 1.
DR   SUPFAM; SSF159936; NSP3A-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF101816; Replicase NSP9; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   SUPFAM; SSF160099; SARS Nsp1-like; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS51961; AV_NSP11N_COV_NSP15M; 1.
DR   PROSITE; PS51963; BCOV_NSP1_C; 1.
DR   PROSITE; PS51942; BCOV_NSP3C_C; 1.
DR   PROSITE; PS51941; BCOV_NSP3C_M; 1.
DR   PROSITE; PS51994; BCOV_NSP3E_G2M; 1.
DR   PROSITE; PS51945; BCOV_NSP3E_NAB; 1.
DR   PROSITE; PS51993; COV_3ECTO; 1.
DR   PROSITE; PS51952; COV_EXON_MTASE_COACT; 1.
DR   PROSITE; PS51954; COV_N7_MTASE; 1.
DR   PROSITE; PS51962; COV_NSP1; 1.
DR   PROSITE; PS52000; COV_NSP12_IF; 1.
DR   PROSITE; PS51948; COV_NSP12_RDRP; 1.
DR   PROSITE; PS51960; COV_NSP15_NTD; 1.
DR   PROSITE; PS51991; COV_NSP2_C; 1.
DR   PROSITE; PS51990; COV_NSP2_M; 1.
DR   PROSITE; PS51989; COV_NSP2_N; 1.
DR   P",34257
ACCGTG CCGTGG CGTGGC GTGGCG TGGCGG GGCGGG GCGGGG CGGGGG GGGGGC GGGGCA GGGCAT GGCATC GCATCG CATCGC ATCGCC TCGCCA CGCCAG GCCAGA CCAGAA CAGAAG AGAAGA GAAGAC AAGACA AGACAA GACAAG ACAAGC CAAGCT AAGCTC AGCTCA GCTCAG CTCAGG TCAGGG CAGGGA AGGGAG GGGAGT GGAGTT GAGTTG AGTTGG GTTGGT TTGGTG TGGTGG GGTGGC GTGGCG TGGCGC GGCGCT GCGCTA CGCTAC GCTACA CTACAG TACAGG ACAGGC CAGGCC AGGCCC GGCCCG GCCCGT CCCGTG CCGTGG CGTGGG GTGGGC TGGGCA GGGCAC GGCACC GCACCG CACCGA ACCGAG CCGAGT CGAGTG GAGTGG AGTGGC GTGGCC TGGCCA GGCCAT GCCATG CCATGG CATGGT ATGGTG TGGTGG GGTGGG GTGGGC TGGGCG GGGCGA GGCGAC GCGACG CGACGG GACGGG ACGGGT CGGGTT GGGTTG GGTTGA GTTGAA TTGAAC TGAACG GAACGA AACGAT ACGATG CGATGG GATGGC ATGGCC TGGCCC GGCCCC GCCCCG CCCCGT CCCGTT CCGTTT CGTTTT GTTTTG TTTTGG TTTGGC TTGGCG TGGCGC GGCGCG GCGCGC CGCGCG GCGCGC CGCGCC GCGCCC CGCCCA GCCCAT CCCATA CCATAC CATACC,2,121,ACCG CCGT CGTG GTGG TGGC GGCG GCGG CGGG GGGG GGGG GGGC GGCA GCAT CATC ATCG TCGC CGCC GCCA CCAG CAGA AGAA GAAG AAGA AGAC GACA ACAA CAAG AAGC AGCT GCTC CTCA TCAG CAGG AGGG GGGA GGAG GAGT AGTT GTTG TTGG TGGT GGTG GTGG TGGC GGCG GCGC CGCT GCTA CTAC TACA ACAG CAGG AGGC GGCC GCCC CCCG CCGT CGTG GTGG TGGG GGGC GGCA GCAC CACC ACCG CCGA CGAG GAGT AGTG GTGG TGGC GGCC GCCA CCAT CATG ATGG TGGT GGTG GTGG TGGG GGGC GGCG GCGA CGAC GACG ACGG CGGG GGGT GGTT GTTG TTGA TGAA GAAC AACG ACGA CGAT GATG ATGG TGGC GGCC GCCC CCCC CCCG CCGT CGTT GTTT TTTT TTTG TTGG TGGC GGCG GCGC CGCG GCGC CGCG GCGC CGCC GCCC CCCA CCAT CATA ATAC TACC,ACCGT CCGTG CGTGG GTGGC TGGCG GGCGG GCGGG CGGGG GGGGG GGGGC GGGCA GGCAT GCATC CATCG ATCGC TCGCC CGCCA GCCAG CCAGA CAGAA AGAAG GAAGA AAGAC AGACA GACAA ACAAG CAAGC AAGCT AGCTC GCTCA CTCAG TCAGG CAGGG AGGGA GGGAG GGAGT GAGTT AGTTG GTTGG TTGGT TGGTG GGTGG GTGGC TGGCG GGCGC GCGCT CGCTA GCTAC CTACA TACAG ACAGG CAGGC AGGCC GGCCC GCCCG CCCGT CCGTG CGTGG GTGGG TGGGC GGGCA GGCAC GCACC CACCG ACCGA CCGAG CGAGT GAGTG AGTGG GTGGC TGGCC GGCCA GCCAT CCATG CATGG ATGGT TGGTG GGTGG GTGGG TGGGC GGGCG GGCGA GCGAC CGACG GACGG ACGGG CGGGT GGGTT GGTTG GTTGA TTGAA TGAAC GAACG AACGA ACGAT CGATG GATGG ATGGC TGGCC GGCCC GCCCC CCCCG CCCGT CCGTT CGTTT GTTTT TTTTG TTTGG TTGGC TGGCG GGCGC GCGCG CGCGC GCGCG CGCGC GCGCC CGCCC GCCCA CCCAT CCATA CATAC ATACC,ACCGTG CCGTGG CGTGGC GTGGCG TGGCGG GGCGGG GCGGGG CGGGGG GGGGGC GGGGCA GGGCAT GGCATC GCATCG CATCGC ATCGCC TCGCCA CGCCAG GCCAGA CCAGAA CAGAAG AGAAGA GAAGAC AAGACA AGACAA GACAAG ACAAGC CAAGCT AAGCTC AGCTCA GCTCAG CTCAGG TCAGGG CAGGGA AGGGAG GGGAGT GGAGTT GAGTTG AGTTGG GTTGGT TTGGTG TGGTGG GGTGGC GTGGCG TGGCGC GGCGCT GCGCTA CGCTAC GCTACA CTACAG TACAGG ACAGGC CAGGCC AGGCCC GGCCCG GCCCGT CCCGTG CCGTGG CGTGGG GTGGGC TGGGCA GGGCAC GGCACC GCACCG CACCGA ACCGAG CCGAGT CGAGTG GAGTGG AGTGGC GTGGCC TGGCCA GGCCAT GCCATG CCATGG CATGGT ATGGTG TGGTGG GGTGGG GTGGGC TGGGCG GGGCGA GGCGAC GCGACG CGACGG GACGGG ACGGGT CGGGTT GGGTTG GGTTGA GTTGAA TTGAAC TGAACG GAACGA AACGAT ACGATG CGATGG GATGGC ATGGCC TGGCCC GGCCCC GCCCCG CCCCGT CCCGTT CCGTTT CGTTTT GTTTTG TTTTGG TTTGGC TTGGCG TGGCGC GGCGCG GCGCGC CGCGCG GCGCGC CGCGCC GCGCCC CGCCCA GCCCAT CCCATA CCATAC CATACC,ACCGTGG CCGTGGC CGTGGCG GTGGCGG TGGCGGG GGCGGGG GCGGGGG CGGGGGC GGGGGCA GGGGCAT GGGCATC GGCATCG GCATCGC CATCGCC ATCGCCA TCGCCAG CGCCAGA GCCAGAA CCAGAAG CAGAAGA AGAAGAC GAAGACA AAGACAA AGACAAG GACAAGC ACAAGCT CAAGCTC AAGCTCA AGCTCAG GCTCAGG CTCAGGG TCAGGGA CAGGGAG AGGGAGT GGGAGTT GGAGTTG GAGTTGG AGTTGGT GTTGGTG TTGGTGG TGGTGGC GGTGGCG GTGGCGC TGGCGCT GGCGCTA GCGCTAC CGCTACA GCTACAG CTACAGG TACAGGC ACAGGCC CAGGCCC AGGCCCG GGCCCGT GCCCGTG CCCGTGG CCGTGGG CGTGGGC GTGGGCA TGGGCAC GGGCACC GGCACCG GCACCGA CACCGAG ACCGAGT CCGAGTG CGAGTGG GAGTGGC AGTGGCC GTGGCCA TGGCCAT GGCCATG GCCATGG CCATGGT CATGGTG ATGGTGG TGGTGGG GGTGGGC GTGGGCG TGGGCGA GGGCGAC GGCGACG GCGACGG CGACGGG GACGGGT ACGGGTT CGGGTTG GGGTTGA GGTTGAA GTTGAAC TTGAACG TGAACGA GAACGAT AACGATG ACGATGG CGATGGC GATGGCC ATGGCCC TGGCCCC GGCCCCG GCCCCGT CCCCGTT CCCGTTT CCGTTTT CGTTTTG GTTTTGG TTTTGGC TTTGGCG TTGGCGC TGGCGCG GGCGCGC GCGCGCG CGCGCGC GCGCGCC CGCGCCC GCGCCCA CGCCCAT GCCCATA CCCATAC CCATACC,"ID   CTPF_MYCBO              Reviewed;         905 AA.
AC   P63688; A0A1R3Y0A8; Q10860; Q10861; X2BJ82;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   05-FEB-2025, entry version 127.
DE   RecName: Full=Probable cation-transporting ATPase F;
DE            EC=7.2.2.-;
GN   Name=ctpF; OrderedLocusNames=BQ2027_MB2020;
OS   Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97).
OC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Mycobacteriales;
OC   Mycobacteriaceae; Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=233413;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-935 / AF2122/97;
RX   PubMed=12788972; DOI=10.1073/pnas.1130426100;
RA   Garnier T., Eiglmeier K., Camus J.-C., Medina N., Mansoor H., Pryor M.,
RA   Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B.,
RA   Atkin R., Doggett J., Mayes R., Keating L., Wheeler P.R., Parkhill J.,
RA   Barrell B.G., Cole S.T., Gordon S.V., Hewinson R.G.;
RT   ""The complete genome sequence of Mycobacterium bovis."";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7877-7882(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND GENOME REANNOTATION.
RC   STRAIN=ATCC BAA-935 / AF2122/97;
RX   PubMed=28385856; DOI=10.1128/genomea.00157-17;
RA   Malone K.M., Farrell D., Stuber T.P., Schubert O.T., Aebersold R.,
RA   Robbe-Austerman S., Gordon S.V.;
RT   ""Updated reference genome sequence and annotation of Mycobacterium bovis
RT   AF2122/97."";
RL   Genome Announc. 5:E00157-E00157(2017).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIA subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; LT708304; SIU00627.1; -; Genomic_DNA.
DR   RefSeq; NP_855670.1; NC_002945.3.
DR   RefSeq; WP_003410027.1; NC_002945.4.
DR   AlphaFoldDB; P63688; -.
DR   SMR; P63688; -.
DR   PATRIC; fig|233413.5.peg.2219; -.
DR   Proteomes; UP000001419; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005391; F:P-type sodium:potassium-exchanging transporter activity; IEA:TreeGrafter.
DR   GO; GO:0030007; P:intracellular potassium ion homeostasis; IEA:TreeGrafter.
DR   GO; GO:0006883; P:intracellular sodium ion homeostasis; IEA:TreeGrafter.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IEA:TreeGrafter.
DR   GO; GO:1902600; P:proton transmembrane transport; IEA:TreeGrafter.
DR   GO; GO:0036376; P:sodium ion export across plasma membrane; IEA:TreeGrafter.
DR   CDD; cd02080; P-type_ATPase_cation; 1.
DR   FunFam; 2.70.150.10:FF:000016; Calcium-transporting P-type ATPase putative; 1.
DR   FunFam; 3.40.50.1000:FF:000028; Calcium-transporting P-type ATPase, putative; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR050510; Cation_transp_ATPase_P-type.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01494; ATPase_P-type; 3.
DR   PANTHER; PTHR43294:SF21; CATION TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR43294; SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF08282; Hydrolase_3; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00120; HATPASE.
DR   SFLD; SFLDG00002; C1.7:_P-type_atpase_like; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell membrane; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Translocase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..905
FT                   /note=""Probable cation-transporting ATPase F""
FT                   /id=""PRO_0000046342""
FT   TRANSMEM        84..104
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        248..268
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        283..303
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        716..736
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        738..758
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        778..798
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        808..828
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        842..862
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        872..892
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   ACT_SITE        333
FT                   /note=""4-aspartylphosphate intermediate""
FT                   /evidence=""ECO:0000250""
FT   BINDING         643
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /evidence=""ECO:0000250""
FT   BINDING         647
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /evidence=""ECO:0000250""
SQ   SEQUENCE   905 AA;  95033 MW;  7A1E6A23CF4D4DA6 CRC64;
     MSASVSATTA HHGLPAHEVV LLLESDPYHG LSDGEAAQRL ERFGPNTLAV VTRASLLARI
     LRQFHHPLIY VLLVAGTITA GLKEFVDAAV IFGVVVINAI VGFIQESKAE AALQGLRSMV
     HTHAKVVREG HEHTMPSEEL VPGDLVLLAA GDKVPADLRL VRQTGLSVNE SALTGESTPV
     HKDEVALPEG TPVADRRNIA YSGTLVTAGH GAGIVVATGA ETELGEIHRL VGAAEVVATP
     LTAKLAWFSK FLTIAILGLA ALTFGVGLLR RQDAVETFTA AIALAVGAIP EGLPTAVTIT
     LAIGMARMAK RRAVIRRLPA VETLGSTTVI CADKTGTLTE NQMTVQSIWT PHGEIRATGT
     GYAPDVLLCD TDDAPVPVNA NAALRWSLLA GACSNDAALV RDGTRWQIVG DPTEGAMLVV
     AAKAGFNPER LATTLPQVAA IPFSSERQYM ATLHRDGTDH VVLAKGAVER MLDLCGTEMG
     ADGALRPLDR ATVLRATEML TSRGLRVLAT GMGAGAGTPD DFDENVIPGS LALTGLQAMS
     DPPRAAAASA VAACHSAGIA VKMITGDHAG TATAIATEVG LLDNTEPAAG SVLTGAELAA
     LSADQYPEAV DTASVFARVS PEQKLRLVQA LQARGHVVAM TGDGVNDAPA LRQANIGVAM
     GRGGTEVAKD AADMVLTDDD FATIEAAVEE GRGVFDNLTK FITWTLPTNL GEGLVILAAI
     AVGVALPILP TQILWINMTT AIALGLMLAF EPKEAGIMTR PPRDPDQPLL TGWLVRRTLL
     VSTLLVASAW WLFAWELDNG AGLHEARTAA LNLFVVVEAF YLFSCRSLTR SAWRLGMFAN
     RWIILGVSAQ AIAQFAITYL PAMNMVFDTA PIDIGVWVRI FAVATAITIV VATDTLLPRI
     RAQPP
//
",764
CTCGAC TCGACA CGACAC GACACC ACACCG CACCGT ACCGTC CCGTCG CGTCGA GTCGAT TCGATC CGATCG GATCGC ATCGCG TCGCGG CGCGGA GCGGAA CGGAAG GGAAGC GAAGCA AAGCAT AGCATC GCATCA CATCAT ATCATC TCATCC CATCCA ATCCAC TCCACG CCACGA CACGAC ACGACG CGACGG GACGGC ACGGCC CGGCCG GGCCGC GCCGCC CCGCCG CGCCGC GCCGCG CCGCGT CGCGTC GCGTCG CGTCGA GTCGAC TCGACG CGACGG GACGGC ACGGCC CGGCCC GGCCCC GCCCCA CCCCAG CCCAGC CCAGCC CAGCCT AGCCTG GCCTGA CCTGAC CTGACA TGACAC GACACG ACACGC CACGCG ACGCGG CGCGGC GCGGCA CGGCAT GGCATC GCATCG CATCGT ATCGTC TCGTCT CGTCTT GTCTTT TCTTTC CTTTCA TTTCAG TTCAGG TCAGGA CAGGAG AGGAGC GGAGCC GAGCCC AGCCCA GCCCAG CCCAGG CCAGGC CAGGCT AGGCTC GGCTCT GCTCTT CTCTTC TCTTCC CTTCCC TTCCCC TCCCCT CCCCTG CCCTGG CCTGGC CTGGCT TGGCTG GGCTGA GCTGAC CTGACG TGACGG GACGGT ACGGTC CGGTCA GGTCAC GTCACC TCACCG CACCGA ACCGAA CCGAAA CGAAAA GAAAAC AAAACA AAACAT AACATC ACATCG CATCGC ATCGCG TCGCGC CGCGCT GCGCTT CGCTTG GCTTGG CTTGGC TTGGCC TGGCCT GGCCTG GCCTGG CCTGGA CTGGAG TGGAGA GGAGAA GAGAAT AGAATG GAATGC AATGCG,2,142,CTCCG G T TCGAGCGAGA A C CGCGA CGAC C G GAGACACACA A AGCC TCCACAC C C CACACACCCC  ACACCCCGCG G CCG CCGCGTGT T C CGCGTGTCTC C G GTGTCTCGCG CGG TCTCGCGAGA A CCGAGATA AT G GAGATAATTC C GT CATCTG  GTG TAAGCGCGC C CCGCGCGG G GCC CCGGGG G C CGCGGGGAGA A G GGGGAAA G G ATTCGAG  AAAAGAGCGC C A AGAGCGCACA A G GCCATAT T C CAGC ATCTC ATCTCACA A T TCCCCCATAT TCT CACATATCTC  CCTCCCC C T TCTCCCCACA A CACACCACACAC C C CACACACGCG G A ACTG GCCGA A C CGCGAGACAC C G GAGACACGAT G A ACACGCGGGG G C CGCGGGGCGC C GGGCA GC A GC CACCGG CG C CCCCGCGCGC C CCGCGCCC G GCGCCCG G C CCCCGCGCGC C C CGCGCCG G G CG TGCCCGT T CGACCGTGTCGCGC GCG GTCTCGCG G T TCTCGCGAGA A C CGCGAGACAC C G GAGACCAGCG T CACGCGGGG G CCACCGGGGCGC C GGGCGCCCC C G GCGCC CCCC C C CCCCCCCCCC C C CCCGTCCACA A C CCCCACAGAG CG  CACAGAGCC AAGCGCCCC T T GC ACCCTCT T C CCCTGTG G C CTCTGTGAGA A T TGTGAGACAC C GAAAGACACACA A A ACC AAC C C CAC CACG CT AA ACACGGC C C CGATCGCGTT G G GCGCGCGGGG GCT CGG TGGCGC C G GGGCACA CAT GCGCACATAT T C CACCAATCTC ATCTCGCG G T TCCGTGT T C GCCGTGTCTC C G GTGTCTCTCT T T TCTCTCTTTT T C AGCTTTTTCG T T TTCATTTCC T TTTTCTCACA ACG TCTCACAGAG G C CACAGG A AGGC GA A G GGGGATCGAG CC  GAGAGAGCGC C A AGGCCCCC GG GCGCCCCCC C CCTCACCATG  CCGCACAGAG G C CAACGAGGGG G A AGAGGGC C G GGGGCGCTCT T G GCCTCC CTCTC G TC GAGACTT T CCTTTTCC T TTTTCTCCCC GTC TCTCCCCCCTTGCG CCCCCCCCCC C C CCCC CCTCT  GA CCCCTCTGACGG CCG CTGG CG T TGTGGGC C G GGGGCGCTCT T G GCGCTTTGTG TGG CTCTGTGAGA A T TGTGAAC C GT CGACA TCG G A ACACGCGGGC G C CGGGTGT GCT GGGGTGTCTC TCG GTC TTCACA A TACA ACCACAC C CGCCACCCC C A ACACCCCGCG G C CCCGAGA TCG CGCGAGAAA G GAGAAAAAAA A AG AAAA AAGAAAACAC C A AAAACACACA TGCACA GC AC CACATCGCTC C A ATATCTCGCG  TCTCGCGCA GC C CGTC CG A G GCGCGCGCGC  CGCGCT GCT T GCG GCTGGCTT T C CTCTTTTGTG G T TTCTGTGGGG G T TGTGGGGCC G GGGGCGCCCC C G GCCGACCTCT T C CCCCTCTGC GG C CTCTGTGGGG G TGCGTGGGA G GGGAGAGAG G GGAGAGAGA A A CTGAAAA A G GAGAAAT T AAATATGCA G AATGGG C T TGAT GCG,TCGCGAGA A T TCCGAGACAC C C CGACACA ATC GAGACACA GAACACTT ACACACACACCCC C C CACACACCCCGCG G A ACACCCCGCGTGT T C CCCGTCTGTC C C CGCGTGTCTCGG G GTGTCTCGCGA AAA T TCTCGCGAGATAT T C CGCGAGATATCCCAC G GAGATATCTCGACAG A ATACGCGCCGCC T TCTCGTCTGCGA AG C CGTGGGCGCGGGG G G GCGCGGGAGA A C CGGCCGGAGAAAA A G GGGGAGAAAAGG G GAGAAAAGAGCGC C A AAAT AGCTT CA CG  AG CTCATATCT GCGACATATCTC  CACATATCTCACA TCG ATA GCATAT T T GCTCACATATCTC C C CATCCC AAGCATCTCCACGCA A T TCC AG CCACAC C C CCCCACACACGCG G C CACAC TCC TA A ACACGCGAGACAC C C CGCCGCG G G GAGACACGCGGGG G A ACACGCGGGGCGC CC  CGCC GGCGCCCC C G GGGGCTCGCCGCG  GCCCGCGCGC CGC CCACGCGCGC CC C C CGCGCCCGGA  GCGA CCGCGCCC C CCCGAGCCG G C CGCGCGCGGG GT T G GCGCGCGTGTCTC CCT CGCGTGTCTCGACCG G GTGTCAT CGAGA A TCACA ACGACC C C CGCGAGACACGCG G G GAGACTC CGGGG G A ACCGGGGCGC  CGCGGCGGGTC GG GGGGCGCCCC C GGCGGCCGCGCC C C CCCCCCCCCCACA A C CCGGCCCACAGAG G C CCCCACAGGCGC C CAAGCGCCCC TCC AGAGCGCCCCTCT T G CTATCCCTCTGTG AAA CCCCTGA A C CTCTGGCGAC C T TGTGAGACACACA A GGACACACACAC C A ACAC ACGCG G C CACACCGCGC C A ACACGTTT GCCG G C CGCGCTGACGGAT GC CGGGGCGCGC C CGGGCGCACA A G GGGGCCATAT T G GCGCATCCATCTC C CCATATCTCGCG G A ATATCACGGT T T TCCGCCGTGTCTC C C CGCGTGCCTCTCT CTC GTGTCTCTCTTTT T T TCTCTCTTTT T CGCACTTTTTTTCTC  TTGC TTCTCACA AGG TTTTC GGCAGAG G TCGATCAAGGGG G C CACAGAGGGGAA A AGAGGGGAGAGAG G GCCAGGAAGCC G GAGAGATCGCCCC C A AGAGCGCCCCCCC C GGCCCCCCCACC  CCCCCTC CAGAG  TC CCCCA TCCGTG C CACAGA TGGCGC GCC AGGGCGCTCT T CT GGGCGCTC G GCTGGCTCTCTCT T C CTCTCCGCCTTTT T T TCTCTCTTTTCTC C C GCCTTTTCTCCCGGC TTTCTCCCCCCA GA  TCCATCCCCCCC CC C CCCCCCCCCCTCT T C CCCCCTG G C CCCCTCTGTGGGG  CTCTGTGGGGCGC C T TGTGGGGCGCTCT T G GGGGCGCTCTGTG G G GCGCTCTGTGAGA TC  CTGTCTGAGACAC C T TGTGAGACCG G G GAGACACGCGGGG G A ACTCGCGGTG GT T C CGCGGGTC GGC GTCAGGTGTCTCACA A G GTGTCTCA TCAC C T TCTCACACACCC AC C CACACCG CCGCG G A ACACCCCGCGACG A C CCCCGCGAGAAAA A C CGCGAGAAAAAAA A G GAGAAAAAAAAAA A A AAG CAAAAACAC C TAAAAACACACA A A AAAACCG CATAAGT A ACACACATATCA CC C CACATATCCG G A ATTCGCGCGC GA G CGCC TTGCGCCCG CACGCGCCGCGC  GCC CGCTCT GCC CGCGCGCTGCAT G GCGCTCTTTTGGGTG CCTTTTGTGGGG G TTTGGGCGC C T TGCG GCCAC C GC GGGCGCCCCTCT T GAGGGCCCCTCTGTG G G CCCCTTGGCGAG C CTCTGTGGGGA TGCGCGGAGAGAG G G GGGGAGAGAGAGA  GAGAGAGAGAAAA A A AGAGAGAAAATTCGT G GAGAAAATATGTG G A AAAATTGCGC C A ATATGTGC,CTCTCGCGAGACAC C T TCTCGCGAGACTGGCA CAT CGCGAGACAG CACAT C GGACCACACCCC C A ACCGTCAC CCCCGCG  CACACCCGACAGT T ATTGACCCCGGTCGCCC C CCCCGCACTCGG C CGCGTGTCTCGCGAGA A G GTGTCTCGCGAAT T T TCAC CGAGATG GTC C C CGGATATCTCGACGG G GAG CATCGA CGCGC C A ATATCATCTGAGCGCG G TTGGTCGTCTGCGCGGG C CGCGCGCGCGGGGAGA A G CTGCGGGAGAAAA A CCGGGGAGAAAAGAG G G GGGGAGAAAAGAGCCGCC G GAGAAAAGAGCCA  AAAAGGCCCATAC T A AGAGCCATATC TC GCGCAATCTCACA  CACATTGCCATAT GAC ATATCTCACATCCATC C TGAATCATCC CTCC C C CACATATCACGCCACA A A ATATCCATTCGCACAC TCT TCTCCCCACACCCGCG G C CCCCACACACGCGACCAGT CACACGCGAGACC A ACCGAGACACGCG G C CGCGAGCCACGCGGGG G GCCCGACACGGCAGGCC ACATACGGC GGCGCA CGCTGCGGGGCGCCA GATC GGGGCG CCCGAAAGC C G GCGCCCCGATCGCCC C CCCCGGCC GAG CCC CGCCC CCGCGCGC C G GCGG CCGCGCGCGCG G CCGCCCGCGCCGTA CT C CGCGCGCGCGTGTCTC CCA GCGCGCGTGTCG TCG G C CGCGTGTCTCGCGAGA A G GTGTCCGCCGAGACAC TCGCGAT AG C CGGACCG CGGGG G GTGAGACACGCGGGCCGC C A ACACGCGGGGCGCCCC C CGGCCGGGGCGCCCCCCC C G GGGGCGCCCCCCCCCC C G GCCCCCCCCCACA A C CCCCCCCAAG GAT CCCCCGGACAGAG ACAC C CCCCACTGAGCGACCC C C CACAGAGCGGCCCTCT T AGGAAGCGCCCCT TTTG G G GCGCCCCTCTGTGAGA A C CCCCTC CTGAGACAC C C CTCTGTGAGAC CTCA A T TGCGCGACACACGTAC ACG GAGACACATCCCG G A ACACAACGCGCGC GAGTCGCACACGGGACG G AGG CGCGCGCGGGG  AGCTGCGCCGGGGCGC C G GCGCGGGCGCAC AA C CGCGGGGCGCAGAAAT T G GGGGCGCACATATCTC C G GCGCACCTATCTCGCG G C CAATCTCGCGTGT T AG TCGTGTCTC C T TCTCGCTCGTCTCTCT T C CGCGTGTCTCTCTTTT T G GTGTCTCTCTTTTTTT T T TCCGCTTTTTCTC C C GCTTTTTCTCACA  TC TTTTTTTCTCAAG G TCTGTTCTCACAGAGG ACG TA TG CAGGGGAGA A C CACAGAGGGGAGAGAG G A AGAGGGCGGAGAGCGC  GGC GAGCGCCGTCC G GAGAGAGCGCCCCCCA G CAGCGCCCCCCCACA A G GCCCT GATCGCAGACATCACCCCCACAGAGGGG G C CCCCACAG CAGGCGC C C CACAGAGGGGCGCTCT T A AGAGG CGGCTCGTTC C G GGGGCGCTTCT CCT G GCGCTCTCTCTCTTTT T CCTCTCTCTTTTCTC C T TCC TCTTTTCTCCC C CT GATTCTCCCCCGCCC T TTTTCTCCCCCCC  TCTCCCCCCCCCATCT T C CCCCCCCCCCTCTGTG G C CCCCCCCTCTGTGGGG ACC CG GAGC C C CTCTGTGGGGCGCTCT T T TGTGGGAGCAGTG G G GGGGCCTGTGAGA  GCGCTCTGTGAGACC CCTGAA GACACGCG G TGCGTGACGGACGCGGGG G GCATGACACGCGGGGTGT T A ACACGCGGGGTGTCTC C C CGCGGGGTGTCTCACA A G GGGGTCC TCACACC G GTGTCTCACACC T TCTCACACACCCCGCG G C CAATGCGAGA A A ACACCCCGCGAGAA GAA CCT CCGCGAGAAAGGAA A C CGAAATGGAA A G CCGAAAAAAAAAACTCGC A AA GCAACACACA A A AAAAAAACACACATAT GGCAACACACATATCTC C A ACACACATTCGCG G C CAA CATCTCGCGCGC C A ATATCTCGCGCCG TCG TCTCGGCG GAGC C C CGCGCGCGCGCGCTT G GCATCCGCGCTCTTTT T C CGGCTCTTTTGTG ACGAAAGCTCTTGCGGG  CTCTT ACTGGGGCGC C T TTTTGTGGGGCGCCCC C T TG TCT AGCCGCCT GGGCCCTCTGTG G G GCGCCCCTCTGTGGTC G C CCCCTCTGTGGGGAGA A CACACTGACA AGGAGCGC TGTGGGGAAGAGA A G GGGGAC CAGAGGCAA G GCTTGAGAGAGAAAATAT T A AGAGAGAAAATATGTG G GCG  TCAATCCGATCGC C A AAAATATGGCG,CTCTCGACACA ACC TCTCGCGAACACACC CCGG CGGACACACC ACA GAGACACACACACCCCGCG GCC ACACACACCTGCGTGT T C GCACCAGACGT CATC C A ACACCCCGCGTGTCTCGCG G C CCCGTAGGTCGGA A CACCTCCTCGCGACGCAT ACC GTTTCTCGCGAGATGGATC C TCGCTCGCGAGATATCTCGCG CTCCGACTGTCGCGCAGAC G GAGATATCTCGCGC ATATCTCGCGCGCGCGGGG G T TCGCTCGCGCGTGAGA A C CGCGCGCGCGGATCGAAAA A G CAGCGGGAGAAAAGCAT GA CGCGCGGAC CAAGAGCGC C GGAA GGAGCGCACA A GGCGGAAAAGAGCGCACATAT T A AAAAGAGCGCACATTC C A AGAGCGCACATTC TCACA A G GCGCACATATCTCAT CTCTCATATCTCACATATCTC C A ATATCTCAATCACGCC TCTC CTCAA GATCT CGC CA A C CACATATCTCCCCAAC C A ATATCCCGCCACACACGCG G T TCTCCCCCCACACGCGAGA  TC CCCCATGAACGCGAGACAC C C CACACACGAG GACACGCG G A ACACGCGAGACACGCGGGG G C CGCGAGACACGCGGT GC G GAGACACG GCGGCGCCCC C AC GGCT GCGGCGCCCCGCG G C CGCGGAAAGCCCCGCGCGC C G GGGCC CACTGGCCCC  AC GCTGAAGCCGCGCCCCGCG G C CCCCGCGCGCCCGCGC C C CGCGCGCCCGCTG CG G G CCGCCCCG TCCGTCTG CCCCGCGCGTCGTCTC C C CGCGCCATCGTGTCTCGCG G G GC GAGCGCATCGAGA A CCGTGTCTCG GGGACACGC G GTGTCTCGCGAGACACGCG G T TCAGGCGAGACACGCGGGG G C CGCGAGACACGCGGTGGGC C T GAG GACGGCCCC C A ACACGCGGGGCG ACCCCC C CCGGGGCGCCCCCCC C GAAGGGCGCCCCCGGCCCACA A G GCGCCCCCCCCCCACAGAG ATC CCCCACCCCCAAGCGC C C CCCCCCCACAGAGCCC AC CCA CCCAGAGCGCCCCT CTT CGTCCAGAGCGCCCCTTG G AAGCGCCCCTCTGA CGA A G GC CTCCTCTGTGAGACGCGC C CCCCTCTGTGAGACCATCA A C CTCTGTGACATACACACAC C G TGTGAGACACACACACGCG G G GAGACACACACACGA CGC C A ACACACACGCGCG  CACACACGCGCGCGCGGGG G A ACACGCGCGCGC C CGCGCGCGCGGGGCGCACA A GCGGGCGCGGGGCGCACATAT T C CGCGGGGCGCATT TC C T GGCTTCATATCTCGGCAG G GCGCACATATCTCGCGTT C CACATATCTCGCGT ATC ATC CTCTCGCGT AGTCGCT T TC TTCGCGTGTCTCTAG T C CGCGTTCTCTTTTTAT T G GTGTCTCTCTTTTTTTCATCC TC TCG TTTTTCCA A C CTCTTGTCTCAAG G TTTTTTCTCACAGAGGGG G TTTCTCACAGAGGGGA TCTCACAGAGGGGAGAGAG G CCCGT CAGGGAGCGTGC GTC AGAGGGGAGACGACCC C G GGGGAGAGAGCGCCCCCCC C G GAGAGAGCCCCCCAACAA AAGCGCCCCCCCACAGAG CCG GCGCCCCACCCAGGGG G C CCCCCCCACAGTCGGGCCTGGAA CCCCACGGAGGCCCGCTCT T C CACAGAGGGGCTT TC CGGGTCGGCGCTCTCTCTCT GAC GGGGCGCTG CTCTCTTCTCTTG GCGCTCTCTCTTTCTC CT  CTG CCTTTTCTCCCC C T TCTCTCTTTTCTCCCTTCC C CG CCCCTTCTCCGG CCCCC  TC TTTTCCCCCAGCCTCT T T TCTCCCCCCCCCCTCTGTG G C CCCCCCCCCCTCTGTGGCCCG C GCCCCCCTATCTGGGGCGC TGA CCCCTCTGTGGGGCGCTCT T CC CACCTGGGGCGCTCTGGCG TGTGGGCTCTGGCCGA CAT GGGGCGCTCTGTGAAC C GCGGCAGTGAGACACG CTGCCCTGC CGCCGTCCGGGG G T TGCACT GACGCGGGGTGT ACC GAAATAC CAGGGTTC C A ACACGCGGGTCTCACA CGC CGCGGGGTGTCTCACACAC C G GGGGTGTCTCACACA TCC C G GTGTCCACACCCCGCG G T TCTCACACT GCCGCGAGA A C CAACCTCCGAAAA A A ACCCGCGAGAAAAAAA A C CCGGCCGAGAAAAAGGCAA A C CGGAAAAAAC C G GAGAAAAAAAAAACCA CA A A AAAAAAAAAACCGACATAT T A AAAAAAACACAACAATCTC C A AAAACACACTTATCTCGCG G A ACC GATCTCGCGCCCA CACATATCTCGGCGGCGCG G A ATTCGCGCGCGGC  TCTCTCGCGCGCGCGCTCT TCCGATGCGCGCGCTCTTTT T G CTGCGCGCACGCTTTG G C CGCGCGCTTCGTTGGGCGG G G GCGCTCTTT GTGGGGCGC C C GCGGCTGGGGCGCCCC C G TTTTGTGGGGCGCCCCTCT T TTGGGGCGCCCCTCGCG G GGGGCGCCCCTTGGCCCG G GCGCCCCTCTGTGGGGAGA A CCCTCTGTGGGGAGAGCGAG C CTCTGTGGGGAGAGAGAGA A T TGGGAGAGAGAGAAAA  GGGGAGAGAGAGAAAATAT GC  GAGAGGC GAAAATATGTG G A AGCCGGAAAATATGTGCGC G CGAAGACATGTGC,"ID   SSUB_BACAH              Reviewed;         251 AA.
AC   A0RFA4;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   05-FEB-2025, entry version 90.
DE   RecName: Full=Aliphatic sulfonates import ATP-binding protein SsuB {ECO:0000255|HAMAP-Rule:MF_01724};
DE            EC=7.6.2.14 {ECO:0000255|HAMAP-Rule:MF_01724};
GN   Name=ssuB {ECO:0000255|HAMAP-Rule:MF_01724};
GN   OrderedLocusNames=BALH_2614;
OS   Bacillus thuringiensis (strain Al Hakam).
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus;
OC   Bacillus cereus group.
OX   NCBI_TaxID=412694;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Al Hakam;
RX   PubMed=17337577; DOI=10.1128/jb.00241-07;
RA   Challacombe J.F., Altherr M.R., Xie G., Bhotika S.S., Brown N., Bruce D.,
RA   Campbell C.S., Campbell M.L., Chen J., Chertkov O., Cleland C.,
RA   Dimitrijevic M., Doggett N.A., Fawcett J.J., Glavina T., Goodwin L.A.,
RA   Green L.D., Han C.S., Hill K.K., Hitchcock P., Jackson P.J., Keim P.,
RA   Kewalramani A.R., Longmire J., Lucas S., Malfatti S., Martinez D.,
RA   McMurry K., Meincke L.J., Misra M., Moseman B.L., Mundt M., Munk A.C.,
RA   Okinaka R.T., Parson-Quintana B., Reilly L.P., Richardson P.,
RA   Robinson D.L., Saunders E., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Ticknor L.O., Wills P.L., Gilna P., Brettin T.S.;
RT   ""The complete genome sequence of Bacillus thuringiensis Al Hakam."";
RL   J. Bacteriol. 189:3680-3681(2007).
CC   -!- FUNCTION: Part of the ABC transporter complex SsuABC involved in
CC       aliphatic sulfonates import. Responsible for energy coupling to the
CC       transport system. {ECO:0000255|HAMAP-Rule:MF_01724}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + aliphatic sulfonate-[sulfonate-binding
CC         protein]Side 1 = ADP + phosphate + aliphatic sulfonateSide 2 +
CC         [sulfonate-binding protein]Side 1.; EC=7.6.2.14;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01724};
CC   -!- SUBUNIT: The complex is composed of two ATP-binding proteins (SsuB),
CC       two transmembrane proteins (SsuC) and a solute-binding protein (SsuA).
CC       {ECO:0000255|HAMAP-Rule:MF_01724}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|HAMAP-Rule:MF_01724};
CC       Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_01724}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. Aliphatic
CC       sulfonates importer (TC 3.A.1.17.2) family. {ECO:0000255|HAMAP-
CC       Rule:MF_01724}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABK85897.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000485; ABK85897.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; WP_000217287.1; NC_008600.1.
DR   AlphaFoldDB; A0RFA4; -.
DR   SMR; A0RFA4; -.
DR   KEGG; btl:BALH_2614; -.
DR   HOGENOM; CLU_000604_1_22_9; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   CDD; cd03293; ABC_NrtD_SsuB_transporters; 1.
DR   FunFam; 3.40.50.300:FF:001273; Aliphatic sulfonates import ATP-binding protein SsuB; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR050166; ABC_transporter_ATP-bind.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR42788:SF13; ALIPHATIC SULFONATES IMPORT ATP-BINDING PROTEIN SSUB; 1.
DR   PANTHER; PTHR42788; TAURINE IMPORT ATP-BINDING PROTEIN-RELATED; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
DR   PROSITE; PS51291; SSUB; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell membrane; Membrane; Nucleotide-binding; Translocase;
KW   Transport.
FT   CHAIN           1..251
FT                   /note=""Aliphatic sulfonates import ATP-binding protein
FT                   SsuB""
FT                   /id=""PRO_0000279892""
FT   DOMAIN          3..231
FT                   /note=""ABC transporter""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01724""
FT   BINDING         39..46
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01724""
SQ   SEQUENCE   251 AA;  28509 MW;  8D0CF4EF849566FF CRC64;
     MTVLINEVSK YFSKQTGTVQ VLENINFQLE KGDFVTVIGP SGCGKSTLLK IVAGLDNDFE
     GEIIIDGERI TKPSKKQGFI FQEHRLFPWL TVEENIAADL SLKDKYVKDK VKEWVEIVRL
     DGFEKSYPKE ISGGMSQRVA IARALLRDPS VLLLDEPFGA LDAFTRSHLQ EVLLNIWEQK
     KTTMIFVTHD IDEAIYLSNR IVIMSAKPGK IHKVIENNLP YPRSKTSESF QEIRKKVLQQ
     FEHGGLIQTS I
//
",12008
TTGACT TGACTC GACTCA ACTCAC CTCACC TCACCC CACCCT ACCCTG CCCTGA CCTGAA CTGAAA TGAAAT GAAATC AAATCT AATCTA ATCTAT TCTATG CTATGA TATGAA ATGAAG TGAAGA GAAGAC AAGACA AGACAT GACATG ACATGG CATGGG ATGGGT TGGGTA GGGTAT GGTATT GTATTA TATTAA ATTAAA TTAAAC TAAACC AAACCA AACCAC ACCACC CCACCT CACCTA ACCTAA CCTAAG CTAAGG TAAGGG AAGGGT AGGGTG GGGTGT GGTGTT GTGTTA TGTTAT GTTATC TTATCA TATCAT ATCATG TCATGT CATGTA ATGTAT TGTATG GTATGG TATGGC ATGGCC TGGCCC GGCCCA GCCCAC CCCACC CCACCT CACCTG ACCTGG CCTGGT,3,70,TTGA TGAC GACT ACTC CTCA TCAC CACC ACCC CCCT CCTG CTGA TGAA GAAA AAAT AATC ATCT TCTA CTAT TATG ATGA TGAA GAAG AAGA AGAC GACA ACAT CATG ATGG TGGG GGGT GGTA GTAT TATT ATTA TTAA TAAA AAAC AACC ACCA CCAC CACC ACCT CCTA CTAA TAAG AAGG AGGG GGGT GGTG GTGT TGTT GTTA TTAT TATC ATCA TCAT CATG ATGT TGTA GTAT TATG ATGG TGGC GGCC GCCC CCCA CCAC CACC ACCT CCTG CTGG TGGT,TTGAC TGACT GACTC ACTCA CTCAC TCACC CACCC ACCCT CCCTG CCTGA CTGAA TGAAA GAAAT AAATC AATCT ATCTA TCTAT CTATG TATGA ATGAA TGAAG GAAGA AAGAC AGACA GACAT ACATG CATGG ATGGG TGGGT GGGTA GGTAT GTATT TATTA ATTAA TTAAA TAAAC AAACC AACCA ACCAC CCACC CACCT ACCTA CCTAA CTAAG TAAGG AAGGG AGGGT GGGTG GGTGT GTGTT TGTTA GTTAT TTATC TATCA ATCAT TCATG CATGT ATGTA TGTAT GTATG TATGG ATGGC TGGCC GGCCC GCCCA CCCAC CCACC CACCT ACCTG CCTGG CTGGT,TTGACT TGACTC GACTCA ACTCAC CTCACC TCACCC CACCCT ACCCTG CCCTGA CCTGAA CTGAAA TGAAAT GAAATC AAATCT AATCTA ATCTAT TCTATG CTATGA TATGAA ATGAAG TGAAGA GAAGAC AAGACA AGACAT GACATG ACATGG CATGGG ATGGGT TGGGTA GGGTAT GGTATT GTATTA TATTAA ATTAAA TTAAAC TAAACC AAACCA AACCAC ACCACC CCACCT CACCTA ACCTAA CCTAAG CTAAGG TAAGGG AAGGGT AGGGTG GGGTGT GGTGTT GTGTTA TGTTAT GTTATC TTATCA TATCAT ATCATG TCATGT CATGTA ATGTAT TGTATG GTATGG TATGGC ATGGCC TGGCCC GGCCCA GCCCAC CCCACC CCACCT CACCTG ACCTGG CCTGGT,TTGACTC TGACTCA GACTCAC ACTCACC CTCACCC TCACCCT CACCCTG ACCCTGA CCCTGAA CCTGAAA CTGAAAT TGAAATC GAAATCT AAATCTA AATCTAT ATCTATG TCTATGA CTATGAA TATGAAG ATGAAGA TGAAGAC GAAGACA AAGACAT AGACATG GACATGG ACATGGG CATGGGT ATGGGTA TGGGTAT GGGTATT GGTATTA GTATTAA TATTAAA ATTAAAC TTAAACC TAAACCA AAACCAC AACCACC ACCACCT CCACCTA CACCTAA ACCTAAG CCTAAGG CTAAGGG TAAGGGT AAGGGTG AGGGTGT GGGTGTT GGTGTTA GTGTTAT TGTTATC GTTATCA TTATCAT TATCATG ATCATGT TCATGTA CATGTAT ATGTATG TGTATGG GTATGGC TATGGCC ATGGCCC TGGCCCA GGCCCAC GCCCACC CCCACCT CCACCTG CACCTGG ACCTGGT,"ID   PRS4_SCHPO              Reviewed;         448 AA.
AC   P36612;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   05-FEB-2025, entry version 179.
DE   RecName: Full=26S proteasome regulatory subunit 4 homolog;
DE   AltName: Full=Protein mts2;
GN   Name=mts2; ORFNames=SPBC4.07c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales; Schizosaccharomycetaceae;
OC   Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=8247131; DOI=10.1038/366355a0;
RA   Gordon C.B., McGurk G., Dillon P., Rosen C., Hastie N.D.;
RT   ""Defective mitosis due to a mutation in the gene for a fission yeast 26S
RT   protease subunit."";
RL   Nature 366:355-357(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M., Collins M.,
RA   Connor R., Cronin A., Davis P., Feltwell T., Fraser A., Gentles S.,
RA   Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G., Holroyd S.,
RA   Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K., James K.D.,
RA   Jones L., Jones M., Leather S., McDonald S., McLean J., Mooney P.,
RA   Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C., Oliver K.,
RA   O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E., Rutherford K.M.,
RA   Rutter S., Saunders D., Seeger K., Sharp S., Skelton J., Simmonds M.N.,
RA   Squares R., Squares S., Stevens K., Taylor K., Taylor R.G., Tivey A.,
RA   Walsh S.V., Warren T., Whitehead S., Woodward J.R., Volckaert G., Aert R.,
RA   Robben J., Grymonprez B., Weltjens I., Vanstreels E., Rieger M.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Duesterhoeft A.,
RA   Fritzc C., Holzer E., Moestl D., Hilbert H., Borzym K., Langer I., Beck A.,
RA   Lehrach H., Reinhardt R., Pohl T.M., Eger P., Zimmermann W., Wedler H.,
RA   Wambutt R., Purnelle B., Goffeau A., Cadieu E., Dreano S., Gloux S.,
RA   Lelaure V., Mottier S., Galibert F., Aves S.J., Xiang Z., Hunt C.,
RA   Moore K., Hurst S.M., Lucas M., Rochet M., Gaillardin C., Tallada V.A.,
RA   Garzon A., Thode G., Daga R.R., Cruzado L., Jimenez J., Sanchez M.,
RA   del Rey F., Benito J., Dominguez A., Revuelta J.L., Moreno S.,
RA   Armstrong J., Forsburg S.L., Cerutti L., Lowe T., McCombie W.R.,
RA   Paulsen I., Potashkin J., Shpakovski G.V., Ussery D., Barrell B.G.,
RA   Nurse P.;
RT   ""The genome sequence of Schizosaccharomyces pombe."";
RL   Nature 415:871-880(2002).
CC   -!- FUNCTION: The 26S proteasome is involved in the ATP-dependent
CC       degradation of ubiquitinated proteins. The regulatory (or ATPase)
CC       complex confers ATP dependency and substrate specificity to the 26S
CC       complex.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z29366; CAA82554.1; -; mRNA.
DR   EMBL; CU329671; CAB58406.1; -; Genomic_DNA.
DR   PIR; S39348; S39348.
DR   RefSeq; NP_595480.1; NM_001021391.2.
DR   AlphaFoldDB; P36612; -.
DR   SMR; P36612; -.
DR   BioGRID; 277455; 30.
DR   ComplexPortal; CPX-9077; 26S proteasome complex.
DR   IntAct; P36612; 1.
DR   STRING; 284812.P36612; -.
DR   iPTMnet; P36612; -.
DR   PaxDb; 4896-SPBC4.07c.1; -.
DR   EnsemblFungi; SPBC4.07c.1; SPBC4.07c.1:pep; SPBC4.07c.
DR   GeneID; 2540939; -.
DR   KEGG; spo:2540939; -.
DR   PomBase; SPBC4.07c; -.
DR   VEuPathDB; FungiDB:SPBC4.07c; -.
DR   eggNOG; KOG0726; Eukaryota.
DR   HOGENOM; CLU_000688_2_3_1; -.
DR   InParanoid; P36612; -.
DR   OMA; QDDTDPM; -.
DR   PhylomeDB; P36612; -.
DR   Reactome; R-SPO-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-SPO-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-SPO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-SPO-5689603; UCH proteinases.
DR   Reactome; R-SPO-5689880; Ub-specific processing proteases.
DR   Reactome; R-SPO-68949; Orc1 removal from chromatin.
DR   Reactome; R-SPO-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-SPO-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-SPO-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-SPO-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-SPO-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-SPO-8951664; Neddylation.
DR   Reactome; R-SPO-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-SPO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   Reactome; R-SPO-9907900; Proteasome assembly.
DR   PRO; PR:P36612; -.
DR   Proteomes; UP000002485; Chromosome II.
DR   GO; GO:0000785; C:chromatin; IDA:PomBase.
DR   GO; GO:0005829; C:cytosol; HDA:PomBase.
DR   GO; GO:0005634; C:nucleus; HDA:PomBase.
DR   GO; GO:0005838; C:proteasome regulatory particle; IDA:PomBase.
DR   GO; GO:0008540; C:proteasome regulatory particle, base subcomplex; IDA:PomBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; NAS:PomBase.
DR   GO; GO:0036402; F:proteasome-activating activity; ISM:PomBase.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; EXP:PomBase.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   FunFam; 2.40.50.140:FF:000067; 26S protease regulatory subunit 4; 1.
DR   FunFam; 1.10.8.60:FF:000007; 26S proteasome regulatory subunit 4; 1.
DR   FunFam; 3.40.50.300:FF:000039; 26S proteasome regulatory subunit 4; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR050221; 26S_Proteasome_ATPase.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR032501; Prot_ATP_ID_OB_2nd.
DR   PANTHER; PTHR23073; 26S PROTEASOME REGULATORY SUBUNIT; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF17862; AAA_lid_3; 1.
DR   Pfam; PF16450; Prot_ATP_ID_OB_C; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00674; AAA; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cytoplasm; Nucleotide-binding; Nucleus; Proteasome;
KW   Reference proteome.
FT   CHAIN           1..448
FT                   /note=""26S proteasome regulatory subunit 4 homolog""
FT                   /id=""PRO_0000084684""
FT   REGION          1..58
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        1..10
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        19..31
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         232..239
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   448 AA;  50060 MW;  451AEEF6A24C29D4 CRC64;
     MGQAQSGNFS NFGDGANGDN KKDQKKDKPK YEPPVPTRTG RRKKKAQSGP DASAKLPTVI
     PTTRCRLRLL KMQRIHDHLL MEEEYVQNQE RLKPQDERTQ EERNRVDEIR GTPMSVGTLE
     EIIDDDHAIV STAGPEYYVS IMSFVDKDML EPGCSVLLHH KAMSIVGLLL DDTDPMINVM
     KLDKAPTESY ADIGGLESQI QEIKEAVELP LTHPELYEEM GIKPPKGVIL YGAPGTGKTL
     LAKAVANQTS ATFLRVVGSE LIQKYLGDGP RLVRQLFNAA EEHSPSIVFI DEIDAIGTKR
     YDAQSGAERE IQRTMLELLN QLDGFDTSQR DIKVIMATNR ISDLDPALIR PGRIDRKILF
     ENPDEATKRK IFTIHTSKMN LGEDVNLEEL IQCKDDLSGA EIKAIVSEAG LLALRERRMR
     VVMDDFRQAR EKVLKTKDEG GPAGGLYI
//
",36540
TCCCGC CCCGCG CCGCGC CGCGCT GCGCTG CGCTGA GCTGAT CTGATC TGATCC GATCCC ATCCCT TCCCTC CCCTCT CCTCTG CTCTGT TCTGTC CTGTCC TGTCCT GTCCTG TCCTGG CCTGGG CTGGGC TGGGCC GGGCCG GGCCGC GCCGCT CCGCTG CGCTGG GCTGGT CTGGTG TGGTGG GGTGGT GTGGTG TGGTGG GGTGGA GTGGAC TGGACC GGACCG GACCGT ACCGTC CCGTCG CGTCGA GTCGAC TCGACC CGACCG GACCGC ACCGCT CCGCTG CGCTGG GCTGGA CTGGAC TGGACG GGACGC GACGCT ACGCTG CGCTGG GCTGGG CTGGGG TGGGGG GGGGGC GGGGCG GGGCGA GGCGAT GCGATC CGATCG GATCGG ATCGGG TCGGGA CGGGAT GGGATC GGATCC GATCCT ATCCTG TCCTGA CCTGAT CTGATC TGATCG GATCGC ATCGCC TCGCCG CGCCGT GCCGTC CCGTCG CGTCGG GTCGGC TCGGCT CGGCTA GGCTAC GCTACA CTACAT TACATC ACATCA CATCAT ATCATG TCATGA CATGAT ATGATG TGATGC GATGCT ATGCTG TGCTGG GCTGGC CTGGCC TGGCCG GGCCGC GCCGCC CCGCCA CGCCAC GCCACG CCACGC CACGCC ACGCCA CGCCAT GCCATC CCATCG CATCGG ATCGGT TCGGTC CGGTCG GGTCGC GTCGCC TCGCCG CGCCGA GCCGAA CCGAAC CGAACG GAACGC,2,127,TCCC CCCG CCGC CGCG GCGC CGCT GCTG CTGA TGAT GATC ATCC TCCC CCCT CCTC CTCT TCTG CTGT TGTC GTCC TCCT CCTG CTGG TGGG GGGC GGCC GCCG CCGC CGCT GCTG CTGG TGGT GGTG GTGG TGGT GGTG GTGG TGGA GGAC GACC ACCG CCGT CGTC GTCG TCGA CGAC GACC ACCG CCGC CGCT GCTG CTGG TGGA GGAC GACG ACGC CGCT GCTG CTGG TGGG GGGG GGGG GGGC GGCG GCGA CGAT GATC ATCG TCGG CGGG GGGA GGAT GATC ATCC TCCT CCTG CTGA TGAT GATC ATCG TCGC CGCC GCCG CCGT CGTC GTCG TCGG CGGC GGCT GCTA CTAC TACA ACAT CATC ATCA TCAT CATG ATGA TGAT GATG ATGC TGCT GCTG CTGG TGGC GGCC GCCG CCGC CGCC GCCA CCAC CACG ACGC CGCC GCCA CCAT CATC ATCG TCGG CGGT GGTC GTCG TCGC CGCC GCCG CCGA CGAA GAAC AACG ACGC,TCCCG CCCGC CCGCG CGCGC GCGCT CGCTG GCTGA CTGAT TGATC GATCC ATCCC TCCCT CCCTC CCTCT CTCTG TCTGT CTGTC TGTCC GTCCT TCCTG CCTGG CTGGG TGGGC GGGCC GGCCG GCCGC CCGCT CGCTG GCTGG CTGGT TGGTG GGTGG GTGGT TGGTG GGTGG GTGGA TGGAC GGACC GACCG ACCGT CCGTC CGTCG GTCGA TCGAC CGACC GACCG ACCGC CCGCT CGCTG GCTGG CTGGA TGGAC GGACG GACGC ACGCT CGCTG GCTGG CTGGG TGGGG GGGGG GGGGC GGGCG GGCGA GCGAT CGATC GATCG ATCGG TCGGG CGGGA GGGAT GGATC GATCC ATCCT TCCTG CCTGA CTGAT TGATC GATCG ATCGC TCGCC CGCCG GCCGT CCGTC CGTCG GTCGG TCGGC CGGCT GGCTA GCTAC CTACA TACAT ACATC CATCA ATCAT TCATG CATGA ATGAT TGATG GATGC ATGCT TGCTG GCTGG CTGGC TGGCC GGCCG GCCGC CCGCC CGCCA GCCAC CCACG CACGC ACGCC CGCCA GCCAT CCATC CATCG ATCGG TCGGT CGGTC GGTCG GTCGC TCGCC CGCCG GCCGA CCGAA CGAAC GAACG AACGC,TCCCGC CCCGCG CCGCGC CGCGCT GCGCTG CGCTGA GCTGAT CTGATC TGATCC GATCCC ATCCCT TCCCTC CCCTCT CCTCTG CTCTGT TCTGTC CTGTCC TGTCCT GTCCTG TCCTGG CCTGGG CTGGGC TGGGCC GGGCCG GGCCGC GCCGCT CCGCTG CGCTGG GCTGGT CTGGTG TGGTGG GGTGGT GTGGTG TGGTGG GGTGGA GTGGAC TGGACC GGACCG GACCGT ACCGTC CCGTCG CGTCGA GTCGAC TCGACC CGACCG GACCGC ACCGCT CCGCTG CGCTGG GCTGGA CTGGAC TGGACG GGACGC GACGCT ACGCTG CGCTGG GCTGGG CTGGGG TGGGGG GGGGGC GGGGCG GGGCGA GGCGAT GCGATC CGATCG GATCGG ATCGGG TCGGGA CGGGAT GGGATC GGATCC GATCCT ATCCTG TCCTGA CCTGAT CTGATC TGATCG GATCGC ATCGCC TCGCCG CGCCGT GCCGTC CCGTCG CGTCGG GTCGGC TCGGCT CGGCTA GGCTAC GCTACA CTACAT TACATC ACATCA CATCAT ATCATG TCATGA CATGAT ATGATG TGATGC GATGCT ATGCTG TGCTGG GCTGGC CTGGCC TGGCCG GGCCGC GCCGCC CCGCCA CGCCAC GCCACG CCACGC CACGCC ACGCCA CGCCAT GCCATC CCATCG CATCGG ATCGGT TCGGTC CGGTCG GGTCGC GTCGCC TCGCCG CGCCGA GCCGAA CCGAAC CGAACG GAACGC,TCCCGCG CCCGCGC CCGCGCT CGCGCTG GCGCTGA CGCTGAT GCTGATC CTGATCC TGATCCC GATCCCT ATCCCTC TCCCTCT CCCTCTG CCTCTGT CTCTGTC TCTGTCC CTGTCCT TGTCCTG GTCCTGG TCCTGGG CCTGGGC CTGGGCC TGGGCCG GGGCCGC GGCCGCT GCCGCTG CCGCTGG CGCTGGT GCTGGTG CTGGTGG TGGTGGT GGTGGTG GTGGTGG TGGTGGA GGTGGAC GTGGACC TGGACCG GGACCGT GACCGTC ACCGTCG CCGTCGA CGTCGAC GTCGACC TCGACCG CGACCGC GACCGCT ACCGCTG CCGCTGG CGCTGGA GCTGGAC CTGGACG TGGACGC GGACGCT GACGCTG ACGCTGG CGCTGGG GCTGGGG CTGGGGG TGGGGGC GGGGGCG GGGGCGA GGGCGAT GGCGATC GCGATCG CGATCGG GATCGGG ATCGGGA TCGGGAT CGGGATC GGGATCC GGATCCT GATCCTG ATCCTGA TCCTGAT CCTGATC CTGATCG TGATCGC GATCGCC ATCGCCG TCGCCGT CGCCGTC GCCGTCG CCGTCGG CGTCGGC GTCGGCT TCGGCTA CGGCTAC GGCTACA GCTACAT CTACATC TACATCA ACATCAT CATCATG ATCATGA TCATGAT CATGATG ATGATGC TGATGCT GATGCTG ATGCTGG TGCTGGC GCTGGCC CTGGCCG TGGCCGC GGCCGCC GCCGCCA CCGCCAC CGCCACG GCCACGC CCACGCC CACGCCA ACGCCAT CGCCATC GCCATCG CCATCGG CATCGGT ATCGGTC TCGGTCG CGGTCGC GGTCGCC GTCGCCG TCGCCGA CGCCGAA GCCGAAC CCGAACG CGAACGC,"ID   FTSW_CAUVN              Reviewed;         390 AA.
AC   B8H092;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   05-FEB-2025, entry version 75.
DE   RecName: Full=Probable peptidoglycan glycosyltransferase FtsW {ECO:0000250|UniProtKB:P39604};
DE            Short=PGT {ECO:0000250|UniProtKB:P39604};
DE            EC=2.4.99.28 {ECO:0000250|UniProtKB:P39604};
DE   AltName: Full=Cell division protein FtsW {ECO:0000250|UniProtKB:O07639};
DE   AltName: Full=Cell wall polymerase {ECO:0000250|UniProtKB:P39604};
DE   AltName: Full=Peptidoglycan polymerase {ECO:0000250|UniProtKB:P39604};
DE            Short=PG polymerase {ECO:0000250|UniProtKB:P39604};
GN   Name=ftsW; OrderedLocusNames=CCNA_02635;
OS   Caulobacter vibrioides (strain NA1000 / CB15N) (Caulobacter crescentus).
OC   Bacteria; Pseudomonadota; Alphaproteobacteria; Caulobacterales;
OC   Caulobacteraceae; Caulobacter.
OX   NCBI_TaxID=565050;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NA1000 / CB15N;
RX   PubMed=20472802; DOI=10.1128/jb.00255-10;
RA   Marks M.E., Castro-Rojas C.M., Teiling C., Du L., Kapatral V.,
RA   Walunas T.L., Crosson S.;
RT   ""The genetic basis of laboratory adaptation in Caulobacter crescentus."";
RL   J. Bacteriol. 192:3678-3688(2010).
RN   [2]
RP   INTERACTION WITH FTSI; FTSN AND SIDA, AND MUTAGENESIS OF PHE-145 AND
RP   THR-180.
RC   STRAIN=NA1000 / CB15N;
RX   PubMed=21685367; DOI=10.1101/gad.2038911;
RA   Modell J.W., Hopkins A.C., Laub M.T.;
RT   ""A DNA damage checkpoint in Caulobacter crescentus inhibits cell division
RT   through a direct interaction with FtsW."";
RL   Genes Dev. 25:1328-1343(2011).
CC   -!- FUNCTION: Peptidoglycan polymerase that is essential for cell division.
CC       {ECO:0000250|UniProtKB:P39604}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-
CC         Ala)](n)-di-trans,octa-cis-undecaprenyl diphosphate + beta-D-GlcNAc-
CC         (1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-
CC         cis-undecaprenyl diphosphate = [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-
CC         D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-di-trans,octa-cis-undecaprenyl
CC         diphosphate + di-trans,octa-cis-undecaprenyl diphosphate + H(+);
CC         Xref=Rhea:RHEA:23708, Rhea:RHEA-COMP:9602, Rhea:RHEA-COMP:9603,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58405, ChEBI:CHEBI:60033,
CC         ChEBI:CHEBI:78435; EC=2.4.99.28;
CC         Evidence={ECO:0000250|UniProtKB:P39604};
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC       {ECO:0000250|UniProtKB:P39604}.
CC   -!- SUBUNIT: Interacts with FtsI, FtsN and the cell division inhibitor
CC       SidA. {ECO:0000269|PubMed:21685367}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=Localizes to the division septum.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SEDS family. FtsW subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001340; ACL96100.1; -; Genomic_DNA.
DR   RefSeq; WP_010920409.1; NC_011916.1.
DR   RefSeq; YP_002518008.1; NC_011916.1.
DR   AlphaFoldDB; B8H092; -.
DR   SMR; B8H092; -.
DR   DIP; DIP-61066N; -.
DR   IntAct; B8H092; 2.
DR   GeneID; 7332737; -.
DR   KEGG; ccs:CCNA_02635; -.
DR   PATRIC; fig|565050.3.peg.2583; -.
DR   HOGENOM; CLU_029243_1_1_5; -.
DR   OrthoDB; 9768187at2; -.
DR   PhylomeDB; B8H092; -.
DR   UniPathway; UPA00219; -.
DR   Proteomes; UP000001364; Chromosome.
DR   GO; GO:0032153; C:cell division site; IEA:TreeGrafter.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015648; F:lipid-linked peptidoglycan transporter activity; IEA:TreeGrafter.
DR   GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IEA:RHEA.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   InterPro; IPR013437; FtsW.
DR   InterPro; IPR001182; FtsW/RodA.
DR   NCBIfam; TIGR02614; ftsW; 1.
DR   PANTHER; PTHR30474; CELL CYCLE PROTEIN; 1.
DR   PANTHER; PTHR30474:SF2; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE FTSW-RELATED; 1.
DR   Pfam; PF01098; FTSW_RODA_SPOVE; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Cell inner membrane; Cell membrane; Cell shape;
KW   Cell wall biogenesis/degradation; Glycosyltransferase; Membrane;
KW   Peptidoglycan synthesis; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..390
FT                   /note=""Probable peptidoglycan glycosyltransferase FtsW""
FT                   /id=""PRO_0000420268""
FT   TRANSMEM        27..47
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        60..80
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        91..111
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        125..145
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        153..173
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        181..201
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        279..299
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        315..335
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        348..368
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   MUTAGEN         145
FT                   /note=""F->L: Decreases interaction with SidA.""
FT                   /evidence=""ECO:0000269|PubMed:21685367""
FT   MUTAGEN         180
FT                   /note=""T->A: Decreases interaction with SidA.""
FT                   /evidence=""ECO:0000269|PubMed:21685367""
SQ   SEQUENCE   390 AA;  42014 MW;  282DFE558231AB36 CRC64;
     MASNATHAFA RTDRTALGLW WWTTDRWLLG ATALLVTLGM LLSFASSPAA AQRIGIDDQF
     HFALRMCFFA TASSVLMLIT SMLSPRDIRR AAFFIYLGAI AVMIALPFIG HNAKGATRWL
     QFAGFTLQPS EFMKPALIVL VSWMFAEGQK GEGVPGVSIA FLLYFIAVAL LLIQPDVGQT
     VLITIAFGAA FWMAGVPISW IMGLGGVALA GLGSTYFLFD HVHARVQKFL SPDQADTHQI
     TRAAEAIRAG GLFGRGPGEG VMKRHVPDLH TDFIYSVAAE EYGLIFSWSL IGLFAFVVVR
     GLYKAMKLND PFEQVAAAGL FVLVGQQALI NIAVNLNMIP TKGMTLPFIS YGGSSMLAMG
     LTLGMALALL RKRPGAYGAS GEFGFGRADA
//
",64775
ATGGTG TGGTGG GGTGGG GTGGGC TGGGCG GGGCGA GGCGAC GCGACC CGACCC GACCCG ACCCGT CCCGTC CCGTCG CGTCGA GTCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGA GGCGAA GCGAAG CGAAGA GAAGAG AAGAGT AGAGTC GAGTCA AGTCAG GTCAGT TCAGTT CAGTTG AGTTGC GTTGCT TTGCTG TGCTGC GCTGCG CTGCGG TGCGGG GCGGGC CGGGCG GGGCGG GGCGGT GCGGTG CGGTGT GGTGTT GTGTTG TGTTGG GTTGGA TTGGAC TGGACA GGACAT GACATC ACATCG CATCGC ATCGCG TCGCGC CGCGCC GCGCCG CGCCGC GCCGCT CCGCTG CGCTGG GCTGGC CTGGCG TGGCGA GGCGAT GCGATA CGATAT GATATC ATATCG TATCGA ATCGAC TCGACG CGACGA GACGAC ACGACG CGACGG GACGGG ACGGGT CGGGTC GGGTCG GGTCGC GTCGCG TCGCGG CGCGGG GCGGGT CGGGTC GGGTCG GGTCGT GTCGTC TCGTCG CGTCGG GTCGGG TCGGGC CGGGCG GGGCGT GGCGTG GCGTGG CGTGGG GTGGGT TGGGTC GGGTCT GGTCTG GTCTGA TCTGAC CTGACG TGACGG GACGGC ACGGCG CGGCGG GGCGGC GCGGCG CGGCGG GGCGGT GCGGTG CGGTGA GGTGAC GTGACG TGACGT GACGTT ACGTTC CGTTCG GTTCGA TTCGAC TCGACA CGACAG GACAGC ACAGCG CAGCGA AGCGAG GCGAGA CGAGAC GAGACA AGACAG GACAGG ACAGGC CAGGCG AGGCGA GGCGAG GCGAGA CGAGAA GAGAAG AGAAGC GAAGCG AAGCGT,3,145,ATGG TGGT GGTG GTGG TGGG GGGC GGCG GCGA CGAC GACC ACCC CCCG CCGT CGTC GTCG TCGA CGAC GACG ACGG CGGC GGCG GCGA CGAA GAAG AAGA AGAG GAGT AGTC GTCA TCAG CAGT AGTT GTTG TTGC TGCT GCTG CTGC TGCG GCGG CGGG GGGC GGCG GCGG CGGT GGTG GTGT TGTT GTTG TTGG TGGA GGAC GACA ACAT CATC ATCG TCGC CGCG GCGC CGCC GCCG CCGC CGCT GCTG CTGG TGGC GGCG GCGA CGAT GATA ATAT TATC ATCG TCGA CGAC GACG ACGA CGAC GACG ACGG CGGG GGGT GGTC GTCG TCGC CGCG GCGG CGGG GGGT GGTC GTCG TCGT CGTC GTCG TCGG CGGG GGGC GGCG GCGT CGTG GTGG TGGG GGGT GGTC GTCT TCTG CTGA TGAC GACG ACGG CGGC GGCG GCGG CGGC GGCG GCGG CGGT GGTG GTGA TGAC GACG ACGT CGTT GTTC TTCG TCGA CGAC GACA ACAG CAGC AGCG GCGA CGAG GAGA AGAC GACA ACAG CAGG AGGC GGCG GCGA CGAG GAGA AGAA GAAG AAGC AGCG GCGT,ATGGT TGGTG GGTGG GTGGG TGGGC GGGCG GGCGA GCGAC CGACC GACCC ACCCG CCCGT CCGTC CGTCG GTCGA TCGAC CGACG GACGG ACGGC CGGCG GGCGA GCGAA CGAAG GAAGA AAGAG AGAGT GAGTC AGTCA GTCAG TCAGT CAGTT AGTTG GTTGC TTGCT TGCTG GCTGC CTGCG TGCGG GCGGG CGGGC GGGCG GGCGG GCGGT CGGTG GGTGT GTGTT TGTTG GTTGG TTGGA TGGAC GGACA GACAT ACATC CATCG ATCGC TCGCG CGCGC GCGCC CGCCG GCCGC CCGCT CGCTG GCTGG CTGGC TGGCG GGCGA GCGAT CGATA GATAT ATATC TATCG ATCGA TCGAC CGACG GACGA ACGAC CGACG GACGG ACGGG CGGGT GGGTC GGTCG GTCGC TCGCG CGCGG GCGGG CGGGT GGGTC GGTCG GTCGT TCGTC CGTCG GTCGG TCGGG CGGGC GGGCG GGCGT GCGTG CGTGG GTGGG TGGGT GGGTC GGTCT GTCTG TCTGA CTGAC TGACG GACGG ACGGC CGGCG GGCGG GCGGC CGGCG GGCGG GCGGT CGGTG GGTGA GTGAC TGACG GACGT ACGTT CGTTC GTTCG TTCGA TCGAC CGACA GACAG ACAGC CAGCG AGCGA GCGAG CGAGA GAGAC AGACA GACAG ACAGG CAGGC AGGCG GGCGA GCGAG CGAGA GAGAA AGAAG GAAGC AAGCG AGCGT,ATGGTG TGGTGG GGTGGG GTGGGC TGGGCG GGGCGA GGCGAC GCGACC CGACCC GACCCG ACCCGT CCCGTC CCGTCG CGTCGA GTCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGA GGCGAA GCGAAG CGAAGA GAAGAG AAGAGT AGAGTC GAGTCA AGTCAG GTCAGT TCAGTT CAGTTG AGTTGC GTTGCT TTGCTG TGCTGC GCTGCG CTGCGG TGCGGG GCGGGC CGGGCG GGGCGG GGCGGT GCGGTG CGGTGT GGTGTT GTGTTG TGTTGG GTTGGA TTGGAC TGGACA GGACAT GACATC ACATCG CATCGC ATCGCG TCGCGC CGCGCC GCGCCG CGCCGC GCCGCT CCGCTG CGCTGG GCTGGC CTGGCG TGGCGA GGCGAT GCGATA CGATAT GATATC ATATCG TATCGA ATCGAC TCGACG CGACGA GACGAC ACGACG CGACGG GACGGG ACGGGT CGGGTC GGGTCG GGTCGC GTCGCG TCGCGG CGCGGG GCGGGT CGGGTC GGGTCG GGTCGT GTCGTC TCGTCG CGTCGG GTCGGG TCGGGC CGGGCG GGGCGT GGCGTG GCGTGG CGTGGG GTGGGT TGGGTC GGGTCT GGTCTG GTCTGA TCTGAC CTGACG TGACGG GACGGC ACGGCG CGGCGG GGCGGC GCGGCG CGGCGG GGCGGT GCGGTG CGGTGA GGTGAC GTGACG TGACGT GACGTT ACGTTC CGTTCG GTTCGA TTCGAC TCGACA CGACAG GACAGC ACAGCG CAGCGA AGCGAG GCGAGA CGAGAC GAGACA AGACAG GACAGG ACAGGC CAGGCG AGGCGA GGCGAG GCGAGA CGAGAA GAGAAG AGAAGC GAAGCG AAGCGT,ATGGTGG TGGTGGG GGTGGGC GTGGGCG TGGGCGA GGGCGAC GGCGACC GCGACCC CGACCCG GACCCGT ACCCGTC CCCGTCG CCGTCGA CGTCGAC GTCGACG TCGACGG CGACGGC GACGGCG ACGGCGA CGGCGAA GGCGAAG GCGAAGA CGAAGAG GAAGAGT AAGAGTC AGAGTCA GAGTCAG AGTCAGT GTCAGTT TCAGTTG CAGTTGC AGTTGCT GTTGCTG TTGCTGC TGCTGCG GCTGCGG CTGCGGG TGCGGGC GCGGGCG CGGGCGG GGGCGGT GGCGGTG GCGGTGT CGGTGTT GGTGTTG GTGTTGG TGTTGGA GTTGGAC TTGGACA TGGACAT GGACATC GACATCG ACATCGC CATCGCG ATCGCGC TCGCGCC CGCGCCG GCGCCGC CGCCGCT GCCGCTG CCGCTGG CGCTGGC GCTGGCG CTGGCGA TGGCGAT GGCGATA GCGATAT CGATATC GATATCG ATATCGA TATCGAC ATCGACG TCGACGA CGACGAC GACGACG ACGACGG CGACGGG GACGGGT ACGGGTC CGGGTCG GGGTCGC GGTCGCG GTCGCGG TCGCGGG CGCGGGT GCGGGTC CGGGTCG GGGTCGT GGTCGTC GTCGTCG TCGTCGG CGTCGGG GTCGGGC TCGGGCG CGGGCGT GGGCGTG GGCGTGG GCGTGGG CGTGGGT GTGGGTC TGGGTCT GGGTCTG GGTCTGA GTCTGAC TCTGACG CTGACGG TGACGGC GACGGCG ACGGCGG CGGCGGC GGCGGCG GCGGCGG CGGCGGT GGCGGTG GCGGTGA CGGTGAC GGTGACG GTGACGT TGACGTT GACGTTC ACGTTCG CGTTCGA GTTCGAC TTCGACA TCGACAG CGACAGC GACAGCG ACAGCGA CAGCGAG AGCGAGA GCGAGAC CGAGACA GAGACAG AGACAGG GACAGGC ACAGGCG CAGGCGA AGGCGAG GGCGAGA GCGAGAA CGAGAAG GAGAAGC AGAAGCG GAAGCGT,"ID   MCM3_ORYSI              Reviewed;         770 AA.
AC   B8AZ99;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   05-FEB-2025, entry version 95.
DE   RecName: Full=DNA replication licensing factor MCM3;
DE            EC=3.6.4.12;
DE   AltName: Full=Minichromosome maintenance protein 3;
GN   Name=MCM3; ORFNames=OsI_20328;
OS   Oryza sativa subsp. indica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39946;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. 93-11;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H., Cong L.,
RA   Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J., Wang J.,
RA   Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X., Wang J., Wang X.,
RA   Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y., Zhang Z., Bao J., Han Y.,
RA   Dong L., Ji J., Chen P., Wu S., Liu J., Xiao Y., Bu D., Tan J., Yang L.,
RA   Ye C., Zhang J., Xu J., Zhou Y., Yu Y., Zhang B., Zhuang S., Wei H.,
RA   Liu B., Lei M., Yu H., Li Y., Xu H., Wei S., He X., Fang L., Zhang Z.,
RA   Zhang Y., Huang X., Su Z., Tong W., Li J., Tong Z., Li S., Ye J., Wang L.,
RA   Fang L., Lei T., Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F.,
RA   Xu H., Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q.,
RA   Li W., Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J.,
RA   Gao L., Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M.,
RA   McDermott J., Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   ""The genomes of Oryza sativa: a history of duplications."";
RL   PLoS Biol. 3:266-281(2005).
CC   -!- FUNCTION: Probable component of the MCM2-7 complex (MCM complex) that
CC       may function as a DNA helicase and which is essential to undergo a
CC       single round of replication initiation and elongation per cell cycle in
CC       eukaryotic cells. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- SUBUNIT: Component of the minichromosome maintenance (MCM) complex, a
CC       heterotetramer composed of MCM2, MCM3, MCM4, MCM5, MCM6 and MCM7.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MCM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CM000130; EEC79399.1; -; Genomic_DNA.
DR   AlphaFoldDB; B8AZ99; -.
DR   SMR; B8AZ99; -.
DR   STRING; 39946.B8AZ99; -.
DR   EnsemblPlants; BGIOSGA020045-TA; BGIOSGA020045-PA; BGIOSGA020045.
DR   Gramene; BGIOSGA020045-TA; BGIOSGA020045-PA; BGIOSGA020045.
DR   HOGENOM; CLU_000995_6_0_1; -.
DR   OMA; NVYPQED; -.
DR   Proteomes; UP000007015; Chromosome 5.
DR   GO; GO:0000785; C:chromatin; IEA:EnsemblPlants.
DR   GO; GO:0042555; C:MCM complex; IEA:InterPro.
DR   GO; GO:0000347; C:THO complex; IEA:EnsemblPlants.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0036121; F:double-stranded DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0061749; F:forked DNA-dependent helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009378; F:four-way junction helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:1990518; F:single-stranded 3'-5' DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003697; F:single-stranded DNA binding; IEA:TreeGrafter.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; IEA:TreeGrafter.
DR   GO; GO:0006268; P:DNA unwinding involved in DNA replication; IEA:UniProtKB-ARBA.
DR   GO; GO:0000727; P:double-strand break repair via break-induced replication; IEA:TreeGrafter.
DR   GO; GO:1902975; P:mitotic DNA replication initiation; IEA:TreeGrafter.
DR   CDD; cd17754; MCM3; 1.
DR   FunFam; 2.20.28.10:FF:000008; DNA helicase; 1.
DR   FunFam; 3.30.1640.10:FF:000012; DNA helicase; 1.
DR   Gene3D; 2.20.28.10; -; 1.
DR   Gene3D; 3.30.1640.10; mini-chromosome maintenance (MCM) complex, chain A, domain 1; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR031327; MCM.
DR   InterPro; IPR008046; Mcm3.
DR   InterPro; IPR018525; MCM_CS.
DR   InterPro; IPR001208; MCM_dom.
DR   InterPro; IPR041562; MCM_lid.
DR   InterPro; IPR027925; MCM_N.
DR   InterPro; IPR033762; MCM_OB.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11630; DNA REPLICATION LICENSING FACTOR MCM FAMILY MEMBER; 1.
DR   PANTHER; PTHR11630:SF46; DNA REPLICATION LICENSING FACTOR MCM3-RELATED; 1.
DR   Pfam; PF00493; MCM; 1.
DR   Pfam; PF17855; MCM_lid; 1.
DR   Pfam; PF14551; MCM_N; 1.
DR   Pfam; PF17207; MCM_OB; 1.
DR   PRINTS; PR01657; MCMFAMILY.
DR   PRINTS; PR01659; MCMPROTEIN3.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00350; MCM; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00847; MCM_1; 1.
DR   PROSITE; PS50051; MCM_2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell cycle; DNA replication; DNA-binding; Helicase; Hydrolase;
KW   Nucleotide-binding; Nucleus; Reference proteome.
FT   CHAIN           1..770
FT                   /note=""DNA replication licensing factor MCM3""
FT                   /id=""PRO_0000425990""
FT   DOMAIN          290..496
FT                   /note=""MCM""
FT   REGION          653..698
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   MOTIF           472..475
FT                   /note=""Arginine finger""
FT   COMPBIAS        653..670
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         340..347
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000250""
SQ   SEQUENCE   770 AA;  85402 MW;  92FFF7156A1662E4 CRC64;
     MDVNEEAMAA HKRAFLDFLD QDVGKGVYMQ AVRDMVQNKR HRLIIGMDDL RNHSLDLARR
     VIRSPAEYMQ PASDAVTEVA RNLDPKFLKE GQRVLVGFSG PFGFHRVTPR DLMSSFIGTM
     VCVEGIVTKC SLVRPKVVKS VHYCPATGGT LSREYRDITS FVGLPTGSVY PTRDENGNLL
     VTEYGMCEYK DHQTLSMQEV PENSAPGQLP RTVDIIVEDD LVDSCKPGDR VSIVGVYKAL
     PGKSKGSVSG VFRTVLIANN VSLMNKEANA PVYTREDLKR MKEISRRNDT FDLLGNSLAP
     SIYGHLWIKK AVVLLMLGGV EKNLKNGTHL RGDINMMMVG DPSVAKSQLL RAVMNIAPLA
     ISTTGRGSSG VGLTAAVTSD QETGERRLEA GAMVLADRGV VCIDEFDKMN DQDRVAIHEV
     MEQQTVTIAK AGIHASLNAR CSVIAAANPI YGTYDRSLTP TKNIGLPDSL LSRFDLLFIV
     LDQMDPEIDR QISEHVARMH RYCTDDGGAR SLDKTGYAEE DDGDVNAAIF VKYDRMLHGQ
     DRRRGKKSKQ DRLTVKFLKK YIHYAKNLIQ PRLTDEASDH IATSYAELRD GGANAKSGGG
     TLPITARTLE TIIRLSTAHA KMKLRHEVLK TDVEAALQVL NFAIYHKELT EMEEREQREM
     EMKQQADHDA GASGGNADEH RSSGNDPMDV DVGNASNDQD VPAERIEAFE AILGQHVLAN
     HLDQISIDEI EQTVNREAAA PYNRRQVEFI LERMQDANRI MIRDGIVRII
//
",46326
GACAGC ACAGCA CAGCAC AGCACC GCACCT CACCTT ACCTTC CCTTCG CTTCGC TTCGCT TCGCTG CGCTGC GCTGCC CTGCCA TGCCAT GCCATT CCATTG CATTGA ATTGAA TTGAAC TGAACT GAACTG AACTGA ACTGAA CTGAAG TGAAGG GAAGGA AAGGAC AGGACG GGACGC GACGCC ACGCCA CGCCAC GCCACC CCACCA CACCAG ACCAGC CCAGCT CAGCTT AGCTTC GCTTCG CTTCGA TTCGAC TCGACA CGACAT GACATG ACATGC CATGCT ATGCTC TGCTCA GCTCAA CTCAAA TCAAAG CAAAGG AAAGGC AAGGCG AGGCGC GGCGCG GCGCGA CGCGAC GCGACC CGACCT GACCTT ACCTTT CCTTTG CTTTGT TTTGTT TTGTTG TGTTGG GTTGGC TTGGCG TGGCGT GGCGTG GCGTGA CGTGAT GTGATC TGATCT GATCTC ATCTCG TCTCGC CTCGCT TCGCTG CGCTGA GCTGAT CTGATG TGATGG GATGGC ATGGCC TGGCCT GGCCTG GCCTGG CCTGGG CTGGGG TGGGGC GGGGCC GGGCCT GGCCTG GCCTGG CCTGGG CTGGGC TGGGCT GGGCTA GGCTAC GCTACT CTACTT TACTTC ACTTCG CTTCGG TTCGGC,2,109,GACA ACAG CAGC AGCA GCAC CACC ACCT CCTT CTTC TTCG TCGC CGCT GCTG CTGC TGCC GCCA CCAT CATT ATTG TTGA TGAA GAAC AACT ACTG CTGA TGAA GAAG AAGG AGGA GGAC GACG ACGC CGCC GCCA CCAC CACC ACCA CCAG CAGC AGCT GCTT CTTC TTCG TCGA CGAC GACA ACAT CATG ATGC TGCT GCTC CTCA TCAA CAAA AAAG AAGG AGGC GGCG GCGC CGCG GCGA CGAC GACC ACCT CCTT CTTT TTTG TTGT TGTT GTTG TTGG TGGC GGCG GCGT CGTG GTGA TGAT GATC ATCT TCTC CTCG TCGC CGCT GCTG CTGA TGAT GATG ATGG TGGC GGCC GCCT CCTG CTGG TGGG GGGG GGGC GGCC GCCT CCTG CTGG TGGG GGGC GGCT GCTA CTAC TACT ACTT CTTC TTCG TCGG CGGC,GACAG ACAGC CAGCA AGCAC GCACC CACCT ACCTT CCTTC CTTCG TTCGC TCGCT CGCTG GCTGC CTGCC TGCCA GCCAT CCATT CATTG ATTGA TTGAA TGAAC GAACT AACTG ACTGA CTGAA TGAAG GAAGG AAGGA AGGAC GGACG GACGC ACGCC CGCCA GCCAC CCACC CACCA ACCAG CCAGC CAGCT AGCTT GCTTC CTTCG TTCGA TCGAC CGACA GACAT ACATG CATGC ATGCT TGCTC GCTCA CTCAA TCAAA CAAAG AAAGG AAGGC AGGCG GGCGC GCGCG CGCGA GCGAC CGACC GACCT ACCTT CCTTT CTTTG TTTGT TTGTT TGTTG GTTGG TTGGC TGGCG GGCGT GCGTG CGTGA GTGAT TGATC GATCT ATCTC TCTCG CTCGC TCGCT CGCTG GCTGA CTGAT TGATG GATGG ATGGC TGGCC GGCCT GCCTG CCTGG CTGGG TGGGG GGGGC GGGCC GGCCT GCCTG CCTGG CTGGG TGGGC GGGCT GGCTA GCTAC CTACT TACTT ACTTC CTTCG TTCGG TCGGC,GACAGC ACAGCA CAGCAC AGCACC GCACCT CACCTT ACCTTC CCTTCG CTTCGC TTCGCT TCGCTG CGCTGC GCTGCC CTGCCA TGCCAT GCCATT CCATTG CATTGA ATTGAA TTGAAC TGAACT GAACTG AACTGA ACTGAA CTGAAG TGAAGG GAAGGA AAGGAC AGGACG GGACGC GACGCC ACGCCA CGCCAC GCCACC CCACCA CACCAG ACCAGC CCAGCT CAGCTT AGCTTC GCTTCG CTTCGA TTCGAC TCGACA CGACAT GACATG ACATGC CATGCT ATGCTC TGCTCA GCTCAA CTCAAA TCAAAG CAAAGG AAAGGC AAGGCG AGGCGC GGCGCG GCGCGA CGCGAC GCGACC CGACCT GACCTT ACCTTT CCTTTG CTTTGT TTTGTT TTGTTG TGTTGG GTTGGC TTGGCG TGGCGT GGCGTG GCGTGA CGTGAT GTGATC TGATCT GATCTC ATCTCG TCTCGC CTCGCT TCGCTG CGCTGA GCTGAT CTGATG TGATGG GATGGC ATGGCC TGGCCT GGCCTG GCCTGG CCTGGG CTGGGG TGGGGC GGGGCC GGGCCT GGCCTG GCCTGG CCTGGG CTGGGC TGGGCT GGGCTA GGCTAC GCTACT CTACTT TACTTC ACTTCG CTTCGG TTCGGC,GACAGCA ACAGCAC CAGCACC AGCACCT GCACCTT CACCTTC ACCTTCG CCTTCGC CTTCGCT TTCGCTG TCGCTGC CGCTGCC GCTGCCA CTGCCAT TGCCATT GCCATTG CCATTGA CATTGAA ATTGAAC TTGAACT TGAACTG GAACTGA AACTGAA ACTGAAG CTGAAGG TGAAGGA GAAGGAC AAGGACG AGGACGC GGACGCC GACGCCA ACGCCAC CGCCACC GCCACCA CCACCAG CACCAGC ACCAGCT CCAGCTT CAGCTTC AGCTTCG GCTTCGA CTTCGAC TTCGACA TCGACAT CGACATG GACATGC ACATGCT CATGCTC ATGCTCA TGCTCAA GCTCAAA CTCAAAG TCAAAGG CAAAGGC AAAGGCG AAGGCGC AGGCGCG GGCGCGA GCGCGAC CGCGACC GCGACCT CGACCTT GACCTTT ACCTTTG CCTTTGT CTTTGTT TTTGTTG TTGTTGG TGTTGGC GTTGGCG TTGGCGT TGGCGTG GGCGTGA GCGTGAT CGTGATC GTGATCT TGATCTC GATCTCG ATCTCGC TCTCGCT CTCGCTG TCGCTGA CGCTGAT GCTGATG CTGATGG TGATGGC GATGGCC ATGGCCT TGGCCTG GGCCTGG GCCTGGG CCTGGGG CTGGGGC TGGGGCC GGGGCCT GGGCCTG GGCCTGG GCCTGGG CCTGGGC CTGGGCT TGGGCTA GGGCTAC GGCTACT GCTACTT CTACTTC TACTTCG ACTTCGG CTTCGGC,"ID   PUTP_STAHJ              Reviewed;         512 AA.
AC   Q4L7L6;
DT   10-FEB-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   05-FEB-2025, entry version 120.
DE   RecName: Full=Sodium/proline symporter;
DE   AltName: Full=Proline permease;
GN   Name=putP; OrderedLocusNames=SH1050;
OS   Staphylococcus haemolyticus (strain JCSC1435).
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=279808;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JCSC1435;
RX   PubMed=16237012; DOI=10.1128/jb.187.21.7292-7308.2005;
RA   Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y.,
RA   Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., Lee J.C.,
RA   Hiramatsu K.;
RT   ""Whole-genome sequencing of Staphylococcus haemolyticus uncovers the
RT   extreme plasticity of its genome and the evolution of human-colonizing
RT   staphylococcal species."";
RL   J. Bacteriol. 187:7292-7308(2005).
CC   -!- FUNCTION: Catalyzes the sodium-dependent uptake of extracellular L-
CC       proline. {ECO:0000250|UniProtKB:P07117}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-proline(in) + Na(+)(in) = L-proline(out) + Na(+)(out);
CC         Xref=Rhea:RHEA:28967, ChEBI:CHEBI:29101, ChEBI:CHEBI:60039;
CC         Evidence={ECO:0000250|UniProtKB:P07117};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF) (TC 2.A.21)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE04359.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP006716; BAE04359.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; WP_016931028.1; NC_007168.1.
DR   AlphaFoldDB; Q4L7L6; -.
DR   SMR; Q4L7L6; -.
DR   GeneID; 93780434; -.
DR   KEGG; sha:SH1050; -.
DR   eggNOG; COG0591; Bacteria.
DR   HOGENOM; CLU_018808_15_2_9; -.
DR   OrthoDB; 9810181at2; -.
DR   Proteomes; UP000000543; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015193; F:L-proline transmembrane transporter activity; IEA:TreeGrafter.
DR   GO; GO:0005298; F:proline:sodium symporter activity; IEA:InterPro.
DR   GO; GO:0031402; F:sodium ion binding; IEA:InterPro.
DR   GO; GO:0015824; P:proline transport; IEA:InterPro.
DR   CDD; cd11475; SLC5sbd_PutP; 1.
DR   FunFam; 1.20.1730.10:FF:000002; Sodium/proline symporter; 1.
DR   Gene3D; 1.20.1730.10; Sodium/glucose cotransporter; 1.
DR   InterPro; IPR038377; Na/Glc_symporter_sf.
DR   InterPro; IPR011851; Na/Pro_symporter.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   InterPro; IPR018212; Na/solute_symporter_CS.
DR   InterPro; IPR050277; Sodium:Solute_Symporter.
DR   NCBIfam; TIGR02121; Na_Pro_sym; 1.
DR   NCBIfam; TIGR00813; sss; 1.
DR   PANTHER; PTHR48086; SODIUM/PROLINE SYMPORTER-RELATED; 1.
DR   PANTHER; PTHR48086:SF3; SODIUM_PROLINE SYMPORTER; 1.
DR   Pfam; PF00474; SSF; 1.
DR   PROSITE; PS00457; NA_SOLUT_SYMP_2; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   3: Inferred from homology;
KW   Amino-acid transport; Cell membrane; Ion transport; Membrane; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..512
FT                   /note=""Sodium/proline symporter""
FT                   /id=""PRO_0000364108""
FT   TRANSMEM        16..36
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        54..74
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        85..105
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        139..159
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        174..194
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        200..220
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        246..266
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        288..308
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        327..347
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        381..401
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        410..430
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        438..458
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        467..487
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   512 AA;  56122 MW;  AA5D80CABFC7CBFE CRC64;
     MLILGASLPS QVNTNWQTYI MIAIYFIILL IIGYYGYKQA TGNLSEYMLG GRSIGPYITA
     LSAGASDMSG WMIMGLPGSV YSTGLSAIWI TIGLTLGAYV NYLVVAPRLR VYTEVAGDAI
     TLPDFFKNRL NDKENIIKII SGLIIVVFFT LYTHSGFVSG GKLFESAFGL NYHFGLILVA
     VIVIAYTFFG GYLAVSITDF FQGVIMLIAM VMVPIVAMLQ LNGWDTFSRV AEMKPTNMDL
     FRGTTFLGIV SLFAWGLGYF GQPHIIVRFM SIKSQKMLPK ARRLGISWMT VGLLGAVGVG
     LTGIAFIPDN HIKMDDPETL FIIMSQILFH PLVGGFLLAA ILAAIMSTIS SQLLVTSSSL
     TEDFYKLIRG EERVKTHQKE FVLVGRLSVL VVAIVAIAIA WSPNDTILNL VGNAWAGFGA
     SFSPLVLFSL YWKKLTRAGA ISGMVAGALV VIIWIAWIKP LASINEIFGM YEIIPGFIIS
     VIVTYVVSLL TQHPGDFVER DIEKVKSIVR EK
//
",21977
TTCGAA TCGAAG CGAAGA GAAGAA AAGAAG AGAAGG GAAGGC AAGGCC AGGCCA GGCCAG GCCAGG CCAGGG CAGGGA AGGGAA GGGAAA GGAAAC GAAACG AAACGC AACGCA ACGCAG CGCAGT GCAGTC CAGTCG AGTCGA GTCGAA TCGAAA CGAAAT GAAATC AAATCA AATCAT ATCATC TCATCA CATCAG ATCAGG TCAGGC CAGGCA AGGCAC GGCACG GCACGG CACGGC ACGGCT CGGCTA GGCTAC GCTACA CTACAA TACAAA ACAAAT CAAATA AAATAC AATACG ATACGC TACGCG ACGCGC CGCGCA GCGCAG CGCAGG GCAGGA CAGGAC AGGACA GGACAA GACAAC ACAACG CAACGG AACGGC ACGGCT CGGCTT GGCTTC GCTTCG CTTCGA TTCGAC TCGACC CGACCT GACCTC ACCTCG CCTCGT CTCGTC TCGTCA CGTCAT GTCATC TCATCT CATCTA ATCTAC TCTACG CTACGA TACGAT ACGATA CGATAC GATACC ATACCG TACCGC ACCGCA CCGCAG CGCAGG GCAGGC CAGGCC AGGCCG GGCCGC GCCGCC CCGCCT CGCCTG GCCTGC CCTGCA CTGCAG TGCAGA GCAGAT CAGATA AGATAG GATAGA ATAGAC TAGACG AGACGA GACGAT ACGATA CGATAC GATACG ATACGC TACGCT ACGCTG CGCTGA GCTGAT CTGATG TGATGC GATGCA ATGCAG TGCAGG GCAGGA CAGGAA AGGAAC GGAACT GAACTC AACTCG ACTCGA CTCGAA TCGAAA CGAAAG GAAAGC AAAGCG AAGCGC AGCGCG GCGCGC CGCGCG GCGCGC,3,142,TTCG TCGA CGAA GAAG AAGA AGAA GAAG AAGG AGGC GGCC GCCA CCAG CAGG AGGG GGGA GGAA GAAA AAAC AACG ACGC CGCA GCAG CAGT AGTC GTCG TCGA CGAA GAAA AAAT AATC ATCA TCAT CATC ATCA TCAG CAGG AGGC GGCA GCAC CACG ACGG CGGC GGCT GCTA CTAC TACA ACAA CAAA AAAT AATA ATAC TACG ACGC CGCG GCGC CGCA GCAG CAGG AGGA GGAC GACA ACAA CAAC AACG ACGG CGGC GGCT GCTT CTTC TTCG TCGA CGAC GACC ACCT CCTC CTCG TCGT CGTC GTCA TCAT CATC ATCT TCTA CTAC TACG ACGA CGAT GATA ATAC TACC ACCG CCGC CGCA GCAG CAGG AGGC GGCC GCCG CCGC CGCC GCCT CCTG CTGC TGCA GCAG CAGA AGAT GATA ATAG TAGA AGAC GACG ACGA CGAT GATA ATAC TACG ACGC CGCT GCTG CTGA TGAT GATG ATGC TGCA GCAG CAGG AGGA GGAA GAAC AACT ACTC CTCG TCGA CGAA GAAA AAAG AAGC AGCG GCGC CGCG GCGC CGCG GCGC,TTCGA TCGAA CGAAG GAAGA AAGAA AGAAG GAAGG AAGGC AGGCC GGCCA GCCAG CCAGG CAGGG AGGGA GGGAA GGAAA GAAAC AAACG AACGC ACGCA CGCAG GCAGT CAGTC AGTCG GTCGA TCGAA CGAAA GAAAT AAATC AATCA ATCAT TCATC CATCA ATCAG TCAGG CAGGC AGGCA GGCAC GCACG CACGG ACGGC CGGCT GGCTA GCTAC CTACA TACAA ACAAA CAAAT AAATA AATAC ATACG TACGC ACGCG CGCGC GCGCA CGCAG GCAGG CAGGA AGGAC GGACA GACAA ACAAC CAACG AACGG ACGGC CGGCT GGCTT GCTTC CTTCG TTCGA TCGAC CGACC GACCT ACCTC CCTCG CTCGT TCGTC CGTCA GTCAT TCATC CATCT ATCTA TCTAC CTACG TACGA ACGAT CGATA GATAC ATACC TACCG ACCGC CCGCA CGCAG GCAGG CAGGC AGGCC GGCCG GCCGC CCGCC CGCCT GCCTG CCTGC CTGCA TGCAG GCAGA CAGAT AGATA GATAG ATAGA TAGAC AGACG GACGA ACGAT CGATA GATAC ATACG TACGC ACGCT CGCTG GCTGA CTGAT TGATG GATGC ATGCA TGCAG GCAGG CAGGA AGGAA GGAAC GAACT AACTC ACTCG CTCGA TCGAA CGAAA GAAAG AAAGC AAGCG AGCGC GCGCG CGCGC GCGCG CGCGC,TTCGAA TCGAAG CGAAGA GAAGAA AAGAAG AGAAGG GAAGGC AAGGCC AGGCCA GGCCAG GCCAGG CCAGGG CAGGGA AGGGAA GGGAAA GGAAAC GAAACG AAACGC AACGCA ACGCAG CGCAGT GCAGTC CAGTCG AGTCGA GTCGAA TCGAAA CGAAAT GAAATC AAATCA AATCAT ATCATC TCATCA CATCAG ATCAGG TCAGGC CAGGCA AGGCAC GGCACG GCACGG CACGGC ACGGCT CGGCTA GGCTAC GCTACA CTACAA TACAAA ACAAAT CAAATA AAATAC AATACG ATACGC TACGCG ACGCGC CGCGCA GCGCAG CGCAGG GCAGGA CAGGAC AGGACA GGACAA GACAAC ACAACG CAACGG AACGGC ACGGCT CGGCTT GGCTTC GCTTCG CTTCGA TTCGAC TCGACC CGACCT GACCTC ACCTCG CCTCGT CTCGTC TCGTCA CGTCAT GTCATC TCATCT CATCTA ATCTAC TCTACG CTACGA TACGAT ACGATA CGATAC GATACC ATACCG TACCGC ACCGCA CCGCAG CGCAGG GCAGGC CAGGCC AGGCCG GGCCGC GCCGCC CCGCCT CGCCTG GCCTGC CCTGCA CTGCAG TGCAGA GCAGAT CAGATA AGATAG GATAGA ATAGAC TAGACG AGACGA GACGAT ACGATA CGATAC GATACG ATACGC TACGCT ACGCTG CGCTGA GCTGAT CTGATG TGATGC GATGCA ATGCAG TGCAGG GCAGGA CAGGAA AGGAAC GGAACT GAACTC AACTCG ACTCGA CTCGAA TCGAAA CGAAAG GAAAGC AAAGCG AAGCGC AGCGCG GCGCGC CGCGCG GCGCGC,TTCGAAG TCGAAGA CGAAGAA GAAGAAG AAGAAGG AGAAGGC GAAGGCC AAGGCCA AGGCCAG GGCCAGG GCCAGGG CCAGGGA CAGGGAA AGGGAAA GGGAAAC GGAAACG GAAACGC AAACGCA AACGCAG ACGCAGT CGCAGTC GCAGTCG CAGTCGA AGTCGAA GTCGAAA TCGAAAT CGAAATC GAAATCA AAATCAT AATCATC ATCATCA TCATCAG CATCAGG ATCAGGC TCAGGCA CAGGCAC AGGCACG GGCACGG GCACGGC CACGGCT ACGGCTA CGGCTAC GGCTACA GCTACAA CTACAAA TACAAAT ACAAATA CAAATAC AAATACG AATACGC ATACGCG TACGCGC ACGCGCA CGCGCAG GCGCAGG CGCAGGA GCAGGAC CAGGACA AGGACAA GGACAAC GACAACG ACAACGG CAACGGC AACGGCT ACGGCTT CGGCTTC GGCTTCG GCTTCGA CTTCGAC TTCGACC TCGACCT CGACCTC GACCTCG ACCTCGT CCTCGTC CTCGTCA TCGTCAT CGTCATC GTCATCT TCATCTA CATCTAC ATCTACG TCTACGA CTACGAT TACGATA ACGATAC CGATACC GATACCG ATACCGC TACCGCA ACCGCAG CCGCAGG CGCAGGC GCAGGCC CAGGCCG AGGCCGC GGCCGCC GCCGCCT CCGCCTG CGCCTGC GCCTGCA CCTGCAG CTGCAGA TGCAGAT GCAGATA CAGATAG AGATAGA GATAGAC ATAGACG TAGACGA AGACGAT GACGATA ACGATAC CGATACG GATACGC ATACGCT TACGCTG ACGCTGA CGCTGAT GCTGATG CTGATGC TGATGCA GATGCAG ATGCAGG TGCAGGA GCAGGAA CAGGAAC AGGAACT GGAACTC GAACTCG AACTCGA ACTCGAA CTCGAAA TCGAAAG CGAAAGC GAAAGCG AAAGCGC AAGCGCG AGCGCGC GCGCGCG CGCGCGC,"ID   SRP54_SYNE7             Reviewed;         485 AA.
AC   Q55311; Q31MB8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-FEB-2025, entry version 138.
DE   RecName: Full=Signal recognition particle protein {ECO:0000255|HAMAP-Rule:MF_00306};
DE            EC=3.6.5.4 {ECO:0000255|HAMAP-Rule:MF_00306};
DE   AltName: Full=Fifty-four homolog {ECO:0000255|HAMAP-Rule:MF_00306};
GN   Name=ffh {ECO:0000255|HAMAP-Rule:MF_00306};
GN   OrderedLocusNames=Synpcc7942_1771;
OS   Synechococcus elongatus (strain ATCC 33912 / PCC 7942 / FACHB-805)
OS   (Anacystis nidulans R2).
OC   Bacteria; Bacillati; Cyanobacteriota; Cyanophyceae; Synechococcales;
OC   Synechococcaceae; Synechococcus.
OX   NCBI_TaxID=1140;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8605315; DOI=10.1007/bf00049341;
RA   Packer J.C.L., Howe C.J.;
RT   ""The cyanobacterial genome contains a single copy of the ffh gene encoding
RT   a homologue of the 54 kDa subunit of signal recognition particle."";
RL   Plant Mol. Biol. 30:659-665(1996).
RN   [2]
RP   ERRATUM OF PUBMED:8605315.
RX   PubMed=8756611;
RA   Packer J.C.L., Howe C.J.;
RL   Plant Mol. Biol. 31:659-665(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33912 / PCC 7942 / FACHB-805;
RG   US DOE Joint Genome Institute;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C., Glavina T.,
RA   Hammon N., Israni S., Pitluck S., Schmutz J., Larimer F., Land M.,
RA   Kyrpides N., Lykidis A., Golden S., Richardson P.;
RT   ""Complete sequence of chromosome 1 of Synechococcus elongatus PCC 7942."";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in targeting and insertion of nascent membrane
CC       proteins into the cytoplasmic membrane. Binds to the hydrophobic signal
CC       sequence of the ribosome-nascent chain (RNC) as it emerges from the
CC       ribosomes. The SRP-RNC complex is then targeted to the cytoplasmic
CC       membrane where it interacts with the SRP receptor FtsY.
CC       {ECO:0000255|HAMAP-Rule:MF_00306}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.4;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00306};
CC   -!- SUBUNIT: Part of the signal recognition particle protein translocation
CC       system, which is composed of SRP and FtsY. {ECO:0000255|HAMAP-
CC       Rule:MF_00306}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00306}.
CC       Note=The SRP-RNC complex is targeted to the cytoplasmic membrane.
CC       {ECO:0000255|HAMAP-Rule:MF_00306}.
CC   -!- DOMAIN: Composed of three domains: the N-terminal N domain, which is
CC       responsible for interactions with the ribosome, the central G domain,
CC       which binds GTP, and the C-terminal M domain, which binds the RNA and
CC       the signal sequence of the RNC. {ECO:0000255|HAMAP-Rule:MF_00306}.
CC   -!- SIMILARITY: Belongs to the GTP-binding SRP family. SRP54 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_00306}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABB57801.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X92071; CAA63054.1; -; Genomic_DNA.
DR   EMBL; CP000100; ABB57801.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; WP_039755651.1; NZ_JACJTX010000001.1.
DR   AlphaFoldDB; Q55311; -.
DR   SMR; Q55311; -.
DR   STRING; 1140.Synpcc7942_1771; -.
DR   PaxDb; 1140-Synpcc7942_1771; -.
DR   GeneID; 72430642; -.
DR   KEGG; syf:Synpcc7942_1771; -.
DR   eggNOG; COG0541; Bacteria.
DR   HOGENOM; CLU_009301_6_0_3; -.
DR   OrthoDB; 9804720at2; -.
DR   BioCyc; SYNEL:SYNPCC7942_1771-MONOMER; -.
DR   Proteomes; UP000889800; Chromosome.
DR   GO; GO:0048500; C:signal recognition particle; IEA:UniProtKB-UniRule.
DR   GO; GO:0008312; F:7S RNA binding; IEA:InterPro.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; IEA:InterPro.
DR   CDD; cd18539; SRP_G; 1.
DR   FunFam; 3.40.50.300:FF:000022; Signal recognition particle 54 kDa subunit; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.20.120.140; Signal recognition particle SRP54, nucleotide-binding domain; 1.
DR   Gene3D; 1.10.260.30; Signal recognition particle, SRP54 subunit, M-domain; 1.
DR   HAMAP; MF_00306; SRP54; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036891; Signal_recog_part_SRP54_M_sf.
DR   InterPro; IPR013822; Signal_recog_particl_SRP54_hlx.
DR   InterPro; IPR004125; Signal_recog_particle_SRP54_M.
DR   InterPro; IPR004780; SRP.
DR   InterPro; IPR022941; SRP54.
DR   InterPro; IPR000897; SRP54_GTPase_dom.
DR   InterPro; IPR042101; SRP54_N_sf.
DR   NCBIfam; TIGR00959; ffh; 1.
DR   PANTHER; PTHR11564; SIGNAL RECOGNITION PARTICLE 54K PROTEIN SRP54; 1.
DR   PANTHER; PTHR11564:SF5; SIGNAL RECOGNITION PARTICLE SUBUNIT SRP54; 1.
DR   Pfam; PF00448; SRP54; 1.
DR   Pfam; PF02881; SRP54_N; 1.
DR   Pfam; PF02978; SRP_SPB; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00962; SRP54; 1.
DR   SMART; SM00963; SRP54_N; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF47446; Signal peptide-binding domain; 1.
DR   PROSITE; PS00300; SRP54; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; GTP-binding; Hydrolase; Nucleotide-binding; Reference proteome;
KW   Ribonucleoprotein; RNA-binding; Signal recognition particle.
FT   CHAIN           1..485
FT                   /note=""Signal recognition particle protein""
FT                   /id=""PRO_0000101168""
FT   REGION          452..485
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        471..485
FT                   /note=""Basic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         107..114
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00306""
FT   BINDING         189..193
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00306""
FT   BINDING         247..250
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00306""
SQ   SEQUENCE   485 AA;  52820 MW;  789F3509127537AA CRC64;
     MFDALAERLE QAWTKLRGQD KISESNVQEA LKEVRRALLE ADVNLGVVKE FIAQVQEKAV
     GTQVISGIRP DQQFIKVVYD ELVQVMGETH VPLAQAAKAP TVILMAGLQG AGKTTATAKL
     ALHLRKEGRS TLLVATDVYR PAAIDQLITL GKQIDVPVFE LGSDANPVEI ARQGVEKARQ
     EGIDTVIVDT AGRLQIDTEM MEELAQVKEA IAPHEVLLVV DSMIGQEAAS LTRSFHERIG
     ITGAILTKLD GDSRGGAALS IRRVSGQPIK FVGLGEKVEA LQPFHPERMA SRILGMGDVL
     TLVEKAQEEI DLADVEKMQE KILAAKFDFT DFLKQMRLLK NMGSLAGFIK LIPGLGGKIN
     DEQLRQGERQ LKRVEAMINS MTPQERRDPD LLSNSPSRRH RIAKGCGQTE AEIRQIIQQF
     QQMRTMMQQM SQGGFPGMGG MGMPGFGGGM PGFGGGAPAP QPGFRGYGPP KKQKKGSKKK
     KGFGL
//
",30705
CCTCCT CTCCTG TCCTGG CCTGGT CTGGTG TGGTGC GGTGCC GTGCCC TGCCCC GCCCCT CCCCTG CCCTGT CCTGTC CTGTCG TGTCGT GTCGTG TCGTGT CGTGTC GTGTCC TGTCCT GTCCTC TCCTCG CCTCGC CTCGCT TCGCTG CGCTGC GCTGCC CTGCCC TGCCCG GCCCGG CCCGGC CCGGCG CGGCGA GGCGAG GCGAGC CGAGCC GAGCCT AGCCTG GCCTGC CCTGCT CTGCTG TGCTGC GCTGCT CTGCTG TGCTGA GCTGAC CTGACC TGACCT GACCTC ACCTCG CCTCGG CTCGGT TCGGTC CGGTCA GGTCAA GTCAAG TCAAGC CAAGCC AAGCCC AGCCCT GCCCTG CCCTGC CCTGCG CTGCGC TGCGCA GCGCAC CGCACG GCACGG CACGGT ACGGTG CGGTGC GGTGCC GTGCCC TGCCCC GCCCCG CCCCGG CCCGGG CCGGGC CGGGCC GGGCCG GGCCGC GCCGCA CCGCAC CGCACC GCACCC CACCCC ACCCCG CCCCGG CCCGGG CCGGGC CGGGCC GGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCA ACGCAC CGCACG GCACGG CACGGA ACGGAA CGGAAA GGAAAT GAAATC AAATCC AATCCA ATCCAG TCCAGA CCAGAT CAGATC AGATCC GATCCG ATCCGT TCCGTG CCGTGG CGTGGG GTGGGG TGGGGC GGGGCC GGGCCC GGCCCG GCCCGC CCCGCA CCGCAC CGCACG GCACGC CACGCA ACGCAC CGCACA GCACAA CACAAC ACAACC CAACCT AACCTG ACCTGA CCTGAA CTGAAA TGAAAA GAAAAA AAAAAC,2,142,CCTC CTCC TCCT CCTG CTGG TGGT GGTG GTGC TGCC GCCC CCCC CCCT CCTG CTGT TGTC GTCG TCGT CGTG GTGT TGTC GTCC TCCT CCTC CTCG TCGC CGCT GCTG CTGC TGCC GCCC CCCG CCGG CGGC GGCG GCGA CGAG GAGC AGCC GCCT CCTG CTGC TGCT GCTG CTGC TGCT GCTG CTGA TGAC GACC ACCT CCTC CTCG TCGG CGGT GGTC GTCA TCAA CAAG AAGC AGCC GCCC CCCT CCTG CTGC TGCG GCGC CGCA GCAC CACG ACGG CGGT GGTG GTGC TGCC GCCC CCCC CCCG CCGG CGGG GGGC GGCC GCCG CCGC CGCA GCAC CACC ACCC CCCC CCCG CCGG CGGG GGGC GGCC GCCG CCGA CGAA GAAC AACG ACGC CGCA GCAC CACG ACGG CGGA GGAA GAAA AAAT AATC ATCC TCCA CCAG CAGA AGAT GATC ATCC TCCG CCGT CGTG GTGG TGGG GGGG GGGC GGCC GCCC CCCG CCGC CGCA GCAC CACG ACGC CGCA GCAC CACA ACAA CAAC AACC ACCT CCTG CTGA TGAA GAAA AAAA AAAA AAAC,CCTCC CTCCT TCCTG CCTGG CTGGT TGGTG GGTGC GTGCC TGCCC GCCCC CCCCT CCCTG CCTGT CTGTC TGTCG GTCGT TCGTG CGTGT GTGTC TGTCC GTCCT TCCTC CCTCG CTCGC TCGCT CGCTG GCTGC CTGCC TGCCC GCCCG CCCGG CCGGC CGGCG GGCGA GCGAG CGAGC GAGCC AGCCT GCCTG CCTGC CTGCT TGCTG GCTGC CTGCT TGCTG GCTGA CTGAC TGACC GACCT ACCTC CCTCG CTCGG TCGGT CGGTC GGTCA GTCAA TCAAG CAAGC AAGCC AGCCC GCCCT CCCTG CCTGC CTGCG TGCGC GCGCA CGCAC GCACG CACGG ACGGT CGGTG GGTGC GTGCC TGCCC GCCCC CCCCG CCCGG CCGGG CGGGC GGGCC GGCCG GCCGC CCGCA CGCAC GCACC CACCC ACCCC CCCCG CCCGG CCGGG CGGGC GGGCC GGCCG GCCGA CCGAA CGAAC GAACG AACGC ACGCA CGCAC GCACG CACGG ACGGA CGGAA GGAAA GAAAT AAATC AATCC ATCCA TCCAG CCAGA CAGAT AGATC GATCC ATCCG TCCGT CCGTG CGTGG GTGGG TGGGG GGGGC GGGCC GGCCC GCCCG CCCGC CCGCA CGCAC GCACG CACGC ACGCA CGCAC GCACA CACAA ACAAC CAACC AACCT ACCTG CCTGA CTGAA TGAAA GAAAA AAAAA AAAAC,CCTCCT CTCCTG TCCTGG CCTGGT CTGGTG TGGTGC GGTGCC GTGCCC TGCCCC GCCCCT CCCCTG CCCTGT CCTGTC CTGTCG TGTCGT GTCGTG TCGTGT CGTGTC GTGTCC TGTCCT GTCCTC TCCTCG CCTCGC CTCGCT TCGCTG CGCTGC GCTGCC CTGCCC TGCCCG GCCCGG CCCGGC CCGGCG CGGCGA GGCGAG GCGAGC CGAGCC GAGCCT AGCCTG GCCTGC CCTGCT CTGCTG TGCTGC GCTGCT CTGCTG TGCTGA GCTGAC CTGACC TGACCT GACCTC ACCTCG CCTCGG CTCGGT TCGGTC CGGTCA GGTCAA GTCAAG TCAAGC CAAGCC AAGCCC AGCCCT GCCCTG CCCTGC CCTGCG CTGCGC TGCGCA GCGCAC CGCACG GCACGG CACGGT ACGGTG CGGTGC GGTGCC GTGCCC TGCCCC GCCCCG CCCCGG CCCGGG CCGGGC CGGGCC GGGCCG GGCCGC GCCGCA CCGCAC CGCACC GCACCC CACCCC ACCCCG CCCCGG CCCGGG CCGGGC CGGGCC GGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCA ACGCAC CGCACG GCACGG CACGGA ACGGAA CGGAAA GGAAAT GAAATC AAATCC AATCCA ATCCAG TCCAGA CCAGAT CAGATC AGATCC GATCCG ATCCGT TCCGTG CCGTGG CGTGGG GTGGGG TGGGGC GGGGCC GGGCCC GGCCCG GCCCGC CCCGCA CCGCAC CGCACG GCACGC CACGCA ACGCAC CGCACA GCACAA CACAAC ACAACC CAACCT AACCTG ACCTGA CCTGAA CTGAAA TGAAAA GAAAAA AAAAAC,CCTCCTG CTCCTGG TCCTGGT CCTGGTG CTGGTGC TGGTGCC GGTGCCC GTGCCCC TGCCCCT GCCCCTG CCCCTGT CCCTGTC CCTGTCG CTGTCGT TGTCGTG GTCGTGT TCGTGTC CGTGTCC GTGTCCT TGTCCTC GTCCTCG TCCTCGC CCTCGCT CTCGCTG TCGCTGC CGCTGCC GCTGCCC CTGCCCG TGCCCGG GCCCGGC CCCGGCG CCGGCGA CGGCGAG GGCGAGC GCGAGCC CGAGCCT GAGCCTG AGCCTGC GCCTGCT CCTGCTG CTGCTGC TGCTGCT GCTGCTG CTGCTGA TGCTGAC GCTGACC CTGACCT TGACCTC GACCTCG ACCTCGG CCTCGGT CTCGGTC TCGGTCA CGGTCAA GGTCAAG GTCAAGC TCAAGCC CAAGCCC AAGCCCT AGCCCTG GCCCTGC CCCTGCG CCTGCGC CTGCGCA TGCGCAC GCGCACG CGCACGG GCACGGT CACGGTG ACGGTGC CGGTGCC GGTGCCC GTGCCCC TGCCCCG GCCCCGG CCCCGGG CCCGGGC CCGGGCC CGGGCCG GGGCCGC GGCCGCA GCCGCAC CCGCACC CGCACCC GCACCCC CACCCCG ACCCCGG CCCCGGG CCCGGGC CCGGGCC CGGGCCG GGGCCGA GGCCGAA GCCGAAC CCGAACG CGAACGC GAACGCA AACGCAC ACGCACG CGCACGG GCACGGA CACGGAA ACGGAAA CGGAAAT GGAAATC GAAATCC AAATCCA AATCCAG ATCCAGA TCCAGAT CCAGATC CAGATCC AGATCCG GATCCGT ATCCGTG TCCGTGG CCGTGGG CGTGGGG GTGGGGC TGGGGCC GGGGCCC GGGCCCG GGCCCGC GCCCGCA CCCGCAC CCGCACG CGCACGC GCACGCA CACGCAC ACGCACA CGCACAA GCACAAC CACAACC ACAACCT CAACCTG AACCTGA ACCTGAA CCTGAAA CTGAAAA TGAAAAA GAAAAAC,"ID   UVRA_SERMA              Reviewed;          74 AA.
AC   P25735;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   03-MAY-2023, entry version 84.
DE   RecName: Full=UvrABC system protein A;
DE            Short=UvrA protein;
DE   AltName: Full=Excinuclease ABC subunit A;
DE   Flags: Fragment;
GN   Name=uvrA;
OS   Serratia marcescens.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Yersiniaceae; Serratia.
OX   NCBI_TaxID=615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sr41;
RX   PubMed=8486286; DOI=10.1016/0378-1119(93)90614-9;
RA   de Vries J., Wackernagel W.;
RT   ""Cloning and sequencing of the Serratia marcescens gene encoding a single-
RT   stranded DNA-binding protein (SSB) and its promoter region."";
RL   Gene 127:39-45(1993).
CC   -!- FUNCTION: The UvrABC repair system catalyzes the recognition and
CC       processing of DNA lesions. UvrA is an ATPase and a DNA-binding protein.
CC       A damage recognition complex composed of 2 UvrA and 2 UvrB subunits
CC       scans DNA for abnormalities. When the presence of a lesion has been
CC       verified by UvrB, the UvrA molecules dissociate (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Forms a heterotetramer with UvrB during the search for
CC       lesions. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. UvrA family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X65080; CAA46207.1; -; Genomic_DNA.
DR   PIR; PN0540; PN0540.
DR   AlphaFoldDB; P25735; -.
DR   SMR; P25735; -.
DR   STRING; 273526.SMDB11_3694; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004518; F:nuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0009432; P:SOS response; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR43152; UVRABC SYSTEM PROTEIN A; 1.
DR   PANTHER; PTHR43152:SF3; UVRABC SYSTEM PROTEIN A; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cytoplasm; DNA damage; DNA excision; DNA repair; DNA-binding;
KW   Excision nuclease; Nucleotide-binding; Repeat; SOS response.
FT   CHAIN           1..>74
FT                   /note=""UvrABC system protein A""
FT                   /id=""PRO_0000093087""
FT   BINDING         31..38
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""
FT   NON_TER         74
SQ   SEQUENCE   74 AA;  8283 MW;  9F57E8D37702D3D1 CRC64;
     MDNIEVRGAR THNLKNINLI IPRDKLIVVT GLSGSGKSSL AFDTLYAEGQ RRYVESLSAY
     ARQFLSLMEK PDVD
//
",27284
GAACTT AACTTA ACTTAC CTTACA TTACAC TACACC ACACCA CACCAG ACCAGT CCAGTT CAGTTG AGTTGT GTTGTT TTGTTC TGTTCA GTTCAG TTCAGA TCAGAC CAGACT AGACTA GACTAT ACTATT CTATTG TATTGA ATTGAA TTGAAG TGAAGT GAAGTG AAGTGA AGTGAA GTGAAT TGAATA GAATAG AATAGT ATAGTT TAGTTT AGTTTT GTTTTA TTTTAG TTTAGT TTAGTG TAGTGG AGTGGT GTGGTT TGGTTA GGTTAT GTTATT TTATTT TATTTA ATTTAA TTTAAA TTAAAA TAAAAC AAAACT AAACTT AACTTA ACTTAC CTTACT TTACTG TACTGA ACTGAC,0,61,GAAC AACT ACTT CTTA TTAC TACA ACAC CACC ACCA CCAG CAGT AGTT GTTG TTGT TGTT GTTC TTCA TCAG CAGA AGAC GACT ACTA CTAT TATT ATTG TTGA TGAA GAAG AAGT AGTG GTGA TGAA GAAT AATA ATAG TAGT AGTT GTTT TTTT TTTA TTAG TAGT AGTG GTGG TGGT GGTT GTTA TTAT TATT ATTT TTTA TTAA TAAA AAAA AAAC AACT ACTT CTTA TTAC TACT ACTG CTGA TGAC,GAACT AACTT ACTTA CTTAC TTACA TACAC ACACC CACCA ACCAG CCAGT CAGTT AGTTG GTTGT TTGTT TGTTC GTTCA TTCAG TCAGA CAGAC AGACT GACTA ACTAT CTATT TATTG ATTGA TTGAA TGAAG GAAGT AAGTG AGTGA GTGAA TGAAT GAATA AATAG ATAGT TAGTT AGTTT GTTTT TTTTA TTTAG TTAGT TAGTG AGTGG GTGGT TGGTT GGTTA GTTAT TTATT TATTT ATTTA TTTAA TTAAA TAAAA AAAAC AAACT AACTT ACTTA CTTAC TTACT TACTG ACTGA CTGAC,GAACTT AACTTA ACTTAC CTTACA TTACAC TACACC ACACCA CACCAG ACCAGT CCAGTT CAGTTG AGTTGT GTTGTT TTGTTC TGTTCA GTTCAG TTCAGA TCAGAC CAGACT AGACTA GACTAT ACTATT CTATTG TATTGA ATTGAA TTGAAG TGAAGT GAAGTG AAGTGA AGTGAA GTGAAT TGAATA GAATAG AATAGT ATAGTT TAGTTT AGTTTT GTTTTA TTTTAG TTTAGT TTAGTG TAGTGG AGTGGT GTGGTT TGGTTA GGTTAT GTTATT TTATTT TATTTA ATTTAA TTTAAA TTAAAA TAAAAC AAAACT AAACTT AACTTA ACTTAC CTTACT TTACTG TACTGA ACTGAC,GAACTTA AACTTAC ACTTACA CTTACAC TTACACC TACACCA ACACCAG CACCAGT ACCAGTT CCAGTTG CAGTTGT AGTTGTT GTTGTTC TTGTTCA TGTTCAG GTTCAGA TTCAGAC TCAGACT CAGACTA AGACTAT GACTATT ACTATTG CTATTGA TATTGAA ATTGAAG TTGAAGT TGAAGTG GAAGTGA AAGTGAA AGTGAAT GTGAATA TGAATAG GAATAGT AATAGTT ATAGTTT TAGTTTT AGTTTTA GTTTTAG TTTTAGT TTTAGTG TTAGTGG TAGTGGT AGTGGTT GTGGTTA TGGTTAT GGTTATT GTTATTT TTATTTA TATTTAA ATTTAAA TTTAAAA TTAAAAC TAAAACT AAAACTT AAACTTA AACTTAC ACTTACT CTTACTG TTACTGA TACTGAC,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",7189
TCTATA CTATAG TATAGT ATAGTA TAGTAG AGTAGC GTAGCT TAGCTG AGCTGG GCTGGT CTGGTG TGGTGG GGTGGT GTGGTA TGGTAT GGTATT GTATTG TATTGT ATTGTG TTGTGG TGTGGC GTGGCT TGGCTA GGCTAT GCTATC CTATCG TATCGT ATCGTA TCGTAG CGTAGT GTAGTA TAGTAA AGTAAC GTAACA TAACAT AACATG ACATGC CATGCC ATGCCT TGCCTT GCCTTG CCTTGC CTTGCC TTGCCT TGCCTA GCCTAC CCTACT CTACTA TACTAT ACTATT CTATTT TATTTT ATTTTA TTTTAT TTTATG TTATGA TATGAG ATGAGG TGAGGT GAGGTT AGGTTT GGTTTA GTTTAG TTTAGA TTAGAA TAGAAG AGAAGA,0,67,TCTA CTAT TATA ATAG TAGT AGTA GTAG TAGC AGCT GCTG CTGG TGGT GGTG GTGG TGGT GGTA GTAT TATT ATTG TTGT TGTG GTGG TGGC GGCT GCTA CTAT TATC ATCG TCGT CGTA GTAG TAGT AGTA GTAA TAAC AACA ACAT CATG ATGC TGCC GCCT CCTT CTTG TTGC TGCC GCCT CCTA CTAC TACT ACTA CTAT TATT ATTT TTTT TTTA TTAT TATG ATGA TGAG GAGG AGGT GGTT GTTT TTTA TTAG TAGA AGAA GAAG AAGA,TCTAT CTATA TATAG ATAGT TAGTA AGTAG GTAGC TAGCT AGCTG GCTGG CTGGT TGGTG GGTGG GTGGT TGGTA GGTAT GTATT TATTG ATTGT TTGTG TGTGG GTGGC TGGCT GGCTA GCTAT CTATC TATCG ATCGT TCGTA CGTAG GTAGT TAGTA AGTAA GTAAC TAACA AACAT ACATG CATGC ATGCC TGCCT GCCTT CCTTG CTTGC TTGCC TGCCT GCCTA CCTAC CTACT TACTA ACTAT CTATT TATTT ATTTT TTTTA TTTAT TTATG TATGA ATGAG TGAGG GAGGT AGGTT GGTTT GTTTA TTTAG TTAGA TAGAA AGAAG GAAGA,TCTATA CTATAG TATAGT ATAGTA TAGTAG AGTAGC GTAGCT TAGCTG AGCTGG GCTGGT CTGGTG TGGTGG GGTGGT GTGGTA TGGTAT GGTATT GTATTG TATTGT ATTGTG TTGTGG TGTGGC GTGGCT TGGCTA GGCTAT GCTATC CTATCG TATCGT ATCGTA TCGTAG CGTAGT GTAGTA TAGTAA AGTAAC GTAACA TAACAT AACATG ACATGC CATGCC ATGCCT TGCCTT GCCTTG CCTTGC CTTGCC TTGCCT TGCCTA GCCTAC CCTACT CTACTA TACTAT ACTATT CTATTT TATTTT ATTTTA TTTTAT TTTATG TTATGA TATGAG ATGAGG TGAGGT GAGGTT AGGTTT GGTTTA GTTTAG TTTAGA TTAGAA TAGAAG AGAAGA,TCTATAG CTATAGT TATAGTA ATAGTAG TAGTAGC AGTAGCT GTAGCTG TAGCTGG AGCTGGT GCTGGTG CTGGTGG TGGTGGT GGTGGTA GTGGTAT TGGTATT GGTATTG GTATTGT TATTGTG ATTGTGG TTGTGGC TGTGGCT GTGGCTA TGGCTAT GGCTATC GCTATCG CTATCGT TATCGTA ATCGTAG TCGTAGT CGTAGTA GTAGTAA TAGTAAC AGTAACA GTAACAT TAACATG AACATGC ACATGCC CATGCCT ATGCCTT TGCCTTG GCCTTGC CCTTGCC CTTGCCT TTGCCTA TGCCTAC GCCTACT CCTACTA CTACTAT TACTATT ACTATTT CTATTTT TATTTTA ATTTTAT TTTTATG TTTATGA TTATGAG TATGAGG ATGAGGT TGAGGTT GAGGTTT AGGTTTA GGTTTAG GTTTAGA TTTAGAA TTAGAAG TAGAAGA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",6580
GTCGCA TCGCAC CGCACA GCACAA CACAAA ACAAAC CAAACG AAACGG AACGGC ACGGCC CGGCCT GGCCTT GCCTTC CCTTCC CTTCCC TTCCCG TCCCGC CCCGCA CCGCAC CGCACC GCACCA CACCAG ACCAGG CCAGGC CAGGCC AGGCCA GGCCAA GCCAAC CCAACG CAACGG AACGGC ACGGCA CGGCAG GGCAGC GCAGCC CAGCCT AGCCTC GCCTCA CCTCAT CTCATC TCATCA CATCAC ATCACC TCACCC CACCCA ACCCAG CCCAGG CCAGGG CAGGGT AGGGTG GGGTGG GGTGGC GTGGCA TGGCAC GGCACG GCACGA CACGAC ACGACA CGACAG GACAGT ACAGTG CAGTGG AGTGGG GTGGGC TGGGCT GGGCTC GGCTCC GCTCCG CTCCGA TCCGAG CCGAGC CGAGCT GAGCTG AGCTGA GCTGAT CTGATC TGATCG GATCGG ATCGGC TCGGCC CGGCCA GGCCAG GCCAGT CCAGTC CAGTCG AGTCGT GTCGTT TCGTTC,2,88,GTCG TCGC CGCA GCAC CACA ACAA CAAA AAAC AACG ACGG CGGC GGCC GCCT CCTT CTTC TTCC TCCC CCCG CCGC CGCA GCAC CACC ACCA CCAG CAGG AGGC GGCC GCCA CCAA CAAC AACG ACGG CGGC GGCA GCAG CAGC AGCC GCCT CCTC CTCA TCAT CATC ATCA TCAC CACC ACCC CCCA CCAG CAGG AGGG GGGT GGTG GTGG TGGC GGCA GCAC CACG ACGA CGAC GACA ACAG CAGT AGTG GTGG TGGG GGGC GGCT GCTC CTCC TCCG CCGA CGAG GAGC AGCT GCTG CTGA TGAT GATC ATCG TCGG CGGC GGCC GCCA CCAG CAGT AGTC GTCG TCGT CGTT GTTC,GTCGC TCGCA CGCAC GCACA CACAA ACAAA CAAAC AAACG AACGG ACGGC CGGCC GGCCT GCCTT CCTTC CTTCC TTCCC TCCCG CCCGC CCGCA CGCAC GCACC CACCA ACCAG CCAGG CAGGC AGGCC GGCCA GCCAA CCAAC CAACG AACGG ACGGC CGGCA GGCAG GCAGC CAGCC AGCCT GCCTC CCTCA CTCAT TCATC CATCA ATCAC TCACC CACCC ACCCA CCCAG CCAGG CAGGG AGGGT GGGTG GGTGG GTGGC TGGCA GGCAC GCACG CACGA ACGAC CGACA GACAG ACAGT CAGTG AGTGG GTGGG TGGGC GGGCT GGCTC GCTCC CTCCG TCCGA CCGAG CGAGC GAGCT AGCTG GCTGA CTGAT TGATC GATCG ATCGG TCGGC CGGCC GGCCA GCCAG CCAGT CAGTC AGTCG GTCGT TCGTT CGTTC,GTCGCA TCGCAC CGCACA GCACAA CACAAA ACAAAC CAAACG AAACGG AACGGC ACGGCC CGGCCT GGCCTT GCCTTC CCTTCC CTTCCC TTCCCG TCCCGC CCCGCA CCGCAC CGCACC GCACCA CACCAG ACCAGG CCAGGC CAGGCC AGGCCA GGCCAA GCCAAC CCAACG CAACGG AACGGC ACGGCA CGGCAG GGCAGC GCAGCC CAGCCT AGCCTC GCCTCA CCTCAT CTCATC TCATCA CATCAC ATCACC TCACCC CACCCA ACCCAG CCCAGG CCAGGG CAGGGT AGGGTG GGGTGG GGTGGC GTGGCA TGGCAC GGCACG GCACGA CACGAC ACGACA CGACAG GACAGT ACAGTG CAGTGG AGTGGG GTGGGC TGGGCT GGGCTC GGCTCC GCTCCG CTCCGA TCCGAG CCGAGC CGAGCT GAGCTG AGCTGA GCTGAT CTGATC TGATCG GATCGG ATCGGC TCGGCC CGGCCA GGCCAG GCCAGT CCAGTC CAGTCG AGTCGT GTCGTT TCGTTC,GTCGCAC TCGCACA CGCACAA GCACAAA CACAAAC ACAAACG CAAACGG AAACGGC AACGGCC ACGGCCT CGGCCTT GGCCTTC GCCTTCC CCTTCCC CTTCCCG TTCCCGC TCCCGCA CCCGCAC CCGCACC CGCACCA GCACCAG CACCAGG ACCAGGC CCAGGCC CAGGCCA AGGCCAA GGCCAAC GCCAACG CCAACGG CAACGGC AACGGCA ACGGCAG CGGCAGC GGCAGCC GCAGCCT CAGCCTC AGCCTCA GCCTCAT CCTCATC CTCATCA TCATCAC CATCACC ATCACCC TCACCCA CACCCAG ACCCAGG CCCAGGG CCAGGGT CAGGGTG AGGGTGG GGGTGGC GGTGGCA GTGGCAC TGGCACG GGCACGA GCACGAC CACGACA ACGACAG CGACAGT GACAGTG ACAGTGG CAGTGGG AGTGGGC GTGGGCT TGGGCTC GGGCTCC GGCTCCG GCTCCGA CTCCGAG TCCGAGC CCGAGCT CGAGCTG GAGCTGA AGCTGAT GCTGATC CTGATCG TGATCGG GATCGGC ATCGGCC TCGGCCA CGGCCAG GGCCAGT GCCAGTC CCAGTCG CAGTCGT AGTCGTT GTCGTTC,"ID   KDPC_NITHX              Reviewed;         205 AA.
AC   Q1QJ48;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 1.
DT   27-MAR-2024, entry version 93.
DE   RecName: Full=Potassium-transporting ATPase KdpC subunit {ECO:0000255|HAMAP-Rule:MF_00276};
DE   AltName: Full=ATP phosphohydrolase [potassium-transporting] C chain {ECO:0000255|HAMAP-Rule:MF_00276};
DE   AltName: Full=Potassium-binding and translocating subunit C {ECO:0000255|HAMAP-Rule:MF_00276};
DE   AltName: Full=Potassium-translocating ATPase C chain {ECO:0000255|HAMAP-Rule:MF_00276};
GN   Name=kdpC {ECO:0000255|HAMAP-Rule:MF_00276};
GN   OrderedLocusNames=Nham_2992;
OS   Nitrobacter hamburgensis (strain DSM 10229 / NCIMB 13809 / X14).
OC   Bacteria; Pseudomonadota; Alphaproteobacteria; Hyphomicrobiales;
OC   Nitrobacteraceae; Nitrobacter.
OX   NCBI_TaxID=323097;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 10229 / NCIMB 13809 / X14;
RG   US DOE Joint Genome Institute;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C.,
RA   Glavina del Rio T., Hammon N., Israni S., Dalin E., Tice H., Pitluck S.,
RA   Chain P., Malfatti S., Shin M., Vergez L., Schmutz J., Larimer F., Land M.,
RA   Hauser L., Kyrpides N., Ivanova N., Ward B., Arp D., Klotz M., Stein L.,
RA   O'Mullan G., Starkenburg S., Sayavedra L., Poret-Peterson A.T.,
RA   Gentry M.E., Bruce D., Richardson P.;
RT   ""Complete sequence of chromosome of Nitrobacter hamburgensis X14."";
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Part of the high-affinity ATP-driven potassium transport (or
CC       Kdp) system, which catalyzes the hydrolysis of ATP coupled with the
CC       electrogenic transport of potassium into the cytoplasm. This subunit
CC       acts as a catalytic chaperone that increases the ATP-binding affinity
CC       of the ATP-hydrolyzing subunit KdpB by the formation of a transient
CC       KdpB/KdpC/ATP ternary complex. {ECO:0000255|HAMAP-Rule:MF_00276}.
CC   -!- SUBUNIT: The system is composed of three essential subunits: KdpA, KdpB
CC       and KdpC. {ECO:0000255|HAMAP-Rule:MF_00276}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_00276}; Single-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_00276}.
CC   -!- SIMILARITY: Belongs to the KdpC family. {ECO:0000255|HAMAP-
CC       Rule:MF_00276}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000319; ABE63749.1; -; Genomic_DNA.
DR   RefSeq; WP_011511411.1; NC_007964.1.
DR   AlphaFoldDB; Q1QJ48; -.
DR   SMR; Q1QJ48; -.
DR   STRING; 323097.Nham_2992; -.
DR   KEGG; nha:Nham_2992; -.
DR   eggNOG; COG2156; Bacteria.
DR   HOGENOM; CLU_077094_2_0_5; -.
DR   OrthoDB; 9788285at2; -.
DR   Proteomes; UP000001953; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008556; F:P-type potassium transmembrane transporter activity; IEA:InterPro.
DR   HAMAP; MF_00276; KdpC; 1.
DR   InterPro; IPR003820; KdpC.
DR   NCBIfam; TIGR00681; kdpC; 1.
DR   PANTHER; PTHR30042; POTASSIUM-TRANSPORTING ATPASE C CHAIN; 1.
DR   PANTHER; PTHR30042:SF2; POTASSIUM-TRANSPORTING ATPASE KDPC SUBUNIT; 1.
DR   Pfam; PF02669; KdpC; 1.
DR   PIRSF; PIRSF001296; K_ATPase_KdpC; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell inner membrane; Cell membrane; Ion transport; Membrane;
KW   Nucleotide-binding; Potassium; Potassium transport; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..205
FT                   /note=""Potassium-transporting ATPase KdpC subunit""
FT                   /id=""PRO_1000022298""
FT   TRANSMEM        7..27
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00276""
SQ   SEQUENCE   205 AA;  21584 MW;  5284DBCF653BD642 CRC64;
     MLKELRPAIV ILVALTIITG LIYPLAMTGA AQVLFPYQAQ GSLIEQGGKT IGSALIGQSF
     TADRYFHGRP SATTAPDPKD ASKTVPAPYN AVNSMGSNLG PTSKALADRL RQDVATLKAQ
     NPSAAVPVDL VTASGSGLDP DISPQAARFQ VPRVAKARNL PEAEVETLID SRTEGRDLGF
     LGEPRVNVLK LNLALDRMAA SGQPR
//
",26513
CGCAAG GCAAGC CAAGCA AAGCAG AGCAGC GCAGCT CAGCTT AGCTTG GCTTGA CTTGAA TTGAAC TGAACG GAACGG AACGGG ACGGGT CGGGTA GGGTAG GGTAGC GTAGCC TAGCCC AGCCCA GCCCAG CCCAGT CCAGTT CAGTTT AGTTTG GTTTGC TTTGCT TTGCTT TGCTTC GCTTCT CTTCTG TTCTGA TCTGAT CTGATC TGATCT GATCTC ATCTCG TCTCGA CTCGAC TCGACG CGACGA GACGAG ACGAGG CGAGGC GAGGCT AGGCTA GGCTAC GCTACC CTACCC TACCCG ACCCGC CCCGCA CCGCAA CGCAAG GCAAGC CAAGCA AAGCAG AGCAGC GCAGCT CAGCTT AGCTTG GCTTGA CTTGAA TTGAAC TGAACG GAACGC AACGCG ACGCGG CGCGGC GCGGCC CGGCCA GGCCAG GCCAGC CCAGCG CAGCGG AGCGGG GCGGGT CGGGTC GGGTCA GGTCAC GTCACC TCACCG CACCGA ACCGAG CCGAGT CGAGTT GAGTTA AGTTAA GTTAAT TTAATG TAATGA AATGAA ATGAAG TGAAGC GAAGCA AAGCAA AGCAAA GCAAAA CAAAAG AAAAGC AAAGCA AAGCAG AGCAGT GCAGTA CAGTAT AGTATT GTATTC TATTCG ATTCGC TTCGCC TCGCCG CGCCGA GCCGAT CCGATG CGATGT GATGTC ATGTCC TGTCCG GTCCGC TCCGCC,3,121,CGCA GCAA CAAG AAGC AGCA GCAG CAGC AGCT GCTT CTTG TTGA TGAA GAAC AACG ACGG CGGG GGGT GGTA GTAG TAGC AGCC GCCC CCCA CCAG CAGT AGTT GTTT TTTG TTGC TGCT GCTT CTTC TTCT TCTG CTGA TGAT GATC ATCT TCTC CTCG TCGA CGAC GACG ACGA CGAG GAGG AGGC GGCT GCTA CTAC TACC ACCC CCCG CCGC CGCA GCAA CAAG AAGC AGCA GCAG CAGC AGCT GCTT CTTG TTGA TGAA GAAC AACG ACGC CGCG GCGG CGGC GGCC GCCA CCAG CAGC AGCG GCGG CGGG GGGT GGTC GTCA TCAC CACC ACCG CCGA CGAG GAGT AGTT GTTA TTAA TAAT AATG ATGA TGAA GAAG AAGC AGCA GCAA CAAA AAAA AAAG AAGC AGCA GCAG CAGT AGTA GTAT TATT ATTC TTCG TCGC CGCC GCCG CCGA CGAT GATG ATGT TGTC GTCC TCCG CCGC CGCC,CGCAA GCAAG CAAGC AAGCA AGCAG GCAGC CAGCT AGCTT GCTTG CTTGA TTGAA TGAAC GAACG AACGG ACGGG CGGGT GGGTA GGTAG GTAGC TAGCC AGCCC GCCCA CCCAG CCAGT CAGTT AGTTT GTTTG TTTGC TTGCT TGCTT GCTTC CTTCT TTCTG TCTGA CTGAT TGATC GATCT ATCTC TCTCG CTCGA TCGAC CGACG GACGA ACGAG CGAGG GAGGC AGGCT GGCTA GCTAC CTACC TACCC ACCCG CCCGC CCGCA CGCAA GCAAG CAAGC AAGCA AGCAG GCAGC CAGCT AGCTT GCTTG CTTGA TTGAA TGAAC GAACG AACGC ACGCG CGCGG GCGGC CGGCC GGCCA GCCAG CCAGC CAGCG AGCGG GCGGG CGGGT GGGTC GGTCA GTCAC TCACC CACCG ACCGA CCGAG CGAGT GAGTT AGTTA GTTAA TTAAT TAATG AATGA ATGAA TGAAG GAAGC AAGCA AGCAA GCAAA CAAAA AAAAG AAAGC AAGCA AGCAG GCAGT CAGTA AGTAT GTATT TATTC ATTCG TTCGC TCGCC CGCCG GCCGA CCGAT CGATG GATGT ATGTC TGTCC GTCCG TCCGC CCGCC,CGCAAG GCAAGC CAAGCA AAGCAG AGCAGC GCAGCT CAGCTT AGCTTG GCTTGA CTTGAA TTGAAC TGAACG GAACGG AACGGG ACGGGT CGGGTA GGGTAG GGTAGC GTAGCC TAGCCC AGCCCA GCCCAG CCCAGT CCAGTT CAGTTT AGTTTG GTTTGC TTTGCT TTGCTT TGCTTC GCTTCT CTTCTG TTCTGA TCTGAT CTGATC TGATCT GATCTC ATCTCG TCTCGA CTCGAC TCGACG CGACGA GACGAG ACGAGG CGAGGC GAGGCT AGGCTA GGCTAC GCTACC CTACCC TACCCG ACCCGC CCCGCA CCGCAA CGCAAG GCAAGC CAAGCA AAGCAG AGCAGC GCAGCT CAGCTT AGCTTG GCTTGA CTTGAA TTGAAC TGAACG GAACGC AACGCG ACGCGG CGCGGC GCGGCC CGGCCA GGCCAG GCCAGC CCAGCG CAGCGG AGCGGG GCGGGT CGGGTC GGGTCA GGTCAC GTCACC TCACCG CACCGA ACCGAG CCGAGT CGAGTT GAGTTA AGTTAA GTTAAT TTAATG TAATGA AATGAA ATGAAG TGAAGC GAAGCA AAGCAA AGCAAA GCAAAA CAAAAG AAAAGC AAAGCA AAGCAG AGCAGT GCAGTA CAGTAT AGTATT GTATTC TATTCG ATTCGC TTCGCC TCGCCG CGCCGA GCCGAT CCGATG CGATGT GATGTC ATGTCC TGTCCG GTCCGC TCCGCC,CGCAAGC GCAAGCA CAAGCAG AAGCAGC AGCAGCT GCAGCTT CAGCTTG AGCTTGA GCTTGAA CTTGAAC TTGAACG TGAACGG GAACGGG AACGGGT ACGGGTA CGGGTAG GGGTAGC GGTAGCC GTAGCCC TAGCCCA AGCCCAG GCCCAGT CCCAGTT CCAGTTT CAGTTTG AGTTTGC GTTTGCT TTTGCTT TTGCTTC TGCTTCT GCTTCTG CTTCTGA TTCTGAT TCTGATC CTGATCT TGATCTC GATCTCG ATCTCGA TCTCGAC CTCGACG TCGACGA CGACGAG GACGAGG ACGAGGC CGAGGCT GAGGCTA AGGCTAC GGCTACC GCTACCC CTACCCG TACCCGC ACCCGCA CCCGCAA CCGCAAG CGCAAGC GCAAGCA CAAGCAG AAGCAGC AGCAGCT GCAGCTT CAGCTTG AGCTTGA GCTTGAA CTTGAAC TTGAACG TGAACGC GAACGCG AACGCGG ACGCGGC CGCGGCC GCGGCCA CGGCCAG GGCCAGC GCCAGCG CCAGCGG CAGCGGG AGCGGGT GCGGGTC CGGGTCA GGGTCAC GGTCACC GTCACCG TCACCGA CACCGAG ACCGAGT CCGAGTT CGAGTTA GAGTTAA AGTTAAT GTTAATG TTAATGA TAATGAA AATGAAG ATGAAGC TGAAGCA GAAGCAA AAGCAAA AGCAAAA GCAAAAG CAAAAGC AAAAGCA AAAGCAG AAGCAGT AGCAGTA GCAGTAT CAGTATT AGTATTC GTATTCG TATTCGC ATTCGCC TTCGCCG TCGCCGA CGCCGAT GCCGATG CCGATGT CGATGTC GATGTCC ATGTCCG TGTCCGC GTCCGCC,"ID   ATPA_STRM5              Reviewed;         515 AA.
AC   B4SJS1;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 1.
DT   27-NOV-2024, entry version 92.
DE   RecName: Full=ATP synthase subunit alpha {ECO:0000255|HAMAP-Rule:MF_01346};
DE            EC=7.1.2.2 {ECO:0000255|HAMAP-Rule:MF_01346};
DE   AltName: Full=ATP synthase F1 sector subunit alpha {ECO:0000255|HAMAP-Rule:MF_01346};
DE   AltName: Full=F-ATPase subunit alpha {ECO:0000255|HAMAP-Rule:MF_01346};
GN   Name=atpA {ECO:0000255|HAMAP-Rule:MF_01346};
GN   OrderedLocusNames=Smal_3513;
OS   Stenotrophomonas maltophilia (strain R551-3).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Lysobacterales;
OC   Lysobacteraceae; Stenotrophomonas; Stenotrophomonas maltophilia group.
OX   NCBI_TaxID=391008;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=R551-3;
RG   US DOE Joint Genome Institute;
RA   Lucas S., Copeland A., Lapidus A., Glavina del Rio T., Dalin E., Tice H.,
RA   Pitluck S., Chain P., Malfatti S., Shin M., Vergez L., Lang D., Schmutz J.,
RA   Larimer F., Land M., Hauser L., Kyrpides N., Mikhailova N., Taghavi S.,
RA   Monchy S., Newman L., Vangronsveld J., van der Lelie D., Richardson P.;
RT   ""Complete sequence of Stenotrophomonas maltophilia R551-3."";
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Produces ATP from ADP in the presence of a proton gradient
CC       across the membrane. The alpha chain is a regulatory subunit.
CC       {ECO:0000255|HAMAP-Rule:MF_01346}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + 4 H(+)(in) = ADP + phosphate + 5 H(+)(out);
CC         Xref=Rhea:RHEA:57720, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=7.1.2.2;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01346};
CC   -!- SUBUNIT: F-type ATPases have 2 components, CF(1) - the catalytic core
CC       - and CF(0) - the membrane proton channel. CF(1) has five subunits:
CC       alpha(3), beta(3), gamma(1), delta(1), epsilon(1). CF(0) has three main
CC       subunits: a(1), b(2) and c(9-12). The alpha and beta chains form an
CC       alternating ring which encloses part of the gamma chain. CF(1) is
CC       attached to CF(0) by a central stalk formed by the gamma and epsilon
CC       chains, while a peripheral stalk is formed by the delta and b chains.
CC       {ECO:0000255|HAMAP-Rule:MF_01346}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01346}; Peripheral membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01346}.
CC   -!- SIMILARITY: Belongs to the ATPase alpha/beta chains family.
CC       {ECO:0000255|HAMAP-Rule:MF_01346}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001111; ACF53212.1; -; Genomic_DNA.
DR   RefSeq; WP_012512168.1; NC_011071.1.
DR   AlphaFoldDB; B4SJS1; -.
DR   SMR; B4SJS1; -.
DR   STRING; 391008.Smal_3513; -.
DR   KEGG; smt:Smal_3513; -.
DR   eggNOG; COG0056; Bacteria.
DR   HOGENOM; CLU_010091_2_1_6; -.
DR   OrthoDB; 9803053at2; -.
DR   Proteomes; UP000001867; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045261; C:proton-transporting ATP synthase complex, catalytic core F(1); IEA:UniProtKB-KW.
DR   GO; GO:0043531; F:ADP binding; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:UniProtKB-UniRule.
DR   GO; GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:UniProtKB-EC.
DR   CDD; cd18113; ATP-synt_F1_alpha_C; 1.
DR   CDD; cd18116; ATP-synt_F1_alpha_N; 1.
DR   CDD; cd01132; F1-ATPase_alpha_CD; 1.
DR   FunFam; 1.20.150.20:FF:000001; ATP synthase subunit alpha; 1.
DR   FunFam; 2.40.30.20:FF:000001; ATP synthase subunit alpha; 1.
DR   FunFam; 3.40.50.300:FF:000002; ATP synthase subunit alpha; 1.
DR   Gene3D; 2.40.30.20; -; 1.
DR   Gene3D; 1.20.150.20; ATP synthase alpha/beta chain, C-terminal domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   HAMAP; MF_01346; ATP_synth_alpha_bact; 1.
DR   InterPro; IPR023366; ATP_synth_asu-like_sf.
DR   InterPro; IPR000793; ATP_synth_asu_C.
DR   InterPro; IPR038376; ATP_synth_asu_C_sf.
DR   InterPro; IPR033732; ATP_synth_F1_a_nt-bd_dom.
DR   InterPro; IPR005294; ATP_synth_F1_asu.
DR   InterPro; IPR020003; ATPase_a/bsu_AS.
DR   InterPro; IPR004100; ATPase_F1/V1/A1_a/bsu_N.
DR   InterPro; IPR036121; ATPase_F1/V1/A1_a/bsu_N_sf.
DR   InterPro; IPR000194; ATPase_F1/V1/A1_a/bsu_nucl-bd.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR00962; atpA; 1.
DR   PANTHER; PTHR48082; ATP SYNTHASE SUBUNIT ALPHA, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR48082:SF2; ATP SYNTHASE SUBUNIT ALPHA, MITOCHONDRIAL; 1.
DR   Pfam; PF00006; ATP-synt_ab; 1.
DR   Pfam; PF00306; ATP-synt_ab_C; 1.
DR   Pfam; PF02874; ATP-synt_ab_N; 1.
DR   SUPFAM; SSF47917; C-terminal domain of alpha and beta subunits of F1 ATP synthase; 1.
DR   SUPFAM; SSF50615; N-terminal domain of alpha and beta subunits of F1 ATP synthase; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00152; ATPASE_ALPHA_BETA; 1.
PE   3: Inferred from homology;
KW   ATP synthesis; ATP-binding; Cell inner membrane; Cell membrane; CF(1);
KW   Hydrogen ion transport; Ion transport; Membrane; Nucleotide-binding;
KW   Translocase; Transport.
FT   CHAIN           1..515
FT                   /note=""ATP synthase subunit alpha""
FT                   /id=""PRO_1000143441""
FT   BINDING         171..178
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01346""
FT   SITE            375
FT                   /note=""Required for activity""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01346""
SQ   SEQUENCE   515 AA;  55437 MW;  A9116F92280A1D06 CRC64;
     MATTLNPSEI SELIKNRIEK VKLAAESRNE GTVTSVSDGI VRIFGLADVM QGEMIELPNN
     SFALALNLER DSVGAVVLGG YEHLREGDVA KTTGRILEVP VGPELLGRVV NALGEPIDGK
     GPLGTDLTAP VERVAPGVIW RKSVDQPVQT GYKSVDSMIP IGRGQRELII GDRQTGKTAM
     AIDAVINQKG TGIKCVYVAI GQKASTIANI VRKLEENGAL AHTVVVAATA SESAAMQYIS
     AYSGCTMGEY FMDRGEDALI VYDDLSKQAV AYRQISLLLK RPPGREAYPG DVFYLHSRLL
     ERAARVSEEY VEKFTEGKVT GKTGSLTALP IIETQAGDVS AFVPTNVISI TDGQIFLETD
     LFNAGIRPAV NAGISVSRVG GSAQTKIIKK LSGGIRISLA QYRELAAFAQ FASDLDEATR
     KQLERGQRVT ELMKQKQYAP MSIANQALSI YAVNEGYLDD VPVNKLLAFE EGLHAHFANT
     QGELINKVNA TGGWDNDIEG AFKKGIAEFK TTGSW
//
",28270
GACACG ACACGC CACGCT ACGCTT CGCTTA GCTTAC CTTACC TTACCG TACCGC ACCGCC CCGCCA CGCCAT GCCATC CCATCG CATCGA ATCGAA TCGAAC CGAACG GAACGC AACGCA ACGCAC CGCACC GCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACC CCACCA CACCAA ACCAAG CCAAGC CAAGCG AAGCGC AGCGCG GCGCGG CGCGGC GCGGCC CGGCCT GGCCTG GCCTGA CCTGAC CTGACC TGACCG GACCGC ACCGCC CCGCCG CGCCGT GCCGTC CCGTCG CGTCGA GTCGAC TCGACC CGACCT GACCTG ACCTGT CCTGTC CTGTCC TGTCCC GTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCA CCTCAC CTCACC TCACCG CACCGA ACCGAC CCGACG CGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGC CCTGCA CTGCAG TGCAGG GCAGGC CAGGCC AGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCG ACGCGA CGCGAG GCGAGC CGAGCA GAGCAG AGCAGG GCAGGG CAGGGC AGGGCA GGGCAT GGCATC GCATCA CATCAC ATCACC TCACCA CACCAT ACCATC CCATCG CATCGA ATCGAC TCGACG CGACGT GACGTC ACGTCG CGTCGC GTCGCC TCGCCT CGCCTA GCCTAC CCTACC CTACCG TACCGT ACCGTT CCGTTA CGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTC TTCTCC TCTCCA CTCCAC TCCACC CCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACA CCACAC CACACG ACACGC,3,142,GACA ACAC CACG ACGC CGCT GCTT CTTA TTAC TACC ACCG CCGC CGCC GCCA CCAT CATC ATCG TCGA CGAA GAAC AACG ACGC CGCA GCAC CACC ACCT CCTC CTCC TCCA CCAC CACC ACCA CCAA CAAG AAGC AGCG GCGC CGCG GCGG CGGC GGCC GCCT CCTG CTGA TGAC GACC ACCG CCGC CGCC GCCG CCGT CGTC GTCG TCGA CGAC GACC ACCT CCTG CTGT TGTC GTCC TCCC CCCT CCTC CTCC TCCT CCTC CTCA TCAC CACC ACCG CCGA CGAC GACG ACGG CGGC GGCC GCCT CCTG CTGC TGCA GCAG CAGG AGGC GGCC GCCG CCGA CGAA GAAC AACG ACGC CGCG GCGA CGAG GAGC AGCA GCAG CAGG AGGG GGGC GGCA GCAT CATC ATCA TCAC CACC ACCA CCAT CATC ATCG TCGA CGAC GACG ACGT CGTC GTCG TCGC CGCC GCCT CCTA CTAC TACC ACCG CCGT CGTT GTTA TTAC TACT ACTT CTTC TTCT TCTC CTCC TCCA CCAC CACC ACCT CCTC CTCC TCCA CCAC CACA ACAC CACG ACGC,GACAC ACACG CACGC ACGCT CGCTT GCTTA CTTAC TTACC TACCG ACCGC CCGCC CGCCA GCCAT CCATC CATCG ATCGA TCGAA CGAAC GAACG AACGC ACGCA CGCAC GCACC CACCT ACCTC CCTCC CTCCA TCCAC CCACC CACCA ACCAA CCAAG CAAGC AAGCG AGCGC GCGCG CGCGG GCGGC CGGCC GGCCT GCCTG CCTGA CTGAC TGACC GACCG ACCGC CCGCC CGCCG GCCGT CCGTC CGTCG GTCGA TCGAC CGACC GACCT ACCTG CCTGT CTGTC TGTCC GTCCC TCCCT CCCTC CCTCC CTCCT TCCTC CCTCA CTCAC TCACC CACCG ACCGA CCGAC CGACG GACGG ACGGC CGGCC GGCCT GCCTG CCTGC CTGCA TGCAG GCAGG CAGGC AGGCC GGCCG GCCGA CCGAA CGAAC GAACG AACGC ACGCG CGCGA GCGAG CGAGC GAGCA AGCAG GCAGG CAGGG AGGGC GGGCA GGCAT GCATC CATCA ATCAC TCACC CACCA ACCAT CCATC CATCG ATCGA TCGAC CGACG GACGT ACGTC CGTCG GTCGC TCGCC CGCCT GCCTA CCTAC CTACC TACCG ACCGT CCGTT CGTTA GTTAC TTACT TACTT ACTTC CTTCT TTCTC TCTCC CTCCA TCCAC CCACC CACCT ACCTC CCTCC CTCCA TCCAC CCACA CACAC ACACG CACGC,GACACG ACACGC CACGCT ACGCTT CGCTTA GCTTAC CTTACC TTACCG TACCGC ACCGCC CCGCCA CGCCAT GCCATC CCATCG CATCGA ATCGAA TCGAAC CGAACG GAACGC AACGCA ACGCAC CGCACC GCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACC CCACCA CACCAA ACCAAG CCAAGC CAAGCG AAGCGC AGCGCG GCGCGG CGCGGC GCGGCC CGGCCT GGCCTG GCCTGA CCTGAC CTGACC TGACCG GACCGC ACCGCC CCGCCG CGCCGT GCCGTC CCGTCG CGTCGA GTCGAC TCGACC CGACCT GACCTG ACCTGT CCTGTC CTGTCC TGTCCC GTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCA CCTCAC CTCACC TCACCG CACCGA ACCGAC CCGACG CGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGC CCTGCA CTGCAG TGCAGG GCAGGC CAGGCC AGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCG ACGCGA CGCGAG GCGAGC CGAGCA GAGCAG AGCAGG GCAGGG CAGGGC AGGGCA GGGCAT GGCATC GCATCA CATCAC ATCACC TCACCA CACCAT ACCATC CCATCG CATCGA ATCGAC TCGACG CGACGT GACGTC ACGTCG CGTCGC GTCGCC TCGCCT CGCCTA GCCTAC CCTACC CTACCG TACCGT ACCGTT CCGTTA CGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTC TTCTCC TCTCCA CTCCAC TCCACC CCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACA CCACAC CACACG ACACGC,GACACGC ACACGCT CACGCTT ACGCTTA CGCTTAC GCTTACC CTTACCG TTACCGC TACCGCC ACCGCCA CCGCCAT CGCCATC GCCATCG CCATCGA CATCGAA ATCGAAC TCGAACG CGAACGC GAACGCA AACGCAC ACGCACC CGCACCT GCACCTC CACCTCC ACCTCCA CCTCCAC CTCCACC TCCACCA CCACCAA CACCAAG ACCAAGC CCAAGCG CAAGCGC AAGCGCG AGCGCGG GCGCGGC CGCGGCC GCGGCCT CGGCCTG GGCCTGA GCCTGAC CCTGACC CTGACCG TGACCGC GACCGCC ACCGCCG CCGCCGT CGCCGTC GCCGTCG CCGTCGA CGTCGAC GTCGACC TCGACCT CGACCTG GACCTGT ACCTGTC CCTGTCC CTGTCCC TGTCCCT GTCCCTC TCCCTCC CCCTCCT CCTCCTC CTCCTCA TCCTCAC CCTCACC CTCACCG TCACCGA CACCGAC ACCGACG CCGACGG CGACGGC GACGGCC ACGGCCT CGGCCTG GGCCTGC GCCTGCA CCTGCAG CTGCAGG TGCAGGC GCAGGCC CAGGCCG AGGCCGA GGCCGAA GCCGAAC CCGAACG CGAACGC GAACGCG AACGCGA ACGCGAG CGCGAGC GCGAGCA CGAGCAG GAGCAGG AGCAGGG GCAGGGC CAGGGCA AGGGCAT GGGCATC GGCATCA GCATCAC CATCACC ATCACCA TCACCAT CACCATC ACCATCG CCATCGA CATCGAC ATCGACG TCGACGT CGACGTC GACGTCG ACGTCGC CGTCGCC GTCGCCT TCGCCTA CGCCTAC GCCTACC CCTACCG CTACCGT TACCGTT ACCGTTA CCGTTAC CGTTACT GTTACTT TTACTTC TACTTCT ACTTCTC CTTCTCC TTCTCCA TCTCCAC CTCCACC TCCACCT CCACCTC CACCTCC ACCTCCA CCTCCAC CTCCACA TCCACAC CCACACG CACACGC,"ID   CYSN_LARHH              Reviewed;         481 AA.
AC   C1D890;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   05-FEB-2025, entry version 87.
DE   RecName: Full=Sulfate adenylyltransferase subunit 1 {ECO:0000255|HAMAP-Rule:MF_00062};
DE            EC=2.7.7.4 {ECO:0000255|HAMAP-Rule:MF_00062};
DE   AltName: Full=ATP-sulfurylase large subunit {ECO:0000255|HAMAP-Rule:MF_00062};
DE   AltName: Full=Sulfate adenylate transferase {ECO:0000255|HAMAP-Rule:MF_00062};
DE            Short=SAT {ECO:0000255|HAMAP-Rule:MF_00062};
GN   Name=cysN {ECO:0000255|HAMAP-Rule:MF_00062};
GN   OrderedLocusNames=LHK_01695;
OS   Laribacter hongkongensis (strain HLHK9).
OC   Bacteria; Pseudomonadota; Betaproteobacteria; Neisseriales;
OC   Aquaspirillaceae; Laribacter.
OX   NCBI_TaxID=557598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HLHK9;
RX   PubMed=19283063; DOI=10.1371/journal.pgen.1000416;
RA   Woo P.C.Y., Lau S.K.P., Tse H., Teng J.L.L., Curreem S.O., Tsang A.K.L.,
RA   Fan R.Y.Y., Wong G.K.M., Huang Y., Loman N.J., Snyder L.A.S., Cai J.J.,
RA   Huang J.-D., Mak W., Pallen M.J., Lok S., Yuen K.-Y.;
RT   ""The complete genome and proteome of Laribacter hongkongensis reveal
RT   potential mechanisms for adaptations to different temperatures and
RT   habitats."";
RL   PLoS Genet. 5:E1000416-E1000416(2009).
CC   -!- FUNCTION: With CysD forms the ATP sulfurylase (ATPS) that catalyzes the
CC       adenylation of sulfate producing adenosine 5'-phosphosulfate (APS) and
CC       diphosphate, the first enzymatic step in sulfur assimilation pathway.
CC       APS synthesis involves the formation of a high-energy phosphoric-
CC       sulfuric acid anhydride bond driven by GTP hydrolysis by CysN coupled
CC       to ATP hydrolysis by CysD. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sulfate + ATP + H(+) = adenosine 5'-phosphosulfate +
CC         diphosphate; Xref=Rhea:RHEA:18133, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16189, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:58243; EC=2.7.7.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00062};
CC   -!- PATHWAY: Sulfur metabolism; hydrogen sulfide biosynthesis; sulfite from
CC       sulfate: step 1/3. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- SUBUNIT: Heterodimer composed of CysD, the smaller subunit, and CysN.
CC       {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC       superfamily. Classic translation factor GTPase family. CysN/NodQ
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001154; ACO74680.1; -; Genomic_DNA.
DR   RefSeq; WP_012697166.1; NC_012559.1.
DR   AlphaFoldDB; C1D890; -.
DR   SMR; C1D890; -.
DR   STRING; 557598.LHK_01695; -.
DR   KEGG; lhk:LHK_01695; -.
DR   eggNOG; COG2895; Bacteria.
DR   HOGENOM; CLU_007265_5_2_4; -.
DR   UniPathway; UPA00140; UER00204.
DR   Proteomes; UP000002010; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0004781; F:sulfate adenylyltransferase (ATP) activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0000103; P:sulfate assimilation; IEA:UniProtKB-UniRule.
DR   CDD; cd04166; CysN_ATPS; 1.
DR   CDD; cd03695; CysN_NodQ_II; 1.
DR   CDD; cd04095; CysN_NoDQ_III; 1.
DR   FunFam; 2.40.30.10:FF:000027; Sulfate adenylyltransferase subunit 1; 1.
DR   FunFam; 3.40.50.300:FF:000119; Sulfate adenylyltransferase subunit 1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 2.
DR   HAMAP; MF_00062; Sulf_adenylyltr_sub1; 1.
DR   InterPro; IPR041757; CysN_GTP-bd.
DR   InterPro; IPR044138; CysN_II.
DR   InterPro; IPR044139; CysN_NoDQ_III.
DR   InterPro; IPR031157; G_TR_CS.
DR   InterPro; IPR054696; GTP-eEF1A_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011779; SO4_adenylTrfase_lsu.
DR   InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR   InterPro; IPR050100; TRAFAC_GTPase_members.
DR   InterPro; IPR009000; Transl_B-barrel_sf.
DR   InterPro; IPR009001; Transl_elong_EF1A/Init_IF2_C.
DR   NCBIfam; TIGR02034; CysN; 1.
DR   PANTHER; PTHR23115; TRANSLATION FACTOR; 1.
DR   Pfam; PF22594; GTP-eEF1A_C; 1.
DR   Pfam; PF00009; GTP_EFTU; 1.
DR   PRINTS; PR00315; ELONGATNFCT.
DR   SUPFAM; SSF50465; EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50447; Translation proteins; 1.
DR   PROSITE; PS00301; G_TR_1; 1.
DR   PROSITE; PS51722; G_TR_2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; GTP-binding; Nucleotide-binding; Nucleotidyltransferase;
KW   Reference proteome; Transferase.
FT   CHAIN           1..481
FT                   /note=""Sulfate adenylyltransferase subunit 1""
FT                   /id=""PRO_1000117915""
FT   DOMAIN          22..236
FT                   /note=""tr-type G""
FT   REGION          31..38
FT                   /note=""G1""
FT                   /evidence=""ECO:0000250""
FT   REGION          89..93
FT                   /note=""G2""
FT                   /evidence=""ECO:0000250""
FT   REGION          110..113
FT                   /note=""G3""
FT                   /evidence=""ECO:0000250""
FT   REGION          165..168
FT                   /note=""G4""
FT                   /evidence=""ECO:0000250""
FT   REGION          202..204
FT                   /note=""G5""
FT                   /evidence=""ECO:0000250""
FT   BINDING         31..38
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
FT   BINDING         110..114
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
FT   BINDING         165..168
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
SQ   SEQUENCE   481 AA;  53901 MW;  14AE3915869E9999 CRC64;
     MTHQSDLIAE DIHAYLARHE TKDLLRFITC GSVDDGKSTL IGRLLHDSRL IFEDQLAAIE
     RDSQKHNTTD EAVDLALLVD GLQAEREQGI TIDVAYRYFS TDTRKFIIAD CPGHEQYTRN
     MATGASTADL AIILIDARYG VQTQTRRHSF IASLLGIRHV IVAVNKMDLL EFDQAVFERI
     RQDYLTFAKA LDIHDIRFVP LSALRGDNVV SPSERMPWYD GPSLMQLLDS IRLDADQALQ
     AFRLPVQYVN RPNLDFRGFC GTIAAGVIRP GDQVTVLPSG RQSRVRAIVT TDGELPVAAT
     GQAVTLTLED EIDISRGDMI VRHGEPLPLV ADRLTVELVW MHDAPLQTGR AYWVKLAGKW
     LPGRVTAVHH RVNVNTMERE AASSLALNEI AEVTLEIDAP MAVDAYRQCR ATGSLILVDR
     ISNATLGAGM IRSAEPSAGI QSEKDAARRW QAFEIEFNEL VRRHFPHWQA RDMRDWPGHK
     E
//
",26477
ACGGGC CGGGCA GGGCAC GGCACG GCACGC CACGCT ACGCTG CGCTGA GCTGAG CTGAGG TGAGGA GAGGAA AGGAAC GGAACT GAACTT AACTTC ACTTCA CTTCAA TTCAAC TCAACT CAACTA AACTAC ACTACC CTACCG TACCGT ACCGTC CCGTCT CGTCTT GTCTTC TCTTCG CTTCGT TTCGTC TCGTCG CGTCGG GTCGGC TCGGCA CGGCAG GGCAGC GCAGCG CAGCGT AGCGTC GCGTCA CGTCAG GTCAGA TCAGAG CAGAGG AGAGGT GAGGTT AGGTTT GGTTTA GTTTAA TTTAAA TTAAAA TAAAAG AAAAGA AAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGC ACAGCC CAGCCC AGCCCC GCCCCT CCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGA GGTGAA GTGAAA TGAAAA GAAAAC AAAACA AAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGC GTTGCA TTGCAC TGCACC GCACCT CACCTG ACCTGA CCTGAG CTGAGG TGAGGG GAGGGA AGGGAG GGGAGC GGAGCC GAGCCT AGCCTG GCCTGG CCTGGA CTGGAA TGGAAT GGAATA GAATAC AATACA ATACAC TACACA ACACAA CACAAA ACAAAA CAAAAA AAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAC ATCACA TCACAT CACATG ACATGG CATGGG ATGGGC TGGGCC GGGCCC GGCCCC GCCCCC CCCCCG CCCCGC,1,145,ACGG CGGG GGGC GGCA GCAC CACG ACGC CGCT GCTG CTGA TGAG GAGG AGGA GGAA GAAC AACT ACTT CTTC TTCA TCAA CAAC AACT ACTA CTAC TACC ACCG CCGT CGTC GTCT TCTT CTTC TTCG TCGT CGTC GTCG TCGG CGGC GGCA GCAG CAGC AGCG GCGT CGTC GTCA TCAG CAGA AGAG GAGG AGGT GGTT GTTT TTTA TTAA TAAA AAAA AAAG AAGA AGAG GAGA AGAC GACA ACAG CAGC AGCC GCCC CCCC CCCT CCTA CTAT TATG ATGG TGGT GGTG GTGA TGAA GAAA AAAA AAAC AACA ACAA CAAA AAAG AAGA AGAC GACG ACGG CGGC GGCA GCAT CATC ATCA TCAT CATA ATAT TATG ATGG TGGG GGGT GGTT GTTG TTGC TGCA GCAC CACC ACCT CCTG CTGA TGAG GAGG AGGG GGGA GGAG GAGC AGCC GCCT CCTG CTGG TGGA GGAA GAAT AATA ATAC TACA ACAC CACA ACAA CAAA AAAA AAAA AAAG AAGA AGAT GATC ATCA TCAC CACA ACAT CATG ATGG TGGG GGGC GGCC GCCC CCCC CCCC CCCG CCGC,ACGGG CGGGC GGGCA GGCAC GCACG CACGC ACGCT CGCTG GCTGA CTGAG TGAGG GAGGA AGGAA GGAAC GAACT AACTT ACTTC CTTCA TTCAA TCAAC CAACT AACTA ACTAC CTACC TACCG ACCGT CCGTC CGTCT GTCTT TCTTC CTTCG TTCGT TCGTC CGTCG GTCGG TCGGC CGGCA GGCAG GCAGC CAGCG AGCGT GCGTC CGTCA GTCAG TCAGA CAGAG AGAGG GAGGT AGGTT GGTTT GTTTA TTTAA TTAAA TAAAA AAAAG AAAGA AAGAG AGAGA GAGAC AGACA GACAG ACAGC CAGCC AGCCC GCCCC CCCCT CCCTA CCTAT CTATG TATGG ATGGT TGGTG GGTGA GTGAA TGAAA GAAAA AAAAC AAACA AACAA ACAAA CAAAG AAAGA AAGAC AGACG GACGG ACGGC CGGCA GGCAT GCATC CATCA ATCAT TCATA CATAT ATATG TATGG ATGGG TGGGT GGGTT GGTTG GTTGC TTGCA TGCAC GCACC CACCT ACCTG CCTGA CTGAG TGAGG GAGGG AGGGA GGGAG GGAGC GAGCC AGCCT GCCTG CCTGG CTGGA TGGAA GGAAT GAATA AATAC ATACA TACAC ACACA CACAA ACAAA CAAAA AAAAA AAAAG AAAGA AAGAT AGATC GATCA ATCAC TCACA CACAT ACATG CATGG ATGGG TGGGC GGGCC GGCCC GCCCC CCCCC CCCCG CCCGC,ACGGGC CGGGCA GGGCAC GGCACG GCACGC CACGCT ACGCTG CGCTGA GCTGAG CTGAGG TGAGGA GAGGAA AGGAAC GGAACT GAACTT AACTTC ACTTCA CTTCAA TTCAAC TCAACT CAACTA AACTAC ACTACC CTACCG TACCGT ACCGTC CCGTCT CGTCTT GTCTTC TCTTCG CTTCGT TTCGTC TCGTCG CGTCGG GTCGGC TCGGCA CGGCAG GGCAGC GCAGCG CAGCGT AGCGTC GCGTCA CGTCAG GTCAGA TCAGAG CAGAGG AGAGGT GAGGTT AGGTTT GGTTTA GTTTAA TTTAAA TTAAAA TAAAAG AAAAGA AAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGC ACAGCC CAGCCC AGCCCC GCCCCT CCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGA GGTGAA GTGAAA TGAAAA GAAAAC AAAACA AAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGC GTTGCA TTGCAC TGCACC GCACCT CACCTG ACCTGA CCTGAG CTGAGG TGAGGG GAGGGA AGGGAG GGGAGC GGAGCC GAGCCT AGCCTG GCCTGG CCTGGA CTGGAA TGGAAT GGAATA GAATAC AATACA ATACAC TACACA ACACAA CACAAA ACAAAA CAAAAA AAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAC ATCACA TCACAT CACATG ACATGG CATGGG ATGGGC TGGGCC GGGCCC GGCCCC GCCCCC CCCCCG CCCCGC,ACGGGCA CGGGCAC GGGCACG GGCACGC GCACGCT CACGCTG ACGCTGA CGCTGAG GCTGAGG CTGAGGA TGAGGAA GAGGAAC AGGAACT GGAACTT GAACTTC AACTTCA ACTTCAA CTTCAAC TTCAACT TCAACTA CAACTAC AACTACC ACTACCG CTACCGT TACCGTC ACCGTCT CCGTCTT CGTCTTC GTCTTCG TCTTCGT CTTCGTC TTCGTCG TCGTCGG CGTCGGC GTCGGCA TCGGCAG CGGCAGC GGCAGCG GCAGCGT CAGCGTC AGCGTCA GCGTCAG CGTCAGA GTCAGAG TCAGAGG CAGAGGT AGAGGTT GAGGTTT AGGTTTA GGTTTAA GTTTAAA TTTAAAA TTAAAAG TAAAAGA AAAAGAG AAAGAGA AAGAGAC AGAGACA GAGACAG AGACAGC GACAGCC ACAGCCC CAGCCCC AGCCCCT GCCCCTA CCCCTAT CCCTATG CCTATGG CTATGGT TATGGTG ATGGTGA TGGTGAA GGTGAAA GTGAAAA TGAAAAC GAAAACA AAAACAA AAACAAA AACAAAG ACAAAGA CAAAGAC AAAGACG AAGACGG AGACGGC GACGGCA ACGGCAT CGGCATC GGCATCA GCATCAT CATCATA ATCATAT TCATATG CATATGG ATATGGG TATGGGT ATGGGTT TGGGTTG GGGTTGC GGTTGCA GTTGCAC TTGCACC TGCACCT GCACCTG CACCTGA ACCTGAG CCTGAGG CTGAGGG TGAGGGA GAGGGAG AGGGAGC GGGAGCC GGAGCCT GAGCCTG AGCCTGG GCCTGGA CCTGGAA CTGGAAT TGGAATA GGAATAC GAATACA AATACAC ATACACA TACACAA ACACAAA CACAAAA ACAAAAA CAAAAAG AAAAAGA AAAAGAT AAAGATC AAGATCA AGATCAC GATCACA ATCACAT TCACATG CACATGG ACATGGG CATGGGC ATGGGCC TGGGCCC GGGCCCC GGCCCCC GCCCCCG CCCCCGC,"ID   NCAP_SARS2              Reviewed;         419 AA.
AC   P0DTC9;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Nucleoprotein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=N;
DE   AltName: Full=Nucleocapsid protein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=NC {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=Protein N {ECO:0000255|HAMAP-Rule:MF_04096};
GN   Name=N {ECO:0000255|HAMAP-Rule:MF_04096};
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3] {ECO:0007744|PDB:6WZO, ECO:0007744|PDB:6WZQ}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 247-364, AND SUBUNIT.
RX   PubMed=32654247; DOI=10.1002/pro.3909;
RA   Ye Q., West A.M.V., Silletti S., Corbett K.D.;
RT   ""Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein."";
RL   Protein Sci. 29:1890-1901(2020).
RN   [4]
RP   REVIEW.
RX   PubMed=32974389; DOI=10.3389/fmolb.2020.00219;
RA   Nikolakaki E., Giannakouros T.;
RT   ""SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle."";
RL   Front. Mol. Biosci. 7:219-219(2020).
RN   [5]
RP   VARIANTS LEU-3 AND PHE-235.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=34341353; DOI=10.1038/s41467-021-25015-6;
RA   Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J.,
RA   Jia Y., Wang W., Wan P., Zhang J., Chen W., Lei Z., Chen X., Luo Z.,
RA   Zhang Q., Xu M., Li G., Li Y., Wu J.;
RT   ""SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce
RT   hyperinflammation."";
RL   Nat. Commun. 12:4664-4664(2021).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 41-174, AND MUTAGENESIS OF
RP   TYR-109.
RX   PubMed=32363136; DOI=10.1016/j.apsb.2020.04.009;
RA   Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z.,
RA   Zhou Z., Chen Q., Yan Y., Zhang C., Shan H., Chen S.;
RT   ""Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain
RT   reveals potential unique drug targeting sites."";
RL   Acta Pharmacol. Sin. 10:1228-1238(2020).
RN   [8] {ECO:0007744|PDB:6YI3, ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT}
RP   STRUCTURE BY NMR OF 44-180, FUNCTION, AND MUTAGENESIS OF ARG-68; ARG-92;
RP   ILE-94; ARG-107; GLN-163; TYR-172 AND GLU-174.
RX   PubMed=33264373; DOI=10.1371/journal.ppat.1009100;
RA   Dinesh D.C., Chalupska D., Silhan J., Koutna E., Nencka R., Veverka V.,
RA   Boura E.;
RT   ""Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid
RT   phosphoprotein."";
RL   PLoS Pathog. 16:1-16(2020).
RN   [9]
RP   MUTAGENESIS OF SER-188 AND SER-206, AND PHOSPHORYLATION AT SER-206.
RX   PubMed=34593624; DOI=10.1073/pnas.2113401118;
RA   Liu X., Verma A., Garcia G. Jr., Ramage H., Lucas A., Myers R.L.,
RA   Michaelson J.J., Coryell W., Kumar A., Charney A.W., Kazanietz M.G.,
RA   Rader D.J., Ritchie M.D., Berrettini W.H., Schultz D.C., Cherry S.,
RA   Damoiseaux R., Arumugaswami V., Klein P.S.;
RT   ""Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:1-9(2021).
RN   [10]
RP   CLEAVAGE.
RX   PubMed=35922005; DOI=10.1038/s41586-022-05148-4;
RA   Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., Shi J., Chai Y.,
RA   Yuen T.T., Hu B., Li C., Zhao X., Wang Y., Huang X., Lee K.S., Luo C.,
RA   Cai J.P., Poon V.K., Chan C.C., Zhang A.J., Yuan S., Sit K.Y., Foo D.C.,
RA   Au W.K., Wong K.K., Zhou J., Kok K.H., Jin D.Y., Chan J.F., Yuen K.Y.;
RT   ""Coronaviruses exploit a host cysteine-aspartic protease for replication."";
RL   Nature 0:0-0(2022).
RN   [11]
RP   MUTAGENESIS OF 203-ARG-GLY-204 AND ARG-203, AND PHOSPHORYLATION.
RX   PubMed=35728038; DOI=10.1371/journal.ppat.1010627;
RA   Johnson B.A., Zhou Y., Lokugamage K.G., Vu M.N., Bopp N.,
RA   Crocquet-Valdes P.A., Kalveram B., Schindewolf C., Liu Y., Scharton D.,
RA   Plante J.A., Xie X., Aguilar P., Weaver S.C., Shi P.Y., Walker D.H.,
RA   Routh A.L., Plante K.S., Menachery V.D.;
RT   ""Nucleocapsid mutations in SARS-CoV-2 augment replication and
RT   pathogenesis."";
RL   PLoS Pathog. 18:e1010627-e1010627(2022).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=35921414; DOI=10.1126/sciadv.abp9770;
RA   Lopez-Munoz A.D., Kosik I., Holly J., Yewdell J.W.;
RT   ""Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive
RT   immunity."";
RL   Sci. Adv. 8:eabp9770-eabp9770(2022).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=34901782; DOI=10.1016/j.isci.2021.103562;
RA   Nabeel-Shah S., Lee H., Ahmed N., Burke G.L., Farhangmehr S., Ashraf K.,
RA   Pu S., Braunschweig U., Zhong G., Wei H., Tang H., Yang J., Marcon E.,
RA   Blencowe B.J., Zhang Z., Greenblatt J.F.;
RT   ""SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress
RT   granules to impair host stress response."";
RL   IScience 25:103562-103562(2022).
RN   [14]
RP   FUNCTION.
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [15] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 191-263, AND INTERACTION WITH NSP3.
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
CC   -!- FUNCTION: Packages the positive strand viral genome RNA into a helical
CC       ribonucleocapsid (RNP) and plays a fundamental role during virion
CC       assembly through its interactions with the viral genome and membrane
CC       protein M (PubMed:33264373). Plays an important role in enhancing the
CC       efficiency of subgenomic viral RNA transcription as well as viral
CC       replication. Attenuates the stress granules formation by reducing host
CC       G3BP1 access to host mRNAs under stress conditions (PubMed:34901782,
CC       PubMed:36534661). {ECO:0000269|PubMed:32974389,
CC       ECO:0000269|PubMed:33264373, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: May block host chemokine function in vivo, facilitating viral
CC       replication and transmission (PubMed:35921414). Acts by being secreted
CC       into the extracellular space where it competes to host chemokines for
CC       binding to host glycosaminoglycans (GAG) (PubMed:35921414).
CC       {ECO:0000269|PubMed:35921414}.
CC   -!- FUNCTION: May induce inflammasome responses in cultured cells and mice.
CC       Acts by interacting with host NLRP3 to facilitate inflammasome
CC       assembly, which induces cytokine release that may play a role in COVID
CC       lung injury. {ECO:0000269|PubMed:34341353}.
CC   -!- SUBUNIT: Homodimer, homotetramer, homooligomer with RNA
CC       (PubMed:32654247). Both monomeric and oligomeric forms interact with
CC       RNA. Interacts with protein M (By similarity). Interacts with protein E
CC       (By similarity). Interacts with NSP3; this interaction serves to tether
CC       the genome to the newly translated replicase-transcriptase complex at a
CC       very early stage of infection (PubMed:35044811). May interact with host
CC       NLRP3 (PubMed:34341353). {ECO:0000250|UniProtKB:P59595,
CC       ECO:0000255|HAMAP-Rule:MF_04096, ECO:0000269|PubMed:32654247,
CC       ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:35044811}.
CC   -!- INTERACTION:
CC       P0DTC9; P0DTC4: E; NbExp=3; IntAct=EBI-25475856, EBI-25475850;
CC       P0DTC9; P0DTC5: M; NbExp=6; IntAct=EBI-25475856, EBI-25475853;
CC       P0DTC9; P0DTC9: N; NbExp=105; IntAct=EBI-25475856, EBI-25475856;
CC       P0DTC9; PRO_0000449621 [P0DTD1]: rep; NbExp=15; IntAct=EBI-25475856, EBI-25492388;
CC       P0DTC9; P78563: ADARB1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2967304;
CC       P0DTC9; O15145: ARPC3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351829;
CC       P0DTC9; Q13895: BYSL; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358049;
CC       P0DTC9; Q16543: CDC37; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-295634;
CC       P0DTC9; Q92793: CREBBP; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-81215;
CC       P0DTC9; Q92499: DDX1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-358474;
CC       P0DTC9; Q9NR30: DDX21; Xeno; NbExp=12; IntAct=EBI-25475856, EBI-357942;
CC       P0DTC9; P26196: DDX6; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351257;
CC       P0DTC9; Q08426: EHHADH; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2339219;
CC       P0DTC9; P19525: EIF2AK2; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-640775;
CC       P0DTC9; Q14241: ELOA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-742350;
CC       P0DTC9; Q13283: G3BP1; Xeno; NbExp=71; IntAct=EBI-25475856, EBI-1047359;
CC       P0DTC9; Q9UN86: G3BP2; Xeno; NbExp=37; IntAct=EBI-25475856, EBI-1044298;
CC       P0DTC9; P57764: GSDMD; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2798865;
CC       P0DTC9; P49841: GSK3B; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-373586;
CC       P0DTC9; P10412: H1-4; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358163;
CC       P0DTC9; O14920: IKBKB; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-81266;
CC       P0DTC9; Q92830: KAT2A; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477622;
CC       P0DTC9; Q92831: KAT2B; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477430;
CC       P0DTC9; Q07866: KLC1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-721019;
CC       P0DTC9; Q9H0B6: KLC2; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-726994;
CC       P0DTC9; Q9NSK0: KLC4; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-949319;
CC       P0DTC9; Q9NX58: LYAR; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-713507;
CC       P0DTC9; O43318: MAP3K7; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-358684;
CC       P0DTC9; Q9UBU8: MORF4L1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-399246;
CC       P0DTC9; Q15014: MORF4L2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-399257;
CC       P0DTC9; Q9HCE1: MOV10; Xeno; NbExp=11; IntAct=EBI-25475856, EBI-1055820;
CC       P0DTC9; Q9HC36: MRM3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-1045440;
CC       P0DTC9; O15226: NKRF; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-766011;
CC       P0DTC9; Q96P20: NLRP3; Xeno; NbExp=18; IntAct=EBI-25475856, EBI-6253230;
CC       P0DTC9; O15118: NPC1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-2368710;
CC       P0DTC9; Q96HA8: NTAQ1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-741158;
CC       P0DTC9; P11940: PABPC1; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-81531;
CC       P0DTC9; P62937: PPIA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-437708;
CC       P0DTC9; O75569: PRKRA; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-713955;
CC       P0DTC9; Q99873: PRMT1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-78738;
CC       P0DTC9; P61289: PSME3; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-355546;
CC       P0DTC9; P26022: PTX3; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-11574553;
CC       P0DTC9; P54727: RAD23B; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-954531;
CC       P0DTC9; O95786: RIGI; Xeno; NbExp=15; IntAct=EBI-25475856, EBI-995350;
CC       P0DTC9; P62899: RPL31; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1053664;
CC       P0DTC9; P62753: RPS6; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-356625;
CC       P0DTC9; P37840: SNCA; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-985879;
CC       P0DTC9; Q96SB4: SRPK1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-539478;
CC       P0DTC9; P78362: SRPK2; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-593303;
CC       P0DTC9; P42224: STAT1; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1057697;
CC       P0DTC9; P52630: STAT2; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-1546963;
CC       P0DTC9; Q15633: TARBP2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-978581;
CC       P0DTC9; Q14258: TRIM25; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2341129;
CC       P0DTC9; O60763: USO1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-356164;
CC       P0DTC9; Q93008: USP9X; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-302524;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04096}. Host
CC       cytoplasm {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34341353}.
CC       Secreted {ECO:0000269|PubMed:35921414}. Host extracellular space
CC       {ECO:0000269|PubMed:35921414}. Note=Probably associates with ER-derived
CC       membranes where it participates in viral RNA synthesis and virus
CC       budding. When located inside the virion, complexed with the viral RNA.
CC       Can be secreted by unconventional protein secretion (UPS)
CC       (PubMed:35921414). When secreted, can bind to host glycosaminoglycans
CC       on infected and non infected cells (PubMed:35921414). Found in host
CC       cytoplasmic stress granules (PubMed:34901782). {ECO:0000255|HAMAP-
CC       Rule:MF_04096, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:35921414}.
CC   -!- PTM: ADP-ribosylated. The ADP-ribosylation is retained in the virion
CC       during infection. {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   -!- PTM: Phosphorylated on serine residues by host GSK3A and GSK3B
CC       (PubMed:34593624, PubMed:35728038). This promotes the solubility of
CC       homodimers that would otherwise aggregate (PubMed:32974389). Host
CC       phosphatase would dephosphorylate the protein during assembly at M
CC       bound membranes (PubMed:32974389). {ECO:0000269|PubMed:34593624,
CC       ECO:0000269|PubMed:35728038, ECO:0000305|PubMed:32974389}.
CC   -!- PTM: Proteolytically cleaved by host CASP6. The cleavage leads to two
CC       fragments and facilitates viral replication by inhibiting host IFN
CC       signaling. The two fragments may interact with IRF3 inhibiting its
CC       nuclear translocation after activation and reduce the expression of
CC       IFNB and IFN-stimulated genes. {ECO:0000269|PubMed:35922005}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (December 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1. {ECO:0000305|PubMed:33413740}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronavirus nucleocapsid protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43423.2; -; Genomic_RNA.
DR   PDB; 6M3M; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 6VYO; X-ray; 1.70 A; A/B/C/D=47-173.
DR   PDB; 6WJI; X-ray; 2.05 A; A/B/C/D/E/F=257-364.
DR   PDB; 6WKP; X-ray; 2.67 A; A/B/C/D=47-173.
DR   PDB; 6WZO; X-ray; 1.42 A; A/B/C/D=247-364.
DR   PDB; 6WZQ; X-ray; 1.45 A; A/B/C/D=247-364.
DR   PDB; 6YI3; NMR; -; A=44-180.
DR   PDB; 6YUN; X-ray; 1.44 A; A/B=249-364.
DR   PDB; 6ZCO; X-ray; 1.36 A; A=247-364.
DR   PDB; 7ACS; NMR; -; A=44-180.
DR   PDB; 7ACT; NMR; -; A=44-180.
DR   PDB; 7C22; X-ray; 2.00 A; A/B/C/D=248-364.
DR   PDB; 7CDZ; X-ray; 1.80 A; A/B/C/D=44-174.
DR   PDB; 7CE0; X-ray; 1.50 A; A/B/C/D=255-364.
DR   PDB; 7CR5; X-ray; 2.08 A; A=41-174.
DR   PDB; 7DE1; X-ray; 2.00 A; A/B=250-364.
DR   PDB; 7F2B; X-ray; 2.00 A; A/B=257-362.
DR   PDB; 7F2E; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=255-362.
DR   PDB; 7KGO; X-ray; 2.15 A; C=351-359.
DR   PDB; 7KGP; X-ray; 1.40 A; C=316-324.
DR   PDB; 7KGQ; X-ray; 1.34 A; C=222-230.
DR   PDB; 7KGR; X-ray; 1.55 A; C=159-167.
DR   PDB; 7KGS; X-ray; 1.58 A; C=138-146.
DR   PDB; 7KGT; X-ray; 1.90 A; C=226-234.
DR   PDB; 7LGD; X-ray; 2.88 A; E/F=105-113.
DR   PDB; 7LTU; X-ray; 1.12 A; A/B=217-222.
DR   PDB; 7LUX; X-ray; 1.30 A; A=217-222.
DR   PDB; 7LUZ; X-ray; 1.10 A; A=243-248.
DR   PDB; 7LV2; X-ray; 1.30 A; A=179-184.
DR   PDB; 7N0I; X-ray; 2.20 A; A/B/C/D/E/F/G/H=269-364.
DR   PDB; 7N0R; X-ray; 1.42 A; A/B=49-174.
DR   PDB; 7N3C; X-ray; 1.82 A; C=47-173.
DR   PDB; 7N3D; X-ray; 1.53 A; C=47-173.
DR   PDB; 7O05; X-ray; 1.94 A; A/B/C/D=247-364.
DR   PDB; 7O35; X-ray; 1.80 A; A/B/C/D=247-364.
DR   PDB; 7O36; X-ray; 2.00 A; A/B/C/D=247-364.
DR   PDB; 7PKU; NMR; -; B=191-263.
DR   PDB; 7QIK; X-ray; 2.01 A; E/F=193-200.
DR   PDB; 7QIP; X-ray; 2.65 A; C/D=201-210.
DR   PDB; 7R98; X-ray; 2.51 A; A/B/C=49-174.
DR   PDB; 7SD4; NMR; -; A=40-174.
DR   PDB; 7STR; X-ray; 1.50 A; C=47-173.
DR   PDB; 7STS; X-ray; 2.16 A; C/D=47-173.
DR   PDB; 7SUE; X-ray; 2.90 A; C/D/J/K=47-173.
DR   PDB; 7SUO; X-ray; 2.35 A; C/D=12-22.
DR   PDB; 7UW3; X-ray; 1.70 A; A/B/C/D=40-174.
DR   PDB; 7UXX; X-ray; 1.85 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7UXZ; X-ray; 1.73 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7VBD; X-ray; 1.94 A; A/B/C/D=48-174.
DR   PDB; 7VBE; X-ray; 1.59 A; A/B=257-364.
DR   PDB; 7VBF; X-ray; 1.30 A; A/B=255-364.
DR   PDB; 7VNU; X-ray; 1.95 A; A/B/C/D=47-174.
DR   PDB; 7WKJ; X-ray; 1.50 A; C=361-369.
DR   PDB; 7WZO; X-ray; 2.64 A; A=47-174.
DR   PDB; 7XWX; X-ray; 3.00 A; A/B/C/D/E/F/G/H=269-367.
DR   PDB; 7XWZ; X-ray; 2.25 A; A/B=48-172.
DR   PDB; 7XX1; X-ray; 1.90 A; A/B/C/D=49-173.
DR   PDB; 7XXK; X-ray; 2.00 A; A/B/C/D/E/F=248-364.
DR   PDB; 7YLB; X-ray; 2.41 A; A/B/C/D/G/H/J/K=247-364.
DR   PDB; 7YLD; X-ray; 2.80 A; A/B/C/D=47-174.
DR   PDB; 7ZIT; X-ray; 1.79 A; C/D=194-200.
DR   PDB; 8DNT; X-ray; 3.18 A; D/J/Q/X=222-230.
DR   PDB; 8FD5; EM; 4.57 A; A=1-419.
DR   PDB; 8FG2; EM; 6.00 A; A/B=1-419.
DR   PDB; 8IQJ; X-ray; 2.30 A; A/B/C/D=41-174.
DR   PDB; 8IV3; X-ray; 1.90 A; A/B/C/D=41-174.
DR   PDB; 8J6X; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 8TH1; X-ray; 1.80 A; E/F/G/H=1-25.
DR   PDB; 8TH5; X-ray; 2.62 A; K/L/M/N/O/P/Q=1-25.
DR   PDB; 8X1H; X-ray; 2.00 A; A/B/C/D=44-175.
DR   PDBsum; 6M3M; -.
DR   PDBsum; 6VYO; -.
DR   PDBsum; 6WJI; -.
DR   PDBsum; 6WKP; -.
DR   PDBsum; 6WZO; -.
DR   PDBsum; 6WZQ; -.
DR   PDBsum; 6YI3; -.
DR   PDBsum; 6YUN; -.
DR   PDBsum; 6ZCO; -.
DR   PDBsum; 7ACS; -.
DR   PDBsum; 7ACT; -.
DR   PDBsum; 7C22; -.
DR   PDBsum; 7CDZ; -.
DR   PDBsum; 7CE0; -.
DR   PDBsum; 7CR5; -.
DR   PDBsum; 7DE1; -.
DR   PDBsum; 7F2B; -.
DR   PDBsum; 7F2E; -.
DR   PDBsum; 7KGO; -.
DR   PDBsum; 7KGP; -.
DR   PDBsum; 7KGQ; -.
DR   PDBsum; 7KGR; -.
DR   PDBsum; 7KGS; -.
DR   PDBsum; 7KGT; -.
DR   PDBsum; 7LGD; -.
DR   PDBsum; 7LTU; -.
DR   PDBsum; 7LUX; -.
DR   PDBsum; 7LUZ; -.
DR   PDBsum; 7LV2; -.
DR   PDBsum; 7N0I; -.
DR   PDBsum; 7N0R; -.
DR   PDBsum; 7N3C; -.
DR   PDBsum; 7N3D; -.
DR   PDBsum; 7O05; -.
DR   PDBsum; 7O35; -.
DR   PDBsum; 7O36; -.
DR   PDBsum; 7PKU; -.
DR   PDBsum; 7QIK; -.
DR   PDBsum; 7QIP; -.
DR   PDBsum; 7R98; -.
DR   PDBsum; 7SD4; -.
DR   PDBsum; 7STR; -.
DR   PDBsum; 7STS; -.
DR   PDBsum; 7SUE; -.
DR   PDBsum; 7SUO; -.
DR   PDBsum; 7UW3; -.
DR   PDBsum; 7UXX; -.
DR   PDBsum; 7UXZ; -.
DR   PDBsum; 7VBD; -.
DR   PDBsum; 7VBE; -.
DR   PDBsum; 7VBF; -.
DR   PDBsum; 7VNU; -.
DR   PDBsum; 7WKJ; -.
DR   PDBsum; 7WZO; -.
DR   PDBsum; 7XWX; -.
DR   PDBsum; 7XWZ; -.
DR   PDBsum; 7XX1; -.
DR   PDBsum; 7XXK; -.
DR   PDBsum; 7YLB; -.
DR   PDBsum; 7YLD; -.
DR   PDBsum; 7ZIT; -.
DR   PDBsum; 8DNT; -.
DR   PDBsum; 8FD5; -.
DR   PDBsum; 8FG2; -.
DR   PDBsum; 8IQJ; -.
DR   PDBsum; 8IV3; -.
DR   PDBsum; 8J6X; -.
DR   PDBsum; 8TH1; -.
DR   PDBsum; 8TH5; -.
DR   PDBsum; 8X1H; -.
DR   BMRB; P0DTC9; -.
DR   EMDB; EMD-29002; -.
DR   EMDB; EMD-29072; -.
DR   SASBDB; P0DTC9; -.
DR   SMR; P0DTC9; -.
DR   BioGRID; 4383847; 1532.
DR   ComplexPortal; CPX-5686; SARS-CoV-2 nucleocapsid complex.
DR   IntAct; P0DTC9; 608.
DR   MINT; P0DTC9; -.
DR   ChEMBL; CHEMBL5169223; -.
DR   iPTMnet; P0DTC9; -.
DR   ABCD; P0DTC9; 27 sequenced antibodies.
DR   DNASU; 43740575; -.
DR   KEGG; vg:43740575; -.
DR   AGR; RefSeq:YP_009724397; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694786; Transcription of SARS-CoV-2 sgRNAs.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC9; -.
DR   PRO; PR:P0DTC9; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0044177; C:host cell Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043655; C:host extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt.
DR   GO; GO:0042612; C:MHC class I protein complex; EXP:DisProt.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0019028; C:viral capsid; IPI:ComplexPortal.
DR   GO; GO:0019013; C:viral nucleocapsid; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042288; F:MHC class I protein binding; EXP:DisProt.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; IDA:DisProt.
DR   GO; GO:0008266; F:poly(U) RNA binding; IMP:DisProt.
DR   GO; GO:0042803; F:protein homodimerization activity; EXP:DisProt.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProt.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:DisProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IDA:ComplexPortal.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0052572; P:response to host immune response; IDA:DisProt.
DR   GO; GO:0019074; P:viral RNA genome packaging; NAS:ComplexPortal.
DR   CDD; cd21595; CoV_N-CTD; 1.
DR   CDD; cd21554; CoV_N-NTD; 1.
DR   HAMAP; MF_04096; BETA_CORONA_NCAP; 1.
DR   InterPro; IPR044344; N_prot_C_CoV.
DR   InterPro; IPR044345; N_prot_N_CoV.
DR   InterPro; IPR043505; NCAP_bCoV.
DR   InterPro; IPR001218; Nucleocap_CoV.
DR   InterPro; IPR037179; Nucleocapsid_C.
DR   InterPro; IPR037195; Nucleocapsid_N.
DR   Pfam; PF00937; CoV_nucleocap; 1.
DR   PIRSF; PIRSF003888; Corona_nucleocap; 1.
DR   SUPFAM; SSF110304; Coronavirus RNA-binding domain; 1.
DR   SUPFAM; SSF103068; Nucleocapsid protein dimerization domain; 1.
DR   PROSITE; PS51929; COV_N_CTD; 1.
DR   PROSITE; PS51928; COV_N_NTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Host cytoplasm; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Secreted;
KW   Transcription; Transcription regulation; Viral nucleoprotein; Virion.
FT   CHAIN           1..419
FT                   /note=""Nucleoprotein""
FT                   /id=""PRO_0000449656""
FT   DOMAIN          48..174
FT                   /note=""CoV N NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01276,
FT                   ECO:0000269|PubMed:32363136""
FT   DOMAIN          247..364
FT                   /note=""CoV N CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01277""
FT   REGION          1..51
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          41..186
FT                   /note=""RNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          63..83
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          168..212
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          176..206
FT                   /note=""SR region""
FT                   /evidence=""ECO:0000305|PubMed:32974389""
FT   REGION          233..266
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          258..361
FT                   /note=""Dimerization""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          260..340
FT                   /note=""Putative NLRP3 binding""
FT                   /evidence=""ECO:0000269|PubMed:34341353""
FT   REGION          361..391
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          400..419
FT                   /note=""Tetramerization""
FT                   /evidence=""ECO:0000269|PubMed:32654247""
FT   MOTIF           256..264
FT                   /note=""Nuclear localization signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   COMPBIAS        1..11
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        21..31
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        367..378
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         92
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         107
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         149
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   SITE            399..402
FT                   /note=""Cleavage (by host CASP6)""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   MOD_RES         176
FT                   /note=""Phosphoserine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   MOD_RES         206
FT                   /note=""Phosphoserine; by host GSK3-alpha and GSK3-beta""
FT                   /evidence=""ECO:0000269|PubMed:34593624""
FT   VARIANT         2..3
FT                   /note=""SD -> Y (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> L (in strain: Alpha/B.1.1.7)""
FT                   /evidence=""ECO:0000305|PubMed:33413740""
FT   VARIANT         12
FT                   /note=""A -> G (in strain: Eta/B.1.525)""
FT   VARIANT         13
FT                   /note=""P -> L (in strain: Lambda/C.37, Omicron/BA.1,
FT                   Omicron/BA.2, Omicron/BA.2.12.1, Omicron/BA.2.75,
FT                   Omicron/BA.4, Omicron/BA.5, Omicron/BQ.1.1,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         31..33
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""D -> G (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT  ",9705
GACATG ACATGG CATGGC ATGGCC TGGCCC GGCCCG GCCCGC CCCGCG CCGCGC CGCGCC GCGCCA CGCCAA GCCAAG CCAAGG CAAGGC AAGGCG AGGCGA GGCGAT GCGATC CGATCG GATCGA ATCGAG TCGAGG CGAGGC GAGGCG AGGCGC GGCGCT GCGCTG CGCTGG GCTGGA CTGGAG TGGAGC GGAGCA GAGCAT AGCATG GCATGT CATGTG ATGTGC TGTGCG GTGCGC TGCGCA GCGCAT CGCATC GCATCC CATCCG ATCCGC TCCGCG CCGCGA CGCGAC GCGACG CGACGC GACGCG ACGCGG CGCGGC GCGGCG CGGCGA GGCGAA GCGAAG CGAAGC GAAGCG AAGCGC AGCGCT GCGCTA CGCTAC GCTACC CTACCA TACCAC ACCACG CCACGC CACGCC ACGCCT CGCCTA GCCTAT CCTATC CTATCC TATCCC ATCCCT TCCCTT CCCTTC CCTTCG CTTCGA TTCGAG TCGAGC CGAGCT GAGCTG AGCTGT GCTGTC CTGTCC TGTCCG GTCCGG TCCGGC CCGGCG CGGCGG GGCGGC GCGGCA CGGCAT GGCATG GCATGT CATGTG ATGTGC TGTGCC GTGCCA TGCCAG GCCAGC CCAGCG CAGCGC AGCGCG GCGCGT CGCGTG GCGTGG CGTGGT GTGGTC TGGTCA GGTCAT GTCATT TCATTG CATTGC ATTGCC TTGCCA TGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGC TGCGCT GCGCTG CGCTGG GCTGGC CTGGCC TGGCCT GGCCTG GCCTGC CCTGCA CTGCAA TGCAAA GCAAAC CAAACC AAACCG AACCGC ACCGCA CCGCAG CGCAGC GCAGCT CAGCTG,2,145,GACA ACAT CATG ATGG TGGC GGCC GCCC CCCG CCGC CGCG GCGC CGCC GCCA CCAA CAAG AAGG AGGC GGCG GCGA CGAT GATC ATCG TCGA CGAG GAGG AGGC GGCG GCGC CGCT GCTG CTGG TGGA GGAG GAGC AGCA GCAT CATG ATGT TGTG GTGC TGCG GCGC CGCA GCAT CATC ATCC TCCG CCGC CGCG GCGA CGAC GACG ACGC CGCG GCGG CGGC GGCG GCGA CGAA GAAG AAGC AGCG GCGC CGCT GCTA CTAC TACC ACCA CCAC CACG ACGC CGCC GCCT CCTA CTAT TATC ATCC TCCC CCCT CCTT CTTC TTCG TCGA CGAG GAGC AGCT GCTG CTGT TGTC GTCC TCCG CCGG CGGC GGCG GCGG CGGC GGCA GCAT CATG ATGT TGTG GTGC TGCC GCCA CCAG CAGC AGCG GCGC CGCG GCGT CGTG GTGG TGGT GGTC GTCA TCAT CATT ATTG TTGC TGCC GCCA CCAT CATT ATTG TTGC TGCG GCGC CGCT GCTG CTGG TGGC GGCC GCCT CCTG CTGC TGCA GCAA CAAA AAAC AACC ACCG CCGC CGCA GCAG CAGC AGCT GCTG,GACAT ACATG CATGG ATGGC TGGCC GGCCC GCCCG CCCGC CCGCG CGCGC GCGCC CGCCA GCCAA CCAAG CAAGG AAGGC AGGCG GGCGA GCGAT CGATC GATCG ATCGA TCGAG CGAGG GAGGC AGGCG GGCGC GCGCT CGCTG GCTGG CTGGA TGGAG GGAGC GAGCA AGCAT GCATG CATGT ATGTG TGTGC GTGCG TGCGC GCGCA CGCAT GCATC CATCC ATCCG TCCGC CCGCG CGCGA GCGAC CGACG GACGC ACGCG CGCGG GCGGC CGGCG GGCGA GCGAA CGAAG GAAGC AAGCG AGCGC GCGCT CGCTA GCTAC CTACC TACCA ACCAC CCACG CACGC ACGCC CGCCT GCCTA CCTAT CTATC TATCC ATCCC TCCCT CCCTT CCTTC CTTCG TTCGA TCGAG CGAGC GAGCT AGCTG GCTGT CTGTC TGTCC GTCCG TCCGG CCGGC CGGCG GGCGG GCGGC CGGCA GGCAT GCATG CATGT ATGTG TGTGC GTGCC TGCCA GCCAG CCAGC CAGCG AGCGC GCGCG CGCGT GCGTG CGTGG GTGGT TGGTC GGTCA GTCAT TCATT CATTG ATTGC TTGCC TGCCA GCCAT CCATT CATTG ATTGC TTGCG TGCGC GCGCT CGCTG GCTGG CTGGC TGGCC GGCCT GCCTG CCTGC CTGCA TGCAA GCAAA CAAAC AAACC AACCG ACCGC CCGCA CGCAG GCAGC CAGCT AGCTG,GACATG ACATGG CATGGC ATGGCC TGGCCC GGCCCG GCCCGC CCCGCG CCGCGC CGCGCC GCGCCA CGCCAA GCCAAG CCAAGG CAAGGC AAGGCG AGGCGA GGCGAT GCGATC CGATCG GATCGA ATCGAG TCGAGG CGAGGC GAGGCG AGGCGC GGCGCT GCGCTG CGCTGG GCTGGA CTGGAG TGGAGC GGAGCA GAGCAT AGCATG GCATGT CATGTG ATGTGC TGTGCG GTGCGC TGCGCA GCGCAT CGCATC GCATCC CATCCG ATCCGC TCCGCG CCGCGA CGCGAC GCGACG CGACGC GACGCG ACGCGG CGCGGC GCGGCG CGGCGA GGCGAA GCGAAG CGAAGC GAAGCG AAGCGC AGCGCT GCGCTA CGCTAC GCTACC CTACCA TACCAC ACCACG CCACGC CACGCC ACGCCT CGCCTA GCCTAT CCTATC CTATCC TATCCC ATCCCT TCCCTT CCCTTC CCTTCG CTTCGA TTCGAG TCGAGC CGAGCT GAGCTG AGCTGT GCTGTC CTGTCC TGTCCG GTCCGG TCCGGC CCGGCG CGGCGG GGCGGC GCGGCA CGGCAT GGCATG GCATGT CATGTG ATGTGC TGTGCC GTGCCA TGCCAG GCCAGC CCAGCG CAGCGC AGCGCG GCGCGT CGCGTG GCGTGG CGTGGT GTGGTC TGGTCA GGTCAT GTCATT TCATTG CATTGC ATTGCC TTGCCA TGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGC TGCGCT GCGCTG CGCTGG GCTGGC CTGGCC TGGCCT GGCCTG GCCTGC CCTGCA CTGCAA TGCAAA GCAAAC CAAACC AAACCG AACCGC ACCGCA CCGCAG CGCAGC GCAGCT CAGCTG,GACATGG ACATGGC CATGGCC ATGGCCC TGGCCCG GGCCCGC GCCCGCG CCCGCGC CCGCGCC CGCGCCA GCGCCAA CGCCAAG GCCAAGG CCAAGGC CAAGGCG AAGGCGA AGGCGAT GGCGATC GCGATCG CGATCGA GATCGAG ATCGAGG TCGAGGC CGAGGCG GAGGCGC AGGCGCT GGCGCTG GCGCTGG CGCTGGA GCTGGAG CTGGAGC TGGAGCA GGAGCAT GAGCATG AGCATGT GCATGTG CATGTGC ATGTGCG TGTGCGC GTGCGCA TGCGCAT GCGCATC CGCATCC GCATCCG CATCCGC ATCCGCG TCCGCGA CCGCGAC CGCGACG GCGACGC CGACGCG GACGCGG ACGCGGC CGCGGCG GCGGCGA CGGCGAA GGCGAAG GCGAAGC CGAAGCG GAAGCGC AAGCGCT AGCGCTA GCGCTAC CGCTACC GCTACCA CTACCAC TACCACG ACCACGC CCACGCC CACGCCT ACGCCTA CGCCTAT GCCTATC CCTATCC CTATCCC TATCCCT ATCCCTT TCCCTTC CCCTTCG CCTTCGA CTTCGAG TTCGAGC TCGAGCT CGAGCTG GAGCTGT AGCTGTC GCTGTCC CTGTCCG TGTCCGG GTCCGGC TCCGGCG CCGGCGG CGGCGGC GGCGGCA GCGGCAT CGGCATG GGCATGT GCATGTG CATGTGC ATGTGCC TGTGCCA GTGCCAG TGCCAGC GCCAGCG CCAGCGC CAGCGCG AGCGCGT GCGCGTG CGCGTGG GCGTGGT CGTGGTC GTGGTCA TGGTCAT GGTCATT GTCATTG TCATTGC CATTGCC ATTGCCA TTGCCAT TGCCATT GCCATTG CCATTGC CATTGCG ATTGCGC TTGCGCT TGCGCTG GCGCTGG CGCTGGC GCTGGCC CTGGCCT TGGCCTG GGCCTGC GCCTGCA CCTGCAA CTGCAAA TGCAAAC GCAAACC CAAACCG AAACCGC AACCGCA ACCGCAG CCGCAGC CGCAGCT GCAGCTG,"ID   METN1_PSEAB             Reviewed;         369 AA.
AC   Q02ME3;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 1.
DT   05-FEB-2025, entry version 104.
DE   RecName: Full=Methionine import ATP-binding protein MetN 1 {ECO:0000255|HAMAP-Rule:MF_01719};
DE            EC=7.4.2.11 {ECO:0000255|HAMAP-Rule:MF_01719};
GN   Name=metN1 {ECO:0000255|HAMAP-Rule:MF_01719};
GN   OrderedLocusNames=PA14_34270;
OS   Pseudomonas aeruginosa (strain UCBPP-PA14).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208963;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UCBPP-PA14;
RX   PubMed=17038190; DOI=10.1186/gb-2006-7-10-r90;
RA   Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S.,
RA   Diggins L.T., He J., Saucier M., Deziel E., Friedman L., Li L., Grills G.,
RA   Montgomery K., Kucherlapati R., Rahme L.G., Ausubel F.M.;
RT   ""Genomic analysis reveals that Pseudomonas aeruginosa virulence is
RT   combinatorial."";
RL   Genome Biol. 7:R90.1-R90.14(2006).
CC   -!- FUNCTION: Part of the ABC transporter complex MetNIQ involved in
CC       methionine import. Responsible for energy coupling to the transport
CC       system. {ECO:0000255|HAMAP-Rule:MF_01719}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-methionine(out) + ATP + H2O = L-methionine(in) + ADP +
CC         phosphate + H(+); Xref=Rhea:RHEA:29779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57844, ChEBI:CHEBI:456216; EC=7.4.2.11;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01719};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-methionine(out) + ATP + H2O = D-methionine(in) + ADP +
CC         phosphate + H(+); Xref=Rhea:RHEA:29767, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57932, ChEBI:CHEBI:456216; EC=7.4.2.11;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01719};
CC   -!- SUBUNIT: The complex is composed of two ATP-binding proteins (MetN),
CC       two transmembrane proteins (MetI) and a solute-binding protein (MetQ).
CC       {ECO:0000255|HAMAP-Rule:MF_01719}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01719}; Peripheral membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01719}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. Methionine
CC       importer (TC 3.A.1.24) family. {ECO:0000255|HAMAP-Rule:MF_01719}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000438; ABJ11526.1; -; Genomic_DNA.
DR   RefSeq; WP_003139341.1; NZ_CP034244.1.
DR   AlphaFoldDB; Q02ME3; -.
DR   SMR; Q02ME3; -.
DR   KEGG; pau:PA14_34270; -.
DR   PseudoCAP; PA14_34270; -.
DR   HOGENOM; CLU_000604_1_3_6; -.
DR   BioCyc; PAER208963:G1G74-2881-MONOMER; -.
DR   Proteomes; UP000000653; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0033232; F:ABC-type D-methionine transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   CDD; cd03258; ABC_MetN_methionine_transporter; 1.
DR   FunFam; 3.40.50.300:FF:000056; Cell division ATP-binding protein FtsE; 1.
DR   Gene3D; 3.30.70.260; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR045865; ACT-like_dom_sf.
DR   InterPro; IPR041701; MetN_ABC.
DR   InterPro; IPR050086; MetN_ABC_transporter-like.
DR   InterPro; IPR018449; NIL_domain.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR43166; AMINO ACID IMPORT ATP-BINDING PROTEIN; 1.
DR   PANTHER; PTHR43166:SF30; METHIONINE IMPORT ATP-BINDING PROTEIN METN; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   Pfam; PF09383; NIL; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00930; NIL; 1.
DR   SUPFAM; SSF55021; ACT-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
DR   PROSITE; PS51264; METN; 1.
PE   3: Inferred from homology;
KW   Amino-acid transport; ATP-binding; Cell inner membrane; Cell membrane;
KW   Membrane; Nucleotide-binding; Translocase; Transport.
FT   CHAIN           1..369
FT                   /note=""Methionine import ATP-binding protein MetN 1""
FT                   /id=""PRO_0000277689""
FT   DOMAIN          29..265
FT                   /note=""ABC transporter""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01719""
FT   REGION          1..26
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         62..69
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01719""
SQ   SEQUENCE   369 AA;  39965 MW;  E47436987F6497AD CRC64;
     MTTMTVPPSL LPLEPFPTAP DTRASTPHIR LHGLGKRYPG GVQALREIDL EIRRGEVFGI
     IGRSGAGKSS LIRTLNRLER PSEGQVLIDG EDIGGYDGQR LVALRRRIGM IFQHFNLMSA
     KTVRQNIALP LRVAGVPRAR IEERVAGLLQ LVGLEEKRDA YPAQLSGGQK QRVGIARALV
     HQPQILLCDE ATSALDPEST QAILALLRDI NRRLGLTIVL ITHEMAVIRE ICDRVVVLEC
     GRIVEQGEVW EVFGDPRHAV TRSLLGSLRA ALPADLQARL RQAPGGGDPV LLDLQYTGAS
     RRVPDLLAIA RAIGQRVDLL HGGIERIQGR ALGRLLLQVG APPGELPGVL AKAALVADKV
     EVLGHVAHA
//
",14003
GACCTG ACCTGT CCTGTC CTGTCC TGTCCC GTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCA CCTCAC CTCACC TCACCG CACCGA ACCGAC CCGACG CGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGC CCTGCA CTGCAG TGCAGG GCAGGC CAGGCC AGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCG ACGCGA CGCGAG GCGAGC CGAGCA GAGCAG AGCAGG GCAGGG CAGGGC AGGGCA GGGCAT GGCATC GCATCA CATCAC ATCACC TCACCA CACCAT ACCATC CCATCG CATCGA ATCGAC TCGACG CGACGT GACGTC ACGTCG CGTCGC GTCGCC TCGCCT CGCCTA GCCTAC CCTACC CTACCG TACCGT ACCGTT CCGTTA CGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTC TTCTCC TCTCCA CTCCAC TCCACC CCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACA CCACAC CACACG ACACGC,3,88,GACC ACCT CCTG CTGT TGTC GTCC TCCC CCCT CCTC CTCC TCCT CCTC CTCA TCAC CACC ACCG CCGA CGAC GACG ACGG CGGC GGCC GCCT CCTG CTGC TGCA GCAG CAGG AGGC GGCC GCCG CCGA CGAA GAAC AACG ACGC CGCG GCGA CGAG GAGC AGCA GCAG CAGG AGGG GGGC GGCA GCAT CATC ATCA TCAC CACC ACCA CCAT CATC ATCG TCGA CGAC GACG ACGT CGTC GTCG TCGC CGCC GCCT CCTA CTAC TACC ACCG CCGT CGTT GTTA TTAC TACT ACTT CTTC TTCT TCTC CTCC TCCA CCAC CACC ACCT CCTC CTCC TCCA CCAC CACA ACAC CACG ACGC,GACCT ACCTG CCTGT CTGTC TGTCC GTCCC TCCCT CCCTC CCTCC CTCCT TCCTC CCTCA CTCAC TCACC CACCG ACCGA CCGAC CGACG GACGG ACGGC CGGCC GGCCT GCCTG CCTGC CTGCA TGCAG GCAGG CAGGC AGGCC GGCCG GCCGA CCGAA CGAAC GAACG AACGC ACGCG CGCGA GCGAG CGAGC GAGCA AGCAG GCAGG CAGGG AGGGC GGGCA GGCAT GCATC CATCA ATCAC TCACC CACCA ACCAT CCATC CATCG ATCGA TCGAC CGACG GACGT ACGTC CGTCG GTCGC TCGCC CGCCT GCCTA CCTAC CTACC TACCG ACCGT CCGTT CGTTA GTTAC TTACT TACTT ACTTC CTTCT TTCTC TCTCC CTCCA TCCAC CCACC CACCT ACCTC CCTCC CTCCA TCCAC CCACA CACAC ACACG CACGC,GACCTG ACCTGT CCTGTC CTGTCC TGTCCC GTCCCT TCCCTC CCCTCC CCTCCT CTCCTC TCCTCA CCTCAC CTCACC TCACCG CACCGA ACCGAC CCGACG CGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGC CCTGCA CTGCAG TGCAGG GCAGGC CAGGCC AGGCCG GGCCGA GCCGAA CCGAAC CGAACG GAACGC AACGCG ACGCGA CGCGAG GCGAGC CGAGCA GAGCAG AGCAGG GCAGGG CAGGGC AGGGCA GGGCAT GGCATC GCATCA CATCAC ATCACC TCACCA CACCAT ACCATC CCATCG CATCGA ATCGAC TCGACG CGACGT GACGTC ACGTCG CGTCGC GTCGCC TCGCCT CGCCTA GCCTAC CCTACC CTACCG TACCGT ACCGTT CCGTTA CGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTC TTCTCC TCTCCA CTCCAC TCCACC CCACCT CACCTC ACCTCC CCTCCA CTCCAC TCCACA CCACAC CACACG ACACGC,GACCTGT ACCTGTC CCTGTCC CTGTCCC TGTCCCT GTCCCTC TCCCTCC CCCTCCT CCTCCTC CTCCTCA TCCTCAC CCTCACC CTCACCG TCACCGA CACCGAC ACCGACG CCGACGG CGACGGC GACGGCC ACGGCCT CGGCCTG GGCCTGC GCCTGCA CCTGCAG CTGCAGG TGCAGGC GCAGGCC CAGGCCG AGGCCGA GGCCGAA GCCGAAC CCGAACG CGAACGC GAACGCG AACGCGA ACGCGAG CGCGAGC GCGAGCA CGAGCAG GAGCAGG AGCAGGG GCAGGGC CAGGGCA AGGGCAT GGGCATC GGCATCA GCATCAC CATCACC ATCACCA TCACCAT CACCATC ACCATCG CCATCGA CATCGAC ATCGACG TCGACGT CGACGTC GACGTCG ACGTCGC CGTCGCC GTCGCCT TCGCCTA CGCCTAC GCCTACC CCTACCG CTACCGT TACCGTT ACCGTTA CCGTTAC CGTTACT GTTACTT TTACTTC TACTTCT ACTTCTC CTTCTCC TTCTCCA TCTCCAC CTCCACC TCCACCT CCACCTC CACCTCC ACCTCCA CCTCCAC CTCCACA TCCACAC CCACACG CACACGC,"ID   CYSN_LARHH              Reviewed;         481 AA.
AC   C1D890;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 1.
DT   05-FEB-2025, entry version 87.
DE   RecName: Full=Sulfate adenylyltransferase subunit 1 {ECO:0000255|HAMAP-Rule:MF_00062};
DE            EC=2.7.7.4 {ECO:0000255|HAMAP-Rule:MF_00062};
DE   AltName: Full=ATP-sulfurylase large subunit {ECO:0000255|HAMAP-Rule:MF_00062};
DE   AltName: Full=Sulfate adenylate transferase {ECO:0000255|HAMAP-Rule:MF_00062};
DE            Short=SAT {ECO:0000255|HAMAP-Rule:MF_00062};
GN   Name=cysN {ECO:0000255|HAMAP-Rule:MF_00062};
GN   OrderedLocusNames=LHK_01695;
OS   Laribacter hongkongensis (strain HLHK9).
OC   Bacteria; Pseudomonadota; Betaproteobacteria; Neisseriales;
OC   Aquaspirillaceae; Laribacter.
OX   NCBI_TaxID=557598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HLHK9;
RX   PubMed=19283063; DOI=10.1371/journal.pgen.1000416;
RA   Woo P.C.Y., Lau S.K.P., Tse H., Teng J.L.L., Curreem S.O., Tsang A.K.L.,
RA   Fan R.Y.Y., Wong G.K.M., Huang Y., Loman N.J., Snyder L.A.S., Cai J.J.,
RA   Huang J.-D., Mak W., Pallen M.J., Lok S., Yuen K.-Y.;
RT   ""The complete genome and proteome of Laribacter hongkongensis reveal
RT   potential mechanisms for adaptations to different temperatures and
RT   habitats."";
RL   PLoS Genet. 5:E1000416-E1000416(2009).
CC   -!- FUNCTION: With CysD forms the ATP sulfurylase (ATPS) that catalyzes the
CC       adenylation of sulfate producing adenosine 5'-phosphosulfate (APS) and
CC       diphosphate, the first enzymatic step in sulfur assimilation pathway.
CC       APS synthesis involves the formation of a high-energy phosphoric-
CC       sulfuric acid anhydride bond driven by GTP hydrolysis by CysN coupled
CC       to ATP hydrolysis by CysD. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sulfate + ATP + H(+) = adenosine 5'-phosphosulfate +
CC         diphosphate; Xref=Rhea:RHEA:18133, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16189, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:58243; EC=2.7.7.4; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00062};
CC   -!- PATHWAY: Sulfur metabolism; hydrogen sulfide biosynthesis; sulfite from
CC       sulfate: step 1/3. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- SUBUNIT: Heterodimer composed of CysD, the smaller subunit, and CysN.
CC       {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC       superfamily. Classic translation factor GTPase family. CysN/NodQ
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_00062}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001154; ACO74680.1; -; Genomic_DNA.
DR   RefSeq; WP_012697166.1; NC_012559.1.
DR   AlphaFoldDB; C1D890; -.
DR   SMR; C1D890; -.
DR   STRING; 557598.LHK_01695; -.
DR   KEGG; lhk:LHK_01695; -.
DR   eggNOG; COG2895; Bacteria.
DR   HOGENOM; CLU_007265_5_2_4; -.
DR   UniPathway; UPA00140; UER00204.
DR   Proteomes; UP000002010; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0004781; F:sulfate adenylyltransferase (ATP) activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0000103; P:sulfate assimilation; IEA:UniProtKB-UniRule.
DR   CDD; cd04166; CysN_ATPS; 1.
DR   CDD; cd03695; CysN_NodQ_II; 1.
DR   CDD; cd04095; CysN_NoDQ_III; 1.
DR   FunFam; 2.40.30.10:FF:000027; Sulfate adenylyltransferase subunit 1; 1.
DR   FunFam; 3.40.50.300:FF:000119; Sulfate adenylyltransferase subunit 1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 2.
DR   HAMAP; MF_00062; Sulf_adenylyltr_sub1; 1.
DR   InterPro; IPR041757; CysN_GTP-bd.
DR   InterPro; IPR044138; CysN_II.
DR   InterPro; IPR044139; CysN_NoDQ_III.
DR   InterPro; IPR031157; G_TR_CS.
DR   InterPro; IPR054696; GTP-eEF1A_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011779; SO4_adenylTrfase_lsu.
DR   InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR   InterPro; IPR050100; TRAFAC_GTPase_members.
DR   InterPro; IPR009000; Transl_B-barrel_sf.
DR   InterPro; IPR009001; Transl_elong_EF1A/Init_IF2_C.
DR   NCBIfam; TIGR02034; CysN; 1.
DR   PANTHER; PTHR23115; TRANSLATION FACTOR; 1.
DR   Pfam; PF22594; GTP-eEF1A_C; 1.
DR   Pfam; PF00009; GTP_EFTU; 1.
DR   PRINTS; PR00315; ELONGATNFCT.
DR   SUPFAM; SSF50465; EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50447; Translation proteins; 1.
DR   PROSITE; PS00301; G_TR_1; 1.
DR   PROSITE; PS51722; G_TR_2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; GTP-binding; Nucleotide-binding; Nucleotidyltransferase;
KW   Reference proteome; Transferase.
FT   CHAIN           1..481
FT                   /note=""Sulfate adenylyltransferase subunit 1""
FT                   /id=""PRO_1000117915""
FT   DOMAIN          22..236
FT                   /note=""tr-type G""
FT   REGION          31..38
FT                   /note=""G1""
FT                   /evidence=""ECO:0000250""
FT   REGION          89..93
FT                   /note=""G2""
FT                   /evidence=""ECO:0000250""
FT   REGION          110..113
FT                   /note=""G3""
FT                   /evidence=""ECO:0000250""
FT   REGION          165..168
FT                   /note=""G4""
FT                   /evidence=""ECO:0000250""
FT   REGION          202..204
FT                   /note=""G5""
FT                   /evidence=""ECO:0000250""
FT   BINDING         31..38
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
FT   BINDING         110..114
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
FT   BINDING         165..168
FT                   /ligand=""GTP""
FT                   /ligand_id=""ChEBI:CHEBI:37565""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00062""
SQ   SEQUENCE   481 AA;  53901 MW;  14AE3915869E9999 CRC64;
     MTHQSDLIAE DIHAYLARHE TKDLLRFITC GSVDDGKSTL IGRLLHDSRL IFEDQLAAIE
     RDSQKHNTTD EAVDLALLVD GLQAEREQGI TIDVAYRYFS TDTRKFIIAD CPGHEQYTRN
     MATGASTADL AIILIDARYG VQTQTRRHSF IASLLGIRHV IVAVNKMDLL EFDQAVFERI
     RQDYLTFAKA LDIHDIRFVP LSALRGDNVV SPSERMPWYD GPSLMQLLDS IRLDADQALQ
     AFRLPVQYVN RPNLDFRGFC GTIAAGVIRP GDQVTVLPSG RQSRVRAIVT TDGELPVAAT
     GQAVTLTLED EIDISRGDMI VRHGEPLPLV ADRLTVELVW MHDAPLQTGR AYWVKLAGKW
     LPGRVTAVHH RVNVNTMERE AASSLALNEI AEVTLEIDAP MAVDAYRQCR ATGSLILVDR
     ISNATLGAGM IRSAEPSAGI QSEKDAARRW QAFEIEFNEL VRRHFPHWQA RDMRDWPGHK
     E
//
",28269
ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGC AGAGCT GAGCTA AGCTAC GCTACC CTACCA TACCAG ACCAGA CCAGAC CAGACG AGACGA GACGAA ACGAAT CGAATT GAATTC AATTCG ATTCGT TTCGTG TCGTGG CGTGGT GTGGTG TGGTGG GGTGGT GTGGTG TGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTA CGGTAA GGTAAA GTAAAA TAAAAT AAAATG AAATGA AATGAA ATGAAA TGAAAG GAAAGA AAAGAT AAGATC AGATCT GATCTC ATCTCA TCTCAG CTCAGT TCAGTC CAGTCC AGTCCA GTCCAA TCCAAG CCAAGA CAAGAT AAGATG AGATGG GATGGT ATGGTA TGGTAT GGTATT GTATTT TATTTC ATTTCT TTTCTA TTCTAC TCTACT CTACTC TACTCC ACTCCC CTCCCT TCCCTA CCCTAG CCTAGG CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA,1,100,ATTG TTGG TGGC GGCT GCTA CTAC TACT ACTA CTAC TACC ACCG CCGA CGAA GAAG AAGA AGAG GAGC AGCT GCTA CTAC TACC ACCA CCAG CAGA AGAC GACG ACGA CGAA GAAT AATT ATTC TTCG TCGT CGTG GTGG TGGT GGTG GTGG TGGT GGTG GTGA TGAC GACG ACGG CGGT GGTA GTAA TAAA AAAA AAAT AATG ATGA TGAA GAAA AAAG AAGA AGAT GATC ATCT TCTC CTCA TCAG CAGT AGTC GTCC TCCA CCAA CAAG AAGA AGAT GATG ATGG TGGT GGTA GTAT TATT ATTT TTTC TTCT TCTA CTAC TACT ACTC CTCC TCCC CCCT CCTA CTAG TAGG AGGA GGAA GAAC AACT ACTG CTGG TGGG GGGC GGCC GCCA CCAG CAGA AGAA,ATTGG TTGGC TGGCT GGCTA GCTAC CTACT TACTA ACTAC CTACC TACCG ACCGA CCGAA CGAAG GAAGA AAGAG AGAGC GAGCT AGCTA GCTAC CTACC TACCA ACCAG CCAGA CAGAC AGACG GACGA ACGAA CGAAT GAATT AATTC ATTCG TTCGT TCGTG CGTGG GTGGT TGGTG GGTGG GTGGT TGGTG GGTGA GTGAC TGACG GACGG ACGGT CGGTA GGTAA GTAAA TAAAA AAAAT AAATG AATGA ATGAA TGAAA GAAAG AAAGA AAGAT AGATC GATCT ATCTC TCTCA CTCAG TCAGT CAGTC AGTCC GTCCA TCCAA CCAAG CAAGA AAGAT AGATG GATGG ATGGT TGGTA GGTAT GTATT TATTT ATTTC TTTCT TTCTA TCTAC CTACT TACTC ACTCC CTCCC TCCCT CCCTA CCTAG CTAGG TAGGA AGGAA GGAAC GAACT AACTG ACTGG CTGGG TGGGC GGGCC GGCCA GCCAG CCAGA CAGAA,ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGC AGAGCT GAGCTA AGCTAC GCTACC CTACCA TACCAG ACCAGA CCAGAC CAGACG AGACGA GACGAA ACGAAT CGAATT GAATTC AATTCG ATTCGT TTCGTG TCGTGG CGTGGT GTGGTG TGGTGG GGTGGT GTGGTG TGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTA CGGTAA GGTAAA GTAAAA TAAAAT AAAATG AAATGA AATGAA ATGAAA TGAAAG GAAAGA AAAGAT AAGATC AGATCT GATCTC ATCTCA TCTCAG CTCAGT TCAGTC CAGTCC AGTCCA GTCCAA TCCAAG CCAAGA CAAGAT AAGATG AGATGG GATGGT ATGGTA TGGTAT GGTATT GTATTT TATTTC ATTTCT TTTCTA TTCTAC TCTACT CTACTC TACTCC ACTCCC CTCCCT TCCCTA CCCTAG CCTAGG CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA,ATTGGCT TTGGCTA TGGCTAC GGCTACT GCTACTA CTACTAC TACTACC ACTACCG CTACCGA TACCGAA ACCGAAG CCGAAGA CGAAGAG GAAGAGC AAGAGCT AGAGCTA GAGCTAC AGCTACC GCTACCA CTACCAG TACCAGA ACCAGAC CCAGACG CAGACGA AGACGAA GACGAAT ACGAATT CGAATTC GAATTCG AATTCGT ATTCGTG TTCGTGG TCGTGGT CGTGGTG GTGGTGG TGGTGGT GGTGGTG GTGGTGA TGGTGAC GGTGACG GTGACGG TGACGGT GACGGTA ACGGTAA CGGTAAA GGTAAAA GTAAAAT TAAAATG AAAATGA AAATGAA AATGAAA ATGAAAG TGAAAGA GAAAGAT AAAGATC AAGATCT AGATCTC GATCTCA ATCTCAG TCTCAGT CTCAGTC TCAGTCC CAGTCCA AGTCCAA GTCCAAG TCCAAGA CCAAGAT CAAGATG AAGATGG AGATGGT GATGGTA ATGGTAT TGGTATT GGTATTT GTATTTC TATTTCT ATTTCTA TTTCTAC TTCTACT TCTACTC CTACTCC TACTCCC ACTCCCT CTCCCTA TCCCTAG CCCTAGG CCTAGGA CTAGGAA TAGGAAC AGGAACT GGAACTG GAACTGG AACTGGG ACTGGGC CTGGGCC TGGGCCA GGGCCAG GGCCAGA GCCAGAA,"ID   NCAP_SARS2              Reviewed;         419 AA.
AC   P0DTC9;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Nucleoprotein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=N;
DE   AltName: Full=Nucleocapsid protein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=NC {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=Protein N {ECO:0000255|HAMAP-Rule:MF_04096};
GN   Name=N {ECO:0000255|HAMAP-Rule:MF_04096};
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3] {ECO:0007744|PDB:6WZO, ECO:0007744|PDB:6WZQ}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 247-364, AND SUBUNIT.
RX   PubMed=32654247; DOI=10.1002/pro.3909;
RA   Ye Q., West A.M.V., Silletti S., Corbett K.D.;
RT   ""Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein."";
RL   Protein Sci. 29:1890-1901(2020).
RN   [4]
RP   REVIEW.
RX   PubMed=32974389; DOI=10.3389/fmolb.2020.00219;
RA   Nikolakaki E., Giannakouros T.;
RT   ""SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle."";
RL   Front. Mol. Biosci. 7:219-219(2020).
RN   [5]
RP   VARIANTS LEU-3 AND PHE-235.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=34341353; DOI=10.1038/s41467-021-25015-6;
RA   Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J.,
RA   Jia Y., Wang W., Wan P., Zhang J., Chen W., Lei Z., Chen X., Luo Z.,
RA   Zhang Q., Xu M., Li G., Li Y., Wu J.;
RT   ""SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce
RT   hyperinflammation."";
RL   Nat. Commun. 12:4664-4664(2021).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 41-174, AND MUTAGENESIS OF
RP   TYR-109.
RX   PubMed=32363136; DOI=10.1016/j.apsb.2020.04.009;
RA   Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z.,
RA   Zhou Z., Chen Q., Yan Y., Zhang C., Shan H., Chen S.;
RT   ""Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain
RT   reveals potential unique drug targeting sites."";
RL   Acta Pharmacol. Sin. 10:1228-1238(2020).
RN   [8] {ECO:0007744|PDB:6YI3, ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT}
RP   STRUCTURE BY NMR OF 44-180, FUNCTION, AND MUTAGENESIS OF ARG-68; ARG-92;
RP   ILE-94; ARG-107; GLN-163; TYR-172 AND GLU-174.
RX   PubMed=33264373; DOI=10.1371/journal.ppat.1009100;
RA   Dinesh D.C., Chalupska D., Silhan J., Koutna E., Nencka R., Veverka V.,
RA   Boura E.;
RT   ""Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid
RT   phosphoprotein."";
RL   PLoS Pathog. 16:1-16(2020).
RN   [9]
RP   MUTAGENESIS OF SER-188 AND SER-206, AND PHOSPHORYLATION AT SER-206.
RX   PubMed=34593624; DOI=10.1073/pnas.2113401118;
RA   Liu X., Verma A., Garcia G. Jr., Ramage H., Lucas A., Myers R.L.,
RA   Michaelson J.J., Coryell W., Kumar A., Charney A.W., Kazanietz M.G.,
RA   Rader D.J., Ritchie M.D., Berrettini W.H., Schultz D.C., Cherry S.,
RA   Damoiseaux R., Arumugaswami V., Klein P.S.;
RT   ""Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:1-9(2021).
RN   [10]
RP   CLEAVAGE.
RX   PubMed=35922005; DOI=10.1038/s41586-022-05148-4;
RA   Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., Shi J., Chai Y.,
RA   Yuen T.T., Hu B., Li C., Zhao X., Wang Y., Huang X., Lee K.S., Luo C.,
RA   Cai J.P., Poon V.K., Chan C.C., Zhang A.J., Yuan S., Sit K.Y., Foo D.C.,
RA   Au W.K., Wong K.K., Zhou J., Kok K.H., Jin D.Y., Chan J.F., Yuen K.Y.;
RT   ""Coronaviruses exploit a host cysteine-aspartic protease for replication."";
RL   Nature 0:0-0(2022).
RN   [11]
RP   MUTAGENESIS OF 203-ARG-GLY-204 AND ARG-203, AND PHOSPHORYLATION.
RX   PubMed=35728038; DOI=10.1371/journal.ppat.1010627;
RA   Johnson B.A., Zhou Y., Lokugamage K.G., Vu M.N., Bopp N.,
RA   Crocquet-Valdes P.A., Kalveram B., Schindewolf C., Liu Y., Scharton D.,
RA   Plante J.A., Xie X., Aguilar P., Weaver S.C., Shi P.Y., Walker D.H.,
RA   Routh A.L., Plante K.S., Menachery V.D.;
RT   ""Nucleocapsid mutations in SARS-CoV-2 augment replication and
RT   pathogenesis."";
RL   PLoS Pathog. 18:e1010627-e1010627(2022).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=35921414; DOI=10.1126/sciadv.abp9770;
RA   Lopez-Munoz A.D., Kosik I., Holly J., Yewdell J.W.;
RT   ""Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive
RT   immunity."";
RL   Sci. Adv. 8:eabp9770-eabp9770(2022).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=34901782; DOI=10.1016/j.isci.2021.103562;
RA   Nabeel-Shah S., Lee H., Ahmed N., Burke G.L., Farhangmehr S., Ashraf K.,
RA   Pu S., Braunschweig U., Zhong G., Wei H., Tang H., Yang J., Marcon E.,
RA   Blencowe B.J., Zhang Z., Greenblatt J.F.;
RT   ""SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress
RT   granules to impair host stress response."";
RL   IScience 25:103562-103562(2022).
RN   [14]
RP   FUNCTION.
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [15] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 191-263, AND INTERACTION WITH NSP3.
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
CC   -!- FUNCTION: Packages the positive strand viral genome RNA into a helical
CC       ribonucleocapsid (RNP) and plays a fundamental role during virion
CC       assembly through its interactions with the viral genome and membrane
CC       protein M (PubMed:33264373). Plays an important role in enhancing the
CC       efficiency of subgenomic viral RNA transcription as well as viral
CC       replication. Attenuates the stress granules formation by reducing host
CC       G3BP1 access to host mRNAs under stress conditions (PubMed:34901782,
CC       PubMed:36534661). {ECO:0000269|PubMed:32974389,
CC       ECO:0000269|PubMed:33264373, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: May block host chemokine function in vivo, facilitating viral
CC       replication and transmission (PubMed:35921414). Acts by being secreted
CC       into the extracellular space where it competes to host chemokines for
CC       binding to host glycosaminoglycans (GAG) (PubMed:35921414).
CC       {ECO:0000269|PubMed:35921414}.
CC   -!- FUNCTION: May induce inflammasome responses in cultured cells and mice.
CC       Acts by interacting with host NLRP3 to facilitate inflammasome
CC       assembly, which induces cytokine release that may play a role in COVID
CC       lung injury. {ECO:0000269|PubMed:34341353}.
CC   -!- SUBUNIT: Homodimer, homotetramer, homooligomer with RNA
CC       (PubMed:32654247). Both monomeric and oligomeric forms interact with
CC       RNA. Interacts with protein M (By similarity). Interacts with protein E
CC       (By similarity). Interacts with NSP3; this interaction serves to tether
CC       the genome to the newly translated replicase-transcriptase complex at a
CC       very early stage of infection (PubMed:35044811). May interact with host
CC       NLRP3 (PubMed:34341353). {ECO:0000250|UniProtKB:P59595,
CC       ECO:0000255|HAMAP-Rule:MF_04096, ECO:0000269|PubMed:32654247,
CC       ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:35044811}.
CC   -!- INTERACTION:
CC       P0DTC9; P0DTC4: E; NbExp=3; IntAct=EBI-25475856, EBI-25475850;
CC       P0DTC9; P0DTC5: M; NbExp=6; IntAct=EBI-25475856, EBI-25475853;
CC       P0DTC9; P0DTC9: N; NbExp=105; IntAct=EBI-25475856, EBI-25475856;
CC       P0DTC9; PRO_0000449621 [P0DTD1]: rep; NbExp=15; IntAct=EBI-25475856, EBI-25492388;
CC       P0DTC9; P78563: ADARB1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2967304;
CC       P0DTC9; O15145: ARPC3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351829;
CC       P0DTC9; Q13895: BYSL; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358049;
CC       P0DTC9; Q16543: CDC37; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-295634;
CC       P0DTC9; Q92793: CREBBP; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-81215;
CC       P0DTC9; Q92499: DDX1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-358474;
CC       P0DTC9; Q9NR30: DDX21; Xeno; NbExp=12; IntAct=EBI-25475856, EBI-357942;
CC       P0DTC9; P26196: DDX6; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351257;
CC       P0DTC9; Q08426: EHHADH; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2339219;
CC       P0DTC9; P19525: EIF2AK2; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-640775;
CC       P0DTC9; Q14241: ELOA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-742350;
CC       P0DTC9; Q13283: G3BP1; Xeno; NbExp=71; IntAct=EBI-25475856, EBI-1047359;
CC       P0DTC9; Q9UN86: G3BP2; Xeno; NbExp=37; IntAct=EBI-25475856, EBI-1044298;
CC       P0DTC9; P57764: GSDMD; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2798865;
CC       P0DTC9; P49841: GSK3B; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-373586;
CC       P0DTC9; P10412: H1-4; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358163;
CC       P0DTC9; O14920: IKBKB; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-81266;
CC       P0DTC9; Q92830: KAT2A; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477622;
CC       P0DTC9; Q92831: KAT2B; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477430;
CC       P0DTC9; Q07866: KLC1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-721019;
CC       P0DTC9; Q9H0B6: KLC2; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-726994;
CC       P0DTC9; Q9NSK0: KLC4; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-949319;
CC       P0DTC9; Q9NX58: LYAR; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-713507;
CC       P0DTC9; O43318: MAP3K7; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-358684;
CC       P0DTC9; Q9UBU8: MORF4L1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-399246;
CC       P0DTC9; Q15014: MORF4L2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-399257;
CC       P0DTC9; Q9HCE1: MOV10; Xeno; NbExp=11; IntAct=EBI-25475856, EBI-1055820;
CC       P0DTC9; Q9HC36: MRM3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-1045440;
CC       P0DTC9; O15226: NKRF; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-766011;
CC       P0DTC9; Q96P20: NLRP3; Xeno; NbExp=18; IntAct=EBI-25475856, EBI-6253230;
CC       P0DTC9; O15118: NPC1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-2368710;
CC       P0DTC9; Q96HA8: NTAQ1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-741158;
CC       P0DTC9; P11940: PABPC1; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-81531;
CC       P0DTC9; P62937: PPIA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-437708;
CC       P0DTC9; O75569: PRKRA; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-713955;
CC       P0DTC9; Q99873: PRMT1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-78738;
CC       P0DTC9; P61289: PSME3; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-355546;
CC       P0DTC9; P26022: PTX3; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-11574553;
CC       P0DTC9; P54727: RAD23B; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-954531;
CC       P0DTC9; O95786: RIGI; Xeno; NbExp=15; IntAct=EBI-25475856, EBI-995350;
CC       P0DTC9; P62899: RPL31; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1053664;
CC       P0DTC9; P62753: RPS6; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-356625;
CC       P0DTC9; P37840: SNCA; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-985879;
CC       P0DTC9; Q96SB4: SRPK1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-539478;
CC       P0DTC9; P78362: SRPK2; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-593303;
CC       P0DTC9; P42224: STAT1; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1057697;
CC       P0DTC9; P52630: STAT2; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-1546963;
CC       P0DTC9; Q15633: TARBP2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-978581;
CC       P0DTC9; Q14258: TRIM25; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2341129;
CC       P0DTC9; O60763: USO1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-356164;
CC       P0DTC9; Q93008: USP9X; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-302524;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04096}. Host
CC       cytoplasm {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34341353}.
CC       Secreted {ECO:0000269|PubMed:35921414}. Host extracellular space
CC       {ECO:0000269|PubMed:35921414}. Note=Probably associates with ER-derived
CC       membranes where it participates in viral RNA synthesis and virus
CC       budding. When located inside the virion, complexed with the viral RNA.
CC       Can be secreted by unconventional protein secretion (UPS)
CC       (PubMed:35921414). When secreted, can bind to host glycosaminoglycans
CC       on infected and non infected cells (PubMed:35921414). Found in host
CC       cytoplasmic stress granules (PubMed:34901782). {ECO:0000255|HAMAP-
CC       Rule:MF_04096, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:35921414}.
CC   -!- PTM: ADP-ribosylated. The ADP-ribosylation is retained in the virion
CC       during infection. {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   -!- PTM: Phosphorylated on serine residues by host GSK3A and GSK3B
CC       (PubMed:34593624, PubMed:35728038). This promotes the solubility of
CC       homodimers that would otherwise aggregate (PubMed:32974389). Host
CC       phosphatase would dephosphorylate the protein during assembly at M
CC       bound membranes (PubMed:32974389). {ECO:0000269|PubMed:34593624,
CC       ECO:0000269|PubMed:35728038, ECO:0000305|PubMed:32974389}.
CC   -!- PTM: Proteolytically cleaved by host CASP6. The cleavage leads to two
CC       fragments and facilitates viral replication by inhibiting host IFN
CC       signaling. The two fragments may interact with IRF3 inhibiting its
CC       nuclear translocation after activation and reduce the expression of
CC       IFNB and IFN-stimulated genes. {ECO:0000269|PubMed:35922005}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (December 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1. {ECO:0000305|PubMed:33413740}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronavirus nucleocapsid protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43423.2; -; Genomic_RNA.
DR   PDB; 6M3M; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 6VYO; X-ray; 1.70 A; A/B/C/D=47-173.
DR   PDB; 6WJI; X-ray; 2.05 A; A/B/C/D/E/F=257-364.
DR   PDB; 6WKP; X-ray; 2.67 A; A/B/C/D=47-173.
DR   PDB; 6WZO; X-ray; 1.42 A; A/B/C/D=247-364.
DR   PDB; 6WZQ; X-ray; 1.45 A; A/B/C/D=247-364.
DR   PDB; 6YI3; NMR; -; A=44-180.
DR   PDB; 6YUN; X-ray; 1.44 A; A/B=249-364.
DR   PDB; 6ZCO; X-ray; 1.36 A; A=247-364.
DR   PDB; 7ACS; NMR; -; A=44-180.
DR   PDB; 7ACT; NMR; -; A=44-180.
DR   PDB; 7C22; X-ray; 2.00 A; A/B/C/D=248-364.
DR   PDB; 7CDZ; X-ray; 1.80 A; A/B/C/D=44-174.
DR   PDB; 7CE0; X-ray; 1.50 A; A/B/C/D=255-364.
DR   PDB; 7CR5; X-ray; 2.08 A; A=41-174.
DR   PDB; 7DE1; X-ray; 2.00 A; A/B=250-364.
DR   PDB; 7F2B; X-ray; 2.00 A; A/B=257-362.
DR   PDB; 7F2E; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=255-362.
DR   PDB; 7KGO; X-ray; 2.15 A; C=351-359.
DR   PDB; 7KGP; X-ray; 1.40 A; C=316-324.
DR   PDB; 7KGQ; X-ray; 1.34 A; C=222-230.
DR   PDB; 7KGR; X-ray; 1.55 A; C=159-167.
DR   PDB; 7KGS; X-ray; 1.58 A; C=138-146.
DR   PDB; 7KGT; X-ray; 1.90 A; C=226-234.
DR   PDB; 7LGD; X-ray; 2.88 A; E/F=105-113.
DR   PDB; 7LTU; X-ray; 1.12 A; A/B=217-222.
DR   PDB; 7LUX; X-ray; 1.30 A; A=217-222.
DR   PDB; 7LUZ; X-ray; 1.10 A; A=243-248.
DR   PDB; 7LV2; X-ray; 1.30 A; A=179-184.
DR   PDB; 7N0I; X-ray; 2.20 A; A/B/C/D/E/F/G/H=269-364.
DR   PDB; 7N0R; X-ray; 1.42 A; A/B=49-174.
DR   PDB; 7N3C; X-ray; 1.82 A; C=47-173.
DR   PDB; 7N3D; X-ray; 1.53 A; C=47-173.
DR   PDB; 7O05; X-ray; 1.94 A; A/B/C/D=247-364.
DR   PDB; 7O35; X-ray; 1.80 A; A/B/C/D=247-364.
DR   PDB; 7O36; X-ray; 2.00 A; A/B/C/D=247-364.
DR   PDB; 7PKU; NMR; -; B=191-263.
DR   PDB; 7QIK; X-ray; 2.01 A; E/F=193-200.
DR   PDB; 7QIP; X-ray; 2.65 A; C/D=201-210.
DR   PDB; 7R98; X-ray; 2.51 A; A/B/C=49-174.
DR   PDB; 7SD4; NMR; -; A=40-174.
DR   PDB; 7STR; X-ray; 1.50 A; C=47-173.
DR   PDB; 7STS; X-ray; 2.16 A; C/D=47-173.
DR   PDB; 7SUE; X-ray; 2.90 A; C/D/J/K=47-173.
DR   PDB; 7SUO; X-ray; 2.35 A; C/D=12-22.
DR   PDB; 7UW3; X-ray; 1.70 A; A/B/C/D=40-174.
DR   PDB; 7UXX; X-ray; 1.85 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7UXZ; X-ray; 1.73 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7VBD; X-ray; 1.94 A; A/B/C/D=48-174.
DR   PDB; 7VBE; X-ray; 1.59 A; A/B=257-364.
DR   PDB; 7VBF; X-ray; 1.30 A; A/B=255-364.
DR   PDB; 7VNU; X-ray; 1.95 A; A/B/C/D=47-174.
DR   PDB; 7WKJ; X-ray; 1.50 A; C=361-369.
DR   PDB; 7WZO; X-ray; 2.64 A; A=47-174.
DR   PDB; 7XWX; X-ray; 3.00 A; A/B/C/D/E/F/G/H=269-367.
DR   PDB; 7XWZ; X-ray; 2.25 A; A/B=48-172.
DR   PDB; 7XX1; X-ray; 1.90 A; A/B/C/D=49-173.
DR   PDB; 7XXK; X-ray; 2.00 A; A/B/C/D/E/F=248-364.
DR   PDB; 7YLB; X-ray; 2.41 A; A/B/C/D/G/H/J/K=247-364.
DR   PDB; 7YLD; X-ray; 2.80 A; A/B/C/D=47-174.
DR   PDB; 7ZIT; X-ray; 1.79 A; C/D=194-200.
DR   PDB; 8DNT; X-ray; 3.18 A; D/J/Q/X=222-230.
DR   PDB; 8FD5; EM; 4.57 A; A=1-419.
DR   PDB; 8FG2; EM; 6.00 A; A/B=1-419.
DR   PDB; 8IQJ; X-ray; 2.30 A; A/B/C/D=41-174.
DR   PDB; 8IV3; X-ray; 1.90 A; A/B/C/D=41-174.
DR   PDB; 8J6X; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 8TH1; X-ray; 1.80 A; E/F/G/H=1-25.
DR   PDB; 8TH5; X-ray; 2.62 A; K/L/M/N/O/P/Q=1-25.
DR   PDB; 8X1H; X-ray; 2.00 A; A/B/C/D=44-175.
DR   PDBsum; 6M3M; -.
DR   PDBsum; 6VYO; -.
DR   PDBsum; 6WJI; -.
DR   PDBsum; 6WKP; -.
DR   PDBsum; 6WZO; -.
DR   PDBsum; 6WZQ; -.
DR   PDBsum; 6YI3; -.
DR   PDBsum; 6YUN; -.
DR   PDBsum; 6ZCO; -.
DR   PDBsum; 7ACS; -.
DR   PDBsum; 7ACT; -.
DR   PDBsum; 7C22; -.
DR   PDBsum; 7CDZ; -.
DR   PDBsum; 7CE0; -.
DR   PDBsum; 7CR5; -.
DR   PDBsum; 7DE1; -.
DR   PDBsum; 7F2B; -.
DR   PDBsum; 7F2E; -.
DR   PDBsum; 7KGO; -.
DR   PDBsum; 7KGP; -.
DR   PDBsum; 7KGQ; -.
DR   PDBsum; 7KGR; -.
DR   PDBsum; 7KGS; -.
DR   PDBsum; 7KGT; -.
DR   PDBsum; 7LGD; -.
DR   PDBsum; 7LTU; -.
DR   PDBsum; 7LUX; -.
DR   PDBsum; 7LUZ; -.
DR   PDBsum; 7LV2; -.
DR   PDBsum; 7N0I; -.
DR   PDBsum; 7N0R; -.
DR   PDBsum; 7N3C; -.
DR   PDBsum; 7N3D; -.
DR   PDBsum; 7O05; -.
DR   PDBsum; 7O35; -.
DR   PDBsum; 7O36; -.
DR   PDBsum; 7PKU; -.
DR   PDBsum; 7QIK; -.
DR   PDBsum; 7QIP; -.
DR   PDBsum; 7R98; -.
DR   PDBsum; 7SD4; -.
DR   PDBsum; 7STR; -.
DR   PDBsum; 7STS; -.
DR   PDBsum; 7SUE; -.
DR   PDBsum; 7SUO; -.
DR   PDBsum; 7UW3; -.
DR   PDBsum; 7UXX; -.
DR   PDBsum; 7UXZ; -.
DR   PDBsum; 7VBD; -.
DR   PDBsum; 7VBE; -.
DR   PDBsum; 7VBF; -.
DR   PDBsum; 7VNU; -.
DR   PDBsum; 7WKJ; -.
DR   PDBsum; 7WZO; -.
DR   PDBsum; 7XWX; -.
DR   PDBsum; 7XWZ; -.
DR   PDBsum; 7XX1; -.
DR   PDBsum; 7XXK; -.
DR   PDBsum; 7YLB; -.
DR   PDBsum; 7YLD; -.
DR   PDBsum; 7ZIT; -.
DR   PDBsum; 8DNT; -.
DR   PDBsum; 8FD5; -.
DR   PDBsum; 8FG2; -.
DR   PDBsum; 8IQJ; -.
DR   PDBsum; 8IV3; -.
DR   PDBsum; 8J6X; -.
DR   PDBsum; 8TH1; -.
DR   PDBsum; 8TH5; -.
DR   PDBsum; 8X1H; -.
DR   BMRB; P0DTC9; -.
DR   EMDB; EMD-29002; -.
DR   EMDB; EMD-29072; -.
DR   SASBDB; P0DTC9; -.
DR   SMR; P0DTC9; -.
DR   BioGRID; 4383847; 1532.
DR   ComplexPortal; CPX-5686; SARS-CoV-2 nucleocapsid complex.
DR   IntAct; P0DTC9; 608.
DR   MINT; P0DTC9; -.
DR   ChEMBL; CHEMBL5169223; -.
DR   iPTMnet; P0DTC9; -.
DR   ABCD; P0DTC9; 27 sequenced antibodies.
DR   DNASU; 43740575; -.
DR   KEGG; vg:43740575; -.
DR   AGR; RefSeq:YP_009724397; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694786; Transcription of SARS-CoV-2 sgRNAs.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC9; -.
DR   PRO; PR:P0DTC9; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0044177; C:host cell Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043655; C:host extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt.
DR   GO; GO:0042612; C:MHC class I protein complex; EXP:DisProt.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0019028; C:viral capsid; IPI:ComplexPortal.
DR   GO; GO:0019013; C:viral nucleocapsid; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042288; F:MHC class I protein binding; EXP:DisProt.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; IDA:DisProt.
DR   GO; GO:0008266; F:poly(U) RNA binding; IMP:DisProt.
DR   GO; GO:0042803; F:protein homodimerization activity; EXP:DisProt.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProt.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:DisProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IDA:ComplexPortal.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0052572; P:response to host immune response; IDA:DisProt.
DR   GO; GO:0019074; P:viral RNA genome packaging; NAS:ComplexPortal.
DR   CDD; cd21595; CoV_N-CTD; 1.
DR   CDD; cd21554; CoV_N-NTD; 1.
DR   HAMAP; MF_04096; BETA_CORONA_NCAP; 1.
DR   InterPro; IPR044344; N_prot_C_CoV.
DR   InterPro; IPR044345; N_prot_N_CoV.
DR   InterPro; IPR043505; NCAP_bCoV.
DR   InterPro; IPR001218; Nucleocap_CoV.
DR   InterPro; IPR037179; Nucleocapsid_C.
DR   InterPro; IPR037195; Nucleocapsid_N.
DR   Pfam; PF00937; CoV_nucleocap; 1.
DR   PIRSF; PIRSF003888; Corona_nucleocap; 1.
DR   SUPFAM; SSF110304; Coronavirus RNA-binding domain; 1.
DR   SUPFAM; SSF103068; Nucleocapsid protein dimerization domain; 1.
DR   PROSITE; PS51929; COV_N_CTD; 1.
DR   PROSITE; PS51928; COV_N_NTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Host cytoplasm; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Secreted;
KW   Transcription; Transcription regulation; Viral nucleoprotein; Virion.
FT   CHAIN           1..419
FT                   /note=""Nucleoprotein""
FT                   /id=""PRO_0000449656""
FT   DOMAIN          48..174
FT                   /note=""CoV N NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01276,
FT                   ECO:0000269|PubMed:32363136""
FT   DOMAIN          247..364
FT                   /note=""CoV N CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01277""
FT   REGION          1..51
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          41..186
FT                   /note=""RNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          63..83
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          168..212
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          176..206
FT                   /note=""SR region""
FT                   /evidence=""ECO:0000305|PubMed:32974389""
FT   REGION          233..266
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          258..361
FT                   /note=""Dimerization""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          260..340
FT                   /note=""Putative NLRP3 binding""
FT                   /evidence=""ECO:0000269|PubMed:34341353""
FT   REGION          361..391
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          400..419
FT                   /note=""Tetramerization""
FT                   /evidence=""ECO:0000269|PubMed:32654247""
FT   MOTIF           256..264
FT                   /note=""Nuclear localization signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   COMPBIAS        1..11
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        21..31
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        367..378
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         92
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         107
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         149
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   SITE            399..402
FT                   /note=""Cleavage (by host CASP6)""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   MOD_RES         176
FT                   /note=""Phosphoserine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   MOD_RES         206
FT                   /note=""Phosphoserine; by host GSK3-alpha and GSK3-beta""
FT                   /evidence=""ECO:0000269|PubMed:34593624""
FT   VARIANT         2..3
FT                   /note=""SD -> Y (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> L (in strain: Alpha/B.1.1.7)""
FT                   /evidence=""ECO:0000305|PubMed:33413740""
FT   VARIANT         12
FT                   /note=""A -> G (in strain: Eta/B.1.525)""
FT   VARIANT         13
FT                   /note=""P -> L (in strain: Lambda/C.37, Omicron/BA.1,
FT                   Omicron/BA.2, Omicron/BA.2.12.1, Omicron/BA.2.75,
FT                   Omicron/BA.4, Omicron/BA.5, Omicron/BQ.1.1,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         31..33
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""D -> G (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT  ",64115
GTCAAC TCAACG CAACGA AACGAC ACGACA CGACAA GACAAC ACAACG CAACGT AACGTC ACGTCG CGTCGT GTCGTC TCGTCT CGTCTA GTCTAC TCTACG CTACGC TACGCC ACGCCA CGCCAA GCCAAG CCAAGA CAAGAT AAGATC AGATCG GATCGT ATCGTC TCGTCC CGTCCT GTCCTT TCCTTG CCTTGC CTTGCC TTGCCA TGCCAT GCCATG CCATGA CATGAA ATGAAG TGAAGT GAAGTC AAGTCC AGTCCC GTCCCG TCCCGC CCCGCT CCGCTT CGCTTC GCTTCA CTTCAA TTCAAC TCAACG CAACGC AACGCC ACGCCA CGCCAA GCCAAC CCAACG CAACGA AACGAG ACGAGA CGAGAC GAGACC AGACCG GACCGA ACCGAC CCGACT CGACTT GACTTC ACTTCT CTTCTC TTCTCC TCTCCG CTCCGA TCCGAC CCGACT CGACTT GACTTC ACTTCA CTTCAT TTCATG TCATGG CATGGA ATGGAG TGGAGG GGAGGA GAGGAG AGGAGG GGAGGA GAGGAG AGGAGG GGAGGA GAGGAG AGGAGG GGAGGT GAGGTT AGGTTG GGTTGA GTTGAC TTGACC TGACCG GACCGC ACCGCG CCGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCC TCGCCA CGCCAG GCCAGG CCAGGC CAGGCC AGGCCG GGCCGC GCCGCC CCGCCC CGCCCT GCCCTG CCCTGA CCTGAT CTGATC TGATCT GATCTC ATCTCC TCTCCA CTCCAT TCCATG CCATGG CATGGG ATGGGT TGGGTA GGGTAC GGTACC GTACCG TACCGA ACCGAG CCGAGA CGAGAT GAGATC AGATCG GATCGC ATCGCC,3,145,GTCA TCAA CAAC AACG ACGA CGAC GACA ACAA CAAC AACG ACGT CGTC GTCG TCGT CGTC GTCT TCTA CTAC TACG ACGC CGCC GCCA CCAA CAAG AAGA AGAT GATC ATCG TCGT CGTC GTCC TCCT CCTT CTTG TTGC TGCC GCCA CCAT CATG ATGA TGAA GAAG AAGT AGTC GTCC TCCC CCCG CCGC CGCT GCTT CTTC TTCA TCAA CAAC AACG ACGC CGCC GCCA CCAA CAAC AACG ACGA CGAG GAGA AGAC GACC ACCG CCGA CGAC GACT ACTT CTTC TTCT TCTC CTCC TCCG CCGA CGAC GACT ACTT CTTC TTCA TCAT CATG ATGG TGGA GGAG GAGG AGGA GGAG GAGG AGGA GGAG GAGG AGGA GGAG GAGG AGGT GGTT GTTG TTGA TGAC GACC ACCG CCGC CGCG GCGT CGTT GTTC TTCG TCGC CGCC GCCA CCAG CAGG AGGC GGCC GCCG CCGC CGCC GCCC CCCT CCTG CTGA TGAT GATC ATCT TCTC CTCC TCCA CCAT CATG ATGG TGGG GGGT GGTA GTAC TACC ACCG CCGA CGAG GAGA AGAT GATC ATCG TCGC CGCC,GTCAA TCAAC CAACG AACGA ACGAC CGACA GACAA ACAAC CAACG AACGT ACGTC CGTCG GTCGT TCGTC CGTCT GTCTA TCTAC CTACG TACGC ACGCC CGCCA GCCAA CCAAG CAAGA AAGAT AGATC GATCG ATCGT TCGTC CGTCC GTCCT TCCTT CCTTG CTTGC TTGCC TGCCA GCCAT CCATG CATGA ATGAA TGAAG GAAGT AAGTC AGTCC GTCCC TCCCG CCCGC CCGCT CGCTT GCTTC CTTCA TTCAA TCAAC CAACG AACGC ACGCC CGCCA GCCAA CCAAC CAACG AACGA ACGAG CGAGA GAGAC AGACC GACCG ACCGA CCGAC CGACT GACTT ACTTC CTTCT TTCTC TCTCC CTCCG TCCGA CCGAC CGACT GACTT ACTTC CTTCA TTCAT TCATG CATGG ATGGA TGGAG GGAGG GAGGA AGGAG GGAGG GAGGA AGGAG GGAGG GAGGA AGGAG GGAGG GAGGT AGGTT GGTTG GTTGA TTGAC TGACC GACCG ACCGC CCGCG CGCGT GCGTT CGTTC GTTCG TTCGC TCGCC CGCCA GCCAG CCAGG CAGGC AGGCC GGCCG GCCGC CCGCC CGCCC GCCCT CCCTG CCTGA CTGAT TGATC GATCT ATCTC TCTCC CTCCA TCCAT CCATG CATGG ATGGG TGGGT GGGTA GGTAC GTACC TACCG ACCGA CCGAG CGAGA GAGAT AGATC GATCG ATCGC TCGCC,GTCAAC TCAACG CAACGA AACGAC ACGACA CGACAA GACAAC ACAACG CAACGT AACGTC ACGTCG CGTCGT GTCGTC TCGTCT CGTCTA GTCTAC TCTACG CTACGC TACGCC ACGCCA CGCCAA GCCAAG CCAAGA CAAGAT AAGATC AGATCG GATCGT ATCGTC TCGTCC CGTCCT GTCCTT TCCTTG CCTTGC CTTGCC TTGCCA TGCCAT GCCATG CCATGA CATGAA ATGAAG TGAAGT GAAGTC AAGTCC AGTCCC GTCCCG TCCCGC CCCGCT CCGCTT CGCTTC GCTTCA CTTCAA TTCAAC TCAACG CAACGC AACGCC ACGCCA CGCCAA GCCAAC CCAACG CAACGA AACGAG ACGAGA CGAGAC GAGACC AGACCG GACCGA ACCGAC CCGACT CGACTT GACTTC ACTTCT CTTCTC TTCTCC TCTCCG CTCCGA TCCGAC CCGACT CGACTT GACTTC ACTTCA CTTCAT TTCATG TCATGG CATGGA ATGGAG TGGAGG GGAGGA GAGGAG AGGAGG GGAGGA GAGGAG AGGAGG GGAGGA GAGGAG AGGAGG GGAGGT GAGGTT AGGTTG GGTTGA GTTGAC TTGACC TGACCG GACCGC ACCGCG CCGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCC TCGCCA CGCCAG GCCAGG CCAGGC CAGGCC AGGCCG GGCCGC GCCGCC CCGCCC CGCCCT GCCCTG CCCTGA CCTGAT CTGATC TGATCT GATCTC ATCTCC TCTCCA CTCCAT TCCATG CCATGG CATGGG ATGGGT TGGGTA GGGTAC GGTACC GTACCG TACCGA ACCGAG CCGAGA CGAGAT GAGATC AGATCG GATCGC ATCGCC,GTCAACG TCAACGA CAACGAC AACGACA ACGACAA CGACAAC GACAACG ACAACGT CAACGTC AACGTCG ACGTCGT CGTCGTC GTCGTCT TCGTCTA CGTCTAC GTCTACG TCTACGC CTACGCC TACGCCA ACGCCAA CGCCAAG GCCAAGA CCAAGAT CAAGATC AAGATCG AGATCGT GATCGTC ATCGTCC TCGTCCT CGTCCTT GTCCTTG TCCTTGC CCTTGCC CTTGCCA TTGCCAT TGCCATG GCCATGA CCATGAA CATGAAG ATGAAGT TGAAGTC GAAGTCC AAGTCCC AGTCCCG GTCCCGC TCCCGCT CCCGCTT CCGCTTC CGCTTCA GCTTCAA CTTCAAC TTCAACG TCAACGC CAACGCC AACGCCA ACGCCAA CGCCAAC GCCAACG CCAACGA CAACGAG AACGAGA ACGAGAC CGAGACC GAGACCG AGACCGA GACCGAC ACCGACT CCGACTT CGACTTC GACTTCT ACTTCTC CTTCTCC TTCTCCG TCTCCGA CTCCGAC TCCGACT CCGACTT CGACTTC GACTTCA ACTTCAT CTTCATG TTCATGG TCATGGA CATGGAG ATGGAGG TGGAGGA GGAGGAG GAGGAGG AGGAGGA GGAGGAG GAGGAGG AGGAGGA GGAGGAG GAGGAGG AGGAGGT GGAGGTT GAGGTTG AGGTTGA GGTTGAC GTTGACC TTGACCG TGACCGC GACCGCG ACCGCGT CCGCGTT CGCGTTC GCGTTCG CGTTCGC GTTCGCC TTCGCCA TCGCCAG CGCCAGG GCCAGGC CCAGGCC CAGGCCG AGGCCGC GGCCGCC GCCGCCC CCGCCCT CGCCCTG GCCCTGA CCCTGAT CCTGATC CTGATCT TGATCTC GATCTCC ATCTCCA TCTCCAT CTCCATG TCCATGG CCATGGG CATGGGT ATGGGTA TGGGTAC GGGTACC GGTACCG GTACCGA TACCGAG ACCGAGA CCGAGAT CGAGATC GAGATCG AGATCGC GATCGCC,"ID   NOP58_CRYNB             Reviewed;         565 AA.
AC   P0CP27; Q55Q74; Q5KFZ2;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 1.
DT   05-FEB-2025, entry version 46.
DE   RecName: Full=Nucleolar protein 58;
GN   Name=NOP58; OrderedLocusNames=CNBF4620;
OS   Cryptococcus neoformans var. neoformans serotype D (strain B-3501A)
OS   (Filobasidiella neoformans).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Tremellomycetes;
OC   Tremellales; Cryptococcaceae; Cryptococcus;
OC   Cryptococcus neoformans species complex.
OX   NCBI_TaxID=283643;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=B-3501A;
RX   PubMed=15653466; DOI=10.1126/science.1103773;
RA   Loftus B.J., Fung E., Roncaglia P., Rowley D., Amedeo P., Bruno D.,
RA   Vamathevan J., Miranda M., Anderson I.J., Fraser J.A., Allen J.E.,
RA   Bosdet I.E., Brent M.R., Chiu R., Doering T.L., Donlin M.J., D'Souza C.A.,
RA   Fox D.S., Grinberg V., Fu J., Fukushima M., Haas B.J., Huang J.C.,
RA   Janbon G., Jones S.J.M., Koo H.L., Krzywinski M.I., Kwon-Chung K.J.,
RA   Lengeler K.B., Maiti R., Marra M.A., Marra R.E., Mathewson C.A.,
RA   Mitchell T.G., Pertea M., Riggs F.R., Salzberg S.L., Schein J.E.,
RA   Shvartsbeyn A., Shin H., Shumway M., Specht C.A., Suh B.B., Tenney A.,
RA   Utterback T.R., Wickes B.L., Wortman J.R., Wye N.H., Kronstad J.W.,
RA   Lodge J.K., Heitman J., Davis R.W., Fraser C.M., Hyman R.W.;
RT   ""The genome of the basidiomycetous yeast and human pathogen Cryptococcus
RT   neoformans."";
RL   Science 307:1321-1324(2005).
CC   -!- FUNCTION: Required for pre-18S rRNA processing. May bind microtubules
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NOP5/NOP56 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAEY01000033; EAL19927.1; -; Genomic_DNA.
DR   RefSeq; XP_774574.1; XM_769481.1.
DR   AlphaFoldDB; P0CP27; -.
DR   SMR; P0CP27; -.
DR   GeneID; 4937014; -.
DR   KEGG; cnb:CNBF4620; -.
DR   VEuPathDB; FungiDB:CNBF4620; -.
DR   HOGENOM; CLU_015495_5_2_1; -.
DR   OrthoDB; 8196at5206; -.
DR   GO; GO:0031428; C:box C/D methylation guide snoRNP complex; IEA:InterPro.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0032040; C:small-subunit processome; IEA:InterPro.
DR   GO; GO:0030515; F:snoRNA binding; IEA:InterPro.
DR   GO; GO:0006364; P:rRNA processing; IEA:UniProtKB-KW.
DR   FunFam; 1.10.246.90:FF:000003; Nucleolar protein 58; 1.
DR   FunFam; 1.10.287.4070:FF:000001; Probable Nucleolar protein 58; 1.
DR   Gene3D; 1.10.287.4070; -; 1.
DR   Gene3D; 1.10.246.90; Nop domain; 1.
DR   InterPro; IPR045056; Nop56/Nop58.
DR   InterPro; IPR012974; NOP58/56_N.
DR   InterPro; IPR042239; Nop_C.
DR   InterPro; IPR002687; Nop_dom.
DR   InterPro; IPR036070; Nop_dom_sf.
DR   InterPro; IPR012976; NOSIC.
DR   PANTHER; PTHR10894; NUCLEOLAR PROTEIN 5 NUCLEOLAR PROTEIN NOP5 NOP58; 1.
DR   PANTHER; PTHR10894:SF1; NUCLEOLAR PROTEIN 58; 1.
DR   Pfam; PF01798; Nop; 1.
DR   Pfam; PF08156; NOP5NT; 1.
DR   SMART; SM00931; NOSIC; 1.
DR   SUPFAM; SSF89124; Nop domain; 1.
DR   PROSITE; PS51358; NOP; 1.
PE   3: Inferred from homology;
KW   Nucleus; Ribonucleoprotein; Ribosome biogenesis; rRNA processing.
FT   CHAIN           1..565
FT                   /note=""Nucleolar protein 58""
FT                   /id=""PRO_0000410170""
FT   DOMAIN          293..417
FT                   /note=""Nop""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00690""
FT   REGION          430..565
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        471..481
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        519..530
FT                   /note=""Basic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        531..541
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
SQ   SEQUENCE   565 AA;  61979 MW;  41570781B93DEEF4 CRC64;
     MLVLTETSVG FVVFKLSSDA KIDNKDLWKE FETPEGANKA LKVQAIQRFT STASAVEDLT
     AVQDGRLTDS LSRFLLDTVG GADDGEKKKK KKKIEEMLVV SDPKLAGTIN KALSIPVLSD
     SSTQDLYRGI RQQLASLLGG VDQKDLNTMS LGLGHSLSRF KLKFSTDKVD TMVIQAIALL
     DDLDKEINIY AMRVKEWYGW HFPEMAKIIV DNIAFARVVK AMGFRTNAVT TDFSLLLPED
     LEATLKSAAE LSMGTEISDS DMTHIHSLCD QVISISEYRT QLSEYLRNRM QAIAPNLTAL
     VGELVGARLI SHAGSLMNLA KHPASTVQIL GAEKALFRAL KTKHDTPKYG LIYHASLIGQ
     APQKLKGKMA RMVATKAALS IRVDALSDAD SRSDVSAAEV GISNRVKLES RLRALEHQAG
     IQSVRKVVSA NGQQGRQQPR FEMSGVTGSY NAATDNVPLN GDLLPTQPAT EEVKEEKDEK
     KDKKKKRKSE VAEAGDVTMD GDADLSMVAG ETKEERRARK EAKKAAKAAK KAAEESGDGD
     KKSKKRRADE DEDSEKKKKK KKKDE
//
",46065
CAAAAG AAAAGG AAAGGT AAGGTG AGGTGT GGTGTC GTGTCT TGTCTG GTCTGC TCTGCC CTGCCA TGCCAA GCCAAA CCAAAA CAAAAT AAAATC AAATCA AATCAT ATCATC TCATCG CATCGC ATCGCG TCGCGG CGCGGT GCGGTA CGGTAG GGTAGC GTAGCG TAGCGA AGCGAA GCGAAT CGAATC GAATCA AATCAG ATCAGA TCAGAA CAGAAA AGAAAG GAAAGG AAAGGC AAGGCG AGGCGG GGCGGC GCGGCG CGGCGT GGCGTC GCGTCG CGTCGG GTCGGC TCGGCA CGGCAA GGCAAA GCAAAA CAAAAC AAAACC AAACCA AACCAC ACCACG CCACGA CACGAC ACGACG CGACGT GACGTC ACGTCC CGTCCG GTCCGT TCCGTC CCGTCA CGTCAA GTCAAT TCAATC CAATCT AATCTC ATCTCT TCTCTC CTCTCG TCTCGG CTCGGC TCGGCC CGGCCT GGCCTG GCCTGT CCTGTC CTGTCT TGTCTG GTCTGG TCTGGC CTGGCC TGGCCG GGCCGC GCCGCC CCGCCA CGCCAA GCCAAC CCAACG CAACGA AACGAC ACGACA CGACAA GACAAG ACAAGC CAAGCG AAGCGC AGCGCA GCGCAT CGCATC GCATCC CATCCT ATCCTG TCCTGC CCTGCT CTGCTG TGCTGG GCTGGT CTGGTG TGGTGG GGTGGA GTGGAT TGGATA GGATAT GATATC ATATCG TATCGA ATCGAC TCGACC CGACCC GACCCT ACCCTC CCCTCA CCTCAG CTCAGG TCAGGC CAGGCC AGGCCA GGCCAA GCCAAC CCAACG CAACGC AACGCC ACGCCA CGCCAC GCCACC,3,142,CAACTGAA A AACGAAA ACAA A A AACCCAAGAG G A AACGTC AGG G A AGAAAGT T G GGGGTCC TG G G GTGTGTGTGT T T TGTGTGTCTC C GTCTCT  TCTCTCTGTG G C CTCTGTGCGC C T TGTGCGCCCC C G GCGCCCCAAGAA C CACCACAAAA A C CACAAAAAAA A A AAAAAAA A A AAAAAAATCTGT A AAAATTCGC A AT CGCA  TCCAACATAT T C CACATAACTC C A ATATCTCGCG  TCTCGCGCGC C GG CCG  GC GCGGACGGGGT GGGGTGTA GTA GTA GTATAGAG G T TATAGAGCGC C A AGAGCGCGCG G G GCGA A C CGCGAAA A GG GAAT AAAATATCTC C A ATATCTCACA A T TCG GCAGAG G C CCCAGCA GA A AAGAAA A G GACCAG CTCCA A AAAAGAG G A AA GGAGGGG G A AGAGGGC C G GGGGCGCGG G GC CGCGGGG G C CGCGGGGCGC C G GGGGCCG  GT GCGCGCGTC GT C CGAAGTC C G GTGTCTCGG AG T TCTCGCGGG C CGCGGC GAT GCACA  GCGCACAAAA A CTCAAAAA A AAAATAAAAA A A AAAAAAACAC C A AACC C A ACACCCCGCA A C CCCCACACAC AT GACCAC GACG  ACACGCGTA CTCACGA CAAC  GAACGCG G A ACACGCGTGT T C CGCGTGTCTC C GT TGTCTCCCC C TTCCCCGCG G CCTGC GCGTGT T C CGCGAGTCTC C G GTGTCTCACA CG  TCTCACAAAA A C CAGGCAT T A AAAATATCTC AGG ATATCTCTCT GAA TCTCTTC C C CTCTCTCTCT  GT TCTCTCTCTC C C CTCTCTCGCG G T TCCGG AACGGGGCGC CCAGGTCG CC C G GCGCCCCTCT T C CCCCT CCGCG CTCTGTGTGT T T TGTGTGTCTC ATC GTTCTCT  TCTCTCTGTG G C CTAAAG T TGTGGT TGC C G GGGGCGCCCGC GCC CCCGCG G C CCCCGCGCGC C CGCGCGCGCCCC GT  GCGCCCC A C CCCCACAAAA A C CAAACAC C AAACACGCG G A ACACGCGAGA A C CGCGAAC C G GAGACACACA A AAAAACACAAAA GGC CACAAAAGAG CG GG AAGAGC ACC A AGCATA TG GAAAGCGCGCGC C C CGCGCGCACA A G GCGCACATAT T C CAGCGATCTC C AATCTCCCC C T TCAA CCTCT T C CCCCTCTG CTT TGC C TGCTGGCT G GCGCTCTGTG G C CTC CTGGGG G T TGTGG TAGT T GAAGGGTTC TG ACG GTGAAG T TGTGG GGGA A G GGGGAGATAAATATGATATATA A A ATATAAT T TCTGTATATCTC C ACG ATCATC ATG T TCTCGCGAGA A CCGAGACAC C G GAGACACCCC C AACCAAACC C C CCCCCCCTT C CCCTCTC C C CTCA TCACA A T TCTCACAGG C CACAGAGGGG  GC AGA CC G GGGCCGTGC GG ACCACA A C CCCCACAAAA A C CACAAC GAC C A AAAACACGGGCG A AC AACGCGC GCC CGCGCGCCGG C G GCGCCCCACTCA C CCGAAAC C C CACACGTC, CGAAAAAAAA A A AAAAAAATAAGAG G A AAAAAAAGAA GG G A AAAAGCATGGTGTCT A AGAGGGGTGTGTG GAAGGTGTGTGTGT T G GTGTGTGTGTCCCAGCC TGTGTGTCTCTCT T G GTGTCTCTCTGTG G T TCTCTCTGTGCGC C CTGCGCCCC C TGTATGCGCCCA A GCCACCTAA A CAC GCCCAA GCAA A C AAT C CCAAAAA A A AA CGAAAAAAAT  AAAAAA ATC C AGCGAATATCTCACA A AT GATCCATT TTCACATATCTC  CAAGGATCTCGCG G A ATATCTCGCGCGC C T TCTCGCGCGCGCG G CCGCGCGCGGGG G G GCGCGCGGGGTGT T C CGCGGGTATA A G GGGGTGCGTAGG G AA TGAGCGC C T TATAGAGCGCGCG GCC AGAGCGCGCGAGA GTC GCGCGGCGAA A C CGCGATC AATCGCT G GAGAAAATATCC A GTAATATCTCACA  ACATCTCACAGCCAG TC ATCAAGAGA  AA CACAG CTAA A A AGCCCG GAAAAA A G GAGAAAAAAAG CCCGT AAAAAAAGAGGGG G AC AAAGAGGGGCGC AC AGGGGCC AA GG GCT GGCGTACGGGG G GAAAGGCGC C C CGCGGGGCGCGCG  GGGGC AT GCCGACGTTC C C CGCGTTCGCG ATCCTGCC CGGGG  TCACCGGCATA CGGGCGCACA A G GGGGCCAAC GA G GCCAAAAAAA CTC CACAAAAAAAAAA TAGAAAAACAC C A AAAAAACCCC GC  CAAACACCCCACA A ACGGCACAC C C CCCCACACACGGT G CTCGCACACGCGAGA  ACACGCGAGACC CCGAGACACGCG G G GAGACACG ACACGGTCTC C C CGCGTGTCTCCCC C GG AA GTCCCCGCG G T TCTCCCCGCGTGCAT C CCCCGCGTGTCTC C C GCCGTGT GCACA A G GTGTCTCACAAAA A T TCTCACAATGGAT C C CACAAAATATCGT C A AAAATATCTCTCCAT A ATATCTCTCTCGAAC T TCTCTCTCCT GGAGAACTCTCTCTC TGC T TCTCTTCGCG G C CTA CTCGGG G T TCTCGCGGGGCGC C C CG GTGCC GTC G GGGGCGCCCCTCT T G GCGCCCCTCTGTG G C CCCCTCTGTGTC CT C CTCTGTGTGTCTC C T TGAGGT GCGGGTCTCTCTGTG G T TCTCTGA TC GG  AA CTAATGGCCTGC T TGTGGGGCGCCCC AAC GGGGCGCCCCGCG G GGCCCCGCGCTCCC C CCCCGCGCGCCCC C C CGCGCGCCCT CA A G GCC GCCACAAAA A C CCCCACAAC C CACAAAACACGACC AAC TACGC CCTGA A ACACGCGAGACAC C C CGCGAGACACACG  GAGACACACAACT  ACACACAAAAGAG G C CAAAGGC  TC AAAAG GGGCGCG GT  AGAGCGCGCGCGC AA  GCG CCGCGCACA A C CGGCACATTC  GCGCACATATCTC C C CACATATCGC CC C A ATATCTCCCAAT T TCCCTCTGTG  CCCCTT GGC C C CTCTGTGCGCTCT T T TGTGCGCTCTGTG G G GCGCTCTGTGGGG  CTCTGTC GGTGT T TTC GGTGTGTG G G GGGTGTGGGG G GTGGGGAGA A T TGTGGCAAAT C CAGCGGAGATATATA G C GATCGCGAAT T A ATATATAT GTC TTATTCGCG G A ATATCTCGCGAGA A T TC CACGAGACAC T CAAACGAGACACCCC C G GAGACCG CCCCC C A ACACCCCCCCT GGT C CCAGACTCC A CCCTCTCACA A C CTTCACAGAG G TTCACAGAGGGG A G CACAGAGGGGCGC GCG AGAGGGGCGCCC G GGCA A GGCCCCAAA A C CCCCA CTC C CACAAAACACGCG G A AAAACACGAT GC A AACGCGCGCCCC C C CGCGCAG CCAA G GCGCCAC GT CCACACACC,CAAAA AAAAAGAG G A AAAAAAAAAAGAT GG G A AACAAC AAGGGGTGT TGC AAAAGTGGGGTGTGTG G A AGAGGGACGTGTGTCC T G GGGGTCT TGTGTCTC C G GTGTGTGTGTCTCTCT T T TGTATGTCTCTCTGTG G G GTGTC AACTGT AGC  TCTCTCTGTGCGCCCC C C CTATCTGCGCCCCACA A TTC TGCGCCAAACAATCTC A GCGCCCCACAAAA A CGT CCACAACCAAAAAAAA C CACAAAAAAAAAATAT T A AAAAAAAAAATATCC A AAAAAAATATCTCACGGA ATCTAATATC GCCATAT T A ATATCTCACATATC TCTCACATATCTCGCG G C CACATTCGCGCGC C AGCCATCTCGCGCGCG GACAG TCAAGGCGCGGGG G C CGCGCGCGCGGGGT CCT GTCAGCGCGGGGTCAATA  CGCGGGGTGTATAGAG G G GGGCAGTATAGAGCGC C G GTGTATAGG TGCGCAAG T TAAGGAGCGCG CAGT A ACG AGCGCGCGAGAAAA  GCGCGCGAGAAAATAT T C CGCGAGAAGTGATCC GCG GAAAATATCTCACA  GGC TAATATCTCACAGG AG ATCACAGGA A T TCTCACAGAGAGAAAA A C CACAGAGAGAAGGCAA A A AGAGAGAAAA AAGCGA GATGGAAACGAAGGGG G A AAAAAAGGGGCGC GGCG CAAGGGCG CGCGCG G A AGAGGGGCAGGCGGGG G GGGTGGCGCGCGGGGCGC C G GCGCGCGGGGCGCGCGTCGGGGCGCGCGT GAT G GGGCGCCTC G GCGCGGTCCG G C CGCGTCTCTCGCGGG G GTGTCTCGCA GGCC T TCTCGATCGCACA A C CGCGGGCAAGA GGC AGCACAAAAACGCA GA AGCACAAAAAAAAA C CACAAAAAAAAAACAC  AAAAAAACC CCC GTCAAAAACACCCCAA AAATAACACCCCACACAC AAG ACACCCCACACACGCG G C CCCCACACGA A CCGAAGGACGCGAGGTAC C A ACACGCGACTGACGG C CGCGAGAC AACGTGT T GG TGACCGTGTCTC C A ACACGCGTCTGTCCCC ACC CGCGTTCCTCCCCGCG G G GTGTCTCCCCGGCTGT T T TCTCCCCGGGCGTCTC C C CCCCGCGTC ATCACA A CGTCTCACAAAA A G GTGTCTCAGTAAT T T TCTCACAA AAGCCTC C C CAAAAG TATCAA TCTT AAATGTCTCTCTCTC C A ATGACTCTCTCTCTCT T T TCAATCTCTCTCTCTC C C CTCTCTCTCTCG TCG G TTCTGTCTCGCGGACGGGTCTCCGGTAGGC C TAAATCGCGGGGCATCCC  CGCGGGGCCGTCT T G GGGGCGCCCCTCTGTG G GAAC ATCCTCTGTGTGT T C CCCCTATCTGTTC C C CTCTGTGTAA TCTCT T T TGTGT TGTCTCTGTG G G GTGTCTCTCTGTGGGG G TGCGTGGGGCGC C C CTCTGTGGAAAGCCCC C TAC TGGGGCGCCCCGCG G G GGTCGGCCCGC CGC G GCGCCCCGCGCGCCCC C C CCCCGGCCCCACA A C CGCGCGCCCCACAAAA GGTCCACAAAC C C CCCCACAAAACACGCG G C CACAAAACACGAAGA A AAAACACGGACAC C A ACACGG GGACACACA A CGC CGAGACCAAAA A GGACACACAAAAGAG  AT ACACACG AAGCACGC GT  CACAAAGCTCTCG G A AAAAGGCGCGCGC C AG TAGCGCGTCGA GCA A GTGCGCGGCAGCAAC AT T C CGAA CGCCATATCC G GCGCACATTCCCC C C CACATCCTGTCCT ATCATCTCCCCTCTG TCCCTCTGGC C C CCCTGTGCCT T C CTCTG GCGCTCTGTG AAT TGTGCGCTTGGGG G G GCGCTTGG CTGT T C CTCTG GGGTGG TTGGGGTGTG GGGGTGTGAGCGGAGA CC  GTGTGTGGGGAGATT T TGTGGGGAATAA G GGAATGATTATAT T G GAGATATATATATC TGC A ATTATATCTCGCG TCG TATGTTCGCAG GC ATT ATCGCGAGAC AA TCATACGAACCA GC CCGAGACACCCCCCC C G GAGACACCCCCCGGCT T A ACACCCCCCCTACGTC C C CCCCCCCTCTCTCACA A C CCCCTCTCTCACAGAG G C CTCTCTCAGA GGCGG  AG TCCAGAGGAGGGC C C CAGA AGGGGCGCCC CC A AGGCGGGCGCCCCACA A GA AGGCGCCCCACAAAA A G GCGCCCCACAAAACAC C C CCCCACAAACGCG G CCAAAACACGCGCC A AA GCACGCGCGCCCC A G ACACGCGCCCACA A C CGCGCGCCCCACACGTCC G GCGCCCCACACACC,AAAAAAAAGAGGGG G A AAAAAAAAAAGAGGGGTGT T ATC AAAAAGAGGGTGGGCGAA AAAAGAGGGGTTGTGT T A AGAGGGGTGTGGCCGTCTC C G GG CCGTGTGTGTCTCTCT GATGTGTGTGTCAGACTGTG  TG CTCG CTGTGCGC C G GTGGCTCTCTGTGCGCCC T TCTCTC CTGCGCCCCAGTCA C CTCTGTGCGCCCCAT CA T TGA ACGCCCACAAAAAAA A G GCGCCCCACAAAAAAA A CCCACAAAAAAAAAATAT CC  CACAAAAAAAAAATATCTC C A AAAAAAAAATCTCACA TC GTAAAAAATATCTCACATAT T A AAATCTCACATATCTC C A ATAAGTCACATATCTCGCG G TCA TCACCGATCTCGCGCGC C C CAGAAATCTCGCGCGCGCG G ACGTTCGCGCGCGCGGGG G T TCTCGGCGCGGGT  CGCGCGCGCGGGGTTGGTA A G GCGCGCGGC TGTATAGCG CGGTGGGTATAGACG CAGCGC CGGTTAGAGCGCGCG G GGTAGCGCGAGA A T TATAGAGCGCGGAAAA  CG AGAGCGCGCATAATAT AAC TCCTGCGAG AATCTC C C CGCAGCTGAATATCCA A GGAAAATCCTCAGAG  AAAATATCTCACAGGA A A ATTCACAGTCTGC AA A T TCTCACAGAGAGAAAAATG C A CACGAAGAGAAAAAAAGAG T CA CGAACGGCGAGG G G GAGAAAAAAAGAGGGGCGC C A AAAAAAAGAGGTCTGCGC GG A AAAAGAGGGGCGCGCGG ATG A AGAGGGCGCGGGGCC G GGGGCGCGCGGGGCGCGCG  GCGCGCGGGGCGCGGT AA C CCGGGGCGCGCGTGTCTC C G GGGGCGCGCGTTCGCG G G GCGCGCGTGTCTCG CGGCAAAA CGCGTTCGCGGGGCGC C G GTC ATCGAAGGGCGCA TCA TTCGCGGGGCGCACAAAA A C CGAACCAAG CAA A GAAATG GCAAAAAAAA G GCGCACAAAAAAAAAACGCG CACAAAAAAACACCCC C A AAAAAAAAAACACCCCACA A A CC GGAACACCCACAC  CA AAAACACCCCACACACGCG G AACCCCACACACGCGAGA  CCCCACACACGCGAGACAC C CTC CACACGATCGACACGCG G A ACACGCGACGAACGCGTGT T CCGGCGAGACACGCGTCTGTC C G GAGACAGCCGT GGTCCCC C A ACACGATCGTCTCCCCGCG G C CGATCGTCTCCCCGCGTGT T G GTGTCTCCCCGCGTGTC AAC T TCTCCGCCGTCTCACA AGAGTCCCGCGTGTCTCACAAAA A C CGCGTGTCTCA CTCAT GTGTCTCACAAAATATCTC GGT TCTCACAAAATCGATCTCT T C CACAAAATATCTCTCTC CAA C AAAATATCTCTCTCTCTCT T AATCCTCTCTCTCTC CAATCTCTCCTCCGACG G C CTCTCTCTTCGGG G T TCTCTCTCTCGCGGGGCGC C CTGTC ATCGCGGGGCGCCCC C T GCTCGCGG GCTGTCCTACAT CTGGCGGTGTGCCCCTCTGTG G GGTCCAAGCCCCTCTGTGTGT T GGGCGCCATATGTGTCTC  CCCCTGTCTGTGTCTCTCT  AGAT CTGGGCGAAG T TGTGTGTCTCTCTGTGGGG G GCA TCTCTGTGGGGCC T TCGGCCCGTGGGGCGCCCC C C CTCTGTGGGGCGCCCCGCG G T TGTGGGTCCCGCATCGCGC C GGGCGCCCTGCGCGCCGCC GCGCCCCGCGCGCCCCACA CCGCGCGCCCCACAAAA A C CGCGCGCCCCACAAAAC CCC G GCCCACAAAACACGG CG C CCCCACAAAACACGGA TCGCAAAACACGGACC A AAACGCGAGACACACA  TG ACACGCGAGACACA TCAA A ATCGGACACAAAGAG G G GAAC CT CAAATCAGCGC C A ACGATAAGAGCGCGCG G C CACAAAAGAGCGCGGCCG C CG AAAAGAGCCGCGCACA A A AGAGCC GCGCGG CATAT  GCGCGGCACATATC GG CGCGCGCACAAATCTCCC G GCGCACATGTGTCCCCTGTGCATATCCC CCTCTGCCAGG ATCTCCCTGTGCGAAC T TCTCCCCTCTGTGCGCTCC T C CCCCTCTGTGCTCTTCAGC  CTCTGTGCGCTCTGTGGGG G TTGCTGCCTG CGT GGCTCTGTGGGGTGTGTG G C CTATCTGGGGTCT TGGGG TGGGGTGTGTGGGGAGA A G GGGGTATCTGGGGAACAT G GTGGTGGATCAATAA T TG AAGGAGATCTGTATAT T G GGGGAGATATACGAATCTC C G GAGATATATATTCGTCTG AATATATATCGCCCCAGA A TACGTATATCTCGCGAAC GTC ATCTGA CCGAG AACCCC C T TCTCGGACACCCCCCC C CCTCCGAGACAGGCCCCCTCT T G GAGACACCGGCCCTCTCTC  ACACCCCTCTCTCACA A CGGTATCCTCTCACAGAG G C CCCCTCTCT GCAGAGGGG G C CTCTCTCACAGCT GGCGC C T GGTCACAGAGGGCCT C CGGC CAGAGGGGCGCCCCACA A A AGACCGGCCCACAAAA C A GGGGCGCCGACCAAAACAC C G GCCG TA CAAAACACGCG G C CCCAAAACACGCGCGC C C CAGGCT GCGCCGCGCCAGGA G AAGGCA ACGCGCCCCACA  TA ACACGCGCTCGCCACACAC C C CGCGCGCCCCACACACC,"ID   SOJ_HALH5               Reviewed;         253 AA.
AC   Q9K5N0;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   05-FEB-2025, entry version 117.
DE   RecName: Full=Sporulation initiation inhibitor protein Soj;
DE            EC=3.6.-.-;
GN   Name=soj; OrderedLocusNames=BH4058;
OS   Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344
OS   / JCM 9153 / C-125) (Bacillus halodurans).
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Bacillaceae;
OC   Halalkalibacterium (ex Joshi et al. 2022).
OX   NCBI_TaxID=272558;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125;
RX   PubMed=11058132; DOI=10.1093/nar/28.21.4317;
RA   Takami H., Nakasone K., Takaki Y., Maeno G., Sasaki R., Masui N., Fuji F.,
RA   Hirama C., Nakamura Y., Ogasawara N., Kuhara S., Horikoshi K.;
RT   ""Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans
RT   and genomic sequence comparison with Bacillus subtilis."";
RL   Nucleic Acids Res. 28:4317-4331(2000).
CC   -!- FUNCTION: Inhibits the initiation of sporulation, Spo0J antagonizes
CC       this inhibition. Soj ultimately inhibits the activation
CC       (phosphorylation) of Spo0A. It is not required for chromosome
CC       partitioning (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC   -!- SIMILARITY: Belongs to the ParA family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000004; BAB07777.1; -; Genomic_DNA.
DR   PIR; B84157; B84157.
DR   RefSeq; WP_010900182.1; NC_002570.2.
DR   AlphaFoldDB; Q9K5N0; -.
DR   SMR; Q9K5N0; -.
DR   STRING; 272558.gene:10729976; -.
DR   GeneID; 87599641; -.
DR   KEGG; bha:BH4058; -.
DR   eggNOG; COG1192; Bacteria.
DR   HOGENOM; CLU_037612_1_4_9; -.
DR   OrthoDB; 9815116at2; -.
DR   Proteomes; UP000001258; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0030435; P:sporulation resulting in formation of a cellular spore; IEA:UniProtKB-KW.
DR   CDD; cd02042; ParAB_family; 1.
DR   FunFam; 3.40.50.300:FF:000285; Sporulation initiation inhibitor Soj; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR025669; AAA_dom.
DR   InterPro; IPR050678; DNA_Partitioning_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR13696; P-LOOP CONTAINING NUCLEOSIDE TRIPHOSPHATE HYDROLASE; 1.
DR   PANTHER; PTHR13696:SF52; PARA FAMILY PROTEIN CT_582; 1.
DR   Pfam; PF13614; AAA_31; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Hydrolase; Nucleotide-binding; Reference proteome;
KW   Sporulation.
FT   CHAIN           1..253
FT                   /note=""Sporulation initiation inhibitor protein Soj""
FT                   /id=""PRO_0000201980""
FT   BINDING         10..17
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   253 AA;  27619 MW;  A403B2CC039D967E CRC64;
     MAKVISIANQ KGGVGKTTTA VNLSACLAHL GQRVLLVDID PQGNATSGVG IEKGDIDECI
     YDVLVEDVDT QDVIRTTNME NLDVLPSTIQ LSGAEIELVS TISREVRLKR ALDQVGRKYD
     FIFIDCPPSL GLLTINALTA SDSVLIPVQC EYYALEGLSQ LLNTVRLVQK HLNTDLAIEG
     VLLTMLDART NLGIQVIDEV KKYFREKVFD TIIPRNVRLG EAPSHGEPII RYDAKSRGAE
     VYLDLAKEVV ANG
//
",55562
TATTGT ATTGTC TTGTCA TGTCAA GTCAAG TCAAGT CAAGTC AAGTCC AGTCCA GTCCAT TCCATG CCATGG CATGGT ATGGTA TGGTAA GGTAAT GTAATG TAATGC AATGCA ATGCAC TGCACA GCACAT CACATG ACATGT CATGTA ATGTAG TGTAGC GTAGCT TAGCTA AGCTAG GCTAGT CTAGTT TAGTTG AGTTGT GTTGTG TTGTGA TGTGAT GTGATG TGATGC GATGCA ATGCAA TGCAAT GCAATC CAATCA AATCAT ATCATG TCATGA CATGAC ATGACT TGACTA GACTAG ACTAGG CTAGGT TAGGTG AGGTGT GGTGTC GTGTCT TGTCTA GTCTAG TCTAGC CTAGCT TAGCTG AGCTGT GCTGTC CTGTCC TGTCCA GTCCAC TCCACG CCACGA CACGAG ACGAGT CGAGTG GAGTGC AGTGCT GTGCTT TGCTTT GCTTTG CTTTGT TTTGTT TTGTTA TGTTAA GTTAAG TTAAGC TAAGCG AAGCGT AGCGTG GCGTGT CGTGTT GTGTTG TGTTGA GTTGAC,0,91,TATT ATTG TTGT TGTC GTCA TCAA CAAG AAGT AGTC GTCC TCCA CCAT CATG ATGG TGGT GGTA GTAA TAAT AATG ATGC TGCA GCAC CACA ACAT CATG ATGT TGTA GTAG TAGC AGCT GCTA CTAG TAGT AGTT GTTG TTGT TGTG GTGA TGAT GATG ATGC TGCA GCAA CAAT AATC ATCA TCAT CATG ATGA TGAC GACT ACTA CTAG TAGG AGGT GGTG GTGT TGTC GTCT TCTA CTAG TAGC AGCT GCTG CTGT TGTC GTCC TCCA CCAC CACG ACGA CGAG GAGT AGTG GTGC TGCT GCTT CTTT TTTG TTGT TGTT GTTA TTAA TAAG AAGC AGCG GCGT CGTG GTGT TGTT GTTG TTGA TGAC,TATTG ATTGT TTGTC TGTCA GTCAA TCAAG CAAGT AAGTC AGTCC GTCCA TCCAT CCATG CATGG ATGGT TGGTA GGTAA GTAAT TAATG AATGC ATGCA TGCAC GCACA CACAT ACATG CATGT ATGTA TGTAG GTAGC TAGCT AGCTA GCTAG CTAGT TAGTT AGTTG GTTGT TTGTG TGTGA GTGAT TGATG GATGC ATGCA TGCAA GCAAT CAATC AATCA ATCAT TCATG CATGA ATGAC TGACT GACTA ACTAG CTAGG TAGGT AGGTG GGTGT GTGTC TGTCT GTCTA TCTAG CTAGC TAGCT AGCTG GCTGT CTGTC TGTCC GTCCA TCCAC CCACG CACGA ACGAG CGAGT GAGTG AGTGC GTGCT TGCTT GCTTT CTTTG TTTGT TTGTT TGTTA GTTAA TTAAG TAAGC AAGCG AGCGT GCGTG CGTGT GTGTT TGTTG GTTGA TTGAC,TATTGT ATTGTC TTGTCA TGTCAA GTCAAG TCAAGT CAAGTC AAGTCC AGTCCA GTCCAT TCCATG CCATGG CATGGT ATGGTA TGGTAA GGTAAT GTAATG TAATGC AATGCA ATGCAC TGCACA GCACAT CACATG ACATGT CATGTA ATGTAG TGTAGC GTAGCT TAGCTA AGCTAG GCTAGT CTAGTT TAGTTG AGTTGT GTTGTG TTGTGA TGTGAT GTGATG TGATGC GATGCA ATGCAA TGCAAT GCAATC CAATCA AATCAT ATCATG TCATGA CATGAC ATGACT TGACTA GACTAG ACTAGG CTAGGT TAGGTG AGGTGT GGTGTC GTGTCT TGTCTA GTCTAG TCTAGC CTAGCT TAGCTG AGCTGT GCTGTC CTGTCC TGTCCA GTCCAC TCCACG CCACGA CACGAG ACGAGT CGAGTG GAGTGC AGTGCT GTGCTT TGCTTT GCTTTG CTTTGT TTTGTT TTGTTA TGTTAA GTTAAG TTAAGC TAAGCG AAGCGT AGCGTG GCGTGT CGTGTT GTGTTG TGTTGA GTTGAC,TATTGTC ATTGTCA TTGTCAA TGTCAAG GTCAAGT TCAAGTC CAAGTCC AAGTCCA AGTCCAT GTCCATG TCCATGG CCATGGT CATGGTA ATGGTAA TGGTAAT GGTAATG GTAATGC TAATGCA AATGCAC ATGCACA TGCACAT GCACATG CACATGT ACATGTA CATGTAG ATGTAGC TGTAGCT GTAGCTA TAGCTAG AGCTAGT GCTAGTT CTAGTTG TAGTTGT AGTTGTG GTTGTGA TTGTGAT TGTGATG GTGATGC TGATGCA GATGCAA ATGCAAT TGCAATC GCAATCA CAATCAT AATCATG ATCATGA TCATGAC CATGACT ATGACTA TGACTAG GACTAGG ACTAGGT CTAGGTG TAGGTGT AGGTGTC GGTGTCT GTGTCTA TGTCTAG GTCTAGC TCTAGCT CTAGCTG TAGCTGT AGCTGTC GCTGTCC CTGTCCA TGTCCAC GTCCACG TCCACGA CCACGAG CACGAGT ACGAGTG CGAGTGC GAGTGCT AGTGCTT GTGCTTT TGCTTTG GCTTTGT CTTTGTT TTTGTTA TTGTTAA TGTTAAG GTTAAGC TTAAGCG TAAGCGT AAGCGTG AGCGTGT GCGTGTT CGTGTTG GTGTTGA TGTTGAC,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",9
ACCGGG CCGGGG CGGGGT GGGGTG GGGTGC GGTGCC GTGCCG TGCCGC GCCGCT CCGCTT CGCTTG GCTTGC CTTGCG TTGCGC TGCGCT GCGCTC CGCTCA GCTCAC CTCACC TCACCG CACCGG ACCGGC CCGGCG CGGCGG GGCGGC GCGGCG CGGCGT GGCGTC GCGTCG CGTCGC GTCGCC TCGCCG CGCCGC GCCGCT CCGCTC CGCTCT GCTCTC CTCTCT TCTCTG CTCTGG TCTGGC CTGGCT TGGCTG GGCTGC GCTGCG CTGCGC TGCGCG GCGCGA CGCGAC GCGACA CGACAT GACATC ACATCC CATCCC ATCCCG TCCCGC CCCGCT CCGCTG CGCTGT GCTGTC CTGTCC TGTCCA GTCCAT TCCATT CCATTT CATTTC ATTTCG TTTCGG TTCGGC TCGGCC CGGCCG GGCCGG GCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGG GTGGGA TGGGAT GGGATT GGATTC GATTCA ATTCAT TTCATC TCATCG CATCGC ATCGCG TCGCGC CGCGCT GCGCTC CGCTCT GCTCTC CTCTCC TCTCCG CTCCGG TCCGGC CCGGCG CGGCGT GGCGTC GCGTCG CGTCGC GTCGCT TCGCTG CGCTGT GCTGTG CTGTGC TGTGCT GTGCTC TGCTCA GCTCAA CTCAAC TCAACG CAACGG AACGGT ACGGTC CGGTCT GGTCTC GTCTCG TCTCGT CTCGTC TCGTCA CGTCAT GTCATG TCATGA CATGAT ATGATC TGATCT GATCTC ATCTCC TCTCCT CTCCTT TCCTTT CCTTTA CTTTAT TTTATC TTATCC TATCCG ATCCGC TCCGCA CCGCAG CGCAGT,2,142,ACCG CCGG CGGG GGGG GGGT GGTG GTGC TGCC GCCG CCGC CGCT GCTT CTTG TTGC TGCG GCGC CGCT GCTC CTCA TCAC CACC ACCG CCGG CGGC GGCG GCGG CGGC GGCG GCGT CGTC GTCG TCGC CGCC GCCG CCGC CGCT GCTC CTCT TCTC CTCT TCTG CTGG TGGC GGCT GCTG CTGC TGCG GCGC CGCG GCGA CGAC GACA ACAT CATC ATCC TCCC CCCG CCGC CGCT GCTG CTGT TGTC GTCC TCCA CCAT CATT ATTT TTTC TTCG TCGG CGGC GGCC GCCG CCGG CGGC GGCG GCGT CGTG GTGG TGGG GGGA GGAT GATT ATTC TTCA TCAT CATC ATCG TCGC CGCG GCGC CGCT GCTC CTCT TCTC CTCC TCCG CCGG CGGC GGCG GCGT CGTC GTCG TCGC CGCT GCTG CTGT TGTG GTGC TGCT GCTC CTCA TCAA CAAC AACG ACGG CGGT GGTC GTCT TCTC CTCG TCGT CGTC GTCA TCAT CATG ATGA TGAT GATC ATCT TCTC CTCC TCCT CCTT CTTT TTTA TTAT TATC ATCC TCCG CCGC CGCA GCAG CAGT,ACCGG CCGGG CGGGG GGGGT GGGTG GGTGC GTGCC TGCCG GCCGC CCGCT CGCTT GCTTG CTTGC TTGCG TGCGC GCGCT CGCTC GCTCA CTCAC TCACC CACCG ACCGG CCGGC CGGCG GGCGG GCGGC CGGCG GGCGT GCGTC CGTCG GTCGC TCGCC CGCCG GCCGC CCGCT CGCTC GCTCT CTCTC TCTCT CTCTG TCTGG CTGGC TGGCT GGCTG GCTGC CTGCG TGCGC GCGCG CGCGA GCGAC CGACA GACAT ACATC CATCC ATCCC TCCCG CCCGC CCGCT CGCTG GCTGT CTGTC TGTCC GTCCA TCCAT CCATT CATTT ATTTC TTTCG TTCGG TCGGC CGGCC GGCCG GCCGG CCGGC CGGCG GGCGT GCGTG CGTGG GTGGG TGGGA GGGAT GGATT GATTC ATTCA TTCAT TCATC CATCG ATCGC TCGCG CGCGC GCGCT CGCTC GCTCT CTCTC TCTCC CTCCG TCCGG CCGGC CGGCG GGCGT GCGTC CGTCG GTCGC TCGCT CGCTG GCTGT CTGTG TGTGC GTGCT TGCTC GCTCA CTCAA TCAAC CAACG AACGG ACGGT CGGTC GGTCT GTCTC TCTCG CTCGT TCGTC CGTCA GTCAT TCATG CATGA ATGAT TGATC GATCT ATCTC TCTCC CTCCT TCCTT CCTTT CTTTA TTTAT TTATC TATCC ATCCG TCCGC CCGCA CGCAG GCAGT,ACCGGG CCGGGG CGGGGT GGGGTG GGGTGC GGTGCC GTGCCG TGCCGC GCCGCT CCGCTT CGCTTG GCTTGC CTTGCG TTGCGC TGCGCT GCGCTC CGCTCA GCTCAC CTCACC TCACCG CACCGG ACCGGC CCGGCG CGGCGG GGCGGC GCGGCG CGGCGT GGCGTC GCGTCG CGTCGC GTCGCC TCGCCG CGCCGC GCCGCT CCGCTC CGCTCT GCTCTC CTCTCT TCTCTG CTCTGG TCTGGC CTGGCT TGGCTG GGCTGC GCTGCG CTGCGC TGCGCG GCGCGA CGCGAC GCGACA CGACAT GACATC ACATCC CATCCC ATCCCG TCCCGC CCCGCT CCGCTG CGCTGT GCTGTC CTGTCC TGTCCA GTCCAT TCCATT CCATTT CATTTC ATTTCG TTTCGG TTCGGC TCGGCC CGGCCG GGCCGG GCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGG GTGGGA TGGGAT GGGATT GGATTC GATTCA ATTCAT TTCATC TCATCG CATCGC ATCGCG TCGCGC CGCGCT GCGCTC CGCTCT GCTCTC CTCTCC TCTCCG CTCCGG TCCGGC CCGGCG CGGCGT GGCGTC GCGTCG CGTCGC GTCGCT TCGCTG CGCTGT GCTGTG CTGTGC TGTGCT GTGCTC TGCTCA GCTCAA CTCAAC TCAACG CAACGG AACGGT ACGGTC CGGTCT GGTCTC GTCTCG TCTCGT CTCGTC TCGTCA CGTCAT GTCATG TCATGA CATGAT ATGATC TGATCT GATCTC ATCTCC TCTCCT CTCCTT TCCTTT CCTTTA CTTTAT TTTATC TTATCC TATCCG ATCCGC TCCGCA CCGCAG CGCAGT,ACCGGGG CCGGGGT CGGGGTG GGGGTGC GGGTGCC GGTGCCG GTGCCGC TGCCGCT GCCGCTT CCGCTTG CGCTTGC GCTTGCG CTTGCGC TTGCGCT TGCGCTC GCGCTCA CGCTCAC GCTCACC CTCACCG TCACCGG CACCGGC ACCGGCG CCGGCGG CGGCGGC GGCGGCG GCGGCGT CGGCGTC GGCGTCG GCGTCGC CGTCGCC GTCGCCG TCGCCGC CGCCGCT GCCGCTC CCGCTCT CGCTCTC GCTCTCT CTCTCTG TCTCTGG CTCTGGC TCTGGCT CTGGCTG TGGCTGC GGCTGCG GCTGCGC CTGCGCG TGCGCGA GCGCGAC CGCGACA GCGACAT CGACATC GACATCC ACATCCC CATCCCG ATCCCGC TCCCGCT CCCGCTG CCGCTGT CGCTGTC GCTGTCC CTGTCCA TGTCCAT GTCCATT TCCATTT CCATTTC CATTTCG ATTTCGG TTTCGGC TTCGGCC TCGGCCG CGGCCGG GGCCGGC GCCGGCG CCGGCGT CGGCGTG GGCGTGG GCGTGGG CGTGGGA GTGGGAT TGGGATT GGGATTC GGATTCA GATTCAT ATTCATC TTCATCG TCATCGC CATCGCG ATCGCGC TCGCGCT CGCGCTC GCGCTCT CGCTCTC GCTCTCC CTCTCCG TCTCCGG CTCCGGC TCCGGCG CCGGCGT CGGCGTC GGCGTCG GCGTCGC CGTCGCT GTCGCTG TCGCTGT CGCTGTG GCTGTGC CTGTGCT TGTGCTC GTGCTCA TGCTCAA GCTCAAC CTCAACG TCAACGG CAACGGT AACGGTC ACGGTCT CGGTCTC GGTCTCG GTCTCGT TCTCGTC CTCGTCA TCGTCAT CGTCATG GTCATGA TCATGAT CATGATC ATGATCT TGATCTC GATCTCC ATCTCCT TCTCCTT CTCCTTT TCCTTTA CCTTTAT CTTTATC TTTATCC TTATCCG TATCCGC ATCCGCA TCCGCAG CCGCAGT,"ID   CZCA_ALCSC              Reviewed;        1063 AA.
AC   P94177;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   05-FEB-2025, entry version 84.
DE   RecName: Full=Cation efflux system protein CzcA;
GN   Name=czcA;
OS   Alcaligenes sp. (strain CT14).
OC   Bacteria; Pseudomonadota; Betaproteobacteria; Burkholderiales;
OC   Alcaligenaceae; Alcaligenes.
OX   NCBI_TaxID=68998;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8829543; DOI=10.1271/bbb.60.699;
RA   Kunito T., Kusano T., Oyaizu H., Senoo K., Kanazawa S., Matsumoto S.;
RT   ""Cloning and sequence analysis of czc genes in Alcaligenes sp. strain
RT   CT14."";
RL   Biosci. Biotechnol. Biochem. 60:699-704(1996).
CC   -!- FUNCTION: Has a low cation transport activity for cobalt, it is
CC       essential for the expression of cobalt, zinc, and cadmium resistance.
CC       CzcA and CzcB together would act in zinc efflux nearly as effectively
CC       as the complete CZC efflux system (CzcABC).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the resistance-nodulation-cell division (RND)
CC       (TC 2.A.6) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D67044; BAA11061.1; -; Genomic_DNA.
DR   PIR; JC4700; JC4700.
DR   AlphaFoldDB; P94177; -.
DR   SMR; P94177; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008324; F:monoatomic cation transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:TreeGrafter.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR   Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR   Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR   Gene3D; 3.30.2090.10; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR   InterPro; IPR027463; AcrB_DN_DC_subdom.
DR   InterPro; IPR001036; Acrflvin-R.
DR   InterPro; IPR004763; CusA-like.
DR   NCBIfam; TIGR00914; 2A0601; 1.
DR   PANTHER; PTHR32063; -; 1.
DR   PANTHER; PTHR32063:SF24; CATION EFFLUX SYSTEM (ACRB_ACRD_ACRF FAMILY); 1.
DR   Pfam; PF00873; ACR_tran; 1.
DR   PRINTS; PR00702; ACRIFLAVINRP.
DR   SUPFAM; SSF82693; Multidrug efflux transporter AcrB pore domain, PN1, PN2, PC1 and PC2 subdomains; 3.
DR   SUPFAM; SSF82714; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE   3: Inferred from homology;
KW   Cadmium resistance; Cell membrane; Cobalt; Membrane; Plasmid;
KW   Transmembrane; Transmembrane helix; Transport; Zinc.
FT   CHAIN           1..1063
FT                   /note=""Cation efflux system protein CzcA""
FT                   /id=""PRO_0000161819""
FT   TRANSMEM        14..29
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        350..370
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        452..472
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        487..507
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        534..554
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        883..903
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        906..926
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        937..957
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        982..1004
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        1013..1033
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   REGION          1040..1063
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        1049..1063
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
SQ   SEQUENCE   1063 AA;  115656 MW;  FBA0F8D56FB6710B CRC64;
     MFERIISFAI QQRWLVLLAV FGMAGLGIFS YNRLPIDAVP DITNVQVQVN TSAPGYSPLE
     TEQRVTYPIE VVMAGLPGLE QTRSLSRYGL SQVTVIFKDG TDVYFARQLV NQRIQEAKDN
     LPEGVVPAMG PISTGLGEIY LWTVEAEEGA RKADGTAYTP TDLREIQDWV VRPQLRNVPG
     VTEINTIGGF NKQYLVAPSL ERLASYGLTL TDVVNALNKN NDNVGAGYIE RRGEQYLVRA
     PGQVASEDDI RNIIVGTAQG QPIRIRDIGD VEIGKELRTG AATENGKEVV LGTVFMLIGE
     NSRAVSKAVD EKVASINRTM PEGVKIVTVY DRTRLVDKAI ATVKKNLLEG AVLVIVILFL
     FLGNIRAALI TATIIPLAML FTFTGMVNYK ISANLMSLGA LDFGIIIDGA VVIVENCVRR
     LAHAQEHHGR PLTRSERFHE VFAAAKEARR PLIFGQLIIM IVYLPIFALT GVEGKMFHPM
     AFTVVLALLG AMILSVTFVP AAVALFIGER VAEKENRLML WAKRRYEPLL EKSLANTAVV
     LTFAAVSIVL CVAIAARLGS EFIPNLNEGD IAIQALRIPG TSLSQSVEMQ KTIETTLKAK
     FPEIERVFAR TGTAEIASDP MPPNISDGYI MLKPEKDWPE PKKTHAELLS AIQEEAGKIP
     GNNYEFSQPI QLRFNELISG VRSDVAVKIF GDDNNVLSET AKKVSAVLQG IPGAQEVKVE
     QTTGLPMLTV KIDREKAARY GLNMSDVQDA VATGVGGRDS GTFFQGDRRF DIVVRLPEAV
     RGEVEALRRL PIPLPKGVDA RTTFIPLSEV ATLEMAPGPN QISRENGKRR IVISANVRGR
     DIGSFVPEAE AAIQSQVKIP AGYWMTWGGT FEQLQSATTR LQVVVPVALL LVFVLLFAMF
     NNIKDGLLVF TGIPFALTGG ILALWIRGIP MSITAAVGFI ALCGVAVLNG LVMLSFIRSL
     REEGHSLDSA VRVGALTRLR PVLMTALVAS LGFVPMAIAT GTGAEVQRPL ATVVIGGILS
     STALTLLVLP VLYRLAHRKD EDAEDTREPV TQTHQPDQGR QPA
//
",28140
GTCGCA TCGCAA CGCAAC GCAACA CAACAG AACAGT ACAGTT CAGTTC AGTTCA GTTCAA TTCAAG TCAAGA CAAGAA AAGAAA AGAAAT GAAATT AAATTC AATTCA ATTCAA TTCAAC TCAACT CAACTC AACTCC ACTCCA CTCCAG TCCAGG CCAGGC CAGGCA AGGCAG GGCAGC GCAGCA CAGCAG AGCAGT GCAGTA CAGTAA AGTAAA GTAAAC TAAACG AAACGA AACGAA ACGAAC CGAACT GAACTT AACTTC ACTTCC CTTCCC TTCCCC TCCCCT CCCCTG CCCTGC CCTGCT CTGCTA TGCTAG GCTAGA CTAGAA TAGAAT AGAATG GAATGG AATGGC ATGGCT TGGCTG GGCTGG GCTGGC CTGGCA TGGCAA GGCAAT GCAATG CAATGG AATGGC ATGGCG TGGCGG GGCGGC GCGGCG CGGCGA GGCGAT GCGATG CGATGC GATGCT ATGCTG TGCTGC GCTGCA CTGCAC TGCACT GCACTT CACTTG ACTTGC CTTGCC TTGCCT TGCCTT GCCTTG CCTTGT CTTGTC TTGTCG TGTCGC GTCGCT TCGCTC CGCTCG GCTCGC CTCGCT TCGCTT CGCTTA GCTTAC CTTACC TTACCG TACCGA ACCGAT CCGATT CGATTT GATTTA ATTTAA TTTAAT TTAATC TAATCC AATCCG ATCCGC TCCGCT CCGCTC CGCTCG GCTCGC CTCGCG TCGCGA CGCGAG GCGAGC CGAGCG GAGCGA AGCGAA GCGAAA CGAAAT GAAATT AAATTC AATTCT ATTCTT TTCTTG TCTTGG CTTGGT TTGGTG TGGTGA GGTGAA GTGAAG TGAAGG GAAGGC AAGGCC,3,142,GTCG TCGC CGCA GCAA CAAC AACA ACAG CAGT AGTT GTTC TTCA TCAA CAAG AAGA AGAA GAAA AAAT AATT ATTC TTCA TCAA CAAC AACT ACTC CTCC TCCA CCAG CAGG AGGC GGCA GCAG CAGC AGCA GCAG CAGT AGTA GTAA TAAA AAAC AACG ACGA CGAA GAAC AACT ACTT CTTC TTCC TCCC CCCC CCCT CCTG CTGC TGCT GCTA CTAG TAGA AGAA GAAT AATG ATGG TGGC GGCT GCTG CTGG TGGC GGCA GCAA CAAT AATG ATGG TGGC GGCG GCGG CGGC GGCG GCGA CGAT GATG ATGC TGCT GCTG CTGC TGCA GCAC CACT ACTT CTTG TTGC TGCC GCCT CCTT CTTG TTGT TGTC GTCG TCGC CGCT GCTC CTCG TCGC CGCT GCTT CTTA TTAC TACC ACCG CCGA CGAT GATT ATTT TTTA TTAA TAAT AATC ATCC TCCG CCGC CGCT GCTC CTCG TCGC CGCG GCGA CGAG GAGC AGCG GCGA CGAA GAAA AAAT AATT ATTC TTCT TCTT CTTG TTGG TGGT GGTG GTGA TGAA GAAG AAGG AGGC GGCC,GTCGC TCGCA CGCAA GCAAC CAACA AACAG ACAGT CAGTT AGTTC GTTCA TTCAA TCAAG CAAGA AAGAA AGAAA GAAAT AAATT AATTC ATTCA TTCAA TCAAC CAACT AACTC ACTCC CTCCA TCCAG CCAGG CAGGC AGGCA GGCAG GCAGC CAGCA AGCAG GCAGT CAGTA AGTAA GTAAA TAAAC AAACG AACGA ACGAA CGAAC GAACT AACTT ACTTC CTTCC TTCCC TCCCC CCCCT CCCTG CCTGC CTGCT TGCTA GCTAG CTAGA TAGAA AGAAT GAATG AATGG ATGGC TGGCT GGCTG GCTGG CTGGC TGGCA GGCAA GCAAT CAATG AATGG ATGGC TGGCG GGCGG GCGGC CGGCG GGCGA GCGAT CGATG GATGC ATGCT TGCTG GCTGC CTGCA TGCAC GCACT CACTT ACTTG CTTGC TTGCC TGCCT GCCTT CCTTG CTTGT TTGTC TGTCG GTCGC TCGCT CGCTC GCTCG CTCGC TCGCT CGCTT GCTTA CTTAC TTACC TACCG ACCGA CCGAT CGATT GATTT ATTTA TTTAA TTAAT TAATC AATCC ATCCG TCCGC CCGCT CGCTC GCTCG CTCGC TCGCG CGCGA GCGAG CGAGC GAGCG AGCGA GCGAA CGAAA GAAAT AAATT AATTC ATTCT TTCTT TCTTG CTTGG TTGGT TGGTG GGTGA GTGAA TGAAG GAAGG AAGGC AGGCC,GTCGCA TCGCAA CGCAAC GCAACA CAACAG AACAGT ACAGTT CAGTTC AGTTCA GTTCAA TTCAAG TCAAGA CAAGAA AAGAAA AGAAAT GAAATT AAATTC AATTCA ATTCAA TTCAAC TCAACT CAACTC AACTCC ACTCCA CTCCAG TCCAGG CCAGGC CAGGCA AGGCAG GGCAGC GCAGCA CAGCAG AGCAGT GCAGTA CAGTAA AGTAAA GTAAAC TAAACG AAACGA AACGAA ACGAAC CGAACT GAACTT AACTTC ACTTCC CTTCCC TTCCCC TCCCCT CCCCTG CCCTGC CCTGCT CTGCTA TGCTAG GCTAGA CTAGAA TAGAAT AGAATG GAATGG AATGGC ATGGCT TGGCTG GGCTGG GCTGGC CTGGCA TGGCAA GGCAAT GCAATG CAATGG AATGGC ATGGCG TGGCGG GGCGGC GCGGCG CGGCGA GGCGAT GCGATG CGATGC GATGCT ATGCTG TGCTGC GCTGCA CTGCAC TGCACT GCACTT CACTTG ACTTGC CTTGCC TTGCCT TGCCTT GCCTTG CCTTGT CTTGTC TTGTCG TGTCGC GTCGCT TCGCTC CGCTCG GCTCGC CTCGCT TCGCTT CGCTTA GCTTAC CTTACC TTACCG TACCGA ACCGAT CCGATT CGATTT GATTTA ATTTAA TTTAAT TTAATC TAATCC AATCCG ATCCGC TCCGCT CCGCTC CGCTCG GCTCGC CTCGCG TCGCGA CGCGAG GCGAGC CGAGCG GAGCGA AGCGAA GCGAAA CGAAAT GAAATT AAATTC AATTCT ATTCTT TTCTTG TCTTGG CTTGGT TTGGTG TGGTGA GGTGAA GTGAAG TGAAGG GAAGGC AAGGCC,GTCGCAA TCGCAAC CGCAACA GCAACAG CAACAGT AACAGTT ACAGTTC CAGTTCA AGTTCAA GTTCAAG TTCAAGA TCAAGAA CAAGAAA AAGAAAT AGAAATT GAAATTC AAATTCA AATTCAA ATTCAAC TTCAACT TCAACTC CAACTCC AACTCCA ACTCCAG CTCCAGG TCCAGGC CCAGGCA CAGGCAG AGGCAGC GGCAGCA GCAGCAG CAGCAGT AGCAGTA GCAGTAA CAGTAAA AGTAAAC GTAAACG TAAACGA AAACGAA AACGAAC ACGAACT CGAACTT GAACTTC AACTTCC ACTTCCC CTTCCCC TTCCCCT TCCCCTG CCCCTGC CCCTGCT CCTGCTA CTGCTAG TGCTAGA GCTAGAA CTAGAAT TAGAATG AGAATGG GAATGGC AATGGCT ATGGCTG TGGCTGG GGCTGGC GCTGGCA CTGGCAA TGGCAAT GGCAATG GCAATGG CAATGGC AATGGCG ATGGCGG TGGCGGC GGCGGCG GCGGCGA CGGCGAT GGCGATG GCGATGC CGATGCT GATGCTG ATGCTGC TGCTGCA GCTGCAC CTGCACT TGCACTT GCACTTG CACTTGC ACTTGCC CTTGCCT TTGCCTT TGCCTTG GCCTTGT CCTTGTC CTTGTCG TTGTCGC TGTCGCT GTCGCTC TCGCTCG CGCTCGC GCTCGCT CTCGCTT TCGCTTA CGCTTAC GCTTACC CTTACCG TTACCGA TACCGAT ACCGATT CCGATTT CGATTTA GATTTAA ATTTAAT TTTAATC TTAATCC TAATCCG AATCCGC ATCCGCT TCCGCTC CCGCTCG CGCTCGC GCTCGCG CTCGCGA TCGCGAG CGCGAGC GCGAGCG CGAGCGA GAGCGAA AGCGAAA GCGAAAT CGAAATT GAAATTC AAATTCT AATTCTT ATTCTTG TTCTTGG TCTTGGT CTTGGTG TTGGTGA TGGTGAA GGTGAAG GTGAAGG TGAAGGC GAAGGCC,"ID   ORF9C_SARS2             Reviewed;          73 AA.
AC   P0DTD3;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   27-NOV-2024, entry version 16.
DE   RecName: Full=Putative ORF9c protein {ECO:0000305|PubMed:32854725};
DE            Short=ORF9c;
DE   AltName: Full=Uncharacterized protein 14;
DE            Short=ORF14;
GN   ORFNames=9c;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   CONCEPTUAL TRANSLATION.
RX   PubMed=32854725; DOI=10.1186/s12985-020-01402-1;
RA   Michel C.J., Mayer C., Poch O., Thompson J.D.;
RT   ""Characterization of accessory genes in coronavirus genomes."";
RL   Virol. J. 17:131-131(2020).
RN   [3]
RP   GENOME REANNOTATION.
RX   PubMed=33976134; DOI=10.1038/s41467-021-22905-7;
RA   Jungreis I., Sealfon R., Kellis M.;
RT   ""SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44
RT   Sarbecovirus genomes."";
RL   Nat. Commun. 12:2642-2642(2021).
RN   [4]
RP   FUNCTION.
RX   PubMed=35180394; DOI=10.1016/j.stemcr.2022.01.014;
RA   Liu J., Zhang Y., Han L., Guo S., Wu S., Doud E.H., Wang C., Chen H.,
RA   Rubart-von der Lohe M., Wan J., Yang L.;
RT   ""Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral
RT   gene Orf9c on human pluripotent stem cell-derived cardiomyocytes."";
RL   Stem Cell Reports 17:522-537(2022).
CC   -!- FUNCTION: May induce apoptosis in cardiomyocytes when overexpressed ex-
CC       vivo. {ECO:0000269|PubMed:35180394}.
CC   -!- INTERACTION:
CC       P0DTD3; Q9H3K2: GHITM; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-2868909;
CC       P0DTD3; Q86VR2: RETREG3; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-10192441;
CC       P0DTD3; O43765: SGTA; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-347996;
CC       P0DTD3; Q9UMX0: UBQLN1; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-741480;
CC       P0DTD3; Q9UHD9: UBQLN2; Xeno; NbExp=4; IntAct=EBI-25475917, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane
CC       protein {ECO:0000255}.
CC   -!- CAUTION: Product of a dubious CDS prediction.
CC       {ECO:0000303|PubMed:33976134}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   BioGRID; 4383954; 514.
DR   IntAct; P0DTD3; 126.
DR   MINT; P0DTD3; -.
DR   AGR; RefSeq:P0DTD3; -.
DR   PRO; PR:P0DTD3; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR035113; Protein_14_SARS-like.
DR   Pfam; PF17635; bCoV_Orf14; 1.
PE   5: Uncertain;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..73
FT                   /note=""Putative ORF9c protein""
FT                   /id=""PRO_0000449658""
FT   TRANSMEM        47..67
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   VARIANT         49
FT                   /note=""V -> L (in strain: Gamma)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         50
FT                   /note=""G -> N (in strain: Alpha/B.1.1.7, Gamma/P.1,
FT                   Omicron/BA.1, Omicron/BA.2, Omicron/BA.2.12.2,
FT                   Omicron/BA.4, Omicron BA.5)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         50
FT                   /note=""G -> W (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         52
FT                   /note=""L -> F (in strain: Beta/B.1.351)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   73 AA;  8050 MW;  8CCDEF1C0EA37D06 CRC64;
     MLQSCYNFLK EQHCQKASTQ KGAEAAVKPL LVPHHVVATV QEIQLQAAVG ELLLLEWLAM
     AVMLLLLCCC LTD
//
",46013
TCTTCA CTTCAA TTCAAC TCAACC CAACCG AACCGG ACCGGT CCGGTC CGGTCA GGTCAC GTCACG TCACGC CACGCT ACGCTA CGCTAC GCTACC CTACCA TACCAA ACCAAT CCAATG CAATGT AATGTT ATGTTA TGTTAT GTTATC TTATCG TATCGG ATCGGT TCGGTG CGGTGG GGTGGT GTGGTC TGGTCT GGTCTG GTCTGG TCTGGC CTGGCT TGGCTG GGCTGT GCTGTG CTGTGG TGTGGG GTGGGA TGGGAA GGGAAT GGAATG GAATGG AATGGA ATGGAA TGGAAT GGAATC GAATCT AATCTA ATCTAC TCTACC CTACCT TACCTG ACCTGC CCTGCT CTGCTT TGCTTG GCTTGC CTTGCC TTGCCT TGCCTA GCCTAT CCTATC CTATCC TATCCT ATCCTG TCCTGG CCTGGT CTGGTA TGGTAC GGTACT GTACTG TACTGG ACTGGC CTGGCA TGGCAG GGCAGG GCAGGC CAGGCG AGGCGG GGCGGT GCGGTA CGGTAT GGTATC GTATCT TATCTG ATCTGG TCTGGG CTGGGG TGGGGT GGGGTT GGGTTC GGTTCT GTTCTT TTCTTA TCTTAT CTTATG TTATGA TATGAG ATGAGT TGAGTG GAGTGT AGTGTG GTGTGC TGTGCA GTGCAG TGCAGG GCAGGC CAGGCT AGGCTT GGCTTG GCTTGT CTTGTA TTGTAT TGTATG GTATGG TATGGT ATGGTG TGGTGT GGTGTG GTGTGG TGTGGC GTGGCC TGGCCA GGCCAT GCCATT CCATTG CATTGC ATTGCC TTGCCG TGCCGC GCCGCA CCGCAG CGCAGC GCAGCC CAGCCG AGCCGG GCCGGT CCGGTA CGGTAT GGTATG,2,145,TCTT CTTC TTCA TCAA CAAC AACC ACCG CCGG CGGT GGTC GTCA TCAC CACG ACGC CGCT GCTA CTAC TACC ACCA CCAA CAAT AATG ATGT TGTT GTTA TTAT TATC ATCG TCGG CGGT GGTG GTGG TGGT GGTC GTCT TCTG CTGG TGGC GGCT GCTG CTGT TGTG GTGG TGGG GGGA GGAA GAAT AATG ATGG TGGA GGAA GAAT AATC ATCT TCTA CTAC TACC ACCT CCTG CTGC TGCT GCTT CTTG TTGC TGCC GCCT CCTA CTAT TATC ATCC TCCT CCTG CTGG TGGT GGTA GTAC TACT ACTG CTGG TGGC GGCA GCAG CAGG AGGC GGCG GCGG CGGT GGTA GTAT TATC ATCT TCTG CTGG TGGG GGGG GGGT GGTT GTTC TTCT TCTT CTTA TTAT TATG ATGA TGAG GAGT AGTG GTGT TGTG GTGC TGCA GCAG CAGG AGGC GGCT GCTT CTTG TTGT TGTA GTAT TATG ATGG TGGT GGTG GTGT TGTG GTGG TGGC GGCC GCCA CCAT CATT ATTG TTGC TGCC GCCG CCGC CGCA GCAG CAGC AGCC GCCG CCGG CGGT GGTA GTAT TATG,TCTTC CTTCA TTCAA TCAAC CAACC AACCG ACCGG CCGGT CGGTC GGTCA GTCAC TCACG CACGC ACGCT CGCTA GCTAC CTACC TACCA ACCAA CCAAT CAATG AATGT ATGTT TGTTA GTTAT TTATC TATCG ATCGG TCGGT CGGTG GGTGG GTGGT TGGTC GGTCT GTCTG TCTGG CTGGC TGGCT GGCTG GCTGT CTGTG TGTGG GTGGG TGGGA GGGAA GGAAT GAATG AATGG ATGGA TGGAA GGAAT GAATC AATCT ATCTA TCTAC CTACC TACCT ACCTG CCTGC CTGCT TGCTT GCTTG CTTGC TTGCC TGCCT GCCTA CCTAT CTATC TATCC ATCCT TCCTG CCTGG CTGGT TGGTA GGTAC GTACT TACTG ACTGG CTGGC TGGCA GGCAG GCAGG CAGGC AGGCG GGCGG GCGGT CGGTA GGTAT GTATC TATCT ATCTG TCTGG CTGGG TGGGG GGGGT GGGTT GGTTC GTTCT TTCTT TCTTA CTTAT TTATG TATGA ATGAG TGAGT GAGTG AGTGT GTGTG TGTGC GTGCA TGCAG GCAGG CAGGC AGGCT GGCTT GCTTG CTTGT TTGTA TGTAT GTATG TATGG ATGGT TGGTG GGTGT GTGTG TGTGG GTGGC TGGCC GGCCA GCCAT CCATT CATTG ATTGC TTGCC TGCCG GCCGC CCGCA CGCAG GCAGC CAGCC AGCCG GCCGG CCGGT CGGTA GGTAT GTATG,TCTTCA CTTCAA TTCAAC TCAACC CAACCG AACCGG ACCGGT CCGGTC CGGTCA GGTCAC GTCACG TCACGC CACGCT ACGCTA CGCTAC GCTACC CTACCA TACCAA ACCAAT CCAATG CAATGT AATGTT ATGTTA TGTTAT GTTATC TTATCG TATCGG ATCGGT TCGGTG CGGTGG GGTGGT GTGGTC TGGTCT GGTCTG GTCTGG TCTGGC CTGGCT TGGCTG GGCTGT GCTGTG CTGTGG TGTGGG GTGGGA TGGGAA GGGAAT GGAATG GAATGG AATGGA ATGGAA TGGAAT GGAATC GAATCT AATCTA ATCTAC TCTACC CTACCT TACCTG ACCTGC CCTGCT CTGCTT TGCTTG GCTTGC CTTGCC TTGCCT TGCCTA GCCTAT CCTATC CTATCC TATCCT ATCCTG TCCTGG CCTGGT CTGGTA TGGTAC GGTACT GTACTG TACTGG ACTGGC CTGGCA TGGCAG GGCAGG GCAGGC CAGGCG AGGCGG GGCGGT GCGGTA CGGTAT GGTATC GTATCT TATCTG ATCTGG TCTGGG CTGGGG TGGGGT GGGGTT GGGTTC GGTTCT GTTCTT TTCTTA TCTTAT CTTATG TTATGA TATGAG ATGAGT TGAGTG GAGTGT AGTGTG GTGTGC TGTGCA GTGCAG TGCAGG GCAGGC CAGGCT AGGCTT GGCTTG GCTTGT CTTGTA TTGTAT TGTATG GTATGG TATGGT ATGGTG TGGTGT GGTGTG GTGTGG TGTGGC GTGGCC TGGCCA GGCCAT GCCATT CCATTG CATTGC ATTGCC TTGCCG TGCCGC GCCGCA CCGCAG CGCAGC GCAGCC CAGCCG AGCCGG GCCGGT CCGGTA CGGTAT GGTATG,TCTTCAA CTTCAAC TTCAACC TCAACCG CAACCGG AACCGGT ACCGGTC CCGGTCA CGGTCAC GGTCACG GTCACGC TCACGCT CACGCTA ACGCTAC CGCTACC GCTACCA CTACCAA TACCAAT ACCAATG CCAATGT CAATGTT AATGTTA ATGTTAT TGTTATC GTTATCG TTATCGG TATCGGT ATCGGTG TCGGTGG CGGTGGT GGTGGTC GTGGTCT TGGTCTG GGTCTGG GTCTGGC TCTGGCT CTGGCTG TGGCTGT GGCTGTG GCTGTGG CTGTGGG TGTGGGA GTGGGAA TGGGAAT GGGAATG GGAATGG GAATGGA AATGGAA ATGGAAT TGGAATC GGAATCT GAATCTA AATCTAC ATCTACC TCTACCT CTACCTG TACCTGC ACCTGCT CCTGCTT CTGCTTG TGCTTGC GCTTGCC CTTGCCT TTGCCTA TGCCTAT GCCTATC CCTATCC CTATCCT TATCCTG ATCCTGG TCCTGGT CCTGGTA CTGGTAC TGGTACT GGTACTG GTACTGG TACTGGC ACTGGCA CTGGCAG TGGCAGG GGCAGGC GCAGGCG CAGGCGG AGGCGGT GGCGGTA GCGGTAT CGGTATC GGTATCT GTATCTG TATCTGG ATCTGGG TCTGGGG CTGGGGT TGGGGTT GGGGTTC GGGTTCT GGTTCTT GTTCTTA TTCTTAT TCTTATG CTTATGA TTATGAG TATGAGT ATGAGTG TGAGTGT GAGTGTG AGTGTGC GTGTGCA TGTGCAG GTGCAGG TGCAGGC GCAGGCT CAGGCTT AGGCTTG GGCTTGT GCTTGTA CTTGTAT TTGTATG TGTATGG GTATGGT TATGGTG ATGGTGT TGGTGTG GGTGTGG GTGTGGC TGTGGCC GTGGCCA TGGCCAT GGCCATT GCCATTG CCATTGC CATTGCC ATTGCCG TTGCCGC TGCCGCA GCCGCAG CCGCAGC CGCAGCC GCAGCCG CAGCCGG AGCCGGT GCCGGTA CCGGTAT CGGTATG,"ID   HPPA_FUSNN              Reviewed;         671 AA.
AC   Q8RHJ2;
DT   25-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   05-FEB-2025, entry version 123.
DE   RecName: Full=Putative K(+)-stimulated pyrophosphate-energized sodium pump {ECO:0000255|HAMAP-Rule:MF_01129};
DE            EC=7.2.3.1 {ECO:0000255|HAMAP-Rule:MF_01129};
DE   AltName: Full=Membrane-bound sodium-translocating pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_01129};
DE   AltName: Full=Pyrophosphate-energized inorganic pyrophosphatase {ECO:0000255|HAMAP-Rule:MF_01129};
DE            Short=Na(+)-PPase {ECO:0000255|HAMAP-Rule:MF_01129};
GN   Name=hppA {ECO:0000255|HAMAP-Rule:MF_01129}; OrderedLocusNames=FN2030;
OS   Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 /
OS   BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355).
OC   Bacteria; Fusobacteriota; Fusobacteriia; Fusobacteriales; Fusobacteriaceae;
OC   Fusobacterium.
OX   NCBI_TaxID=190304;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 /
RC   KCTC 2640 / LMG 13131 / VPI 4355;
RX   PubMed=11889109; DOI=10.1128/jb.184.7.2005-2018.2002;
RA   Kapatral V., Anderson I., Ivanova N., Reznik G., Los T., Lykidis A.,
RA   Bhattacharyya A., Bartman A., Gardner W., Grechkin G., Zhu L., Vasieva O.,
RA   Chu L., Kogan Y., Chaga O., Goltsman E., Bernal A., Larsen N., D'Souza M.,
RA   Walunas T., Pusch G., Haselkorn R., Fonstein M., Kyrpides N.C.,
RA   Overbeek R.;
RT   ""Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum
RT   strain ATCC 25586."";
RL   J. Bacteriol. 184:2005-2018(2002).
CC   -!- FUNCTION: Sodium pump that utilizes the energy of pyrophosphate
CC       hydrolysis as the driving force for Na(+) movement across the membrane.
CC       {ECO:0000255|HAMAP-Rule:MF_01129}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) + diphosphate + H2O = Na(+)(out) + 2 phosphate +
CC         H(+); Xref=Rhea:RHEA:57884, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:33019, ChEBI:CHEBI:43474; EC=7.2.3.1;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01129};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01129};
CC   -!- ACTIVITY REGULATION: Requires K(+) for maximal activity.
CC       {ECO:0000255|HAMAP-Rule:MF_01129}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01129}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01129}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01129}.
CC   -!- SIMILARITY: Belongs to the H(+)-translocating pyrophosphatase
CC       (TC 3.A.10) family. K(+)-stimulated subfamily. {ECO:0000255|HAMAP-
CC       Rule:MF_01129}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE009951; AAL94115.1; -; Genomic_DNA.
DR   RefSeq; NP_602816.1; NC_003454.1.
DR   RefSeq; WP_011015989.1; NZ_CP084110.1.
DR   AlphaFoldDB; Q8RHJ2; -.
DR   SMR; Q8RHJ2; -.
DR   STRING; 190304.FN2030; -.
DR   PaxDb; 190304-FN2030; -.
DR   EnsemblBacteria; AAL94115; AAL94115; FN2030.
DR   GeneID; 79782963; -.
DR   KEGG; fnu:FN2030; -.
DR   PATRIC; fig|190304.8.peg.493; -.
DR   eggNOG; COG3808; Bacteria.
DR   HOGENOM; CLU_008743_3_1_0; -.
DR   InParanoid; Q8RHJ2; -.
DR   BioCyc; FNUC190304:G1FZS-517-MONOMER; -.
DR   Proteomes; UP000002521; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009678; F:diphosphate hydrolysis-driven proton transmembrane transporter activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004427; F:inorganic diphosphate phosphatase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0030955; F:potassium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-UniRule.
DR   HAMAP; MF_01129; PPase_energized_pump; 1.
DR   InterPro; IPR004131; PPase-energised_H-pump.
DR   NCBIfam; TIGR01104; V_PPase; 1.
DR   PANTHER; PTHR31998; K(+)-INSENSITIVE PYROPHOSPHATE-ENERGIZED PROTON PUMP; 1.
DR   Pfam; PF03030; H_PPase; 1.
DR   PIRSF; PIRSF001265; H+-PPase; 1.
PE   3: Inferred from homology;
KW   Calcium; Cell inner membrane; Cell membrane; Ion transport; Magnesium;
KW   Membrane; Metal-binding; Potassium; Reference proteome; Sodium;
KW   Sodium transport; Translocase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..671
FT                   /note=""Putative K(+)-stimulated pyrophosphate-energized
FT                   sodium pump""
FT                   /id=""PRO_0000217003""
FT   TRANSMEM        3..23
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        60..80
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        81..101
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        130..150
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        154..174
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        229..249
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        255..275
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        295..315
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        317..337
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        365..385
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        392..412
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        450..470
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        493..513
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        559..579
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        581..601
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   TRANSMEM        651..671
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   BINDING         184
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250""
FT   BINDING         187
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""1""
FT                   /evidence=""ECO:0000250""
FT   BINDING         191
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""1""
FT                   /evidence=""ECO:0000250""
FT   BINDING         214
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""2""
FT                   /evidence=""ECO:0000250""
FT   BINDING         217
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""2""
FT                   /evidence=""ECO:0000250""
FT   BINDING         420
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_label=""2""
FT                   /evidence=""ECO:0000250""
FT   BINDING         608
FT                   /ligand=""Ca(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29108""
FT                   /evidence=""ECO:0000250""
FT   BINDING         635
FT                   /ligand=""Ca(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29108""
FT                   /evidence=""ECO:0000250""
FT   BINDING         639
FT                   /ligand=""Ca(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29108""
FT                   /evidence=""ECO:0000250""
FT   BINDING         642
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000250""
FT   SITE            176
FT                   /note=""Important for ion transport""
FT                   /evidence=""ECO:0000250""
FT   SITE            221
FT                   /note=""Important for ion transport""
FT                   /evidence=""ECO:0000250""
FT   SITE            228
FT                   /note=""Important for ion transport""
FT                   /evidence=""ECO:0000250""
FT   SITE            450
FT                   /note=""Determinant of potassium dependence""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01129""
FT   SITE            643
FT                   /note=""Important for ion transport""
FT                   /evidence=""ECO:0000250""
FT   SITE            654
FT                   /note=""Important for ion transport""
FT                   /evidence=""ECO:0000250""
SQ   SEQUENCE   671 AA;  68989 MW;  B9519DE6D3554ACB CRC64;
     MDLLTQVMYI GIAVGIISLL AAFYYAKKVE HYQINIPKVE EITAAIREGA MAFLAAEYKI
     LIVFVIVVAV ALGIFISVPT AGAFILGAIT SAIAGNAGMR IATKANGRTA IAAKEGGLAK
     ALNVAFSGGA VMGLTVVGLG MFMLSLILLV SRTVGISVND VTGFGMGASS IALFARVGGG
     IYTKAADVGA DLVGKVEAGI PEDDPRNPAT IADNVGDNVG DVAGMGADLF ESYVGSIIAT
     ITLAFLLPVD DATPYVAAPL LISAFGIISS IIATLTVKTD DGSKVHAKLE MGTRIAGILT
     IIASFGIIKY LGLDMGIFYA IVAGLVAGLV IAYFTGVYTD TGRRAVNRVS DAAGTGAATA
     IIEGLAIGME STVAPLIVIA IAIIISFKTG GLYGISIAAV GMLATTGMVV AVDAYGPVAD
     NAGGIAEMSE LPPEVRETTD KLDAVGNSTA AVGKGFAIGS AALTALSLFA AYKEAVDKLT
     SEALVIDVTD PEVIAGLFIG GMLTFLFSAL TMTAVGKAAI EMVEEVRRQF REFPGIMDRT
     QKPDYKRCVE ISTHSSLKQM ILPGVLAIIV PVIIGLWSVK ALGGLLAGAL VTGVLMAIMM
     ANAGGAWDNG KKQIEGGYKG DKKGSDRHKA AVVGDTVGDP FKDTSGPSLN ILIKLMSIVS
     LVLVPLFVKF M
//
",2286
AGTTTG GTTTGG TTTGGC TTGGCC TGGCCT GGCCTT GCCTTG CCTTGT CTTGTT TTGTTG TGTTGT GTTGTT TTGTTG TGTTGT GTTGTT TTGTTG TGTTGG GTTGGC TTGGCC TGGCCT GGCCTT GCCTTT CCTTTA CTTTAC TTTACC TTACCA TACCAG ACCAGA CCAGAC CAGACA AGACAT GACATT ACATTT CATTTT ATTTTG TTTTGC TTTGCT TTGCTC TGCTCT GCTCTC CTCTCA TCTCAA CTCAAG TCAAGC CAAGCT AAGCTG AGCTGG GCTGGG CTGGGC TGGGCG GGGCGG GGCGGT GCGGTG CGGTGA GGTGAT GTGATG TGATGC GATGCT ATGCTG TGCTGC GCTGCT CTGCTC TGCTCT GCTCTT CTCTTG TCTTGC CTTGCT TTGCTT TGCTTT GCTTTG CTTTGC TTTGCT TTGCTG TGCTGC GCTGCT CTGCTG TGCTGC GCTGCT CTGCTT TGCTTG GCTTGA CTTGAC TTGACA TGACAG GACAGA ACAGAT CAGATT AGATTG GATTGA ATTGAA TTGAAC TGAACC GAACCA AACCAG ACCAGC CCAGCT CAGCTT AGCTTG GCTTGA CTTGAG TTGAGA TGAGAG GAGAGC AGAGCA GAGCAA AGCAAA GCAAAA CAAAAT AAAATG AAATGT AATGTC ATGTCT TGTCTG GTCTGG TCTGGT CTGGTA TGGTAA GGTAAA GTAAAG TAAAGG AAAGGC AAGGCC AGGCCA GGCCAA GCCAAC CCAACA CAACAA AACAAC ACAACA CAACAA AACAAC ACAACA CAACAA AACAAG ACAAGG CAAGGC AAGGCC AGGCCA GGCCAA,1,139,AGTT GTTT TTTG TTGG TGGC GGCC GCCT CCTT CTTG TTGT TGTT GTTG TTGT TGTT GTTG TTGT TGTT GTTG TTGG TGGC GGCC GCCT CCTT CTTT TTTA TTAC TACC ACCA CCAG CAGA AGAC GACA ACAT CATT ATTT TTTT TTTG TTGC TGCT GCTC CTCT TCTC CTCA TCAA CAAG AAGC AGCT GCTG CTGG TGGG GGGC GGCG GCGG CGGT GGTG GTGA TGAT GATG ATGC TGCT GCTG CTGC TGCT GCTC CTCT TCTT CTTG TTGC TGCT GCTT CTTT TTTG TTGC TGCT GCTG CTGC TGCT GCTG CTGC TGCT GCTT CTTG TTGA TGAC GACA ACAG CAGA AGAT GATT ATTG TTGA TGAA GAAC AACC ACCA CCAG CAGC AGCT GCTT CTTG TTGA TGAG GAGA AGAG GAGC AGCA GCAA CAAA AAAA AAAT AATG ATGT TGTC GTCT TCTG CTGG TGGT GGTA GTAA TAAA AAAG AAGG AGGC GGCC GCCA CCAA CAAC AACA ACAA CAAC AACA ACAA CAAC AACA ACAA CAAG AAGG AGGC GGCC GCCA CCAA,AGTTT GTTTG TTTGG TTGGC TGGCC GGCCT GCCTT CCTTG CTTGT TTGTT TGTTG GTTGT TTGTT TGTTG GTTGT TTGTT TGTTG GTTGG TTGGC TGGCC GGCCT GCCTT CCTTT CTTTA TTTAC TTACC TACCA ACCAG CCAGA CAGAC AGACA GACAT ACATT CATTT ATTTT TTTTG TTTGC TTGCT TGCTC GCTCT CTCTC TCTCA CTCAA TCAAG CAAGC AAGCT AGCTG GCTGG CTGGG TGGGC GGGCG GGCGG GCGGT CGGTG GGTGA GTGAT TGATG GATGC ATGCT TGCTG GCTGC CTGCT TGCTC GCTCT CTCTT TCTTG CTTGC TTGCT TGCTT GCTTT CTTTG TTTGC TTGCT TGCTG GCTGC CTGCT TGCTG GCTGC CTGCT TGCTT GCTTG CTTGA TTGAC TGACA GACAG ACAGA CAGAT AGATT GATTG ATTGA TTGAA TGAAC GAACC AACCA ACCAG CCAGC CAGCT AGCTT GCTTG CTTGA TTGAG TGAGA GAGAG AGAGC GAGCA AGCAA GCAAA CAAAA AAAAT AAATG AATGT ATGTC TGTCT GTCTG TCTGG CTGGT TGGTA GGTAA GTAAA TAAAG AAAGG AAGGC AGGCC GGCCA GCCAA CCAAC CAACA AACAA ACAAC CAACA AACAA ACAAC CAACA AACAA ACAAG CAAGG AAGGC AGGCC GGCCA GCCAA,AGTTTG GTTTGG TTTGGC TTGGCC TGGCCT GGCCTT GCCTTG CCTTGT CTTGTT TTGTTG TGTTGT GTTGTT TTGTTG TGTTGT GTTGTT TTGTTG TGTTGG GTTGGC TTGGCC TGGCCT GGCCTT GCCTTT CCTTTA CTTTAC TTTACC TTACCA TACCAG ACCAGA CCAGAC CAGACA AGACAT GACATT ACATTT CATTTT ATTTTG TTTTGC TTTGCT TTGCTC TGCTCT GCTCTC CTCTCA TCTCAA CTCAAG TCAAGC CAAGCT AAGCTG AGCTGG GCTGGG CTGGGC TGGGCG GGGCGG GGCGGT GCGGTG CGGTGA GGTGAT GTGATG TGATGC GATGCT ATGCTG TGCTGC GCTGCT CTGCTC TGCTCT GCTCTT CTCTTG TCTTGC CTTGCT TTGCTT TGCTTT GCTTTG CTTTGC TTTGCT TTGCTG TGCTGC GCTGCT CTGCTG TGCTGC GCTGCT CTGCTT TGCTTG GCTTGA CTTGAC TTGACA TGACAG GACAGA ACAGAT CAGATT AGATTG GATTGA ATTGAA TTGAAC TGAACC GAACCA AACCAG ACCAGC CCAGCT CAGCTT AGCTTG GCTTGA CTTGAG TTGAGA TGAGAG GAGAGC AGAGCA GAGCAA AGCAAA GCAAAA CAAAAT AAAATG AAATGT AATGTC ATGTCT TGTCTG GTCTGG TCTGGT CTGGTA TGGTAA GGTAAA GTAAAG TAAAGG AAAGGC AAGGCC AGGCCA GGCCAA GCCAAC CCAACA CAACAA AACAAC ACAACA CAACAA AACAAC ACAACA CAACAA AACAAG ACAAGG CAAGGC AAGGCC AGGCCA GGCCAA,AGTTTGG GTTTGGC TTTGGCC TTGGCCT TGGCCTT GGCCTTG GCCTTGT CCTTGTT CTTGTTG TTGTTGT TGTTGTT GTTGTTG TTGTTGT TGTTGTT GTTGTTG TTGTTGG TGTTGGC GTTGGCC TTGGCCT TGGCCTT GGCCTTT GCCTTTA CCTTTAC CTTTACC TTTACCA TTACCAG TACCAGA ACCAGAC CCAGACA CAGACAT AGACATT GACATTT ACATTTT CATTTTG ATTTTGC TTTTGCT TTTGCTC TTGCTCT TGCTCTC GCTCTCA CTCTCAA TCTCAAG CTCAAGC TCAAGCT CAAGCTG AAGCTGG AGCTGGG GCTGGGC CTGGGCG TGGGCGG GGGCGGT GGCGGTG GCGGTGA CGGTGAT GGTGATG GTGATGC TGATGCT GATGCTG ATGCTGC TGCTGCT GCTGCTC CTGCTCT TGCTCTT GCTCTTG CTCTTGC TCTTGCT CTTGCTT TTGCTTT TGCTTTG GCTTTGC CTTTGCT TTTGCTG TTGCTGC TGCTGCT GCTGCTG CTGCTGC TGCTGCT GCTGCTT CTGCTTG TGCTTGA GCTTGAC CTTGACA TTGACAG TGACAGA GACAGAT ACAGATT CAGATTG AGATTGA GATTGAA ATTGAAC TTGAACC TGAACCA GAACCAG AACCAGC ACCAGCT CCAGCTT CAGCTTG AGCTTGA GCTTGAG CTTGAGA TTGAGAG TGAGAGC GAGAGCA AGAGCAA GAGCAAA AGCAAAA GCAAAAT CAAAATG AAAATGT AAATGTC AATGTCT ATGTCTG TGTCTGG GTCTGGT TCTGGTA CTGGTAA TGGTAAA GGTAAAG GTAAAGG TAAAGGC AAAGGCC AAGGCCA AGGCCAA GGCCAAC GCCAACA CCAACAA CAACAAC AACAACA ACAACAA CAACAAC AACAACA ACAACAA CAACAAG AACAAGG ACAAGGC CAAGGCC AAGGCCA AGGCCAA,"ID   NCAP_SARS2              Reviewed;         419 AA.
AC   P0DTC9;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Nucleoprotein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=N;
DE   AltName: Full=Nucleocapsid protein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=NC {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=Protein N {ECO:0000255|HAMAP-Rule:MF_04096};
GN   Name=N {ECO:0000255|HAMAP-Rule:MF_04096};
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3] {ECO:0007744|PDB:6WZO, ECO:0007744|PDB:6WZQ}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 247-364, AND SUBUNIT.
RX   PubMed=32654247; DOI=10.1002/pro.3909;
RA   Ye Q., West A.M.V., Silletti S., Corbett K.D.;
RT   ""Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein."";
RL   Protein Sci. 29:1890-1901(2020).
RN   [4]
RP   REVIEW.
RX   PubMed=32974389; DOI=10.3389/fmolb.2020.00219;
RA   Nikolakaki E., Giannakouros T.;
RT   ""SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle."";
RL   Front. Mol. Biosci. 7:219-219(2020).
RN   [5]
RP   VARIANTS LEU-3 AND PHE-235.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=34341353; DOI=10.1038/s41467-021-25015-6;
RA   Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J.,
RA   Jia Y., Wang W., Wan P., Zhang J., Chen W., Lei Z., Chen X., Luo Z.,
RA   Zhang Q., Xu M., Li G., Li Y., Wu J.;
RT   ""SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce
RT   hyperinflammation."";
RL   Nat. Commun. 12:4664-4664(2021).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 41-174, AND MUTAGENESIS OF
RP   TYR-109.
RX   PubMed=32363136; DOI=10.1016/j.apsb.2020.04.009;
RA   Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z.,
RA   Zhou Z., Chen Q., Yan Y., Zhang C., Shan H., Chen S.;
RT   ""Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain
RT   reveals potential unique drug targeting sites."";
RL   Acta Pharmacol. Sin. 10:1228-1238(2020).
RN   [8] {ECO:0007744|PDB:6YI3, ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT}
RP   STRUCTURE BY NMR OF 44-180, FUNCTION, AND MUTAGENESIS OF ARG-68; ARG-92;
RP   ILE-94; ARG-107; GLN-163; TYR-172 AND GLU-174.
RX   PubMed=33264373; DOI=10.1371/journal.ppat.1009100;
RA   Dinesh D.C., Chalupska D., Silhan J., Koutna E., Nencka R., Veverka V.,
RA   Boura E.;
RT   ""Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid
RT   phosphoprotein."";
RL   PLoS Pathog. 16:1-16(2020).
RN   [9]
RP   MUTAGENESIS OF SER-188 AND SER-206, AND PHOSPHORYLATION AT SER-206.
RX   PubMed=34593624; DOI=10.1073/pnas.2113401118;
RA   Liu X., Verma A., Garcia G. Jr., Ramage H., Lucas A., Myers R.L.,
RA   Michaelson J.J., Coryell W., Kumar A., Charney A.W., Kazanietz M.G.,
RA   Rader D.J., Ritchie M.D., Berrettini W.H., Schultz D.C., Cherry S.,
RA   Damoiseaux R., Arumugaswami V., Klein P.S.;
RT   ""Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:1-9(2021).
RN   [10]
RP   CLEAVAGE.
RX   PubMed=35922005; DOI=10.1038/s41586-022-05148-4;
RA   Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., Shi J., Chai Y.,
RA   Yuen T.T., Hu B., Li C., Zhao X., Wang Y., Huang X., Lee K.S., Luo C.,
RA   Cai J.P., Poon V.K., Chan C.C., Zhang A.J., Yuan S., Sit K.Y., Foo D.C.,
RA   Au W.K., Wong K.K., Zhou J., Kok K.H., Jin D.Y., Chan J.F., Yuen K.Y.;
RT   ""Coronaviruses exploit a host cysteine-aspartic protease for replication."";
RL   Nature 0:0-0(2022).
RN   [11]
RP   MUTAGENESIS OF 203-ARG-GLY-204 AND ARG-203, AND PHOSPHORYLATION.
RX   PubMed=35728038; DOI=10.1371/journal.ppat.1010627;
RA   Johnson B.A., Zhou Y., Lokugamage K.G., Vu M.N., Bopp N.,
RA   Crocquet-Valdes P.A., Kalveram B., Schindewolf C., Liu Y., Scharton D.,
RA   Plante J.A., Xie X., Aguilar P., Weaver S.C., Shi P.Y., Walker D.H.,
RA   Routh A.L., Plante K.S., Menachery V.D.;
RT   ""Nucleocapsid mutations in SARS-CoV-2 augment replication and
RT   pathogenesis."";
RL   PLoS Pathog. 18:e1010627-e1010627(2022).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=35921414; DOI=10.1126/sciadv.abp9770;
RA   Lopez-Munoz A.D., Kosik I., Holly J., Yewdell J.W.;
RT   ""Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive
RT   immunity."";
RL   Sci. Adv. 8:eabp9770-eabp9770(2022).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=34901782; DOI=10.1016/j.isci.2021.103562;
RA   Nabeel-Shah S., Lee H., Ahmed N., Burke G.L., Farhangmehr S., Ashraf K.,
RA   Pu S., Braunschweig U., Zhong G., Wei H., Tang H., Yang J., Marcon E.,
RA   Blencowe B.J., Zhang Z., Greenblatt J.F.;
RT   ""SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress
RT   granules to impair host stress response."";
RL   IScience 25:103562-103562(2022).
RN   [14]
RP   FUNCTION.
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [15] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 191-263, AND INTERACTION WITH NSP3.
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
CC   -!- FUNCTION: Packages the positive strand viral genome RNA into a helical
CC       ribonucleocapsid (RNP) and plays a fundamental role during virion
CC       assembly through its interactions with the viral genome and membrane
CC       protein M (PubMed:33264373). Plays an important role in enhancing the
CC       efficiency of subgenomic viral RNA transcription as well as viral
CC       replication. Attenuates the stress granules formation by reducing host
CC       G3BP1 access to host mRNAs under stress conditions (PubMed:34901782,
CC       PubMed:36534661). {ECO:0000269|PubMed:32974389,
CC       ECO:0000269|PubMed:33264373, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: May block host chemokine function in vivo, facilitating viral
CC       replication and transmission (PubMed:35921414). Acts by being secreted
CC       into the extracellular space where it competes to host chemokines for
CC       binding to host glycosaminoglycans (GAG) (PubMed:35921414).
CC       {ECO:0000269|PubMed:35921414}.
CC   -!- FUNCTION: May induce inflammasome responses in cultured cells and mice.
CC       Acts by interacting with host NLRP3 to facilitate inflammasome
CC       assembly, which induces cytokine release that may play a role in COVID
CC       lung injury. {ECO:0000269|PubMed:34341353}.
CC   -!- SUBUNIT: Homodimer, homotetramer, homooligomer with RNA
CC       (PubMed:32654247). Both monomeric and oligomeric forms interact with
CC       RNA. Interacts with protein M (By similarity). Interacts with protein E
CC       (By similarity). Interacts with NSP3; this interaction serves to tether
CC       the genome to the newly translated replicase-transcriptase complex at a
CC       very early stage of infection (PubMed:35044811). May interact with host
CC       NLRP3 (PubMed:34341353). {ECO:0000250|UniProtKB:P59595,
CC       ECO:0000255|HAMAP-Rule:MF_04096, ECO:0000269|PubMed:32654247,
CC       ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:35044811}.
CC   -!- INTERACTION:
CC       P0DTC9; P0DTC4: E; NbExp=3; IntAct=EBI-25475856, EBI-25475850;
CC       P0DTC9; P0DTC5: M; NbExp=6; IntAct=EBI-25475856, EBI-25475853;
CC       P0DTC9; P0DTC9: N; NbExp=105; IntAct=EBI-25475856, EBI-25475856;
CC       P0DTC9; PRO_0000449621 [P0DTD1]: rep; NbExp=15; IntAct=EBI-25475856, EBI-25492388;
CC       P0DTC9; P78563: ADARB1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2967304;
CC       P0DTC9; O15145: ARPC3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351829;
CC       P0DTC9; Q13895: BYSL; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358049;
CC       P0DTC9; Q16543: CDC37; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-295634;
CC       P0DTC9; Q92793: CREBBP; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-81215;
CC       P0DTC9; Q92499: DDX1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-358474;
CC       P0DTC9; Q9NR30: DDX21; Xeno; NbExp=12; IntAct=EBI-25475856, EBI-357942;
CC       P0DTC9; P26196: DDX6; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351257;
CC       P0DTC9; Q08426: EHHADH; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2339219;
CC       P0DTC9; P19525: EIF2AK2; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-640775;
CC       P0DTC9; Q14241: ELOA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-742350;
CC       P0DTC9; Q13283: G3BP1; Xeno; NbExp=71; IntAct=EBI-25475856, EBI-1047359;
CC       P0DTC9; Q9UN86: G3BP2; Xeno; NbExp=37; IntAct=EBI-25475856, EBI-1044298;
CC       P0DTC9; P57764: GSDMD; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2798865;
CC       P0DTC9; P49841: GSK3B; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-373586;
CC       P0DTC9; P10412: H1-4; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358163;
CC       P0DTC9; O14920: IKBKB; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-81266;
CC       P0DTC9; Q92830: KAT2A; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477622;
CC       P0DTC9; Q92831: KAT2B; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477430;
CC       P0DTC9; Q07866: KLC1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-721019;
CC       P0DTC9; Q9H0B6: KLC2; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-726994;
CC       P0DTC9; Q9NSK0: KLC4; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-949319;
CC       P0DTC9; Q9NX58: LYAR; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-713507;
CC       P0DTC9; O43318: MAP3K7; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-358684;
CC       P0DTC9; Q9UBU8: MORF4L1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-399246;
CC       P0DTC9; Q15014: MORF4L2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-399257;
CC       P0DTC9; Q9HCE1: MOV10; Xeno; NbExp=11; IntAct=EBI-25475856, EBI-1055820;
CC       P0DTC9; Q9HC36: MRM3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-1045440;
CC       P0DTC9; O15226: NKRF; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-766011;
CC       P0DTC9; Q96P20: NLRP3; Xeno; NbExp=18; IntAct=EBI-25475856, EBI-6253230;
CC       P0DTC9; O15118: NPC1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-2368710;
CC       P0DTC9; Q96HA8: NTAQ1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-741158;
CC       P0DTC9; P11940: PABPC1; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-81531;
CC       P0DTC9; P62937: PPIA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-437708;
CC       P0DTC9; O75569: PRKRA; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-713955;
CC       P0DTC9; Q99873: PRMT1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-78738;
CC       P0DTC9; P61289: PSME3; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-355546;
CC       P0DTC9; P26022: PTX3; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-11574553;
CC       P0DTC9; P54727: RAD23B; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-954531;
CC       P0DTC9; O95786: RIGI; Xeno; NbExp=15; IntAct=EBI-25475856, EBI-995350;
CC       P0DTC9; P62899: RPL31; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1053664;
CC       P0DTC9; P62753: RPS6; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-356625;
CC       P0DTC9; P37840: SNCA; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-985879;
CC       P0DTC9; Q96SB4: SRPK1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-539478;
CC       P0DTC9; P78362: SRPK2; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-593303;
CC       P0DTC9; P42224: STAT1; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1057697;
CC       P0DTC9; P52630: STAT2; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-1546963;
CC       P0DTC9; Q15633: TARBP2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-978581;
CC       P0DTC9; Q14258: TRIM25; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2341129;
CC       P0DTC9; O60763: USO1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-356164;
CC       P0DTC9; Q93008: USP9X; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-302524;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04096}. Host
CC       cytoplasm {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34341353}.
CC       Secreted {ECO:0000269|PubMed:35921414}. Host extracellular space
CC       {ECO:0000269|PubMed:35921414}. Note=Probably associates with ER-derived
CC       membranes where it participates in viral RNA synthesis and virus
CC       budding. When located inside the virion, complexed with the viral RNA.
CC       Can be secreted by unconventional protein secretion (UPS)
CC       (PubMed:35921414). When secreted, can bind to host glycosaminoglycans
CC       on infected and non infected cells (PubMed:35921414). Found in host
CC       cytoplasmic stress granules (PubMed:34901782). {ECO:0000255|HAMAP-
CC       Rule:MF_04096, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:35921414}.
CC   -!- PTM: ADP-ribosylated. The ADP-ribosylation is retained in the virion
CC       during infection. {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   -!- PTM: Phosphorylated on serine residues by host GSK3A and GSK3B
CC       (PubMed:34593624, PubMed:35728038). This promotes the solubility of
CC       homodimers that would otherwise aggregate (PubMed:32974389). Host
CC       phosphatase would dephosphorylate the protein during assembly at M
CC       bound membranes (PubMed:32974389). {ECO:0000269|PubMed:34593624,
CC       ECO:0000269|PubMed:35728038, ECO:0000305|PubMed:32974389}.
CC   -!- PTM: Proteolytically cleaved by host CASP6. The cleavage leads to two
CC       fragments and facilitates viral replication by inhibiting host IFN
CC       signaling. The two fragments may interact with IRF3 inhibiting its
CC       nuclear translocation after activation and reduce the expression of
CC       IFNB and IFN-stimulated genes. {ECO:0000269|PubMed:35922005}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (December 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1. {ECO:0000305|PubMed:33413740}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronavirus nucleocapsid protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43423.2; -; Genomic_RNA.
DR   PDB; 6M3M; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 6VYO; X-ray; 1.70 A; A/B/C/D=47-173.
DR   PDB; 6WJI; X-ray; 2.05 A; A/B/C/D/E/F=257-364.
DR   PDB; 6WKP; X-ray; 2.67 A; A/B/C/D=47-173.
DR   PDB; 6WZO; X-ray; 1.42 A; A/B/C/D=247-364.
DR   PDB; 6WZQ; X-ray; 1.45 A; A/B/C/D=247-364.
DR   PDB; 6YI3; NMR; -; A=44-180.
DR   PDB; 6YUN; X-ray; 1.44 A; A/B=249-364.
DR   PDB; 6ZCO; X-ray; 1.36 A; A=247-364.
DR   PDB; 7ACS; NMR; -; A=44-180.
DR   PDB; 7ACT; NMR; -; A=44-180.
DR   PDB; 7C22; X-ray; 2.00 A; A/B/C/D=248-364.
DR   PDB; 7CDZ; X-ray; 1.80 A; A/B/C/D=44-174.
DR   PDB; 7CE0; X-ray; 1.50 A; A/B/C/D=255-364.
DR   PDB; 7CR5; X-ray; 2.08 A; A=41-174.
DR   PDB; 7DE1; X-ray; 2.00 A; A/B=250-364.
DR   PDB; 7F2B; X-ray; 2.00 A; A/B=257-362.
DR   PDB; 7F2E; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=255-362.
DR   PDB; 7KGO; X-ray; 2.15 A; C=351-359.
DR   PDB; 7KGP; X-ray; 1.40 A; C=316-324.
DR   PDB; 7KGQ; X-ray; 1.34 A; C=222-230.
DR   PDB; 7KGR; X-ray; 1.55 A; C=159-167.
DR   PDB; 7KGS; X-ray; 1.58 A; C=138-146.
DR   PDB; 7KGT; X-ray; 1.90 A; C=226-234.
DR   PDB; 7LGD; X-ray; 2.88 A; E/F=105-113.
DR   PDB; 7LTU; X-ray; 1.12 A; A/B=217-222.
DR   PDB; 7LUX; X-ray; 1.30 A; A=217-222.
DR   PDB; 7LUZ; X-ray; 1.10 A; A=243-248.
DR   PDB; 7LV2; X-ray; 1.30 A; A=179-184.
DR   PDB; 7N0I; X-ray; 2.20 A; A/B/C/D/E/F/G/H=269-364.
DR   PDB; 7N0R; X-ray; 1.42 A; A/B=49-174.
DR   PDB; 7N3C; X-ray; 1.82 A; C=47-173.
DR   PDB; 7N3D; X-ray; 1.53 A; C=47-173.
DR   PDB; 7O05; X-ray; 1.94 A; A/B/C/D=247-364.
DR   PDB; 7O35; X-ray; 1.80 A; A/B/C/D=247-364.
DR   PDB; 7O36; X-ray; 2.00 A; A/B/C/D=247-364.
DR   PDB; 7PKU; NMR; -; B=191-263.
DR   PDB; 7QIK; X-ray; 2.01 A; E/F=193-200.
DR   PDB; 7QIP; X-ray; 2.65 A; C/D=201-210.
DR   PDB; 7R98; X-ray; 2.51 A; A/B/C=49-174.
DR   PDB; 7SD4; NMR; -; A=40-174.
DR   PDB; 7STR; X-ray; 1.50 A; C=47-173.
DR   PDB; 7STS; X-ray; 2.16 A; C/D=47-173.
DR   PDB; 7SUE; X-ray; 2.90 A; C/D/J/K=47-173.
DR   PDB; 7SUO; X-ray; 2.35 A; C/D=12-22.
DR   PDB; 7UW3; X-ray; 1.70 A; A/B/C/D=40-174.
DR   PDB; 7UXX; X-ray; 1.85 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7UXZ; X-ray; 1.73 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7VBD; X-ray; 1.94 A; A/B/C/D=48-174.
DR   PDB; 7VBE; X-ray; 1.59 A; A/B=257-364.
DR   PDB; 7VBF; X-ray; 1.30 A; A/B=255-364.
DR   PDB; 7VNU; X-ray; 1.95 A; A/B/C/D=47-174.
DR   PDB; 7WKJ; X-ray; 1.50 A; C=361-369.
DR   PDB; 7WZO; X-ray; 2.64 A; A=47-174.
DR   PDB; 7XWX; X-ray; 3.00 A; A/B/C/D/E/F/G/H=269-367.
DR   PDB; 7XWZ; X-ray; 2.25 A; A/B=48-172.
DR   PDB; 7XX1; X-ray; 1.90 A; A/B/C/D=49-173.
DR   PDB; 7XXK; X-ray; 2.00 A; A/B/C/D/E/F=248-364.
DR   PDB; 7YLB; X-ray; 2.41 A; A/B/C/D/G/H/J/K=247-364.
DR   PDB; 7YLD; X-ray; 2.80 A; A/B/C/D=47-174.
DR   PDB; 7ZIT; X-ray; 1.79 A; C/D=194-200.
DR   PDB; 8DNT; X-ray; 3.18 A; D/J/Q/X=222-230.
DR   PDB; 8FD5; EM; 4.57 A; A=1-419.
DR   PDB; 8FG2; EM; 6.00 A; A/B=1-419.
DR   PDB; 8IQJ; X-ray; 2.30 A; A/B/C/D=41-174.
DR   PDB; 8IV3; X-ray; 1.90 A; A/B/C/D=41-174.
DR   PDB; 8J6X; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 8TH1; X-ray; 1.80 A; E/F/G/H=1-25.
DR   PDB; 8TH5; X-ray; 2.62 A; K/L/M/N/O/P/Q=1-25.
DR   PDB; 8X1H; X-ray; 2.00 A; A/B/C/D=44-175.
DR   PDBsum; 6M3M; -.
DR   PDBsum; 6VYO; -.
DR   PDBsum; 6WJI; -.
DR   PDBsum; 6WKP; -.
DR   PDBsum; 6WZO; -.
DR   PDBsum; 6WZQ; -.
DR   PDBsum; 6YI3; -.
DR   PDBsum; 6YUN; -.
DR   PDBsum; 6ZCO; -.
DR   PDBsum; 7ACS; -.
DR   PDBsum; 7ACT; -.
DR   PDBsum; 7C22; -.
DR   PDBsum; 7CDZ; -.
DR   PDBsum; 7CE0; -.
DR   PDBsum; 7CR5; -.
DR   PDBsum; 7DE1; -.
DR   PDBsum; 7F2B; -.
DR   PDBsum; 7F2E; -.
DR   PDBsum; 7KGO; -.
DR   PDBsum; 7KGP; -.
DR   PDBsum; 7KGQ; -.
DR   PDBsum; 7KGR; -.
DR   PDBsum; 7KGS; -.
DR   PDBsum; 7KGT; -.
DR   PDBsum; 7LGD; -.
DR   PDBsum; 7LTU; -.
DR   PDBsum; 7LUX; -.
DR   PDBsum; 7LUZ; -.
DR   PDBsum; 7LV2; -.
DR   PDBsum; 7N0I; -.
DR   PDBsum; 7N0R; -.
DR   PDBsum; 7N3C; -.
DR   PDBsum; 7N3D; -.
DR   PDBsum; 7O05; -.
DR   PDBsum; 7O35; -.
DR   PDBsum; 7O36; -.
DR   PDBsum; 7PKU; -.
DR   PDBsum; 7QIK; -.
DR   PDBsum; 7QIP; -.
DR   PDBsum; 7R98; -.
DR   PDBsum; 7SD4; -.
DR   PDBsum; 7STR; -.
DR   PDBsum; 7STS; -.
DR   PDBsum; 7SUE; -.
DR   PDBsum; 7SUO; -.
DR   PDBsum; 7UW3; -.
DR   PDBsum; 7UXX; -.
DR   PDBsum; 7UXZ; -.
DR   PDBsum; 7VBD; -.
DR   PDBsum; 7VBE; -.
DR   PDBsum; 7VBF; -.
DR   PDBsum; 7VNU; -.
DR   PDBsum; 7WKJ; -.
DR   PDBsum; 7WZO; -.
DR   PDBsum; 7XWX; -.
DR   PDBsum; 7XWZ; -.
DR   PDBsum; 7XX1; -.
DR   PDBsum; 7XXK; -.
DR   PDBsum; 7YLB; -.
DR   PDBsum; 7YLD; -.
DR   PDBsum; 7ZIT; -.
DR   PDBsum; 8DNT; -.
DR   PDBsum; 8FD5; -.
DR   PDBsum; 8FG2; -.
DR   PDBsum; 8IQJ; -.
DR   PDBsum; 8IV3; -.
DR   PDBsum; 8J6X; -.
DR   PDBsum; 8TH1; -.
DR   PDBsum; 8TH5; -.
DR   PDBsum; 8X1H; -.
DR   BMRB; P0DTC9; -.
DR   EMDB; EMD-29002; -.
DR   EMDB; EMD-29072; -.
DR   SASBDB; P0DTC9; -.
DR   SMR; P0DTC9; -.
DR   BioGRID; 4383847; 1532.
DR   ComplexPortal; CPX-5686; SARS-CoV-2 nucleocapsid complex.
DR   IntAct; P0DTC9; 608.
DR   MINT; P0DTC9; -.
DR   ChEMBL; CHEMBL5169223; -.
DR   iPTMnet; P0DTC9; -.
DR   ABCD; P0DTC9; 27 sequenced antibodies.
DR   DNASU; 43740575; -.
DR   KEGG; vg:43740575; -.
DR   AGR; RefSeq:YP_009724397; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694786; Transcription of SARS-CoV-2 sgRNAs.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC9; -.
DR   PRO; PR:P0DTC9; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0044177; C:host cell Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043655; C:host extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt.
DR   GO; GO:0042612; C:MHC class I protein complex; EXP:DisProt.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0019028; C:viral capsid; IPI:ComplexPortal.
DR   GO; GO:0019013; C:viral nucleocapsid; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042288; F:MHC class I protein binding; EXP:DisProt.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; IDA:DisProt.
DR   GO; GO:0008266; F:poly(U) RNA binding; IMP:DisProt.
DR   GO; GO:0042803; F:protein homodimerization activity; EXP:DisProt.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProt.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:DisProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IDA:ComplexPortal.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0052572; P:response to host immune response; IDA:DisProt.
DR   GO; GO:0019074; P:viral RNA genome packaging; NAS:ComplexPortal.
DR   CDD; cd21595; CoV_N-CTD; 1.
DR   CDD; cd21554; CoV_N-NTD; 1.
DR   HAMAP; MF_04096; BETA_CORONA_NCAP; 1.
DR   InterPro; IPR044344; N_prot_C_CoV.
DR   InterPro; IPR044345; N_prot_N_CoV.
DR   InterPro; IPR043505; NCAP_bCoV.
DR   InterPro; IPR001218; Nucleocap_CoV.
DR   InterPro; IPR037179; Nucleocapsid_C.
DR   InterPro; IPR037195; Nucleocapsid_N.
DR   Pfam; PF00937; CoV_nucleocap; 1.
DR   PIRSF; PIRSF003888; Corona_nucleocap; 1.
DR   SUPFAM; SSF110304; Coronavirus RNA-binding domain; 1.
DR   SUPFAM; SSF103068; Nucleocapsid protein dimerization domain; 1.
DR   PROSITE; PS51929; COV_N_CTD; 1.
DR   PROSITE; PS51928; COV_N_NTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Host cytoplasm; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Secreted;
KW   Transcription; Transcription regulation; Viral nucleoprotein; Virion.
FT   CHAIN           1..419
FT                   /note=""Nucleoprotein""
FT                   /id=""PRO_0000449656""
FT   DOMAIN          48..174
FT                   /note=""CoV N NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01276,
FT                   ECO:0000269|PubMed:32363136""
FT   DOMAIN          247..364
FT                   /note=""CoV N CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01277""
FT   REGION          1..51
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          41..186
FT                   /note=""RNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          63..83
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          168..212
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          176..206
FT                   /note=""SR region""
FT                   /evidence=""ECO:0000305|PubMed:32974389""
FT   REGION          233..266
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          258..361
FT                   /note=""Dimerization""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          260..340
FT                   /note=""Putative NLRP3 binding""
FT                   /evidence=""ECO:0000269|PubMed:34341353""
FT   REGION          361..391
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          400..419
FT                   /note=""Tetramerization""
FT                   /evidence=""ECO:0000269|PubMed:32654247""
FT   MOTIF           256..264
FT                   /note=""Nuclear localization signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   COMPBIAS        1..11
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        21..31
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        367..378
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         92
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         107
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         149
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   SITE            399..402
FT                   /note=""Cleavage (by host CASP6)""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   MOD_RES         176
FT                   /note=""Phosphoserine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   MOD_RES         206
FT                   /note=""Phosphoserine; by host GSK3-alpha and GSK3-beta""
FT                   /evidence=""ECO:0000269|PubMed:34593624""
FT   VARIANT         2..3
FT                   /note=""SD -> Y (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> L (in strain: Alpha/B.1.1.7)""
FT                   /evidence=""ECO:0000305|PubMed:33413740""
FT   VARIANT         12
FT                   /note=""A -> G (in strain: Eta/B.1.525)""
FT   VARIANT         13
FT                   /note=""P -> L (in strain: Lambda/C.37, Omicron/BA.1,
FT                   Omicron/BA.2, Omicron/BA.2.12.1, Omicron/BA.2.75,
FT                   Omicron/BA.4, Omicron/BA.5, Omicron/BQ.1.1,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         31..33
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""D -> G (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT  ",4112
ACAAAA CAAAAT AAAATA AAATAC AATACA ATACAA TACAAT ACAATC CAATCC AATCCA ATCCAC TCCACG CCACGA CACGAG ACGAGA CGAGAA GAGAAA AGAAAT GAAATA AAATAG AATAGA ATAGAA TAGAAA AGAAAA GAAAAA AAAAAA AAAAAC AAAACA AAACAG AACAGA ACAGAT CAGATG AGATGC GATGCC ATGCCA TGCCAA GCCAAT CCAATA CAATAT AATATT ATATTG TATTGA ATTGAT TTGATG TGATGC GATGCA ATGCAT TGCATT GCATTG CATTGG ATTGGC TTGGCA TGGCAA GGCAAA GCAAAG CAAAGT AAAGTT AAGTTT AGTTTA GTTTAT TTTATT TTATTG TATTGC ATTGCC TTGCCG TGCCGA GCCGAT CCGATG CGATGC GATGCA ATGCAT TGCATT GCATTA CATTAT ATTATC TTATCA TATCAG ATCAGG TCAGGA CAGGAA AGGAAA GGAAAA GAAAAA AAAAAC AAAACA AAACAC AACACC ACACCT CACCTT ACCTTT CCTTTC CTTTCC TTTCCT TTCCTT TCCTTA CCTTAT CTTATG TTATGC TATGCT ATGCTG TGCTGG GCTGGA CTGGAA TGGAAA GGAAAT GAAATT AAATTA AATTAC ATTACC TTACCA TACCAC ACCACC CCACCT CACCTA ACCTAC CCTACG CTACGC TACGCT ACGCTA CGCTAA GCTAAA CTAAAA TAAAAC AAAACA AAACAG AACAGG ACAGGC CAGGCA AGGCAA GGCAAG GCAAGG CAAGGC AAGGCT AGGCTC GGCTCA GCTCAG CTCAGG TCAGGA CAGGAA AGGAAG GGAAGT GAAGTG AAGTGT AGTGTA GTGTAT,3,145,GGACAAAA AA CAAAAAAA A AAAAAAAAA ACA AAAAAAT T A AAAATATATA A A ATATATACAA C T ATTAC AACACA A ACACACAAAA AAA CACAAAATT AAATG ATC C A ATATCTCCCC C TTTATCCCCAT AA C GACCAC TAC C CAA TC ATACG G TCGAGA A C CGCGAAG G G GAGAG AAGA A A AGAGAGAAAA A G GAGAAGG AA TG  AAAAAAATAT TC TA  ATATATAGAG G T TATAGAGAGA A A AGAGAGAAAA A GAC GAAAAAAA C ATTATA  ATA A AAAAA CAA A AAAAAAAAAA  AAAAAAC  AAAACACACA A A ACTACCAGC C CACAGAGA CCA A AGAGAGATAT T GTTATGGATGTG G A ATTGCCAGGAT TGTGCGCCCC C G GCGCCCCACA A CCCAAA A C CACAAAATAT CACAGAAATATAACCA A ATACGG TAT T T TATATATTTT T A ATTG G T TTTTGGA A T TGTGAGATCGAT G GAGATATGAA G A ATATGTGCGC C T TGTGCGCACA GA  GCGCACATAT T C CAC TTT T A ATATTTTGACGG T TTTTGTGGG A TGGATGGC AAC G GGGGCGCACA A G GCGCA CAA C CACAAA CAA AAAAAGAG G AGC AAGA AGT CA  AGAGTGTTTT T G GTGTTTTTTT T T TTTTTTA A T TT TCGT AT T T TACA ATTTT T A AT ACTTGTG TAT TTTTGTGCGC C TTGCGCC GCGCCCCGCG G CCCGCGAGA A C CGAT GATAT GGC GAG AATGTG  TAATGTGCGC CA  TGTGCGCACA A G GCGCACATTG T C CACATATTTT AGT ATATT CCTA A T TTTTATATAT T T TATATATCCACTCACA A T TCTCACAGAG AC CAGAGGT AG ATA AGGGGAGA A GG AGGAGAATTAA G GAGAAAAAA ATGGAAAAA A A AAAAAAT A A AAAAAAC C A AAAACACATAT CTACAAACAG CACAAACC  ACACCA ACT  CCCCTCTT GAT C CTCTTTT T T TTTTTTTCT AC T TTTTCCC C T TCTCCATCCT T C CCCCTCTTTT T C CTCTTTTATA A T TTTTATATAT T T TATATATGTG C T ATATGTGCGC C T TG ACGCTCT T G GCGCTCTGTG G C CTCTGC AGG G T TGTGGACAGA A G GGGGAGAAA GGAAAAAAA  AG AAAAAAATAT T A AAATTTT  ATATTAA TA A TTTATACAC GAA TATACACCCC A A ACACCCCACA A C CCCCAAC  CACACACCCC C A ACACCT CA GCCTCTA AGA CCTAACAAC TAA TATACACGCG G A ACACGCGCGC C C CGGCTCT T G GCGCTCTATA A CTAATT A T TAAAAAA A A AAAAAAAAAA CCT AAAACG CAAA AAA AACACA A ACAAACACAGAG G C CACAG GCGG G A AGAGGGGCGC C G GGT GGCACA A G GCGCACAAAA  CATGCAAGAG ATC AAAAGAGGGG G A AGAGGGGCGC C G GGGCTGCTCT T GGTGGGCCTCTC C CATTCTCTCAA T TCTCACAGAG G C CAGC AGGGG G A AGAGGGGAGA AATAA  GAC TAAGAG G A AAAAGAGTT AAACGG GTGA AG GAGGTGTGT  TGTGTTA A G GTGTATAT,CAAAAACG GCA CACC AAAAAAAA A A AAAAAAAAAATAT T AAAAAATATATA A A AATTTATATACAC C A ATATATACACACA A T TATACACACAAAA  ACACA CTTA AT T C CACAAAATATCTC  AAAATATCTCCGGCC A ATATCAGGCCACA  TCTCCCCACACAC C C CCCCACACTT G C CACACACGGA A A ACACGCGAGAGAG G CCGAGAGAGAGA A GC AGAGGAAAA  AGGAAAAAAA A G GAC GTATAT  AAAAATA ATATA A ACT AATATAGCCG A ATATATAGCAGCAG CG TATAGC AGAAAA A A AGGCC GAGAAAAAAAAAA A A AAAAAAAGAA A A AAAAAAAACAGAA A AAAATG AACAC C AAAAAACACACA GCA AAAACACACAGAG G A ACACACAGAGAGA A C CA ATAGAGATAT T A AGAGAGATATGTG G G GAATGTGCGC C AAAATGCGCCCAAC T TGTGCGCCCCACA A G GCGCC TGTTGAA  CCCCACAAATCAT AAC CACAAATATA A A AACAGATATATAT CC  ATATATATT T TATATTGGTTGG A ATATTTTGTGAAAAA T TTTTGCCAGATAT T T TGTGAGATATGCAT GAATGTGCC A ATATGTGCCA A T TGTGCCT CATAT T G GCGCACATATTTT T CCATATTTTGTG G A ATAAGGG G TTT TTGGGCGC C T TGGG GGCGCACCGA G GGGGCGCATGGCCTA G GCGCACAAAAAAA  CACAAAATAAGAG G A AAAAATTGAGTGT  AAAAGGTT AG TAGTTTTTTGTT G GTGTTGAATTAACAA TAATTTATATAT T T TTGT ATTACGT T TAAATATTTTGTG G A ATATTCAATGCGC C T TTTTGAG AGAT AC T TGGCCCA G G GCTAGTTACGACAGA C CCCGAGATAT T CA TCGAGATATGTG G G GAGATATGAGAA TATGTGCA CA T TGTGCGCACATAT T G GCGCACATATTTT T C CATG ATTTTAAATA A ATATTTTATATAT T TTTATATATCTC C TCTGTCAACCA A ATATCTCAG T TCTCACAGAGGGG G C CAGA GGAGA A A AGAGGGGAGAAAA AA  GGGCTAA A G GATTTGA AAAA GA A AAAAAAAA AAAA A AAAAA CAACC A AAAAAACAA AAACACACACAC  AA ACGCTCACACCCC C C CACACACCCCTCT T A ACACCCCTCTT TTT C CCCCTTT T CCAG GGTTTTTCC T TTTTCTCCCC C T TTTTCTCCCCTGCAT T TCAA TT TCA CCCCTCAGTA A C CTCTTTTATATAT T T TTCCGTATATGT CT TTATTGCGC  GA ATATGGCT TATGATGCGCTCTGTG G G GCT GGAAC AGG G CCTGCAAGGAGA CAG TGTGGGGAGAAAA A G GGGGAGAAAAAAA A G GAGAAAAAAT T A AAAAAAATATTAG  AAAATCT TTATA A A ATATTTTATACAC C T TTTTATACACCCC C TGA TACACCCCACA A A ACACCCCACAC AA CCCCAACCCC C C CAA AACCCCT TCT ACA CCTAGGA C CCCCTCTATACAC C CCAACTAACGCG G T TATACACGCGCGC C AACGCGCAAACT T CCGCGCTCTATA A G GCGCTCTATAAA C CTCTATAAAAAAA A T TATAAAAAAAAAGAA A AAAAAAAAAACAC TGG AAAAAA CA A AA CTTA G TAG G A ACAAAAGGTGGG C CAAGAGGCGC C A AGAGGGGCGCACA A G GGCC A ACAAAA A G GCGCAAAGG C CACAAAAGAGGGG G AC AAAGAGGGC  AGAGGGGCGCTATTGCTGGCACACTCTC TAT GCGCTCTCTCACA  AT CTCTCTG AAATGCG T AAT CCAGAGGATTG C CACTTAGGGGACAC AGG GGGAGAAAA A GCTTGAAAAGAG G G GAAAGAGTGT T AC CAATAGTGTGAAAG A AGAGTTT TATT G GTGTGTGTGTATA A T TGTGTGTATAT,ACACAAAAATAC CACAATTCAAAAATAT T AA ATACAAAAATATAA A AAATAT AAC C A AA ATTACACACA  ATTACACA ACAA A T TATACACACAACAGT A ACCAAAATATCCGAC C CACAA GCTCCCC GGA AACAGATCTCCCCACA G G ATTCCCACAC C T TCTCCCCACACCG G C CCCCACACACGCGAGA A C CA ATACGTTGGAGAG G AA AAAA ACGAGAGAAAAA C CGCGAGAGGCTGGCTATA G GAGAGAGAGAAAAAAA GCA AGAGAGAAAAAAATAT T GAGGAAAAAT TC ACA A AAAAAAATATATAGAG G ATT AATATATAGAGAGA A A ATATATAGCGCGAAAA A T TATAGAGAGAAAAAAA A AAGAGAAAAAAAAAA A G GAGAAAAAT AGAAAA  AAAAAAAAAAAGA AA A ACCTAAGAAAAAAAACAC C A AAAAAAAAAACA A AAAAATATACAAA  GGG AAACACAAATAGAGA CAGACACAGAAAGATT C CACAGAGAGATATGG AATTAGAGATTA GC C G GAGATATGTGCGCCCC C A ATATGGCCCCACA A TAC TGCGCCCCACAAAA  CTCCACAAAATAT T C CCCCACAAAATATATA A C CAAAAAATTAT CTT A AAAATATATATATTTT  CAGGATATATTTTGTG G TA GAA ATTTTGTGAGA A A ATATTTTGTGAGATAT T T TTCGATGAGATTG  CA TGTGAGATATGTGCGT C G GAGATATGTGCGCA AA ATT ATGCGCACATAT T T TGTGCGG AGGATTTT T G AAGCACATTTATTGATAG C CAAAAATTTTGTGGGG  ATATTTTGTGGGGCGC C T TTTTGTGGGGCA T TGTGGGGCGCACAAAA A G GGGAAGCACAAAG AA A G GCGCACAAAAAAAGAG TCACAAAAAAAGAGTGT T A AA AAAAGAGTTT T A AAAGTGTTTTTTT T A AGAGTGTTTTTTTATA GGA GTGTTTTTTTATATAT T TTTTTTAAACTAAACCT T TTTTATATATTTTGTG G T TATATACGTGCCACATTTGCGCCCC C T TTTTGTGCACGCCGG T TGGCCCCGCGAGA TAAAAC GGCCGCGA GCAT T C CCCCGTC GATATGTG G C CGCGAGATATGTGCGC  GAGATATGTGCGCACA A A ATATGTGCA ACATAT T T TGTGCGCA GCGGAT GATCGCACATATTTA A CCATATTTTATCAAT T A ATATTTTATATATCTC C T TTTTATATCA A TTATATCAC G A ATAGGGG G TATATCAGGAGA A C CATT GAAAA  AGAGGGGAT AAAAA GTA GGAGAAAAA ACAA  GAGAAAAAAAAAAAAA A A AAAGACA AAAAACAC C A AAAAAAACACACA A A AAAAAAACACACACAC  AAAAC TTAAAACCCC C ATA  CACACACCCCTT CA CCACACC GGCTTA AAA  ACACCCCTCTTTTTTT T C CCCCTCTTTTTAAAACGATGCTTTTCTCCC TTTTTTCTCCCCTAAAT T TTTTCCCTCTTTT T T TCTCCCCTCTTTTATA  TA CCCCTCTTTTATATAT T C CTCTTTTATATATGTG G T TATTATATATGTGCGC C T TATATATGTGCCT T A ATATGTGCGCTCTGTG G TA ATGCCTGGG G G GCGCTCTGTGGGGAGA GAA CTTGG ATGAAAA A T TGTGGCCTGAAG TAA  GGGGAGAACT AATAT T G GAAAAATTTT  CT AAAAAAATATTTA  AA AAGTGATTTTAGCCAC C ATG ATTATTCT ACCCC CAG TTTTATACACCCCACA A T TATACACCCCACACAG C ACAAACCCCACACACCCC C C CCCCACACACCCCTCT T CAAAACC AACTAATGA A ACAGGCCTCTAAAA TGC C CCCCTCTATACTTGCG G C CTCTATACA CTACACGCGCGCTCT AAACGAAGAGCTCTA GGA C CGCGCGCTCTATAAA AA G GCGCTCTATAAAAAAA A C GCTCAATTAAAAAAAA A T TAA GAAACAACATAC C A AAAATAAAAACACACA  TGGATAAAA CACACAGAG G A AAAACACACAG CAGG G A ACACAC TGGCGC C C CAAGGGGCGCACATA A AGAGGGGCGCAAGGAATA GGGAGGCGCAAAGAG G G GCGCACAAAAGAGGGCAG CTT CAAAAGAGGGGCC A AAAAGGGCGCTTACT A AGAGGGGCGCTCTCC GTACGGCGCTTCACA A G GCAGAACACAGAG G CAT CTCTCACAGCATGG G T TCTATCAGGGAGA  CACAGAGGAAAAA AA  AGAGGC AGAAAG AAAA GGAAAAAAGTGT T G GAGAAAAGAGTGTGTG G A AAAAGAGTAATT A AGAGTGTGGTATA A G GTGTGTGTTAT,ACACAAAAAAAAAATTCAT C CATGCAAAAAAAATATACACTGC AAAAAAAAAATATATGCAC C AAAAAATATATACACAATCA A AAAAAATATACACACAAAA  ATATATACCAAAATTCA TATACACACAAAATGCATC C AACACAAAAT GACC C C CACAAAATATCTCCCCACA A A AAAATTCCCCACACAGGC A ATATCTCCCCAGTTCA CG A T TC AAACGAGTGA A C CCCCACACACGCGAAG  CACACACGCGAGAGAGAGA A A ACACGCGAGAGAGAGAAAA A C CG GGGAGTATAAAAA A GTCCGAGAGAGAAAAAAATAT T A AGAGAATAAAAAATTA A GGAAAAAAAATAGAG G A AAAATATATAGAGAGA A A AACCTATATAGAGAGAATTAA A ATATAGATAGAGAAAATAA G T TAGAATACA AAA GAA AGAGAGAAAAAAAAAAAGCT GAGAAAAAAAAGCTAAAAA A A AAAAAAAAAAAAAAAACAC C A AAAAAAAAAAAAACACAA A AAAAAAAATGTACAG AATTAAAAACACACAGAGAAAACGA GTAACACACAGAGAGATAT T ATACACACAGAGAGATATGAC G CAA CAGCCTGATTGCG GTTAAGAGATTGCGCCCC ATCA TGATATGTGCGCCCCACA A A ATG ATGCGCCCAAAA A T TGGCCCCACAAAATAT TTTGCCCCAAATATATA A C CCCCACAAGAATATAT T C CATATATATATATTTT  AAAATATAATTTTGTTGG A ATATAAGAATTTTGT CGA A TTATATGTTGTGAGATAT T A ATATTCCATGAGATATGT AG T TTTGAGATATGT TGC TGC TGTGATAGTAGA AATCCA A G GAGATATGTGCGCACATAT T A ATATGTGCGCACATATTG CA T TG ACGCACATATTTG TG GC  GCGCACCTATTTTGTGGGG G C CACATATTTTGTGGGC C A ATATTTTGTGGGGCGCACA A T TTTTGTGGGGCGCAA TAA TGGGGCGCACAAAAAAA A GCTCAGTCCTCAAAAAA AAG G GGATGCACAAAAAAGTGT T C CACAAAAAAAGAGTGTTTT T A AAGATAAGAGTGTTTTTTT TAA AAAAGCGACACTTTTTATA  AGTTTTTATATT GA GGTTTTT AGTATATTTT T T TTTTTTTAATTTTGTG G TTTATATAGGTTGTGC AAC T TATATATTTTGTGCGCCCC GAT ATCTATGCGCCCCGCG G T TTTTGATCGCCCGAA AT TTCCTGCGCCCCGCGA GCAT TGA GCGCCCCGCGAC AATGTG T T CCCGAC AATGTGCGC  GG CGCGAGATATGGCACA A G GAGCTATGCAGGCACATAT T ACTAATGTGCGCACATATTTT TGCTGCGCAATTTTATA CTG GCGCAACC GGTTATATAT T C CACATAAAATCC A ATATTTTATATATGATCCTAA T TTTATTGCTCACAGAG G T TATATTCACAGAGGGG G A ATCA TCACAGTT GA  GA TCAT A AAGGGGAGAAAA  CACAGCAAA AAGGGAAAAAAA A GATTGGAGAAAAAAAAAAAAA A GGAAAAAAAAAAAAC C A AAAAAAAAAAAAACACAAAA AAATTAAAAACCACAC C AAAAAACACACACACCTCA AAAACGTGCACCCTCT T A ACACACACACCCCTCTTTT T C CAACCCTTTTTTT T A ACACCCCTTTTTGGTC C C CCCCTCTTTTTTTCTCCCC C C CTCTTTTTGGATCCCCTCT T T TT GCTTCTCCCTTAGGT T TTTTCTCCCATCTTTTAA T TC TGG CTTATATAT T C CCCCTCTTTTACAAATGTG G C CTAA TATATGGC C TC ATTATATATGTGCGCTCT T T TATATATCTGCGCTA GTG ATGTGCAAACTGGG G TTGCGCTCTGTGGGGAGA A G GCGCTAA GGAA AAA  CTCTGTGGTA GAAAAAA T TGTGGGGAAAAAATAT T GA AGGAGAACTCAATATTTT T G GAGAAAAAAATATTTTAA A AAAAAAATATTTTATACAC C A AAAATATTAACTACACCCC  TT ATATTTTATACACCCA A T TTTTAAAAACCCCACACAC C T TATACCCACACCATCC C A ACACCTTGGGAACCCCTCT T G CCCCACAC ATCGCCTATA A C CACACACCAGAATTTACTG C A ACCCTTACCA G C CCCCTACCTACGC C C CTCTATAC TACGCGCTCT T TACGTACACG GG TGCTAA A ACACGCGCGCTCTAT AAA A C CGCGCGATAAAAAAAA GCTTAAATAAAAAA A C CTCTATAAAAAAAATTAAC C T TATAAAAAGA AACACACA GA  AACA AAAAAC ATCAGAG G A AAAAAAACACAGC ATTGG G A AAAACACAAGGGGCCAGC A ACACACAGAGGGGCGCACA A CCAGAGGGCACAACTGA A AGAGGGGCGCACAAAAGAG G G GGAGTGCATTCAAGAGGCACG G GCGCAAAGAGGGGCGC C C CACAAAAGAGGACCGCTCT T A AAGCTAAATC C A AGAGGGGCGCTCTCAAACA A GC CGGCGCTCTCTCACAGAG G G GCGCTAATAGGGG TT  CTCTCCTTCAGAGGGGAA T TCTCACAGAGGGGAGAAAA A C CACAGAGGGGAGAAAAGAG G A AGAC GGAGAAAAGAGTGT T G GGGGAAAGAGTGTG GAGAAAAGAGTGTGTGTGT T AGG AAGGGCTGTTA GAA AGGAAACAAACGTATAT,"ID   CSY3_PSEAB              Reviewed;         342 AA.
AC   Q02MM1;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 1.
DT   27-NOV-2024, entry version 83.
DE   RecName: Full=CRISPR-associated protein Csy3;
GN   Name=csy3; Synonyms=csy1-3; OrderedLocusNames=PA14_33310;
OS   Pseudomonas aeruginosa (strain UCBPP-PA14).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208963;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UCBPP-PA14;
RX   PubMed=17038190; DOI=10.1186/gb-2006-7-10-r90;
RA   Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S.,
RA   Diggins L.T., He J., Saucier M., Deziel E., Friedman L., Li L., Grills G.,
RA   Montgomery K., Kucherlapati R., Rahme L.G., Ausubel F.M.;
RT   ""Genomic analysis reveals that Pseudomonas aeruginosa virulence is
RT   combinatorial."";
RL   Genome Biol. 7:R90.1-R90.14(2006).
RN   [2]
RP   FUNCTION IN INHIBITION OF BIOFILM FORMATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=UCBPP-PA14;
RX   PubMed=21398535; DOI=10.1128/jb.01411-10;
RA   Cady K.C., O'Toole G.A.;
RT   ""Non-identity-mediated CRISPR-bacteriophage interaction mediated via the
RT   Csy and Cas3 proteins."";
RL   J. Bacteriol. 193:3433-3445(2011).
RN   [3]
RP   NO ROLE IN PHAGE PROTECTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=UCBPP-PA14;
RX   PubMed=21081758; DOI=10.1099/mic.0.045732-0;
RA   Cady K.C., White A.S., Hammond J.H., Abendroth M.D., Karthikeyan R.S.,
RA   Lalitha P., Zegans M.E., O'Toole G.A.;
RT   ""Prevalence, conservation and functional analysis of Yersinia and
RT   Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates."";
RL   Microbiology 157:430-437(2011).
RN   [4]
RP   SUBUNIT, AND MASS SPECTROMETRY.
RC   STRAIN=UCBPP-PA14;
RX   PubMed=21536913; DOI=10.1073/pnas.1102716108;
RA   Wiedenheft B., van Duijn E., Bultema J.B., Waghmare S.P., Zhou K.,
RA   Barendregt A., Westphal W., Heck A.J., Boekema E.J., Dickman M.J.,
RA   Doudna J.A.;
RT   ""RNA-guided complex from a bacterial immune system enhances target
RT   recognition through seed sequence interactions."";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:10092-10097(2011).
RN   [5]
RP   FUNCTION IN CRRNA FORMATION, AND SUBUNIT.
RC   STRAIN=UCBPP-PA14;
RX   PubMed=22522703; DOI=10.1038/emboj.2012.107;
RA   Haurwitz R.E., Sternberg S.H., Doudna J.A.;
RT   ""Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR
RT   RNA."";
RL   EMBO J. 31:2824-2832(2012).
CC   -!- FUNCTION: CRISPR (clustered regularly interspaced short palindromic
CC       repeat) is an adaptive immune system that provides protection against
CC       mobile genetic elements (viruses, transposable elements and conjugative
CC       plasmids). CRISPR clusters contain sequences complementary to
CC       antecedent mobile elements and target invading nucleic acids. CRISPR
CC       clusters are transcribed and processed into CRISPR RNA (crRNA). Cas3
CC       and Cascade participate in CRISPR interference, the third stage of
CC       CRISPR immunity (Potential). Involved in crRNA production or stability.
CC       The Csy ribonucleoprotein complex binds target ssDNA with high affinity
CC       but target dsDNA with much lower affinity.
CC       {ECO:0000269|PubMed:21398535, ECO:0000269|PubMed:22522703,
CC       ECO:0000305}.
CC   -!- SUBUNIT: Part of the Csy ribonucleoprotein complex with a probable
CC       stoichiometry of Csy1(1),Csy2(1),Csy3(6),Cas6/Csy4(1)-crRNA(1). A
CC       Csy3(6),Cas6/Csy4(1)-crRNA(1) subcomplex is also formed.
CC       {ECO:0000269|PubMed:21536913, ECO:0000269|PubMed:22522703}.
CC   -!- INTERACTION:
CC       Q02MM1; Q02MM2: cas6f; NbExp=12; IntAct=EBI-15924841, EBI-15924852;
CC   -!- MASS SPECTROMETRY: Mass=37401; Mass_error=1.2; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:21536913};
CC   -!- DISRUPTION PHENOTYPE: Mutants lose phage DMS3 infection-dependent
CC       inhibition of biofilm formation while there is normal biofilm formation
CC       in the absence of phage infection. Decreased production of crRNA in the
CC       presence or absence of phage. Disruption of the entire Y.pestis-subtype
CC       CRISPR region disrupts crRNA production but does not alter phage
CC       resistance (possibly OLNs PA14_33350 to PA14_33310, and the flanking
CC       CRISPR loci), indicating this CRISPR is not involved in phage
CC       resistance. {ECO:0000269|PubMed:21081758, ECO:0000269|PubMed:21398535}.
CC   -!- MISCELLANEOUS: In this bacteria, Y.pestis-subtype CRISPRs do not confer
CC       resistance to phage DMS3 or MP22, but instead are required for DMS3
CC       infection-dependent inhibition of biofilm formation and possibly
CC       motility.
CC   -!- SIMILARITY: Belongs to the CRISPR-associated Csy3 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000438; ABJ11604.1; -; Genomic_DNA.
DR   RefSeq; WP_003139222.1; NZ_CP034244.1.
DR   PDB; 5UZ9; EM; 3.40 A; C/D/E/F/G/H=2-342.
DR   PDB; 5XLO; EM; 3.80 A; A/B/C/D/E/F=1-342.
DR   PDB; 5XLP; EM; 4.20 A; C/D/E/F=1-342.
DR   PDB; 6B44; EM; 2.90 A; C/D/E/F/G/H=1-342.
DR   PDB; 6B45; EM; 3.50 A; C/D/E/F/G/H=1-342.
DR   PDB; 6B46; EM; 3.10 A; C/D/E/F/G/H=1-342.
DR   PDB; 6B47; EM; 3.20 A; C/D/E/F/G/H=1-342.
DR   PDB; 6B48; EM; 3.60 A; C/D/E/F/G/H=1-342.
DR   PDB; 6NE0; EM; 3.40 A; C/D/E/F/G/H=1-342.
DR   PDB; 6VQV; EM; 2.57 A; E/F/G/H/I/J=2-342.
DR   PDB; 6VQW; EM; 3.42 A; D/E/F/G/H/I=2-342.
DR   PDB; 6VQX; EM; 3.15 A; D/E/F/G/H/I=2-342.
DR   PDB; 6W1X; EM; 3.90 A; C/D/E/F/G/H=2-342.
DR   PDB; 6WHI; EM; 4.20 A; C/D/E/F/G/H=2-342.
DR   PDB; 7ECV; EM; 3.43 A; C/D/E/F/G/H=1-342.
DR   PDB; 7ECW; EM; 3.10 A; C/D/E/F/G/H=1-342.
DR   PDB; 7ELM; EM; 2.88 A; C/D/E/F/G/H/M/N/O/P/Q/R=1-342.
DR   PDB; 7ELN; EM; 3.00 A; C/D/E/F/G/H/M/N/O/P/Q/R=1-342.
DR   PDB; 7EQG; EM; 3.20 A; D/E/F/G/H/I=1-342.
DR   PDB; 7JZW; EM; 3.20 A; D/E/F/G/H/I=1-342.
DR   PDB; 7JZX; EM; 3.40 A; D/E/F/G/H/I=1-342.
DR   PDB; 7JZY; EM; 3.60 A; D/E/F/G/H/I=1-342.
DR   PDB; 7JZZ; EM; 3.20 A; D/E/F/G/H/I=1-342.
DR   PDB; 7T3J; EM; 3.20 A; D/E/F/G/H/I=2-342.
DR   PDB; 7T3K; EM; 3.50 A; D/E/F/G/H/I/d/e/f/g/h/i=2-342.
DR   PDB; 7T3L; EM; 3.60 A; D/E/F/G/H/I/d/e/f/g/h/i=2-342.
DR   PDB; 7TAW; EM; 2.70 A; D/E/F/G/H/I/d/e/f/g/h/i=2-342.
DR   PDB; 7TAX; EM; 2.80 A; D/E/F/G/H/I=2-342.
DR   PDB; 7WE6; EM; 3.20 A; C/D/E/F/G/H/M/N/O/P/Q/R=1-342.
DR   PDB; 8JDI; X-ray; 3.37 A; A/B/C/D=1-342.
DR   PDBsum; 5UZ9; -.
DR   PDBsum; 5XLO; -.
DR   PDBsum; 5XLP; -.
DR   PDBsum; 6B44; -.
DR   PDBsum; 6B45; -.
DR   PDBsum; 6B46; -.
DR   PDBsum; 6B47; -.
DR   PDBsum; 6B48; -.
DR   PDBsum; 6NE0; -.
DR   PDBsum; 6VQV; -.
DR   PDBsum; 6VQW; -.
DR   PDBsum; 6VQX; -.
DR   PDBsum; 6W1X; -.
DR   PDBsum; 6WHI; -.
DR   PDBsum; 7ECV; -.
DR   PDBsum; 7ECW; -.
DR   PDBsum; 7ELM; -.
DR   PDBsum; 7ELN; -.
DR   PDBsum; 7EQG; -.
DR   PDBsum; 7JZW; -.
DR   PDBsum; 7JZX; -.
DR   PDBsum; 7JZY; -.
DR   PDBsum; 7JZZ; -.
DR   PDBsum; 7T3J; -.
DR   PDBsum; 7T3K; -.
DR   PDBsum; 7T3L; -.
DR   PDBsum; 7TAW; -.
DR   PDBsum; 7TAX; -.
DR   PDBsum; 7WE6; -.
DR   PDBsum; 8JDI; -.
DR   AlphaFoldDB; Q02MM1; -.
DR   EMDB; EMD-21517; -.
DR   EMDB; EMD-6729; -.
DR   EMDB; EMD-6731; -.
DR   EMDB; EMD-7048; -.
DR   EMDB; EMD-7049; -.
DR   EMDB; EMD-7050; -.
DR   EMDB; EMD-7051; -.
DR   EMDB; EMD-7052; -.
DR   EMDB; EMD-8624; -.
DR   EMDB; EMD-9191; -.
DR   SMR; Q02MM1; -.
DR   DIP; DIP-59680N; -.
DR   IntAct; Q02MM1; 5.
DR   KEGG; pau:PA14_33310; -.
DR   PseudoCAP; PA14_33310; -.
DR   HOGENOM; CLU_063672_0_0_6; -.
DR   BioCyc; PAER208963:G1G74-2803-MONOMER; -.
DR   Proteomes; UP000000653; Chromosome.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   CDD; cd09737; Csy3_I-F; 1.
DR   InterPro; IPR013399; CRISPR-assoc_prot_Csy3.
DR   NCBIfam; TIGR02566; cas_Csy3; 1.
DR   Pfam; PF09615; Cas_Csy3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense.
FT   CHAIN           1..342
FT                   /note=""CRISPR-associated protein Csy3""
FT                   /id=""PRO_0000417878""
FT   STRAND          12..14
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   STRAND          17..20
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          23..28
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   HELIX           33..35
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   HELIX           36..38
FT                   /evidence=""ECO:0007829|PDB:6B47""
FT   STRAND          45..50
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          59..61
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   HELIX           64..70
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          71..73
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          76..81
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          86..88
FT                   /evidence=""ECO:0007829|PDB:7ECW""
FT   STRAND          90..99
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          107..110
FT                   /evidence=""ECO:0007829|PDB:7ELM""
FT   HELIX           112..128
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          129..131
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   HELIX           132..143
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   TURN            144..147
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          148..152
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          158..173
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          176..178
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          183..185
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   HELIX           193..204
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          209..217
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          234..236
FT                   /evidence=""ECO:0007829|PDB:7ELM""
FT   STRAND          238..240
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   STRAND          244..246
FT                   /evidence=""ECO:0007829|PDB:7T3J""
FT   STRAND          248..255
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   HELIX           257..260
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   HELIX           261..263
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          265..268
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          271..273
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          275..277
FT                   /evidence=""ECO:0007829|PDB:6B44""
FT   HELIX           284..286
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   TURN            289..291
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          293..296
FT                   /evidence=""ECO:0007829|PDB:7TAW""
FT   STRAND          298..301
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   HELIX           304..312
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   TURN            320..322
FT                   /evidence=""ECO:0007829|PDB:6B44""
FT   HELIX           324..332
FT                   /evidence=""ECO:0007829|PDB:6VQV""
FT   STRAND          334..336
FT                   /evidence=""ECO:0007829|PDB:7TAW""
SQ   SEQUENCE   342 AA;  37530 MW;  D0C8687209C35F91 CRC64;
     MSKPILSTAS VLAFERKLDP SDALMSAGAW AQRDASQEWP AVTVREKSVR GTISNRLKTK
     DRDPAKLDAS IQSPNLQTVD VANLPSDADT LKVRFTLRVL GGAGTPSACN DAAYRDKLLQ
     TVATYVNDQG FAELARRYAH NLANARFLWR NRVGAEAVEV RINHIRQGEV ARAWRFDALA
     IGLRDFKADA ELDALAELIA SGLSGSGHVL LEVVAFARIG DGQEVFPSQE LILDKGDKKG
     QKSKTLYSVR DAAAIHSQKI GNALRTIDTW YPDEDGLGPI AVEPYGSVTS QGKAYRQPKQ
     KLDFYTLLDN WVLRDEAPAV EQQHYVIANL IRGGVFGEAE EK
//
",25838
TCGCGA CGCGAC GCGACC CGACCA GACCAA ACCAAC CCAACC CAACCC AACCCC ACCCCG CCCCGA CCCGAC CCGACC CGACCA GACCAA ACCAAC CCAACT CAACTG AACTGG ACTGGG CTGGGA TGGGAT GGGATT GGATTG GATTGG ATTGGC TTGGCG TGGCGC GGCGCA GCGCAA CGCAAT GCAATT CAATTC AATTCA ATTCAC TTCACC TCACCG CACCGT ACCGTC CCGTCC CGTCCT GTCCTA TCCTAT CCTATC CTATCC TATCCG ATCCGG TCCGGT CCGGTC CGGTCA GGTCAA GTCAAT TCAATC CAATCC AATCCA ATCCAG TCCAGC CCAGCG CAGCGC AGCGCC GCGCCC CGCCCG GCCCGC CCCGCG CCGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCA TCGCAG CGCAGG GCAGGC CAGGCT AGGCTC GGCTCG GCTCGG CTCGGT TCGGTT CGGTTG GGTTGC GTTGCG TTGCGA TGCGAC GCGACC CGACCG GACCGC ACCGCG CCGCGC CGCGCT GCGCTT CGCTTG GCTTGC CTTGCC TTGCCG TGCCGA GCCGAA CCGAAG CGAAGG GAAGGC AAGGCG AGGCGG GGCGGC GCGGCT CGGCTT GGCTTG GCTTGG CTTGGC TTGGCC TGGCCG GGCCGG GCCGGC CCGGCT CGGCTT GGCTTC GCTTCG CTTCGA TTCGAT TCGATG CGATGT GATGTC ATGTCG TGTCGG GTCGGC TCGGCG CGGCGC GGCGCG GCGCGC CGCGCC GCGCCG CGCCGA GCCGAC CCGACC CGACCG GACCGC ACCGCC CCGCCG CGCCGA GCCGAC CCGACG CGACGT GACGTG ACGTGC CGTGCG GTGCGC,3,145,TCGC CGCG GCGA CGAC GACC ACCA CCAA CAAC AACC ACCC CCCC CCCG CCGA CGAC GACC ACCA CCAA CAAC AACT ACTG CTGG TGGG GGGA GGAT GATT ATTG TTGG TGGC GGCG GCGC CGCA GCAA CAAT AATT ATTC TTCA TCAC CACC ACCG CCGT CGTC GTCC TCCT CCTA CTAT TATC ATCC TCCG CCGG CGGT GGTC GTCA TCAA CAAT AATC ATCC TCCA CCAG CAGC AGCG GCGC CGCC GCCC CCCG CCGC CGCG GCGT CGTT GTTC TTCG TCGC CGCA GCAG CAGG AGGC GGCT GCTC CTCG TCGG CGGT GGTT GTTG TTGC TGCG GCGA CGAC GACC ACCG CCGC CGCG GCGC CGCT GCTT CTTG TTGC TGCC GCCG CCGA CGAA GAAG AAGG AGGC GGCG GCGG CGGC GGCT GCTT CTTG TTGG TGGC GGCC GCCG CCGG CGGC GGCT GCTT CTTC TTCG TCGA CGAT GATG ATGT TGTC GTCG TCGG CGGC GGCG GCGC CGCG GCGC CGCC GCCG CCGA CGAC GACC ACCG CCGC CGCC GCCG CCGA CGAC GACG ACGT CGTG GTGC TGCG GCGC,TCGCG CGCGA GCGAC CGACC GACCA ACCAA CCAAC CAACC AACCC ACCCC CCCCG CCCGA CCGAC CGACC GACCA ACCAA CCAAC CAACT AACTG ACTGG CTGGG TGGGA GGGAT GGATT GATTG ATTGG TTGGC TGGCG GGCGC GCGCA CGCAA GCAAT CAATT AATTC ATTCA TTCAC TCACC CACCG ACCGT CCGTC CGTCC GTCCT TCCTA CCTAT CTATC TATCC ATCCG TCCGG CCGGT CGGTC GGTCA GTCAA TCAAT CAATC AATCC ATCCA TCCAG CCAGC CAGCG AGCGC GCGCC CGCCC GCCCG CCCGC CCGCG CGCGT GCGTT CGTTC GTTCG TTCGC TCGCA CGCAG GCAGG CAGGC AGGCT GGCTC GCTCG CTCGG TCGGT CGGTT GGTTG GTTGC TTGCG TGCGA GCGAC CGACC GACCG ACCGC CCGCG CGCGC GCGCT CGCTT GCTTG CTTGC TTGCC TGCCG GCCGA CCGAA CGAAG GAAGG AAGGC AGGCG GGCGG GCGGC CGGCT GGCTT GCTTG CTTGG TTGGC TGGCC GGCCG GCCGG CCGGC CGGCT GGCTT GCTTC CTTCG TTCGA TCGAT CGATG GATGT ATGTC TGTCG GTCGG TCGGC CGGCG GGCGC GCGCG CGCGC GCGCC CGCCG GCCGA CCGAC CGACC GACCG ACCGC CCGCC CGCCG GCCGA CCGAC CGACG GACGT ACGTG CGTGC GTGCG TGCGC,TCGCGA CGCGAC GCGACC CGACCA GACCAA ACCAAC CCAACC CAACCC AACCCC ACCCCG CCCCGA CCCGAC CCGACC CGACCA GACCAA ACCAAC CCAACT CAACTG AACTGG ACTGGG CTGGGA TGGGAT GGGATT GGATTG GATTGG ATTGGC TTGGCG TGGCGC GGCGCA GCGCAA CGCAAT GCAATT CAATTC AATTCA ATTCAC TTCACC TCACCG CACCGT ACCGTC CCGTCC CGTCCT GTCCTA TCCTAT CCTATC CTATCC TATCCG ATCCGG TCCGGT CCGGTC CGGTCA GGTCAA GTCAAT TCAATC CAATCC AATCCA ATCCAG TCCAGC CCAGCG CAGCGC AGCGCC GCGCCC CGCCCG GCCCGC CCCGCG CCGCGT CGCGTT GCGTTC CGTTCG GTTCGC TTCGCA TCGCAG CGCAGG GCAGGC CAGGCT AGGCTC GGCTCG GCTCGG CTCGGT TCGGTT CGGTTG GGTTGC GTTGCG TTGCGA TGCGAC GCGACC CGACCG GACCGC ACCGCG CCGCGC CGCGCT GCGCTT CGCTTG GCTTGC CTTGCC TTGCCG TGCCGA GCCGAA CCGAAG CGAAGG GAAGGC AAGGCG AGGCGG GGCGGC GCGGCT CGGCTT GGCTTG GCTTGG CTTGGC TTGGCC TGGCCG GGCCGG GCCGGC CCGGCT CGGCTT GGCTTC GCTTCG CTTCGA TTCGAT TCGATG CGATGT GATGTC ATGTCG TGTCGG GTCGGC TCGGCG CGGCGC GGCGCG GCGCGC CGCGCC GCGCCG CGCCGA GCCGAC CCGACC CGACCG GACCGC ACCGCC CCGCCG CGCCGA GCCGAC CCGACG CGACGT GACGTG ACGTGC CGTGCG GTGCGC,TCGCGAC CGCGACC GCGACCA CGACCAA GACCAAC ACCAACC CCAACCC CAACCCC AACCCCG ACCCCGA CCCCGAC CCCGACC CCGACCA CGACCAA GACCAAC ACCAACT CCAACTG CAACTGG AACTGGG ACTGGGA CTGGGAT TGGGATT GGGATTG GGATTGG GATTGGC ATTGGCG TTGGCGC TGGCGCA GGCGCAA GCGCAAT CGCAATT GCAATTC CAATTCA AATTCAC ATTCACC TTCACCG TCACCGT CACCGTC ACCGTCC CCGTCCT CGTCCTA GTCCTAT TCCTATC CCTATCC CTATCCG TATCCGG ATCCGGT TCCGGTC CCGGTCA CGGTCAA GGTCAAT GTCAATC TCAATCC CAATCCA AATCCAG ATCCAGC TCCAGCG CCAGCGC CAGCGCC AGCGCCC GCGCCCG CGCCCGC GCCCGCG CCCGCGT CCGCGTT CGCGTTC GCGTTCG CGTTCGC GTTCGCA TTCGCAG TCGCAGG CGCAGGC GCAGGCT CAGGCTC AGGCTCG GGCTCGG GCTCGGT CTCGGTT TCGGTTG CGGTTGC GGTTGCG GTTGCGA TTGCGAC TGCGACC GCGACCG CGACCGC GACCGCG ACCGCGC CCGCGCT CGCGCTT GCGCTTG CGCTTGC GCTTGCC CTTGCCG TTGCCGA TGCCGAA GCCGAAG CCGAAGG CGAAGGC GAAGGCG AAGGCGG AGGCGGC GGCGGCT GCGGCTT CGGCTTG GGCTTGG GCTTGGC CTTGGCC TTGGCCG TGGCCGG GGCCGGC GCCGGCT CCGGCTT CGGCTTC GGCTTCG GCTTCGA CTTCGAT TTCGATG TCGATGT CGATGTC GATGTCG ATGTCGG TGTCGGC GTCGGCG TCGGCGC CGGCGCG GGCGCGC GCGCGCC CGCGCCG GCGCCGA CGCCGAC GCCGACC CCGACCG CGACCGC GACCGCC ACCGCCG CCGCCGA CGCCGAC GCCGACG CCGACGT CGACGTG GACGTGC ACGTGCG CGTGCGC,"ID   MUTL_AFIC5              Reviewed;         612 AA.
AC   B6JIV1; F8BZU0;
DT   24-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 1.
DT   27-NOV-2024, entry version 86.
DE   RecName: Full=DNA mismatch repair protein MutL {ECO:0000255|HAMAP-Rule:MF_00149};
GN   Name=mutL {ECO:0000255|HAMAP-Rule:MF_00149};
GN   OrderedLocusNames=OCAR_7241, OCA5_c08730;
OS   Afipia carboxidovorans (strain ATCC 49405 / DSM 1227 / KCTC 32145 / OM5)
OS   (Oligotropha carboxidovorans).
OC   Bacteria; Pseudomonadota; Alphaproteobacteria; Hyphomicrobiales;
OC   Nitrobacteraceae; Afipia.
OX   NCBI_TaxID=504832;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 49405 / DSM 1227 / KCTC 32145 / OM5;
RX   PubMed=18539730; DOI=10.1128/jb.00614-08;
RA   Paul D., Bridges S., Burgess S.C., Dandass Y., Lawrence M.L.;
RT   ""Genome sequence of the chemolithoautotrophic bacterium Oligotropha
RT   carboxidovorans OM5T."";
RL   J. Bacteriol. 190:5531-5532(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 49405 / DSM 1227 / KCTC 32145 / OM5;
RX   PubMed=21742883; DOI=10.1128/jb.05619-11;
RA   Volland S., Rachinger M., Strittmatter A., Daniel R., Gottschalk G.,
RA   Meyer O.;
RT   ""Complete genome sequences of the chemolithoautotrophic Oligotropha
RT   carboxidovorans strains OM4 and OM5."";
RL   J. Bacteriol. 193:5043-5043(2011).
CC   -!- FUNCTION: This protein is involved in the repair of mismatches in DNA.
CC       It is required for dam-dependent methyl-directed DNA mismatch repair.
CC       May act as a 'molecular matchmaker', a protein that promotes the
CC       formation of a stable complex between two or more DNA-binding proteins
CC       in an ATP-dependent manner without itself being part of a final
CC       effector complex. {ECO:0000255|HAMAP-Rule:MF_00149}.
CC   -!- SIMILARITY: Belongs to the DNA mismatch repair MutL/HexB family.
CC       {ECO:0000255|HAMAP-Rule:MF_00149}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001196; ACI94345.1; -; Genomic_DNA.
DR   EMBL; CP002826; AEI05595.1; -; Genomic_DNA.
DR   RefSeq; WP_012564371.1; NC_015684.1.
DR   AlphaFoldDB; B6JIV1; -.
DR   SMR; B6JIV1; -.
DR   STRING; 504832.OCA5_c08730; -.
DR   KEGG; oca:OCAR_7241; -.
DR   KEGG; ocg:OCA5_c08730; -.
DR   PATRIC; fig|504832.7.peg.923; -.
DR   eggNOG; COG0323; Bacteria.
DR   HOGENOM; CLU_004131_4_2_5; -.
DR   OrthoDB; 9763467at2; -.
DR   Proteomes; UP000007730; Chromosome.
DR   GO; GO:0032300; C:mismatch repair complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140664; F:ATP-dependent DNA damage sensor activity; IEA:InterPro.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0006298; P:mismatch repair; IEA:UniProtKB-UniRule.
DR   CDD; cd16926; HATPase_MutL-MLH-PMS-like; 1.
DR   CDD; cd00782; MutL_Trans; 1.
DR   FunFam; 3.30.565.10:FF:000003; DNA mismatch repair endonuclease MutL; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1.
DR   Gene3D; 3.30.1540.20; MutL, C-terminal domain, dimerisation subdomain; 1.
DR   Gene3D; 3.30.1370.100; MutL, C-terminal domain, regulatory subdomain; 1.
DR   HAMAP; MF_00149; DNA_mis_repair; 1.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR020667; DNA_mismatch_repair_MutL.
DR   InterPro; IPR013507; DNA_mismatch_S5_2-like.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR002099; MutL/Mlh/PMS.
DR   InterPro; IPR038973; MutL/Mlh/Pms-like.
DR   InterPro; IPR014790; MutL_C.
DR   InterPro; IPR042120; MutL_C_dimsub.
DR   InterPro; IPR042121; MutL_C_regsub.
DR   InterPro; IPR037198; MutL_C_sf.
DR   InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF.
DR   InterPro; IPR014721; Ribsml_uS5_D2-typ_fold_subgr.
DR   NCBIfam; TIGR00585; mutl; 1.
DR   PANTHER; PTHR10073; DNA MISMATCH REPAIR PROTEIN MLH, PMS, MUTL; 1.
DR   PANTHER; PTHR10073:SF12; DNA MISMATCH REPAIR PROTEIN MLH1; 1.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF13589; HATPase_c_3; 1.
DR   Pfam; PF08676; MutL_C; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00853; MutL_C; 1.
DR   SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1.
DR   SUPFAM; SSF118116; DNA mismatch repair protein MutL; 1.
DR   SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
PE   3: Inferred from homology;
KW   DNA damage; DNA repair; Reference proteome.
FT   CHAIN           1..612
FT                   /note=""DNA mismatch repair protein MutL""
FT                   /id=""PRO_1000096668""
SQ   SEQUENCE   612 AA;  66004 MW;  12B324B87B7376C0 CRC64;
     MPVRQLPEQI VNRIAAGEVV ERPASAVKEL VENAIDAGGT RIDIFTEGGG RRRIVITDDG
     SGMTQGDLAL AVERHATSKL DDEDLLRIRT LGFRGEALPS ISSVAKLAIT TRHAAEPHAW
     AVEVDAGAKS AIAPAALQRG TRVEVSDLFY ATPARLKFLK TDRTEAEAIR EVVRRLAMAR
     PDIAFTLAGE ERAPVTWAAA LPGAPGRLTR LGDILGSDFR THAIEVGSER EGVSVEGFAA
     APSLTRANAL GQYLFVNGRP VRDKLILGAV RAAYADYLPR DRHPIVALFV TLDPQEVDAN
     VHPAKTEVRF RNAGLVRALI VHALKDGLAR EGRRTAANTN GAAITTAFRT EGFSREGFAR
     ESLPRGGYDW RSSPAAPWPP QAAAQAPAMG FDESAQAAFD AGAPSADTRG NEAPLGDALG
     RPLGAARTQI HENYIVAQTN DGLILVDQHA AHERIVYERL KASLTKNGVA RQMLLIPEIV
     EMDEASVEKL LARASELEKY GLSIESFGPG AVAVRETPAL LGKANAASLL RDLAEHMAEW
     DEALPLERRL MHVAATMACH GSVRSGRILK VEEMNALLRE MEATPNSGQC NHGRPTYVEL
     KLADIEKLFG RR
//
",54844
ATGCGC TGCGCC GCGCCC CGCCCG GCCCGC CCCGCC CCGCCC CGCCCT GCCCTA CCCTAC CCTACA CTACAT TACATC ACATCG CATCGC ATCGCG TCGCGC CGCGCA GCGCAG CGCAGG GCAGGT CAGGTG AGGTGG GGTGGG GTGGGC TGGGCC GGGCCT GGCCTG GCCTGT CCTGTT CTGTTT TGTTTG GTTTGG TTTGGC TTGGCA TGGCAG GGCAGC GCAGCC CAGCCC AGCCCC GCCCCA CCCCAC CCCACG CCACGC CACGCT ACGCTG CGCTGG GCTGGA CTGGAG TGGAGC GGAGCA GAGCAC AGCACA GCACAA CACAAC ACAACT CAACTT AACTTT ACTTTG CTTTGA TTTGAA TTGAAA TGAAAC GAAACG AAACGC AACGCT ACGCTT CGCTTT GCTTTA CTTTAC TTTACT TTACTG TACTGG ACTGGG CTGGGT TGGGTG GGGTGC GGTGCG GTGCGC TGCGCG GCGCGA CGCGAT GCGATA CGATAT GATATC ATATCG TATCGT ATCGTC TCGTCG CGTCGA GTCGAG TCGAGC CGAGCG GAGCGC AGCGCG GCGCGG CGCGGC GCGGCC CGGCCC GGCCCG GCCCGC CCCGCA CCGCAG CGCAGT GCAGTG CAGTGG AGTGGT GTGGTT TGGTTT GGTTTG GTTTGC TTTGCC TTGCCA TGCCAG GCCAGC CCAGCT CAGCTT AGCTTT GCTTTG CTTTGG TTTGGC TTGGCC TGGCCG GGCCGC,3,124,ATGC TGCG GCGC CGCC GCCC CCCG CCGC CGCC GCCC CCCT CCTA CTAC TACA ACAT CATC ATCG TCGC CGCG GCGC CGCA GCAG CAGG AGGT GGTG GTGG TGGG GGGC GGCC GCCT CCTG CTGT TGTT GTTT TTTG TTGG TGGC GGCA GCAG CAGC AGCC GCCC CCCC CCCA CCAC CACG ACGC CGCT GCTG CTGG TGGA GGAG GAGC AGCA GCAC CACA ACAA CAAC AACT ACTT CTTT TTTG TTGA TGAA GAAA AAAC AACG ACGC CGCT GCTT CTTT TTTA TTAC TACT ACTG CTGG TGGG GGGT GGTG GTGC TGCG GCGC CGCG GCGA CGAT GATA ATAT TATC ATCG TCGT CGTC GTCG TCGA CGAG GAGC AGCG GCGC CGCG GCGG CGGC GGCC GCCC CCCG CCGC CGCA GCAG CAGT AGTG GTGG TGGT GGTT GTTT TTTG TTGC TGCC GCCA CCAG CAGC AGCT GCTT CTTT TTTG TTGG TGGC GGCC GCCG CCGC,ATGCG TGCGC GCGCC CGCCC GCCCG CCCGC CCGCC CGCCC GCCCT CCCTA CCTAC CTACA TACAT ACATC CATCG ATCGC TCGCG CGCGC GCGCA CGCAG GCAGG CAGGT AGGTG GGTGG GTGGG TGGGC GGGCC GGCCT GCCTG CCTGT CTGTT TGTTT GTTTG TTTGG TTGGC TGGCA GGCAG GCAGC CAGCC AGCCC GCCCC CCCCA CCCAC CCACG CACGC ACGCT CGCTG GCTGG CTGGA TGGAG GGAGC GAGCA AGCAC GCACA CACAA ACAAC CAACT AACTT ACTTT CTTTG TTTGA TTGAA TGAAA GAAAC AAACG AACGC ACGCT CGCTT GCTTT CTTTA TTTAC TTACT TACTG ACTGG CTGGG TGGGT GGGTG GGTGC GTGCG TGCGC GCGCG CGCGA GCGAT CGATA GATAT ATATC TATCG ATCGT TCGTC CGTCG GTCGA TCGAG CGAGC GAGCG AGCGC GCGCG CGCGG GCGGC CGGCC GGCCC GCCCG CCCGC CCGCA CGCAG GCAGT CAGTG AGTGG GTGGT TGGTT GGTTT GTTTG TTTGC TTGCC TGCCA GCCAG CCAGC CAGCT AGCTT GCTTT CTTTG TTTGG TTGGC TGGCC GGCCG GCCGC,ATGCGC TGCGCC GCGCCC CGCCCG GCCCGC CCCGCC CCGCCC CGCCCT GCCCTA CCCTAC CCTACA CTACAT TACATC ACATCG CATCGC ATCGCG TCGCGC CGCGCA GCGCAG CGCAGG GCAGGT CAGGTG AGGTGG GGTGGG GTGGGC TGGGCC GGGCCT GGCCTG GCCTGT CCTGTT CTGTTT TGTTTG GTTTGG TTTGGC TTGGCA TGGCAG GGCAGC GCAGCC CAGCCC AGCCCC GCCCCA CCCCAC CCCACG CCACGC CACGCT ACGCTG CGCTGG GCTGGA CTGGAG TGGAGC GGAGCA GAGCAC AGCACA GCACAA CACAAC ACAACT CAACTT AACTTT ACTTTG CTTTGA TTTGAA TTGAAA TGAAAC GAAACG AAACGC AACGCT ACGCTT CGCTTT GCTTTA CTTTAC TTTACT TTACTG TACTGG ACTGGG CTGGGT TGGGTG GGGTGC GGTGCG GTGCGC TGCGCG GCGCGA CGCGAT GCGATA CGATAT GATATC ATATCG TATCGT ATCGTC TCGTCG CGTCGA GTCGAG TCGAGC CGAGCG GAGCGC AGCGCG GCGCGG CGCGGC GCGGCC CGGCCC GGCCCG GCCCGC CCCGCA CCGCAG CGCAGT GCAGTG CAGTGG AGTGGT GTGGTT TGGTTT GGTTTG GTTTGC TTTGCC TTGCCA TGCCAG GCCAGC CCAGCT CAGCTT AGCTTT GCTTTG CTTTGG TTTGGC TTGGCC TGGCCG GGCCGC,ATGCGCC TGCGCCC GCGCCCG CGCCCGC GCCCGCC CCCGCCC CCGCCCT CGCCCTA GCCCTAC CCCTACA CCTACAT CTACATC TACATCG ACATCGC CATCGCG ATCGCGC TCGCGCA CGCGCAG GCGCAGG CGCAGGT GCAGGTG CAGGTGG AGGTGGG GGTGGGC GTGGGCC TGGGCCT GGGCCTG GGCCTGT GCCTGTT CCTGTTT CTGTTTG TGTTTGG GTTTGGC TTTGGCA TTGGCAG TGGCAGC GGCAGCC GCAGCCC CAGCCCC AGCCCCA GCCCCAC CCCCACG CCCACGC CCACGCT CACGCTG ACGCTGG CGCTGGA GCTGGAG CTGGAGC TGGAGCA GGAGCAC GAGCACA AGCACAA GCACAAC CACAACT ACAACTT CAACTTT AACTTTG ACTTTGA CTTTGAA TTTGAAA TTGAAAC TGAAACG GAAACGC AAACGCT AACGCTT ACGCTTT CGCTTTA GCTTTAC CTTTACT TTTACTG TTACTGG TACTGGG ACTGGGT CTGGGTG TGGGTGC GGGTGCG GGTGCGC GTGCGCG TGCGCGA GCGCGAT CGCGATA GCGATAT CGATATC GATATCG ATATCGT TATCGTC ATCGTCG TCGTCGA CGTCGAG GTCGAGC TCGAGCG CGAGCGC GAGCGCG AGCGCGG GCGCGGC CGCGGCC GCGGCCC CGGCCCG GGCCCGC GCCCGCA CCCGCAG CCGCAGT CGCAGTG GCAGTGG CAGTGGT AGTGGTT GTGGTTT TGGTTTG GGTTTGC GTTTGCC TTTGCCA TTGCCAG TGCCAGC GCCAGCT CCAGCTT CAGCTTT AGCTTTG GCTTTGG CTTTGGC TTTGGCC TTGGCCG TGGCCGC,"ID   NUOF_AQUAE              Reviewed;         426 AA.
AC   O66841;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   27-NOV-2024, entry version 135.
DE   RecName: Full=NADH-quinone oxidoreductase subunit F;
DE            EC=7.1.1.-;
DE   AltName: Full=NADH dehydrogenase I subunit F;
DE   AltName: Full=NDH-1 subunit F;
GN   Name=nuoF; OrderedLocusNames=aq_573;
OS   Aquifex aeolicus (strain VF5).
OC   Bacteria; Aquificota; Aquificia; Aquificales; Aquificaceae; Aquifex.
OX   NCBI_TaxID=224324;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=VF5;
RX   PubMed=9537320; DOI=10.1038/32831;
RA   Deckert G., Warren P.V., Gaasterland T., Young W.G., Lenox A.L.,
RA   Graham D.E., Overbeek R., Snead M.A., Keller M., Aujay M., Huber R.,
RA   Feldman R.A., Short J.M., Olsen G.J., Swanson R.V.;
RT   ""The complete genome of the hyperthermophilic bacterium Aquifex aeolicus."";
RL   Nature 392:353-358(1998).
CC   -!- FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur
CC       (Fe-S) centers, to quinones in the respiratory chain. Couples the redox
CC       reaction to proton translocation (for every two electrons transferred,
CC       four hydrogen ions are translocated across the cytoplasmic membrane),
CC       and thus conserves the redox energy in a proton gradient (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + NADH + 5 H(+)(in) = a quinol + NAD(+) + 4
CC         H(+)(out); Xref=Rhea:RHEA:57888, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:24646, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:132124;
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000305};
CC       Note=Binds 1 FMN. {ECO:0000305};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000305};
CC       Note=Binds 1 [4Fe-4S] cluster. {ECO:0000305};
CC   -!- SIMILARITY: Belongs to the complex I 51 kDa subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE000657; AAC06800.1; -; Genomic_DNA.
DR   PIR; E70351; E70351.
DR   RefSeq; NP_213401.1; NC_000918.1.
DR   RefSeq; WP_010880339.1; NC_000918.1.
DR   PDB; 6HL2; X-ray; 1.95 A; B/D=1-426.
DR   PDB; 6HL3; X-ray; 2.04 A; B/D=1-426.
DR   PDB; 6HL4; X-ray; 2.06 A; B/D=1-426.
DR   PDB; 6HLA; X-ray; 1.90 A; B/D=1-426.
DR   PDB; 6HLI; X-ray; 2.38 A; B/D=1-426.
DR   PDB; 6HLJ; X-ray; 2.10 A; B/D=1-426.
DR   PDB; 6HLM; X-ray; 1.80 A; B/D=1-426.
DR   PDB; 6Q9C; X-ray; 1.78 A; B/D=2-419.
DR   PDB; 6Q9G; X-ray; 2.10 A; B/D=1-426.
DR   PDB; 6Q9J; X-ray; 1.83 A; B/D=1-426.
DR   PDB; 6Q9K; X-ray; 1.99 A; B/D=2-419.
DR   PDB; 6R7P; X-ray; 3.22 A; B/D=1-426.
DR   PDB; 6SAQ; X-ray; 2.02 A; B/D=1-426.
DR   PDB; 7Q5Y; X-ray; 2.70 A; C/I/O/U=1-426.
DR   PDB; 8QG1; X-ray; 2.00 A; B/D=1-426.
DR   PDB; 8QGW; X-ray; 1.60 A; B/D=1-426.
DR   PDB; 8QH4; X-ray; 1.96 A; B/D=1-426.
DR   PDB; 8QH7; X-ray; 1.85 A; B/D=1-426.
DR   PDB; 8QHK; X-ray; 1.95 A; B/D=1-426.
DR   PDB; 9FDJ; X-ray; 1.70 A; B/D=1-426.
DR   PDB; 9FDK; X-ray; 1.80 A; B/D=1-426.
DR   PDB; 9FDV; X-ray; 1.99 A; B/D=1-426.
DR   PDB; 9FE0; X-ray; 2.20 A; B/D=1-426.
DR   PDB; 9FE5; X-ray; 2.10 A; B/D=1-426.
DR   PDB; 9FE7; X-ray; 2.28 A; B/D=1-426.
DR   PDB; 9FE8; X-ray; 2.34 A; B/D=1-426.
DR   PDB; 9FEA; X-ray; 1.66 A; B/D=1-426.
DR   PDB; 9FIF; X-ray; 1.77 A; B/D=1-426.
DR   PDB; 9FIH; X-ray; 2.08 A; B/D=1-426.
DR   PDB; 9FII; X-ray; 2.50 A; B/D=1-426.
DR   PDB; 9FIJ; X-ray; 2.35 A; B/D=1-426.
DR   PDB; 9FIL; X-ray; 2.54 A; B/D=1-426.
DR   PDBsum; 6HL2; -.
DR   PDBsum; 6HL3; -.
DR   PDBsum; 6HL4; -.
DR   PDBsum; 6HLA; -.
DR   PDBsum; 6HLI; -.
DR   PDBsum; 6HLJ; -.
DR   PDBsum; 6HLM; -.
DR   PDBsum; 6Q9C; -.
DR   PDBsum; 6Q9G; -.
DR   PDBsum; 6Q9J; -.
DR   PDBsum; 6Q9K; -.
DR   PDBsum; 6R7P; -.
DR   PDBsum; 6SAQ; -.
DR   PDBsum; 7Q5Y; -.
DR   PDBsum; 8QG1; -.
DR   PDBsum; 8QGW; -.
DR   PDBsum; 8QH4; -.
DR   PDBsum; 8QH7; -.
DR   PDBsum; 8QHK; -.
DR   PDBsum; 9FDJ; -.
DR   PDBsum; 9FDK; -.
DR   PDBsum; 9FDV; -.
DR   PDBsum; 9FE0; -.
DR   PDBsum; 9FE5; -.
DR   PDBsum; 9FE7; -.
DR   PDBsum; 9FE8; -.
DR   PDBsum; 9FEA; -.
DR   PDBsum; 9FIF; -.
DR   PDBsum; 9FIH; -.
DR   PDBsum; 9FII; -.
DR   PDBsum; 9FIJ; -.
DR   PDBsum; 9FIL; -.
DR   AlphaFoldDB; O66841; -.
DR   SMR; O66841; -.
DR   STRING; 224324.aq_573; -.
DR   EnsemblBacteria; AAC06800; AAC06800; aq_573.
DR   KEGG; aae:aq_573; -.
DR   PATRIC; fig|224324.8.peg.468; -.
DR   eggNOG; COG1894; Bacteria.
DR   HOGENOM; CLU_014881_0_1_0; -.
DR   InParanoid; O66841; -.
DR   OrthoDB; 9761899at2; -.
DR   Proteomes; UP000000798; Chromosome.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IEA:InterPro.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   FunFam; 3.40.50.11540:FF:000001; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial; 1.
DR   Gene3D; 3.10.20.600; -; 1.
DR   Gene3D; 6.10.250.1450; -; 1.
DR   Gene3D; 3.40.50.11540; NADH-ubiquinone oxidoreductase 51kDa subunit; 1.
DR   Gene3D; 1.20.1440.230; NADH-ubiquinone oxidoreductase 51kDa subunit, iron-sulphur binding domain; 1.
DR   InterPro; IPR001949; NADH-UbQ_OxRdtase_51kDa_CS.
DR   InterPro; IPR011538; Nuo51_FMN-bd.
DR   InterPro; IPR037225; Nuo51_FMN-bd_sf.
DR   InterPro; IPR019575; Nuop51_4Fe4S-bd.
DR   InterPro; IPR037207; Nuop51_4Fe4S-bd_sf.
DR   InterPro; IPR019554; Soluble_ligand-bd.
DR   PANTHER; PTHR43578; NADH-QUINONE OXIDOREDUCTASE SUBUNIT F; 1.
DR   PANTHER; PTHR43578:SF3; NADH-QUINONE OXIDOREDUCTASE SUBUNIT F; 1.
DR   Pfam; PF01512; Complex1_51K; 1.
DR   Pfam; PF10589; NADH_4Fe-4S; 1.
DR   Pfam; PF10531; SLBB; 1.
DR   SMART; SM00928; NADH_4Fe-4S; 1.
DR   SUPFAM; SSF142019; Nqo1 FMN-binding domain-like; 1.
DR   SUPFAM; SSF142984; Nqo1 middle domain-like; 1.
DR   SUPFAM; SSF140490; Nqo1C-terminal domain-like; 1.
DR   PROSITE; PS00644; COMPLEX1_51K_1; 1.
DR   PROSITE; PS00645; COMPLEX1_51K_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Flavoprotein; FMN; Iron; Iron-sulfur; Metal-binding;
KW   NAD; Quinone; Reference proteome; Translocase.
FT   CHAIN           1..426
FT                   /note=""NADH-quinone oxidoreductase subunit F""
FT                   /id=""PRO_0000118570""
FT   BINDING         65..74
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   BINDING         176..223
FT                   /ligand=""FMN""
FT                   /ligand_id=""ChEBI:CHEBI:58210""
FT                   /evidence=""ECO:0000250""
FT   BINDING         347
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255""
FT   BINDING         350
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255""
FT   BINDING         353
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255""
FT   BINDING         393
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255""
FT   STRAND          12..16
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   TURN            19..24
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          25..27
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           31..36
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   TURN            37..40
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           41..47
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           51..60
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          66..69
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           73..81
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          87..93
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           102..109
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           111..125
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          127..134
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           139..154
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          157..161
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           162..164
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          169..175
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           180..183
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           185..192
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          202..204
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   TURN            206..208
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           211..213
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          216..220
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           221..225
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           227..233
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           235..239
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           244..246
FT                   /evidence=""ECO:0007829|PDB:6HLM""
FT   STRAND          248..260
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          262..267
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           272..277
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           284..286
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          289..294
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   TURN            295..297
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          298..301
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           302..304
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          307..312
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          322..326
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           331..345
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          348..350
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           351..368
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           374..384
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   STRAND          386..388
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           394..398
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           401..409
FT                   /evidence=""ECO:0007829|PDB:8QGW""
FT   HELIX           411..419
FT                   /evidence=""ECO:0007829|PDB:8QGW""
SQ   SEQUENCE   426 AA;  47508 MW;  A876712CBFA2E122 CRC64;
     MRSYPAIPRI YAETTLNMLL KRAKKPRVHS IDEYLKDGGY QALEKALNMS PEEIIDWVDK
     STLRGRGGAG FPTGKKWKFA VQNPGPRYFI CNADESEPGT FKDRIIIERD PHLLIEGIII
     SSYAIGANEA YIYIRGEYPA GYYILRDAIE EAKKKGFLGK NILGSGFDLE IYVARGAGAY
     ICGEETALIE SLEGKRGHPR LKPPYPVQKG LWGKPTVVNN VETIANVPFI ISMGWEEYRY
     IGPSDYAGPK LFPVSGKVKK PGVYELPMNT TLREVIFKYA GGTLGNKKVK AVFSGALDCF
     SSEELDIPMD YSPLGFGGTG TVIVLTEEDD IVEAALKIAE FYEHETCGQC TPCRVGCYEQ
     ANLLEKIYKG EATEQDWEGF DFVNRNIQPT SICGLGAVAG RLIRQTLEKF PEEWEKYRKK
     SASLPL
//
",30501
ACCTTA CCTTAA CTTAAC TTAACC TAACCC AACCCA ACCCAC CCCACG CCACGA CACGAT ACGATT CGATTA GATTAC ATTACG TTACGC TACGCG ACGCGA CGCGAT GCGATT CGATTG GATTGG ATTGGC TTGGCA TGGCAC GGCACA GCACAT CACATT ACATTG CATTGA ATTGAT TTGATG TGATGG GATGGG ATGGGC TGGGCT GGGCTT GGCTTG GCTTGC CTTGCC TTGCCC TGCCCG GCCCGA CCCGAG CCGAGA CGAGAT GAGATT AGATTG GATTGC ATTGCG TTGCGC TGCGCA GCGCAA CGCAAA GCAAAG CAAAGC AAAGCC AAGCCT AGCCTC GCCTCA CCTCAG CTCAGC TCAGCG CAGCGC AGCGCC GCGCCC CGCCCT GCCCTA CCCTAC CCTACC CTACCC TACCCG ACCCGC CCCGCC CCGCCA CGCCAC GCCACT CCACTC CACTCG ACTCGG CTCGGC TCGGCA CGGCAA GGCAAG GCAAGA CAAGAT AAGATG AGATGC GATGCG ATGCGG TGCGGA GCGGAG CGGAGC GGAGCG GAGCGC AGCGCT GCGCTG CGCTGG GCTGGG CTGGGG TGGGGT GGGGTA GGGTAT GGTATT GTATTG TATTGC ATTGCA TTGCAG TGCAGC GCAGCG CAGCGT AGCGTT GCGTTT CGTTTA GTTTAG TTTAGG TTAGGC TAGGCT AGGCTT GGCTTA GCTTAC CTTACC TTACCT TACCTG ACCTGA,2,124,ACCT CCTT CTTA TTAA TAAC AACC ACCC CCCA CCAC CACG ACGA CGAT GATT ATTA TTAC TACG ACGC CGCG GCGA CGAT GATT ATTG TTGG TGGC GGCA GCAC CACA ACAT CATT ATTG TTGA TGAT GATG ATGG TGGG GGGC GGCT GCTT CTTG TTGC TGCC GCCC CCCG CCGA CGAG GAGA AGAT GATT ATTG TTGC TGCG GCGC CGCA GCAA CAAA AAAG AAGC AGCC GCCT CCTC CTCA TCAG CAGC AGCG GCGC CGCC GCCC CCCT CCTA CTAC TACC ACCC CCCG CCGC CGCC GCCA CCAC CACT ACTC CTCG TCGG CGGC GGCA GCAA CAAG AAGA AGAT GATG ATGC TGCG GCGG CGGA GGAG GAGC AGCG GCGC CGCT GCTG CTGG TGGG GGGG GGGT GGTA GTAT TATT ATTG TTGC TGCA GCAG CAGC AGCG GCGT CGTT GTTT TTTA TTAG TAGG AGGC GGCT GCTT CTTA TTAC TACC ACCT CCTG CTGA,ACCTT CCTTA CTTAA TTAAC TAACC AACCC ACCCA CCCAC CCACG CACGA ACGAT CGATT GATTA ATTAC TTACG TACGC ACGCG CGCGA GCGAT CGATT GATTG ATTGG TTGGC TGGCA GGCAC GCACA CACAT ACATT CATTG ATTGA TTGAT TGATG GATGG ATGGG TGGGC GGGCT GGCTT GCTTG CTTGC TTGCC TGCCC GCCCG CCCGA CCGAG CGAGA GAGAT AGATT GATTG ATTGC TTGCG TGCGC GCGCA CGCAA GCAAA CAAAG AAAGC AAGCC AGCCT GCCTC CCTCA CTCAG TCAGC CAGCG AGCGC GCGCC CGCCC GCCCT CCCTA CCTAC CTACC TACCC ACCCG CCCGC CCGCC CGCCA GCCAC CCACT CACTC ACTCG CTCGG TCGGC CGGCA GGCAA GCAAG CAAGA AAGAT AGATG GATGC ATGCG TGCGG GCGGA CGGAG GGAGC GAGCG AGCGC GCGCT CGCTG GCTGG CTGGG TGGGG GGGGT GGGTA GGTAT GTATT TATTG ATTGC TTGCA TGCAG GCAGC CAGCG AGCGT GCGTT CGTTT GTTTA TTTAG TTAGG TAGGC AGGCT GGCTT GCTTA CTTAC TTACC TACCT ACCTG CCTGA,ACCTTA CCTTAA CTTAAC TTAACC TAACCC AACCCA ACCCAC CCCACG CCACGA CACGAT ACGATT CGATTA GATTAC ATTACG TTACGC TACGCG ACGCGA CGCGAT GCGATT CGATTG GATTGG ATTGGC TTGGCA TGGCAC GGCACA GCACAT CACATT ACATTG CATTGA ATTGAT TTGATG TGATGG GATGGG ATGGGC TGGGCT GGGCTT GGCTTG GCTTGC CTTGCC TTGCCC TGCCCG GCCCGA CCCGAG CCGAGA CGAGAT GAGATT AGATTG GATTGC ATTGCG TTGCGC TGCGCA GCGCAA CGCAAA GCAAAG CAAAGC AAAGCC AAGCCT AGCCTC GCCTCA CCTCAG CTCAGC TCAGCG CAGCGC AGCGCC GCGCCC CGCCCT GCCCTA CCCTAC CCTACC CTACCC TACCCG ACCCGC CCCGCC CCGCCA CGCCAC GCCACT CCACTC CACTCG ACTCGG CTCGGC TCGGCA CGGCAA GGCAAG GCAAGA CAAGAT AAGATG AGATGC GATGCG ATGCGG TGCGGA GCGGAG CGGAGC GGAGCG GAGCGC AGCGCT GCGCTG CGCTGG GCTGGG CTGGGG TGGGGT GGGGTA GGGTAT GGTATT GTATTG TATTGC ATTGCA TTGCAG TGCAGC GCAGCG CAGCGT AGCGTT GCGTTT CGTTTA GTTTAG TTTAGG TTAGGC TAGGCT AGGCTT GGCTTA GCTTAC CTTACC TTACCT TACCTG ACCTGA,ACCTTAA CCTTAAC CTTAACC TTAACCC TAACCCA AACCCAC ACCCACG CCCACGA CCACGAT CACGATT ACGATTA CGATTAC GATTACG ATTACGC TTACGCG TACGCGA ACGCGAT CGCGATT GCGATTG CGATTGG GATTGGC ATTGGCA TTGGCAC TGGCACA GGCACAT GCACATT CACATTG ACATTGA CATTGAT ATTGATG TTGATGG TGATGGG GATGGGC ATGGGCT TGGGCTT GGGCTTG GGCTTGC GCTTGCC CTTGCCC TTGCCCG TGCCCGA GCCCGAG CCCGAGA CCGAGAT CGAGATT GAGATTG AGATTGC GATTGCG ATTGCGC TTGCGCA TGCGCAA GCGCAAA CGCAAAG GCAAAGC CAAAGCC AAAGCCT AAGCCTC AGCCTCA GCCTCAG CCTCAGC CTCAGCG TCAGCGC CAGCGCC AGCGCCC GCGCCCT CGCCCTA GCCCTAC CCCTACC CCTACCC CTACCCG TACCCGC ACCCGCC CCCGCCA CCGCCAC CGCCACT GCCACTC CCACTCG CACTCGG ACTCGGC CTCGGCA TCGGCAA CGGCAAG GGCAAGA GCAAGAT CAAGATG AAGATGC AGATGCG GATGCGG ATGCGGA TGCGGAG GCGGAGC CGGAGCG GGAGCGC GAGCGCT AGCGCTG GCGCTGG CGCTGGG GCTGGGG CTGGGGT TGGGGTA GGGGTAT GGGTATT GGTATTG GTATTGC TATTGCA ATTGCAG TTGCAGC TGCAGCG GCAGCGT CAGCGTT AGCGTTT GCGTTTA CGTTTAG GTTTAGG TTTAGGC TTAGGCT TAGGCTT AGGCTTA GGCTTAC GCTTACC CTTACCT TTACCTG TACCTGA,"ID   DABA_BURM1              Reviewed;         869 AA.
AC   A9ASJ1;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 1.
DT   05-FEB-2025, entry version 76.
DE   RecName: Full=Probable inorganic carbon transporter subunit DabA {ECO:0000255|HAMAP-Rule:MF_01871};
GN   Name=dabA {ECO:0000255|HAMAP-Rule:MF_01871};
GN   OrderedLocusNames=Bmul_5850, BMULJ_05674;
OS   Burkholderia multivorans (strain ATCC 17616 / 249).
OC   Bacteria; Pseudomonadota; Betaproteobacteria; Burkholderiales;
OC   Burkholderiaceae; Burkholderia; Burkholderia cepacia complex.
OX   NCBI_TaxID=395019;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 17616 / 249;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Glavina del Rio T., Dalin E.,
RA   Tice H., Pitluck S., Chain P., Malfatti S., Shin M., Vergez L., Schmutz J.,
RA   Larimer F., Land M., Hauser L., Kyrpides N., Kim E., Tiedje J.,
RA   Richardson P.;
RT   ""Complete sequence of chromosome 3 of Burkholderia multivorans ATCC
RT   17616."";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 17616 / 249;
RA   Ohtsubo Y., Yamashita A., Kurokawa K., Takami H., Yuhara S., Nishiyama E.,
RA   Endo R., Miyazaki R., Ono A., Yano K., Ito M., Sota M., Yuji N.,
RA   Hattori M., Tsuda M.;
RT   ""Complete genome sequence of Burkholderia multivorans ATCC 17616."";
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Part of an energy-coupled inorganic carbon pump.
CC       {ECO:0000255|HAMAP-Rule:MF_01871}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01871};
CC   -!- SUBUNIT: Forms a complex with DabB. {ECO:0000255|HAMAP-Rule:MF_01871}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01871}; Peripheral membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01871}.
CC   -!- SIMILARITY: Belongs to the inorganic carbon transporter (TC 9.A.2) DabA
CC       family. {ECO:0000255|HAMAP-Rule:MF_01871}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000870; ABX19513.1; -; Genomic_DNA.
DR   EMBL; AP009387; BAG47496.1; -; Genomic_DNA.
DR   RefSeq; WP_012218207.1; NC_010801.1.
DR   AlphaFoldDB; A9ASJ1; -.
DR   STRING; 395019.BMULJ_05674; -.
DR   GeneID; 93169245; -.
DR   KEGG; bmj:BMULJ_05674; -.
DR   KEGG; bmu:Bmul_5850; -.
DR   eggNOG; COG3002; Bacteria.
DR   HOGENOM; CLU_009885_1_0_4; -.
DR   Proteomes; UP000008815; Chromosome 3.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR   HAMAP; MF_01871; DabA; 1.
DR   InterPro; IPR018752; DabA.
DR   PANTHER; PTHR38344:SF1; INORGANIC CARBON TRANSPORTER SUBUNIT DABA-RELATED; 1.
DR   PANTHER; PTHR38344; UPF0753 PROTEIN AQ_863; 1.
DR   Pfam; PF10070; DabA; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Membrane; Metal-binding;
KW   Reference proteome; Transport; Zinc.
FT   CHAIN           1..869
FT                   /note=""Probable inorganic carbon transporter subunit DabA""
FT                   /id=""PRO_0000387255""
FT   REGION          1..32
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        8..17
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         376
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01871""
FT   BINDING         378
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01871""
FT   BINDING         555
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01871""
FT   BINDING         570
FT                   /ligand=""Zn(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:29105""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01871""
SQ   SEQUENCE   869 AA;  94861 MW;  41313BFB8ABDD8EA CRC64;
     MSTATLEQRA KRGEAPRAND AGHCAHPADG ARRGYPRERI DAACDAACRS IAPAWPLDRA
     IAVNPHWERI GRPVREIAAR MAVLADIKVF PPREQIRSAW ESARIAPADL RYALQALPAA
     QAAGMTERNC IDALARPLNL PRLPLLIDVL DDDPLRHERL SWRQAITHQV SQTCAAYFDE
     HQADWRPHHD QSLYAFWRDT ISHDHGIGVL MGLPRLGQSL RALPATRQEA EAWVLERLGL
     PEAVWPDYLE AVLLTVNGWA SWCAYLGWQA RLAGESDEHL RDLLAIRLAW GVLLLDCKDD
     AAARRAFAAV QGHWRDSAAL LADAQARLLV DEVWQLAFEA GYQRELAGKL GAVGQPQTIP
     EAATPAEEIE VQAAFCIDVR SEPLRRAVES IWPAVQTIGF AGFFGLPVAY TPLATSARRP
     QLPGLLAPSL EVTDAVSGPA GEGGGTMRAA ASTARRTRFA LSNQASAATR LPGTSFSFVE
     AAGLGYLGKL RQWLKPSRNP RVRDDLAGLP PRYKAVCRPA LVGIDDQAKA DLAARILHGM
     GIARSLAPLV VLVGHASQSA NNAHAAALDC GACCGQSGEV NVRVLAQLLN DRATRAGLAQ
     RGIDVPDDTT FVAALHNTTT DEIEGFDVDL LNPIAAARWA KLLSVFGHAS DQVRRERAVR
     VGLDPRMEGG RLLASLRERA NDGAQTRPEW GLAGNAAFVI GPRTRSHGAV LDGRCFLHDY
     DFTQDTDGSL LELLMTAPML VAHWINWQYH ASTCDPAHMG CGNKVLHNVV GGHIGVFEGN
     SGDLRIGLSK QSLHDGQRWM HEPLRLTVII DAPGASIERV IDRHPTVRHL IDHGWLHLWR
     FGETGLLRFS DRQWHPLAMG ADPATRQSP
//
",30794
CACGTA ACGTAC CGTACC GTACCT TACCTA ACCTAT CCTATG CTATGG TATGGA ATGGAT TGGATG GGATGC GATGCA ATGCAA TGCAAA GCAAAA CAAAAG AAAAGT AAAGTA AAGTAT AGTATT GTATTA TATTAT ATTATG TTATGG TATGGG ATGGGG TGGGGT GGGGTG GGGTGA GGTGAA GTGAAG TGAAGC GAAGCC AAGCCA AGCCAA GCCAAT CCAATG CAATGT AATGTA ATGTAA TGTAAA GTAAAT TAAATG AAATGA AATGAA ATGAAG TGAAGC GAAGCC AAGCCA AGCCAT GCCATT CCATTG CATTGT ATTGTT TTGTTA TGTTAC GTTACC TTACCG TACCGG ACCGGA CCGGAG CGGAGA GGAGAA GAGAAA AGAAAG GAAAGC AAAGCA AAGCAT AGCATT GCATTC CATTCC ATTCCT TTCCTG TCCTGT CCTGTT CTGTTG TGTTGA GTTGAA TTGAAA TGAAAA GAAAAA AAAAAA AAAAAA AAAAAA AAAAAA AAAAAT AAAATG AAATGA AATGAA ATGAAC TGAACG GAACGA AACGAC ACGACA CGACAA GACAAA ACAAAC CAAACT AAACTG AACTGA ACTGAT CTGATC TGATCG GATCGG ATCGGC TCGGCG CGGCGG GGCGGA GCGGAA CGGAAG GGAAGC GAAGCA AAGCAT AGCATT GCATTG CATTGT ATTGTT,2,118, AGACGCG G A ACACGCGTT C CGCGTGTATA A G GTGTAGAAAC C TATTGC ACCCC C ACCTCT T C CC TTA C CTCTATATAT T T TAA AATGTG ACT ATATGA AGG G TATCTGGGGAGTTA G GG ATAAGAT T G GAATGCATG A ATATGTGCGC C T TGAAAGCACA A G GCCAAAA A C CACAAAAAAA A A AATGAA GAA TAT AAAAAAAGAG G A AAAAGGT TAC AG TGAAAA G GTTATAT  TG TATATATT AGT AC TATTTTAA TA T CGTATAT  AATTCTATATGTG G A ATATGGG G T TGTGGGGGGG G G GGGGGGGGGG G T GGGGGGGTGT T G GGGGTGTGTG G G GTGTGTGAGA A T TGTGAGAATCC GAAAGAG G C AAAAGAGCGC C A AGAGCGCCCC TCGGCCCCACA  CCGCATGAAA A C CAAATT A AAAATATGGCCAAATGTGT T TGTATGTGTATA A G GTTAAA TTAAAAAAA A A AAAATAT T A AAAATATGTG G AGCAATGTGAGA  TGTGAT AAAAA G GAG CAG AAGAGCGC C ACACAGCGCCCC C G GCGGACCACA A C CCCCATG AT T C CACATATTTT T A ATTTGG G TTTTGTGTGT T T TGTGTGA TT T G GTGTTTTATA  TT TTTTATACAC C T TAGAACC C A ACA GCCGCG G ACCG GGGG G C CGCGGGGAGA A GCGGAAGGAGAG G G GAGAGGA A AG AAGAGAAAA A G GAGAAAAAAA A ATGCAAGAG G A AAGATAGCTACC ATT AGCGCACA A G GCAACCATAT T C CACATATTTT T A AT TATC  AT TT TATCCCC C T TCACCCCTCT T C CCAG CTGTG G C CTCTGTGTGT T T TGTGTGTTTT T GG AGTTTTGTG G TCTATTGTGAGA A T TGTGAGAA ATA G GAGAAAAAAA A A AAAA AAAAA A A AAAAAAAAAA A AAT TG AAAAA A A AAAAAAAAAA A AT TAAAAAA GCA A AAAAAAA TGG AAAATAT T A AAAATATGAAAG A ATATGTGAGA A TAA GAAAA A G GA TGAC C A AAAACACGCG  AT ACACGCGAGA A C CGCGAGACAC C G GAGACACACA A A ACACACAAAA A CC ACAAAA A A AAAAAAACAC C A AAAACACTCT T A ACG ACTGTG G C GCCTGCAAGA  GACCAAAAGATAT T G GAGATATCCGGC AG A TGTCGCG  TCTGATC GAAGGCGC C G GGGGCGCGCG G G CTGCGCGGGG G C CGCGGGGAGA A G GGGGAACCAA TA A TGAACCT AG AAAAGAGCGC  CA AGGCACA A G GC ATCATGATT C CACATATTTT T AATTTTGTG G T TTTTGTGTGT T TT TTGTGTT,CACACGCGTAAAT A AC GTA CGTATA A C AGGTATACAC C G GTGTATACACGTGTC TTACCGGCCTCT T A ACACCCTATA A C CCCCTAAGTATAT T CCTAATGTG G T TATATGG G A ATATGCG GGA AG TGTGGGGAGATAT T G GGGGAGATATGGGTG GG AGATTGCTTAC A ATATGTGCCA A T AATGCGCACAAAA A G AAAAAAA  CACAAAAATGTAA A A AAAAAAAACA AG T A AAAAAAAGAA GT  AAAAGAGTGTATA A AGA AGTAGTAT T GGCCGTATATATTTT  TAT AATTTTATA A A ATATTTTATATAT T TTG TTACGGATGTG TCC TATATTGGGG G A ATATGTGGGGGGG G TTGGGGGGGGGG G G GGGGGGGGCATGCAT G GGGGG TTGTGTG G G GGGGTTGAAAA CTACCGTGTGAGAAAA  TGTGAGAAAAGAG  GAGAAAAGAGCGC C A AAGAAAGCGCCCC C A CGGCCCCACA  GCGCCCCACAAAA A C CCCCACAAAATAT T C CACAAAATATGTG  AA TG AAGT T A ATATGTGTGTATA A TATGAAAGTATAAAA A G GTGTATAAAAA GA TATAAAAAAATAT CC AAAGCGCATGT  AAAATATGTGAGA A A ATATGAA GAAA TTGAGAAAAGAG  TCGCAGAAAGCGC  AAAGC GTCC C A AGAGCGCCTCGAGCA G GCGCCCCACATAT T C CCCCACATATTTT T C CAATTTTGTG G A ATATTTTGTGTGT CGGTTGTGTGTTTT T TGGATGTGTTTTATA A G GTGTTCTATACAC C T TTTTATACACCCC C T TATACACCCCGCG  ACACCCCGCGGGG G C CCCCGCGG TGGA A C CGCGGGGAGAGAG TC  GGGGAAGAC CG AAAAAGAGAAAA A A AGAGAGACAAAAA A GTTCGAAAAAGC AG G A AAAAAAGCGC  AATGAAGCCA A A AGATGGT CATAT TGA GCAAACATT C CATG ATTTTCTC C A ATATT GATCCC T TTTTCTCCCCTCT T T GAT GTTGG C CCCCTCTGTGTGT T CA GTGTGTTTT T TTGTGTTTTGCTGG G GTGTTTTGTGAGA A T TTTTGTGAGAAAA A T TGAAGGAAAAAAA A G GAA AAAAAAAAA A A AAGCAGAGAAAAA A A AAAAAAAAAA A A TGAAAAAAAAAG TA A AAAAAAAAAAAAA AAG AAAAACAAAAAA A AAGA G AAATAT G A AAAAAAATATGTG A AAAT TT TGA A ATATGTGAAA A T TGTGAGAAAACGAAAACACGCG  GA AAC CACGCGAGA  AA ACACGCGAGACAC A G CGCGAGAAACACA A G GAGACACAAAAAA A A ACACACAAAAAAA A CCAAAAAAACC A AAAAAAACCT  AAAACATTCTGTG G A ACACTTG TGAGA A C CTCTGTGAGATAT T T TGTGAGATATCG GC GGATTCGTGGG A ATATCCCACGGGG AAG TCTCGACCGGCGC AAC CGTATGGCGCGCG G G GGGCGCGGAAGG G GCAGCCGGGGAGA  CGTGAGGAGAAAA A G GGGGAGAAAAGAG G GG GGAAG TAGCGC  GCAAGAAGGCACA A A AGAATGCACATAT T G GACATATTTT T C CACATATTCTGTG G A ATACTTTGATGGT T T TTTTGTGT,CACACGCGTTA AAAGAACA CGTT GTAC GGC C CGCGTGTATAC GACC C GGTATACACCCCTCT T T TATACACCCCTCTATA CTGACCCCTAGCTATAT T C CCCATGCCTATAAATG G C CTCTATATATGTGG GC TATATATGTGGGA A A ATATGTGGGGAGATAT T T TGTGGCC GAT ATG GG GAC GGAATGTGCAAA GAGAT ATTGCCA A AATGTGCTA CAAAA A TCCACATGCAT TATGAA A G GCGCACAAGAAAAAAA A CCCACAAAAAAAAAAGAG G A AAAAAAAAAAGAGTGT T A AAAAAAAGAGTGTATA A AAAGAGTGTATATAT  TG AGAGTGTATATATT TCT G GTGTATATATTTTAGCAA T TAGT ATTTATATGATTTTAATGACCG T TTTTATATATGTGGGG GGAAACTATATGTGGAAAGG G A ATATGGGGGGGTACG T TGTGGGGGGGTGT T G GGA AGGGGGTGTGTG G G GGGGGGGTTGACAT GGGGT CTTGAGAAAA A G GTGTGTGA ACAAGAG G T TGTGAGAAAGCGC C GAAAAAGAGCGCCCC C ATGGAAGAGC TGATGACA AGAGCCCACAAAA A GGG GCCCCACAAAATAT AACCCACAAAATCCGTG  CCCAAAATATGTGTGT T A AAAATATGTGTGTATA C A ATATGTGTGTATAAAA CAATGTGTATAAAAAGAT TG GTGTAAATAT T T TATAAAAAAATATGG A AAAAAAATATGGAAGA AATATGTGAGAA ATATGTGAGAAAAGAG ATT TGTGAGAAAAGAGCGC C GGAAAAGAGCGCCG TC A AAAAGAGCGCCAAACA  ACCTACCATGCAT GTA GCGCC CACATTT  CCCCACATATTTTGG C CACAT GATTGTGTGT T A ATATTTTGTGTGTTTT T T TTTTGTGTTTATA A T TGTGTGTTTTATACG CC GAAATTAGG GGACC C T TTTTATACCCGG TTACACCCCGCGGG A AGACCCCGGTTCG GA A CAAGG ACGGTG GAGAG G C CGCGGGGAGAGAGAGA A G GGATCGAGGTTGAAAA  GAGAGAGATGAAAAAA A AG TG CGAAAAAAAGA CG GATTGAAAAA CGAGCGC A AAAAAAGAGCGCACA A A AAAAGAGCGCACAT GTT A AG AT ACCCTATTTT T G GCGTGCATATTTTCTC C C CACATATTTTCTCCCC C ATTCTCCCCTCT CAA TTTTCTCCCCT ACTG G TTT TCCCCTCTGTGTGT T CAC CGACTGTGTGTTTT T CGTGCTGTGTGTTTTGTG G TT ATGTA TTTGTGAGA A GAGATTGTGAGAAA T TTTTGTGAGAAAAAAA A T TGGAAAAAAAAAA  CT GAGAAAAAAAAAAAAA A A AAGC GC AAAAAAAA A AAAAGTTGGGAAAAA A A AAA AAAAAAAAA A A AAAAAAAAAG AAAAA A A AAAAAAAAAAAAATAT T A AAAAAAAAAATATGTG G A AAAAAAATACGTGAGA A AAATATGTGAAA A AATTATGTGAGAAAACAC C TA GTGAAACACGCG TG  GAGAAAACACGCGAGA A A AAT CACGCGAGACAC C AACACCTGACACACA AAA CGCGAGACCAAAA GACA ACAATGTAA A A GAACAGTTAAAAACAC C C CAAAACT  AAAAAAACACTTG ATG AAAACACTCTGTGAGA GGG ACACTCTGGATAT T CA GCTGGATGGATC C T TGTGAGATATCTCGTATG GACCAA ATCTCGCGGGG G AATGATCTCGCGGGGCAAA TCTCGCGGGGCGCGCG AGA CGCGGGCGCGGGG G GGGC GTCGGGGA GTA G GCGCGCGGGC GAAAA A CCGGGGAT A CCAG  GGGGAGAAAAGAGCGGAC GGAAAAGAGCGCACA A A AAAGCGCAGA AT  AGGCACATATTTT T G GCGGGCATATTTTGTG G C CA ATTTGTGTGGAT A AT AGTTGAAACGG,CACAT GCATACC A ACACGCGTGTATACACCGCAC C CGCGTGTATACATGAACCT AAGGTATACCCTCTAGCAA T TA TTACCA TCTAGCCACGTGAACCCCTCTACGAAATTG G C CCCCTCTATATATGTGGGG G C CTCTATATT ATGGGGAGA A T TATATATGTG GGAGATAT AGT ATATGTGGATTGATATGTG A C TGTGGTGATTGTT GC AAG GGGGAGATATGTGCGCAA G GAGATT GTGCGTAA GAA A A ATATGTGCCAAAAAAA A T TGTGCGCACAAAAAAAAAA A G GCGCACAAAAAAAAAAGTGAAAG CACCGAAAAAAC GAGTGT T A AAAAAAAAAAGAGTGTAA AACCAAAAAGAGTGTATATAT  AAAAGAGTGTATATATTTT CTGT AGTATATATTT GA GGTATATATTTTATATAT CGA TATATATTTTATATG GTG CAT ATATTTTAATTTGGGG G T TTTTATATATGTGGGGGGG CGGGATTATATGTGGGGGGGGGG CAA ATATTTGGGGGGGTGT AAT TGTGGGGGGGGGGTGTGTG G GACCGGGGGTGTGTGAA GCGGGGGGT GTGATGAA A GAAAGGTGTGAAAGAAAAGATG GTTGAGAAT GGC C T TGTGAGAAAAGAGCGCCCC C G GAGAAAAGAGCGCCCCAGAAA A AAAAGAGCGCCCCACAAAA A A AGAGCGCCCCACGGGA TGAATG GCCCTCAAT TATGTG G C CC ACAATCTGTGTGT T C CACAAT AATGTGTGTATA A A AAAATATGTGTGTACCGAA A A ATATGTGTAAAAA A T TGTGTGTATAAAAAAATAT T G GTGTATAAAATATGTG G T TAAAAAATATGAG GA A A GGAAT GATGAGAAA A AAAATATGTGAGAAAAGAG G A ATGTTTGAGAAA AAGCGC C T TGTGAGAAAAGAGCCC C G GAGAAAAGAGCGCCCCACA A A AAAAGAGCTACCCACATAT AAA AGAGCGCCCCACATTATTT TTA GCATGATTTTGTG  TG CCCCACATTTGTGTGT T C CACATATTTTGTGTTT TGT ATATTGATTGTGTTTA A T TTTTGTGTGTTTTATACC TG CTGTGTTTTATACACCCC C G GTGTTTTATAC GGTAACG G T TTGGGTACACCCCGCGGG T TATACCCGCGGGGAGA A A ACACCCCGCGGGGAAG G C CCTTCCGGGGAAA AGAGA A C CGCG GAGAGAGAAAA  GGGGAGAGAGAAGCA G GAGAGAGAGAAAAAGGAAG TGC AGAAAGAAAAAAAGAGCGC C GATGGAAAAAAAGGCACA AAG AAAAAAAGAGCGCACATT A AAG CAGCCATATTT ATT GCACATATTTTCGACATG GCGCAG AACATTCTCCCC AAA CACATATTTTCCCTACA ATATTTCCCCTCTGTG G T TTTTCTCCCCTCTGT AGT T TTCCCCACTGTGTGTTCATT CCCTCTGTGTGTTTTGTG G C CT AGTGTGTTTTATGAA T TGTGTATGTTGTGAGAAAA A G GTGTTTTGTGAGAAAAACCTGCCTTGTGACA AAAAAAAA A TTGAGAAAAAAAAAAAAA A G GAGAAAAAAAAAAAAA A A AAAAAAAAAAAAAAAA A ACAAAAAAAA AGAAAAAAAA A A AAAAAAAAAAAAA A A AAAAAAAATGAAAAAATAT T A AAAAAAAAAAAGGCATGTGGG A AAAATAAAATGAAGC GA A AAAAAATGATGGAAAA A AGGTATGTGAGAAAACAC  AA ATCGATGAGAAAATACGG T TGTGAGAACGAGA A G GAGAAAACACGCGAGACC AAACACGATGTC ACACA A A ACACGTATGACATTCAAGAGG T CGT TGACACACAAA AAA A G GAGACACACAAAAAC AACTT A AAAAAAACACTCT T C CA AAAAAAACACTCTGG ACAAC CAACACTCCTTGAGA AAAAACCTGTGAGATAT T A ACCAATGAGATATCTC C CAA CTG TAATCTCGCG G T TGTGAGATATCTCGCGGGG G G GAGATATCTCGCGGGGCGC C A ATATCTCG GGGGCGCGG T TCTCGG TAATGCGGG G C CGGG GGCGCGGGAGA A G GGGGCGCGCGGGGAGAA CTA G GCC ACGGGGAGAAAAGAG G C CGCGGGGACCAAAGAGCGC C G GGGGAGAAAGCCA  GAGAAAAGAGCTA CATAT T A AAAGCGCACATATTTT T A AGGCACATTTGTG G G GCGCACATGGATGTAATT C CACATATGTTGTGTGTT,"ID   ATCS_SYNE7              Reviewed;         747 AA.
AC   P37279; Q8KPV5;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 2.
DT   05-FEB-2025, entry version 166.
DE   RecName: Full=Probable copper-transporting ATPase PacS;
DE            EC=7.2.2.8;
GN   Name=pacS; OrderedLocusNames=Synpcc7942_1570; ORFNames=sed0002;
OS   Synechococcus elongatus (strain ATCC 33912 / PCC 7942 / FACHB-805)
OS   (Anacystis nidulans R2).
OC   Bacteria; Bacillati; Cyanobacteriota; Cyanophyceae; Synechococcales;
OC   Synechococcaceae; Synechococcus.
OX   NCBI_TaxID=1140;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8370468; DOI=10.1016/0014-5793(93)80928-n;
RA   Kanamaru K., Kashiwagi S., Mizuno T.;
RT   ""The cyanobacterium, Synechococcus sp. PCC7942, possesses two distinct
RT   genes encoding cation-transporting P-type ATPases."";
RL   FEBS Lett. 330:99-104(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Holtman C.K., Sandoval P., Chen Y., Socias T., Mohler B.J., Gonzalez A.,
RA   Salinas I., McMurtry S., Golden S.S., Youderian P.;
RT   ""Synechococcus elongatus PCC7942 cosmid 6C3."";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33912 / PCC 7942 / FACHB-805;
RG   US DOE Joint Genome Institute;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C., Glavina T.,
RA   Hammon N., Israni S., Pitluck S., Schmutz J., Larimer F., Land M.,
RA   Kyrpides N., Lykidis A., Golden S., Richardson P.;
RT   ""Complete sequence of chromosome 1 of Synechococcus elongatus PCC 7942."";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May play a role in the osmotic adaptation.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cu(+)(in) + ATP + H2O = Cu(+)(out) + ADP + phosphate + H(+);
CC         Xref=Rhea:RHEA:25792, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:49552,
CC         ChEBI:CHEBI:456216; EC=7.2.2.8;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IB subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16437; BAA03907.1; -; Genomic_DNA.
DR   EMBL; AY120852; AAM82673.1; -; Genomic_DNA.
DR   EMBL; CP000100; ABB57600.1; -; Genomic_DNA.
DR   RefSeq; WP_011378089.1; NZ_JACJTX010000004.1.
DR   AlphaFoldDB; P37279; -.
DR   SMR; P37279; -.
DR   STRING; 1140.Synpcc7942_1570; -.
DR   PaxDb; 1140-Synpcc7942_1570; -.
DR   GeneID; 72430392; -.
DR   KEGG; syf:Synpcc7942_1570; -.
DR   eggNOG; COG2217; Bacteria.
DR   HOGENOM; CLU_001771_0_3_3; -.
DR   OrthoDB; 438550at2; -.
DR   BioCyc; SYNEL:SYNPCC7942_1570-MONOMER; -.
DR   Proteomes; UP000889800; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005507; F:copper ion binding; IEA:TreeGrafter.
DR   GO; GO:0043682; F:P-type divalent copper transporter activity; IEA:TreeGrafter.
DR   GO; GO:0140581; F:P-type monovalent copper transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0055070; P:copper ion homeostasis; IEA:TreeGrafter.
DR   CDD; cd00371; HMA; 1.
DR   CDD; cd02094; P-type_ATPase_Cu-like; 1.
DR   FunFam; 2.70.150.10:FF:000020; Copper-exporting P-type ATPase A; 1.
DR   FunFam; 3.30.70.100:FF:000005; Copper-exporting P-type ATPase A; 1.
DR   Gene3D; 3.30.70.100; -; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR017969; Heavy-metal-associated_CS.
DR   InterPro; IPR006121; HMA_dom.
DR   InterPro; IPR036163; HMA_dom_sf.
DR   InterPro; IPR027256; P-typ_ATPase_IB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01511; ATPase-IB1_Cu; 1.
DR   NCBIfam; TIGR01525; ATPase-IB_hvy; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 2.
DR   PANTHER; PTHR43520; ATP7, ISOFORM B; 1.
DR   PANTHER; PTHR43520:SF8; P-TYPE CU(+) TRANSPORTER; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF00403; HMA; 1.
DR   Pfam; PF00702; Hydrolase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00943; CUATPASE.
DR   SFLD; SFLDG00002; C1.7:_P-type_atpase_like; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF55008; HMA, heavy metal-associated domain; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
DR   PROSITE; PS01047; HMA_1; 1.
DR   PROSITE; PS50846; HMA_2; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cell membrane; Copper; Copper transport; Ion transport;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Translocase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..747
FT                   /note=""Probable copper-transporting ATPase PacS""
FT                   /id=""PRO_0000046160""
FT   TOPO_DOM        1..101
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        102..122
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        123..132
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        133..151
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        152..158
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        159..179
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        180..199
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        200..220
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        221..348
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        349..371
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        372..378
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        379..396
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        397..688
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        689..708
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        709..720
FT                   /note=""Extracellular""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        721..739
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TOPO_DOM        740..747
FT                   /note=""Cytoplasmic""
FT                   /evidence=""ECO:0000255""
FT   DOMAIN          3..69
FT                   /note=""HMA""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00280""
FT   ACT_SITE        434
FT                   /note=""4-aspartylphosphate intermediate""
FT                   /evidence=""ECO:0000250""
FT   BINDING         14
FT                   /ligand=""a metal cation""
FT                   /ligand_id=""ChEBI:CHEBI:25213""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00280""
FT   BINDING         17
FT                   /ligand=""a metal cation""
FT                   /ligand_id=""ChEBI:CHEBI:25213""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00280""
FT   BINDING         634
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT   BINDING         638
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT   CONFLICT        366
FT                   /note=""V -> L (in Ref. 1; BAA03907)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        386
FT                   /note=""L -> M (in Ref. 1; BAA03907)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   747 AA;  79700 MW;  125EFF764BEF17D9 CRC64;
     MVNQQTLTLR GMGCAACAGR IEALIQALPG VQECSVNFGA EQAQVCYDPA LTQVAAIQAA
     IEAAGYHAFP LQDPWDNEVE AQERHRRARS QRQLAQRVWV SGLIASLLVI GSLPMMLGIS
     IPGIPMWLHH PGLQLGLTLP VLWAGRSFFI NAWKAFRQNT ATMDTLVAVG TGAAFLYSLA
     VTLFPQWLTR QGLPPDVYYE AIAVIIALLL LGRSLEERAK GQTSAAIRQL IGLQAKTARV
     LRQGQELTLP ITEVQVEDWV RVRPGEKVPV DGEVIDGRST VDESMVTGES LPVQKQVGDE
     VIGATLNKTG SLTIRATRVG RETFLAQIVQ LVQQAQASKA PIQRLADQVT GWFVPAVIAI
     AILTFVLWFN WIGNVTLALI TAVGVLIIAC PCALGLATPT SIMVGTGKGA EYGILIKSAE
     SLELAQTIQT VILDKTGTLT QGQPSVTDFL AIGDRDQQQT LLGWAASLEN YSEHPLAEAI
     VRYGEAQGIT LSTVTDFEAI PGSGVQGQVE GIWLQIGTQR WLGELGIETS ALQNQWEDWE
     AAGKTVVGVA ADGHLQAILS IADQLKPSSV AVVRSLQRLG LQVVMLTGDN RRTADAIAQA
     VGITQVLAEV RPDQKAAQVA QLQSRGQVVA MVGDGINDAP ALAQADVGIA IGTGTDVAIA
     ASDITLISGD LQGIVTAIQL SRATMTNIRQ NLFFAFIYNV AGIPIAAGIL YPLLGWLLSP
     MLAGAAMAFS SVSVVTNALR LRQFQPR
//
",13064
ACCAAT CCAATG CAATGT AATGTG ATGTGG TGTGGA GTGGAA TGGAAC GGAACT GAACTG AACTGG ACTGGC CTGGCC TGGCCA GGCCAA GCCAAG CCAAGC CAAGCG AAGCGC AGCGCG GCGCGT CGCGTC GCGTCG CGTCGG GTCGGA TCGGAA CGGAAT GGAATT GAATTT AATTTC ATTTCG TTTCGC TTCGCC TCGCCG CGCCGC GCCGCC CCGCCG CGCCGC GCCGCC CCGCCC CGCCCT GCCCTG CCCTGT CCTGTC CTGTCT TGTCTG GTCTGC TCTGCG CTGCGG TGCGGC GCGGCG CGGCGT GGCGTG GCGTGT CGTGTG GTGTGC TGTGCG GTGCGG TGCGGA GCGGAC CGGACT GGACTC GACTCT ACTCTG CTCTGG TCTGGA CTGGAG TGGAGG GGAGGA GAGGAA AGGAAG GGAAGA GAAGAG AAGAGG AGAGGG GAGGGC AGGGCT GGGCTA GGCTAC GCTACA CTACAT TACATC ACATCA CATCAC ATCACC TCACCG CACCGG ACCGGC CCGGCT CGGCTA GGCTAT GCTATC CTATCG TATCGA ATCGAG TCGAGG CGAGGT GAGGTC AGGTCT GGTCTG GTCTGC TCTGCT CTGCTC TGCTCG GCTCGA CTCGAT TCGATC CGATCC GATCCG ATCCGC TCCGCG CCGCGC CGCGCA GCGCAA CGCAAG GCAAGC CAAGCT AAGCTT AGCTTG GCTTGG CTTGGC TTGGCT TGGCTT GGCTTC GCTTCG CTTCGA TTCGAC TCGACG CGACGT GACGTC ACGTCA CGTCAC GTCACC TCACCG CACCGT ACCGTC CCGTCT CGTCTT GTCTTC TCTTCG CTTCGC TTCGCT,3,142,ACCAT CA A CAC CCACAAAA A CAATT A AAAATATG GGG A ATATGTGTT T TGTGTGTGTG G G GTGTGTGGGG G TTGGGGAGA A GTC GGAAA A G GAAAC CCC AAACACTCT  ACACTCTGTG G C CTCTGGG G T TG ATCG GC C GC GAA TG CG GCC GCC CCCACA  CCCCACAAAA A C CACAAAAGAG CGT AAGATAGCGC C A AGAGCTTCCG G G GCGCGCGCT CC G CGCGCGCGCG  TC GCGCGGT T C CGCGTTC C C GTGTCTCGCG G T TCTCGCGGGG G C CGCGGCTGT T TC GGGGAGAAGGCA G GAGAAGAGAT T A AAAATATTTT T ACTGATTTTTTT  TA TTTTTTTCTC C T TTTTCTCGGGCTCTTCGCG ACG CGCGCGCCCG C G GCGCCCG G CG GCCGCGCGC CTT CGGCCCC C GGGAGCCCCGCG G C CCCCGGC  CGCGCGCCCC C G GCGCCCCCCC C C CCG GCT T C CCCCTTC TG G C CT ATTGTTC T T TGTGTGTCGAGC G GTGTCTCTCT  CGTCTTG G C CTCTGTGCGC  CGG TGCG TTTGG GCGCGCGGCGGG C CGGG GGCGC  CG GGGGCGCGCG  GCGCGTGTGT GC  CGCGTGTGAAGG G GTCATTGTGT T T TGCGTGTGTGCG G GTTGCGC C T TGTGCGCGCGCG GTC  TGCGGGG G C TCCGGGGAGA A G GGGGAGACC G GAGACACTCT T A ACC TCTC GGC C CTTCTCT GA  TCTCT CTGA  CTCTGTGGGG C AGCG GAGGAGA A G GG GCGAGAG G G GAGAGAGGGG G A AGAGGGGAGA A G GGGGAGAAAA A G GAAAGG A AAAGAGA A AGAGAG G GGAGAGGGG G AGCGAGGGGGGG G G GGGGGGGCGC C G GGGGCCT  GCGCTCTATA CTATACAC G C TATACCA A A ACACACATCCAT C CAG AATCTC C ATGGATCTCACA A T TCTCACACAC C C CACACACCC A ACACCCCGCG C T CCCGGGG G CGC CGGGGCC TC G GGGGCGCTCT T G GCGCTCTATA A CCTGTCCTATAT T TT TTATATCGT C A ATATCTCGCG G T TCTCGCGAGA A C CGCGA GCAG  CC GA TGAGGGG GTG AGT GGGTGT T GGGTGTCCTGC G GTGTCTCTCT T T TCTCTCTGTG G CGGATGCGC  TGTGCGCTCT  GCGCTTC C C CTCTCTCGCG TCGA C CGCGAAAGCA AGG GAGATTC G T ATATCTCCCC C T TCCTACCGCG G C CCCGCGC C C CGCGC AGG G GCGC C TCGCCA A G GCGCACAAA C CACAAAAGAG G A AATT AGCGC C A AGAGCGCTCT T G GCGCTCTTTT ACACTTTTGTG G T TTAT G GGG A T TGTGGGGCGC T C GGGGCGCTCT T G GCGCTGCCTT  CTCTTTTCTC C T TTGCGTCGCCCTCGCGAGA A C CGCGAGACAC  GAGACAGA CAG AACGCGTGT  CGCGTGTCTC C G GTTCAAT AATTCACACAC C C CACACACCCC C A ACACCCCGCG G C CCCCGG AGT T CC GCGTGTCTC C G GTGTCG TCT T T TCTCTAAGT C CTCTTTTCC CCG TTCTCGCG G T TCTCGCGCGC C C CGGCT,ACCCAAGCT CCCCACAAAATAT T C CATGCATGTG G A AAAATATGTGTGT T A ATTGTGTGTG G T TGGG TGGGG  GTTGGTC TGGT GAA A G GGGAAAACAC C G GAGAAGCG CGT A AAACTCTGTG T G ACACTCTGTGGGG G CAAGTC TGGGGCGC C T TGTGGC GC GATCGGCCCACA A G GCGCCCCATGGCGGA C CCCCACAAAAGAG  CACAA CTAGCGC C A AAAGCGCGCG G A AGAGCGCGCGCGC C G GCGCGCGCGCGCG  TT CGGCGCGTGT T G GCGCGCGTGTCTC C C CGTGCTCGCG G GCGGGG G T TCTCGGGAGA  CGCGGGC GAAAA A G GGGGAGAAAT GGACG GAAAATATTGG T A AAAATATTTTTGACT A ATATTGGCTTCTC ATC TT CTTTCTCGCG G TG CTTCTCGCGCGC C TCGCGCTCGCGCCCC C C CG TCGCCCCGCG G G GCGCCCGCGGAC C CCCCGCGCGCCCC C CCT CGCGCCCCGCG G G GCGCCCCGCGCCCGC CCCGCGCGCCCC ACG CTCGCGCCCCCCC CTT GC TGCCCCCTCT T C CCCCCCCTCTGTG G CCCTCTGTGTGT T C CTC CGTCG CTGTTCTCT T G GTGTCTTCCTGGGAG TACACATTGTAATC C GACTGTGCGCGCG G TAT TGCGCGCGGTT  GCGCGAA GC C CCGGGGCGCGCG G G GGTTTGCGGCAGT T G GCGCGCGTGTG CT CGCGTGCTTGTGGGT GGTGGT GTGTG G T TGGTGTGCGC C G GTGTGGTCC CCGG TGTGCGCG CGG G GCGCGCGGGGAGA  CGG TGGATT AC CGC GGGGAACTGG T GGACACTCTCTGGTT TCTCTCCT T C CTCTCTCTCTGTG G T TC ACCTGTGGGG G C CTCTGTGGGGAGA TC  TGTG AGCAG TCTGGAGAGAGGCT G G GAGAGAGGGGAGA A A AGAGGGGAGAAAA TAT GGGGAGAAAAGAG G G GAAAGAGAGA A A AAAAGAGAGAGG A AGAGAGAGAGGTGTG G GAGAGAGGGGGGG G AGGGGGCGC C G GGGT GGCGCTCT T G GGGGCGCTCTATA A G GCTGGCTAC CC C CTCTAC TGC CA A T TATACCATT A ACACACATTC C C CACTG GGTCACA A A ATATCTCACACAC C T TCTCACACACCC CCACACCCCGCG G A ACACCCGGGG G CCTCGC CGGGGCGC CTG CGCGGGCTCT T G GGGGCGCTCTATA A G GCAT  GAA GAT T C CTCTAATCTC C TGTGTATC TTCGCG G A ATATCTCGCGAGA A T TCTCGGAGAG G C CGCGAAGGCG G G GACGCGGTCCGT AAGGGGTGTCTC C G GGGGTGTCTCTCT  GTTCTCTGG T TCTCTCTGGC C CG CCTGCC A C CCGT  TGTGCGTGCTCTC C G GCCT TCGCG G C CTCTCTCGCGAGA  TCTCGCGAGATT C CGCGAGATATCTC C GCTAGATATCTCCCC C A ATATCTCCCCGG CT A TCTCCCCGCGCGC TAC CCCCGCGCGCGCG G C CGCGCGCGTGCGC C G GCGCGCGCCGTCG A C CGGCACAAA G GCGCATGTG AAG C T CACAAAAGG GC A AAAAGGAGTCGCT T A AGAGCGCTCTTC AAAG GCGCTCTTTTGTG GC  CGCTTTC A TGG G T TTTTGGC G C TGGCTT GGCTGGC GGGGCGCTCTTTT T G GCGCTCTTCCGCTGC CTCTTTCTCGGG G T TTTTCTCGCGAGA  TCTCGGAC TAC C CGGACACGCG G GTTTGACCGTT TG T ACCGTGTCTC GG CGTGTCTCACA A G GTGTCTCACACAC C T TCTCACACACCCC C C CACACACCCCG GAG A ACACCCCGCGTGT T C CCTGCCGTGTCTTGCG CGTGTCTCTCT T G GTAACTCTTT T T TCTCTCTTTTCA T CTTTCCG G T TTTTCTCGAGG TGTAC TCTCGGCT,ACCGTGGGAAATAT  CCCCACAAAATATGTG G CCC CAAAATCTGTGTT A AAAATTCTGTGTG G A ATGCGTGTC ATGGGG G T TGTGTGTGTGGCCA AGA G GTGTGTGGGGAGAAC TA TAG TGGGGAGAATCGAC C GGGAGAAAACACTCT GGA GAGAAAACACTCTGTG AGA AAAACACTCTGTGGGG  ACACTCTGTGGGGCGC C C CTCTGCAACGGGCCCC  CGGGCCT A G GGCTTGCCCCACAAAA A G GCCCACAAAAGAG G AGGACAAC CCAAAAGGCGCG G A AAAAGAGCGCGCGCGC C AACAAGCGCG GTGTCCG GGC GCGCGCGCGCACGTGT T C CGCGCGCGCGTGTCTC C G GCGCGCGTGTCTCGCG G C CGCGTGTCTCGAA GG G GGTCAGACGGGGAAGG TCTCGCGGGGAGAAAA  TC CGCGTGGAGAAAATCCAT G GGGGAGAAAATATTTT  GAGCGAATGGATT T A AAAATATTTTTTTCTC C ACACCGATTTTTCTCGCG G TAACTTTTTCTCGCGCGC C T TTTTCTCGCGCGCCCC C T TCTCGCGCGCCGGACG G C CGCGCGCCCGCGC C G GCGCCG GCGCGCCCC C C CCCCG CTGCCCG CGCGCCCCGCGCGC C G GCGCCCCGCGCGCCCC  CCCCGCGCCCCG CC CCGCGCCCCCCCTCT T GC CGCCCCCCCTCTGTG  CA CCCCCCCTTGTGT T C CCGTCCTGGGGGTCTC C C CTCTGTGT GCCT T T TGTGTTCTGAGTG G G GTTCTCTGTGCGC C T TCATGCTGTGCCG G C CTCTGTGCGCGGA GG G T TGTGCGCGG GGGCC GAGCGCGCGGGGCGCGCG G C CGCGGGGCGCGCGGGT T G GGGGCGCGCA GTGA CG G GCATG ATGTG CT CGCGTGTGTGTCCATG G G GTGTGTGTGTGGC C T TGGCGGTGGCGCG CTA GTGTGTGCGAACGGGG TTG TGGAAGCGCGGT GGA  CT GCGCGCGGTCAGACCTTC C CCCGGATTGACCT  AG GGGACACTCTCTC C G GAGACCTCTGGCT AG AG T GTCTCTGTG G C CTCTCCTGGCTGG G T TCTCTCTGTGGGGAGA A CCGCCTGTGGCCGGAGGCTG T TGTGGGGAGTCAGGGG CGG GGGGACTGAGGGGATACA G GAGAGGAACTTA A CCGA GGAGAAAAGAG  GGCAAGAAAAGGA T T GATGCAAGTCGGAG AC AAAAGAGAGAGAGGGG G AGA  TCGAGAGGGGGGG G G GAAGGGGGGGCGC C A AGAGGG CCTTGCTCT T GGGGGGCGCTCTATA A G GGAGGGCTG GAC  CG GCGCTCTAACTACACA A T CTCTATAC AGCATAT T T TATACACACATATCTC C A ACACACATATCTCACA  CATCTCATATCGGACACTCTC ACGTATCTCACACACCCC C T TCCACACCCCGCG TGT CA ATACCCCGCGGGG T A ACACCCCGCGGGGCGC C C CGCCGCGGGGCGCTCT T C CGCGGGGCGCTCTATA C T GGGGCTCTCTATATAT T G GCTG CTATATATCTC C C CTCTATATATCTCGCG G T TATATATCTCGCGAGA A A ATATCTCGCGAGAGAG G T TCTCGGCCGAGAGGGG G C TGCGAGAGGGTGT T G GAGAGAGGGGTGAGTC GTGT GAGGA GGCTCT T G GGGGTGTCTCTTG G G GTTGTCTGTGCGC C TG ATCTCTGGCTCGT GGGT CTGTGCGCTCTCTC C T TGTGCGCTCTCTCGCG G G GCGCTCTCCGCGA TCC CTCTCTCGAT A CCCGGATATCTC  GC CGCGAGATATCTCCCC C G GAGATATCTCCCCGG A ATATCTCGCGCGC GGC TCTCCCCGCGCGCGCG G C CCC GGCGCGCGC C C CGCGCTGTCGAGCACA A G GCGCGCGCCAAAA A C CGCGCGCACAA TGG GTCTGCGTGGAAGAGCGC GC  CACAA GCACTCT T A AAAAGAGCGCTGGCTT  CC AGAGCGCTCTTTTGTG G G GCGCTCTTG TTGGGG G C CTCTTTTGGC A G TTTTGTGGGGCGCTCT GGTTGGCGCGCTCTTTT T G GGGCTTTCTC C G GCGCTGGCTTC TTCG G C CTTTCTCGCGACGGA T TTTTCATTGACAC  TCGACACGCG G C CGCGAGACCGTGT CTC GAGACACGCGTTC C A ACACGCGTGTC GTCA A CC GCGTGTCTCACACAC CCGG GTCACACCC C T TCTCACACACCCCGG CCACACCCCGCGTGT T A ACACCCCGGTCTC C C AGCCGCGTGTCTCTCT T C CGCGTGTCTCTCTTTT T GTCAAC AC TTCTC  TCTCTCTTTCGCG G CA GCTTTTCTCGCGCGC C T TTTTCTCGCGCGCT,ACCCCACAAAATTG G C CCCCACAAAATATGTGTGT T C CACAAAATATGGGCG A CTAATACAGTGTGG TAG A ATATGTGTGTGTGGGGAGA A T TGTGTGTGCTGGGAGAAAA A G GTGGCTGGGGAC CAACAC C T TG CGGGAGAAAACACCCT T G GGGGAGAAAACACTCTGATTG G GAGCTAACACTCGGCTGGG G AAACCTGTGGTCTGC C A ACACTGAGGGCGCCCC C CA TCTGTGGGGCTGTCCAA T TGTGGGGC AGCCA GAAA A GGGCGCCCCACAAAAGCGGG G GCCCACAAAAGAGCGGCCCACAAAAGAGCGCGCG G C CACAACTTAGCCGCGC C A AAAAGAGCGCGCGCGCGCG CTGCA AGCTAC CC GCGT T G GCGCGCGCGCG GGGTCTC C CCTGCGCGCGCGTCG T GCG G G GCGCGCGTGTCTCGCGGGG G C CGCGTT CTCGCGGCGAGA A G GTGTCTCGCGGGGAGAATGT TCGCT TCGGAGAAAATAT T C CGAATGGAGAACGGATTTT  GGGGAGCTAATATTTTTTT T G GACGGAATTG TTTTTCTC C G AA GCATTTTTTTCTCGCG G A ATTGGTTTGCGTCGATCGC C T CTTTTTTCTCGCGCGCCCC ACT TTTTCG TAGCGC GACG T TCTCGCGCGCCCTAGC C C CGCGCGCCCCGCGCGCCCC C GCGAGCCCGCCGCGCCCCGCG G C CCCCGCGCCCGCGCGC C C CGTTCGCCCCGCGCCC  GCGCCCCGCGCGCCCCCGGG CCCCGCGCGCCCCCT C CGTCGCCCCTGTG TATAC GCCCCCCCTTGGTGTGT T C TCCCCCCTACCGTCTC C C CCCCTCTGTGTGTCTCTCT CT T GTCGA TGTCTCTCTGTG  CT TGTGTGTCTCTCTGTGCGC C G GTGTCTCT GTTGCGCGCG G T CCTCTCTGGCGCGGGG G C CTGCGCGGGGCGC C T TGTGCGCGCGGGTGTTCCG G G GCGCGCGGGCGCGTT C CGCGGGGCGCGGTGTG G G GGGGCGCGCGTGTGTGTGT T G GCGCGCGTGTGGCCGTGG CTCGGTGTGTGTGTGCGC  CT GTGTGCCGGTGTGCGCGCG G T TGTTCGTGTGCGCGAG GG G G GTGTGTGCGCGGA A T TGTGCGCGCGGGCTGAC GCC GGCG GACGCGACACTCT GTCTGGCGGGGAGACACTCTCTC C G GGGGAGCTACTCTCTCTCTGTCG GAGACC TCTCTCTCTGTG G A ACTTGCTGTGGGG  TTCTCTCTCTGTGGGGAGA  CT TCTCT GATGGGGAGAGAG G CG ATGGGGAGAGAGGGG G TTGGGGAGAGAGGGGAA GGGAGAGCTTGGAGAAA GCGGTGGAGGGGAGAAAAGAG G A AGAGGGGAAGA CGA G GGGGAGCTAAGAGAGAGAG G GTACGAAAAGAGAGAGCACGG G A AAAAGGGCGAGAGGGGG ACG AGAGAGGGGGTCTGC CTAGAGAGGCC GGCGCTCT T ACGACTCGGGAGAGCTCTATA A G GGGGGGGCCTA GAAC C G GGGGCGAACTATACACACA A G GCATCGCGACACATAT T C CTCCGTAC GCCATCTATC C T TATACACACATATCTCA AGA A ACTGTCATATCTCACACAC C CCATATCTCACACTGTCC C A ATATCTCACACACCG GCG G T TCTCACACACCCCGCGGGG G C CACACACCCCGGGCTCTC A ACCTCCTTCGGGGCGCTCT  CCCCGCGGGGCGCTACTTA A C CGCGGGCTT CTATAT  CT GGGGCGCTAGGTATTC C GACATGCCTAG GTCGCG G CCTATATCGCTCG CGGA AG GG TATATC CGCGAGAGAG G A ATATCTCGCGAGAGAGGGG G T TCTCGCGAGAGAGGGGTGT CTACGAGAGGACCT TC C GCTGGAGAGGGGTGTCTCTCT T AGCCAGGGGTGTCTCTCTGTG G GCGTGGTGTCCTGGC GTCTCTTGCGCTCT T TGAATCTCTGTGCGCTCTCTC C C CTCTGTGCGAATCGCG G T TGTGCCTC ACGGAGA A G GCGCTCTCCGC AGGATAT  CTACCTCGCGAGATATCC T TCTCGCGTGATATCTCCC C CGCGAGATATCTCCCCGCG  GAATCTCCCCGCGCGC C A ATATCCGCGCGCG G T TCTCCCCGCGCATTCGCGC C C CCCCGGGAGCGCCGGCACA A C CGCGCGCGCGCGCACAAAA A G GCGCGCGCGCACCGA TTCA CGCGCGCACAAAAGC AGC C G GCGCACAAAAGAGCCG T CT C CACAAAAGAGCGCTCTTTT T A AAAAGCGCCTTTTGTG G A AGAGCGGACTTTTGTGGGG CAAAATGCTCTTAGGTGGC CGCCTTG AACTTTGGGCTCT T T TTTTGGGCTCGCTTTT T T TGTGGGGCGCTCTTTGTTC C G GGGGCGCTCTTTTCTCGGTCG G GCGCTCTTTTCTCGCGAGA A C CTCTTTTCTCGCGAGACAC C T TTTTCTCGCGAGACACGCG G T TCTCGCGAAGGACGGT CCT CGCGAGACCGTGTCTC C G GAGACACGCGTGTCG CCA A ACTGCGTGTCAC C CCGTGTCTCACAAACCCC C AGTCCACACCCCGCG G T TCTCACACACCCCGCGTGT T C CACACCTACCGCGTGTCTC AGCGG ACCCCGCGTGTCTCTGGTT CCCGCGTGTCCTTTT T C CGGTCTGTCT TTCC GGCGGTCGGCAGGCGCTCGCG G T TCCCGTTCTCGCGCC C CTCTTTTCTCGCGCGCT,"ID   LRP_RHIME               Reviewed;         156 AA.
AC   P56901;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 1.
DT   27-NOV-2024, entry version 132.
DE   RecName: Full=Leucine-responsive regulatory protein;
GN   Name=lrp; OrderedLocusNames=R01568; ORFNames=SMc01223;
OS   Rhizobium meliloti (strain 1021) (Ensifer meliloti) (Sinorhizobium
OS   meliloti).
OC   Bacteria; Pseudomonadota; Alphaproteobacteria; Hyphomicrobiales;
OC   Rhizobiaceae; Sinorhizobium/Ensifer group; Sinorhizobium.
OX   NCBI_TaxID=266834;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=RCR2011 / SU47;
RX   PubMed=11157937; DOI=10.1128/jb.183.4.1248-1258.2001;
RA   Lagares A., Hozbor D.F., Niehaus K., Pich Otero A.J.L., Lorenzen J.,
RA   Arnold W., Puehler A.;
RT   ""Genetic characterization of a Sinorhizobium meliloti chromosomal region
RT   involved in lipopolysaccharide biosynthesis."";
RL   J. Bacteriol. 183:1248-1258(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1021;
RX   PubMed=11481430; DOI=10.1073/pnas.161294398;
RA   Capela D., Barloy-Hubler F., Gouzy J., Bothe G., Ampe F., Batut J.,
RA   Boistard P., Becker A., Boutry M., Cadieu E., Dreano S., Gloux S.,
RA   Godrie T., Goffeau A., Kahn D., Kiss E., Lelaure V., Masuy D., Pohl T.,
RA   Portetelle D., Puehler A., Purnelle B., Ramsperger U., Renard C.,
RA   Thebault P., Vandenbol M., Weidner S., Galibert F.;
RT   ""Analysis of the chromosome sequence of the legume symbiont Sinorhizobium
RT   meliloti strain 1021."";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9877-9882(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=1021;
RX   PubMed=11474104; DOI=10.1126/science.1060966;
RA   Galibert F., Finan T.M., Long S.R., Puehler A., Abola P., Ampe F.,
RA   Barloy-Hubler F., Barnett M.J., Becker A., Boistard P., Bothe G.,
RA   Boutry M., Bowser L., Buhrmester J., Cadieu E., Capela D., Chain P.,
RA   Cowie A., Davis R.W., Dreano S., Federspiel N.A., Fisher R.F., Gloux S.,
RA   Godrie T., Goffeau A., Golding B., Gouzy J., Gurjal M., Hernandez-Lucas I.,
RA   Hong A., Huizar L., Hyman R.W., Jones T., Kahn D., Kahn M.L., Kalman S.,
RA   Keating D.H., Kiss E., Komp C., Lelaure V., Masuy D., Palm C., Peck M.C.,
RA   Pohl T.M., Portetelle D., Purnelle B., Ramsperger U., Surzycki R.,
RA   Thebault P., Vandenbol M., Vorhoelter F.J., Weidner S., Wells D.H.,
RA   Wong K., Yeh K.-C., Batut J.;
RT   ""The composite genome of the legume symbiont Sinorhizobium meliloti."";
RL   Science 293:668-672(2001).
CC   -!- FUNCTION: Mediates a global response to leucine. Exogenous leucine
CC       affects the expression of a number of different operons; lrp mediates
CC       this effect for at least some of these operons (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF193023; AAF06012.1; -; Genomic_DNA.
DR   EMBL; AL591688; CAC46147.1; -; Genomic_DNA.
DR   RefSeq; NP_385674.1; NC_003047.1.
DR   RefSeq; WP_003529557.1; NC_003047.1.
DR   AlphaFoldDB; P56901; -.
DR   SMR; P56901; -.
DR   EnsemblBacteria; CAC46147; CAC46147; SMc01223.
DR   GeneID; 89575894; -.
DR   KEGG; sme:SMc01223; -.
DR   PATRIC; fig|266834.11.peg.2994; -.
DR   eggNOG; COG1522; Bacteria.
DR   HOGENOM; CLU_091233_0_3_5; -.
DR   OrthoDB; 9811243at2; -.
DR   Proteomes; UP000001976; Chromosome.
DR   GO; GO:0005829; C:cytosol; IEA:TreeGrafter.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0043200; P:response to amino acid; IEA:TreeGrafter.
DR   CDD; cd00090; HTH_ARSR; 1.
DR   FunFam; 1.10.10.10:FF:000186; AsnC family transcriptional regulator; 1.
DR   Gene3D; 3.30.70.920; -; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR011991; ArsR-like_HTH.
DR   InterPro; IPR000485; AsnC-type_HTH_dom.
DR   InterPro; IPR011008; Dimeric_a/b-barrel.
DR   InterPro; IPR019888; Tscrpt_reg_AsnC-like.
DR   InterPro; IPR019887; Tscrpt_reg_AsnC/Lrp_C.
DR   InterPro; IPR019885; Tscrpt_reg_HTH_AsnC-type_CS.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR30154; LEUCINE-RESPONSIVE REGULATORY PROTEIN; 1.
DR   PANTHER; PTHR30154:SF34; TRANSCRIPTIONAL REGULATOR AZLB; 1.
DR   Pfam; PF01037; AsnC_trans_reg; 1.
DR   Pfam; PF13412; HTH_24; 1.
DR   PRINTS; PR00033; HTHASNC.
DR   SMART; SM00344; HTH_ASNC; 1.
DR   SUPFAM; SSF54909; Dimeric alpha+beta barrel; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00519; HTH_ASNC_1; 1.
DR   PROSITE; PS50956; HTH_ASNC_2; 1.
PE   3: Inferred from homology;
KW   Activator; DNA-binding; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..156
FT                   /note=""Leucine-responsive regulatory protein""
FT                   /id=""PRO_0000111734""
FT   DOMAIN          7..68
FT                   /note=""HTH asnC-type""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00319""
FT   DNA_BIND        26..45
FT                   /note=""H-T-H motif""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00319""
SQ   SEQUENCE   156 AA;  17413 MW;  278285498E0903B2 CRC64;
     MVVRVELDAI DMKILRELQD DGRITNVELA ERVGISAPPC LRRVRKLEEA GVIRGYRALL
     NASALGYDLV AFCMVGLKHQ SDANLKAFAA RTASWPLVRE AWMVSGESDF LLQCVAENLA
     SFQDFVIEEL TATENVDTVR TMLTIRQVKD ACQVEI
//
",4842
TCTAAA CTAAAC TAAACT AAACTG AACTGA ACTGAT CTGATA TGATAA GATAAA ATAAAT TAAATA AAATAT AATATT ATATTA TATTAT ATTATA TTATAA TATAAT ATAATT TAATTT AATTTG ATTTGG TTTGGT TTGGTT TGGTTT GGTTTT GTTTTT TTTTTA TTTTAC TTTACT TTACTA TACTAT ACTATT CTATTA TATTAA ATTAAG TTAAGT TAAGTG AAGTGT AGTGTT GTGTTT TGTTTG GTTTGC TTTGCC TTGCCT TGCCTA GCCTAG CCTAGG CTAGGT TAGGTT AGGTTC GGTTCT GTTCTT TTCTTT TCTTTA CTTTAA TTTAAT TTAATC TAATCT AATCTA ATCTAC TCTACT CTACTC TACTCA ACTCAA CTCAAC TCAACC CAACCG AACCGC ACCGCT CCGCTG CGCTGC GCTGCT CTGCTT TGCTTT GCTTTA CTTTAG TTTAGG TTAGGT TAGGTG AGGTGT GGTGTT GTGTTT TGTTTT GTTTTA TTTTAA TTTAAT TTAATG TAATGT AATGTC ATGTCT TGTCTA GTCTAA TCTAAT CTAATT TAATTT AATTTA ATTTAG TTTAGG TTAGGC TAGGCA AGGCAT GGCATG GCATGC CATGCC ATGCCT TGCCTT GCCTTC CCTTCT CTTCTT TTCTTA TCTTAC CTTACT TTACTG TACTGT ACTGTA CTGTAC TGTACT GTACTG TACTGG ACTGGT CTGGTT TGGTTA GGTTAC GTTACA TTACAG TACAGA ACAGAG CAGAGA AGAGAA GAGAAG AGAAGG GAAGGC AAGGCT AGGCTA GGCTAT GCTATT CTATTT TATTTG ATTTGA TTTGAA TTGAAC,0,142,TCTA CTAA TAAA AAAC AACT ACTG CTGA TGAT GATA ATAA TAAA AAAT AATA ATAT TATT ATTA TTAT TATA ATAA TAAT AATT ATTT TTTG TTGG TGGT GGTT GTTT TTTT TTTT TTTA TTAC TACT ACTA CTAT TATT ATTA TTAA TAAG AAGT AGTG GTGT TGTT GTTT TTTG TTGC TGCC GCCT CCTA CTAG TAGG AGGT GGTT GTTC TTCT TCTT CTTT TTTA TTAA TAAT AATC ATCT TCTA CTAC TACT ACTC CTCA TCAA CAAC AACC ACCG CCGC CGCT GCTG CTGC TGCT GCTT CTTT TTTA TTAG TAGG AGGT GGTG GTGT TGTT GTTT TTTT TTTA TTAA TAAT AATG ATGT TGTC GTCT TCTA CTAA TAAT AATT ATTT TTTA TTAG TAGG AGGC GGCA GCAT CATG ATGC TGCC GCCT CCTT CTTC TTCT TCTT CTTA TTAC TACT ACTG CTGT TGTA GTAC TACT ACTG CTGG TGGT GGTT GTTA TTAC TACA ACAG CAGA AGAG GAGA AGAA GAAG AAGG AGGC GGCT GCTA CTAT TATT ATTT TTTG TTGA TGAA GAAC,TCTAA CTAAA TAAAC AAACT AACTG ACTGA CTGAT TGATA GATAA ATAAA TAAAT AAATA AATAT ATATT TATTA ATTAT TTATA TATAA ATAAT TAATT AATTT ATTTG TTTGG TTGGT TGGTT GGTTT GTTTT TTTTT TTTTA TTTAC TTACT TACTA ACTAT CTATT TATTA ATTAA TTAAG TAAGT AAGTG AGTGT GTGTT TGTTT GTTTG TTTGC TTGCC TGCCT GCCTA CCTAG CTAGG TAGGT AGGTT GGTTC GTTCT TTCTT TCTTT CTTTA TTTAA TTAAT TAATC AATCT ATCTA TCTAC CTACT TACTC ACTCA CTCAA TCAAC CAACC AACCG ACCGC CCGCT CGCTG GCTGC CTGCT TGCTT GCTTT CTTTA TTTAG TTAGG TAGGT AGGTG GGTGT GTGTT TGTTT GTTTT TTTTA TTTAA TTAAT TAATG AATGT ATGTC TGTCT GTCTA TCTAA CTAAT TAATT AATTT ATTTA TTTAG TTAGG TAGGC AGGCA GGCAT GCATG CATGC ATGCC TGCCT GCCTT CCTTC CTTCT TTCTT TCTTA CTTAC TTACT TACTG ACTGT CTGTA TGTAC GTACT TACTG ACTGG CTGGT TGGTT GGTTA GTTAC TTACA TACAG ACAGA CAGAG AGAGA GAGAA AGAAG GAAGG AAGGC AGGCT GGCTA GCTAT CTATT TATTT ATTTG TTTGA TTGAA TGAAC,TCTAAA CTAAAC TAAACT AAACTG AACTGA ACTGAT CTGATA TGATAA GATAAA ATAAAT TAAATA AAATAT AATATT ATATTA TATTAT ATTATA TTATAA TATAAT ATAATT TAATTT AATTTG ATTTGG TTTGGT TTGGTT TGGTTT GGTTTT GTTTTT TTTTTA TTTTAC TTTACT TTACTA TACTAT ACTATT CTATTA TATTAA ATTAAG TTAAGT TAAGTG AAGTGT AGTGTT GTGTTT TGTTTG GTTTGC TTTGCC TTGCCT TGCCTA GCCTAG CCTAGG CTAGGT TAGGTT AGGTTC GGTTCT GTTCTT TTCTTT TCTTTA CTTTAA TTTAAT TTAATC TAATCT AATCTA ATCTAC TCTACT CTACTC TACTCA ACTCAA CTCAAC TCAACC CAACCG AACCGC ACCGCT CCGCTG CGCTGC GCTGCT CTGCTT TGCTTT GCTTTA CTTTAG TTTAGG TTAGGT TAGGTG AGGTGT GGTGTT GTGTTT TGTTTT GTTTTA TTTTAA TTTAAT TTAATG TAATGT AATGTC ATGTCT TGTCTA GTCTAA TCTAAT CTAATT TAATTT AATTTA ATTTAG TTTAGG TTAGGC TAGGCA AGGCAT GGCATG GCATGC CATGCC ATGCCT TGCCTT GCCTTC CCTTCT CTTCTT TTCTTA TCTTAC CTTACT TTACTG TACTGT ACTGTA CTGTAC TGTACT GTACTG TACTGG ACTGGT CTGGTT TGGTTA GGTTAC GTTACA TTACAG TACAGA ACAGAG CAGAGA AGAGAA GAGAAG AGAAGG GAAGGC AAGGCT AGGCTA GGCTAT GCTATT CTATTT TATTTG ATTTGA TTTGAA TTGAAC,TCTAAAC CTAAACT TAAACTG AAACTGA AACTGAT ACTGATA CTGATAA TGATAAA GATAAAT ATAAATA TAAATAT AAATATT AATATTA ATATTAT TATTATA ATTATAA TTATAAT TATAATT ATAATTT TAATTTG AATTTGG ATTTGGT TTTGGTT TTGGTTT TGGTTTT GGTTTTT GTTTTTA TTTTTAC TTTTACT TTTACTA TTACTAT TACTATT ACTATTA CTATTAA TATTAAG ATTAAGT TTAAGTG TAAGTGT AAGTGTT AGTGTTT GTGTTTG TGTTTGC GTTTGCC TTTGCCT TTGCCTA TGCCTAG GCCTAGG CCTAGGT CTAGGTT TAGGTTC AGGTTCT GGTTCTT GTTCTTT TTCTTTA TCTTTAA CTTTAAT TTTAATC TTAATCT TAATCTA AATCTAC ATCTACT TCTACTC CTACTCA TACTCAA ACTCAAC CTCAACC TCAACCG CAACCGC AACCGCT ACCGCTG CCGCTGC CGCTGCT GCTGCTT CTGCTTT TGCTTTA GCTTTAG CTTTAGG TTTAGGT TTAGGTG TAGGTGT AGGTGTT GGTGTTT GTGTTTT TGTTTTA GTTTTAA TTTTAAT TTTAATG TTAATGT TAATGTC AATGTCT ATGTCTA TGTCTAA GTCTAAT TCTAATT CTAATTT TAATTTA AATTTAG ATTTAGG TTTAGGC TTAGGCA TAGGCAT AGGCATG GGCATGC GCATGCC CATGCCT ATGCCTT TGCCTTC GCCTTCT CCTTCTT CTTCTTA TTCTTAC TCTTACT CTTACTG TTACTGT TACTGTA ACTGTAC CTGTACT TGTACTG GTACTGG TACTGGT ACTGGTT CTGGTTA TGGTTAC GGTTACA GTTACAG TTACAGA TACAGAG ACAGAGA CAGAGAA AGAGAAG GAGAAGG AGAAGGC GAAGGCT AAGGCTA AGGCTAT GGCTATT GCTATTT CTATTTG TATTTGA ATTTGAA TTTGAAC,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",12740
ATTTTA TTTTAA TTTAAT TTAATG TAATGA AATGAG ATGAGA TGAGAT GAGATT AGATTC GATTCT ATTCTT TTCTTT TCTTTA CTTTAC TTTACA TTACAG TACAGT ACAGTT CAGTTG AGTTGG GTTGGT TTGGTA TGGTAA GGTAAT GTAATG TAATGC AATGCT ATGCTA TGCTAA GCTAAG CTAAGG TAAGGA AAGGAA AGGAAG GGAAGC GAAGCA AAGCAA AGCAAG GCAAGA CAAGAA AAGAAA AGAAAA GAAAAT AAAATC AAATCT AATCTG ATCTGT TCTGTT CTGTTG TGTTGT GTTGTT TTGTTT TGTTTA GTTTAT TTTATG TTATGC TATGCA ATGCAA TGCAAC GCAACT CAACTG AACTGG ACTGGA CTGGAT TGGATT GGATTT GATTTA ATTTAT TTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTA GGTTAC GTTACT TTACTT TACTTC ACTTCT CTTCTA TTCTAC TCTACT CTACTT TACTTA ACTTAA CTTAAT TTAATT TAATTA AATTAT ATTATT TTATTG TATTGC ATTGCT TTGCTG TGCTGT GCTGTT CTGTTA TGTTAT GTTATT TTATTG TATTGG ATTGGT TTGGTT TGGTTT GGTTTA GTTTAG TTTAGG TTAGGA TAGGAG AGGAGC GGAGCT GAGCTA AGCTAT GCTATT CTATTG TATTGT ATTGTA TTGTAT TGTATT GTATTC TATTCT ATTCTT TTCTTA TCTTAA CTTAAA TTAAAT TAAATT AAATTC AATTCA ATTCAC TTCACC TCACCA CACCAG ACCAGA CCAGAG CAGAGG AGAGGG GAGGGT AGGGTG GGGTGC GGTGCT GTGCTC TGCTCA GCTCAA,2,145,ATTTTTTT T TCTTTTTTTTTT T T TTGAAAATTA A TTTCTTATAAAA A T GGTAAAATAT T A AAAATATGGAT ATATGTGAGA A TGTTTGAGAGAG G G GAG ACAAGA  CT AGAGAGGTAT T G CTTG ATTTT T A ATATTTTCG CC T TTTT TCTCT GG  TCTCT TTTT  GG CTTTTTT T T TTTTTTTATA A T TT TATACAAG TATACACACA A AACACAGAG TC C TCAGAGTT A AGGTTT G GTGTTTTGTG T TTTGTGGTTAG T TGTGGGGTGT T G GGGTAC C GTGTATAAAA A T TATAAAAT CTT A AAATGTG G ATGGATGTGCGC C T TGTGCGCTCT T G GCGCTTACG AA C CTCTATAAAA A T TATAAAAGAG C TGG AAGAGGGG G A AGA TGGAAA A G GGGGATTTAA TG  GAAAGAAGG A AAAC TA GC C A AGAGCGCACA A GA GGCAAGAAA A C CACAAAAGAG G A AAAG AGAGA CTA AGAGAGAAAA A G GAGAAAAAAA A A AAAAAAA A AAAAT A CTAATATCTC AAT ATATCTCTCT CTG TCTCTT TTG G C AATGTG TT TCTTTGTTTCA TT G GTGTTTTGTG GT  TTTTGGTTGT T T TGTGTTGTCCA GTGTTTTTT T TTT CTTATA A T TATATAT T T TAT GTG  ATTGCC T TGTGCGCACA  GC GCGCACAAAA A C CACAAAACAC C A AAAACACTCT T A ACACTCTGTG G C GACTGTGGGG G T TGTGGGGAGA A GGGAGGAGATAT ATGGT GATATTTT T A ATATTTTTTTCT TTTTTTATA AGG TTTTATATAT T T TATATATTT A ATATTTG G T TTC TTGGGG G T TG ATGT T G GGGGTGTTTT T GA CT TTA A T TTTTATACAC AATTTACTAACTCT T AT TACT TTTT T C CTCTT TTTC  CA TTTTCTCTCT T T TCTCTCTATA  GT CTA ATACAC C T TAACTCT T A ACACTTT T CA ACTTAGCA T TTTTATAAAA  CTTTATAAAATAT T A AAC TC TTT T A ATATTTTATA A T TTTTATATAT T T TATATATTTT T ATTGTG G T TTTTGTGCGC TTG TGTGCCT A G GCGCTCTGTG G C CTCTGGT G TTGTGTTTT T G GTGTTGC TA TT  TTTTATATAT  ACTA TATATTTT T A ATT ATTGTG G T TTTTGTGGGG G TTGGGGTGT T G TAGGT TGTT T G GTGTTTTTTT T T TTTTTTTATA TTT TT AATAGAG G T TATAGAGGGG GAG AGAGGGGAGA T GA T GGGAGAG G G GAGAGAGCGC C A AGAGCGCTCT T G GCGCTCTATA A C CTTATGTT TATATATTTT T A ATATTG GTG G T TTTTGTGTGT  TGTGTGTA TAA G GTGTAAT T T TATTGATTTT TTCTC TA  TTGTTTCTT T TCTCTCTTTT T CAT  TGTTAA T TTTTACACAA A T TATAATT GA A A AAAT ATT AATTAATTTT T A ATATTTTCTC C T TTTTCTCACA A T TCTCAAGGC C CACACCC C A ACACCCA A C CCAATCAGAG G C CACAGAGAGA A AAGAGAGAG TTG GAGAGG AAGGGGGGG G G GGGGGGGT GAT G GGGGT GTA GG GGTGGTGTGCGC C T TGTGCGCTCT  GCGCTCTCTC A GA TCTCTCACA A T TCTCACAA,ATTTTTGTTTT AAG TTTCTGG TTATA A T TTTTTA CAA A T TTTTATAAAATAT T T TATAAAATATGTG G A AATTAATGTGCGA A A ATATGTGAGAGAG G TATTTTGGAGAGAGA A GAATGAGAGA TTAT T A AGAGAGATATTTT T G GAGATATTTTCC AATTTTCGT CT  TTTTCCT CTTTT T TT TTCTCTTTT T CATTCTTTTTTTATA A T TTCTTTTATACAC C TTTATTATACCA A TTACACACAGAG  ACCTTACACAGAGTGT T C CACAGAGCGTTTT T A AGAGTC CA T GTGTTTTGTGGGG G TTTATTGTGGGGTGT T T TGTGGGGTGTATA A G GGGGTGTATAAA G GTGTATAAAATAT T T TATAAAATTG G A AAAATATGTGCGC GA  ATCTGA TGCTCT T TTGCGCTCTATA A GTGGGCTCTATAAA C CTTAAAAGAG G T TATAAAAGAGGGG G ATGGAGGGGAGA A A AGAGGGGATGCAA A G GGAACAG G G GAGAAAAGAGCC A AAT TAGCGCACA  TT AGAGCGCACAAAA A G GCGCACAAAAGAG G C CACAAGG  GTGA TTT AAAAGAGAAATAA A A AG TAAAAAA ATCGAAAAATG AA A A AAAAAAAA GAAT T AAAAAATATCTC C A AAAATATCTCTCT T A GATTTCTGTG G T TCTCTCTGGGGT C CTCTGTGTGTTTT T TTGTGTTTTGTG G G GTGTTTTGGT T T TTTTGTGT TTTT T T TGTGTGTTTGGTT T GAGAAA TTTTTATA A T TTA ATGGTATAT T TA TTTATATATGG T TAATG ACGC C A ATTGCGCAA T TGTGCCAAAA A GT GGCACAAAACAC C CCAATTACT T AAAC TGCTG CT ACACTATG ATG C CTCTGTGGGGAC AATT TGT TGGAGATAT  GGG GGATATTTT T G GAGATATTTT T AA GATTTTATA A T TTTTATAT TA TT TTTATATTTT T T TATATATTTTGTG G A ATATTATT GCTTTG TTTGTTAGGTGT T T TGTTTGGTGTT GCTATGGTTTTGAATA A G GTGTTTTATACAC C T TTTTATACCT T T TATACACTCTTTT T AACTCTTTTCTC GTT CTCTTTTCTCTTCTT TA ATTCTCTTA TT  TCTCTCTATACAC C C CTCTATACACTCT  TCAT TTAACTCTTTT T AACTTTTTTATA A C CTCTT TTTAAGTTA T TTTTATAAAATAT T T TATAAATTTT  AAAATATTTTATA GTG ATT CTTATATAT TGG TTTTA GGATTTGCTATAGGTTGTG G A ATGTTTTGTGCGC  TTTTGTGCGCTCT T T TGTGCTGAAAA GCGCTCTGTGTGT ACT CTTATGTTTT T T TGTGTGTTTTATA A G GTGTTTTAG AAT T T TTTTAATTTT T T TATATATTTTGTG TGG GATTGTGGG T TTTTGAAGGGTGAGT T TGTGGGGTGTTTT  GGGGTGTTTTTTT T G GTTGTTTTTTATA G G TTTTTAATTAGAG G T TTTAGAGGAAGG T TAATTGGAT G AGCA GGAGT AG CTG GGGGAAGCT TC GTAGGAGAGCGCTTATT A AGGCTCTATA  GCCTATATAT T CCTAG GATTTT A A TATATATTTTGTG G A ATATTGT T TGATTTGTGTGTAA T TGTGTCT AT T G GTGTATATATTTT T T TATATATTTTCTC C A ATATTTCTCT  TTTTCTCT ACTT T T TCTCTTTATA C C CTTTATAAAA A T TTTTATAAAAAAA  AAGAATAACTCAATAT T A AA ACAATATTTT T AA TAATTGATTCTC C A ATG ATTCTCACA TAA TTTTCTCACACAC C T TCTCACACCC  CACACACCCCAATTA AGAAACCCCACAGAG G C CCCCACAGAGAGA A C CACAGAGAGAGT TG A AGAGAGAGAGGGGA GAGAGAGGGGGGG G A AGAGGTGTGGTGT TCA GGGGGGC TG G G GGGGTGTGTTCGC C G GTGTGTGCGCT TGTGCGCTCTCTC C G GCGCTAAATCACA A T CTCTCT GCAA,ATTTTTTTATA A TTTTAGCTTAG GAA A T TTTTTTTATAAAATTTGTGATTATAAATGTG G T TATAAAATA TTAGTTG AAAATATGTGATACG A ATATGTGACTACTTGA ATG TG CTGAGAGAAT GGT GAGAGAGAGATATTTT T A AGAGAGATATTTTCTC C GGGGGATATTTA TCTCT T A ATATTTTCCTTTT T T TTTCTCTTTTTTT T T TCTCTCTTTTTTTACTGA C CTCTTTTTTTATACAC T T TTTTTTTAGAGACAA T TTTTATACACACAGAG G T TATACACAAG AGTTT CAGGTTTT T C CAGTTAGTGTTTTGG A AGAGTGTTTTGTGGGG TTT GTGTTTTGTGGGGTGT T T TTTTGTGGGTATA A T TGTGGTAAAA A GAGAGGTGTATAAAATT GGAAGTAAC AATATGG T TATAAAATATGTGCGC  AAAATATGTGCGCTCT T A ATTGCGCTCTATA A T TGACTGCTTAAAA A G GCGCTCTATAAAAGCAGG CTGACTAAAGG AGG G T TATAAAAGAGGAG GA A A AAGTTAGGTCAGAAAA A AAGGGGAAAGAG AGGATGGGAGAAAAGAGCCAAC G GATCTAAGAGCGCAAT A AGGT TTGCACAAAA ACT AGACTTGCCAAAAGAG G G GCGA A C CACAAAAGAGAGAGATTA A AATG AGAGAAAAAAA A A AG GGGAAAAAAA ATT GAGAAAAAAAAT A AAAAAAAAAATATCTC C A AAAAAGTGATCTCTCT T A AAAATATCTCTCTGGT  ATATCTCTCTGAATGT  TCTCTCTGTGTAA TTAT CGTGTGTGTTTTGTG G T TGTGTGTTTTGTGTGT T G GTCAGTTGTGT CTTT TA  TTTTGTGTGTTTTTTT  TGGTTTTTTTATTCA G GTGTTTTTTT TATAT TTTTTATAT GAAAGAA  TTTTATATT GGC C T TATATATGTGCGCACA A A AT GGTGCGCACAAG TA T TGTGCGCACAAAACAC C G GCGCACAAAACACTCT T C CATCTACTCTGTG AGGATTAACAGCCTGGA GG TGTAGGCTGTGGGGAGA A C CTCTGTGGGGAGATAT ATT TGTGGGGAGATATT GTT G GGGGAGATATTTTTTT T G GAGATATTTTTTTATA A A ATATTTATTAGT T TTGTGTTATATAT TT A C TTTTATATATTTTGTG G T TATATATTTTGTGGAGAG A ATATTTTGTGGGT T T TTTTGTGGGGTCTTTT  TGTGGGGTGTTTTATA A G GGTTATACC G GTTG TTATACCT T T TTTTAT T ACCAATT T T TATACA AAGATTCTC C AACTCTT AAGAACT T C CTCTTCTTCTATA A T TTTCTCTATGTC T TCTCTCTATACATTCT T CTTATACACTTG T TTAATACTGCGTTTTATA A ATAAACTCTTTTATAAA C CT TATGTTTAT T TTTTATAAATTTT T T TATAAAATATTTTATA TTG AAAATATTTTAAT CAA ATATTTTATATGCTTT T TGCTTTATATATTTTGG T TATATGTTTTGGCAGC C A ATATTA ATGCGCTCT T T TTTGCGCTCTGA TT T TGGTAGCTCTGTGTGT T G GCGCTTA TGTGTTTT T C CTCTGG AAAGTTATA A T TGTGTGTTTATAT T G GTGTTTTATATATTT T TTTTAATTTTGTG G T TAAC T T ACGG G A ATACTAGGTGGGGTGT T T TTTTGTGGGGTGTTTT T T TGTTTTT T G GGGGTGTTTTTTTAG TA G GTGTTG GTTAATTAG G T TTTTTTTATAGG GGG G T TTAT TAGA AGGAGA A T TATGGAGGGGAGAGAG G A AGTTGGGAGAGAGCGC  GGGGAGAGAGCGCTCT T GATGGAGAGCGCTCTATA A ACTTTATAT  GCGCTCTATATTT T C CTCTATATATTGTTG T TATATTTCTTGTGT ATATTAT TGTGTAA T TTTTGTGTGTATATAT T T TGTACGTATATA GTT T G GTGTATATATTTTCTC C T TAGCTATTTTCTCTCT T A ATATTTTCTCTCTTTT  TTAACCTTTAATA TG  TCTCTCTTTAAAA C T CTCTTTTATAATAAAA A TTTTTTATTAAAAAATTAC TAAAAAATTT T AGAGAAATC ATTTTCTC C A AAAATATTTTCTCAA A ATATTTTCTCACACTATC T TTTTCACCCC C TTCACACACCCCACA A C CACACACCCCACAGAG G AACCCCACAGAGAGA A CCCACAGAGAGAGGGAG C CACAGAGAGAGAGGGG G A AGGAGAGGGGGGG TAA GAAGGGGTGT T A AGAGGGGGGGTAATTG G G GG GAGGTGTTTGCGC C GGGTGTGTGCTATCT T GTTTTGCGCT TTC TTG TGCATTCTCGGACA A G GC TTCTCTCA AG,ATT TCTAGTTATAAAA A T TT ATTTTTTACCAAATTGTAG TTATAAAATG T TTTTATT AATATGA T TATAAG TTG TGAT TG A AAAATATTTGAGAGAGAA A ATTTCTGAGAGAGAGATAT AAC TGTGAGAGAGATATATTGTAGCAGAGAGAGATATTTTCTC C AGTTAGATAAATTTTCTCTCT T G GAGATTTCTCTCTTAATT ATTTATTTTCTTACTTT TAGTT T TT CTCTTTTTTTATA A TTACTCTCTTACTTTATACAC C C CTCTTTTATACCTCCA GGTGGGTTTTTAACACAGAG G T TTTTTCAGAGTGT T TTACACACAGAAGGTT ATTT  ACGGTTT GTTTG G CTGGCAGAGTGTTTTGTGGGG G A AGT AGTT CAGGTGT T A GTGTTTTG GG CTGTATA A T TTTTGCAAGTATAAAA A T TGTGGGGTTAAAT T GGGTGTATAAAATATGTG G G GTGTATAAAATTGCGC C T TATAAATGTGCGCTCT T A AACTG GTTGCGCTCTATA TTG ATAGGGCTCTATAATTAA T TGTGCGCTT TTAAAAGT TG G GCGCTCTATAAAAGAGGGG  CTCTATAAAAGTA TTT TAG AAGGGAAAA A A AAAAGAGGGGA GGAG G A AGAGGGGAGAAAAGAGCC G GGGGAGAAAAGAGCGCACA A G GAGAAATTAGCG AGGTAA C G AAAAGAGCCAGAG G A AGGCACAAAAGGA ATT GCCAAAAGAGAGAAAA A C CACAAAGTAGAGAAAAAAA  TA AAAAGCTGGAAAAAA A AGAGAAAAAAAAATAT T G GAGAAAAAAAAAATTC TTA AAAAAAAAATGATCTCTCT T A AAAAAAATATCTCTCTGTG G A AAAATTCTTGTT AATCTCTG TTGTGTTTT AGT TCTCT TGTGTGTTTTGCCAG C CTGTTTGTGT T T TGTGTTTGTGTGTTTT T G GTGTTTTGATGGTTTTTTT T T TTAT TGTGTTTTTAA TA A TGGAGTTTTATATAT T G GTGTTTTTTTATATATGTC  TTTTTTTATATTGCGC C T TTTTATATATGTGCT GCA A TA ATATATGTGCGCACAAAA A ATTAATGTGCGCATTGAACAC GA  TGTGCGCA TGT TCT T G GCGCACAAAACACTCTGTG G C CAAACACTAATGG AAG AAAACACTATTTGGGGAGA A A ACACTCTGTGGGATAT T CGGTTGGGGAGATATTACTT T TGTGGGGAGATTTTTT T G GGGGAGATATTTTTTTATA A G GAGATATTTTT TGTCT ATATTTTTTTATATATTTT  TTTTTTTATATATTTTGTG G T TTTTATATATTTTGTGGG TAA TATA GTTGTGGGGTGT T AAC ATTTTGTGGGGTGTTTT AG  TTTTGTGGGGTGTTTTATA A T TGGTTTTATACAC C G GGGGTTTATACTTTCT T GAATTTATACCTT TAT T TTTTATACACTCTTTTCAGAC T TAACTCTTTTCTATCT T A ACAG CTTTTCTCTCTAAGGA C CTT GTTCTCTCTAGGTC TTTCCTATACACTCT CTA TCTCTCTATACTT CTTT CAT CTATTATA A T TATACACTTTATAAAA  ACACTCTTAATTTGT C CTCTTTTATAAAATCTGTAAT T TTTTATAAAATATTTA A T TATAACTGATTTTAC GAT T ACTGATTC ATATATTTT T A ATATTA ATATATTTG G T TTTTATATGTTTTGTTTACC TATATATTA ATGCGCTCT T A ATATTTTGTGCGCTCTGTG G T TTCAATGCGCTAATTGTGT CT  TGTGC CTCTGTGTGTTT G GCGCTCTGTGTGTTTTATA A C CTCTGGTTTTATATAT T TCAATGTGTTTTATATATTT GTTAGATATTTTGTG G TTTATATATTTTGTGGG TTT TATATTTTGTGGGGTGT T ATT ATTTTGTGGGGTGTTT T TTTTGTGGGGTGTTTTTTT T TCTGTGGATTTTATTA CAA G GGGGTTGCTTTTTATAGAG G G GTGTTTGCTTATAGATGGG  TTTTATTTAGGGGAGA A T TTTAGGGAGAGACTG T TA GTAGGGGAGAGAGCGC C A AGAGGGAGAGCGCTT GTGGGGAGAGAGCGCTCTATA A G GAGAGAGCGCTCTATATAT T A AGAGCGCTCTATATATTTT GCA GCGCTCTATATATTTTGTG G C CTCTATATATTTTGTGTGT T TA ATATAAGTTGTGTAATTA A A ATATTAAATGTGTATATAT T T TTAATTGTG CTATTT T T TGTGTGTATCTATTTTCATG GTGTATTCTCTCT T T TATATATTTTCA TCTTTT T AATTTTCGGGCTTTTATA  TTTTCTCTCTTTCTAA TCT TCCTTTTATAA CCCTGTAAGCTCTTTAAAAAAATAT  TTTTATAAAAATTGT TAATATTTTCTC C A AAATGAATATTTCAA A AATT ATTTCACAC AT ATATTTTCTCAACCCC C T TTTTCCACGC CCACA A TAGGTCACACACCCCAAAGAG G C CACACACCGATCAGC T TA ACACCTG CAGAGAAG G CTTGGGTCAGAGAGAGAGGGG G CTA AGAGAGAGGTCTGG GCA AGGAGGGGGT T G GAGAGAGGGGGGGTGTGTG  AG TC TTGGTTGCGC C G GGCCAGTGGTTGCTCT T GGAAGGTTGCGCTACATC TT  GTGTGTGCGCTCTCTCACA A TTATGCTCTCTCACAA,"ID   ACTP_YERE8              Reviewed;         551 AA.
AC   A1JIK1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   05-FEB-2025, entry version 95.
DE   RecName: Full=Cation/acetate symporter ActP {ECO:0000255|HAMAP-Rule:MF_01426};
DE   AltName: Full=Acetate permease {ECO:0000255|HAMAP-Rule:MF_01426};
DE   AltName: Full=Acetate transporter ActP {ECO:0000255|HAMAP-Rule:MF_01426};
GN   Name=actP {ECO:0000255|HAMAP-Rule:MF_01426}; OrderedLocusNames=YE0307;
OS   Yersinia enterocolitica serotype O:8 / biotype 1B (strain NCTC 13174 /
OS   8081).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Yersiniaceae; Yersinia.
OX   NCBI_TaxID=393305;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 13174 / 8081;
RX   PubMed=17173484; DOI=10.1371/journal.pgen.0020206;
RA   Thomson N.R., Howard S., Wren B.W., Holden M.T.G., Crossman L.,
RA   Challis G.L., Churcher C., Mungall K., Brooks K., Chillingworth T.,
RA   Feltwell T., Abdellah Z., Hauser H., Jagels K., Maddison M., Moule S.,
RA   Sanders M., Whitehead S., Quail M.A., Dougan G., Parkhill J.,
RA   Prentice M.B.;
RT   ""The complete genome sequence and comparative genome analysis of the high
RT   pathogenicity Yersinia enterocolitica strain 8081."";
RL   PLoS Genet. 2:2039-2051(2006).
CC   -!- FUNCTION: Transports acetate. {ECO:0000255|HAMAP-Rule:MF_01426}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01426}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_01426}.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF) (TC 2.A.21)
CC       family. {ECO:0000255|HAMAP-Rule:MF_01426}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM286415; CAL10439.1; -; Genomic_DNA.
DR   RefSeq; WP_005175651.1; NC_008800.1.
DR   RefSeq; YP_001004688.1; NC_008800.1.
DR   AlphaFoldDB; A1JIK1; -.
DR   SMR; A1JIK1; -.
DR   GeneID; 31411460; -.
DR   KEGG; yen:YE0307; -.
DR   PATRIC; fig|393305.7.peg.400; -.
DR   eggNOG; COG4147; Bacteria.
DR   HOGENOM; CLU_018808_8_3_6; -.
DR   OrthoDB; 9764416at2; -.
DR   Proteomes; UP000000642; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015123; F:acetate transmembrane transporter activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0043879; F:glycolate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0006847; P:plasma membrane acetate transport; IEA:TreeGrafter.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   CDD; cd11480; SLC5sbd_u4; 1.
DR   FunFam; 1.20.1730.10:FF:000001; Cation/acetate symporter ActP; 1.
DR   Gene3D; 1.20.1730.10; Sodium/glucose cotransporter; 1.
DR   HAMAP; MF_01426; Acet_symport_ActP; 1.
DR   InterPro; IPR014083; Cation/Ac_symporter_ActP.
DR   InterPro; IPR038377; Na/Glc_symporter_sf.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   InterPro; IPR018212; Na/solute_symporter_CS.
DR   InterPro; IPR050277; Sodium:Solute_Symporter.
DR   NCBIfam; TIGR00813; sss; 1.
DR   NCBIfam; TIGR02711; symport_actP; 1.
DR   PANTHER; PTHR48086:SF6; CATION_ACETATE SYMPORTER ACTP; 1.
DR   PANTHER; PTHR48086; SODIUM/PROLINE SYMPORTER-RELATED; 1.
DR   Pfam; PF00474; SSF; 1.
DR   PROSITE; PS00456; NA_SOLUT_SYMP_1; 1.
DR   PROSITE; PS00457; NA_SOLUT_SYMP_2; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Ion transport; Membrane; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..551
FT                   /note=""Cation/acetate symporter ActP""
FT                   /id=""PRO_1000024343""
FT   TRANSMEM        34..54
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        77..97
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        104..124
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        150..170
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        184..204
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        207..227
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        263..283
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        304..324
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        356..376
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        406..426
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        430..450
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        469..489
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
FT   TRANSMEM        498..518
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01426""
SQ   SEQUENCE   551 AA;  59314 MW;  18C4D0FA7148EF17 CRC64;
     MKTRHWSVLS LLALPALSQA EAITGEVHRQ PLNIEAIVMF VLFVGATLYI TYWASKRTRS
     RGDYYTAGGR ITGFQNGLAI AGDFMSAASF LGISALVYTS GYDGLIYSIG FLIGWPIILF
     LIAERLRNLG RYTFADVASY RLKQRPIRTL SACGSLVVVA LYLIAQMVGA GKLIELLFGL
     NYHVAVVLVG ILMVMYVLFG GMLATTWVQI IKAVLLLAGA SFMALMVMKS VNFNFNTLFS
     EAVKVHPKGL SIMSPGGLVS DPISALSLGL ALMFGTAGLP HILMRFFTVS DAKEARKSVF
     YATGFIGYFY ILTFIIGFGA ILLVGPNPAF KDAAGALLGG NNMAAVHLAD AVGGSFFLGF
     ISAVAFATIL AVVAGLTLAG ASAVSHDLYA SVIKKGKANE RDELKVSKIT VVVLGFVAIG
     LGILFEKQNI AFMVGLAFSI AASCNFPIIF ISMYWEKLTT RGAMIGGWLG LLTAVILMIL
     GPTIWVTILG HAKPIYPYEY PALFSMIVAF VGIWFFSITD NSEEGQQERL RFKAQFVRSQ
     TGLGASQSSS H
//
",43038
TCCAAG CCAAGG CAAGGG AAGGGC AGGGCA GGGCAA GGCAAG GCAAGG CAAGGG AAGGGC AGGGCA GGGCAC GGCACC GCACCG CACCGC ACCGCT CCGCTG CGCTGG GCTGGC CTGGCG TGGCGT GGCGTC GCGTCA CGTCAT GTCATG TCATGA CATGAA ATGAAG TGAAGC GAAGCG AAGCGC AGCGCC GCGCCA CGCCAC GCCACG CCACGG CACGGC ACGGCT CGGCTT GGCTTC GCTTCG CTTCGG TTCGGC TCGGCG CGGCGG GGCGGT GCGGTA CGGTAT GGTATG GTATGA TATGAG ATGAGC TGAGCG GAGCGC AGCGCC GCGCCT CGCCTC GCCTCG CCTCGC CTCGCA TCGCAC CGCACG GCACGG CACGGT ACGGTA CGGTAC GGTACC GTACCC TACCCA ACCCAC CCCACC CCACCG CACCGC ACCGCA CCGCAA CGCAAG GCAAGC CAAGCA AAGCAC AGCACC GCACCG CACCGC ACCGCG CCGCGC CGCGCG GCGCGC CGCGCC GCGCCC CGCCCG GCCCGG CCCGGC CCGGCT CGGCTC GGCTCG GCTCGA CTCGAT TCGATC CGATCG GATCGG ATCGGC TCGGCC CGGCCA GGCCAG GCCAGT CCAGTC CAGTCG AGTCGG GTCGGC TCGGCC CGGCCA GGCCAC GCCACC CCACCC CACCCC ACCCCG CCCCGG CCCGGG CCGGGT CGGGTC GGGTCG GGTCGC GTCGCG TCGCGT CGCGTG GCGTGT CGTGTT GTGTTC TGTTCG GTTCGC TTCGCC TCGCCG CGCCGG GCCGGC CCGGCA CGGCAT GGCATG GCATGA CATGAA ATGAAG TGAAGA GAAGAT AAGATG,1,142,TCCCCA CGA C CCCCACAAAA A C CACAAG GG A AAAAGAGGGG G A AGAGGGGGGC G GG GGGGC GGC  TG GGGGCGCACA A G GCGCA AAA C CACAAAAGAG G A AAAAGAGGGG G AAGGAT GG G GG AGGGC CCGCC G GGGGCGCACA A G GCGCACACC CCGTCC C A ACACCGG CG G C CCCCGC CGC C C CACGCGCTCT TGGGCTCTGTG G C CTCTGTGGGG G T TGT GGGCGC C G GGGGCGCGCG  GCGCGCGTGT T C CGCGTGTCTC C GCC GTC GCCCG TCTCAAA T C CACATATGGCCG A ATA GGA CCG TGTGACATA G GAGAATG AG G A AAAAGAGCGC C A AGAGCGCGGC G G GCGCGGCGGC C C CGCGCGCCCC C G GCCCACA CCGCCACACAC C C CACACACGCG  GG ACACGCGGGG G CCGGGGCGC C GG CCCCGCTT G GCGA CTT GTT C CTCTTTTCTC C T TTTTCTCGCG G T TCTCGCGGGG G C CGCGGGGCGC C G GGGGCGCGCG G G GCCGCCGGGG G C CGA TGT T G GGGGTGTATA A GTT GTATATAT T T TATATATGG A ATGG TGAGGTA T TGTGAGAGG G GAGAGAGCGC C A AGAGCGCGCG G G GCGCGCGCTCA CGCGCTG CC CA GCCCCTT C CCCCTCTCTC C C CTCTCTCGCG GCA TCCGCGC C C CGCG GCACA A GGGCGCACACAC C C CACACACGCGCG A ACACCGG G C CGCGGGGTGT T G GGGGTGTAA CGTATACAC C T TATACACCCC  CG ACACCCCCGGCAA CCCCCA GCA C CCCCACACAC A CC CACCCC C A ACCCGCG G C CCCGGCGCGC C C CGCGCGCACA A GGCACAAAA A C CAAAGG A AAAAGAGCGC C A AGAGCGCACA A G GCGCAGCGC GTCG CACACAT CC  GT ACACCCCGG TCCC CCCCGCGCGC C C CGCGCCG G G GCGCGCGCGC  CG CCGCGCG  GG GCCGCCG C C CGCGCGCCCC C G GCGCCCCCCC C C CCCCCCA CG G C CCCG G CGG G C CGCGG GCGC C G GGGGCGCTCT T GGT CTCTC C C GGCTCTCGCG G T TCTCGCGAGCT CC CGCGAGATAT T G GAGATATCTC C A ATTCGCG G T TCTCGGC GG G C CGCGGGGCCGGAC  GGGGCGCCCC C G GCGCCCCACA A CG CCCACAGAG  CATC AGTGT  AGGTCGAAC G GTGTCTCGCG C TTCGCGGGG CGGCA GTTGC C G CTGGCCC C G GCGCCCCACA TA  CCCCACACAC C C CAACCC A ACACCGGCC C CCG CCC C C CCCCCCCGCG  CC CACCG GGC ACGGGGGGG G G GGGGGGGTGT T G GGG GGTCTC  GT GTGTCC C TTG T TCTCGGGCGC  CGCGCGCGTG GGT GCGCGCGCT C CAAAGAG  GTGTGTGTGT T T TGTGTGTTTT T G GTGGCTTCTC G TCG TTCTCGCG CG  TCTCGCGCGC C C CGCGCGCCCC C G GCGCCCCGCG G CA CCCGCGGGG G C CGCGGGGCGC ATG GGGGCGCACA GA  GCG TCATAT T C CGCATCCGG A ATATGTGAGA A TTGACAG CCA G GAGAAAAGAG G AAA AAGAGAGA A A AGGATGGGT GGATATG,TCCCCACAAAA A CTCGCCACAAAG G CCAAAAGAGGGG G TCCAAAGGGG GCG A AGAGGGGGTCGC G GGTCGGGCGCACA A GGGCGCACAAA G GCGCACAAAAGAG G CGGTCAAAGGGG G A AAAAGAGGGG CC AGGGGGGGCGC C G GGGGGGCAG GA G GGGGCGCAGTCC G GCCACACCGCT CACATACCCCGG A ACACCCCGGC CGCCCGCGCGCTCGGT C CGCGCGCTCTGTG TGAGTACG CTGGG  CTCTGTGGGT  TGGGCGCGCG G GAT GGCGCGC CT GGG GCGCGTGTCTC C CGGCCGTGCTTCACA TCGGTCTCACACAT T TAC TCACATATGTG CAC CACATATGGA A A ATG GAA A TACCTGAGAAAAGAG G G GAGAAAAGAGCC A AAAAGAGCGGTCG C GGCGCGCCGCC G GCGCGCGC TCC C CGCGCGCCCCACA  GCGCCCACAC C C CCCCACACACGCG G CG CCACACGCGGGG G A ACACGCGGGGCGC C C CGCGGGGCGCTTGAT G GGGGCGCTCTTTT T GA CGTCCTTTC C C CTCTTTCGCG G T TTTTCTCGCGGGG G T TCTCGCGGGGCC C CGCGGGGCGCGCG G G GGGGCGCGCGGGG G G GCGCGG CC TTTC CGCGGGGTA G GGGGTGTATATAT  CG GTGTAATGTG G T TATATATGTGAGA A A ATATGG TGAGAG G A TCTGAGAGAGCGC C GGT AGCGCGCG G A AGAGCCGCGC ACG GCCCTCCGCC C C CGCGCGCCCACCT T G GCGCCCCTCTCTC  CCGCGCTCTCGGCTG C CTCTCTCGCGC GCC T TCTCGCGCGCACA A CT GCGCGCACACAC C CGC GCACACC GCG  CACACACGCGGGG G A GTACGCT GT GTT CGGGGGTATA A G GGGGTGTATACAC C G GTGTATACACCCC C T TAGCCCCCCC C A ACGCACCCCCACA A C CCCCCCCAAGAAC GAT CCCCACACACCCC C C CACACACCCCGCG G A ACACCCCGCGCGC  CCCCGGCACA  GC CGCGGGCACAAAA A G GCGCAAAGAG GCG CACAAAAGC CGC C A AAAAGAGCGCACA A A AGAGCG CAC AGC GCGCACACACCCC C CCACACCCCGCG GGT ACACCGCCGC GC  CCCCGCGCGCGCG G C CGCGC CACGCGC C G GCCGGCGCGCGCG G C CGCGCGCGCGCGC C G GCGCGGCCCC C CCGCGCCCCCCC C G GCC TCCCCCGCG G C CCCCGCGGGG G C CCCCG CAGGCGC C CGGCC GGATT G GGGGCGCTCTCTC C G GCCC CTCTCGCG G C CTTCGGA A TTCGC C GGC A CGCGAGATATCTC C G GAGATATCGCACG  ATATCTCGCGGGG G T TCGGGAA CCGGC C C CGCGGGGCGCCCC C G GGGGCGCCCCACA A GCGCGCCCCACAGAG G C CCGT AGTCAGT C CACAGTC C A AGAGTGTCTCGCGCG G ACAC TCGCGGGG CT GC TCGCGCGGCC C CGCGGGGCGCCCC C G GGGGCGCC GC GCGCCCCACAC CGC C CCCCACACACCCC GT  CAACC TGCC  ACACCCCCCCCG AC G CCCCCCCGCG G C CCCCCCCGCGGGG G C CCGGCGCGGGGGG  CGCGGCGGGGTGAGT GGGGGGTGTCTC C G GGG AGTCCG G G GTGTCTCGCGCGC GCCACCGCGCG G C CGCGCGCGCGTT G GCGCGCGTTG G C CGCGTTGTGT T G GTGTGTGTGTTC CT T TGTGTGTTTTCTC GCTT CT C GTCG G T TTTTCTCGCGC TCC TTCGCGCGCCCC TT  CG GCGCCCCGCG CA  GCGCCT CCGGCCGCGGGGC TCC C AACGGGGCGCACA A GGGCGC CATCT T G GCGCACATATGTG  CC CACATATGTGAGA A A ATATGTGAGAAAA A T TGTGAGAAG G GAGAAAAGAGAGA A ACGAAAGAGAAT AT T AGATATG,AAGCCACAA ATG C CCCCAAAGGTCGG G C CACAAAAGC GGG G A AACGGGGGGGCGC C A AGCACGGGGGCGCACA A G GGTCGGGCGCACAAAA  GGGGCGCACAAAAGG GGCACAAAAGAGGG C CACAAAAGAGGTC GG G A AAAAGAGGGGGGGCGC C G AGGGCGGGGGCGCACGT GGGGGAGGGCACACAC C G GGGGCCACACCCC C G GCGCACACACCCCGCG G CTCGCACACCCGCGC C AGGGACCCCGCGCGCTCT T CAT CCGCGCGCT ACG C CGCGCCTGTGGG G GCGCTCACGGCGC C C CTCTGTGGGGCGCGCG TCGTGGGGCC CCGTGT AGTGGCGCGCGTGTCTT C G GCGCGCGTCA A C CGCGTCTGTCACATAT T G GTGTCGCCCATTG G T TCTCACATATGCTCGA CGG CAATGCCAGAAAA A A ATATGTGAGAAAAGAG G GCCGTGATCCAGCGC C GGAAAAGAGCGC A CG A AAAAGAGCCG C A AGAGCGCGCGCGCCCC C G TCGCGCGCGCCCCAGGGA C CGGCGGCC CGCACAC C A GCGCACCA CAACGCG G CCCACACACGCGGGG CACGT ACGCGGGGCC A ACACGCGGGGCGCTCT T C CGA CGGCGCTCTTTT T G GGGGCGCTCCCTTCTC CC  GCGCT TGTTCTCGC C CTCTTTTCTCGCGGGG TGA TTT ACGGGGCGC  GCCGGCG G C CGGGCCGCCGGGG G G GGGGCGCGCGGGTTT GGCTCGGGGTGTATA A CTCGCGGGTAAT T G GGGGTGTATATATGTG G G GTGTATATATGGA A TTATATGTGAGAGAG TG ATGTGAGAGAGCGC C T TGTGAGAGAGCGCGCG  GAGGCGCGCGCGC GCA AGAGCCGCGCCCC C G GCCGCGCCCCTCT T C CGAAGCCTCTCTC C G GCGCCCCTCTCTCGCG G C CCCCT CAGC C C CT CGCGCGCAA T TCCC GGTGCACACC C CGCGCGCAACGCG G G GCGGGCACACGCGG CCG CCACACGCGGCGCGT TCG ACACGCGGGGTGTACC A C CGCGGGGTGTATACAC CC  GGGGTGGCACCTCGC G GTGTATACACCCCCC GCCCTACACCCCCCCACA A A AC GGCCCCCACACAC C C CCCCCCCACACACCCCGTGTCCACACACCGCGG C CAACCCC CGCCGCC A ACACCGCCCA A C CCCGCGCACAAAA A CCGCGCACAAACCAG G G GCCAAAAGAGCGC C C CACAAAAGAGCGCAA AG GAGCGCATGGAC  AGGCACACACCCC TC  GCGCACACACCCCGG TCACAGGACCCCGCGCCGCG T ACAAGCCGCGCGCGCG GAT CCCGCGCGGC GC C C CGCGCCGCGCGCG G G GCCGCGCGCGCGC C C CGCGCGCGGC GCCCC C G GCGCGCGCGCCCCCCC CGCGCCCCCCCGCG CG  GCTCA TA AGCGGGG  CCCCCCCGCGGGGCC C CCCCGCGGAGCGCTC GT C CGCGGGGCGCTCTCTC C GGGCTC TGAG GCCCG G GC GCCTCGCGCGAGA  CTCTCTCGCGAGATAT T T TCTCGCGAGATATCG C CGTG ATCTCGCG G G GAGCCATCTCGCGGGG G ACGGATCCGGGGCGC C T TCTCGCGGGGCCC  CGCGGCG GCC CCCA A G GGGGCG CCAGAG G G GCGCCCCACAGGA GT T C CCCCACAGAGTGTCC C CACAGAGTGTCTCGCG G ACCGT GGTCTCGGG G G GTGTC ATGC C TTCGTCGCGGGGCGCCTA GCGCGGGGCGCCCCACA A G GGGGCGCCCCACACCT  GCGCCTCGACCCC  CCCCAGGCACCCCCC C CAACCCCCG CC AATGACCCCCCG CCGG C CCCCCCCCCCGCGGGG G C CCCTTCCGAGGGGGGG CCGGG G CCGGCA GGTCACT CTGACGGCGGGGTGTCTC TTCACCAGGTCG AAG G GGGTCCACCGCGC C G GTGTCGCGCG G T TCGGGCGCA GT C CGCGCGCGCGTGTGAG TCG GCGCGCGTGTG CCT CCGT ATTGTGGTGCTT G GTTGTGTTTTCGCAC TCTTTGTGTTTTCTCGCG G G GTC G TCGC C T TTTTCTCGCGCGCCCC C T TCCGCGCCCCGCG CCC CGCGCCCGCGGG G GCCGGGGCTCGC CCCGGGCGCACAC CGCGGGCACATAT GGCGCACATATGGAT AA GCGCACATATGG TAGTA C CACATATGTGAGAAAA GTGATGTGAGAAAAGAG G T TGTGAGAAAAGAC GA A GGTCGAAAAGGAT CCT ACG AAGAGAGATATG,TCCCCACAAATCAGGGG G C CCCCACAACCAGATGGGG CAGGCAACGGAGGGGG CCCGG AAAG AGGGGGGGCGCACG A A AGAGGGGGGGCGCACAATCGA GGGGGGCGCACAAAAGAG G G GGGGCGCACAAAAG CAGG ATGGCACCGAAGAGGGGGG C CACAAAAGAGGGGGGGCC A AAGGGAGGGGGGGCGCACA A AG AAGGGGGGGCGCACA AC  GGGGCGCACACACCCC C G GGGGCGCCACCCCGCG GCA GCCACACCCCGCGGC CCACACCCGCGCTCCGT A ACACCCCGCGCGCTCTGCATG CGCCCCGCGCCTGTGGG C CGCGCGCTCCCTGGGGCGC GCG GCGCTCTGCG GGCGCGCG GCG CTTGGGGCGCGGT T TTGGGGCGCGCGTGTCTC  GGCGCGCGGCTGTCCA A GGCGCGTGTCTCA CCAT T C CGGTCTCACATCGGCT C GTCATG ATGTGAGA A T TCTCACATATGTGACACAA A C CACATTGAGAA GAATG ATATGTGAGAAAAGAGCGC C TTGAGAAAAGAGCCGCCG G G GAGAAAAGAGCGCGCGC ATC ATGAAGCGCGCGCGCCCC C AAGCGCGCGCGCCCCACA A G GCGCGCGCGCCCCACACAC C C CGCGCGCC CGCACACGG G GCGCACACACGCGGGG CT CCACACACGGGCG AGCA CACACACGTCGGGCGCT CCT AACGGGCGCTTT  CTG CCGGGGCGCTCTTTTCGCC GGCGGGCTCTTTTCTCGCG G G GCGCTCTTTTCC ACGGGG G CCTTTTCTCGCAAGC C TTTCCACCGGGGCGCGCG G T TCCGGCGGGGCGCGCGGGG  CGCGGGGCCCACGGGGTGT T G GGGGCGCGCTTGGTGTATA GGTCGGGCGGGTGTATATAT AGT CGG GA GGTATATATGTG G G GGGGTGTATATATG TTA G GTGTATAT GCTGAGAGAG G T GCTATATGTGAGAGAGCGGCC AGC AAGGAGAGCGCGG T TGTGAGAGAGCGCGGC C GGATGAGAGCCGCCGCGCCCC  AGAGCGCGCGGGCCCCTTG G GGCGCGCGCCCCTCTCTC C C CGGCCCCTCTCTCGCG G G GCG CCTCCCCCCAGC C C CCCCTCTCTCGCGCCA A C CTCTCTCGCGCGCACACCGCC T TCTCGGCACACACGCG  CGCGCGCACACACGCGCGG CGG GCCACACGGC GT T C CAGAAACGAAGGGTGTATA A A ACACGGCCGGTGTATACAC C C CGCGGGGTTACACCCC C G GGGGTGTACAGACCGTCC G GTTACACCCCCCCACA A T TATACACCTC CGCCACTCGTCG ACCCCCCAAAGACCCC C C CCCCCCCACACACCCCGCG  CCCCAACCCCGCGCGC C C CACACACCCCGCGCCA CC  ACACCCCGCGCC CCAAAA A C CCCCGGCACAAAAGAG G C CG GTGCACAAAAGAGCGC C G GCCAAAAGGAAGCAAA A C CACACAGCGCACACAC TC CCGAAGACCGCACACACCCC C A AGAGCGCACACACCCGGG G GCC GCACACCCCGCGCGC  CACACACCCCGCGCGCGCG G A ACCCGCGCGCGCGCGC C C CCCCGCGCAC CGCCG G C CGCGCGCGCGCGCGCGCGC C GC GCGC GCCGC CCCC C C CGCGCGCGCGCGCCCCCCC C G GCGCGCGCGCCCTGCCGCG G C CGCGCGCCCCCAAGCGGGG G G GCCATCG CCGCGGGGCGC C C CCCCCCCGCGGGGCGCTCT T C CCCCGCGGGCTCTCTC C CGT CGGGGCGCTCTCTCGG G GGGGCCGTGCGTCGCGAGA  GCGCTCTCTCGCGAGATAT T CT CCTCCGGCGAAGGATCTC C T TCGAACGAGATTCGCG G C CGCGAGATATCTCG GTG G GAGATATCTCGCGGGGCGC C ATCGAAGCGGGGCGCCCC C T TCG AGTGGCCCA A C CGCGGGGCTC CCACAGAAGG G GGGGCGCCCCACAGT CGT T GGCCGCGCAGAGTGTCC C CC CCAGTGTCTCGAGAGCGTACAGTCA CGGGG GC  AGAGTGCATCGGGCGC  CGC GGTCTCGCGGGGCGCCCC C TT TTCGGGCCCACA A C CGGGCGCCCCACACAC GCG GGGGCGCCCCACACAGCCC GCA GCGCCCCACACACCCCCCC C C CCCCACACCG CCCCCCA AC C CAACCCCCCCCCCGTCG AG ACACCCCCCCGCGGGG G CGGCCCCCCCCCGCGGGGGGG G CGCCCCCCCGCGGGGTGT T C CCCGGAAGGGTGTCC AC CAAGGC GGGGGTGTCTCGACCG G GGGGGCC TCGCGCGC C G GGGTCTCGCGCGCGCG  GTGTCATGCGC CAAG  CG TCCGCGCGCGTGTGTG G C CGGCGCGTGTGTGTT G GCGCGGTGTGTGTTTT T C CGCGTGTGTGTGTTTTCC GCGGGGCGGGGTTTTCTCGCG G T TGTGTGTTTTCTCGCGCGC C G GTGTTTTCCGCCC C TTGAATGTCGCGCGCCCCGCG G TGCCCGCCGGCGGGG G C CGGCCCCGTCGGGCGC C G TCCCGCGGGGCGCACA A CCAGCCGCGGGGCGCACATAT T C CGGGCGCACATATGTG G G GGGGCGCACATATGTGAGA A G GCGTCCATATGTGAAGCA C CACATTGATCGAAGCGTG A AT ATTGAGAAAAGGCCG CA T TGGAACCGAGAGATAT T GGAAAAGAGAAG TTC,"ID   RL3_THEFY               Reviewed;         216 AA.
AC   Q47LJ3;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   05-FEB-2025, entry version 120.
DE   RecName: Full=Large ribosomal subunit protein uL3 {ECO:0000255|HAMAP-Rule:MF_01325};
DE   AltName: Full=50S ribosomal protein L3 {ECO:0000305};
GN   Name=rplC {ECO:0000255|HAMAP-Rule:MF_01325};
GN   OrderedLocusNames=Tfu_2646;
OS   Thermobifida fusca (strain YX).
OC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Streptosporangiales;
OC   Nocardiopsidaceae; Thermobifida.
OX   NCBI_TaxID=269800;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=YX;
RX   PubMed=17209016; DOI=10.1128/jb.01899-06;
RA   Lykidis A., Mavromatis K., Ivanova N., Anderson I., Land M., DiBartolo G.,
RA   Martinez M., Lapidus A., Lucas S., Copeland A., Richardson P., Wilson D.B.,
RA   Kyrpides N.;
RT   ""Genome sequence and analysis of the soil cellulolytic actinomycete
RT   Thermobifida fusca YX."";
RL   J. Bacteriol. 189:2477-2486(2007).
CC   -!- FUNCTION: One of the primary rRNA binding proteins, it binds directly
CC       near the 3'-end of the 23S rRNA, where it nucleates assembly of the 50S
CC       subunit. {ECO:0000255|HAMAP-Rule:MF_01325}.
CC   -!- SUBUNIT: Part of the 50S ribosomal subunit. Forms a cluster with
CC       proteins L14 and L19. {ECO:0000255|HAMAP-Rule:MF_01325}.
CC   -!- SIMILARITY: Belongs to the universal ribosomal protein uL3 family.
CC       {ECO:0000255|HAMAP-Rule:MF_01325}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000088; AAZ56679.1; -; Genomic_DNA.
DR   RefSeq; WP_011293069.1; NC_007333.1.
DR   AlphaFoldDB; Q47LJ3; -.
DR   SMR; Q47LJ3; -.
DR   STRING; 269800.Tfu_2646; -.
DR   KEGG; tfu:Tfu_2646; -.
DR   eggNOG; COG0087; Bacteria.
DR   HOGENOM; CLU_044142_4_1_11; -.
DR   OrthoDB; 9806135at2; -.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; IEA:TreeGrafter.
DR   GO; GO:0019843; F:rRNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003735; F:structural constituent of ribosome; IEA:InterPro.
DR   GO; GO:0006412; P:translation; IEA:UniProtKB-UniRule.
DR   FunFam; 2.40.30.10:FF:000004; 50S ribosomal protein L3; 1.
DR   FunFam; 3.30.160.810:FF:000001; 50S ribosomal protein L3; 1.
DR   Gene3D; 3.30.160.810; -; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   HAMAP; MF_01325_B; Ribosomal_uL3_B; 1.
DR   InterPro; IPR000597; Ribosomal_uL3.
DR   InterPro; IPR019927; Ribosomal_uL3_bac/org-type.
DR   InterPro; IPR019926; Ribosomal_uL3_CS.
DR   InterPro; IPR009000; Transl_B-barrel_sf.
DR   NCBIfam; TIGR03625; L3_bact; 1.
DR   PANTHER; PTHR11229; 50S RIBOSOMAL PROTEIN L3; 1.
DR   PANTHER; PTHR11229:SF16; LARGE RIBOSOMAL SUBUNIT PROTEIN UL3C; 1.
DR   Pfam; PF00297; Ribosomal_L3; 1.
DR   SUPFAM; SSF50447; Translation proteins; 1.
DR   PROSITE; PS00474; RIBOSOMAL_L3; 1.
PE   3: Inferred from homology;
KW   Ribonucleoprotein; Ribosomal protein; RNA-binding; rRNA-binding.
FT   CHAIN           1..216
FT                   /note=""Large ribosomal subunit protein uL3""
FT                   /id=""PRO_0000241427""
FT   REGION          135..156
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
SQ   SEQUENCE   216 AA;  22995 MW;  E209C103DDB7B055 CRC64;
     MTTKQIKGVL GEKLGMTQVF DESGKVVPVT VLKAGPAVVT RVRTPETDGY SAIQLGYGHI
     NPRKVNKPLG DYLRKHNLTP RRHYVEVRTS DASEYTVGQE ITADVFQPGE KVDVTGKTKG
     KGYAGVMKRH GFGGLGASHG TQRKHRSPGS IGGCATPGRV FKGMRMAGRM GNVRRTVQNL
     TVHSVDAEKG LLLVKGAVPG PNGGLVLVRT AVKGGK
//
",56316
ATGTGT TGTGTA GTGTAT TGTATA GTATAA TATAAG ATAAGA TAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGC ACAGCC CAGCCT AGCCTA GCCTAG CCTAGG CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA CAGAAG AGAAGC GAAGCT AAGCTG AGCTGG GCTGGA CTGGAC TGGACT GGACTT GACTTC ACTTCC CTTCCC TTCCCT TCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGC GGTGCT GTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG,1,73,ATGT TGTG GTGT TGTA GTAT TATA ATAA TAAG AAGA AGAG GAGA AGAC GACA ACAG CAGC AGCC GCCT CCTA CTAG TAGG AGGA GGAA GAAC AACT ACTG CTGG TGGG GGGC GGCC GCCA CCAG CAGA AGAA GAAG AAGC AGCT GCTG CTGG TGGA GGAC GACT ACTT CTTC TTCC TCCC CCCT CCTA CTAT TATG ATGG TGGT GGTG GTGC TGCT GCTA CTAA TAAC AACA ACAA CAAA AAAG AAGA AGAC GACG ACGG CGGC GGCA GCAT CATC ATCA TCAT CATA ATAT TATG ATGG,ATGTG TGTGT GTGTA TGTAT GTATA TATAA ATAAG TAAGA AAGAG AGAGA GAGAC AGACA GACAG ACAGC CAGCC AGCCT GCCTA CCTAG CTAGG TAGGA AGGAA GGAAC GAACT AACTG ACTGG CTGGG TGGGC GGGCC GGCCA GCCAG CCAGA CAGAA AGAAG GAAGC AAGCT AGCTG GCTGG CTGGA TGGAC GGACT GACTT ACTTC CTTCC TTCCC TCCCT CCCTA CCTAT CTATG TATGG ATGGT TGGTG GGTGC GTGCT TGCTA GCTAA CTAAC TAACA AACAA ACAAA CAAAG AAAGA AAGAC AGACG GACGG ACGGC CGGCA GGCAT GCATC CATCA ATCAT TCATA CATAT ATATG TATGG,ATGTGT TGTGTA GTGTAT TGTATA GTATAA TATAAG ATAAGA TAAGAG AAGAGA AGAGAC GAGACA AGACAG GACAGC ACAGCC CAGCCT AGCCTA GCCTAG CCTAGG CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA CAGAAG AGAAGC GAAGCT AAGCTG AGCTGG GCTGGA CTGGAC TGGACT GGACTT GACTTC ACTTCC CTTCCC TTCCCT TCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGC GGTGCT GTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG,ATGTGTA TGTGTAT GTGTATA TGTATAA GTATAAG TATAAGA ATAAGAG TAAGAGA AAGAGAC AGAGACA GAGACAG AGACAGC GACAGCC ACAGCCT CAGCCTA AGCCTAG GCCTAGG CCTAGGA CTAGGAA TAGGAAC AGGAACT GGAACTG GAACTGG AACTGGG ACTGGGC CTGGGCC TGGGCCA GGGCCAG GGCCAGA GCCAGAA CCAGAAG CAGAAGC AGAAGCT GAAGCTG AAGCTGG AGCTGGA GCTGGAC CTGGACT TGGACTT GGACTTC GACTTCC ACTTCCC CTTCCCT TTCCCTA TCCCTAT CCCTATG CCTATGG CTATGGT TATGGTG ATGGTGC TGGTGCT GGTGCTA GTGCTAA TGCTAAC GCTAACA CTAACAA TAACAAA AACAAAG ACAAAGA CAAAGAC AAAGACG AAGACGG AGACGGC GACGGCA ACGGCAT CGGCATC GGCATCA GCATCAT CATCATA ATCATAT TCATATG CATATGG,"ID   NCAP_SARS2              Reviewed;         419 AA.
AC   P0DTC9;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Nucleoprotein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=N;
DE   AltName: Full=Nucleocapsid protein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=NC {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=Protein N {ECO:0000255|HAMAP-Rule:MF_04096};
GN   Name=N {ECO:0000255|HAMAP-Rule:MF_04096};
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3] {ECO:0007744|PDB:6WZO, ECO:0007744|PDB:6WZQ}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 247-364, AND SUBUNIT.
RX   PubMed=32654247; DOI=10.1002/pro.3909;
RA   Ye Q., West A.M.V., Silletti S., Corbett K.D.;
RT   ""Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein."";
RL   Protein Sci. 29:1890-1901(2020).
RN   [4]
RP   REVIEW.
RX   PubMed=32974389; DOI=10.3389/fmolb.2020.00219;
RA   Nikolakaki E., Giannakouros T.;
RT   ""SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle."";
RL   Front. Mol. Biosci. 7:219-219(2020).
RN   [5]
RP   VARIANTS LEU-3 AND PHE-235.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=34341353; DOI=10.1038/s41467-021-25015-6;
RA   Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J.,
RA   Jia Y., Wang W., Wan P., Zhang J., Chen W., Lei Z., Chen X., Luo Z.,
RA   Zhang Q., Xu M., Li G., Li Y., Wu J.;
RT   ""SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce
RT   hyperinflammation."";
RL   Nat. Commun. 12:4664-4664(2021).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 41-174, AND MUTAGENESIS OF
RP   TYR-109.
RX   PubMed=32363136; DOI=10.1016/j.apsb.2020.04.009;
RA   Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z.,
RA   Zhou Z., Chen Q., Yan Y., Zhang C., Shan H., Chen S.;
RT   ""Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain
RT   reveals potential unique drug targeting sites."";
RL   Acta Pharmacol. Sin. 10:1228-1238(2020).
RN   [8] {ECO:0007744|PDB:6YI3, ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT}
RP   STRUCTURE BY NMR OF 44-180, FUNCTION, AND MUTAGENESIS OF ARG-68; ARG-92;
RP   ILE-94; ARG-107; GLN-163; TYR-172 AND GLU-174.
RX   PubMed=33264373; DOI=10.1371/journal.ppat.1009100;
RA   Dinesh D.C., Chalupska D., Silhan J., Koutna E., Nencka R., Veverka V.,
RA   Boura E.;
RT   ""Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid
RT   phosphoprotein."";
RL   PLoS Pathog. 16:1-16(2020).
RN   [9]
RP   MUTAGENESIS OF SER-188 AND SER-206, AND PHOSPHORYLATION AT SER-206.
RX   PubMed=34593624; DOI=10.1073/pnas.2113401118;
RA   Liu X., Verma A., Garcia G. Jr., Ramage H., Lucas A., Myers R.L.,
RA   Michaelson J.J., Coryell W., Kumar A., Charney A.W., Kazanietz M.G.,
RA   Rader D.J., Ritchie M.D., Berrettini W.H., Schultz D.C., Cherry S.,
RA   Damoiseaux R., Arumugaswami V., Klein P.S.;
RT   ""Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:1-9(2021).
RN   [10]
RP   CLEAVAGE.
RX   PubMed=35922005; DOI=10.1038/s41586-022-05148-4;
RA   Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., Shi J., Chai Y.,
RA   Yuen T.T., Hu B., Li C., Zhao X., Wang Y., Huang X., Lee K.S., Luo C.,
RA   Cai J.P., Poon V.K., Chan C.C., Zhang A.J., Yuan S., Sit K.Y., Foo D.C.,
RA   Au W.K., Wong K.K., Zhou J., Kok K.H., Jin D.Y., Chan J.F., Yuen K.Y.;
RT   ""Coronaviruses exploit a host cysteine-aspartic protease for replication."";
RL   Nature 0:0-0(2022).
RN   [11]
RP   MUTAGENESIS OF 203-ARG-GLY-204 AND ARG-203, AND PHOSPHORYLATION.
RX   PubMed=35728038; DOI=10.1371/journal.ppat.1010627;
RA   Johnson B.A., Zhou Y., Lokugamage K.G., Vu M.N., Bopp N.,
RA   Crocquet-Valdes P.A., Kalveram B., Schindewolf C., Liu Y., Scharton D.,
RA   Plante J.A., Xie X., Aguilar P., Weaver S.C., Shi P.Y., Walker D.H.,
RA   Routh A.L., Plante K.S., Menachery V.D.;
RT   ""Nucleocapsid mutations in SARS-CoV-2 augment replication and
RT   pathogenesis."";
RL   PLoS Pathog. 18:e1010627-e1010627(2022).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=35921414; DOI=10.1126/sciadv.abp9770;
RA   Lopez-Munoz A.D., Kosik I., Holly J., Yewdell J.W.;
RT   ""Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive
RT   immunity."";
RL   Sci. Adv. 8:eabp9770-eabp9770(2022).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=34901782; DOI=10.1016/j.isci.2021.103562;
RA   Nabeel-Shah S., Lee H., Ahmed N., Burke G.L., Farhangmehr S., Ashraf K.,
RA   Pu S., Braunschweig U., Zhong G., Wei H., Tang H., Yang J., Marcon E.,
RA   Blencowe B.J., Zhang Z., Greenblatt J.F.;
RT   ""SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress
RT   granules to impair host stress response."";
RL   IScience 25:103562-103562(2022).
RN   [14]
RP   FUNCTION.
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [15] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 191-263, AND INTERACTION WITH NSP3.
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
CC   -!- FUNCTION: Packages the positive strand viral genome RNA into a helical
CC       ribonucleocapsid (RNP) and plays a fundamental role during virion
CC       assembly through its interactions with the viral genome and membrane
CC       protein M (PubMed:33264373). Plays an important role in enhancing the
CC       efficiency of subgenomic viral RNA transcription as well as viral
CC       replication. Attenuates the stress granules formation by reducing host
CC       G3BP1 access to host mRNAs under stress conditions (PubMed:34901782,
CC       PubMed:36534661). {ECO:0000269|PubMed:32974389,
CC       ECO:0000269|PubMed:33264373, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: May block host chemokine function in vivo, facilitating viral
CC       replication and transmission (PubMed:35921414). Acts by being secreted
CC       into the extracellular space where it competes to host chemokines for
CC       binding to host glycosaminoglycans (GAG) (PubMed:35921414).
CC       {ECO:0000269|PubMed:35921414}.
CC   -!- FUNCTION: May induce inflammasome responses in cultured cells and mice.
CC       Acts by interacting with host NLRP3 to facilitate inflammasome
CC       assembly, which induces cytokine release that may play a role in COVID
CC       lung injury. {ECO:0000269|PubMed:34341353}.
CC   -!- SUBUNIT: Homodimer, homotetramer, homooligomer with RNA
CC       (PubMed:32654247). Both monomeric and oligomeric forms interact with
CC       RNA. Interacts with protein M (By similarity). Interacts with protein E
CC       (By similarity). Interacts with NSP3; this interaction serves to tether
CC       the genome to the newly translated replicase-transcriptase complex at a
CC       very early stage of infection (PubMed:35044811). May interact with host
CC       NLRP3 (PubMed:34341353). {ECO:0000250|UniProtKB:P59595,
CC       ECO:0000255|HAMAP-Rule:MF_04096, ECO:0000269|PubMed:32654247,
CC       ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:35044811}.
CC   -!- INTERACTION:
CC       P0DTC9; P0DTC4: E; NbExp=3; IntAct=EBI-25475856, EBI-25475850;
CC       P0DTC9; P0DTC5: M; NbExp=6; IntAct=EBI-25475856, EBI-25475853;
CC       P0DTC9; P0DTC9: N; NbExp=105; IntAct=EBI-25475856, EBI-25475856;
CC       P0DTC9; PRO_0000449621 [P0DTD1]: rep; NbExp=15; IntAct=EBI-25475856, EBI-25492388;
CC       P0DTC9; P78563: ADARB1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2967304;
CC       P0DTC9; O15145: ARPC3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351829;
CC       P0DTC9; Q13895: BYSL; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358049;
CC       P0DTC9; Q16543: CDC37; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-295634;
CC       P0DTC9; Q92793: CREBBP; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-81215;
CC       P0DTC9; Q92499: DDX1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-358474;
CC       P0DTC9; Q9NR30: DDX21; Xeno; NbExp=12; IntAct=EBI-25475856, EBI-357942;
CC       P0DTC9; P26196: DDX6; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351257;
CC       P0DTC9; Q08426: EHHADH; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2339219;
CC       P0DTC9; P19525: EIF2AK2; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-640775;
CC       P0DTC9; Q14241: ELOA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-742350;
CC       P0DTC9; Q13283: G3BP1; Xeno; NbExp=71; IntAct=EBI-25475856, EBI-1047359;
CC       P0DTC9; Q9UN86: G3BP2; Xeno; NbExp=37; IntAct=EBI-25475856, EBI-1044298;
CC       P0DTC9; P57764: GSDMD; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2798865;
CC       P0DTC9; P49841: GSK3B; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-373586;
CC       P0DTC9; P10412: H1-4; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358163;
CC       P0DTC9; O14920: IKBKB; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-81266;
CC       P0DTC9; Q92830: KAT2A; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477622;
CC       P0DTC9; Q92831: KAT2B; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477430;
CC       P0DTC9; Q07866: KLC1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-721019;
CC       P0DTC9; Q9H0B6: KLC2; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-726994;
CC       P0DTC9; Q9NSK0: KLC4; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-949319;
CC       P0DTC9; Q9NX58: LYAR; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-713507;
CC       P0DTC9; O43318: MAP3K7; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-358684;
CC       P0DTC9; Q9UBU8: MORF4L1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-399246;
CC       P0DTC9; Q15014: MORF4L2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-399257;
CC       P0DTC9; Q9HCE1: MOV10; Xeno; NbExp=11; IntAct=EBI-25475856, EBI-1055820;
CC       P0DTC9; Q9HC36: MRM3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-1045440;
CC       P0DTC9; O15226: NKRF; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-766011;
CC       P0DTC9; Q96P20: NLRP3; Xeno; NbExp=18; IntAct=EBI-25475856, EBI-6253230;
CC       P0DTC9; O15118: NPC1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-2368710;
CC       P0DTC9; Q96HA8: NTAQ1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-741158;
CC       P0DTC9; P11940: PABPC1; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-81531;
CC       P0DTC9; P62937: PPIA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-437708;
CC       P0DTC9; O75569: PRKRA; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-713955;
CC       P0DTC9; Q99873: PRMT1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-78738;
CC       P0DTC9; P61289: PSME3; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-355546;
CC       P0DTC9; P26022: PTX3; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-11574553;
CC       P0DTC9; P54727: RAD23B; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-954531;
CC       P0DTC9; O95786: RIGI; Xeno; NbExp=15; IntAct=EBI-25475856, EBI-995350;
CC       P0DTC9; P62899: RPL31; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1053664;
CC       P0DTC9; P62753: RPS6; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-356625;
CC       P0DTC9; P37840: SNCA; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-985879;
CC       P0DTC9; Q96SB4: SRPK1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-539478;
CC       P0DTC9; P78362: SRPK2; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-593303;
CC       P0DTC9; P42224: STAT1; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1057697;
CC       P0DTC9; P52630: STAT2; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-1546963;
CC       P0DTC9; Q15633: TARBP2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-978581;
CC       P0DTC9; Q14258: TRIM25; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2341129;
CC       P0DTC9; O60763: USO1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-356164;
CC       P0DTC9; Q93008: USP9X; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-302524;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04096}. Host
CC       cytoplasm {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34341353}.
CC       Secreted {ECO:0000269|PubMed:35921414}. Host extracellular space
CC       {ECO:0000269|PubMed:35921414}. Note=Probably associates with ER-derived
CC       membranes where it participates in viral RNA synthesis and virus
CC       budding. When located inside the virion, complexed with the viral RNA.
CC       Can be secreted by unconventional protein secretion (UPS)
CC       (PubMed:35921414). When secreted, can bind to host glycosaminoglycans
CC       on infected and non infected cells (PubMed:35921414). Found in host
CC       cytoplasmic stress granules (PubMed:34901782). {ECO:0000255|HAMAP-
CC       Rule:MF_04096, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:35921414}.
CC   -!- PTM: ADP-ribosylated. The ADP-ribosylation is retained in the virion
CC       during infection. {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   -!- PTM: Phosphorylated on serine residues by host GSK3A and GSK3B
CC       (PubMed:34593624, PubMed:35728038). This promotes the solubility of
CC       homodimers that would otherwise aggregate (PubMed:32974389). Host
CC       phosphatase would dephosphorylate the protein during assembly at M
CC       bound membranes (PubMed:32974389). {ECO:0000269|PubMed:34593624,
CC       ECO:0000269|PubMed:35728038, ECO:0000305|PubMed:32974389}.
CC   -!- PTM: Proteolytically cleaved by host CASP6. The cleavage leads to two
CC       fragments and facilitates viral replication by inhibiting host IFN
CC       signaling. The two fragments may interact with IRF3 inhibiting its
CC       nuclear translocation after activation and reduce the expression of
CC       IFNB and IFN-stimulated genes. {ECO:0000269|PubMed:35922005}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (December 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1. {ECO:0000305|PubMed:33413740}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronavirus nucleocapsid protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43423.2; -; Genomic_RNA.
DR   PDB; 6M3M; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 6VYO; X-ray; 1.70 A; A/B/C/D=47-173.
DR   PDB; 6WJI; X-ray; 2.05 A; A/B/C/D/E/F=257-364.
DR   PDB; 6WKP; X-ray; 2.67 A; A/B/C/D=47-173.
DR   PDB; 6WZO; X-ray; 1.42 A; A/B/C/D=247-364.
DR   PDB; 6WZQ; X-ray; 1.45 A; A/B/C/D=247-364.
DR   PDB; 6YI3; NMR; -; A=44-180.
DR   PDB; 6YUN; X-ray; 1.44 A; A/B=249-364.
DR   PDB; 6ZCO; X-ray; 1.36 A; A=247-364.
DR   PDB; 7ACS; NMR; -; A=44-180.
DR   PDB; 7ACT; NMR; -; A=44-180.
DR   PDB; 7C22; X-ray; 2.00 A; A/B/C/D=248-364.
DR   PDB; 7CDZ; X-ray; 1.80 A; A/B/C/D=44-174.
DR   PDB; 7CE0; X-ray; 1.50 A; A/B/C/D=255-364.
DR   PDB; 7CR5; X-ray; 2.08 A; A=41-174.
DR   PDB; 7DE1; X-ray; 2.00 A; A/B=250-364.
DR   PDB; 7F2B; X-ray; 2.00 A; A/B=257-362.
DR   PDB; 7F2E; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=255-362.
DR   PDB; 7KGO; X-ray; 2.15 A; C=351-359.
DR   PDB; 7KGP; X-ray; 1.40 A; C=316-324.
DR   PDB; 7KGQ; X-ray; 1.34 A; C=222-230.
DR   PDB; 7KGR; X-ray; 1.55 A; C=159-167.
DR   PDB; 7KGS; X-ray; 1.58 A; C=138-146.
DR   PDB; 7KGT; X-ray; 1.90 A; C=226-234.
DR   PDB; 7LGD; X-ray; 2.88 A; E/F=105-113.
DR   PDB; 7LTU; X-ray; 1.12 A; A/B=217-222.
DR   PDB; 7LUX; X-ray; 1.30 A; A=217-222.
DR   PDB; 7LUZ; X-ray; 1.10 A; A=243-248.
DR   PDB; 7LV2; X-ray; 1.30 A; A=179-184.
DR   PDB; 7N0I; X-ray; 2.20 A; A/B/C/D/E/F/G/H=269-364.
DR   PDB; 7N0R; X-ray; 1.42 A; A/B=49-174.
DR   PDB; 7N3C; X-ray; 1.82 A; C=47-173.
DR   PDB; 7N3D; X-ray; 1.53 A; C=47-173.
DR   PDB; 7O05; X-ray; 1.94 A; A/B/C/D=247-364.
DR   PDB; 7O35; X-ray; 1.80 A; A/B/C/D=247-364.
DR   PDB; 7O36; X-ray; 2.00 A; A/B/C/D=247-364.
DR   PDB; 7PKU; NMR; -; B=191-263.
DR   PDB; 7QIK; X-ray; 2.01 A; E/F=193-200.
DR   PDB; 7QIP; X-ray; 2.65 A; C/D=201-210.
DR   PDB; 7R98; X-ray; 2.51 A; A/B/C=49-174.
DR   PDB; 7SD4; NMR; -; A=40-174.
DR   PDB; 7STR; X-ray; 1.50 A; C=47-173.
DR   PDB; 7STS; X-ray; 2.16 A; C/D=47-173.
DR   PDB; 7SUE; X-ray; 2.90 A; C/D/J/K=47-173.
DR   PDB; 7SUO; X-ray; 2.35 A; C/D=12-22.
DR   PDB; 7UW3; X-ray; 1.70 A; A/B/C/D=40-174.
DR   PDB; 7UXX; X-ray; 1.85 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7UXZ; X-ray; 1.73 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7VBD; X-ray; 1.94 A; A/B/C/D=48-174.
DR   PDB; 7VBE; X-ray; 1.59 A; A/B=257-364.
DR   PDB; 7VBF; X-ray; 1.30 A; A/B=255-364.
DR   PDB; 7VNU; X-ray; 1.95 A; A/B/C/D=47-174.
DR   PDB; 7WKJ; X-ray; 1.50 A; C=361-369.
DR   PDB; 7WZO; X-ray; 2.64 A; A=47-174.
DR   PDB; 7XWX; X-ray; 3.00 A; A/B/C/D/E/F/G/H=269-367.
DR   PDB; 7XWZ; X-ray; 2.25 A; A/B=48-172.
DR   PDB; 7XX1; X-ray; 1.90 A; A/B/C/D=49-173.
DR   PDB; 7XXK; X-ray; 2.00 A; A/B/C/D/E/F=248-364.
DR   PDB; 7YLB; X-ray; 2.41 A; A/B/C/D/G/H/J/K=247-364.
DR   PDB; 7YLD; X-ray; 2.80 A; A/B/C/D=47-174.
DR   PDB; 7ZIT; X-ray; 1.79 A; C/D=194-200.
DR   PDB; 8DNT; X-ray; 3.18 A; D/J/Q/X=222-230.
DR   PDB; 8FD5; EM; 4.57 A; A=1-419.
DR   PDB; 8FG2; EM; 6.00 A; A/B=1-419.
DR   PDB; 8IQJ; X-ray; 2.30 A; A/B/C/D=41-174.
DR   PDB; 8IV3; X-ray; 1.90 A; A/B/C/D=41-174.
DR   PDB; 8J6X; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 8TH1; X-ray; 1.80 A; E/F/G/H=1-25.
DR   PDB; 8TH5; X-ray; 2.62 A; K/L/M/N/O/P/Q=1-25.
DR   PDB; 8X1H; X-ray; 2.00 A; A/B/C/D=44-175.
DR   PDBsum; 6M3M; -.
DR   PDBsum; 6VYO; -.
DR   PDBsum; 6WJI; -.
DR   PDBsum; 6WKP; -.
DR   PDBsum; 6WZO; -.
DR   PDBsum; 6WZQ; -.
DR   PDBsum; 6YI3; -.
DR   PDBsum; 6YUN; -.
DR   PDBsum; 6ZCO; -.
DR   PDBsum; 7ACS; -.
DR   PDBsum; 7ACT; -.
DR   PDBsum; 7C22; -.
DR   PDBsum; 7CDZ; -.
DR   PDBsum; 7CE0; -.
DR   PDBsum; 7CR5; -.
DR   PDBsum; 7DE1; -.
DR   PDBsum; 7F2B; -.
DR   PDBsum; 7F2E; -.
DR   PDBsum; 7KGO; -.
DR   PDBsum; 7KGP; -.
DR   PDBsum; 7KGQ; -.
DR   PDBsum; 7KGR; -.
DR   PDBsum; 7KGS; -.
DR   PDBsum; 7KGT; -.
DR   PDBsum; 7LGD; -.
DR   PDBsum; 7LTU; -.
DR   PDBsum; 7LUX; -.
DR   PDBsum; 7LUZ; -.
DR   PDBsum; 7LV2; -.
DR   PDBsum; 7N0I; -.
DR   PDBsum; 7N0R; -.
DR   PDBsum; 7N3C; -.
DR   PDBsum; 7N3D; -.
DR   PDBsum; 7O05; -.
DR   PDBsum; 7O35; -.
DR   PDBsum; 7O36; -.
DR   PDBsum; 7PKU; -.
DR   PDBsum; 7QIK; -.
DR   PDBsum; 7QIP; -.
DR   PDBsum; 7R98; -.
DR   PDBsum; 7SD4; -.
DR   PDBsum; 7STR; -.
DR   PDBsum; 7STS; -.
DR   PDBsum; 7SUE; -.
DR   PDBsum; 7SUO; -.
DR   PDBsum; 7UW3; -.
DR   PDBsum; 7UXX; -.
DR   PDBsum; 7UXZ; -.
DR   PDBsum; 7VBD; -.
DR   PDBsum; 7VBE; -.
DR   PDBsum; 7VBF; -.
DR   PDBsum; 7VNU; -.
DR   PDBsum; 7WKJ; -.
DR   PDBsum; 7WZO; -.
DR   PDBsum; 7XWX; -.
DR   PDBsum; 7XWZ; -.
DR   PDBsum; 7XX1; -.
DR   PDBsum; 7XXK; -.
DR   PDBsum; 7YLB; -.
DR   PDBsum; 7YLD; -.
DR   PDBsum; 7ZIT; -.
DR   PDBsum; 8DNT; -.
DR   PDBsum; 8FD5; -.
DR   PDBsum; 8FG2; -.
DR   PDBsum; 8IQJ; -.
DR   PDBsum; 8IV3; -.
DR   PDBsum; 8J6X; -.
DR   PDBsum; 8TH1; -.
DR   PDBsum; 8TH5; -.
DR   PDBsum; 8X1H; -.
DR   BMRB; P0DTC9; -.
DR   EMDB; EMD-29002; -.
DR   EMDB; EMD-29072; -.
DR   SASBDB; P0DTC9; -.
DR   SMR; P0DTC9; -.
DR   BioGRID; 4383847; 1532.
DR   ComplexPortal; CPX-5686; SARS-CoV-2 nucleocapsid complex.
DR   IntAct; P0DTC9; 608.
DR   MINT; P0DTC9; -.
DR   ChEMBL; CHEMBL5169223; -.
DR   iPTMnet; P0DTC9; -.
DR   ABCD; P0DTC9; 27 sequenced antibodies.
DR   DNASU; 43740575; -.
DR   KEGG; vg:43740575; -.
DR   AGR; RefSeq:YP_009724397; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694786; Transcription of SARS-CoV-2 sgRNAs.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC9; -.
DR   PRO; PR:P0DTC9; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0044177; C:host cell Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043655; C:host extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt.
DR   GO; GO:0042612; C:MHC class I protein complex; EXP:DisProt.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0019028; C:viral capsid; IPI:ComplexPortal.
DR   GO; GO:0019013; C:viral nucleocapsid; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042288; F:MHC class I protein binding; EXP:DisProt.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; IDA:DisProt.
DR   GO; GO:0008266; F:poly(U) RNA binding; IMP:DisProt.
DR   GO; GO:0042803; F:protein homodimerization activity; EXP:DisProt.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProt.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:DisProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IDA:ComplexPortal.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0052572; P:response to host immune response; IDA:DisProt.
DR   GO; GO:0019074; P:viral RNA genome packaging; NAS:ComplexPortal.
DR   CDD; cd21595; CoV_N-CTD; 1.
DR   CDD; cd21554; CoV_N-NTD; 1.
DR   HAMAP; MF_04096; BETA_CORONA_NCAP; 1.
DR   InterPro; IPR044344; N_prot_C_CoV.
DR   InterPro; IPR044345; N_prot_N_CoV.
DR   InterPro; IPR043505; NCAP_bCoV.
DR   InterPro; IPR001218; Nucleocap_CoV.
DR   InterPro; IPR037179; Nucleocapsid_C.
DR   InterPro; IPR037195; Nucleocapsid_N.
DR   Pfam; PF00937; CoV_nucleocap; 1.
DR   PIRSF; PIRSF003888; Corona_nucleocap; 1.
DR   SUPFAM; SSF110304; Coronavirus RNA-binding domain; 1.
DR   SUPFAM; SSF103068; Nucleocapsid protein dimerization domain; 1.
DR   PROSITE; PS51929; COV_N_CTD; 1.
DR   PROSITE; PS51928; COV_N_NTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Host cytoplasm; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Secreted;
KW   Transcription; Transcription regulation; Viral nucleoprotein; Virion.
FT   CHAIN           1..419
FT                   /note=""Nucleoprotein""
FT                   /id=""PRO_0000449656""
FT   DOMAIN          48..174
FT                   /note=""CoV N NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01276,
FT                   ECO:0000269|PubMed:32363136""
FT   DOMAIN          247..364
FT                   /note=""CoV N CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01277""
FT   REGION          1..51
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          41..186
FT                   /note=""RNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          63..83
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          168..212
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          176..206
FT                   /note=""SR region""
FT                   /evidence=""ECO:0000305|PubMed:32974389""
FT   REGION          233..266
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          258..361
FT                   /note=""Dimerization""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          260..340
FT                   /note=""Putative NLRP3 binding""
FT                   /evidence=""ECO:0000269|PubMed:34341353""
FT   REGION          361..391
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          400..419
FT                   /note=""Tetramerization""
FT                   /evidence=""ECO:0000269|PubMed:32654247""
FT   MOTIF           256..264
FT                   /note=""Nuclear localization signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   COMPBIAS        1..11
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        21..31
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        367..378
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         92
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         107
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         149
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   SITE            399..402
FT                   /note=""Cleavage (by host CASP6)""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   MOD_RES         176
FT                   /note=""Phosphoserine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   MOD_RES         206
FT                   /note=""Phosphoserine; by host GSK3-alpha and GSK3-beta""
FT                   /evidence=""ECO:0000269|PubMed:34593624""
FT   VARIANT         2..3
FT                   /note=""SD -> Y (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> L (in strain: Alpha/B.1.1.7)""
FT                   /evidence=""ECO:0000305|PubMed:33413740""
FT   VARIANT         12
FT                   /note=""A -> G (in strain: Eta/B.1.525)""
FT   VARIANT         13
FT                   /note=""P -> L (in strain: Lambda/C.37, Omicron/BA.1,
FT                   Omicron/BA.2, Omicron/BA.2.12.1, Omicron/BA.2.75,
FT                   Omicron/BA.4, Omicron/BA.5, Omicron/BQ.1.1,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         31..33
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""D -> G (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT  ",5809
ATAAAG TAAAGA AAAGAA AAGAAC AGAACT GAACTT AACTTT ACTTTA CTTTAA TTTAAG TTAAGT TAAGTC AAGTCA AGTCAG GTCAGT TCAGTT CAGTTC AGTTCT GTTCTT TTCTTT TCTTTA CTTTAT TTTATT TTATTA TATTAT ATTATC TTATCA TATCAA ATCAAA TCAAAA CAAAAC AAAACA AAACAA AACAAT ACAATG CAATGT AATGTT ATGTTT TGTTTT GTTTTT TTTTTA TTTTAT TTTATG TTATGT TATGTC ATGTCT TGTCTG GTCTGA TCTGAA CTGAAG TGAAGC GAAGCA AAGCAA AGCAAA GCAAAA CAAAAT AAAATG AAATGT AATGTT ATGTTG TGTTGG GTTGGA TTGGAC TGGACT GGACTG GACTGA ACTGAG CTGAGA TGAGAC GAGACT AGACTG GACTGA ACTGAC CTGACC TGACCT GACCTT ACCTTA CCTTAC CTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGG AAAGGA AAGGAC AGGACC GGACCT GACCTC ACCTCA CCTCAT CTCATG TCATGA CATGAA ATGAAT TGAATT GAATTT AATTTT ATTTTG TTTTGC TTTGCT TTGCTC TGCTCT GCTCTC CTCTCA TCTCAA CTCAAC TCAACA CAACAT AACATA ACATAC CATACA ATACAA TACAAA ACAAAT CAAATG AAATGT AATGTT ATGTTG TGTTGA GTTGAG TTGAGA TGAGAG GAGAGC AGAGCA GAGCAA AGCAAA GCAAAA CAAAAT AAAATT AAATTC AATTCA ATTCAT TTCATG TCATGA CATGAG ATGAGG TGAGGT GAGGTC AGGTCC GGTCCT GTCCTT TCCTTT CCTTTA CTTTAG,0,145,ATAA TAAA AAAG AAGA AGAA GAAC AACT ACTT CTTT TTTA TTAA TAAG AAGT AGTC GTCA TCAG CAGT AGTT GTTC TTCT TCTT CTTT TTTA TTAT TATT ATTA TTAT TATC ATCA TCAA CAAA AAAA AAAC AACA ACAA CAAT AATG ATGT TGTT GTTT TTTT TTTT TTTA TTAT TATG ATGT TGTC GTCT TCTG CTGA TGAA GAAG AAGC AGCA GCAA CAAA AAAA AAAT AATG ATGT TGTT GTTG TTGG TGGA GGAC GACT ACTG CTGA TGAG GAGA AGAC GACT ACTG CTGA TGAC GACC ACCT CCTT CTTA TTAC TACT ACTA CTAA TAAA AAAG AAGG AGGA GGAC GACC ACCT CCTC CTCA TCAT CATG ATGA TGAA GAAT AATT ATTT TTTT TTTG TTGC TGCT GCTC CTCT TCTC CTCA TCAA CAAC AACA ACAT CATA ATAC TACA ACAA CAAA AAAT AATG ATGT TGTT GTTG TTGA TGAG GAGA AGAG GAGC AGCA GCAA CAAA AAAA AAAT AATT ATTC TTCA TCAT CATG ATGA TGAG GAGG AGGT GGTC GTCC TCCT CCTT CTTT TTTA TTAG,ATAAA TAAAG AAAGA AAGAA AGAAC GAACT AACTT ACTTT CTTTA TTTAA TTAAG TAAGT AAGTC AGTCA GTCAG TCAGT CAGTT AGTTC GTTCT TTCTT TCTTT CTTTA TTTAT TTATT TATTA ATTAT TTATC TATCA ATCAA TCAAA CAAAA AAAAC AAACA AACAA ACAAT CAATG AATGT ATGTT TGTTT GTTTT TTTTT TTTTA TTTAT TTATG TATGT ATGTC TGTCT GTCTG TCTGA CTGAA TGAAG GAAGC AAGCA AGCAA GCAAA CAAAA AAAAT AAATG AATGT ATGTT TGTTG GTTGG TTGGA TGGAC GGACT GACTG ACTGA CTGAG TGAGA GAGAC AGACT GACTG ACTGA CTGAC TGACC GACCT ACCTT CCTTA CTTAC TTACT TACTA ACTAA CTAAA TAAAG AAAGG AAGGA AGGAC GGACC GACCT ACCTC CCTCA CTCAT TCATG CATGA ATGAA TGAAT GAATT AATTT ATTTT TTTTG TTTGC TTGCT TGCTC GCTCT CTCTC TCTCA CTCAA TCAAC CAACA AACAT ACATA CATAC ATACA TACAA ACAAA CAAAT AAATG AATGT ATGTT TGTTG GTTGA TTGAG TGAGA GAGAG AGAGC GAGCA AGCAA GCAAA CAAAA AAAAT AAATT AATTC ATTCA TTCAT TCATG CATGA ATGAG TGAGG GAGGT AGGTC GGTCC GTCCT TCCTT CCTTT CTTTA TTTAG,ATAAAG TAAAGA AAAGAA AAGAAC AGAACT GAACTT AACTTT ACTTTA CTTTAA TTTAAG TTAAGT TAAGTC AAGTCA AGTCAG GTCAGT TCAGTT CAGTTC AGTTCT GTTCTT TTCTTT TCTTTA CTTTAT TTTATT TTATTA TATTAT ATTATC TTATCA TATCAA ATCAAA TCAAAA CAAAAC AAAACA AAACAA AACAAT ACAATG CAATGT AATGTT ATGTTT TGTTTT GTTTTT TTTTTA TTTTAT TTTATG TTATGT TATGTC ATGTCT TGTCTG GTCTGA TCTGAA CTGAAG TGAAGC GAAGCA AAGCAA AGCAAA GCAAAA CAAAAT AAAATG AAATGT AATGTT ATGTTG TGTTGG GTTGGA TTGGAC TGGACT GGACTG GACTGA ACTGAG CTGAGA TGAGAC GAGACT AGACTG GACTGA ACTGAC CTGACC TGACCT GACCTT ACCTTA CCTTAC CTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGG AAAGGA AAGGAC AGGACC GGACCT GACCTC ACCTCA CCTCAT CTCATG TCATGA CATGAA ATGAAT TGAATT GAATTT AATTTT ATTTTG TTTTGC TTTGCT TTGCTC TGCTCT GCTCTC CTCTCA TCTCAA CTCAAC TCAACA CAACAT AACATA ACATAC CATACA ATACAA TACAAA ACAAAT CAAATG AAATGT AATGTT ATGTTG TGTTGA GTTGAG TTGAGA TGAGAG GAGAGC AGAGCA GAGCAA AGCAAA GCAAAA CAAAAT AAAATT AAATTC AATTCA ATTCAT TTCATG TCATGA CATGAG ATGAGG TGAGGT GAGGTC AGGTCC GGTCCT GTCCTT TCCTTT CCTTTA CTTTAG,ATAAAGA TAAAGAA AAAGAAC AAGAACT AGAACTT GAACTTT AACTTTA ACTTTAA CTTTAAG TTTAAGT TTAAGTC TAAGTCA AAGTCAG AGTCAGT GTCAGTT TCAGTTC CAGTTCT AGTTCTT GTTCTTT TTCTTTA TCTTTAT CTTTATT TTTATTA TTATTAT TATTATC ATTATCA TTATCAA TATCAAA ATCAAAA TCAAAAC CAAAACA AAAACAA AAACAAT AACAATG ACAATGT CAATGTT AATGTTT ATGTTTT TGTTTTT GTTTTTA TTTTTAT TTTTATG TTTATGT TTATGTC TATGTCT ATGTCTG TGTCTGA GTCTGAA TCTGAAG CTGAAGC TGAAGCA GAAGCAA AAGCAAA AGCAAAA GCAAAAT CAAAATG AAAATGT AAATGTT AATGTTG ATGTTGG TGTTGGA GTTGGAC TTGGACT TGGACTG GGACTGA GACTGAG ACTGAGA CTGAGAC TGAGACT GAGACTG AGACTGA GACTGAC ACTGACC CTGACCT TGACCTT GACCTTA ACCTTAC CCTTACT CTTACTA TTACTAA TACTAAA ACTAAAG CTAAAGG TAAAGGA AAAGGAC AAGGACC AGGACCT GGACCTC GACCTCA ACCTCAT CCTCATG CTCATGA TCATGAA CATGAAT ATGAATT TGAATTT GAATTTT AATTTTG ATTTTGC TTTTGCT TTTGCTC TTGCTCT TGCTCTC GCTCTCA CTCTCAA TCTCAAC CTCAACA TCAACAT CAACATA AACATAC ACATACA CATACAA ATACAAA TACAAAT ACAAATG CAAATGT AAATGTT AATGTTG ATGTTGA TGTTGAG GTTGAGA TTGAGAG TGAGAGC GAGAGCA AGAGCAA GAGCAAA AGCAAAA GCAAAAT CAAAATT AAAATTC AAATTCA AATTCAT ATTCATG TTCATGA TCATGAG CATGAGG ATGAGGT TGAGGTC GAGGTCC AGGTCCT GGTCCTT GTCCTTT TCCTTTA CCTTTAG,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",49120
GCTATG CTATGA TATGAA ATGAAG TGAAGT GAAGTA AAGTAC AGTACA GTACAA TACAAT ACAATT CAATTA AATTAT ATTATG TTATGA TATGAA ATGAAC TGAACC GAACCT AACCTC ACCTCT CCTCTA CTCTAA TCTAAC CTAACA TAACAC AACACA ACACAA CACAAG ACAAGA CAAGAC AAGACC AGACCA GACCAT ACCATG CCATGT CATGTT ATGTTG TGTTGA GTTGAC TTGACA TGACAT GACATA ACATAC CATACT ATACTA TACTAG ACTAGG CTAGGA TAGGAC AGGACC GGACCT GACCTC ACCTCT CCTCTT CTCTTT TCTTTC CTTTCT TTTCTG TTCTGC TCTGCT CTGCTC TGCTCA GCTCAA CTCAAA TCAAAC CAAACT AAACTG AACTGG ACTGGA CTGGAA TGGAAT GGAATT GAATTG AATTGC ATTGCC TTGCCG TGCCGT GCCGTT CCGTTT CGTTTT GTTTTA TTTTAG TTTAGA TTAGAT TAGATA AGATAT GATATG ATATGT TATGTG ATGTGT TGTGTG GTGTGC TGTGCT GTGCTT TGCTTC GCTTCA CTTCAT TTCATT TCATTA CATTAA ATTAAA TTAAAA TAAAAG AAAAGA AAAGAA AAGAAT AGAATT GAATTA AATTAC ATTACT TTACTG TACTGC ACTGCA CTGCAA TGCAAA GCAAAA CAAAAT AAAATG AAATGG AATGGT ATGGTA TGGTAT GGTATG GTATGA TATGAA ATGAAT TGAATG GAATGG AATGGA ATGGAC TGGACG GGACGT GACGTA ACGTAC CGTACC GTACCA TACCAT ACCATA CCATAT CATATT ATATTG TATTGG ATTGGG TTGGGT,0,145,GCTA CTAT TATG ATGA TGAA GAAG AAGT AGTA GTAC TACA ACAA CAAT AATT ATTA TTAT TATG ATGA TGAA GAAC AACC ACCT CCTC CTCT TCTA CTAA TAAC AACA ACAC CACA ACAA CAAG AAGA AGAC GACC ACCA CCAT CATG ATGT TGTT GTTG TTGA TGAC GACA ACAT CATA ATAC TACT ACTA CTAG TAGG AGGA GGAC GACC ACCT CCTC CTCT TCTT CTTT TTTC TTCT TCTG CTGC TGCT GCTC CTCA TCAA CAAA AAAC AACT ACTG CTGG TGGA GGAA GAAT AATT ATTG TTGC TGCC GCCG CCGT CGTT GTTT TTTT TTTA TTAG TAGA AGAT GATA ATAT TATG ATGT TGTG GTGT TGTG GTGC TGCT GCTT CTTC TTCA TCAT CATT ATTA TTAA TAAA AAAA AAAG AAGA AGAA GAAT AATT ATTA TTAC TACT ACTG CTGC TGCA GCAA CAAA AAAA AAAT AATG ATGG TGGT GGTA GTAT TATG ATGA TGAA GAAT AATG ATGG TGGA GGAC GACG ACGT CGTA GTAC TACC ACCA CCAT CATA ATAT TATT ATTG TTGG TGGG GGGT,GCTAT CTATG TATGA ATGAA TGAAG GAAGT AAGTA AGTAC GTACA TACAA ACAAT CAATT AATTA ATTAT TTATG TATGA ATGAA TGAAC GAACC AACCT ACCTC CCTCT CTCTA TCTAA CTAAC TAACA AACAC ACACA CACAA ACAAG CAAGA AAGAC AGACC GACCA ACCAT CCATG CATGT ATGTT TGTTG GTTGA TTGAC TGACA GACAT ACATA CATAC ATACT TACTA ACTAG CTAGG TAGGA AGGAC GGACC GACCT ACCTC CCTCT CTCTT TCTTT CTTTC TTTCT TTCTG TCTGC CTGCT TGCTC GCTCA CTCAA TCAAA CAAAC AAACT AACTG ACTGG CTGGA TGGAA GGAAT GAATT AATTG ATTGC TTGCC TGCCG GCCGT CCGTT CGTTT GTTTT TTTTA TTTAG TTAGA TAGAT AGATA GATAT ATATG TATGT ATGTG TGTGT GTGTG TGTGC GTGCT TGCTT GCTTC CTTCA TTCAT TCATT CATTA ATTAA TTAAA TAAAA AAAAG AAAGA AAGAA AGAAT GAATT AATTA ATTAC TTACT TACTG ACTGC CTGCA TGCAA GCAAA CAAAA AAAAT AAATG AATGG ATGGT TGGTA GGTAT GTATG TATGA ATGAA TGAAT GAATG AATGG ATGGA TGGAC GGACG GACGT ACGTA CGTAC GTACC TACCA ACCAT CCATA CATAT ATATT TATTG ATTGG TTGGG TGGGT,GCTATG CTATGA TATGAA ATGAAG TGAAGT GAAGTA AAGTAC AGTACA GTACAA TACAAT ACAATT CAATTA AATTAT ATTATG TTATGA TATGAA ATGAAC TGAACC GAACCT AACCTC ACCTCT CCTCTA CTCTAA TCTAAC CTAACA TAACAC AACACA ACACAA CACAAG ACAAGA CAAGAC AAGACC AGACCA GACCAT ACCATG CCATGT CATGTT ATGTTG TGTTGA GTTGAC TTGACA TGACAT GACATA ACATAC CATACT ATACTA TACTAG ACTAGG CTAGGA TAGGAC AGGACC GGACCT GACCTC ACCTCT CCTCTT CTCTTT TCTTTC CTTTCT TTTCTG TTCTGC TCTGCT CTGCTC TGCTCA GCTCAA CTCAAA TCAAAC CAAACT AAACTG AACTGG ACTGGA CTGGAA TGGAAT GGAATT GAATTG AATTGC ATTGCC TTGCCG TGCCGT GCCGTT CCGTTT CGTTTT GTTTTA TTTTAG TTTAGA TTAGAT TAGATA AGATAT GATATG ATATGT TATGTG ATGTGT TGTGTG GTGTGC TGTGCT GTGCTT TGCTTC GCTTCA CTTCAT TTCATT TCATTA CATTAA ATTAAA TTAAAA TAAAAG AAAAGA AAAGAA AAGAAT AGAATT GAATTA AATTAC ATTACT TTACTG TACTGC ACTGCA CTGCAA TGCAAA GCAAAA CAAAAT AAAATG AAATGG AATGGT ATGGTA TGGTAT GGTATG GTATGA TATGAA ATGAAT TGAATG GAATGG AATGGA ATGGAC TGGACG GGACGT GACGTA ACGTAC CGTACC GTACCA TACCAT ACCATA CCATAT CATATT ATATTG TATTGG ATTGGG TTGGGT,GCTATGA CTATGAA TATGAAG ATGAAGT TGAAGTA GAAGTAC AAGTACA AGTACAA GTACAAT TACAATT ACAATTA CAATTAT AATTATG ATTATGA TTATGAA TATGAAC ATGAACC TGAACCT GAACCTC AACCTCT ACCTCTA CCTCTAA CTCTAAC TCTAACA CTAACAC TAACACA AACACAA ACACAAG CACAAGA ACAAGAC CAAGACC AAGACCA AGACCAT GACCATG ACCATGT CCATGTT CATGTTG ATGTTGA TGTTGAC GTTGACA TTGACAT TGACATA GACATAC ACATACT CATACTA ATACTAG TACTAGG ACTAGGA CTAGGAC TAGGACC AGGACCT GGACCTC GACCTCT ACCTCTT CCTCTTT CTCTTTC TCTTTCT CTTTCTG TTTCTGC TTCTGCT TCTGCTC CTGCTCA TGCTCAA GCTCAAA CTCAAAC TCAAACT CAAACTG AAACTGG AACTGGA ACTGGAA CTGGAAT TGGAATT GGAATTG GAATTGC AATTGCC ATTGCCG TTGCCGT TGCCGTT GCCGTTT CCGTTTT CGTTTTA GTTTTAG TTTTAGA TTTAGAT TTAGATA TAGATAT AGATATG GATATGT ATATGTG TATGTGT ATGTGTG TGTGTGC GTGTGCT TGTGCTT GTGCTTC TGCTTCA GCTTCAT CTTCATT TTCATTA TCATTAA CATTAAA ATTAAAA TTAAAAG TAAAAGA AAAAGAA AAAGAAT AAGAATT AGAATTA GAATTAC AATTACT ATTACTG TTACTGC TACTGCA ACTGCAA CTGCAAA TGCAAAA GCAAAAT CAAAATG AAAATGG AAATGGT AATGGTA ATGGTAT TGGTATG GGTATGA GTATGAA TATGAAT ATGAATG TGAATGG GAATGGA AATGGAC ATGGACG TGGACGT GGACGTA GACGTAC ACGTACC CGTACCA GTACCAT TACCATA ACCATAT CCATATT CATATTG ATATTGG TATTGGG ATTGGGT,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",15086
TTTCTC TTCTCA TCTCAA CTCAAT TCAATC CAATCG AATCGA ATCGAT TCGATT CGATTT GATTTA ATTTAC TTTACC TTACCA TACCAC ACCACA CCACAA CACAAC ACAACT CAACTC AACTCT ACTCTT CTCTTA TCTTAA CTTAAT TTAATG TAATGA AATGAC ATGACT TGACTT GACTTT ACTTTA CTTTAA TTTAAC TTAACC TAACCT AACCTT ACCTTG CCTTGT CTTGTG TTGTGG TGTGGC GTGGCT TGGCTA GGCTAT GCTATG CTATGA TATGAA ATGAAG TGAAGT GAAGTA AAGTAC AGTACA GTACAA TACAAT ACAATT CAATTA AATTAT ATTATG TTATGA TATGAA ATGAAC TGAACC GAACCT AACCTC ACCTCT CCTCTA CTCTAA TCTAAC CTAACA,0,70,TTTC TTCT TCTC CTCA TCAA CAAT AATC ATCG TCGA CGAT GATT ATTT TTTA TTAC TACC ACCA CCAC CACA ACAA CAAC AACT ACTC CTCT TCTT CTTA TTAA TAAT AATG ATGA TGAC GACT ACTT CTTT TTTA TTAA TAAC AACC ACCT CCTT CTTG TTGT TGTG GTGG TGGC GGCT GCTA CTAT TATG ATGA TGAA GAAG AAGT AGTA GTAC TACA ACAA CAAT AATT ATTA TTAT TATG ATGA TGAA GAAC AACC ACCT CCTC CTCT TCTA CTAA TAAC AACA,TTTCT TTCTC TCTCA CTCAA TCAAT CAATC AATCG ATCGA TCGAT CGATT GATTT ATTTA TTTAC TTACC TACCA ACCAC CCACA CACAA ACAAC CAACT AACTC ACTCT CTCTT TCTTA CTTAA TTAAT TAATG AATGA ATGAC TGACT GACTT ACTTT CTTTA TTTAA TTAAC TAACC AACCT ACCTT CCTTG CTTGT TTGTG TGTGG GTGGC TGGCT GGCTA GCTAT CTATG TATGA ATGAA TGAAG GAAGT AAGTA AGTAC GTACA TACAA ACAAT CAATT AATTA ATTAT TTATG TATGA ATGAA TGAAC GAACC AACCT ACCTC CCTCT CTCTA TCTAA CTAAC TAACA,TTTCTC TTCTCA TCTCAA CTCAAT TCAATC CAATCG AATCGA ATCGAT TCGATT CGATTT GATTTA ATTTAC TTTACC TTACCA TACCAC ACCACA CCACAA CACAAC ACAACT CAACTC AACTCT ACTCTT CTCTTA TCTTAA CTTAAT TTAATG TAATGA AATGAC ATGACT TGACTT GACTTT ACTTTA CTTTAA TTTAAC TTAACC TAACCT AACCTT ACCTTG CCTTGT CTTGTG TTGTGG TGTGGC GTGGCT TGGCTA GGCTAT GCTATG CTATGA TATGAA ATGAAG TGAAGT GAAGTA AAGTAC AGTACA GTACAA TACAAT ACAATT CAATTA AATTAT ATTATG TTATGA TATGAA ATGAAC TGAACC GAACCT AACCTC ACCTCT CCTCTA CTCTAA TCTAAC CTAACA,TTTCTCA TTCTCAA TCTCAAT CTCAATC TCAATCG CAATCGA AATCGAT ATCGATT TCGATTT CGATTTA GATTTAC ATTTACC TTTACCA TTACCAC TACCACA ACCACAA CCACAAC CACAACT ACAACTC CAACTCT AACTCTT ACTCTTA CTCTTAA TCTTAAT CTTAATG TTAATGA TAATGAC AATGACT ATGACTT TGACTTT GACTTTA ACTTTAA CTTTAAC TTTAACC TTAACCT TAACCTT AACCTTG ACCTTGT CCTTGTG CTTGTGG TTGTGGC TGTGGCT GTGGCTA TGGCTAT GGCTATG GCTATGA CTATGAA TATGAAG ATGAAGT TGAAGTA GAAGTAC AAGTACA AGTACAA GTACAAT TACAATT ACAATTA CAATTAT AATTATG ATTATGA TTATGAA TATGAAC ATGAACC TGAACCT GAACCTC AACCTCT ACCTCTA CCTCTAA CTCTAAC TCTAACA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",19721
TTAACA TAACAT AACATT ACATTA CATTAG ATTAGC TTAGCT TAGCTG AGCTGT GCTGTA CTGTAC TGTACC GTACCC TACCCT ACCCTA CCCTAT CCTATA CTATAA TATAAT ATAATA TAATAT AATATG ATATGA TATGAG ATGAGA TGAGAG GAGAGT AGAGTT GAGTTA AGTTAT GTTATA TTATAC TATACA ATACAT TACATT ACATTT CATTTT ATTTTG TTTTGG TTTGGT TTGGTG TGGTGC GGTGCT GTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCT GTTCTG TTCTGA TCTGAT CTGATA TGATAA GATAAA ATAAAG TAAAGG AAAGGA AAGGAG AGGAGT GGAGTT GAGTTG AGTTGC GTTGCA TTGCAC TGCACC GCACCA CACCAG ACCAGG CCAGGT CAGGTA AGGTAC GGTACA GTACAG TACAGC ACAGCT CAGCTG AGCTGT GCTGTT CTGTTT TGTTTT GTTTTA TTTTAA TTTAAG TTAAGA TAAGAC AAGACA AGACAG GACAGT ACAGTG CAGTGG AGTGGT GTGGTT TGGTTC GGTTCT GTTCTG TTCTGT TCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA,0,142,TTAA TAAC AACA ACAT CATT ATTA TTAG TAGC AGCT GCTG CTGT TGTA GTAC TACC ACCC CCCT CCTA CTAT TATA ATAA TAAT AATA ATAT TATG ATGA TGAG GAGA AGAG GAGT AGTT GTTA TTAT TATA ATAC TACA ACAT CATT ATTT TTTT TTTG TTGG TGGT GGTG GTGC TGCT GCTG CTGG TGGT GGTT GTTC TTCT TCTG CTGA TGAT GATA ATAA TAAA AAAG AAGG AGGA GGAG GAGT AGTT GTTG TTGC TGCA GCAC CACC ACCA CCAG CAGG AGGT GGTA GTAC TACA ACAG CAGC AGCT GCTG CTGT TGTT GTTT TTTT TTTA TTAA TAAG AAGA AGAC GACA ACAG CAGT AGTG GTGG TGGT GGTT GTTC TTCT TCTG CTGT TGTC GTCT TCTC CTCT TCTT CTTA TTAT TATA ATAC TACA ACAC CACA ACAT CATT ATTC TTCC TCCG CCGA CGAG GAGC AGCC GCCC CCCA CCAC CACG ACGA CGAG GAGA AGAC GACT ACTC CTCC TCCT CCTG CTGA TGAG GAGC AGCA GCAT CATC ATCT TCTC CTCG TCGT CGTA,TTAAC TAACA AACAT ACATT CATTA ATTAG TTAGC TAGCT AGCTG GCTGT CTGTA TGTAC GTACC TACCC ACCCT CCCTA CCTAT CTATA TATAA ATAAT TAATA AATAT ATATG TATGA ATGAG TGAGA GAGAG AGAGT GAGTT AGTTA GTTAT TTATA TATAC ATACA TACAT ACATT CATTT ATTTT TTTTG TTTGG TTGGT TGGTG GGTGC GTGCT TGCTG GCTGG CTGGT TGGTT GGTTC GTTCT TTCTG TCTGA CTGAT TGATA GATAA ATAAA TAAAG AAAGG AAGGA AGGAG GGAGT GAGTT AGTTG GTTGC TTGCA TGCAC GCACC CACCA ACCAG CCAGG CAGGT AGGTA GGTAC GTACA TACAG ACAGC CAGCT AGCTG GCTGT CTGTT TGTTT GTTTT TTTTA TTTAA TTAAG TAAGA AAGAC AGACA GACAG ACAGT CAGTG AGTGG GTGGT TGGTT GGTTC GTTCT TTCTG TCTGT CTGTC TGTCT GTCTC TCTCT CTCTT TCTTA CTTAT TTATA TATAC ATACA TACAC ACACA CACAT ACATT CATTC ATTCC TTCCG TCCGA CCGAG CGAGC GAGCC AGCCC GCCCA CCCAC CCACG CACGA ACGAG CGAGA GAGAC AGACT GACTC ACTCC CTCCT TCCTG CCTGA CTGAG TGAGC GAGCA AGCAT GCATC CATCT ATCTC TCTCG CTCGT TCGTA,TTAACA TAACAT AACATT ACATTA CATTAG ATTAGC TTAGCT TAGCTG AGCTGT GCTGTA CTGTAC TGTACC GTACCC TACCCT ACCCTA CCCTAT CCTATA CTATAA TATAAT ATAATA TAATAT AATATG ATATGA TATGAG ATGAGA TGAGAG GAGAGT AGAGTT GAGTTA AGTTAT GTTATA TTATAC TATACA ATACAT TACATT ACATTT CATTTT ATTTTG TTTTGG TTTGGT TTGGTG TGGTGC GGTGCT GTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCT GTTCTG TTCTGA TCTGAT CTGATA TGATAA GATAAA ATAAAG TAAAGG AAAGGA AAGGAG AGGAGT GGAGTT GAGTTG AGTTGC GTTGCA TTGCAC TGCACC GCACCA CACCAG ACCAGG CCAGGT CAGGTA AGGTAC GGTACA GTACAG TACAGC ACAGCT CAGCTG AGCTGT GCTGTT CTGTTT TGTTTT GTTTTA TTTTAA TTTAAG TTAAGA TAAGAC AAGACA AGACAG GACAGT ACAGTG CAGTGG AGTGGT GTGGTT TGGTTC GGTTCT GTTCTG TTCTGT TCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA,TTAACAT TAACATT AACATTA ACATTAG CATTAGC ATTAGCT TTAGCTG TAGCTGT AGCTGTA GCTGTAC CTGTACC TGTACCC GTACCCT TACCCTA ACCCTAT CCCTATA CCTATAA CTATAAT TATAATA ATAATAT TAATATG AATATGA ATATGAG TATGAGA ATGAGAG TGAGAGT GAGAGTT AGAGTTA GAGTTAT AGTTATA GTTATAC TTATACA TATACAT ATACATT TACATTT ACATTTT CATTTTG ATTTTGG TTTTGGT TTTGGTG TTGGTGC TGGTGCT GGTGCTG GTGCTGG TGCTGGT GCTGGTT CTGGTTC TGGTTCT GGTTCTG GTTCTGA TTCTGAT TCTGATA CTGATAA TGATAAA GATAAAG ATAAAGG TAAAGGA AAAGGAG AAGGAGT AGGAGTT GGAGTTG GAGTTGC AGTTGCA GTTGCAC TTGCACC TGCACCA GCACCAG CACCAGG ACCAGGT CCAGGTA CAGGTAC AGGTACA GGTACAG GTACAGC TACAGCT ACAGCTG CAGCTGT AGCTGTT GCTGTTT CTGTTTT TGTTTTA GTTTTAA TTTTAAG TTTAAGA TTAAGAC TAAGACA AAGACAG AGACAGT GACAGTG ACAGTGG CAGTGGT AGTGGTT GTGGTTC TGGTTCT GGTTCTG GTTCTGT TTCTGTC TCTGTCT CTGTCTC TGTCTCT GTCTCTT TCTCTTA CTCTTAT TCTTATA CTTATAC TTATACA TATACAC ATACACA TACACAT ACACATT CACATTC ACATTCC CATTCCG ATTCCGA TTCCGAG TCCGAGC CCGAGCC CGAGCCC GAGCCCA AGCCCAC GCCCACG CCCACGA CCACGAG CACGAGA ACGAGAC CGAGACT GAGACTC AGACTCC GACTCCT ACTCCTG CTCCTGA TCCTGAG CCTGAGC CTGAGCA TGAGCAT GAGCATC AGCATCT GCATCTC CATCTCG ATCTCGT TCTCGTA,"ID   R1AB_BCHK3              Reviewed;        7067 AA.
AC   P0C6W2; Q3LZX2;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   05-FEB-2025, entry version 109.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE              Short=nsp1;
DE     AltName: Full=Leader protein;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like proteinase nsp3;
DE              Short=PL-PRO;
DE              EC=3.4.19.12;
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.-;
DE     AltName: Full=nsp5;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9;
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE     AltName: Full=p12;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50;
DE     AltName: Full=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              Short=ExoN;
DE              EC=2.1.1.56;
DE              EC=3.1.13.-;
DE     AltName: Full=nsp14;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.-;
DE     AltName: Full=NendoU;
DE     AltName: Full=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Bat coronavirus HKU3 (BtCoV) (SARS-like coronavirus HKU3).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=442736;
OH   NCBI_TaxID=89399; Rhinolophus sinicus (Chinese rufous horseshoe bat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate HKU3-1;
RX   PubMed=16169905; DOI=10.1073/pnas.0506735102;
RA   Lau S.K.P., Woo P.C.Y., Li K.S.M., Huang Y., Tsoi H.-W., Wong B.H.L.,
RA   Wong S.S.Y., Leung S.-Y., Chan K.-H., Yuen K.-Y.;
RT   ""Severe acute respiratory syndrome coronavirus-like virus in Chinese
RT   horseshoe bats."";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14040-14045(2005).
CC   -!- FUNCTION: The replicase polyprotein of coronaviruses is a
CC       multifunctional protein: it contains the activities necessary for the
CC       transcription of negative stranded RNA, leader RNA, subgenomic mRNAs
CC       and progeny virion RNA as well as proteinases responsible for the
CC       cleavage of the polyprotein into functional products.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome
CC       complex further induces an endonucleolytic cleavage near the 5'UTR of
CC       host mRNAs, targeting them for degradation. Viral mRNAs are not
CC       susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the
CC       presence of a 5'-end leader sequence and are therefore protected from
CC       degradation. By suppressing host gene expression, nsp1 facilitates
CC       efficient viral gene expression in infected cells and evasion from host
CC       immune response. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 2]: May play a role in the modulation
CC       of host cell survival signaling pathway by interacting with host PHB
CC       and PHB2. Indeed, these two proteins play a role in maintaining the
CC       functional integrity of the mitochondria and protecting cells from
CC       various stresses. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Papain-like proteinase nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. In addition,
CC       PL-PRO possesses a deubiquitinating/deISGylating activity and processes
CC       both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates. Participates together with nsp4 in the assembly of virally-
CC       induced cytoplasmic double-membrane vesicles necessary for viral
CC       replication. Antagonizes innate immune induction of type I interferon
CC       by blocking the phosphorylation, dimerization and subsequent nuclear
CC       translocation of host IRF3. Prevents also host NF-kappa-B signaling.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 4]: Participates in the assembly of
CC       virally-induced cytoplasmic double-membrane vesicles necessary for
CC       viral replication. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [3C-like proteinase nsp5]: Cleaves the C-terminus of
CC       replicase polyprotein at 11 sites. Recognizes substrates containing the
CC       core sequence [ILMVF]-Q-|-[SGACN]. Also able to bind an ADP-ribose-1''-
CC       phosphate (ADRP). {ECO:0000250|UniProtKB:P0C6X7, ECO:0000255|PROSITE-
CC       ProRule:PRU00772}.
CC   -!- FUNCTION: [Non-structural protein 6]: Plays a role in the initial
CC       induction of autophagosomes from host endoplasmic reticulum. Later,
CC       limits the expansion of these phagosomes that are no longer able to
CC       deliver viral components to lysosomes. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 7]: Forms a hexadecamer with nsp8 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 8]: Forms a hexadecamer with nsp7 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Viral protein genome-linked nsp9]: Forms a primer, NSP9-pU,
CC       which is utilized by the polymerase for the initiation of RNA chains.
CC       Interacts with ribosome signal recognition particle RNA (SRP). Together
CC       with NSP8, suppress protein integration into the cell membrane, thereby
CC       disrupting host immune defenses. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16
CC       2'-O-methyltransferase activities. Therefore plays an essential role in
CC       viral mRNAs cap methylation. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [RNA-directed RNA polymerase nsp12]: RNA-directed RNA
CC       polymerase that catalyzes the transcription of viral genomic and
CC       subgenomic RNAs. Acts in complex with nsp7 and nsp8 to transcribe both
CC       the minus and positive strands of genomic RNA. The kinase-like NiRAN
CC       domain of NSP12 attaches one or more nucleotides to the amino terminus
CC       of NSP9, forming a covalent RNA-protein intermediate that serves as
CC       transcription/replication primer. Subgenomic RNAs (sgRNAs) are formed
CC       by discontinuous transcription: The polymerase has the ability to pause
CC       at transcription-regulating sequences (TRS) and jump to the leader TRS,
CC       resulting in a major deletion. This creates a series of subgenomic RNAs
CC       that are replicated, transcribed and translated. In addition, Nsp12 is
CC       a subunit of the viral RNA capping enzyme that catalyzes the RNA
CC       guanylyltransferase reaction for genomic and sub-genomic RNAs.
CC       Subsequently, the NiRAN domain transfers RNA to GDP, and forms the core
CC       cap structure GpppA-RNA. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Helicase nsp13]: Multi-functional protein with a zinc-
CC       binding domain in N-terminus displaying RNA and DNA duplex-unwinding
CC       activities with 5' to 3' polarity. Activity of helicase is dependent on
CC       magnesium. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Guanine-N7 methyltransferase nsp14]: Plays a role in viral
CC       RNA synthesis through two distinct activities. The N7-guanine
CC       methyltransferase activity plays a role in the formation of the cap
CC       structure GpppA-RNA. The proofreading exoribonuclease reduces the
CC       sensitivity of the virus to RNA mutagens during replication. This
CC       activity acts on both ssRNA and dsRNA in a 3'-5' direction.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Uridylate-specific endoribonuclease nsp15]: Plays a role in
CC       viral transcription/replication and prevents the simultaneous
CC       activation of host cell dsRNA sensors, such as MDA5/IFIH1, OAS, and PKR
CC       (By similarity). Acts by degrading the 5'-polyuridines generated during
CC       replication of the poly(A) region of viral genomic and subgenomic RNAs.
CC       Catalyzes a two-step reaction in which a 2'3'-cyclic phosphate (2'3'-
CC       cP) is first generated by 2'-O transesterification, which is then
CC       hydrolyzed to a 3'-phosphate (3'-P) (By similarity). If not degraded,
CC       poly(U) RNA would hybridize with poly(A) RNA tails and activate host
CC       dsRNA sensors (By similarity). {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [2'-O-methyltransferase nsp16]: Methyltransferase that
CC       mediates mRNA cap 2'-O-ribose methylation to the 5'-cap structure of
CC       viral mRNAs. N7-methyl guanosine cap is a prerequisite for binding of
CC       nsp16. Therefore plays an essential role in viral mRNAs cap methylation
CC       which is essential to evade immune system.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) +
CC         diphosphate; Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC         COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- CATALYTIC ACTIVITY: [Papain-like proteinase nsp3]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12;
CC   -!- CATALYTIC ACTIVITY: [2'-O-methyltransferase nsp16]:
CC       Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside
CC         in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA + S-
CC         adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:67020, Rhea:RHEA-
CC         COMP:17167, Rhea:RHEA-COMP:17168, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167609; EC=2.1.1.57;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [Uridylate-specific endoribonuclease nsp15]:
CC       Reaction=uridylyl-uridylyl-ribonucleotide-RNA = a 3'-end uridylyl-
CC         2',3'-cyclophospho-uridine-RNA + a 5'-end dephospho-ribonucleoside-
CC         RNA; Xref=Rhea:RHEA:67732, Rhea:RHEA-COMP:13936, Rhea:RHEA-
CC         COMP:17334, Rhea:RHEA-COMP:17335, ChEBI:CHEBI:138284,
CC         ChEBI:CHEBI:173079, ChEBI:CHEBI:173080;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67013;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- CATALYTIC ACTIVITY: [Guanine-N7 methyltransferase nsp14]:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + S-
CC         adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67009;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [Uridylate-specific endoribonuclease nsp15]:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       Note=Likely affects Nsp15 binding to RNA.
CC       {ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [RNA-directed RNA polymerase nsp12]:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- SUBUNIT: [Non-structural protein 2]: Interacts with host PHB and PHB2.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 4]: Interacts with papain-like
CC       protease nsp3 and non-structural protein 6.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [3C-like proteinase nsp5]: Monomer. Homodimer. Only the
CC       homodimer shows catalytic activity. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 7]: Interacts with nsp8 and nsp12 to
CC       form the replication-transcription complex (RTC): nsp12, nsp7, two
CC       subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 8]: Interacts with nsp7, nsp13 and
CC       nsp12 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Viral protein genome-linked nsp9]: Interacts with nsp12.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 10]: Interacts with proofreading
CC       exoribonuclease nsp14 and 2'-O-methyltransferase nsp16; these
CC       interactions enhance nsp14 and nsp16 enzymatic activities.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [RNA-directed RNA polymerase nsp12]: Interacts with nsp7 and
CC       nsp8 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13. Interacts with
CC       nsp9. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Helicase nsp13]: Interacts with nsp8 to form the replication-
CC       transcription complex (RTC): nsp12, nsp7, two subunits of nsp8, and up
CC       to two subunits of nsp13. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBCELLULAR LOCATION: [Papain-like proteinase nsp3]: Host membrane;
CC       Multi-pass membrane protein. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 4]: Host membrane; Multi-
CC       pass membrane protein. Host cytoplasm. Note=Localizes in virally-
CC       induced cytoplasmic double-membrane vesicles.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 6]: Host membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 7]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 8]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Viral protein genome-linked nsp9]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9
CC       and nsp10 are localized in cytoplasmic foci, largely perinuclear. Late
CC       in infection, they merge into confluent complexes (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 10]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Helicase nsp13]: Host endoplasmic reticulum-
CC       Golgi intermediate compartment {ECO:0000305}. Note=The helicase
CC       interacts with the N protein in membranous complexes and colocalizes
CC       with sites of synthesis of new viral RNA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Uridylate-specific endoribonuclease nsp15]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC       Name=Replicase polyprotein 1ab; Synonyms=pp1ab;
CC         IsoId=P0C6W2-1; Sequence=Displayed;
CC       Name=Replicase polyprotein 1a; Synonyms=pp1a, ORF1a polyprotein;
CC         IsoId=P0C6F8-1; Sequence=External;
CC   -!- DOMAIN: The hydrophobic domains (HD) could mediate the membrane
CC       association of the replication complex and thereby alter the
CC       architecture of the host cell membrane. {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages in vivo by its own proteases yield
CC       mature proteins. 3CL-PRO and PL-PRO proteinases are autocatalytically
CC       processed (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Bat coronavirus HKU3 is highly similar to SARS-CoV
CC       (SARS-like).
CC   -!- MISCELLANEOUS: [Isoform Replicase polyprotein 1ab]: Produced by -1
CC       ribosomal frameshifting at the 1a-1b genes boundary.
CC   -!- SIMILARITY: Belongs to the coronaviruses polyprotein 1ab family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ022305; AAY88865.2; -; Genomic_RNA.
DR   BMRB; P0C6W2; -.
DR   SMR; P0C6W2; -.
DR   MEROPS; C16.009; -.
DR   MEROPS; C30.005; -.
DR   Proteomes; UP000007450; Segment.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000175; F:3'-5'-RNA exonuclease activity; IEA:InterPro.
DR   GO; GO:0043139; F:5'-3' DNA helicase activity; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0036121; F:double-stranded DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0061749; F:forked DNA-dependent helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009378; F:four-way junction helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0002151; F:G-quadruplex RNA binding; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0004482; F:mRNA 5'-cap (guanine-N7-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0008242; F:omega peptidase activity; IEA:InterPro.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:1990518; F:single-stranded 3'-5' DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0039595; P:symbiont-mediated degradation of host mRNA; IEA:UniProtKB-KW.
DR   GO; GO:0039648; P:symbiont-mediated perturbation of host ubiquitin-like protein modification; IEA:UniProtKB-KW.
DR   GO; GO:0039657; P:symbiont-mediated suppression of host gene expression; IEA:UniProtKB-KW.
DR   GO; GO:0039579; P:symbiont-mediated suppression of host ISG15-protein conjugation; IEA:UniProtKB-KW.
DR   GO; GO:0085034; P:symbiont-mediated suppression of host NF-kappaB cascade; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0019082; P:viral protein processing; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   GO; GO:0075523; P:viral translational frameshifting; IEA:UniProtKB-KW.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21409; 1B_cv_Nsp13-like; 1.
DR   CDD; cd21560; betaCoV-Nsp6; 1.
DR   CDD; cd21722; betaCoV_Nsp13-helicase; 1.
DR   CDD; cd21659; betaCoV_Nsp14; 1.
DR   CDD; cd21516; betaCoV_Nsp2_SARS-like; 1.
DR   CDD; cd21666; betaCoV_Nsp5_Mpro; 1.
DR   CDD; cd21827; betaCoV_Nsp7; 1.
DR   CDD; cd21831; betaCoV_Nsp8; 1.
DR   CDD; cd21898; betaCoV_Nsp9; 1.
DR   CDD; cd21732; betaCoV_PLPro; 1.
DR   CDD; cd20762; capping_2-OMTase_Nidovirales; 1.
DR   CDD; cd21872; CoV_Nsp10; 1.
DR   CDD; cd21473; cv_Nsp4_TM; 1.
DR   CDD; cd21167; M_alpha_beta_cv_Nsp15-like; 1.
DR   CDD; cd21563; Macro_cv_SUD-M_Nsp3-like; 1.
DR   CDD; cd21562; Macro_cv_SUD-N_Nsp3-like; 1.
DR   CDD; cd21557; Macro_X_Nsp3-like; 1.
DR   CDD; cd21161; NendoU_cv_Nsp15-like; 1.
DR   CDD; cd21171; NTD_alpha_betaCoV_Nsp15-like; 1.
DR   CDD; cd22662; SARS-CoV-like_Nsp1_C; 1.
DR   CDD; cd21796; SARS-CoV-like_Nsp1_N; 1.
DR   CDD; cd21814; SARS-CoV-like_Nsp3_betaSM; 1.
DR   CDD; cd21822; SARS-CoV-like_Nsp3_NAB; 1.
DR   CDD; cd21591; SARS-CoV-like_RdRp; 1.
DR   CDD; cd21689; stalk_CoV_Nsp13-like; 1.
DR   CDD; cd21525; SUD_C_SARS-CoV_Nsp3; 1.
DR   CDD; cd21717; TM_Y_SARS-CoV-like_Nsp3_C; 1.
DR   CDD; cd21467; Ubl1_cv_Nsp3_N-like; 1.
DR   CDD; cd21401; ZBD_cv_Nsp13-like; 1.
DR   FunFam; 1.10.8.370:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 2.40.10.250:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.40.220.30:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.30.160.820:FF:000001; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.150:FF:000162; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001105; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001139; Orf1ab polyprotein; 1.
DR   FunFam; 1.10.150.420:FF:000001; Replicase polyprotein; 1.
DR   FunFam; 1.10.1840.10:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 1.10.8.1190:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 2.40.10.10:FF:000033; Replicase polyprotein 1a; 1.
DR   FunFam; 3.40.50.11580:FF:000001; Replicase polyprotein 1ab; 1.
DR   Gene3D; 1.10.8.1190; -; 1.
DR   Gene3D; 2.60.120.1680; -; 1.
DR   Gene3D; 3.10.20.350; -; 1.
DR   Gene3D; 3.10.20.540; -; 1.
DR   Gene3D; 3.40.50.11580; -; 1.
DR   Gene3D; 6.10.140.2090; -; 1.
DR   Gene3D; 1.10.150.420; Coronavirus nonstructural protein 4 C-terminus; 1.
DR   Gene3D; 3.40.30.150; Coronavirus polyprotein cleavage domain; 1.
DR   Gene3D; 3.40.220.10; Leucine Aminopeptidase, subunit E, domain 1; 1.
DR   Gene3D; 1.10.1840.10; main proteinase (3clpro) structure, domain 3; 1.
DR   Gene3D; 3.30.160.820; Nsp15 N-terminal domain-like; 1.
DR   Gene3D; 3.40.220.20; Nsp3, SUD-M subdomain; 1.
DR   Gene3D; 3.40.220.30; Nsp3, SUD-N subdomain; 1.
DR   Gene3D; 1.10.8.370; nsp7 replicase; 1.
DR   Gene3D; 3.30.70.3540; Nsp8 replicase, head domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   Gene3D; 2.40.10.250; Replicase NSP9; 1.
DR   Gene3D; 3.40.50.11020; Replicase polyprotein, nucleic acid-binding domain; 1.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR027351; (+)RNA_virus_helicase_core_dom.
DR   InterPro; IPR046443; a/bCoV_NSP1_glob.
DR   InterPro; IPR046440; AV_NSP11N_COV_NSP15M.
DR   InterPro; IPR046442; bCoV_NSP1_C.
DR   InterPro; IPR050534; Coronavir_polyprotein_1ab.
DR   InterPro; IPR043608; CoV_NSP15_M.
DR   InterPro; IPR043606; CoV_NSP15_N.
DR   InterPro; IPR043613; CoV_NSP2_C.
DR   InterPro; IPR047573; CoV_NSP2_M.
DR   InterPro; IPR049894; COV_NSP3_3ECTO.
DR   InterPro; IPR043611; CoV_NSP3_C.
DR   InterPro; IPR047566; CoV_NSP3_Y.
DR   InterPro; IPR032505; CoV_NSP4_C.
DR   InterPro; IPR043612; CoV_NSP4_N.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR041679; DNA2/NAM7-like_C.
DR   InterPro; IPR022733; DPUP_SUD_C_bCoV.
DR   InterPro; IPR037227; EndoU-like.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR044371; Macro_X_NSP3-like.
DR   InterPro; IPR046435; N7_MTase_CoV.
DR   InterPro; IPR043609; NendoU_nidovirus.
DR   InterPro; IPR044863; NIRAN.
DR   InterPro; IPR046438; NIV_2_O_MTASE.
DR   InterPro; IPR046436; NIV_EXON.
DR   InterPro; IPR036333; NSP10_sf_CoV.
DR   InterPro; IPR047570; NSP12_IF_CoV.
DR   InterPro; IPR044343; NSP13_1B_dom_CoV.
DR   InterPro; IPR048673; NSP13_stalk_CoV.
DR   InterPro; IPR048672; NSP13_ZBD_CoV.
DR   InterPro; IPR027352; NSP13_ZBD_CoV-like.
DR   InterPro; IPR044315; NSP14_betaCoV.
DR   InterPro; IPR009466; NSP14_CoV.
DR   InterPro; IPR044330; NSP15_alpha_betaCoV_N.
DR   InterPro; IPR044322; NSP15_M_alpha_beta_CoV.
DR   InterPro; IPR043174; NSP15_middle_sf.
DR   InterPro; IPR042515; NSP15_N_CoV.
DR   InterPro; IPR044401; NSP15_NendoU_CoV.
DR   InterPro; IPR009461; NSP16_CoV-like.
DR   InterPro; IPR021590; NSP1_glob_bCoV.
DR   InterPro; IPR038030; NSP1_glob_sf_bCoV.
DR   InterPro; IPR043615; NSP2_N_CoV.
DR   InterPro; IPR044389; NSP2_SARS-CoV-like.
DR   InterPro; IPR024375; NSP3_bCoV.
DR   InterPro; IPR047567; NSP3_G2M_bCoV.
DR   InterPro; IPR024358; NSP3_N_bCoV.
DR   InterPro; IPR032592; NSP3_NAB_bCoV.
DR   InterPro; IPR042570; NSP3_NAB_bCoV_sf.
DR   InterPro; IPR038166; NSP3_PL2pro_sf_bCoV.
DR   InterPro; IPR038400; NSP3_SUD-M_sf_bCoV.
DR   InterPro; IPR044864; NSP3_SUD-N_bCoV.
DR   InterPro; IPR044374; NSP3_SUD-N_SARS-CoV.
DR   InterPro; IPR043478; NSP3_SUD-N_sf_bCoV.
DR   InterPro; IPR044357; NSP3_Ubl1_dom_CoV.
DR   InterPro; IPR044353; Nsp3_Ubl2_dom_CoV.
DR   InterPro; IPR038083; NSP3A-like.
DR   InterPro; IPR038123; NSP4_C_sf_CoV.
DR   InterPro; IPR044367; NSP6_betaCoV.
DR   InterPro; IPR043610; NSP6_CoV.
DR   InterPro; IPR014828; NSP7_CoV.
DR   InterPro; IPR037204; NSP7_sf_CoV.
DR   InterPro; IPR014829; NSP8_CoV.
DR   InterPro; IPR037230; NSP8_sf_CoV.
DR   InterPro; IPR014822; NSP9_CoV.
DR   InterPro; IPR036499; NSP9_sf_CoV.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR013016; Peptidase_C16_CoV.
DR   InterPro; IPR008740; Peptidase_C30_CoV.
DR   InterPro; IPR043477; Peptidase_C30_dom3_CoV.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR043177; PLpro_N_sf_CoV.
DR   InterPro; IPR043503; PLpro_palm_finger_dom_CoV.
DR   InterPro; IPR043178; PLpro_thumb_sf_CoV.
DR   InterPro; IPR046441; RdRp_CoV.
DR   InterPro; IPR009469; RdRp_N_CoV.
DR   InterPro; IPR044351; RdRp_SARS-CoV-like.
DR   InterPro; IPR001205; RNA-dir_pol_C.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR018995; RNA_synth_NSP10_CoV.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR43788; DNA2/NAM7 HELICASE FAMILY MEMBER; 1.
DR   PANTHER; PTHR43788:SF16; HELICASE WITH ZINC FINGER 2; 1.
DR   Pfam; PF13087; AAA_12; 1.
DR   Pfam; PF16251; bCoV_NAB; 1.
DR   Pfam; PF11501; bCoV_NSP1; 1.
DR   Pfam; PF12379; bCoV_NSP3_N; 1.
DR   Pfam; PF12124; bCoV_SUD_C; 1.
DR   Pfam; PF11633; bCoV_SUD_M; 1.
DR   Pfam; PF06471; CoV_ExoN; 1.
DR   Pfam; PF06460; CoV_Methyltr_2; 1.
DR   Pfam; PF09401; CoV_NSP10; 1.
DR   Pfam; PF20631; CoV_NSP13_1B; 1.
DR   Pfam; PF20633; CoV_NSP13_stalk; 1.
DR   Pfam; PF20632; CoV_NSP13_ZBD; 1.
DR   Pfam; PF19215; CoV_NSP15_C; 1.
DR   Pfam; PF19216; CoV_NSP15_M; 1.
DR   Pfam; PF19219; CoV_NSP15_N; 1.
DR   Pfam; PF19212; CoV_NSP2_C; 1.
DR   Pfam; PF19211; CoV_NSP2_N; 1.
DR   Pfam; PF19218; CoV_NSP3_C; 1.
DR   Pfam; PF16348; CoV_NSP4_C; 1.
DR   Pfam; PF19217; CoV_NSP4_N; 1.
DR   Pfam; PF19213; CoV_NSP6; 1.
DR   Pfam; PF08716; CoV_NSP7; 1.
DR   Pfam; PF08717; CoV_NSP8; 1.
DR   Pfam; PF08710; CoV_NSP9; 1.
DR   Pfam; PF08715; CoV_peptidase; 1.
DR   Pfam; PF06478; CoV_RPol_N; 1.
DR   Pfam; PF01661; Macro; 1.
DR   Pfam; PF05409; Peptidase_C30; 1.
DR   Pfam; PF00680; RdRP_1; 1.
DR   SMART; SM00506; A1pp; 1.
DR   SUPFAM; SSF144246; Coronavirus NSP10-like; 1.
DR   SUPFAM; SSF140367; Coronavirus NSP7-like; 1.
DR   SUPFAM; SSF143076; Coronavirus NSP8-like; 1.
DR   SUPFAM; SSF56672; DNA/RNA polymerases; 1.
DR   SUPFAM; SSF142877; EndoU-like; 1.
DR   SUPFAM; SSF52949; Macro domain-like; 1.
DR   SUPFAM; SSF159936; NSP3A-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF101816; Replicase NSP9; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   SUPFAM; SSF160099; SARS Nsp1-like; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS51961; AV_NSP11N_COV_NSP15M; 1.
DR   PROSITE; PS51963; BCOV_NSP1_C; 1.
DR   PROSITE; PS51942; BCOV_NSP3C_C; 1.
DR   PROSITE; PS51941; BCOV_NSP3C_M; 1.
DR   PROSITE; PS51994; BCOV_NSP3E_G2M; 1.
DR   PROSITE; PS51945; BCOV_NSP3E_NAB; 1.
DR   PROSITE; PS51993; COV_3ECTO; 1.
DR   PROSITE; PS51952; COV_EXON_MTASE_COACT; 1.
DR   PROSITE; PS51954; COV_N7_MTASE; 1.
DR   PROSITE; PS51962; COV_NSP1; 1.
DR   PROSITE; PS52000; COV_NSP12_IF; 1.
DR   PROSITE; PS51948; COV_NSP12_RDRP; 1.
DR   PROSITE; PS51960; COV_NSP15_NTD; 1.
DR   PROSITE; PS51991; COV_NSP2_C; 1.
DR   PROSITE; PS51990; COV_NSP2_M; 1.
DR   PROSITE; PS51989; COV_NSP2_N; 1.
DR   P",52909
TTACTG TACTGC ACTGCA CTGCAA TGCAAA GCAAAA CAAAAT AAAATG AAATGG AATGGT ATGGTA TGGTAT GGTATG GTATGA TATGAA ATGAAT TGAATG GAATGG AATGGA ATGGAC TGGACG GGACGT GACGTA ACGTAC CGTACC GTACCA TACCAT ACCATA CCATAT CATATT ATATTG TATTGG ATTGGG TTGGGT TGGGTA GGGTAG GGTAGT GTAGTG TAGTGC AGTGCT GTGCTT TGCTTT GCTTTA CTTTAT TTTATT TTATTA TATTAG ATTAGA TTAGAA TAGAAG AGAAGA GAAGAT AAGATG AGATGA GATGAA ATGAAT TGAATT GAATTT AATTTA ATTTAC TTTACA TTACAC TACACC ACACCT CACCTT ACCTTT CCTTTT CTTTTG TTTTGA TTTGAT TTGATG TGATGT GATGTT ATGTTG TGTTGT GTTGTT TTGTTA TGTTAG GTTAGA TTAGAC TAGACA AGACAA GACAAT ACAATG CAATGC AATGCT ATGCTC TGCTCA GCTCAG CTCAGG TCAGGT CAGGTG AGGTGT GGTGTT GTGTTA TGTTAC GTTACT TTACTT TACTTT ACTTTC CTTTCC TTTCCA TTCCAA TCCAAA CCAAAG CAAAGT AAAGTG AAGTGC AGTGCA GTGCAG TGCAGT GCAGTG CAGTGA AGTGAA GTGAAA TGAAAA GAAAAG AAAAGA AAAGAA AAGAAC AGAACA GAACAA AACAAT ACAATC CAATCA AATCAA ATCAAG TCAAGG CAAGGG AAGGGT AGGGTA GGGTAC GGTACA GTACAC TACACA ACACAC CACACC ACACCA CACCAC ACCACT CCACTG CACTGG,0,142,TTAC TACT ACTG CTGC TGCA GCAA CAAA AAAA AAAT AATG ATGG TGGT GGTA GTAT TATG ATGA TGAA GAAT AATG ATGG TGGA GGAC GACG ACGT CGTA GTAC TACC ACCA CCAT CATA ATAT TATT ATTG TTGG TGGG GGGT GGTA GTAG TAGT AGTG GTGC TGCT GCTT CTTT TTTA TTAT TATT ATTA TTAG TAGA AGAA GAAG AAGA AGAT GATG ATGA TGAA GAAT AATT ATTT TTTA TTAC TACA ACAC CACC ACCT CCTT CTTT TTTT TTTG TTGA TGAT GATG ATGT TGTT GTTG TTGT TGTT GTTA TTAG TAGA AGAC GACA ACAA CAAT AATG ATGC TGCT GCTC CTCA TCAG CAGG AGGT GGTG GTGT TGTT GTTA TTAC TACT ACTT CTTT TTTC TTCC TCCA CCAA CAAA AAAG AAGT AGTG GTGC TGCA GCAG CAGT AGTG GTGA TGAA GAAA AAAA AAAG AAGA AGAA GAAC AACA ACAA CAAT AATC ATCA TCAA CAAG AAGG AGGG GGGT GGTA GTAC TACA ACAC CACA ACAC CACC ACCA CCAC CACT ACTG CTGG,TTACT TACTG ACTGC CTGCA TGCAA GCAAA CAAAA AAAAT AAATG AATGG ATGGT TGGTA GGTAT GTATG TATGA ATGAA TGAAT GAATG AATGG ATGGA TGGAC GGACG GACGT ACGTA CGTAC GTACC TACCA ACCAT CCATA CATAT ATATT TATTG ATTGG TTGGG TGGGT GGGTA GGTAG GTAGT TAGTG AGTGC GTGCT TGCTT GCTTT CTTTA TTTAT TTATT TATTA ATTAG TTAGA TAGAA AGAAG GAAGA AAGAT AGATG GATGA ATGAA TGAAT GAATT AATTT ATTTA TTTAC TTACA TACAC ACACC CACCT ACCTT CCTTT CTTTT TTTTG TTTGA TTGAT TGATG GATGT ATGTT TGTTG GTTGT TTGTT TGTTA GTTAG TTAGA TAGAC AGACA GACAA ACAAT CAATG AATGC ATGCT TGCTC GCTCA CTCAG TCAGG CAGGT AGGTG GGTGT GTGTT TGTTA GTTAC TTACT TACTT ACTTT CTTTC TTTCC TTCCA TCCAA CCAAA CAAAG AAAGT AAGTG AGTGC GTGCA TGCAG GCAGT CAGTG AGTGA GTGAA TGAAA GAAAA AAAAG AAAGA AAGAA AGAAC GAACA AACAA ACAAT CAATC AATCA ATCAA TCAAG CAAGG AAGGG AGGGT GGGTA GGTAC GTACA TACAC ACACA CACAC ACACC CACCA ACCAC CCACT CACTG ACTGG,TTACTG TACTGC ACTGCA CTGCAA TGCAAA GCAAAA CAAAAT AAAATG AAATGG AATGGT ATGGTA TGGTAT GGTATG GTATGA TATGAA ATGAAT TGAATG GAATGG AATGGA ATGGAC TGGACG GGACGT GACGTA ACGTAC CGTACC GTACCA TACCAT ACCATA CCATAT CATATT ATATTG TATTGG ATTGGG TTGGGT TGGGTA GGGTAG GGTAGT GTAGTG TAGTGC AGTGCT GTGCTT TGCTTT GCTTTA CTTTAT TTTATT TTATTA TATTAG ATTAGA TTAGAA TAGAAG AGAAGA GAAGAT AAGATG AGATGA GATGAA ATGAAT TGAATT GAATTT AATTTA ATTTAC TTTACA TTACAC TACACC ACACCT CACCTT ACCTTT CCTTTT CTTTTG TTTTGA TTTGAT TTGATG TGATGT GATGTT ATGTTG TGTTGT GTTGTT TTGTTA TGTTAG GTTAGA TTAGAC TAGACA AGACAA GACAAT ACAATG CAATGC AATGCT ATGCTC TGCTCA GCTCAG CTCAGG TCAGGT CAGGTG AGGTGT GGTGTT GTGTTA TGTTAC GTTACT TTACTT TACTTT ACTTTC CTTTCC TTTCCA TTCCAA TCCAAA CCAAAG CAAAGT AAAGTG AAGTGC AGTGCA GTGCAG TGCAGT GCAGTG CAGTGA AGTGAA GTGAAA TGAAAA GAAAAG AAAAGA AAAGAA AAGAAC AGAACA GAACAA AACAAT ACAATC CAATCA AATCAA ATCAAG TCAAGG CAAGGG AAGGGT AGGGTA GGGTAC GGTACA GTACAC TACACA ACACAC CACACC ACACCA CACCAC ACCACT CCACTG CACTGG,TTACTGC TACTGCA ACTGCAA CTGCAAA TGCAAAA GCAAAAT CAAAATG AAAATGG AAATGGT AATGGTA ATGGTAT TGGTATG GGTATGA GTATGAA TATGAAT ATGAATG TGAATGG GAATGGA AATGGAC ATGGACG TGGACGT GGACGTA GACGTAC ACGTACC CGTACCA GTACCAT TACCATA ACCATAT CCATATT CATATTG ATATTGG TATTGGG ATTGGGT TTGGGTA TGGGTAG GGGTAGT GGTAGTG GTAGTGC TAGTGCT AGTGCTT GTGCTTT TGCTTTA GCTTTAT CTTTATT TTTATTA TTATTAG TATTAGA ATTAGAA TTAGAAG TAGAAGA AGAAGAT GAAGATG AAGATGA AGATGAA GATGAAT ATGAATT TGAATTT GAATTTA AATTTAC ATTTACA TTTACAC TTACACC TACACCT ACACCTT CACCTTT ACCTTTT CCTTTTG CTTTTGA TTTTGAT TTTGATG TTGATGT TGATGTT GATGTTG ATGTTGT TGTTGTT GTTGTTA TTGTTAG TGTTAGA GTTAGAC TTAGACA TAGACAA AGACAAT GACAATG ACAATGC CAATGCT AATGCTC ATGCTCA TGCTCAG GCTCAGG CTCAGGT TCAGGTG CAGGTGT AGGTGTT GGTGTTA GTGTTAC TGTTACT GTTACTT TTACTTT TACTTTC ACTTTCC CTTTCCA TTTCCAA TTCCAAA TCCAAAG CCAAAGT CAAAGTG AAAGTGC AAGTGCA AGTGCAG GTGCAGT TGCAGTG GCAGTGA CAGTGAA AGTGAAA GTGAAAA TGAAAAG GAAAAGA AAAAGAA AAAGAAC AAGAACA AGAACAA GAACAAT AACAATC ACAATCA CAATCAA AATCAAG ATCAAGG TCAAGGG CAAGGGT AAGGGTA AGGGTAC GGGTACA GGTACAC GTACACA TACACAC ACACACC CACACCA ACACCAC CACCACT ACCACTG CCACTGG,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",35118
GTGTTG TGTTGG GTTGGA TTGGAC TGGACC GGACCG GACCGC ACCGCG CCGCGT CGCGTG GCGTGG CGTGGC GTGGCG TGGCGG GGCGGC GCGGCG CGGCGT GGCGTT GCGTTG CGTTGC GTTGCA TTGCAG TGCAGC GCAGCG CAGCGC AGCGCA GCGCAC CGCACG GCACGC CACGCT ACGCTG CGCTGC GCTGCG CTGCGT TGCGTG GCGTGA CGTGAG GTGAGA TGAGAC GAGACG AGACGC GACGCA ACGCAG CGCAGC GCAGCA CAGCAG AGCAGC GCAGCG CAGCGG AGCGGA GCGGAA CGGAAG GGAAGG GAAGGC AAGGCA AGGCAG GGCAGA GCAGAC CAGACT AGACTT GACTTG ACTTGG CTTGGA TTGGAG TGGAGG GGAGGC GAGGCC AGGCCC GGCCCA GCCCAG CCCAGG CCAGGC CAGGCT AGGCTG GGCTGC GCTGCT CTGCTC TGCTCG GCTCGT CTCGTG TCGTGC CGTGCG GTGCGA TGCGAC GCGACG CGACGA GACGAA ACGAAG CGAAGC GAAGCA AAGCAG AGCAGC GCAGCT CAGCTG AGCTGG GCTGGA CTGGAA TGGAAC GGAACG GAACGC AACGCG ACGCGC CGCGCC GCGCCG CGCCGG GCCGGT CCGGTC CGGTCA GGTCAG GTCAGT TCAGTT CAGTTG AGTTGA GTTGAT TTGATC TGATCG GATCGG ATCGGT TCGGTG CGGTGG GGTGGA GTGGAT TGGATT GGATTG GATTGG ATTGGG TTGGGC TGGGCG GGGCGG GGCGGT GCGGTG CGGTGA GGTGAG GTGAGA TGAGAA GAGAAG AGAAGG GAAGGT AAGGTC AGGTCC GGTCCG GTCCGT TCCGTT CCGTTG CGTTGG,3,145,GTGT TGTT GTTG TTGG TGGA GGAC GACC ACCG CCGC CGCG GCGT CGTG GTGG TGGC GGCG GCGG CGGC GGCG GCGT CGTT GTTG TTGC TGCA GCAG CAGC AGCG GCGC CGCA GCAC CACG ACGC CGCT GCTG CTGC TGCG GCGT CGTG GTGA TGAG GAGA AGAC GACG ACGC CGCA GCAG CAGC AGCA GCAG CAGC AGCG GCGG CGGA GGAA GAAG AAGG AGGC GGCA GCAG CAGA AGAC GACT ACTT CTTG TTGG TGGA GGAG GAGG AGGC GGCC GCCC CCCA CCAG CAGG AGGC GGCT GCTG CTGC TGCT GCTC CTCG TCGT CGTG GTGC TGCG GCGA CGAC GACG ACGA CGAA GAAG AAGC AGCA GCAG CAGC AGCT GCTG CTGG TGGA GGAA GAAC AACG ACGC CGCG GCGC CGCC GCCG CCGG CGGT GGTC GTCA TCAG CAGT AGTT GTTG TTGA TGAT GATC ATCG TCGG CGGT GGTG GTGG TGGA GGAT GATT ATTG TTGG TGGG GGGC GGCG GCGG CGGT GGTG GTGA TGAG GAGA AGAA GAAG AAGG AGGT GGTC GTCC TCCG CCGT CGTT GTTG TTGG,GTGTT TGTTG GTTGG TTGGA TGGAC GGACC GACCG ACCGC CCGCG CGCGT GCGTG CGTGG GTGGC TGGCG GGCGG GCGGC CGGCG GGCGT GCGTT CGTTG GTTGC TTGCA TGCAG GCAGC CAGCG AGCGC GCGCA CGCAC GCACG CACGC ACGCT CGCTG GCTGC CTGCG TGCGT GCGTG CGTGA GTGAG TGAGA GAGAC AGACG GACGC ACGCA CGCAG GCAGC CAGCA AGCAG GCAGC CAGCG AGCGG GCGGA CGGAA GGAAG GAAGG AAGGC AGGCA GGCAG GCAGA CAGAC AGACT GACTT ACTTG CTTGG TTGGA TGGAG GGAGG GAGGC AGGCC GGCCC GCCCA CCCAG CCAGG CAGGC AGGCT GGCTG GCTGC CTGCT TGCTC GCTCG CTCGT TCGTG CGTGC GTGCG TGCGA GCGAC CGACG GACGA ACGAA CGAAG GAAGC AAGCA AGCAG GCAGC CAGCT AGCTG GCTGG CTGGA TGGAA GGAAC GAACG AACGC ACGCG CGCGC GCGCC CGCCG GCCGG CCGGT CGGTC GGTCA GTCAG TCAGT CAGTT AGTTG GTTGA TTGAT TGATC GATCG ATCGG TCGGT CGGTG GGTGG GTGGA TGGAT GGATT GATTG ATTGG TTGGG TGGGC GGGCG GGCGG GCGGT CGGTG GGTGA GTGAG TGAGA GAGAA AGAAG GAAGG AAGGT AGGTC GGTCC GTCCG TCCGT CCGTT CGTTG GTTGG,GTGTTG TGTTGG GTTGGA TTGGAC TGGACC GGACCG GACCGC ACCGCG CCGCGT CGCGTG GCGTGG CGTGGC GTGGCG TGGCGG GGCGGC GCGGCG CGGCGT GGCGTT GCGTTG CGTTGC GTTGCA TTGCAG TGCAGC GCAGCG CAGCGC AGCGCA GCGCAC CGCACG GCACGC CACGCT ACGCTG CGCTGC GCTGCG CTGCGT TGCGTG GCGTGA CGTGAG GTGAGA TGAGAC GAGACG AGACGC GACGCA ACGCAG CGCAGC GCAGCA CAGCAG AGCAGC GCAGCG CAGCGG AGCGGA GCGGAA CGGAAG GGAAGG GAAGGC AAGGCA AGGCAG GGCAGA GCAGAC CAGACT AGACTT GACTTG ACTTGG CTTGGA TTGGAG TGGAGG GGAGGC GAGGCC AGGCCC GGCCCA GCCCAG CCCAGG CCAGGC CAGGCT AGGCTG GGCTGC GCTGCT CTGCTC TGCTCG GCTCGT CTCGTG TCGTGC CGTGCG GTGCGA TGCGAC GCGACG CGACGA GACGAA ACGAAG CGAAGC GAAGCA AAGCAG AGCAGC GCAGCT CAGCTG AGCTGG GCTGGA CTGGAA TGGAAC GGAACG GAACGC AACGCG ACGCGC CGCGCC GCGCCG CGCCGG GCCGGT CCGGTC CGGTCA GGTCAG GTCAGT TCAGTT CAGTTG AGTTGA GTTGAT TTGATC TGATCG GATCGG ATCGGT TCGGTG CGGTGG GGTGGA GTGGAT TGGATT GGATTG GATTGG ATTGGG TTGGGC TGGGCG GGGCGG GGCGGT GCGGTG CGGTGA GGTGAG GTGAGA TGAGAA GAGAAG AGAAGG GAAGGT AAGGTC AGGTCC GGTCCG GTCCGT TCCGTT CCGTTG CGTTGG,GTGTTGG TGTTGGA GTTGGAC TTGGACC TGGACCG GGACCGC GACCGCG ACCGCGT CCGCGTG CGCGTGG GCGTGGC CGTGGCG GTGGCGG TGGCGGC GGCGGCG GCGGCGT CGGCGTT GGCGTTG GCGTTGC CGTTGCA GTTGCAG TTGCAGC TGCAGCG GCAGCGC CAGCGCA AGCGCAC GCGCACG CGCACGC GCACGCT CACGCTG ACGCTGC CGCTGCG GCTGCGT CTGCGTG TGCGTGA GCGTGAG CGTGAGA GTGAGAC TGAGACG GAGACGC AGACGCA GACGCAG ACGCAGC CGCAGCA GCAGCAG CAGCAGC AGCAGCG GCAGCGG CAGCGGA AGCGGAA GCGGAAG CGGAAGG GGAAGGC GAAGGCA AAGGCAG AGGCAGA GGCAGAC GCAGACT CAGACTT AGACTTG GACTTGG ACTTGGA CTTGGAG TTGGAGG TGGAGGC GGAGGCC GAGGCCC AGGCCCA GGCCCAG GCCCAGG CCCAGGC CCAGGCT CAGGCTG AGGCTGC GGCTGCT GCTGCTC CTGCTCG TGCTCGT GCTCGTG CTCGTGC TCGTGCG CGTGCGA GTGCGAC TGCGACG GCGACGA CGACGAA GACGAAG ACGAAGC CGAAGCA GAAGCAG AAGCAGC AGCAGCT GCAGCTG CAGCTGG AGCTGGA GCTGGAA CTGGAAC TGGAACG GGAACGC GAACGCG AACGCGC ACGCGCC CGCGCCG GCGCCGG CGCCGGT GCCGGTC CCGGTCA CGGTCAG GGTCAGT GTCAGTT TCAGTTG CAGTTGA AGTTGAT GTTGATC TTGATCG TGATCGG GATCGGT ATCGGTG TCGGTGG CGGTGGA GGTGGAT GTGGATT TGGATTG GGATTGG GATTGGG ATTGGGC TTGGGCG TGGGCGG GGGCGGT GGCGGTG GCGGTGA CGGTGAG GGTGAGA GTGAGAA TGAGAAG GAGAAGG AGAAGGT GAAGGTC AAGGTCC AGGTCCG GGTCCGT GTCCGTT TCCGTTG CCGTTGG,"ID   DYH7_RAT                Reviewed;        4057 AA.
AC   Q63170; Q62821;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   05-FEB-2025, entry version 130.
DE   RecName: Full=Dynein axonemal heavy chain 7;
DE   AltName: Full=Axonemal beta dynein heavy chain 7;
DE   AltName: Full=Axonemal dynein heavy chain b;
DE   AltName: Full=Ciliary dynein heavy chain 7;
DE   AltName: Full=Dynein-like protein 7;
GN   Name=Dnah7; Synonyms=Axob, Dlp7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   ""Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution."";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1369-1529, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=7657712; DOI=10.1242/jcs.108.5.1883;
RA   Tanaka Y., Zhang Z., Hirokawa N.;
RT   ""Identification and molecular evolution of new dynein-like protein
RT   sequences in rat brain."";
RL   J. Cell Sci. 108:1883-1893(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1372-1459, AND INDUCTION.
RC   TISSUE=Trachea;
RX   PubMed=8741840; DOI=10.1091/mbc.7.1.71;
RA   Andrews K.L., Nettesheim P., Asai D.J., Ostrowski L.E.;
RT   ""Identification of seven rat axonemal dynein heavy chain genes: expression
RT   during ciliated cell differentiation."";
RL   Mol. Biol. Cell 7:71-79(1996).
CC   -!- FUNCTION: Force generating protein that probably plays an important
CC       role in respiratory cilia and sperm flagella beating (By similarity).
CC       Produces force towards the minus ends of microtubules. Dynein has
CC       ATPase activity; the force-producing power stroke is thought to occur
CC       on release of ADP (By similarity). {ECO:0000250|UniProtKB:Q8WXX0}.
CC   -!- SUBUNIT: The dynein complex consists of at least two heavy chains and a
CC       number of intermediate and light chains. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium axoneme
CC       {ECO:0000250|UniProtKB:Q8WXX0}. Cell projection, cilium, flagellum
CC       {ECO:0000250|UniProtKB:Q8WXX0}.
CC   -!- TISSUE SPECIFICITY: Detected in brain. {ECO:0000269|PubMed:7657712}.
CC   -!- INDUCTION: Up-regulated during ciliogenesis.
CC       {ECO:0000269|PubMed:8741840}.
CC   -!- DOMAIN: Dynein heavy chains probably consist of an N-terminal stem
CC       (which binds cargo and interacts with other dynein components), and the
CC       head or motor domain. The motor contains six tandemly-linked AAA
CC       domains in the head, which form a ring. A stalk-like structure (formed
CC       by two of the coiled coil domains) protrudes between AAA 4 and AAA 5
CC       and terminates in a microtubule-binding site. A seventh domain may also
CC       contribute to this ring; it is not clear whether the N-terminus or the
CC       C-terminus forms this extra domain. There are four well-conserved and
CC       two non-conserved ATPase sites, one per AAA domain. Probably only one
CC       of these (within AAA 1) actually hydrolyzes ATP, the others may serve a
CC       regulatory function (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the dynein heavy chain family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03068169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03068266; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03068762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03068958; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03068975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03069173; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03069339; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03069471; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03070154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03071231; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03071501; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03071646; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03071706; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03071857; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03072256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; D26498; BAA05506.1; -; mRNA.
DR   EMBL; U32180; AAC52363.1; -; mRNA.
DR   PIR; I70177; I70177.
DR   SMR; Q63170; -.
DR   STRING; 10116.ENSRNOP00000070606; -.
DR   CarbonylDB; Q63170; -.
DR   PhosphoSitePlus; Q63170; -.
DR   PaxDb; 10116-ENSRNOP00000016465; -.
DR   UCSC; RGD:621798; rat.
DR   AGR; RGD:621798; -.
DR   RGD; 621798; Dnah7.
DR   eggNOG; KOG3595; Eukaryota.
DR   InParanoid; Q63170; -.
DR   PhylomeDB; Q63170; -.
DR   PRO; PR:Q63170; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097729; C:9+2 motile cilium; IBA:GO_Central.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0036156; C:inner dynein arm; ISO:RGD.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0045505; F:dynein intermediate chain binding; IBA:GO_Central.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IBA:GO_Central.
DR   GO; GO:0008569; F:minus-end-directed microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0003341; P:cilium movement; ISO:RGD.
DR   GO; GO:0060294; P:cilium movement involved in cell motility; IBA:GO_Central.
DR   GO; GO:0036159; P:inner dynein arm assembly; ISO:RGD.
DR   FunFam; 1.20.1270.280:FF:000038; AT13908p; 1.
DR   FunFam; 1.20.920.30:FF:000002; Dynein axonemal heavy chain 3; 1.
DR   FunFam; 1.10.8.1220:FF:000001; Dynein axonemal heavy chain 5; 1.
DR   FunFam; 1.10.8.710:FF:000004; Dynein axonemal heavy chain 6; 1.
DR   FunFam; 1.20.140.100:FF:000004; Dynein axonemal heavy chain 6; 1.
DR   FunFam; 1.10.472.130:FF:000005; Dynein axonemal heavy chain 7; 1.
DR   FunFam; 3.40.50.300:FF:002141; Dynein heavy chain; 1.
DR   FunFam; 3.20.180.20:FF:000003; Dynein heavy chain 12, axonemal; 1.
DR   FunFam; 1.10.287.2620:FF:000002; Dynein heavy chain 2, axonemal; 1.
DR   FunFam; 3.40.50.300:FF:000223; Dynein heavy chain 3, axonemal; 1.
DR   FunFam; 3.40.50.300:FF:001328; Dynein heavy chain 6, axonemal; 1.
DR   FunFam; 3.40.50.300:FF:000063; dynein heavy chain 6, axonemal; 1.
DR   FunFam; 1.10.8.720:FF:000001; dynein heavy chain 7, axonemal; 1.
DR   FunFam; 3.10.490.20:FF:000001; dynein heavy chain 7, axonemal; 1.
DR   FunFam; 1.20.58.1120:FF:000005; Dynein, axonemal, heavy chain 12; 1.
DR   FunFam; 1.20.920.20:FF:000006; Dynein, axonemal, heavy chain 6; 1.
DR   FunFam; 3.40.50.300:FF:000362; Dynein, axonemal, heavy chain 6; 1.
DR   FunFam; 1.20.1270.280:FF:000037; Dynein, axonemal, heavy chain 7; 1.
DR   Gene3D; 1.10.287.2620; -; 1.
DR   Gene3D; 1.10.472.130; -; 1.
DR   Gene3D; 1.10.8.1220; -; 1.
DR   Gene3D; 1.10.8.710; -; 1.
DR   Gene3D; 1.20.1270.280; -; 1.
DR   Gene3D; 1.20.58.1120; -; 1.
DR   Gene3D; 1.20.920.20; -; 1.
DR   Gene3D; 1.20.920.30; -; 1.
DR   Gene3D; 3.10.490.20; -; 1.
DR   Gene3D; 6.10.140.1060; -; 1.
DR   Gene3D; 1.20.140.100; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.20.180.20; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 5.
DR   Gene3D; 1.10.8.720; Region D6 of dynein motor; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR035699; AAA_6.
DR   InterPro; IPR035706; AAA_9.
DR   InterPro; IPR041658; AAA_lid_11.
DR   InterPro; IPR042219; AAA_lid_11_sf.
DR   InterPro; IPR026983; DHC.
DR   InterPro; IPR041589; DNAH3_AAA_lid_1.
DR   InterPro; IPR042222; Dynein_2_N.
DR   InterPro; IPR043157; Dynein_AAA1S.
DR   InterPro; IPR041466; Dynein_AAA5_ext.
DR   InterPro; IPR041228; Dynein_C.
DR   InterPro; IPR043160; Dynein_C_barrel.
DR   InterPro; IPR024743; Dynein_HC_stalk.
DR   InterPro; IPR024317; Dynein_heavy_chain_D4_dom.
DR   InterPro; IPR004273; Dynein_heavy_D6_P-loop.
DR   InterPro; IPR013602; Dynein_heavy_linker.
DR   InterPro; IPR042228; Dynein_linker_3.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR22878:SF66; DYNEIN AXONEMAL HEAVY CHAIN 7; 1.
DR   PANTHER; PTHR22878; DYNEIN HEAVY CHAIN 6, AXONEMAL-LIKE-RELATED; 1.
DR   Pfam; PF12774; AAA_6; 1.
DR   Pfam; PF12775; AAA_7; 1.
DR   Pfam; PF12780; AAA_8; 1.
DR   Pfam; PF12781; AAA_9; 1.
DR   Pfam; PF17857; AAA_lid_1; 1.
DR   Pfam; PF18198; AAA_lid_11; 1.
DR   Pfam; PF08393; DHC_N2; 1.
DR   Pfam; PF17852; Dynein_AAA_lid; 1.
DR   Pfam; PF18199; Dynein_C; 1.
DR   Pfam; PF03028; Dynein_heavy; 1.
DR   Pfam; PF12777; MT; 1.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 4.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell projection; Cilium; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Dynein; Flagellum; Microtubule; Motor protein; Nucleotide-binding;
KW   Reference proteome; Repeat.
FT   CHAIN           1..4057
FT                   /note=""Dynein axonemal heavy chain 7""
FT                   /id=""PRO_0000317667""
FT   REGION          1..21
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          130..154
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          1323..1544
FT                   /note=""AAA 1""
FT                   /evidence=""ECO:0000250""
FT   REGION          1604..1835
FT                   /note=""AAA 2""
FT                   /evidence=""ECO:0000250""
FT   REGION          1971..2222
FT                   /note=""AAA 3""
FT                   /evidence=""ECO:0000250""
FT   REGION          2335..2588
FT                   /note=""AAA 4""
FT                   /evidence=""ECO:0000250""
FT   REGION          2605..2906
FT                   /note=""Stalk""
FT                   /evidence=""ECO:0000250""
FT   REGION          2987..3217
FT                   /note=""AAA 5""
FT                   /evidence=""ECO:0000250""
FT   REGION          3430..3653
FT                   /note=""AAA 6""
FT                   /evidence=""ECO:0000250""
FT   COILED          716..779
FT                   /evidence=""ECO:0000255""
FT   COILED          2602..2646
FT                   /evidence=""ECO:0000255""
FT   COILED          2860..2916
FT                   /evidence=""ECO:0000255""
FT   BINDING         165..172
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
FT   BINDING         1361..1368
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
FT   BINDING         1642..1649
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
FT   BINDING         2009..2016
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
FT   BINDING         2374..2381
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
FT   CONFLICT        1449..1451
FT                   /note=""TEL -> NRT (in Ref. 2; BAA05506)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   4057 AA;  464557 MW;  ECFA19724BABCFD4 CRC64;
     MSSEQVRAGS PGSRVPGARR TGAVWTAPSE NLDSSTIPAL CVSLLFPSQP LDVVVTMGHN
     TLGMRQLWKL ALQRPQLLSG STGVKPQWQQ TAPSFHLNVK QENPIEPYNV KNEQSYAEYM
     EHFGKKGKLL DQIDDTRSAP STSRSKVKSP HKERENFRST LVNVIMQQDS SLEPDVTDES
     GIPKATTSAI EKDILRYYYY IHHGIDTDNV APMEDSWLEH VLQLVPQHLK VLTNSITVLS
     DEMREDYLLS VKKSIVDFVL KDPREKEDDT KITELPPHRA EMEVLPKPWR RSFLSACSYI
     RDHLNAMNPT MLAVLDLWHS TFKKLRLVDI EEFHNRQDAL ELSGFQNIVI KHMESAKETL
     LKTWFPEVQN IYYQGNKKKQ LPTGDSSAKL ESFFNCAATL MTLQLQDLIL VSMQDFTDLI
     AQPPESIRAF EHPGFIMRLV LDKKAVKFEP EFTDYIDILV NVYEIMIKAV SFVPRVETKL
     YSKWESKSKP TTLKPIILDE IIDAHKEKIR EVVLRESVAP TEHLKMYDKY QFLITRQAEQ
     DIEEFLTQSQ NYERLIEEIR KYQKLGEEIQ YTSRKTVRLG MFEMHCEELI RSLVKRADII
     CGKLIAKMFR DHQEVNTMLC EEFEKIAEKA LSTPPNTAEL MEMKAHIQKV ETTDMLDLGQ
     RLVDSKNCLA FLIECVNFSP ADIRLNNSVF QWYGRMGEIF DEHRKIIKDK TEQYQEGLKL
     RCERFVEELE SYAKQAEEFY TFGDLQDVQR YLKKAQVLNS KLDAAADKIE QFNAEEEAFG
     WIPSVYPQRK KIQDGLNPYL RLYETAVEFS TKHRAWTEGP YHKVNPDQVE ADVGNYWRGL
     YKLEKAFHDS PNALAMTKKV RARVEDFKQY IPLVQVICNP GLRPRHWEAM SAIVGYPLQP
     SDDSTVFSFI DMNLEPFLDR FEGISEAASK EYSLEKSMDK MMTEWEAMEF VIHPYRESGT
     FILSAVDDIQ MLLDDHIIKT QTMRGSPFIK PYEKQMREWE GKLLLLQEIL DEWLKVQATW
     LYLEPIFSSP DIMSQMPEEG RRFTAVDKTW RDVMKMVVQN KHVLAVVTIE RMLERMKKSN
     ELLELILKGL NEYLEKKRLF FPRFFFLSND ELLEILSETK DPTRVQPHLK KCFEGIARVE
     FTETLDITHM KSSEGEVVEL VDTISTTKAR GQVEKWLVEL ERIMIKSIHK VIGDAITAYT
     KNARINWVRD WPGQTVLCVS QTFWTVEVQV AIPMGHKALE DYLGKCNHQI DDIVTLVRGK
     LSKQNRVTLG ALVVLDVHAR DVLANLVKKR ISDDTDFEWL SQLRYYWHEN NLETKMINAG
     LRYGYEYLGN SPRMVLAPFC DYCFLTLFGA LHLHLGGAPE GPAGTGKTET TKDLAKAVAK
     QCVVFNCSDG LDYLALGKFF KGLLSCGAWA CFDEFNRIDL EVLSVVAQQI LTIQIGINSG
     TELLVFEGTE LKLDPTCAVF ITMNPGYAGR SELPDNLKAL FRTVAMMVPD YAMIAEIVLY
     SCGFVTARPL SIKIVATYRL CSEQLSSQHH YDYGMRAVKS VLTAAGNLKL KYPNENEEIL
     LLRSIIDVNL PKFLSHDLPL FEGITSDLFP GVKLPKPDYN DLLAAIRENC HSMNLQMTNF
     FSEKILQIYE MMIVRHGFMI VGEPFGGKTS AYRVLAGALG DICEKGLMEE NKVQITVLNP
     KSVTMGQLYG QFDLVSHEWS DGILAVSFRA FAASSTPDRK WLIFDGPVDA VWIENMNTVL
     DDNKKLCLMS GEIIQMSPQM NLIFEPMDLE VASPATVSRC GMIYMEPQML GWRPLMVSWI
     NTLPQSVSII QKEFIEGLFD RMVPLSVEFI RRHTKELSPT SDTNLVRSLM NLIDCFMDDF
     ADENKQKERN DRENFSLLEG IFLFSLIWSV GASCTADDRI KYNKILRELM EGPISDLTRN
     KFKLLSGTEQ TSSKALTVPF PEKGTIYDYQ FIPEGLGRWD QWIKKLADTP PIPKDVQFNE
     IIVPTLDTVR YSALMSLLTT HQKPSIFVGP TGTGKSVYII NFLLNQLNKD IYKPLIVNFS
     AQTTAAQTQN IIMSKLDKRR KGVFGPPLGK RMIVFVDDVN MPAREVYGAQ PPIELLRQWL
     DHWNWYDLKD CSMIKLVDIQ IMCAMGPPGG GRNPITPRYM RHFNIITINE FSDKSMFTIF
     SRILTWHLRT CYKFPDDFLD LTTQIVNGTM TLYKDAMKNL LPTPAKSHYL FNLRDFSRVI
     QGVCLSRPET AENKEAIKRL WVHEVLRVYY DRLLDNADRS WLVNYIQEIL RNYMQEDFHD
     LFKNLDFDND GIVEEDDLRS LMFCDFHDPK REDFGYREIP NVDALRVIVE GHLDEYNNMS
     KKPMNLVLFR FAIEHISRIS RILKQPRSHA LLVGVGGSGR QSVTRLAAHM ADYSLFQVEI
     SKGYGSHEWH EDLKVILRKC AEGDMQGVFL FTDTQIKRES FLEDVNNLLN AGEVPNLFAL
     DEKQEICEKM RQLDRQRDKT KQTDGSPIAL FNMFIDRCRN QLHVVLAMSP IGDAFRIRLR
     KFPALVNCCT IDWFQSWPED ALEAVASRFL EDIEMSEEIR EGCIDMCKSF HTSTINLSTT
     FHNELQRYNY VTPTSYLELI STFKLLLEKK RNEVMKMKRR YEVGLDKLDS ASSQVATMQG
     ELEALHPQLK VASRQVDDMM IMIEKESIEV AKTEKIVKAD ETVANDQAMA AKAIKDECDA
     DLAEALPILE SALAALDTLT AQDITVVKSM KSPPAGVKLV MEAICILKGI KADKIPDPTG
     SGKKIEDFWG PAKRLLGDIR FLQSLHEYDK DNIPPAYMNI IRKSYIPNPD FVPEKIRNAS
     TAAEGLCKWV IAMDSYDKVA KIVAPKKIKL AAAEGELRIA MEGLRKKQAA LREVQDKLAK
     LQDTLELNKQ KKADLENQVD LCSKKLERAE QLIGGLGGEK TRWSNSALEL GHLYVNLTGD
     ILISSGVVAY LGAFTSNYRQ HQTKEWSHSC KERDIPCSDD YSLMGTLGEA VTIRAWNIAG
     LPSDLFSIDN GIIIMNARRW PLMIDPQGQA NKWIKNMEKT NSLQLIKLSD PDYVRTLENC
     IQFGTPVLLE NVGEELDPIL EPLLLKQTFK QGGSTCIRLG DSTIEYAPDF RFYITTKLRN
     PHYLPETSVK VTLLNFMITP EGMQDQLLGI VVARERPDLE EEKQALILQG AENKRQLKEI
     EDKILEVLSS SEGNILEDET AIKILSSSKA LANEISQKQE VAEETEKKID NTRMGYRPIA
     VHSSILFFSI ADLANIEPMY QYSLTWFINL FILSIENSEK SDILSQRLHI LRDHFTYSLY
     VNICRSLFEK DKMLFSFCLT VNLLIHENAI NKAEWRFLLT GGIGLDNPYT NPCTWLPQKS
     WDEICRLDEL HAFKTIRREF MRLKEGWKKV YDSMEPHHEI FPEEWENKAN DFQRMLIIRC
     LRPDKVIPML QEFIIKKLGR SFIEPPPFDL AKAFGDSNCC APLIFVLSPG ADPMNALLKF
     ADDQGYGGSK LSSLSLGQGQ GPIAMKMLEK AVKDGTWVVL QNCHLATSWM PTLEKVCEEL
     SPESTHPDFR IWLTSYPSPN FPVSVLQNGV KMTNEAPKGL RANIIRSYLM DPISDPEFFG
     SCRKPEEFKK LLYGLCFFHA LVQERRKFGP LGWNIPYEFN ETDLRISVQQ LHMFLNQYEE
     LPYDALRYMT GECNYGGRVT DDWDRRTLRS ILNKFFCTEL VENPQYKFDS SGIYFVPPSG
     DHKSYIEYTK TLPLIPDPEI FGMNANADIT KDQSETQLLF DNILLTQSRS SGSGAKSSDE
     VVNEVAGDIL GKLPNNFDIE SAMRRYPTTY TQSMNTVLVQ EMGRFNKLLI TIRESCINIQ
     KAIKGLVVMS TELEEVVSSI LNVKIPGMWM GKSYPSLKPL GSYVNDFLAR LKFLQQWYEV
     GPPPVFWLSG FFFTQAFLTG AQQNYARKFT IPIDLLGFDY EVMDDKEYKN APEDGVYIHG
     LFLDGASWNR KTKKLAESHP KVLYDTVPVM WLKPCKKSDI PKRPSYVAPL YKTSERRGTL
     STTGHSTNFV IAMILPSDQP KEHWIGRGVA LLCQLNS
//
",48395
TGTAAT GTAATG TAATGG AATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGC GTTGCA TTGCAG TGCAGG GCAGGT CAGGTT AGGTTT GGTTTT GTTTTA TTTTAA TTTAAT TTAATT TAATTG AATTGT ATTGTT TTGTTA TGTTAC GTTACT TTACTT TACTTT ACTTTC CTTTCC TTTCCT TTCCTT TCCTTT CCTTTA CTTTAC TTTACG TTACGA TACGAT ACGATC CGATCA GATCAT ATCATA TCATAT CATATG ATATGG TATGGT ATGGTT TGGTTT GGTTTC GTTTCC TTTCCG TTCCGA TCCGAC CCGACC CGACCC GACCCA ACCCAC CCCACT CCACTT CACTTA ACTTAT CTTATG TTATGG TATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGG GTTGGT TTGGTC TGGTCA GGTCAC GTCACC TCACCA CACCAA ACCAAC CCAACC CAACCA AACCAT ACCATA CCATAC CATACA ATACAG TACAGA ACAGAG CAGAGT AGAGTA GAGTAG AGTAGT GTAGTA,1,91,TGTA GTAA TAAT AATG ATGG TGGT GGTG GTGT TGTT GTTG TTGC TGCA GCAG CAGG AGGT GGTT GTTT TTTT TTTA TTAA TAAT AATT ATTG TTGT TGTT GTTA TTAC TACT ACTT CTTT TTTC TTCC TCCT CCTT CTTT TTTA TTAC TACG ACGA CGAT GATC ATCA TCAT CATA ATAT TATG ATGG TGGT GGTT GTTT TTTC TTCC TCCG CCGA CGAC GACC ACCC CCCA CCAC CACT ACTT CTTA TTAT TATG ATGG TGGT GGTG GTGT TGTT GTTG TTGG TGGT GGTC GTCA TCAC CACC ACCA CCAA CAAC AACC ACCA CCAT CATA ATAC TACA ACAG CAGA AGAG GAGT AGTA GTAG TAGT AGTA,TGTAA GTAAT TAATG AATGG ATGGT TGGTG GGTGT GTGTT TGTTG GTTGC TTGCA TGCAG GCAGG CAGGT AGGTT GGTTT GTTTT TTTTA TTTAA TTAAT TAATT AATTG ATTGT TTGTT TGTTA GTTAC TTACT TACTT ACTTT CTTTC TTTCC TTCCT TCCTT CCTTT CTTTA TTTAC TTACG TACGA ACGAT CGATC GATCA ATCAT TCATA CATAT ATATG TATGG ATGGT TGGTT GGTTT GTTTC TTTCC TTCCG TCCGA CCGAC CGACC GACCC ACCCA CCCAC CCACT CACTT ACTTA CTTAT TTATG TATGG ATGGT TGGTG GGTGT GTGTT TGTTG GTTGG TTGGT TGGTC GGTCA GTCAC TCACC CACCA ACCAA CCAAC CAACC AACCA ACCAT CCATA CATAC ATACA TACAG ACAGA CAGAG AGAGT GAGTA AGTAG GTAGT TAGTA,TGTAAT GTAATG TAATGG AATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGC GTTGCA TTGCAG TGCAGG GCAGGT CAGGTT AGGTTT GGTTTT GTTTTA TTTTAA TTTAAT TTAATT TAATTG AATTGT ATTGTT TTGTTA TGTTAC GTTACT TTACTT TACTTT ACTTTC CTTTCC TTTCCT TTCCTT TCCTTT CCTTTA CTTTAC TTTACG TTACGA TACGAT ACGATC CGATCA GATCAT ATCATA TCATAT CATATG ATATGG TATGGT ATGGTT TGGTTT GGTTTC GTTTCC TTTCCG TTCCGA TCCGAC CCGACC CGACCC GACCCA ACCCAC CCCACT CCACTT CACTTA ACTTAT CTTATG TTATGG TATGGT ATGGTG TGGTGT GGTGTT GTGTTG TGTTGG GTTGGT TTGGTC TGGTCA GGTCAC GTCACC TCACCA CACCAA ACCAAC CCAACC CAACCA AACCAT ACCATA CCATAC CATACA ATACAG TACAGA ACAGAG CAGAGT AGAGTA GAGTAG AGTAGT GTAGTA,TGTAATG GTAATGG TAATGGT AATGGTG ATGGTGT TGGTGTT GGTGTTG GTGTTGC TGTTGCA GTTGCAG TTGCAGG TGCAGGT GCAGGTT CAGGTTT AGGTTTT GGTTTTA GTTTTAA TTTTAAT TTTAATT TTAATTG TAATTGT AATTGTT ATTGTTA TTGTTAC TGTTACT GTTACTT TTACTTT TACTTTC ACTTTCC CTTTCCT TTTCCTT TTCCTTT TCCTTTA CCTTTAC CTTTACG TTTACGA TTACGAT TACGATC ACGATCA CGATCAT GATCATA ATCATAT TCATATG CATATGG ATATGGT TATGGTT ATGGTTT TGGTTTC GGTTTCC GTTTCCG TTTCCGA TTCCGAC TCCGACC CCGACCC CGACCCA GACCCAC ACCCACT CCCACTT CCACTTA CACTTAT ACTTATG CTTATGG TTATGGT TATGGTG ATGGTGT TGGTGTT GGTGTTG GTGTTGG TGTTGGT GTTGGTC TTGGTCA TGGTCAC GGTCACC GTCACCA TCACCAA CACCAAC ACCAACC CCAACCA CAACCAT AACCATA ACCATAC CCATACA CATACAG ATACAGA TACAGAG ACAGAGT CAGAGTA AGAGTAG GAGTAGT AGTAGTA,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",29186
ATGGTA TGGTAA GGTAAG GTAAGG TAAGGT AAGGTT AGGTTC GGTTCG GTTCGG TTCGGC TCGGCA CGGCAA GGCAAC GCAACG CAACGT AACGTT ACGTTT CGTTTT GTTTTA TTTTAG TTTAGG TTAGGT TAGGTT AGGTTC GGTTCT GTTCTT TTCTTC TCTTCA CTTCAG TTCAGG TCAGGT CAGGTT AGGTTC GGTTCG GTTCGG TTCGGT TCGGTT CGGTTG GGTTGT GTTGTG TTGTGC TGTGCC GTGCCG TGCCGC GCCGCT CCGCTC CGCTCT GCTCTT CTCTTT TCTTTC CTTTCG TTTCGC TTCGCC TCGCCG CGCCGG GCCGGC CCGGCA CGGCAG GGCAGA GCAGAT CAGATT AGATTG GATTGC ATTGCA TTGCAG TGCAGC GCAGCC CAGCCG AGCCGG GCCGGA CCGGAG CGGAGG GGAGGC GAGGCC AGGCCC GGCCCG GCCCGA CCCGAT CCGATT,3,79,ATGTGG TCG T TGTGG GGGT T G GGGGTGTAGGAA G GTG CTAAAA A T TATAAAAGAG G ATGCAGGG A AGAGGGGTGT T G GGGGTT G GTGTTCGCTC T C TTTCGCG G T TCTCGCGGGG G CGGTCGGGGCGG C GGGTGGCGCACA A G GCGCACAACG A C CACAAAACAC C ACT AACACGCG G A ACACGGT TCT CGGT TT AT  GTGTTTTTTT T T TTTTTTTTTT T T TTC CTTAA T TTTTATAGAG G A TATAGAGGGG G A AGAGGGGTT GTT  CGCGTTT T G GTTTCA AC T TTTTCTCTGCCT T TCTCTCTT GGCC  CTCTTTTCTC C TGTTTTC CCCA A T TCTCAAG G C CACAGAGGGG G A AGTGCGT T G GGGGTGTT GTGTTTTCTC C T TTTTCTCGAA GGTTCGCGGGG G CCGGGGTT G GGGGTTT CGC GTGTTTTGTA G T TTTGTGT T T TGTGTTG G G GTGTG AAGC C T TGTGCGCCCC C G GCGCCTA CG G C AGGCTTTT CGTTCGCTCT T G GCCGCCTCTC C C CTT G AATCTT T CATT C TGC CTTTTTTT  TTTTTTTCTC C T TTTTCTCGCG G TGG TCGT GGC  GGAT CGCGCCCC  GCGCCCCGCG G C CCCCGCGGGG G C CGCGGGC C GC CGGCCA A GGTTGCACAGGTACTTCAGAGACCGTC  AGAGAGATCTCT G GAGATATTTT T AATTTTGTG G T TTTTGTGCGC C T GG TCCA A G GCGCACAGAG G C CACAGAGCGC C ACCGAGCCT CC C G GCGCCCCGCG G C CCGA CGGG C CGCGGGGAA GCCGAG G G GAGAGAGGG T AGAGGGGCGA  GGGGCGCCCC C G GCGCCT CC C CCCCCCG G CTCACCGCGAGA A C CGCGAGAT CGT G GAGATATT, TAGGTT TTGGGGTGTATA A G GGG CGTATAACCGA G GTTAACGAG T CCTAAAAGAGGGG G A AAAAGAGGGT T ATG  GAGGTGTTTT C T GGGGTGTTTTCTTGC G GTGTTTTCTCGCG  CC TTTTCGTTGG  TCTCGGGCGC C C CGCGGGGCGCACA A GGCTGGCGCACAAAA A G CACAAAACAC C C CACAAAACACGTTCG A AAAACTCTGT  AC TTGTTTT T C CGCGTGTTTTTGGTT G GTGTTTTTTTTTT T T TTTTTTTTTTATA A TCCCTTTTTATAGAG AGGTTATAGAGGG TG TTGGTAGAGGGGTGT  GG AG TTGGTGTTTT T G GGGGTGTTTTCTC C G GTGTTTTCCT T T TTTTCCTTG TT T TCTCTCTTTTCTC  CTCTTTTCTCACA ATTGCCTTC CACAGAG G TTC TCACAGAGGTT GGTAGGCAG CAGGTGT T A AGCG GTTTT T G GGGGTCG TC CCG GTCGGTTCTCGCG G T TTTTCTCGGG GAT TCTCGCGGGGTGT T C CGCGGGGTGTTTT T GT AGGTGTTTTGTG G GACGGTTTTGGT T T TTCTCTCAGTG AGGG  TGTGTGTGTGCGC C G GTGTGTGCGCCCC C T TGTGCCGTCCGA TG G GCGCCCCGCGCC C CCC GCGC GGCT TTC CGCGCGCTTTGTC AAG GCGCTCTCCGTCT T C CTTCTCTTTT T T TCTCTTTTTT T C CT CGTTTT C TCC T TTTTTTCG TTG T TTTCGGC T G TCGGTCGCGCCCC  CGGCCAA G G GCGCCCCGCGGGG G C TACCGCGGG TGC C CTCGCGGGGCGCAA G GGGCACAGAG G G GCGCACAGAGAGA A CGCACAGAGAGATAT T A AGAGAGATATTTT T GGCAATTTTGTG G A ATA TTTGTGCGC GGCCG TC TGCG TCG  TGTGCGCACAGAG G G GCGCACAGAGCGC C CTGTCAGAGCGCCCC C A AGAGCCCGCCGCG G G GCGCCCCGCGGGG G CTT CCGCGGGGAA C CGCGGGGAGAGAG G GGGAGAGAGGG G GAGAGAGGGGCGC  AGAGGGGCGCCCC C G GGGCC TTCC C G GCGCCCCCAG CG G C CCCCCCCGCGAGA A C CCGCCGATAT CTTCGAGATATT,TTGGTATA A T TGGGTTAACG A G GGGGTGTATAAAAGG G GTTAAAAGTCTCCGG T TATAAAAGAGGGGTGT TCG AAAAGAGGGGTGTTTT T ATTTAGGGGTGTTTTCTC C GGTTGGTGTTTTCTCGCG TTT GTGTTC ATCGCGGGG G T TTTTCCGGCCGGC C T TCGG GCACA  CGCGGGCACAAAA  GGGGCGCACAAAACGT C G GCCAAAACACGCG G C CAAACACGATTT AT A AAAACACGCGT GGCGGGT  ACCGTGTTTTTTT T C CGCGTA TTTTTCATT T G GTCGCTTTTTTCC G ATT  TTTTTG GTTATAGAG G T TT AGTTATAGAGGGG G TTTATAGAGGGGTAC TGT TATAGAGGGGTGTTTT T AAGGGTTTTCAGAC G GGGGTGTTTTCCGCTGTT GGCATTCTCTCTTT T TTTTCTCTCTTTTCTC C T TCGTTCTTTTCTCACA  CTCTTTTCTCACAGTTTCGATTCTTTAGGT CGG CGT TCCC CAGAGGGGTGT T C CA GTAGGGGTGTTTT  AGAGGGGTGTTTTCTC C G GGGGTGTTTTCTCGAA  GTGTTTCTCGGGCTG T TTTTCT ATT GGTGT T T TCTCGCGGGGTGTTT C CGCGGGGTGTTTTGTG G G CGAGCTTGGT T GATTGTTTTGT TGTGTG  TTTTGCT GTGC CGC C T TGGTGTGCGCCCC TTC GTGTGTGCGCCGG CG G T TGTGCA GCGCC G GCGCCCCGCGCGCTCT T C CCCCGGTTGCTCTCTC C C CGCGCGCTCTCTCTCT C C GCTCGCTCCAGCTTTT T C CTTCTCTTTTTTT T T TCTCTCTTTTCTC T G CTCTTG TTCGCG  TTTTTTTCTCGGAGGC C T TTTTCTCGAGAGCCCC C T TCTCGCGCGCCCCGCG G C CG GCGCCCCGCGGCCGG G GCGCCCCCCGGGGCGC  CCTC CGGGGCGCACA A C CGCGGGGCCAGCAGAG GAGGGCGCACAGGGCGA A G GCGCACAGAGAGATAT  CACAGAGAATTTT T A AGCGCGATATTTTGTG G G GATTGTGCGC  AT GTGGTTGCGCACA GTT TTTTGTGCGCACAGG T TGTGCGCACAGTTCGC C G GCGCACAGAGCGCCC C CACAGAGCGCCCCGCG TA  AGAGCGCCCCGCGGGG G GTCTGCCCCGCGGGGAGA A C CCCCGGC GGAGAGC GG CGGTCGGGGAGAGAGGGG G G GGGGACGCAGGGGCCGGC G GA GGGGCGCCTCATTC AGGGCGCCCCGC G GGGGCCCCCCGCG G G GCGCCCCCGG CGAGA A C CCCCCCCGCGAGATAT T C CCCCG TTATT,ATGTGGGGTGTATAAAA A TT GTGGGTA CCAAGG G GGGG GTATAAGCAATTGG G GCG TTCTAAAAGAGGGGTGT T TTGCAAGAGGGGTG CCC  AAAAGAGGGTTTTCTC C AGGTTAGGGTTCG GTG G GGGTTTTCCGGGG AGA GTGTTTTCTCGCGGGGCGC GGT TTTTCTCGCGGGA GCACTTA T TCCGGGGCGCATTC GCA C CGCGGGGCGCACAATCAC G GGGGCGCACAAACGCG G GAA CTTCAAAACACGCGTT C CACGGAACACGGC GTTT TT A AAAACACGCGTGTTTTTTT T AACGCGTGTTTTTTTT CGCGTGGA CGTTTTTATA A GCA GTTTTTTTTTAGAG G T TTTGCTTATAGAGGGG G T TTTTTTTAGTTAGGGGTGT T T TTTTATAG TCGGTTGCTT TTC TATAGAGGGGTGTTTTCTC C AAGGGGTGTTTTCCT T GGGTTTCTCTCTTTT T G GTGTTTTCTCTCTTTC C T TTTTCTCTCTTTTCTCACA A T TCTCTTTCAC CAG AGCGACTTTTCTCAAGGTTCG TTTCTCACAGTGCGGTGT CAGAGGGTTTT T C CACAGAGGC TGTTTTCA CC A AGAGGGGTGTTCAACG G G GGGGTGTTCCGTCGCAAGG G GGTTTTCTCGCGGGGTGT  TTTTCCGGGGTGTTTT T TAGGTCGCGGGGTGTTAGGTG G CAGACGGTTT TATGTGT T G GGGGTGTTTTGGTGTG AG  GTGTTTTGTTCGTGTGCGC C TCCGTTGTGTGTGGTTGCCC T TGTGTTGCGCCCCGG G GTGGCTGCGCCCCGCGCGC C T TGGCCCCGCGCGCTCT T G GCGCCCCGGCTCTCGGT CCTTCCGCGCTTCTCT T C CGCGCGCTCTCTCTCA TT T G GCTCTCTT TTTT T C CTCTCTCTCTTTGTTC C T TCTCTCAGTTGTTCTCGCG G C CTCTTTTTGTATCGCGCGC GGA TTTTTTTCTCGCGCGCCCC  TTT TTCGCGCGCCCCGCG G T TCTCGCGC GTCCGCGGG CCGCGCCCCGCGGGGCCGTC G GCGCCCGGGGCAAGCA TC  CCCCGCGGGGCAG G C CGCGGGGCGCACAGTTTGA A G GGGTGGCAGT G GGATAT TT GCACAGAGAGATTTGTT T C CACAGGCAGATATTTG AGAATTTTGCAGC GGATATTTTGTAAAGAGCCA A ATATTAGGGCACAGAG G T TTTTGTGCGCACAGAGCGC C T TGTGCGCAAGCGCC GCGCACAGAGCGCCCCGCG G C CAAGCGCCCCGCCCGG G AGTTAGCGCCCCGCGGGTTTTTGGT GCGCCCCGGGAGAGAG  CCCCGCGGGGAGAGAGGGG G C CGCGGGAGGGCC G GGC TGAGAGGGCCCC C G GAAGGGGCGCCGCCCC C A AGAGGGGCCCCCG G G GGCCCCCCCCGCGAGGCTGC GCGCCCGGGGT CTGATAT T CTAACCCCCGGATATT,"ID   CAPD_STAAU              Reviewed;         599 AA.
AC   P39853;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   05-FEB-2025, entry version 92.
DE   RecName: Full=Capsular polysaccharide biosynthesis protein CapD;
GN   Name=capD;
OS   Staphylococcus aureus.
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=1280;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 49951 / M / NCTC 10649;
RX   PubMed=7961465; DOI=10.1128/jb.176.22.7005-7016.1994;
RA   Lin W.S., Cunneen T., Lee C.Y.;
RT   ""Sequence analysis and molecular characterization of genes required for the
RT   biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus."";
RL   J. Bacteriol. 176:7005-7016(1994).
CC   -!- FUNCTION: Required for the biosynthesis of type 1 capsular
CC       polysaccharide.
CC   -!- PATHWAY: Capsule biogenesis; capsule polysaccharide biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the polysaccharide synthase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10927; AAA64643.1; -; Genomic_DNA.
DR   AlphaFoldDB; P39853; -.
DR   SMR; P39853; -.
DR   UniPathway; UPA00934; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045227; P:capsule polysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd05237; UDP_invert_4-6DH_SDR_e; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR003869; Polysac_CapD-like.
DR   InterPro; IPR051203; Polysaccharide_Synthase-Rel.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR43318:SF1; POLYSACCHARIDE BIOSYNTHESIS PROTEIN EPSC-RELATED; 1.
DR   PANTHER; PTHR43318; UDP-N-ACETYLGLUCOSAMINE 4,6-DEHYDRATASE; 1.
DR   Pfam; PF13727; CoA_binding_3; 1.
DR   Pfam; PF02719; Polysacc_synt_2; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
PE   3: Inferred from homology;
KW   Capsule biogenesis/degradation; Cell membrane; Exopolysaccharide synthesis;
KW   Membrane; Transmembrane; Transmembrane helix.
FT   CHAIN           1..599
FT                   /note=""Capsular polysaccharide biosynthesis protein CapD""
FT                   /id=""PRO_0000166445""
FT   TRANSMEM        12..32
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        41..61
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        79..99
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        102..122
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   599 AA;  67562 MW;  11ECBB26D729E6DB CRC64;
     MTSISAKLRF LILIIIDSFI VTFSVFLGYA ILEPYFKGYS IDLLVLSSVI LLVSHHIFAY
     VFNLYHRAWE YASVSELMSV LKAVTSSIVV TLLLVSLLIS ESPFLRLYFI TWMMHLLLIG
     GSRLFWRVYR RYFIDNAVEK KATLVVGAGQ GGSVLIREML RSQDMRMQPV LAVDDDKNKQ
     KMTITERVKV QGYVEDIPEL VKKFRIKKII IAIPTLSQKR LNEINKICNI EGVELFKMPN
     IEDVLSGELE VNNLKKVEVE DLLGRDPVEL DMALISRELT NKTILVTGAG GSIGSEICRQ
     VSKFDPQKII LLGHGENSIY SIHQELSKTY GNRIEFVPVI ADVQNKTRIL EVMNEFKPYA
     VYHAAAHKHV PLMEYNPHEA IRNNILGTKN VAESAKEGEV SKFVMISTDK AVNPSNVMGA
     TKRIAEMVIQ SLNEDNSKTS FVAVRFGNVL GSRGSVIPLF KNQIESGGPV TVTHPEMTRY
     FMTIPEASRL VLQAGALAQG GEVFVLDMGK PVKIVDLAKN LIRLSGKKEE DIGIEFSGIR
     PGEKLYEELL NKNEIHPQQV YEKIYRGKVD HYIKTEVDLI VEDLINNFSK EKLLKIANR
//
",283
ATCTGG TCTGGA CTGGAG TGGAGT GGAGTG GAGTGC AGTGCG GTGCGC TGCGCC GCGCCT CGCCTG GCCTGC CCTGCG CTGCGG TGCGGC GCGGCG CGGCGC GGCGCT GCGCTC CGCTCT GCTCTG CTCTGC TCTGCA CTGCAA TGCAAT GCAATC CAATCT AATCTG ATCTGG TCTGGT CTGGTG TGGTGA GGTGAT GTGATC TGATCA GATCAT ATCATG TCATGG CATGGG ATGGGC TGGGCT GGGCTG GGCTGG GCTGGT CTGGTT TGGTTG GGTTGC GTTGCT TTGCTG TGCTGG GCTGGG CTGGGC TGGGCA GGGCAT GGCATG GCATGC CATGCA ATGCAG TGCAGG GCAGGA CAGGAT AGGATG GGATGC GATGCC ATGCCC TGCCCG GCCCGC CCCGCA CCGCAG CGCAGC GCAGCC CAGCCC AGCCCC GCCCCA CCCCAT CCCATG CCATGC CATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGC GTTGCT TTGCTG TGCTGA GCTGAT CTGATC TGATCT GATCTT ATCTTC TCTTCA CTTCAC TTCACC TCACCA CACCAA ACCAAC CCAACC CAACCT AACCTG ACCTGA CCTGAT CTGATC TGATCA GATCAA ATCAAC TCAACA CAACAT AACATG ACATGG CATGGC ATGGCG TGGCGC GGCGCT GCGCTG CGCTGG GCTGGA CTGGAT TGGATA GGATAC GATACC ATACCT TACCTT ACCTTG CCTTGT CTTGTT TTGTTC TGTTCG GTTCGT TTCGTA TCGTAC CGTACT GTACTG TACTGG ACTGGG CTGGGG TGGGGC GGGGCT GGGCTG GGCTGG GCTGGG CTGGGC,2,142,ATCT TCTG CTGG TGGA GGAG GAGT AGTG GTGC TGCG GCGC CGCC GCCT CCTG CTGC TGCG GCGG CGGC GGCG GCGC CGCT GCTC CTCT TCTG CTGC TGCA GCAA CAAT AATC ATCT TCTG CTGG TGGT GGTG GTGA TGAT GATC ATCA TCAT CATG ATGG TGGG GGGC GGCT GCTG CTGG TGGT GGTT GTTG TTGC TGCT GCTG CTGG TGGG GGGC GGCA GCAT CATG ATGC TGCA GCAG CAGG AGGA GGAT GATG ATGC TGCC GCCC CCCG CCGC CGCA GCAG CAGC AGCC GCCC CCCC CCCA CCAT CATG ATGC TGCT GCTG CTGT TGTT GTTG TTGC TGCT GCTG CTGA TGAT GATC ATCT TCTT CTTC TTCA TCAC CACC ACCA CCAA CAAC AACC ACCT CCTG CTGA TGAT GATC ATCA TCAA CAAC AACA ACAT CATG ATGG TGGC GGCG GCGC CGCT GCTG CTGG TGGA GGAT GATA ATAC TACC ACCT CCTT CTTG TTGT TGTT GTTC TTCG TCGT CGTA GTAC TACT ACTG CTGG TGGG GGGG GGGC GGCT GCTG CTGG TGGG GGGC,ATCTG TCTGG CTGGA TGGAG GGAGT GAGTG AGTGC GTGCG TGCGC GCGCC CGCCT GCCTG CCTGC CTGCG TGCGG GCGGC CGGCG GGCGC GCGCT CGCTC GCTCT CTCTG TCTGC CTGCA TGCAA GCAAT CAATC AATCT ATCTG TCTGG CTGGT TGGTG GGTGA GTGAT TGATC GATCA ATCAT TCATG CATGG ATGGG TGGGC GGGCT GGCTG GCTGG CTGGT TGGTT GGTTG GTTGC TTGCT TGCTG GCTGG CTGGG TGGGC GGGCA GGCAT GCATG CATGC ATGCA TGCAG GCAGG CAGGA AGGAT GGATG GATGC ATGCC TGCCC GCCCG CCCGC CCGCA CGCAG GCAGC CAGCC AGCCC GCCCC CCCCA CCCAT CCATG CATGC ATGCT TGCTG GCTGT CTGTT TGTTG GTTGC TTGCT TGCTG GCTGA CTGAT TGATC GATCT ATCTT TCTTC CTTCA TTCAC TCACC CACCA ACCAA CCAAC CAACC AACCT ACCTG CCTGA CTGAT TGATC GATCA ATCAA TCAAC CAACA AACAT ACATG CATGG ATGGC TGGCG GGCGC GCGCT CGCTG GCTGG CTGGA TGGAT GGATA GATAC ATACC TACCT ACCTT CCTTG CTTGT TTGTT TGTTC GTTCG TTCGT TCGTA CGTAC GTACT TACTG ACTGG CTGGG TGGGG GGGGC GGGCT GGCTG GCTGG CTGGG TGGGC,ATCTGG TCTGGA CTGGAG TGGAGT GGAGTG GAGTGC AGTGCG GTGCGC TGCGCC GCGCCT CGCCTG GCCTGC CCTGCG CTGCGG TGCGGC GCGGCG CGGCGC GGCGCT GCGCTC CGCTCT GCTCTG CTCTGC TCTGCA CTGCAA TGCAAT GCAATC CAATCT AATCTG ATCTGG TCTGGT CTGGTG TGGTGA GGTGAT GTGATC TGATCA GATCAT ATCATG TCATGG CATGGG ATGGGC TGGGCT GGGCTG GGCTGG GCTGGT CTGGTT TGGTTG GGTTGC GTTGCT TTGCTG TGCTGG GCTGGG CTGGGC TGGGCA GGGCAT GGCATG GCATGC CATGCA ATGCAG TGCAGG GCAGGA CAGGAT AGGATG GGATGC GATGCC ATGCCC TGCCCG GCCCGC CCCGCA CCGCAG CGCAGC GCAGCC CAGCCC AGCCCC GCCCCA CCCCAT CCCATG CCATGC CATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGC GTTGCT TTGCTG TGCTGA GCTGAT CTGATC TGATCT GATCTT ATCTTC TCTTCA CTTCAC TTCACC TCACCA CACCAA ACCAAC CCAACC CAACCT AACCTG ACCTGA CCTGAT CTGATC TGATCA GATCAA ATCAAC TCAACA CAACAT AACATG ACATGG CATGGC ATGGCG TGGCGC GGCGCT GCGCTG CGCTGG GCTGGA CTGGAT TGGATA GGATAC GATACC ATACCT TACCTT ACCTTG CCTTGT CTTGTT TTGTTC TGTTCG GTTCGT TTCGTA TCGTAC CGTACT GTACTG TACTGG ACTGGG CTGGGG TGGGGC GGGGCT GGGCTG GGCTGG GCTGGG CTGGGC,ATCTGGA TCTGGAG CTGGAGT TGGAGTG GGAGTGC GAGTGCG AGTGCGC GTGCGCC TGCGCCT GCGCCTG CGCCTGC GCCTGCG CCTGCGG CTGCGGC TGCGGCG GCGGCGC CGGCGCT GGCGCTC GCGCTCT CGCTCTG GCTCTGC CTCTGCA TCTGCAA CTGCAAT TGCAATC GCAATCT CAATCTG AATCTGG ATCTGGT TCTGGTG CTGGTGA TGGTGAT GGTGATC GTGATCA TGATCAT GATCATG ATCATGG TCATGGG CATGGGC ATGGGCT TGGGCTG GGGCTGG GGCTGGT GCTGGTT CTGGTTG TGGTTGC GGTTGCT GTTGCTG TTGCTGG TGCTGGG GCTGGGC CTGGGCA TGGGCAT GGGCATG GGCATGC GCATGCA CATGCAG ATGCAGG TGCAGGA GCAGGAT CAGGATG AGGATGC GGATGCC GATGCCC ATGCCCG TGCCCGC GCCCGCA CCCGCAG CCGCAGC CGCAGCC GCAGCCC CAGCCCC AGCCCCA GCCCCAT CCCCATG CCCATGC CCATGCT CATGCTG ATGCTGT TGCTGTT GCTGTTG CTGTTGC TGTTGCT GTTGCTG TTGCTGA TGCTGAT GCTGATC CTGATCT TGATCTT GATCTTC ATCTTCA TCTTCAC CTTCACC TTCACCA TCACCAA CACCAAC ACCAACC CCAACCT CAACCTG AACCTGA ACCTGAT CCTGATC CTGATCA TGATCAA GATCAAC ATCAACA TCAACAT CAACATG AACATGG ACATGGC CATGGCG ATGGCGC TGGCGCT GGCGCTG GCGCTGG CGCTGGA GCTGGAT CTGGATA TGGATAC GGATACC GATACCT ATACCTT TACCTTG ACCTTGT CCTTGTT CTTGTTC TTGTTCG TGTTCGT GTTCGTA TTCGTAC TCGTACT CGTACTG GTACTGG TACTGGG ACTGGGG CTGGGGC TGGGGCT GGGGCTG GGGCTGG GGCTGGG GCTGGGC,"ID   DINF_ECOLI              Reviewed;         459 AA.
AC   P28303; Q2M6R0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   05-FEB-2025, entry version 165.
DE   RecName: Full=DNA damage-inducible protein F;
GN   Name=dinF; OrderedLocusNames=b4044, JW4004;
OS   Escherichia coli (strain K12).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Lilley P.E., Dixon N.E.;
RT   ""E. coli dinF gene."";
RL   Submitted (SEP-1992) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8265357; DOI=10.1093/nar/21.23.5408;
RA   Blattner F.R., Burland V.D., Plunkett G. III, Sofia H.J., Daniels D.L.;
RT   ""Analysis of the Escherichia coli genome. IV. DNA sequence of the region
RT   from 89.2 to 92.8 minutes."";
RL   Nucleic Acids Res. 21:5408-5417(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   ""The complete genome sequence of Escherichia coli K-12."";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   ""Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110."";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   ""Global topology analysis of the Escherichia coli inner membrane
RT   proteome."";
RL   Science 308:1321-1323(2005).
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000269|PubMed:15919996}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15919996}.
CC   -!- INDUCTION: By DNA damage.
CC   -!- SIMILARITY: Belongs to the multi antimicrobial extrusion (MATE)
CC       (TC 2.A.66.1) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L02362; AAA24069.1; -; Genomic_DNA.
DR   EMBL; U00006; AAC43138.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC77014.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE78046.1; -; Genomic_DNA.
DR   PIR; C65212; C65212.
DR   RefSeq; NP_418468.3; NC_000913.3.
DR   AlphaFoldDB; P28303; -.
DR   SMR; P28303; -.
DR   BioGRID; 4261722; 64.
DR   STRING; 511145.b4044; -.
DR   TCDB; 2.A.66.1.4; the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
DR   PaxDb; 511145-b4044; -.
DR   EnsemblBacteria; AAC77014; AAC77014; b4044.
DR   GeneID; 948554; -.
DR   KEGG; ecj:JW4004; -.
DR   KEGG; eco:b4044; -.
DR   PATRIC; fig|511145.12.peg.4161; -.
DR   EchoBASE; EB1454; -.
DR   eggNOG; COG0534; Bacteria.
DR   HOGENOM; CLU_012893_16_0_6; -.
DR   InParanoid; P28303; -.
DR   OMA; MDGIWLA; -.
DR   OrthoDB; 9789527at2; -.
DR   PhylomeDB; P28303; -.
DR   BioCyc; EcoCyc:DINF-MONOMER; -.
DR   PRO; PR:P28303; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:0015297; F:antiporter activity; IEA:InterPro.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:InterPro.
DR   CDD; cd13136; MATE_DinF_like; 1.
DR   InterPro; IPR044644; DinF-like.
DR   InterPro; IPR002528; MATE_fam.
DR   NCBIfam; TIGR00797; matE; 1.
DR   PANTHER; PTHR42893:SF46; PROTEIN DETOXIFICATION 44, CHLOROPLASTIC; 1.
DR   PANTHER; PTHR42893; PROTEIN DETOXIFICATION 44, CHLOROPLASTIC-RELATED; 1.
DR   Pfam; PF01554; MatE; 2.
PE   2: Evidence at transcript level;
KW   Cell inner membrane; Cell membrane; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..459
FT                   /note=""DNA damage-inducible protein F""
FT                   /id=""PRO_0000164258""
FT   TRANSMEM        2..22
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        29..49
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        63..83
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        111..131
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        154..174
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        180..200
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        207..227
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        265..285
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        289..309
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        338..358
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        373..393
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        416..436
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   459 AA;  49646 MW;  8F35355FE350079C CRC64;
     MPPGVAVCFS SLFIRLVCMA FLTSSDKALW HLALPMIFSN ITVPLLGLVD TAVIGHLDSP
     VYLGGVAVGA TATSFLFMLL LFLRMSTTGL TAQAYGAKNP QALARTLVQP LLLALGAGAL
     IALLRTPIID LALHIVGGSE AVLEQARRFL EIRWLSAPAS LANLVLLGWL LGVQYARAPV
     ILLVVGNILN IVLDVWLVMG LHMNVQGAAL ATVIAEYATL LIGLLMVRKI LKLRGISGEM
     LKTAWRGNFR RLLALNRDIM LRSLLLQLCF GAITVLGARL GSDIIAVNAV LMTLLTFTAY
     ALDGFAYAVE AHSGQAYGAR DGSQLLDVWR AACRQSGIVA LLFSVVYLLA GEHIIALLTS
     LTQIQQLADR YLIWQVILPV VGVWCYLLDG MFIGATRATE MRNSMAVAAA GFALTLLTLP
     WLGNHALWLA LTVFLALRGL SLAAIWRRHW RNGTWFAAT
//
",3839
ACCCAG CCCAGT CCAGTC CAGTCC AGTCCC GTCCCT TCCCTA CCCTAC CCTACT CTACTT TACTTA ACTTAT CTTATT TTATTG TATTGT ATTGTT TTGTTA TGTTAA GTTAAT TTAATA TAATAA AATAAC ATAACG TAACGC AACGCT ACGCTA CGCTAC GCTACT CTACTA TACTAA ACTAAT CTAATG TAATGT AATGTT ATGTTG TGTTGT GTTGTT TTGTTA TGTTAT GTTATT TTATTA TATTAA ATTAAA TTAAAG TAAAGT AAAGTC AAGTCT AGTCTG GTCTGT TCTGTG CTGTGA TGTGAA GTGAAT TGAATT GAATTT AATTTC ATTTCA TTTCAA TTCAAT TCAATT CAATTT AATTTT ATTTTG TTTTGT TTTGTA TTGTAA TGTAAT GTAATG TAATGA AATGAT ATGATC TGATCC GATCCA ATCCAT TCCATT CCATTT CATTTT ATTTTT TTTTTG TTTTGG TTTGGA TTGGAT TGGATG GGATGT GATGTT ATGTTT TGTTTA GTTTAT TTTATT TTATTA TATTAC ATTACC TTACCA TACCAC ACCACA CCACAA CACAAA ACAAAA CAAAAA AAAAAC AAAACA AAACAA AACAAC ACAACA CAACAA AACAAA ACAAAA CAAAAG AAAAGT AAAGTT AAGTTG AGTTGG GTTGGA TTGGAT TGGATG GGATGG GATGGA ATGGAA TGGAAA GGAAAG GAAAGT AAAGTG AAGTGA AGTGAG GTGAGT TGAGTT GAGTTC AGTTCA GTTCAG TTCAGA TCAGAG CAGAGT AGAGTT GAGTTT AGTTTA GTTTAT TTTATT TTATTC TATTCT ATTCTA TTCTAG TCTAGT,1,142,ACCCCC TTC C CCCCCCCACA CAC CCCCACAGAG G CTG CAGAGTGT T A ACAGTTC C GCC AACCC C T TCTCCCCC TAC CTTATG CCTCT T CT TCCTCTAATGA CCTATACAC C T TATACACTCT  ACTAATT T C CTCTTTTATA A T TTTTATATAT T T TATATAA AA T A ATATTGTTTG G TTTGTGTGT CAGG T AG TTT G GTGTTGGAGATA T TTTAAA T TATAAAATAT AATACTTA A A ATATATAATT A TCC TAAA TAC C A AAAACACGCG G A ACACGCGC CAC C CGGCTCT T G GCGCTCTATA A C CTCTATACC T TATACACTCT T A AGACTA CTA CA  CTACATAAAA A T TAATAAT T A AAAATG A CAG A ATATGTGTGT T T TGTGTGTTTT T GAGTGTTTTGTG G TAAATTGTGTGT AA AA GTTTT T G GTGTTTTATA A T TTTTATATAT T TAA T A ATAC C AATTA TTTATAAAA  TATAAAA A AAAAAAGAG TA  AAA AAGTGT TT  AGAGTGTCTC C G GTGTCTCTCT T T TC CACTGTG G C CTCTGTGTAGTT T TGTGTGTGTG G G GTGTGGA  TGTGAAA AAA GAGAAAATAT  AAAATG T TTT A ATATTTTTTT  TTTTCTC C T TTTTCTCACA A T TCTCACAAAA A A CACAATTTT ACC ATTTT T A ATATTTT T TT ATTTTTTTT T T TTTTTTTGCCCTGTA TTGTGT T T TGTGTGTATA A G GTGTATAAAA A T TATAAAATAT CAA TTATGTG G A ATATGTGAGA T G TGTGAGATAT T G GAGATATCTC C AATCTCCC T AA TCTCCCCACA A C CCCCACATAT T CCATTGAT A ATA CTT T T TTTTTTTTGT T T TTTTTTTTT T TTTTTTG G T TTTTGTGGGG G T TGTGGGGAGA A GAACGGATACAT T GCAAGATATGTG G A ATATGTGTGT T T TGTGTTTGTT T G GTGTTTTTTT  CC TTTTTTTATA  TT CCAT T T TATATATTTT ATTTTATA A T TTTTAGATAG C T TATACACC GTTTA ACACCCA CTA CCCCAA CATTC CCACACACA A A ACACACAATGTA CTCTCAAAAAAA A A AAA GAAAAA A A AAAAAAAAAA A A AAAAAAACAC C A AAAACCTACA A A AC TTATT CA AATCCAC C A AAAACTG A CA AACACAAAA A C CACAAAAAAA A AAAA AG AAAAAAAGAC G A AAAAGAGTGT AAT GTGTTTT T GGTTTTGTG G TAATTTGAT GG G T TGA TGGAGA A GTTAGGATA AT A T GAGATAT TG G A ATATGTGGGG ATT TGTGGTTAAG A G GGGGAGAATATA G GAGAAAAAT TA A AAAAAAAGAG G A AAAAGAGTTT T AA CAGTGTGACAG G GTGTGTT  GAA T TGTGAGAGAG G G GAGAGAGTGT T A AGGT GTTTT  GTTC C TCC TTCTCACA GA  TCTCACAGAG G C CA TGGA AAGGTTAGAGAGAG G G GAGAGAGTGT T A AGAGTGTTTT T G GTGTTTTTTT T T TTTGGTTATA TT  GGTATATGT T TATATTA TT T A ATATTTTCTC C TTTCTCTCT T T TCTCTCTATA A C CTTAGGA G T TATAGAGT,ACCCCCCCAA AA C CCCCCTTACAGAG G C CCTGGTAAAGTGT T C CACAGGGAGTCTC C A AGAGTGTCTCCCC  GTGTCTCCCCCCC CTA TCTCCCCCCCT CCCCCCCTCTATA A C CCCCTCTATACAC  CTCTATACACTCT T T TATACACTCTT TAT AT CACTCTTTTATA A C CTCTTTATAT  TTTGTTA TT T TTATTTAGT TG G A ATATTTTGTGTGT TT  TTTTGTGTGTTTT T T TGTGTGTTTTAA G GTTGTATTTAAAA A T TTTTATAAAATAT T TGTCTAAAATTA A A AAAATATATAATAAA A ATATATAATGAAC GTTTAAAACACGCG G A AAAACACGCGCGC TATT TACGCGCGCTCT T CCGCT TCTATA CTAGCTCTATACAC C C CTCTATACACTCT CCA TATACTTACTATA A AACTCTAAA AA  CT GCTAAAATAT T T TGAATAA AATTGTGT CAA ATATGTGTGTTT TT T TGGTTTTGTG G G GTATTTTGGTTT CATTC TTTGTTAGTTTT A G TGTGTGTTTTATA A G TTG GTTATATAT T T TTTTATATATTTT T T TAATTTTATA A ATCTATTTGAAA A T GTTTAT TTTCAA A T TATAAAAGAG G AAAAAAGGT T A AAAAGAGTTC C A AGAGTGTCAACCT T G GTTT TCTCTGTG G T TCTCTCTGTGTGT  AC CTCTGTGTGTGTG  TGTGTAG TGAGA  GTGTGTGAGAAAT A TAAATGAGAAAATAT T GTT GAAAATATTTT CCA AAAATTC TTTTT T A ATATTTTTAAATC AGT TTTTTTTCTCACA  TTTTCTCACAAGTGA T TCTCACAAAT TTG CACAAACAAGTTT T A AAAATT TAGTTT T A ATATTTTTTTTTT T T TTTTTTTTTTGTG G T TTTTTTTGGT  TG TTTTGGTATA A T TGGTAC TAA A G GTAATAT  AC TATAAAATATGG A AAAATATGTGAGA CA ATG TTGATAT T T TGTTAGATATCTC GTT GAGATTCC CAC A ATATCT TA T TCTCCCATAT T C CCCCACATATTTT T CCATATTTTTTT T A ATATTTTTTTTTATT T TTTTTTTTTTTTT TTTTTTTTGTG G TTTTTTG ACG T TTTTGTGGGGAGA A TGATACCC TTG AT  GGGGAGATATGTG AA  GAGATATG CAGT T A ATATGTGTTGATT AAG TGTGTGTTTTTTT T G GTGTTTTTTTATA A T TTTTTTTATATAT C C TTTTAATTTT T T TATATTTATA A A ATATTTTATACAC TAATTACCAC T TATACACCCCACA A AT TACCCCACACAC TT  CCCACACACA A C CACACAATCAAA A TTACACAAAAAAA A CC ACAAAA  AAAAAAAAAAAAA A A AAAAAAAAAACAC  CA AAAAA GAACACA A A AAAACACACAAAA A AGG CAAAACAC C CCC TATAAAACACA A A AAAACACAATTAA A A ACACAT AAAAAA A CAAA AAA A AAAAAAAAAAGAG G A AAAAAT TAGTGT T A AAAAGGTT AGAGTA TTTGATGG G GTGTTTTGTGGGG G TTTGGGAGA A TTAATGGGGAGATAT T G GGGATGATTG GTT ATGCTCC TGGGG TTT ATT ATGGGGAGA A T TGTGGGGAGAAG AA GGGAGAAAAAAA  GAGAA TAAG G A AA TGAAGAGTGT ATG AAAAGAGTGTGTG G A AGAGTGTGAACGA T A GTAA TGAGAGA CG T TGTGAGAGAGTGT T G GAGAGAGTGTTTT T A AGAGTGTTTTCTC C G GTGTTTTCTCACA A T TTTTCTCACAGGTGG T TCTCACAGAGAGA AG  CAAGAGAGAG G AAGAGAGG CT G GAAGTGTT GAT A AGAGTGTTTTTTT T G GTGTTTTTTTATA GTT TTG GA GC AAA T T TTTTATT ATTT TT T TATATTTCATTC A ATATTTTCTCT AC TTTTCTCTTATCTAA T TCTCTCTATAGAG GT  CTC TTAGAGT,ACCCCC GTCAGAG TT  CCGTACCACAGTATGT T C CCCCACAGAGTGTCTC C C CACAGAATCC C A AGAGTGTCTCCCCC ACC GCCAGTCTCCCCCGGAT TT ATCCAGTTA A C CCCCCCCTCTAAC C C CCCTATACACTCT T C CTTTTTACTCTCTTTT T T TATACACTCTTTTAA A ACACTACTTTATATAT T C CTCTTTTACTGATTTT T T TTTTATATATTTTGTG G T TATTAATTTTGTGTGT T A ATTTGTGTGTGTT T TTTGTGTGTTTTATA A TTC TGTGTTTTATAAA G GTGTTTTAAATAT T T TTTTATAAAATATATA A T TATAAAATTAAAA A AAATTAAAACGT ATATAAAAC ATG TTGATAAAACACGTTCTG C A AAACGCGCGCTCT T A ACACGCGCGCTAAATA  CGCGCGCTCTATACAC C G GCA TCTATACTCACT T C CTCTATACACTCTAGCT TATACACTCTATAAAA  ACAATCTATAAGTGT CCTATAAAATATGTG G T TATAAAATT GTGT TCT A AAAATATGTGTGTTTTTT A ATATGTGTTTTTTGTG G T TGTGTGTTTTGTGTGTGT GAACGTTTGTGTTTT T TTTGTGT AA AATA A T TGTGTAC TTATATAT  GTCT TTATATATTT T TTTTATATATTTTATA A T TATATATTA ATAAT A ATATTTTAAAAAA A T TTTTATAACA AAGG G TATT AAAAAGGT T A AAAATAAGAGTGTCTC C AGTTAAGAGTGTCTCTCT TA GATAGTGTCTCTGC G G GTGTCTCTCTGTGTGT T T TCTCTTATTTAGTGTG G C CTCTGTGTGTGTGAGA A T TGAATAGATGAGAAAA A G GTAATGAAAATAT T TTGTTGAGAAATTTT T T GAGAAAATGTTTT T A AAATTTTTCGCTC C A ATATTC ATTCACTCA A T TTTTTTTCT ACAAAA A T TTTCAAGTCAAAT T TGT TCACAAAAAATTT C CACAAAATATTTTTTT T A AAACTTGATTTTT GGA ATATTTTTTTTTTGTG G T TTTT TTGTGTAAAT TTTGCCCTA  TTTTGTGTGTATAAAA A TAACTGTATCTAATGTAT TA  GTGTATAAAATATGTG G T TATCCATGA A AAAATATGGT CAAAT T A ATATGTGAGATATCTC C T TGTGAGATATCATGCC C G GAGATGTATCCCCACA AAC ATATCTCCCCACATAT T T TCGTTCCAAGTATTAGTT C CCCCACATATTTTTTT T C CAAGAATTTTTTTTTT  TC AT AGTTTTTTTTTTT T TTTTTTTGA G TTTTACCTGGTG G T TTTTTGTTTGGAAAGA  TTTGGGGAGATCACT T TGTGGGGAGATATGTG G G GGGGAGATATGTGTAC  GAGATATGTGTGTTTAGT A ATATGTGTTTGTTTTT  ATTGTGTTTTTTTAATGA G GTGTTTTTTTATATAT T T TTCAGTATATTG CAAA TTTTATATATTTTATA A T TATATATTTTATACAC C A ATAGTTACTTGCC GATTTTTTATACACCCCACA A T TATACACCCCACACGTTC A ACACCCACACAAAAA C CCCCACACACACAAAA A C CAAT ACACAAAAAA TA A TTACAC TAAAAAAAA A C CAAATAAAAAGAAAAA A A AAAAAAAAAAAA AAC C ATTAAAATAGAACACAA A AAAACACAAA AGA AAAACACACAA GTAC TTT ACTTTCAAAACACACA A C CACAA TGCAAAA TGTAACACACAAAAAAA A ACC ACACAACTAAAAAA A C CAAAAAAAAAGAG G A AAAAAAAAAAGGT T A AAAAAAAGAGTGTTTT T A AAAAGTT GTTTTGTG G AAA AGTGTTAA TGGGG G G GTTTGTGGGGATG  TTTTGTGGA AGATAT T T TGTGGTAAGATATGGG G GC AGGAGATATGTGGAG  GA AGTCCCT GA A AT GATGTGGGGAGAAAA A TAA TGGT GAAAATTA G GGGGAGAAAAAAAGAG G GGAAGTTT TAGTGT T A AAGGAAAGAGTGTGTG G AAAGAGTGTGTGAGA A A AGAGTGTTTGAAG G G GTGTGATTCAAGT T T TGTGAGAGAGTGTTTT GAA GAGAGGTTGTTTTC TGATAAGTGTTTTCTCACA A GGTTTTCTCACAGAG AGT TTTTCCAGA AGA AA  TCTCACTTCATGAGAG G C CACAGGAGAGTGT  AGAGAGAGCCCGTTTT T G GAGAGAGTAAAACAT A AGG TGTTTTAT AA G GTGTTTTTTTATATAT T T TTTTTTTATATTT T T TTTTATATATTTTCC T TATATATTTTCTCTTCCT AATTTTCTCTCTATA A T TTTTCTGACTATTACATG T TCTCTCTATT AG ,AGTCCACAGCAAGT T CC ACCCCAGAGTGTCTC C C CCCCACAGAGTGTCTCCCC C C CACT AGTGTCTCCCCCCC C ATT T GGTCTTGCCTCT T G GTGTCTCCCCCCCTTA A T TCGTACCTCTATACGT C CCCCCCTCTAACTTATT C AGCCTCTATAAACTCTTT TT C CTCTATAC TTCTTTA A T TACTTTTAGTTAT AA ACTCTTTGGTATATT AGATT CTCTTTTATATTTGTG G T TTTTATATT A TCGT T T TAAACATTTTGGGATT T ATCCTGTGTTTTAAATA TTTTTGTG TTTATAAT GA T TGTTGTTATAAAATAT T G GTT ATTATAATA ATATA A T TTGAGTAAAATTAAAA A T TAAATTAAAACAAGC A AAAATTAAAACCG G ATAAAACACGCGCGAAC T TATAAAACACGCCAGCTCT T AGA AACACGCGCGCTCTAACAA A ACACGCGCGCTCTATACCA  CGCGCCTATACACTCAGAGT GCGCTCTATACACTCTATA A C CTCTATTAACTCTA CCAA A T TATACAAGCTATAAAATAT T AACTCTAAT AATATGTG G CCTATAAAATATGTGTGT T TTACAATATGTGTGTTTGGTTA AA AAATGTGTGTTTTGTG G A ATATGAA TTTTTGTGTAC T T TGTGTGTTTTGTGTGTTTT  GTGTTTTGTGTTGTTTATA A T TTTTGTGTGTTTTATATACTT T TG CAGTTTTAATTTT T G GTGTTTTATATATTT ATA A TACTTACTATATTTTATAAAA TTT TATGTATTTAAAAC TA TT ATATTTTATAAAAAAT AG TTATAAAAGAGTGT TT  TATAATGAGAGAGTGTCG TC A AAAAAAAGGTCTCT AAAAGAGTGTCTCTCTGTG G AGTCTCTCTGTGTTTTT G GTGTCTCTCTGTGTGTGTG G G AATCTCTGGTTGTGTGAGA TTT CTCTGTGTGTGTGAGAAAA GAT TGTGTGTGTGAGAAAATAT T G GTGTGTTTGAAAATTT T T TGTGAGAAAATATTTTTTT T G GAGAAAATATTTTTTTCTC C A CTAATTTTTTCTCACA A A ATT CTTGTTCTCACAA ACA TTTTTTCTGGAATT T TTGTGTCACAAAATATTTT T TGATTCACAAAATATTTTTTT T C CACAAAATATTTTTTTTTT T A AAAATATTTTTTTTTTGTG G A ATGC TTTA TGT T T TTAAATTTTTGTGTGTATA A T TTGT AA C CCCCTAAAA AAC TT AGT GGTAAATAT T TAAATGTGTATAAAATTG G G GTGTATAAAATATGTGAGA A T TAAATATGTGAGATAT  AAAATATGTGAGATATCTC  CC ATATGAAAGATATCTCCCC C T TGTATGATATCTCCCCACA A G GAGATAA TCCCCAAAGT A ATATCTCCCCACATATTTT T TTGGTCCCATATTTTTTT T C CCCCACATATTTTTTTCTATT CTGTCATATTTTTACCTTTTT ATT ATATTTTTTTTACATTGTG GTT TTTTTTTTTTTTTGTGGGG G T TTTTTTTTGGAGA  TTTTTTTGTGGGGAAAGAT T T TTTTGGGAGATATGTG G T TGTT GATATGGAAGT T G GGGGAT GATGGTTTT T GGATATGTGTGTTTTTTT T A ATATGTGTGTTTTTTTAGTTA T TGTGTGTTTTATATTTTT G GTGTTTTATATATTTT CAG TTTA TTATGATTATA A TG ATTATATATTTTATACAAAC TTATTTATACACCCC C A ATATTTTATACACCCCATATA T TTTTATACACCCCAAA AC C T TATACACCCGCCA A A ACACCCCAACACAAATCA CCCACACACACAAAAAT T CAACAACAAGTAAAAAA GAA A ACACAAAAAAACACA CCAAAAAAACAC C A AAAAAAAAAAAAAAACACA A A AAAAAAAACAAAA A A AAAAAAACACACAAAACAC C A AAAACCACCAAAACACACA A A ACACACAATTTAA A C CACAAAACACAGTTAA A A AATCTACACAAAAAAAAA A ACTA CAAAAAAAAAAGAG G C CAAAAAAAAAGAGTGT T ATATAAAAAAAAGAGTGTTTT ATT AAAAAAAGAGTGTTTGTTG  TT AACATAGTGTTTTGTGGGG G AAGTT TTTGTGGGTTGA A G GTAAGTGGGGA AAAT T T TTTTGTGGGGAGATATGTG G TTGGGGATTGAG TTAGG TC  GGGGAGATATGGA GATATGTGGA A ATATGTGGGGAGAATTTAA A T TGTGGGGATGTAAAAA AG G G GGGGAATT TGTTGAGTGT A TAA GAAAAAAAGAGTGTGG AAATAAAAAGAGTGTGTGAGATA ATTAAAGAGTTTCTGAGAGAG G A AGAGTGTGTGAGAGAGTGT AA  GTGTG AGGAGTAAGTTTT T T TGTGAGAGCAATTCTC TAA GAGAGAGTGTTTTCTCATGAA A AGAGTGTTTTCTCATGTAG G GCA TTCTCACAGAGAGA A T TTTTCTCAAGAGAGAG G T TCTCACAGAGAGATAGTT C CACAGAGA TCAGTGTTTT GTTAGAGAGAGTGTTTGATT T G GAGAGAGTTT TTTTA A AAGTGTTTTTTATAT T G GTGTTA CTTATATATTTT  TTTTTTTATATATTTTCTGTC T TTTTA AAATTTTCTATCT T T TATAGT ATTCTCTCTATA A A ATATTTTTTCTCTATAGATGG T TTTTCTCTCTAAGTAGT,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",18760
GCCGAG CCGAGG CGAGGA GAGGAG AGGAGA GGAGAA GAGAAG AGAAGG GAAGGG AAGGGC AGGGCA GGGCAC GGCACT GCACTG CACTGG ACTGGT CTGGTA TGGTAA GGTAAG GTAAGA TAAGAA AAGAAG AGAAGA GAAGAA AAGAAC AGAACC GAACCA AACCAG ACCAGA CCAGAT CAGATC AGATCA GATCAC ATCACC TCACCA CACCAT ACCATC CCATCA CATCAC ATCACC TCACCA CACCAA ACCAAC CCAACG CAACGA AACGAC ACGACA CGACAA GACAAG ACAAGG CAAGGG AAGGGC AGGGCC GGGCCG GGCCGC GCCGCC CCGCCT CGCCTC GCCTCT CCTCTC CTCTCC TCTCCA CTCCAA TCCAAG CCAAGG CAAGGC AAGGCC AGGCCG GGCCGA GCCGAG CCGAGA CGAGAT GAGATT AGATTG GATTGA ATTGAG TTGAGC TGAGCG GAGCGC AGCGCA GCGCAT CGCATG GCATGG CATGGT ATGGTC TGGTCA GGTCAA GTCAAT TCAATG CAATGA AATGAC ATGACG TGACGC GACGCC ACGCCT CGCCTC GCCTCC CCTCCA CTCCAA TCCAAG CCAAGT CAAGTT AAGTTC AGTTCG GTTCGA TTCGAG TCGAGG CGAGGC GAGGCC AGGCCG GGCCGC GCCGCT CCGCTG CGCTGA GCTGAC CTGACA TGACAA GACAAG ACAAGG CAAGGA AAGGAG AGGAGC GGAGCA GAGCAG AGCAGC GCAGCG CAGCGT AGCGTG GCGTGA CGTGAC GTGACC TGACCG GACCGC ACCGCA CCGCAT CGCATC GCATCG CATCGG ATCGGG TCGGGG CGGGGC GGGGCT GGGCTA GGCTAA GCTAAG,3,145,GCCCCGCG G C CCCCGA C CG ACATC CGG G GAGAGAGGCAAG AAGGGGAA G GGGGAGAGAG  GATT AGAC AA AAGAGAA GAA GACAGAAAAGAG C G AACATAGGGG G AAGAAGGGGGGG G GGTGGGGGGCC G GGGGCGCACA A G GCGCAAC C CCAGCACACTCT T A ACGA CTGTG  AACTGAA GG G T TGTGGAGTGT T G GGGGTGTATA A G GAGTATAAAA A T TATAAAAG GG AAAGA TCA AAC GAAG AA GT AGAAC A GAG A AAAAGAGAGA  AGAGAGAAAA A GGAAAACAC C A CCAACTGACC C A AC AACCAA CCAGAG G C CA CAAGAGA GCCAGAGATT GGATTC ATCTCA AAA TACTTCACACAC ACC CACACACCCC GAG ACACCCA A C CCAT  CAATCTC GA  ATATCTCAA TTCACACAGAGG  CACACACCCC  GGTCCCCACA A C CCCCA GAG GA CCAAAACAC C AAACACGG A ACACGCGAGA A C CGCGAGACAC C GGACAG CA  GC ACACACAA AG CACAAAAGG A CTAAGAGGGG G A AGAGGGGGC CG GG AATGGGCGC C G TCGGCCCTCC  GCGCCCCGCG G C GTCCGCGCGC C CGGGCGCGCCC G GCGCCCCTCT T C AGCTCTC C C CTCTCTCTCT T TTCTCTCTC C C CTCTCTCCCC C T TCTCCCCACA A C CCCCAAA  CAGG AAGAG AA  AAAAGAGGGG G A AGAGGGGCGC TGA GGGCCCC C G GCGCCC CAA G C CCCCGCGAGA A C CGGAGAG  CG GAGAG AGA A AGAGACATAT T G GAGATATTTT  GA ATATTTTGTG  TTTTGTGAGA A T TGTGAGAGAG G G CCGAGAGCGC C AGGCAGC CACG G GGGGGCG GCGC C CGCACA A G GCCATAT G GGCGCATTG G A ATATGTGGG T TGTGGGGTCTCT G GGGGTTC C G GTGTCCA A TTCAAA A C CACAAAATGA T A AAAATGGGTG G A ATATGC GA T TGTGAGACAC G AGCCACG ACACGCGCGC AG CGC GACC C GGCCCCTCT T C CCG ACTCTC C CGT TCCCC C T TCCCGG GCA A C CCCCACAACG A C CACAAGAGAG G A AAAAGAGTGT T A AGGGTT G GTGTTTTCTC  TTTTCTCGCG G T TCTCGCGAA C CGCGAGAGAG AA  GTAAGAGGGG  AGAGGGGCGC AA GCCCC C G GCGCTCG G CCCGCGCGC C C CGCGCA GCT T G GCGCTTG G C CTCTGTGAGA A T TGTGAT CC GC G GAGACACACA A A ACACACAAAA A C CACAAAAGG AACCCG AGGGG G A AGAGGGGAAT CCG GGAG G GCAAGAGAGCGC AAG AGAGCGCACA A G GCGCACAGG C CACAGAGCTC C AAGCGCGG GCGCGCGCGTGT  CGT CGTGTG G G CC ACTGAGA  TGACCAC C GTGGGACACCCC CGAACCCCGCG CA CCGCGCGC C C CGCGCGCACA A G GCGCACATAT GAC CAGATATCGC C A ATGAGTCGCG GCC GGGC CGGGG G C CGCGG GCGG  GGCCAGGGGG G G GGGGGGGCTCGC G GGGGCGCTCT A AGCTCTATA A C CTCTATAAAA A T TATAAAAG,GCCCCGCGAGA  CCC A AGCAAGAGG C CGCGAGAGGG G GGTTGGTAGGGA A A ACGGAGAGGT  GGGGAGAGAGAGA A GAAGGAGAGAGAAAA A AAGAGAAAAGGC G G GAGAAAAGAGGGCGGC GCAAAG ATGGGGG G A AGAGGGGGGGCGC C GGGGGCACA TG  GGGGCGCACACAC TCG GCCACACTCT  CACACACTCTG AGGG  ACACTG GTGGGG G C CTCTGTGGGGTGT T T TGGGTGTACCTATCGAGCC TAAAA C TTGATAAAAGAG  TATAAAAGAGAGA A A AA GAAGAGCGA A AGAGGGAAAAGAG G G GAGAAAAGAGAGA A A AAAAGGAAAA A A AGGAAAACAC C G GAGAAAACACCCC CA  AAAACACCCCAC A ACCATACGCAGC TG C CCCCACAGAGAGA  CACAGAGCGATC C AGAGAG AATCTC C G GAGATATCTCACA C GTCACACAC C T CCTCACACACCCCAC CATT CACCACA A A ACACCCCACATAT T C CCCCACATATCTC GCCCAT GATCACA A A ATATCC CCACAC A G TCTCACACACC CAT GAGGCACCCACA A A AGACCCAAAA A CCAACC CAAAACAC C CACCCAAAACACGCG  TCAACACGTCAGA A A ACCCACGAGACC C CGCGAGACA TCA A G GAGACACACAAAA  GA ACCAAAAGAG G C CACAAAAGAGGGG GAT AAAAGAGGGGGGG G ATG GGGGGCAT C C GGGGGGGCGT A ATGAGCCCCGCG G G GCGCCCCGCGCGC C C CCCCGCGCGCCCC C C CGCGCGCCCT  GCC CCCTCTCTC C CGACCCTCTCTCTCT T C CTCTCTCTCTCTC AG  TCCTCTCCCC GAG CTCTCTCCCCAGCTA T TCTCCCCACAACGAA CCCACAAAAGAG G CCAAAAGAGGGG  AAAAGAGGGGCGC C A AGAGAGGCGCCC CC GGGCGCCCG G G GCCCGCGA CCCCGCGAGAGAG G C CGAA GAGAGAGGGA GA AAGAAT T A AGAGAGATATTTT  GAGAT CATTGTG TGA ATTTGGTAGA A T TTTTGAG G T TGTGAGAGAGCGC C G GACC AGCGCGCG  AGAGACGCCGCAG C G GCGG CGCGCACA A CCGC CGCATAT T G GC AACAT CCTG G C CACATCAAGG G AAGGATGTGGGGTGT T T TGTGGGGTGTCTC C GCGAGGTGTCTCACA A G GTGTCTCA CCAA ACA GCCGAATGAATT C CACAAAATATGTG G A AAAATGCTTGAGA  ATATG GGGACAC C T TGTGAGACACGG AG G GAACGCGCG AC A ACACGAA GCCCC C CCGCGCCCCTCT T G TCGCCCCGCTCTC G A CCCCTCTCTCCC C CTCTCTCCCCACA A T TCTCCCCACAAAA A C CCCCACAAAAGAG G C CACAAATTAGTG GTCG AACGCAGTATCTT T A AGAGTGTTTTCTC C G GTGTTGAGTCGCG G TTTCCGAA T TCTCGCGAGAGAG G CG CCGAGAGAGGGG G G GATTCAGGGGCGC ATG AGAGGGGCGCCCC T G GGGGCGCCCCGCG G G GC TGTA CGCGC CG CCGCGCCA GGC CGCGCGCTCTGTG G G GCGCTCTGGA A C CTCTGGACAC C TGCCTGAGACACACA A G GA CGACACAA GAA A ACACAGGAAAGG C CACAAAAG CAGG G AAAGAGGGTGGA CCGGGAGAGAG CTG GGGGAGAGGC C GC GGAGAGCCA A AAGCCAGG GGCACAGAGCGC C C CACAGAGCGCGCG G A AGAGCGCGCGTCC C G GCGCGCGTGTGA GGAC CGCGTGTGTGAGA A G GTTGAA CAC C T TGTGAGACACCATCC GAA GACCCGCG  ACACCCCGCGCGC C C CCCCGCGCGCACA A CAG AAGGCACATAT T G GCGCACATGTATC C CCC ATCT ACG G A ATC GCGGGG G T TCTCGCGGGGGG AG CCGGGGGGGGGG G G GGGGGGAAT CGC  GA GGGGGGGCGCTCT T G GGGGCATGCTATA A G GCCTATAAAA A C CTCTATAAAAG,GCCCCGCGAGAGCGCG C CCCCGCGAGAGA GGG G CTCAGAGAGGGGAA GGAGAGGAAGGAGAG G A AGACCAAGAGAGA  GGGGAAGAGAAAA A GCGCGAAAGGCGC AGAGAGAAAAGAGG CAG G GAG CAAGAGGGGGGG  AAAAGAGGGAGGGCGC C A AGAGGGGGGGCGCACA  GGGGGTCAGCACACAC C G GGGGCGCACACACTCT  GCGCACACACTCTGTG G CGG TGAACTCTGTGGGG G A ACACTCTGTGGGGTGT T C CTGCGGGTGTATA A T TGTGGGGTGTATAA ACA G GGGGTGTATAAAAGAG G GC GGTATAAAAGAGATGG TATAAGGAAGAGAAAA AAGAC GAAGAGAG G A AGAGAGAAAAGTCTGA A G GAACGAGAGAATGATCG AAAAG TGGAAAACAC  CC AGAGAGAAAACACCCC C G GA AAAACAGACCACA A A AAAACACCTCAAG G A ACACCCCACAGGA A CCCACAGAGAGATT CA TCAGGATTC C A AGA TGATATCTCACA A GA GGATATCTCACACAC AG ATCTCACACACCCC C T TCGGCCACACCCCACA A C CA GAACCCCACATAT T A ACT TCCATA ATCTC C C CCCCACATCGACA A C CACAT GTTCAAGTAC C A ATATCTCACACACCCC C T TCCAGCACACCAGCCA A C CACACCCACAAAA A A ACACCCCACAAAACGG C C CCCCACAAAACACGCG  CACAAAACACGCGA CGA AAACACGGACAC C A ACCGCCTCGACCA A CCGAACACAAAA A GAAGGACACAG CAAGAG ACACAAAAGGAGGG G C CACAAAAGAGGGGGGG G A AAAAGAGGCAAGGCGC C A TCGGCGCCCC C G GGGGGGGCGCCCCGCG G GGAGGGCGCCCCGCTAA G GCGCCCCGCGCGCCCC C CC ACCGAGAGCCCCTCT T C CGCGCGCCCCTC GAGCGCCCCTCTCTCTCT T C CCT AAGACTCTC C C CTCTCTCTCGATCCCC C T TCTCTCTCTCCCCACA A C CTCTCTCCCCAAA A TTCCCCACAAAAGAG G C CCCAAAAGTT GG  GG CACAA AGGCGGGCGC C A AAAAGAGGGGCGCCCC CAT AGAGGGGCGCCCCGG G GGGGCCGAGA A G GCGCCCCGCGAAG G C CC GGAGAGA A C CGCGAGAGAGAGATAT ACC GAGAGAGAGATTT T A AGAGAGATTTGG G GAGATATTTTGTGAAGCA A AT CCTTGGAGAG G T TTTTGAA AGGGA G AC TGC TGAAGCCTG AAG G GAGGG GCGCGCGCC AAAGCCAGCGAC CA A G GCGCGGCAAT T CG CCGCACAATGTG G G GCGCACATATGGG CAA CACATATGTGGGGTGT CCT ATATGCGATC C T TGG AGGTGTCA TA GG CGGTGTCTCACAAAA A G GTGTCGGGCAAAATAT ACC TCTCATGAAATATGTG CAA CACAAAATATGTGAGA A ACG AATATGTGAGACGCAC A ATATGGACCG G T TGCGTGACACGCGCGC C GCACGACACGG AGCCCC GACCGCGCCCCTCT T C CGCGCGCCCCTCTCTC C G GCGCCCCTG TTCCCC C C CCCCTCTCCTGCA A C CTCTCTCCCCACAAAA AGA TCTCCCCACAAAAGAG G CCCACAAAGTGT T CAGTGGGAAGCTCGTTAGGT A AAAAGGTTTTCTC C A AGAGTTTCTCGCG G G GTGTTTTCTCGGGTGA A T TTTTCA ACGAGAGAG CTC TCTCGCGAGGGAGGGG G C CGCGAGCAAGGGGCGCAC G GAACAAGGGGCGCC CAC A AGAAGGGCGCCCCGCG G T GGGCCCCGCGCGC ATC GCGCCCCGACGGCTCT T C CCGA CGCCGACTGTG G CTGACGCGA TCCAA CCGA G GCGCTCTGTGAGTGC C CTCTGTGAGACCA  TGG CGAGCAAAA A G GAGACACACAAAAGTGG ACC ACAAAAGAGGGG G C CACAAAAGAGG GAGA A A AA GAAGGGGAGAGAG G A AGAGGGGAGAGAGCGC C G GGGGAGAGAGCGAGCA  GAGGAGAG GGGC CAG ATG A AGGCACAGAGCGC C G GCGCACAGAGCGCGCG G C CACAGAGCAGGCGTGT T AAGCTAACGTGTGTG G G GCGAG CGGA A C CGCACGACTGAGACACCC GTGAGACT GCC AGATGAGACACCCCGCG G G GAGACACCCCGCGCGC GGA ACAGGATCCGCGGGCA A C CCCCGGCACATAT T CGCTCGCGCACATTC C GGCACATATCTCGCG  CG CACATATCTCGA G TGATCTCGCGGGGGAC G G TCTCG CGGGGGGGGG GAA CGCGGGGGGCAGC C G GGTCAGTGGGCGCTCT T GAGCGGGGGCGCTCGCCATAGG GGGGCCTATAATGAA G GCCTAGCGAAG,GCCCCGCGAAGGGG  GCCCGCGAGAGAGGGGACGCA C CGCGAGAGAGGGGAGAGAG AGC GAAGGGGAGAGAGAGA A A AGCG GGAAGAGAAAA  GGGGAGAGAGAGAAAAGAG G GATGCA AGAGAA TCAGGGG G A AGCCAGAAAAGAGGGGGG GCAAAAGAGGGGCA CC A AAAAGAGGGGGGGCGCA CAA AAGGGGGGGCGCACACC GA CGGGGGCCCGCACACTCT T G GGGGCGCACACACTTGAG GGCACACACTG CGG AGT CACACACTTGGGGTC GT A ACCTGTGGGTATA A C CTCTGTGGGGTGTACGCAA A T TGTGGGGTCAATAAAAGAG G G GGA TTAAAAGAGAGA A G GTGTATAAAAGAGAGAAAA A T TATAAAGGAGAGAAAAGG A AAAAGAGAGAAACCAGAGA A A AGC GGAAAAGAGAGAAAA A GGAAGG AGAGAAAACT GCA  CGAAGAGAGAAGGCACCCC AAG AGAGAGAAAACCA  GAGAAAACGAGGCCCAGAG A G AAACCCCACAGCAGGA  GGACCCCACAGAGAGATAT T CC ACCAGATATCTC C C CAAGAGATATCTCAGAGA A AGAGACACTCACACAC C G GACGAATCTCAGAAACCCC C A ATCCTTCACACACCAAGC AGGT TCCACACC GACATAT T CGCCGATACCCCACATATCAA  CC ACACCCCACATATCTCACA  GGCCACATATCTCAAC C C CAAC ATCGCCGAGACCCC C A ATTCACACACCAGACA A TAAGTCACACACCCCACACAA A C CACACACCCCAC AAACAC C A ACACC AACAAAACACGCG G C CCCCAGTAAACCTCATCA C CAGGGAACCGAGACAC CCAAACCGAGACAGGG AGA  ACGC CGAGACACACG AA A C CGCGAGAC TGCAAAAGAG G G GAGACACACAAAAGAGGGG G AGACACAAAGCGA CACAAG C CACAAAAGAG GGGGC  AAAAGAGGGGGGGCGCCCC  AGGGGGGCGCCCCGCG G G GGGGGGGCCCGGC C G GGGGC CACGCGCCCC  GCGCCCGCGCCCCTCT  GC CCCCGCGCGCCCCTCTCC CGGCCGCGCC TCCTCCT T G CCGCCGA ACGCTCTC CCTGG G CCTCTCTCTCTCCCC C CTCTCTCTCCCCAACAA TC CTCTCTCTCCCCACAA AAA C CTTCCCCACAAAAGAG G T TCTCCCCACAA CGAGGGGGG C CCCCACAAAAGGGCGC C C CACAAAGGGGCGCCCC C AAA AAG CGGCCCCGG A AGAGGGGCGCCCCGCGAGA A G GGGGCGCCCCGCGAGAGAG G G GCGCCT CCGAGAGAGAGA A CCCGACAGAGAGAGATAT T C CGCGAGA GATATTTT T GCCAGAGAGAGATATTTTGTG G A AGGCCGATATTTGAGA A GGCGGATATTTTGTGAGAGG A ATATTTTGTGAGAGAGCTG C T TTTTGCGAGAGAGCGCGCG G T TGTGAGCG GACGCGC C G GACACAGCGCGCGCGCAC AA ACAAAGCGCGCGCGCACATAT T G GCGCGCGCGCACATATGTG G CAGGCGCGCAC A GATGGGG G G GCGCACATTGGGGTTCG AG CACATATGTGGGCGGTCTC C A ATATGTGGGGTGTCTCACA A T TGTGGGGTGTCTCAAA GGG GGGGTGTCAGCAATAT T G GTGTCTCACAAATGTG CAG TCTCACAAAATATGTGAGC CA CAAAATATGTGA ACAC C A AAAATA GTGAGACACGCG CA  ATATGTGAGACACGCGCGC C TACATG GACACGCACGT  GAACGCGCCGGGGAT A ACCGCCCACTCTC C CCGCGCCCTCCC  GCGCCCCTCTCCCACA A C CCCCTCTCTCCCCACAAAA A C CTAGATCCCCA AGAAGAG G T TCTCCCCACAACCAGCAGT T C CCCCACAAA AAGTGTTTT T C CACAAAAGCTGGTTTTCTC C A AAAAGGTTGACG AAGTGTTTTCTCGTGAGA G A GTTTCGCAGATGAGAG G T TTTTCCGAGAGAGGGG  TCGT  CCAGGGGCGC C CCGAGAGAGGGGCAGACC C G GAGAGAGGGGCCG G A AGAGGGGCTCACCGCGCGC AGA GGGGCGCCCCGTAAGCTCT T G GCGCCCCGCGCAAGG CCCGCGCAACCTGGA A CCTGAGATGAGACAC C G GCGCTCTGTGAGACACACA A C CTCTGA A GAACACAATC A T TGTGAGACCAAAAGAG G G GAGACACAAAGAGGGG G A ACCA CAAGGATGAA C CAAAGAGGGGAGAGCT TGGAAGAGGGGAGAGAGCGC  AG CGGGAAAGAGCGAGCA ATG GGGAGAGCGCAG TAG G G GAGAGGCACAGAGCACGCA  AGAGCGCACAGAGCGCGCG TCAT CGCATCGCAAGGTCGTGT CCGCAACAGAGCCTGGTGGC G A AGTCTGCGCGTGTGTGAGA A G GCGAGCGTGTGTGAGACAC C C AACGTGTGTGAGACACCCC C G GTGTGTGAGACACCCCGCAA TGTGAGACACCCCGCGCGC AGAGACACCTCGCGCCA A A ACCCGCGCAGTCATAT T C CCCCGCGCGCACATATCTC C C CGCGCGCACATATCC CG G GCGCACATATCTCGCGGGG G C CAATCTCGCGGGGGGG  ATATCTCGCGGGGGGGGGG G T TCTCGCGG CCGGGAACGC CG  CGGCCGGGA GGGCGCTG ACAT ACGGGGGCGCTCTATA A G GGGGCCTATAAAA A G GGGGCGCTCTATAAAAG,"ID   HSP70_LEIBR             Reviewed;         228 AA.
AC   P27894;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   05-FEB-2025, entry version 81.
DE   RecName: Full=Heat shock 70 kDa protein;
DE            Short=HSP 70;
DE   Flags: Fragment;
GN   Name=HSP70;
OS   Leishmania braziliensis.
OC   Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;
OC   Trypanosomatida; Trypanosomatidae; Leishmaniinae; Leishmania;
OC   Leishmania braziliensis species complex.
OX   NCBI_TaxID=5660;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Boytron;
RX   PubMed=1548032; DOI=10.1016/0165-2478(92)90006-a;
RA   Levy Yeyati P., Bonnefoy S., Mirkin G., Debrabant A., Lafon S., Panebra A.,
RA   Gonzalez-Cappa E., Dedet J.P., Hontebeyrie-Joskowicz M., Levin M.J.;
RT   ""The 70-kDa heat-shock protein is a major antigenic determinant in human
RT   Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection."";
RL   Immunol. Lett. 31:27-33(1992).
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62485; CAA44351.1; -; mRNA.
DR   PIR; S17349; S17349.
DR   AlphaFoldDB; P27894; -.
DR   SMR; P27894; -.
DR   VEuPathDB; TriTrypDB:LbrM.28.2990; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   FunFam; 1.20.1270.10:FF:000055; Heat shock 70 kDa protein; 1.
DR   FunFam; 2.60.34.10:FF:000012; Heat shock 70 kDa protein; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; Substrate Binding Domain Of DNAk, Chain A, domain 1; 1.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Nucleotide-binding; Stress response.
FT   CHAIN           <1..228
FT                   /note=""Heat shock 70 kDa protein""
FT                   /id=""PRO_0000078303""
FT   REGION          191..228
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   NON_TER         1
SQ   SEQUENCE   228 AA;  24637 MW;  DE4BBFA18BA139B9 CRC64;
     KSQIFSTYAD NQPGVHIQVF EGERAMTKDC HLLGTFDLSA IPPAPRGVPQ IEVTFDLDAN
     GILNVSAEEK GTGKRNHITI TNDKGRLSKD EIERMVNDAS KYEQADKMQR DALEAKNGLE
     NYAYSMKNTV SDTNVSGKLE ESDRSALNLA IDTALEWLNS NQEASKEEYE HRQKELESTC
     NPIMTKMYQS MGGGAGGMPG GMPDMSGMGG GQGPAAGASS GPKVEEVD
//
",57392
TTAACA TAACAT AACATT ACATTA CATTAG ATTAGC TTAGCT TAGCTG AGCTGT GCTGTA CTGTAC TGTACC GTACCC TACCCT ACCCTA CCCTAT CCTATA CTATAA TATAAT ATAATA TAATAT AATATG ATATGA TATGAG ATGAGA TGAGAG GAGAGT AGAGTT GAGTTA AGTTAT GTTATA TTATAC TATACA ATACAT TACATT ACATTT CATTTT ATTTTG TTTTGG TTTGGT TTGGTG TGGTGC GGTGCT GTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCT GTTCTG TTCTGA TCTGAT CTGATA TGATAA GATAAA ATAAAG TAAAGG AAAGGA AAGGAG AGGAGT GGAGTT GAGTTG AGTTGC GTTGCA TTGCAC TGCACC GCACCA CACCAG ACCAGG CCAGGT CAGGTA AGGTAC GGTACA GTACAG TACAGC ACAGCT CAGCTG AGCTGT GCTGTT CTGTTT TGTTTT GTTTTA TTTTAA TTTAAG TTAAGA TAAGAC AAGACA AGACAG GACAGT ACAGTG CAGTGG AGTGGT GTGGTT TGGTTC GGTTCT GTTCTG TTCTGT TCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA,0,142,TTAA TAAC AACA ACAT CATT ATTA TTAG TAGC AGCT GCTG CTGT TGTA GTAC TACC ACCC CCCT CCTA CTAT TATA ATAA TAAT AATA ATAT TATG ATGA TGAG GAGA AGAG GAGT AGTT GTTA TTAT TATA ATAC TACA ACAT CATT ATTT TTTT TTTG TTGG TGGT GGTG GTGC TGCT GCTG CTGG TGGT GGTT GTTC TTCT TCTG CTGA TGAT GATA ATAA TAAA AAAG AAGG AGGA GGAG GAGT AGTT GTTG TTGC TGCA GCAC CACC ACCA CCAG CAGG AGGT GGTA GTAC TACA ACAG CAGC AGCT GCTG CTGT TGTT GTTT TTTT TTTA TTAA TAAG AAGA AGAC GACA ACAG CAGT AGTG GTGG TGGT GGTT GTTC TTCT TCTG CTGT TGTC GTCT TCTC CTCT TCTT CTTA TTAT TATA ATAC TACA ACAC CACA ACAT CATT ATTC TTCC TCCG CCGA CGAG GAGC AGCC GCCC CCCA CCAC CACG ACGA CGAG GAGA AGAC GACT ACTC CTCC TCCT CCTG CTGA TGAG GAGC AGCA GCAT CATC ATCT TCTC CTCG TCGT CGTA,TTAAC TAACA AACAT ACATT CATTA ATTAG TTAGC TAGCT AGCTG GCTGT CTGTA TGTAC GTACC TACCC ACCCT CCCTA CCTAT CTATA TATAA ATAAT TAATA AATAT ATATG TATGA ATGAG TGAGA GAGAG AGAGT GAGTT AGTTA GTTAT TTATA TATAC ATACA TACAT ACATT CATTT ATTTT TTTTG TTTGG TTGGT TGGTG GGTGC GTGCT TGCTG GCTGG CTGGT TGGTT GGTTC GTTCT TTCTG TCTGA CTGAT TGATA GATAA ATAAA TAAAG AAAGG AAGGA AGGAG GGAGT GAGTT AGTTG GTTGC TTGCA TGCAC GCACC CACCA ACCAG CCAGG CAGGT AGGTA GGTAC GTACA TACAG ACAGC CAGCT AGCTG GCTGT CTGTT TGTTT GTTTT TTTTA TTTAA TTAAG TAAGA AAGAC AGACA GACAG ACAGT CAGTG AGTGG GTGGT TGGTT GGTTC GTTCT TTCTG TCTGT CTGTC TGTCT GTCTC TCTCT CTCTT TCTTA CTTAT TTATA TATAC ATACA TACAC ACACA CACAT ACATT CATTC ATTCC TTCCG TCCGA CCGAG CGAGC GAGCC AGCCC GCCCA CCCAC CCACG CACGA ACGAG CGAGA GAGAC AGACT GACTC ACTCC CTCCT TCCTG CCTGA CTGAG TGAGC GAGCA AGCAT GCATC CATCT ATCTC TCTCG CTCGT TCGTA,TTAACA TAACAT AACATT ACATTA CATTAG ATTAGC TTAGCT TAGCTG AGCTGT GCTGTA CTGTAC TGTACC GTACCC TACCCT ACCCTA CCCTAT CCTATA CTATAA TATAAT ATAATA TAATAT AATATG ATATGA TATGAG ATGAGA TGAGAG GAGAGT AGAGTT GAGTTA AGTTAT GTTATA TTATAC TATACA ATACAT TACATT ACATTT CATTTT ATTTTG TTTTGG TTTGGT TTGGTG TGGTGC GGTGCT GTGCTG TGCTGG GCTGGT CTGGTT TGGTTC GGTTCT GTTCTG TTCTGA TCTGAT CTGATA TGATAA GATAAA ATAAAG TAAAGG AAAGGA AAGGAG AGGAGT GGAGTT GAGTTG AGTTGC GTTGCA TTGCAC TGCACC GCACCA CACCAG ACCAGG CCAGGT CAGGTA AGGTAC GGTACA GTACAG TACAGC ACAGCT CAGCTG AGCTGT GCTGTT CTGTTT TGTTTT GTTTTA TTTTAA TTTAAG TTAAGA TAAGAC AAGACA AGACAG GACAGT ACAGTG CAGTGG AGTGGT GTGGTT TGGTTC GGTTCT GTTCTG TTCTGT TCTGTC CTGTCT TGTCTC GTCTCT TCTCTT CTCTTA TCTTAT CTTATA TTATAC TATACA ATACAC TACACA ACACAT CACATT ACATTC CATTCC ATTCCG TTCCGA TCCGAG CCGAGC CGAGCC GAGCCC AGCCCA GCCCAC CCCACG CCACGA CACGAG ACGAGA CGAGAC GAGACT AGACTC GACTCC ACTCCT CTCCTG TCCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATC GCATCT CATCTC ATCTCG TCTCGT CTCGTA,TTAACAT TAACATT AACATTA ACATTAG CATTAGC ATTAGCT TTAGCTG TAGCTGT AGCTGTA GCTGTAC CTGTACC TGTACCC GTACCCT TACCCTA ACCCTAT CCCTATA CCTATAA CTATAAT TATAATA ATAATAT TAATATG AATATGA ATATGAG TATGAGA ATGAGAG TGAGAGT GAGAGTT AGAGTTA GAGTTAT AGTTATA GTTATAC TTATACA TATACAT ATACATT TACATTT ACATTTT CATTTTG ATTTTGG TTTTGGT TTTGGTG TTGGTGC TGGTGCT GGTGCTG GTGCTGG TGCTGGT GCTGGTT CTGGTTC TGGTTCT GGTTCTG GTTCTGA TTCTGAT TCTGATA CTGATAA TGATAAA GATAAAG ATAAAGG TAAAGGA AAAGGAG AAGGAGT AGGAGTT GGAGTTG GAGTTGC AGTTGCA GTTGCAC TTGCACC TGCACCA GCACCAG CACCAGG ACCAGGT CCAGGTA CAGGTAC AGGTACA GGTACAG GTACAGC TACAGCT ACAGCTG CAGCTGT AGCTGTT GCTGTTT CTGTTTT TGTTTTA GTTTTAA TTTTAAG TTTAAGA TTAAGAC TAAGACA AAGACAG AGACAGT GACAGTG ACAGTGG CAGTGGT AGTGGTT GTGGTTC TGGTTCT GGTTCTG GTTCTGT TTCTGTC TCTGTCT CTGTCTC TGTCTCT GTCTCTT TCTCTTA CTCTTAT TCTTATA CTTATAC TTATACA TATACAC ATACACA TACACAT ACACATT CACATTC ACATTCC CATTCCG ATTCCGA TTCCGAG TCCGAGC CCGAGCC CGAGCCC GAGCCCA AGCCCAC GCCCACG CCCACGA CCACGAG CACGAGA ACGAGAC CGAGACT GAGACTC AGACTCC GACTCCT ACTCCTG CTCCTGA TCCTGAG CCTGAGC CTGAGCA TGAGCAT GAGCATC AGCATCT GCATCTC CATCTCG ATCTCGT TCTCGTA,"ID   R1AB_BCHK3              Reviewed;        7067 AA.
AC   P0C6W2; Q3LZX2;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   05-FEB-2025, entry version 109.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE              Short=nsp1;
DE     AltName: Full=Leader protein;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like proteinase nsp3;
DE              Short=PL-PRO;
DE              EC=3.4.19.12;
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.-;
DE     AltName: Full=nsp5;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9;
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE     AltName: Full=p12;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50;
DE     AltName: Full=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              Short=ExoN;
DE              EC=2.1.1.56;
DE              EC=3.1.13.-;
DE     AltName: Full=nsp14;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.-;
DE     AltName: Full=NendoU;
DE     AltName: Full=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Bat coronavirus HKU3 (BtCoV) (SARS-like coronavirus HKU3).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=442736;
OH   NCBI_TaxID=89399; Rhinolophus sinicus (Chinese rufous horseshoe bat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Isolate HKU3-1;
RX   PubMed=16169905; DOI=10.1073/pnas.0506735102;
RA   Lau S.K.P., Woo P.C.Y., Li K.S.M., Huang Y., Tsoi H.-W., Wong B.H.L.,
RA   Wong S.S.Y., Leung S.-Y., Chan K.-H., Yuen K.-Y.;
RT   ""Severe acute respiratory syndrome coronavirus-like virus in Chinese
RT   horseshoe bats."";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14040-14045(2005).
CC   -!- FUNCTION: The replicase polyprotein of coronaviruses is a
CC       multifunctional protein: it contains the activities necessary for the
CC       transcription of negative stranded RNA, leader RNA, subgenomic mRNAs
CC       and progeny virion RNA as well as proteinases responsible for the
CC       cleavage of the polyprotein into functional products.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome
CC       complex further induces an endonucleolytic cleavage near the 5'UTR of
CC       host mRNAs, targeting them for degradation. Viral mRNAs are not
CC       susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the
CC       presence of a 5'-end leader sequence and are therefore protected from
CC       degradation. By suppressing host gene expression, nsp1 facilitates
CC       efficient viral gene expression in infected cells and evasion from host
CC       immune response. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 2]: May play a role in the modulation
CC       of host cell survival signaling pathway by interacting with host PHB
CC       and PHB2. Indeed, these two proteins play a role in maintaining the
CC       functional integrity of the mitochondria and protecting cells from
CC       various stresses. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Papain-like proteinase nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. In addition,
CC       PL-PRO possesses a deubiquitinating/deISGylating activity and processes
CC       both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates. Participates together with nsp4 in the assembly of virally-
CC       induced cytoplasmic double-membrane vesicles necessary for viral
CC       replication. Antagonizes innate immune induction of type I interferon
CC       by blocking the phosphorylation, dimerization and subsequent nuclear
CC       translocation of host IRF3. Prevents also host NF-kappa-B signaling.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 4]: Participates in the assembly of
CC       virally-induced cytoplasmic double-membrane vesicles necessary for
CC       viral replication. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [3C-like proteinase nsp5]: Cleaves the C-terminus of
CC       replicase polyprotein at 11 sites. Recognizes substrates containing the
CC       core sequence [ILMVF]-Q-|-[SGACN]. Also able to bind an ADP-ribose-1''-
CC       phosphate (ADRP). {ECO:0000250|UniProtKB:P0C6X7, ECO:0000255|PROSITE-
CC       ProRule:PRU00772}.
CC   -!- FUNCTION: [Non-structural protein 6]: Plays a role in the initial
CC       induction of autophagosomes from host endoplasmic reticulum. Later,
CC       limits the expansion of these phagosomes that are no longer able to
CC       deliver viral components to lysosomes. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 7]: Forms a hexadecamer with nsp8 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Non-structural protein 8]: Forms a hexadecamer with nsp7 (8
CC       subunits of each) that may participate in viral replication by acting
CC       as a primase. Alternatively, may synthesize substantially longer
CC       products than oligonucleotide primers. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Viral protein genome-linked nsp9]: Forms a primer, NSP9-pU,
CC       which is utilized by the polymerase for the initiation of RNA chains.
CC       Interacts with ribosome signal recognition particle RNA (SRP). Together
CC       with NSP8, suppress protein integration into the cell membrane, thereby
CC       disrupting host immune defenses. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Non-structural protein 10]: Plays a pivotal role in viral
CC       transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16
CC       2'-O-methyltransferase activities. Therefore plays an essential role in
CC       viral mRNAs cap methylation. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [RNA-directed RNA polymerase nsp12]: RNA-directed RNA
CC       polymerase that catalyzes the transcription of viral genomic and
CC       subgenomic RNAs. Acts in complex with nsp7 and nsp8 to transcribe both
CC       the minus and positive strands of genomic RNA. The kinase-like NiRAN
CC       domain of NSP12 attaches one or more nucleotides to the amino terminus
CC       of NSP9, forming a covalent RNA-protein intermediate that serves as
CC       transcription/replication primer. Subgenomic RNAs (sgRNAs) are formed
CC       by discontinuous transcription: The polymerase has the ability to pause
CC       at transcription-regulating sequences (TRS) and jump to the leader TRS,
CC       resulting in a major deletion. This creates a series of subgenomic RNAs
CC       that are replicated, transcribed and translated. In addition, Nsp12 is
CC       a subunit of the viral RNA capping enzyme that catalyzes the RNA
CC       guanylyltransferase reaction for genomic and sub-genomic RNAs.
CC       Subsequently, the NiRAN domain transfers RNA to GDP, and forms the core
CC       cap structure GpppA-RNA. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- FUNCTION: [Helicase nsp13]: Multi-functional protein with a zinc-
CC       binding domain in N-terminus displaying RNA and DNA duplex-unwinding
CC       activities with 5' to 3' polarity. Activity of helicase is dependent on
CC       magnesium. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Guanine-N7 methyltransferase nsp14]: Plays a role in viral
CC       RNA synthesis through two distinct activities. The N7-guanine
CC       methyltransferase activity plays a role in the formation of the cap
CC       structure GpppA-RNA. The proofreading exoribonuclease reduces the
CC       sensitivity of the virus to RNA mutagens during replication. This
CC       activity acts on both ssRNA and dsRNA in a 3'-5' direction.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Uridylate-specific endoribonuclease nsp15]: Plays a role in
CC       viral transcription/replication and prevents the simultaneous
CC       activation of host cell dsRNA sensors, such as MDA5/IFIH1, OAS, and PKR
CC       (By similarity). Acts by degrading the 5'-polyuridines generated during
CC       replication of the poly(A) region of viral genomic and subgenomic RNAs.
CC       Catalyzes a two-step reaction in which a 2'3'-cyclic phosphate (2'3'-
CC       cP) is first generated by 2'-O transesterification, which is then
CC       hydrolyzed to a 3'-phosphate (3'-P) (By similarity). If not degraded,
CC       poly(U) RNA would hybridize with poly(A) RNA tails and activate host
CC       dsRNA sensors (By similarity). {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [2'-O-methyltransferase nsp16]: Methyltransferase that
CC       mediates mRNA cap 2'-O-ribose methylation to the 5'-cap structure of
CC       viral mRNAs. N7-methyl guanosine cap is a prerequisite for binding of
CC       nsp16. Therefore plays an essential role in viral mRNAs cap methylation
CC       which is essential to evade immune system.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) +
CC         diphosphate; Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC         COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- CATALYTIC ACTIVITY: [Helicase nsp13]:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- CATALYTIC ACTIVITY: [Papain-like proteinase nsp3]:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12;
CC   -!- CATALYTIC ACTIVITY: [2'-O-methyltransferase nsp16]:
CC       Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside
CC         in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA + S-
CC         adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:67020, Rhea:RHEA-
CC         COMP:17167, Rhea:RHEA-COMP:17168, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167609; EC=2.1.1.57;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [Uridylate-specific endoribonuclease nsp15]:
CC       Reaction=uridylyl-uridylyl-ribonucleotide-RNA = a 3'-end uridylyl-
CC         2',3'-cyclophospho-uridine-RNA + a 5'-end dephospho-ribonucleoside-
CC         RNA; Xref=Rhea:RHEA:67732, Rhea:RHEA-COMP:13936, Rhea:RHEA-
CC         COMP:17334, Rhea:RHEA-COMP:17335, ChEBI:CHEBI:138284,
CC         ChEBI:CHEBI:173079, ChEBI:CHEBI:173080;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- CATALYTIC ACTIVITY: [RNA-directed RNA polymerase nsp12]:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67013;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- CATALYTIC ACTIVITY: [Guanine-N7 methyltransferase nsp14]:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + S-
CC         adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67009;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [Uridylate-specific endoribonuclease nsp15]:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P0C6X7};
CC       Note=Likely affects Nsp15 binding to RNA.
CC       {ECO:0000250|UniProtKB:P0C6X7};
CC   -!- COFACTOR: [RNA-directed RNA polymerase nsp12]:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P0DTD1};
CC   -!- SUBUNIT: [Non-structural protein 2]: Interacts with host PHB and PHB2.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 4]: Interacts with papain-like
CC       protease nsp3 and non-structural protein 6.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [3C-like proteinase nsp5]: Monomer. Homodimer. Only the
CC       homodimer shows catalytic activity. {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBUNIT: [Non-structural protein 7]: Interacts with nsp8 and nsp12 to
CC       form the replication-transcription complex (RTC): nsp12, nsp7, two
CC       subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 8]: Interacts with nsp7, nsp13 and
CC       nsp12 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Viral protein genome-linked nsp9]: Interacts with nsp12.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Non-structural protein 10]: Interacts with proofreading
CC       exoribonuclease nsp14 and 2'-O-methyltransferase nsp16; these
CC       interactions enhance nsp14 and nsp16 enzymatic activities.
CC       {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [RNA-directed RNA polymerase nsp12]: Interacts with nsp7 and
CC       nsp8 to form the replication-transcription complex (RTC): nsp12, nsp7,
CC       two subunits of nsp8, and up to two subunits of nsp13. Interacts with
CC       nsp9. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBUNIT: [Helicase nsp13]: Interacts with nsp8 to form the replication-
CC       transcription complex (RTC): nsp12, nsp7, two subunits of nsp8, and up
CC       to two subunits of nsp13. {ECO:0000250|UniProtKB:P0DTD1}.
CC   -!- SUBCELLULAR LOCATION: [Papain-like proteinase nsp3]: Host membrane;
CC       Multi-pass membrane protein. Host cytoplasm
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 4]: Host membrane; Multi-
CC       pass membrane protein. Host cytoplasm. Note=Localizes in virally-
CC       induced cytoplasmic double-membrane vesicles.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 6]: Host membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 7]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 8]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Viral protein genome-linked nsp9]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9
CC       and nsp10 are localized in cytoplasmic foci, largely perinuclear. Late
CC       in infection, they merge into confluent complexes (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Non-structural protein 10]: Host cytoplasm, host
CC       perinuclear region {ECO:0000250}. Note=nsp7, nsp8, nsp9 and nsp10 are
CC       localized in cytoplasmic foci, largely perinuclear. Late in infection,
CC       they merge into confluent complexes (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Helicase nsp13]: Host endoplasmic reticulum-
CC       Golgi intermediate compartment {ECO:0000305}. Note=The helicase
CC       interacts with the N protein in membranous complexes and colocalizes
CC       with sites of synthesis of new viral RNA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Uridylate-specific endoribonuclease nsp15]: Host
CC       cytoplasm, host perinuclear region {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC       Name=Replicase polyprotein 1ab; Synonyms=pp1ab;
CC         IsoId=P0C6W2-1; Sequence=Displayed;
CC       Name=Replicase polyprotein 1a; Synonyms=pp1a, ORF1a polyprotein;
CC         IsoId=P0C6F8-1; Sequence=External;
CC   -!- DOMAIN: The hydrophobic domains (HD) could mediate the membrane
CC       association of the replication complex and thereby alter the
CC       architecture of the host cell membrane. {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages in vivo by its own proteases yield
CC       mature proteins. 3CL-PRO and PL-PRO proteinases are autocatalytically
CC       processed (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Bat coronavirus HKU3 is highly similar to SARS-CoV
CC       (SARS-like).
CC   -!- MISCELLANEOUS: [Isoform Replicase polyprotein 1ab]: Produced by -1
CC       ribosomal frameshifting at the 1a-1b genes boundary.
CC   -!- SIMILARITY: Belongs to the coronaviruses polyprotein 1ab family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ022305; AAY88865.2; -; Genomic_RNA.
DR   BMRB; P0C6W2; -.
DR   SMR; P0C6W2; -.
DR   MEROPS; C16.009; -.
DR   MEROPS; C30.005; -.
DR   Proteomes; UP000007450; Segment.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000175; F:3'-5'-RNA exonuclease activity; IEA:InterPro.
DR   GO; GO:0043139; F:5'-3' DNA helicase activity; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0140849; F:ATP-dependent H2AZ histone chaperone activity; IEA:RHEA.
DR   GO; GO:0140665; F:ATP-dependent H3-H4 histone complex chaperone activity; IEA:RHEA.
DR   GO; GO:0140584; F:chromatin extrusion motor activity; IEA:RHEA.
DR   GO; GO:0061775; F:cohesin loader activity; IEA:RHEA.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:RHEA.
DR   GO; GO:0036121; F:double-stranded DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0061749; F:forked DNA-dependent helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009378; F:four-way junction helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0002151; F:G-quadruplex RNA binding; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0004482; F:mRNA 5'-cap (guanine-N7-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0008242; F:omega peptidase activity; IEA:InterPro.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:1990518; F:single-stranded 3'-5' DNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0039595; P:symbiont-mediated degradation of host mRNA; IEA:UniProtKB-KW.
DR   GO; GO:0039648; P:symbiont-mediated perturbation of host ubiquitin-like protein modification; IEA:UniProtKB-KW.
DR   GO; GO:0039657; P:symbiont-mediated suppression of host gene expression; IEA:UniProtKB-KW.
DR   GO; GO:0039579; P:symbiont-mediated suppression of host ISG15-protein conjugation; IEA:UniProtKB-KW.
DR   GO; GO:0085034; P:symbiont-mediated suppression of host NF-kappaB cascade; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0019082; P:viral protein processing; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   GO; GO:0075523; P:viral translational frameshifting; IEA:UniProtKB-KW.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21409; 1B_cv_Nsp13-like; 1.
DR   CDD; cd21560; betaCoV-Nsp6; 1.
DR   CDD; cd21722; betaCoV_Nsp13-helicase; 1.
DR   CDD; cd21659; betaCoV_Nsp14; 1.
DR   CDD; cd21516; betaCoV_Nsp2_SARS-like; 1.
DR   CDD; cd21666; betaCoV_Nsp5_Mpro; 1.
DR   CDD; cd21827; betaCoV_Nsp7; 1.
DR   CDD; cd21831; betaCoV_Nsp8; 1.
DR   CDD; cd21898; betaCoV_Nsp9; 1.
DR   CDD; cd21732; betaCoV_PLPro; 1.
DR   CDD; cd20762; capping_2-OMTase_Nidovirales; 1.
DR   CDD; cd21872; CoV_Nsp10; 1.
DR   CDD; cd21473; cv_Nsp4_TM; 1.
DR   CDD; cd21167; M_alpha_beta_cv_Nsp15-like; 1.
DR   CDD; cd21563; Macro_cv_SUD-M_Nsp3-like; 1.
DR   CDD; cd21562; Macro_cv_SUD-N_Nsp3-like; 1.
DR   CDD; cd21557; Macro_X_Nsp3-like; 1.
DR   CDD; cd21161; NendoU_cv_Nsp15-like; 1.
DR   CDD; cd21171; NTD_alpha_betaCoV_Nsp15-like; 1.
DR   CDD; cd22662; SARS-CoV-like_Nsp1_C; 1.
DR   CDD; cd21796; SARS-CoV-like_Nsp1_N; 1.
DR   CDD; cd21814; SARS-CoV-like_Nsp3_betaSM; 1.
DR   CDD; cd21822; SARS-CoV-like_Nsp3_NAB; 1.
DR   CDD; cd21591; SARS-CoV-like_RdRp; 1.
DR   CDD; cd21689; stalk_CoV_Nsp13-like; 1.
DR   CDD; cd21525; SUD_C_SARS-CoV_Nsp3; 1.
DR   CDD; cd21717; TM_Y_SARS-CoV-like_Nsp3_C; 1.
DR   CDD; cd21467; Ubl1_cv_Nsp3_N-like; 1.
DR   CDD; cd21401; ZBD_cv_Nsp13-like; 1.
DR   FunFam; 1.10.8.370:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 2.40.10.250:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.40.220.30:FF:000001; Orf1a polyprotein; 1.
DR   FunFam; 3.30.160.820:FF:000001; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.150:FF:000162; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001105; Orf1ab polyprotein; 1.
DR   FunFam; 3.40.50.300:FF:001139; Orf1ab polyprotein; 1.
DR   FunFam; 1.10.150.420:FF:000001; Replicase polyprotein; 1.
DR   FunFam; 1.10.1840.10:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 1.10.8.1190:FF:000001; Replicase polyprotein 1a; 1.
DR   FunFam; 2.40.10.10:FF:000033; Replicase polyprotein 1a; 1.
DR   FunFam; 3.40.50.11580:FF:000001; Replicase polyprotein 1ab; 1.
DR   Gene3D; 1.10.8.1190; -; 1.
DR   Gene3D; 2.60.120.1680; -; 1.
DR   Gene3D; 3.10.20.350; -; 1.
DR   Gene3D; 3.10.20.540; -; 1.
DR   Gene3D; 3.40.50.11580; -; 1.
DR   Gene3D; 6.10.140.2090; -; 1.
DR   Gene3D; 1.10.150.420; Coronavirus nonstructural protein 4 C-terminus; 1.
DR   Gene3D; 3.40.30.150; Coronavirus polyprotein cleavage domain; 1.
DR   Gene3D; 3.40.220.10; Leucine Aminopeptidase, subunit E, domain 1; 1.
DR   Gene3D; 1.10.1840.10; main proteinase (3clpro) structure, domain 3; 1.
DR   Gene3D; 3.30.160.820; Nsp15 N-terminal domain-like; 1.
DR   Gene3D; 3.40.220.20; Nsp3, SUD-M subdomain; 1.
DR   Gene3D; 3.40.220.30; Nsp3, SUD-N subdomain; 1.
DR   Gene3D; 1.10.8.370; nsp7 replicase; 1.
DR   Gene3D; 3.30.70.3540; Nsp8 replicase, head domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   Gene3D; 2.40.10.250; Replicase NSP9; 1.
DR   Gene3D; 3.40.50.11020; Replicase polyprotein, nucleic acid-binding domain; 1.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR027351; (+)RNA_virus_helicase_core_dom.
DR   InterPro; IPR046443; a/bCoV_NSP1_glob.
DR   InterPro; IPR046440; AV_NSP11N_COV_NSP15M.
DR   InterPro; IPR046442; bCoV_NSP1_C.
DR   InterPro; IPR050534; Coronavir_polyprotein_1ab.
DR   InterPro; IPR043608; CoV_NSP15_M.
DR   InterPro; IPR043606; CoV_NSP15_N.
DR   InterPro; IPR043613; CoV_NSP2_C.
DR   InterPro; IPR047573; CoV_NSP2_M.
DR   InterPro; IPR049894; COV_NSP3_3ECTO.
DR   InterPro; IPR043611; CoV_NSP3_C.
DR   InterPro; IPR047566; CoV_NSP3_Y.
DR   InterPro; IPR032505; CoV_NSP4_C.
DR   InterPro; IPR043612; CoV_NSP4_N.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR041679; DNA2/NAM7-like_C.
DR   InterPro; IPR022733; DPUP_SUD_C_bCoV.
DR   InterPro; IPR037227; EndoU-like.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR044371; Macro_X_NSP3-like.
DR   InterPro; IPR046435; N7_MTase_CoV.
DR   InterPro; IPR043609; NendoU_nidovirus.
DR   InterPro; IPR044863; NIRAN.
DR   InterPro; IPR046438; NIV_2_O_MTASE.
DR   InterPro; IPR046436; NIV_EXON.
DR   InterPro; IPR036333; NSP10_sf_CoV.
DR   InterPro; IPR047570; NSP12_IF_CoV.
DR   InterPro; IPR044343; NSP13_1B_dom_CoV.
DR   InterPro; IPR048673; NSP13_stalk_CoV.
DR   InterPro; IPR048672; NSP13_ZBD_CoV.
DR   InterPro; IPR027352; NSP13_ZBD_CoV-like.
DR   InterPro; IPR044315; NSP14_betaCoV.
DR   InterPro; IPR009466; NSP14_CoV.
DR   InterPro; IPR044330; NSP15_alpha_betaCoV_N.
DR   InterPro; IPR044322; NSP15_M_alpha_beta_CoV.
DR   InterPro; IPR043174; NSP15_middle_sf.
DR   InterPro; IPR042515; NSP15_N_CoV.
DR   InterPro; IPR044401; NSP15_NendoU_CoV.
DR   InterPro; IPR009461; NSP16_CoV-like.
DR   InterPro; IPR021590; NSP1_glob_bCoV.
DR   InterPro; IPR038030; NSP1_glob_sf_bCoV.
DR   InterPro; IPR043615; NSP2_N_CoV.
DR   InterPro; IPR044389; NSP2_SARS-CoV-like.
DR   InterPro; IPR024375; NSP3_bCoV.
DR   InterPro; IPR047567; NSP3_G2M_bCoV.
DR   InterPro; IPR024358; NSP3_N_bCoV.
DR   InterPro; IPR032592; NSP3_NAB_bCoV.
DR   InterPro; IPR042570; NSP3_NAB_bCoV_sf.
DR   InterPro; IPR038166; NSP3_PL2pro_sf_bCoV.
DR   InterPro; IPR038400; NSP3_SUD-M_sf_bCoV.
DR   InterPro; IPR044864; NSP3_SUD-N_bCoV.
DR   InterPro; IPR044374; NSP3_SUD-N_SARS-CoV.
DR   InterPro; IPR043478; NSP3_SUD-N_sf_bCoV.
DR   InterPro; IPR044357; NSP3_Ubl1_dom_CoV.
DR   InterPro; IPR044353; Nsp3_Ubl2_dom_CoV.
DR   InterPro; IPR038083; NSP3A-like.
DR   InterPro; IPR038123; NSP4_C_sf_CoV.
DR   InterPro; IPR044367; NSP6_betaCoV.
DR   InterPro; IPR043610; NSP6_CoV.
DR   InterPro; IPR014828; NSP7_CoV.
DR   InterPro; IPR037204; NSP7_sf_CoV.
DR   InterPro; IPR014829; NSP8_CoV.
DR   InterPro; IPR037230; NSP8_sf_CoV.
DR   InterPro; IPR014822; NSP9_CoV.
DR   InterPro; IPR036499; NSP9_sf_CoV.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR013016; Peptidase_C16_CoV.
DR   InterPro; IPR008740; Peptidase_C30_CoV.
DR   InterPro; IPR043477; Peptidase_C30_dom3_CoV.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR043177; PLpro_N_sf_CoV.
DR   InterPro; IPR043503; PLpro_palm_finger_dom_CoV.
DR   InterPro; IPR043178; PLpro_thumb_sf_CoV.
DR   InterPro; IPR046441; RdRp_CoV.
DR   InterPro; IPR009469; RdRp_N_CoV.
DR   InterPro; IPR044351; RdRp_SARS-CoV-like.
DR   InterPro; IPR001205; RNA-dir_pol_C.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR018995; RNA_synth_NSP10_CoV.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR43788; DNA2/NAM7 HELICASE FAMILY MEMBER; 1.
DR   PANTHER; PTHR43788:SF16; HELICASE WITH ZINC FINGER 2; 1.
DR   Pfam; PF13087; AAA_12; 1.
DR   Pfam; PF16251; bCoV_NAB; 1.
DR   Pfam; PF11501; bCoV_NSP1; 1.
DR   Pfam; PF12379; bCoV_NSP3_N; 1.
DR   Pfam; PF12124; bCoV_SUD_C; 1.
DR   Pfam; PF11633; bCoV_SUD_M; 1.
DR   Pfam; PF06471; CoV_ExoN; 1.
DR   Pfam; PF06460; CoV_Methyltr_2; 1.
DR   Pfam; PF09401; CoV_NSP10; 1.
DR   Pfam; PF20631; CoV_NSP13_1B; 1.
DR   Pfam; PF20633; CoV_NSP13_stalk; 1.
DR   Pfam; PF20632; CoV_NSP13_ZBD; 1.
DR   Pfam; PF19215; CoV_NSP15_C; 1.
DR   Pfam; PF19216; CoV_NSP15_M; 1.
DR   Pfam; PF19219; CoV_NSP15_N; 1.
DR   Pfam; PF19212; CoV_NSP2_C; 1.
DR   Pfam; PF19211; CoV_NSP2_N; 1.
DR   Pfam; PF19218; CoV_NSP3_C; 1.
DR   Pfam; PF16348; CoV_NSP4_C; 1.
DR   Pfam; PF19217; CoV_NSP4_N; 1.
DR   Pfam; PF19213; CoV_NSP6; 1.
DR   Pfam; PF08716; CoV_NSP7; 1.
DR   Pfam; PF08717; CoV_NSP8; 1.
DR   Pfam; PF08710; CoV_NSP9; 1.
DR   Pfam; PF08715; CoV_peptidase; 1.
DR   Pfam; PF06478; CoV_RPol_N; 1.
DR   Pfam; PF01661; Macro; 1.
DR   Pfam; PF05409; Peptidase_C30; 1.
DR   Pfam; PF00680; RdRP_1; 1.
DR   SMART; SM00506; A1pp; 1.
DR   SUPFAM; SSF144246; Coronavirus NSP10-like; 1.
DR   SUPFAM; SSF140367; Coronavirus NSP7-like; 1.
DR   SUPFAM; SSF143076; Coronavirus NSP8-like; 1.
DR   SUPFAM; SSF56672; DNA/RNA polymerases; 1.
DR   SUPFAM; SSF142877; EndoU-like; 1.
DR   SUPFAM; SSF52949; Macro domain-like; 1.
DR   SUPFAM; SSF159936; NSP3A-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF101816; Replicase NSP9; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   SUPFAM; SSF160099; SARS Nsp1-like; 1.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS51961; AV_NSP11N_COV_NSP15M; 1.
DR   PROSITE; PS51963; BCOV_NSP1_C; 1.
DR   PROSITE; PS51942; BCOV_NSP3C_C; 1.
DR   PROSITE; PS51941; BCOV_NSP3C_M; 1.
DR   PROSITE; PS51994; BCOV_NSP3E_G2M; 1.
DR   PROSITE; PS51945; BCOV_NSP3E_NAB; 1.
DR   PROSITE; PS51993; COV_3ECTO; 1.
DR   PROSITE; PS51952; COV_EXON_MTASE_COACT; 1.
DR   PROSITE; PS51954; COV_N7_MTASE; 1.
DR   PROSITE; PS51962; COV_NSP1; 1.
DR   PROSITE; PS52000; COV_NSP12_IF; 1.
DR   PROSITE; PS51948; COV_NSP12_RDRP; 1.
DR   PROSITE; PS51960; COV_NSP15_NTD; 1.
DR   PROSITE; PS51991; COV_NSP2_C; 1.
DR   PROSITE; PS51990; COV_NSP2_M; 1.
DR   PROSITE; PS51989; COV_NSP2_N; 1.
DR   P",52909
ACCAAA CCAAAA CAAAAT AAAATA AAATAA AATAAT ATAATA TAATAG AATAGG ATAGGG TAGGGC AGGGCT GGGCTC GGCTCG GCTCGA CTCGAT TCGATC CGATCA GATCAA ATCAAA TCAAAA CAAAAC AAAACA AAACAA AACAAC ACAACG CAACGG AACGGC ACGGCG CGGCGG GGCGGC GCGGCT CGGCTC GGCTCC GCTCCG CTCCGA TCCGAG CCGAGG CGAGGG GAGGGA AGGGAT GGGATA GGATAC GATACC ATACCC TACCCA ACCCAA CCCAAT CCAATA CAATAA AATAAT ATAATG TAATGC AATGCT ATGCTG TGCTGC GCTGCG CTGCGA TGCGAC GCGACT CGACTT GACTTG ACTTGG CTTGGT TTGGTT TGGTTC GGTTCA GTTCAC TTCACC TCACCG CACCGG ACCGGT CCGGTC CGGTCA GGTCAC GTCACG TCACGC CACGCA ACGCAC CGCACA GCACAA CACAAC ACAACA CAACAG AACAGA ACAGAG CAGAGC AGAGCA GAGCAA AGCAAG GCAAGG CAAGGA AAGGAA AGGAAG GGAAGA GAAGAC AAGACA AGACAT GACATT ACATTA CATTAA ATTAAA TTAAAT TAAATT AAATTC AATTCC ATTCCC TTCCCT TCCCTC CCCTCG CCTCGG CTCGGG TCGGGG CGGGGA GGGGAC GGGACA GGACAA GACAAA ACAAAG CAAAGG AAAGGG AAGGGT AGGGTG GGGTGC GGTGCC GTGCCG TGCCGA GCCGAT CCGATT CGATTA GATTAA ATTAAC TTAACG TAACGC AACGCC ACGCCA CGCCAA GCCAAT CCAATA,1,139,ACCA CCAA CAAA AAAA AAAT AATA ATAA TAAT AATA ATAG TAGG AGGG GGGC GGCT GCTC CTCG TCGA CGAT GATC ATCA TCAA CAAA AAAA AAAC AACA ACAA CAAC AACG ACGG CGGC GGCG GCGG CGGC GGCT GCTC CTCC TCCG CCGA CGAG GAGG AGGG GGGA GGAT GATA ATAC TACC ACCC CCCA CCAA CAAT AATA ATAA TAAT AATG ATGC TGCT GCTG CTGC TGCG GCGA CGAC GACT ACTT CTTG TTGG TGGT GGTT GTTC TTCA TCAC CACC ACCG CCGG CGGT GGTC GTCA TCAC CACG ACGC CGCA GCAC CACA ACAA CAAC AACA ACAG CAGA AGAG GAGC AGCA GCAA CAAG AAGG AGGA GGAA GAAG AAGA AGAC GACA ACAT CATT ATTA TTAA TAAA AAAT AATT ATTC TTCC TCCC CCCT CCTC CTCG TCGG CGGG GGGG GGGA GGAC GACA ACAA CAAA AAAG AAGG AGGG GGGT GGTG GTGC TGCC GCCG CCGA CGAT GATT ATTA TTAA TAAC AACG ACGC CGCC GCCA CCAA CAAT AATA,ACCAA CCAAA CAAAA AAAAT AAATA AATAA ATAAT TAATA AATAG ATAGG TAGGG AGGGC GGGCT GGCTC GCTCG CTCGA TCGAT CGATC GATCA ATCAA TCAAA CAAAA AAAAC AAACA AACAA ACAAC CAACG AACGG ACGGC CGGCG GGCGG GCGGC CGGCT GGCTC GCTCC CTCCG TCCGA CCGAG CGAGG GAGGG AGGGA GGGAT GGATA GATAC ATACC TACCC ACCCA CCCAA CCAAT CAATA AATAA ATAAT TAATG AATGC ATGCT TGCTG GCTGC CTGCG TGCGA GCGAC CGACT GACTT ACTTG CTTGG TTGGT TGGTT GGTTC GTTCA TTCAC TCACC CACCG ACCGG CCGGT CGGTC GGTCA GTCAC TCACG CACGC ACGCA CGCAC GCACA CACAA ACAAC CAACA AACAG ACAGA CAGAG AGAGC GAGCA AGCAA GCAAG CAAGG AAGGA AGGAA GGAAG GAAGA AAGAC AGACA GACAT ACATT CATTA ATTAA TTAAA TAAAT AAATT AATTC ATTCC TTCCC TCCCT CCCTC CCTCG CTCGG TCGGG CGGGG GGGGA GGGAC GGACA GACAA ACAAA CAAAG AAAGG AAGGG AGGGT GGGTG GGTGC GTGCC TGCCG GCCGA CCGAT CGATT GATTA ATTAA TTAAC TAACG AACGC ACGCC CGCCA GCCAA CCAAT CAATA,ACCAAA CCAAAA CAAAAT AAAATA AAATAA AATAAT ATAATA TAATAG AATAGG ATAGGG TAGGGC AGGGCT GGGCTC GGCTCG GCTCGA CTCGAT TCGATC CGATCA GATCAA ATCAAA TCAAAA CAAAAC AAAACA AAACAA AACAAC ACAACG CAACGG AACGGC ACGGCG CGGCGG GGCGGC GCGGCT CGGCTC GGCTCC GCTCCG CTCCGA TCCGAG CCGAGG CGAGGG GAGGGA AGGGAT GGGATA GGATAC GATACC ATACCC TACCCA ACCCAA CCCAAT CCAATA CAATAA AATAAT ATAATG TAATGC AATGCT ATGCTG TGCTGC GCTGCG CTGCGA TGCGAC GCGACT CGACTT GACTTG ACTTGG CTTGGT TTGGTT TGGTTC GGTTCA GTTCAC TTCACC TCACCG CACCGG ACCGGT CCGGTC CGGTCA GGTCAC GTCACG TCACGC CACGCA ACGCAC CGCACA GCACAA CACAAC ACAACA CAACAG AACAGA ACAGAG CAGAGC AGAGCA GAGCAA AGCAAG GCAAGG CAAGGA AAGGAA AGGAAG GGAAGA GAAGAC AAGACA AGACAT GACATT ACATTA CATTAA ATTAAA TTAAAT TAAATT AAATTC AATTCC ATTCCC TTCCCT TCCCTC CCCTCG CCTCGG CTCGGG TCGGGG CGGGGA GGGGAC GGGACA GGACAA GACAAA ACAAAG CAAAGG AAAGGG AAGGGT AGGGTG GGGTGC GGTGCC GTGCCG TGCCGA GCCGAT CCGATT CGATTA GATTAA ATTAAC TTAACG TAACGC AACGCC ACGCCA CGCCAA GCCAAT CCAATA,ACCAAAA CCAAAAT CAAAATA AAAATAA AAATAAT AATAATA ATAATAG TAATAGG AATAGGG ATAGGGC TAGGGCT AGGGCTC GGGCTCG GGCTCGA GCTCGAT CTCGATC TCGATCA CGATCAA GATCAAA ATCAAAA TCAAAAC CAAAACA AAAACAA AAACAAC AACAACG ACAACGG CAACGGC AACGGCG ACGGCGG CGGCGGC GGCGGCT GCGGCTC CGGCTCC GGCTCCG GCTCCGA CTCCGAG TCCGAGG CCGAGGG CGAGGGA GAGGGAT AGGGATA GGGATAC GGATACC GATACCC ATACCCA TACCCAA ACCCAAT CCCAATA CCAATAA CAATAAT AATAATG ATAATGC TAATGCT AATGCTG ATGCTGC TGCTGCG GCTGCGA CTGCGAC TGCGACT GCGACTT CGACTTG GACTTGG ACTTGGT CTTGGTT TTGGTTC TGGTTCA GGTTCAC GTTCACC TTCACCG TCACCGG CACCGGT ACCGGTC CCGGTCA CGGTCAC GGTCACG GTCACGC TCACGCA CACGCAC ACGCACA CGCACAA GCACAAC CACAACA ACAACAG CAACAGA AACAGAG ACAGAGC CAGAGCA AGAGCAA GAGCAAG AGCAAGG GCAAGGA CAAGGAA AAGGAAG AGGAAGA GGAAGAC GAAGACA AAGACAT AGACATT GACATTA ACATTAA CATTAAA ATTAAAT TTAAATT TAAATTC AAATTCC AATTCCC ATTCCCT TTCCCTC TCCCTCG CCCTCGG CCTCGGG CTCGGGG TCGGGGA CGGGGAC GGGGACA GGGACAA GGACAAA GACAAAG ACAAAGG CAAAGGG AAAGGGT AAGGGTG AGGGTGC GGGTGCC GGTGCCG GTGCCGA TGCCGAT GCCGATT CCGATTA CGATTAA GATTAAC ATTAACG TTAACGC TAACGCC AACGCCA ACGCCAA CGCCAAT GCCAATA,"ID   ORF9B_SARS2             Reviewed;          97 AA.
AC   P0DTD2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   27-NOV-2024, entry version 24.
DE   RecName: Full=ORF9b protein;
DE            Short=ORF9b;
DE   AltName: Full=Accessory protein 9b;
DE   AltName: Full=ORF-9b;
DE   AltName: Full=Protein 9b;
GN   ORFNames=9b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.05 ANGSTROMS), INTERACTION WITH HUMAN
RP   TOMM70, AND SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH HOST TOMM70.
RX   PubMed=32728199; DOI=10.1038/s41423-020-0514-8;
RA   Jiang H.W., Zhang H.N., Meng Q.F., Xie J., Li Y., Chen H., Zheng Y.X.,
RA   Wang X.N., Qi H., Zhang J., Wang P.H., Han Z.G., Tao S.C.;
RT   ""SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting
RT   TOM70."";
RL   Cell. Mol. Immunol. 17:998-1000(2020).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF SER-53, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   HOST TOMM70.
RX   PubMed=34502139; DOI=10.3390/ijms22179233;
RA   Brandherm L., Kobas A.M., Kloehn M., Brueggemann Y., Pfaender S.,
RA   Rassow J., Kreimendahl S.;
RT   ""Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding
RT   Sites in TOM70 and Recruitment of Hsp90."";
RL   Int. J. Mol. Sci. 22:0-0(2021).
RN   [5] {ECO:0007744|PDB:6Z4U}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS), AND HOMODIMERIZATION.
RA   Weeks S.D., De Graef S., Munawar A.;
RT   ""X-ray Crystallographic Structure of Orf9b from SARS-CoV-2."";
RL   Submitted (MAY-2020) to the PDB data bank.
RN   [6]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.20 ANGSTROMS) OF 1-97, AND INTERACTION
RP   WITH HOST TOMM70.
RX   PubMed=33990585; DOI=10.1038/s41467-021-23118-8;
RA   Gao X., Zhu K., Qin B., Olieric V., Wang M., Cui S.;
RT   ""Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests
RT   unusual virus-host interactions."";
RL   Nat. Commun. 12:2843-2843(2021).
CC   -!- FUNCTION: Plays a role in inhibiting the host innate immune response by
CC       targeting the mitochondrial-associated innate immune response. Acts by
CC       binding to host TOMM70, inhibiting its binding to HSP90AB1 thereby
CC       disrupting the interferon activation pathway.
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:34502139}.
CC   -!- SUBUNIT: Homodimer (Ref.5). Interacts with host TOMM70
CC       (PubMed:33060197, PubMed:32728199, PubMed:34502139, PubMed:33990585);
CC       the interaction occurs only with monomer (PubMed:33990585).
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:33060197,
CC       ECO:0000269|PubMed:33990585, ECO:0000269|PubMed:34502139,
CC       ECO:0000269|Ref.5}.
CC   -!- INTERACTION:
CC       P0DTD2; P0DTD2: 9b; NbExp=5; IntAct=EBI-25475909, EBI-25475909;
CC       P0DTD2; Q9Y6K9: IKBKG; Xeno; NbExp=3; IntAct=EBI-25475909, EBI-81279;
CC       P0DTD2; O94826: TOMM70; Xeno; NbExp=28; IntAct=EBI-25475909, EBI-2800236;
CC   -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34502139}. Host
CC       mitochondrion {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- MISCELLANEOUS: The open reading frame (ORF) encoding for this protein
CC       overlaps with the N ORF. {ECO:0000269|PubMed:32015508}.
CC   -!- SIMILARITY: Belongs to the coronavirus group 2 protein 9b family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   PDB; 6Z4U; X-ray; 1.95 A; A/B=1-97.
DR   PDB; 7DHG; X-ray; 2.20 A; B=1-97.
DR   PDB; 7KDT; EM; 3.05 A; B=1-97.
DR   PDB; 7YE7; X-ray; 2.95 A; A/B/C/D=1-97.
DR   PDB; 7YE8; X-ray; 3.01 A; A/B/C/D=1-97.
DR   PDBsum; 6Z4U; -.
DR   PDBsum; 7DHG; -.
DR   PDBsum; 7KDT; -.
DR   PDBsum; 7YE7; -.
DR   PDBsum; 7YE8; -.
DR   EMDB; EMD-22829; -.
DR   SMR; P0DTD2; -.
DR   BioGRID; 4383874; 613.
DR   ComplexPortal; CPX-6100; SARS-CoV-2 9b complex.
DR   IntAct; P0DTD2; 94.
DR   MINT; P0DTD2; -.
DR   iPTMnet; P0DTD2; -.
DR   AGR; RefSeq:P0DTD2; -.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9727281; Translation of Accessory Proteins.
DR   PRO; PR:P0DTD2; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0033650; C:host cell mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProt.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:ComplexPortal.
DR   GO; GO:0098799; C:outer mitochondrial membrane protein complex; ISO:ComplexPortal.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; IDA:ComplexPortal.
DR   GO; GO:0090258; P:negative regulation of mitochondrial fission; ISO:ComplexPortal.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; ISO:ComplexPortal.
DR   GO; GO:0039545; P:symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity; IDA:UniProt.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21955; SARS-CoV_ORF9b; 1.
DR   InterPro; IPR018542; Protein_9b_Betacoronavirus.
DR   InterPro; IPR037223; Protein_9b_SARS.
DR   Pfam; PF09399; bCoV_lipid_BD; 1.
DR   SUPFAM; SSF141666; SARS ORF9b-like; 1.
DR   PROSITE; PS51920; SARS_9B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Host cytoplasm; Host mitochondrion; Host-virus interaction;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host MAVS by virus; Inhibition of host RLR pathway by virus;
KW   Reference proteome; Viral immunoevasion.
FT   CHAIN           1..97
FT                   /note=""ORF9b protein""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT                   /id=""PRO_0000449657""
FT   DOMAIN          8..97
FT                   /note=""9b""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01268""
FT   MOTIF           45..53
FT                   /note=""Nuclear export signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT   VARIANT         10
FT                   /note=""P -> S (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         27..29
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         60
FT                   /note=""T -> A (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         77
FT                   /note=""Q -> E (in strain: Gamma/P.1)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         53
FT                   /note=""S->E: Complete loss of binding to host TOMM70.""
FT                   /evidence=""ECO:0000269|PubMed:34502139""
FT   HELIX           5..7
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          12..15
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          19..23
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          40..42
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          44..50
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          52..61
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          64..66
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          68..74
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          78..80
FT                   /evidence=""ECO:0007829|PDB:7YE7""
FT   HELIX           84..86
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          89..96
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
SQ   SEQUENCE   97 AA;  10797 MW;  62CFB65C1804545E CRC64;
     MDPKISEMHP ALRLVDPQIQ LAVTRMENAV GRDQNNVGPK VYPIILRLGS PLSLNMARKT
     LNSLEDKAFQ LTPIAVQMTK LATTEELPDE FVVVTVK
//
",12344
CTGCAG TGCAGG GCAGGG CAGGGC AGGGCG GGGCGA GGCGAA GCGAAG CGAAGC GAAGCC AAGCCG AGCCGA GCCGAT CCGATG CGATGT GATGTG ATGTGG TGTGGC GTGGCC TGGCCT GGCCTC GCCTCG CCTCGG CTCGGC TCGGCC CGGCCA GGCCAA GCCAAG CCAAGG CAAGGC AAGGCC AGGCCG GGCCGC GCCGCA CCGCAC CGCACT GCACTG CACTGC ACTGCA CTGCAA TGCAAA GCAAAC CAAACC AAACCG AACCGC ACCGCC CCGCCA CGCCAA GCCAAG CCAAGA CAAGAT AAGATT AGATTA GATTAA ATTAAC TTAACC TAACCT AACCTC ACCTCG CCTCGA CTCGAC TCGACT CGACTA GACTAC ACTACA CTACAC TACACG ACACGC CACGCG ACGCGC CGCGCA GCGCAT CGCATC GCATCG CATCGT ATCGTT TCGTTG CGTTGC GTTGCC TTGCCC TGCCCC GCCCCC CCCCCA CCCCAT CCCATC CCATCA CATCAG ATCAGC TCAGCG CAGCGG AGCGGG GCGGGC CGGGCG GGGCGC GGCGCA GCGCAT CGCATC GCATCG CATCGG ATCGGC TCGGCA CGGCAA GGCAAG GCAAGT CAAGTC AAGTCG AGTCGG GTCGGC TCGGCG CGGCGG GGCGGT GCGGTG CGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTG CGGTGG GGTGGG GTGGGC TGGGCG GGGCGC GGCGCG GCGCGT CGCGTT GCGTTG CGTTGG GTTGGT TTGGTT TGGTTA GGTTAC GTTACC TTACCG TACCGC ACCGCC CCGCCA CGCCAA GCCAAC CCAACC CAACCA AACCAG,2,142,CTGC TGCA GCAG CAGG AGGG GGGC GGCG GCGA CGAA GAAG AAGC AGCC GCCG CCGA CGAT GATG ATGT TGTG GTGG TGGC GGCC GCCT CCTC CTCG TCGG CGGC GGCC GCCA CCAA CAAG AAGG AGGC GGCC GCCG CCGC CGCA GCAC CACT ACTG CTGC TGCA GCAA CAAA AAAC AACC ACCG CCGC CGCC GCCA CCAA CAAG AAGA AGAT GATT ATTA TTAA TAAC AACC ACCT CCTC CTCG TCGA CGAC GACT ACTA CTAC TACA ACAC CACG ACGC CGCG GCGC CGCA GCAT CATC ATCG TCGT CGTT GTTG TTGC TGCC GCCC CCCC CCCC CCCA CCAT CATC ATCA TCAG CAGC AGCG GCGG CGGG GGGC GGCG GCGC CGCA GCAT CATC ATCG TCGG CGGC GGCA GCAA CAAG AAGT AGTC GTCG TCGG CGGC GGCG GCGG CGGT GGTG GTGA TGAC GACG ACGG CGGT GGTG GTGG TGGG GGGC GGCG GCGC CGCG GCGT CGTT GTTG TTGG TGGT GGTT GTTA TTAC TACC ACCG CCGC CGCC GCCA CCAA CAAC AACC ACCA CCAG,CTGCA TGCAG GCAGG CAGGG AGGGC GGGCG GGCGA GCGAA CGAAG GAAGC AAGCC AGCCG GCCGA CCGAT CGATG GATGT ATGTG TGTGG GTGGC TGGCC GGCCT GCCTC CCTCG CTCGG TCGGC CGGCC GGCCA GCCAA CCAAG CAAGG AAGGC AGGCC GGCCG GCCGC CCGCA CGCAC GCACT CACTG ACTGC CTGCA TGCAA GCAAA CAAAC AAACC AACCG ACCGC CCGCC CGCCA GCCAA CCAAG CAAGA AAGAT AGATT GATTA ATTAA TTAAC TAACC AACCT ACCTC CCTCG CTCGA TCGAC CGACT GACTA ACTAC CTACA TACAC ACACG CACGC ACGCG CGCGC GCGCA CGCAT GCATC CATCG ATCGT TCGTT CGTTG GTTGC TTGCC TGCCC GCCCC CCCCC CCCCA CCCAT CCATC CATCA ATCAG TCAGC CAGCG AGCGG GCGGG CGGGC GGGCG GGCGC GCGCA CGCAT GCATC CATCG ATCGG TCGGC CGGCA GGCAA GCAAG CAAGT AAGTC AGTCG GTCGG TCGGC CGGCG GGCGG GCGGT CGGTG GGTGA GTGAC TGACG GACGG ACGGT CGGTG GGTGG GTGGG TGGGC GGGCG GGCGC GCGCG CGCGT GCGTT CGTTG GTTGG TTGGT TGGTT GGTTA GTTAC TTACC TACCG ACCGC CCGCC CGCCA GCCAA CCAAC CAACC AACCA ACCAG,CTGCAG TGCAGG GCAGGG CAGGGC AGGGCG GGGCGA GGCGAA GCGAAG CGAAGC GAAGCC AAGCCG AGCCGA GCCGAT CCGATG CGATGT GATGTG ATGTGG TGTGGC GTGGCC TGGCCT GGCCTC GCCTCG CCTCGG CTCGGC TCGGCC CGGCCA GGCCAA GCCAAG CCAAGG CAAGGC AAGGCC AGGCCG GGCCGC GCCGCA CCGCAC CGCACT GCACTG CACTGC ACTGCA CTGCAA TGCAAA GCAAAC CAAACC AAACCG AACCGC ACCGCC CCGCCA CGCCAA GCCAAG CCAAGA CAAGAT AAGATT AGATTA GATTAA ATTAAC TTAACC TAACCT AACCTC ACCTCG CCTCGA CTCGAC TCGACT CGACTA GACTAC ACTACA CTACAC TACACG ACACGC CACGCG ACGCGC CGCGCA GCGCAT CGCATC GCATCG CATCGT ATCGTT TCGTTG CGTTGC GTTGCC TTGCCC TGCCCC GCCCCC CCCCCA CCCCAT CCCATC CCATCA CATCAG ATCAGC TCAGCG CAGCGG AGCGGG GCGGGC CGGGCG GGGCGC GGCGCA GCGCAT CGCATC GCATCG CATCGG ATCGGC TCGGCA CGGCAA GGCAAG GCAAGT CAAGTC AAGTCG AGTCGG GTCGGC TCGGCG CGGCGG GGCGGT GCGGTG CGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTG CGGTGG GGTGGG GTGGGC TGGGCG GGGCGC GGCGCG GCGCGT CGCGTT GCGTTG CGTTGG GTTGGT TTGGTT TGGTTA GGTTAC GTTACC TTACCG TACCGC ACCGCC CCGCCA CGCCAA GCCAAC CCAACC CAACCA AACCAG,CTGCAGG TGCAGGG GCAGGGC CAGGGCG AGGGCGA GGGCGAA GGCGAAG GCGAAGC CGAAGCC GAAGCCG AAGCCGA AGCCGAT GCCGATG CCGATGT CGATGTG GATGTGG ATGTGGC TGTGGCC GTGGCCT TGGCCTC GGCCTCG GCCTCGG CCTCGGC CTCGGCC TCGGCCA CGGCCAA GGCCAAG GCCAAGG CCAAGGC CAAGGCC AAGGCCG AGGCCGC GGCCGCA GCCGCAC CCGCACT CGCACTG GCACTGC CACTGCA ACTGCAA CTGCAAA TGCAAAC GCAAACC CAAACCG AAACCGC AACCGCC ACCGCCA CCGCCAA CGCCAAG GCCAAGA CCAAGAT CAAGATT AAGATTA AGATTAA GATTAAC ATTAACC TTAACCT TAACCTC AACCTCG ACCTCGA CCTCGAC CTCGACT TCGACTA CGACTAC GACTACA ACTACAC CTACACG TACACGC ACACGCG CACGCGC ACGCGCA CGCGCAT GCGCATC CGCATCG GCATCGT CATCGTT ATCGTTG TCGTTGC CGTTGCC GTTGCCC TTGCCCC TGCCCCC GCCCCCA CCCCCAT CCCCATC CCCATCA CCATCAG CATCAGC ATCAGCG TCAGCGG CAGCGGG AGCGGGC GCGGGCG CGGGCGC GGGCGCA GGCGCAT GCGCATC CGCATCG GCATCGG CATCGGC ATCGGCA TCGGCAA CGGCAAG GGCAAGT GCAAGTC CAAGTCG AAGTCGG AGTCGGC GTCGGCG TCGGCGG CGGCGGT GGCGGTG GCGGTGA CGGTGAC GGTGACG GTGACGG TGACGGT GACGGTG ACGGTGG CGGTGGG GGTGGGC GTGGGCG TGGGCGC GGGCGCG GGCGCGT GCGCGTT CGCGTTG GCGTTGG CGTTGGT GTTGGTT TTGGTTA TGGTTAC GGTTACC GTTACCG TTACCGC TACCGCC ACCGCCA CCGCCAA CGCCAAC GCCAACC CCAACCA CAACCAG,"ID   ACRE_ECOLI              Reviewed;         385 AA.
AC   P24180; Q2M8V0;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 2.
DT   05-FEB-2025, entry version 163.
DE   RecName: Full=Multidrug export protein AcrE;
DE   AltName: Full=Acriflavine resistance protein E;
DE   AltName: Full=Protein EnvC;
DE   Flags: Precursor;
GN   Name=acrE; Synonyms=envC; OrderedLocusNames=b3265, JW3233;
OS   Escherichia coli (strain K12).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Xu J., Bertrand K.P.;
RT   ""Nucleotide sequence of the acrEF operon from Escherichia coli."";
RL   Submitted (MAY-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1720861; DOI=10.1007/bf00290673;
RA   Klein J.R., Henrich B., Plapp R.;
RT   ""Molecular analysis and nucleotide sequence of the envCD operon of
RT   Escherichia coli."";
RL   Mol. Gen. Genet. 230:230-240(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   ""The complete genome sequence of Escherichia coli K-12."";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   ""Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110."";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-96.
RC   STRAIN=K12;
RA   Klein J.R., Henrich B., Plapp R.;
RT   ""Molecular cloning of the envC gene of Escherichia coli."";
RL   Curr. Microbiol. 21:341-347(1990).
RN   [6]
RP   PROTEIN SEQUENCE OF 291-299, FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11274125; DOI=10.1128/jb.183.8.2646-2653.2001;
RA   Kobayashi K., Tsukagoshi N., Aono R.;
RT   ""Suppression of hypersensitivity of Escherichia coli acrB mutant to organic
RT   solvents by integrational activation of the acrEF operon with the IS1 or
RT   IS2 element."";
RL   J. Bacteriol. 183:2646-2653(2001).
RN   [7]
RP   FUNCTION.
RC   STRAIN=K12;
RX   PubMed=10518736; DOI=10.1111/j.1574-6968.1999.tb08748.x;
RA   Kawamura-Sato K., Shibayama K., Horii T., Iimuma Y., Arakawa Y., Ohta M.;
RT   ""Role of multiple efflux pumps in Escherichia coli in indole expulsion."";
RL   FEMS Microbiol. Lett. 179:345-352(1999).
RN   [8]
RP   OPERON STRUCTURE, AND INDUCTION.
RC   STRAIN=K12 / BW25113;
RX   PubMed=19429622; DOI=10.1128/jb.00108-09;
RA   Shimada T., Yamamoto K., Ishihama A.;
RT   ""Involvement of the leucine response transcription factor LeuO in
RT   regulation of the genes for sulfa drug efflux."";
RL   J. Bacteriol. 191:4562-4571(2009).
CC   -!- FUNCTION: Part of the tripartite efflux system AcrEF-TolC. Involved in
CC       the efflux of indole and organic solvents.
CC       {ECO:0000269|PubMed:10518736, ECO:0000269|PubMed:11274125}.
CC   -!- SUBUNIT: Part of the tripartite efflux system AcrEF-TolC, which is
CC       composed of an inner membrane transporter, AcrF, a periplasmic membrane
CC       fusion protein, AcrE, and an outer membrane component, TolC. The
CC       complex forms a large protein conduit and can translocate molecules
CC       across both the inner and outer membranes (Probable).
CC       {ECO:0000305|PubMed:11274125}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000305|PubMed:11274125}; Lipid-anchor
CC       {ECO:0000305|PubMed:11274125}.
CC   -!- INDUCTION: Induced by LeuO, part of the acrEF operon.
CC       {ECO:0000269|PubMed:19429622}.
CC   -!- SIMILARITY: Belongs to the membrane fusion protein (MFP) (TC 8.A.1)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M96848; AAA02931.1; -; Unassigned_DNA.
DR   EMBL; X57948; CAA41016.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA58069.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76297.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77306.1; -; Genomic_DNA.
DR   PIR; C65119; C65119.
DR   RefSeq; NP_417731.1; NC_000913.3.
DR   RefSeq; WP_000160334.1; NZ_STEB01000012.1.
DR   AlphaFoldDB; P24180; -.
DR   SMR; P24180; -.
DR   BioGRID; 4261953; 367.
DR   ComplexPortal; CPX-4265; AcrEF-TolC multidrug efflux transport complex.
DR   STRING; 511145.b3265; -.
DR   PaxDb; 511145-b3265; -.
DR   EnsemblBacteria; AAC76297; AAC76297; b3265.
DR   GeneID; 75206113; -.
DR   GeneID; 947706; -.
DR   KEGG; ecj:JW3233; -.
DR   KEGG; eco:b3265; -.
DR   KEGG; ecoc:C3026_17760; -.
DR   PATRIC; fig|1411691.4.peg.3463; -.
DR   EchoBASE; EB0262; -.
DR   eggNOG; COG0845; Bacteria.
DR   HOGENOM; CLU_018816_2_1_6; -.
DR   InParanoid; P24180; -.
DR   OMA; PAKGVPW; -.
DR   OrthoDB; 9800613at2; -.
DR   PhylomeDB; P24180; -.
DR   BioCyc; EcoCyc:EG10266-MONOMER; -.
DR   BioCyc; MetaCyc:EG10266-MONOMER; -.
DR   PRO; PR:P24180; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:1990281; C:efflux pump complex; NAS:ComplexPortal.
DR   GO; GO:0098567; C:periplasmic side of plasma membrane; NAS:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0022857; F:transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0046677; P:response to antibiotic; IBA:GO_Central.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISS:EcoliWiki.
DR   GO; GO:0140330; P:xenobiotic detoxification by transmembrane export across the cell outer membrane; EXP:ComplexPortal.
DR   FunFam; 1.10.287.470:FF:000002; Efflux RND transporter periplasmic adaptor subunit; 1.
DR   FunFam; 2.40.420.20:FF:000001; Efflux RND transporter periplasmic adaptor subunit; 1.
DR   FunFam; 2.40.30.170:FF:000001; Multidrug resistance efflux transporter MdtE; 1.
DR   Gene3D; 2.40.30.170; -; 1.
DR   Gene3D; 2.40.420.20; -; 1.
DR   Gene3D; 2.40.50.100; -; 1.
DR   Gene3D; 1.10.287.470; Helix hairpin bin; 1.
DR   InterPro; IPR043602; CusB_dom_1.
DR   InterPro; IPR032317; HlyD_D23.
DR   InterPro; IPR051160; MFP_Efflux.
DR   InterPro; IPR006143; RND_pump_MFP.
DR   NCBIfam; TIGR01730; RND_mfp; 1.
DR   PANTHER; PTHR30158; ACRA/E-RELATED COMPONENT OF DRUG EFFLUX TRANSPORTER; 1.
DR   PANTHER; PTHR30158:SF21; MULTIDRUG EXPORT PROTEIN ACRE; 1.
DR   Pfam; PF00529; CusB_dom_1; 1.
DR   Pfam; PF16576; HlyD_D23; 1.
DR   SUPFAM; SSF111369; HlyD-like secretion proteins; 1.
DR   PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Direct protein sequencing; Lipoprotein;
KW   Membrane; Palmitate; Reference proteome; Signal; Transport.
FT   SIGNAL          1..23
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00303""
FT   CHAIN           24..385
FT                   /note=""Multidrug export protein AcrE""
FT                   /id=""PRO_0000018688""
FT   REGION          366..385
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        373..385
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   LIPID           24
FT                   /note=""N-palmitoyl cysteine""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00303""
FT   LIPID           24
FT                   /note=""S-diacylglycerol cysteine""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU00303""
FT   CONFLICT        191..212
FT                   /note=""GALVTNGQTTELATVQQLDPIY -> ALLSLMGKRLNWRLSSSSILST (in
FT                   Ref. 2)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        313..314
FT                   /note=""SR -> T (in Ref. 2)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   385 AA;  41318 MW;  EDBF82C853CF42A9 CRC64;
     MTKHARFFLL PSFILISAAL IAGCNDKGEE KAHVGEPQVT VHIVKTAPLE VKTELPGRTN
     AYRIAEVRPQ VSGIVLNRNF TEGSDVQAGQ SLYQIDPATY QANYDSAKGE LAKSEAAAAI
     AHLTVKRYVP LVGTKYISQQ EYDQAIADAR QADAAVIAAK ATVESARINL AYTKVTAPIS
     GRIGKSTVTE GALVTNGQTT ELATVQQLDP IYVDVTQSSN DFMRLKQSVE QGNLHKENAT
     SNVELVMENG QTYPLKGTLQ FSDVTVDEST GSITLRAVFP NPQHTLLPGM FVRARIDEGV
     QPDAILIPQQ GVSRTPRGDA TVLIVNDKSQ VEARPVVASQ AIGDKWLISE GLKSGDQVIV
     SGLQKARPGE QVKATTDTPA DTASK
//
",63846
CCGATC CGATCA GATCAA ATCAAT TCAATA CAATAC AATACA ATACAA TACAAT ACAATC CAATCC AATCCC ATCCCG TCCCGT CCCGTT CCGTTC CGTTCA GTTCAA TTCAAT TCAATA CAATAC AATACA ATACAG TACAGC ACAGCT CAGCTA AGCTAC GCTACC CTACCC TACCCC ACCCCA CCCCAA CCCAAA CCAAAC CAAACA AAACAG AACAGG ACAGGG CAGGGC AGGGCA GGGCAA GGCAAT GCAATG CAATGA AATGAA ATGAAT TGAATC GAATCC AATCCC ATCCCA TCCCAC CCCACG CCACGC CACGCC ACGCCG CGCCGG GCCGGC CCGGCA CGGCAG GGCAGA GCAGAA CAGAAA AGAAAT GAAATA AAATAC AATACT ATACTG TACTGA ACTGAA CTGAAA TGAAAG GAAAGG AAAGGC AAGGCA AGGCAT GGCATT GCATTC CATTCC ATTCCC TTCCCC TCCCCG CCCCGC CCCGCA CCGCAG CGCAGC GCAGCC CAGCCA AGCCAT GCCATA CCATAA CATAAA ATAAAG TAAAGA AAAGAT AAGATA AGATAT GATATC ATATCA TATCAC ATCACC TCACCC CACCCC ACCCCC CCCCCC CCCCCC CCCCCT CCCCTA CCCTAT CCTATG CTATGG TATGGC ATGGCA TGGCAG GGCAGA GCAGAT CAGATA AGATAA GATAAA ATAAAG TAAAGG AAAGGG AAGGGA AGGGAT GGGATT GGATTG GATTGC ATTGCG TTGCGG TGCGGA GCGGAA CGGAAA GGAAAA GAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAG ATCAGT TCAGTA CAGTAT AGTATA GTATAC TATACA ATACAA,2,145,CCGA CGAT GATC ATCA TCAA CAAT AATA ATAC TACA ACAA CAAT AATC ATCC TCCC CCCG CCGT CGTT GTTC TTCA TCAA CAAT AATA ATAC TACA ACAG CAGC AGCT GCTA CTAC TACC ACCC CCCC CCCA CCAA CAAA AAAC AACA ACAG CAGG AGGG GGGC GGCA GCAA CAAT AATG ATGA TGAA GAAT AATC ATCC TCCC CCCA CCAC CACG ACGC CGCC GCCG CCGG CGGC GGCA GCAG CAGA AGAA GAAA AAAT AATA ATAC TACT ACTG CTGA TGAA GAAA AAAG AAGG AGGC GGCA GCAT CATT ATTC TTCC TCCC CCCC CCCG CCGC CGCA GCAG CAGC AGCC GCCA CCAT CATA ATAA TAAA AAAG AAGA AGAT GATA ATAT TATC ATCA TCAC CACC ACCC CCCC CCCC CCCC CCCC CCCT CCTA CTAT TATG ATGG TGGC GGCA GCAG CAGA AGAT GATA ATAA TAAA AAAG AAGG AGGG GGGA GGAT GATT ATTG TTGC TGCG GCGG CGGA GGAA GAAA AAAA AAAG AAGA AGAT GATC ATCA TCAG CAGT AGTA GTAT TATA ATAC TACA ACAA,CCGAT CGATC GATCA ATCAA TCAAT CAATA AATAC ATACA TACAA ACAAT CAATC AATCC ATCCC TCCCG CCCGT CCGTT CGTTC GTTCA TTCAA TCAAT CAATA AATAC ATACA TACAG ACAGC CAGCT AGCTA GCTAC CTACC TACCC ACCCC CCCCA CCCAA CCAAA CAAAC AAACA AACAG ACAGG CAGGG AGGGC GGGCA GGCAA GCAAT CAATG AATGA ATGAA TGAAT GAATC AATCC ATCCC TCCCA CCCAC CCACG CACGC ACGCC CGCCG GCCGG CCGGC CGGCA GGCAG GCAGA CAGAA AGAAA GAAAT AAATA AATAC ATACT TACTG ACTGA CTGAA TGAAA GAAAG AAAGG AAGGC AGGCA GGCAT GCATT CATTC ATTCC TTCCC TCCCC CCCCG CCCGC CCGCA CGCAG GCAGC CAGCC AGCCA GCCAT CCATA CATAA ATAAA TAAAG AAAGA AAGAT AGATA GATAT ATATC TATCA ATCAC TCACC CACCC ACCCC CCCCC CCCCC CCCCC CCCCT CCCTA CCTAT CTATG TATGG ATGGC TGGCA GGCAG GCAGA CAGAT AGATA GATAA ATAAA TAAAG AAAGG AAGGG AGGGA GGGAT GGATT GATTG ATTGC TTGCG TGCGG GCGGA CGGAA GGAAA GAAAA AAAAG AAAGA AAGAT AGATC GATCA ATCAG TCAGT CAGTA AGTAT GTATA TATAC ATACA TACAA,CCGATC CGATCA GATCAA ATCAAT TCAATA CAATAC AATACA ATACAA TACAAT ACAATC CAATCC AATCCC ATCCCG TCCCGT CCCGTT CCGTTC CGTTCA GTTCAA TTCAAT TCAATA CAATAC AATACA ATACAG TACAGC ACAGCT CAGCTA AGCTAC GCTACC CTACCC TACCCC ACCCCA CCCCAA CCCAAA CCAAAC CAAACA AAACAG AACAGG ACAGGG CAGGGC AGGGCA GGGCAA GGCAAT GCAATG CAATGA AATGAA ATGAAT TGAATC GAATCC AATCCC ATCCCA TCCCAC CCCACG CCACGC CACGCC ACGCCG CGCCGG GCCGGC CCGGCA CGGCAG GGCAGA GCAGAA CAGAAA AGAAAT GAAATA AAATAC AATACT ATACTG TACTGA ACTGAA CTGAAA TGAAAG GAAAGG AAAGGC AAGGCA AGGCAT GGCATT GCATTC CATTCC ATTCCC TTCCCC TCCCCG CCCCGC CCCGCA CCGCAG CGCAGC GCAGCC CAGCCA AGCCAT GCCATA CCATAA CATAAA ATAAAG TAAAGA AAAGAT AAGATA AGATAT GATATC ATATCA TATCAC ATCACC TCACCC CACCCC ACCCCC CCCCCC CCCCCC CCCCCT CCCCTA CCCTAT CCTATG CTATGG TATGGC ATGGCA TGGCAG GGCAGA GCAGAT CAGATA AGATAA GATAAA ATAAAG TAAAGG AAAGGG AAGGGA AGGGAT GGGATT GGATTG GATTGC ATTGCG TTGCGG TGCGGA GCGGAA CGGAAA GGAAAA GAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAG ATCAGT TCAGTA CAGTAT AGTATA GTATAC TATACA ATACAA,CCGATCA CGATCAA GATCAAT ATCAATA TCAATAC CAATACA AATACAA ATACAAT TACAATC ACAATCC CAATCCC AATCCCG ATCCCGT TCCCGTT CCCGTTC CCGTTCA CGTTCAA GTTCAAT TTCAATA TCAATAC CAATACA AATACAG ATACAGC TACAGCT ACAGCTA CAGCTAC AGCTACC GCTACCC CTACCCC TACCCCA ACCCCAA CCCCAAA CCCAAAC CCAAACA CAAACAG AAACAGG AACAGGG ACAGGGC CAGGGCA AGGGCAA GGGCAAT GGCAATG GCAATGA CAATGAA AATGAAT ATGAATC TGAATCC GAATCCC AATCCCA ATCCCAC TCCCACG CCCACGC CCACGCC CACGCCG ACGCCGG CGCCGGC GCCGGCA CCGGCAG CGGCAGA GGCAGAA GCAGAAA CAGAAAT AGAAATA GAAATAC AAATACT AATACTG ATACTGA TACTGAA ACTGAAA CTGAAAG TGAAAGG GAAAGGC AAAGGCA AAGGCAT AGGCATT GGCATTC GCATTCC CATTCCC ATTCCCC TTCCCCG TCCCCGC CCCCGCA CCCGCAG CCGCAGC CGCAGCC GCAGCCA CAGCCAT AGCCATA GCCATAA CCATAAA CATAAAG ATAAAGA TAAAGAT AAAGATA AAGATAT AGATATC GATATCA ATATCAC TATCACC ATCACCC TCACCCC CACCCCC ACCCCCC CCCCCCC CCCCCCT CCCCCTA CCCCTAT CCCTATG CCTATGG CTATGGC TATGGCA ATGGCAG TGGCAGA GGCAGAT GCAGATA CAGATAA AGATAAA GATAAAG ATAAAGG TAAAGGG AAAGGGA AAGGGAT AGGGATT GGGATTG GGATTGC GATTGCG ATTGCGG TTGCGGA TGCGGAA GCGGAAA CGGAAAA GGAAAAG GAAAAGA AAAAGAT AAAGATC AAGATCA AGATCAG GATCAGT ATCAGTA TCAGTAT CAGTATA AGTATAC GTATACA TATACAA,"ID   HELA_LEGPN              Reviewed;        1052 AA.
AC   Q48815;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-FEB-2025, entry version 75.
DE   RecName: Full=Protein HelA;
GN   Name=helA;
OS   Legionella pneumophila.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Legionellales;
OC   Legionellaceae; Legionella.
OX   NCBI_TaxID=446;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8613357; DOI=10.1128/iai.64.5.1532-1540.1996;
RA   McClain M.S., Hurley M.C., Brieland J.K., Engleberg N.C.;
RT   ""The Legionella pneumophila hel locus encodes intracellularly induced
RT   homologs of heavy-metal ion transporters of Alcaligenes spp."";
RL   Infect. Immun. 64:1532-1540(1996).
CC   -!- FUNCTION: Presumed to function with HelC and HelB in efflux of an
CC       unidentified substrate.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the resistance-nodulation-cell division (RND)
CC       (TC 2.A.6) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49498; AAB05679.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q48815; -.
DR   SMR; Q48815; -.
DR   STRING; 91892.BIZ52_11460; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008324; F:monoatomic cation transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:TreeGrafter.
DR   Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR   Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR   Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR   Gene3D; 3.30.2090.10; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR   InterPro; IPR027463; AcrB_DN_DC_subdom.
DR   InterPro; IPR001036; Acrflvin-R.
DR   InterPro; IPR004763; CusA-like.
DR   NCBIfam; TIGR00914; 2A0601; 1.
DR   PANTHER; PTHR32063; -; 1.
DR   PANTHER; PTHR32063:SF24; CATION EFFLUX SYSTEM (ACRB_ACRD_ACRF FAMILY); 1.
DR   Pfam; PF00873; ACR_tran; 1.
DR   PRINTS; PR00702; ACRIFLAVINRP.
DR   SUPFAM; SSF82693; Multidrug efflux transporter AcrB pore domain, PN1, PN2, PC1 and PC2 subdomains; 3.
DR   SUPFAM; SSF82714; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Membrane; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1052
FT                   /note=""Protein HelA""
FT                   /id=""PRO_0000161820""
FT   TRANSMEM        14..34
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        121..141
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        348..368
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        369..389
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        393..413
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        450..470
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        483..503
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        537..557
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        878..898
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        903..923
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        934..954
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        979..999
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        1011..1031
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   1052 AA;  115821 MW;  5C97817D7B13EBCE CRC64;
     MLEKIIRFSL KHRWFVLLFT LVIAILGVYN FQRLPIDAVP DITNVQVQIN TQASGYSPFE
     VEQRITFPIE LAMSGLPSLD YTRSLSRYGL SQVTVVFKDG TNIYFARQLI NERLQEVKDK
     LPPGVETTLG PISTGLGEIF MYTVTNKPNV PISQHYNPTE LRTIQDWIIK PQLRNVEGVA
     EVNTIGGYEK QFHITPDPSK LVRYRLSLND VVEALERNNA NVGAGYIETN GEQNLIRVPG
     QVQNMADIEN IVIASFEGTP VRIRDVAEVA LGKELRTGAA TENSKEVVLG TVFILMGENS
     RTVSERVAAK MKDINKTLPE GVEAITVYNR TTLVNATINT VKNNLLEGAL LVCVILFLFL
     GNIRAALITA MVIPLSMLLT ITGMVENQIS ANLMSLGALD FGLIVDGAVI IVENCIKHLA
     EQQHALHRVL NLEERLKVIS YATTEVIRPS IFGVFIITVV YLPILTLTGV EGKMFLPMAQ
     TVIIALLASM LFALTFVPAA VAIFLRGHLQ EKENWLVHYL SLGYAKVLRR CFHARRVVIS
     AAVALVVVSL GIAFHLGGEF IPSLDEGDIA MHAMRIPGTS LTQAITMQDL VEKRIRQFSE
     VKNVFAKLGT AEVATDPMPP NVADTFIILK SRKKWTNPKK TKPGLVQEIE SAVQQIPGNN
     YEFTQPIQMR FNELISGVRS DVAVKVFGDD MDTLLKTAEA ISAQLKQVPG AADVKVEQVS
     GLPLLTVEIN RDVLARYGLQ IGTVQEAVVI ATGGKKGGEL FEGDKRFDIV VRLPESLRSD
     PNVLRQIFIP LPLSKDGEQH FIPLSEVASL IRSESPNQIS RENGKRRVVV TANVRNRDLS
     SFVSEAKKRI DGQVKLPSGY WITWGGQFEQ LQSAYQRLQI VVPITLLGIF LLLFISFGKV
     RDALLVFTGI PLALTGGVFA LWLRGIPLSI SAGVGFIALS GVAVLNGLVM ITFINKLREQ
     KKVYLKDAVL QGSLARLRPV LMTALVASLG FVPMALATGT GSEVQRPLAT VVIGGIISST
     FLTLLVLPGL YYVFHGRRKK GQSKSEPQEQ IM
//
",30333
GAGAGC AGAGCT GAGCTT AGCTTT GCTTTC CTTTCG TTTCGC TTCGCC TCGCCA CGCCAC GCCACC CCACCA CACCAC ACCACT CCACTC CACTCC ACTCCT CTCCTA TCCTAT CCTATA CTATAT TATATT ATATTG TATTGC ATTGCT TTGCTT TGCTTC GCTTCT CTTCTG TTCTGC TCTGCC CTGCCG TGCCGC GCCGCT CCGCTA CGCTAA GCTAAG CTAAGG TAAGGC AAGGCC AGGCCG GGCCGT GCCGTG CCGTGA CGTGAT GTGATG TGATGT GATGTG ATGTGC TGTGCG GTGCGG TGCGGT GCGGTT CGGTTT GGTTTT GTTTTG TTTTGG TTTGGC TTGGCG TGGCGT GGCGTG GCGTGA CGTGAA GTGAAA TGAAAG GAAAGG AAAGGC AAGGCT AGGCTA GGCTAT GCTATG CTATGG TATGGC ATGGCC TGGCCT GGCCTG GCCTGG CCTGGC CTGGCC TGGCCA GGCCAT GCCATT CCATTG CATTGA ATTGAC TTGACG TGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGG CCTGGC CTGGCC TGGCCG GGCCGG GCCGGG CCGGGC CGGGCT GGGCTG GGCTGT GCTGTA CTGTAA,3,103,GAGA AGAG GAGC AGCT GCTT CTTT TTTC TTCG TCGC CGCC GCCA CCAC CACC ACCA CCAC CACT ACTC CTCC TCCT CCTA CTAT TATA ATAT TATT ATTG TTGC TGCT GCTT CTTC TTCT TCTG CTGC TGCC GCCG CCGC CGCT GCTA CTAA TAAG AAGG AGGC GGCC GCCG CCGT CGTG GTGA TGAT GATG ATGT TGTG GTGC TGCG GCGG CGGT GGTT GTTT TTTT TTTG TTGG TGGC GGCG GCGT CGTG GTGA TGAA GAAA AAAG AAGG AGGC GGCT GCTA CTAT TATG ATGG TGGC GGCC GCCT CCTG CTGG TGGC GGCC GCCA CCAT CATT ATTG TTGA TGAC GACG ACGG CGGC GGCC GCCT CCTG CTGG TGGC GGCC GCCG CCGG CGGG GGGC GGCT GCTG CTGT TGTA GTAA,GAGAG AGAGC GAGCT AGCTT GCTTT CTTTC TTTCG TTCGC TCGCC CGCCA GCCAC CCACC CACCA ACCAC CCACT CACTC ACTCC CTCCT TCCTA CCTAT CTATA TATAT ATATT TATTG ATTGC TTGCT TGCTT GCTTC CTTCT TTCTG TCTGC CTGCC TGCCG GCCGC CCGCT CGCTA GCTAA CTAAG TAAGG AAGGC AGGCC GGCCG GCCGT CCGTG CGTGA GTGAT TGATG GATGT ATGTG TGTGC GTGCG TGCGG GCGGT CGGTT GGTTT GTTTT TTTTG TTTGG TTGGC TGGCG GGCGT GCGTG CGTGA GTGAA TGAAA GAAAG AAAGG AAGGC AGGCT GGCTA GCTAT CTATG TATGG ATGGC TGGCC GGCCT GCCTG CCTGG CTGGC TGGCC GGCCA GCCAT CCATT CATTG ATTGA TTGAC TGACG GACGG ACGGC CGGCC GGCCT GCCTG CCTGG CTGGC TGGCC GGCCG GCCGG CCGGG CGGGC GGGCT GGCTG GCTGT CTGTA TGTAA,GAGAGC AGAGCT GAGCTT AGCTTT GCTTTC CTTTCG TTTCGC TTCGCC TCGCCA CGCCAC GCCACC CCACCA CACCAC ACCACT CCACTC CACTCC ACTCCT CTCCTA TCCTAT CCTATA CTATAT TATATT ATATTG TATTGC ATTGCT TTGCTT TGCTTC GCTTCT CTTCTG TTCTGC TCTGCC CTGCCG TGCCGC GCCGCT CCGCTA CGCTAA GCTAAG CTAAGG TAAGGC AAGGCC AGGCCG GGCCGT GCCGTG CCGTGA CGTGAT GTGATG TGATGT GATGTG ATGTGC TGTGCG GTGCGG TGCGGT GCGGTT CGGTTT GGTTTT GTTTTG TTTTGG TTTGGC TTGGCG TGGCGT GGCGTG GCGTGA CGTGAA GTGAAA TGAAAG GAAAGG AAAGGC AAGGCT AGGCTA GGCTAT GCTATG CTATGG TATGGC ATGGCC TGGCCT GGCCTG GCCTGG CCTGGC CTGGCC TGGCCA GGCCAT GCCATT CCATTG CATTGA ATTGAC TTGACG TGACGG GACGGC ACGGCC CGGCCT GGCCTG GCCTGG CCTGGC CTGGCC TGGCCG GGCCGG GCCGGG CCGGGC CGGGCT GGGCTG GGCTGT GCTGTA CTGTAA,GAGAGCT AGAGCTT GAGCTTT AGCTTTC GCTTTCG CTTTCGC TTTCGCC TTCGCCA TCGCCAC CGCCACC GCCACCA CCACCAC CACCACT ACCACTC CCACTCC CACTCCT ACTCCTA CTCCTAT TCCTATA CCTATAT CTATATT TATATTG ATATTGC TATTGCT ATTGCTT TTGCTTC TGCTTCT GCTTCTG CTTCTGC TTCTGCC TCTGCCG CTGCCGC TGCCGCT GCCGCTA CCGCTAA CGCTAAG GCTAAGG CTAAGGC TAAGGCC AAGGCCG AGGCCGT GGCCGTG GCCGTGA CCGTGAT CGTGATG GTGATGT TGATGTG GATGTGC ATGTGCG TGTGCGG GTGCGGT TGCGGTT GCGGTTT CGGTTTT GGTTTTG GTTTTGG TTTTGGC TTTGGCG TTGGCGT TGGCGTG GGCGTGA GCGTGAA CGTGAAA GTGAAAG TGAAAGG GAAAGGC AAAGGCT AAGGCTA AGGCTAT GGCTATG GCTATGG CTATGGC TATGGCC ATGGCCT TGGCCTG GGCCTGG GCCTGGC CCTGGCC CTGGCCA TGGCCAT GGCCATT GCCATTG CCATTGA CATTGAC ATTGACG TTGACGG TGACGGC GACGGCC ACGGCCT CGGCCTG GGCCTGG GCCTGGC CCTGGCC CTGGCCG TGGCCGG GGCCGGG GCCGGGC CCGGGCT CGGGCTG GGGCTGT GGCTGTA GCTGTAA,"ID   AROQ_ACISJ              Reviewed;         148 AA.
AC   A1W6C8;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   27-NOV-2024, entry version 88.
DE   RecName: Full=3-dehydroquinate dehydratase {ECO:0000255|HAMAP-Rule:MF_00169};
DE            Short=3-dehydroquinase {ECO:0000255|HAMAP-Rule:MF_00169};
DE            EC=4.2.1.10 {ECO:0000255|HAMAP-Rule:MF_00169};
DE   AltName: Full=Type II DHQase {ECO:0000255|HAMAP-Rule:MF_00169};
GN   Name=aroQ {ECO:0000255|HAMAP-Rule:MF_00169};
GN   OrderedLocusNames=Ajs_1610;
OS   Acidovorax sp. (strain JS42).
OC   Bacteria; Pseudomonadota; Betaproteobacteria; Burkholderiales;
OC   Comamonadaceae; Acidovorax.
OX   NCBI_TaxID=232721;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JS42;
RA   Copeland A., Lucas S., Lapidus A., Barry K., Detter J.C.,
RA   Glavina del Rio T., Dalin E., Tice H., Pitluck S., Chertkov O., Brettin T.,
RA   Bruce D., Han C., Tapia R., Gilna P., Schmutz J., Larimer F., Land M.,
RA   Hauser L., Kyrpides N., Kim E., Stahl D., Richardson P.;
RT   ""Complete sequence of chromosome 1 of Acidovorax sp. JS42."";
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes a trans-dehydration via an enolate intermediate.
CC       {ECO:0000255|HAMAP-Rule:MF_00169}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-dehydroquinate = 3-dehydroshikimate + H2O;
CC         Xref=Rhea:RHEA:21096, ChEBI:CHEBI:15377, ChEBI:CHEBI:16630,
CC         ChEBI:CHEBI:32364; EC=4.2.1.10; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00169};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; chorismate biosynthesis;
CC       chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step
CC       3/7. {ECO:0000255|HAMAP-Rule:MF_00169}.
CC   -!- SUBUNIT: Homododecamer. {ECO:0000255|HAMAP-Rule:MF_00169}.
CC   -!- SIMILARITY: Belongs to the type-II 3-dehydroquinase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00169}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000539; ABM41803.1; -; Genomic_DNA.
DR   AlphaFoldDB; A1W6C8; -.
DR   SMR; A1W6C8; -.
DR   STRING; 232721.Ajs_1610; -.
DR   KEGG; ajs:Ajs_1610; -.
DR   eggNOG; COG0757; Bacteria.
DR   HOGENOM; CLU_090968_2_0_4; -.
DR   UniPathway; UPA00053; UER00086.
DR   Proteomes; UP000000645; Chromosome.
DR   GO; GO:0003855; F:3-dehydroquinate dehydratase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0008652; P:amino acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009073; P:aromatic amino acid family biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009423; P:chorismate biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0019631; P:quinate catabolic process; IEA:TreeGrafter.
DR   CDD; cd00466; DHQase_II; 1.
DR   Gene3D; 3.40.50.9100; Dehydroquinase, class II; 1.
DR   HAMAP; MF_00169; AroQ; 1.
DR   InterPro; IPR001874; DHquinase_II.
DR   InterPro; IPR018509; DHquinase_II_CS.
DR   InterPro; IPR036441; DHquinase_II_sf.
DR   NCBIfam; TIGR01088; aroQ; 1.
DR   PANTHER; PTHR21272; CATABOLIC 3-DEHYDROQUINASE; 1.
DR   PANTHER; PTHR21272:SF3; CATABOLIC 3-DEHYDROQUINASE; 1.
DR   Pfam; PF01220; DHquinase_II; 1.
DR   PIRSF; PIRSF001399; DHquinase_II; 1.
DR   SUPFAM; SSF52304; Type II 3-dehydroquinate dehydratase; 1.
DR   PROSITE; PS01029; DEHYDROQUINASE_II; 1.
PE   3: Inferred from homology;
KW   Amino-acid biosynthesis; Aromatic amino acid biosynthesis; Lyase.
FT   CHAIN           1..148
FT                   /note=""3-dehydroquinate dehydratase""
FT                   /id=""PRO_1000023445""
FT   ACT_SITE        24
FT                   /note=""Proton acceptor""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   ACT_SITE        106
FT                   /note=""Proton donor""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   BINDING         80
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   BINDING         86
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   BINDING         93
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   BINDING         107..108
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   BINDING         117
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
FT   SITE            19
FT                   /note=""Transition state stabilizer""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00169""
SQ   SEQUENCE   148 AA;  15696 MW;  614F5324D4F8418C CRC64;
     MTKTVYVLNG PNLNLLGTRE PQVYGSQTLA DVEQLCTAAC ARHGLALVFR QSNHEGALVD
     WIHEAGRLHA AGQLAGVVLN AAAYTHTSVA LLDAVKGTGV PVVELHISNV HARESFRHHS
     YLAGAARAVM CGFGVQGYAL AIDGLAQW
//
",62842
CCAATA CAATAG AATAGC ATAGCA TAGCAG AGCAGT GCAGTC CAGTCC AGTCCA GTCCAG TCCAGA CCAGAT CAGATG AGATGA GATGAC ATGACC TGACCA GACCAA ACCAAA CCAAAT CAAATT AAATTG AATTGG ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGC AGAGCT GAGCTA AGCTAC GCTACC CTACCA TACCAG ACCAGA CCAGAC CAGACG AGACGA GACGAA ACGAAT CGAATT GAATTC AATTCG ATTCGT TTCGTG TCGTGG CGTGGT GTGGTG TGGTGG GGTGGT GTGGTG TGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTA CGGTAA GGTAAA GTAAAA TAAAAT AAAATG AAATGA,1,73,CCAA CAAT AATA ATAG TAGC AGCA GCAG CAGT AGTC GTCC TCCA CCAG CAGA AGAT GATG ATGA TGAC GACC ACCA CCAA CAAA AAAT AATT ATTG TTGG TGGC GGCT GCTA CTAC TACT ACTA CTAC TACC ACCG CCGA CGAA GAAG AAGA AGAG GAGC AGCT GCTA CTAC TACC ACCA CCAG CAGA AGAC GACG ACGA CGAA GAAT AATT ATTC TTCG TCGT CGTG GTGG TGGT GGTG GTGG TGGT GGTG GTGA TGAC GACG ACGG CGGT GGTA GTAA TAAA AAAA AAAT AATG ATGA,CCAAT CAATA AATAG ATAGC TAGCA AGCAG GCAGT CAGTC AGTCC GTCCA TCCAG CCAGA CAGAT AGATG GATGA ATGAC TGACC GACCA ACCAA CCAAA CAAAT AAATT AATTG ATTGG TTGGC TGGCT GGCTA GCTAC CTACT TACTA ACTAC CTACC TACCG ACCGA CCGAA CGAAG GAAGA AAGAG AGAGC GAGCT AGCTA GCTAC CTACC TACCA ACCAG CCAGA CAGAC AGACG GACGA ACGAA CGAAT GAATT AATTC ATTCG TTCGT TCGTG CGTGG GTGGT TGGTG GGTGG GTGGT TGGTG GGTGA GTGAC TGACG GACGG ACGGT CGGTA GGTAA GTAAA TAAAA AAAAT AAATG AATGA,CCAATA CAATAG AATAGC ATAGCA TAGCAG AGCAGT GCAGTC CAGTCC AGTCCA GTCCAG TCCAGA CCAGAT CAGATG AGATGA GATGAC ATGACC TGACCA GACCAA ACCAAA CCAAAT CAAATT AAATTG AATTGG ATTGGC TTGGCT TGGCTA GGCTAC GCTACT CTACTA TACTAC ACTACC CTACCG TACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGC AGAGCT GAGCTA AGCTAC GCTACC CTACCA TACCAG ACCAGA CCAGAC CAGACG AGACGA GACGAA ACGAAT CGAATT GAATTC AATTCG ATTCGT TTCGTG TCGTGG CGTGGT GTGGTG TGGTGG GGTGGT GTGGTG TGGTGA GGTGAC GTGACG TGACGG GACGGT ACGGTA CGGTAA GGTAAA GTAAAA TAAAAT AAAATG AAATGA,CCAATAG CAATAGC AATAGCA ATAGCAG TAGCAGT AGCAGTC GCAGTCC CAGTCCA AGTCCAG GTCCAGA TCCAGAT CCAGATG CAGATGA AGATGAC GATGACC ATGACCA TGACCAA GACCAAA ACCAAAT CCAAATT CAAATTG AAATTGG AATTGGC ATTGGCT TTGGCTA TGGCTAC GGCTACT GCTACTA CTACTAC TACTACC ACTACCG CTACCGA TACCGAA ACCGAAG CCGAAGA CGAAGAG GAAGAGC AAGAGCT AGAGCTA GAGCTAC AGCTACC GCTACCA CTACCAG TACCAGA ACCAGAC CCAGACG CAGACGA AGACGAA GACGAAT ACGAATT CGAATTC GAATTCG AATTCGT ATTCGTG TTCGTGG TCGTGGT CGTGGTG GTGGTGG TGGTGGT GGTGGTG GTGGTGA TGGTGAC GGTGACG GTGACGG TGACGGT GACGGTA ACGGTAA CGGTAAA GGTAAAA GTAAAAT TAAAATG AAAATGA,"ID   ORF9B_SARS2             Reviewed;          97 AA.
AC   P0DTD2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   27-NOV-2024, entry version 24.
DE   RecName: Full=ORF9b protein;
DE            Short=ORF9b;
DE   AltName: Full=Accessory protein 9b;
DE   AltName: Full=ORF-9b;
DE   AltName: Full=Protein 9b;
GN   ORFNames=9b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.05 ANGSTROMS), INTERACTION WITH HUMAN
RP   TOMM70, AND SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH HOST TOMM70.
RX   PubMed=32728199; DOI=10.1038/s41423-020-0514-8;
RA   Jiang H.W., Zhang H.N., Meng Q.F., Xie J., Li Y., Chen H., Zheng Y.X.,
RA   Wang X.N., Qi H., Zhang J., Wang P.H., Han Z.G., Tao S.C.;
RT   ""SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting
RT   TOM70."";
RL   Cell. Mol. Immunol. 17:998-1000(2020).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF SER-53, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   HOST TOMM70.
RX   PubMed=34502139; DOI=10.3390/ijms22179233;
RA   Brandherm L., Kobas A.M., Kloehn M., Brueggemann Y., Pfaender S.,
RA   Rassow J., Kreimendahl S.;
RT   ""Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding
RT   Sites in TOM70 and Recruitment of Hsp90."";
RL   Int. J. Mol. Sci. 22:0-0(2021).
RN   [5] {ECO:0007744|PDB:6Z4U}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS), AND HOMODIMERIZATION.
RA   Weeks S.D., De Graef S., Munawar A.;
RT   ""X-ray Crystallographic Structure of Orf9b from SARS-CoV-2."";
RL   Submitted (MAY-2020) to the PDB data bank.
RN   [6]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.20 ANGSTROMS) OF 1-97, AND INTERACTION
RP   WITH HOST TOMM70.
RX   PubMed=33990585; DOI=10.1038/s41467-021-23118-8;
RA   Gao X., Zhu K., Qin B., Olieric V., Wang M., Cui S.;
RT   ""Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests
RT   unusual virus-host interactions."";
RL   Nat. Commun. 12:2843-2843(2021).
CC   -!- FUNCTION: Plays a role in inhibiting the host innate immune response by
CC       targeting the mitochondrial-associated innate immune response. Acts by
CC       binding to host TOMM70, inhibiting its binding to HSP90AB1 thereby
CC       disrupting the interferon activation pathway.
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:34502139}.
CC   -!- SUBUNIT: Homodimer (Ref.5). Interacts with host TOMM70
CC       (PubMed:33060197, PubMed:32728199, PubMed:34502139, PubMed:33990585);
CC       the interaction occurs only with monomer (PubMed:33990585).
CC       {ECO:0000269|PubMed:32728199, ECO:0000269|PubMed:33060197,
CC       ECO:0000269|PubMed:33990585, ECO:0000269|PubMed:34502139,
CC       ECO:0000269|Ref.5}.
CC   -!- INTERACTION:
CC       P0DTD2; P0DTD2: 9b; NbExp=5; IntAct=EBI-25475909, EBI-25475909;
CC       P0DTD2; Q9Y6K9: IKBKG; Xeno; NbExp=3; IntAct=EBI-25475909, EBI-81279;
CC       P0DTD2; O94826: TOMM70; Xeno; NbExp=28; IntAct=EBI-25475909, EBI-2800236;
CC   -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34502139}. Host
CC       mitochondrion {ECO:0000269|PubMed:32728199,
CC       ECO:0000269|PubMed:33060197}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- MISCELLANEOUS: The open reading frame (ORF) encoding for this protein
CC       overlaps with the N ORF. {ECO:0000269|PubMed:32015508}.
CC   -!- SIMILARITY: Belongs to the coronavirus group 2 protein 9b family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   PDB; 6Z4U; X-ray; 1.95 A; A/B=1-97.
DR   PDB; 7DHG; X-ray; 2.20 A; B=1-97.
DR   PDB; 7KDT; EM; 3.05 A; B=1-97.
DR   PDB; 7YE7; X-ray; 2.95 A; A/B/C/D=1-97.
DR   PDB; 7YE8; X-ray; 3.01 A; A/B/C/D=1-97.
DR   PDBsum; 6Z4U; -.
DR   PDBsum; 7DHG; -.
DR   PDBsum; 7KDT; -.
DR   PDBsum; 7YE7; -.
DR   PDBsum; 7YE8; -.
DR   EMDB; EMD-22829; -.
DR   SMR; P0DTD2; -.
DR   BioGRID; 4383874; 613.
DR   ComplexPortal; CPX-6100; SARS-CoV-2 9b complex.
DR   IntAct; P0DTD2; 94.
DR   MINT; P0DTD2; -.
DR   iPTMnet; P0DTD2; -.
DR   AGR; RefSeq:P0DTD2; -.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9727281; Translation of Accessory Proteins.
DR   PRO; PR:P0DTD2; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0033650; C:host cell mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProt.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:ComplexPortal.
DR   GO; GO:0098799; C:outer mitochondrial membrane protein complex; ISO:ComplexPortal.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; IDA:ComplexPortal.
DR   GO; GO:0090258; P:negative regulation of mitochondrial fission; ISO:ComplexPortal.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; ISO:ComplexPortal.
DR   GO; GO:0039545; P:symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity; IDA:UniProt.
DR   GO; GO:0039502; P:symbiont-mediated suppression of host type I interferon-mediated signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21955; SARS-CoV_ORF9b; 1.
DR   InterPro; IPR018542; Protein_9b_Betacoronavirus.
DR   InterPro; IPR037223; Protein_9b_SARS.
DR   Pfam; PF09399; bCoV_lipid_BD; 1.
DR   SUPFAM; SSF141666; SARS ORF9b-like; 1.
DR   PROSITE; PS51920; SARS_9B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Host cytoplasm; Host mitochondrion; Host-virus interaction;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host MAVS by virus; Inhibition of host RLR pathway by virus;
KW   Reference proteome; Viral immunoevasion.
FT   CHAIN           1..97
FT                   /note=""ORF9b protein""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT                   /id=""PRO_0000449657""
FT   DOMAIN          8..97
FT                   /note=""9b""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01268""
FT   MOTIF           45..53
FT                   /note=""Nuclear export signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59636""
FT   VARIANT         10
FT                   /note=""P -> S (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         27..29
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.4, Omicron/BA.5,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         60
FT                   /note=""T -> A (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         77
FT                   /note=""Q -> E (in strain: Gamma/P.1)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         53
FT                   /note=""S->E: Complete loss of binding to host TOMM70.""
FT                   /evidence=""ECO:0000269|PubMed:34502139""
FT   HELIX           5..7
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          12..15
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          19..23
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          40..42
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          44..50
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          52..61
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          64..66
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          68..74
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          78..80
FT                   /evidence=""ECO:0007829|PDB:7YE7""
FT   HELIX           84..86
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
FT   STRAND          89..96
FT                   /evidence=""ECO:0007829|PDB:6Z4U""
SQ   SEQUENCE   97 AA;  10797 MW;  62CFB65C1804545E CRC64;
     MDPKISEMHP ALRLVDPQIQ LAVTRMENAV GRDQNNVGPK VYPIILRLGS PLSLNMARKT
     LNSLEDKAFQ LTPIAVQMTK LATTEELPDE FVVVTVK
//
",15055
ATGGAT TGGATC GGATCT GATCTG ATCTGT TCTGTT CTGTTG TGTTGC GTTGCA TTGCAG TGCAGG GCAGGA CAGGAG AGGAGG GGAGGC GAGGCC AGGCCG GGCCGG GCCGGC CCGGCC CGGCCT GGCCTT GCCTTC CCTTCC CTTCCG TTCCGC TCCGCC CCGCCC CGCCCG GCCCGG CCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGC GTGGCC TGGCCA GGCCAA GCCAAC CCAACC CAACCT AACCTG ACCTGG CCTGGT CTGGTG TGGTGC GGTGCA GTGCAC TGCACG GCACGG CACGGG ACGGGC CGGGCG GGGCGG GGCGGG GCGGGG CGGGGC GGGGCC GGGCCA GGCCAC GCCACA CCACAT CACATC ACATCA CATCAC ATCACG TCACGG CACGGG ACGGGC CGGGCG GGGCGA GGCGAC GCGACG CGACGC GACGCG ACGCGC CGCGCT GCGCTG CGCTGG GCTGGT CTGGTG TGGTGC GGTGCG GTGCGC TGCGCC GCGCCA CGCCAT GCCATC CCATCC CATCCT ATCCTT TCCTTA CCTTAC,3,94,ATGG TGGA GGAT GATC ATCT TCTG CTGT TGTT GTTG TTGC TGCA GCAG CAGG AGGA GGAG GAGG AGGC GGCC GCCG CCGG CGGC GGCC GCCT CCTT CTTC TTCC TCCG CCGC CGCC GCCC CCCG CCGG CGGC GGCG GCGT CGTG GTGG TGGC GGCC GCCA CCAA CAAC AACC ACCT CCTG CTGG TGGT GGTG GTGC TGCA GCAC CACG ACGG CGGG GGGC GGCG GCGG CGGG GGGG GGGC GGCC GCCA CCAC CACA ACAT CATC ATCA TCAC CACG ACGG CGGG GGGC GGCG GCGA CGAC GACG ACGC CGCG GCGC CGCT GCTG CTGG TGGT GGTG GTGC TGCG GCGC CGCC GCCA CCAT CATC ATCC TCCT CCTT CTTA TTAC,ATGGA TGGAT GGATC GATCT ATCTG TCTGT CTGTT TGTTG GTTGC TTGCA TGCAG GCAGG CAGGA AGGAG GGAGG GAGGC AGGCC GGCCG GCCGG CCGGC CGGCC GGCCT GCCTT CCTTC CTTCC TTCCG TCCGC CCGCC CGCCC GCCCG CCCGG CCGGC CGGCG GGCGT GCGTG CGTGG GTGGC TGGCC GGCCA GCCAA CCAAC CAACC AACCT ACCTG CCTGG CTGGT TGGTG GGTGC GTGCA TGCAC GCACG CACGG ACGGG CGGGC GGGCG GGCGG GCGGG CGGGG GGGGC GGGCC GGCCA GCCAC CCACA CACAT ACATC CATCA ATCAC TCACG CACGG ACGGG CGGGC GGGCG GGCGA GCGAC CGACG GACGC ACGCG CGCGC GCGCT CGCTG GCTGG CTGGT TGGTG GGTGC GTGCG TGCGC GCGCC CGCCA GCCAT CCATC CATCC ATCCT TCCTT CCTTA CTTAC,ATGGAT TGGATC GGATCT GATCTG ATCTGT TCTGTT CTGTTG TGTTGC GTTGCA TTGCAG TGCAGG GCAGGA CAGGAG AGGAGG GGAGGC GAGGCC AGGCCG GGCCGG GCCGGC CCGGCC CGGCCT GGCCTT GCCTTC CCTTCC CTTCCG TTCCGC TCCGCC CCGCCC CGCCCG GCCCGG CCCGGC CCGGCG CGGCGT GGCGTG GCGTGG CGTGGC GTGGCC TGGCCA GGCCAA GCCAAC CCAACC CAACCT AACCTG ACCTGG CCTGGT CTGGTG TGGTGC GGTGCA GTGCAC TGCACG GCACGG CACGGG ACGGGC CGGGCG GGGCGG GGCGGG GCGGGG CGGGGC GGGGCC GGGCCA GGCCAC GCCACA CCACAT CACATC ACATCA CATCAC ATCACG TCACGG CACGGG ACGGGC CGGGCG GGGCGA GGCGAC GCGACG CGACGC GACGCG ACGCGC CGCGCT GCGCTG CGCTGG GCTGGT CTGGTG TGGTGC GGTGCG GTGCGC TGCGCC GCGCCA CGCCAT GCCATC CCATCC CATCCT ATCCTT TCCTTA CCTTAC,ATGGATC TGGATCT GGATCTG GATCTGT ATCTGTT TCTGTTG CTGTTGC TGTTGCA GTTGCAG TTGCAGG TGCAGGA GCAGGAG CAGGAGG AGGAGGC GGAGGCC GAGGCCG AGGCCGG GGCCGGC GCCGGCC CCGGCCT CGGCCTT GGCCTTC GCCTTCC CCTTCCG CTTCCGC TTCCGCC TCCGCCC CCGCCCG CGCCCGG GCCCGGC CCCGGCG CCGGCGT CGGCGTG GGCGTGG GCGTGGC CGTGGCC GTGGCCA TGGCCAA GGCCAAC GCCAACC CCAACCT CAACCTG AACCTGG ACCTGGT CCTGGTG CTGGTGC TGGTGCA GGTGCAC GTGCACG TGCACGG GCACGGG CACGGGC ACGGGCG CGGGCGG GGGCGGG GGCGGGG GCGGGGC CGGGGCC GGGGCCA GGGCCAC GGCCACA GCCACAT CCACATC CACATCA ACATCAC CATCACG ATCACGG TCACGGG CACGGGC ACGGGCG CGGGCGA GGGCGAC GGCGACG GCGACGC CGACGCG GACGCGC ACGCGCT CGCGCTG GCGCTGG CGCTGGT GCTGGTG CTGGTGC TGGTGCG GGTGCGC GTGCGCC TGCGCCA GCGCCAT CGCCATC GCCATCC CCATCCT CATCCTT ATCCTTA TCCTTAC,"ID   AL8A1_DANRE             Reviewed;         487 AA.
AC   Q66I21;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   05-FEB-2025, entry version 136.
DE   RecName: Full=2-aminomuconic semialdehyde dehydrogenase;
DE            EC=1.2.1.32 {ECO:0000250|UniProtKB:Q9H2A2};
DE   AltName: Full=Aldehyde dehydrogenase family 8 member A1;
GN   Name=aldh8a1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Intestine;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (AUG-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the NAD-dependent oxidation of 2-aminomuconic
CC       semialdehyde of the kynurenine metabolic pathway in L-tryptophan
CC       degradation. {ECO:0000250|UniProtKB:Q9H2A2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-aminomuconate 6-semialdehyde + NAD(+) + H2O = (2Z,4E)-2-
CC         aminomuconate + NADH + 2 H(+); Xref=Rhea:RHEA:14469,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:77634, ChEBI:CHEBI:77859; EC=1.2.1.32;
CC         Evidence={ECO:0000250|UniProtKB:Q9H2A2};
CC   -!- PATHWAY: Amino-acid degradation; L-kynurenine degradation.
CC       {ECO:0000250|UniProtKB:Q9H2A2}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC081581; AAH81581.1; -; mRNA.
DR   EMBL; BC152164; AAI52165.1; -; mRNA.
DR   RefSeq; NP_001004540.1; NM_001004540.1.
DR   AlphaFoldDB; Q66I21; -.
DR   SMR; Q66I21; -.
DR   STRING; 7955.ENSDARP00000053398; -.
DR   PaxDb; 7955-ENSDARP00000053398; -.
DR   Ensembl; ENSDART00000053399; ENSDARP00000053398; ENSDARG00000036776.
DR   GeneID; 447801; -.
DR   KEGG; dre:447801; -.
DR   AGR; ZFIN:ZDB-GENE-040912-3; -.
DR   CTD; 64577; -.
DR   ZFIN; ZDB-GENE-040912-3; aldh8a1.
DR   eggNOG; KOG2450; Eukaryota.
DR   HOGENOM; CLU_005391_0_2_1; -.
DR   InParanoid; Q66I21; -.
DR   OMA; INGGPFN; -.
DR   OrthoDB; 310895at2759; -.
DR   PhylomeDB; Q66I21; -.
DR   TreeFam; TF314129; -.
DR   Reactome; R-DRE-5365859; RA biosynthesis pathway.
DR   UniPathway; UPA00334; -.
DR   PRO; PR:Q66I21; -.
DR   Proteomes; UP000000437; Alternate scaffold 23.
DR   Proteomes; UP000000437; Chromosome 23.
DR   Bgee; ENSDARG00000036776; Expressed in liver and 19 other cell types or tissues.
DR   ExpressionAtlas; Q66I21; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0047102; F:aminomuconate-semialdehyde dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0001889; P:liver development; IMP:ZFIN.
DR   GO; GO:0042573; P:retinoic acid metabolic process; IBA:GO_Central.
DR   CDD; cd07093; ALDH_F8_HMSADH; 1.
DR   FunFam; 3.40.605.10:FF:000001; Aldehyde dehydrogenase 1; 1.
DR   FunFam; 3.40.309.10:FF:000021; Aldehyde dehydrogenase family 8 member A1; 1.
DR   Gene3D; 3.40.605.10; Aldehyde Dehydrogenase, Chain A, domain 1; 1.
DR   Gene3D; 3.40.309.10; Aldehyde Dehydrogenase, Chain A, domain 2; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   PANTHER; PTHR43720; 2-AMINOMUCONIC SEMIALDEHYDE DEHYDROGENASE; 1.
DR   PANTHER; PTHR43720:SF2; 2-AMINOMUCONIC SEMIALDEHYDE DEHYDROGENASE; 1.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; ALDH-like; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..487
FT                   /note=""2-aminomuconic semialdehyde dehydrogenase""
FT                   /id=""PRO_0000312956""
FT   ACT_SITE        253
FT                   /note=""Proton acceptor""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU10007,
FT                   ECO:0000255|PROSITE-ProRule:PRU10008""
FT   ACT_SITE        287
FT                   /note=""Nucleophile""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU10007,
FT                   ECO:0000255|PROSITE-ProRule:PRU10008""
FT   BINDING         231..236
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   SITE            155
FT                   /note=""Transition state stabilizer""
FT                   /evidence=""ECO:0000250""
SQ   SEQUENCE   487 AA;  53354 MW;  4F13284B613DE146 CRC64;
     MSKDMKYLVL ENYIGGKFVP CSKLIDSFDP STGEVYCKVP DSGAEEVNAA VRAAKEAFPD
     WSAKSPADRS KVLNKLADLI EARLEEFVQA ESKDQGKTIT FARNVDIPRS AYNFRFFASS
     VLHHTNDCSQ MDHMGCLNYT IRCPVGVAGL ISPWNLPLYL LTWKIAPAVA TGNTVVAKPS
     EMTSVTAWMM CQLLEEAGFP PGVVNIVFGT GPRAGDALVS HPDVPLISFT GSTATARLIT
     ERSAPHCKKL SLELGGKNPA IIFADADMEQ CISTTVRSSF SNQGEICLCT SRIFVERSVY
     PEFLTRFVEA TRRWKTGVPS DPSNDNGALI SKEHLQKVKG YITLALAEGA QVHCGEGVDK
     LALPQQNIGG YFMLPTIISG VKDSSALMQE EIFGPVTCVT PFDEEEEVIS RANNVRYGLS
     ATVWSRDVGR VHRVARKLQA GLVWTNCWLV RDLNLPFGGM KHSGIGREGG KDSYHFFTEV
     KSVTVKH
//
",29498
GTGCCA TGCCAC GCCACT CCACTT CACTTC ACTTCA CTTCAT TTCATG TCATGG CATGGC ATGGCA TGGCAC GGCACT GCACTA CACTAT ACTATT CTATTC TATTCT ATTCTG TTCTGA TCTGAT CTGATC TGATCA GATCAG ATCAGC TCAGCC CAGCCC AGCCCG GCCCGC CCCGCT CCGCTT CGCTTC GCTTCT CTTCTA TTCTAG TCTAGA CTAGAA TAGAAA AGAAAG GAAAGT AAAGTG AAGTGA AGTGAA GTGAAC TGAACT GAACTC AACTCG ACTCGT CTCGTA TCGTAA CGTAAT GTAATC TAATCG AATCGG ATCGGA TCGGAG CGGAGC GGAGCT GAGCTG AGCTGT GCTGTG CTGTGA TGTGAT GTGATC TGATCC GATCCT ATCCTT TCCTTC CCTTCG CTTCGT TTCGTG TCGTGG CGTGGA GTGGAA TGGAAG GGAAGA GAAGAT AAGATG AGATGT GATGTC ATGTCC TGTCCA GTCCAC TCCACG CCACGA CACGAA ACGAAG CGAAGG GAAGGA AAGGAT AGGATC GGATCA GATCAC ATCACA TCACAG CACAGC ACAGCT CAGCTC AGCTCC GCTCCG CTCCGA TCCGAT CCGATT CGATTA GATTAC ATTACG TTACGC TACGCG ACGCGT CGCGTT GCGTTC CGTTCA GTTCAC TTCACT TCACTT CACTTT ACTTTC CTTTCT TTTCTA TTCTAG TCTAGT CTAGTA TAGTAG AGTAGC GTAGCG TAGCGG AGCGGT GCGGTC CGGTCT GGTCTG GTCTGG TCTGGT CTGGTC TGGTCA GGTCAG GTCAGA TCAGAA CAGAAT AGAATA GAATAG AATAGT ATAGTG TAGTGC AGTGCC GTGCCA,1,145,GTGTGCA CC T TATGCGCCC GGCCA TCA GC  CCCCACACAC C C CACACACTCT T A ACCGGT C ATCTTTTCACAC TTTCCA A T TCCATAT T C CAA GATGTG G A ATATGATGGG CGA TGTGGGGCGC C G GGGGCGCACA A G GCGCACACTCG CACACACTCT  ACACT ATTA A CCTATATTTCAA  TAAGAATTTT T A ATATTTTCTC C T TTTTCTCTCT TCTTG G C CTCTGC AA T TGTGAGATAT T G AAGATACT CCCTTCA TCACA A TCACTCACAGAG  CAG TGG GC C A AGAGCGCCAGAG A GCGCCTGGCC C C CCTT CG G C CCCCGCGCGC  CGCGCGCTCT T G GCGCTCTTTT T C CTCTTTC C T TTTCTTGTT T TCTCGCCGTA A C CTCTATAGAG G TTAGAGAGA A A AGTATGAAAA A G GAGAAAAAAA A A AAAAGAG G A AAAAGAGTG C AGAGTGTGG G GTGTGTGAGA  CA TGTGAGAAAA A G GAGAAAACAC AA  AAAACATCCT  ACACTCTCTC GTGCTCTCGCG CAG TCC CCGTGT T C CGCGTGTATA  GTGTA GAA T TATAAAATAT T A AAAATATCTC CTATCA TGCG G T TCTCGG CG C CG GTGGAGA  CT GGGAGG G GAGAGAGCGC TGAAGCGCTCT T GCTGGCTCTGG C CTCTGTGTA TTCTTGTGTG GTGTGTGAGA A TG TTGAGATAT T GGATATCC A ATATCTCCCC C T TCTCCCT T CG ACCTCTTT CCTACTTTTCTC C T TTAT TCGCG G T TCTCGCGTGT  TCCGTC CTG  GTCCC TG TGTCCTGCTC  GGGGAGAAAA  GAGAAAAGG A AAAAGCC GA A A AGAGAGATAT T G GAGATATGTG  CC ATTGGCT GT  TGTGTGTCC G GTGTCTCCCC C T TCTCCCCACA A CCCA TCAC C CA TCACCG GCC ACACGG TGA A C CGCGA TAA G GAGAAAAGG AAAGAGGAGCG A AGAGGGGAGA A G GGGGAGATAT  GAGATATCTC C A ATATCTCACA A T TCTCACACAC C C CACACACACA A A ACTC AG G C CATTCGC C A AGAGCGCTT G GCGCTCTCTC C CCTCTCCCC C T TCCCGCG AGCT GCCGCGA AT CGCGAGATAT T G GAGATATTTT CTT ATATTTTACGGT T TTTTATACAC C T TGTACACGCG GCC ACACGCGCGC GCGCG G GGCGCGTC GT C CG GGGTTTT TC GTTTTCC TTCATTCCA GT  TCTCACACTG C C CACACACTCT  ACACTT ATT T C CTCTTTTTTT GAA TTTTTTTC CGC TCT TTCTCTT T TCTCT CTTA  GC CTCTAG T TATAGAGTGT T A AGAGTTA A G GTGTATAGAG G T TATAGAGCGC C AAGCGCGCG G G GCGCGCGGGG  TTTC CGGGGTGT CGTCAGGTCTC  GTGTCTCTCT T T TCTG G C CT GCTGGGG  TGTGGGGTGT T GGTCTC AG A CGTCATCCCA TCTCAGGTAG GT  CACAGAGAGA A A AGAGAAA  GAGAAAATC G AAAATATATA CATATATAGC GG T TATAGAGTGT T A AGAGTGTGTG G G GTGTGTGCGC C TGGAC GCC GT  GCG ACCA,GTGGCCCC C TTGCGCCCCACA A G GCGCCCCACACTC C C CCCTTCACACTCT T C CACACACTCTTTATT A ACACTCTTTTCTC C CTAGCTTTTCTCACA A TACGTTCTCACATAT T T TCTCAC CTG G CCATATGTGGG A ATGG TGGC T TGTGGGGCGCACA A G GGGGCGCATTCAC C G GCGCACACCT T CGGTCTATA A A ACACTCTATC AT  AT CTTATATT TATATATTTTCTC C AATTTTCTCTCT T TAG CA CTGTG G TTAATCTCTATGAGA A C CTCTGTGAAT  TGTGAATCTC C G GAGATCTTTCACA A ACAGATCTCACAG GTG T TCTCA ATAGCGC C C CACAGAGCGCCTCCC A AGAGCGCCCCCCC C G GCGCCCCCCCGCG G C CCCCCCCGCGCGC C CGATCCGCGCGTCCT AAT CGCGCGCTCTTTT  GCGCTTTCTT C C CTT TTTCAGCCT T T TTTTCTCTCTAA T TCTCTCTATAGTGCG C CTCTGTAGGG A T TAAA AGAGAAAA TGG AGAGAGAAAAAAA A GGAAGTGAAGG A CTAAAGT T AAAGAGTGA G A AGGTGTGAGA A G GTAAGTGAT CAA A T TGTGAGAAAACAC C G GAGAAAACA AT A AAAACACTCTCTC C A ACCG TCGAG G C CTCTCCGTGT T T GGTCGCGTGTATA G G CGCGTGTATACA G GAGTA TCAATAT T T TAAATATCTC C A AAAATGA CG G A ATATCTCGCGGATGG TGA TCGT TGGAGTG GG CGCGGGGAG G GGGGACG AGCGC C G GAGAGAGCT AAGCGCTCTGTG G G GCGCTCTGTGTGT CGCTTCCTGTGTGTGTG  TGTGTGTGTGAGA  GTGTGTGAGATAT T T TGTGAGATAGTTC C GGATCC CC C A ATATCTCCGATCT T T TCTCCCCACACT C CCCCTCTTTC C C CTCTTTTCTCGCG  TTTTCTCGCGTGT T T TCG GCGTGTG TGG C CGCGTGTGA AGG TTC GTAAATGGGA A T TGTGGGGAGAAAA  GGGGAGAAAAGAG G G GAGAAGCCAGAA A AAAAGAGATC AT T A AGAGA CCCG TG G G GTG TATGTGTGT T A ATATGTGTGTCTC C TTGTGTCTCACC GAGCACGTCTCCAGTTCTA T TCTCCCCACACGCGC C CCCACACGCTCTCACACACGTCTGA A A ACGCGCGAGAAAA A C CGCGAGAAAAGAG G G GCGAAGTGAGG TC AAAAGAGGGGAC CA A AGAGGGGAGATAT T GGGAGATATCTC C G CAGATATCTCACA A AT CATCTCC GTAC  TCTCACACACACA A C CACACACACAGAG G A ACCAGAGCGC TCG GAAGCGCTGAGT A AGTCTGCTCTCGATC G GAGCTCTCTCCCC CAT CTCTCTCCCCGCG G T TCGC CCGCGAA C CCCCGCGAGATAT  GT CGG TGATTT T GATTTTATA A A ATATTTTATACAC  TTT TTACACGCT G T TACC ACGCGCC A ACC TCGCAG ATG CGT CGCGCGTGT T G GCGCGCGTGTTTT T C CGCGTGTTTTCTC C G GTGTTG GTCACA A T TTTTCTCACACAC C T TCTCACACACTCT CAGACTC GTT T A ACACTCTTTT T C CTATCTTTTTCC T TTTTTTTCTCTCT TTAGG  CTTCTTA  TCTCTTAGCG CTA CTCCAACGCGG TA AGGGCTA TAGAGTGTATAGGT TCG GTTAGAGCTCCC T TATAGAGCGCGCG G A AGAGCGCGCGGGG A C GCAC CGGGGTGT T C CGCGGCACGTCAC C GAT GGTGCTTCTCT T GAG GTCTCTCTGCGA TCTGGGG G C CTCTGTGGGGTGT T T TGTGGGGTGTCTC A CCGAGTCTCACA A GT CG CCAGAG GAT TCTCAAGAGA A C CACAGAGA GGCT  AGAGAGAAAATT G GAGAAAATATATA A A AAT CTAGAG G A ATATATAGATCGT  TATAGAGTGTGG A AGAGTGTGTGCGC C G GTAG AAGTAA TTTG TGCGCCCCA,GTGGCCA CA GTCA TGTGCGCCCCAAC C GCACGCCCCAT GCT T C CCGAACACGTGCTTTT TCC CACACACTCTTCC  AGC A ACACTTAGTTCCA A CAA CTTTCACATAT T T TTTTCTCAAC ATGG T CTATGTGGGG G C CACATATGTGGGGCGC C A ATATGTGGGATGCACA A TCC TGGGGCGCAT AAC C G GGGGCGCACACACTCT ACTGCACACACTCTATA  CACACT ACTATCGAT T AACTA GATTTT T C CTCTATATATTTTCTC TC  TATATATTTTCTCTGATT AGTCATTTTCTCTCTGTG G T TTTTCTCTCTGT CGA A T TCTCTCTGTGAGATAT GA CATCTGTGAGATGGAGTCC TC ATGAGATTCACA A G GAGATATCTCAAG G A ATATCTCACAGAGCC TTCACAGAGCCC  CT CACAGAGCGCCCCCCC C A AGAGCGCCCCCCCGCG G G GCCCCCCGCGTC C CCCCCCCGCGC GTT C CCG CGCT TTTT ACA CGCGCGCTCTTTTCTC A AGCTCTT TCTCTAGCTGA CTCTTTGATA A T TTTCATCTCTATAGAG G T TCTCTTGGTT AGAGA A C CTTAGAGAGAAAA A T TCTAGAGAGAAAAAAA A A AGAGAGAAAAAAAGAG G G GAGAAG AAAGAGTTAGT A AAAAAAAGAGTGTGTG G A AAAAGAGTGTGAAAC G AGAGTGTGAATGAAAA  GTGTGTGAGAAAACAC C T TGTGAA TAACACTTCTT GCGTGAACT ACTTGGTC  AAAACACTCTCTCG ACACTCTCTCGCGTGT  CTCTCTATTG GTATA A T TCTCGTAA AAA C CGCGTGTATAAAATT G GTGTATAAAATATCC TTCATAAGTA CATCGCG T CAA ATCTCGGG G AATCTCGCGGGCCGA A T TCCGCCGGGT GAGAG G C CGCGGGAGAGCGC  GGGGAGAGAGCCT T G GCAGCGCTCTGTG G A AGAGCGCTCTGTGTGT T C GCCTGTGT ACCGTG C GTCTGTGTGTGTGAGA A T TGTGTGTGATCGATAT CC  GTGTGTGAGATATCTC C T TGACTGATATCTCCC GGGCATCCCT ATATCT CCCTCTTTT T TAGCACGCCTCTTTTCTC C C CCCCTCTTTTCTCGCG  CTCTTTTCTTACGT TAT T TTTTCCGTGTGTG G T TCTCGCGTGTGTGGGG G C CGCGTGTGTGGGGAGA TAT GTACTTGGGGAGGTGTCA T TGTGGGGAGAAAAGG G GGGAAAAGAGAGA CA  GACG AAGAGA CTAT T A AATTC TAGATATGTG G ATC GATATGTGTGT T G GAGATATGTGTTC TC C A ATATGTGTGTCT GC T TGTGTTCCCCACA A G GTGTCTCCCCACACC T TCTCCCCAACGCG G C CCCCAACGCGAGA  CACACACGCGAGAAAA A AACGCGAAAGGATCCG CGCGAGAAAAGGG G G GACCAAAGAGG AGGA A A AAGAAAGGGGAAG AT CAC AGAGGGGAGATATCTC C G GGGGAGATATCA TCAGA G GAGATCT TCAAC C AAATATCTCACAC AACA A TTCAG ACAGAG G C CACACACACAGAACGC C A ACACACAGTTCGCTCT T CATCCAGTCAGCTCTCTC C AAGCGCTCTCTCCC G GCGCTTCCCCGGTG CTCTCCCGGA ATC TCTCCCCGGATAT T G CCCGAGCGATTT CCGAGATATTTCGTA  GAGATATTTTATACAC  TG ATATTTTATACTCCTT G T TTTTATACACGCGCGC  TAGT TACACGCGCGCGCG G AA GACGTCGGCGCGTGT T C CGCGCGC GTTT G GCGCGCGTACTTTCTC GAA CG GAGTTAAGCA A G GTGTTTTC TACACCATC TTCACACACTCT T TTTTTCACACACTCTTCG T C CACAC ATCTTTTTTT ACT ACTGACTTTTTTTCC TC C CTCTTTTCTCTCT T T TT TCTTCCTATA A TCTTTTCTCTCTATAG GAG T TCCTATAGAGTGGAT CCTATAGAGTGTATA AAGTAGAGTGTATAGAG G A AGAATTAGAGCGC C GCT GTATAGAGCTCTGAAG T TATAGAGCCT CGGGG G A AGAGCCGGGGT AGT GGAGGGTGTCTC  CGC GGGTAA GCGCT T G GGGAATCTCTGTG G G GT ATTCTCTGGG  TCTCTCTGCTCGGTGT T C CTCTGCTAGGTGTCGCTC T TGTGGGGTGTCTCACA  AC GGGGTGTCAG G GGATT ACAGAGAGA A T TCTCAAGAC CC CCCA CACAGAGAGAA ATAT T AAGGAGAGAAAATATATA A G GAGAAAATATATAGAG G AT CAATATAGT AGTGT T A ATATATAGAGTGTGTG G TAGACTTAGTGTGGC GT GTGTGC TGC G GTG CTGCGCCCCA,GTGTGCGCCCCACACAC CT  TGTGCGCCCCACACACTC TT G GCGCCCCACCTCTTTT T CCCACACGAACTTTTCTC C C CACACTTCTCACA A A ACACTCTTTTCTCACATAT T C CTTTCTCACATATGGCTG TTTCTCACATATGCGAGG G TCC TCAATGTGGGGCGC C C CAATGTGGGGCCA CGTGA ATGGG GGCGCACACAC C T TGTGGCTGGCACACACTCT T GTCGGCACACACTCTA TCA G GCGCAGAGACTCTAAT T C CACACACTTAGTATATTTT T ACTATATATTTTCC CTCCACTATTTTCA CACG TATATATTTTCTCTCTG GCG ACTATTCTCTTGA CTA TTTCTCTGTATGAGATTAGT T TCTGGGGCTGAATCC C CTCTGTGAGATATCTCAA T TGTGAGATATCTCAAG G G GAGATATCTCACAGACAGC C A ATATCTCACAGGAAGCCCC C T TCTCACAGAGCATTC GTAAC CGATAGCGCC GGCTCCG G AAGGAGCGCCCCCCCGCGCCTTC G GCGCCCCCCCGCGCGCTCT T C CCCCCCCGCGCTG CTTTT T CGAACCGCGCGCTCTTTTCTC C C TCCGCCCTT TTTCCT T G GCGCTCTTATCCTA CGTCT CTTTCTCTA CTAGAG G T TTTTCTCTCTACACAGAGA G G TC AGCTATAGAGATCGAA CTATAGAGAGAAAAACCAA TAGAGAAAAAAAGAG G A AGAGAGAAAAAAAGAGTGT T GAGCAAAAAGTG G AGGAAAAAACAGTGTGTGAGA A A AAAAGAGTGTGTGAGAAAA G CAGTGTGGAAAACAC C G GTGTGTGAGAACTTACTCGTT T TGTGAGAAAACACTCTCTC C G GAGAAGCGACTCTCTCGCG G A AAACTCTCTCGCGTGT T A ACACTTCGCGTGTATA A C CTCTCTCGCGTTTCTAAAA A T TCTCGCGTCTATAAAATAT GG  CGGTATAAAATATCTC C G GTGTACC AATACTTCGATATAAAATATCTCGCGGGG G A AAAATATCTCGGGAGA A A ATATCTCGCGGGGAGAGAG G T GGCGG CTGAGAGCGC  CGG TAGCGCT GGT G AAGAGGCTCTGCACG G GATAGAGCGCTAT TGTCTA TGTCTAGCGCTCTGTGTTG G G GCCTGTGTTCGTGAGA A C CTCTGTGTGTCTGAGATT T TGTGTTGAGATATCTC TCAA CGATATCTCCCC  TGTGACAGTCCCT T G GAGATATCTCCACTCTTTT T A ATATCTCCCCTCTTTG C T TCTCC TACTTTCGCACG CGGATTCTCGCGTCTCT C CTTC TTCCGTC GTG GGA TTGTGCGTGTGTGGTGGG T CGGAACGTGTGTGGGGAGA AGA CGA AGTGTGGGGAGAAAA A G GTGTGTGGGGAGAAAAGAG G T TGTGGGGAGAAAAGAGA ATA G GGGGAGAAAAGGTCGATAT T G GAGAAAAGAGAGATTG G A AAAAGAGAGATATGTGTGT C G AGAGAGATTGTGTGCTTC GGATATGGTCCC C A ATATGGTCTCCCCACA A TT ATGTGTCGCTCCACACAC  GTGTCTCCAA CACCGGCG AGGCCACACACGCGAGA A GCCACACT TCGAAA A C CACACACGCGAGAAAAGAG G AACGCGAGAAAAGTCCGG A ATA CGAGAAGT GGAGA A GC AAAGAGGGATAT T A AAAAGAGGGATATCTC C A AGGGAGATATCTCACA ACTTTCGCTGATATCTCAGT AC  GAATCCACACACA A A ATATCACACAGAG G T TCTCACACAGCCAGAGCGC GTG CACACGA CAGAGCGCTCT T A ACACACAGAGCGCTCTCTC C C CACAGAGCGCTAAGTCCCC C AAGCGCTCTCTCC GTG G GCTCCTCCCCG ACACAA C CTCCG ATCCGCGA CGAT T T TCTCCCCGCGAGATATTTT T CCCGTGGGATATTTTAGGTA C CGCGAGATATAGCGAC C G GAGATTT TTATACACGCG G AGGAATTTTAACGCGCGC C T TTTTAACGCGCGCGCG G T TATACAAGCGCACGCT GT T A ACACGCGCGCGCGTGTTTT T C CGCGCCGT TATTCTC CCCTG CGTGTTTTCTCACA GTG CGCGTGTTTTCTCACACT T GTGTTTCACACACTCT AC GGTTTCTCACACACTGCCCTT TCTCACACTATCTTT C CATG ACTGC TTTTTCTC  GA ACGTACTTTTTTCTCT T CTTTCT GTGCTATA A T TTTTCTCTCTATAGAG G T TTTCTCTATAGAGTGT  TCTCTCTGTAGAGTGTATA A C CTCTACTGGTATAGAG G TTAGAGTGTATAGGTAGC C A AGAGTAGCTAGAGCGCGCG GTATAGCTGGCGCGGT CG T TATAGAGCTACCGGGGTGT T A AGAGCGCGACGTA GTCTC C G GCGCGTT GGTTCTC AT CGATCGGGGTGTCTCTCTGTC A T GGGTCTCTCTGTGGGG G G GTGTCCTGT A TTGT T T TCTCTAGTTGGGGTGTCTC C CGA AGCTCTGGTGTCGTGCA A T TGTGGGGTAGATCACAGAG G GCCCGGTGTCTCAGTCAGAGA  CC GTCAGTCACAGAGAGAAAA A T TCTCACAGAGAGAAAATAT T C CACAGA CA GAATATATA A A AGAATTTATAGAG G GGAAATATAGAGTGT TGG AAAATCG TAGAGTTCTC GATATAGAGTGTGC TCCTTAGAGTGTGTGCGCC TCCT  AGAGTGTGTGCGCCCCA,"ID   VME1_SARS2              Reviewed;         222 AA.
AC   P0DTC5;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Membrane protein {ECO:0000255|HAMAP-Rule:MF_04202};
DE            Short=M;
DE   AltName: Full=E1 glycoprotein {ECO:0000255|HAMAP-Rule:MF_04202};
DE   AltName: Full=Matrix glycoprotein {ECO:0000255|HAMAP-Rule:MF_04202};
DE   AltName: Full=Membrane glycoprotein {ECO:0000255|HAMAP-Rule:MF_04202};
GN   ORFNames=M;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3]
RP   INTERACTION WITH S PROTEIN, AND FUNCTION.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-5, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=38666819; DOI=10.3390/biology13040207;
RA   Schwarze M., Volke D., Rojas Echeverri J.C., Schick R., Lakowa N.,
RA   Gruenewald T., Wolf J., Borte S., Scholz M., Krizsan A., Hoffmann R.;
RT   ""Influence of Mutations and N-Glycosylation Sites in the Receptor-Binding
RT   Domain (RBD) and the Membrane Protein of SARS-CoV-2 Variants of Concern on
RT   Antibody Binding in ELISA."";
RL   Biology 13:1-21(2024).
RN   [5] {ECO:0007744|PDB:8CTK}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.52 ANGSTROMS), TOPOLOGY, AND
RP   GLYCOSYLATION AT ASN-5.
RX   PubMed=36264056; DOI=10.7554/elife.81702;
RA   Dolan K.A., Dutta M., Kern D.M., Kotecha A., Voth G.A., Brohawn S.G.;
RT   ""Structure of SARS-CoV-2 M protein in lipid nanodiscs."";
RL   Elife 11:1-16(2022).
RN   [6] {ECO:0007744|PDB:7VGR, ECO:0007744|PDB:7VGS}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS), SUBUNIT, MUTAGENESIS OF
RP   42-ARG--ARG-44, AND GLYCOSYLATION AT ASN-5.
RX   PubMed=35931673; DOI=10.1038/s41467-022-32019-3;
RA   Zhang Z., Nomura N., Muramoto Y., Ekimoto T., Uemura T., Liu K., Yui M.,
RA   Kono N., Aoki J., Ikeguchi M., Noda T., Iwata S., Ohto U., Shimizu T.;
RT   ""Structure of SARS-CoV-2 membrane protein essential for virus assembly."";
RL   Nat. Commun. 13:1-12(2022).
CC   -!- FUNCTION: Component of the viral envelope that plays a central role in
CC       virus morphogenesis and assembly via its interactions with other viral
CC       proteins (By similarity). Regulates the localization of S protein at
CC       cis-Golgi, the place of virus budding (PubMed:33229438). May act by
CC       binding cytoplasmic c-terminus of S (PubMed:33229438).
CC       {ECO:0000255|HAMAP-Rule:MF_04202, ECO:0000255|PROSITE-ProRule:PRU01275,
CC       ECO:0000269|PubMed:33229438}.
CC   -!- SUBUNIT: Homomultimer (PubMed:35931673). Interacts with envelope E
CC       protein in the budding compartment of the host cell, which is located
CC       between endoplasmic reticulum and the Golgi complex (By similarity).
CC       Forms a complex with S proteins (PubMed:33229438). Interacts with
CC       nucleocapsid N protein. This interaction probably participates in RNA
CC       packaging into the virus (PubMed:35931673). Interacts with the
CC       accessory proteins 3a and 7a (By similarity).
CC       {ECO:0000250|UniProtKB:P59596, ECO:0000255|HAMAP-Rule:MF_04202,
CC       ECO:0000269|PubMed:33229438, ECO:0000269|PubMed:35931673}.
CC   -!- INTERACTION:
CC       P0DTC5; P0DTD8: 7b; NbExp=4; IntAct=EBI-25475853, EBI-25475914;
CC       P0DTC5; P0DTC4: E; NbExp=5; IntAct=EBI-25475853, EBI-25475850;
CC       P0DTC5; P0DTC5: M; NbExp=4; IntAct=EBI-25475853, EBI-25475853;
CC       P0DTC5; P0DTC9: N; NbExp=6; IntAct=EBI-25475853, EBI-25475856;
CC       P0DTC5; Q9BYX4: IFIH1; Xeno; NbExp=3; IntAct=EBI-25475853, EBI-6115771;
CC       P0DTC5; Q7Z434: MAVS; Xeno; NbExp=11; IntAct=EBI-25475853, EBI-995373;
CC       P0DTC5; O00487: PSMD14; Xeno; NbExp=2; IntAct=EBI-25475853, EBI-722193;
CC       P0DTC5; Q9UHD2: TBK1; Xeno; NbExp=10; IntAct=EBI-25475853, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Virion membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04202}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_04202}. Host Golgi apparatus membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04202, ECO:0000269|PubMed:33060197}; Multi-pass membrane
CC       protein {ECO:0000255|HAMAP-Rule:MF_04202}. Host membrane
CC       {ECO:0000269|PubMed:33060197}; Multi-pass membrane protein.
CC       Note=Largely embedded in the lipid bilayer. {ECO:0000255|HAMAP-
CC       Rule:MF_04202}.
CC   -!- PTM: Glycosylated at N-terminus by host. {ECO:0000269|PubMed:35931673,
CC       ECO:0000269|PubMed:36264056, ECO:0000269|PubMed:38666819}.
CC   -!- POLYMORPHISM: Variant Delta/B.1.617.2 belongs to a lineage first
CC       isolated in India (October 2020) and is also called G/478K.V1. It has
CC       an estimated 97% increase of transmissibility. {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronaviruses M protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04202}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43419.1; -; Genomic_RNA.
DR   PDB; 7VGR; EM; 2.70 A; A/B=1-222.
DR   PDB; 7VGS; EM; 2.80 A; A/B=1-222.
DR   PDB; 8CME; X-ray; 2.26 A; C/F/I=176-190.
DR   PDB; 8CTK; EM; 3.52 A; A/B=1-222.
DR   PDBsum; 7VGR; -.
DR   PDBsum; 7VGS; -.
DR   PDBsum; 8CME; -.
DR   PDBsum; 8CTK; -.
DR   EMDB; EMD-26993; -.
DR   EMDB; EMD-31977; -.
DR   EMDB; EMD-31978; -.
DR   SMR; P0DTC5; -.
DR   BioGRID; 4383846; 2055.
DR   IntAct; P0DTC5; 270.
DR   MINT; P0DTC5; -.
DR   TCDB; 1.A.117.1.2; the coronavirus membrane matrix-protein (m-protein) family.
DR   GlyGen; P0DTC5; 1 site.
DR   iPTMnet; P0DTC5; -.
DR   ABCD; P0DTC5; 10 sequenced antibodies.
DR   DNASU; 43740571; -.
DR   KEGG; vg:43740571; -.
DR   AGR; RefSeq:YP_009724393; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-918233; TRAF3-dependent IRF activation pathway.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694594; Maturation of protein M.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9754560; SARS-CoV-2 modulates autophagy.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC5; -.
DR   PRO; PR:P0DTC5; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProt.
DR   GO; GO:0044178; C:host cell Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-UniRule.
DR   GO; GO:0055036; C:virion membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0039660; F:structural constituent of virion; IDA:UniProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0039545; P:symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of MAVS activity; IDA:UniProt.
DR   GO; GO:0019049; P:virus-mediated perturbation of host defense response; IEA:UniProtKB-KW.
DR   CDD; cd21569; SARS-like-CoV_M; 1.
DR   HAMAP; MF_04202; BETA_CORONA_M; 1.
DR   InterPro; IPR002574; M_CoV.
DR   InterPro; IPR044361; M_SARS-like-CoV.
DR   Pfam; PF01635; CoV_M; 1.
DR   PROSITE; PS51927; COV_M; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Glycoprotein; Host Golgi apparatus; Host membrane;
KW   Host-virus interaction; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Viral envelope protein; Viral immunoevasion;
KW   Viral matrix protein; Virion.
FT   CHAIN           1..222
FT                   /note=""Membrane protein""
FT                   /id=""PRO_0000449652""
FT   TOPO_DOM        2..16
FT                   /note=""Virion surface""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TRANSMEM        17..36
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TOPO_DOM        37..44
FT                   /note=""Intravirion""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TRANSMEM        45..70
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TOPO_DOM        71..75
FT                   /note=""Virion surface""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TRANSMEM        76..105
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   TOPO_DOM        106..222
FT                   /note=""Intravirion""
FT                   /evidence=""ECO:0000269|PubMed:36264056""
FT   CARBOHYD        5
FT                   /note=""N-linked (GlcNAc...) asparagine; by host""
FT                   /evidence=""ECO:0000269|PubMed:35931673,
FT                   ECO:0000269|PubMed:36264056, ECO:0000269|PubMed:38666819""
FT   VARIANT         3
FT                   /note=""D -> G (in strain: Omicron/BA.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> N (in strain: Omicron/BA.5, Omicron/BQ.1.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         19
FT                   /note=""Q -> E (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""A -> T (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         82
FT                   /note=""I -> T (in strain: Eta/B.1.525 and Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         42..44
FT                   /note=""RNR->ANA: Partial loss of N-RNA binding.""
FT                   /evidence=""ECO:0000269|PubMed:35931673""
FT   HELIX           11..36
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   TURN            40..42
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   HELIX           44..70
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   HELIX           77..105
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   HELIX           109..112
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          117..135
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          138..140
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   TURN            145..147
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          149..151
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          154..157
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          167..170
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          172..174
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          177..182
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          188..190
FT                   /evidence=""ECO:0007829|PDB:7VGR""
FT   STRAND          195..200
FT                   /evidence=""ECO:0007829|PDB:7VGR""
SQ   SEQUENCE   222 AA;  25147 MW;  ED44D84C3BB9A6DB CRC64;
     MADSNGTITV EELKKLLEQW NLVIGFLFLT WICLLQFAYA NRNRFLYIIK LIFLWLLWPV
     TLACFVLAAV YRINWITGGI AIAMACLVGL MWLSYFIASF RLFARTRSMW SFNPETNILL
     NVPLHGTILT RPLLESELVI GAVILRGHLR IAGHHLGRCD IKDLPKEITV ATSRTLSYYK
     LGASQRVAGD SGFAAYSRYR IGNYKLNTDH SSSSDNIALL VQ
//
",45794
GTGATG TGATGA GATGAT ATGATC TGATCG GATCGA ATCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGT GGCGTG GCGTGC CGTGCC GTGCCG TGCCGT GCCGTT CCGTTG CGTTGA GTTGAC TTGACC TGACCG GACCGG ACCGGC CCGGCT CGGCTC GGCTCG GCTCGC CTCGCG TCGCGT CGCGTG GCGTGA CGTGAT GTGATG TGATGG GATGGC ATGGCG TGGCGC GGCGCA GCGCAC CGCACG GCACGT CACGTC ACGTCA CGTCAG GTCAGC TCAGCT CAGCTC AGCTCA GCTCAA CTCAAC TCAACA CAACAG AACAGC ACAGCA CAGCAT AGCATC GCATCA CATCAG ATCAGC TCAGCC CAGCCC AGCCCG GCCCGG CCCGGT CCGGTG CGGTGA GGTGAT GTGATG TGATGA GATGAT ATGATT TGATTG GATTGA ATTGAG TTGAGC TGAGCG GAGCGC AGCGCG GCGCGT CGCGTC GCGTCG CGTCGA GTCGAA TCGAAG CGAAGT GAAGTA AAGTAA AGTAAT GTAATC TAATCT AATCTC ATCTCC TCTCCG CTCCGG TCCGGC CCGGCG CGGCGC GGCGCC GCGCCT CGCCTC GCCTCC CCTCCA CTCCAG TCCAGC CCAGCA CAGCAT AGCATC GCATCT CATCTA ATCTAC TCTACG CTACGG TACGGT ACGGTG CGGTGC GGTGCC GTGCCG TGCCGG GCCGGG CCGGGG CGGGGC GGGGCC GGGCCA GGCCAC GCCACG CCACGG CACGGG ACGGGC CGGGCG GGGCGG GGCGGT GCGGTC CGGTCT GGTCTG GTCTGA TCTGAT CTGATC,2,139,GTGA TGAT GATG ATGA TGAT GATC ATCG TCGA CGAC GACG ACGG CGGC GGCG GCGT CGTG GTGC TGCC GCCG CCGT CGTT GTTG TTGA TGAC GACC ACCG CCGG CGGC GGCT GCTC CTCG TCGC CGCG GCGT CGTG GTGA TGAT GATG ATGG TGGC GGCG GCGC CGCA GCAC CACG ACGT CGTC GTCA TCAG CAGC AGCT GCTC CTCA TCAA CAAC AACA ACAG CAGC AGCA GCAT CATC ATCA TCAG CAGC AGCC GCCC CCCG CCGG CGGT GGTG GTGA TGAT GATG ATGA TGAT GATT ATTG TTGA TGAG GAGC AGCG GCGC CGCG GCGT CGTC GTCG TCGA CGAA GAAG AAGT AGTA GTAA TAAT AATC ATCT TCTC CTCC TCCG CCGG CGGC GGCG GCGC CGCC GCCT CCTC CTCC TCCA CCAG CAGC AGCA GCAT CATC ATCT TCTA CTAC TACG ACGG CGGT GGTG GTGC TGCC GCCG CCGG CGGG GGGG GGGC GGCC GCCA CCAC CACG ACGG CGGG GGGC GGCG GCGG CGGT GGTC GTCT TCTG CTGA TGAT GATC,GTGAT TGATG GATGA ATGAT TGATC GATCG ATCGA TCGAC CGACG GACGG ACGGC CGGCG GGCGT GCGTG CGTGC GTGCC TGCCG GCCGT CCGTT CGTTG GTTGA TTGAC TGACC GACCG ACCGG CCGGC CGGCT GGCTC GCTCG CTCGC TCGCG CGCGT GCGTG CGTGA GTGAT TGATG GATGG ATGGC TGGCG GGCGC GCGCA CGCAC GCACG CACGT ACGTC CGTCA GTCAG TCAGC CAGCT AGCTC GCTCA CTCAA TCAAC CAACA AACAG ACAGC CAGCA AGCAT GCATC CATCA ATCAG TCAGC CAGCC AGCCC GCCCG CCCGG CCGGT CGGTG GGTGA GTGAT TGATG GATGA ATGAT TGATT GATTG ATTGA TTGAG TGAGC GAGCG AGCGC GCGCG CGCGT GCGTC CGTCG GTCGA TCGAA CGAAG GAAGT AAGTA AGTAA GTAAT TAATC AATCT ATCTC TCTCC CTCCG TCCGG CCGGC CGGCG GGCGC GCGCC CGCCT GCCTC CCTCC CTCCA TCCAG CCAGC CAGCA AGCAT GCATC CATCT ATCTA TCTAC CTACG TACGG ACGGT CGGTG GGTGC GTGCC TGCCG GCCGG CCGGG CGGGG GGGGC GGGCC GGCCA GCCAC CCACG CACGG ACGGG CGGGC GGGCG GGCGG GCGGT CGGTC GGTCT GTCTG TCTGA CTGAT TGATC,GTGATG TGATGA GATGAT ATGATC TGATCG GATCGA ATCGAC TCGACG CGACGG GACGGC ACGGCG CGGCGT GGCGTG GCGTGC CGTGCC GTGCCG TGCCGT GCCGTT CCGTTG CGTTGA GTTGAC TTGACC TGACCG GACCGG ACCGGC CCGGCT CGGCTC GGCTCG GCTCGC CTCGCG TCGCGT CGCGTG GCGTGA CGTGAT GTGATG TGATGG GATGGC ATGGCG TGGCGC GGCGCA GCGCAC CGCACG GCACGT CACGTC ACGTCA CGTCAG GTCAGC TCAGCT CAGCTC AGCTCA GCTCAA CTCAAC TCAACA CAACAG AACAGC ACAGCA CAGCAT AGCATC GCATCA CATCAG ATCAGC TCAGCC CAGCCC AGCCCG GCCCGG CCCGGT CCGGTG CGGTGA GGTGAT GTGATG TGATGA GATGAT ATGATT TGATTG GATTGA ATTGAG TTGAGC TGAGCG GAGCGC AGCGCG GCGCGT CGCGTC GCGTCG CGTCGA GTCGAA TCGAAG CGAAGT GAAGTA AAGTAA AGTAAT GTAATC TAATCT AATCTC ATCTCC TCTCCG CTCCGG TCCGGC CCGGCG CGGCGC GGCGCC GCGCCT CGCCTC GCCTCC CCTCCA CTCCAG TCCAGC CCAGCA CAGCAT AGCATC GCATCT CATCTA ATCTAC TCTACG CTACGG TACGGT ACGGTG CGGTGC GGTGCC GTGCCG TGCCGG GCCGGG CCGGGG CGGGGC GGGGCC GGGCCA GGCCAC GCCACG CCACGG CACGGG ACGGGC CGGGCG GGGCGG GGCGGT GCGGTC CGGTCT GGTCTG GTCTGA TCTGAT CTGATC,GTGATGA TGATGAT GATGATC ATGATCG TGATCGA GATCGAC ATCGACG TCGACGG CGACGGC GACGGCG ACGGCGT CGGCGTG GGCGTGC GCGTGCC CGTGCCG GTGCCGT TGCCGTT GCCGTTG CCGTTGA CGTTGAC GTTGACC TTGACCG TGACCGG GACCGGC ACCGGCT CCGGCTC CGGCTCG GGCTCGC GCTCGCG CTCGCGT TCGCGTG CGCGTGA GCGTGAT CGTGATG GTGATGG TGATGGC GATGGCG ATGGCGC TGGCGCA GGCGCAC GCGCACG CGCACGT GCACGTC CACGTCA ACGTCAG CGTCAGC GTCAGCT TCAGCTC CAGCTCA AGCTCAA GCTCAAC CTCAACA TCAACAG CAACAGC AACAGCA ACAGCAT CAGCATC AGCATCA GCATCAG CATCAGC ATCAGCC TCAGCCC CAGCCCG AGCCCGG GCCCGGT CCCGGTG CCGGTGA CGGTGAT GGTGATG GTGATGA TGATGAT GATGATT ATGATTG TGATTGA GATTGAG ATTGAGC TTGAGCG TGAGCGC GAGCGCG AGCGCGT GCGCGTC CGCGTCG GCGTCGA CGTCGAA GTCGAAG TCGAAGT CGAAGTA GAAGTAA AAGTAAT AGTAATC GTAATCT TAATCTC AATCTCC ATCTCCG TCTCCGG CTCCGGC TCCGGCG CCGGCGC CGGCGCC GGCGCCT GCGCCTC CGCCTCC GCCTCCA CCTCCAG CTCCAGC TCCAGCA CCAGCAT CAGCATC AGCATCT GCATCTA CATCTAC ATCTACG TCTACGG CTACGGT TACGGTG ACGGTGC CGGTGCC GGTGCCG GTGCCGG TGCCGGG GCCGGGG CCGGGGC CGGGGCC GGGGCCA GGGCCAC GGCCACG GCCACGG CCACGGG CACGGGC ACGGGCG CGGGCGG GGGCGGT GGCGGTC GCGGTCT CGGTCTG GGTCTGA GTCTGAT TCTGATC,"ID   IUTA_KLEPN              Reviewed;         733 AA.
AC   Q6U607;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   27-NOV-2024, entry version 99.
DE   RecName: Full=Ferric aerobactin receptor;
DE   AltName: Full=Iron-regulated outer membrane proteins;
DE            Short=IROMPs;
DE   Flags: Precursor;
GN   Name=iutA; ORFNames=LV107;
OS   Klebsiella pneumoniae.
OG   Plasmid pLVPK.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella.
OX   NCBI_TaxID=573;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=CG43;
RX   PubMed=15276215; DOI=10.1016/j.gene.2004.05.008;
RA   Chen Y.-T., Chang H.-Y., Lai Y.-C., Pan C.-C., Tsai S.-F., Peng H.-L.;
RT   ""Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella
RT   pneumoniae CG43."";
RL   Gene 337:189-198(2004).
RN   [2]
RP   FUNCTION AS AN AEROBACTIN RECEPTOR, INDUCTION, AND SUBCELLULAR LOCATION.
RA   Williams P., Chart H., Griffiths E., Stevenson P.;
RT   ""Expression of high affinity iron uptake systems by clinical isolates of
RT   Klebsiella."";
RL   FEMS Microbiol. Lett. 44:407-412(1987).
CC   -!- FUNCTION: Receptor for aerobactin. {ECO:0000269|Ref.2}.
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU01360, ECO:0000269|Ref.2}; Multi-pass membrane protein
CC       {ECO:0000255|PROSITE-ProRule:PRU01360}.
CC   -!- INDUCTION: Under iron starvation. {ECO:0000269|Ref.2}.
CC   -!- SIMILARITY: Belongs to the TonB-dependent receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY378100; AAR07714.1; -; Genomic_DNA.
DR   RefSeq; NP_943364.1; NC_005249.1.
DR   RefSeq; WP_004213924.1; NZ_WYAM01000033.1.
DR   AlphaFoldDB; Q6U607; -.
DR   SMR; Q6U607; -.
DR   PHI-base; PHI:6563; -.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015344; F:siderophore uptake transmembrane transporter activity; IEA:TreeGrafter.
DR   GO; GO:0038023; F:signaling receptor activity; IEA:InterPro.
DR   GO; GO:0019271; P:aerobactin transport; ISS:UniProtKB.
DR   CDD; cd01347; ligand_gated_channel; 1.
DR   FunFam; 2.40.170.20:FF:000007; Ferric aerobactin receptor; 1.
DR   FunFam; 2.170.130.10:FF:000011; TonB-dependent siderophore receptor; 1.
DR   Gene3D; 2.40.170.20; TonB-dependent receptor, beta-barrel domain; 1.
DR   Gene3D; 2.170.130.10; TonB-dependent receptor, plug domain; 1.
DR   InterPro; IPR012910; Plug_dom.
DR   InterPro; IPR037066; Plug_dom_sf.
DR   InterPro; IPR039426; TonB-dep_rcpt-like.
DR   InterPro; IPR000531; TonB-dep_rcpt_b-brl.
DR   InterPro; IPR010916; TonB_box_CS.
DR   InterPro; IPR036942; TonB_rcpt_b-brl_sf.
DR   InterPro; IPR010917; TonB_rcpt_CS.
DR   InterPro; IPR010105; TonB_sidphr_rcpt.
DR   NCBIfam; TIGR01783; TonB-siderophor; 1.
DR   PANTHER; PTHR30069:SF42; FERRIC AEROBACTIN RECEPTOR; 1.
DR   PANTHER; PTHR30069; TONB-DEPENDENT OUTER MEMBRANE RECEPTOR; 1.
DR   Pfam; PF07715; Plug; 1.
DR   Pfam; PF00593; TonB_dep_Rec_b-barrel; 1.
DR   SUPFAM; SSF56935; Porins; 1.
DR   PROSITE; PS00430; TONB_DEPENDENT_REC_1; 1.
DR   PROSITE; PS01156; TONB_DEPENDENT_REC_2; 1.
DR   PROSITE; PS52016; TONB_DEPENDENT_REC_3; 1.
PE   1: Evidence at protein level;
KW   Cell outer membrane; Ion transport; Iron; Iron transport; Membrane;
KW   Plasmid; Receptor; Signal; TonB box; Transmembrane;
KW   Transmembrane beta strand; Transport.
FT   SIGNAL          1..25
FT   CHAIN           26..733
FT                   /note=""Ferric aerobactin receptor""
FT                   /id=""PRO_0000415650""
FT   DOMAIN          43..153
FT                   /note=""TBDR plug""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01360""
FT   DOMAIN          158..733
FT                   /note=""TBDR beta-barrel""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01360""
FT   MOTIF           31..38
FT                   /note=""TonB box""
FT                   /evidence=""ECO:0000250""
FT   MOTIF           716..733
FT                   /note=""TonB C-terminal box""
FT                   /evidence=""ECO:0000250""
SQ   SEQUENCE   733 AA;  80853 MW;  3CC6ED07B19467D9 CRC64;
     MMISKKYTLW ALNPLLLTMM APAVAQQTDD ETFVVSANRS NRTVAEMAQT TWVIENAELE
     QQIQGGKELK DALAQLIPGL DVSSRSRTNY GMNVRGRPLV VLVDGVRLNS SRTDSRQLDS
     IDPFNIDRIE VISGATSLYG GGSTGGLINI VTKKGQPETI MEFEAGTKSG FSSSKDHDER
     IAGAVSGGNE HISGRLSVAY QKFGGWFDGN GDATLLDNTQ TGLQYSDRLD IMGTGTLNID
     ESRQLQLITQ YYKSQGDDDY GLNLGKGFSA IRGTSTPFVS NGLNSDRIPG TERHLISLQY
     SDSAFLGQEL VGQVYYRDES LRFYPFPTVN ANKQVTAFSS SQQDTDQYGM KLTLNSKPMD
     GWQITWGLDA DHERFTSNQM FFDLAQASAS GGLNNKKIYT TGRYPSYDIT NLAAFLQSGY
     DINNLFTLNG GVRYQYTENK IDDFIGYAQQ RQIAAGKATS ADAIPGGSVD YDNFLFNAGL
     LMHITERQQA WLNFSQGVEL PDPGKYYGRG IYGAAVNGHL PLTKSVNVSD SKLEGVKVDS
     YELGWRFTGN NLRTQIAAYY SISDKSVVAN KDLTISVVDD KRRIYGVEGA VDYLIPDTDW
     STGVNFNVLK TESKVNGTWQ KYDVKTASPS KATAYIGWAP DPWSLRVQST TSFDVSDAQG
     YKVDGYTTVD LLGSYQLPVG TLSFSIENLF DRDYTTVWGQ RAPLYYSPGY GPASLYDYKG
     RGRTFGLNYS VLF
//
",28350
TTGACT TGACTC GACTCA ACTCAC CTCACC TCACCC CACCCT ACCCTG CCCTGA CCTGAA CTGAAA TGAAAT GAAATC AAATCT AATCTA ATCTAT TCTATG CTATGA TATGAA ATGAAG TGAAGA GAAGAC AAGACA AGACAT GACATG ACATGG CATGGG ATGGGT TGGGTA GGGTAT GGTATT GTATTA TATTAA ATTAAA TTAAAC TAAACC AAACCA AACCAC ACCACC CCACCT CACCTA ACCTAA CCTAAG CTAAGG TAAGGG AAGGGT AGGGTG GGGTGT GGTGTT GTGTTA TGTTAT GTTATC TTATCA TATCAT ATCATG TCATGT CATGTA ATGTAT TGTATG GTATGG TATGGC ATGGCC TGGCCC GGCCCA GCCCAC CCCACC CCACCT,3,67, GGTGATA A T TGCTGGACAC C GTGA CAACT CCT A ACACTCTCC C CTCTCCA  TCTCACACG G TA CACAC GCCC  ACACCCCCAAAAT  TCCCTCT GA  CCCCTTGATG G C CTCTG GAA T TGTGAA G GAGAAAAAAA GTTCACCACAATAT T A AAAATATCTC TGG ATAAGTCTCT T T TCTCTCTATA A C CTCTATATAT T T TATATATGTG TGA ATATGTGAT CA T TGG AGAAAA A G GAGAAAAGTGTG A AAAAGAGAGA A A AGAGAGACC G GAGACACATA A A ACACACATAT T C CAATGTG ACC ATATGTC  TAG T TGGGGGG AC  ATGGTGT T G GGGGTGTAA G GTGTATATAT T T TATATATTT AAAA AATA A T TTTTAAA A T TATAAGGGAA A ACC AACAC CCAACCCC C A ACACCA C CCCCA AAC CGACCACACCCC C A ACG ACCTCT T C CCCCTCTAGA A C CTAC TAAC AA TGG TAAATCGT G A AAAAGAGGGG G A AGAGGGG G GGGGGGTGT T G GGGGTGTGGGCG G GTTGTT T TGTGTTT T G GTTTACA A T TTTTATATAT T T TATATATCC AATCTCACA A T CCTCACATAT T CTC ATGTG  ATATGAG AG T TTGTGTATA A G GTGTATATC CT T CATATATGTG G A ATATGC AGG G T TGTGGTG GC TTGGGCGCCCC C GACCGCCCC C C CCCCCC ACA A CCT CCACACAC C C CAAAAACCCC C A ACACCCCT,TTG GTGACA AC T TGTGAGACACTCT T G GAGACACTCTCTC  AT ACACTCTCTCAGAAA C CTCTCTCACACAC C T TCCACACCCC C CCACACCCC C A ACACCCCCCT T C CCCCCGA CTGTG GTGCCTCTGTGACCTA C CTCTGTGACA AA C CTGAGAAAAAAA A GATGGAAAAAAATAT T A AAAA ATCTC  GA AAAATATCTCTCT T A ATATCTCTCTATA AT  TCTCTCTAAT TGG CTCTATATATGTG G T TAAA ATGTGA ATATGTGAGAAA T TGTGAGAAAAGAG G GC AGAATCAAGAG TAC  AAAAGAGAGACAC C A AGAGACACACAA GCACGACACACATTATT A ACACACAT GTTG CCT CACATATGT CGG CCT ATATGTGGGG  TGTGGGGGGT  GGGGGGGTGTAAACA G GGGGTGCCA TAT T G GTGTATATATTGTT TATATATTTTATA A ACCCATTTTATAATATA T TTGA TAAAAAA T TATAAAAATA TGAC A AAAAAACCCC C A AAAAGACCCA A A ACACCCCAAC C C CC GAACCGGT CACACATGT A ACACCCCTCTATA A C CCCTATAA CTCTATAA AGG T TATAAAGGGG G AAAGAGGGGGGG G AG CAGGGGGGGTGT T G GGGGGCC GTGTG G G GGGGTAAGTGTGT T GCA GTGTGTTT T T TGTGTTTATA A GAC GTTTTATATAT T T TTTTATATGTATC  TATATATCAAGCATA A ATATCTCACA AT T T TCTCACATATG CCG C CAATG TAT A ATTGTA T TGTGTTATAT T GATGGTATATATGTG G TTAT GATGGG AC ACT GGCGC C T TGTGGGGCGTACC C G GGGGCGCCCCCCC A A GCGCCCCCCCACA A C CCCCCCACAC C CTG CCACACCC C C CAGACCCT,TTGTGAGACGACT AT TC ATGAGACACTAC TC C GGACACTCTCCCACA  ACTG CTCA AAC C C CTCTCCACACCCC C T TCTCACACCCCCC  CACACACCCCCCCTCT CT  ACACCCCTCTGTG G C CCCCCCCTAAAGA CAT CCCCTCTGTGAGAAAA A C CTCTGTGAGAAAAAAA GGG TGTGAA TAAAT GTCTGAA AAAATATCTC C AAAAAAAATGATCTCTCT TGTAGGAATATCTCTCTA TTGGTCC ATC ACCTATAT GACAC TCAT CTATATATGTGT CTCTATATATGGA A T TAATG GGAA A A ATTGAGAAAAGG T TGTGAAAGGAAAGAGA AAG GAGAAAAGAGAGACC CC A AAAAGAGAGACACACA A A AGAGAGACGTACATAT T G GAACTACA GGATG ACCATATGTGGGG G CCATATGTGGGGGGG ATGA AGT T T TGGGGGGTGTATA A GGGGGGTGTATATAT AA GGTATGTATATTTT T G GTGTATATTTA TATATATTTTATAAAA  ATATTTTATAAAAAT GA TCACTTATAATGACTCC TTGGTATAAAACCACCCC C A AAAAAAACACCCCACA A A AAAACACCCCACACAC C ACCAT T TA ATACT CCCCACACACCCCTCT T C CAACCCCTCTATA A A ACAACCCTTAAAA A C CCCCTCTATAAAG G C CTCTATAAGC AGGGG G TATGTAAA GAGGA TGG G A AAAAG AAGGGGGTTTAT AAGGGGGGGTGTGC CG G TTGGGGGTGTGTGTGT T GCATGGTGTGTGTGTTTT AAG GTGTGTGT GGGT TA A T TGT AGTTTTATATAT T G GTGTTTATATCTC C TTGATTATATATCTCACA GAAACCTATATCTCACATAT T A ATATCTCAATGTG G T TCTCAATGTGTCTG CAA CATGTGTTA A A ATATGTG ACATATAT T T TGTGTGTATATGTAG G GTGTATATGTTTGGGG  TATATAATTGGT G TG ATATGTGGGGCGCCCC C T TGTGGGGCGCCCCCCC C GATGGGCGCCCCCCA A G GCGCCCCCCACAC C CCCCCCATA ACCCC AC  CCCCAACCCCT,TTGTGGAC ACTCTCTC C T TGGACCTCGAAGGTA GGACACTCTCTCACACAC C A ACACTCTCTCAAAGACCCC C C CTCTCTCAA GCCCCC C T TCTCAACCGCCCCTCT T CAGAGCCCCCCCTCTGTG G A ACACCCCCCCTCACTGAGA A C CCCCCCCTCCTTGAGAAAA A C CCCCTCTGTGAGAAAAAAA A C CTCTGCATAAAAATT T TGTGAGAAG TAATATCTC  GG GAAAAAATATGT ACT T AAAAAATATCTCTCTATA A A AAAATTCTCTATATAT T AATCCTATATT ATG G T TCTCTCTATATATGTATGA A C CTCTATATATGTGAGAAAA A T ATTATATGTGAGAAAAGC GG A ATATGGAAAAGCACGA A T TGTGAGAAAAGAGAGACATCC G GAGAAGTAAGAGACACAA A AAAAGAGAGACACACATAT T A AGAGAGACACACATTG G G GAGACACACATAC TGAGG G A ACACACATATGTGGGGGGG G C CAGAAATGTGGGGGTATT A ATATGTGGGGGGTATA A T TGTGGGGGGGTGTATGAAT T G TAGGGGGTGTATAT TATT T G GGGTATATATTTTATA A G GTTA AG ATTTTATAAAA A TTGATATATTTTATAAAAAC TATTTAAAAAAACGACTGT TTTTACACAAAAACACCCC C T GGTAAAAAACCCCACA  AAAAAAACACCCCAAC C A AAAACCCACACACCCC C A ACACCCCACACACCGGCCT T C CCCCACTGACCCCTCATGGTA C CACACACCCTGTCATAAAA CCA ACACCCCTCTATAACACAG G C CCCCTCTATAAATGAGGGG G C CTCTATAAAAGAGGGGGGG AAA TATAAGGCAGGGGGTGTGT TCT AAAAGAGGCCCGGTGTGTG  AGAGGATGGGTGTGTGTGT T G GGAAGGTGTGTGTTTT T G GGGGTGTGTGTGTTTTATA A G GTCATTGTGTTTTATATT TTGTTTATATATCTC C G GTGTTCCAATCTCACA A TTAATTATATATCCTACATAT T T TATATATCTCAGGGTG G A TAATCTCACATATG GCGT T T TCTCACACGCCGTATA A C CACTAATGTGTGTATATAT ATG ATATGTGTCC TATATGTG G T TGTGTCACTATAAGTGGGG G G GTTATATGTGGGGCGC C TATTTATATGTGGCCTGGGCC C A ATTGGAAGCACCCCGTAC T TGTGGGGCAA CCCCCACA ACCGGCACCCCCA A TTAC C GGGTGCCCCCCCACACACCCC C C CCCCCCA CACACC,"ID   PRS4_CHICK              Reviewed;         440 AA.
AC   Q90732;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   05-FEB-2025, entry version 120.
DE   RecName: Full=26S proteasome regulatory subunit 4;
DE            Short=P26s4;
DE   AltName: Full=26S proteasome AAA-ATPase subunit RPT2;
DE   AltName: Full=Proteasome 26S subunit ATPase 1;
GN   Name=PSMC1;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8806779; DOI=10.1006/abbi.1996.0389;
RA   Singh I., Cai H., Wagner B.J.;
RT   ""cDNA cloning of a chick homologue of human ATPase complex subunit 4,
RT   quantitative tissue distribution and tertiary structure comparison of the
RT   ATPase domain to RecA."";
RL   Arch. Biochem. Biophys. 333:260-266(1996).
CC   -!- FUNCTION: The 26S proteasome is involved in the ATP-dependent
CC       degradation of ubiquitinated proteins. The regulatory (or ATPase)
CC       complex confers ATP dependency and substrate specificity to the 26S
CC       complex.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U60187; AAC60013.1; -; mRNA.
DR   PIR; S74197; S74197.
DR   RefSeq; NP_990289.1; NM_204958.1.
DR   AlphaFoldDB; Q90732; -.
DR   SMR; Q90732; -.
DR   STRING; 9031.ENSGALP00000017347; -.
DR   PaxDb; 9031-ENSGALP00000017347; -.
DR   GeneID; 395804; -.
DR   KEGG; gga:395804; -.
DR   CTD; 5700; -.
DR   VEuPathDB; HostDB:geneid_395804; -.
DR   eggNOG; KOG0726; Eukaryota.
DR   InParanoid; Q90732; -.
DR   OrthoDB; 10255768at2759; -.
DR   PhylomeDB; Q90732; -.
DR   PRO; PR:Q90732; -.
DR   Proteomes; UP000000539; Unassembled WGS sequence.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0022624; C:proteasome accessory complex; ISS:UniProtKB.
DR   GO; GO:0008540; C:proteasome regulatory particle, base subcomplex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0036402; F:proteasome-activating activity; IBA:GO_Central.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   CDD; cd19502; RecA-like_PAN_like; 1.
DR   FunFam; 2.40.50.140:FF:000067; 26S protease regulatory subunit 4; 1.
DR   FunFam; 1.10.8.60:FF:000007; 26S proteasome regulatory subunit 4; 1.
DR   FunFam; 3.40.50.300:FF:000039; 26S proteasome regulatory subunit 4; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR050221; 26S_Proteasome_ATPase.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR032501; Prot_ATP_ID_OB_2nd.
DR   PANTHER; PTHR23073; 26S PROTEASOME REGULATORY SUBUNIT; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF17862; AAA_lid_3; 1.
DR   Pfam; PF16450; Prot_ATP_ID_OB_C; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00674; AAA; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cytoplasm; Nucleotide-binding; Nucleus; Proteasome;
KW   Reference proteome.
FT   CHAIN           1..440
FT                   /note=""26S proteasome regulatory subunit 4""
FT                   /id=""PRO_0000084680""
FT   REGION          1..53
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          84..105
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        14..26
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        86..103
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         226..233
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   440 AA;  49204 MW;  259F5CA691218527 CRC64;
     MGQSQSGGHG PGGGKKDDKD KKKKYEPPVP TRVGKKKKKT KGPDAASKPP LVTPHTQCRL
     KLLKLERIKD YLLMEEEFIR NQEQMKPLEE KQEEERSKVD DLRGTPMSVG TLEEIIDDNH
     AIVSTSVGSE HYVSILSFVD KDLLEPGCSV LLNHKVHAVI GVLMDDTDPL VTVMKLEKAP
     QETYADIGGL DNQIQEIKES VELPLTHPEY YEEMGIKPPK GVILYGPPGT GKTLLAKAVA
     NQTSATFLRV VGSELIQKYL GDGPKLVREL FRVAEEHGPS IVFIDEIDAI GTKRYDSNSG
     GEREIQRTML ELLNQLDGFD SRGDVKVIMA TNRIETLDPA LIRPGRIDRK IEFPLPDEKT
     KKRIFQIHTS RMTLADDVTL DELIMAKDDL SGADIKAICT EAGLMALRER RMKVTNEDFK
     KSKENFLYKK TEGTPEGLYL
//
",35154
GTCGCA TCGCAA CGCAAC GCAACA CAACAG AACAGT ACAGTT CAGTTC AGTTCA GTTCAA TTCAAG TCAAGA CAAGAA AAGAAA AGAAAT GAAATT AAATTC AATTCA ATTCAA TTCAAC TCAACT CAACTC AACTCC ACTCCA CTCCAG TCCAGG CCAGGC CAGGCA AGGCAG GGCAGC GCAGCA CAGCAG AGCAGT GCAGTA CAGTAA AGTAAA GTAAAC TAAACG AAACGA AACGAA ACGAAC CGAACT GAACTT AACTTC ACTTCT CTTCTC TTCTCC TCTCCT CTCCTG TCCTGC CCTGCT CTGCTA TGCTAG GCTAGA CTAGAA TAGAAT AGAATG GAATGG AATGGC ATGGCA TGGCAG GGCAGG GCAGGC CAGGCA AGGCAA GGCAAT GCAATG CAATGG AATGGC ATGGCG TGGCGG GGCGGA GCGGAG CGGAGC GGAGCT GAGCTT AGCTTC GCTTCT CTTCTG TTCTGC TCTGCA CTGCAC TGCACC GCACCT CACCTG ACCTGG CCTGGT CTGGTT TGGTTT GGTTTG GTTTGC TTTGCT TTGCTG TGCTGG GCTGGT CTGGTG TGGTGC GGTGCC GTGCCT TGCCTG GCCTGA CCTGAA CTGAAA TGAAAG GAAAGA AAAGAA AAGAAT AGAATT GAATTA AATTAA ATTAAC TTAACC TAACCA AACCAG ACCAGG CCAGGT CAGGTT AGGTTG GGTTGT GTTGTG TTGTGC TGTGCG GTGCGC TGCGCT GCGCTA CGCTAA GCTAAA CTAAAC TAAACG AAACGT AACGTT ACGTTT CGTTTT GTTTTG TTTTGT TTTGTT TTGTTA TGTTAA GTTAAG TTAAGG TAAGGC AAGGCC AGGCCT GGCCTA GCCTAA,3,145,GTCG TCGC CGCA GCAA CAAC AACA ACAG CAGT AGTT GTTC TTCA TCAA CAAG AAGA AGAA GAAA AAAT AATT ATTC TTCA TCAA CAAC AACT ACTC CTCC TCCA CCAG CAGG AGGC GGCA GCAG CAGC AGCA GCAG CAGT AGTA GTAA TAAA AAAC AACG ACGA CGAA GAAC AACT ACTT CTTC TTCT TCTC CTCC TCCT CCTG CTGC TGCT GCTA CTAG TAGA AGAA GAAT AATG ATGG TGGC GGCA GCAG CAGG AGGC GGCA GCAA CAAT AATG ATGG TGGC GGCG GCGG CGGA GGAG GAGC AGCT GCTT CTTC TTCT TCTG CTGC TGCA GCAC CACC ACCT CCTG CTGG TGGT GGTT GTTT TTTG TTGC TGCT GCTG CTGG TGGT GGTG GTGC TGCC GCCT CCTG CTGA TGAA GAAA AAAG AAGA AGAA GAAT AATT ATTA TTAA TAAC AACC ACCA CCAG CAGG AGGT GGTT GTTG TTGT TGTG GTGC TGCG GCGC CGCT GCTA CTAA TAAA AAAC AACG ACGT CGTT GTTT TTTT TTTG TTGT TGTT GTTA TTAA TAAG AAGG AGGC GGCC GCCT CCTA CTAA,GTCGC TCGCA CGCAA GCAAC CAACA AACAG ACAGT CAGTT AGTTC GTTCA TTCAA TCAAG CAAGA AAGAA AGAAA GAAAT AAATT AATTC ATTCA TTCAA TCAAC CAACT AACTC ACTCC CTCCA TCCAG CCAGG CAGGC AGGCA GGCAG GCAGC CAGCA AGCAG GCAGT CAGTA AGTAA GTAAA TAAAC AAACG AACGA ACGAA CGAAC GAACT AACTT ACTTC CTTCT TTCTC TCTCC CTCCT TCCTG CCTGC CTGCT TGCTA GCTAG CTAGA TAGAA AGAAT GAATG AATGG ATGGC TGGCA GGCAG GCAGG CAGGC AGGCA GGCAA GCAAT CAATG AATGG ATGGC TGGCG GGCGG GCGGA CGGAG GGAGC GAGCT AGCTT GCTTC CTTCT TTCTG TCTGC CTGCA TGCAC GCACC CACCT ACCTG CCTGG CTGGT TGGTT GGTTT GTTTG TTTGC TTGCT TGCTG GCTGG CTGGT TGGTG GGTGC GTGCC TGCCT GCCTG CCTGA CTGAA TGAAA GAAAG AAAGA AAGAA AGAAT GAATT AATTA ATTAA TTAAC TAACC AACCA ACCAG CCAGG CAGGT AGGTT GGTTG GTTGT TTGTG TGTGC GTGCG TGCGC GCGCT CGCTA GCTAA CTAAA TAAAC AAACG AACGT ACGTT CGTTT GTTTT TTTTG TTTGT TTGTT TGTTA GTTAA TTAAG TAAGG AAGGC AGGCC GGCCT GCCTA CCTAA,GTCGCA TCGCAA CGCAAC GCAACA CAACAG AACAGT ACAGTT CAGTTC AGTTCA GTTCAA TTCAAG TCAAGA CAAGAA AAGAAA AGAAAT GAAATT AAATTC AATTCA ATTCAA TTCAAC TCAACT CAACTC AACTCC ACTCCA CTCCAG TCCAGG CCAGGC CAGGCA AGGCAG GGCAGC GCAGCA CAGCAG AGCAGT GCAGTA CAGTAA AGTAAA GTAAAC TAAACG AAACGA AACGAA ACGAAC CGAACT GAACTT AACTTC ACTTCT CTTCTC TTCTCC TCTCCT CTCCTG TCCTGC CCTGCT CTGCTA TGCTAG GCTAGA CTAGAA TAGAAT AGAATG GAATGG AATGGC ATGGCA TGGCAG GGCAGG GCAGGC CAGGCA AGGCAA GGCAAT GCAATG CAATGG AATGGC ATGGCG TGGCGG GGCGGA GCGGAG CGGAGC GGAGCT GAGCTT AGCTTC GCTTCT CTTCTG TTCTGC TCTGCA CTGCAC TGCACC GCACCT CACCTG ACCTGG CCTGGT CTGGTT TGGTTT GGTTTG GTTTGC TTTGCT TTGCTG TGCTGG GCTGGT CTGGTG TGGTGC GGTGCC GTGCCT TGCCTG GCCTGA CCTGAA CTGAAA TGAAAG GAAAGA AAAGAA AAGAAT AGAATT GAATTA AATTAA ATTAAC TTAACC TAACCA AACCAG ACCAGG CCAGGT CAGGTT AGGTTG GGTTGT GTTGTG TTGTGC TGTGCG GTGCGC TGCGCT GCGCTA CGCTAA GCTAAA CTAAAC TAAACG AAACGT AACGTT ACGTTT CGTTTT GTTTTG TTTTGT TTTGTT TTGTTA TGTTAA GTTAAG TTAAGG TAAGGC AAGGCC AGGCCT GGCCTA GCCTAA,GTCGCAA TCGCAAC CGCAACA GCAACAG CAACAGT AACAGTT ACAGTTC CAGTTCA AGTTCAA GTTCAAG TTCAAGA TCAAGAA CAAGAAA AAGAAAT AGAAATT GAAATTC AAATTCA AATTCAA ATTCAAC TTCAACT TCAACTC CAACTCC AACTCCA ACTCCAG CTCCAGG TCCAGGC CCAGGCA CAGGCAG AGGCAGC GGCAGCA GCAGCAG CAGCAGT AGCAGTA GCAGTAA CAGTAAA AGTAAAC GTAAACG TAAACGA AAACGAA AACGAAC ACGAACT CGAACTT GAACTTC AACTTCT ACTTCTC CTTCTCC TTCTCCT TCTCCTG CTCCTGC TCCTGCT CCTGCTA CTGCTAG TGCTAGA GCTAGAA CTAGAAT TAGAATG AGAATGG GAATGGC AATGGCA ATGGCAG TGGCAGG GGCAGGC GCAGGCA CAGGCAA AGGCAAT GGCAATG GCAATGG CAATGGC AATGGCG ATGGCGG TGGCGGA GGCGGAG GCGGAGC CGGAGCT GGAGCTT GAGCTTC AGCTTCT GCTTCTG CTTCTGC TTCTGCA TCTGCAC CTGCACC TGCACCT GCACCTG CACCTGG ACCTGGT CCTGGTT CTGGTTT TGGTTTG GGTTTGC GTTTGCT TTTGCTG TTGCTGG TGCTGGT GCTGGTG CTGGTGC TGGTGCC GGTGCCT GTGCCTG TGCCTGA GCCTGAA CCTGAAA CTGAAAG TGAAAGA GAAAGAA AAAGAAT AAGAATT AGAATTA GAATTAA AATTAAC ATTAACC TTAACCA TAACCAG AACCAGG ACCAGGT CCAGGTT CAGGTTG AGGTTGT GGTTGTG GTTGTGC TTGTGCG TGTGCGC GTGCGCT TGCGCTA GCGCTAA CGCTAAA GCTAAAC CTAAACG TAAACGT AAACGTT AACGTTT ACGTTTT CGTTTTG GTTTTGT TTTTGTT TTTGTTA TTGTTAA TGTTAAG GTTAAGG TTAAGGC TAAGGCC AAGGCCT AGGCCTA GGCCTAA,"ID   ORF9C_SARS2             Reviewed;          73 AA.
AC   P0DTD3;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   27-NOV-2024, entry version 16.
DE   RecName: Full=Putative ORF9c protein {ECO:0000305|PubMed:32854725};
DE            Short=ORF9c;
DE   AltName: Full=Uncharacterized protein 14;
DE            Short=ORF14;
GN   ORFNames=9c;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   CONCEPTUAL TRANSLATION.
RX   PubMed=32854725; DOI=10.1186/s12985-020-01402-1;
RA   Michel C.J., Mayer C., Poch O., Thompson J.D.;
RT   ""Characterization of accessory genes in coronavirus genomes."";
RL   Virol. J. 17:131-131(2020).
RN   [3]
RP   GENOME REANNOTATION.
RX   PubMed=33976134; DOI=10.1038/s41467-021-22905-7;
RA   Jungreis I., Sealfon R., Kellis M.;
RT   ""SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44
RT   Sarbecovirus genomes."";
RL   Nat. Commun. 12:2642-2642(2021).
RN   [4]
RP   FUNCTION.
RX   PubMed=35180394; DOI=10.1016/j.stemcr.2022.01.014;
RA   Liu J., Zhang Y., Han L., Guo S., Wu S., Doud E.H., Wang C., Chen H.,
RA   Rubart-von der Lohe M., Wan J., Yang L.;
RT   ""Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral
RT   gene Orf9c on human pluripotent stem cell-derived cardiomyocytes."";
RL   Stem Cell Reports 17:522-537(2022).
CC   -!- FUNCTION: May induce apoptosis in cardiomyocytes when overexpressed ex-
CC       vivo. {ECO:0000269|PubMed:35180394}.
CC   -!- INTERACTION:
CC       P0DTD3; Q9H3K2: GHITM; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-2868909;
CC       P0DTD3; Q86VR2: RETREG3; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-10192441;
CC       P0DTD3; O43765: SGTA; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-347996;
CC       P0DTD3; Q9UMX0: UBQLN1; Xeno; NbExp=3; IntAct=EBI-25475917, EBI-741480;
CC       P0DTD3; Q9UHD9: UBQLN2; Xeno; NbExp=4; IntAct=EBI-25475917, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane
CC       protein {ECO:0000255}.
CC   -!- CAUTION: Product of a dubious CDS prediction.
CC       {ECO:0000303|PubMed:33976134}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   BioGRID; 4383954; 514.
DR   IntAct; P0DTD3; 126.
DR   MINT; P0DTD3; -.
DR   AGR; RefSeq:P0DTD3; -.
DR   PRO; PR:P0DTD3; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR035113; Protein_14_SARS-like.
DR   Pfam; PF17635; bCoV_Orf14; 1.
PE   5: Uncertain;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..73
FT                   /note=""Putative ORF9c protein""
FT                   /id=""PRO_0000449658""
FT   TRANSMEM        47..67
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   VARIANT         49
FT                   /note=""V -> L (in strain: Gamma)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         50
FT                   /note=""G -> N (in strain: Alpha/B.1.1.7, Gamma/P.1,
FT                   Omicron/BA.1, Omicron/BA.2, Omicron/BA.2.12.2,
FT                   Omicron/BA.4, Omicron BA.5)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         50
FT                   /note=""G -> W (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         52
FT                   /note=""L -> F (in strain: Beta/B.1.351)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   73 AA;  8050 MW;  8CCDEF1C0EA37D06 CRC64;
     MLQSCYNFLK EQHCQKASTQ KGAEAAVKPL LVPHHVVATV QEIQLQAAVG ELLLLEWLAM
     AVMLLLLCCC LTD
//
",40251
CTTCCG TTCCGG TCCGGA CCGGAA CGGAAG GGAAGG GAAGGA AAGGAG AGGAGT GGAGTT GAGTTT AGTTTA GTTTAC TTTACG TTACGC TACGCA ACGCAA CGCAAG GCAAGA CAAGAG AAGAGA AGAGAT GAGATC AGATCT GATCTG ATCTGA TCTGAT CTGATT TGATTC GATTCT ATTCTT TTCTTA TCTTAC CTTACA TTACAA TACAAT ACAATC CAATCA AATCAT ATCATT TCATTG CATTGG ATTGGG TTGGGG TGGGGA GGGGAA GGGAAA GGAAAT GAAATC AAATCG AATCGG ATCGGA TCGGAG CGGAGC GGAGCA GAGCAA AGCAAA GCAAAT CAAATG AAATGG AATGGA ATGGAT TGGATG GGATGT GATGTA ATGTAA TGTAAC GTAACT TAACTA AACTAT ACTATC CTATCA TATCAG ATCAGG TCAGGC CAGGCA AGGCAA GGCAAT GCAATG CAATGG AATGGA ATGGAA TGGAAT GGAATT GAATTT AATTTA ATTTAC TTTACA TTACAG TACAGG ACAGGC CAGGCG AGGCGA GGCGAG GCGAGG CGAGGG GAGGGT AGGGTG GGGTGC GGTGCG GTGCGA TGCGAA GCGAAA CGAAAA GAAAAC AAAACA AAACAC AACACT ACACTC CACTCA ACTCAG CTCAGT TCAGTA CAGTAT AGTATC GTATCA TATCAG ATCAGT TCAGTG CAGTGA AGTGAT GTGATC TGATCG GATCGT ATCGTA TCGTAT CGTATG GTATGG TATGGC ATGGCG TGGCGC GGCGCT GCGCTT CGCTTT GCTTTG CTTTGC TTTGCA TTGCAA TGCAAC GCAACA CAACAT AACATG ACATGG CATGGC ATGGCA,3,145,ACATTCTC C T TTTTCCC  TCTCCCCGCG  GC CCCCGCGGG CCGACGGGGAGA A GAAAGGAA GAA A G GAAAGCT G AAG AAGAGGGG TGG AGAGGGGAGA A G GGGGAGAGG G GAGAGA GGT  AGAGTGTTTT T AGTTTTTTT C T TTTTT CTTA  TTTACAC C T TATACACGCG T TC GCGCGC A C CGCGCGCACA A GG CGCAAA A CCAATCAAG G AAAGAGAA A AGAGAGAGAG G G GAGAGA CGA A A AGAGAGATAT T G GAGATATCTC C A ATATCTCTCT ATT TCTCTCTGG C CTTGAA TGTATGATATAT T G GAGATATT AAT ATGTATTTTCTC C T TTTTCAA CT G AGCTTT CTTTT T C CTTTAA TA CTTATAC CGC TGCGTACACACA A A ACCAA ACAGAATTCAAAT T A AAAATGCATC TGG ATATCGA CA A T TCAAGCATAT  ATATTTT T A ATT TTTGTG G T TTTTGTGGGG AATTGGGGGGG TTA GGGGGGGGGG G G GGGGGGGAC AA G GGAC GAAAA A G GAGAAAA A A AAAAAG TAT T A AA GCATCTC C A ATATCCG G TAC CGGGG G C CGCGGGGAGA A G GGGGAGAGAG G G GAGAGAGCGC C A AGAGCGCACA A G GCGCACAAAA A C CACAAAAAAA GGAAAAAATAT T A AAAATATGTG G A GGATGTGGGG G T TGG AGGAGA TCA GGGGAGATAT T G GAGATATGTG G A ATATG ATGT T T TGTGTCAGTA GAA GTGTATAA GG TATAAAACAC C A AAAACACTCT T G ACACTCTATA TGA CTCTAGATAT T T TAGGATC C A ATTCACA A T TCTCACAGAG G C CAGTA TTG A AGAGGAGGC G GGGGCCA A G GCGCACAAAA GAGTACCAAAATAT T A AAAATATGTG G AT CATGTGGGG G T TGC ATCTAGTCTTGGAGAAAA A GGAAAATAC T A AAAAT CATT  GC ATATTCA T T TTTTTTTATA A TAGGTTAAC  TA CAACATT A A ACACACAGAG G C CACAGGGCGG G A AGA CGGCCGA AC GGGGCGCGCG G GG TGCGCGAT A CGCGAA C AAG G GA TAGGCG AAGGGGGGG G GA TGGGGGTGT T GATGG G GTGTGTGCGC C T TGTGCCG G GCTTAGGACGA CGAAAA A G GAGAAAAAGAGT A AAAAAAAAAA A A AA GGAACAC GA AACCA A A ACACACACTATC C CACACACTAG T A ACACTCTCTC C C CTCTCCA A T TCTCACGCAG G C CACAGAGTGT C C AGAGTGTATA A G GTGTATATAT T T TATATATCTC C A ATATCTCACA A T TCTCACAGAG G C CACAGAGTT AAGT AGGTGTG G G GTGTGCG GA A T TGTGAGATAT T G GAGATATCTC  ATATCTCG TTG T TCTCGCGTGT T CTCGCGT TGTA A G GTTATAT T T TATATATGTG  GGTGGAAT TGTGGGGCGC C G GGGGCGCGCG G G GCCTTCAGGC C C CGCGCCT T GA AGCT GGTT T CG GCTTTTTTT T T TTTTTTTGTG ATG TTTTGGC C T TGTGCGCACA A G GCGCACAAAGG CACAAAACAT  AAAACACACA A AAA  GCCATGC T C CACATATGTG G A ATG TTGGG T TGGGCGC C G ATGG ATC,CTTTTCTCC AGC TGGCTTCTCCCCGCG  TCCCGCGGGG G T CCCCGCGGGGAGA A C CGCGGGAAAA A G GGGGAGG AAGAG G G GAGAAAGGGG G A AAAAGAGGGGAGA AGGG AGAGAG  GGGGAGAGGTTGT T GGTTTT T ACAGAGT ACTTTTT ATTA AAGTTTTTTATA TTA TTTTTTTATACAC C TACGAG G T TATACACGCGCGC C ACGGACGCGCGCACA A CCGCGCACAAAA A G GCTGTAAGGAAG C CAA TAAGAGAGA A A AAAAGAGAGAGAG G A AGAGAGAGAGAGA A G GAGAGAGAGATACTT A AGAGAAT ATCTC C G GAGATATCCT T A ATCA CTGCTCG T TCTCTTGAGA A C CTGATAT T T TGTGAGATATTT G GAGATATTTTCTC C A ATATTTTCTCTCT T TTTATCTTGGTA  TCTCTCTT GATA A CCTTTACAC TGC TTTTA TGTCGCA A T TAGGCACACAAA A ACACACAATTAAT T C CACAAAATATCTC C A AAAATATCCA A A ATATCTCAACAA T TCTCACATATTTT T CGCACATC TTTGTG G A ATATTTTGTGGGAAG T TTTTGTGGGGG TGCTTGTAGGGGG G GTGTGGGGGAGA A G GGGG GGAAA A GGGAGAAAAAA G TTGAAAAAAATAT T A AAAAAAATATCC GC A AAAATATCTCGGA GGAATCTCG ACA GA ACGGGGAGA A CCGGGAGGAGAG G G GGGAGAGCGC  GAGAGAGCAATGC A A AGAGCA GCAAGG A G GCGCAC GA C CACAAAAAAATAT T A AAAAAAATTG G A AAATGTATAA G A ATATGTGGT CGA CAA TGTGGGGAGATAT  GGGGAGATATGTG G G AAGATATGGCA GTT A ATATG CT GCTA A T ATGTATAAAA A GGTATAAAACAC ATT TATAAAACACTG TT AAACACTCTATA TGA ACACTCAAT CTGTCTATGGATCTC C T TA CGATCTCACA CT  ATATCTCAGCT AGG T TCTCAAGGGG G C CACAGGGCGC C A AGAGGGGCGCACA  GGGGCAA A G GCGCACAAGCAAT T C CACAAAATTG GGA AAAATATGTGGGG G A ATATGTGGGGAGA A T ATAG AA A G GGGGAGAAAATAT T G GAGAAAATTATTT T A AAAATATTTTTTT T A ATATTTTTTTAT TATG TTTTTGGGTACAC C T TTTACACAATCA T TATAC TCCAGAG G A ACACACAGGG G C CACAGAGGGGCAATCC AGGGGCCG G G GGAACGCGCG A G GCCTGCGACAAAG G CCGAGAGAGGGGGG G GAGGAAGGT TGG G A AGAGGGGGG AGT T G GGGGG CGGTGA TG G GGGGTGTGTGCTC  TGGTGTGCGCGCG G C TGTGCGCGCGAGA A GGGC GGAA A C CGCGAGAAAAAAA A G GAGAAAAAAAAAA AT  AAAAAAACAC C A AAAAAGGCACAGGAA A AAAACACACACAC C AGTTACACACACTTATT C CACACAT TG GGA ACACTCTCTCACA A C CTCTCTCACAGAG G TCAGAGTGT T C CACAGAGTGTATA A AAG AGTGTATATAT T G GTGGGTATATCTC C T TAT GATC TTGGGATCTCA AGCG G T TCTCACAGAGTGT  AG CACAGAGTGTGTG G A AGAGTGTGTGAGA A GGT GTGTGAGATAT T T TG GTGATATCTC C G GAGATATCTCGCG G AATCTCGCGTGT T T TCACA TGGTATA A CCGTGTATATA AT G GTGTATATATGTG G A TATATATGTGGGG GGT ATATGTGG GCCA C TTGGGGCGCGCG  GGTACGCGCGCGC C G GCGCGCGCCAGCT T CTATCGCGCTCTTTT T GGTACA CTTTTTTT TC  CTCTTTTTTTGTG G T TTTTTTTGTGCGC C TTCATTGC TGCACA TG  TGTGCGCAGAGAA GG  GCGCACAAAACAC C C CACAAAACACAGCTA A AAAACACACATGATT A ACCATCATTG  CACATATGTGGGG G A ATA TGGCC T TG TTGCA,CTTTTCTCCCCGCG G T TTTTCTCCACATC GG G TTCCCCGCGGGGAA C CCCCGCGGGGAACAAC CGGGGAGAACAGAG G G GGGGAGAAAAGAGGGG G GATCAAGAGGGGATA A A AAAAGAGGGGAT AAG G AAG GGAGGAGAGAGTGT T G GGGGAAC AGTGTTTT T G GAGAGGTTTTTTT GAG AGAGTTTTTTATA A GAG TTTTTAAC C T TTTTTTACACGCG G T TTTACACGCGCC T TAACGCGCGCACA A A ACTCGCAA AAA C CGCGCGCACAAAAGAG G G GCGCAAAGAGAGA A C CACAACGTAGAGAGATC AAAAGAGAGAGTCAA A GTAGAGAGAGAGATATG GAGAGAGAGATATCTC C A ATAGAGATATCTCTCT T G GAGATATCATGCTGTG G A ATTCTTGAGA  GC TCTGGCTGTGAGATAT T C CTCTGTGAATGTT T TTGAGATATTTTCCGGC GGATATTTTCG GCT T A ATATTTTCTCTCTTTT T T TTA T CGCTATTA TA GG TCTCT ACTTATACA CC C CTCTTTTGTACACACA A T TTTTACAAAA A TGA ATGA G GGT AACAACACAAAATATCTC TTA ACCAAAATG ATCACA A ATCTAATATCCATTCAAT T A ATATC AACATATTTT T T TCTCACATATTTTGG C CACATCG TTGTGGGG G A ATATTTTGTGGGGGAAAG TATCTTGTGGGGG GGGG G T TGTGGGGGGGATC CAC GGGGGGGGGGAAA A GCAAGGGGGAAAA GG CGGAAAAATGCAT T G GAGAAAAAAAT TTTC C A AAAAAAATATCTCGG AAATTCGCGGGG G A ATATCAG CGGAGGGA AA  TCTCGCGGGAGAG G CGCGCGGGGAGAGAGCGC TCG GGGCGGAGAGCGCACA CAG GAGAGG CGAGCAAAA A A AGAGC TCCAAAAAA TA G GCGCACAAAAAAATAT T C CACAAAAAAATATGTG G AAA GG AATATGTGGGG G ATCA ATTCAGGAGA GG ATGTGGGGAGATAT AGG TGTCTGGAGATATGG GGGAGATATGTGTGT T G GAGATTACTGTGTATA A AGAAATGTGTGTATAA GC TGCGACTTTAAAACAC C G GTC CGTTAACACTCT T TTAAAACACTCTATA GC  AAAACACTGTATGGAT T A CAACTCTATATATCTC  GA CTCTATATATCTCAAACA TACATATATCTCACAGAG  ATATCATGCAGAGGTGG TCTCACAGAGGC C CACAGAGGGGCAACCA  AGAGGGGCGGACAAC GGGCGCACAAAC AT ATGA TGCACAAAATT GTG G C CACAAAATATGTGGGG G AAATATGTGGGCAGA A A ATT GG TGGAGAAAA TGGGGAGAACCGAT T G GGGGAGAAAATATTT G GA AGAATATTTTTTT T AAATATTCATC CTA  ATATTTTTTAC ACC T TTTTTA T TTTTA TACAG GTG T TATACACACAGAGGGG  ACACACAGAGGGGCTTTC C CAAGGGGCGCGCG  AGAGGGGCAGTCGAGA A G GGGGCGCGCGAGAGAG TCTGCGCGAGAGCA G C CGGTAGAGGGGGG G G GAGCAAGGGGGGT T A AGAGGGGGGGTGTGTG G G GGGGGGTGTGCCAA GGGGTGTGTGCGCGG G GTTGCGGACGAGA A T TGTGCGCGTGTGAAA G GCGCGGAAAAAAA A C CGCGAGAAAAAAAAAA A G GAGAAAAAAAACA AC TCGAAAGCAACACA A A AATTGAACACACACAATAT  AAAACACACACCT T A ACCTTGAAACTCTCTC C C CAGTGACTCTCTCACA A ACAGACTCTCTCAAAG AGG C CTCTCTCA ACAGTGT T T TCGA CAGAGTGTAA T CACAGGTATATAT T A AGGCGGTATATATCTC C G GTGTATATATCTCACA  TATATATCTCATT AG G ATA ATCGCTCAGAGTGT T T TCTCACAGAGTGTGTG AGCAGTGTGTGAGA A A AGAGTCACTGAGATAT T G GTGTGTGAGATATCGA C T TGTGAGATACGCG G G GAGATATCTCGAAGT AAATGAAAA C AGTA ATA TGCATCGCGTGTATATC AT CTCTCGTGTATATGATG GGTA AATGGA A TATATATGGGCC A ATATGTGGGGCGCGCG G T TGTGGGGCGCGCGCGC C G GGGGCGGACGCGCTCT T GA TGCGCGCTCACTTTT  CGCGCGCTCTTA ATT T G GCGCTCTTTTTTTGTG G C CTCTTTTTTTGTGCGC C T TTTTTAAAAATGCATTATGCCAAAA A C TGTGCGCACAAAACAC C G GCGCACAAAACACACA A C CACAAAACACACATAT  AAAACACACATATGTG G AGAGACATTTATGTGGGG G C CACATATGGGCGC CGTATGTGGGGCGCA,CTTG CTCCCGGGG G TTGGTTCTCCCCGCGGGGAGA A T TCTCCCCGCGGGGAAA A C CCCCGCGGGAAAAGAG G C CGAGTGGAAAGAGGGG AGTGGAGAAAAGAGGGGAGA A G GAGAAAAGAGGGGAGAGAAGG A AACATG GATGCCGGT GAG AGAGGGAAGAGCGGGTTTT AAA GGGGA TCAGTTT T GC AGAGCGCTTTTTATA A A AGAGTGTTTTTCA TACAC C G GTGTTTTTTTATACACGCG G T TTTTTTTAACGGGGGC C T TTTTAACGCGCGCACA A TAGGTT T CGCACAAAA A A ACACGCGCGCAAG CGT CGTATGCACAAAAGGA A G GCGCACAAAAGGAGAG A A CACAAAAGAGAT AACAGA  AAAAGAGAAGAGTTAT T A AGAGAGATTCATTGC G GAGAGGATATCT CCT AGAGATATCTCTATTATCGGAGATATCTCTCTGAGGGA CAG ATG GTCTCTGTGAGATAT T T TCTCT CATGAGATATTTT T CCTGTGAGATATTTTCC TATCTGAGATATTTTCTCTCT T GGGGTTCCTTTT  TAACTATTTTCTCTCTTTTATA A T TTTTCTCTCTTTACAC  AGGAGTCTCTTTTATACACACA A CGAGTTATAC ACCAAAA A TTTATACACACAAAATAT T T TATACA TCAAAAT CATC C A ACACA ATAATATCTCACA  CACAAAATATCTCATGGCAAT A AAAATATCTCACATACGT ACAAATCATCCATATTTTGTG G T TCTCGATTTC TGGGG TTCATCCTGTGGAGT ATG A ATAGCTTGTGGGGGGGGG T TTTTGAG GGGGGAGA ACATGGATTGGAGAAAA A G GGGGGGGGGGAGAAAA A G GGGGGGGAGAAAAAAATAT T GG CGGAT AT CAATATCTC C G GAGAAAAAAATATCTCGAGTG A AAAAAAATATCTCGCGGGG G A AATTGTTATCGCGGGGAGA A A ATATCCGGGAGG T TCCATCGGGGAGAGAGCGC C C CGCGGGGAAGCGCAA G GGGGAGAGAGCGCAAA A G GAGAG CTGCACAAAAA TGA A AGATTGCACAAAACAATG TT G GCGCACAAAAAAATATGTG CTGCAACA AATACATGGGG TCG AAAAAAATATGTGGGGAGA A A AAAATATGTGGGGAGATAT  ATATGTGGGGATGAATGTG AT GGATGGGGAGATATGTGTGT T GGGAAACATGTGTGTATA  GAGATATGTGTTAAAA A A ATTGTGTATAAAACC T TGGTACGCAAC ATCT T G GTGTATAAGTGGGTCTATA A TGAATAAAACACTCTATATAT T A AAAAAACTCTATATATCTC C AACAACTCTATATATCTCACA A C CT AAAATATCTCACAGAG G T TATATATCAGATG AGGGG G A ATATCTCACAGGGCGC C T TCTCACAGAGGGGCGCACA A C CACAGTTTGGCGCAAT GGTA A AGTGAGGCAGGCAAAATAT  GGGGCGCACAAAATATGTG GCA GCGCACAAAATTGGAAAAC  CACAAATGTGGGA A A AAAATTGGGGAGAAAA A A ATATGTGGGAGGAAAATAT T T TGCGAGGAT AATTTT A G GGGGAGAAAATTTTT G GAGGAAATATTTTTTTATA A A AAAATATTTTTTTAAC  ATATTTTTTTATACCA A TTTATTTTCGTACACAGGGG T TTTTATACACACAGAGGGG G T TATCACAGGGCGC C A ACACACAGATCATCCG G C CACAGAGGGGCGCGCGAGA A A AGGGCGCGCGAGAGAG G GGGCGCGCGA CTGG  GCGAGAGGGGGG C CGCGAGAGAGGGGGACTGT T G GAGAGAGGGGGAA GTGTG G A AGATCGGGGGTGTGTGCC G GGCGCGGTGTGTGCGCGCG G G GGGGTGTGTGCGCGCGAGA A GGTGTGCGCGCGAA T TGTGCGCGCGAGAAAAAAA A G GCGCGCGAGAAGG T GAA A C CGTGGGAAAAAAAAAACAC C G GAGAAAAAAAAAACACACATG CAAAAAAAACACACACAC  CA AAAAAGATAGGCACACTCT GAA AAAACATGCACACTCTCTC  GA ACACACACACTCTCTCACA A C CACACTATCAGAG T T ACACTCTCTCACAGGGGCGC CTCTCCAGAGTTA A T TCTCACAGAGTCG TATAT T CCAGGTATATATCTC C A AGTACGTATCAATCTCACA A G GTGGCTATAGGTCACAGG T TATATATCTCAGTAGT T AATCTCACAGAGTGTGA AG T TCTCACAGAGTGTGTGAGA A C CACAGAGTAGTTGAGATAT T AC TG GTGAGATATCTC C G GTGTGTGA TGTCGCG G T TGGATGATATCTCGCGTGT T G GAGATATCGCTCGTGTAA A ATGCGTCGAT TATAT G A TCG ACGTGTATATATGG CTCGCGTGTATATATGGG G GGTATATTGGGGCGC GCT TATATATGTGGGGCGCGCG G A ATATG GGGGCGCGCGCGC C TAA TGGGTAGCGCGCC TCT T GCA GGCGCGCGCGCTCTTTT T G GCGCGTAAGCTCTTTTTTT TCT CGCAAGCTCTTTTTGAGTTT GCGCATTTTTGTGCGC C C CTCTTTG TTGTGCGGCAAAA T TTTTTAATTGCCAAAA A T TTTTGTGCGCACATAC C T TGTGCGCAAACACACA A G GCGCACAAACAAAC GGAAA CACAAAACCTCCATATGTG G AAACACACATATG TTGG G A ACACACATTGGGGCGC C CC AGTTATGTGGGGC,"ID   LEUC1_METKA             Reviewed;         418 AA.
AC   Q8TVF2;
DT   26-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   05-FEB-2025, entry version 127.
DE   RecName: Full=3-isopropylmalate dehydratase large subunit 1 {ECO:0000255|HAMAP-Rule:MF_01027};
DE            EC=4.2.1.33 {ECO:0000255|HAMAP-Rule:MF_01027};
DE   AltName: Full=Alpha-IPM isomerase 1 {ECO:0000255|HAMAP-Rule:MF_01027};
DE            Short=IPMI 1 {ECO:0000255|HAMAP-Rule:MF_01027};
DE   AltName: Full=Isopropylmalate isomerase 1 {ECO:0000255|HAMAP-Rule:MF_01027};
GN   Name=leuC1 {ECO:0000255|HAMAP-Rule:MF_01027};
GN   OrderedLocusNames=MK1440;
OS   Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938).
OC   Archaea; Methanobacteriati; Methanobacteriota; Methanomada group;
OC   Methanopyri; Methanopyrales; Methanopyraceae; Methanopyrus.
OX   NCBI_TaxID=190192;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AV19 / DSM 6324 / JCM 9639 / NBRC 100938;
RX   PubMed=11930014; DOI=10.1073/pnas.032671499;
RA   Slesarev A.I., Mezhevaya K.V., Makarova K.S., Polushin N.N.,
RA   Shcherbinina O.V., Shakhova V.V., Belova G.I., Aravind L., Natale D.A.,
RA   Rogozin I.B., Tatusov R.L., Wolf Y.I., Stetter K.O., Malykh A.G.,
RA   Koonin E.V., Kozyavkin S.A.;
RT   ""The complete genome of hyperthermophile Methanopyrus kandleri AV19 and
RT   monophyly of archaeal methanogens."";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:4644-4649(2002).
CC   -!- FUNCTION: Catalyzes the isomerization between 2-isopropylmalate and 3-
CC       isopropylmalate, via the formation of 2-isopropylmaleate.
CC       {ECO:0000255|HAMAP-Rule:MF_01027}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R,3S)-3-isopropylmalate = (2S)-2-isopropylmalate;
CC         Xref=Rhea:RHEA:32287, ChEBI:CHEBI:1178, ChEBI:CHEBI:35121;
CC         EC=4.2.1.33; Evidence={ECO:0000255|HAMAP-Rule:MF_01027};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01027};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_01027};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-leucine biosynthesis; L-leucine
CC       from 3-methyl-2-oxobutanoate: step 2/4. {ECO:0000255|HAMAP-
CC       Rule:MF_01027}.
CC   -!- SUBUNIT: Heterodimer of LeuC and LeuD. {ECO:0000255|HAMAP-
CC       Rule:MF_01027}.
CC   -!- SIMILARITY: Belongs to the aconitase/IPM isomerase family. LeuC type 2
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01027}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE009439; AAM02653.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q8TVF2; -.
DR   SMR; Q8TVF2; -.
DR   STRING; 190192.MK1440; -.
DR   PaxDb; 190192-MK1440; -.
DR   EnsemblBacteria; AAM02653; AAM02653; MK1440.
DR   KEGG; mka:MK1440; -.
DR   PATRIC; fig|190192.8.peg.1596; -.
DR   HOGENOM; CLU_006714_3_4_2; -.
DR   InParanoid; Q8TVF2; -.
DR   OrthoDB; 255at2157; -.
DR   UniPathway; UPA00048; UER00071.
DR   Proteomes; UP000001826; Chromosome.
DR   GO; GO:0003861; F:3-isopropylmalate dehydratase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009098; P:L-leucine biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd01583; IPMI; 1.
DR   Gene3D; 3.30.499.10; Aconitase, domain 3; 2.
DR   HAMAP; MF_01027; LeuC_type2; 1.
DR   InterPro; IPR015931; Acnase/IPM_dHydase_lsu_aba_1/3.
DR   InterPro; IPR001030; Acoase/IPM_deHydtase_lsu_aba.
DR   InterPro; IPR018136; Aconitase_4Fe-4S_BS.
DR   InterPro; IPR036008; Aconitase_4Fe-4S_dom.
DR   InterPro; IPR011826; HAcnase/IPMdehydase_lsu_prok.
DR   InterPro; IPR006251; Homoacnase/IPMdehydase_lsu.
DR   InterPro; IPR050067; IPM_dehydratase_rel_enz.
DR   InterPro; IPR033941; IPMI_cat.
DR   NCBIfam; TIGR01343; hacA_fam; 1.
DR   NCBIfam; NF040615; HacA_Meth; 1.
DR   NCBIfam; TIGR02086; IPMI_arch; 1.
DR   PANTHER; PTHR43822:SF2; HOMOACONITASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43822; HOMOACONITASE, MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF00330; Aconitase; 2.
DR   PRINTS; PR00415; ACONITASE.
DR   SUPFAM; SSF53732; Aconitase iron-sulfur domain; 1.
DR   PROSITE; PS00450; ACONITASE_1; 1.
PE   3: Inferred from homology;
KW   4Fe-4S; Amino-acid biosynthesis; Branched-chain amino acid biosynthesis;
KW   Iron; Iron-sulfur; Leucine biosynthesis; Lyase; Metal-binding;
KW   Reference proteome.
FT   CHAIN           1..418
FT                   /note=""3-isopropylmalate dehydratase large subunit 1""
FT                   /id=""PRO_0000076870""
FT   BINDING         298
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01027""
FT   BINDING         358
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01027""
FT   BINDING         361
FT                   /ligand=""[4Fe-4S] cluster""
FT                   /ligand_id=""ChEBI:CHEBI:49883""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_01027""
SQ   SEQUENCE   418 AA;  45202 MW;  FABA735A9BD51C72 CRC64;
     MGKTMAEKIL SRASGEDAEA GDIVVANIDV AMVHDITGPI TVQRLEEMGV ERVWDPSKIV
     VLFDHQVPAD SVEAAENHKI MREFVEEQGI EHFYDVREGV CHQVLPEKGH VRPGDVIVGA
     DSHTCTHGAL GAFATGIGST DMAAVFATGK LWFRVPETYR VEITGELPEG VYAKDVVLKV
     TGEIGADGAT YMAIEYHGEV VREMSVSDRM CLCNMAIEMG AKTGMVPPDE KTLEYVKKRA
     GTEGRPVEPD PDARYEAELT LDVSDLEPQV AKPFSPDNVV PVGEVEGIAI DQVFIGSCTN
     GRYEDLKVAA EVLEGEEVHD DVRLIVIPAS REVYHRTLKD GVLEVLHEAG ALICPPNCGP
     CLGGHMGVLA EGERCVATSN RNFPGRMGHR ESEVYLASPA TAAASAIEGE ITDPRPYL
//
",31347
ACTCAA CTCAAG TCAAGA CAAGAC AAGACG AGACGC GACGCC ACGCCA CGCCAC GCCACC CCACCC CACCCC ACCCCG CCCCGC CCCGCT CCGCTG CGCTGA GCTGAC CTGACG TGACGC GACGCT ACGCTG CGCTGG GCTGGG CTGGGG TGGGGC GGGGCA GGGCAG GGCAGG GCAGGA CAGGAA AGGAAT GGAATT GAATTT AATTTT ATTTTC TTTTCC TTTCCG TTCCGG TCCGGT CCGGTT CGGTTA GGTTAT GTTATG TTATGC TATGCA ATGCAT TGCATC GCATCG CATCGC ATCGCA TCGCAG CGCAGG GCAGGT CAGGTG AGGTGC GGTGCA GTGCAG TGCAGA GCAGAG CAGAGC AGAGCG GAGCGG AGCGGC GCGGCA CGGCAT GGCATC GCATCC CATCCA ATCCAT TCCATC CCATCG CATCGC ATCGCA TCGCAC CGCACG GCACGC CACGCG ACGCGG CGCGGC GCGGCT CGGCTG GGCTGG GCTGGC CTGGCG TGGCGC GGCGCT GCGCTC CGCTCA GCTCAA CTCAAG TCAAGG CAAGGA AAGGAA AGGAAC GGAACT GAACTC AACTCT ACTCTA CTCTAC,3,100,ACTC CTCA TCAA CAAG AAGA AGAC GACG ACGC CGCC GCCA CCAC CACC ACCC CCCC CCCG CCGC CGCT GCTG CTGA TGAC GACG ACGC CGCT GCTG CTGG TGGG GGGG GGGC GGCA GCAG CAGG AGGA GGAA GAAT AATT ATTT TTTT TTTC TTCC TCCG CCGG CGGT GGTT GTTA TTAT TATG ATGC TGCA GCAT CATC ATCG TCGC CGCA GCAG CAGG AGGT GGTG GTGC TGCA GCAG CAGA AGAG GAGC AGCG GCGG CGGC GGCA GCAT CATC ATCC TCCA CCAT CATC ATCG TCGC CGCA GCAC CACG ACGC CGCG GCGG CGGC GGCT GCTG CTGG TGGC GGCG GCGC CGCT GCTC CTCA TCAA CAAG AAGG AGGA GGAA GAAC AACT ACTC CTCT TCTA CTAC,ACTCA CTCAA TCAAG CAAGA AAGAC AGACG GACGC ACGCC CGCCA GCCAC CCACC CACCC ACCCC CCCCG CCCGC CCGCT CGCTG GCTGA CTGAC TGACG GACGC ACGCT CGCTG GCTGG CTGGG TGGGG GGGGC GGGCA GGCAG GCAGG CAGGA AGGAA GGAAT GAATT AATTT ATTTT TTTTC TTTCC TTCCG TCCGG CCGGT CGGTT GGTTA GTTAT TTATG TATGC ATGCA TGCAT GCATC CATCG ATCGC TCGCA CGCAG GCAGG CAGGT AGGTG GGTGC GTGCA TGCAG GCAGA CAGAG AGAGC GAGCG AGCGG GCGGC CGGCA GGCAT GCATC CATCC ATCCA TCCAT CCATC CATCG ATCGC TCGCA CGCAC GCACG CACGC ACGCG CGCGG GCGGC CGGCT GGCTG GCTGG CTGGC TGGCG GGCGC GCGCT CGCTC GCTCA CTCAA TCAAG CAAGG AAGGA AGGAA GGAAC GAACT AACTC ACTCT CTCTA TCTAC,ACTCAA CTCAAG TCAAGA CAAGAC AAGACG AGACGC GACGCC ACGCCA CGCCAC GCCACC CCACCC CACCCC ACCCCG CCCCGC CCCGCT CCGCTG CGCTGA GCTGAC CTGACG TGACGC GACGCT ACGCTG CGCTGG GCTGGG CTGGGG TGGGGC GGGGCA GGGCAG GGCAGG GCAGGA CAGGAA AGGAAT GGAATT GAATTT AATTTT ATTTTC TTTTCC TTTCCG TTCCGG TCCGGT CCGGTT CGGTTA GGTTAT GTTATG TTATGC TATGCA ATGCAT TGCATC GCATCG CATCGC ATCGCA TCGCAG CGCAGG GCAGGT CAGGTG AGGTGC GGTGCA GTGCAG TGCAGA GCAGAG CAGAGC AGAGCG GAGCGG AGCGGC GCGGCA CGGCAT GGCATC GCATCC CATCCA ATCCAT TCCATC CCATCG CATCGC ATCGCA TCGCAC CGCACG GCACGC CACGCG ACGCGG CGCGGC GCGGCT CGGCTG GGCTGG GCTGGC CTGGCG TGGCGC GGCGCT GCGCTC CGCTCA GCTCAA CTCAAG TCAAGG CAAGGA AAGGAA AGGAAC GGAACT GAACTC AACTCT ACTCTA CTCTAC,ACTCAAG CTCAAGA TCAAGAC CAAGACG AAGACGC AGACGCC GACGCCA ACGCCAC CGCCACC GCCACCC CCACCCC CACCCCG ACCCCGC CCCCGCT CCCGCTG CCGCTGA CGCTGAC GCTGACG CTGACGC TGACGCT GACGCTG ACGCTGG CGCTGGG GCTGGGG CTGGGGC TGGGGCA GGGGCAG GGGCAGG GGCAGGA GCAGGAA CAGGAAT AGGAATT GGAATTT GAATTTT AATTTTC ATTTTCC TTTTCCG TTTCCGG TTCCGGT TCCGGTT CCGGTTA CGGTTAT GGTTATG GTTATGC TTATGCA TATGCAT ATGCATC TGCATCG GCATCGC CATCGCA ATCGCAG TCGCAGG CGCAGGT GCAGGTG CAGGTGC AGGTGCA GGTGCAG GTGCAGA TGCAGAG GCAGAGC CAGAGCG AGAGCGG GAGCGGC AGCGGCA GCGGCAT CGGCATC GGCATCC GCATCCA CATCCAT ATCCATC TCCATCG CCATCGC CATCGCA ATCGCAC TCGCACG CGCACGC GCACGCG CACGCGG ACGCGGC CGCGGCT GCGGCTG CGGCTGG GGCTGGC GCTGGCG CTGGCGC TGGCGCT GGCGCTC GCGCTCA CGCTCAA GCTCAAG CTCAAGG TCAAGGA CAAGGAA AAGGAAC AGGAACT GGAACTC GAACTCT AACTCTA ACTCTAC,"ID   FUMC2_BRADU             Reviewed;         473 AA.
AC   P28894;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 3.
DT   27-NOV-2024, entry version 143.
DE   RecName: Full=Fumarate hydratase class II 2 {ECO:0000255|HAMAP-Rule:MF_00743};
DE            Short=Fumarase C 2 {ECO:0000255|HAMAP-Rule:MF_00743};
DE            EC=4.2.1.2 {ECO:0000255|HAMAP-Rule:MF_00743};
DE   AltName: Full=Aerobic fumarase 2 {ECO:0000255|HAMAP-Rule:MF_00743};
DE   AltName: Full=Iron-independent fumarase 2 {ECO:0000255|HAMAP-Rule:MF_00743};
GN   Name=fumC2 {ECO:0000255|HAMAP-Rule:MF_00743}; Synonyms=fumC;
GN   OrderedLocusNames=blr6519;
OS   Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 /
OS   NBRC 14792 / USDA 110).
OC   Bacteria; Pseudomonadota; Alphaproteobacteria; Hyphomicrobiales;
OC   Nitrobacteraceae; Bradyrhizobium.
OX   NCBI_TaxID=224911;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=USDA 110spc4;
RX   PubMed=1856685; DOI=10.1099/00221287-137-4-991;
RA   Acuna G., Ebeling S., Hennecke H.;
RT   ""Cloning, sequencing, and mutational analysis of the Bradyrhizobium
RT   japonicum fumC-like gene: evidence for the existence of two different
RT   fumarases."";
RL   J. Gen. Microbiol. 137:991-1000(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110;
RX   PubMed=12597275; DOI=10.1093/dnares/9.6.189;
RA   Kaneko T., Nakamura Y., Sato S., Minamisawa K., Uchiumi T., Sasamoto S.,
RA   Watanabe A., Idesawa K., Iriguchi M., Kawashima K., Kohara M.,
RA   Matsumoto M., Shimpo S., Tsuruoka H., Wada T., Yamada M., Tabata S.;
RT   ""Complete genomic sequence of nitrogen-fixing symbiotic bacterium
RT   Bradyrhizobium japonicum USDA110."";
RL   DNA Res. 9:189-197(2002).
CC   -!- FUNCTION: Involved in the TCA cycle. Catalyzes the stereospecific
CC       interconversion of fumarate to L-malate. {ECO:0000255|HAMAP-
CC       Rule:MF_00743}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-malate = fumarate + H2O; Xref=Rhea:RHEA:12460,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15589, ChEBI:CHEBI:29806; EC=4.2.1.2;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00743};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate
CC       from fumarate: step 1/1. {ECO:0000255|HAMAP-Rule:MF_00743}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_00743}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00743}.
CC   -!- MISCELLANEOUS: There are 2 substrate-binding sites: the catalytic A
CC       site, and the non-catalytic B site that may play a role in the transfer
CC       of substrate or product between the active site and the solvent.
CC       Alternatively, the B site may bind allosteric effectors.
CC       {ECO:0000255|HAMAP-Rule:MF_00743}.
CC   -!- SIMILARITY: Belongs to the class-II fumarase/aspartase family. Fumarase
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_00743}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA26211.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC51784.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M79457; AAA26211.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M79457; AAA26212.1; -; Genomic_DNA.
DR   EMBL; BA000040; BAC51784.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; NP_773159.2; NC_004463.1.
DR   AlphaFoldDB; P28894; -.
DR   SMR; P28894; -.
DR   STRING; 224911.AAV28_30155; -.
DR   EnsemblBacteria; BAC51784; BAC51784; BAC51784.
DR   KEGG; bja:blr6519; -.
DR   PATRIC; fig|224911.5.peg.6668; -.
DR   eggNOG; COG0114; Bacteria.
DR   HOGENOM; CLU_021594_4_1_5; -.
DR   InParanoid; P28894; -.
DR   OrthoDB; 9802809at2; -.
DR   UniPathway; UPA00223; UER01007.
DR   Proteomes; UP000002526; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004333; F:fumarate hydratase activity; IBA:GO_Central.
DR   GO; GO:0006106; P:fumarate metabolic process; IBA:GO_Central.
DR   GO; GO:0006108; P:malate metabolic process; IBA:GO_Central.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IBA:GO_Central.
DR   CDD; cd01362; Fumarase_classII; 1.
DR   FunFam; 1.10.40.30:FF:000002; Fumarate hydratase class II; 1.
DR   FunFam; 1.10.275.10:FF:000001; Fumarate hydratase, mitochondrial; 1.
DR   FunFam; 1.20.200.10:FF:000001; Fumarate hydratase, mitochondrial; 1.
DR   Gene3D; 1.10.40.30; Fumarase/aspartase (C-terminal domain); 1.
DR   Gene3D; 1.20.200.10; Fumarase/aspartase (Central domain); 1.
DR   Gene3D; 1.10.275.10; Fumarase/aspartase (N-terminal domain); 1.
DR   HAMAP; MF_00743; FumaraseC; 1.
DR   InterPro; IPR005677; Fum_hydII.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR018951; Fumarase_C_C.
DR   InterPro; IPR020557; Fumarate_lyase_CS.
DR   InterPro; IPR000362; Fumarate_lyase_fam.
DR   InterPro; IPR022761; Fumarate_lyase_N.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   NCBIfam; TIGR00979; fumC_II; 1.
DR   PANTHER; PTHR11444; ASPARTATEAMMONIA/ARGININOSUCCINATE/ADENYLOSUCCINATE LYASE; 1.
DR   PANTHER; PTHR11444:SF1; FUMARATE HYDRATASE, MITOCHONDRIAL; 1.
DR   Pfam; PF10415; FumaraseC_C; 1.
DR   Pfam; PF00206; Lyase_1; 1.
DR   PRINTS; PR00149; FUMRATELYASE.
DR   SUPFAM; SSF48557; L-aspartase-like; 1.
DR   PROSITE; PS00163; FUMARATE_LYASES; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Lyase; Reference proteome; Tricarboxylic acid cycle.
FT   CHAIN           1..473
FT                   /note=""Fumarate hydratase class II 2""
FT                   /id=""PRO_0000161259""
FT   REGION          1..28
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   ACT_SITE        198
FT                   /note=""Proton donor/acceptor""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   ACT_SITE        328
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         108..110
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         139..142
FT                   /ligand=""substrate""
FT                   /note=""in site B""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         149..151
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         197
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         329
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   BINDING         334..336
FT                   /ligand=""substrate""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   SITE            341
FT                   /note=""Important for catalytic activity""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00743""
FT   CONFLICT        91..94
FT                   /note=""IDGS -> STAD (in Ref. 1; AAA26211/AAA26212)""
FT                   /evidence=""ECO:0000305""
FT   CONFLICT        220
FT                   /note=""S -> R (in Ref. 1; AAA26211/AAA26212)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   473 AA;  50924 MW;  CDB35CFA32062957 CRC64;
     MAKSARTKTA RPATRTETDS FGPIEVPSDR YWGAQTERSR QNFRIGTDRM PISLVHALGI
     VKLAAAQSNR ELGLLDQRRA SAIIRAAREV IDGSLDDHFP LVVWQTGSGT QTNMNLNEVI
     ANRANELLGG ELGAKKPVHP NDHVNMSQSS NDSFPTAMHI AAASRITADL VPALGELLRA
     LRKKEKEFAK IVKIGRTHTQ DATPLTLGQE FSGYAAQVES GIARLKVAVK ELYPLAQGGT
     AVGTGLNAKP RFARLFAKHV AGITKLPFTS AANKFEALAS NDAYVLAHGA ISSVATGLFK
     IANDIRLLGS GPRSGLGELI LPENEPGSSI MPGKVNPTQC EAMTMVCCQV FGNHTAITVA
     GSQGHFELNV YKPVLAYNML HSIRLMADAA RSFTEHCVSG IRADEKRISE LMQRSLMLVT
     ALAPKIGYDN AAKVAKTAHA NGTTLKEEAL RLGFVTADEF DRLVQPEKMT KPG
//
",26978
GCGAAG CGAAGA GAAGAT AAGATC AGATCA GATCAA ATCAAA TCAAAG CAAAGA AAAGAG AAGAGA AGAGAT GAGATC AGATCA GATCAG ATCAGC TCAGCA CAGCAA AGCAAG GCAAGG CAAGGT AAGGTC AGGTCC GGTCCT GTCCTG TCCTGC CCTGCC CTGCCC TGCCCC GCCCCC CCCCCG CCCCGG CCCGGG CCGGGG CGGGGA GGGGAT GGGATC GGATCT GATCTA ATCTAC TCTACG CTACGC TACGCG ACGCGC CGCGCA GCGCAC CGCACG GCACGC CACGCC ACGCCG CGCCGT GCCGTG CCGTGC CGTGCT GTGCTC TGCTCA GCTCAA CTCAAC TCAACC CAACCG AACCGC ACCGCA CCGCAC CGCACG GCACGC CACGCA ACGCAG CGCAGT GCAGTT CAGTTG AGTTGG GTTGGT TTGGTC TGGTCG GGTCGA GTCGAT TCGATG CGATGC GATGCC ATGCCA TGCCAC GCCACC CCACCA CACCAT ACCATC CCATCT CATCTA ATCTAT TCTATA CTATAC TATACC ATACCG TACCGT ACCGTG CCGTGG CGTGGC GTGGCG TGGCGA GGCGAA GCGAAA CGAAAA GAAAAA AAAAAC AAAACC AAACCT AACCTC ACCTCG CCTCGC CTCGCT TCGCTG CGCTGA GCTGAA CTGAAG TGAAGG GAAGGT AAGGTG AGGTGC GGTGCG GTGCGC TGCGCT GCGCTG CGCTGC GCTGCT CTGCTA TGCTAG GCTAGT CTAGTG TAGTGA AGTGAT GTGATC TGATCA GATCAC ATCACG TCACGG CACGGT ACGGTT CGGTTC GGTTCT GTTCTG TTCTGT TCTGTT CTGTTC TGTTCG GTTCGC TTCGCG,2,145,GCGA CGAA GAAG AAGA AGAT GATC ATCA TCAA CAAA AAAG AAGA AGAG GAGA AGAT GATC ATCA TCAG CAGC AGCA GCAA CAAG AAGG AGGT GGTC GTCC TCCT CCTG CTGC TGCC GCCC CCCC CCCC CCCG CCGG CGGG GGGG GGGA GGAT GATC ATCT TCTA CTAC TACG ACGC CGCG GCGC CGCA GCAC CACG ACGC CGCC GCCG CCGT CGTG GTGC TGCT GCTC CTCA TCAA CAAC AACC ACCG CCGC CGCA GCAC CACG ACGC CGCA GCAG CAGT AGTT GTTG TTGG TGGT GGTC GTCG TCGA CGAT GATG ATGC TGCC GCCA CCAC CACC ACCA CCAT CATC ATCT TCTA CTAT TATA ATAC TACC ACCG CCGT CGTG GTGG TGGC GGCG GCGA CGAA GAAA AAAA AAAA AAAC AACC ACCT CCTC CTCG TCGC CGCT GCTG CTGA TGAA GAAG AAGG AGGT GGTG GTGC TGCG GCGC CGCT GCTG CTGC TGCT GCTA CTAG TAGT AGTG GTGA TGAT GATC ATCA TCAC CACG ACGG CGGT GGTT GTTC TTCT TCTG CTGT TGTT GTTC TTCG TCGC CGCG,GCGAA CGAAG GAAGA AAGAT AGATC GATCA ATCAA TCAAA CAAAG AAAGA AAGAG AGAGA GAGAT AGATC GATCA ATCAG TCAGC CAGCA AGCAA GCAAG CAAGG AAGGT AGGTC GGTCC GTCCT TCCTG CCTGC CTGCC TGCCC GCCCC CCCCC CCCCG CCCGG CCGGG CGGGG GGGGA GGGAT GGATC GATCT ATCTA TCTAC CTACG TACGC ACGCG CGCGC GCGCA CGCAC GCACG CACGC ACGCC CGCCG GCCGT CCGTG CGTGC GTGCT TGCTC GCTCA CTCAA TCAAC CAACC AACCG ACCGC CCGCA CGCAC GCACG CACGC ACGCA CGCAG GCAGT CAGTT AGTTG GTTGG TTGGT TGGTC GGTCG GTCGA TCGAT CGATG GATGC ATGCC TGCCA GCCAC CCACC CACCA ACCAT CCATC CATCT ATCTA TCTAT CTATA TATAC ATACC TACCG ACCGT CCGTG CGTGG GTGGC TGGCG GGCGA GCGAA CGAAA GAAAA AAAAA AAAAC AAACC AACCT ACCTC CCTCG CTCGC TCGCT CGCTG GCTGA CTGAA TGAAG GAAGG AAGGT AGGTG GGTGC GTGCG TGCGC GCGCT CGCTG GCTGC CTGCT TGCTA GCTAG CTAGT TAGTG AGTGA GTGAT TGATC GATCA ATCAC TCACG CACGG ACGGT CGGTT GGTTC GTTCT TTCTG TCTGT CTGTT TGTTC GTTCG TTCGC TCGCG,GCGAAG CGAAGA GAAGAT AAGATC AGATCA GATCAA ATCAAA TCAAAG CAAAGA AAAGAG AAGAGA AGAGAT GAGATC AGATCA GATCAG ATCAGC TCAGCA CAGCAA AGCAAG GCAAGG CAAGGT AAGGTC AGGTCC GGTCCT GTCCTG TCCTGC CCTGCC CTGCCC TGCCCC GCCCCC CCCCCG CCCCGG CCCGGG CCGGGG CGGGGA GGGGAT GGGATC GGATCT GATCTA ATCTAC TCTACG CTACGC TACGCG ACGCGC CGCGCA GCGCAC CGCACG GCACGC CACGCC ACGCCG CGCCGT GCCGTG CCGTGC CGTGCT GTGCTC TGCTCA GCTCAA CTCAAC TCAACC CAACCG AACCGC ACCGCA CCGCAC CGCACG GCACGC CACGCA ACGCAG CGCAGT GCAGTT CAGTTG AGTTGG GTTGGT TTGGTC TGGTCG GGTCGA GTCGAT TCGATG CGATGC GATGCC ATGCCA TGCCAC GCCACC CCACCA CACCAT ACCATC CCATCT CATCTA ATCTAT TCTATA CTATAC TATACC ATACCG TACCGT ACCGTG CCGTGG CGTGGC GTGGCG TGGCGA GGCGAA GCGAAA CGAAAA GAAAAA AAAAAC AAAACC AAACCT AACCTC ACCTCG CCTCGC CTCGCT TCGCTG CGCTGA GCTGAA CTGAAG TGAAGG GAAGGT AAGGTG AGGTGC GGTGCG GTGCGC TGCGCT GCGCTG CGCTGC GCTGCT CTGCTA TGCTAG GCTAGT CTAGTG TAGTGA AGTGAT GTGATC TGATCA GATCAC ATCACG TCACGG CACGGT ACGGTT CGGTTC GGTTCT GTTCTG TTCTGT TCTGTT CTGTTC TGTTCG GTTCGC TTCGCG,GCGAAGA CGAAGAT GAAGATC AAGATCA AGATCAA GATCAAA ATCAAAG TCAAAGA CAAAGAG AAAGAGA AAGAGAT AGAGATC GAGATCA AGATCAG GATCAGC ATCAGCA TCAGCAA CAGCAAG AGCAAGG GCAAGGT CAAGGTC AAGGTCC AGGTCCT GGTCCTG GTCCTGC TCCTGCC CCTGCCC CTGCCCC TGCCCCC GCCCCCG CCCCCGG CCCCGGG CCCGGGG CCGGGGA CGGGGAT GGGGATC GGGATCT GGATCTA GATCTAC ATCTACG TCTACGC CTACGCG TACGCGC ACGCGCA CGCGCAC GCGCACG CGCACGC GCACGCC CACGCCG ACGCCGT CGCCGTG GCCGTGC CCGTGCT CGTGCTC GTGCTCA TGCTCAA GCTCAAC CTCAACC TCAACCG CAACCGC AACCGCA ACCGCAC CCGCACG CGCACGC GCACGCA CACGCAG ACGCAGT CGCAGTT GCAGTTG CAGTTGG AGTTGGT GTTGGTC TTGGTCG TGGTCGA GGTCGAT GTCGATG TCGATGC CGATGCC GATGCCA ATGCCAC TGCCACC GCCACCA CCACCAT CACCATC ACCATCT CCATCTA CATCTAT ATCTATA TCTATAC CTATACC TATACCG ATACCGT TACCGTG ACCGTGG CCGTGGC CGTGGCG GTGGCGA TGGCGAA GGCGAAA GCGAAAA CGAAAAA GAAAAAC AAAAACC AAAACCT AAACCTC AACCTCG ACCTCGC CCTCGCT CTCGCTG TCGCTGA CGCTGAA GCTGAAG CTGAAGG TGAAGGT GAAGGTG AAGGTGC AGGTGCG GGTGCGC GTGCGCT TGCGCTG GCGCTGC CGCTGCT GCTGCTA CTGCTAG TGCTAGT GCTAGTG CTAGTGA TAGTGAT AGTGATC GTGATCA TGATCAC GATCACG ATCACGG TCACGGT CACGGTT ACGGTTC CGGTTCT GGTTCTG GTTCTGT TTCTGTT TCTGTTC CTGTTCG TGTTCGC GTTCGCG,"ID   HELA_LEGPN              Reviewed;        1052 AA.
AC   Q48815;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-FEB-2025, entry version 75.
DE   RecName: Full=Protein HelA;
GN   Name=helA;
OS   Legionella pneumophila.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Legionellales;
OC   Legionellaceae; Legionella.
OX   NCBI_TaxID=446;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8613357; DOI=10.1128/iai.64.5.1532-1540.1996;
RA   McClain M.S., Hurley M.C., Brieland J.K., Engleberg N.C.;
RT   ""The Legionella pneumophila hel locus encodes intracellularly induced
RT   homologs of heavy-metal ion transporters of Alcaligenes spp."";
RL   Infect. Immun. 64:1532-1540(1996).
CC   -!- FUNCTION: Presumed to function with HelC and HelB in efflux of an
CC       unidentified substrate.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the resistance-nodulation-cell division (RND)
CC       (TC 2.A.6) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49498; AAB05679.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q48815; -.
DR   SMR; Q48815; -.
DR   STRING; 91892.BIZ52_11460; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008324; F:monoatomic cation transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IEA:TreeGrafter.
DR   Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR   Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR   Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR   Gene3D; 3.30.2090.10; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR   InterPro; IPR027463; AcrB_DN_DC_subdom.
DR   InterPro; IPR001036; Acrflvin-R.
DR   InterPro; IPR004763; CusA-like.
DR   NCBIfam; TIGR00914; 2A0601; 1.
DR   PANTHER; PTHR32063; -; 1.
DR   PANTHER; PTHR32063:SF24; CATION EFFLUX SYSTEM (ACRB_ACRD_ACRF FAMILY); 1.
DR   Pfam; PF00873; ACR_tran; 1.
DR   PRINTS; PR00702; ACRIFLAVINRP.
DR   SUPFAM; SSF82693; Multidrug efflux transporter AcrB pore domain, PN1, PN2, PC1 and PC2 subdomains; 3.
DR   SUPFAM; SSF82714; Multidrug efflux transporter AcrB TolC docking domain, DN and DC subdomains; 2.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Membrane; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1052
FT                   /note=""Protein HelA""
FT                   /id=""PRO_0000161820""
FT   TRANSMEM        14..34
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        121..141
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        348..368
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        369..389
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        393..413
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        450..470
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        483..503
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        537..557
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        878..898
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        903..923
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        934..954
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        979..999
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        1011..1031
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   1052 AA;  115821 MW;  5C97817D7B13EBCE CRC64;
     MLEKIIRFSL KHRWFVLLFT LVIAILGVYN FQRLPIDAVP DITNVQVQIN TQASGYSPFE
     VEQRITFPIE LAMSGLPSLD YTRSLSRYGL SQVTVVFKDG TNIYFARQLI NERLQEVKDK
     LPPGVETTLG PISTGLGEIF MYTVTNKPNV PISQHYNPTE LRTIQDWIIK PQLRNVEGVA
     EVNTIGGYEK QFHITPDPSK LVRYRLSLND VVEALERNNA NVGAGYIETN GEQNLIRVPG
     QVQNMADIEN IVIASFEGTP VRIRDVAEVA LGKELRTGAA TENSKEVVLG TVFILMGENS
     RTVSERVAAK MKDINKTLPE GVEAITVYNR TTLVNATINT VKNNLLEGAL LVCVILFLFL
     GNIRAALITA MVIPLSMLLT ITGMVENQIS ANLMSLGALD FGLIVDGAVI IVENCIKHLA
     EQQHALHRVL NLEERLKVIS YATTEVIRPS IFGVFIITVV YLPILTLTGV EGKMFLPMAQ
     TVIIALLASM LFALTFVPAA VAIFLRGHLQ EKENWLVHYL SLGYAKVLRR CFHARRVVIS
     AAVALVVVSL GIAFHLGGEF IPSLDEGDIA MHAMRIPGTS LTQAITMQDL VEKRIRQFSE
     VKNVFAKLGT AEVATDPMPP NVADTFIILK SRKKWTNPKK TKPGLVQEIE SAVQQIPGNN
     YEFTQPIQMR FNELISGVRS DVAVKVFGDD MDTLLKTAEA ISAQLKQVPG AADVKVEQVS
     GLPLLTVEIN RDVLARYGLQ IGTVQEAVVI ATGGKKGGEL FEGDKRFDIV VRLPESLRSD
     PNVLRQIFIP LPLSKDGEQH FIPLSEVASL IRSESPNQIS RENGKRRVVV TANVRNRDLS
     SFVSEAKKRI DGQVKLPSGY WITWGGQFEQ LQSAYQRLQI VVPITLLGIF LLLFISFGKV
     RDALLVFTGI PLALTGGVFA LWLRGIPLSI SAGVGFIALS GVAVLNGLVM ITFINKLREQ
     KKVYLKDAVL QGSLARLRPV LMTALVASLG FVPMALATGT GSEVQRPLAT VVIGGIISST
     FLTLLVLPGL YYVFHGRRKK GQSKSEPQEQ IM
//
",43408
GGGAAT GGAATG GAATGC AATGCA ATGCAG TGCAGC GCAGCC CAGCCC AGCCCA GCCCAC CCCACG CCACGT CACGTT ACGTTC CGTTCA GTTCAG TTCAGG TCAGGC CAGGCA AGGCAC GGCACA GCACAC CACACG ACACGC CACGCC ACGCCG CGCCGC GCCGCC CCGCCG CGCCGA GCCGAG CCGAGC CGAGCT GAGCTG AGCTGG GCTGGG CTGGGC TGGGCG GGGCGT GGCGTA GCGTAG CGTAGC GTAGCG TAGCGC AGCGCT GCGCTC CGCTCG GCTCGA CTCGAC TCGACC CGACCA GACCAG ACCAGC CCAGCT CAGCTC AGCTCG GCTCGG CTCGGC TCGGCG CGGCGG GGCGGC GCGGCG CGGCGT GGCGTG GCGTGT CGTGTG GTGTGC TGTGCC GTGCCT TGCCTG GCCTGA CCTGAA CTGAAC TGAACG GAACGT AACGTG ACGTGG CGTGGG GTGGGC TGGGCT GGGCTG GGCTGC GCTGCA CTGCAT TGCATT GCATTC CATTCC ATTCCC TTCCCA TCCCAG CCCAGC CCAGCA CAGCAA AGCAAG GCAAGG CAAGGC AAGGCG AGGCGC GGCGCT GCGCTG CGCTGC GCTGCT CTGCTG TGCTGC GCTGCA CTGCAT TGCATG GCATGT CATGTG ATGTGG TGTGGC GTGGCC TGGCCG GGCCGC GCCGCC CCGCCG CGCCGT GCCGTG CCGTGA CGTGAT GTGATG TGATGG GATGGA ATGGAC TGGACG GGACGA GACGAA ACGAAG CGAAGT GAAGTG AAGTGT AGTGTC GTGTCG TGTCGC GTCGCA TCGCAC CGCACA GCACAT CACATG ACATGG CATGGC ATGGCC,3,142,GC C AGA A G GGGAAAA ATGGC  GTAATAT T AAATTG G ATG ATGCATCA C TATTTGC TG GCGCACAGAG G CCAGAGCGC C A AGAGCGCCCGC GCGCCCCCCC C C CCCCCCCACA A C CCCGCCACGTAC C CACACACGCG G A ACACGCGTGT T C CGCC GTGTT T G GTGTTTTCTC C T TTTCACA A T TCTCACAGAG G C CACAGAGGGG G A AGAGGGGCGC C G GGGGCGCAA G GCGCACACAC C C CACACACACA A AT GGTGAC C CCACGT  TG ACCCGCGCGC C C CGCGCCC C GGCCCCGCG G C CCCCGCGCGC CTG CGCTCGCCCC C GCCGCG G C CCCCGGA A C CG TGGAGAG G GCG GAGAGCGC A G AGCC GCTCT T G GCGCTCCT ATG C CTGAATGGGG  TGC TGGGAGTG G GGGGGGC C G GGGGCGCGCG G G GCGCGCGTT C CGCGTGTATA A G GTGGCTAGAG G T TATAGAGCGC C A AGAGCGATCG G GGACGCGCGCGC C C GAGCTCGCCT T GGCTCTCTC G C CTCTCTCGCG G T TCTCGCGAGA A C CGCGAGGGC G GAGACTGTAGCC AACCGC GC A C CCCCACAGAG  CACAGAGCGGGC A AGAGCGACCT T GATGGCTTC  TGCT TCGCG  TCTCGCGGGG G C CGCGGGGCC G GGGGCGTG GA GCGCGCGG GCG C CGCGGAC GC C G GGGGCGCGCG  GCGCGCGTGT T C CGCGTTG G G GTGTGTGTGATTGTA TTG GCCGAATGCCA C T TGTGCGCCCC C GGG GCCCTGCT  CCCCTCTGACGTTC CTCTGTGAGA GCG TGT CGAACTG GA CAAC C A AAAACACGCG G A ACCGTGT T C CGCGTGTGTG G G GTGTGTGGG T TGTGG GCGG G GTCCGGCGC C G GGA CGCTCT T G GCGCTCTGTG G C CTCTGTGCG GC T TGGCAA G GCGCAAT T C CACATATTTT T AC CTTCTC G A TTG C GGCC C T TCTCCCCCCC C C CCCCCCCAGC A C CCCCATTCAG G CGAAC TC GTG G G AGAGCGCACA A G GCGCAA C CACAAAAGG A AAGTGAGGGG  AA AGAGGGGCGC AGC GGGGCGCGCG G G GCGCGCGCGC C C CGCGTGCTT G GCGCTC CTG C CCTGCCATGGA GTGCGCTCT ACA GCGCTCTGTG G C CTTGCGC CAG TGGCACA A G GCGCACATAT TGA CACAT GCG A ATATGAAGGT T T TGTGTTG G G GTGTTTGGGG G TCGCTGGGGCGC  GGGGCG GCC  GCGCCCCGG C CCCCGGC C C CGC TGCCCC C G GCGCCCG G C CCCCGCGTGT T C CGCGTGTGTG G G GTCACTGAGA A T TGTGAT TT G GAGCGATGGC G A ATATGTGGGG G TTGGGGAGA A G GGGG AC C G GAGACACGCG G A ACACGCGAGA GGC CGCGACTGAA C A CGAAGAG G A AAGCTGT T A AGGTGAAGGGA GTGTGTGTGT T T TGACCGTCTC C G GTGTCTCGCG G TTCGCGC GAC C CGCGCGCACA A G GCGCAAC C C CACACACACA A AACACATAT T C CATGCATGG A ATA G GCGG G TCGATGGGGCGC C GGGCGCC,GGGGGAGAAAA ATGGGAAA  TGT G GAGAAATGTG G A AAAATGGCTGCGC C A ATATGTCGCA A T TGTGCGCACAGAG G GGCACAGAGCGC CAGAGCGCCCC C A AGGCC CGCC  TGGCCCCCCCA CA TC CCCCCCCACAC GCC C CCG C GCCG G C CACACACGGT C G ACACGCGTGTTTT T C CGCGTTTCTC T A GTGTTTTCTCACA A T TTTTCTCAAG A CTCACAGAGGGG G C CACAGAGGGGCGC C A AGAGGGGCGCACA  GG GGGCACACAC C G GCCACACACTCA C CAACATG AC GCA ACACACACACGCG CA  CAGC ACGCGCGC C ATCGACGCGCGCC AGC C CGCGCCCGCG AG  GCG TCGCGC C C CCCCGCGCGCCC C CGCGCGCCCCGCG  GCGCCCCGCGATTCA C CCCCGCGAGAGG G TG CGCGA TGAGCCACC G GACT CT ACGAGCGCTCTGTCGG G GCGCTGACGG G C CTCTGTGGGG G T TG CGGGGGGCGC  GGGGGGGCCG G GA GGGCGCGCGTGT T G GCGCGCGTGTATA GC  CGCGTGTATGGAG G G GTGTATAGAGCGC C T TATAGAGC CTCG  AGAGCGCGCGCGC C G GCGCGCGCGCTGCT CGCGCGAATC C G GCCACTCGCG G C CTCA  ACCGAGA  TCTCGCGAGCCAC C C CGCGAGACAGGCC C G GAGACACCCCACA A AGGGCCACAGAG G C CCCCACAGCGTGC C CG CCAGAGCGCTT A AGAGCCGGC GGCTCTCTCGCG G CGCGCTCTGGGCTG T TCTG CGGGGCGC C C CGCGTCC GCGCG G G GGGGC CGCGGGG G G GCGCGCGGGGCGC C C CGCGGGGCGCGCTGG GGGC TGCGTGT  AT GCGCGCGTGAATG G C CGCGTGTGTGTGT T G GTGTGGTGG T TGTGTGTGGC CTG GTGTGGCCCC C T TGTGCGCCCCTCT T GCAAGACCCTCTGTG G C CCCCTCTGTGAGA A CCCGGAAAA A T TGTGAGAAAAC GAACGCG G AAACACGAGCGT T A ACACGGTGTG G C CGCGTGTGGG G G GTGTGTGGGGGGG G TAC TGGGCAGGCGC C GGGGGGCGCTCT T G GGGGCC GTG G GCACGCTCTGTGCGC C C CTC CTGCGCACA A TCCATGCGCACATAT T G GCGCACATATTTT T C CAC AATTGA TC C AATTTTCTCCCC C T TTTTCTCCCCCC T TCCCGCCCCCACA A CTGTCAGAG G CCCAAGCGC CTG GCAGCGCACA A A AGAGCGCA GCAA A G GCGCACAAAAGAG G C CACAAAAGACCGG TCGTC AAGAGGGGCGC C AATGAGGGGCTGA GT GGGGCGCGCGCGC C G GCGCGCGCGATCT T C CGCGCG GCTGTG GCTTGCGCTCTGTGCGC C C CTCTGTGCGCT GG TGGCTCTGTG G G GCGCTCTGTGCA CC C CT GCGCACA A TTGCGAGGCACATAT T G GCGCACAC CCTG  CAATGTGTT A ATATGTGTGTGCATG TCCATGTTAGGG G GCG GTGTGGGGCGC C TTGGGGCGCCTGGC G GGGGCGCCCCGCG G G GCGCCCCGCGCGC C C CCCCGCGCGCCCC C CCCCCGCGCCCCGCG G G GCGCCCCGCGTGT T C CCTCCCGGGTGTG G C CGCGTGTGTGAAGTGTT GTGTGTGAAT  CAGCGGCGGAT GTTG G G GAGGCATGTCGGG TGG ATATGTGGGGAGA A T TGCC GGAG AAC C G GGGGAGACACGCG G G GAGACACGGA A A ACT ACGACTCA CGCGCGAATGAAGAG GTC GAGAAAAGAGTGT T A AAAAG CAGTGTG G A AGGA GTGTGTGT T GATGGTGTGTGTCTC C TAT TGTG GG ACG G G GTGTCTGCCGCGC  TCTCGCGCCATCA T TCGCGCACACAC  GCGCAGCTACACA AGTCACACACT AT T A ACACACATATGTG G CA CCATCATTGGGG G AT GATGTGGGCTGC C T TGTGGGGC,GGGGGAGAAAATTCAT G GGGGAGAAGCAATGTG G G GCAATATGTGCGC GC AATTGCGCACA A AATGTGCGCACAGAG G T TGTGCGCACAGAGCGC C G GCGCACTGAGCGCCCC AAC CACAGAGCGCCCC GCCAGCCCCCGCCA A G GCCCCCCAAC C C CCCCCCCACACACGCG G CCGACCACACACGTTCGT ATG CATTCACGGTTGTTCGAT A ACACGCGTCGTCGTTC C C CGCGTG GTTCAT CA A G GTGTTTTCCAGAG G T TTCACCCAAGGGG G T TCTCATGCTCG AA CACAGAGGGGCGCACA A AAGGGCCCACAC C GGGCGCAACACA A G GCGCACACACACACAC C C AGCACACACACACGCG G A ACACACACACGCGCGC C CCACACGCGCTGGCC C A ACATGCGCGCCCCGCG G CCGCGCCGGCCGCGC C G GCGCCCCGCGCCC CTGCCGGCCCGCCG G C CGCGCGCCCCGCGAGA A G GCGCCCCGCGAGAGAG G C CCCGCCGAGAGGCAGC C C CG CCGAGAGCGCTT G GAGAGAGCGCTCTGA GG AAAGAGCGCTCTGTGGGG G G GCGCTCTGTGGGGGGG GCT CTGCTTGGGCCG CGT  TGTGGGGGGGCGCGTT G G GGGGGCCGCGTGT T G GGGCAGCGGTATA A G GCCGTGTATAGG C CGCGTTAGAGCGC C G GTGTATAGAGCGCGCG G TTAGAGCGCGCGCGC C A AGAGCGCGCGCGCTCT T G GCGCGACGGCTCTCTC C CTG GAAGCTCTCCG CAGGCTTCGCGAGA A CGC CTCGGCCGAGACAC C T TCTCGCGACCCACCCC C C CGCGATGTACCCCATG  GAGACACCCCACAGAG  ACACCCCACAGG TGC C C CCCCACAGAGCGCTCT T CTGGAGCCTCAC C ACGCAGCGGCCTCTCGCG CA  GCGCTCTCTCGAGCG CTGC CTCTCTCGCGGGGCC T TCGGCGCGCG G C CGCGGGGC GACGGGG G G GGGGCGCGCGGGGCGC C G GCCGGGAAGCGCG GC  CGCGGGGCACACGT GGGGCATTCGTGCCTG CAC GCGCGCGTGTGTGTGT T C CGCGTGTGTGTGTGGTTCAAGTGGTG CGGC C TTGTTGCGCCCC  CCGTGTGCGCCCCTGCTT TGGCTGCGCCCCTCTGTG G G GCGCCCCTCTGTGAGA A C CCCCTCA TGAGAAGGCA C CTCTGTGAAACC CCGAC T TGTGAGAAAACACGCG G G GA AAGAAACGT AGAAAACACGCGTGTGTG G A ACCGTGTGTGGGG TGCCGTGTGTGGGGGGG G GGTGTGGGGGGGCGC C T TGATGGGCGCTCT T G GGGGGGGCG CTG G G GGGGCCT CTGTGCGC C G GCGCT CCTGCGCACTGA C CT GCTGCAGTCATAT T T TGG CGCACATATTTC GCACAT AAT GC C CAGCGTTCTCCCC  ATATTTTCTCCCCCCC C T TTTTCTCCCA A T TCCTGCCCTCACAGAG G C GTCCCCCACAGGTGC CCCACAGAGCCTGCA A C CACAGAGCGCACAAAA A A CAAGCCAAAAGAG G G GCGCA GTAAGAGGGG G C CACAAAAGAGGGC TCAC A AA AGAGGGGCCG G A AGAGGGGCGCGCGCGC C G GGAA CATGCTCT T GGCGCCAGCTCTGTG G C TGCGCGCTCTGTGCC G GAGCTCTGTGCGCTC AT C CTTCCTGCGCTCTG AG TGTGCGCTGCATGCGC C G GCCTGCTGTGCGCACA A CCTGTGCGCACGTT T TGGCAGCTT CCCGG G GCAGCCATATGTGTGT T C CACATATGTGTG A ATCCGTGTGTGTGGGG CGG TGTGTTGGGGCACGC G GTGTGTGGGGCGCCCC  TGCAG CGC AACGCG G G GGGGCGCCCCGAAGGC C G GCGCCCCGCCGGGGC C CCCCGCAGG TCCGCG G C CGCGCGCCCGTGT CC  GCGCCCGTAGCTG G C CCCCGAT GTGTGAA CCGTGTGGATAT T G GTGTGGATATGTG G TATGTGGGG G GGATATGTGGGGAA AGCGATGTGGGGAGACAC C T TGTGGGGAGACACGCG G G GGGGAATGCG GA A GGCGGACCCGTC CGCAA A A ACGGCCGAGAAAG G C CGCGAAAGAGTGT GGCAGTGTGTG G AATTAAGAGTGTGTGTTCGG TAATGTGTGTGTCTC C GGTGTGTGTCTCGCG  TGTGTGTCG GGC C G GTGTCTCGCGCGCACA A TCGCTCGCGCGCACACAC C C CGCGC AGCACACAG GA G GCGCACGCACACATAT T C CACACACACATTGGTG G AGCGATGTGGGG G C CACATATGTGGGGC CTGAA ATGACGGCGCC,GGGGGAGAAGCGATGG GCACGGAGAAAATATGTGCGC TGT GAGAA GGTGC CGCA TG  AAAATTGCCAGAG G A ATATGGCAAGCGC C T TGTGCGCA AGAGCGCCTCAC G GCGCACAGAGCGGCCCCCC C C CACAGAGCCCCCCACA A A AGAGCGCCCCCCCACACAC C GAGGCCCCCACAGACGCG GGC CCCCCCCACACACGTGCGT T C CCCCACACACGCGTGTTTT T C CACACACGCGTGTTTC CGT ACACGGTTTTCTCACA TGCCGTCCGTTCCAGAG G G GTGTTTTCTCACAGAGGG T TTTTCCC CAGT TGGCGC C T TCTGCAGGGGCTGTCA A C CACAGAGGGGCGCACACAC C A AGAGGGGC GACAC AGCA CGC GGACAGCACACACAAC C G GCGCACACACACACCG G CCACACACACACGA GGC C A ACACACACACGCGCGCCCC  CACACACGC TGCCGTTG A ACG ACGCGCCCCGCGCGC TGG CGG CGCCCCGCGCGCCAG  GCGC CCGCGCGCCCCGCG GTG CCCCGATGCCGCGAA CGCACGCCGAGAGCC G G GCGCCCCGCGAGAGAGCGC T G CCCCGC GGAGAGCGCTCT T CT CCGAGAGGCTCTGTG G GCGAGAGA GCTGTGGGG G A AGAGCAGCTG TGGGGGGTGG G GCTGGGGGGGCC C CTCTGTGGGGGGGCGCGCG  TGTGGGGGGGCGCGCGTGT T G GGGGGGGCGCGCGTGTATA A G GGGGCGCGCGTTGGTAGGCCG GTGCCGTGTATG GC C C CGCGTGTATAGAGCGCGCG G G GTTAGAGCGCGCGCGC C T TATAGT GGCGCGCGCTCT T ACACAGCGCGCGCGCTCCTC G GCGCGCGCGCTCTCTCGCG G C CGAG GC TCGCGACTCA G GCGCTGCAATGGACAC C C CTGGCTCGGACACCC T TCTCGGACACCAGGCA  CGCGAGACCCACAGAG G G GAC CACCCCACAGC A ACACCCCACAGTCAGCTCT T C CCCCACAGAGCGCTCCGC C CACAGAGCGC CTCTCGCG G AGCGAGCGCTCTCCGGGG CG  GCGCTCTCTCGGGCGC C C CTCTCTCGCGGCTCCTGCG G TTGCGCTCGGCGGGCGCGGGG CGC CGGCTGGCCGGGCGGGCGC C G GGGGCGCGCGGGGCGCGCG  GCGCGCGGGGCGCGCGTTGCT CGA CGGG GGCGCGTGTGCC G GGGCTGCCGTGG  CGGT CGCGCGCGTTGGTGTGTGTG G C CGCGTGTGTGTGTG GCC G GTGTGTGTGTGGCC GC TGTGTTGCGCCCCTCT  GTGTGTGCGCCCCTCTGTG ATG TGTGCGCCCTCCTGTGAGA A G GCCCTCTGTGAAA A C CCCCTCTGTGATTCAACAC C C CTCTGTGAGAAAACACGCG G T TGTGAATTAACACGC AGT T GGCAGAAAACACGGTGTG G A AAA GACGCGTGTGGG G AGGGACGCGTGTGGAC ACGC C C CGCGTGTGGGGGGCGCCC G GTCTGGGGCTGGCTT T TGTGGGGGG CGCTCTGTG G G GGGGGGCTCTGTCAA G GA GGGGCAGCCTGTGC GCGCTCTGGCACATAT ACGCTGGCGGCACATATTTT AGG TGA CGCACATCC TTCTC GCGGCACATATTGAATCCCGG CACATAT TTCTCCCCCCC C A ATGAATTCTCCCCCCCACA A T TTTCCCCCCCACAGAG CGC TCTCCCCCCCACAGGC C CCCCCAGAGCGCACA A C CCCCACAGGCACAAAA  CACAGAGCGCACAAAAGAG G A AGGCTGCACAAAAGAGGGG G GGCACAAAAG GCGGCGC C C CACAAAAGCCAAGGGCGCG G A AAGGCGGCC GCGCGC C A AGAGGGGCGCGCGCGCTCT GCT GGGGCGCGCGCGCTCTGTG G G GC AGCGCGCTCTGTGCGACGT  CGCGCGCTCTGTGCGCTCT T G GCGGCCTGTGCGCTCTGTG TGGTGCAATCTGTGCGC C C TG TCTCGGCTTGCCGACA GC  GCGCTGGCGT GCACATAT T C CTCTGTGCGCACATATGCTGAAG TGCGTGCACATATGTGTGT G CCAGGCACATATGC GG CTG TG  CACATATGTGGGG G AG TTGTGTGTGGGGCGC C T TGTGTGTGTGGGGCGCCATTC G GTGTGTGGGGCGCCCCGG GG T TGTGGGGCGCCCCGCGCC GGCCG CCGCGCCCC C G GCGCCCCGCGCGCCCG G CCCGCGCGCCGT T C CGCGCCGCCCGCGTGTGTG G G GCTC TGAGTCA CCCGCGTGTGGATAT  CGCGTGTGTGAGATA ATG GGC GTGTGTGAGATTCGTGGGG G TGACTGAGATATGTGGGGA CGAAC GAGATATGTGGGGAGACAC C AATGTGGGGAACGCG G T TGTGGGGAGACACGCGAGA GTG GGGGAGG ACGCGAGAAAA GCT GA TGTGGCGAGAAAAGAG T C ACACGCGAGAAAAGTGTGT T C CGCGAGAAAAGAGTGTGTG G G GAGAAAAGGTCGTG CGC CT A AAAGTGTGTGTAGTTC C AACAAGTGTGTGTTCGGA G GGTGTGTGTCTCGCGCGC C T CATGTGTCTCGCGCGCACA A G GTGTCG TGCACACAC C T TCTCGCGCCACGGCCA A CGCACGCGCACACACACATATTT G GCCACACACATATGAGCG C TGACACATATGACGGG G A ACACACATATGTGGGCCGC C C CACATATGTGGGGCGCC,"ID   DLDH_VIBPA              Reviewed;         475 AA.
AC   O50286;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2003, sequence version 2.
DT   05-FEB-2025, entry version 157.
DE   RecName: Full=Dihydrolipoyl dehydrogenase;
DE            EC=1.8.1.4;
DE   AltName: Full=Dihydrolipoamide dehydrogenase;
DE   AltName: Full=E3 component of 2-oxoglutarate dehydrogenase complex;
GN   Name=lpd; OrderedLocusNames=VP2517;
OS   Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Vibrionales; Vibrionaceae;
OC   Vibrio.
OX   NCBI_TaxID=223926;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=BB22;
RX   PubMed=9620967; DOI=10.1128/jb.180.12.3166-3173.1998;
RA   McCarter L.L.;
RT   ""OpaR, a homolog of Vibrio harveyi LuxR, controls opacity of Vibrio
RT   parahaemolyticus."";
RL   J. Bacteriol. 180:3166-3173(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=RIMD 2210633;
RX   PubMed=12620739; DOI=10.1016/s0140-6736(03)12659-1;
RA   Makino K., Oshima K., Kurokawa K., Yokoyama K., Uda T., Tagomori K.,
RA   Iijima Y., Najima M., Nakano M., Yamashita A., Kubota Y., Kimura S.,
RA   Yasunaga T., Honda T., Shinagawa H., Hattori M., Iida T.;
RT   ""Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism
RT   distinct from that of V. cholerae."";
RL   Lancet 361:743-749(2003).
CC   -!- FUNCTION: The branched-chain alpha-keto dehydrogenase complex catalyzes
CC       the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It
CC       contains multiple copies of 3 enzymatic components: branched-chain
CC       alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and
CC       lipoamide dehydrogenase (E3) (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein] + NAD(+) = N(6)-
CC         [(R)-lipoyl]-L-lysyl-[protein] + NADH + H(+); Xref=Rhea:RHEA:15045,
CC         Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099,
CC         ChEBI:CHEBI:83100; EC=1.8.1.4;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC       Note=Binds 1 FAD per subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF035967; AAC46405.1; -; Genomic_DNA.
DR   EMBL; BA000031; BAC60780.1; -; Genomic_DNA.
DR   RefSeq; NP_798896.1; NC_004603.1.
DR   RefSeq; WP_005479684.1; NC_004603.1.
DR   AlphaFoldDB; O50286; -.
DR   SMR; O50286; -.
DR   GeneID; 1190032; -.
DR   KEGG; vpa:VP2517; -.
DR   PATRIC; fig|223926.6.peg.2414; -.
DR   eggNOG; COG1249; Bacteria.
DR   HOGENOM; CLU_016755_0_1_6; -.
DR   Proteomes; UP000002493; Chromosome 1.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004148; F:dihydrolipoyl dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IEA:TreeGrafter.
DR   GO; GO:0006090; P:pyruvate metabolic process; IEA:TreeGrafter.
DR   FunFam; 3.30.390.30:FF:000001; Dihydrolipoyl dehydrogenase; 1.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 2.
DR   InterPro; IPR050151; Class-I_Pyr_Nuc-Dis_Oxidored.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR006258; Lipoamide_DH.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   NCBIfam; TIGR01350; lipoamide_DH; 1.
DR   PANTHER; PTHR22912:SF160; DIHYDROLIPOYL DEHYDROGENASE; 1.
DR   PANTHER; PTHR22912; DISULFIDE OXIDOREDUCTASE; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   PRINTS; PR00368; FADPNR.
DR   PRINTS; PR00411; PNDRDTASEI.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
DR   SUPFAM; SSF55424; FAD/NAD-linked reductases, dimerisation (C-terminal) domain; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Disulfide bond; FAD; Flavoprotein; NAD; Oxidoreductase;
KW   Redox-active center.
FT   CHAIN           1..475
FT                   /note=""Dihydrolipoyl dehydrogenase""
FT                   /id=""PRO_0000068053""
FT   ACT_SITE        445
FT                   /note=""Proton acceptor""
FT                   /evidence=""ECO:0000250""
FT   BINDING         36..45
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250""
FT   BINDING         54
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250""
FT   BINDING         117
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250""
FT   BINDING         182..186
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   BINDING         205
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   BINDING         238
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   BINDING         270..273
FT                   /ligand=""NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:57540""
FT                   /evidence=""ECO:0000250""
FT   BINDING         313
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250""
FT   BINDING         321
FT                   /ligand=""FAD""
FT                   /ligand_id=""ChEBI:CHEBI:57692""
FT                   /evidence=""ECO:0000250""
FT   DISULFID        45..50
FT                   /note=""Redox-active""
FT                   /evidence=""ECO:0000250""
FT   CONFLICT        160
FT                   /note=""P -> S (in Ref. 1; AAC46405)""
FT                   /evidence=""ECO:0000305""
SQ   SEQUENCE   475 AA;  50988 MW;  67F6E3A8C28DFB44 CRC64;
     MSKEIKAQVV VLGSGPAGYS AAFRCADLGL ETVLVERYST LGGVCLNVGC IPSKALLHVS
     KVIEEAKAMA DHGVVFGEPQ TDINKIRIWK EKVVNQLTGG LSGMAKMRNV TVVNGYGKFT
     GPNSILVEGE GESTVVNFDN AIVAAGSRPI KLPFIPHEDP RIWDSTDALE LKEVPEKLLI
     MGGGIIGLEM GTVYHSLGSK VEVVEMFDQV IPAADKDIVK VYTKRIKDKF KLMLETKVTA
     VEAKEDGIYV SMEGKKAPAE AERYDAVLVA IGRVPNGKLI DGEKAGLEID ERGFINVDKQ
     MRTNVPHIFA IGDIVGQPML AHKGVHEGHV AAEVISGKKH YFDPKVIPSI AYTEPEVAWV
     GKTEKEAKAE GIKYEVATFP WAASGRAIAS DCSDGMTKLI FDKETHRVIG GAIVGTNGGE
     LLGEIGLAIE MGCDAEDIAL TIHAHPTLHE SVGLAAEVFE GSITDLPNKK AVKKK
//
",1330
ACTAAA CTAAAG TAAAGA AAAGAA AAGAAG AGAAGG GAAGGT AAGGTG AGGTGC GGTGCC GTGCCA TGCCAC GCCACT CCACTA CACTAC ACTACT CTACTT TACTTG ACTTGT CTTGTG TTGTGG TGTGGT GTGGTT TGGTTA GGTTAC GTTACT TTACTT TACTTA ACTTAC CTTACC TTACCC TACCCC ACCCCA CCCCAA CCCAAA CCAAAA CAAAAT AAAATG AAATGC AATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGT GTTGTT TTGTTA TGTTAA GTTAAA TTAAAA TAAAAT AAAATT AAATTT AATTTA ATTTAT TTTATT TTATTG TATTGT ATTGTC TTGTCC TGTCCA GTCCAG TCCAGC CCAGCA CAGCAT AGCATG GCATGT CATGTC ATGTCA TGTCAC GTCACA TCACAA CACAAT ACAATT CAATTC AATTCA ATTCAG TTCAGA TCAGAA CAGAAG AGAAGT GAAGTA AAGTAG AGTAGG GTAGGA TAGGAC AGGACC GGACCT GACCTG ACCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATA GCATAG CATAGT ATAGTC TAGTCT AGTCTT GTCTTG TCTTGC CTTGCC TTGCCG TGCCGA GCCGAA CCGAAT CGAATA GAATAC AATACC ATACCA TACCAT ACCATA CCATAA CATAAT ATAATG TAATGA AATGAA ATGAAT TGAATC GAATCT AATCTG ATCTGG TCTGGC CTGGCT TGGCTT GGCTTG GCTTGA CTTGAA TTGAAA TGAAAA GAAAAC AAAACC AAACCA AACCAT ACCATT,0,136,ACTA CTAA TAAA AAAG AAGA AGAA GAAG AAGG AGGT GGTG GTGC TGCC GCCA CCAC CACT ACTA CTAC TACT ACTT CTTG TTGT TGTG GTGG TGGT GGTT GTTA TTAC TACT ACTT CTTA TTAC TACC ACCC CCCC CCCA CCAA CAAA AAAA AAAT AATG ATGC TGCT GCTG CTGT TGTT GTTG TTGT TGTT GTTA TTAA TAAA AAAA AAAT AATT ATTT TTTA TTAT TATT ATTG TTGT TGTC GTCC TCCA CCAG CAGC AGCA GCAT CATG ATGT TGTC GTCA TCAC CACA ACAA CAAT AATT ATTC TTCA TCAG CAGA AGAA GAAG AAGT AGTA GTAG TAGG AGGA GGAC GACC ACCT CCTG CTGA TGAG GAGC AGCA GCAT CATA ATAG TAGT AGTC GTCT TCTT CTTG TTGC TGCC GCCG CCGA CGAA GAAT AATA ATAC TACC ACCA CCAT CATA ATAA TAAT AATG ATGA TGAA GAAT AATC ATCT TCTG CTGG TGGC GGCT GCTT CTTG TTGA TGAA GAAA AAAA AAAC AACC ACCA CCAT CATT,ACTAA CTAAA TAAAG AAAGA AAGAA AGAAG GAAGG AAGGT AGGTG GGTGC GTGCC TGCCA GCCAC CCACT CACTA ACTAC CTACT TACTT ACTTG CTTGT TTGTG TGTGG GTGGT TGGTT GGTTA GTTAC TTACT TACTT ACTTA CTTAC TTACC TACCC ACCCC CCCCA CCCAA CCAAA CAAAA AAAAT AAATG AATGC ATGCT TGCTG GCTGT CTGTT TGTTG GTTGT TTGTT TGTTA GTTAA TTAAA TAAAA AAAAT AAATT AATTT ATTTA TTTAT TTATT TATTG ATTGT TTGTC TGTCC GTCCA TCCAG CCAGC CAGCA AGCAT GCATG CATGT ATGTC TGTCA GTCAC TCACA CACAA ACAAT CAATT AATTC ATTCA TTCAG TCAGA CAGAA AGAAG GAAGT AAGTA AGTAG GTAGG TAGGA AGGAC GGACC GACCT ACCTG CCTGA CTGAG TGAGC GAGCA AGCAT GCATA CATAG ATAGT TAGTC AGTCT GTCTT TCTTG CTTGC TTGCC TGCCG GCCGA CCGAA CGAAT GAATA AATAC ATACC TACCA ACCAT CCATA CATAA ATAAT TAATG AATGA ATGAA TGAAT GAATC AATCT ATCTG TCTGG CTGGC TGGCT GGCTT GCTTG CTTGA TTGAA TGAAA GAAAA AAAAC AAACC AACCA ACCAT CCATT,ACTAAA CTAAAG TAAAGA AAAGAA AAGAAG AGAAGG GAAGGT AAGGTG AGGTGC GGTGCC GTGCCA TGCCAC GCCACT CCACTA CACTAC ACTACT CTACTT TACTTG ACTTGT CTTGTG TTGTGG TGTGGT GTGGTT TGGTTA GGTTAC GTTACT TTACTT TACTTA ACTTAC CTTACC TTACCC TACCCC ACCCCA CCCCAA CCCAAA CCAAAA CAAAAT AAAATG AAATGC AATGCT ATGCTG TGCTGT GCTGTT CTGTTG TGTTGT GTTGTT TTGTTA TGTTAA GTTAAA TTAAAA TAAAAT AAAATT AAATTT AATTTA ATTTAT TTTATT TTATTG TATTGT ATTGTC TTGTCC TGTCCA GTCCAG TCCAGC CCAGCA CAGCAT AGCATG GCATGT CATGTC ATGTCA TGTCAC GTCACA TCACAA CACAAT ACAATT CAATTC AATTCA ATTCAG TTCAGA TCAGAA CAGAAG AGAAGT GAAGTA AAGTAG AGTAGG GTAGGA TAGGAC AGGACC GGACCT GACCTG ACCTGA CCTGAG CTGAGC TGAGCA GAGCAT AGCATA GCATAG CATAGT ATAGTC TAGTCT AGTCTT GTCTTG TCTTGC CTTGCC TTGCCG TGCCGA GCCGAA CCGAAT CGAATA GAATAC AATACC ATACCA TACCAT ACCATA CCATAA CATAAT ATAATG TAATGA AATGAA ATGAAT TGAATC GAATCT AATCTG ATCTGG TCTGGC CTGGCT TGGCTT GGCTTG GCTTGA CTTGAA TTGAAA TGAAAA GAAAAC AAAACC AAACCA AACCAT ACCATT,ACTAAAG CTAAAGA TAAAGAA AAAGAAG AAGAAGG AGAAGGT GAAGGTG AAGGTGC AGGTGCC GGTGCCA GTGCCAC TGCCACT GCCACTA CCACTAC CACTACT ACTACTT CTACTTG TACTTGT ACTTGTG CTTGTGG TTGTGGT TGTGGTT GTGGTTA TGGTTAC GGTTACT GTTACTT TTACTTA TACTTAC ACTTACC CTTACCC TTACCCC TACCCCA ACCCCAA CCCCAAA CCCAAAA CCAAAAT CAAAATG AAAATGC AAATGCT AATGCTG ATGCTGT TGCTGTT GCTGTTG CTGTTGT TGTTGTT GTTGTTA TTGTTAA TGTTAAA GTTAAAA TTAAAAT TAAAATT AAAATTT AAATTTA AATTTAT ATTTATT TTTATTG TTATTGT TATTGTC ATTGTCC TTGTCCA TGTCCAG GTCCAGC TCCAGCA CCAGCAT CAGCATG AGCATGT GCATGTC CATGTCA ATGTCAC TGTCACA GTCACAA TCACAAT CACAATT ACAATTC CAATTCA AATTCAG ATTCAGA TTCAGAA TCAGAAG CAGAAGT AGAAGTA GAAGTAG AAGTAGG AGTAGGA GTAGGAC TAGGACC AGGACCT GGACCTG GACCTGA ACCTGAG CCTGAGC CTGAGCA TGAGCAT GAGCATA AGCATAG GCATAGT CATAGTC ATAGTCT TAGTCTT AGTCTTG GTCTTGC TCTTGCC CTTGCCG TTGCCGA TGCCGAA GCCGAAT CCGAATA CGAATAC GAATACC AATACCA ATACCAT TACCATA ACCATAA CCATAAT CATAATG ATAATGA TAATGAA AATGAAT ATGAATC TGAATCT GAATCTG AATCTGG ATCTGGC TCTGGCT CTGGCTT TGGCTTG GGCTTGA GCTTGAA CTTGAAA TTGAAAA TGAAAAC GAAAACC AAAACCA AAACCAT AACCATT,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",606
ATGGAG TGGAGA GGAGAG GAGAGC AGAGCC GAGCCT AGCCTT GCCTTG CCTTGT CTTGTC TTGTCC TGTCCC GTCCCT TCCCTG CCCTGG CCTGGT CTGGTT TGGTTT GGTTTC GTTTCA TTTCAA TTCAAC TCAACG CAACGA AACGAG ACGAGA CGAGAA GAGAAA AGAAAA GAAAAC AAAACA AAACAC AACACA ACACAC CACACG ACACGT CACGTC ACGTCC CGTCCA GTCCAA TCCAAC CCAACT CAACTC AACTCA ACTCAG CTCAGT TCAGTT CAGTTT AGTTTG GTTTGC TTTGCC TTGCCT TGCCTG GCCTGT CCTGTT CTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGG ACAGGT CAGGTT AGGTTC GGTTCG GTTCGC TTCGCG TCGCGA CGCGAC GCGACG CGACGT GACGTG ACGTGC CGTGCT GTGCTC TGCTCG GCTCGT CTCGTA,0,79,ATGG TGGA GGAG GAGA AGAG GAGC AGCC GCCT CCTT CTTG TTGT TGTC GTCC TCCC CCCT CCTG CTGG TGGT GGTT GTTT TTTC TTCA TCAA CAAC AACG ACGA CGAG GAGA AGAA GAAA AAAA AAAC AACA ACAC CACA ACAC CACG ACGT CGTC GTCC TCCA CCAA CAAC AACT ACTC CTCA TCAG CAGT AGTT GTTT TTTG TTGC TGCC GCCT CCTG CTGT TGTT GTTT TTTT TTTA TTAC TACA ACAG CAGG AGGT GGTT GTTC TTCG TCGC CGCG GCGA CGAC GACG ACGT CGTG GTGC TGCT GCTC CTCG TCGT CGTA,ATGGA TGGAG GGAGA GAGAG AGAGC GAGCC AGCCT GCCTT CCTTG CTTGT TTGTC TGTCC GTCCC TCCCT CCCTG CCTGG CTGGT TGGTT GGTTT GTTTC TTTCA TTCAA TCAAC CAACG AACGA ACGAG CGAGA GAGAA AGAAA GAAAA AAAAC AAACA AACAC ACACA CACAC ACACG CACGT ACGTC CGTCC GTCCA TCCAA CCAAC CAACT AACTC ACTCA CTCAG TCAGT CAGTT AGTTT GTTTG TTTGC TTGCC TGCCT GCCTG CCTGT CTGTT TGTTT GTTTT TTTTA TTTAC TTACA TACAG ACAGG CAGGT AGGTT GGTTC GTTCG TTCGC TCGCG CGCGA GCGAC CGACG GACGT ACGTG CGTGC GTGCT TGCTC GCTCG CTCGT TCGTA,ATGGAG TGGAGA GGAGAG GAGAGC AGAGCC GAGCCT AGCCTT GCCTTG CCTTGT CTTGTC TTGTCC TGTCCC GTCCCT TCCCTG CCCTGG CCTGGT CTGGTT TGGTTT GGTTTC GTTTCA TTTCAA TTCAAC TCAACG CAACGA AACGAG ACGAGA CGAGAA GAGAAA AGAAAA GAAAAC AAAACA AAACAC AACACA ACACAC CACACG ACACGT CACGTC ACGTCC CGTCCA GTCCAA TCCAAC CCAACT CAACTC AACTCA ACTCAG CTCAGT TCAGTT CAGTTT AGTTTG GTTTGC TTTGCC TTGCCT TGCCTG GCCTGT CCTGTT CTGTTT TGTTTT GTTTTA TTTTAC TTTACA TTACAG TACAGG ACAGGT CAGGTT AGGTTC GGTTCG GTTCGC TTCGCG TCGCGA CGCGAC GCGACG CGACGT GACGTG ACGTGC CGTGCT GTGCTC TGCTCG GCTCGT CTCGTA,ATGGAGA TGGAGAG GGAGAGC GAGAGCC AGAGCCT GAGCCTT AGCCTTG GCCTTGT CCTTGTC CTTGTCC TTGTCCC TGTCCCT GTCCCTG TCCCTGG CCCTGGT CCTGGTT CTGGTTT TGGTTTC GGTTTCA GTTTCAA TTTCAAC TTCAACG TCAACGA CAACGAG AACGAGA ACGAGAA CGAGAAA GAGAAAA AGAAAAC GAAAACA AAAACAC AAACACA AACACAC ACACACG CACACGT ACACGTC CACGTCC ACGTCCA CGTCCAA GTCCAAC TCCAACT CCAACTC CAACTCA AACTCAG ACTCAGT CTCAGTT TCAGTTT CAGTTTG AGTTTGC GTTTGCC TTTGCCT TTGCCTG TGCCTGT GCCTGTT CCTGTTT CTGTTTT TGTTTTA GTTTTAC TTTTACA TTTACAG TTACAGG TACAGGT ACAGGTT CAGGTTC AGGTTCG GGTTCGC GTTCGCG TTCGCGA TCGCGAC CGCGACG GCGACGT CGACGTG GACGTGC ACGTGCT CGTGCTC GTGCTCG TGCTCGT GCTCGTA,"ID   R1AB_SARS2              Reviewed;        7096 AA.
AC   P0DTD1;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Replicase polyprotein 1ab;
DE            Short=pp1ab;
DE   AltName: Full=ORF1ab polyprotein;
DE   Contains:
DE     RecName: Full=Host translation inhibitor nsp1;
DE     AltName: Full=Leader protein;
DE     AltName: Full=Non-structural protein 1;
DE              Short=nsp1;
DE   Contains:
DE     RecName: Full=Non-structural protein 2;
DE              Short=nsp2;
DE     AltName: Full=p65 homolog;
DE   Contains:
DE     RecName: Full=Papain-like protease nsp3 {ECO:0000303|PubMed:32726803};
DE              EC=3.4.19.12 {ECO:0000269|PubMed:32726803};
DE              EC=3.4.22.-;
DE     AltName: Full=Non-structural protein 3;
DE              Short=nsp3;
DE     AltName: Full=PL2-PRO;
DE     AltName: Full=Papain-like proteinase;
DE              Short=PL-PRO;
DE   Contains:
DE     RecName: Full=Non-structural protein 4;
DE              Short=nsp4;
DE   Contains:
DE     RecName: Full=3C-like proteinase nsp5;
DE              Short=3CL-PRO;
DE              Short=3CLp;
DE              EC=3.4.22.69 {ECO:0000269|PubMed:32198291, ECO:0000269|PubMed:32272481};
DE     AltName: Full=Main protease;
DE              Short=Mpro {ECO:0000303|PubMed:32272481};
DE     AltName: Full=Non-structural protein 5;
DE              Short=nsp5;
DE     AltName: Full=SARS coronavirus main proteinase;
DE   Contains:
DE     RecName: Full=Non-structural protein 6;
DE              Short=nsp6;
DE   Contains:
DE     RecName: Full=Non-structural protein 7;
DE              Short=nsp7;
DE   Contains:
DE     RecName: Full=Non-structural protein 8;
DE              Short=nsp8;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked nsp9 {ECO:0000305|PubMed:37794589};
DE     AltName: Full=Non-structural protein 9;
DE              Short=nsp9;
DE     AltName: Full=RNA-capping enzyme subunit nsp9;
DE   Contains:
DE     RecName: Full=Non-structural protein 10;
DE              Short=nsp10;
DE     AltName: Full=Growth factor-like peptide;
DE              Short=GFL;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase nsp12;
DE              Short=Pol;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:35944563};
DE     AltName: Full=Non-structural protein 12;
DE              Short=nsp12;
DE   Contains:
DE     RecName: Full=Helicase nsp13;
DE              Short=Hel;
DE              EC=3.6.4.12;
DE              EC=3.6.4.13;
DE     AltName: Full=Non-structural protein 13;
DE              Short=nsp13;
DE   Contains:
DE     RecName: Full=Guanine-N7 methyltransferase nsp14;
DE              EC=2.1.1.56 {ECO:0000269|PubMed:35944563};
DE              EC=3.1.13.-;
DE     AltName: Full=Non-structural protein 14;
DE              Short=nsp14;
DE     AltName: Full=Proofreading exoribonuclease nsp14;
DE              Short=ExoN;
DE   Contains:
DE     RecName: Full=Uridylate-specific endoribonuclease nsp15;
DE              EC=4.6.1.- {ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093};
DE     AltName: Full=NendoU;
DE     AltName: Full=Non-structural protein 15;
DE              Short=nsp15;
DE   Contains:
DE     RecName: Full=2'-O-methyltransferase nsp16;
DE              EC=2.1.1.57;
DE     AltName: Full=Non-structural protein 16;
DE              Short=nsp16;
GN   Name=rep; ORFNames=1a-1b;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   VARIANTS ILE-1001; ASP-1708; THR-2230 AND 3675-SER--PHE-3677 DEL.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [3]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=33479166; DOI=10.1073/pnas.2017715118;
RA   Lapointe C.P., Grosely R., Johnson A.G., Wang J., Fernandez I.S.,
RA   Puglisi J.D.;
RT   ""Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome
RT   inhibits translation initiation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [4]
RP   FUNCTION (2'-O-METHYLTRANSFERASE NSP16), SUBCELLULAR LOCATION
RP   (2'-O-METHYLTRANSFERASE NSP16), FUNCTION (HOST TRANSLATION INHIBITOR NSP1),
RP   FUNCTION(NON-STRUCTURAL PROTEIN 8), FUNCTION (NON-STRUCTURAL PROTEIN 9),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 8), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=33080218; DOI=10.1016/j.cell.2020.10.004;
RA   Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A.,
RA   Bhat P., Ollikainen N., Quinodoz S.A., Loney C., Thai J., Miller Z.D.,
RA   Lin A.E., Schmidt M.M., Stewart D.G., Goldfarb D., De Lorenzo G.,
RA   Rihn S.J., Voorhees R.M., Botten J.W., Majumdar D., Guttman M.;
RT   ""SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to
RT   Suppress Host Defenses."";
RL   Cell 183:1325-1339(2020).
RN   [5]
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), AND MUTAGENESIS OF CYS-1674.
RX   PubMed=33727702; DOI=10.1038/s41564-021-00884-1;
RA   Liu G., Lee J.H., Parker Z.M., Acharya D., Chiang J.J., van Gent M.,
RA   Riedl W., Davis-Gardner M.E., Wies E., Chiang C., Gack M.U.;
RT   ""ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-
RT   CoV-2 papain-like protease to evade host innate immunity."";
RL   Nat. Microbiol. 6:467-478(2021).
RN   [6]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3.
RA   Liu X., Zhang B., Jin Z., Yang H., Rao Z.;
RT   ""The crystal structure of 2019-nCoV main protease in complex with an
RT   inhibitor N3."";
RL   Submitted (FEB-2020) to the PDB data bank.
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH ALPHA-KETOAMIDE 13B INHIBITOR, SUBUNIT (3C-LIKE PROTEINASE
RP   NSP5), FUNCTION (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE
RP   PROTEINASE NSP5), ACTIVE SITE (3C-LIKE PROTEINASE NSP5), AND ACTIVITY
RP   REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32198291; DOI=10.1126/science.abb3405;
RA   Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S.,
RA   Rox K., Hilgenfeld R.;
RT   ""Crystal structure of SARS-CoV-2 main protease provides a basis for design
RT   of improved alpha-ketoamide inhibitors."";
RL   Science 368:409-412(2020).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 AND IN
RP   COMPLEX WITH MICHAEL ACCEPTOR INHIBITOR N3, FUNCTION (3C-LIKE PROTEINASE
RP   NSP5) (3C-LIKE PROTEINASE NSP5), CATALYTIC ACTIVITY (3C-LIKE PROTEINASE
RP   NSP5), AND ACTIVITY REGULATION (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32272481; DOI=10.1038/s41586-020-2223-y;
RA   Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L.,
RA   Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X.,
RA   You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W.,
RA   Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H.;
RT   ""Structure of Mpro from COVID-19 virus and discovery of its inhibitors."";
RL   Nature 582:289-293(2020).
RN   [10]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), AND FUNCTION (RNA-DIRECTED RNA
RP   POLYMERASE NSP12).
RX   PubMed=32277040; DOI=10.1126/science.abb7498;
RA   Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q.,
RA   Ming Z., Zhang L., Ge J., Zheng L., Zhang Y., Wang H., Zhu Y., Zhu C.,
RA   Hu T., Hua T., Zhang B., Yang X., Li J., Yang H., Liu Z., Xu W.,
RA   Guddat L.W., Wang Q., Lou Z., Rao Z.;
RT   ""Structure of the RNA-dependent RNA polymerase from COVID-19 virus."";
RL   Science 368:779-782(2020).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.5 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12 IN
RP   COMPLEX WITH REMDESIVIR ANTIVIRAL DRUG AND IN COMPLEX WITH ZINC ION,
RP   SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8),
RP   SUBUNIT (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12), AND
RP   ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32358203; DOI=10.1126/science.abc1560;
RA   Yin W., Mao C., Luan X., Shen D.D., Shen Q., Su H., Wang X., Zhou F.,
RA   Zhao W., Gao M., Chang S., Xie Y.C., Tian G., Jiang H.W., Tao S.C.,
RA   Shen J., Jiang Y., Jiang H., Xu Y., Zhang S., Zhang Y., Xu H.E.;
RT   ""Structural basis for inhibition of the RNA-dependent RNA polymerase from
RT   SARS-CoV-2 by remdesivir."";
RL   Science 368:1499-1504(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 3C-LIKE PROTEINASE NSP5 IN COMPLEX
RP   WITH COMPOUND 11A AND COMPOUND 11B, FUNCTION (3C-LIKE PROTEINASE NSP5),
RP   CATALYTIC ACTIVITY (3C-LIKE PROTEINASE NSP5), AND ACTIVITY REGULATION
RP   (3C-LIKE PROTEINASE NSP5).
RX   PubMed=32321856; DOI=10.1126/science.abb4489;
RA   Dai W., Zhang B., Su H., Li J., Zhao Y., Xie X., Jin Z., Liu F., Li C.,
RA   Li Y., Bai F., Wang H., Cheng X., Cen X., Hu S., Yang X., Wang J., Liu X.,
RA   Xiao G., Jiang H., Rao Z., Zhang L.K., Xu Y., Yang H., Liu H.;
RT   ""Structure-based design of antiviral drug candidates targeting the SARS-
RT   CoV-2 main protease."";
RL   Science 368:1331-1335(2020).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE NSP12, SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE), FUNCTION (NON-STRUCTURAL PROTEIN 7),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND CATALYTIC ACTIVITY (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=32438371; DOI=10.1038/s41586-020-2368-8;
RA   Hillen H.S., Kokic G., Farnung L., Dienemann C., Tegunov D., Cramer P.;
RT   ""Structure of replicating SARS-CoV-2 polymerase."";
RL   Nature 584:154-156(2020).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3 MACRO
RP   DOMAIN, AND FUNCTION (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=32578982; DOI=10.1021/acs.biochem.0c00309;
RA   Frick D.N., Virdi R.S., Vuksanovic N., Dahal N., Silvaggi N.R.;
RT   ""Molecular Basis for ADP-ribose Binding to the Mac1 Domain of SARS-CoV-2
RT   Nsp3."";
RL   Biochemistry 59:2608-2615(2020).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.93 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8 AND RNA-DIRECTED RNA POLYMERASE IN COMPLEX WITH
RP   ZINC ION, SUBUNIT (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL
RP   PROTEIN 8), SUBUNIT (RNA-DIRECTED RNA POLYMERASE NSP12), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 7), FUNCTION (NON-STRUCTURAL PROTEIN 8), FUNCTION
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), CATALYTIC ACTIVITY (RNA-DIRECTED RNA
RP   POLYMERASE NSP12), ACTIVITY REGULATION (RNA-DIRECTED RNA POLYMERASE NSP12),
RP   AND MUTAGENESIS OF SER-5253.
RX   PubMed=32526208; DOI=10.1016/j.cell.2020.05.034;
RA   Wang Q., Wu J., Wang H., Gao Y., Liu Q., Mu A., Ji W., Yan L., Zhu Y.,
RA   Zhu C., Fang X., Yang X., Huang Y., Gao H., Liu F., Ge J., Sun Q., Yang X.,
RA   Xu W., Liu Z., Yang H., Lou Z., Jiang B., Guddat L.W., Gong P., Rao Z.;
RT   ""Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase."";
RL   Cell 182:417-428(2020).
RN   [16] {ECO:0007744|PDB:6YVA}
RP   X-RAY CRYSTALLOGRAPHY (3.18 ANGSTROMS) OF NON-STRUCTURAL PROTEIN 3,
RP   FUNCTION (PAPAIN-LIKE PROTEASE NSP3), CATALYTIC ACTIVITY (PAPAIN-LIKE
RP   PROTEASE NSP3), ACTIVITY REGULATION (PAPAIN-LIKE PROTEASE NSP3), AND
RP   MUTAGENESIS OF VAL-1629; PHE-1632; THR-1638; CYS-1674 AND TYR-1831.
RX   PubMed=32726803; DOI=10.1038/s41586-020-2601-5;
RA   Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A.,
RA   Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A.,
RA   van der Heden van Noort G.J., Ovaa H., Mueller S., Knobeloch K.P.,
RA   Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I.;
RT   ""Papain-like protease regulates SARS-CoV-2 viral spread and innate
RT   immunity."";
RL   Nature 587:657-662(2020).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.6 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF LYS-164 AND
RP   HIS-165.
RX   PubMed=32680882; DOI=10.1126/science.abc8665;
RA   Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T.,
RA   Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J.,
RA   Straub J.H., Stuerzel C.M., Froehlich T., Berninghausen O., Becker T.,
RA   Kirchhoff F., Sparrer K.M.J., Beckmann R.;
RT   ""Structural basis for translational shutdown and immune evasion by the Nsp1
RT   protein of SARS-CoV-2."";
RL   Science 369:1249-1255(2020).
RN   [18]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1).
RX   PubMed=32733001; DOI=10.1038/s41467-020-17665-9;
RA   Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L.,
RA   Ren L., Guo F., Zhao Z., Zhou Z., Xiang Z., Wang J.;
RT   ""Activation and evasion of type I interferon responses by SARS-CoV-2."";
RL   Nat. Commun. 11:3810-3810(2020).
RN   [19]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 1), FUNCTION (NON-STRUCTURAL PROTEIN 6),
RP   FUNCTION (HELICASE NSP13), INTERACTION WITH HOST TBK1 (NON-STRUCTURAL
RP   PROTEIN 6), AND INTERACTION WITH HOST TBK1 (HELICASE NSP13).
RX   PubMed=32979938; DOI=10.1016/j.celrep.2020.108234;
RA   Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D.,
RA   Rajsbaum R., Shi P.Y.;
RT   ""Evasion of Type I Interferon by SARS-CoV-2."";
RL   Cell Rep. 33:108234-108234(2020).
RN   [20]
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 1), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION (3C-LIKE PROTEINASE NSP5),
RP   SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 7), SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 8), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN
RP   9), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 10), AND SUBCELLULAR
RP   LOCATION (PROOFREADING EXORIBONUCLEASE).
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [21]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 3), AND SUBCELLULAR LOCATION
RP   (NON-STRUCTURAL PROTEIN 3).
RX   PubMed=32763915; DOI=10.1126/science.abd3629;
RA   Wolff G., Limpens R.W.A.L., Zevenhoven-Dobbe J.C., Laugks U., Zheng S.,
RA   de Jong A.W.M., Koning R.I., Agard D.A., Gruenewald K., Koster A.J.,
RA   Snijder E.J., Barcena M.;
RT   ""A molecular pore spans the double membrane of the coronavirus replication
RT   organelle."";
RL   Science 369:1395-1398(2020).
RN   [22]
RP   FUNCTION (RNA-CAPPING ENZYME NSP9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), FUNCTION (GUANINE-N7 METHYLTRANSFERASE NSP14), FUNCTION
RP   (NON-STRUCTURAL PROTEIN 10), FUNCTION (2'-O-METHYLTRANSFERASE NSP16),
RP   MUTAGENESIS OF ASN-4141; ASN-4142 AND ARG-5125, INTERACTION WITH NSP9
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND INTERACTION WITH NSP12
RP   (RNA-CAPPING ENZYME NSP9).
RX   PubMed=35944563; DOI=10.1038/s41586-022-05185-z;
RA   Park G.J., Osinski A., Hernandez G., Eitson J.L., Majumdar A., Tonelli M.,
RA   Henzler-Wildman K., Pawlowski K., Chen Z., Li Y., Schoggins J.W.,
RA   Tagliabracci V.S.;
RT   ""The mechanism of RNA capping by SARS-CoV-2."";
RL   Nature 0:0-0(2022).
RN   [23]
RP   REVIEW, FUNCTION (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT
RP   (NON-STRUCTURAL PROTEIN 7), SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT
RP   (RNA-DIRECTED RNA POLYMERASE NSP12), AND SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13).
RX   PubMed=34562452; DOI=10.1016/j.jbc.2021.101218;
RA   Perry J.K., Appleby T.C., Bilello J.P., Feng J.Y., Schmitz U.,
RA   Campbell E.A.;
RT   ""An atomistic model of the coronavirus replication-transcription complex as
RT   a hexamer assembled around nsp15."";
RL   J. Biol. Chem. 297:101218-101218(2021).
RN   [24]
RP   FUNCTION (RNA-DIRECTED RNA POLYMERASE NSP12).
RX   PubMed=33713597; DOI=10.1016/j.molcel.2021.02.036;
RA   Wang D., Jiang A., Feng J., Li G., Guo D., Sajid M., Wu K., Zhang Q.,
RA   Ponty Y., Will S., Liu F., Yu X., Li S., Liu Q., Yang X.L., Guo M., Li X.,
RA   Chen M., Shi Z.L., Lan K., Chen Y., Zhou Y.;
RT   ""The SARS-CoV-2 subgenome landscape and its novel regulatory features."";
RL   Mol. Cell 81:2135-2147(2021).
RN   [25]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 15).
RX   PubMed=35706445; DOI=10.3389/fgene.2022.904513;
RA   Liang J., Shi J., Chen S., Duan G., Yang F., Cheng Z., Li X., Ruan J.,
RA   Mi D., Gao S.;
RT   ""How the Replication and Transcription Complex Functions in Jumping
RT   Transcription of SARS-CoV-2."";
RL   Front. Genet. 13:904513-904513(2022).
RN   [26]
RP   FUNCTION (3C-LIKE PROTEINASE NSP5), AND MUTAGENESIS OF CYS-3408.
RX   PubMed=35594856; DOI=10.1016/j.molcel.2022.04.033;
RG   COVID Human Genetic Effort;
RA   Planes R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K.,
RA   Paillette P., Valadao A.C., Robinson K.S., Bastard P., Lam N., Fadrique R.,
RA   Rossi I., Pericat D., Bagayoko S., Leon-Icaza S.A., Rombouts Y.,
RA   Perouzel E., Tiraby M., Zhang Q., Cicuta P., Jouanguy E., Neyrolles O.,
RA   Bryant C.E., Floto A.R., Goujon C., Lei F.Z., Martin-Blondel G., Silva S.,
RA   Casanova J.L., Cougoule C., Reversade B., Marcoux J., Ravet E., Meunier E.;
RT   ""Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung
RT   epithelial cells."";
RL   Mol. Cell 82:2385-2400(2022).
RN   [27]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 6), FUNCTION (NON-STRUCTURAL PROTEIN 3),
RP   FUNCTION (NON-STRUCTURAL PROTEIN 4), SUBCELLULAR LOCATION (NON-STRUCTURAL
RP   PROTEIN 6), SUBCELLULAR LOCATION (NON-STRUCTURAL PROTEIN 3), SUBCELLULAR
RP   LOCATION (NON-STRUCTURAL PROTEIN 4), MUTAGENESIS OF 3675-SER--PHE-3677;
RP   PHE-3789 AND THR-3791, ACTIVITY REGULATION (NON-STRUCTURAL PROTEIN 6), AND
RP   INTERACTION WITH HOST ZFYVE1 (NON-STRUCTURAL PROTEIN 6).
RX   PubMed=35551511; DOI=10.1038/s41586-022-04835-6;
RA   Ricciardi S., Guarino A.M., Giaquinto L., Polishchuk E.V., Santoro M.,
RA   Di Tullio G., Wilson C., Panariello F., Soares V.C., Dias S.S.G.,
RA   Santos J.C., Souza T.M.L., Fusco G., Viscardi M., Brandi S., Bozza P.T.,
RA   Polishchuk R.S., Venditti R., De Matteis M.A.;
RT   ""The role of NSP6 in the biogenesis of the SARS-CoV-2 replication
RT   organelle."";
RL   Nature 606:761-768(2022).
RN   [28]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 2), INTERACTION WITH HOST GIGYF2
RP   (NON-STRUCTURAL PROTEIN 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   GLY-442.
RX   PubMed=35878012; DOI=10.1073/pnas.2204539119;
RA   Xu Z., Choi J.H., Dai D.L., Luo J., Ladak R.J., Li Q., Wang Y., Zhang C.,
RA   Wiebe S., Liu A.C.H., Ran X., Yang J., Naeli P., Garzia A., Zhou L.,
RA   Mahmood N., Deng Q., Elaish M., Lin R., Mahal L.K., Hobman T.C.,
RA   Pelletier J., Alain T., Vidal S.M., Duchaine T., Mazhab-Jafari M.T.,
RA   Mao X., Jafarnejad S.M., Sonenberg N.;
RT   ""SARS-CoV-2 impairs interferon production via NSP2-induced repression of
RT   mRNA translation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2204539119-e2204539119(2022).
RN   [29]
RP   FUNCTION (HOST TRANSLATION INHIBITOR NSP1).
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [30]
RP   FUNCTION (NON-STRUCTURAL PROTEIN 9), FUNCTION (RNA-DIRECTED RNA POLYMERASE
RP   NSP12), AND INTERACTION WITH HOST SND1 (NON-STRUCTURAL PROTEIN 9).
RX   PubMed=37794589; DOI=10.1016/j.cell.2023.09.002;
RA   Schmidt N., Ganskih S., Wei Y., Gabel A., Zielinski S., Keshishian H.,
RA   Lareau C.A., Zimmermann L., Makroczyova J., Pearce C., Krey K., Hennig T.,
RA   Stegmaier S., Moyon L., Horlacher M., Werner S., Aydin J., Olguin-Nava M.,
RA   Potabattula R., Kibe A., Doelken L., Smyth R.P., Caliskan N., Marsico A.,
RA   Krempl C., Bodem J., Pichlmair A., Carr S.A., Chlanda P., Erhard F.,
RA   Munschauer M.;
RT   ""SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis
RT   through NSP9."";
RL   Cell 186:1-17(2023).
RN   [31]
RP   INTERACTION WITH HOST FBXO22 (3C-LIKE PROTEINASE NSP5), SUBCELLULAR
RP   LOCATION (3C-LIKE PROTEINASE NSP5), AND UBIQUITINATION AT LYS-3268 AND
RP   LYS-3353 (3C-LIKE PROTEINASE NSP5).
RX   PubMed=39223933; DOI=10.1002/jmv.29891;
RA   Zhou Y., Feng W., Yang C., Wei X., Fan L., Wu Y., Gao X., Shen X.,
RA   Zhang Z., Zhao J.;
RT   ""E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting
RT   proteasome-dependent degradation of NSP5."";
RL   J. Med. Virol. 96:e29891-e29891(2024).
RN   [32]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.8 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   1, FUNCTION (NON-STRUCTURAL PROTEIN 1), AND MUTAGENESIS OF
RP   154-TYR--PHE-157; 164-LYS-HIS-165 AND 171-ARG--ARG-175.
RX   PubMed=32908316; DOI=10.1038/s41594-020-0511-8;
RA   Schubert K., Karousis E.D., Jomaa A., Scaiola A., Echeverria B.,
RA   Gurzeler L.A., Leibundgut M., Thiel V., Muehlemann O., Ban N.;
RT   ""SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation."";
RL   Nat. Struct. Mol. Biol. 27:959-966(2020).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15 IN COMPLEX WITH UTP, CATALYTIC ACTIVITY
RP   (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), MUTAGENESIS OF HIS-6686 AND HIS-6701, AND ACTIVE
RP   SITE (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33504779; DOI=10.1038/s41467-020-20608-z;
RA   Pillon M.C., Frazier M.N., Dillard L.B., Williams J.G., Kocaman S.,
RA   Krahn J.M., Perera L., Hayne C.K., Gordon J., Stewart Z.D., Sobhany M.,
RA   Deterding L.J., Hsu A.L., Dandey V.P., Borgnia M.J., Stanley R.E.;
RT   ""Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight
RT   into nuclease specificity and dynamics."";
RL   Nat. Commun. 12:636-636(2021).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 6453-679 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND INHIBITOR, FUNCTION (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), CATALYTIC ACTIVITY (URIDYLATE-SPECIFIC
RP   ENDORIBONUCLEASE NSP15), SUBUNIT (URIDYLATE-SPECIFIC ENDORIBONUCLEASE
RP   NSP15), AND COFACTOR (URIDYLATE-SPECIFIC ENDORIBONUCLEASE NSP15).
RX   PubMed=33564093; DOI=10.1038/s42003-021-01735-9;
RA   Kim Y., Wower J., Maltseva N., Chang C., Jedrzejczak R., Wilamowski M.,
RA   Kang S., Nicolaescu V., Randall G., Michalska K., Joachimiak A.;
RT   ""Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU
RT   from SARS-CoV-2."";
RL   Commun. Biol. 4:193-193(2021).
RN   [35]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.3 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   7; NON-STRUCTURAL PROTEIN 8; NON-STRUCTURAL PROTEIN 9; NON-STRUCTURAL
RP   PROTEIN 10; RNA-DIRECTED RNA POLYMERASE NSP12 AND NON-STRUCTURAL PROTEIN
RP   13, SUBUNIT (NON-STRUCTURAL PROTEIN 8), SUBUNIT (NON-STRUCTURAL PROTEIN
RP   13), AND FUNCTION (NON-STRUCTURAL PROTEIN 13).
RX   PubMed=33232691; DOI=10.1016/j.cell.2020.11.016;
RA   Yan L., Ge J., Zheng L., Zhang Y., Gao Y., Wang T., Huang Y., Yang Y.,
RA   Gao S., Li M., Liu Z., Wang H., Li Y., Chen Y., Guddat L.W., Wang Q.,
RA   Rao Z., Lou Z.;
RT   ""Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription
RT   Complex Reveals an Intermediate State in Cap Synthesis."";
RL   Cell 184:184-193(2021).
RN   [36] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 834-929 (PAPAIN-LIKE PROTEASE NSP3), AND INTERACTION
RP   WITH N (PAPAIN-LIKE PROTEASE NSP3).
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
RN   [37]
RP   STRUCTURE BY ELECTRON MICROSCOPY (1.65 ANGSTROMS) OF NON-STRUCTURAL PROTEIN
RP   14, INTERACTION WITH NSP10 (NON-STRUCTURAL PROTEIN 14), AND INTERACTION
RP   WITH NSP14 (NON-STRUCTURAL PROTEIN 10).
RX   PubMed=36546776; DOI=10.1093/nar/gkac1207;
RA   Imprachim N., Yosaatmadja Y., Newman J.A.;
RT   ""Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal
RT   details of exoribonuclease activation and mRNA capping and provide starting
RT   points for antiviral drug development."";
RL   Nucleic Acids Res. 51:475-487(2023).
CC   -!- FUNCTION: [Replicase polyprotein 1ab]: Multifunctional protein involved
CC       in the transcription and replication of viral RNAs. Contains the
CC       proteinases responsible for the cleavages of the polyprotein.
CC       {ECO:0000250|UniProtKB:P0C6X7}.
CC   -!- FUNCTION: [Host translation inhibitor nsp1]: Inhibits host translation
CC       by associating with the open head conformation of the 40S subunit
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       The C-terminus binds to and obstructs ribosomal mRNA entry tunnel
CC       (PubMed:32680882, PubMed:32908316, PubMed:33080218, PubMed:33479166).
CC       Thereby inhibits antiviral response triggered by innate immunity or
CC       interferons (PubMed:32680882, PubMed:32979938, PubMed:33080218). The
CC       nsp1-40S ribosome complex further induces an endonucleolytic cleavage
CC       near the 5'UTR of host mRNAs, targeting them for degradation (By
CC       similarity). This inhibits the integrated stress response (ISR) in the
CC       infected cell by preventing EIF2S1/eIF2-alpha phosphorylation upstream
CC       of stress granule formation and depletes host G3BP1 (PubMed:36534661).
CC       Viral mRNAs less susceptible to nsp1-mediated inhibition of
CC       translation, because of their 5'-end leader sequence (PubMed:32908316,
CC       PubMed:33080218). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32680882, ECO:0000269|PubMed:32908316,
CC       ECO:0000269|PubMed:32979938, ECO:0000269|PubMed:33080218,
CC       ECO:0000269|PubMed:33479166, ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: [Non-structural protein 2]: Enhances mRNA repression of the
CC       4EHP-GYF2 complex in the host, thereby inhibiting the antiviral
CC       response and facilitating SARS-CoV-2 replication. Possibly acts in
CC       cooperation with nsp1, which induces ribosome stalling on host mRNA,
CC       triggering mRNA repression by the host 4EHP-GYF2 complex which is
CC       enhanced by nsp2. {ECO:0000269|PubMed:35878012}.
CC   -!- FUNCTION: [Papain-like protease nsp3]: Responsible for the cleavages
CC       located at the N-terminus of the replicase polyprotein. Participates
CC       together with nsp4 in the assembly of virally-induced cytoplasmic
CC       double-membrane vesicles necessary for viral replication
CC       (PubMed:35551511). Antagonizes innate immune induction of type I
CC       interferon by blocking the phosphorylation, dimerization and subsequent
CC       nuclear translocation of host IRF3 (PubMed:32733001). Prevents also
CC       host NF-kappa-B signaling (By similarity). In addition, PL-PRO
CC       possesses a deubiquitinating/deISGylating activity and processes both
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular
CC       substrates (PubMed:32726803). Cleaves preferentially ISG15 from
CC       antiviral protein IFIH1 (MDA5), but not RIGI (PubMed:33727702). Can
CC       play a role in host ADP-ribosylation by ADP-ribose (PubMed:32578982).
CC       Plays a role in the formation and maintenance of double membrane
CC       vesicles (DMVs) replication organelles (PubMed:35551511). DMVs are
CC       formed by nsp3 and nsp4, while nsp6 zippers ER membranes and connects
CC       to lipid droplets (PubMed:35551511). {ECO:0000250|UniProtKB:P0C6X7,
CC       ECO:0000269|PubMed:32578982, ECO:0000269|PubMed:32726803,
CC       ECO:0000269|PubMed:32733001, ECO:0000269|PubMed:33727702,
CC       ECO:0000269|PubMed:35551511}.
CC   -!- FUNCTION: [Non-structural protein 4]: Plays a role in the formation and
CC       maintenance of double membrane vesicles (DMVs) replication organelles
CC       (PubMed:35551511). DMVs are formed by",52808
CTAGTG TAGTGA AGTGAC GTGACA TGACAC GACACT ACACTA CACTAG ACTAGC CTAGCC TAGCCG AGCCGT GCCGTC CCGTCC CGTCCT GTCCTT TCCTTA CCTTAC CTTACT TTACTA TACTAC ACTACG CTACGC TACGCT ACGCTT CGCTTC GCTTCG CTTCGA TTCGAT TCGATT CGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGC TGTGCG GTGCGT TGCGTA GCGTAC CGTACT GTACTG TACTGC ACTGCT CTGCTG TGCTGC GCTGCA CTGCAA TGCAAT GCAATA CAATAT AATATT ATATTG TATTGT ATTGTT TTGTTA TGTTAA GTTAAC TTAACG TAACGT AACGTG ACGTGA CGTGAG GTGAGT TGAGTC GAGTCT AGTCTT GTCTTG TCTTGT CTTGTA TTGTAA TGTAAA GTAAAA TAAAAC AAAACC AAACCT AACCTT ACCTTC CCTTCT CTTCTT TTCTTT TCTTTT CTTTTT TTTTTA TTTTAC TTTACG TTACGT TACGTT ACGTTT CGTTTA GTTTAC TTTACT TTACTC TACTCT ACTCTC CTCTCG TCTCGT CTCGTG TCGTGT CGTGTT GTGTTA TGTTAA GTTAAA TTAAAA TAAAAA AAAAAT AAAATC AAATCT AATCTG ATCTGA TCTGAA CTGAAT TGAATG GAATGC AATGCA ATGCAT TGCATC GCATCT CATCTA ATCTAG TCTAGA CTAGAG TAGAGT AGAGTT GAGTTC AGTTCC GTTCCT TTCCTG TCCTGT CCTGTT CTGTTC TGTTCT GTTCTG TTCTGC TCTGCT CTGCTG TGCTGA GCTGAT CTGATC TGATCA GATCAA ATCAAA,1,142,CTAG TAGT AGTG GTGA TGAC GACA ACAC CACT ACTA CTAG TAGC AGCC GCCG CCGT CGTC GTCC TCCT CCTT CTTA TTAC TACT ACTA CTAC TACG ACGC CGCT GCTT CTTC TTCG TCGA CGAT GATT ATTG TTGT TGTG GTGT TGTG GTGC TGCG GCGT CGTA GTAC TACT ACTG CTGC TGCT GCTG CTGC TGCA GCAA CAAT AATA ATAT TATT ATTG TTGT TGTT GTTA TTAA TAAC AACG ACGT CGTG GTGA TGAG GAGT AGTC GTCT TCTT CTTG TTGT TGTA GTAA TAAA AAAA AAAC AACC ACCT CCTT CTTC TTCT TCTT CTTT TTTT TTTT TTTA TTAC TACG ACGT CGTT GTTT TTTA TTAC TACT ACTC CTCT TCTC CTCG TCGT CGTG GTGT TGTT GTTA TTAA TAAA AAAA AAAA AAAT AATC ATCT TCTG CTGA TGAA GAAT AATG ATGC TGCA GCAT CATC ATCT TCTA CTAG TAGA AGAG GAGT AGTT GTTC TTCC TCCT CCTG CTGT TGTT GTTC TTCT TCTG CTGC TGCT GCTG CTGA TGAT GATC ATCA TCAA CAAA,CTAGT TAGTG AGTGA GTGAC TGACA GACAC ACACT CACTA ACTAG CTAGC TAGCC AGCCG GCCGT CCGTC CGTCC GTCCT TCCTT CCTTA CTTAC TTACT TACTA ACTAC CTACG TACGC ACGCT CGCTT GCTTC CTTCG TTCGA TCGAT CGATT GATTG ATTGT TTGTG TGTGT GTGTG TGTGC GTGCG TGCGT GCGTA CGTAC GTACT TACTG ACTGC CTGCT TGCTG GCTGC CTGCA TGCAA GCAAT CAATA AATAT ATATT TATTG ATTGT TTGTT TGTTA GTTAA TTAAC TAACG AACGT ACGTG CGTGA GTGAG TGAGT GAGTC AGTCT GTCTT TCTTG CTTGT TTGTA TGTAA GTAAA TAAAA AAAAC AAACC AACCT ACCTT CCTTC CTTCT TTCTT TCTTT CTTTT TTTTT TTTTA TTTAC TTACG TACGT ACGTT CGTTT GTTTA TTTAC TTACT TACTC ACTCT CTCTC TCTCG CTCGT TCGTG CGTGT GTGTT TGTTA GTTAA TTAAA TAAAA AAAAA AAAAT AAATC AATCT ATCTG TCTGA CTGAA TGAAT GAATG AATGC ATGCA TGCAT GCATC CATCT ATCTA TCTAG CTAGA TAGAG AGAGT GAGTT AGTTC GTTCC TTCCT TCCTG CCTGT CTGTT TGTTC GTTCT TTCTG TCTGC CTGCT TGCTG GCTGA CTGAT TGATC GATCA ATCAA TCAAA,CTAGTG TAGTGA AGTGAC GTGACA TGACAC GACACT ACACTA CACTAG ACTAGC CTAGCC TAGCCG AGCCGT GCCGTC CCGTCC CGTCCT GTCCTT TCCTTA CCTTAC CTTACT TTACTA TACTAC ACTACG CTACGC TACGCT ACGCTT CGCTTC GCTTCG CTTCGA TTCGAT TCGATT CGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGC TGTGCG GTGCGT TGCGTA GCGTAC CGTACT GTACTG TACTGC ACTGCT CTGCTG TGCTGC GCTGCA CTGCAA TGCAAT GCAATA CAATAT AATATT ATATTG TATTGT ATTGTT TTGTTA TGTTAA GTTAAC TTAACG TAACGT AACGTG ACGTGA CGTGAG GTGAGT TGAGTC GAGTCT AGTCTT GTCTTG TCTTGT CTTGTA TTGTAA TGTAAA GTAAAA TAAAAC AAAACC AAACCT AACCTT ACCTTC CCTTCT CTTCTT TTCTTT TCTTTT CTTTTT TTTTTA TTTTAC TTTACG TTACGT TACGTT ACGTTT CGTTTA GTTTAC TTTACT TTACTC TACTCT ACTCTC CTCTCG TCTCGT CTCGTG TCGTGT CGTGTT GTGTTA TGTTAA GTTAAA TTAAAA TAAAAA AAAAAT AAAATC AAATCT AATCTG ATCTGA TCTGAA CTGAAT TGAATG GAATGC AATGCA ATGCAT TGCATC GCATCT CATCTA ATCTAG TCTAGA CTAGAG TAGAGT AGAGTT GAGTTC AGTTCC GTTCCT TTCCTG TCCTGT CCTGTT CTGTTC TGTTCT GTTCTG TTCTGC TCTGCT CTGCTG TGCTGA GCTGAT CTGATC TGATCA GATCAA ATCAAA,CTAGTGA TAGTGAC AGTGACA GTGACAC TGACACT GACACTA ACACTAG CACTAGC ACTAGCC CTAGCCG TAGCCGT AGCCGTC GCCGTCC CCGTCCT CGTCCTT GTCCTTA TCCTTAC CCTTACT CTTACTA TTACTAC TACTACG ACTACGC CTACGCT TACGCTT ACGCTTC CGCTTCG GCTTCGA CTTCGAT TTCGATT TCGATTG CGATTGT GATTGTG ATTGTGT TTGTGTG TGTGTGC GTGTGCG TGTGCGT GTGCGTA TGCGTAC GCGTACT CGTACTG GTACTGC TACTGCT ACTGCTG CTGCTGC TGCTGCA GCTGCAA CTGCAAT TGCAATA GCAATAT CAATATT AATATTG ATATTGT TATTGTT ATTGTTA TTGTTAA TGTTAAC GTTAACG TTAACGT TAACGTG AACGTGA ACGTGAG CGTGAGT GTGAGTC TGAGTCT GAGTCTT AGTCTTG GTCTTGT TCTTGTA CTTGTAA TTGTAAA TGTAAAA GTAAAAC TAAAACC AAAACCT AAACCTT AACCTTC ACCTTCT CCTTCTT CTTCTTT TTCTTTT TCTTTTT CTTTTTA TTTTTAC TTTTACG TTTACGT TTACGTT TACGTTT ACGTTTA CGTTTAC GTTTACT TTTACTC TTACTCT TACTCTC ACTCTCG CTCTCGT TCTCGTG CTCGTGT TCGTGTT CGTGTTA GTGTTAA TGTTAAA GTTAAAA TTAAAAA TAAAAAT AAAAATC AAAATCT AAATCTG AATCTGA ATCTGAA TCTGAAT CTGAATG TGAATGC GAATGCA AATGCAT ATGCATC TGCATCT GCATCTA CATCTAG ATCTAGA TCTAGAG CTAGAGT TAGAGTT AGAGTTC GAGTTCC AGTTCCT GTTCCTG TTCCTGT TCCTGTT CCTGTTC CTGTTCT TGTTCTG GTTCTGC TTCTGCT TCTGCTG CTGCTGA TGCTGAT GCTGATC CTGATCA TGATCAA GATCAAA,"ID   VEMP_SARS2              Reviewed;          75 AA.
AC   P0DTC4;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Envelope small membrane protein {ECO:0000255|HAMAP-Rule:MF_04204};
DE            Short=E;
DE            Short=sM protein {ECO:0000255|HAMAP-Rule:MF_04204};
GN   Name=E {ECO:0000255|HAMAP-Rule:MF_04204}; ORFNames=4;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH HUMAN PALS1/MPP5.
RX   PubMed=32891874; DOI=10.1016/j.micinf.2020.08.006;
RA   De Maio F., Lo Cascio E., Babini G., Sali M., Della Longa S., Tilocca B.,
RA   Roncada P., Arcovito A., Sanguinetti M., Scambia G., Urbani A.;
RT   ""Improved binding of SARS-CoV-2 Envelope protein to tight junction-
RT   associated PALS1 could play a key role in COVID-19 pathogenesis."";
RL   Microbes Infect. 22:592-597(2020).
RN   [3]
RP   TOPOLOGY.
RX   PubMed=32898469; DOI=10.1098/rsob.200209;
RA   Duart G., Garcia-Murria M.J., Grau B., Acosta-Caceres J.M.,
RA   Martinez-Gil L., Mingarro I.;
RT   ""SARS-CoV-2 envelope protein topology in eukaryotic membranes."";
RL   Open Biol. 10:200209-200209(2020).
RN   [4]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [5]
RP   STRUCTURE BY NMR OF 8-38, SUBUNIT, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=33177698; DOI=10.1038/s41594-020-00536-8;
RA   Mandala V.S., McKay M.J., Shcherbakov A.A., Dregni A.J., Kolocouris A.,
RA   Hong M.;
RT   ""Structure and drug binding of the SARS-CoV-2 envelope protein
RT   transmembrane domain in lipid bilayers."";
RL   Nat. Struct. Mol. Biol. 27:1202-1208(2020).
RN   [6]
RP   FUNCTION.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [7] {ECO:0007744|PDB:7QCR, ECO:0007744|PDB:7QCS, ECO:0007744|PDB:7QCT}
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 64-75, INTERACTION WITH HOST
RP   PALS1/MPP5, INTERACTION WITH HOST TJP1/ZO1, INTERACTION WITH HOST LNX2,
RP   INTERACTION WITH HOST PARD3, INTERACTION WITH HOST AFDN/MLLT4, AND
RP   MUTAGENESIS OF PRO-71.
RX   PubMed=35283834; DOI=10.3389/fmicb.2022.829094;
RA   Zhu Y., Alvarez F., Wolff N., Mechaly A., Brule S., Neitthoffer B.,
RA   Etienne-Manneville S., Haouz A., Boeda B., Caillet-Saguy C.;
RT   ""Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E
RT   With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins."";
RL   Front. Microbiol. 13:829094-829094(2022).
CC   -!- FUNCTION: Plays a central role in virus morphogenesis and assembly.
CC       Acts as a viroporin and self-assembles in host membranes forming
CC       pentameric protein-lipid pores that allow ion transport. Also plays a
CC       role in the induction of apoptosis (By similarity). Regulates the
CC       localization of S protein at cis-Golgi, the place of virus budding
CC       (PubMed:33229438). May act by slowing down the cell secretory pathway
CC       (PubMed:33229438). May interfere with tight-junction stability by
CC       interacting with host MPP5. This would result in disruption of
CC       epithelial barriers, thereby amplifying inflammatory processes
CC       (PubMed:32891874). {ECO:0000255|HAMAP-Rule:MF_04204,
CC       ECO:0000269|PubMed:33229438, ECO:0000303|PubMed:32891874}.
CC   -!- SUBUNIT: Homopentamer (PubMed:33177698). Interacts via C-terminus PDM
CC       domain with PDZ domain-containing host proteins such as PALS1/MPP5
CC       (PubMed:32891874, PubMed:35283834), TJP1/ZO1 (PubMed:35283834), LNX2
CC       (PubMed:35283834), PARD3 (PubMed:35283834), and AFDN/MLLT4
CC       (PubMed:35283834). This may lead to disruption of tight junctions
CC       between epithelial cells (PubMed:32891874). Interacts with membrane
CC       protein M in the budding compartment of the host cell, which is located
CC       between endoplasmic reticulum and the Golgi complex. Interacts with
CC       Nucleoprotein (By similarity). {ECO:0000250|UniProtKB:P59637,
CC       ECO:0000255|HAMAP-Rule:MF_04204, ECO:0000269|PubMed:33177698,
CC       ECO:0000269|PubMed:35283834, ECO:0000303|PubMed:32891874}.
CC   -!- INTERACTION:
CC       P0DTC4; P0DTD8: 7b; NbExp=5; IntAct=EBI-25475850, EBI-25475914;
CC       P0DTC4; P0DTC4: E; NbExp=6; IntAct=EBI-25475850, EBI-25475850;
CC       P0DTC4; P0DTC5: M; NbExp=5; IntAct=EBI-25475850, EBI-25475853;
CC       P0DTC4; P0DTC9: N; NbExp=3; IntAct=EBI-25475850, EBI-25475856;
CC       P0DTC4; O95429: BAG4; Xeno; NbExp=3; IntAct=EBI-25475850, EBI-2949658;
CC       P0DTC4; PRO_0000018590 [Q07021]: C1QBP; Xeno; NbExp=2; IntAct=EBI-25475850, EBI-14032968;
CC       P0DTC4; Q8N3R9: PALS1; Xeno; NbExp=6; IntAct=EBI-25475850, EBI-2513978;
CC       P0DTC4; O75360: PROP1; Xeno; NbExp=3; IntAct=EBI-25475850, EBI-9027467;
CC       P0DTC4; P61165: TMEM258; Xeno; NbExp=3; IntAct=EBI-25475850, EBI-12019210;
CC       P0DTC4; Q86VM9: ZC3H18; Xeno; NbExp=3; IntAct=EBI-25475850, EBI-1045965;
CC   -!- SUBCELLULAR LOCATION: Host Golgi apparatus membrane {ECO:0000255|HAMAP-
CC       Rule:MF_04204}; Single-pass type III membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_04204, ECO:0000269|PubMed:32898469,
CC       ECO:0000269|PubMed:33177698}. Note=The cytoplasmic tail functions as a
CC       Golgi complex-targeting signal. {ECO:0000255|HAMAP-Rule:MF_04204}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronaviruses E protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04204}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43418.1; -; Genomic_RNA.
DR   PDB; 7K3G; NMR; -; A/B/C/D/E=8-38.
DR   PDB; 7M4R; EM; 3.65 A; C=58-75.
DR   PDB; 7NTK; X-ray; 1.90 A; C/E/G/H=68-75.
DR   PDB; 7QCR; X-ray; 2.28 A; C/D=64-75.
DR   PDB; 7QCS; X-ray; 2.80 A; C/D=64-75.
DR   PDB; 7QCT; X-ray; 3.20 A; C/D=64-75.
DR   PDB; 7TUQ; X-ray; 2.68 A; C=60-68.
DR   PDB; 7TV0; X-ray; 2.60 A; E/G=53-64.
DR   PDB; 8SUZ; NMR; -; A/B/C/D/E=8-38.
DR   PDB; 8U1T; NMR; -; A/B=12-37.
DR   PDBsum; 7K3G; -.
DR   PDBsum; 7M4R; -.
DR   PDBsum; 7NTK; -.
DR   PDBsum; 7QCR; -.
DR   PDBsum; 7QCS; -.
DR   PDBsum; 7QCT; -.
DR   PDBsum; 7TUQ; -.
DR   PDBsum; 7TV0; -.
DR   PDBsum; 8SUZ; -.
DR   PDBsum; 8U1T; -.
DR   BMRB; P0DTC4; -.
DR   EMDB; EMD-23665; -.
DR   SMR; P0DTC4; -.
DR   BioGRID; 4383845; 1097.
DR   IntAct; P0DTC4; 71.
DR   MINT; P0DTC4; -.
DR   TCDB; 1.A.65.1.7; the coronavirus viroporin e protein (viroporin e) family.
DR   ABCD; P0DTC4; 9 sequenced antibodies.
DR   KEGG; vg:43740570; -.
DR   AGR; RefSeq:YP_009724392; -.
DR   Reactome; R-HSA-191650; Regulation of gap junction activity.
DR   Reactome; R-HSA-420029; Tight junction interactions.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694493; Maturation of protein E.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9705677; SARS-CoV-2 targets PDZ proteins in cell-cell junction.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   PRO; PR:P0DTC4; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProt.
DR   GO; GO:0044178; C:host cell Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0055036; C:virion membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005216; F:monoatomic ion channel activity; IDA:UniProt.
DR   GO; GO:0039660; F:structural constituent of virion; IDA:UniProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0140975; P:disruption of cellular anatomical structure in another organism; IEA:UniProtKB-UniRule.
DR   GO; GO:0046760; P:viral budding from Golgi membrane; IEA:UniProtKB-UniRule.
DR   CDD; cd21536; SARS-CoV-2_E; 1.
DR   Gene3D; 6.10.250.1810; -; 1.
DR   HAMAP; MF_04204; BETA_CORONA_E; 1.
DR   InterPro; IPR043506; E_protein_bCoV.
DR   InterPro; IPR003873; E_protein_CoV.
DR   InterPro; IPR044377; E_SARS-CoV-2.
DR   Pfam; PF02723; CoV_E; 1.
DR   PROSITE; PS51926; COV_E; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Host Golgi apparatus; Host membrane; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..75
FT                   /note=""Envelope small membrane protein""
FT                   /id=""PRO_0000449651""
FT   TOPO_DOM        1..13
FT                   /note=""Virion surface""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04204,
FT                   ECO:0000305|PubMed:32898469""
FT   TRANSMEM        14..34
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04204,
FT                   ECO:0000269|PubMed:33177698, ECO:0000305|PubMed:32898469""
FT   TOPO_DOM        35..75
FT                   /note=""Intravirion""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04204,
FT                   ECO:0000305|PubMed:32898469""
FT   REGION          61..75
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000305|PubMed:35108439""
FT   MOTIF           72..75
FT                   /note=""PDZ-binding; required for interaction with human
FT                   MPP5""
FT                   /evidence=""ECO:0000250|UniProtKB:P59637""
FT   VARIANT         9
FT                   /note=""T -> I (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         11
FT                   /note=""T -> A (in strain: Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         21
FT                   /note=""L -> F (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         71
FT                   /note=""P -> L (in strain: Beta/B.1.351)""
FT                   /evidence=""ECO:0000305""
FT   MUTAGEN         71
FT                   /note=""P->L: Complete loss of interaction with host PARD3
FT                   and MLLT4. Partial loss of interaction with host ZO1.""
FT                   /evidence=""ECO:0000269|PubMed:35283834""
FT   HELIX           11..18
FT                   /evidence=""ECO:0007829|PDB:7K3G""
FT   HELIX           19..21
FT                   /evidence=""ECO:0007829|PDB:7K3G""
FT   HELIX           22..36
FT                   /evidence=""ECO:0007829|PDB:7K3G""
FT   HELIX           56..62
FT                   /evidence=""ECO:0007829|PDB:7TV0""
FT   STRAND          72..75
FT                   /evidence=""ECO:0007829|PDB:7QCT""
SQ   SEQUENCE   75 AA;  8365 MW;  5C431BD2AA1B6B99 CRC64;
     MYSFVSEETG TLIVNSVLLF LAFVVFLLVT LAILTALRLC AYCCNIVNVS LVKPSFYVYS
     RVKNLNSSRV PDLLV
//
",11086
CTCGAA TCGAAG CGAAGT GAAGTA AAGTAG AGTAGT GTAGTG TAGTGC AGTGCC GTGCCG TGCCGC GCCGCA CCGCAT CGCATC GCATCC CATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGC GATGCC ATGCCG TGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTG AGTTGC GTTGCG TTGCGC TGCGCG GCGCGT CGCGTT GCGTTA CGTTAC GTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGT AAAGTC AAGTCA AGTCAG GTCAGC TCAGCA CAGCAC AGCACA GCACAG CACAGG ACAGGC CAGGCT AGGCTC GGCTCT GCTCTG CTCTGA TCTGAG CTGAGA TGAGAC GAGACT AGACTT GACTTT ACTTTG CTTTGC TTTGCA TTGCAG TGCAGA GCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGT TGTGTG GTGTGG TGTGGT GTGGTG TGGTGC GGTGCG GTGCGG TGCGGC GCGGCA CGGCAA GGCAAA GCAAAC CAAACG AAACGT AACGTG ACGTGC CGTGCG GTGCGT TGCGTG GCGTGT CGTGTT GTGTTG TGTTGG GTTGGC TTGGCT TGGCTT GGCTTG GCTTGC CTTGCG TTGCGT TGCGTG GCGTGT CGTGTT GTGTTG TGTTGC GTTGCC TTGCCG TGCCGT GCCGTG CCGTGG CGTGGC GTGGCC TGGCCG GGCCGT GCCGTC CCGTCG CGTCGT GTCGTT TCGTTG CGTTGG GTTGGT TTGGTG TGGTGC GGTGCC GTGCCG TGCCGT GCCGTG CCGTGC CGTGCT GTGCTG TGCTGC GCTGCC CTGCCG TGCCGG GCCGGG CCGGGG,3,145,CTCG TCGA CGAA GAAG AAGT AGTA GTAG TAGT AGTG GTGC TGCC GCCG CCGC CGCA GCAT CATC ATCC TCCA CCAG CAGA AGAT GATG ATGC TGCC GCCG CCGA CGAC GACA ACAA CAAG AAGT AGTT GTTG TTGC TGCG GCGC CGCG GCGT CGTT GTTA TTAC TACT ACTA CTAA TAAA AAAG AAGT AGTC GTCA TCAG CAGC AGCA GCAC CACA ACAG CAGG AGGC GGCT GCTC CTCT TCTG CTGA TGAG GAGA AGAC GACT ACTT CTTT TTTG TTGC TGCA GCAG CAGA AGAT GATT ATTG TTGT TGTG GTGT TGTG GTGT TGTG GTGG TGGT GGTG GTGC TGCG GCGG CGGC GGCA GCAA CAAA AAAC AACG ACGT CGTG GTGC TGCG GCGT CGTG GTGT TGTT GTTG TTGG TGGC GGCT GCTT CTTG TTGC TGCG GCGT CGTG GTGT TGTT GTTG TTGC TGCC GCCG CCGT CGTG GTGG TGGC GGCC GCCG CCGT CGTC GTCG TCGT CGTT GTTG TTGG TGGT GGTG GTGC TGCC GCCG CCGT CGTG GTGC TGCT GCTG CTGC TGCC GCCG CCGG CGGG GGGG,CTCGA TCGAA CGAAG GAAGT AAGTA AGTAG GTAGT TAGTG AGTGC GTGCC TGCCG GCCGC CCGCA CGCAT GCATC CATCC ATCCA TCCAG CCAGA CAGAT AGATG GATGC ATGCC TGCCG GCCGA CCGAC CGACA GACAA ACAAG CAAGT AAGTT AGTTG GTTGC TTGCG TGCGC GCGCG CGCGT GCGTT CGTTA GTTAC TTACT TACTA ACTAA CTAAA TAAAG AAAGT AAGTC AGTCA GTCAG TCAGC CAGCA AGCAC GCACA CACAG ACAGG CAGGC AGGCT GGCTC GCTCT CTCTG TCTGA CTGAG TGAGA GAGAC AGACT GACTT ACTTT CTTTG TTTGC TTGCA TGCAG GCAGA CAGAT AGATT GATTG ATTGT TTGTG TGTGT GTGTG TGTGT GTGTG TGTGG GTGGT TGGTG GGTGC GTGCG TGCGG GCGGC CGGCA GGCAA GCAAA CAAAC AAACG AACGT ACGTG CGTGC GTGCG TGCGT GCGTG CGTGT GTGTT TGTTG GTTGG TTGGC TGGCT GGCTT GCTTG CTTGC TTGCG TGCGT GCGTG CGTGT GTGTT TGTTG GTTGC TTGCC TGCCG GCCGT CCGTG CGTGG GTGGC TGGCC GGCCG GCCGT CCGTC CGTCG GTCGT TCGTT CGTTG GTTGG TTGGT TGGTG GGTGC GTGCC TGCCG GCCGT CCGTG CGTGC GTGCT TGCTG GCTGC CTGCC TGCCG GCCGG CCGGG CGGGG,CTCGAA TCGAAG CGAAGT GAAGTA AAGTAG AGTAGT GTAGTG TAGTGC AGTGCC GTGCCG TGCCGC GCCGCA CCGCAT CGCATC GCATCC CATCCA ATCCAG TCCAGA CCAGAT CAGATG AGATGC GATGCC ATGCCG TGCCGA GCCGAC CCGACA CGACAA GACAAG ACAAGT CAAGTT AAGTTG AGTTGC GTTGCG TTGCGC TGCGCG GCGCGT CGCGTT GCGTTA CGTTAC GTTACT TTACTA TACTAA ACTAAA CTAAAG TAAAGT AAAGTC AAGTCA AGTCAG GTCAGC TCAGCA CAGCAC AGCACA GCACAG CACAGG ACAGGC CAGGCT AGGCTC GGCTCT GCTCTG CTCTGA TCTGAG CTGAGA TGAGAC GAGACT AGACTT GACTTT ACTTTG CTTTGC TTTGCA TTGCAG TGCAGA GCAGAT CAGATT AGATTG GATTGT ATTGTG TTGTGT TGTGTG GTGTGT TGTGTG GTGTGG TGTGGT GTGGTG TGGTGC GGTGCG GTGCGG TGCGGC GCGGCA CGGCAA GGCAAA GCAAAC CAAACG AAACGT AACGTG ACGTGC CGTGCG GTGCGT TGCGTG GCGTGT CGTGTT GTGTTG TGTTGG GTTGGC TTGGCT TGGCTT GGCTTG GCTTGC CTTGCG TTGCGT TGCGTG GCGTGT CGTGTT GTGTTG TGTTGC GTTGCC TTGCCG TGCCGT GCCGTG CCGTGG CGTGGC GTGGCC TGGCCG GGCCGT GCCGTC CCGTCG CGTCGT GTCGTT TCGTTG CGTTGG GTTGGT TTGGTG TGGTGC GGTGCC GTGCCG TGCCGT GCCGTG CCGTGC CGTGCT GTGCTG TGCTGC GCTGCC CTGCCG TGCCGG GCCGGG CCGGGG,CTCGAAG TCGAAGT CGAAGTA GAAGTAG AAGTAGT AGTAGTG GTAGTGC TAGTGCC AGTGCCG GTGCCGC TGCCGCA GCCGCAT CCGCATC CGCATCC GCATCCA CATCCAG ATCCAGA TCCAGAT CCAGATG CAGATGC AGATGCC GATGCCG ATGCCGA TGCCGAC GCCGACA CCGACAA CGACAAG GACAAGT ACAAGTT CAAGTTG AAGTTGC AGTTGCG GTTGCGC TTGCGCG TGCGCGT GCGCGTT CGCGTTA GCGTTAC CGTTACT GTTACTA TTACTAA TACTAAA ACTAAAG CTAAAGT TAAAGTC AAAGTCA AAGTCAG AGTCAGC GTCAGCA TCAGCAC CAGCACA AGCACAG GCACAGG CACAGGC ACAGGCT CAGGCTC AGGCTCT GGCTCTG GCTCTGA CTCTGAG TCTGAGA CTGAGAC TGAGACT GAGACTT AGACTTT GACTTTG ACTTTGC CTTTGCA TTTGCAG TTGCAGA TGCAGAT GCAGATT CAGATTG AGATTGT GATTGTG ATTGTGT TTGTGTG TGTGTGT GTGTGTG TGTGTGG GTGTGGT TGTGGTG GTGGTGC TGGTGCG GGTGCGG GTGCGGC TGCGGCA GCGGCAA CGGCAAA GGCAAAC GCAAACG CAAACGT AAACGTG AACGTGC ACGTGCG CGTGCGT GTGCGTG TGCGTGT GCGTGTT CGTGTTG GTGTTGG TGTTGGC GTTGGCT TTGGCTT TGGCTTG GGCTTGC GCTTGCG CTTGCGT TTGCGTG TGCGTGT GCGTGTT CGTGTTG GTGTTGC TGTTGCC GTTGCCG TTGCCGT TGCCGTG GCCGTGG CCGTGGC CGTGGCC GTGGCCG TGGCCGT GGCCGTC GCCGTCG CCGTCGT CGTCGTT GTCGTTG TCGTTGG CGTTGGT GTTGGTG TTGGTGC TGGTGCC GGTGCCG GTGCCGT TGCCGTG GCCGTGC CCGTGCT CGTGCTG GTGCTGC TGCTGCC GCTGCCG CTGCCGG TGCCGGG GCCGGGG,"ID   SYFB_SHEON              Reviewed;         795 AA.
AC   Q8EF99;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   05-FEB-2025, entry version 125.
DE   RecName: Full=Phenylalanine--tRNA ligase beta subunit {ECO:0000255|HAMAP-Rule:MF_00283};
DE            EC=6.1.1.20 {ECO:0000255|HAMAP-Rule:MF_00283};
DE   AltName: Full=Phenylalanyl-tRNA synthetase beta subunit {ECO:0000255|HAMAP-Rule:MF_00283};
DE            Short=PheRS {ECO:0000255|HAMAP-Rule:MF_00283};
GN   Name=pheT {ECO:0000255|HAMAP-Rule:MF_00283};
GN   OrderedLocusNames=SO_2086;
OS   Shewanella oneidensis (strain ATCC 700550 / JCM 31522 / CIP 106686 / LMG
OS   19005 / NCIMB 14063 / MR-1).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Alteromonadales;
OC   Shewanellaceae; Shewanella.
OX   NCBI_TaxID=211586;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700550 / JCM 31522 / CIP 106686 / LMG 19005 / NCIMB 14063
RC   / MR-1;
RX   PubMed=12368813; DOI=10.1038/nbt749;
RA   Heidelberg J.F., Paulsen I.T., Nelson K.E., Gaidos E.J., Nelson W.C.,
RA   Read T.D., Eisen J.A., Seshadri R., Ward N.L., Methe B.A., Clayton R.A.,
RA   Meyer T., Tsapin A., Scott J., Beanan M.J., Brinkac L.M., Daugherty S.C.,
RA   DeBoy R.T., Dodson R.J., Durkin A.S., Haft D.H., Kolonay J.F., Madupu R.,
RA   Peterson J.D., Umayam L.A., White O., Wolf A.M., Vamathevan J.J.,
RA   Weidman J.F., Impraim M., Lee K., Berry K.J., Lee C., Mueller J.,
RA   Khouri H.M., Gill J., Utterback T.R., McDonald L.A., Feldblyum T.V.,
RA   Smith H.O., Venter J.C., Nealson K.H., Fraser C.M.;
RT   ""Genome sequence of the dissimilatory metal ion-reducing bacterium
RT   Shewanella oneidensis."";
RL   Nat. Biotechnol. 20:1118-1123(2002).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tRNA(Phe) + L-phenylalanine + ATP = L-phenylalanyl-tRNA(Phe) +
CC         AMP + diphosphate + H(+); Xref=Rhea:RHEA:19413, Rhea:RHEA-COMP:9668,
CC         Rhea:RHEA-COMP:9699, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:58095, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78531, ChEBI:CHEBI:456215; EC=6.1.1.20;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00283};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00283};
CC       Note=Binds 2 magnesium ions per tetramer. {ECO:0000255|HAMAP-
CC       Rule:MF_00283};
CC   -!- SUBUNIT: Tetramer of two alpha and two beta subunits.
CC       {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   -!- SIMILARITY: Belongs to the phenylalanyl-tRNA synthetase beta subunit
CC       family. Type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_00283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE014299; AAN55133.1; -; Genomic_DNA.
DR   RefSeq; NP_717689.1; NC_004347.2.
DR   RefSeq; WP_011072150.1; NZ_CP053946.1.
DR   AlphaFoldDB; Q8EF99; -.
DR   SMR; Q8EF99; -.
DR   STRING; 211586.SO_2086; -.
DR   PaxDb; 211586-SO_2086; -.
DR   KEGG; son:SO_2086; -.
DR   PATRIC; fig|211586.12.peg.2002; -.
DR   eggNOG; COG0072; Bacteria.
DR   eggNOG; COG0073; Bacteria.
DR   HOGENOM; CLU_016891_0_0_6; -.
DR   OrthoDB; 9805455at2; -.
DR   PhylomeDB; Q8EF99; -.
DR   BioCyc; SONE211586:G1GMP-1917-MONOMER; -.
DR   Proteomes; UP000008186; Chromosome.
DR   GO; GO:0009328; C:phenylalanine-tRNA ligase complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004826; F:phenylalanine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006432; P:phenylalanyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd00769; PheRS_beta_core; 1.
DR   CDD; cd02796; tRNA_bind_bactPheRS; 1.
DR   FunFam; 2.40.50.140:FF:000045; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.56.10:FF:000002; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.70.380:FF:000001; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.30.930.10:FF:000022; Phenylalanine--tRNA ligase beta subunit; 1.
DR   FunFam; 3.50.40.10:FF:000001; Phenylalanine--tRNA ligase beta subunit; 1.
DR   Gene3D; 3.30.56.10; -; 2.
DR   Gene3D; 3.30.930.10; Bira Bifunctional Protein, Domain 2; 1.
DR   Gene3D; 3.30.70.380; Ferrodoxin-fold anticodon-binding domain; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.50.40.10; Phenylalanyl-trna Synthetase, Chain B, domain 3; 1.
DR   HAMAP; MF_00283; Phe_tRNA_synth_beta1; 1.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR005146; B3/B4_tRNA-bd.
DR   InterPro; IPR009061; DNA-bd_dom_put_sf.
DR   InterPro; IPR005121; Fdx_antiC-bd.
DR   InterPro; IPR036690; Fdx_antiC-bd_sf.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR045060; Phe-tRNA-ligase_IIc_bsu.
DR   InterPro; IPR004532; Phe-tRNA-ligase_IIc_bsu_bact.
DR   InterPro; IPR020825; Phe-tRNA_synthase-like_B3/B4.
DR   InterPro; IPR041616; PheRS_beta_core.
DR   InterPro; IPR002547; tRNA-bd_dom.
DR   InterPro; IPR033714; tRNA_bind_bactPheRS.
DR   InterPro; IPR005147; tRNA_synthase_B5-dom.
DR   NCBIfam; TIGR00472; pheT_bact; 1.
DR   NCBIfam; NF045760; YtpR; 1.
DR   PANTHER; PTHR10947:SF0; PHENYLALANINE--TRNA LIGASE BETA SUBUNIT; 1.
DR   PANTHER; PTHR10947; PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN AND LEUCINE-RICH REPEAT-CONTAINING PROTEIN 47; 1.
DR   Pfam; PF03483; B3_4; 1.
DR   Pfam; PF03484; B5; 1.
DR   Pfam; PF03147; FDX-ACB; 1.
DR   Pfam; PF01588; tRNA_bind; 1.
DR   Pfam; PF17759; tRNA_synthFbeta; 1.
DR   SMART; SM00873; B3_4; 1.
DR   SMART; SM00874; B5; 1.
DR   SMART; SM00896; FDX-ACB; 1.
DR   SUPFAM; SSF54991; Anticodon-binding domain of PheRS; 1.
DR   SUPFAM; SSF55681; Class II aaRS and biotin synthetases; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   SUPFAM; SSF56037; PheT/TilS domain; 1.
DR   SUPFAM; SSF46955; Putative DNA-binding domain; 1.
DR   PROSITE; PS51483; B5; 1.
DR   PROSITE; PS51447; FDX_ACB; 1.
DR   PROSITE; PS50886; TRBD; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Protein biosynthesis;
KW   Reference proteome; RNA-binding; tRNA-binding.
FT   CHAIN           1..795
FT                   /note=""Phenylalanine--tRNA ligase beta subunit""
FT                   /id=""PRO_0000126945""
FT   DOMAIN          39..148
FT                   /note=""tRNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   DOMAIN          401..476
FT                   /note=""B5""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   DOMAIN          701..794
FT                   /note=""FDX-ACB""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         454
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         460
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         463
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
FT   BINDING         464
FT                   /ligand=""Mg(2+)""
FT                   /ligand_id=""ChEBI:CHEBI:18420""
FT                   /ligand_note=""shared with alpha subunit""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_00283""
SQ   SEQUENCE   795 AA;  86574 MW;  D73CD96D4CAE1296 CRC64;
     MKFSESWLRE WVNPAVSREA LSHQITMAGL EVDGVDAVAA EFNGVVIGEV VECGLHPDAD
     KLRVTKVSVG SSELIDIVCG APNCRQGLKV AVAMVGAVLP GDFKIKKAKL RGMPSEGMLC
     SYSELGIDID SDGIIELPLD APLGTDLREY LKLDDAVIEV DLTANRADCL GMVGLAREVG
     VLNRQAVTEP QWQAVTPTTD AKVTINVKES AACPRYLGRV VKNVNVKAAT PLWMQEKLRR
     SGIRSIDPIV DITNFVLVEF GQPMHAFDLA KLTGDIQVRL GNGEEKITLL DGSEVTIPSD
     TLVIADDARP LALAGVFGGE YSGVSDTTQD ILLECAFFAP LAIMGKSRRL GLHTDSSHRF
     ERGVDPEMQH KVIDRATRLV LDICGGEAGP VVEAKSDADL PKPAQILLRR SKLDKILGHY
     VPDSDVVEIL ERLGFSVVKG EGCWQVITAT YRFDMAIEED LIEEVARIYG YNNIPNVAPI
     ASLRMSDHKE TDLSLKRVRS LLVARGFQEA VTYSFVDPKL QNLVHPGEQA MVLPNPISSE
     MSAMRLSMFT GLLTAVGYNQ SRQQGRVRLF ETGLRFVPDI NAESGVRQQA MLGCVITGPQ
     NDEHWAMESK TVDFFDLKGD LEAIIGLTVS ASEFSFRVAT HSALHPGQCA EILRNDRVIG
     HIGAIHPSLE KPFGLNGKTI VFELELDALL HTSLPLAQAV SKFPANRRDI AVVVDESVSA
     GDVMKLIRKV GENQLVGINL FDVYLGKGVE PGKKSLAIAL TLQDTTRTLE EKEIAETVES
     VVSALKTEFN ASLRD
//
",48598
GCGCAA CGCAAT GCAATC CAATCG AATCGC ATCGCT TCGCTC CGCTCG GCTCGC CTCGCC TCGCCG CGCCGT GCCGTC CCGTCA CGTCAT GTCATC TCATCA CATCAA ATCAAC TCAACA CAACAC AACACG ACACGC CACGCT ACGCTC CGCTCG GCTCGG CTCGGC TCGGCC CGGCCT GGCCTC GCCTCG CCTCGA CTCGAC TCGACA CGACAA GACAAG ACAAGG CAAGGC AAGGCC AGGCCA GGCCAA GCCAAG CCAAGG CAAGGT AAGGTC AGGTCA GGTCAA GTCAAT TCAATC CAATCC AATCCC ATCCCA TCCCAT CCCATG CCATGG CATGGG ATGGGC TGGGCG GGGCGG GGCGGC GCGGCG CGGCGC GGCGCC GCGCCA CGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGC TGCGCT GCGCTC CGCTCG GCTCGG CTCGGC TCGGCC CGGCCA GGCCAC GCCACC CCACCC CACCCG ACCCGC CCCGCT CCGCTG CGCTGG GCTGGG CTGGGC TGGGCG GGGCGC GGCGCG GCGCGA CGCGAC GCGACG CGACGG GACGGG ACGGGC CGGGCG GGGCGC GGCGCC GCGCCA CGCCAT GCCATC,3,103,GCGC CGCA GCAA CAAT AATC ATCG TCGC CGCT GCTC CTCG TCGC CGCC GCCG CCGT CGTC GTCA TCAT CATC ATCA TCAA CAAC AACA ACAC CACG ACGC CGCT GCTC CTCG TCGG CGGC GGCC GCCT CCTC CTCG TCGA CGAC GACA ACAA CAAG AAGG AGGC GGCC GCCA CCAA CAAG AAGG AGGT GGTC GTCA TCAA CAAT AATC ATCC TCCC CCCA CCAT CATG ATGG TGGG GGGC GGCG GCGG CGGC GGCG GCGC CGCC GCCA CCAT CATT ATTG TTGC TGCG GCGC CGCT GCTC CTCG TCGG CGGC GGCC GCCA CCAC CACC ACCC CCCG CCGC CGCT GCTG CTGG TGGG GGGC GGCG GCGC CGCG GCGA CGAC GACG ACGG CGGG GGGC GGCG GCGC CGCC GCCA CCAT CATC,GCGCA CGCAA GCAAT CAATC AATCG ATCGC TCGCT CGCTC GCTCG CTCGC TCGCC CGCCG GCCGT CCGTC CGTCA GTCAT TCATC CATCA ATCAA TCAAC CAACA AACAC ACACG CACGC ACGCT CGCTC GCTCG CTCGG TCGGC CGGCC GGCCT GCCTC CCTCG CTCGA TCGAC CGACA GACAA ACAAG CAAGG AAGGC AGGCC GGCCA GCCAA CCAAG CAAGG AAGGT AGGTC GGTCA GTCAA TCAAT CAATC AATCC ATCCC TCCCA CCCAT CCATG CATGG ATGGG TGGGC GGGCG GGCGG GCGGC CGGCG GGCGC GCGCC CGCCA GCCAT CCATT CATTG ATTGC TTGCG TGCGC GCGCT CGCTC GCTCG CTCGG TCGGC CGGCC GGCCA GCCAC CCACC CACCC ACCCG CCCGC CCGCT CGCTG GCTGG CTGGG TGGGC GGGCG GGCGC GCGCG CGCGA GCGAC CGACG GACGG ACGGG CGGGC GGGCG GGCGC GCGCC CGCCA GCCAT CCATC,GCGCAA CGCAAT GCAATC CAATCG AATCGC ATCGCT TCGCTC CGCTCG GCTCGC CTCGCC TCGCCG CGCCGT GCCGTC CCGTCA CGTCAT GTCATC TCATCA CATCAA ATCAAC TCAACA CAACAC AACACG ACACGC CACGCT ACGCTC CGCTCG GCTCGG CTCGGC TCGGCC CGGCCT GGCCTC GCCTCG CCTCGA CTCGAC TCGACA CGACAA GACAAG ACAAGG CAAGGC AAGGCC AGGCCA GGCCAA GCCAAG CCAAGG CAAGGT AAGGTC AGGTCA GGTCAA GTCAAT TCAATC CAATCC AATCCC ATCCCA TCCCAT CCCATG CCATGG CATGGG ATGGGC TGGGCG GGGCGG GGCGGC GCGGCG CGGCGC GGCGCC GCGCCA CGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGC TGCGCT GCGCTC CGCTCG GCTCGG CTCGGC TCGGCC CGGCCA GGCCAC GCCACC CCACCC CACCCG ACCCGC CCCGCT CCGCTG CGCTGG GCTGGG CTGGGC TGGGCG GGGCGC GGCGCG GCGCGA CGCGAC GCGACG CGACGG GACGGG ACGGGC CGGGCG GGGCGC GGCGCC GCGCCA CGCCAT GCCATC,GCGCAAT CGCAATC GCAATCG CAATCGC AATCGCT ATCGCTC TCGCTCG CGCTCGC GCTCGCC CTCGCCG TCGCCGT CGCCGTC GCCGTCA CCGTCAT CGTCATC GTCATCA TCATCAA CATCAAC ATCAACA TCAACAC CAACACG AACACGC ACACGCT CACGCTC ACGCTCG CGCTCGG GCTCGGC CTCGGCC TCGGCCT CGGCCTC GGCCTCG GCCTCGA CCTCGAC CTCGACA TCGACAA CGACAAG GACAAGG ACAAGGC CAAGGCC AAGGCCA AGGCCAA GGCCAAG GCCAAGG CCAAGGT CAAGGTC AAGGTCA AGGTCAA GGTCAAT GTCAATC TCAATCC CAATCCC AATCCCA ATCCCAT TCCCATG CCCATGG CCATGGG CATGGGC ATGGGCG TGGGCGG GGGCGGC GGCGGCG GCGGCGC CGGCGCC GGCGCCA GCGCCAT CGCCATT GCCATTG CCATTGC CATTGCG ATTGCGC TTGCGCT TGCGCTC GCGCTCG CGCTCGG GCTCGGC CTCGGCC TCGGCCA CGGCCAC GGCCACC GCCACCC CCACCCG CACCCGC ACCCGCT CCCGCTG CCGCTGG CGCTGGG GCTGGGC CTGGGCG TGGGCGC GGGCGCG GGCGCGA GCGCGAC CGCGACG GCGACGG CGACGGG GACGGGC ACGGGCG CGGGCGC GGGCGCC GGCGCCA GCGCCAT CGCCATC,"ID   THIK_YEAST              Reviewed;         417 AA.
AC   P27796; D6VVC6;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   05-FEB-2025, entry version 215.
DE   RecName: Full=3-ketoacyl-CoA thiolase, peroxisomal;
DE            EC=2.3.1.16;
DE   AltName: Full=Acetyl-CoA acyltransferase;
DE   AltName: Full=Beta-ketothiolase;
DE   AltName: Full=Peroxisomal 3-oxoacyl-CoA thiolase;
DE   Flags: Precursor;
GN   Name=POT1; Synonyms=FOX3, POX3; OrderedLocusNames=YIL160C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=BJ1991;
RX   PubMed=1715273; DOI=10.1111/j.1432-1033.1991.tb21056.x;
RA   Einerhand A.W.C., Voorn-Brouwer M.M., Erdmann R., Kunau W.H., Tabak H.F.;
RT   ""Regulation of transcription of the gene coding for peroxisomal 3-oxoacyl-
RT   CoA thiolase of Saccharomyces cerevisiae."";
RL   Eur. J. Biochem. 200:113-122(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=1872029; DOI=10.1002/yea.320070408;
RA   Igual J.C., Matallana E., Gonzalez-Bosch C., Franco L., Perez-Ortin J.E.;
RT   ""A new glucose-repressible gene identified from the analysis of chromatin
RT   structure in deletion mutants of yeast SUC2 locus."";
RL   Yeast 7:379-389(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169870; DOI=10.1038/387s084;
RA   Churcher C.M., Bowman S., Badcock K., Bankier A.T., Brown D.,
RA   Chillingworth T., Connor R., Devlin K., Gentles S., Hamlin N., Harris D.E.,
RA   Horsnell T., Hunt S., Jagels K., Jones M., Lye G., Moule S., Odell C.,
RA   Pearson D., Rajandream M.A., Rice P., Rowley N., Skelton J., Smith V.,
RA   Walsh S.V., Whitehead S., Barrell B.G.;
RT   ""The nucleotide sequence of Saccharomyces cerevisiae chromosome IX."";
RL   Nature 387:84-87(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   ""The reference genome sequence of Saccharomyces cerevisiae: Then and now."";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   ""Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae."";
RL   Genome Res. 17:536-543(2007).
RN   [6]
RP   MUTAGENESIS OF N-TERMINAL PTS REGION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=8125978; DOI=10.1016/s0021-9258(17)37323-4;
RA   Glover J.R., Andrews D.W., Subramani S., Rachubinski R.A.;
RT   ""Mutagenesis of the amino targeting signal of Saccharomyces cerevisiae 3-
RT   ketoacyl-CoA thiolase reveals conserved amino acids required for import
RT   into peroxisomes in vivo."";
RL   J. Biol. Chem. 269:7558-7563(1994).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND SUBCELLULAR LOCATION.
RX   PubMed=7754706; DOI=10.1002/yea.320100905;
RA   Erdmann R., Kunau W.H.;
RT   ""Purification and immunolocalization of the peroxisomal 3-oxoacyl-CoA
RT   thiolase from Saccharomyces cerevisiae."";
RL   Yeast 10:1173-1182(1994).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22984289; DOI=10.1074/mcp.m112.021105;
RA   Voegtle F.N., Burkhart J.M., Rao S., Gerbeth C., Hinrichs J.,
RA   Martinou J.C., Chacinska A., Sickmann A., Zahedi R.P., Meisinger C.;
RT   ""Intermembrane space proteome of yeast mitochondria."";
RL   Mol. Cell. Proteomics 11:1840-1852(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), AND SUBUNIT.
RX   PubMed=7812714; DOI=10.1016/s0969-2126(94)00081-6;
RA   Mathieu M., Zeelen J.P., Pauptit R.A., Erdmann R., Kunau W.-H.,
RA   Wierenga R.K.;
RT   ""The 2.8 A crystal structure of peroxisomal 3-ketoacyl-CoA thiolase of
RT   Saccharomyces cerevisiae: a five-layered alpha beta alpha beta alpha
RT   structure constructed from two core domains of identical topology."";
RL   Structure 2:797-808(1994).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), AND SUBUNIT.
RX   PubMed=9402066; DOI=10.1006/jmbi.1997.1331;
RA   Mathieu M., Modis Y., Zeelen J.P., Engel C.K., Abagyan R.A., Ahlberg A.,
RA   Rasmussen B., Lamzin V.S., Kunau W.H., Wierenga R.K.;
RT   ""The 1.8 A crystal structure of the dimeric peroxisomal 3-ketoacyl-CoA
RT   thiolase of Saccharomyces cerevisiae: implications for substrate binding
RT   and reaction mechanism."";
RL   J. Mol. Biol. 273:714-728(1997).
RN   [11] {ECO:0007744|PDB:3W15}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-15 IN COMPLEX WITH PEX7 AND
RP   PEX21.
RX   PubMed=23812376; DOI=10.1038/nsmb.2618;
RA   Pan D., Nakatsu T., Kato H.;
RT   ""Crystal structure of peroxisomal targeting signal-2 bound to its receptor
RT   complex Pex7p-Pex21p."";
RL   Nat. Struct. Mol. Biol. 20:987-993(2013).
CC   -!- FUNCTION: Responsible for the thiolytic cleavage of straight chain 3-
CC       keto fatty acyl-CoAs (3-oxoacyl-CoAs). {ECO:0000305|PubMed:7754706}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an acyl-CoA + acetyl-CoA = a 3-oxoacyl-CoA + CoA;
CC         Xref=Rhea:RHEA:21564, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:58342, ChEBI:CHEBI:90726; EC=2.3.1.16;
CC         Evidence={ECO:0000305|PubMed:7754706};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000305|PubMed:7754706}.
CC   -!- SUBUNIT: Homodimer (PubMed:7812714, PubMed:9402066). Interacts (via
CC       PTS2-type peroxisomal targeting signal region) with PEX7; leading to
CC       its translocation into peroxisomes (PubMed:23812376).
CC       {ECO:0000269|PubMed:23812376, ECO:0000269|PubMed:7812714,
CC       ECO:0000269|PubMed:9402066}.
CC   -!- INTERACTION:
CC       P27796; P50091: PEX21; NbExp=5; IntAct=EBI-19236, EBI-23549;
CC       P27796; P39108: PEX7; NbExp=5; IntAct=EBI-19236, EBI-13183;
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:7754706,
CC       ECO:0000269|PubMed:8125978}. Mitochondrion intermembrane space
CC       {ECO:0000269|PubMed:22984289}.
CC   -!- DOMAIN: The PTS2-type peroxisomal targeting signal, which mediates
CC       interaction with PEX7 and localization to peroxisomes, is cleaved
CC       following import into peroxisomes. {ECO:0000305|PubMed:23812376,
CC       ECO:0000305|PubMed:8125978}.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. Thiolase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z38059; CAA86118.1; -; Genomic_DNA.
DR   EMBL; X53946; CAA37893.1; -; Genomic_DNA.
DR   EMBL; X53395; CAA37472.1; -; Genomic_DNA.
DR   EMBL; AY693184; AAT93203.1; -; Genomic_DNA.
DR   EMBL; BK006942; DAA08392.1; -; Genomic_DNA.
DR   PIR; S22784; S22784.
DR   RefSeq; NP_012106.1; NM_001179508.1.
DR   PDB; 1AFW; X-ray; 1.80 A; A/B=25-417.
DR   PDB; 1PXT; X-ray; 2.80 A; A/B=28-417.
DR   PDB; 3W15; X-ray; 1.80 A; C=1-15.
DR   PDBsum; 1AFW; -.
DR   PDBsum; 1PXT; -.
DR   PDBsum; 3W15; -.
DR   AlphaFoldDB; P27796; -.
DR   SMR; P27796; -.
DR   BioGRID; 34832; 278.
DR   DIP; DIP-1504N; -.
DR   IntAct; P27796; 5.
DR   MINT; P27796; -.
DR   STRING; 4932.YIL160C; -.
DR   SwissLipids; SLP:000001408; -.
DR   PaxDb; 4932-YIL160C; -.
DR   PeptideAtlas; P27796; -.
DR   EnsemblFungi; YIL160C_mRNA; YIL160C; YIL160C.
DR   GeneID; 854646; -.
DR   KEGG; sce:YIL160C; -.
DR   AGR; SGD:S000001422; -.
DR   SGD; S000001422; POT1.
DR   VEuPathDB; FungiDB:YIL160C; -.
DR   eggNOG; KOG1389; Eukaryota.
DR   GeneTree; ENSGT01030000234626; -.
DR   HOGENOM; CLU_031026_1_1_1; -.
DR   InParanoid; P27796; -.
DR   OMA; MTAFPEP; -.
DR   OrthoDB; 5404651at2759; -.
DR   BioCyc; MetaCyc:YIL160C-MONOMER; -.
DR   BioCyc; YEAST:YIL160C-MONOMER; -.
DR   BRENDA; 2.3.1.16; 984.
DR   Reactome; R-SCE-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-SCE-390247; Beta-oxidation of very long chain fatty acids.
DR   Reactome; R-SCE-6798695; Neutrophil degranulation.
DR   Reactome; R-SCE-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00199; -.
DR   BioGRID-ORCS; 854646; 2 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; P27796; -.
DR   PRO; PR:P27796; -.
DR   Proteomes; UP000002311; Chromosome IX.
DR   RNAct; P27796; protein.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IDA:SGD.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:SGD.
DR   GO; GO:0005777; C:peroxisome; IDA:SGD.
DR   GO; GO:0003988; F:acetyl-CoA C-acyltransferase activity; IDA:SGD.
DR   GO; GO:0003729; F:mRNA binding; IDA:SGD.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IMP:SGD.
DR   GO; GO:0010124; P:phenylacetate catabolic process; IBA:GO_Central.
DR   CDD; cd00751; thiolase; 1.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR050215; Thiolase-like_sf_Thiolase.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020610; Thiolase_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   NCBIfam; TIGR01930; AcCoA-C-Actrans; 1.
DR   PANTHER; PTHR43853; 3-KETOACYL-COA THIOLASE, PEROXISOMAL; 1.
DR   PANTHER; PTHR43853:SF8; 3-KETOACYL-COA THIOLASE, PEROXISOMAL; 1.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   PIRSF; PIRSF000429; Ac-CoA_Ac_transf; 1.
DR   SUPFAM; SSF53901; Thiolase-like; 2.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
DR   PROSITE; PS00099; THIOLASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Fatty acid metabolism; Lipid metabolism;
KW   Mitochondrion; Peroxisome; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT         1..15
FT                   /note=""Peroxisome""
FT                   /evidence=""ECO:0000305|PubMed:23812376""
FT   CHAIN           16..417
FT                   /note=""3-ketoacyl-CoA thiolase, peroxisomal""
FT                   /evidence=""ECO:0000305|PubMed:23812376""
FT                   /id=""PRO_0000034078""
FT   REGION          1..15
FT                   /note=""PTS2-type peroxisomal targeting signal""
FT                   /evidence=""ECO:0000269|PubMed:23812376""
FT   ACT_SITE        125
FT                   /note=""Acyl-thioester intermediate""
FT   ACT_SITE        375
FT                   /note=""Proton acceptor""
FT   ACT_SITE        403
FT                   /note=""Proton acceptor""
FT   HELIX           1..15
FT                   /evidence=""ECO:0007829|PDB:3W15""
FT   TURN            26..29
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          36..43
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            49..51
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            53..56
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           59..72
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           76..79
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           82..84
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          88..91
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          93..96
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           97..99
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           100..109
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          118..122
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           124..126
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           127..140
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          145..154
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           155..158
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           159..161
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           171..175
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           179..183
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           186..196
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           201..220
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            225..227
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           251..255
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            263..265
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            270..272
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          276..287
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           288..293
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          300..309
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           312..317
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           318..330
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           334..336
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          338..342
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           347..357
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           361..363
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           370..373
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            377..379
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   HELIX           380..391
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          397..404
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   TURN            405..407
FT                   /evidence=""ECO:0007829|PDB:1AFW""
FT   STRAND          408..416
FT                   /evidence=""ECO:0007829|PDB:1AFW""
SQ   SEQUENCE   417 AA;  44730 MW;  B22AA06130829DE5 CRC64;
     MSQRLQSIKD HLVESAMGKG ESKRKNSLLE KRPEDVVIVA ANRSAIGKGF KGAFKDVNTD
     YLLYNFLNEF IGRFPEPLRA DLNLIEEVAC GNVLNVGAGA TEHRAACLAS GIPYSTPFVA
     LNRQCSSGLT AVNDIANKIK VGQIDIGLAL GVESMTNNYK NVNPLGMISS EELQKNREAK
     KCLIPMGITN ENVAANFKIS RKDQDEFAAN SYQKAYKAKN EGLFEDEILP IKLPDGSICQ
     SDEGPRPNVT AESLSSIRPA FIKDRGTTTA GNASQVSDGV AGVLLARRSV ANQLNLPVLG
     RYIDFQTVGV PPEIMGVGPA YAIPKVLEAT GLQVQDIDIF EINEAFAAQA LYCIHKLGID
     LNKVNPRGGA IALGHPLGCT GARQVATILR ELKKDQIGVV SMCIGTGMGA AAIFIKE
//
",423
CTTATT TTATTG TATTGT ATTGTT TTGTTA TGTTAA GTTAAT TTAATA TAATAA AATAAC ATAACG TAACGC AACGCT ACGCTA CGCTAC GCTACT CTACTA TACTAA ACTAAT CTAATG TAATGT AATGTT ATGTTG TGTTGT GTTGTT TTGTTA TGTTAT GTTATT TTATTA TATTAA ATTAAA TTAAAG TAAAGT AAAGTC AAGTCT AGTCTG GTCTGT TCTGTG CTGTGA TGTGAA GTGAAT TGAATT GAATTT AATTTC ATTTCA TTTCAA TTCAAT TCAATT CAATTT AATTTT ATTTTG TTTTGT TTTGTA TTGTAA TGTAAT GTAATG TAATGA AATGAT ATGATC TGATCC GATCCA ATCCAT TCCATT CCATTT CATTTT ATTTTT TTTTTG TTTTGG TTTGGA TTGGAC TGGACC GGACCA GACCAC ACCACA CCACAA CACAAA ACAAAA CAAAAA AAAAAC AAAACA AAACAA AACAAC ACAACA CAACAA AACAAA ACAAAA CAAAAG AAAAGT AAAGTT AAGTTG AGTTGG GTTGGA TTGGAT TGGATG GGATGG GATGGA ATGGAA TGGAAA GGAAAG GAAAGT AAAGTG AAGTGA AGTGAG GTGAGT TGAGTT GAGTTC,1,106,CTTTTATA  TTTTATATAT T T TATATATTACGT A TGATTTTGTG GGA TTTTGTGTGT T TTGTGTTTT T G GTGTTTTATA A T TTTTATAAAA A T TATAAAATAT T A AAATTATA TTA A ATAA TAAA T TATAAAACAC T TGAGAACTT G ACCAACGC AGC C C CGCGCGCT TTT G GCGCTTGGTA A CAT A TCA  GTC T TACA ACT GTT A AC TCTTTTA TTT CTCTATAAAA A TTAAAATAT T A AAAATATGTG G A ATATGTGTGT T T TG GAGTTT GCT GTTTTGTG G TTTGAA T T TGTGTGTTAT T G GTGTTTTATA A T TTTATAT T T TATATATTTT T A ATCTATTATA A TCT TTATAAAA A T TATAAAAAA A AAAAAAAGAG G A AAAAGAGTGT T AATAAGTGTCTC C GAC GTCTCTCT T T TTCTGTG G C CTTGTGT  ATTGTGTGTG G GGTGTTGGA A T TGTGAGAA AGA GTTAGAAAATAT T A AAAATCC TT T A ATATTGGATT T TTCTTTCTTCTC C T TTCTATCATACA T TCTCAA GA C CACAAAATAT T A AAAATATTTT T A ATATTTT C ATA TTTTTTTT T T TTTTGCAA TTTGA GAGT T T TGTGTGTAAA  GTGTAAA A T TATAAAATAT T A AATG C C ATATGTGAGA  TGTGAGGA CTATCTC TT  ATATCTCCC T TCTCCCCACA A C CCCCACATAT T CTGGTAATT T A ATATTTTTT TTTTTTTTTTT T TTTTTTTTTT T T TTTTGTG G TG TTTGTGGGG G T TGTGGTTTAG A G GGG TAC C GTGTGACACCC A ACACC ACGA A CCCACAC CACACACACA A A ACCAAAACA C CACAAAAAAA A AAAAAAAA A AAAAA GAAA A AT AAAAAACAC C A AAACAA A ACACACAAAA AAT CA TTAACAC C A AAAA ACACA A A ACACAAA  GT CACAAAA AATAAAAAAAA A A AAAAAAAGG A AAAGTGT T A AGAGTGTTCGCT GAAATTGTG G T TTTTGGATGG G T TGTGGGATGA A G GGGATTT T GGATATGTG G A ATATG CAGG G T TGTGGGGAGA A G GGGGAGAAAA A GGTTGAAAAAAA A A AAAAGG A AAAAGAGTGT  AA AGGTGTG G G GTGTGTGAA T TGTGA AAAG G G GAAGTGT  AGAGTGTTTT T GA CGTT,CTTTTATATAT T T TTTTA TTATTTT T T TA CCATTTTGTG TTGATTTTGTGTGT T T TTTTGTGTGTTTT T T TGGATGTTTTATG A G GTGTTTTAAA  TT TTTTA GAAATAT T TAAGTAA GTTA GTTAATATATAAAA A A ATATATAAATGAC C T TAAACCG G A AAAACACGCGCGC C A ACACGCGCGTTCT T CTTTTTTGCTCTATA A G GCGCTCTATACAC GTA CTCTATACACTCT  TATACAATCTATA A AACTCTATAAACAA C CTCTATAAA GAT T TTAAAATAACTG TTGATGTGTGT T A ATATGTGTGTTTG T T TGTGTGTTTTGTG G G GTGTT TTTGTGT TTGTGTGTTTT T T TGTGTGTTTTATA A GATAA ATTATATT A TTTTAATTACAT T TATATATTTTATA A A ATATTGTGTAAAA A T TTTTAAAAAA A T TATAAA CAAGAG AT  AAAAAAGTGT T A AAAAGAGTC A AGAAAGTCAT CT  GTTT TCTTGGA CG T TCTCTCTGTGTGT T C CTCTGTGTTTATG  TGTGTGTGTGAGA AAT GTGTGTGAGAAAA A TTGAGAAAATAT  GAGAAAATATTTT  AT AAAATATTTTTTTGT AATTTTTTTCGACC T TTTTTA T TTTTCTCACAAAA A T TCTCACAAAATG AT C CAAATATTTT T A AAAATATTTTTACCT A ATATTTTTTTTTT T TA TTTTTTTAT AAAG TAAA AATTGTGTGT T T TTTTGTGTC CCACA T TGAA GTATAAAA C A GTGTATAAAATT T TATAAAATATGTG G A AAACTATGGA A A ATATGTGAGATAT T T TGTGAGATATCT TC G GAGATATCTCCCC C A ATATCTCCCA A T TCTCCCCACATAT T C CCCCAATTTT T C CACATATTTTTTT T AT AATTTTTTTTTT T T TT CGTTTTAT TTCGCTTTTG G TT TTTGTGGGG  TTTT GA A T TGTGGGGAAC C G GGGGAGACACCC G GATC TT CCAGAAA A ACACCTTTAC C CTATCCACACACACA TT  CATA ACAAAAAA A A ACACACAAAAAAA AAA CACAAAAAAA A ATTTAAAAAAAGTAA A ATTGAAATTGAACAC A G AATG  TTCA A A AAAACACACAAAA A ATG ACACAAAC C C CAAACACACA A AAA AAC AACAAAA A A ACACACAAAAATGTA C CACAAAAAAAAAA A A AAAAAAAAAAGAG G A AAAAGAGTAAC AAAAGAGTGTTTT T A AGAGTGTTTTGTA G GGCT AATGGGG G T TTG ATGGGGAGA A T TGTGGGGATCTT GAAAGGATGT TAG GTAAGATTGGGG G AATGTGGGGAGA TGATGGGGAAA A G GGTT AAAAA A GGAAAAAAG G A AAGAA TAAGTGT T A AAAAGAGT ACG A AGAGTGTG TGGA A G GTGTGTGAGAGAG G T TGTGAGAGAGTGT T G GAGAGAGTGTTTT AT  AGTG TTC,CTTTTAGACTT GACTTATG ATTTTGTG G T TATATATTTTGA AATT TGTGTGTTTT T T TTTTGGTTTTAA T TGGTTA CTTATAAAA GC GTTTTATAAAAT TAT T TTTTAAATATATA A TAT TAAAATATATAAAA T AAATATATAAAACAC C A ATTAATTCACGCG G TAGTTAAAACACGAACA GC A AAAACACGCGCCT T A ACACGCTGT CTA A CGTGCGCGCTCTATACAC ATT GCGCTCTATAC TCAG T CCTACTATA A T TATACA ATAAAA A A ACACTCTACCAAATAT T C CTCTATAAAATATG CAG T TATAAAATATGTGTGT T A AAAATC ATGT ATATGTGTA ATTGTG G T TGTGTGTT CACATGT A C GTGTTAA TGTGTTT T TTTTGTGTGTTTTACT A T TGTGTAT CAT GTGTTAACTATATTTT AGT TTTTATATATTTTATA A T TATATATTTTAAA ACT ATATT TTTAAT GTTGA T TTTTATAAAAAGTGAG G TTAAAAAAAGAGTGT  AAAAAAAGAGTGTCC A AAAAGAGTGTCTCTCT  AT AGATTGTCTCTCGCTG G G GTGTCTCTCTGTGTGT T TACTCTGCTGTGTGTGTG G C CTTGTGTGCAAGA A TGGATGTGTGTGAGAAAA A G GTGTGGAAAATAT T T TGTGAGAAC GT G GAGAAAATATTTTTAGTT AAATTTCTC C AGATATTATTTCACA TTTTTATTTTTCTCACAAAA TT  TTTTCTCACAAAATAT T T TCTCACAAAATATTTT T C CACAAAGTA ATT T A AAAATATTTTTTAATT T A ATATTTTTTTTTTGTG G TTTTTTTTTTTTGTGTGT T T TTTTTTTGTGTGTATA AAG TTTTG TTGTAAA T GTGTTAAAATAAA GTGTTTAAG T TATAAAATATGTGAGA  AAAATATG TTAT T A ATATGTGAGATATCTC C T TGTGAGATATCTCCCC C G GAGATATCCCACA  ATATCTTTCCACATAT T TTCCGTT TGATTTTG CC AATTTTT  CATGTATTA TGATTT T AATTTTTTTTTT T T TTTGGTTGAA G T TTTTTTTTGCTTGGGG G T TTTTTTTGGGAGA A TTGTTGGGGAGACAC C T TGTGGGGAGACACCCC GGA GGGGAC AG ACCAGAGA G GA TTACCCCACACAC C A ACACCCCAACACA AC CACACACAAT GTT CACACACAAAAATG A A ACACACAAAAAAAAAA  CACAAAAAAAAAA A A AAAAATGGAAAAACAC ATG AAAAAAAAACACA A AAAAAACACATGAAA GT  AAAACAACCAATTACCACGC ACACATTGAACACACA GTACAACAAAACACACAAA AA A AAACAACACAAAAAAA CCA ACACACAAAAAAAAAA A C CACAAAAAAAGAG G A AAAAAAAAAAGA T AAAAAAAGAGTGTTTT ATG AAAAGAGTTTGTG ACC AGGTTTTGTGGGG TAT GTTGTTTGTGGGGAGA A T TTTTTGGAGATAT T TTTGTGGC GGATTG G G GG ATATGTGGGG G G GAGATATGTGGGGAGA A AT ATGG TGGAAAA A T TGAAAGGAGAAAA A GGGAT AAAAAAGAG G G GAGAAAAAA TT TTTTT A AAAAAAAG TAAAGG GG A AAAAGAGTGTGTGA AGTGAGAGTA G G GTGTGTGAGAGGT  CG TGTGACA AGTGTTTT T G GAGAGAGTGTTTTC,TTTCCAATGATTTAATG ATATTATATATTTTGTGTGT AAA TATTGATTTTATGTGTTTT A T ATATTTTGTGTGTTAT TA A T TTTTGTGTCAA AGTAA GGA T TGTGTTTATAAAATAT T G GTGTTTTATAAAATATATA A T TTTTATTGAATATATAAAA  TATAAAAT TTTAAGAAAC C ACAAAATAAATAAAACACGG AATATT AACACGCGCGC C T TAAAAA TTGGCGCGCTT TT A AAAA ACGGCTCTAAAA ACACGCGCGCTCTAGTTAC C CCGCGCTCTATACACTCT T G GCTCACTATACACTCTATA AAG CTTACACTCTATAAA T TAAATACTCTATAAAAT ACACTCTATAAAATTT TG G C CTCTATAAAAGATGTGTGT T T TATAAAATTATTGTAG TT T A AAATGGTTTTGTG GA  ATTGTTTGTGTGT T TACATGTGTTTTGGTTTTTGGA GTGTTTTGTGTGTTTTATA  TTTGTACATTGAT T T TGTGTTTAATTTT T G GTGTTACATATATTTTATA T AGAGTTATATTTATAAGTGC G TAAATATTTTATTGAAAAA TTAATTATTTTATAAAAAAAG TAG T AATAAAAAAAGAGTGT  TTTAAAAAA CAGTGTCC A AAAAATTTAGTGTCTCTT AAATAAGAGTGG TCTCTGTG  AAGTCTCTTTGTGTGT T G GTTCTCTGTGTGTGTG G T TCTCTCTGTGTGTGAA A CTTCCTGCCA TGTGAGAAAA A TTGTGTGTGAGAAAATAT AC  GTAA TGAGAAAGTTT T T TGTGAGAAAATATTTTTTT T G GAGAATATATTTTTTTCTC C AATTTTTTTCTCACA A A ATATTTTTTTCTCACAAAA A T TTTAATTCGCTCAAAATAT T TTTCTCAAAT ATTT T T TCTCACAAAATATTTTTT CCAAAATATTTTTTTTTT T A AATACTTTTTTTTGTG G AATTTTTTTTTTGTGTGT T TAGTTTTAATTAATGTGTATA A T TTTTTTTGTGTTAAAA G A TTTTGG GACATAA AAAT T T TGTGTGTATAAAATATGTG G G GTGTATAAAATATGTGAGA A TAG TAATTTATGTGAGATAA T A AAAATATGTGAGATATCTC C A ATATGTGAGATATCTCCCC C T TGTGAGATATCATTTGTCA A G GAGAT AATCCCATAT T A ATATCAAACCACATTCCTT T T TCTCCA ACATATTTTTT CTTGCCACATATTTTTTT T CCATATTTTTTTTTTTTT T A ATATTTTTTTTTTTTTGTG TTTTTTTTTCTGTGGGG G T TTTTTAAGTTGGTTGGAGA A TCTTTTGTGGAACGACT GC TAAATTGTGGGGAGACACCCC C T TGTGGGGAGACACCA GAA GGAGACACCCCACACAC AAC GAGACACCCCACACACACA A A ACACCCCACACACACAAAA A C CCCCACACTTAAAC CACACACACAAAAATGAAGTA A ACCAAAAATGTAAAAA A CCAAAAAAAAAACAACAC C A AAAAAAAAAACACACA A AAAAAAAA GACACAAAA A A AAAAAAACACAGTTGGAAC C AAACACACAAACACA A A ACACACAAAACACACAAAA A C CACAAAAAACATGAAA A A AAAACTA AAAT TA A ACTGGCAAAAA TTAAGTACG C CACAAAAAAATAGTGT T A AAAAATCCAAGAGTGTTATGT A AAAAAAAGAGTGTT CCTG G A AAAGTGTTTTGTGGGG G A AGAGTGTTTATTGGG AGA AAC GTGTTTTGTGGGATAT  TTTTG CTT GGATATGTG G T TGTGGGGAGATATGTGGGTCG G GGGGAGATATGTGGGGAG AA G GAGATATGTGGGGAGAATTAA A ATATGTGGGGAGAAGTAAA A TGTGTGGGGAGAAA TAAGTGT GGGGAAACTAAAAGAGTGT T G GAGAAAAAAAGAGTGTGTG GGA AATTAAAGAGTGTGTGAATCAAGAGTGTGTGAGAGAG G A AGAGTGTG AAGAGAA GT T G GTGTGTGAGAGAGTGTTTT T T TGAAA TTGTTACG,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",58987
TTACTT TACTTG ACTTGC CTTGCT TTGCTT TGCTTT GCTTTA CTTTAC TTTACA TTACAT TACATA ACATAG CATAGA ATAGAA TAGAAG AGAAGT GAAGTT AAGTTA AGTTAT GTTATT TTATTT TATTTG ATTTGG TTTGGC TTGGCT TGGCTC GGCTCC GCTCCT CTCCTG TCCTGG CCTGGT CTGGTG TGGTGA GGTGAT GTGATT TGATTC GATTCT ATTCTT TTCTTC TCTTCT CTTCTT TTCTTC TCTTCA CTTCAG TTCAGG TCAGGT CAGGTT AGGTTC GGTTCG GTTCGA TTCGAC TCGACA CGACAG GACAGC ACAGCT CAGCTG AGCTGG GCTGGT CTGGTG TGGTGC GGTGCT GTGCTG TGCTGC GCTGCA CTGCAG TGCAGC GCAGCT CAGCTT AGCTTA GCTTAT CTTATT TTATTA TATTAT ATTATG TTATGT TATGTG ATGTGG TGTGGG GTGGGT TGGGTT GGGTTA GGTTAT GTTATC TTATCT TATCTT ATCTTC TCTTCA CTTCAA TTCAAC TCAACC CAACCT AACCTA ACCTAG CCTAGG CTAGGA TAGGAC AGGACT GGACTT GACTTT ACTTTT CTTTTC TTTTCG TTTCGA TTCGAT TCGATT CGATTA GATTAA ATTAAA TTAAAA TAAAAT AAAATA AAATAT AATATA ATATAA TATAAT ATAATG TAATGA AATGAA ATGAAA TGAAAA GAAAAT AAAATG AAATGG AATGGA ATGGAA TGGAAC GGAACC GAACCA AACCAT ACCATT CCATTA CATTAC ATTACA TTACAG TACAGA ACAGAT CAGATG AGATGC GATGCT ATGCTG TGCTGT GCTGTA CTGTAG TGTAGA GTAGAC,1,145,TTAC TACT ACTT CTTG TTGC TGCT GCTT CTTT TTTA TTAC TACA ACAT CATA ATAG TAGA AGAA GAAG AAGT AGTT GTTA TTAT TATT ATTT TTTG TTGG TGGC GGCT GCTC CTCC TCCT CCTG CTGG TGGT GGTG GTGA TGAT GATT ATTC TTCT TCTT CTTC TTCT TCTT CTTC TTCA TCAG CAGG AGGT GGTT GTTC TTCG TCGA CGAC GACA ACAG CAGC AGCT GCTG CTGG TGGT GGTG GTGC TGCT GCTG CTGC TGCA GCAG CAGC AGCT GCTT CTTA TTAT TATT ATTA TTAT TATG ATGT TGTG GTGG TGGG GGGT GGTT GTTA TTAT TATC ATCT TCTT CTTC TTCA TCAA CAAC AACC ACCT CCTA CTAG TAGG AGGA GGAC GACT ACTT CTTT TTTT TTTC TTCG TCGA CGAT GATT ATTA TTAA TAAA AAAA AAAT AATA ATAT TATA ATAA TAAT AATG ATGA TGAA GAAA AAAA AAAT AATG ATGG TGGA GGAA GAAC AACC ACCA CCAT CATT ATTA TTAC TACA ACAG CAGA AGAT GATG ATGC TGCT GCTG CTGT TGTA GTAG TAGA AGAC,TTACT TACTT ACTTG CTTGC TTGCT TGCTT GCTTT CTTTA TTTAC TTACA TACAT ACATA CATAG ATAGA TAGAA AGAAG GAAGT AAGTT AGTTA GTTAT TTATT TATTT ATTTG TTTGG TTGGC TGGCT GGCTC GCTCC CTCCT TCCTG CCTGG CTGGT TGGTG GGTGA GTGAT TGATT GATTC ATTCT TTCTT TCTTC CTTCT TTCTT TCTTC CTTCA TTCAG TCAGG CAGGT AGGTT GGTTC GTTCG TTCGA TCGAC CGACA GACAG ACAGC CAGCT AGCTG GCTGG CTGGT TGGTG GGTGC GTGCT TGCTG GCTGC CTGCA TGCAG GCAGC CAGCT AGCTT GCTTA CTTAT TTATT TATTA ATTAT TTATG TATGT ATGTG TGTGG GTGGG TGGGT GGGTT GGTTA GTTAT TTATC TATCT ATCTT TCTTC CTTCA TTCAA TCAAC CAACC AACCT ACCTA CCTAG CTAGG TAGGA AGGAC GGACT GACTT ACTTT CTTTT TTTTC TTTCG TTCGA TCGAT CGATT GATTA ATTAA TTAAA TAAAA AAAAT AAATA AATAT ATATA TATAA ATAAT TAATG AATGA ATGAA TGAAA GAAAA AAAAT AAATG AATGG ATGGA TGGAA GGAAC GAACC AACCA ACCAT CCATT CATTA ATTAC TTACA TACAG ACAGA CAGAT AGATG GATGC ATGCT TGCTG GCTGT CTGTA TGTAG GTAGA TAGAC,TTACTT TACTTG ACTTGC CTTGCT TTGCTT TGCTTT GCTTTA CTTTAC TTTACA TTACAT TACATA ACATAG CATAGA ATAGAA TAGAAG AGAAGT GAAGTT AAGTTA AGTTAT GTTATT TTATTT TATTTG ATTTGG TTTGGC TTGGCT TGGCTC GGCTCC GCTCCT CTCCTG TCCTGG CCTGGT CTGGTG TGGTGA GGTGAT GTGATT TGATTC GATTCT ATTCTT TTCTTC TCTTCT CTTCTT TTCTTC TCTTCA CTTCAG TTCAGG TCAGGT CAGGTT AGGTTC GGTTCG GTTCGA TTCGAC TCGACA CGACAG GACAGC ACAGCT CAGCTG AGCTGG GCTGGT CTGGTG TGGTGC GGTGCT GTGCTG TGCTGC GCTGCA CTGCAG TGCAGC GCAGCT CAGCTT AGCTTA GCTTAT CTTATT TTATTA TATTAT ATTATG TTATGT TATGTG ATGTGG TGTGGG GTGGGT TGGGTT GGGTTA GGTTAT GTTATC TTATCT TATCTT ATCTTC TCTTCA CTTCAA TTCAAC TCAACC CAACCT AACCTA ACCTAG CCTAGG CTAGGA TAGGAC AGGACT GGACTT GACTTT ACTTTT CTTTTC TTTTCG TTTCGA TTCGAT TCGATT CGATTA GATTAA ATTAAA TTAAAA TAAAAT AAAATA AAATAT AATATA ATATAA TATAAT ATAATG TAATGA AATGAA ATGAAA TGAAAA GAAAAT AAAATG AAATGG AATGGA ATGGAA TGGAAC GGAACC GAACCA AACCAT ACCATT CCATTA CATTAC ATTACA TTACAG TACAGA ACAGAT CAGATG AGATGC GATGCT ATGCTG TGCTGT GCTGTA CTGTAG TGTAGA GTAGAC,TTACTTG TACTTGC ACTTGCT CTTGCTT TTGCTTT TGCTTTA GCTTTAC CTTTACA TTTACAT TTACATA TACATAG ACATAGA CATAGAA ATAGAAG TAGAAGT AGAAGTT GAAGTTA AAGTTAT AGTTATT GTTATTT TTATTTG TATTTGG ATTTGGC TTTGGCT TTGGCTC TGGCTCC GGCTCCT GCTCCTG CTCCTGG TCCTGGT CCTGGTG CTGGTGA TGGTGAT GGTGATT GTGATTC TGATTCT GATTCTT ATTCTTC TTCTTCT TCTTCTT CTTCTTC TTCTTCA TCTTCAG CTTCAGG TTCAGGT TCAGGTT CAGGTTC AGGTTCG GGTTCGA GTTCGAC TTCGACA TCGACAG CGACAGC GACAGCT ACAGCTG CAGCTGG AGCTGGT GCTGGTG CTGGTGC TGGTGCT GGTGCTG GTGCTGC TGCTGCA GCTGCAG CTGCAGC TGCAGCT GCAGCTT CAGCTTA AGCTTAT GCTTATT CTTATTA TTATTAT TATTATG ATTATGT TTATGTG TATGTGG ATGTGGG TGTGGGT GTGGGTT TGGGTTA GGGTTAT GGTTATC GTTATCT TTATCTT TATCTTC ATCTTCA TCTTCAA CTTCAAC TTCAACC TCAACCT CAACCTA AACCTAG ACCTAGG CCTAGGA CTAGGAC TAGGACT AGGACTT GGACTTT GACTTTT ACTTTTC CTTTTCG TTTTCGA TTTCGAT TTCGATT TCGATTA CGATTAA GATTAAA ATTAAAA TTAAAAT TAAAATA AAAATAT AAATATA AATATAA ATATAAT TATAATG ATAATGA TAATGAA AATGAAA ATGAAAA TGAAAAT GAAAATG AAAATGG AAATGGA AATGGAA ATGGAAC TGGAACC GGAACCA GAACCAT AACCATT ACCATTA CCATTAC CATTACA ATTACAG TTACAGA TACAGAT ACAGATG CAGATGC AGATGCT GATGCTG ATGCTGT TGCTGTA GCTGTAG CTGTAGA TGTAGAC,"ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S2 AND S2' BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   ""SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor."";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   ""A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells."";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   ""Site-specific glycan analysis of the SARS-CoV-2 spike."";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   ""Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2."";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   ""Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide."";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   ""Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus."";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   ""In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges."";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   ""Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition."";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   ""Molecular Architecture of the SARS-CoV-2 Virus."";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   ""Spike mutation D614G alters SARS-CoV-2 fitness."";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   ""Neuropilin-1 is a host factor for SARS-CoV-2 infection."";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   ""Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity."";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   ""The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection."";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   ""SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo."";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   ""D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction."";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   ""Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy."";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   ""SARS-CoV-2 spike D614G change enhances replication and transmission."";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   ""The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity."";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   ""Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV."";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   ""Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction."";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   ""Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2."";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   ""The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles."";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, MUTAGENESIS OF ALA-684, AND FUNCTION (SPIKE PROTEIN S2').
RX   PubMed=32703818; DOI=10.26508/lsa.202000786;
RA   Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H.,
RA   Stein D.A., Hardes K., Eickmann M., Dolnik O., Rohde C., Klenk H.D.,
RA   Garten W., Steinmetzer T., Boettcher-Friebertshaeuser E.;
RT   ""TMPRSS2 and furin are both essential for proteolytic activation of SARS-
RT   CoV-2 in human airway cells."";
RL   Life. Sci Alliance 3:1-14(2020).
RN   [26]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, CLEAVAGE BETWEEN S2 AND S2' BY
RP   HOST TMPRSS2, CLEAVAGE BETWEEN S2 AND S2' BY HOST CSTL, AND FUNCTION (SPIKE
RP   PROTEIN S2').
RX   PubMed=34159616; DOI=10.15252/embj.2021107821;
RA   Koch J., Uckeley Z.M., Doldan P., Stanifer M., Boulant S., Lozach P.Y.;
RT   ""TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect
RT   host cells."";
RL   EMBO J. 40:1-20(2021).
RN   [27]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   ""Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein."";
RL   Nature 592:438-443(2021).
RN   [28]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   ""Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021."";
RL   Eurosurveillance 26:0-0(2021).
RN   [29]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   ""SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity."";
RL   Cell Host Microbe 0:0-0(2021).
RN   [30]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   ""Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7."";
RL   Cell Rep. 35:109292-109292(2021).
RN   [31]
RP   VARIANTS ILE-13 AND CYS-152, POLYMORPHISM, AND MASS SPECTROMETRY (SIGNAL).
RX   PubMed=34210893; DOI=10.1126/science.abi7994;
RA   McCallum M., Bassi J., De Marco A., Chen A., Walls A.C., Di Iulio J.,
RA   Tortorici M.A., Navarro M.J., Silacci-Fregni C., Saliba C., Sprouse K.R.,
RA   Agostini M., Pinto D., Culap K., Bianchi S., Jaconi S., Cameroni E.,
RA   Bowen J.E., Tilles S.W., Pizzuto M.S., Guastalla S.B., Bona G.,
RA   Pellanda A.F., Garzoni C., Van Voorhis W.C., Rosen L.E., Snell G.,
RA   Telenti A., Virgin H.W., Piccoli L., Corti D., Veesler D.;
RT   ""SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern."";
RL   Science 373:648-654(2021).
RN   [32]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-1269 AND HIS-1271.
RX   PubMed=34504087; DOI=10.1038/s41467-021-25589-1;
RA   Cattin-Ortola J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S.;
RT   ""Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate
RT   expression at the cell surface and syncytia formation."";
RL   Nat. Commun. 12:5333-5333(2021).
RN   [33]
RP   PALMITOYLATION AT CYS-1235; CYS-1236; CYS-1240; CYS-1241; CYS-1243;
RP   CYS-1247; CYS-1248; CYS-1250; CYS-1253 AND CYS-1254.
RX   PubMed=34599882; DOI=10.1016/j.devcel.2021.09.016;
RA   Mesquita F.S., Abrami L., Sergeeva O., Turelli P., Qing E., Kunz B.,
RA   Raclot C., Paz Montoya J., Abriata L.A., Gallagher T., Dal Peraro M.,
RA   Trono D., D'Angelo G., van der Goot F.G.;
RT   ""S-acylation controls SARS-CoV-2 membrane lipid organization and enhances
RT   infectivity."";
RL   Dev. Cell 56:1-18(2021).
RN   [34] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   ""Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2."";
RL   Science 367:1444-1448(2020).
RN   [35]
RP   SUPERANTIGEN, AND DOMAIN.
RX   PubMed=32989130; DOI=10.1073/pnas.2010722117;
RA   Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L.,
RA   Willscher E., Binder M., Arditi M., Bahar I.;
RT   ""Superantigenic character of an insert unique to SARS-CoV-2 spike supported
RT   by skewed TCR repertoire in patients with hyperinflammation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:25254-25262(2020).
RN   [36]
RP   INTERACTION WITH HUMAN BILIRUBIN, INTERACTION WITH HUMAN BILIVERDIN, AND
RP   MUTAGENESIS OF ASN-121 AND ARG-190.
RX   PubMed=33888467; DOI=10.1126/sciadv.abg7607;
RA   Rosa A., Pye V.E., Graham C., Muir L., Seow J., Ng K.W., Cook N.J.,
RA   Rees-Spear C., Parker E., Dos Santos M.S., Rosadas C., Susana A., Rhys H.,
RA   Nans A., Masino L., Roustan C., Christodoulou E., Ulferts R., Wrobel A.G.,
RA   Short C.E., Fertleman M., Sanders R.W., Heaney J., Spyer M., Kjaer S.,
RA   Riddell A., Malim M.H., Beale R., MacRae J.I., Taylor G.P., Nastouli E.,
RA   van Gils M.J., Rosenthal P.B., Pizzato M., McClure M.O., Tedder R.S.,
RA   Kassiotis G., McCoy L.E., Doores K.J., Cherepanov P.;
RT   ""SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity."";
RL   Sci. Adv. 7:0-0(2021).
RN   [37]
RP   BIOTECHNOLOGY, AND MUTAGENESIS OF 682-ARG--ARG-685 AND 986-LYS-VAL-987.
RX   PubMed=34322129; DOI=10.3389/fimmu.2021.701501;
RA   Martinez-Flores D., Zepeda-Cervantes J., Cruz-Resendiz A.,
RA   Aguirre-Sampieri S., Sampieri A., Vaca L.;
RT   ""SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of
RT   New Viral Variants."";
RL   Front. Immunol. 12:701501-701501(2021).
RN   [38]
RP   GLYCOSYLATION AT THR-676 AND THR-678 BY HOST GALNT1, AND MUTAGENESIS OF
RP   SER-673; THR-676; THR-678; SER-680 AND PRO-681.
RX   PubMed=34732583; DOI=10.1073/pnas.2109905118;
RA   Zhang L., Mann M., Syed Z.A., Reynolds H.M., Tian E., Samara N.L.,
RA   Zeldin D.C., Tabak L.A., Ten Hagen K.G.;
RT   ""Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [39]
RP   REVIEW, PROTEOLITIC PROCESSING, FUNCTION (SPIKE PROTEIN S2), AND FUNCTION
RP   (SPIKE PROTEIN S2').
RX   PubMed=34561887; DOI=10.1111/1348-0421.12945;
RA   Takeda M.;
RT   ""Proteolytic activation of SARS-CoV-2 spike protein."";
RL   Microbiol. Immunol. 66:15-23(2022).
RN   [40]
RP   INTERACTION WITH HOST MBL2.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   ""Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules."";
RL   Nat. Immunol. 23:275-286(2022).
RN   [41]
RP   FUNCTION (SPIKE PROTEIN S1), AND INTERACTION WITH HOST INTEGRIN (SPIKE
RP   PROTEIN S1).
RX   PubMed=35150743; DOI=10.1016/j.jbc.2022.101710;
RA   Liu J., Lu F., Chen Y., Plow E., Qin J.;
RT   ""Integrin mediates cell entry of the SARS-CoV-2 virus independent of
RT   cellular receptor ACE2."";
RL   J. Biol. Chem. 1:101710-101710(2022).
RN   [42]
RP   DISORDERED REGIONS.
RX   PubMed=35108439; DOI=10.1111/febs.16379;
RA   Quaglia F., Salladini E., Carraro M., Minervini G., Tosatto S.C.E.,
RA   Le Mercier P.;
RT   ""SARS-CoV-2 variants preferentially emerge at intrinsically disordered
RT   protein sites helping immune evasion."";
RL   FEBS J. 289:4240-4250(2022).
RN   [43]
RP   SUBUNIT.
RX   PubMed=36735681; DOI=10.1371/journal.pbio.3001959;
RA   Shilts J., Crozier T.W.M., Teixeira-Silva A., Gabaev I., Gerber P.P.,
RA   Greenwood E.J.D., Watson S.J., Ortmann B.M., Gawden-Bone C.M., Pauzaite T.,
RA   Hoffmann M., Nathan J.A., Poehlmann S., Matheson N.J., Lehner P.J.,
RA   Wright G.J.;
RT   ""LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike
RT   protein."";
RL   PLoS Biol. 21:e3001959-e3001959(2023).
RN   [44]
RP   VARIANT ASN-405.
RX   PubMed=36851546; DOI=10.3390/v15020332;
RA   Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A.,
RA   Ciccozzi M., Caruso A., Caccuri F.;
RT   ""The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5
RT   Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung
RT   Microvascular Endothelial Cells."";
RL   Viruses 15:0-0(2023).
RN   [45]
RP   MUTAGENESIS OF GLU-484.
RX   PubMed=37421949; DOI=10.1016/j.cell.2023.06.005;
RA   Baggen J., Jacquemyn M., Persoons L., Vanstreels E., Pye V.E., Wrobel A.G.,
RA   Calvaresi V., Martin S.R., Roustan C., Cronin N.B., Reading E.,
RA   Thibaut H.J., Vercruysse T., Maes P., De Smet F., Yee A., Nivitchanyong T.,
RA   Roell M., Franco-Hernandez N., Rhinn H., Mamchak A.A., Ah Young-Chapon M.,
RA   Brown E., Cherepanov P., Daelemans D.;
RT   ""TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry."";
RL   Cell 186:1-16(2023).
RN   [46] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   ""Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation."";
RL   Science 367:1260-1263(2020).
RN   [47] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   ""Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein."";
RL   Cell 180:1-12(2020).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   ""Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor."";
RL   Nature 581:215-220(2020).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   ""Structural basis of receptor recognition by SARS-CoV-2."";
RL   Nature 581:221-224(2020).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   ""A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV."";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: Attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. The major
CC       receptor is host ACE2 (PubMed:32142651, PubMed:32155444,
CC       PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor
CC       triggers direct fusion at the cell membrane (PubMed:34561887). When
CC       S2/S2' has not been cleaved, binding to the receptor results in
CC       internalization of the virus by endocytosis leading to fusion of the
CC       virion membrane with the host endosomal membrane (PubMed:32075877,
CC       PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294,
CC       PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The
CC       use of NRP1/NRP2 receptors may explain the tropism of the virus in
CC       human olfactory epithelial cells, which express these molecules at high
CC       levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S
CC       contains three hinges, giving the head unexpected orientational freedom
CC       (PubMed:32817270). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32142651,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000269|PubMed:35150743,
CC       ECO:0000303|PubMed:33082293, ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2]: Precursor of the fusion protein processed
CC       in the biosynthesis of the S protein and the formation of virus
CC       particle. Mediates fusion of the virion and cellular membranes by
CC       functioning as a class I viral fusion protein. Contains two viral
CC       fusion peptides that are unmasked after cleavage. The S2/S2' cleavage
CC       occurs during virus entry at the cell membrane by host TMPRSS2
CC       (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818,
CC       PubMed:34159616). In either case, this triggers an extensive and
CC       irreversible conformational change leading to fusion of the viral
CC       envelope with the cellular cytoplasmic membrane, releasing viral
CC       genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the
CC       current model, the protein has at least three conformational states:
CC       pre-fusion native state, pre-hairpin intermediate state, and post-
CC       fusion hairpin state. During fusion of the viral and target cell
CC       membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-
CC       hairpins structure and position the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. Formation of this structure
CC       appears to promote apposition and subsequent fusion of viral and target
CC       cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32703818, ECO:0000269|PubMed:34159616,
CC       ECO:0000305|PubMed:34561887}.
CC   -!- FUNCTION: [Spike protein S2']: Subunit of the fusion protein that is
CC       processed upon entry into the host cell. Mediates fusion of the virion
CC       and cellular membranes by functioning as a class I viral fusion
CC       protein. Contains a viral fusion peptide that is unmasked after S2
CC       cleavage. This cleavage can occur at the cell membrane by host TMPRSS2
CC       or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616).
CC       In either case, this triggers an extensive and irreversible
CC       conformational change that leads to fusion of the viral envelope with
CC       the cellular cytoplasmic membrane, releasing viral genomic RNA into the
CC       host cell cytoplasm (PubMed:34561887). Under the current model, the
CC       protein has at least three conformational states: pre-fusion native
CC       state, pre-hairpin intermediate state, and post-fusion hairpin state.
CC       During fusion of the viral and target cell membranes, the coiled coil
CC       regions (heptad repeats) adopt a trimer-of-hairpins structure and
CC       position the fusion peptide in close proximity to the C-terminal region
CC       of the ectodomain. Formation of this structure appears to promote
CC       apposition and subsequent fusion of viral and target cell membranes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32703818,
CC       ECO:0000269|PubMed:34159616, ECO:0000305|PubMed:34561887}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       Binds to host MBL2 (PubMed:35102342). This binding occurs via glycans
CC       and inhibits viral infectivity. Inhibition is effective against alpha,
CC       beta, gamma, and delta variants (PubMed:35102342). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942, ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32075877,
CC       PubMed:32132184, PubMed:32155444, PubMed:32221306, PubMed:32225175,
CC       PubMed:32225176, PubMed:33607086). RBD also interacts with the N-linked
CC       glycan on 'Asn-90' of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082293,
CC       PubMed:33082294). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438). May interact (via N-
CC       terminus) with host bilirubin and biliverdin, thereby preventing
CC       antibody binding to the SARS-CoV-2 spike NTD via an allosteric
CC       mechanism (PubMed:33888467). May interact with host LRRC15, thereby
CC       allowing attachment to host cells (PubMed:36735681).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225",50926
CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA CAGAAG AGAAGC GAAGCT AAGCTG AGCTGG GCTGGA CTGGAC TGGACT GGACTT GACTTC ACTTCC CTTCCC TTCCCT TCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGC GGTGCT GTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGC GTTGCA TTGCAA TGCAAC GCAACT CAACTG AACTGA ACTGAG CTGAGG TGAGGG GAGGGA AGGGAG GGGAGC GGAGCC GAGCCT AGCCTT GCCTTG CCTTGA CTTGAA TTGAAT TGAATA GAATAC AATACA ATACAC TACACC ACACCA CACCAA ACCAAA CCAAAA CAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAC ATCACA TCACAT CACATT ACATTG CATTGG ATTGGA TTGGAA TGGAAC GGAACC GAACCC AACCCG ACCCGC CCCGCA CCGCAA CGCAAT GCAATC CAATCC AATCCT ATCCTG TCCTGC CCTGCT CTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAT ACAATG CAATGC AATGCT ATGCTG TGCTGC GCTGCA CTGCAA TGCAAT GCAATC CAATCG AATCGT ATCGTG TCGTGC CGTGCT GTGCTA TGCTAC GCTACA CTACAA TACAAC ACAACT CAACTT,1,142,CTAG TAGG AGGA GGAA GAAC AACT ACTG CTGG TGGG GGGC GGCC GCCA CCAG CAGA AGAA GAAG AAGC AGCT GCTG CTGG TGGA GGAC GACT ACTT CTTC TTCC TCCC CCCT CCTA CTAT TATG ATGG TGGT GGTG GTGC TGCT GCTA CTAA TAAC AACA ACAA CAAA AAAG AAGA AGAC GACG ACGG CGGC GGCA GCAT CATC ATCA TCAT CATA ATAT TATG ATGG TGGG GGGT GGTT GTTG TTGC TGCA GCAA CAAC AACT ACTG CTGA TGAG GAGG AGGG GGGA GGAG GAGC AGCC GCCT CCTT CTTG TTGA TGAA GAAT AATA ATAC TACA ACAC CACC ACCA CCAA CAAA AAAA AAAG AAGA AGAT GATC ATCA TCAC CACA ACAT CATT ATTG TTGG TGGA GGAA GAAC AACC ACCC CCCG CCGC CGCA GCAA CAAT AATC ATCC TCCT CCTG CTGC TGCT GCTA CTAA TAAC AACA ACAA CAAT AATG ATGC TGCT GCTG CTGC TGCA GCAA CAAT AATC ATCG TCGT CGTG GTGC TGCT GCTA CTAC TACA ACAA CAAC AACT ACTT,CTAGG TAGGA AGGAA GGAAC GAACT AACTG ACTGG CTGGG TGGGC GGGCC GGCCA GCCAG CCAGA CAGAA AGAAG GAAGC AAGCT AGCTG GCTGG CTGGA TGGAC GGACT GACTT ACTTC CTTCC TTCCC TCCCT CCCTA CCTAT CTATG TATGG ATGGT TGGTG GGTGC GTGCT TGCTA GCTAA CTAAC TAACA AACAA ACAAA CAAAG AAAGA AAGAC AGACG GACGG ACGGC CGGCA GGCAT GCATC CATCA ATCAT TCATA CATAT ATATG TATGG ATGGG TGGGT GGGTT GGTTG GTTGC TTGCA TGCAA GCAAC CAACT AACTG ACTGA CTGAG TGAGG GAGGG AGGGA GGGAG GGAGC GAGCC AGCCT GCCTT CCTTG CTTGA TTGAA TGAAT GAATA AATAC ATACA TACAC ACACC CACCA ACCAA CCAAA CAAAA AAAAG AAAGA AAGAT AGATC GATCA ATCAC TCACA CACAT ACATT CATTG ATTGG TTGGA TGGAA GGAAC GAACC AACCC ACCCG CCCGC CCGCA CGCAA GCAAT CAATC AATCC ATCCT TCCTG CCTGC CTGCT TGCTA GCTAA CTAAC TAACA AACAA ACAAT CAATG AATGC ATGCT TGCTG GCTGC CTGCA TGCAA GCAAT CAATC AATCG ATCGT TCGTG CGTGC GTGCT TGCTA GCTAC CTACA TACAA ACAAC CAACT AACTT,CTAGGA TAGGAA AGGAAC GGAACT GAACTG AACTGG ACTGGG CTGGGC TGGGCC GGGCCA GGCCAG GCCAGA CCAGAA CAGAAG AGAAGC GAAGCT AAGCTG AGCTGG GCTGGA CTGGAC TGGACT GGACTT GACTTC ACTTCC CTTCCC TTCCCT TCCCTA CCCTAT CCTATG CTATGG TATGGT ATGGTG TGGTGC GGTGCT GTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAA ACAAAG CAAAGA AAAGAC AAGACG AGACGG GACGGC ACGGCA CGGCAT GGCATC GCATCA CATCAT ATCATA TCATAT CATATG ATATGG TATGGG ATGGGT TGGGTT GGGTTG GGTTGC GTTGCA TTGCAA TGCAAC GCAACT CAACTG AACTGA ACTGAG CTGAGG TGAGGG GAGGGA AGGGAG GGGAGC GGAGCC GAGCCT AGCCTT GCCTTG CCTTGA CTTGAA TTGAAT TGAATA GAATAC AATACA ATACAC TACACC ACACCA CACCAA ACCAAA CCAAAA CAAAAG AAAAGA AAAGAT AAGATC AGATCA GATCAC ATCACA TCACAT CACATT ACATTG CATTGG ATTGGA TTGGAA TGGAAC GGAACC GAACCC AACCCG ACCCGC CCCGCA CCGCAA CGCAAT GCAATC CAATCC AATCCT ATCCTG TCCTGC CCTGCT CTGCTA TGCTAA GCTAAC CTAACA TAACAA AACAAT ACAATG CAATGC AATGCT ATGCTG TGCTGC GCTGCA CTGCAA TGCAAT GCAATC CAATCG AATCGT ATCGTG TCGTGC CGTGCT GTGCTA TGCTAC GCTACA CTACAA TACAAC ACAACT CAACTT,CTAGGAA TAGGAAC AGGAACT GGAACTG GAACTGG AACTGGG ACTGGGC CTGGGCC TGGGCCA GGGCCAG GGCCAGA GCCAGAA CCAGAAG CAGAAGC AGAAGCT GAAGCTG AAGCTGG AGCTGGA GCTGGAC CTGGACT TGGACTT GGACTTC GACTTCC ACTTCCC CTTCCCT TTCCCTA TCCCTAT CCCTATG CCTATGG CTATGGT TATGGTG ATGGTGC TGGTGCT GGTGCTA GTGCTAA TGCTAAC GCTAACA CTAACAA TAACAAA AACAAAG ACAAAGA CAAAGAC AAAGACG AAGACGG AGACGGC GACGGCA ACGGCAT CGGCATC GGCATCA GCATCAT CATCATA ATCATAT TCATATG CATATGG ATATGGG TATGGGT ATGGGTT TGGGTTG GGGTTGC GGTTGCA GTTGCAA TTGCAAC TGCAACT GCAACTG CAACTGA AACTGAG ACTGAGG CTGAGGG TGAGGGA GAGGGAG AGGGAGC GGGAGCC GGAGCCT GAGCCTT AGCCTTG GCCTTGA CCTTGAA CTTGAAT TTGAATA TGAATAC GAATACA AATACAC ATACACC TACACCA ACACCAA CACCAAA ACCAAAA CCAAAAG CAAAAGA AAAAGAT AAAGATC AAGATCA AGATCAC GATCACA ATCACAT TCACATT CACATTG ACATTGG CATTGGA ATTGGAA TTGGAAC TGGAACC GGAACCC GAACCCG AACCCGC ACCCGCA CCCGCAA CCGCAAT CGCAATC GCAATCC CAATCCT AATCCTG ATCCTGC TCCTGCT CCTGCTA CTGCTAA TGCTAAC GCTAACA CTAACAA TAACAAT AACAATG ACAATGC CAATGCT AATGCTG ATGCTGC TGCTGCA GCTGCAA CTGCAAT TGCAATC GCAATCG CAATCGT AATCGTG ATCGTGC TCGTGCT CGTGCTA GTGCTAC TGCTACA GCTACAA CTACAAC TACAACT ACAACTT,"ID   NCAP_SARS2              Reviewed;         419 AA.
AC   P0DTC9;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   05-FEB-2025, entry version 26.
DE   RecName: Full=Nucleoprotein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=N;
DE   AltName: Full=Nucleocapsid protein {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=NC {ECO:0000255|HAMAP-Rule:MF_04096};
DE            Short=Protein N {ECO:0000255|HAMAP-Rule:MF_04096};
GN   Name=N {ECO:0000255|HAMAP-Rule:MF_04096};
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus;
OC   Severe acute respiratory syndrome coronavirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   ""A new coronavirus associated with human respiratory disease in China."";
RL   Nature 579:265-269(2020).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=33060197; DOI=10.1126/science.abe9403;
RG   QCRG Structural Biology Consortium;
RG   Zoonomia Consortium;
RA   Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H.,
RA   Jureka A.S., Obernier K., Guo J.Z., Batra J., Kaake R.M., Weckstein A.R.,
RA   Owens T.W., Gupta M., Pourmal S., Titus E.W., Cakir M., Soucheray M.,
RA   McGregor M., Cakir Z., Jang G., O'Meara M.J., Tummino T.A., Zhang Z.,
RA   Foussard H., Rojc A., Zhou Y., Kuchenov D., Huettenhain R., Xu J.,
RA   Eckhardt M., Swaney D.L., Fabius J.M., Ummadi M., Tutuncuoglu B.,
RA   Rathore U., Modak M., Haas P., Haas K.M., Naing Z.Z.C., Pulido E.H.,
RA   Shi Y., Barrio-Hernandez I., Memon D., Petsalaki E., Dunham A.,
RA   Marrero M.C., Burke D., Koh C., Vallet T., Silvas J.A., Azumaya C.M.,
RA   Billesboelle C., Brilot A.F., Campbell M.G., Diallo A., Dickinson M.S.,
RA   Diwanji D., Herrera N., Hoppe N., Kratochvil H.T., Liu Y., Merz G.E.,
RA   Moritz M., Nguyen H.C., Nowotny C., Puchades C., Rizo A.N.,
RA   Schulze-Gahmen U., Smith A.M., Sun M., Young I.D., Zhao J., Asarnow D.,
RA   Biel J., Bowen A., Braxton J.R., Chen J., Chio C.M., Chio U.S.,
RA   Deshpande I., Doan L., Faust B., Flores S., Jin M., Kim K., Lam V.L.,
RA   Li F., Li J., Li Y.L., Li Y., Liu X., Lo M., Lopez K.E., Melo A.A.,
RA   Moss F.R. III, Nguyen P., Paulino J., Pawar K.I., Peters J.K.,
RA   Pospiech T.H. Jr., Safari M., Sangwan S., Schaefer K., Thomas P.V.,
RA   Thwin A.C., Trenker R., Tse E., Tsui T.K.M., Wang F., Whitis N., Yu Z.,
RA   Zhang K., Zhang Y., Zhou F., Saltzberg D., Hodder A.J., Shun-Shion A.S.,
RA   Williams D.M., White K.M., Rosales R., Kehrer T., Miorin L., Moreno E.,
RA   Patel A.H., Rihn S., Khalid M.M., Vallejo-Gracia A., Fozouni P.,
RA   Simoneau C.R., Roth T.L., Wu D., Karim M.A., Ghoussaini M., Dunham I.,
RA   Berardi F., Weigang S., Chazal M., Park J., Logue J., McGrath M.,
RA   Weston S., Haupt R., Hastie C.J., Elliott M., Brown F., Burness K.A.,
RA   Reid E., Dorward M., Johnson C., Wilkinson S.G., Geyer A., Giesel D.M.,
RA   Baillie C., Raggett S., Leech H., Toth R., Goodman N., Keough K.C.,
RA   Lind A.L., Klesh R.J., Hemphill K.R., Carlson-Stevermer J., Oki J.,
RA   Holden K., Maures T., Pollard K.S., Sali A., Agard D.A., Cheng Y.,
RA   Fraser J.S., Frost A., Jura N., Kortemme T., Manglik A., Southworth D.R.,
RA   Stroud R.M., Alessi D.R., Davies P., Frieman M.B., Ideker T., Abate C.,
RA   Jouvenet N., Kochs G., Shoichet B., Ott M., Palmarini M., Shokat K.M.,
RA   Garcia-Sastre A., Rassen J.A., Grosse R., Rosenberg O.S., Verba K.A.,
RA   Basler C.F., Vignuzzi M., Peden A.A., Beltrao P., Krogan N.J.;
RT   ""Comparative host-coronavirus protein interaction networks reveal pan-viral
RT   disease mechanisms."";
RL   Science 0:0-0(2020).
RN   [3] {ECO:0007744|PDB:6WZO, ECO:0007744|PDB:6WZQ}
RP   X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 247-364, AND SUBUNIT.
RX   PubMed=32654247; DOI=10.1002/pro.3909;
RA   Ye Q., West A.M.V., Silletti S., Corbett K.D.;
RT   ""Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein."";
RL   Protein Sci. 29:1890-1901(2020).
RN   [4]
RP   REVIEW.
RX   PubMed=32974389; DOI=10.3389/fmolb.2020.00219;
RA   Nikolakaki E., Giannakouros T.;
RT   ""SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle."";
RL   Front. Mol. Biosci. 7:219-219(2020).
RN   [5]
RP   VARIANTS LEU-3 AND PHE-235.
RC   STRAIN=20B/501Y.V1, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   ""Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020."";
RL   Eurosurveillance 26:0-0(2021).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=34341353; DOI=10.1038/s41467-021-25015-6;
RA   Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J.,
RA   Jia Y., Wang W., Wan P., Zhang J., Chen W., Lei Z., Chen X., Luo Z.,
RA   Zhang Q., Xu M., Li G., Li Y., Wu J.;
RT   ""SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce
RT   hyperinflammation."";
RL   Nat. Commun. 12:4664-4664(2021).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 41-174, AND MUTAGENESIS OF
RP   TYR-109.
RX   PubMed=32363136; DOI=10.1016/j.apsb.2020.04.009;
RA   Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z.,
RA   Zhou Z., Chen Q., Yan Y., Zhang C., Shan H., Chen S.;
RT   ""Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain
RT   reveals potential unique drug targeting sites."";
RL   Acta Pharmacol. Sin. 10:1228-1238(2020).
RN   [8] {ECO:0007744|PDB:6YI3, ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT}
RP   STRUCTURE BY NMR OF 44-180, FUNCTION, AND MUTAGENESIS OF ARG-68; ARG-92;
RP   ILE-94; ARG-107; GLN-163; TYR-172 AND GLU-174.
RX   PubMed=33264373; DOI=10.1371/journal.ppat.1009100;
RA   Dinesh D.C., Chalupska D., Silhan J., Koutna E., Nencka R., Veverka V.,
RA   Boura E.;
RT   ""Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid
RT   phosphoprotein."";
RL   PLoS Pathog. 16:1-16(2020).
RN   [9]
RP   MUTAGENESIS OF SER-188 AND SER-206, AND PHOSPHORYLATION AT SER-206.
RX   PubMed=34593624; DOI=10.1073/pnas.2113401118;
RA   Liu X., Verma A., Garcia G. Jr., Ramage H., Lucas A., Myers R.L.,
RA   Michaelson J.J., Coryell W., Kumar A., Charney A.W., Kazanietz M.G.,
RA   Rader D.J., Ritchie M.D., Berrettini W.H., Schultz D.C., Cherry S.,
RA   Damoiseaux R., Arumugaswami V., Klein P.S.;
RT   ""Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition."";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:1-9(2021).
RN   [10]
RP   CLEAVAGE.
RX   PubMed=35922005; DOI=10.1038/s41586-022-05148-4;
RA   Chu H., Hou Y., Yang D., Wen L., Shuai H., Yoon C., Shi J., Chai Y.,
RA   Yuen T.T., Hu B., Li C., Zhao X., Wang Y., Huang X., Lee K.S., Luo C.,
RA   Cai J.P., Poon V.K., Chan C.C., Zhang A.J., Yuan S., Sit K.Y., Foo D.C.,
RA   Au W.K., Wong K.K., Zhou J., Kok K.H., Jin D.Y., Chan J.F., Yuen K.Y.;
RT   ""Coronaviruses exploit a host cysteine-aspartic protease for replication."";
RL   Nature 0:0-0(2022).
RN   [11]
RP   MUTAGENESIS OF 203-ARG-GLY-204 AND ARG-203, AND PHOSPHORYLATION.
RX   PubMed=35728038; DOI=10.1371/journal.ppat.1010627;
RA   Johnson B.A., Zhou Y., Lokugamage K.G., Vu M.N., Bopp N.,
RA   Crocquet-Valdes P.A., Kalveram B., Schindewolf C., Liu Y., Scharton D.,
RA   Plante J.A., Xie X., Aguilar P., Weaver S.C., Shi P.Y., Walker D.H.,
RA   Routh A.L., Plante K.S., Menachery V.D.;
RT   ""Nucleocapsid mutations in SARS-CoV-2 augment replication and
RT   pathogenesis."";
RL   PLoS Pathog. 18:e1010627-e1010627(2022).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=35921414; DOI=10.1126/sciadv.abp9770;
RA   Lopez-Munoz A.D., Kosik I., Holly J., Yewdell J.W.;
RT   ""Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive
RT   immunity."";
RL   Sci. Adv. 8:eabp9770-eabp9770(2022).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=34901782; DOI=10.1016/j.isci.2021.103562;
RA   Nabeel-Shah S., Lee H., Ahmed N., Burke G.L., Farhangmehr S., Ashraf K.,
RA   Pu S., Braunschweig U., Zhong G., Wei H., Tang H., Yang J., Marcon E.,
RA   Blencowe B.J., Zhang Z., Greenblatt J.F.;
RT   ""SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress
RT   granules to impair host stress response."";
RL   IScience 25:103562-103562(2022).
RN   [14]
RP   FUNCTION.
RX   PubMed=36534661; DOI=10.1371/journal.ppat.1011041;
RA   Dolliver S.M., Kleer M., Bui-Marinos M.P., Ying S., Corcoran J.A.,
RA   Khaperskyy D.A.;
RT   ""Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit
RT   stress granule formation."";
RL   PLoS Pathog. 18:e1011041-e1011041(2022).
RN   [15] {ECO:0007744|PDB:7PKU}
RP   STRUCTURE BY NMR OF 191-263, AND INTERACTION WITH NSP3.
RX   PubMed=35044811; DOI=10.1126/sciadv.abm4034;
RA   Bessa L.M., Guseva S., Camacho-Zarco A.R., Salvi N., Maurin D., Perez L.M.,
RA   Botova M., Malki A., Nanao M., Jensen M.R., Ruigrok R.W.H., Blackledge M.;
RT   ""The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex
RT   with its viral partner nsp3a."";
RL   Sci. Adv. 8:4034-4034(2022).
CC   -!- FUNCTION: Packages the positive strand viral genome RNA into a helical
CC       ribonucleocapsid (RNP) and plays a fundamental role during virion
CC       assembly through its interactions with the viral genome and membrane
CC       protein M (PubMed:33264373). Plays an important role in enhancing the
CC       efficiency of subgenomic viral RNA transcription as well as viral
CC       replication. Attenuates the stress granules formation by reducing host
CC       G3BP1 access to host mRNAs under stress conditions (PubMed:34901782,
CC       PubMed:36534661). {ECO:0000269|PubMed:32974389,
CC       ECO:0000269|PubMed:33264373, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:36534661}.
CC   -!- FUNCTION: May block host chemokine function in vivo, facilitating viral
CC       replication and transmission (PubMed:35921414). Acts by being secreted
CC       into the extracellular space where it competes to host chemokines for
CC       binding to host glycosaminoglycans (GAG) (PubMed:35921414).
CC       {ECO:0000269|PubMed:35921414}.
CC   -!- FUNCTION: May induce inflammasome responses in cultured cells and mice.
CC       Acts by interacting with host NLRP3 to facilitate inflammasome
CC       assembly, which induces cytokine release that may play a role in COVID
CC       lung injury. {ECO:0000269|PubMed:34341353}.
CC   -!- SUBUNIT: Homodimer, homotetramer, homooligomer with RNA
CC       (PubMed:32654247). Both monomeric and oligomeric forms interact with
CC       RNA. Interacts with protein M (By similarity). Interacts with protein E
CC       (By similarity). Interacts with NSP3; this interaction serves to tether
CC       the genome to the newly translated replicase-transcriptase complex at a
CC       very early stage of infection (PubMed:35044811). May interact with host
CC       NLRP3 (PubMed:34341353). {ECO:0000250|UniProtKB:P59595,
CC       ECO:0000255|HAMAP-Rule:MF_04096, ECO:0000269|PubMed:32654247,
CC       ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:35044811}.
CC   -!- INTERACTION:
CC       P0DTC9; P0DTC4: E; NbExp=3; IntAct=EBI-25475856, EBI-25475850;
CC       P0DTC9; P0DTC5: M; NbExp=6; IntAct=EBI-25475856, EBI-25475853;
CC       P0DTC9; P0DTC9: N; NbExp=105; IntAct=EBI-25475856, EBI-25475856;
CC       P0DTC9; PRO_0000449621 [P0DTD1]: rep; NbExp=15; IntAct=EBI-25475856, EBI-25492388;
CC       P0DTC9; P78563: ADARB1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2967304;
CC       P0DTC9; O15145: ARPC3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351829;
CC       P0DTC9; Q13895: BYSL; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358049;
CC       P0DTC9; Q16543: CDC37; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-295634;
CC       P0DTC9; Q92793: CREBBP; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-81215;
CC       P0DTC9; Q92499: DDX1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-358474;
CC       P0DTC9; Q9NR30: DDX21; Xeno; NbExp=12; IntAct=EBI-25475856, EBI-357942;
CC       P0DTC9; P26196: DDX6; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-351257;
CC       P0DTC9; Q08426: EHHADH; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-2339219;
CC       P0DTC9; P19525: EIF2AK2; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-640775;
CC       P0DTC9; Q14241: ELOA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-742350;
CC       P0DTC9; Q13283: G3BP1; Xeno; NbExp=71; IntAct=EBI-25475856, EBI-1047359;
CC       P0DTC9; Q9UN86: G3BP2; Xeno; NbExp=37; IntAct=EBI-25475856, EBI-1044298;
CC       P0DTC9; P57764: GSDMD; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2798865;
CC       P0DTC9; P49841: GSK3B; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-373586;
CC       P0DTC9; P10412: H1-4; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-358163;
CC       P0DTC9; O14920: IKBKB; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-81266;
CC       P0DTC9; Q92830: KAT2A; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477622;
CC       P0DTC9; Q92831: KAT2B; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-477430;
CC       P0DTC9; Q07866: KLC1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-721019;
CC       P0DTC9; Q9H0B6: KLC2; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-726994;
CC       P0DTC9; Q9NSK0: KLC4; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-949319;
CC       P0DTC9; Q9NX58: LYAR; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-713507;
CC       P0DTC9; O43318: MAP3K7; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-358684;
CC       P0DTC9; Q9UBU8: MORF4L1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-399246;
CC       P0DTC9; Q15014: MORF4L2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-399257;
CC       P0DTC9; Q9HCE1: MOV10; Xeno; NbExp=11; IntAct=EBI-25475856, EBI-1055820;
CC       P0DTC9; Q9HC36: MRM3; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-1045440;
CC       P0DTC9; O15226: NKRF; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-766011;
CC       P0DTC9; Q96P20: NLRP3; Xeno; NbExp=18; IntAct=EBI-25475856, EBI-6253230;
CC       P0DTC9; O15118: NPC1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-2368710;
CC       P0DTC9; Q96HA8: NTAQ1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-741158;
CC       P0DTC9; P11940: PABPC1; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-81531;
CC       P0DTC9; P62937: PPIA; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-437708;
CC       P0DTC9; O75569: PRKRA; Xeno; NbExp=8; IntAct=EBI-25475856, EBI-713955;
CC       P0DTC9; Q99873: PRMT1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-78738;
CC       P0DTC9; P61289: PSME3; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-355546;
CC       P0DTC9; P26022: PTX3; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-11574553;
CC       P0DTC9; P54727: RAD23B; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-954531;
CC       P0DTC9; O95786: RIGI; Xeno; NbExp=15; IntAct=EBI-25475856, EBI-995350;
CC       P0DTC9; P62899: RPL31; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1053664;
CC       P0DTC9; P62753: RPS6; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-356625;
CC       P0DTC9; P37840: SNCA; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-985879;
CC       P0DTC9; Q96SB4: SRPK1; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-539478;
CC       P0DTC9; P78362: SRPK2; Xeno; NbExp=2; IntAct=EBI-25475856, EBI-593303;
CC       P0DTC9; P42224: STAT1; Xeno; NbExp=6; IntAct=EBI-25475856, EBI-1057697;
CC       P0DTC9; P52630: STAT2; Xeno; NbExp=7; IntAct=EBI-25475856, EBI-1546963;
CC       P0DTC9; Q15633: TARBP2; Xeno; NbExp=5; IntAct=EBI-25475856, EBI-978581;
CC       P0DTC9; Q14258: TRIM25; Xeno; NbExp=13; IntAct=EBI-25475856, EBI-2341129;
CC       P0DTC9; O60763: USO1; Xeno; NbExp=4; IntAct=EBI-25475856, EBI-356164;
CC       P0DTC9; Q93008: USP9X; Xeno; NbExp=3; IntAct=EBI-25475856, EBI-302524;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04096}. Host
CC       cytoplasm {ECO:0000269|PubMed:33060197, ECO:0000269|PubMed:34341353}.
CC       Secreted {ECO:0000269|PubMed:35921414}. Host extracellular space
CC       {ECO:0000269|PubMed:35921414}. Note=Probably associates with ER-derived
CC       membranes where it participates in viral RNA synthesis and virus
CC       budding. When located inside the virion, complexed with the viral RNA.
CC       Can be secreted by unconventional protein secretion (UPS)
CC       (PubMed:35921414). When secreted, can bind to host glycosaminoglycans
CC       on infected and non infected cells (PubMed:35921414). Found in host
CC       cytoplasmic stress granules (PubMed:34901782). {ECO:0000255|HAMAP-
CC       Rule:MF_04096, ECO:0000269|PubMed:34901782,
CC       ECO:0000269|PubMed:35921414}.
CC   -!- PTM: ADP-ribosylated. The ADP-ribosylation is retained in the virion
CC       during infection. {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   -!- PTM: Phosphorylated on serine residues by host GSK3A and GSK3B
CC       (PubMed:34593624, PubMed:35728038). This promotes the solubility of
CC       homodimers that would otherwise aggregate (PubMed:32974389). Host
CC       phosphatase would dephosphorylate the protein during assembly at M
CC       bound membranes (PubMed:32974389). {ECO:0000269|PubMed:34593624,
CC       ECO:0000269|PubMed:35728038, ECO:0000305|PubMed:32974389}.
CC   -!- PTM: Proteolytically cleaved by host CASP6. The cleavage leads to two
CC       fragments and facilitates viral replication by inhibiting host IFN
CC       signaling. The two fragments may interact with IRF3 inhibiting its
CC       nuclear translocation after activation and reduce the expression of
CC       IFNB and IFN-stimulated genes. {ECO:0000269|PubMed:35922005}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (December 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1. {ECO:0000305|PubMed:33413740}.
CC   -!- POLYMORPHISM: Variant Omicron/BA.1 and BA.2 belong to a lineage first
CC       isolated in South Africa (November 2021). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/BQ.1.1 belongs to a lineage first
CC       isolated in Nigeria (November 2022). {ECO:0000305}.
CC   -!- POLYMORPHISM: Variant Omicron/XBB.1.5 belongs to a lineage first
CC       isolated in United States (November 2022). It is the result of
CC       recombination between omicron BJ.1 and BM.1.1. Moreover XBB.1.5 do not
CC       express ORF8. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the betacoronavirus nucleocapsid protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04096}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43423.2; -; Genomic_RNA.
DR   PDB; 6M3M; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 6VYO; X-ray; 1.70 A; A/B/C/D=47-173.
DR   PDB; 6WJI; X-ray; 2.05 A; A/B/C/D/E/F=257-364.
DR   PDB; 6WKP; X-ray; 2.67 A; A/B/C/D=47-173.
DR   PDB; 6WZO; X-ray; 1.42 A; A/B/C/D=247-364.
DR   PDB; 6WZQ; X-ray; 1.45 A; A/B/C/D=247-364.
DR   PDB; 6YI3; NMR; -; A=44-180.
DR   PDB; 6YUN; X-ray; 1.44 A; A/B=249-364.
DR   PDB; 6ZCO; X-ray; 1.36 A; A=247-364.
DR   PDB; 7ACS; NMR; -; A=44-180.
DR   PDB; 7ACT; NMR; -; A=44-180.
DR   PDB; 7C22; X-ray; 2.00 A; A/B/C/D=248-364.
DR   PDB; 7CDZ; X-ray; 1.80 A; A/B/C/D=44-174.
DR   PDB; 7CE0; X-ray; 1.50 A; A/B/C/D=255-364.
DR   PDB; 7CR5; X-ray; 2.08 A; A=41-174.
DR   PDB; 7DE1; X-ray; 2.00 A; A/B=250-364.
DR   PDB; 7F2B; X-ray; 2.00 A; A/B=257-362.
DR   PDB; 7F2E; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J/K/L=255-362.
DR   PDB; 7KGO; X-ray; 2.15 A; C=351-359.
DR   PDB; 7KGP; X-ray; 1.40 A; C=316-324.
DR   PDB; 7KGQ; X-ray; 1.34 A; C=222-230.
DR   PDB; 7KGR; X-ray; 1.55 A; C=159-167.
DR   PDB; 7KGS; X-ray; 1.58 A; C=138-146.
DR   PDB; 7KGT; X-ray; 1.90 A; C=226-234.
DR   PDB; 7LGD; X-ray; 2.88 A; E/F=105-113.
DR   PDB; 7LTU; X-ray; 1.12 A; A/B=217-222.
DR   PDB; 7LUX; X-ray; 1.30 A; A=217-222.
DR   PDB; 7LUZ; X-ray; 1.10 A; A=243-248.
DR   PDB; 7LV2; X-ray; 1.30 A; A=179-184.
DR   PDB; 7N0I; X-ray; 2.20 A; A/B/C/D/E/F/G/H=269-364.
DR   PDB; 7N0R; X-ray; 1.42 A; A/B=49-174.
DR   PDB; 7N3C; X-ray; 1.82 A; C=47-173.
DR   PDB; 7N3D; X-ray; 1.53 A; C=47-173.
DR   PDB; 7O05; X-ray; 1.94 A; A/B/C/D=247-364.
DR   PDB; 7O35; X-ray; 1.80 A; A/B/C/D=247-364.
DR   PDB; 7O36; X-ray; 2.00 A; A/B/C/D=247-364.
DR   PDB; 7PKU; NMR; -; B=191-263.
DR   PDB; 7QIK; X-ray; 2.01 A; E/F=193-200.
DR   PDB; 7QIP; X-ray; 2.65 A; C/D=201-210.
DR   PDB; 7R98; X-ray; 2.51 A; A/B/C=49-174.
DR   PDB; 7SD4; NMR; -; A=40-174.
DR   PDB; 7STR; X-ray; 1.50 A; C=47-173.
DR   PDB; 7STS; X-ray; 2.16 A; C/D=47-173.
DR   PDB; 7SUE; X-ray; 2.90 A; C/D/J/K=47-173.
DR   PDB; 7SUO; X-ray; 2.35 A; C/D=12-22.
DR   PDB; 7UW3; X-ray; 1.70 A; A/B/C/D=40-174.
DR   PDB; 7UXX; X-ray; 1.85 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7UXZ; X-ray; 1.73 A; AAA/BBB/CCC/DDD/EEE/FFF=251-364.
DR   PDB; 7VBD; X-ray; 1.94 A; A/B/C/D=48-174.
DR   PDB; 7VBE; X-ray; 1.59 A; A/B=257-364.
DR   PDB; 7VBF; X-ray; 1.30 A; A/B=255-364.
DR   PDB; 7VNU; X-ray; 1.95 A; A/B/C/D=47-174.
DR   PDB; 7WKJ; X-ray; 1.50 A; C=361-369.
DR   PDB; 7WZO; X-ray; 2.64 A; A=47-174.
DR   PDB; 7XWX; X-ray; 3.00 A; A/B/C/D/E/F/G/H=269-367.
DR   PDB; 7XWZ; X-ray; 2.25 A; A/B=48-172.
DR   PDB; 7XX1; X-ray; 1.90 A; A/B/C/D=49-173.
DR   PDB; 7XXK; X-ray; 2.00 A; A/B/C/D/E/F=248-364.
DR   PDB; 7YLB; X-ray; 2.41 A; A/B/C/D/G/H/J/K=247-364.
DR   PDB; 7YLD; X-ray; 2.80 A; A/B/C/D=47-174.
DR   PDB; 7ZIT; X-ray; 1.79 A; C/D=194-200.
DR   PDB; 8DNT; X-ray; 3.18 A; D/J/Q/X=222-230.
DR   PDB; 8FD5; EM; 4.57 A; A=1-419.
DR   PDB; 8FG2; EM; 6.00 A; A/B=1-419.
DR   PDB; 8IQJ; X-ray; 2.30 A; A/B/C/D=41-174.
DR   PDB; 8IV3; X-ray; 1.90 A; A/B/C/D=41-174.
DR   PDB; 8J6X; X-ray; 2.70 A; A/B/C/D=41-174.
DR   PDB; 8TH1; X-ray; 1.80 A; E/F/G/H=1-25.
DR   PDB; 8TH5; X-ray; 2.62 A; K/L/M/N/O/P/Q=1-25.
DR   PDB; 8X1H; X-ray; 2.00 A; A/B/C/D=44-175.
DR   PDBsum; 6M3M; -.
DR   PDBsum; 6VYO; -.
DR   PDBsum; 6WJI; -.
DR   PDBsum; 6WKP; -.
DR   PDBsum; 6WZO; -.
DR   PDBsum; 6WZQ; -.
DR   PDBsum; 6YI3; -.
DR   PDBsum; 6YUN; -.
DR   PDBsum; 6ZCO; -.
DR   PDBsum; 7ACS; -.
DR   PDBsum; 7ACT; -.
DR   PDBsum; 7C22; -.
DR   PDBsum; 7CDZ; -.
DR   PDBsum; 7CE0; -.
DR   PDBsum; 7CR5; -.
DR   PDBsum; 7DE1; -.
DR   PDBsum; 7F2B; -.
DR   PDBsum; 7F2E; -.
DR   PDBsum; 7KGO; -.
DR   PDBsum; 7KGP; -.
DR   PDBsum; 7KGQ; -.
DR   PDBsum; 7KGR; -.
DR   PDBsum; 7KGS; -.
DR   PDBsum; 7KGT; -.
DR   PDBsum; 7LGD; -.
DR   PDBsum; 7LTU; -.
DR   PDBsum; 7LUX; -.
DR   PDBsum; 7LUZ; -.
DR   PDBsum; 7LV2; -.
DR   PDBsum; 7N0I; -.
DR   PDBsum; 7N0R; -.
DR   PDBsum; 7N3C; -.
DR   PDBsum; 7N3D; -.
DR   PDBsum; 7O05; -.
DR   PDBsum; 7O35; -.
DR   PDBsum; 7O36; -.
DR   PDBsum; 7PKU; -.
DR   PDBsum; 7QIK; -.
DR   PDBsum; 7QIP; -.
DR   PDBsum; 7R98; -.
DR   PDBsum; 7SD4; -.
DR   PDBsum; 7STR; -.
DR   PDBsum; 7STS; -.
DR   PDBsum; 7SUE; -.
DR   PDBsum; 7SUO; -.
DR   PDBsum; 7UW3; -.
DR   PDBsum; 7UXX; -.
DR   PDBsum; 7UXZ; -.
DR   PDBsum; 7VBD; -.
DR   PDBsum; 7VBE; -.
DR   PDBsum; 7VBF; -.
DR   PDBsum; 7VNU; -.
DR   PDBsum; 7WKJ; -.
DR   PDBsum; 7WZO; -.
DR   PDBsum; 7XWX; -.
DR   PDBsum; 7XWZ; -.
DR   PDBsum; 7XX1; -.
DR   PDBsum; 7XXK; -.
DR   PDBsum; 7YLB; -.
DR   PDBsum; 7YLD; -.
DR   PDBsum; 7ZIT; -.
DR   PDBsum; 8DNT; -.
DR   PDBsum; 8FD5; -.
DR   PDBsum; 8FG2; -.
DR   PDBsum; 8IQJ; -.
DR   PDBsum; 8IV3; -.
DR   PDBsum; 8J6X; -.
DR   PDBsum; 8TH1; -.
DR   PDBsum; 8TH5; -.
DR   PDBsum; 8X1H; -.
DR   BMRB; P0DTC9; -.
DR   EMDB; EMD-29002; -.
DR   EMDB; EMD-29072; -.
DR   SASBDB; P0DTC9; -.
DR   SMR; P0DTC9; -.
DR   BioGRID; 4383847; 1532.
DR   ComplexPortal; CPX-5686; SARS-CoV-2 nucleocapsid complex.
DR   IntAct; P0DTC9; 608.
DR   MINT; P0DTC9; -.
DR   ChEMBL; CHEMBL5169223; -.
DR   iPTMnet; P0DTC9; -.
DR   ABCD; P0DTC9; 27 sequenced antibodies.
DR   DNASU; 43740575; -.
DR   KEGG; vg:43740575; -.
DR   AGR; RefSeq:YP_009724397; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694635; Translation of Structural Proteins.
DR   Reactome; R-HSA-9694786; Transcription of SARS-CoV-2 sgRNAs.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   Reactome; R-HSA-9755779; SARS-CoV-2 targets host intracellular signalling and regulatory pathways.
DR   SIGNOR; P0DTC9; -.
DR   PRO; PR:P0DTC9; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0044177; C:host cell Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0044220; C:host cell perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043655; C:host extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt.
DR   GO; GO:0042612; C:MHC class I protein complex; EXP:DisProt.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0019028; C:viral capsid; IPI:ComplexPortal.
DR   GO; GO:0019013; C:viral nucleocapsid; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042288; F:MHC class I protein binding; EXP:DisProt.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; IDA:DisProt.
DR   GO; GO:0008266; F:poly(U) RNA binding; IMP:DisProt.
DR   GO; GO:0042803; F:protein homodimerization activity; EXP:DisProt.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProt.
DR   GO; GO:0035613; F:RNA stem-loop binding; IDA:DisProt.
DR   GO; GO:0039709; P:cytoplasmic capsid assembly; IDA:UniProt.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IDA:ComplexPortal.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0052572; P:response to host immune response; IDA:DisProt.
DR   GO; GO:0019074; P:viral RNA genome packaging; NAS:ComplexPortal.
DR   CDD; cd21595; CoV_N-CTD; 1.
DR   CDD; cd21554; CoV_N-NTD; 1.
DR   HAMAP; MF_04096; BETA_CORONA_NCAP; 1.
DR   InterPro; IPR044344; N_prot_C_CoV.
DR   InterPro; IPR044345; N_prot_N_CoV.
DR   InterPro; IPR043505; NCAP_bCoV.
DR   InterPro; IPR001218; Nucleocap_CoV.
DR   InterPro; IPR037179; Nucleocapsid_C.
DR   InterPro; IPR037195; Nucleocapsid_N.
DR   Pfam; PF00937; CoV_nucleocap; 1.
DR   PIRSF; PIRSF003888; Corona_nucleocap; 1.
DR   SUPFAM; SSF110304; Coronavirus RNA-binding domain; 1.
DR   SUPFAM; SSF103068; Nucleocapsid protein dimerization domain; 1.
DR   PROSITE; PS51929; COV_N_CTD; 1.
DR   PROSITE; PS51928; COV_N_NTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Host cytoplasm; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Secreted;
KW   Transcription; Transcription regulation; Viral nucleoprotein; Virion.
FT   CHAIN           1..419
FT                   /note=""Nucleoprotein""
FT                   /id=""PRO_0000449656""
FT   DOMAIN          48..174
FT                   /note=""CoV N NTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01276,
FT                   ECO:0000269|PubMed:32363136""
FT   DOMAIN          247..364
FT                   /note=""CoV N CTD""
FT                   /evidence=""ECO:0000255|PROSITE-ProRule:PRU01277""
FT   REGION          1..51
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          41..186
FT                   /note=""RNA-binding""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          63..83
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          168..212
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          176..206
FT                   /note=""SR region""
FT                   /evidence=""ECO:0000305|PubMed:32974389""
FT   REGION          233..266
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          258..361
FT                   /note=""Dimerization""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   REGION          260..340
FT                   /note=""Putative NLRP3 binding""
FT                   /evidence=""ECO:0000269|PubMed:34341353""
FT   REGION          361..391
FT                   /note=""Disordered""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   REGION          400..419
FT                   /note=""Tetramerization""
FT                   /evidence=""ECO:0000269|PubMed:32654247""
FT   MOTIF           256..264
FT                   /note=""Nuclear localization signal""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   COMPBIAS        1..11
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        21..31
FT                   /note=""Polar residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   COMPBIAS        367..378
FT                   /note=""Basic and acidic residues""
FT                   /evidence=""ECO:0000256|SAM:MobiDB-lite""
FT   BINDING         92
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         107
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   BINDING         149
FT                   /ligand=""RNA""
FT                   /ligand_id=""ChEBI:CHEBI:33697""
FT                   /evidence=""ECO:0000269|PubMed:33264373,
FT                   ECO:0007744|PDB:7ACS, ECO:0007744|PDB:7ACT""
FT   SITE            399..402
FT                   /note=""Cleavage (by host CASP6)""
FT                   /evidence=""ECO:0000250|UniProtKB:P59595""
FT   MOD_RES         176
FT                   /note=""Phosphoserine; by host""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_04096""
FT   MOD_RES         206
FT                   /note=""Phosphoserine; by host GSK3-alpha and GSK3-beta""
FT                   /evidence=""ECO:0000269|PubMed:34593624""
FT   VARIANT         2..3
FT                   /note=""SD -> Y (in strain: Eta/B.1.525)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         3
FT                   /note=""D -> L (in strain: Alpha/B.1.1.7)""
FT                   /evidence=""ECO:0000305|PubMed:33413740""
FT   VARIANT         12
FT                   /note=""A -> G (in strain: Eta/B.1.525)""
FT   VARIANT         13
FT                   /note=""P -> L (in strain: Lambda/C.37, Omicron/BA.1,
FT                   Omicron/BA.2, Omicron/BA.2.12.1, Omicron/BA.2.75,
FT                   Omicron/BA.4, Omicron/BA.5, Omicron/BQ.1.1,
FT                   Omicron/XBB.1.5, Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         31..33
FT                   /note=""Missing (in strain: Omicron/BA.1, Omicron/BA.2,
FT                   Omicron/BA.2.12.1, Omicron/BA.2.75, Omicron/BA.4,
FT                   Omicron/BA.5, Omicron/BQ.1.1, Omicron/XBB.1.5,
FT                   Omicron/EG.5.1)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT         63
FT                   /note=""D -> G (in strain: Delta/B.1.617.2)""
FT                   /evidence=""ECO:0000305""
FT   VARIANT  ",58519
GATACC ATACCA TACCAC ACCACC CCACCG CACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGA AGAGAA GAGAAT AGAATA GAATAT AATATC ATATCC TATCCA ATCCAG TCCAGG CCAGGC CAGGCG AGGCGC GGCGCG GCGCGC CGCGCA GCGCAT CGCATC GCATCC CATCCG ATCCGC TCCGCG CCGCGG CGCGGC GCGGCA CGGCAA GGCAAC GCAACA CAACAT AACATC ACATCC CATCCT ATCCTG TCCTGA CCTGAT CTGATG TGATGG GATGGC ATGGCG TGGCGC GGCGCT GCGCTG CGCTGT GCTGTC CTGTCG TGTCGA GTCGAA TCGAAC CGAACA GAACAA AACAAG ACAAGA CAAGAC AAGACT AGACTG GACTGG ACTGGG CTGGGG TGGGGC GGGGCG GGGCGC GGCGCT GCGCTG CGCTGG GCTGGT CTGGTC TGGTCC GGTCCT GTCCTG TCCTGA CCTGAC CTGACC TGACCA GACCAC ACCACC CCACCG CACCGG ACCGGC CCGGCA CGGCAA GGCAAC GCAACA CAACAA AACAAG ACAAGT CAAGTC AAGTCG AGTCGG GTCGGA TCGGAA CGGAAA GGAAAT GAAATG AAATGG AATGGC ATGGCG TGGCGG GGCGGT GCGGTC CGGTCG GGTCGG GTCGGC TCGGCT CGGCTA GGCTAC GCTACT CTACTG TACTGC ACTGCA CTGCAC TGCACG GCACGC CACGCT ACGCTG CGCTGT GCTGTA CTGTAC TGTACG GTACGG TACGGC ACGGCG CGGCGA GGCGAC GCGACA CGACAT GACATG ACATGG CATGGC ATGGCT TGGCTG GGCTGG GCTGGC,3,142,GATA ATAC TACC ACCA CCAC CACC ACCG CCGA CGAA GAAG AAGA AGAG GAGA AGAA GAAT AATA ATAT TATC ATCC TCCA CCAG CAGG AGGC GGCG GCGC CGCG GCGC CGCA GCAT CATC ATCC TCCG CCGC CGCG GCGG CGGC GGCA GCAA CAAC AACA ACAT CATC ATCC TCCT CCTG CTGA TGAT GATG ATGG TGGC GGCG GCGC CGCT GCTG CTGT TGTC GTCG TCGA CGAA GAAC AACA ACAA CAAG AAGA AGAC GACT ACTG CTGG TGGG GGGG GGGC GGCG GCGC CGCT GCTG CTGG TGGT GGTC GTCC TCCT CCTG CTGA TGAC GACC ACCA CCAC CACC ACCG CCGG CGGC GGCA GCAA CAAC AACA ACAA CAAG AAGT AGTC GTCG TCGG CGGA GGAA GAAA AAAT AATG ATGG TGGC GGCG GCGG CGGT GGTC GTCG TCGG CGGC GGCT GCTA CTAC TACT ACTG CTGC TGCA GCAC CACG ACGC CGCT GCTG CTGT TGTA GTAC TACG ACGG CGGC GGCG GCGA CGAC GACA ACAT CATG ATGG TGGC GGCT GCTG CTGG TGGC,GATAC ATACC TACCA ACCAC CCACC CACCG ACCGA CCGAA CGAAG GAAGA AAGAG AGAGA GAGAA AGAAT GAATA AATAT ATATC TATCC ATCCA TCCAG CCAGG CAGGC AGGCG GGCGC GCGCG CGCGC GCGCA CGCAT GCATC CATCC ATCCG TCCGC CCGCG CGCGG GCGGC CGGCA GGCAA GCAAC CAACA AACAT ACATC CATCC ATCCT TCCTG CCTGA CTGAT TGATG GATGG ATGGC TGGCG GGCGC GCGCT CGCTG GCTGT CTGTC TGTCG GTCGA TCGAA CGAAC GAACA AACAA ACAAG CAAGA AAGAC AGACT GACTG ACTGG CTGGG TGGGG GGGGC GGGCG GGCGC GCGCT CGCTG GCTGG CTGGT TGGTC GGTCC GTCCT TCCTG CCTGA CTGAC TGACC GACCA ACCAC CCACC CACCG ACCGG CCGGC CGGCA GGCAA GCAAC CAACA AACAA ACAAG CAAGT AAGTC AGTCG GTCGG TCGGA CGGAA GGAAA GAAAT AAATG AATGG ATGGC TGGCG GGCGG GCGGT CGGTC GGTCG GTCGG TCGGC CGGCT GGCTA GCTAC CTACT TACTG ACTGC CTGCA TGCAC GCACG CACGC ACGCT CGCTG GCTGT CTGTA TGTAC GTACG TACGG ACGGC CGGCG GGCGA GCGAC CGACA GACAT ACATG CATGG ATGGC TGGCT GGCTG GCTGG CTGGC,GATACC ATACCA TACCAC ACCACC CCACCG CACCGA ACCGAA CCGAAG CGAAGA GAAGAG AAGAGA AGAGAA GAGAAT AGAATA GAATAT AATATC ATATCC TATCCA ATCCAG TCCAGG CCAGGC CAGGCG AGGCGC GGCGCG GCGCGC CGCGCA GCGCAT CGCATC GCATCC CATCCG ATCCGC TCCGCG CCGCGG CGCGGC GCGGCA CGGCAA GGCAAC GCAACA CAACAT AACATC ACATCC CATCCT ATCCTG TCCTGA CCTGAT CTGATG TGATGG GATGGC ATGGCG TGGCGC GGCGCT GCGCTG CGCTGT GCTGTC CTGTCG TGTCGA GTCGAA TCGAAC CGAACA GAACAA AACAAG ACAAGA CAAGAC AAGACT AGACTG GACTGG ACTGGG CTGGGG TGGGGC GGGGCG GGGCGC GGCGCT GCGCTG CGCTGG GCTGGT CTGGTC TGGTCC GGTCCT GTCCTG TCCTGA CCTGAC CTGACC TGACCA GACCAC ACCACC CCACCG CACCGG ACCGGC CCGGCA CGGCAA GGCAAC GCAACA CAACAA AACAAG ACAAGT CAAGTC AAGTCG AGTCGG GTCGGA TCGGAA CGGAAA GGAAAT GAAATG AAATGG AATGGC ATGGCG TGGCGG GGCGGT GCGGTC CGGTCG GGTCGG GTCGGC TCGGCT CGGCTA GGCTAC GCTACT CTACTG TACTGC ACTGCA CTGCAC TGCACG GCACGC CACGCT ACGCTG CGCTGT GCTGTA CTGTAC TGTACG GTACGG TACGGC ACGGCG CGGCGA GGCGAC GCGACA CGACAT GACATG ACATGG CATGGC ATGGCT TGGCTG GGCTGG GCTGGC,GATACCA ATACCAC TACCACC ACCACCG CCACCGA CACCGAA ACCGAAG CCGAAGA CGAAGAG GAAGAGA AAGAGAA AGAGAAT GAGAATA AGAATAT GAATATC AATATCC ATATCCA TATCCAG ATCCAGG TCCAGGC CCAGGCG CAGGCGC AGGCGCG GGCGCGC GCGCGCA CGCGCAT GCGCATC CGCATCC GCATCCG CATCCGC ATCCGCG TCCGCGG CCGCGGC CGCGGCA GCGGCAA CGGCAAC GGCAACA GCAACAT CAACATC AACATCC ACATCCT CATCCTG ATCCTGA TCCTGAT CCTGATG CTGATGG TGATGGC GATGGCG ATGGCGC TGGCGCT GGCGCTG GCGCTGT CGCTGTC GCTGTCG CTGTCGA TGTCGAA GTCGAAC TCGAACA CGAACAA GAACAAG AACAAGA ACAAGAC CAAGACT AAGACTG AGACTGG GACTGGG ACTGGGG CTGGGGC TGGGGCG GGGGCGC GGGCGCT GGCGCTG GCGCTGG CGCTGGT GCTGGTC CTGGTCC TGGTCCT GGTCCTG GTCCTGA TCCTGAC CCTGACC CTGACCA TGACCAC GACCACC ACCACCG CCACCGG CACCGGC ACCGGCA CCGGCAA CGGCAAC GGCAACA GCAACAA CAACAAG AACAAGT ACAAGTC CAAGTCG AAGTCGG AGTCGGA GTCGGAA TCGGAAA CGGAAAT GGAAATG GAAATGG AAATGGC AATGGCG ATGGCGG TGGCGGT GGCGGTC GCGGTCG CGGTCGG GGTCGGC GTCGGCT TCGGCTA CGGCTAC GGCTACT GCTACTG CTACTGC TACTGCA ACTGCAC CTGCACG TGCACGC GCACGCT CACGCTG ACGCTGT CGCTGTA GCTGTAC CTGTACG TGTACGG GTACGGC TACGGCG ACGGCGA CGGCGAC GGCGACA GCGACAT CGACATG GACATGG ACATGGC CATGGCT ATGGCTG TGGCTGG GGCTGGC,"ID   NADE_ACIAD              Reviewed;         541 AA.
AC   Q6F8K4;
DT   03-MAY-2023, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   05-FEB-2025, entry version 129.
DE   RecName: Full=Glutamine-dependent NAD(+) synthetase {ECO:0000255|HAMAP-Rule:MF_02090};
DE            EC=6.3.5.1 {ECO:0000255|HAMAP-Rule:MF_02090, ECO:0000269|PubMed:20926389};
DE   AltName: Full=NAD synthetase {ECO:0000303|PubMed:20926389};
DE   AltName: Full=NAD(+) synthase [glutamine-hydrolyzing] {ECO:0000255|HAMAP-Rule:MF_02090};
GN   Name=nadE {ECO:0000255|HAMAP-Rule:MF_02090,
GN   ECO:0000303|PubMed:20926389};
GN   OrderedLocusNames=ACIAD2888 {ECO:0000312|EMBL:CAG69611.1};
OS   Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Moraxellales; Moraxellaceae;
OC   Acinetobacter.
OX   NCBI_TaxID=62977;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33305 / BD413 / ADP1;
RX   PubMed=15514110; DOI=10.1093/nar/gkh910;
RA   Barbe V., Vallenet D., Fonknechten N., Kreimeyer A., Oztas S., Labarre L.,
RA   Cruveiller S., Robert C., Duprat S., Wincker P., Ornston L.N.,
RA   Weissenbach J., Marliere P., Cohen G.N., Medigue C.;
RT   ""Unique features revealed by the genome sequence of Acinetobacter sp. ADP1,
RT   a versatile and naturally transformation competent bacterium."";
RL   Nucleic Acids Res. 32:5766-5779(2004).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RC   STRAIN=ATCC 33305 / BD413 / ADP1;
RX   PubMed=20926389; DOI=10.1074/jbc.m110.185629;
RA   Sorci L., Blaby I., De Ingeniis J., Gerdes S., Raffaelli N.,
RA   de Crecy Lagard V., Osterman A.;
RT   ""Genomics-driven reconstruction of acinetobacter NAD metabolism: insights
RT   for antibacterial target selection."";
RL   J. Biol. Chem. 285:39490-39499(2010).
CC   -!- FUNCTION: Catalyzes the ATP-dependent amidation of deamido-NAD to form
CC       NAD. Uses L-glutamine as a nitrogen source (PubMed:20926389). In vitro,
CC       can also use ammonia as donor with comparable specific activity, but
CC       cannot use nicotinate mononucleotide (NaMN) as substrate
CC       (PubMed:20926389). {ECO:0000269|PubMed:20926389}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=deamido-NAD(+) + L-glutamine + ATP + H2O = L-glutamate + AMP +
CC         diphosphate + NAD(+) + H(+); Xref=Rhea:RHEA:24384, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57540, ChEBI:CHEBI:58359,
CC         ChEBI:CHEBI:58437, ChEBI:CHEBI:456215; EC=6.3.5.1;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02090,
CC         ECO:0000269|PubMed:20926389};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24385;
CC         Evidence={ECO:0000269|PubMed:20926389};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.017 mM for deamido-NAD {ECO:0000269|PubMed:20926389};
CC         KM=4.3 mM for nicotinate mononucleotide
CC         {ECO:0000269|PubMed:20926389};
CC         Note=kcat is 0.57 sec(-1) with deamido-NAD as substrate. kcat is
CC         0.0032 sec(-1) with nicotinate mononucleotide as substrate.
CC         {ECO:0000269|PubMed:20926389};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from
CC       deamido-NAD(+) (L-Gln route): step 1/1. {ECO:0000255|HAMAP-
CC       Rule:MF_02090, ECO:0000269|PubMed:20926389}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NAD synthetase
CC       family. {ECO:0000255|HAMAP-Rule:MF_02090}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR543861; CAG69611.1; -; Genomic_DNA.
DR   RefSeq; WP_004929407.1; NC_005966.1.
DR   AlphaFoldDB; Q6F8K4; -.
DR   SMR; Q6F8K4; -.
DR   STRING; 202950.GCA_001485005_03068; -.
DR   GeneID; 45235119; -.
DR   KEGG; aci:ACIAD2888; -.
DR   eggNOG; COG0171; Bacteria.
DR   eggNOG; COG0388; Bacteria.
DR   HOGENOM; CLU_022313_2_0_6; -.
DR   OrthoDB; 9760188at2; -.
DR   BioCyc; ASP62977:ACIAD_RS13020-MONOMER; -.
DR   UniPathway; UPA00253; UER00334.
DR   Proteomes; UP000000430; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004359; F:glutaminase activity; IEA:InterPro.
DR   GO; GO:0003952; F:NAD+ synthase (glutamine-hydrolyzing) activity; IEA:UniProtKB-EC.
DR   GO; GO:0008795; F:NAD+ synthase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd07570; GAT_Gln-NAD-synth; 1.
DR   CDD; cd00553; NAD_synthase; 1.
DR   FunFam; 3.40.50.620:FF:000106; Glutamine-dependent NAD(+) synthetase; 1.
DR   Gene3D; 3.60.110.10; Carbon-nitrogen hydrolase; 1.
DR   Gene3D; 3.40.50.620; HUPs; 1.
DR   HAMAP; MF_02090; NadE_glutamine_dep; 1.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   InterPro; IPR036526; C-N_Hydrolase_sf.
DR   InterPro; IPR014445; Gln-dep_NAD_synthase.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR003694; NAD_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   NCBIfam; TIGR00552; nadE; 1.
DR   PANTHER; PTHR23090:SF9; GLUTAMINE-DEPENDENT NAD(+) SYNTHETASE; 1.
DR   PANTHER; PTHR23090; NH 3 /GLUTAMINE-DEPENDENT NAD + SYNTHETASE; 1.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   PIRSF; PIRSF006630; NADS_GAT; 1.
DR   SUPFAM; SSF52402; Adenine nucleotide alpha hydrolases-like; 1.
DR   SUPFAM; SSF56317; Carbon-nitrogen hydrolase; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Ligase; NAD; Nucleotide-binding.
FT   CHAIN           1..541
FT                   /note=""Glutamine-dependent NAD(+) synthetase""
FT                   /id=""PRO_0000457835""
FT   DOMAIN          4..243
FT                   /note=""CN hydrolase""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   ACT_SITE        44
FT                   /note=""Proton acceptor; for glutaminase activity""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   ACT_SITE        111
FT                   /note=""For glutaminase activity""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   ACT_SITE        147
FT                   /note=""Nucleophile; for glutaminase activity""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         117
FT                   /ligand=""L-glutamine""
FT                   /ligand_id=""ChEBI:CHEBI:58359""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         173
FT                   /ligand=""L-glutamine""
FT                   /ligand_id=""ChEBI:CHEBI:58359""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         179
FT                   /ligand=""L-glutamine""
FT                   /ligand_id=""ChEBI:CHEBI:58359""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         286..293
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         369
FT                   /ligand=""deamido-NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58437""
FT                   /ligand_note=""ligand shared between two neighboring
FT                   subunits""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         393
FT                   /ligand=""ATP""
FT                   /ligand_id=""ChEBI:CHEBI:30616""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         398
FT                   /ligand=""deamido-NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58437""
FT                   /ligand_note=""ligand shared between two neighboring
FT                   subunits""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
FT   BINDING         510
FT                   /ligand=""deamido-NAD(+)""
FT                   /ligand_id=""ChEBI:CHEBI:58437""
FT                   /ligand_note=""ligand shared between two neighboring
FT                   subunits""
FT                   /evidence=""ECO:0000255|HAMAP-Rule:MF_02090""
SQ   SEQUENCE   541 AA;  60778 MW;  7C517C76DEA00650 CRC64;
     MKSFKIALAQ FSPHIGNIDS NAQRMVEQAN EAKKQNADLI IFPELSVIGY PAEDLLLRPN
     LNKRMQKAFQ QLKEVKDIVM VFGFVHQTEE GHRYNSAAVM KDGVVLGVYN KHNLPNYSVF
     DEKRYFSPGH QHLVFEYLGH KFGVLICEDI WSINTVKQLS KLNVETVLVL NASPYEVGKP
     QHRVQTLTEL SKQLNVHLVY LNQVGGQDDL IFDGSSFIIN HDGEVAFQAP SFKEELYYSE
     FDIEQKRYKK IDPAPALDTI AEIYQSLVMA TRDYVQRSGF SGVILGLSGG IDSALTLAIA
     ADAIGADKVQ AVMMPYTYTS QISVEDATEQ ARRMGVTFGI AEIHPIVNSF MQTLYPFFGN
     APADATEENL QARARGTLLM GLSNKFGNLV LSTGNKSELA VGYCTLYGDM VGGFAVLKDV
     YKTIVFELAK YRNTLSETPV IPERVITRPP SAELRPDQKD QDSLPAYDIL DAILYAYIEE
     DQSQSDIIAK GFDKEVVEKV IRLVDRNEYK RRQGAIGPRI SSRAFSRERR YPIVNGWRPD
     D
//
",2122
GTGGGC TGGGCT GGGCTT GGCTTC GCTTCT CTTCTC TTCTCG TCTCGG CTCGGT TCGGTG CGGTGG GGTGGC GTGGCC TGGCCT GGCCTT GCCTTC CCTTCG CTTCGC TTCGCC TCGCCT CGCCTT GCCTTC CCTTCG CTTCGC TTCGCC TCGCCA CGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGG TGCGGC GCGGCC CGGCCC GGCCCT GCCCTG CCCTGC CCTGCT CTGCTG TGCTGT GCTGTC CTGTCC TGTCCG GTCCGG TCCGGC CCGGCC CGGCCG GGCCGC GCCGCC CCGCCT CGCCTC GCCTCG CCTCGA CTCGAT TCGATG CGATGC GATGCC ATGCCG TGCCGC GCCGCC CCGCCT CGCCTG GCCTGG CCTGGG CTGGGC TGGGCG GGGCGC GGCGCG GCGCGC CGCGCT GCGCTG CGCTGG GCTGGT CTGGTC TGGTCA GGTCAC GTCACG TCACGC CACGCC ACGCCC CGCCCG GCCCGT CCCGTG CCGTGG CGTGGA GTGGAC TGGACG GGACGA GACGAC ACGACC CGACCG GACCGC ACCGCT CCGCTG CGCTGC GCTGCG,2,97,GTGG TGGG GGGC GGCT GCTT CTTC TTCT TCTC CTCG TCGG CGGT GGTG GTGG TGGC GGCC GCCT CCTT CTTC TTCG TCGC CGCC GCCT CCTT CTTC TTCG TCGC CGCC GCCA CCAT CATT ATTG TTGC TGCG GCGG CGGC GGCC GCCC CCCT CCTG CTGC TGCT GCTG CTGT TGTC GTCC TCCG CCGG CGGC GGCC GCCG CCGC CGCC GCCT CCTC CTCG TCGA CGAT GATG ATGC TGCC GCCG CCGC CGCC GCCT CCTG CTGG TGGG GGGC GGCG GCGC CGCG GCGC CGCT GCTG CTGG TGGT GGTC GTCA TCAC CACG ACGC CGCC GCCC CCCG CCGT CGTG GTGG TGGA GGAC GACG ACGA CGAC GACC ACCG CCGC CGCT GCTG CTGC TGCG,GTGGG TGGGC GGGCT GGCTT GCTTC CTTCT TTCTC TCTCG CTCGG TCGGT CGGTG GGTGG GTGGC TGGCC GGCCT GCCTT CCTTC CTTCG TTCGC TCGCC CGCCT GCCTT CCTTC CTTCG TTCGC TCGCC CGCCA GCCAT CCATT CATTG ATTGC TTGCG TGCGG GCGGC CGGCC GGCCC GCCCT CCCTG CCTGC CTGCT TGCTG GCTGT CTGTC TGTCC GTCCG TCCGG CCGGC CGGCC GGCCG GCCGC CCGCC CGCCT GCCTC CCTCG CTCGA TCGAT CGATG GATGC ATGCC TGCCG GCCGC CCGCC CGCCT GCCTG CCTGG CTGGG TGGGC GGGCG GGCGC GCGCG CGCGC GCGCT CGCTG GCTGG CTGGT TGGTC GGTCA GTCAC TCACG CACGC ACGCC CGCCC GCCCG CCCGT CCGTG CGTGG GTGGA TGGAC GGACG GACGA ACGAC CGACC GACCG ACCGC CCGCT CGCTG GCTGC CTGCG,GTGGGC TGGGCT GGGCTT GGCTTC GCTTCT CTTCTC TTCTCG TCTCGG CTCGGT TCGGTG CGGTGG GGTGGC GTGGCC TGGCCT GGCCTT GCCTTC CCTTCG CTTCGC TTCGCC TCGCCT CGCCTT GCCTTC CCTTCG CTTCGC TTCGCC TCGCCA CGCCAT GCCATT CCATTG CATTGC ATTGCG TTGCGG TGCGGC GCGGCC CGGCCC GGCCCT GCCCTG CCCTGC CCTGCT CTGCTG TGCTGT GCTGTC CTGTCC TGTCCG GTCCGG TCCGGC CCGGCC CGGCCG GGCCGC GCCGCC CCGCCT CGCCTC GCCTCG CCTCGA CTCGAT TCGATG CGATGC GATGCC ATGCCG TGCCGC GCCGCC CCGCCT CGCCTG GCCTGG CCTGGG CTGGGC TGGGCG GGGCGC GGCGCG GCGCGC CGCGCT GCGCTG CGCTGG GCTGGT CTGGTC TGGTCA GGTCAC GTCACG TCACGC CACGCC ACGCCC CGCCCG GCCCGT CCCGTG CCGTGG CGTGGA GTGGAC TGGACG GGACGA GACGAC ACGACC CGACCG GACCGC ACCGCT CCGCTG CGCTGC GCTGCG,GTGGGCT TGGGCTT GGGCTTC GGCTTCT GCTTCTC CTTCTCG TTCTCGG TCTCGGT CTCGGTG TCGGTGG CGGTGGC GGTGGCC GTGGCCT TGGCCTT GGCCTTC GCCTTCG CCTTCGC CTTCGCC TTCGCCT TCGCCTT CGCCTTC GCCTTCG CCTTCGC CTTCGCC TTCGCCA TCGCCAT CGCCATT GCCATTG CCATTGC CATTGCG ATTGCGG TTGCGGC TGCGGCC GCGGCCC CGGCCCT GGCCCTG GCCCTGC CCCTGCT CCTGCTG CTGCTGT TGCTGTC GCTGTCC CTGTCCG TGTCCGG GTCCGGC TCCGGCC CCGGCCG CGGCCGC GGCCGCC GCCGCCT CCGCCTC CGCCTCG GCCTCGA CCTCGAT CTCGATG TCGATGC CGATGCC GATGCCG ATGCCGC TGCCGCC GCCGCCT CCGCCTG CGCCTGG GCCTGGG CCTGGGC CTGGGCG TGGGCGC GGGCGCG GGCGCGC GCGCGCT CGCGCTG GCGCTGG CGCTGGT GCTGGTC CTGGTCA TGGTCAC GGTCACG GTCACGC TCACGCC CACGCCC ACGCCCG CGCCCGT GCCCGTG CCCGTGG CCGTGGA CGTGGAC GTGGACG TGGACGA GGACGAC GACGACC ACGACCG CGACCGC GACCGCT ACCGCTG CCGCTGC CGCTGCG,"ID   CCMF_PSEFL              Reviewed;         660 AA.
AC   P52225;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   24-JAN-2024, entry version 78.
DE   RecName: Full=Cytochrome c-type biogenesis protein CcmF;
DE   AltName: Full=Cytochrome c-type biogenesis protein CycK;
GN   Name=ccmF; Synonyms=cycK;
OS   Pseudomonas fluorescens.
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=294;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=09906;
RA   Yang C.H., Azad H.R., Cooksey D.A.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Required for the biogenesis of c-type cytochromes. Possible
CC       subunit of a heme lyase (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the CcmF/CycK/Ccl1/NrfE/CcsA family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U44827; AAC44226.1; -; Genomic_DNA.
DR   AlphaFoldDB; P52225; -.
DR   SMR; P52225; -.
DR   eggNOG; COG1138; Bacteria.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0015232; F:heme transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0017004; P:cytochrome complex assembly; IEA:UniProtKB-KW.
DR   InterPro; IPR032523; CcmF_C.
DR   InterPro; IPR002541; Cyt_c_assembly.
DR   InterPro; IPR003567; Cyt_c_biogenesis.
DR   InterPro; IPR003568; Cyt_c_biogenesis_CcmF.
DR   NCBIfam; TIGR00353; nrfE; 1.
DR   PANTHER; PTHR43653; CYTOCHROME C ASSEMBLY PROTEIN-RELATED; 1.
DR   PANTHER; PTHR43653:SF1; CYTOCHROME C-TYPE BIOGENESIS PROTEIN CCMF; 1.
DR   Pfam; PF16327; CcmF_C; 1.
DR   Pfam; PF01578; Cytochrom_C_asm; 1.
DR   PRINTS; PR01410; CCBIOGENESIS.
DR   PRINTS; PR01411; CCMFBIOGNSIS.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Cytochrome c-type biogenesis; Membrane;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..660
FT                   /note=""Cytochrome c-type biogenesis protein CcmF""
FT                   /id=""PRO_0000201586""
FT   TRANSMEM        15..35
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        49..69
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        99..119
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        126..146
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        181..201
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        216..236
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        250..270
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        279..299
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        318..338
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        360..380
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        395..415
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        426..446
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        450..470
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        493..513
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
FT   TRANSMEM        618..638
FT                   /note=""Helical""
FT                   /evidence=""ECO:0000255""
SQ   SEQUENCE   660 AA;  72172 MW;  3C6F4B578C56436B CRC64;
     MTSALFIPEL GQLRMILALC FAVVQAVVPL LGAWPGDRLW MSLAQPARWG QFAFLLFAFG
     CLTYAFMTDD FSVAYVANNS NSALPWYYLF SAVWGAHEGS LLLWALILGG WTFAVSVFSR
     QLPQVMLARV LAVMGMISIG FLLFLIMTSN PFSRMLPQIP ADGHDLNPLL QDIGLIVHPP
     MLYMGYVGFS VAFAFAIAAL LGGRLDAAWA RWSRPWTIVA WAFLGIGITL GSWWAYYELG
     WGGWWFWDPV ENASFMPWLV GTALIHSLAV TEKRGVFKSW TVLLAIAAFS LTLLAAFLVR
     SGVLTSVHAF ASDPERGVFI LIFLLFVVGG SLTLFVRAPV VKSQVGFNLW SRETLLLGNN
     LVLVVAASMI LLGTLYPLVL DALSGAKLSV GPPYFNALFI PLMGLLMVVM AVGVLVRWKD
     TPVKWLVGML APVLLGSVAL AVVAGIAYGD FNWAVLATFL LAAWVLLAGV RDIFDKTRHK
     GLLKGLPTLT RSYWGMQIAH IGIAVCALGV VLSSQNSAER DLRLAPGESM DLAGYHFIFE
     GAKHFEGPNF TSDKGTVRVV RNGKEIAVLH PEKRLYTVQS SMMTEAGIDA GFTRDLYVAL
     GEPLGDGAWA VRVHVKPFVR WIWFGGLLTG FGGLLAALDR RYRVKVKSRV REALGMGAAV
//
",60566
